Citrus Sinensis ID: 008504
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 563 | 2.2.26 [Sep-21-2011] | |||||||
| Q6EU49 | 612 | Probable serine/threonine | yes | no | 0.898 | 0.826 | 0.491 | 1e-132 | |
| Q8S8Y8 | 567 | Probable serine/threonine | yes | no | 0.568 | 0.564 | 0.612 | 1e-116 | |
| Q8LST2 | 557 | Probable serine/threonine | no | no | 0.570 | 0.576 | 0.613 | 1e-114 | |
| Q944Q0 | 563 | Serine/threonine-protein | no | no | 0.589 | 0.589 | 0.610 | 1e-106 | |
| Q8RXE5 | 524 | Probable serine/threonine | no | no | 0.564 | 0.606 | 0.621 | 1e-102 | |
| Q0D598 | 704 | Probable serine/threonine | no | no | 0.564 | 0.451 | 0.543 | 1e-100 | |
| A2YMV6 | 704 | Probable serine/threonine | N/A | no | 0.564 | 0.451 | 0.543 | 1e-100 | |
| Q9STK6 | 516 | Probable serine/threonine | no | no | 0.520 | 0.567 | 0.534 | 2e-97 | |
| Q9CAV6 | 700 | Serine/threonine-protein | no | no | 0.589 | 0.474 | 0.498 | 3e-96 | |
| Q65X23 | 621 | Probable serine/threonine | no | no | 0.564 | 0.512 | 0.538 | 4e-96 |
| >sp|Q6EU49|WNK4_ORYSJ Probable serine/threonine-protein kinase WNK4 OS=Oryza sativa subsp. japonica GN=WNK4 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 473 bits (1218), Expect = e-132, Method: Compositional matrix adjust.
Identities = 276/562 (49%), Positives = 349/562 (62%), Gaps = 56/562 (9%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 60
+ITELFTSG+LRQYR+KH VD+K IKNWARQ+L GL YLH+H PPIIHRDLKCDNIFVN
Sbjct: 103 VITELFTSGSLRQYRQKHPRVDLKAIKNWARQVLRGLDYLHTHQPPIIHRDLKCDNIFVN 162
Query: 61 GNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTF 120
GNHGEVKIGDLGLA M P A+SVIGTPEFMAPELY+E Y+ELVDIYSFGMC+LEM T
Sbjct: 163 GNHGEVKIGDLGLATVMLTPRAKSVIGTPEFMAPELYDENYDELVDIYSFGMCMLEMFTL 222
Query: 121 EYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDLLKDPFL 180
EYPYSEC N AQIFKKV+ G+KPA+LAK+ + Q K FI+KCLVPASERLSAK+LL+DPFL
Sbjct: 223 EYPYSECTNAAQIFKKVSKGVKPAALAKITNIQAKQFIDKCLVPASERLSAKELLQDPFL 282
Query: 181 QVENQKEPICDPLKLPIQSLKMLRLPMSGPSSMDIDSDYKQLSLSTCTESNNGSPHCPVL 240
+N + K P K + + + MD+D++ + + STC ++ G PH VL
Sbjct: 283 CSDNSS--VLVGTKFPSSLPKSVDVSLEAL-HMDVDTN-ESMCTSTCKRNDLGGPHRSVL 338
Query: 241 EFQRMHKNNEFRLRGTKNDDTSVSLTLRIADSSGRVRNIHFLFYLDSDTALSVAGEMVEQ 300
EF R +KN E +L G K DD SVSL LRIAD G RNIHFLFYLDSDTA+SVA EMVEQ
Sbjct: 339 EFTRTNKNTELKLTGEKLDDNSVSLVLRIADLCGHARNIHFLFYLDSDTAMSVAAEMVEQ 398
Query: 301 LDLADHDVAFIAEFIDYLIMKLLPGWKPSYDYSSSGALSFYSVSPILGNGKTSTPSPWDA 360
L+LAD DV FIA+FID LI+ L+PG + D A+ S +G + S
Sbjct: 399 LELADCDVTFIADFIDLLIVNLVPGQQLMND-----AVMSTSSESKMGESEHVITSQQH- 452
Query: 361 MGAGVPSEFVVKQDVVSGPTRNPSQDLAPAQG-ENLHDNAGGGGISSPSLAKLEDQESQS 419
PSE +V G + + +P+ ++L + GG S
Sbjct: 453 -----PSELTHDYVLVEGMMHSKEANASPSDYIDSLLNATNLGG-------------PNS 494
Query: 420 SVASDIFVD-DTSTKNDKASEFSDYSTDRSYKDL--NGYVSELELGDLCYDECKLQGNYS 476
S SDI V D S+K+ S+Y D Y+ L Y +LG C+ S
Sbjct: 495 SEGSDISVQLDGSSKS-----LSEYGVDE-YRTLECGAYKGTDKLG------CR--HPLS 540
Query: 477 EDGEDILLYQFVKNSKLTFPNLSTVLSLTSSYSSLSLTGKDVDELKMEIDAIEAQYEHWF 536
+ ++Q + S + + +S+T ++ D L E+ IEAQYE WF
Sbjct: 541 NGSSNFAIFQMDQASHHSELVIGASVSIT----------ENRDVLNGELGLIEAQYEQWF 590
Query: 537 QELSKMKEEALEASRKRWMAKK 558
+EL++M+EEALE +RK+W+ K
Sbjct: 591 RELTRMREEALEGARKKWLPDK 612
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q8S8Y8|WNK6_ARATH Probable serine/threonine-protein kinase WNK6 OS=Arabidopsis thaliana GN=WNK6 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 419 bits (1077), Expect = e-116, Method: Compositional matrix adjust.
Identities = 209/341 (61%), Positives = 253/341 (74%), Gaps = 21/341 (6%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 60
+ITELFTSG+LR YRKKH+ V++K +KNWARQIL GL YLH PPIIHRDLKCDNIF+N
Sbjct: 106 IITELFTSGSLRHYRKKHRKVNMKAVKNWARQILMGLRYLHGQEPPIIHRDLKCDNIFIN 165
Query: 61 GNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTF 120
GNHGEVKIGDLGLA M+Q A+SVIGTPEFMAPELY+E YNEL DIYSFGMC+LEMVTF
Sbjct: 166 GNHGEVKIGDLGLATVMEQANAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEMVTF 225
Query: 121 EYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDLLKDPFL 180
+YPY ECKN AQI+KKV+SGIKPASL++V DP++K FIEKCL+PASERLSAK+LL DPFL
Sbjct: 226 DYPYCECKNSAQIYKKVSSGIKPASLSRVKDPEVKQFIEKCLLPASERLSAKELLLDPFL 285
Query: 181 QVENQKEPICDPLKLP-----------IQSLKMLRLPMSGPS---SMDIDSDYKQLSLST 226
Q+ + +PL LP + L P + PS S+D+D D +L
Sbjct: 286 QLNGLT--MNNPLPLPDIVMPKEGAFGDRCLMSEGPPTTRPSKTLSIDLDEDS---NLPI 340
Query: 227 CTESNNGSPHCPVLEFQRMHKNNEFRLRGTKNDDTSVSLTLRIADSSGRVRNIHFLFYLD 286
T S+N C +E +R + N F L+G +ND+ SVSL LRI D +GRVRNIHFLFY +
Sbjct: 341 VTFSDNSGSRC--IEVRRAKRGNFFVLKGEENDEQSVSLILRIVDENGRVRNIHFLFYQE 398
Query: 287 SDTALSVAGEMVEQLDLADHDVAFIAEFIDYLIMKLLPGWK 327
DTA V+ EMVEQL+L D +V FIAE ID L++ ++P WK
Sbjct: 399 GDTASKVSSEMVEQLELTDQNVTFIAELIDILLVNMIPTWK 439
|
May regulate flowering time by modulating the photoperiod pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8LST2|WNK7_ARATH Probable serine/threonine-protein kinase WNK7 OS=Arabidopsis thaliana GN=WNK7 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 414 bits (1064), Expect = e-114, Method: Compositional matrix adjust.
Identities = 208/339 (61%), Positives = 254/339 (74%), Gaps = 18/339 (5%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 60
+ITELFTSG+LRQYRKKH+ V++K +K WARQIL GL YLHS +PPIIHRD+KCDNIF+N
Sbjct: 106 IITELFTSGSLRQYRKKHRKVNMKAVKCWARQILTGLKYLHSQDPPIIHRDIKCDNIFIN 165
Query: 61 GNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTF 120
GNHGEVKIGDLGLA M+Q A+SVIGTPEFMAPELY+E YNEL DIYSFGMC+LEMVTF
Sbjct: 166 GNHGEVKIGDLGLATVMEQANAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEMVTF 225
Query: 121 EYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDLLKDPFL 180
EYPY EC+N AQI+KKV+SGIKPASL+KV DP++ FIEKCL+PASERLSA++LL D FL
Sbjct: 226 EYPYCECRNSAQIYKKVSSGIKPASLSKVKDPEVMKFIEKCLLPASERLSAEELLLDSFL 285
Query: 181 QVE----NQKEPICDPLKLPIQSLKMLRLPMS-GPS-------SMDIDSDYKQLSLSTCT 228
V N P+ D + +P + R MS GP SM++D D +L
Sbjct: 286 NVNGLVMNNPLPLPD-IVMPKEGSFGERCLMSEGPPNARNRTMSMNLDEDN---NLPIVI 341
Query: 229 ESNNGSPHCPVLEFQRMHKNNEFRLRGTKNDDTSVSLTLRIADSSGRVRNIHFLFYLDSD 288
SNN +C +E +R + N F L+G +ND+ SVSL LRI D +GRVRNIHFLF+ + D
Sbjct: 342 SSNNSGTNC--IEVRRAKRGNFFVLKGEENDENSVSLILRIVDENGRVRNIHFLFFQEGD 399
Query: 289 TALSVAGEMVEQLDLADHDVAFIAEFIDYLIMKLLPGWK 327
TA +V+ EMVEQL+L D +V FIAE ID L++ L+P WK
Sbjct: 400 TASNVSSEMVEQLELTDKNVKFIAELIDVLLVNLIPNWK 438
|
May regulate flowering time by modulating the photoperiod pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q944Q0|WNK8_ARATH Serine/threonine-protein kinase WNK8 OS=Arabidopsis thaliana GN=WNK8 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 386 bits (991), Expect = e-106, Method: Compositional matrix adjust.
Identities = 207/339 (61%), Positives = 246/339 (72%), Gaps = 7/339 (2%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 60
MITELFTSG+LR YRKKH+ VD K IKNWARQIL GL YLHS NPP+IHRDLKCDNIFVN
Sbjct: 107 MITELFTSGSLRVYRKKHRKVDPKAIKNWARQILKGLNYLHSQNPPVIHRDLKCDNIFVN 166
Query: 61 GNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTF 120
GN GEVKIGDLGLA +QQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMC+LEMVT
Sbjct: 167 GNTGEVKIGDLGLATVLQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCMLEMVTC 226
Query: 121 EYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDLLKDPFL 180
EYPY+EC+N AQI+KKVTS IKP SL KV+DPQ++ FIEKCL+PAS R +A +L KDPFL
Sbjct: 227 EYPYNECRNQAQIYKKVTSNIKPQSLGKVDDPQVRQFIEKCLLPASSRPTALELSKDPFL 286
Query: 181 QVENQKEPICDPLKLPIQSLKMLRLPMSGPSSMDIDSDYKQLSLSTCTESNNGSPHCPVL 240
+ K+ L S K +R P MD+D + + SN P +
Sbjct: 287 ARDGGKDSAL--LASSSTSSKYVRPPQLEHLPMDVDHNENK-----SVSSNEDYPWSQTI 339
Query: 241 EFQRMHKNNEFRLRGTKNDDTSVSLTLRIADSSGRVRNIHFLFYLDSDTALSVAGEMVEQ 300
E QR+ +N EFRLRG ++DD + S+ LRIAD SG+ R +HF FYL+SDTA ++A EMVE+
Sbjct: 340 ELQRIAENKEFRLRGERSDDVTASMVLRIADPSGKCRIVHFAFYLESDTATAIAEEMVEE 399
Query: 301 LDLADHDVAFIAEFIDYLIMKLLPGWKPSYDYSSSGALS 339
L L +V IA+ ID IM+LL S+ +S L+
Sbjct: 400 LHLTSQEVVVIADMIDDFIMQLLSDRTSSHHNQNSPRLT 438
|
Regulates flowering time by modulating the photoperiod pathway. Phosphorylates the vacuolar ATPase subunit C (VATC). Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8RXE5|WNK10_ARATH Probable serine/threonine-protein kinase WNK10 OS=Arabidopsis thaliana GN=WNK10 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 372 bits (955), Expect = e-102, Method: Compositional matrix adjust.
Identities = 202/325 (62%), Positives = 237/325 (72%), Gaps = 7/325 (2%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 60
MITELFTSG+L YRKKH+ VD K I NWARQIL GL YLHS PP+IHRDLKCDNIFVN
Sbjct: 94 MITELFTSGSLTLYRKKHRKVDPKAIMNWARQILKGLHYLHSQTPPVIHRDLKCDNIFVN 153
Query: 61 GNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTF 120
GN G+VKIGDLGLA MQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMC+LEMVT
Sbjct: 154 GNTGKVKIGDLGLAAVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCMLEMVTC 213
Query: 121 EYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDLLKDPFL 180
EYPY EC+N AQI+KKVTSGIKP SL+KV+DPQ+K FIEKCL+PA R +A +LLKD L
Sbjct: 214 EYPYRECRNQAQIYKKVTSGIKPQSLSKVDDPQVKQFIEKCLLPAPSRPTALELLKDQLL 273
Query: 181 QVENQKEPICDPLKLPIQSLKMLRLPMSGPSSMDIDSDYKQLSLSTCTESNNGSPHCPVL 240
V+ K+ + K P MD++ K S+S C+ S S C +L
Sbjct: 274 AVDGAKDSTLTA--SSNTTFKPAMPPQCEYRPMDVEYK-KNTSVSICS-SAKSSQECALL 329
Query: 241 ---EFQRMHKNNEFRLRGTKNDDTSVSLTLRIADSSGRVRNIHFLFYLDSDTALSVAGEM 297
E QR+ ++ EF+L G + DD + S+ LRIA SSG+ R + F F L +DTA +V GEM
Sbjct: 330 QTMEVQRVAESTEFKLSGERRDDVAASMALRIAGSSGQARKVDFDFNLKTDTARAVTGEM 389
Query: 298 VEQLDLADHDVAFIAEFIDYLIMKL 322
VE+LDL+ H+V IAE ID LIMKL
Sbjct: 390 VEELDLSSHEVTVIAEMIDELIMKL 414
|
May regulate flowering time by modulating the photoperiod pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q0D598|WNK1_ORYSJ Probable serine/threonine-protein kinase WNK1 OS=Oryza sativa subsp. japonica GN=WNK1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 367 bits (943), Expect = e-100, Method: Compositional matrix adjust.
Identities = 189/348 (54%), Positives = 234/348 (67%), Gaps = 30/348 (8%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 60
ITE+FTSG LRQYR+KH V+I +K+W RQIL GL+YLHSH+PPIIHRDLKCDNIFVN
Sbjct: 105 FITEMFTSGTLRQYRQKHMRVNIWAVKHWCRQILSGLLYLHSHDPPIIHRDLKCDNIFVN 164
Query: 61 GNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTF 120
GN GEVKIGDLGLA +++ A +GTPEFMAPE+YEEEYNELVDIYSFGMC+LEMVTF
Sbjct: 165 GNQGEVKIGDLGLAAILRKSHAVHCVGTPEFMAPEVYEEEYNELVDIYSFGMCVLEMVTF 224
Query: 121 EYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDLLKDPFL 180
EYPYSEC +P QI+KKV SG KP +L KV DP ++ F+EKCL AS RLSA++LLKDPFL
Sbjct: 225 EYPYSECTHPVQIYKKVISGTKPEALYKVKDPMVRQFVEKCLATASRRLSARELLKDPFL 284
Query: 181 QVENQKEPICDPLKLPIQSLKMLRLP-----------MSGPSSMDIDSDYKQLSLSTCTE 229
QV++ + P + LR P MS S ID D C +
Sbjct: 285 QVDDL---VFCPGDGDYSLMNYLRQPYLEHAYSNVSMMSNGLSESIDEDTPTEDRWDCED 341
Query: 230 SN---------NGSPHCPVLEFQRMHKNNEFRLRGTKNDDTSVSLTLRIADSSGRVRNIH 280
+ NG P+ N + ++G K++D S+ L LRIAD+ G VRNI+
Sbjct: 342 DDIKADGIDLFNGHEDEPL-------GNVDITIKGRKSEDGSIFLRLRIADNDGHVRNIY 394
Query: 281 FLFYLDSDTALSVAGEMVEQLDLADHDVAFIAEFIDYLIMKLLPGWKP 328
F F +++DTALSVA EMV +LD+ DH+V IAE ID + L+P W+P
Sbjct: 395 FPFDIEADTALSVATEMVAELDITDHEVTRIAEMIDGEVSALVPDWRP 442
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|A2YMV6|WNK1_ORYSI Probable serine/threonine-protein kinase WNK1 OS=Oryza sativa subsp. indica GN=WNK1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 367 bits (943), Expect = e-100, Method: Compositional matrix adjust.
Identities = 189/348 (54%), Positives = 234/348 (67%), Gaps = 30/348 (8%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 60
ITE+FTSG LRQYR+KH V+I +K+W RQIL GL+YLHSH+PPIIHRDLKCDNIFVN
Sbjct: 105 FITEMFTSGTLRQYRQKHMRVNIWAVKHWCRQILSGLLYLHSHDPPIIHRDLKCDNIFVN 164
Query: 61 GNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTF 120
GN GEVKIGDLGLA +++ A +GTPEFMAPE+YEEEYNELVDIYSFGMC+LEMVTF
Sbjct: 165 GNQGEVKIGDLGLAAILRKSHAVHCVGTPEFMAPEVYEEEYNELVDIYSFGMCVLEMVTF 224
Query: 121 EYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDLLKDPFL 180
EYPYSEC +P QI+KKV SG KP +L KV DP ++ F+EKCL AS RLSA++LLKDPFL
Sbjct: 225 EYPYSECTHPVQIYKKVISGTKPEALYKVKDPMVRQFVEKCLATASRRLSARELLKDPFL 284
Query: 181 QVENQKEPICDPLKLPIQSLKMLRLP-----------MSGPSSMDIDSDYKQLSLSTCTE 229
QV++ + P + LR P MS S ID D C +
Sbjct: 285 QVDDL---VFCPGDGDYSLMNYLRQPYLEHAYSNVSMMSNGLSESIDEDTPTEDRWDCED 341
Query: 230 SN---------NGSPHCPVLEFQRMHKNNEFRLRGTKNDDTSVSLTLRIADSSGRVRNIH 280
+ NG P+ N + ++G K++D S+ L LRIAD+ G VRNI+
Sbjct: 342 DDIKADGIDLFNGHEDEPL-------GNVDITIKGRKSEDGSIFLRLRIADNDGHVRNIY 394
Query: 281 FLFYLDSDTALSVAGEMVEQLDLADHDVAFIAEFIDYLIMKLLPGWKP 328
F F +++DTALSVA EMV +LD+ DH+V IAE ID + L+P W+P
Sbjct: 395 FPFDIEADTALSVATEMVAELDITDHEVTRIAEMIDGEVSALVPDWRP 442
|
Oryza sativa subsp. indica (taxid: 39946) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9STK6|WNK3_ARATH Probable serine/threonine-protein kinase WNK3 OS=Arabidopsis thaliana GN=WNK3 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 356 bits (914), Expect = 2e-97, Method: Compositional matrix adjust.
Identities = 177/331 (53%), Positives = 225/331 (67%), Gaps = 38/331 (11%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 60
+ITE+FTSGNLRQYRKKHK VD++ +K W+RQIL GLVYLHSH+PP+IHRDLKCDNIF+N
Sbjct: 100 LITEVFTSGNLRQYRKKHKCVDLRALKKWSRQILEGLVYLHSHDPPVIHRDLKCDNIFIN 159
Query: 61 GNHGEVKIGDLGLAIAMQQP-TARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVT 119
GN GEVKIGDLGLA + + +A SVIGTPEFMAPELYEE+YN LVDIY+FGMC+LE+VT
Sbjct: 160 GNQGEVKIGDLGLAAILHRARSAHSVIGTPEFMAPELYEEDYNVLVDIYAFGMCLLELVT 219
Query: 120 FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDLLKDPF 179
FEYPYSEC N AQI++KVTSGIKPA+L V DPQ++ FIEKC+ S+RLSAK+LL DPF
Sbjct: 220 FEYPYSECTNAAQIYRKVTSGIKPAALLNVTDPQVRAFIEKCIAKVSQRLSAKELLDDPF 279
Query: 180 LQVENQKEPICDPLKLPIQSLKMLRLPMSGPSSMDIDSDYKQLSLSTCTESNNGSPHCPV 239
L+ YK+ + + + NG +
Sbjct: 280 LKC------------------------------------YKENTENVSSHKENGYNGNGI 303
Query: 240 LEFQRMHKNNEFRLRGTKNDDTSVSLTLRIADSSGRVRNIHFLFYLDSDTALSVAGEMVE 299
++ + + G + D ++ L LRI DS G++RNIHF F +++DT+ SVA EMVE
Sbjct: 304 VDKLSDSEVGLLTVEGQRKDLNTIFLKLRITDSKGQIRNIHFPFNIETDTSFSVAIEMVE 363
Query: 300 QLDLA-DHDVAFIAEFIDYLIMKLLPGWKPS 329
+LDL D D++ IA+ ID I +P W PS
Sbjct: 364 ELDLTDDQDISTIAKMIDTEIHSHIPDWTPS 394
|
May regulate flowering time by modulating the photoperiod pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9CAV6|WNK1_ARATH Serine/threonine-protein kinase WNK1 OS=Arabidopsis thaliana GN=WNK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 352 bits (904), Expect = 3e-96, Method: Compositional matrix adjust.
Identities = 185/371 (49%), Positives = 236/371 (63%), Gaps = 39/371 (10%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 60
+TELFTSG LRQYR +HK V+I+ +K+W RQIL GL YLHSH+PP+IHRDLKCDNIFVN
Sbjct: 102 FVTELFTSGTLRQYRLRHKRVNIRAMKHWCRQILRGLHYLHSHDPPVIHRDLKCDNIFVN 161
Query: 61 GNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTF 120
GN GEVKIGDLGLA +++ A +GTPEFMAPE+YEE YNELVDIYSFGMCILEMVTF
Sbjct: 162 GNQGEVKIGDLGLAAILRKSHAAHCVGTPEFMAPEVYEEAYNELVDIYSFGMCILEMVTF 221
Query: 121 EYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDLLKDPFL 180
+YPYSEC +PAQI+KKV SG KP +L KV DP++K FIEKCL S R+SA++LL DPFL
Sbjct: 222 DYPYSECTHPAQIYKKVMSGKKPDALYKVKDPEVKCFIEKCLATVSLRVSARELLDDPFL 281
Query: 181 QVEN-------------------QKEPICDPLKLPIQSLKMLRLPMSGPSSMDIDSDYKQ 221
++++ Q + D P S + R +G + S +Q
Sbjct: 282 RIDDGEFDLRSVDMEDSVGPLYRQPHHLPDYYNYPSNSSSLNRQYSNGNYPSNSSSLNRQ 341
Query: 222 LS--LSTCTESNNGSPHCPV------------------LEFQRMHKNNEFRLRGTKNDDT 261
S ++ E NG + P E ++ N + ++G + DD
Sbjct: 342 YSNGYNSHHEYQNGWAYNPAETEETHGIELFESRNNDDQEEEKKSGNVDITIKGKRRDDG 401
Query: 262 SVSLTLRIADSSGRVRNIHFLFYLDSDTALSVAGEMVEQLDLADHDVAFIAEFIDYLIMK 321
+ L LRIAD GRVRNI+F F +++DTALSVA EMV +LD+ DH V IA ID I
Sbjct: 402 GLFLRLRIADKEGRVRNIYFPFDIETDTALSVATEMVAELDMDDHGVTKIANMIDGEISS 461
Query: 322 LLPGWKPSYDY 332
L+P W+P ++
Sbjct: 462 LVPSWRPGPEF 472
|
Regulates flowering time by modulating the photoperiod pathway. Phosphorylates APRR3. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q65X23|WNK2_ORYSJ Probable serine/threonine-protein kinase WNK2 OS=Oryza sativa subsp. japonica GN=WNK2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 352 bits (904), Expect = 4e-96, Method: Compositional matrix adjust.
Identities = 181/336 (53%), Positives = 230/336 (68%), Gaps = 18/336 (5%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 60
ITE+FTSG LRQYR KHK VD++ +K W+RQIL GLVYLHSH+PP+IHRDLKCDNIFVN
Sbjct: 106 FITEVFTSGTLRQYRIKHKKVDVRALKKWSRQILSGLVYLHSHDPPVIHRDLKCDNIFVN 165
Query: 61 GNHGEVKIGDLGLAIAMQQP-TARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVT 119
GN GEVKIGDLGLA + +A S+IGTPEFMAPELY+EEYNELVDIY+FGMC+LE+VT
Sbjct: 166 GNQGEVKIGDLGLATILDNARSAHSIIGTPEFMAPELYDEEYNELVDIYAFGMCLLELVT 225
Query: 120 FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDLLKDPF 179
FEYPY EC N AQI+KKV+ G KP+SLAK+ DP+++ FIEKC+ AS+RLSA++LL DPF
Sbjct: 226 FEYPYCECSNAAQIYKKVSDGEKPSSLAKIEDPEVRFFIEKCIAKASQRLSAQELLMDPF 285
Query: 180 LQVENQKEPICDPLKLPIQS-LKMLRLPMSGPSSMDIDSDYKQLSLSTCTESNNGSPHCP 238
L+ + +K + P+QS K S SSM D S++ + + + P
Sbjct: 286 LRDDGEK------IFYPLQSNTKASDGAGSSNSSMGYKYDRDASSMAIREHTGSFAEEHP 339
Query: 239 VLEFQRMHKNNE--------FRLRGTKNDDTSVSLTLRIADSSGRVRNIHFLFYLDSDTA 290
+ +H + + D ++ L LRIADS+G +NIHF F +++DT+
Sbjct: 340 SDRY--IHSTMDPQAAAGRIITVESQMKDLNTIFLKLRIADSTGHAQNIHFPFDIEADTS 397
Query: 291 LSVAGEMVEQLDLADHDVAFIAEFIDYLIMKLLPGW 326
+SVA EMV QLDL D DV IAE ID I +P W
Sbjct: 398 ISVATEMVVQLDLTDQDVTAIAEMIDAEIRAHIPDW 433
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 563 | ||||||
| 255564615 | 693 | kinase, putative [Ricinus communis] gi|2 | 0.992 | 0.806 | 0.652 | 0.0 | |
| 351721887 | 710 | with no lysine kinase 6 [Glycine max] gi | 0.978 | 0.776 | 0.617 | 0.0 | |
| 356560001 | 723 | PREDICTED: LOW QUALITY PROTEIN: probable | 0.978 | 0.762 | 0.617 | 0.0 | |
| 449433018 | 663 | PREDICTED: probable serine/threonine-pro | 0.989 | 0.840 | 0.643 | 0.0 | |
| 225470964 | 625 | PREDICTED: probable serine/threonine-pro | 0.920 | 0.828 | 0.613 | 1e-175 | |
| 449478217 | 713 | PREDICTED: LOW QUALITY PROTEIN: probable | 0.960 | 0.758 | 0.631 | 1e-174 | |
| 356571256 | 581 | PREDICTED: LOW QUALITY PROTEIN: probable | 0.905 | 0.877 | 0.546 | 1e-158 | |
| 297745505 | 591 | unnamed protein product [Vitis vinifera] | 0.781 | 0.744 | 0.555 | 1e-151 | |
| 359474135 | 645 | PREDICTED: serine/threonine-protein kina | 0.936 | 0.817 | 0.534 | 1e-144 | |
| 224127975 | 425 | predicted protein [Populus trichocarpa] | 0.580 | 0.769 | 0.798 | 1e-143 |
| >gi|255564615|ref|XP_002523302.1| kinase, putative [Ricinus communis] gi|223537390|gb|EEF39018.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 682 bits (1759), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 374/573 (65%), Positives = 436/573 (76%), Gaps = 14/573 (2%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 60
MITELFTSGNLRQYRKKHKNVD+K IKNWARQIL GLVYLH HNPPIIHRDLKCDNIFVN
Sbjct: 119 MITELFTSGNLRQYRKKHKNVDMKAIKNWARQILQGLVYLHGHNPPIIHRDLKCDNIFVN 178
Query: 61 GNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTF 120
G++G VKIGDLGLAI MQQPTA SVIGTPEFMA ELYEEEYNEL+DIYSFGMC+LEMVTF
Sbjct: 179 GHNGVVKIGDLGLAIIMQQPTATSVIGTPEFMATELYEEEYNELIDIYSFGMCMLEMVTF 238
Query: 121 EYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDLLKDPFL 180
EYPYSEC+NPAQI+KKVTSGIKPASL V+DPQ+K FI KCLVPASERLSAK+LLKDPFL
Sbjct: 239 EYPYSECRNPAQIYKKVTSGIKPASLGNVSDPQVKEFILKCLVPASERLSAKELLKDPFL 298
Query: 181 QVENQKEPICDPLKLPIQSLKMLRLPMSGPSSMDIDSDYKQLSLSTCTESNNGSPHCPVL 240
Q +N EP+ DPL LP Q K SGP SMDID+DYKQ+S STCT SNN PV
Sbjct: 299 QPQNLVEPVRDPLLLPNQYPKSSSATKSGPLSMDIDADYKQISSSTCTGSNNEGTRFPVP 358
Query: 241 EFQRMHKNNEFRLRGTKNDDTSVSLTLRIADSSGRVRNIHFLFYLDSDTALSVAGEMVEQ 300
E+QR HKN F+L+G ++DD SVSLTLRIADSSGRV NIHFLFYLDSDTALSVA EMV+Q
Sbjct: 359 EYQREHKNKVFKLKGKESDDNSVSLTLRIADSSGRVWNIHFLFYLDSDTALSVASEMVDQ 418
Query: 301 LDLADHDVAFIAEFIDYLIMKLLPGWKPSYDYSSSGALSFYSVSPILGNGKTSTPSPWDA 360
L+LADHDVAFIAEFID+LIMKL PGWK S +YS + SFY+ S L N S PWD+
Sbjct: 419 LELADHDVAFIAEFIDHLIMKLSPGWKLSSNYSLNELTSFYTASAALEN---SVACPWDS 475
Query: 361 MGAGVPSEFVVKQDVVSGPTRNPSQDLAPAQGENLHDNAGGGGI-----SSPSLAKLEDQ 415
+ V S+ V+Q+ +SG T P + A N +DN G SSPS +EDQ
Sbjct: 476 VLTTVLSQPAVEQEALSGMTTTPPEGSLQADDFNYNDNRDGAVFHINYHSSPSFGYMEDQ 535
Query: 416 ESQSSVASDIFVDDTSTKNDKASEFSDYSTDRSYKDLNGYVSELELGDLCYDECKLQGNY 475
+SQ+S S+I V+D S+K+D+ SE DY+TD + K LNGY SE EL D Y KL+ N
Sbjct: 536 DSQTSGVSEILVEDVSSKDDRISELPDYNTDGNCKYLNGYTSEPELRD-SYSLRKLERND 594
Query: 476 SEDGEDILLYQFVKNSKLTFPNLSTV----LSLTSSYSSLSLTGKDVD-ELKMEIDAIEA 530
S GE I + + K S+ FP LS +SS SSL L GK +D ELK+E+DAIEA
Sbjct: 595 SGVGECIPMNENAKVSETPFPKLSGAPNDMSMTSSSSSSLYLVGKSMDTELKLELDAIEA 654
Query: 531 QYEHWFQELSKMKEEALEASRKRWMAKKRLPVN 563
QY++WF++LS+ +EEALE+++KRW AKK+LPV+
Sbjct: 655 QYQNWFRDLSRRREEALESTKKRWTAKKKLPVH 687
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|351721887|ref|NP_001235945.1| with no lysine kinase 6 [Glycine max] gi|225348641|gb|ACN87282.1| with no lysine kinase [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 676 bits (1744), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 349/565 (61%), Positives = 416/565 (73%), Gaps = 14/565 (2%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 60
MITELFTSGNLRQYRKKHK V++K IK WARQILHGLVYLHSH PPIIHRDLKCDNIFVN
Sbjct: 152 MITELFTSGNLRQYRKKHKYVEMKAIKGWARQILHGLVYLHSHKPPIIHRDLKCDNIFVN 211
Query: 61 GNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTF 120
GN GEVKIGDLGLAI MQQPTA+SVIGTPEFMAPELYEE Y ELVDIYSFGMCILEMVT
Sbjct: 212 GNQGEVKIGDLGLAIVMQQPTAQSVIGTPEFMAPELYEEAYTELVDIYSFGMCILEMVTL 271
Query: 121 EYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDLLKDPFL 180
EYPYSEC+NPAQIFKKVTSGIKPASL KV+DPQ+K FIEKCLVPASERLSA +LLKDPFL
Sbjct: 272 EYPYSECQNPAQIFKKVTSGIKPASLNKVSDPQLKDFIEKCLVPASERLSADELLKDPFL 331
Query: 181 QVENQKEPICDPLKLPIQSLKMLRLPMSGPSSMDIDSDYKQLSLSTCTESNNGSPHCPVL 240
QVEN K+PI PL+ P ++L+ SG SMD+DSDYK S+S +ESN +PHCP+
Sbjct: 332 QVENPKDPILYPLQPPSRTLRAYSFK-SGSLSMDMDSDYKPFSMSIYSESNQENPHCPIF 390
Query: 241 EFQRMHKNNEFRLRGTKNDDTSVSLTLRIADSSGRVRNIHFLFYLDSDTALSVAGEMVEQ 300
E QR +KNN+FRL+GTKND SVSLTLRIAD+ GRVRNIHFLFY D+DTA+SVA EMVE
Sbjct: 391 EVQRTYKNNKFRLKGTKNDVNSVSLTLRIADTCGRVRNIHFLFYPDTDTAVSVATEMVEH 450
Query: 301 LDLADHDVAFIAEFIDYLIMKLLPGWKPSYDYSSSGALSFYSVSPILGNGKTSTPSPWDA 360
L+LADHDV FIAE IDYLIMKLLP WKPS D+ S G LS Y + +G+T PW +
Sbjct: 451 LELADHDVDFIAELIDYLIMKLLPWWKPSPDHCSCGELSPYCTNI---DGQTLMAWPWGS 507
Query: 361 MGAGVPSEFVVKQDVVSGPTRNPSQDLAPAQGENLHDNAGG----GGISSPSLAKLEDQE 416
+ +PSE V+ QD SG P +D ++ ++ A G +S SL KLED+
Sbjct: 508 VSTSIPSELVIGQDGFSGSDTTPKEDFVVSENSSVSKIANNATFEGDCNSSSLVKLEDRY 567
Query: 417 SQSSVASDIFVDDTSTKNDKASEFSDYSTDRSYKDLNGYVSELELGDLCYDECKLQGNYS 476
SQ S AS++ +++TS KND + +D S EL D+ +++CKLQ
Sbjct: 568 SQGSRASEMIIENTSMKNDNCHDSND-----DLSSKCFSSSMSELRDVYFEDCKLQQTEY 622
Query: 477 EDGEDILLYQFVKNSKLTFPNLSTVLSLTSSYSSLSLTGKDVD-ELKMEIDAIEAQYEHW 535
GE +++ +F KNS V +L SS S +S T +D+D LK ++D IEA Y+HW
Sbjct: 623 CVGEGVVINEFPKNSGSVLGTSINVENLASSCSYVSSTEEDIDLGLKFKLDEIEAHYQHW 682
Query: 536 FQELSKMKEEALEASRKRWMAKKRL 560
EL++M EALE++R+RWMAKK+L
Sbjct: 683 IDELNEMMLEALESTRRRWMAKKKL 707
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356560001|ref|XP_003548284.1| PREDICTED: LOW QUALITY PROTEIN: probable serine/threonine-protein kinase WNK4-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 669 bits (1725), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 351/568 (61%), Positives = 419/568 (73%), Gaps = 17/568 (2%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 60
MITELFTSGNLR YRKKHK V++K IK WARQILHGLVYLHSH PPIIHRDLKCDNIFVN
Sbjct: 166 MITELFTSGNLRLYRKKHKYVEMKAIKGWARQILHGLVYLHSHRPPIIHRDLKCDNIFVN 225
Query: 61 GNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTF 120
GN GEVKIGDLGLA+ MQQPTA+SVIGTPEFMAPELYEE Y ELVDIYSFGMCILEMVT
Sbjct: 226 GNQGEVKIGDLGLAVVMQQPTAQSVIGTPEFMAPELYEEAYTELVDIYSFGMCILEMVTL 285
Query: 121 EYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDLLKDPFL 180
EYPYSECKNPAQIFKKVTSGIKPASL KV+DPQ+K FIEKCLVPASERLSA++LLKDPFL
Sbjct: 286 EYPYSECKNPAQIFKKVTSGIKPASLNKVSDPQLKEFIEKCLVPASERLSAEELLKDPFL 345
Query: 181 QVENQKEPICDPLKLPIQSLKMLRLPMSGPSSMDIDSDYKQLSLSTCTESNNGSPHCPVL 240
QVEN K+PI PL+ P ++L+ SG SMD+DSD K S+S C+ESN +PHCPV
Sbjct: 346 QVENPKDPILYPLQPPSRTLRAYSFK-SGSLSMDMDSDCKPFSMSICSESNQENPHCPVF 404
Query: 241 EFQRMHKNNEFRLRGTKNDDTSVSLTLRIADSSGRVRNIHFLFYLDSDTALSVAGEMVEQ 300
E QR + +EFRL+GTKNDD SVSLTLRIAD+ GRVRNIHFLFYLD+DTA+SVA EMVE
Sbjct: 405 EVQRTNNKHEFRLKGTKNDDNSVSLTLRIADTCGRVRNIHFLFYLDTDTAVSVATEMVEH 464
Query: 301 LDLADHDVAFIAEFIDYLIMKLLPGWKPSYDYSSSGALSFYSVSPILGNGKTSTPSPWDA 360
L+LADHDV FIAE IDYLIMKLLP WKPS D+ S G LS YS + I G PW +
Sbjct: 465 LELADHDVDFIAELIDYLIMKLLPWWKPSPDHFSCGELSPYSTN-IDGQW------PWGS 517
Query: 361 MGAGVPSEFVVKQDVVSGPTRNPSQDLAPAQGENLHDNAGG----GGISSPSLAKLEDQE 416
+ +PSE + QD SG P +D ++ ++ N G +S SL KLED+
Sbjct: 518 VLTSIPSELAIDQDGFSGSDTTPKEDFVASEKSSVSKNDSNATFEGDCNSSSLVKLEDRY 577
Query: 417 SQSSVASDIFVDDTSTKNDKASEFSDYSTDRSYKDLNGYVSELELGDLCYDECKLQGNYS 476
SQ S AS++ V++TS KND D + D S + L+ +SELE+G +++CKLQ
Sbjct: 578 SQGSRASEMIVENTSMKNDNC---HDSNADVSSESLSNSMSELEIGGAYFEDCKLQPAEY 634
Query: 477 EDGEDILLYQFVKNSKLTFPNLSTVLSLTSSYSSLSLTGKDVD--ELKMEIDAIEAQYEH 534
GE +++ +F KNS V + T+S S +S T +D+ EL+ ++D IEA Y+H
Sbjct: 635 CSGEGVVINEFPKNSGSVLGTSINVENPTNSCSYVSSTEEDIIDLELQFKLDEIEAHYQH 694
Query: 535 WFQELSKMKEEALEASRKRWMAKKRLPV 562
W EL KM EAL+++R+ W+AKK+L V
Sbjct: 695 WIDELKKMMLEALDSTRRSWVAKKKLAV 722
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449433018|ref|XP_004134295.1| PREDICTED: probable serine/threonine-protein kinase WNK4-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 644 bits (1662), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 367/570 (64%), Positives = 425/570 (74%), Gaps = 13/570 (2%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 60
MITELFTSG+LRQYRKKHK+VD+K IKNWARQIL GLVYLHSH+PPIIHRDLK DNIF+N
Sbjct: 95 MITELFTSGSLRQYRKKHKHVDMKAIKNWARQILRGLVYLHSHDPPIIHRDLKGDNIFIN 154
Query: 61 GNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTF 120
GNHGEVKIGDLGLAI MQQPTARSVIGTPEFMAPELYEEEYNELVD+YSFGMC+LEMVTF
Sbjct: 155 GNHGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDVYSFGMCMLEMVTF 214
Query: 121 EYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDLLKDPFL 180
EYPYSECKNPAQIF+KVTSGIKPASLAKV+DP+ FI KCLVP ERLSAK+LLKD FL
Sbjct: 215 EYPYSECKNPAQIFRKVTSGIKPASLAKVSDPRTMEFINKCLVPVHERLSAKELLKDSFL 274
Query: 181 QVENQKEPICDPLKLPIQSLKMLRLPMSGPSSMDIDSDYKQLSLSTCTESNNGSPHCPVL 240
QVEN KE +PL+L Q K + LP SGP SMDID D K SLST ESN+GSP PV+
Sbjct: 275 QVENPKESARNPLQLSNQVSKSINLPKSGPISMDIDIDQKIHSLSTYAESNSGSPRFPVV 334
Query: 241 EFQRMHKNNEFRLRGTKNDDTSVSLTLRIADSSGRVRNIHFLFYLDSDTALSVAGEMVEQ 300
EFQ M+KNNEFRLRG KNDD SV+LTLRIADS+GRVRNIHF FYLDSDTALSVA EM EQ
Sbjct: 335 EFQTMNKNNEFRLRGNKNDDNSVALTLRIADSNGRVRNIHFTFYLDSDTALSVAAEMAEQ 394
Query: 301 LDLADHDVAFIAEFIDYLIMKLLPGWKPSYDYSSSGALSFYSVSPILGNGKTSTPSPWDA 360
L+L +HDV FIAEFID+LI KL+P WKP YSS+G LS +S P L + K+S S W +
Sbjct: 395 LELINHDVDFIAEFIDFLITKLIPEWKPLSVYSSNGELSLFSAPPFLKSAKSSIGSAWGS 454
Query: 361 MGAGVPSEFVVKQDVVSGPTRNPSQDLAPAQGENLHDNAGGGGI-----SSPSLAKLEDQ 415
+ G + +V QD+ SG +D ++ + + G I SSPSLA ED
Sbjct: 455 ILTG-SHDGLVAQDISSGLGCGTQKDCLQSEEDGWTTDISAGHIFDTCPSSPSLANFEDL 513
Query: 416 ESQSSVASDIFVDDTSTKNDKASEFSDYSTDRSYKDLNGYVSELELGDLCY-DECKLQGN 474
S +S A ++ VDD STK+ K + S+ D S K + ++ELE Y E K Q N
Sbjct: 514 NSHASFALELLVDDCSTKSAKVFDCSN--IDGSSKGSSWSIAELEHHGSSYVVEDKFQRN 571
Query: 475 YSEDGEDILLYQFVKNSKLTFP---NLSTVLSLTSSYSSLSLTGKDVD-ELKMEIDAIEA 530
+ G + F KNS ++ P S V+SLTSS SSLSLT KD+D ELKMEIDAIE
Sbjct: 572 VGDVGIFTPMDYFAKNSVVSMPAPSEASNVMSLTSSCSSLSLTDKDLDAELKMEIDAIET 631
Query: 531 QYEHWFQELSKMKEEALEASRKRWMAKKRL 560
Y F ELS+M+EEALEA+R+RW+AKK+L
Sbjct: 632 HYRQLFDELSRMREEALEATRRRWIAKKKL 661
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225470964|ref|XP_002266888.1| PREDICTED: probable serine/threonine-protein kinase WNK4-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 621 bits (1602), Expect = e-175, Method: Compositional matrix adjust.
Identities = 349/569 (61%), Positives = 407/569 (71%), Gaps = 51/569 (8%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 60
MITELFTSG+LRQYRKKHKNVD+K IKNWARQ+L GLVYLHSHNPPIIHRDLKCDNIFVN
Sbjct: 100 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQVLRGLVYLHSHNPPIIHRDLKCDNIFVN 159
Query: 61 GNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTF 120
GNHGEVKIGDLGLAI MQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMC+LEMVTF
Sbjct: 160 GNHGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCMLEMVTF 219
Query: 121 EYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDLLKDPFL 180
EYPY+ECKNPAQI+KKVTSGIKPASL KV D QIK FI KCL PASERL AK+LLKDPF
Sbjct: 220 EYPYNECKNPAQIYKKVTSGIKPASLCKVTDLQIKEFIVKCLAPASERLPAKELLKDPFF 279
Query: 181 QVENQKEPICDPLKLPIQSLKMLRLPMSGPSSMDIDSDYKQLSLSTCTESNNGSPHCPVL 240
Q EN KEPI PL+LP +S K + L SGP SMDID D+ QLS ST TE NNGSP PVL
Sbjct: 280 QSENPKEPIRVPLQLPSRSPKSIILSKSGPFSMDIDPDHPQLSSSTSTE-NNGSPDFPVL 338
Query: 241 EFQRMHKNNEFRLRGTKNDDTSVSLTLRIADSSGRVRNIHFLFYLDSDTALSVAGEMVEQ 300
EFQRM+K++EFRLR K +D S+SLTLR DS G V+NIHF F LD+DT SV GEMVEQ
Sbjct: 339 EFQRMYKSSEFRLRAKKINDNSISLTLRTVDSYGPVKNIHFPFSLDTDTVHSVVGEMVEQ 398
Query: 301 LDLADHDVAFIAEFIDYLIMKLLPGWKPSYDYSSSGALSFYSVSPILGNGKTSTPSPWDA 360
L+LA+H+VAFIA+FIDY+IM+LLPGWKP D GA S + P+LGNG
Sbjct: 399 LELAEHEVAFIADFIDYVIMRLLPGWKPPRDDPLGGARSPNAEPPVLGNG---------- 448
Query: 361 MGAGVPSEFVVKQDVVSGPTRNPSQDLAPAQGENLHDN--AGGGGISSPSLAKLEDQESQ 418
N HD + G G SSP+LA EDQ+S
Sbjct: 449 ---------------------------------NNHDCTISHGDGNSSPNLANAEDQDSL 475
Query: 419 SSVASDIFVDDTSTKNDKASEFSDYSTDRSYKDLN-GYVSELELGDLCYDECKLQGNYSE 477
+S D S KNDK F DY+ +YK N G+ SE E D +++ KLQ N S
Sbjct: 476 ASAGLVTLTVDASKKNDKTVGFGDYNIGGNYKGSNGGHASEQESRDPYHEDYKLQRNNSS 535
Query: 478 DGEDILLYQFVKNSKLTFPNLSTVLSL-TSSYSSLSLTGKDVDE---LKMEIDAIEAQYE 533
E + +F K++ L+F +LS + ++ + + S SL+ D+D+ LK E+DAI+ QY+
Sbjct: 536 IEEFTPMNKFQKSTVLSFDDLSGLSNVRSLTCSCSSLSLADIDQDPGLKQELDAIDLQYQ 595
Query: 534 HWFQELSKMKEEALEASRKRWMAKKRLPV 562
HWFQELS+M+ EALEA++KRWM KK+L V
Sbjct: 596 HWFQELSRMRVEALEATKKRWMTKKKLAV 624
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449478217|ref|XP_004155253.1| PREDICTED: LOW QUALITY PROTEIN: probable serine/threonine-protein kinase WNK4-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 619 bits (1596), Expect = e-174, Method: Compositional matrix adjust.
Identities = 360/570 (63%), Positives = 415/570 (72%), Gaps = 29/570 (5%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 60
MITELFTSG+LRQYRKKHK+VD+K IKNWARQIL GLVYLHSH+PPIIHRDLK DNIF+N
Sbjct: 161 MITELFTSGSLRQYRKKHKHVDMKAIKNWARQILRGLVYLHSHDPPIIHRDLKGDNIFIN 220
Query: 61 GNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTF 120
GNHGEVKIGDLGLAI MQQPTARSVIGTPEFMAPELYEEEYNELVD+YSFGMC+LEMVTF
Sbjct: 221 GNHGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDVYSFGMCMLEMVTF 280
Query: 121 EYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDLLKDPFL 180
EYPYSECKNPAQIF+KVTSGIKPASLAKV+DP+ FI KCLVP ERLSAK+LLKD FL
Sbjct: 281 EYPYSECKNPAQIFRKVTSGIKPASLAKVSDPRTMEFINKCLVPVHERLSAKELLKDSFL 340
Query: 181 QVENQKEPICDPLKLPIQSLKMLRLPMSGPSSMDIDSDYKQLSLSTCTESNNGSPHCPVL 240
QVEN KE +PL+L Q K + LP SGP SMDID D K SLST ESN+GSP PV+
Sbjct: 341 QVENPKESARNPLQLSNQVSKSINLPKSGPISMDIDIDQKIHSLSTYAESNSGSPRFPVV 400
Query: 241 EFQRMHKNNEFRLRGTKNDDTSVSLTLRIADSSGRVRNIHFLFYLDSDTALSVAGEMVEQ 300
EFQ M+KNNEFRLRG KNDD SV+LTLRIADS+GRVRNIHF YLDSDTALSVA EM EQ
Sbjct: 401 EFQTMNKNNEFRLRGNKNDDNSVALTLRIADSNGRVRNIHFTXYLDSDTALSVAAEMAEQ 460
Query: 301 LDLADHDVAFIAEFIDYLIMKLLPGWKPSYDYSSSGALSFYSVSPILGNGKTSTPSPWDA 360
L+L +HDV FIAEFID+LI KL+P WKP YSS+G L S W +
Sbjct: 461 LELINHDVDFIAEFIDFLITKLIPEWKPLSVYSSNGELR----------------SAWGS 504
Query: 361 MGAGVPSEFVVKQDVVSGPTRNPSQDLAPAQGENLHDNAGGGGI-----SSPSLAKLEDQ 415
+ G + +V QD+ SG +D ++ + + G I SSPSLA ED
Sbjct: 505 ILTG-SHDGLVAQDISSGLGCGTQKDCLQSEEDGWTTDISAGHIFDTCPSSPSLANFEDL 563
Query: 416 ESQSSVASDIFVDDTSTKNDKASEFSDYSTDRSYKDLNGYVSELELGDLCY-DECKLQGN 474
S +S A ++ VDD STK+ K + S+ D S K + ++ELE Y E K Q N
Sbjct: 564 NSHASFALELLVDDCSTKSAKVFDCSN--IDGSSKGSSWSIAELEHHGSSYVVEDKFQRN 621
Query: 475 YSEDGEDILLYQFVKNSKLTFP---NLSTVLSLTSSYSSLSLTGKDVD-ELKMEIDAIEA 530
+ G + F KNS ++ P S V+SLTSS SSLSLT KD+D ELKMEIDAIE
Sbjct: 622 VGDVGIFTPMDYFAKNSVVSMPAPSEASNVMSLTSSCSSLSLTDKDLDAELKMEIDAIET 681
Query: 531 QYEHWFQELSKMKEEALEASRKRWMAKKRL 560
Y F ELS+M+EEALEA+R+RW+AKK+L
Sbjct: 682 HYRQLFDELSRMREEALEATRRRWIAKKKL 711
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356571256|ref|XP_003553795.1| PREDICTED: LOW QUALITY PROTEIN: probable serine/threonine-protein kinase WNK4-like, partial [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 564 bits (1454), Expect = e-158, Method: Compositional matrix adjust.
Identities = 310/567 (54%), Positives = 381/567 (67%), Gaps = 57/567 (10%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 60
+I EL T GNLRQY K+H+ VD+K IK+WA+QIL GLVYLHSHNPPIIH+DLKCDNIFVN
Sbjct: 62 IIIELCTLGNLRQYCKRHRYVDMKAIKDWAKQILQGLVYLHSHNPPIIHKDLKCDNIFVN 121
Query: 61 GNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTF 120
GNHGEVKIGDLGLAI MQQPTA SVIGT EFMAP+LYEEEYNELVD+YSFGMC+LEMVTF
Sbjct: 122 GNHGEVKIGDLGLAIFMQQPTAXSVIGTLEFMAPKLYEEEYNELVDVYSFGMCLLEMVTF 181
Query: 121 EYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDLLKDPFL 180
+YPYSEC NPAQI+KKVTSGI+PASL KVNDPQIK FI+KCLV S+RLS K+LLKDPFL
Sbjct: 182 QYPYSECNNPAQIYKKVTSGIEPASLEKVNDPQIKEFIKKCLVSTSKRLSTKELLKDPFL 241
Query: 181 QVENQKEPICDPLKLPIQSLKMLRLPMSGPSSMDIDSDYKQLSLSTCT-ESNNGSPHCPV 239
QVE+ K+ I D L L +SLK++ L MS SMD+D DY+ +SLSTC ESN +PHC +
Sbjct: 242 QVESPKQSILDHLHLSNKSLKVINLSMSDKLSMDLDVDYQFISLSTCVDESNQENPHCSI 301
Query: 240 LEFQRMHKNNEFRLRGTKNDDTSVSLTLRIADSSGRVRNIHFLFYLDSDTALSVAGEMVE 299
L+ QR +KNN FRL+GTKN D SVS LRIA + NIHFLFYL++D A+SVA EM E
Sbjct: 302 LKVQRTYKNNXFRLKGTKNGDKSVSFILRIA---KFMWNIHFLFYLETDIAISVASEMAE 358
Query: 300 QLDLADHDVAFIAEFIDYLIMKLLPGWKPSYDYSSSGALSFYSVSPILGNGKTSTPSPWD 359
L+L ++DVAFI E IDYLIM+L+ GWKPS+DYSS+G LS SP L + +TS PW
Sbjct: 359 NLELENNDVAFIVELIDYLIMELVLGWKPSFDYSSNGGLSQCDGSPTLIDNQTSISFPWV 418
Query: 360 AMGAGVPSEFVVKQD--VVSGPTRNPSQDLAP-AQGENLHDNAGGGGIS-SPSLAKLEDQ 415
A VPSE V+ QD T+ S P + N+ D G+S S S KL D
Sbjct: 419 RALASVPSELVLDQDNCFRFNTTKKESLTTTPKSYIFNVVDKDTLEGLSCSTSEIKLGDM 478
Query: 416 ESQSSVASDIFVDDTSTKNDKASEFSDYSTDRSYKDLNGYVSE-LELGDLCYDECKLQGN 474
F Y + N VS+ +E+ +L + +
Sbjct: 479 -----------------------HFEGYKLHTT----NCNVSKSIEINELSKNSHHMTST 511
Query: 475 YSEDGEDILLYQFVKNSKLTFPNLSTVLSLTSSYSSLSLTGKDVD-ELKMEIDAIEAQYE 533
+ E + I S T++ SSLSLT K++D ELK ++ IE+QY+
Sbjct: 512 FCETPDHI--------------------SFTNNCSSLSLTHKNIDFELKFNVEEIESQYQ 551
Query: 534 HWFQELSKMKEEALEASRKRWMAKKRL 560
H QEL +M+ +ALEA K+W+AKK++
Sbjct: 552 HLSQELLRMRSKALEAVEKKWIAKKKM 578
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297745505|emb|CBI40585.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 540 bits (1392), Expect = e-151, Method: Compositional matrix adjust.
Identities = 313/563 (55%), Positives = 356/563 (63%), Gaps = 123/563 (21%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 60
MITELFTSG+LRQYRKKHKNVD+K IKNWARQ+L GLVYLHSHNPPIIHRDLKCDNIFVN
Sbjct: 108 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQVLRGLVYLHSHNPPIIHRDLKCDNIFVN 167
Query: 61 GNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTF 120
GNHGEVKIGDLGLAI MQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMC+LEMVTF
Sbjct: 168 GNHGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCMLEMVTF 227
Query: 121 EYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDLLKDPFL 180
EYPY+ECKNPAQI+KKVTSGIKPASL KV D QIK FI KCL PASERL AK+LLKDPF
Sbjct: 228 EYPYNECKNPAQIYKKVTSGIKPASLCKVTDLQIKEFIVKCLAPASERLPAKELLKDPFF 287
Query: 181 QVENQKEPICDPLKLPIQSLKMLRLPMSGPSSMDIDSDYKQLSLSTCTESNNGSPHCPVL 240
Q EN KEPI R+P+ P PVL
Sbjct: 288 QSENPKEPI--------------RVPL--------------------------HPDFPVL 307
Query: 241 EFQRMHKNNEFRLRGTKNDDTSVSLTLRIADSSGRVRNIHFLFYLDSDTALSVAGEMVEQ 300
EFQRM+K++EFRLR K +D S+SLTLR DS G V+NIHF F LD+DT SV GEMVEQ
Sbjct: 308 EFQRMYKSSEFRLRAKKINDNSISLTLRTVDSYGPVKNIHFPFSLDTDTVHSVVGEMVEQ 367
Query: 301 LDLADHDVAFIAEFIDYLIMKLLPGWKPSYDYSSSGALSFYSVSPILGNGKTSTPSPWDA 360
L+LA+H+VAFIA+FIDY+IM+LLPGWKP D GA S + P+LGNG
Sbjct: 368 LELAEHEVAFIADFIDYVIMRLLPGWKPPRDDPLGGARSPNAEPPVLGNG---------- 417
Query: 361 MGAGVPSEFVVKQDVVSGPTRNPSQDLAPAQGENLHDN--AGGGGISSPSLAKLEDQESQ 418
N HD + G G SSP+LA EDQ+S
Sbjct: 418 ---------------------------------NNHDCTISHGDGNSSPNLANAEDQDSL 444
Query: 419 SSVASDIFVDDTSTKNDKASEFSDYSTDRSYKDLN-GYVSELELGDLCYDECKLQGNYSE 477
+S D S KNDK F DY+ +YK N G+ SE E D +++ KLQ N S
Sbjct: 445 ASAGLVTLTVDASKKNDKTVGFGDYNIGGNYKGSNGGHASEQESRDPYHEDYKLQRNNSN 504
Query: 478 DGEDILLYQFVKNSKLTFPNLSTVLSLTSSYSSLSLTGKDVDELKMEIDAIEAQYEHWFQ 537
+D P LK E+DAI+ QY+HWFQ
Sbjct: 505 IDQD--------------PG-----------------------LKQELDAIDLQYQHWFQ 527
Query: 538 ELSKMKEEALEASRKRWMAKKRL 560
ELS+M+ EALEA++KRWM KK+L
Sbjct: 528 ELSRMRVEALEATKKRWMTKKKL 550
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359474135|ref|XP_002273005.2| PREDICTED: serine/threonine-protein kinase WNK8-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 516 bits (1330), Expect = e-144, Method: Compositional matrix adjust.
Identities = 306/572 (53%), Positives = 384/572 (67%), Gaps = 45/572 (7%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 60
+ITELFTSG+LRQYRKKHKNVD+K IKNWA+QIL GL YLHSHNPPIIHRDLKCDNIFVN
Sbjct: 101 LITELFTSGSLRQYRKKHKNVDLKAIKNWAKQILRGLHYLHSHNPPIIHRDLKCDNIFVN 160
Query: 61 GNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTF 120
GN+GEVKIGDLGLAI MQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILE+VT
Sbjct: 161 GNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILELVTC 220
Query: 121 EYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDLLKDPFL 180
EYPY+ECKNPAQI+KKV+SGIKPASL KV+DPQ+K FIEKCLVPAS RLSA++LLKD F
Sbjct: 221 EYPYNECKNPAQIYKKVSSGIKPASLGKVSDPQVKQFIEKCLVPASLRLSAQELLKDAFF 280
Query: 181 QVENQKEPICDPLKL--PIQSL----KMLRLPMSGPSSMDIDSDYKQLSLSTCTESNNGS 234
EN KEP+ + + + +QS ++ LP MD+D +YK+LS+ST +S +G+
Sbjct: 281 ATENSKEPVYNHMHVDDSLQSSNFMPNLMNLPKPELQPMDMDPNYKKLSVSTHMKSISGT 340
Query: 235 PHCPVLEFQRMHKNNEFRLRGTKNDDTSVSLTLRIADSSGRVRNIHFLFYLDSDTALSVA 294
PH L+F+R +KNN F+LRG K DD S+S+TL IAD GR +NIHF FYLDSDTALS+A
Sbjct: 341 PHFRALQFERFNKNNLFKLRGEKIDDNSISMTLHIADPCGRAKNIHFAFYLDSDTALSIA 400
Query: 295 GEMVEQLDLADHDVAFIAEFIDYLIMKLLPGWKPSYDYSSSGALSFYSVSPILGNGKTST 354
GEMVEQLDL + DVA IAE ID +I +L+P WKP+++ GA S S +L NG TS
Sbjct: 401 GEMVEQLDLYNEDVAVIAELIDVMISELVPTWKPAFESMLCGANSSCEDSLVLHNGGTSL 460
Query: 355 PSPWDAMGAGVPSEFVVKQDVVSGPTRNPSQDLAPAQGENLHDNAGGGGISSPSLAKLED 414
P D+ A S+ V + ++S Q + G+S+ +D
Sbjct: 461 RHPSDSGSAKGTSD-AVTEHLISLSANGEEQSTV---------ESALSGMST------KD 504
Query: 415 QESQSSVASDIFVDDTSTKNDKASEFSD---YSTDRSYKDLNGYVSELELGDLCYDECKL 471
+ +S A+DI +D+ E SD ++ DR D + E +
Sbjct: 505 DATVASDANDI--KSLECPDDECYEASDRCCFNGDRQVLDHER-----------HKEGRY 551
Query: 472 QGNYSEDGEDILLYQFVKNSKLTF---PNLSTVLSLTSSYSSLSLTGKD-VDELKMEIDA 527
GN GE + + F K+ +++ + + SS SLSL KD DELK+E+D
Sbjct: 552 NGNI---GEPVAMNGFTKDWEISCIESCSGMSNSLSLSSICSLSLADKDPSDELKLEVDT 608
Query: 528 IEAQYEHWFQELSKMKEEALEASRKRWMAKKR 559
I+ QY FQEL +M+EEA+E ++ RW+ K R
Sbjct: 609 IDTQYHQCFQELLRMREEAIEKAKNRWITKSR 640
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224127975|ref|XP_002320210.1| predicted protein [Populus trichocarpa] gi|222860983|gb|EEE98525.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 513 bits (1322), Expect = e-143, Method: Compositional matrix adjust.
Identities = 262/328 (79%), Positives = 283/328 (86%), Gaps = 1/328 (0%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 60
MITELFTSGNLRQYR+KH+N+DIK IKNWARQIL GLVYLH H+PPIIHRDLKCDNIFVN
Sbjct: 98 MITELFTSGNLRQYRRKHRNIDIKAIKNWARQILRGLVYLHGHSPPIIHRDLKCDNIFVN 157
Query: 61 GNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTF 120
GNHGEVKIGDLGLAI MQ PTA+SVIGTPEFMAPELYEEEYNELVDIYSFGMCILE+VT
Sbjct: 158 GNHGEVKIGDLGLAIVMQNPTAKSVIGTPEFMAPELYEEEYNELVDIYSFGMCILELVTC 217
Query: 121 EYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDLLKDPFL 180
YPYSEC+N AQI+KKVTSGIKPASL V + QIK FIEKCL+PASERLSAK+LLK PFL
Sbjct: 218 NYPYSECRNAAQIYKKVTSGIKPASLKTVGNTQIKEFIEKCLLPASERLSAKELLKHPFL 277
Query: 181 QVENQ-KEPICDPLKLPIQSLKMLRLPMSGPSSMDIDSDYKQLSLSTCTESNNGSPHCPV 239
Q+E E ICDPL +P Q L LP SGP MD+D D KQLS STCT SNNGSP PV
Sbjct: 278 QLEIPILEQICDPLPVPDQFPISLSLPKSGPLFMDMDIDEKQLSESTCTGSNNGSPKSPV 337
Query: 240 LEFQRMHKNNEFRLRGTKNDDTSVSLTLRIADSSGRVRNIHFLFYLDSDTALSVAGEMVE 299
LE+QR HKNNEF L+G KNDD S SLTLRI+D GRVRNIHF+FYLDSDTA+SVA EMVE
Sbjct: 338 LEYQRAHKNNEFGLKGMKNDDNSASLTLRISDLGGRVRNIHFIFYLDSDTAISVASEMVE 397
Query: 300 QLDLADHDVAFIAEFIDYLIMKLLPGWK 327
QL+LADHDVAFIAE ID LI+KLLPGWK
Sbjct: 398 QLELADHDVAFIAELIDSLIVKLLPGWK 425
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 563 | ||||||
| TAIR|locus:2165790 | 563 | WNK8 "with no lysine (K) kinas | 0.637 | 0.637 | 0.581 | 3.4e-113 | |
| TAIR|locus:2093994 | 567 | WNK6 "with no lysine (K) kinas | 0.573 | 0.569 | 0.618 | 2.4e-110 | |
| TAIR|locus:2028521 | 557 | WNK7 [Arabidopsis thaliana (ta | 0.570 | 0.576 | 0.613 | 1.2e-108 | |
| TAIR|locus:2019404 | 524 | WNK10 "with no lysine (K) kina | 0.564 | 0.606 | 0.618 | 1.7e-107 | |
| TAIR|locus:504955638 | 516 | WNK3 "with no lysine (K) kinas | 0.321 | 0.350 | 0.741 | 1.5e-91 | |
| TAIR|locus:2114845 | 700 | WNK1 "with no lysine (K) kinas | 0.325 | 0.261 | 0.704 | 1.3e-90 | |
| TAIR|locus:2182039 | 492 | WNK9 [Arabidopsis thaliana (ta | 0.577 | 0.660 | 0.516 | 4.5e-82 | |
| TAIR|locus:2098242 | 549 | WNK5 "with no lysine (K) kinas | 0.442 | 0.453 | 0.547 | 4.6e-80 | |
| TAIR|locus:2161278 | 571 | WNK4 "with no lysine (K) kinas | 0.317 | 0.313 | 0.677 | 3.6e-76 | |
| UNIPROTKB|J9P5T2 | 2503 | FAM120C "Uncharacterized prote | 0.317 | 0.071 | 0.633 | 1.6e-64 |
| TAIR|locus:2165790 WNK8 "with no lysine (K) kinase 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1023 (365.2 bits), Expect = 3.4e-113, Sum P(2) = 3.4e-113
Identities = 214/368 (58%), Positives = 258/368 (70%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 60
MITELFTSG+LR YRKKH+ VD K IKNWARQIL GL YLHS NPP+IHRDLKCDNIFVN
Sbjct: 107 MITELFTSGSLRVYRKKHRKVDPKAIKNWARQILKGLNYLHSQNPPVIHRDLKCDNIFVN 166
Query: 61 GNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTF 120
GN GEVKIGDLGLA +QQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMC+LEMVT
Sbjct: 167 GNTGEVKIGDLGLATVLQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCMLEMVTC 226
Query: 121 EYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDLLKDPFL 180
EYPY+EC+N AQI+KKVTS IKP SL KV+DPQ++ FIEKCL+PAS R +A +L KDPFL
Sbjct: 227 EYPYNECRNQAQIYKKVTSNIKPQSLGKVDDPQVRQFIEKCLLPASSRPTALELSKDPFL 286
Query: 181 QVENQKEPICDPLKLPIQSLKMLRLPMSGPSSMDIDSDYKQLSLSTCTESNNGSPHCPVL 240
+ K+ L S K +R P MD+D + + S+S SN P +
Sbjct: 287 ARDGGKDSAL--LASSSTSSKYVRPPQLEHLPMDVDHNENK-SVS----SNEDYPWSQTI 339
Query: 241 EFQRMHKNNEFRLRGTKNDDTSVSLTLRIADSSGRVRNIHFLFYLDSDTALSVAGEMVEQ 300
E QR+ +N EFRLRG ++DD + S+ LRIAD SG+ R +HF FYL+SDTA ++A EMVE+
Sbjct: 340 ELQRIAENKEFRLRGERSDDVTASMVLRIADPSGKCRIVHFAFYLESDTATAIAEEMVEE 399
Query: 301 LDLADHDVAFIAEFIDYLIMKLLPGWKPSYDYSSSGALSFYSVSPILGNGKTSTPSPWDA 360
L L +V IA+ ID IM+LL S+ +S L+ N +T +A
Sbjct: 400 LHLTSQEVVVIADMIDDFIMQLLSDRTSSHHNQNSPRLTHEDHEA--ANQQTVNSKDEEA 457
Query: 361 MGAGVPSE 368
G + S+
Sbjct: 458 AGQSMKSD 465
|
|
| TAIR|locus:2093994 WNK6 "with no lysine (K) kinase 6" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1042 (371.9 bits), Expect = 2.4e-110, Sum P(2) = 2.4e-110
Identities = 209/338 (61%), Positives = 254/338 (75%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 60
+ITELFTSG+LR YRKKH+ V++K +KNWARQIL GL YLH PPIIHRDLKCDNIF+N
Sbjct: 106 IITELFTSGSLRHYRKKHRKVNMKAVKNWARQILMGLRYLHGQEPPIIHRDLKCDNIFIN 165
Query: 61 GNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTF 120
GNHGEVKIGDLGLA M+Q A+SVIGTPEFMAPELY+E YNEL DIYSFGMC+LEMVTF
Sbjct: 166 GNHGEVKIGDLGLATVMEQANAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEMVTF 225
Query: 121 EYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDLLKDPFL 180
+YPY ECKN AQI+KKV+SGIKPASL++V DP++K FIEKCL+PASERLSAK+LL DPFL
Sbjct: 226 DYPYCECKNSAQIYKKVSSGIKPASLSRVKDPEVKQFIEKCLLPASERLSAKELLLDPFL 285
Query: 181 QVE----NQKEPICDPLKLPIQSLKMLRLPMS-GP------SSMDIDSDYKQLSLSTCTE 229
Q+ N P+ D + +P + R MS GP ++ ID D + +L T
Sbjct: 286 QLNGLTMNNPLPLPD-IVMPKEGAFGDRCLMSEGPPTTRPSKTLSIDLD-EDSNLPIVTF 343
Query: 230 SNNGSPHCPVLEFQRMHKNNEFRLRGTKNDDTSVSLTLRIADSSGRVRNIHFLFYLDSDT 289
S+N C +E +R + N F L+G +ND+ SVSL LRI D +GRVRNIHFLFY + DT
Sbjct: 344 SDNSGSRC--IEVRRAKRGNFFVLKGEENDEQSVSLILRIVDENGRVRNIHFLFYQEGDT 401
Query: 290 ALSVAGEMVEQLDLADHDVAFIAEFIDYLIMKLLPGWK 327
A V+ EMVEQL+L D +V FIAE ID L++ ++P WK
Sbjct: 402 ASKVSSEMVEQLELTDQNVTFIAELIDILLVNMIPTWK 439
|
|
| TAIR|locus:2028521 WNK7 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1027 (366.6 bits), Expect = 1.2e-108, Sum P(2) = 1.2e-108
Identities = 208/339 (61%), Positives = 254/339 (74%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 60
+ITELFTSG+LRQYRKKH+ V++K +K WARQIL GL YLHS +PPIIHRD+KCDNIF+N
Sbjct: 106 IITELFTSGSLRQYRKKHRKVNMKAVKCWARQILTGLKYLHSQDPPIIHRDIKCDNIFIN 165
Query: 61 GNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTF 120
GNHGEVKIGDLGLA M+Q A+SVIGTPEFMAPELY+E YNEL DIYSFGMC+LEMVTF
Sbjct: 166 GNHGEVKIGDLGLATVMEQANAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEMVTF 225
Query: 121 EYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDLLKDPFL 180
EYPY EC+N AQI+KKV+SGIKPASL+KV DP++ FIEKCL+PASERLSA++LL D FL
Sbjct: 226 EYPYCECRNSAQIYKKVSSGIKPASLSKVKDPEVMKFIEKCLLPASERLSAEELLLDSFL 285
Query: 181 QVE----NQKEPICDPLKLPIQSLKMLRLPMS-GPS-------SMDIDSDYKQLSLSTCT 228
V N P+ D + +P + R MS GP SM++D D +L
Sbjct: 286 NVNGLVMNNPLPLPD-IVMPKEGSFGERCLMSEGPPNARNRTMSMNLDEDN---NLPIVI 341
Query: 229 ESNNGSPHCPVLEFQRMHKNNEFRLRGTKNDDTSVSLTLRIADSSGRVRNIHFLFYLDSD 288
SNN +C +E +R + N F L+G +ND+ SVSL LRI D +GRVRNIHFLF+ + D
Sbjct: 342 SSNNSGTNC--IEVRRAKRGNFFVLKGEENDENSVSLILRIVDENGRVRNIHFLFFQEGD 399
Query: 289 TALSVAGEMVEQLDLADHDVAFIAEFIDYLIMKLLPGWK 327
TA +V+ EMVEQL+L D +V FIAE ID L++ L+P WK
Sbjct: 400 TASNVSSEMVEQLELTDKNVKFIAELIDVLLVNLIPNWK 438
|
|
| TAIR|locus:2019404 WNK10 "with no lysine (K) kinase 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 981 (350.4 bits), Expect = 1.7e-107, Sum P(2) = 1.7e-107
Identities = 201/325 (61%), Positives = 238/325 (73%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 60
MITELFTSG+L YRKKH+ VD K I NWARQIL GL YLHS PP+IHRDLKCDNIFVN
Sbjct: 94 MITELFTSGSLTLYRKKHRKVDPKAIMNWARQILKGLHYLHSQTPPVIHRDLKCDNIFVN 153
Query: 61 GNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTF 120
GN G+VKIGDLGLA MQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMC+LEMVT
Sbjct: 154 GNTGKVKIGDLGLAAVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCMLEMVTC 213
Query: 121 EYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDLLKDPFL 180
EYPY EC+N AQI+KKVTSGIKP SL+KV+DPQ+K FIEKCL+PA R +A +LLKD L
Sbjct: 214 EYPYRECRNQAQIYKKVTSGIKPQSLSKVDDPQVKQFIEKCLLPAPSRPTALELLKDQLL 273
Query: 181 QVENQKEPICDPLKLPIQSLKMLRLPMSGPSSMDIDSDYKQLSLSTCTESNNGSPHCPVL 240
V+ K+ + K P MD++ K S+S C+ + + S C +L
Sbjct: 274 AVDGAKDSTLTASSNT--TFKPAMPPQCEYRPMDVEYK-KNTSVSICSSAKS-SQECALL 329
Query: 241 ---EFQRMHKNNEFRLRGTKNDDTSVSLTLRIADSSGRVRNIHFLFYLDSDTALSVAGEM 297
E QR+ ++ EF+L G + DD + S+ LRIA SSG+ R + F F L +DTA +V GEM
Sbjct: 330 QTMEVQRVAESTEFKLSGERRDDVAASMALRIAGSSGQARKVDFDFNLKTDTARAVTGEM 389
Query: 298 VEQLDLADHDVAFIAEFIDYLIMKL 322
VE+LDL+ H+V IAE ID LIMKL
Sbjct: 390 VEELDLSSHEVTVIAEMIDELIMKL 414
|
|
| TAIR|locus:504955638 WNK3 "with no lysine (K) kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 746 (267.7 bits), Expect = 1.5e-91, Sum P(2) = 1.5e-91
Identities = 135/182 (74%), Positives = 160/182 (87%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 60
+ITE+FTSGNLRQYRKKHK VD++ +K W+RQIL GLVYLHSH+PP+IHRDLKCDNIF+N
Sbjct: 100 LITEVFTSGNLRQYRKKHKCVDLRALKKWSRQILEGLVYLHSHDPPVIHRDLKCDNIFIN 159
Query: 61 GNHGEVKIGDLGLAIAMQQP-TARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVT 119
GN GEVKIGDLGLA + + +A SVIGTPEFMAPELYEE+YN LVDIY+FGMC+LE+VT
Sbjct: 160 GNQGEVKIGDLGLAAILHRARSAHSVIGTPEFMAPELYEEDYNVLVDIYAFGMCLLELVT 219
Query: 120 FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDLLKDPF 179
FEYPYSEC N AQI++KVTSGIKPA+L V DPQ++ FIEKC+ S+RLSAK+LL DPF
Sbjct: 220 FEYPYSECTNAAQIYRKVTSGIKPAALLNVTDPQVRAFIEKCIAKVSQRLSAKELLDDPF 279
Query: 180 LQ 181
L+
Sbjct: 280 LK 281
|
|
| TAIR|locus:2114845 WNK1 "with no lysine (K) kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 709 (254.6 bits), Expect = 1.3e-90, Sum P(2) = 1.3e-90
Identities = 129/183 (70%), Positives = 155/183 (84%)
Query: 2 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG 61
+TELFTSG LRQYR +HK V+I+ +K+W RQIL GL YLHSH+PP+IHRDLKCDNIFVNG
Sbjct: 103 VTELFTSGTLRQYRLRHKRVNIRAMKHWCRQILRGLHYLHSHDPPVIHRDLKCDNIFVNG 162
Query: 62 NHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTFE 121
N GEVKIGDLGLA +++ A +GTPEFMAPE+YEE YNELVDIYSFGMCILEMVTF+
Sbjct: 163 NQGEVKIGDLGLAAILRKSHAAHCVGTPEFMAPEVYEEAYNELVDIYSFGMCILEMVTFD 222
Query: 122 YPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDLLKDPFLQ 181
YPYSEC +PAQI+KKV SG KP +L KV DP++K FIEKCL S R+SA++LL DPFL+
Sbjct: 223 YPYSECTHPAQIYKKVMSGKKPDALYKVKDPEVKCFIEKCLATVSLRVSARELLDDPFLR 282
Query: 182 VEN 184
+++
Sbjct: 283 IDD 285
|
|
| TAIR|locus:2182039 WNK9 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 823 (294.8 bits), Expect = 4.5e-82, P = 4.5e-82
Identities = 174/337 (51%), Positives = 220/337 (65%)
Query: 2 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG 61
+TE+FTSG LRQYR KHK V+I+ +KNW RQIL GL YLH+H+PP+IHRDLKCDNIF+NG
Sbjct: 104 VTEMFTSGTLRQYRLKHKRVNIRAVKNWCRQILRGLNYLHTHDPPVIHRDLKCDNIFING 163
Query: 62 NHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTFE 121
N GEVKIGDLGLA +Q A +GTPEFMAPE+Y+EEYN+LVDIYSFGMC+LEMVTF+
Sbjct: 164 NQGEVKIGDLGLAACLQHSHAAHCVGTPEFMAPEVYKEEYNQLVDIYSFGMCVLEMVTFD 223
Query: 122 YPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDLLKDPFLQ 181
YPYSEC +PAQI+K+V SG KP L KV DP+++GFIEKCL S RLSA +LL D FL
Sbjct: 224 YPYSECSHPAQIYKRVISGKKPDGLDKVKDPEVRGFIEKCLATVSLRLSACELLDDHFLC 283
Query: 182 V-ENQKEPICDPLKLPIQSLKMLRLPMSGPS-SMDIDSDYKQLSLSTCTESNNGSPHCPV 239
+ E+ + L ++ LR P S S Y Q + S +
Sbjct: 284 IDESDMRRVESEKGLIDEAGTPLRHSYHIPHYSNGYYSLYNQNQWDYNGDETVESHEIDL 343
Query: 240 LEFQRMHKNNE---------FRLRGTKNDD-TSVSLTLRIADSSGRVRNIHFLFYLDSDT 289
LEFQ E ++G + D+ + L L+ + G VRNI+F F +++DT
Sbjct: 344 LEFQNDDDEEEEDKRFGSVDISIKGKRRDNGDGLFLRLKTVNKEGCVRNIYFPFDIETDT 403
Query: 290 ALSVAGEMVEQLDLADHDVAFIAEFIDYLIMKLLPGW 326
A+SVA EMVE+L++ D DV IA ID I L+P W
Sbjct: 404 AISVAREMVEELEMDDRDVTKIANMIDGEIASLVPNW 440
|
|
| TAIR|locus:2098242 WNK5 "with no lysine (K) kinase 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 684 (245.8 bits), Expect = 4.6e-80, Sum P(2) = 4.6e-80
Identities = 139/254 (54%), Positives = 176/254 (69%)
Query: 2 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG 61
ITELFTSG LR+YR+K++ VDI+ IK+WARQIL+GL YLH H+PP+IHRDLKCDNIFVNG
Sbjct: 104 ITELFTSGTLREYRRKYQKVDIRAIKSWARQILNGLAYLHGHDPPVIHRDLKCDNIFVNG 163
Query: 62 NHGEVKIGDLGLAIAMQ-QPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTF 120
+ G+VKIGDLGLA ++ A SVIGTPEFMAPELYEE+YNELVDIYSFGMC+LEM+T
Sbjct: 164 HLGQVKIGDLGLAAILRGSQNAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTG 223
Query: 121 EYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDLLKDPFL 180
EYPYSEC NPAQI+KKVTSG P S + + + F+ KCL S RL AK+LL DPFL
Sbjct: 224 EYPYSECTNPAQIYKKVTSGKLPDSFHLIQHTEAQRFVGKCLETVSRRLPAKELLADPFL 283
Query: 181 QVENQKEPICDPLKLPIQSLKMLRLPMSGPSSMDIDS--DYKQLSLSTCTESNNGSPHCP 238
++++ + +LP Q L + L +G + S D + + + T N H
Sbjct: 284 AATDERD-LAPLFRLP-QQLAIQNLAANGTVVEHLPSTTDPTRTTDMSITGKMNSEDHTI 341
Query: 239 VLEFQRMHKNNEFR 252
L+ Q + + R
Sbjct: 342 FLQVQILDGDGHMR 355
|
|
| TAIR|locus:2161278 WNK4 "with no lysine (K) kinase 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 663 (238.4 bits), Expect = 3.6e-76, Sum P(2) = 3.6e-76
Identities = 122/180 (67%), Positives = 149/180 (82%)
Query: 2 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG 61
ITELFTSG LRQY+ K+ +DI+ IK+WARQIL GLVYLH H+PP+IHRDLKCDNIFVNG
Sbjct: 98 ITELFTSGTLRQYKNKYLRIDIRAIKSWARQILEGLVYLHEHDPPVIHRDLKCDNIFVNG 157
Query: 62 NHGEVKIGDLGLAIAMQQ-PTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTF 120
+ G+VKIGDLGLA ++ +A S+IGTPEFMAPELYEE YNEL+D+YSFGMC LEM+T
Sbjct: 158 HLGQVKIGDLGLARMLRDCHSAHSIIGTPEFMAPELYEENYNELIDVYSFGMCFLEMITS 217
Query: 121 EYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDLLKDPFL 180
E+PYSEC +PAQI+KKV G P + +V D + + FI KCLV AS+R+SAK+LL+DPFL
Sbjct: 218 EFPYSECNHPAQIYKKVVGGKLPGAFYRVGDIEAQRFIGKCLVSASKRVSAKELLQDPFL 277
|
|
| UNIPROTKB|J9P5T2 FAM120C "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 602 (217.0 bits), Expect = 1.6e-64, Sum P(3) = 1.6e-64
Identities = 114/180 (63%), Positives = 139/180 (77%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 60
++TEL TSG L+ Y K+ K + KV+++W RQIL GL +LH+ PPIIHRDLKCDNIF+
Sbjct: 225 LVTELMTSGTLKTYLKRFKVMKPKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT 284
Query: 61 GNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTF 120
G G VKIGDLGLA M+ A+SVIGTPEFMAPE+YEE Y+E VD+Y+FGMC+LEM T
Sbjct: 285 GPTGSVKIGDLGLATLMRTSFAKSVIGTPEFMAPEMYEEHYDESVDVYAFGMCMLEMATS 344
Query: 121 EYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPF 179
EYPYSEC+N AQI++KVTSGIKPAS KV DP++K IE C+ SERLS +DLL F
Sbjct: 345 EYPYSECQNAAQIYRKVTSGIKPASFNKVTDPEVKEIIEGCIRQNKSERLSIRDLLNHAF 404
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q6EU49 | WNK4_ORYSJ | 2, ., 7, ., 1, 1, ., 1 | 0.4911 | 0.8987 | 0.8267 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 563 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 5e-50 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-47 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-41 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-38 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-37 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-36 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-36 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 8e-32 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 4e-31 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 4e-31 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-30 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-28 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 7e-28 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-27 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 4e-27 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-26 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-26 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 7e-26 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-25 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-25 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-25 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 6e-25 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-24 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-24 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-24 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 6e-24 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 8e-24 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-23 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-23 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-23 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-23 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 7e-23 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-22 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 5e-22 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 7e-22 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 7e-22 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 8e-22 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 9e-22 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-21 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 7e-21 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-20 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 5e-20 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 5e-20 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 5e-20 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 7e-20 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-19 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-19 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-19 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-19 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 4e-19 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-18 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-18 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-18 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 5e-18 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 8e-18 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-17 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-17 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-17 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-17 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-17 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-17 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-17 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 4e-17 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-17 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 4e-17 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 6e-17 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 7e-17 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 8e-17 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-16 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-16 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-16 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-16 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-16 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-16 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 5e-16 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 7e-16 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 8e-16 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 9e-16 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 9e-16 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-15 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-15 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-15 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-15 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 5e-15 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 6e-15 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 6e-15 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-14 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-14 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-14 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-14 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-14 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-14 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-14 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-14 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-14 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 4e-14 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 4e-14 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 6e-14 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 7e-14 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 9e-14 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-13 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-13 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-13 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-13 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-13 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-13 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-13 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-13 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-13 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 5e-13 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 7e-13 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 8e-13 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-12 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-12 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-12 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-12 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-12 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-12 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 5e-12 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 5e-12 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 7e-12 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 7e-12 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 7e-12 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 7e-12 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 8e-12 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-11 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-11 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-11 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-11 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-11 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-11 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-11 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-11 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-11 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-11 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 4e-11 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 4e-11 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 5e-11 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 5e-11 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 5e-11 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 6e-11 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 6e-11 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 6e-11 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 6e-11 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 6e-11 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-10 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-10 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-10 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-10 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-10 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-10 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-10 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-10 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 3e-10 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-10 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-10 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-10 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 5e-10 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 5e-10 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 6e-10 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 7e-10 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 8e-10 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 8e-10 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 8e-10 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 9e-10 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-09 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-09 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-09 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-09 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-09 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-09 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-09 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-09 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-09 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-09 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 3e-09 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-09 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-09 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 4e-09 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 4e-09 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 4e-09 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 5e-09 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 5e-09 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 6e-09 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 7e-09 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 8e-09 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 8e-09 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-08 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-08 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-08 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-08 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-08 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-08 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-08 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-08 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-08 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-08 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-08 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 4e-08 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-08 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 5e-08 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 5e-08 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 5e-08 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 6e-08 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 6e-08 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 7e-08 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 8e-08 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 9e-08 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 9e-08 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-07 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-07 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-07 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-07 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 3e-07 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 4e-07 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 4e-07 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 4e-07 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 4e-07 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 5e-07 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 6e-07 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 6e-07 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 6e-07 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 6e-07 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 6e-07 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 7e-07 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 9e-07 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-06 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-06 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-06 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-06 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-06 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-06 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-06 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-06 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-06 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-06 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-06 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 6e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 6e-06 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 7e-06 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 8e-06 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 9e-06 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 9e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-05 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 1e-05 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-05 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-05 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-05 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-05 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-05 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-05 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-05 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-05 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-05 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 3e-05 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 4e-05 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 5e-05 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 6e-05 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 6e-05 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 6e-05 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 8e-05 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 9e-05 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 1e-04 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-04 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-04 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-04 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-04 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 5e-04 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 5e-04 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 5e-04 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 6e-04 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 7e-04 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 8e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 0.001 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 0.001 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 0.003 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 172 bits (439), Expect = 5e-50
Identities = 65/185 (35%), Positives = 98/185 (52%), Gaps = 9/185 (4%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 60
++ E G+L KK + + + RQIL L YLHS I+HRDLK +NI ++
Sbjct: 74 LVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKG--IVHRDLKPENILLD 131
Query: 61 GNHGEVKIGDLGLAIAMQQPT-ARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCIL-EM 117
G VK+ D GLA + + +GTPE+MAPE L + Y + VDI+S G IL E+
Sbjct: 132 -EDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGKAVDIWSLG-VILYEL 189
Query: 118 VTFEYPYSECKNPAQIFKKVTSGIKPASLAKVN-DPQIKGFIEKCLVP-ASERLSAKDLL 175
+T + P+ ++FKK+ P + + P+ K I K LV +RL+A++ L
Sbjct: 190 LTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKLLVKDPEKRLTAEEAL 249
Query: 176 KDPFL 180
+ PF
Sbjct: 250 QHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 165 bits (421), Expect = 2e-47
Identities = 69/178 (38%), Positives = 97/178 (54%), Gaps = 9/178 (5%)
Query: 9 GNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKI 68
G+L KK + VI+ + RQIL GL YLHS+ I+HRD+K NI V+ + G VK+
Sbjct: 86 GSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNG--IVHRDIKGANILVDSD-GVVKL 142
Query: 69 GDLGLAIAMQQPTA----RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYP 123
D G A + SV GTP +MAPE+ EEY DI+S G ++EM T + P
Sbjct: 143 ADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPP 202
Query: 124 YSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFL 180
+SE NP K+ S +P + + + K F+ KCL +R +A +LL+ PFL
Sbjct: 203 WSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 150 bits (380), Expect = 2e-41
Identities = 61/189 (32%), Positives = 97/189 (51%), Gaps = 12/189 (6%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 60
++ E G+L Y + + K A QIL GL YLHS+ IIHRDLK +NI ++
Sbjct: 75 LVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNG--IIHRDLKPENILLD 132
Query: 61 GNHGEVKIGDLGLAIAMQ--QPTARSVIGTPEFMAPE--LYEEEYNELVDIYSFGMCILE 116
+G VKI D GLA + + + +GTP +MAPE L Y VD++S G+ + E
Sbjct: 133 -ENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYE 191
Query: 117 MVTFEYPYSECKNPAQ--IFKKVTSGIKPASLAKVNDPQI--KGFIEKCLVP-ASERLSA 171
++T + P+S Q + +++ K + K I+KCL S+R +A
Sbjct: 192 LLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTA 251
Query: 172 KDLLKDPFL 180
+++L+ P+
Sbjct: 252 EEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 140 bits (356), Expect = 1e-38
Identities = 52/184 (28%), Positives = 86/184 (46%), Gaps = 42/184 (22%)
Query: 1 MITELFTSGNLRQY-RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV 59
++ E G+L+ ++ + I QIL GL YLHS+ IIHRDLK +NI +
Sbjct: 68 LVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNG--IIHRDLKPENILL 125
Query: 60 NGNHGEVKIGDLGLAIAMQQP--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCIL 115
+ ++G+VK+ D GL+ + ++++GTP +MAPE+ Y+E DI+S G+ +
Sbjct: 126 DSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILY 185
Query: 116 EMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDL 174
E+ P++K I K L +R SAK++
Sbjct: 186 EL----------------------------------PELKDLIRKMLQKDPEKRPSAKEI 211
Query: 175 LKDP 178
L+
Sbjct: 212 LEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 1e-37
Identities = 70/184 (38%), Positives = 102/184 (55%), Gaps = 14/184 (7%)
Query: 4 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNH 63
EL G+L + KK+ + VI+ + RQIL GL YLH N +HRD+K NI V+ N
Sbjct: 82 ELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRN--TVHRDIKGANILVDTN- 138
Query: 64 GEVKIGDLGLA-IAMQQPTARSVIGTPEFMAPELYEEE--YNELVDIYSFGMCILEMVTF 120
G VK+ D G+A ++ A+S G+P +MAPE+ ++ Y DI+S G +LEM T
Sbjct: 139 GVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATG 198
Query: 121 EYPYSECKNPAQIFKKVTSGIKPA---SLAKVNDPQIKGFIEKCL-VPASERLSAKDLLK 176
+ P+S+ + A +FK S P L+ + K FI KCL S R +A +LL+
Sbjct: 199 KPPWSQLEGVAAVFKIGRSKELPPIPDHLS----DEAKDFILKCLQRDPSLRPTAAELLE 254
Query: 177 DPFL 180
PF+
Sbjct: 255 HPFV 258
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 135 bits (343), Expect = 2e-36
Identities = 58/153 (37%), Positives = 88/153 (57%), Gaps = 6/153 (3%)
Query: 30 ARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR-SVIGT 88
+++L GL YLHS+ IIHRD+K NI + + GEVK+ D GL+ + AR +++GT
Sbjct: 104 CKELLKGLEYLHSNG--IIHRDIKAANILLT-SDGEVKLIDFGLSAQLSDTKARNTMVGT 160
Query: 89 PEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLA 147
P +MAPE + + Y+ DI+S G+ +E+ + PYSE +FK T+G
Sbjct: 161 PYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNP 220
Query: 148 KVNDPQIKGFIEKCLVPASE-RLSAKDLLKDPF 179
+ + K F++KCL E R +A+ LLK PF
Sbjct: 221 EKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 3e-36
Identities = 69/190 (36%), Positives = 105/190 (55%), Gaps = 16/190 (8%)
Query: 1 MITELFTSGNL----RQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDN 56
++ E G+L Q + I + R++L GL YLHS N +IHRD+K DN
Sbjct: 92 VVMEYMDGGSLTDIITQNFVRMNEPQIAYV---CREVLQGLEYLHSQN--VIHRDIKSDN 146
Query: 57 IFVNGNHGEVKIGDLGLA--IAMQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMC 113
I ++ + G VK+ D G A + ++ SV+GTP +MAPE+ + ++Y VDI+S G+
Sbjct: 147 ILLSKD-GSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIM 205
Query: 114 ILEMVTFEYPYSECKNPAQ-IFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSA 171
+EM E PY + P + +F T GI P + P+ K F+ KCLV +R SA
Sbjct: 206 CIEMAEGEPPYLR-EPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSA 264
Query: 172 KDLLKDPFLQ 181
++LL+ PFL+
Sbjct: 265 EELLQHPFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 8e-32
Identities = 59/180 (32%), Positives = 97/180 (53%), Gaps = 10/180 (5%)
Query: 9 GNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHS-HNPPIIHRDLKCDNIFVNGNHGEVK 67
G+L KK + V+ ARQIL GL YLH+ + IIHRD+K N+ +N GEVK
Sbjct: 84 GSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH--IIHRDIKPSNLLINSK-GEVK 140
Query: 68 IGDLGLAIAMQQPTA--RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPY 124
I D G++ ++ + +GT +M+PE + E Y+ DI+S G+ +LE ++P+
Sbjct: 141 IADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPF 200
Query: 125 S--ECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQ 181
+ ++ + + G P+ A+ P+ + FI CL +R SA +LL+ PF++
Sbjct: 201 LPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIK 260
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 4e-31
Identities = 58/180 (32%), Positives = 97/180 (53%), Gaps = 13/180 (7%)
Query: 9 GNLRQYRKKHKNVDI----KVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHG 64
G+L Q KK K + I +W Q+ L YLHS I+HRD+K NIF+ N G
Sbjct: 84 GDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK--ILHRDIKPQNIFLTSN-G 140
Query: 65 EVKIGDLGLAIAMQQPT--ARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTFE 121
VK+GD G++ + A++V+GTP +++PEL + + YN DI+S G + E+ T +
Sbjct: 141 LVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLK 200
Query: 122 YPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFL 180
+P+ E +N ++ K+ G P ++ + +++ + L ER S +L+ PF+
Sbjct: 201 HPF-EGENLLELALKILKGQYPPIPSQYSS-ELRNLVSSLLQKDPEERPSIAQILQSPFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 4e-31
Identities = 69/190 (36%), Positives = 106/190 (55%), Gaps = 17/190 (8%)
Query: 4 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNH 63
E + G L + + + +D VI+ + Q+L GL YLHSH I+HRD+K NIF++ N
Sbjct: 79 EYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHG--IVHRDIKPANIFLDHN- 135
Query: 64 GEVKIGDLGLAIAMQQPTAR------SVIGTPEFMAPELY----EEEYNELVDIYSFGMC 113
G +K+GD G A+ ++ T S+ GTP +MAPE+ + + DI+S G
Sbjct: 136 GVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCV 195
Query: 114 ILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVN-DPQIKGFIEKCLV--PASERLS 170
+LEM T + P+SE N QI V +G KP + P+ K F+++CL P +R +
Sbjct: 196 VLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDP-KKRPT 254
Query: 171 AKDLLKDPFL 180
A +LL+ PF+
Sbjct: 255 ASELLQHPFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 2e-30
Identities = 61/159 (38%), Positives = 86/159 (54%), Gaps = 17/159 (10%)
Query: 31 RQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR--SVIGT 88
Q L GL YLHS+ IHRD+K NI +N G+ K+ D G++ + A+ +VIGT
Sbjct: 106 YQTLKGLEYLHSNK--KIHRDIKAGNILLN-EEGQAKLADFGVSGQLTDTMAKRNTVIGT 162
Query: 89 PEFMAPELYEEE-YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK---PA 144
P +MAPE+ +E YN DI+S G+ +EM + PYS+ IF I P
Sbjct: 163 PFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM-----IPNKPPP 217
Query: 145 SLAKVND--PQIKGFIEKCLV-PASERLSAKDLLKDPFL 180
+L+ P+ F++KCLV ER SA LL+ PF+
Sbjct: 218 TLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 2e-28
Identities = 62/183 (33%), Positives = 97/183 (53%), Gaps = 11/183 (6%)
Query: 4 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNH 63
E G+++ K + + V + + RQIL G+ YLHS+ I+HRD+K NI +
Sbjct: 84 EYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNM--IVHRDIKGANILRDSA- 140
Query: 64 GEVKIGDLGLA-----IAMQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEM 117
G VK+GD G + I +SV GTP +M+PE+ E Y D++S G ++EM
Sbjct: 141 GNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEM 200
Query: 118 VTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 176
+T + P++E + A IFK T P + V P + F+ + V A +R SA++LL+
Sbjct: 201 LTEKPPWAEFEAMAAIFKIATQPTNPQLPSHV-SPDARNFLRRTFVENAKKRPSAEELLR 259
Query: 177 DPF 179
F
Sbjct: 260 HFF 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 7e-28
Identities = 61/183 (33%), Positives = 94/183 (51%), Gaps = 22/183 (12%)
Query: 31 RQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR--SVIGT 88
R++L GL YLH IHRD+K NI ++ G+VK+ D G++ + ++ + +GT
Sbjct: 105 REVLLGLEYLHEEGK--IHRDIKAANILLS-EEGDVKLADFGVSGQLTSTMSKRNTFVGT 161
Query: 89 PEFMAPELY-EEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI---KPA 144
P +MAPE+ + Y+E DI+S G+ +E+ E P S+ +P +V I P
Sbjct: 162 PFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSD-LHPM----RVLFLIPKNNPP 216
Query: 145 SLAKVN-DPQIKGFIEKCLV--PASERLSAKDLLKDPFLQVENQKEPICDPLKLPIQSLK 201
SL K F+ CL P ER SAK+LLK F ++ K+ L L I+ +K
Sbjct: 217 SLEGNKFSKPFKDFVSLCLNKDPK-ERPSAKELLKHKF--IKKAKKT--SYLTLLIERIK 271
Query: 202 MLR 204
+
Sbjct: 272 KWK 274
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 3e-27
Identities = 60/207 (28%), Positives = 92/207 (44%), Gaps = 43/207 (20%)
Query: 10 NLRQY-RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKI 68
+L++Y K+ + +IK+ Q+L GL Y HSH I+HRDLK NI +N + G +K+
Sbjct: 83 DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR--ILHRDLKPQNILINRD-GVLKL 139
Query: 69 GDLGLA----IAMQQPTARSVIGTPEFMAPELY--EEEYNELVDIYSFGMCILEMVTF-- 120
D GLA I ++ T V T + APE+ + Y+ VDI+S G EM+T
Sbjct: 140 ADFGLARAFGIPLRTYTHEVV--TLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKP 197
Query: 121 ------------------------EYP-YSECKNPAQIFKKVTSGIKPASLAKVNDPQIK 155
+P ++ + F K + DP+
Sbjct: 198 LFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFP-PKDLEKVLPRLDPEGI 256
Query: 156 GFIEKCLV--PASERLSAKDLLKDPFL 180
+ K L PA +R+SAK+ LK P+
Sbjct: 257 DLLSKMLQYNPA-KRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 4e-27
Identities = 62/209 (29%), Positives = 96/209 (45%), Gaps = 38/209 (18%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 60
+ E +G L QY +K+ ++D K + +A +IL L YLHS IIHRDLK +NI ++
Sbjct: 79 FVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG--IIHRDLKPENILLD 136
Query: 61 GNHGEVKIGDLGLAIAM----------------------QQPTARSVIGTPEFMAPELYE 98
+ +KI D G A + + S +GT E+++PEL
Sbjct: 137 KD-MHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLN 195
Query: 99 EEY-NELVDIYSFGMCIL-EMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKG 156
E+ + D+++ G CI+ +M+T + P+ N F+K+ S P K
Sbjct: 196 EKPAGKSSDLWALG-CIIYQMLTGKPPFR-GSNEYLTFQKILKL--EYSFPPNFPPDAKD 251
Query: 157 FIEKCLV--PASERLSAKD----LLKDPF 179
IEK LV P +RL + L PF
Sbjct: 252 LIEKLLVLDP-QDRLGVNEGYDELKAHPF 279
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 1e-26
Identities = 53/186 (28%), Positives = 95/186 (51%), Gaps = 13/186 (6%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 60
++ E G L + K + + +A +I+ L YLHS II+RDLK +NI ++
Sbjct: 70 LVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLG--IIYRDLKPENILLD 127
Query: 61 GNHGEVKIGDLGLA--IAMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEM 117
G +K+ D GLA ++ + + GTPE++APE L + Y + VD +S G+ + EM
Sbjct: 128 -ADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEM 186
Query: 118 VTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERL---SAKD 173
+T + P+ ++ +I++K+ P + P+ + I L ++RL A++
Sbjct: 187 LTGKPPF-YAEDRKEIYEKILK--DPLRFPEFLSPEARDLISGLLQKDPTKRLGSGGAEE 243
Query: 174 LLKDPF 179
+ PF
Sbjct: 244 IKAHPF 249
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 3e-26
Identities = 67/166 (40%), Positives = 92/166 (55%), Gaps = 18/166 (10%)
Query: 26 IKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IAMQQPTAR 83
I + +QIL GL YLH + I+HRD+K DN+ VN G VKI D G + +A P
Sbjct: 110 IIFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTE 167
Query: 84 SVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTFEYPYSECKNP-AQIFK---- 135
+ GT ++MAPE+ ++ Y DI+S G I+EM T + P+ E P A +FK
Sbjct: 168 TFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMF 227
Query: 136 KVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFL 180
K+ I P SL+ + K FI +C P +R SA DLL+DPFL
Sbjct: 228 KIHPEI-PESLSA----EAKNFILRCFEPDPDKRASAHDLLQDPFL 268
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 7e-26
Identities = 53/191 (27%), Positives = 88/191 (46%), Gaps = 27/191 (14%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIK--NWARQILHGLVYLHSHNPPIIHRDLKCDNIF 58
++ E G+L Y +K++ ++ + ++A QI G+ YL S N IHRDL N
Sbjct: 78 IVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN--FIHRDLAARNCL 135
Query: 59 VNGNHGEVKIGDLGLAIAMQQPTARSVIGTPE---FMAPE-LYEEEYNELVDIYSFGMCI 114
V N VKI D GL+ + V G +MAPE L E ++ D++SFG+ +
Sbjct: 136 VGENLV-VKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLL 194
Query: 115 LEMVTF-EYPYSECKNPAQIFKKVTSGIK-------PASLAKVNDPQIKGFIEKCLVP-A 165
E+ T E PY N A++ + + G + P L K+ + +C
Sbjct: 195 WEIFTLGEEPYPGMSN-AEVLEYLKKGYRLPKPPNCPPELYKL--------MLQCWAEDP 245
Query: 166 SERLSAKDLLK 176
+R + +L++
Sbjct: 246 EDRPTFSELVE 256
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 2e-25
Identities = 62/183 (33%), Positives = 95/183 (51%), Gaps = 9/183 (4%)
Query: 2 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG 61
I E +G+LRQ KK ++ + Q+L GL YLH +IHRD+K NI
Sbjct: 77 ILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG--VIHRDIKAANILTTK 134
Query: 62 NHGEVKIGDLGLA--IAMQQPTARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMV 118
+ G VK+ D G+A + SV+GTP +MAPE+ E + DI+S G ++E++
Sbjct: 135 D-GVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELL 193
Query: 119 TFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKD 177
T PY + A +F+ V P L + P++K F+ +C + R +AK LLK
Sbjct: 194 TGNPPYYDLNPMAALFRIVQDDHPP--LPEGISPELKDFLMQCFQKDPNLRPTAKQLLKH 251
Query: 178 PFL 180
P++
Sbjct: 252 PWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 57/169 (33%), Positives = 96/169 (56%), Gaps = 11/169 (6%)
Query: 18 HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--I 75
H ++ + I +L L +LH+ +IHRD+K D+I + + G VK+ D G +
Sbjct: 109 HTRMNEEQIATVCLAVLKALSFLHAQG--VIHRDIKSDSILLTSD-GRVKLSDFGFCAQV 165
Query: 76 AMQQPTARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIF 134
+ + P +S++GTP +MAPE+ Y VDI+S G+ ++EMV E PY + P Q
Sbjct: 166 SKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFN-EPPLQAM 224
Query: 135 KKVTSGIKPAS--LAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 180
K++ + P L KV+ P+++ F+++ LV ++R +A +LL PFL
Sbjct: 225 KRIRDNLPPKLKNLHKVS-PRLRSFLDRMLVRDPAQRATAAELLNHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 3e-25
Identities = 56/163 (34%), Positives = 84/163 (51%), Gaps = 19/163 (11%)
Query: 31 RQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARS------ 84
+++L GL YLHS+ IHRD+K NI + G G VKI D G++ ++ R+
Sbjct: 109 KEVLKGLEYLHSNG--QIHRDIKAGNILL-GEDGSVKIADFGVSASLADGGDRTRKVRKT 165
Query: 85 VIGTPEFMAPELYEEE--YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK 142
+GTP +MAPE+ E+ Y+ DI+SFG+ +E+ T PYS+ P ++
Sbjct: 166 FVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYP-PMKVLMLTLQN-D 223
Query: 143 PASL-----AKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPF 179
P SL K + I CL S+R +A++LLK F
Sbjct: 224 PPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKF 266
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 6e-25
Identities = 64/188 (34%), Positives = 102/188 (54%), Gaps = 10/188 (5%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 60
+ E G+++ K + + V + + RQIL G+ YLHS+ I+HRD+K NI +
Sbjct: 83 IFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM--IVHRDIKGANILRD 140
Query: 61 GNHGEVKIGDLGLA-----IAMQQPTARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCI 114
+ G VK+GD G + I M RSV GTP +M+PE+ E Y D++S G +
Sbjct: 141 -SAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTV 199
Query: 115 LEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDL 174
+EM+T + P++E + A IFK T P + +++ + F+ V A R SA++L
Sbjct: 200 VEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISE-HARDFLGCIFVEARHRPSAEEL 258
Query: 175 LKDPFLQV 182
L+ PF Q+
Sbjct: 259 LRHPFAQL 266
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 3e-24
Identities = 53/180 (29%), Positives = 94/180 (52%), Gaps = 10/180 (5%)
Query: 8 SGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPP---IIHRDLKCDNIFVNGNHG 64
+ +++ +K+ K ++ + I Q+L L H+ + P ++HRDLK NIF++ N+
Sbjct: 89 AQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANN- 147
Query: 65 EVKIGDLGLAIAMQQPT--ARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFE 121
VK+GD GLA + + A++ +GTP +M+PE L Y+E DI+S G I E+
Sbjct: 148 NVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALS 207
Query: 122 YPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCL-VPASERLSAKDLLKDPFL 180
P+ +N Q+ K+ G + ++ I+ L V +R S ++LL+ P +
Sbjct: 208 PPF-TARNQLQLASKIKEGKFR-RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 57/172 (33%), Positives = 93/172 (54%), Gaps = 16/172 (9%)
Query: 31 RQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR--SVIGT 88
RQ+L L +LHSH +IHRDLK NI + G+VK+ D G++ + + + IGT
Sbjct: 110 RQMLEALNFLHSHK--VIHRDLKAGNILLT-LDGDVKLADFGVSAKNKSTLQKRDTFIGT 166
Query: 89 PEFMAPELYEEE------YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK 142
P +MAPE+ E Y+ DI+S G+ ++E+ E P+ E NP ++ K+ +
Sbjct: 167 PYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHEL-NPMRVLLKILKS-E 224
Query: 143 PASLAKVN--DPQIKGFIEKCLVPASE-RLSAKDLLKDPFLQVENQKEPICD 191
P +L + + F++ CLV + R +A +LLK PF+ ++ + I D
Sbjct: 225 PPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQSDNKAIKD 276
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 3e-24
Identities = 51/190 (26%), Positives = 84/190 (44%), Gaps = 26/190 (13%)
Query: 1 MITELFTSGNLRQY-RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV 59
++ E G+L Y RK + + + ++A QI G+ YL S N IHRDL N V
Sbjct: 78 IVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESKN--FIHRDLAARNCLV 135
Query: 60 NGNHGEVKIGDLGLAIAMQQPTARSVIGTPE---FMAPE-LYEEEYNELVDIYSFGMCIL 115
N VKI D GL+ + G +MAPE L E ++ D++SFG+ +
Sbjct: 136 GENLV-VKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLW 194
Query: 116 EMVTF-EYPYSECKNPAQIFKKVTSGIK-------PASLAKVNDPQIKGFIEKCLVP-AS 166
E+ T E PY N ++ + + +G + P L + + +C
Sbjct: 195 EIFTLGEQPYPGMSN-EEVLEYLKNGYRLPQPPNCPPELYDL--------MLQCWAEDPE 245
Query: 167 ERLSAKDLLK 176
+R + +L++
Sbjct: 246 DRPTFSELVE 255
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 6e-24
Identities = 61/274 (22%), Positives = 97/274 (35%), Gaps = 30/274 (10%)
Query: 1 MITELFTSGNLRQYRKKH---KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 57
++ E G+L KK + QIL L YLHS IIHRD+K +NI
Sbjct: 75 LVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG--IIHRDIKPENI 132
Query: 58 FVNGNHGEVKIGDLGLAIAM--------QQPTARSVIGTPEFMAPELY----EEEYNELV 105
++ + VK+ D GLA + + +GTP +MAPE+ +
Sbjct: 133 LLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSS 192
Query: 106 DIYSFGMCILEMVTFEYPY---SECKNPAQIFKKVTSGIKPASLAKVN-------DPQIK 155
DI+S G+ + E++T P+ +Q K + P+ + ++
Sbjct: 193 DIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAAS 252
Query: 156 GFIEKCLVP-ASERLSAKDLLKDPFLQVENQKE--PICDPLKLPIQSLKMLRLPMSGPSS 212
++K L RLS+ L L KE L++ P
Sbjct: 253 DLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKPDDSAPLRLSLPPSLEALI 312
Query: 213 MDIDSDYKQLSLSTCTESNNGSPHCPVLEFQRMH 246
++S S +SN P H
Sbjct: 313 SSLNSLAISGSDLKLDDSNFSKELAPNGVSSSPH 346
|
Length = 384 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 8e-24
Identities = 58/178 (32%), Positives = 91/178 (51%), Gaps = 11/178 (6%)
Query: 9 GNLRQY---RKKHKN-VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHG 64
G+L + RKK + + + I Q+L GL LH I+HRDLK NI + N
Sbjct: 84 GDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK--ILHRDLKSANILLVAN-D 140
Query: 65 EVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTFEYP 123
VKIGDLG++ +++ A++ IGTP +MAPE+++ Y+ DI+S G + EM TF P
Sbjct: 141 LVKIGDLGISKVLKKNMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPP 200
Query: 124 YSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFL 180
+ E ++ + KV G P + + ++ FI L R + +L P +
Sbjct: 201 F-EARSMQDLRYKVQRGKYPP-IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV 256
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 99.5 bits (249), Expect = 2e-23
Identities = 43/148 (29%), Positives = 68/148 (45%), Gaps = 13/148 (8%)
Query: 1 MITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV 59
++TE G+L + +KH + +K + A QI G+ YL S N +HRDL N V
Sbjct: 78 IVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESKN--FVHRDLAARNCLV 135
Query: 60 NGNHGEVKIGDLGLAIAMQQPTARSVIGTPEF-----MAPELYEE-EYNELVDIYSFGMC 113
N VKI D GL+ + MAPE ++ ++ D++SFG+
Sbjct: 136 TEN-LVVKISDFGLSRDI-YEDDYYRKRGGGKLPIKWMAPESLKDGKFTSKSDVWSFGVL 193
Query: 114 ILEMVTF-EYPYSECKNPAQIFKKVTSG 140
+ E+ T E PY N ++ + + G
Sbjct: 194 LWEIFTLGEQPYPGMSN-EEVLELLEDG 220
|
Length = 258 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 2e-23
Identities = 58/186 (31%), Positives = 101/186 (54%), Gaps = 11/186 (5%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWAR--QILHGLVYLHSHNPPIIHRDLKCDNIF 58
++ E +G+L + K + + + W QIL GL +LHS I+HRD+K N+F
Sbjct: 76 IVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK--ILHRDIKSLNLF 133
Query: 59 VNGNHGEVKIGDLGLAIAMQQPT--ARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCIL 115
++ VKIGDLG+A + T A +++GTP +++PEL E++ YNE D+++ G+ +
Sbjct: 134 LDAYD-NVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLY 192
Query: 116 EMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCL-VPASERLSAKDL 174
E T ++P+ + N + K+ G+ P + Q+ I++CL +R L
Sbjct: 193 ECCTGKHPF-DANNQGALILKIIRGVFPPVSQMYS-QQLAQLIDQCLTKDYRQRPDTFQL 250
Query: 175 LKDPFL 180
L++P L
Sbjct: 251 LRNPSL 256
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 2e-23
Identities = 63/187 (33%), Positives = 100/187 (53%), Gaps = 10/187 (5%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 60
+ E G+++ K + + V + + RQIL G+ YLHS+ I+HRD+K NI +
Sbjct: 83 IFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNM--IVHRDIKGANILRD 140
Query: 61 GNHGEVKIGDLGLA-----IAMQQPTARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCI 114
+ G VK+GD G + I + +SV GTP +M+PE+ E Y DI+S G +
Sbjct: 141 -SVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTV 199
Query: 115 LEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDL 174
+EM+T + P++E + A IFK T P V+D + F+++ V A R SA +L
Sbjct: 200 VEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSD-HCRDFLKRIFVEAKLRPSADEL 258
Query: 175 LKDPFLQ 181
L+ F+
Sbjct: 259 LRHTFVH 265
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 99.2 bits (247), Expect = 3e-23
Identities = 51/164 (31%), Positives = 84/164 (51%), Gaps = 12/164 (7%)
Query: 25 VIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARS 84
VI N+ Q+L GL YLH + IIHRD+K N+ ++ ++I D G A + +
Sbjct: 104 VIINYTEQLLRGLSYLHENQ--IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGA 161
Query: 85 ------VIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYS--ECKNPAQIFK 135
++GT FMAPE L E+Y D++S G I+EM T + P++ + N +
Sbjct: 162 GEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIF 221
Query: 136 KVTSGIKPASLAKVNDPQIKGFIEKCL-VPASERLSAKDLLKDP 178
K+ S S+ + P ++ +CL + +R +++LLK P
Sbjct: 222 KIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHP 265
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.8 bits (244), Expect = 7e-23
Identities = 53/159 (33%), Positives = 79/159 (49%), Gaps = 14/159 (8%)
Query: 31 RQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR--SVIGT 88
R+ L GL YLH IHRD+K NI + G+VK+ D G++ + A+ S IGT
Sbjct: 108 RETLKGLAYLHETG--KIHRDIKGANILLT-EDGDVKLADFGVSAQLTATIAKRKSFIGT 164
Query: 89 PEFMAPELYEEE----YNELVDIYSFGMCILEMVTFEYPYSECKNPAQ-IFKKVTSGIKP 143
P +MAPE+ E Y+ DI++ G+ +E+ + P + +P + +F S P
Sbjct: 165 PYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDL-HPMRALFLISKSNFPP 223
Query: 144 ASLAKVN--DPQIKGFIEKCLVPA-SERLSAKDLLKDPF 179
L P FI+KCL +R +A LL+ PF
Sbjct: 224 PKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 3e-22
Identities = 62/185 (33%), Positives = 99/185 (53%), Gaps = 10/185 (5%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 60
+ E G+++ K + + V + + RQIL G+ YLHS+ I+HRD+K NI +
Sbjct: 83 IFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNM--IVHRDIKGANILRD 140
Query: 61 GNHGEVKIGDLGLA-----IAMQQPTARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCI 114
+ G VK+GD G + I M +SV GTP +M+PE+ E Y D++S +
Sbjct: 141 -SAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTV 199
Query: 115 LEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDL 174
+EM+T + P++E + A IFK T KP V+D + F+++ V R +A+ L
Sbjct: 200 VEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSD-ACRDFLKQIFVEEKRRPTAEFL 258
Query: 175 LKDPF 179
L+ PF
Sbjct: 259 LRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 95.5 bits (238), Expect = 5e-22
Identities = 54/188 (28%), Positives = 97/188 (51%), Gaps = 9/188 (4%)
Query: 1 MITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV 59
+ E G+L + K+ + +++ A +L GL YLH IIHRD+K NI V
Sbjct: 76 ICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLH-EKHKIIHRDVKPSNILV 134
Query: 60 NGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMV 118
N + G++K+ D G++ + A++ +GT +MAPE + +Y+ DI+S G+ ++E+
Sbjct: 135 N-SRGQIKLCDFGVSGQLVNSLAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELA 193
Query: 119 TFEYPYSEC----KNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKD 173
T +PY ++ + + + P + P + F+ CL+ ER S K+
Sbjct: 194 TGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKE 253
Query: 174 LLKDPFLQ 181
LL+ PF++
Sbjct: 254 LLEHPFIK 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 7e-22
Identities = 58/166 (34%), Positives = 95/166 (57%), Gaps = 15/166 (9%)
Query: 25 VIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA-------IAM 77
+++N+ RQIL GL YLH+ IIHRD+K NI V+ N G +KI D G++ ++
Sbjct: 107 LVRNFVRQILKGLNYLHNRG--IIHRDIKGANILVD-NKGGIKISDFGISKKLEANSLST 163
Query: 78 QQPTAR-SVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFK 135
+ AR S+ G+ +MAPE+ ++ Y DI+S G ++EM+T ++P+ +C IF
Sbjct: 164 KTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIF- 222
Query: 136 KVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFL 180
K+ P + ++ + F+EK ++R +A +LLK PFL
Sbjct: 223 KIGENASPEIPSNISS-EAIDFLEKTFEIDHNKRPTAAELLKHPFL 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 7e-22
Identities = 52/172 (30%), Positives = 90/172 (52%), Gaps = 11/172 (6%)
Query: 1 MITELFTSGNLRQ----YRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDN 56
++ EL +G+L + ++K+ + + + I + Q+ L ++HS I+HRD+K N
Sbjct: 79 IVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR--IMHRDIKPAN 136
Query: 57 IFVNGNHGEVKIGDLGLAIAMQQPT--ARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMC 113
+F+ G VK+GDLGL T A S++GTP +M+PE ++E YN DI+S G
Sbjct: 137 VFITAT-GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCL 195
Query: 114 ILEMVTFEYP-YSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP 164
+ EM + P Y + N + KK+ P A +++ + +C+ P
Sbjct: 196 LYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLVSRCINP 247
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.9 bits (237), Expect = 8e-22
Identities = 47/192 (24%), Positives = 82/192 (42%), Gaps = 21/192 (10%)
Query: 1 MITELFTSGNLRQYRKKHKN---------VDIKVIKNWARQILHGLVYLHSHNPPIIHRD 51
++ E G+L Y +K + + +K + ++A QI G+ YL S +HRD
Sbjct: 73 LVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK--FVHRD 130
Query: 52 LKCDNIFVNGNHGEVKIGDLGLAIAMQQPT-ARSVIGTPE---FMAPE-LYEEEYNELVD 106
L N V G VKI D GL+ + R G +MAPE L + + D
Sbjct: 131 LAARNCLV-GEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSD 189
Query: 107 IYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP- 164
++SFG+ + E+ T PY N ++ + + G + D ++ + C
Sbjct: 190 VWSFGVLLWEIFTLGATPYPGLSN-EEVLEYLRKGYRLPKPEYCPD-ELYELMLSCWQLD 247
Query: 165 ASERLSAKDLLK 176
+R + +L++
Sbjct: 248 PEDRPTFSELVE 259
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 94.6 bits (236), Expect = 9e-22
Identities = 51/171 (29%), Positives = 84/171 (49%), Gaps = 19/171 (11%)
Query: 25 VIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGL--------AIA 76
V + + +I+ L YLHS+ IIHRDLK DNI ++ N G +K+ D GL I
Sbjct: 94 VARIYIAEIVLALEYLHSNG--IIHRDLKPDNILIDSN-GHLKLTDFGLSKVGLVRRQIN 150
Query: 77 MQQPTARS--VIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQI 133
+ ++GTP+++APE + + +++ VD +S G + E + P+ + P +I
Sbjct: 151 LNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHG-ETPEEI 209
Query: 134 FKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASE-RL---SAKDLLKDPFL 180
F+ + +G + I K LVP E RL S +++ PF
Sbjct: 210 FQNILNGKIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFF 260
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 1e-21
Identities = 54/157 (34%), Positives = 84/157 (53%), Gaps = 11/157 (7%)
Query: 31 RQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR--SVIGT 88
R++L L Y+H +IHRD+K NI V N G VK+ D G+A + Q +++ + +GT
Sbjct: 108 REVLVALKYIHKV--GVIHRDIKAANILVT-NTGNVKLCDFGVAALLNQNSSKRSTFVGT 164
Query: 89 PEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASL 146
P +MAPE+ E Y+ DI+S G+ I EM T PYS+ + + + P
Sbjct: 165 PYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSD-VDAFRAMMLIPKSKPPRLE 223
Query: 147 AKVNDPQIKGFIEKCL--VPASERLSAKDLLKDPFLQ 181
++ F+ CL P ERLSA++LLK +++
Sbjct: 224 DNGYSKLLREFVAACLDEEPK-ERLSAEELLKSKWIK 259
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 7e-21
Identities = 60/169 (35%), Positives = 96/169 (56%), Gaps = 11/169 (6%)
Query: 18 HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--I 75
H ++ + I +L L LH+ +IHRD+K D+I + + G VK+ D G +
Sbjct: 110 HTRMNEEQIAAVCLAVLKALSVLHAQG--VIHRDIKSDSILLT-HDGRVKLSDFGFCAQV 166
Query: 76 AMQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIF 134
+ + P +S++GTP +MAPEL Y VDI+S G+ ++EMV E PY + P +
Sbjct: 167 SKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN-EPPLKAM 225
Query: 135 KKVTSGIKP--ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 180
K + + P +L KV+ P +KGF+++ LV ++R +A +LLK PFL
Sbjct: 226 KMIRDNLPPKLKNLHKVS-PSLKGFLDRLLVRDPAQRATAAELLKHPFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 2e-20
Identities = 57/157 (36%), Positives = 89/157 (56%), Gaps = 9/157 (5%)
Query: 31 RQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IAMQQPTARSVIGT 88
R+ L L +LHS+ +IHRD+K DNI + G G VK+ D G I +Q +++GT
Sbjct: 122 RECLQALEFLHSNQ--VIHRDIKSDNILL-GMDGSVKLTDFGFCAQITPEQSKRSTMVGT 178
Query: 89 PEFMAPELY-EEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQ-IFKKVTSGIKPASL 146
P +MAPE+ + Y VDI+S G+ +EMV E PY +NP + ++ T+G
Sbjct: 179 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLN-ENPLRALYLIATNGTPELQN 237
Query: 147 AKVNDPQIKGFIEKCL-VPASERLSAKDLLKDPFLQV 182
+ + F+ +CL + +R SAK+LL+ PFL++
Sbjct: 238 PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKI 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 5e-20
Identities = 57/153 (37%), Positives = 84/153 (54%), Gaps = 9/153 (5%)
Query: 33 ILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IAMQQPTARSVIGTPE 90
+L L YLHS +IHRD+K D+I + + G VK+ D G I+ P +S++GTP
Sbjct: 126 VLQALCYLHSQG--VIHRDIKSDSILLTLD-GRVKLSDFGFCAQISKDVPKRKSLVGTPY 182
Query: 91 FMAPELYEEE-YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP-ASLAK 148
+MAPE+ Y VDI+S G+ ++EMV E PY +P Q K++ P A
Sbjct: 183 WMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFS-DSPVQAMKRLRDSPPPKLKNAH 241
Query: 149 VNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 180
P ++ F+E+ L ER +A++LL PFL
Sbjct: 242 KISPVLRDFLERMLTREPQERATAQELLDHPFL 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 5e-20
Identities = 51/175 (29%), Positives = 85/175 (48%), Gaps = 14/175 (8%)
Query: 16 KKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGL-- 73
+ + + ++++ + Q+L GL YLHS I+HRDLK DN+ V+ + G KI D G+
Sbjct: 100 RTYGRFEEQLVRFFTEQVLEGLAYLHSKG--ILHRDLKADNLLVDAD-GICKISDFGISK 156
Query: 74 --AIAMQQPTARSVIGTPEFMAPE---LYEEEYNELVDIYSFGMCILEMVTFEYPYSECK 128
S+ G+ +MAPE Y + Y+ VDI+S G +LEM P+S+ +
Sbjct: 157 KSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEE 216
Query: 129 NPAQIFK----KVTSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDLLKDPF 179
A +FK + I P ++ + + R +A++LL+ PF
Sbjct: 217 AIAAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 5e-20
Identities = 55/188 (29%), Positives = 86/188 (45%), Gaps = 14/188 (7%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 60
++ +L G+LR + + + +K W +I+ L YLHS IIHRD+K DNI ++
Sbjct: 77 LVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKG--IIHRDIKPDNILLD 134
Query: 61 GNHGEVKIGDLGLAIAMQ-QPTARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMV 118
G V I D +A + S GTP +MAPE+ + Y+ VD +S G+ E +
Sbjct: 135 -EQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECL 193
Query: 119 TFEYPY---SECKNPAQIFKKVTSGIK-PASLAKVNDPQIKGFIEKCLVPASERLS--AK 172
+ PY S K+ T+ + PA+ + I +E +RL K
Sbjct: 194 RGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKLLE---RDPQKRLGDNLK 250
Query: 173 DLLKDPFL 180
DL P+
Sbjct: 251 DLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.6 bits (223), Expect = 7e-20
Identities = 50/165 (30%), Positives = 82/165 (49%), Gaps = 24/165 (14%)
Query: 31 RQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR--SVIGT 88
R+ L GL YLH + +IHRD+K NI + N EVK+ D G++ + R + IGT
Sbjct: 120 RETLRGLAYLHENK--VIHRDIKGQNILLTKN-AEVKLVDFGVSAQLDSTLGRRNTFIGT 176
Query: 89 PEFMAPEL------YEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPA----QIFKKVT 138
P +MAPE+ + Y+ D++S G+ +E+ + P + +P +I +
Sbjct: 177 PYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCD-MHPMRALFKIPRNPP 235
Query: 139 SGIKPASL--AKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFL 180
+K K ND FI +CL+ +R ++LL+ PF+
Sbjct: 236 PTLKSPENWSKKFND-----FISECLIKNYEQRPFMEELLEHPFI 275
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 1e-19
Identities = 57/183 (31%), Positives = 95/183 (51%), Gaps = 12/183 (6%)
Query: 14 YRKKH-KNVDIK--VIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGD 70
Y+K + K + I ++ A I+ L YLHS +IHRD+K N+ +N +G+VK+ D
Sbjct: 90 YKKVYDKGLTIPEDILGKIAVSIVKALEYLHS-KLSVIHRDVKPSNVLIN-RNGQVKLCD 147
Query: 71 LGLAIAMQQPTARSV-IGTPEFMAPELYEEE-----YNELVDIYSFGMCILEMVTFEYPY 124
G++ + A+++ G +MAPE E Y+ D++S G+ ++E+ T +PY
Sbjct: 148 FGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPY 207
Query: 125 SECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVE 183
K P Q K+V P A+ P+ + F+ KCL ER + +LL+ PF ++
Sbjct: 208 DSWKTPFQQLKQVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELH 267
Query: 184 NQK 186
K
Sbjct: 268 LSK 270
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 2e-19
Identities = 57/172 (33%), Positives = 91/172 (52%), Gaps = 16/172 (9%)
Query: 26 IKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR-- 83
I+ +Q L L YLH + IIHRDLK NI + G++K+ D G++ + R
Sbjct: 105 IRVVCKQTLEALNYLHENK--IIHRDLKAGNILFTLD-GDIKLADFGVSAKNTRTIQRRD 161
Query: 84 SVIGTPEFMAPELY------EEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKV 137
S IGTP +MAPE+ + Y+ D++S G+ ++EM E P+ E NP ++ K+
Sbjct: 162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHEL-NPMRVLLKI 220
Query: 138 TSGIKPASLAKVN--DPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQK 186
+P +LA+ + + K F++KCL R + LL+ PF+ V + K
Sbjct: 221 AKS-EPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNSNK 271
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 2e-19
Identities = 55/171 (32%), Positives = 97/171 (56%), Gaps = 11/171 (6%)
Query: 18 HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--I 75
H ++ + I +L L YLH+ +IHRD+K D+I + + G +K+ D G +
Sbjct: 112 HTRMNEEQIATVCLSVLRALSYLHNQG--VIHRDIKSDSILLTSD-GRIKLSDFGFCAQV 168
Query: 76 AMQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIF 134
+ + P +S++GTP +MAPE+ Y VDI+S G+ ++EM+ E PY + P Q
Sbjct: 169 SKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFN-EPPLQAM 227
Query: 135 KKVTSGIKP--ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQV 182
+++ + P KV+ ++GF++ LV S+R +A++LL+ PFL++
Sbjct: 228 RRIRDNLPPRVKDSHKVSS-VLRGFLDLMLVREPSQRATAQELLQHPFLKL 277
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 87.3 bits (217), Expect = 3e-19
Identities = 51/191 (26%), Positives = 86/191 (45%), Gaps = 14/191 (7%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 60
M+ E G L + D + + ++ YLH+ II+RDLK +N+ ++
Sbjct: 70 MLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRG--IIYRDLKPENLLLD 127
Query: 61 GNHGEVKIGDLGLAIAMQQPT-ARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMV 118
N G VK+ D G A ++ + GTPE++APE+ + Y+ VD +S G+ + E++
Sbjct: 128 SN-GYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELL 186
Query: 119 TFEYPYSECK-NPAQIFKKVTSGIKPASLAKVNDPQIKGFIEK--CLVPASERL-----S 170
T P+ E +P +I+ + G D K I++ P ERL
Sbjct: 187 TGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPE-ERLGNLKGG 245
Query: 171 AKDLLKDPFLQ 181
KD+ K +
Sbjct: 246 IKDIKKHKWFN 256
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 4e-19
Identities = 53/174 (30%), Positives = 88/174 (50%), Gaps = 16/174 (9%)
Query: 14 YRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGL 73
++K + V+I I L GL YLHSH IHRD+K NI + G VK+ D G
Sbjct: 108 HKKPLQEVEIAAI---CHGALQGLAYLHSHE--RIHRDIKAGNILLT-EPGTVKLADFGS 161
Query: 74 AIAMQQPTARSVIGTPEFMAPELY----EEEYNELVDIYSFGMCILEMVTFEYPYSECKN 129
A ++ P A S +GTP +MAPE+ E +Y+ VD++S G+ +E+ + P
Sbjct: 162 A-SLVSP-ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 219
Query: 130 PAQIFKKVTSGIKPASLAKVNDPQ-IKGFIEKCLV-PASERLSAKDLLKDPFLQ 181
+ ++ + +L+ + + F++ CL +R S+++LLK F+
Sbjct: 220 MSALYHIAQN--DSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVL 271
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 2e-18
Identities = 50/159 (31%), Positives = 87/159 (54%), Gaps = 9/159 (5%)
Query: 26 IKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM--QQPTAR 83
+ W QI L YLH + I+HRDLK N+F+ + +K+GDLG+A + Q A
Sbjct: 104 VVEWFVQIAMALQYLHEKH--ILHRDLKTQNVFLTRTN-IIKVGDLGIARVLENQCDMAS 160
Query: 84 SVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK 142
++IGTP +M+PEL+ + YN D+++ G C+ EM T ++ ++ + +++ + +
Sbjct: 161 TLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLP 220
Query: 143 PASLAKVNDPQIKGFIEKCLVPASE-RLSAKDLLKDPFL 180
P + K P++ I L E R S K +L+ P++
Sbjct: 221 P--MPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 2e-18
Identities = 56/157 (35%), Positives = 90/157 (57%), Gaps = 9/157 (5%)
Query: 31 RQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IAMQQPTARSVIGT 88
R+ L L +LH++ +IHRD+K DN+ + G G VK+ D G I +Q +++GT
Sbjct: 122 RECLQALEFLHANQ--VIHRDIKSDNVLL-GMDGSVKLTDFGFCAQITPEQSKRSTMVGT 178
Query: 89 PEFMAPELYEEE-YNELVDIYSFGMCILEMVTFEYPYSECKNPAQ-IFKKVTSGIKPASL 146
P +MAPE+ + Y VDI+S G+ +EMV E PY +NP + ++ T+G
Sbjct: 179 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLN-ENPLRALYLIATNGTPELQN 237
Query: 147 AKVNDPQIKGFIEKCL-VPASERLSAKDLLKDPFLQV 182
+ P + F+ +CL + +R SAK+LL+ PFL++
Sbjct: 238 PEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKL 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.9 bits (211), Expect = 3e-18
Identities = 40/101 (39%), Positives = 55/101 (54%), Gaps = 12/101 (11%)
Query: 26 IKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARS- 84
IK + +Q+L GL YLHS+ I+HRD+K NI +N N G +K+ D GLA + +
Sbjct: 102 IKCYMKQLLEGLQYLHSNG--ILHRDIKGSNILIN-NDGVLKLADFGLARPYTKRNSADY 158
Query: 85 ---VIGTPEFMAPELY--EEEYNELVDIYSFGMCIL-EMVT 119
VI T + PEL Y VD++S G CIL E+
Sbjct: 159 TNRVI-TLWYRPPELLLGATRYGPEVDMWSVG-CILAELFL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.2 bits (209), Expect = 5e-18
Identities = 59/201 (29%), Positives = 85/201 (42%), Gaps = 36/201 (17%)
Query: 11 LRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKI 68
L Y K + + IK+ RQ+L G+ +LHSH I+HRDLK NI V + G+VKI
Sbjct: 92 LATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR--IVHRDLKPQNILVT-SDGQVKI 148
Query: 69 GDLGLA-IAMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCIL-EMVTFE---Y 122
D GLA I + SV+ T + APE L + Y VD++S G CI E+
Sbjct: 149 ADFGLARIYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVG-CIFAELFRRRPLFR 207
Query: 123 PYSECKNPAQIFKKV---------------------TSGIKPASLAKVNDPQIKGFIEKC 161
SE +IF + + S + ++K
Sbjct: 208 GTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKM 267
Query: 162 LV--PASERLSAKDLLKDPFL 180
L P R+SA + L+ P+
Sbjct: 268 LTFNPHK-RISAFEALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 84.0 bits (207), Expect = 8e-18
Identities = 57/161 (35%), Positives = 90/161 (55%), Gaps = 17/161 (10%)
Query: 31 RQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IAMQQPTARSVIGT 88
R+ L L +LHS+ +IHRD+K DNI + G G VK+ D G I +Q +++GT
Sbjct: 122 RECLQALDFLHSNQ--VIHRDIKSDNILL-GMDGSVKLTDFGFCAQITPEQSKRSTMVGT 178
Query: 89 PEFMAPELYEEE-YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLA 147
P +MAPE+ + Y VDI+S G+ +EMV E PY +NP + + + P
Sbjct: 179 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLN-ENPLRALYLIATNGTP---- 233
Query: 148 KVNDPQ-----IKGFIEKCL-VPASERLSAKDLLKDPFLQV 182
++ +P+ + F+ +CL + R SAK+LL+ PFL++
Sbjct: 234 ELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKL 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 1e-17
Identities = 53/196 (27%), Positives = 98/196 (50%), Gaps = 19/196 (9%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHS-HNPPIIHRDLKCDNIFV 59
M E G+L + KK + ++++ A ++ GL YL++ H I+HRD+K NI V
Sbjct: 80 MCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHR--IMHRDIKPSNILV 137
Query: 60 NGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMV 118
N G++K+ D G++ + A + +GT +M+PE + +Y D++S G+ I+E+
Sbjct: 138 NS-RGQIKLCDFGVSGELINSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELA 196
Query: 119 TFEYPYSECKNPAQIFKKVTSGI----------KPASLAKVNDPQI-KGFIEKCLV-PAS 166
++P++ N + GI P L + P+ + F++ CL+ +
Sbjct: 197 LGKFPFAF-SNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPT 255
Query: 167 ERLSAKDLLK-DPFLQ 181
ER + + L PF+Q
Sbjct: 256 ERPTPQQLCAMPPFIQ 271
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 2e-17
Identities = 57/154 (37%), Positives = 87/154 (56%), Gaps = 9/154 (5%)
Query: 31 RQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IAMQQPTARSVIGT 88
R+IL GL YLHS IHRD+K N+ ++ HGEVK+ D G+A + Q + +GT
Sbjct: 108 REILKGLDYLHSEKK--IHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRNTFVGT 164
Query: 89 PEFMAPELYEEE-YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLA 147
P +MAPE+ ++ Y+ DI+S G+ +E+ E P+SE +P ++ + P
Sbjct: 165 PFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSEL-HPMKVLFLIPKNNPPTLEG 223
Query: 148 KVNDPQIKGFIEKCL-VPASERLSAKDLLKDPFL 180
+ P +K F+E CL S R +AK+LLK F+
Sbjct: 224 NYSKP-LKEFVEACLNKEPSFRPTAKELLKHKFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 2e-17
Identities = 56/192 (29%), Positives = 94/192 (48%), Gaps = 15/192 (7%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 60
+ TE G+L YRK + V+ A ++ GL YL S I+HRD+K N+ VN
Sbjct: 76 ICTEFMDGGSLDVYRK----IPEHVLGRIAVAVVKGLTYLWSLK--ILHRDVKPSNMLVN 129
Query: 61 GNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 119
G+VK+ D G++ + A++ +GT +MAPE + E+Y D++S G+ +E+
Sbjct: 130 -TRGQVKLCDFGVSTQLVNSIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELAL 188
Query: 120 FEYPYSEC-KN-----PAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCL-VPASERLSAK 172
+PY + KN P Q+ + + P + FI +C+ ER + +
Sbjct: 189 GRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPE 248
Query: 173 DLLKDPFLQVEN 184
+L+ PF+ N
Sbjct: 249 NLMDHPFIVQYN 260
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 3e-17
Identities = 56/174 (32%), Positives = 86/174 (49%), Gaps = 14/174 (8%)
Query: 26 IKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR-- 83
I+ RQ+L L YLHS IIHRDLK N+ + + G++K+ D G++ + R
Sbjct: 112 IQVICRQMLEALQYLHSMK--IIHRDLKAGNVLLTLD-GDIKLADFGVSAKNVKTLQRRD 168
Query: 84 SVIGTPEFMAPE------LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKV 137
S IGTP +MAPE + + Y+ DI+S G+ ++EM E P+ E NP ++ K+
Sbjct: 169 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL-NPMRVLLKI 227
Query: 138 TSGIKPASLAKVN-DPQIKGFIEKCLVPASE-RLSAKDLLKDPFLQVENQKEPI 189
P + + F++ L E R SA LL+ PF+ P+
Sbjct: 228 AKSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSNRPL 281
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 82.2 bits (204), Expect = 3e-17
Identities = 54/175 (30%), Positives = 93/175 (53%), Gaps = 17/175 (9%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 60
++ E G L + +K V + +A Q++ L YLHS + I++RDLK +N+ +
Sbjct: 78 LVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLD--IVYRDLKPENLLL- 134
Query: 61 GNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVT 119
+ G +KI D G A ++ T ++ GTPE++APE+ + Y + VD ++ G+ I EM+
Sbjct: 135 DSDGYIKITDFGFAKRVKGRT-YTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLA 193
Query: 120 FEYP--YSECKNPAQIFKKVTSG-IK-PASLAKVNDPQIKGFIEKCLVP-ASERL 169
YP + + NP QI++K+ G ++ P+ P K I L ++RL
Sbjct: 194 -GYPPFFDD--NPIQIYEKILEGKVRFPSFF----SPDAKDLIRNLLQVDLTKRL 241
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 3e-17
Identities = 51/185 (27%), Positives = 96/185 (51%), Gaps = 14/185 (7%)
Query: 15 RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA 74
+K+ + KV+ A +L GL YLHS IIHRD+K NI + G+VK+ D G++
Sbjct: 96 KKRGGRIGEKVLGKIAESVLKGLSYLHSRK--IIHRDIKPSNILLTRK-GQVKLCDFGVS 152
Query: 75 IAMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPY-SECKNPAQ 132
+ A + GT +MAPE + + Y+ D++S G+ +LE+ +P+ E + P
Sbjct: 153 GELVNSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLG 212
Query: 133 IFKKVTSGIKPASLAKVNDP--------QIKGFIEKCL-VPASERLSAKDLLKDPFLQVE 183
+ ++ + + ++P + K FI++CL + R + D+L+ P+++ +
Sbjct: 213 PIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQ 272
Query: 184 NQKEP 188
+K+
Sbjct: 273 MKKKV 277
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 82.6 bits (205), Expect = 3e-17
Identities = 64/227 (28%), Positives = 93/227 (40%), Gaps = 66/227 (29%)
Query: 32 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEF 91
QIL GL YLHS N +IHRDLK NI VN N ++KI D GLA + F
Sbjct: 111 QILRGLKYLHSAN--VIHRDLKPSNILVNSN-CDLKICDFGLARGVDPDED-----EKGF 162
Query: 92 M----------APE--LYEEEYNELVDIYSFGMCIL-EMVT----F-------------- 120
+ APE L Y + +DI+S G CI E++T F
Sbjct: 163 LTEYVVTRWYRAPELLLSSSRYTKAIDIWSVG-CIFAELLTRKPLFPGRDYIDQLNLIVE 221
Query: 121 --------EYPYSECKNPAQIFKKVTSGIKPASLAKV---NDPQIKGFIEKCLV--PASE 167
+ + + A+ + K L+K+ P+ +EK LV P +
Sbjct: 222 VLGTPSEEDLKFITSEK-ARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPK-K 279
Query: 168 RLSAKDLLKDPFLQV--ENQKEPICDPL---------KLPIQSLKML 203
R++A + L P+L + + EP+ P +L + LK L
Sbjct: 280 RITADEALAHPYLAQLHDPEDEPVAKPPFDFDFFDDDELTEEELKEL 326
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 4e-17
Identities = 60/210 (28%), Positives = 93/210 (44%), Gaps = 39/210 (18%)
Query: 9 GNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKI 68
G+L Q KK + ++ + +L GL YL I+HRD+K NI VN GE+K+
Sbjct: 84 GSLDQVLKKAGRIPENILGKISIAVLRGLTYLRE-KHKIMHRDVKPSNILVNSR-GEIKL 141
Query: 69 GDLGLAIAMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPY--S 125
D G++ + A S +GT +M+PE L Y DI+S G+ ++EM YP
Sbjct: 142 CDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPP 201
Query: 126 ECKNPAQIFKKVTSGIK---------------PASLA-------KVNDP----------- 152
+ K +F + S + P +A VN+P
Sbjct: 202 DAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSD 261
Query: 153 QIKGFIEKCLVP-ASERLSAKDLLKDPFLQ 181
+ + F++KCL ER K+L K PF++
Sbjct: 262 EFQDFVDKCLKKNPKERADLKELTKHPFIK 291
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 4e-17
Identities = 54/175 (30%), Positives = 93/175 (53%), Gaps = 9/175 (5%)
Query: 9 GNLRQYRKKHKN--VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEV 66
G L +Y +K N +D I ++ QIL L ++H+ I+HRDLK NI ++ + V
Sbjct: 84 GTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL--ILHRDLKTQNILLDKHKMVV 141
Query: 67 KIGDLGLA-IAMQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPY 124
KIGD G++ I + A +V+GTP +++PEL E + YN+ DI++ G + E+ + + +
Sbjct: 142 KIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAF 201
Query: 125 SECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCL-VPASERLSAKDLLKDP 178
PA + K+ SG A ++ P ++ I L + S+R ++ P
Sbjct: 202 EAANLPALVL-KIMSG-TFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.4 bits (202), Expect = 4e-17
Identities = 63/213 (29%), Positives = 90/213 (42%), Gaps = 46/213 (21%)
Query: 6 FTSGNLRQYRKKHKNV--DIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNH 63
+ GNL Q K K VI++ QIL GL ++H H HRDLK +N+ V+G
Sbjct: 79 YMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG--FFHRDLKPENLLVSGP- 135
Query: 64 GEVKIGDLGLAIAMQ-QPTARSVIGTPEFMAPE--LYEEEYNELVDIYSFGMCIL-EMVT 119
VKI D GLA ++ +P + T + APE L Y+ VDI++ G CI+ E+ T
Sbjct: 136 EVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALG-CIMAELYT 194
Query: 120 FE--YP-YSECKNPAQIFKKVT-----------SGIKPASLAKVNDPQIKG--------- 156
+P SE Q++K + G K AS PQ
Sbjct: 195 LRPLFPGSSEID---QLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPN 251
Query: 157 -------FIEKCLV--PASERLSAKDLLKDPFL 180
I+ L P +R +A L+ P+
Sbjct: 252 ASPEAIDLIKDMLRWDPK-KRPTASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 6e-17
Identities = 41/99 (41%), Positives = 62/99 (62%), Gaps = 6/99 (6%)
Query: 29 WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ--QPTARSVI 86
+ QI+ GL +LH II+RDLK +N+ ++ N G V+I DLGLA+ ++ Q +
Sbjct: 102 YTAQIISGLEHLHQRR--IIYRDLKPENVLLD-NDGNVRISDLGLAVELKDGQSKTKGYA 158
Query: 87 GTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPY 124
GTP FMAPEL + EEY+ VD ++ G+ + EM+ P+
Sbjct: 159 GTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPF 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 7e-17
Identities = 54/160 (33%), Positives = 83/160 (51%), Gaps = 10/160 (6%)
Query: 26 IKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT--AR 83
I +W QI GL H H+ I+HRD+K NIF++ N K+GD G+A + A
Sbjct: 103 ILSWFVQISLGLK--HIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAY 160
Query: 84 SVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG-I 141
+ +GTP +++PE+ + YN DI+S G + E+ T ++P+ E N Q+ K+ G
Sbjct: 161 TCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPF-EGNNLHQLVLKICQGYF 219
Query: 142 KPASLAKVNDPQIKGFIEKCL-VPASERLSAKDLLKDPFL 180
P S D ++ I + V +R S +LK PFL
Sbjct: 220 APISPNFSRD--LRSLISQLFKVSPRDRPSITSILKRPFL 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 8e-17
Identities = 43/176 (24%), Positives = 80/176 (45%), Gaps = 10/176 (5%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 60
++ E G+ K + K + +++ G+ LH IIHRD+K +N+ ++
Sbjct: 74 LVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRG--IIHRDIKPENLLID 131
Query: 61 GNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT 119
G +K+ D GL+ + + +GTP+++APE +++ D +S G I E +
Sbjct: 132 -QTGHLKLTDFGLSRNGLEN--KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFL- 187
Query: 120 FEYPYSECKNPAQIFKKVTSGIK--PASLAKVNDPQIKGFIEKCLVP-ASERLSAK 172
F YP + P +F + S P + + P+ I + L ++RL A
Sbjct: 188 FGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGAN 243
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 1e-16
Identities = 49/181 (27%), Positives = 87/181 (48%), Gaps = 17/181 (9%)
Query: 9 GNLRQ--YRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEV 66
G L R+K + + +++ + QI+ + Y+H I+HRD+K NIF+ G +
Sbjct: 84 GTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG--ILHRDIKTLNIFLT-KAGLI 140
Query: 67 KIGDLGLAIAMQQPT--ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYP 123
K+GD G++ + A +V+GTP +M+PEL + +YN DI++ G + E++T +
Sbjct: 141 KLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRT 200
Query: 124 YSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIE---KCL-VPASERLSAKDLLKDPF 179
+ + NP + K+ G V I L +R +A ++L P
Sbjct: 201 F-DATNPLNLVVKIVQGNY----TPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPL 255
Query: 180 L 180
L
Sbjct: 256 L 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 1e-16
Identities = 55/161 (34%), Positives = 90/161 (55%), Gaps = 17/161 (10%)
Query: 31 RQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IAMQQPTARSVIGT 88
R+ L L +LHS+ +IHRD+K DNI + G G VK+ D G I +Q +++GT
Sbjct: 123 RECLQALEFLHSNQ--VIHRDIKSDNILL-GMDGSVKLTDFGFCAQITPEQSKRSTMVGT 179
Query: 89 PEFMAPELYEEE-YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLA 147
P +MAPE+ + Y VDI+S G+ +EM+ E PY +NP + + + P
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN-ENPLRALYLIATNGTP---- 234
Query: 148 KVNDPQ-----IKGFIEKCL-VPASERLSAKDLLKDPFLQV 182
++ +P+ + F+ +CL + +R SAK+LL+ FL++
Sbjct: 235 ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 1e-16
Identities = 48/165 (29%), Positives = 77/165 (46%), Gaps = 18/165 (10%)
Query: 29 WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM--QQPTARSVI 86
+A QI+ GL H H I++RDLK +N+ ++ +HG V+I DLGLA+ + +
Sbjct: 100 YAAQIICGL--EHLHQRRIVYRDLKPENVLLD-DHGNVRISDLGLAVELKGGKKIKGRA- 155
Query: 87 GTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYP---YSECKNPAQIFKKVTSGIK 142
GTP +MAPE L E Y+ VD ++ G + EM+ P E ++ ++
Sbjct: 156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLE--M 213
Query: 143 PASLAKVNDPQIKGFIEKCLVP-ASERL-----SAKDLLKDPFLQ 181
P+ K E L +RL SA ++ + P +
Sbjct: 214 AVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFK 258
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 2e-16
Identities = 53/174 (30%), Positives = 88/174 (50%), Gaps = 10/174 (5%)
Query: 11 LRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGD 70
L + + K + + W Q+L G+ Y+H I+HRDLK NIF+ N +KIGD
Sbjct: 93 LEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR--ILHRDLKAKNIFLKNNL--LKIGD 148
Query: 71 LGLAIAMQQPT--ARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSEC 127
G++ + A + GTP +M+PE L + Y+ DI+S G + EM + + E
Sbjct: 149 FGVSRLLMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAF-EG 207
Query: 128 KNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFL 180
+N + ++ G P SL + Q+ ++ L S R SA ++L++PF+
Sbjct: 208 QNFLSVVLRIVEGPTP-SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 2e-16
Identities = 52/167 (31%), Positives = 79/167 (47%), Gaps = 15/167 (8%)
Query: 25 VIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IAM----- 77
V + +QIL G+ YLH++ ++HRD+K +N+ + N G +K+ D G A +A
Sbjct: 103 VFCKYTKQILDGVAYLHNNC--VVHRDIKGNNVMLMPN-GIIKLIDFGCARRLAWVGLHG 159
Query: 78 -QQPTARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFK 135
+S+ GTP +MAPE+ E Y DI+S G + EM T + P + A +F
Sbjct: 160 THSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMF- 218
Query: 136 KVTSGIKPA-SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 180
+ + L F+ CL ER SA LL+ FL
Sbjct: 219 YIGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 3e-16
Identities = 50/176 (28%), Positives = 92/176 (52%), Gaps = 11/176 (6%)
Query: 1 MITELFTSGNL----RQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDN 56
++ EL +G+L + ++K+ + + K + + Q+ L ++HS ++HRD+K N
Sbjct: 79 IVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR--VMHRDIKPAN 136
Query: 57 IFVNGNHGEVKIGDLGLA--IAMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMC 113
+F+ G VK+GDLGL + + A S++GTP +M+PE ++E YN DI+S G
Sbjct: 137 VFITAT-GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCL 195
Query: 114 ILEMVTFEYP-YSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASER 168
+ EM + P Y + N + KK+ P + +++ + C+ P E+
Sbjct: 196 LYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEK 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 78.4 bits (194), Expect = 5e-16
Identities = 36/95 (37%), Positives = 52/95 (54%), Gaps = 10/95 (10%)
Query: 26 IKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR-- 83
IK++ L GL YLHS+ I+HRDLK +N+ + + G +K+ D GLA + P +
Sbjct: 104 IKSYMLMTLRGLEYLHSNW--ILHRDLKPNNLLIASD-GVLKLADFGLARSFGSPNRKMT 160
Query: 84 -SVIGTPEFMAPELY--EEEYNELVDIYSFGMCIL 115
V+ T + APEL Y VD++S G CI
Sbjct: 161 HQVV-TRWYRAPELLFGARHYGVGVDMWSVG-CIF 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 7e-16
Identities = 59/187 (31%), Positives = 95/187 (50%), Gaps = 16/187 (8%)
Query: 11 LRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGD 70
L ++K + V+I I + A L GL YLHSHN +IHRD+K NI + G+VK+ D
Sbjct: 111 LEVHKKPLQEVEIAAITHGA---LQGLAYLHSHN--MIHRDIKAGNILLT-EPGQVKLAD 164
Query: 71 LGLAIAMQQPTARSVIGTPEFMAPELY----EEEYNELVDIYSFGMCILEMVTFEYPYSE 126
G A + P A S +GTP +MAPE+ E +Y+ VD++S G+ +E+ + P
Sbjct: 165 FGSA-SKSSP-ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 222
Query: 127 CKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCL--VPASERLSAKDLLKDPFLQVEN 184
N + P + +GF++ CL +P ER ++ +LL+ F++ +
Sbjct: 223 -MNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDYCLQKIP-QERPASAELLRHDFVRRDR 280
Query: 185 QKEPICD 191
+ D
Sbjct: 281 PARVLID 287
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 8e-16
Identities = 55/172 (31%), Positives = 89/172 (51%), Gaps = 17/172 (9%)
Query: 21 VDIKVIKNWARQILHGLVYL-HSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79
+ V++ ++ GL +L HN IIHRD+K N+ VNGN G+VK+ D G++ +
Sbjct: 99 IPEDVLRRITYAVVKGLKFLKEEHN--IIHRDVKPTNVLVNGN-GQVKLCDFGVSGNLVA 155
Query: 80 PTARSVIGTPEFMAPELYEEE-------YNELVDIYSFGMCILEMVTFEYPYSECKNPAQ 132
A++ IG +MAPE + Y D++S G+ ILEM YPY + A
Sbjct: 156 SLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPP-ETYAN 214
Query: 133 IFKKVTSGIK--PASLAKVNDPQIKGFIEKCL--VPASERLSAKDLLKDPFL 180
IF ++++ + P +L + F+ KCL +P + R + LL+ P+L
Sbjct: 215 IFAQLSAIVDGDPPTLPSGYSDDAQDFVAKCLNKIP-NRRPTYAQLLEHPWL 265
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 9e-16
Identities = 53/154 (34%), Positives = 84/154 (54%), Gaps = 9/154 (5%)
Query: 31 RQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IAMQQPTARSVIGT 88
R+IL GL YLHS IHRD+K N+ ++ G+VK+ D G+A + Q + +GT
Sbjct: 108 REILKGLDYLHSERK--IHRDIKAANVLLS-EQGDVKLADFGVAGQLTDTQIKRNTFVGT 164
Query: 89 PEFMAPELYEEE-YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLA 147
P +MAPE+ ++ Y+ DI+S G+ +E+ E P S+ +P ++ + P
Sbjct: 165 PFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDL-HPMRVLFLIPKNSPPTLEG 223
Query: 148 KVNDPQIKGFIEKCLVPASE-RLSAKDLLKDPFL 180
+ + P K F+E CL R +AK+LLK F+
Sbjct: 224 QYSKP-FKEFVEACLNKDPRFRPTAKELLKHKFI 256
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 9e-16
Identities = 47/172 (27%), Positives = 90/172 (52%), Gaps = 11/172 (6%)
Query: 1 MITELFTSGNLRQ----YRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDN 56
++ EL +G+L Q ++K+ + + + + + Q+ + ++HS ++HRD+K N
Sbjct: 79 IVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR--VMHRDIKPAN 136
Query: 57 IFVNGNHGEVKIGDLGLA--IAMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMC 113
+F+ G VK+GDLGL + + A S++GTP +M+PE ++E YN DI+S G
Sbjct: 137 VFITAT-GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCL 195
Query: 114 ILEMVTFEYP-YSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP 164
+ EM + P Y + N + +K+ P + +++ + C+ P
Sbjct: 196 LYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYP 247
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 76.7 bits (188), Expect = 1e-15
Identities = 57/193 (29%), Positives = 96/193 (49%), Gaps = 19/193 (9%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNW----ARQILHGLVYLHSHNPPIIHRDLKCDN 56
++ E +G++ K K +K + W R+IL GL +LH H +IHRD+K N
Sbjct: 86 LVMEFCGAGSVTDLIKNTKGNTLK--EEWIAYICREILRGLSHLHQHK--VIHRDIKGQN 141
Query: 57 IFVNGNHGEVKIGDLGLAIAMQQPTAR--SVIGTPEFMAPELY------EEEYNELVDIY 108
+ + N EVK+ D G++ + + R + IGTP +MAPE+ + Y+ D++
Sbjct: 142 VLLTEN-AEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLW 200
Query: 109 SFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPA-SE 167
S G+ +EM P + +P + + P +K + + FIE CLV S+
Sbjct: 201 SLGITAIEMAEGAPPLCD-MHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQ 259
Query: 168 RLSAKDLLKDPFL 180
R + + L+K PF+
Sbjct: 260 RPTTEQLMKHPFI 272
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 2e-15
Identities = 40/101 (39%), Positives = 57/101 (56%), Gaps = 8/101 (7%)
Query: 29 WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA---IAMQQPTARSV 85
+A ++ GL YLH + I++RDLK DN+ ++ G VKI D GL + T+ +
Sbjct: 106 YAACVVLGLQYLHENK--IVYRDLKLDNLLLD-TEGFVKIADFGLCKEGMGFGDRTS-TF 161
Query: 86 IGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYS 125
GTPEF+APE L E Y VD + G+ I EM+ E P+
Sbjct: 162 CGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFP 202
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 2e-15
Identities = 57/166 (34%), Positives = 90/166 (54%), Gaps = 10/166 (6%)
Query: 26 IKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IAMQQPTAR 83
I ++IL GL YLHS IHRD+K N+ ++ G+VK+ D G+A + Q
Sbjct: 103 IATMLKEILKGLDYLHSEKK--IHRDIKAANVLLS-EQGDVKLADFGVAGQLTDTQIKRN 159
Query: 84 SVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK 142
+ +GTP +MAPE+ ++ Y+ DI+S G+ +E+ E P S+ +P ++ +
Sbjct: 160 TFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSD-MHPMRVLFLIPK-NN 217
Query: 143 PASLAKVNDPQIKGFIEKCL-VPASERLSAKDLLKDPFLQVENQKE 187
P +L K FI+ CL S R +AK+LLK F+ V+N K+
Sbjct: 218 PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFI-VKNAKK 262
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 3e-15
Identities = 41/129 (31%), Positives = 72/129 (55%), Gaps = 6/129 (4%)
Query: 2 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG 61
+ E G+L + + D + +A +I+ GL +LH II+RDLK DN+ ++
Sbjct: 74 VMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKG--IIYRDLKLDNVLLDK 131
Query: 62 NHGEVKIGDLGLAIA--MQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMV 118
+ G +KI D G+ + A + GTP+++APE+ + ++YNE VD +SFG+ + EM+
Sbjct: 132 D-GHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEML 190
Query: 119 TFEYPYSEC 127
+ P+
Sbjct: 191 IGQSPFHGE 199
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 5e-15
Identities = 59/193 (30%), Positives = 95/193 (49%), Gaps = 19/193 (9%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNW----ARQILHGLVYLHSHNPPIIHRDLKCDN 56
++ E +G++ K K +K ++W R+IL GL +LH+H +IHRD+K N
Sbjct: 96 LVMEFCGAGSVTDLVKNTKGNALK--EDWIAYICREILRGLAHLHAHK--VIHRDIKGQN 151
Query: 57 IFVNGNHGEVKIGDLGLAIAMQQPTAR--SVIGTPEFMAPELY------EEEYNELVDIY 108
+ + N EVK+ D G++ + + R + IGTP +MAPE+ + Y+ DI+
Sbjct: 152 VLLTEN-AEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIW 210
Query: 109 SFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPAS-E 167
S G+ +EM P + +P + + P +K + FIE CLV
Sbjct: 211 SLGITAIEMAEGAPPLCD-MHPMRALFLIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLS 269
Query: 168 RLSAKDLLKDPFL 180
R S + LLK PF+
Sbjct: 270 RPSTEQLLKHPFI 282
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 6e-15
Identities = 53/166 (31%), Positives = 89/166 (53%), Gaps = 12/166 (7%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 60
M+ E G L Y + +A +I+ L YLHS I++RDLK +NI ++
Sbjct: 78 MLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKE--IVYRDLKPENILLD 135
Query: 61 GNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVT 119
G +K+ D G A ++ T ++ GTPE++APE+ + + +N+ VD ++ G+ I EM+
Sbjct: 136 -KEGHIKLTDFGFAKKLRDRTW-TLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLV 193
Query: 120 FEYPYSECKNPAQIFKKVTSG-IK-PASLAKVNDPQIKGFIEKCLV 163
P+ + NP I++K+ +G ++ P L D K I+K LV
Sbjct: 194 GYPPFFD-DNPFGIYEKILAGKLEFPRHL----DLYAKDLIKKLLV 234
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 6e-15
Identities = 43/121 (35%), Positives = 65/121 (53%), Gaps = 7/121 (5%)
Query: 26 IKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT--AR 83
I +W QI L H H+ I+HRD+K NIF+ G +K+GD G+A + AR
Sbjct: 103 ILDWFVQICLALK--HVHDRKILHRDIKSQNIFLT-KDGTIKLGDFGIARVLNSTVELAR 159
Query: 84 SVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK 142
+ IGTP +++PE+ E YN DI++ G + EM T ++ + E N + K+ G
Sbjct: 160 TCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAF-EAGNMKNLVLKIIRGSY 218
Query: 143 P 143
P
Sbjct: 219 P 219
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 1e-14
Identities = 45/119 (37%), Positives = 64/119 (53%), Gaps = 14/119 (11%)
Query: 14 YRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGN---HGEVKIGD 70
+ K ++ ++K+ QIL+G+ YLHS+ ++HRDLK NI V G G VKIGD
Sbjct: 98 RQAKRVSIPPSMVKSLLWQILNGVHYLHSNW--VLHRDLKPANILVMGEGPERGVVKIGD 155
Query: 71 LGLAIAMQQP-----TARSVIGTPEFMAPELY--EEEYNELVDIYSFGMCIL-EMVTFE 121
LGLA P V+ T + APEL Y + +DI++ G CI E++T E
Sbjct: 156 LGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIG-CIFAELLTLE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 60/187 (32%), Positives = 93/187 (49%), Gaps = 16/187 (8%)
Query: 11 LRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGD 70
L ++K + V+I + + A L GL YLHSHN +IHRD+K NI ++ G VK+GD
Sbjct: 105 LEVHKKPLQEVEIAAVTHGA---LQGLAYLHSHN--MIHRDVKAGNILLS-EPGLVKLGD 158
Query: 71 LGLAIAMQQPTARSVIGTPEFMAPELY----EEEYNELVDIYSFGMCILEMVTFEYPYSE 126
G A M A +GTP +MAPE+ E +Y+ VD++S G+ +E+ + P
Sbjct: 159 FGSASIMA--PANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 216
Query: 127 CKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCL--VPASERLSAKDLLKDPFLQVEN 184
N + PA + + F++ CL +P +R +++ LLK F+ E
Sbjct: 217 -MNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIP-QDRPTSEVLLKHRFVLRER 274
Query: 185 QKEPICD 191
I D
Sbjct: 275 PPTVIMD 281
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 1e-14
Identities = 47/161 (29%), Positives = 80/161 (49%), Gaps = 17/161 (10%)
Query: 29 WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TARSVI 86
+A +I+ GL +LH II+RDLK DN+ ++ G +KI D G+ T +
Sbjct: 101 YAAEIVLGLQFLHERG--IIYRDLKLDNVLLDSE-GHIKIADFGMCKEGILGGVTTSTFC 157
Query: 87 GTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG--IKP 143
GTP+++APE L + Y VD ++ G+ + EM+ + P+ E + ++F+ + P
Sbjct: 158 GTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPF-EGDDEDELFQSILEDEVRYP 216
Query: 144 ASLAKVNDPQIKGFIEKCLVPASERLSA-----KDLLKDPF 179
L+K +K F+ K +RL +D+ PF
Sbjct: 217 RWLSKEAKSILKSFLTK---NPEKRLGCLPTGEQDIKGHPF 254
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 74.4 bits (182), Expect = 2e-14
Identities = 59/187 (31%), Positives = 96/187 (51%), Gaps = 16/187 (8%)
Query: 11 LRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGD 70
L ++K + V+I I + A L GL YLHSHN +IHRD+K NI + G+VK+ D
Sbjct: 115 LEVHKKPLQEVEIAAITHGA---LQGLAYLHSHN--MIHRDIKAGNILLT-EPGQVKLAD 168
Query: 71 LGLAIAMQQPTARSVIGTPEFMAPELY----EEEYNELVDIYSFGMCILEMVTFEYPYSE 126
G A ++ P A S +GTP +MAPE+ E +Y+ VD++S G+ +E+ + P
Sbjct: 169 FGSA-SIASP-ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 226
Query: 127 CKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCL--VPASERLSAKDLLKDPFLQVEN 184
N + P + + F++ CL +P +R ++++LLK F+ E
Sbjct: 227 -MNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIP-QDRPTSEELLKHMFVLRER 284
Query: 185 QKEPICD 191
+ + D
Sbjct: 285 PETVLID 291
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 2e-14
Identities = 59/184 (32%), Positives = 86/184 (46%), Gaps = 23/184 (12%)
Query: 30 ARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ---PTARSVI 86
ARQIL G+ YLH + I+HRD+K N+ +N VKI D G++ + Q P SV
Sbjct: 174 ARQILSGIAYLHRRH--IVHRDIKPSNLLINSAK-NVKIADFGVSRILAQTMDPCNSSV- 229
Query: 87 GTPEFMAPELYEEEYNELV------DIYSFGMCILE--MVTFEYPYSECKNPAQIFKKVT 138
GT +M+PE + N DI+S G+ ILE + F + + A + +
Sbjct: 230 GTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAIC 289
Query: 139 SGIKPASLAKVNDPQIKGFIEKCLV--PASERLSAKDLLKDPFL----QVENQKEPICDP 192
P + A + + + FI CL PA +R SA LL+ PF+ + Q P
Sbjct: 290 MSQPPEAPATAS-REFRHFISCCLQREPA-KRWSAMQLLQHPFILRAQPGQGQGGPNLHQ 347
Query: 193 LKLP 196
L P
Sbjct: 348 LLPP 351
|
Length = 353 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 2e-14
Identities = 33/98 (33%), Positives = 54/98 (55%), Gaps = 10/98 (10%)
Query: 26 IKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSV 85
+K++ R +L G+ Y+H++ I+HRDLK N+ + G +KI D GLA + R
Sbjct: 101 VKSYMRMLLKGVAYMHANG--IMHRDLKPANLLI-SADGVLKIADFGLARLFSEEEPRLY 157
Query: 86 ---IGTPEFMAPELY--EEEYNELVDIYSFGMCIL-EM 117
+ T + APEL +Y+ VD+++ G CI E+
Sbjct: 158 SHQVATRWYRAPELLYGARKYDPGVDLWAVG-CIFAEL 194
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 2e-14
Identities = 49/153 (32%), Positives = 75/153 (49%), Gaps = 17/153 (11%)
Query: 31 RQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR--SVIGT 88
R+ L GL YLHS +HRD+K NI + ++G+VK+ D G+A + A+ S IGT
Sbjct: 113 RETLQGLAYLHSKGK--MHRDIKGANILLT-DNGDVKLADFGVAAKITATIAKRKSFIGT 169
Query: 89 PEFMAPELYEEE----YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPA 144
P +MAPE+ E YN+L DI++ G+ +E+ + P + +F S +P
Sbjct: 170 PYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPP 229
Query: 145 SLAKVN--DPQIKGFIEKCLV------PASERL 169
L F++ L P +ERL
Sbjct: 230 KLKDKTKWSSTFHNFVKISLTKNPKKRPTAERL 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 3e-14
Identities = 47/149 (31%), Positives = 74/149 (49%), Gaps = 15/149 (10%)
Query: 1 MITELFTSGNLRQY--RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIF 58
++TEL G+L +Y + + + + + A Q+ G+ YL + N IHRDL N+
Sbjct: 78 IVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN--YIHRDLAARNVL 135
Query: 59 VNGNHGEVKIGDLGLA--IAMQQPTARSVIGTP-EFMAPELYEEEYNELV---DIYSFGM 112
V G + K+ D GLA I AR P ++ APE YN D++SFG+
Sbjct: 136 V-GENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPE--AALYNRFSIKSDVWSFGI 192
Query: 113 CILEMVTF-EYPYSECKNPAQIFKKVTSG 140
+ E+VT+ PY N A++ ++V G
Sbjct: 193 LLTEIVTYGRMPYPGMTN-AEVLQQVDQG 220
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 3e-14
Identities = 49/144 (34%), Positives = 81/144 (56%), Gaps = 13/144 (9%)
Query: 1 MITELFTSGNLRQYRKKHKN-VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV 59
+I E SG+L++Y ++KN +++K +A QI G+ YL S +HRDL N+ V
Sbjct: 85 LIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLV 142
Query: 60 NGNHGEVKIGDLGLAIAMQQP----TARSVIGTPEF-MAPE-LYEEEYNELVDIYSFGMC 113
+ +VKIGD GL A++ T + + +P F APE L + ++ D++SFG+
Sbjct: 143 E-SEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVT 201
Query: 114 ILEMVTFEYPYSECKNPAQIFKKV 137
+ E++T Y SE +P +F K+
Sbjct: 202 LYELLT--YCDSES-SPMTLFLKM 222
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 4e-14
Identities = 52/159 (32%), Positives = 81/159 (50%), Gaps = 12/159 (7%)
Query: 30 ARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR--SVIG 87
+R+ L GL YLHS +HRD+K NI + N G VK+ D G++ + A+ S IG
Sbjct: 112 SRETLQGLYYLHSKGK--MHRDIKGANILLTDN-GHVKLADFGVSAQITATIAKRKSFIG 168
Query: 88 TPEFMAPELYEEE----YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP 143
TP +MAPE+ E YN+L DI++ G+ +E+ + P + +F S +P
Sbjct: 169 TPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQP 228
Query: 144 ASLA-KVN-DPQIKGFIEKCLVP-ASERLSAKDLLKDPF 179
L K+ F++ L +R +A+ LL+ PF
Sbjct: 229 PKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 4e-14
Identities = 44/158 (27%), Positives = 81/158 (51%), Gaps = 12/158 (7%)
Query: 33 ILHGLVYL-HSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARS-VIGTPE 90
I+ L YL H +IHRD+K NI ++ + G VK+ D G++ + A++ G
Sbjct: 123 IVKALHYLKEKHG--VIHRDVKPSNILLDAS-GNVKLCDFGISGRLVDSKAKTRSAGCAA 179
Query: 91 FMAPELYE-----EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPA- 144
+MAPE + +Y+ D++S G+ ++E+ T ++PY CK ++ K+ P+
Sbjct: 180 YMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSL 239
Query: 145 SLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQ 181
+ P F++ CL +R ++LL+ PF++
Sbjct: 240 PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIR 277
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 6e-14
Identities = 47/148 (31%), Positives = 72/148 (48%), Gaps = 8/148 (5%)
Query: 1 MITELFTSGNLRQYRKKHKN--VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIF 58
++ E G+L Q K + I W Q+ G+ H H ++HRD+K NIF
Sbjct: 75 IVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQ--HIHEKRVLHRDIKSKNIF 132
Query: 59 VNGNHGEVKIGDLGLAIAMQQPTARSV--IGTPEFMAPELYEE-EYNELVDIYSFGMCIL 115
+ N G+VK+GD G A + P A + +GTP ++ PE++E YN DI+S G +
Sbjct: 133 LTQN-GKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILY 191
Query: 116 EMVTFEYPYSECKNPAQIFKKVTSGIKP 143
E+ T ++P+ I K KP
Sbjct: 192 ELCTLKHPFQANSWKNLILKVCQGSYKP 219
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 7e-14
Identities = 43/133 (32%), Positives = 65/133 (48%), Gaps = 14/133 (10%)
Query: 1 MITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV 59
+IT+L G L Y + HK N+ + + NW QI G+ YL ++HRDL N+ V
Sbjct: 85 LITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR--LVHRDLAARNVLV 142
Query: 60 NG-NHGEVKIGDLGLAIAMQQPTARSVIGT----P-EFMAPE-LYEEEYNELVDIYSFGM 112
H VKI D GLA + + P ++MA E + Y D++S+G+
Sbjct: 143 KTPQH--VKITDFGLA-KLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGV 199
Query: 113 CILEMVTF-EYPY 124
+ E++TF PY
Sbjct: 200 TVWELMTFGAKPY 212
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 9e-14
Identities = 40/147 (27%), Positives = 74/147 (50%), Gaps = 11/147 (7%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 60
++ EL G L +Y KK + + + +K A Q+ G+ YL S + +HRDL N+ +
Sbjct: 72 LVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKH--FVHRDLAARNVLLV 129
Query: 61 GNHGEVKIGDLGLAIAM----QQPTARSVIGTP-EFMAPE-LYEEEYNELVDIYSFGMCI 114
H + KI D G++ A+ A + P ++ APE + +++ D++S+G+ +
Sbjct: 130 NRH-QAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTL 188
Query: 115 LEMVTF-EYPYSECKNPAQIFKKVTSG 140
E ++ PY E K ++ + SG
Sbjct: 189 WEAFSYGAKPYGEMKGA-EVIAMLESG 214
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 44/137 (32%), Positives = 77/137 (56%), Gaps = 9/137 (6%)
Query: 29 WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA--MQQPTARSVI 86
+A +I GL +LHS II+RDLK DN+ ++ G +KI D G+ T R+
Sbjct: 106 YAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDAE-GHIKIADFGMCKENIFGGKTTRTFC 162
Query: 87 GTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVT--SGIKP 143
GTP+++APE+ + Y + VD ++FG+ + EM+ + P+ + ++ ++F+ + + P
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPF-DGEDEDELFQSIMEHNVSYP 221
Query: 144 ASLAKVNDPQIKGFIEK 160
SL+K KG + K
Sbjct: 222 KSLSKEAVSICKGLLTK 238
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 1e-13
Identities = 62/213 (29%), Positives = 92/213 (43%), Gaps = 43/213 (20%)
Query: 17 KHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 76
+ ++ + I+ + QIL GL Y+HS ++HRDLK NI +N N ++KI D GLA
Sbjct: 101 TSRPLEKQFIQYFLYQILRGLKYVHSAG--VVHRDLKPSNILINEN-CDLKICDFGLA-R 156
Query: 77 MQQPTARSVIGTPEFMAPE--LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIF 134
+Q P + T + APE L ++Y+ VDI+S G EM+ + P K+ F
Sbjct: 157 IQDPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK-PLFPGKDHVNQF 215
Query: 135 KKVTS--GIKP---------------------------ASLAKVNDPQIKGFIEKCLV-P 164
+T G P + K DP +EK LV
Sbjct: 216 SIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFD 275
Query: 165 ASERLSAKDLLKDPFLQVENQKEPICDPLKLPI 197
+R+SA + L P+L P DP P+
Sbjct: 276 PQKRISAAEALAHPYLA------PYHDPTDEPV 302
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 1e-13
Identities = 44/102 (43%), Positives = 62/102 (60%), Gaps = 7/102 (6%)
Query: 31 RQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA-IAMQQPTARSVIGTP 89
+QIL GL YLH+ IIHRD+K +NIF+N + +V IGDLG A + P + GT
Sbjct: 164 KQILEGLRYLHAQR--IIHRDVKTENIFIN-DVDQVCIGDLGAAQFPVVAPAFLGLAGTV 220
Query: 90 EFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNP 130
E APE L ++YN DI+S G+ + EM+ YP + ++P
Sbjct: 221 ETNAPEVLARDKYNSKADIWSAGIVLFEMLA--YPSTIFEDP 260
|
Length = 357 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 1e-13
Identities = 52/200 (26%), Positives = 87/200 (43%), Gaps = 39/200 (19%)
Query: 15 RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA 74
+ + + + +IK++ Q+L GL + HSH I+HRDLK +N+ +N G +K+ D GLA
Sbjct: 89 KDRQRGLPESLIKSYLYQLLQGLAFCHSHG--ILHRDLKPENLLINT-EGVLKLADFGLA 145
Query: 75 --IAMQQPTARSVIGTPEFMAPELY--EEEYNELVDIYSFGMCIL-EMVTFEYPYSECKN 129
+ T + APEL ++ Y+ VDI+S G CI E+++ P K+
Sbjct: 146 RSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVG-CIFAELLSRR-PLFPGKS 203
Query: 130 --------------PAQ-IFKKVTS-------------GIKPASLAKVNDPQIKGFIEKC 161
P ++ K TS G+ L PQ + +
Sbjct: 204 EIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQM 263
Query: 162 LV-PASERLSAKDLLKDPFL 180
L +R++A+ L P+
Sbjct: 264 LHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-13
Identities = 60/199 (30%), Positives = 88/199 (44%), Gaps = 34/199 (17%)
Query: 12 RQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDL 71
R + + K IK++ Q+L G+ + H H ++HRDLK N+ V+ G +KI DL
Sbjct: 98 SNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG--VMHRDLKPQNLLVDKQKGLLKIADL 155
Query: 72 GLAIAMQQPTARSV--IGTPEFMAPE--LYEEEYNELVDIYSFGMCILEMVTFEYPY--- 124
GL A P I T + APE L Y+ VDI+S G EM + +
Sbjct: 156 GLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGD 215
Query: 125 SECKNPAQIFK-------KVTSGI------------KPASLAKVN---DPQIKGFIEKCL 162
SE + IFK +V G+ KP L++ P+ ++K L
Sbjct: 216 SELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKML 275
Query: 163 V--PASERLSAKDLLKDPF 179
PA +R+SAK L P+
Sbjct: 276 RYDPA-KRISAKAALTHPY 293
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 2e-13
Identities = 49/154 (31%), Positives = 74/154 (48%), Gaps = 29/154 (18%)
Query: 1 MITELFTSGNLRQYRKKHKN--VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIF 58
M+TEL G+L +K I + ++A QI +G+ YL S IHRDL NI
Sbjct: 72 MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR--FIHRDLAARNIL 129
Query: 59 VNGNHGEVKIGDLGLAIAMQQ-------------PTARSVIGTPEFMAPE-LYEEEYNEL 104
+ + +VKIGD GL A+ Q P A + APE L ++
Sbjct: 130 LASDD-KVKIGDFGLMRALPQNEDHYVMEEHLKVPFA--------WCAPESLRTRTFSHA 180
Query: 105 VDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKV 137
D++ FG+ + EM T+ E P++ + +QI KK+
Sbjct: 181 SDVWMFGVTLWEMFTYGEEPWAGL-SGSQILKKI 213
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 2e-13
Identities = 49/169 (28%), Positives = 80/169 (47%), Gaps = 12/169 (7%)
Query: 2 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG 61
+ E F S ++K + + I N Q++ L YLH I+HRDL +NI + G
Sbjct: 96 LGEHFNS-----LKEKKQRFTEERIWNIFVQMVLALRYLHKEKR-IVHRDLTPNNIML-G 148
Query: 62 NHGEVKIGDLGLAIAMQQPTAR--SVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMV 118
+V I D GLA +QP ++ SV+GT + PE+ + E Y E D+++FG + +M
Sbjct: 149 EDDKVTITDFGLA-KQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMC 207
Query: 119 TFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASE 167
T + P+ N + K+ + + + I CL P +E
Sbjct: 208 TLQPPFYS-TNMLSLATKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAE 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 3e-13
Identities = 41/150 (27%), Positives = 73/150 (48%), Gaps = 10/150 (6%)
Query: 47 IIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSV-IGTPEFMAPELYEEE----Y 101
IIHRD+K NI ++ +G +K+ D G++ + A++ G +MAPE + Y
Sbjct: 129 IIHRDVKPSNILLDR-NGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARDGY 187
Query: 102 NELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG---IKPASLAKVNDPQIKGFI 158
+ D++S G+ + E+ T ++PY + + +V G I S + P FI
Sbjct: 188 DVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSPSFVNFI 247
Query: 159 EKCLVPASE-RLSAKDLLKDPFLQVENQKE 187
CL+ R K+LL+ PF++ ++
Sbjct: 248 NLCLIKDESKRPKYKELLEHPFIKDYEERN 277
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 3e-13
Identities = 39/96 (40%), Positives = 53/96 (55%), Gaps = 13/96 (13%)
Query: 32 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA-IAMQQPTARSV----- 85
Q+L GL Y+HS N +IHRDLK N+ VN + E++IGD G+A PT
Sbjct: 115 QLLRGLKYIHSAN--VIHRDLKPSNLLVNED-CELRIGDFGMARGLSSSPTEHKYFMTEY 171
Query: 86 IGTPEFMAPELY--EEEYNELVDIYSFGMCIL-EMV 118
+ T + APEL EY +D++S G CI EM+
Sbjct: 172 VATRWYRAPELLLSLPEYTTAIDMWSVG-CIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 5e-13
Identities = 55/209 (26%), Positives = 91/209 (43%), Gaps = 43/209 (20%)
Query: 10 NLRQYRKKHKN-VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKI 68
L + + + ++++ Q+L + Y HSHN IIHRD+K +NI V+ G +K+
Sbjct: 85 TLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN--IIHRDIKPENILVS-ESGVLKL 141
Query: 69 GDLGLAIAMQQPTAR---SVIGTPEFMAPELY--EEEYNELVDIYSFGMCIL-EMVTFE- 121
D G A A++ A + T + APEL + Y + VD+++ G CI+ E++ E
Sbjct: 142 CDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIG-CIMAELLDGEP 200
Query: 122 -YP-----------------------YSECKNPAQIFKKVTSGIKPASL-----AKVNDP 152
+P NP +P SL KV+ P
Sbjct: 201 LFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSP 260
Query: 153 QIKGFIEKCLVP-ASERLSAKDLLKDPFL 180
+ F++ CL ERL+ +LL+ P+
Sbjct: 261 AL-DFLKACLRMDPKERLTCDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 7e-13
Identities = 42/101 (41%), Positives = 58/101 (57%), Gaps = 12/101 (11%)
Query: 26 IKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA----IAMQQPT 81
IK++ +Q+L GL Y H N +HRD+KC NI +N N G++K+ D GLA +P
Sbjct: 118 IKSFMKQLLEGLNYCHKKN--FLHRDIKCSNILLN-NKGQIKLADFGLARLYNSEESRPY 174
Query: 82 ARSVIGTPEFMAPELY--EEEYNELVDIYSFGMCIL-EMVT 119
VI T + PEL EE Y +D++S G CIL E+ T
Sbjct: 175 TNKVI-TLWYRPPELLLGEERYGPAIDVWSCG-CILGELFT 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.6 bits (171), Expect = 8e-13
Identities = 47/216 (21%), Positives = 85/216 (39%), Gaps = 43/216 (19%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 60
++ E G+L + + + + +++ L +H IHRD+K DNI +
Sbjct: 78 LVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLG--FIHRDIKPDNILI- 134
Query: 61 GNHGEVKIGDLGLAIAM-----------------------------QQPT--ARSVIGTP 89
G +K+ D GL M +Q A S +GTP
Sbjct: 135 DADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTP 194
Query: 90 EFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYP--YSECKNPAQIFKKVTSGIKPASL 146
+++APE L Y D +S G+ + EM+ + +P YS+ + + K+ + +
Sbjct: 195 DYIAPEVLRGTPYGLECDWWSLGVILYEML-YGFPPFYSD--TLQETYNKIINWKESLRF 251
Query: 147 AKVND--PQIKGFIEKCLVPASERL-SAKDLLKDPF 179
P+ I + L +RL S +++ PF
Sbjct: 252 PPDPPVSPEAIDLICRLLCDPEDRLGSFEEIKSHPF 287
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 1e-12
Identities = 44/94 (46%), Positives = 55/94 (58%), Gaps = 14/94 (14%)
Query: 32 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIG---T 88
QIL GL Y+HS IIHRDLK NI VN + E+KI D GLA + T + G T
Sbjct: 126 QILRGLKYIHSAG--IIHRDLKPSNIAVNEDC-ELKILDFGLA----RHTDDEMTGYVAT 178
Query: 89 PEFMAPE--LYEEEYNELVDIYSFGMCIL-EMVT 119
+ APE L YN+ VDI+S G CI+ E++T
Sbjct: 179 RWYRAPEIMLNWMHYNQTVDIWSVG-CIMAELLT 211
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 2e-12
Identities = 40/98 (40%), Positives = 55/98 (56%), Gaps = 7/98 (7%)
Query: 26 IKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TAR 83
IK++ Q+L GL + HSH ++HRDLK N+ +N G +K+ D GLA A P T
Sbjct: 102 IKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYT 158
Query: 84 SVIGTPEFMAPE--LYEEEYNELVDIYSFGMCILEMVT 119
+ T + APE L + Y+ VDI+S G EMVT
Sbjct: 159 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 2e-12
Identities = 37/102 (36%), Positives = 60/102 (58%), Gaps = 5/102 (4%)
Query: 29 WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ-PTARSVIG 87
+A +I GL LH I++RDLK +NI ++ ++G ++I DLGLA+ + + T R +G
Sbjct: 107 YAAEITCGLEDLHRER--IVYRDLKPENILLD-DYGHIRISDLGLAVEIPEGETIRGRVG 163
Query: 88 TPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECK 128
T +MAPE+ + E Y D + G I EM+ + P+ + K
Sbjct: 164 TVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRK 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 42/126 (33%), Positives = 71/126 (56%), Gaps = 6/126 (4%)
Query: 2 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG 61
+ E G+L + + D+ +A +I+ GL +LHS I++RDLK DNI ++
Sbjct: 74 VMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG--IVYRDLKLDNILLDT 131
Query: 62 NHGEVKIGDLGLAIAMQQPTARS--VIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMV 118
+ G +KI D G+ A++ GTP+++APE L ++YN VD +SFG+ + EM+
Sbjct: 132 D-GHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEML 190
Query: 119 TFEYPY 124
+ P+
Sbjct: 191 IGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 3e-12
Identities = 41/121 (33%), Positives = 67/121 (55%), Gaps = 3/121 (2%)
Query: 4 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNH 63
E G+L Q K+ K + +++ + +L GL YL + I+HRD+K NI VN +
Sbjct: 83 EHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQ-IMHRDVKPSNILVN-SR 140
Query: 64 GEVKIGDLGLAIAMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEY 122
GE+K+ D G++ + A S +GT +M+PE L Y+ DI+S G+ ++E+ Y
Sbjct: 141 GEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRY 200
Query: 123 P 123
P
Sbjct: 201 P 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 3e-12
Identities = 40/129 (31%), Positives = 70/129 (54%), Gaps = 5/129 (3%)
Query: 2 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG 61
I +L G+L + +H K ++ +A +I+ GL H HN +++RDLK NI ++
Sbjct: 75 ILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLE--HMHNRFVVYRDLKPANILLD- 131
Query: 62 NHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVT 119
HG V+I DLGLA + + +GT +MAPE+ ++ Y+ D +S G + +++
Sbjct: 132 EHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLR 191
Query: 120 FEYPYSECK 128
P+ + K
Sbjct: 192 GHSPFRQHK 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 5e-12
Identities = 48/156 (30%), Positives = 76/156 (48%), Gaps = 6/156 (3%)
Query: 4 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNH 63
E G+L Q KK + +++ + ++ GL YL + I+HRD+K NI VN +
Sbjct: 83 EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK-IMHRDVKPSNILVN-SR 140
Query: 64 GEVKIGDLGLAIAMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEY 122
GE+K+ D G++ + A S +GT +M+PE L Y+ DI+S G+ ++EM Y
Sbjct: 141 GEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRY 200
Query: 123 PY--SECKNPAQIFKKVTSGIKPASLAKVNDPQIKG 156
P + K +F G PA P+ G
Sbjct: 201 PIPPPDAKELELMFGCPVEG-DPAESETSPRPRPPG 235
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 66.5 bits (163), Expect = 5e-12
Identities = 37/99 (37%), Positives = 56/99 (56%), Gaps = 9/99 (9%)
Query: 26 IKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR-- 83
+K Q+L G+ +LH + I+HRDLK N+ +N N G +KI D GLA P
Sbjct: 108 VKCLMLQLLSGVAHLHDNW--ILHRDLKTSNLLLN-NRGILKICDFGLAREYGSPLKPYT 164
Query: 84 SVIGTPEFMAPELY--EEEYNELVDIYSFGMCIL-EMVT 119
++ T + APEL +EY+ +D++S G CI E++T
Sbjct: 165 QLVVTLWYRAPELLLGAKEYSTAIDMWSVG-CIFAELLT 202
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 66.1 bits (162), Expect = 7e-12
Identities = 53/203 (26%), Positives = 86/203 (42%), Gaps = 39/203 (19%)
Query: 10 NLRQYRKKHKN-VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKI 68
NL + K K + K +K++ Q+L L ++H + I HRD+K +NI + + +K+
Sbjct: 85 NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG--IFHRDIKPENILIKDDI--LKL 140
Query: 69 GDLGLA--IAMQQPTARSVIGTPEFMAPE--LYEEEYNELVDIYSFGMCILEMVTFEYPY 124
D G I + P I T + APE L + Y +DI++ G E+++ +P
Sbjct: 141 ADFGSCRGIYSKPPYT-EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSL-FPL 198
Query: 125 SECKNPA-QIFK----------KVTSGIKPASLAKVNDPQIKGF-IEKCLVPAS------ 166
N QI K +V + + N P KG + K L AS
Sbjct: 199 FPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDL 258
Query: 167 ----------ERLSAKDLLKDPF 179
ER++AK L+ P+
Sbjct: 259 LKKLLAYDPDERITAKQALRHPY 281
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 7e-12
Identities = 40/133 (30%), Positives = 77/133 (57%), Gaps = 9/133 (6%)
Query: 1 MITELFTSGNLRQ--YRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIF 58
++ L G+L+ Y + ++++ + +++ QI G+++LHS + I++RD+K +N+
Sbjct: 70 LVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD--IVYRDMKPENVL 127
Query: 59 VNGNHGEVKIGDLGLAIAMQ--QPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCIL 115
++ G ++ DLGLA+ ++ + + GT +MAPE L EE Y+ VD ++ G I
Sbjct: 128 LDDQ-GNCRLSDLGLAVELKDGKTITQRA-GTNGYMAPEILKEEPYSYPVDWFAMGCSIY 185
Query: 116 EMVTFEYPYSECK 128
EMV P+ + K
Sbjct: 186 EMVAGRTPFKDHK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 7e-12
Identities = 45/142 (31%), Positives = 71/142 (50%), Gaps = 12/142 (8%)
Query: 1 MITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV 59
+I E SG+LR Y ++H+ +++K + ++ QI G+ YL S IHRDL NI V
Sbjct: 85 LIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR--YIHRDLAARNILV 142
Query: 60 NGNHGEVKIGDLGLAIAMQQP----TARSVIGTPEF-MAPE-LYEEEYNELVDIYSFGMC 113
VKI D GLA + + + +P F APE L +++ D++SFG+
Sbjct: 143 ESED-LVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVT 201
Query: 114 ILEMVTFEYPYSECKNPAQIFK 135
+ E+ F Y PA+ +
Sbjct: 202 LYEL--FTYGDPSQSPPAEFLR 221
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 7e-12
Identities = 39/110 (35%), Positives = 53/110 (48%), Gaps = 20/110 (18%)
Query: 26 IKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAI----AMQQPT 81
IK + Q+L G+ YLH ++ I+HRD+K NI ++ N G +KI D GLA P
Sbjct: 117 IKCYMLQLLEGINYLHENH--ILHRDIKAANILID-NQGILKIADFGLARPYDGPPPNPK 173
Query: 82 ARSVIGTPEFM---------APELY--EEEYNELVDIYSFGMCIL-EMVT 119
GT ++ PEL E Y VDI+ G C+ EM T
Sbjct: 174 GGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIG-CVFAEMFT 222
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 8e-12
Identities = 52/204 (25%), Positives = 88/204 (43%), Gaps = 56/204 (27%)
Query: 32 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEF 91
Q+L GL Y+HS N ++HRDLK N+ +N N ++KI D GL AR+ +F
Sbjct: 116 QLLRGLKYIHSAN--VLHRDLKPSNLLLNAN-CDLKICDFGL--------ARTTSEKGDF 164
Query: 92 M----------APELY--EEEYNELVDIYSFGMCIL-EMVTFE--YPYSECKNPAQIFKK 136
M APEL EY +D++S G CI E++ + +P + + ++ +
Sbjct: 165 MTEYVVTRWYRAPELLLNCSEYTTAIDVWSVG-CIFAELLGRKPLFPGKDYVHQLKLITE 223
Query: 137 VTSGIKPASLAKVNDPQIKGFI--------------------------EKCLV-PASERL 169
+ L + + + + +I EK LV S+R+
Sbjct: 224 LLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRI 283
Query: 170 SAKDLLKDPFLQV--ENQKEPICD 191
+ ++ L P+L + EP+C
Sbjct: 284 TVEEALAHPYLASLHDPSDEPVCQ 307
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 47/164 (28%), Positives = 83/164 (50%), Gaps = 9/164 (5%)
Query: 2 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG 61
+ E G+L ++ + D + +A ++ L++LH H +I+RDLK DNI ++
Sbjct: 74 VMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG--VIYRDLKLDNILLDA 131
Query: 62 NHGEVKIGDLGLAIA--MQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMV 118
G K+ D G+ + T + GTP+++APE L E EY VD ++ G+ + EM+
Sbjct: 132 E-GHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMM 190
Query: 119 TFEYPYSECKNPAQIFKKVTSG--IKPASLAKVNDPQIKGFIEK 160
+ P+ E N +F+ + + P L+K +K F+ K
Sbjct: 191 AGQPPF-EADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTK 233
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 1e-11
Identities = 40/126 (31%), Positives = 69/126 (54%), Gaps = 6/126 (4%)
Query: 2 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG 61
+ E G+L + + D+ +A +I+ GL +LHS II+RDLK DN+ ++
Sbjct: 74 VMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG--IIYRDLKLDNVMLDR 131
Query: 62 NHGEVKIGDLGLAI--AMQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMV 118
+ G +KI D G+ A + GTP+++APE+ + +Y VD +SFG+ + EM+
Sbjct: 132 D-GHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEML 190
Query: 119 TFEYPY 124
+ P+
Sbjct: 191 IGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 37/96 (38%), Positives = 49/96 (51%), Gaps = 12/96 (12%)
Query: 26 IKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP----T 81
+K Q+L GL YLH + IIHRDLK N+ + G +KI D GLA P T
Sbjct: 110 VKCLMLQLLRGLQYLHENF--IIHRDLKVSNLLLTD-KGCLKIADFGLARTYGLPAKPMT 166
Query: 82 ARSVIGTPEFMAPELY--EEEYNELVDIYSFGMCIL 115
+ V T + APEL Y +D+++ G CIL
Sbjct: 167 PKVV--TLWYRAPELLLGCTTYTTAIDMWAVG-CIL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 1e-11
Identities = 40/122 (32%), Positives = 67/122 (54%), Gaps = 12/122 (9%)
Query: 6 FTSGNLRQYRKKHKN---VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGN 62
+ +L++Y H +D +K++ Q+L G+ + H + ++HRDLK N+ +N
Sbjct: 79 YMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR--VLHRDLKPQNLLINKR 136
Query: 63 HGEVKIGDLGLAIAMQQP--TARSVIGTPEFMAPE--LYEEEYNELVDIYSFGMCIL-EM 117
GE+K+ D GLA A P T + + T + AP+ L Y+ +DI+S G CI+ EM
Sbjct: 137 -GELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVG-CIMAEM 194
Query: 118 VT 119
+T
Sbjct: 195 IT 196
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 43/145 (29%), Positives = 68/145 (46%), Gaps = 11/145 (7%)
Query: 43 HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPE-LYEEEY 101
H IHRDLK +N F+ G +K+ D GL+ + A SV+G+P++MAPE L + Y
Sbjct: 118 HELGYIHRDLKPEN-FLIDASGHIKLTDFGLSKGIVT-YANSVVGSPDYMAPEVLRGKGY 175
Query: 102 NELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIK------ 155
+ VD +S G C+L +P P + ++ + + +DP+
Sbjct: 176 DFTVDYWSLG-CMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAW 234
Query: 156 GFIEKCLVPASERL-SAKDLLKDPF 179
I K + S R S +D+ PF
Sbjct: 235 DLITKLINDPSRRFGSLEDIKNHPF 259
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.0 bits (159), Expect = 2e-11
Identities = 44/121 (36%), Positives = 65/121 (53%), Gaps = 11/121 (9%)
Query: 6 FTSGNLRQY--RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNH 63
F +L++Y +D +IK++ Q+L G+ Y HSH ++HRDLK N+ ++
Sbjct: 79 FLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR--VLHRDLKPQNLLIDRE- 135
Query: 64 GEVKIGDLGLAIAMQQP--TARSVIGTPEFMAPE--LYEEEYNELVDIYSFGMCIL-EMV 118
G +K+ D GLA A P T + T + APE L +Y+ VDI+S G CI EMV
Sbjct: 136 GALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIG-CIFAEMV 194
Query: 119 T 119
Sbjct: 195 N 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 2e-11
Identities = 46/164 (28%), Positives = 83/164 (50%), Gaps = 9/164 (5%)
Query: 2 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG 61
+ E G+L + +K + D + +A +I L++LH II+RDLK DN+ ++
Sbjct: 74 VMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKG--IIYRDLKLDNVLLD- 130
Query: 62 NHGEVKIGDLGLAIA--MQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMV 118
+ G K+ D G+ T + GTP+++APE L E Y VD ++ G+ + EM+
Sbjct: 131 HEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEML 190
Query: 119 TFEYPYSECKNPAQIFKKVTSG--IKPASLAKVNDPQIKGFIEK 160
P+ E +N +F+ + + + P L++ +K F+ K
Sbjct: 191 CGHAPF-EAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTK 233
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 49/189 (25%), Positives = 93/189 (49%), Gaps = 13/189 (6%)
Query: 2 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG 61
I +L G+L + +H ++ +A +I+ GL H HN +++RDLK NI ++
Sbjct: 75 ILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLE--HMHNRFVVYRDLKPANILLD- 131
Query: 62 NHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVT 119
HG V+I DLGLA + + +GT +MAPE+ ++ Y+ D +S G + +++
Sbjct: 132 EHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLR 191
Query: 120 FEYPYSECKNPAQI-FKKVTSGIKPASLAKVNDPQIKGFIEKCL-VPASERL-----SAK 172
P+ + K + ++T + L P+++ +E L + RL A+
Sbjct: 192 GHSPFRQHKTKDKHEIDRMTLTMAV-ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQ 250
Query: 173 DLLKDPFLQ 181
++ + PF +
Sbjct: 251 EVKEHPFFR 259
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 2e-11
Identities = 39/105 (37%), Positives = 59/105 (56%), Gaps = 7/105 (6%)
Query: 21 VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IAMQ 78
+D ++ + QIL G+ + HSHN IIHRD+K +NI V+ + G VK+ D G A +A
Sbjct: 97 LDESRVRKYLFQILRGIEFCHSHN--IIHRDIKPENILVSQS-GVVKLCDFGFARTLAAP 153
Query: 79 QPTARSVIGTPEFMAPELY--EEEYNELVDIYSFGMCILEMVTFE 121
+ T + APEL + +Y VDI++ G + EM+T E
Sbjct: 154 GEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGE 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 2e-11
Identities = 42/157 (26%), Positives = 68/157 (43%), Gaps = 24/157 (15%)
Query: 2 ITELFTSGNLRQYRKKH--KNVDIKV--------IKNWARQILHGLVYLHSHNPPIIHRD 51
+ EL G+L+ Y + + + A +I G+ YL + +HRD
Sbjct: 87 VMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK--FVHRD 144
Query: 52 LKCDNIFVNGNHGEVKIGDLGLAIAMQQ-----PTARSVIGTP-EFMAPE-LYEEEYNEL 104
L N V + VKIGD G+ + + + ++ P +MAPE L + +
Sbjct: 145 LAARNCMVAED-LTVKIGDFGMTRDIYETDYYRKGGKGLL--PVRWMAPESLKDGVFTTK 201
Query: 105 VDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSG 140
D++SFG+ + EM T E PY N ++ K V G
Sbjct: 202 SDVWSFGVVLWEMATLAEQPYQGLSN-EEVLKFVIDG 237
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 3e-11
Identities = 46/142 (32%), Positives = 71/142 (50%), Gaps = 15/142 (10%)
Query: 1 MITELFTSGNLRQYRKKHKN-VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV 59
++ E G+LR Y +KH+ +D + + +A QI G+ YL S +HRDL NI V
Sbjct: 84 LVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR--YVHRDLATRNILV 141
Query: 60 NGNHGEVKIGDLGLAIAMQQPTARSVIGTPE-----FMAPE-LYEEEYNELVDIYSFGMC 113
+ VKIGD GL + Q + P + APE L E +++ D++SFG+
Sbjct: 142 E-SENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVV 200
Query: 114 ILEMVTFEYPYSE-CKNPAQIF 134
+ E+ T YS+ +P F
Sbjct: 201 LYELFT----YSDKSCSPPAEF 218
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 4e-11
Identities = 51/203 (25%), Positives = 86/203 (42%), Gaps = 41/203 (20%)
Query: 26 IKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARS- 84
+ + Q+L GL Y+HS N ++HRDLK N+F+N +KIGD GLA + +
Sbjct: 116 ARLFMYQLLRGLKYIHSAN--VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKG 173
Query: 85 ----VIGTPEFMAPE--LYEEEYNELVDIYSFGMCIL-EMVT------------------ 119
+ T + +P L Y + +D+++ G CI EM+T
Sbjct: 174 YLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAG-CIFAEMLTGKPLFAGAHELEQMQLIL 232
Query: 120 ------FEYPYSECKNPAQIFKKVTSGIKPASLAKV---NDPQIKGFIEKCLVPA-SERL 169
E +E N F + G L + +P+ F+E+ L +RL
Sbjct: 233 ESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRL 292
Query: 170 SAKDLLKDPFLQVEN--QKEPIC 190
+A++ L P++ + EP+
Sbjct: 293 TAEEALMHPYMSCYSCPFDEPVS 315
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 4e-11
Identities = 41/146 (28%), Positives = 74/146 (50%), Gaps = 10/146 (6%)
Query: 1 MITELFTSGNLRQYRK--KHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIF 58
+ITEL G+L + + + + + + + + A Q+ G+ YL N IHRDL NI
Sbjct: 79 IITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN--SIHRDLAARNIL 136
Query: 59 VNGNHGEVKIGDLGLAIAMQQP--TARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCIL 115
V G K+ D GLA +++ + ++ APE ++ D++SFG+ +
Sbjct: 137 V-GEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLY 195
Query: 116 EMVTF-EYPYSECKNPAQIFKKVTSG 140
EM T+ + PY N +++ ++T+G
Sbjct: 196 EMFTYGQVPY-PGMNNHEVYDQITAG 220
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 5e-11
Identities = 32/99 (32%), Positives = 57/99 (57%), Gaps = 6/99 (6%)
Query: 29 WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA--MQQPTARSVI 86
+ +I+ L YLHS + +++RD+K +N+ ++ G +KI D GL T ++
Sbjct: 100 YGAEIVSALEYLHSRD--VVYRDIKLENLMLD-KDGHIKITDFGLCKEGISDGATMKTFC 156
Query: 87 GTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPY 124
GTPE++APE+ E+ +Y VD + G+ + EM+ P+
Sbjct: 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 5e-11
Identities = 46/127 (36%), Positives = 70/127 (55%), Gaps = 14/127 (11%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 60
+I E G+LR Y KH +++ + +A+QI G+ YLHS + IHRDL N+ ++
Sbjct: 85 LIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQH--YIHRDLAARNVLLD 141
Query: 61 GNHGEVKIGDLGLAIAMQQPTA------RSVIGTPEF-MAPE-LYEEEYNELVDIYSFGM 112
N VKIGD GLA A+ P R +P F A E L E +++ D++SFG+
Sbjct: 142 -NDRLVKIGDFGLAKAV--PEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGV 198
Query: 113 CILEMVT 119
+ E++T
Sbjct: 199 TLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 5e-11
Identities = 50/203 (24%), Positives = 86/203 (42%), Gaps = 38/203 (18%)
Query: 11 LRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGD 70
L + K + V +IK Q L + + H HN IHRD+K +NI + G++K+ D
Sbjct: 87 LNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN--CIHRDVKPENILIT-KQGQIKLCD 143
Query: 71 LGLAIAMQQPTAR--SVIGTPEFMAPELY--EEEYNELVDIYSFGMCILEMVTFE--YPY 124
G A + P + T + APEL + +Y VD+++ G E++T + +P
Sbjct: 144 FGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPG 203
Query: 125 SE---------------CKNPAQIFK--KVTSGIK----------PASLAKVNDPQIKGF 157
QIF + G+ + ++ P + F
Sbjct: 204 KSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALS-F 262
Query: 158 IEKCLVP-ASERLSAKDLLKDPF 179
++ CL +ERLS ++LL+ P+
Sbjct: 263 LKGCLQMDPTERLSCEELLEHPY 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 6e-11
Identities = 48/153 (31%), Positives = 79/153 (51%), Gaps = 10/153 (6%)
Query: 29 WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TARSVI 86
+A +I L YLHS N II+RDLK +NI ++ + G V + D GL + T +
Sbjct: 101 YAAEIASALGYLHSLN--IIYRDLKPENILLD-SQGHVVLTDFGLCKEGIEHSKTTSTFC 157
Query: 87 GTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPAS 145
GTPE++APE L ++ Y+ VD + G + EM+ + P ++ A+++ + + KP
Sbjct: 158 GTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEML-YGLPPFYSRDTAEMYDNILN--KPLR 214
Query: 146 LAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKD 177
L + +E L ++RL AKD +
Sbjct: 215 LKPNISVSARHLLEGLLQKDRTKRLGAKDDFLE 247
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 6e-11
Identities = 51/165 (30%), Positives = 81/165 (49%), Gaps = 22/165 (13%)
Query: 33 ILHG--LVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR--SVIGT 88
IL+G L H HN IIHRD+K +NI + G VK+ D G++ + R + +GT
Sbjct: 133 ILYGALLGLQHLHNNRIIHRDVKGNNILLT-TEGGVKLVDFGVSAQLTSTRLRRNTSVGT 191
Query: 89 PEFMAPEL------YEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK 142
P +MAPE+ Y+ Y+ D++S G+ +E+ + P + +P + K+
Sbjct: 192 PFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFD-MHPVKTLFKIPRNPP 250
Query: 143 PASLAKVNDPQ-----IKGFIEKCLVPASE-RLSAKDLLKDPFLQ 181
P L P+ FI +CL+ E R S LL+ PF++
Sbjct: 251 PTLL----HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 6e-11
Identities = 47/137 (34%), Positives = 69/137 (50%), Gaps = 12/137 (8%)
Query: 2 ITELFTSGNLRQYRKKHKNVDIKVIK--NWARQILHGLVYLHSHNPPIIHRDLKCDNIFV 59
+TE + G+L + K + +++ + + A QI G+ YL S N IHRDL NI V
Sbjct: 79 VTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN--YIHRDLAARNILV 136
Query: 60 NGNHGEVKIGDLGLA--IAMQQPTARSVIGTP-EFMAPE--LYEEEYNELVDIYSFGMCI 114
G + KI D GLA I + TAR P ++ APE Y + D++SFG+ +
Sbjct: 137 -GENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANY-GRFTIKSDVWSFGILL 194
Query: 115 LEMVTF-EYPYSECKNP 130
E+VT+ PY N
Sbjct: 195 TEIVTYGRVPYPGMTNR 211
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 6e-11
Identities = 38/114 (33%), Positives = 56/114 (49%), Gaps = 24/114 (21%)
Query: 32 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ----------PT 81
+I + Y+HS ++HRDLK DNI + G GEV I D G AI +
Sbjct: 121 KICATIEYVHSKG--VLHRDLKPDNILL-GLFGEVVILDWGAAIFKKLEEEDLLDIDVDE 177
Query: 82 ARS----------VIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPY 124
++GTP++MAPE L +E DIY+ G+ + +M+T +PY
Sbjct: 178 RNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY 231
|
Length = 932 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 6e-11
Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 45/213 (21%)
Query: 6 FTSGNLRQYR---KKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGN 62
F S +L++Y K + +D +++K++ QIL G+++ HS ++HRDLK N+ ++ N
Sbjct: 80 FLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR--VLHRDLKPQNLLID-N 136
Query: 63 HGEVKIGDLGLAIAMQQP----TARSVIGTPEFMAPE--LYEEEYNELVDIYSFGMCILE 116
G +K+ D GLA A P T V T + APE L Y+ VDI+S G E
Sbjct: 137 KGVIKLADFGLARAFGIPVRVYTHEVV--TLWYRAPEVLLGSPRYSTPVDIWSIGTIFAE 194
Query: 117 MVTFEYPY----SECKNPAQIFKKV---TSGIKP---------ASLAKVNDPQIKGF--- 157
M T + P SE +IF+ + T + P + K ++
Sbjct: 195 MAT-KKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKN 253
Query: 158 --------IEKCLV--PASERLSAKDLLKDPFL 180
+EK L+ PA +R+SAK L P+
Sbjct: 254 LDEDGLDLLEKMLIYDPA-KRISAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 43/137 (31%), Positives = 77/137 (56%), Gaps = 9/137 (6%)
Query: 29 WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA--MQQPTARSVI 86
+A +I GL +LHS II+RDLK DN+ ++ + G +KI D G+ T ++
Sbjct: 106 YAAEIAIGLFFLHSKG--IIYRDLKLDNVMLD-SEGHIKIADFGMCKENMWDGVTTKTFC 162
Query: 87 GTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG--IKP 143
GTP+++APE+ + Y + VD ++FG+ + EM+ + P+ E ++ ++F+ + P
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPF-EGEDEDELFQSIMEHNVAYP 221
Query: 144 ASLAKVNDPQIKGFIEK 160
S++K KG + K
Sbjct: 222 KSMSKEAVAICKGLMTK 238
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 1e-10
Identities = 38/102 (37%), Positives = 54/102 (52%), Gaps = 6/102 (5%)
Query: 22 DIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP- 80
+ ++IK + QIL G+ Y HSH ++HRDLK N+ ++ +K+ D GLA A P
Sbjct: 100 NPRLIKTYLYQILRGIAYCHSHR--VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157
Query: 81 -TARSVIGTPEFMAPE--LYEEEYNELVDIYSFGMCILEMVT 119
T + T + APE L Y+ VDI+S G EMV
Sbjct: 158 RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVN 199
|
Length = 294 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 1e-10
Identities = 45/163 (27%), Positives = 83/163 (50%), Gaps = 26/163 (15%)
Query: 25 VIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARS 84
V K + +++ YLHS + II+RDLK +N+ ++ N G VK+ D G A + T +
Sbjct: 119 VAKFYHAELVLAFEYLHSKD--IIYRDLKPENLLLD-NKGHVKVTDFGFAKKVPDRTF-T 174
Query: 85 VIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP 143
+ GTPE++APE+ + + + + VD ++ G+ + E + P+ + P +I++K+ +G
Sbjct: 175 LCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFD-DTPFRIYEKILAG--- 230
Query: 144 ASLAKVNDPQIKGFIEKCLVPASERLSAKDLLKDPFLQVENQK 186
+ P A+DL+K LQ ++ K
Sbjct: 231 ----------------RLKFPNWFDGRARDLVKG-LLQTDHTK 256
|
Length = 329 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 42/137 (30%), Positives = 77/137 (56%), Gaps = 9/137 (6%)
Query: 29 WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA--MQQPTARSVI 86
+A +I GL +LH II+RDLK DN+ ++ + G +KI D G+ + T R+
Sbjct: 106 YAAEISVGLFFLHRRG--IIYRDLKLDNVMLD-SEGHIKIADFGMCKEHMVDGVTTRTFC 162
Query: 87 GTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG--IKP 143
GTP+++APE+ + Y + VD +++G+ + EM+ + P+ + ++ ++F+ + P
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPF-DGEDEDELFQSIMEHNVSYP 221
Query: 144 ASLAKVNDPQIKGFIEK 160
SL+K KG + K
Sbjct: 222 KSLSKEAVSICKGLMTK 238
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 49/161 (30%), Positives = 85/161 (52%), Gaps = 14/161 (8%)
Query: 29 WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TARSVI 86
+A +I L YLHS N I++RDLK +NI ++ + G + + D GL + T +
Sbjct: 101 YAAEIASALGYLHSLN--IVYRDLKPENILLD-SQGHIVLTDFGLCKENIEHNGTTSTFC 157
Query: 87 GTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPAS 145
GTPE++APE L+++ Y+ VD + G + EM+ + P +N A+++ + + KP
Sbjct: 158 GTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEML-YGLPPFYSRNTAEMYDNILN--KPLQ 214
Query: 146 LAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQ 185
L + +E L ++RL A KD F++++N
Sbjct: 215 LKPNITNSARHLLEGLLQKDRTKRLGA----KDDFMEIKNH 251
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.6 bits (154), Expect = 2e-10
Identities = 54/190 (28%), Positives = 91/190 (47%), Gaps = 28/190 (14%)
Query: 8 SGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHS-----HNPPIIHRDLKCDNIFV--- 59
S N+++ K ++ I + RQ+LH L Y H+ + ++HRDLK NIF+
Sbjct: 102 SRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTG 161
Query: 60 -----------NGNHGE--VKIGDLGLAIAMQ-QPTARSVIGTPEFMAPELYEEE---YN 102
N +G KIGD GL+ + + A S +GTP + +PEL E Y+
Sbjct: 162 IRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYD 221
Query: 103 ELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCL 162
+ D+++ G I E+ + + P+ + N +Q+ ++ G P K ++ I+ L
Sbjct: 222 DKSDMWALGCIIYELCSGKTPFHKANNFSQLISELKRG--PDLPIKGKSKELNILIKNLL 279
Query: 163 -VPASERLSA 171
+ A ER SA
Sbjct: 280 NLSAKERPSA 289
|
Length = 1021 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 36/98 (36%), Positives = 52/98 (53%), Gaps = 12/98 (12%)
Query: 26 IKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ------Q 79
+++ QIL GL Y+HS N ++HRDLK N+ VN + E+KI D GLA
Sbjct: 107 FQSFIYQILCGLKYIHSAN--VLHRDLKPGNLLVNAD-CELKICDFGLARGFSENPGENA 163
Query: 80 PTARSVIGTPEFMAPE--LYEEEYNELVDIYSFGMCIL 115
+ T + APE L + Y + +D++S G CIL
Sbjct: 164 GFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVG-CIL 200
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 41/99 (41%), Positives = 56/99 (56%), Gaps = 5/99 (5%)
Query: 21 VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA-IAMQQ 79
V + IK+ Q+L GL +LHSH ++HRDLK NI V + G++K+ D GLA I Q
Sbjct: 107 VPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSS-GQIKLADFGLARIYSFQ 163
Query: 80 PTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEM 117
SV+ T + APE L + Y VD++S G EM
Sbjct: 164 MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEM 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 3e-10
Identities = 35/113 (30%), Positives = 65/113 (57%), Gaps = 9/113 (7%)
Query: 31 RQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-TARSV--IG 87
+Q+L + Y+H +IHRD+K +NIF+N + G++ +GD G A+ ++ A +G
Sbjct: 274 KQLLCAVEYIHDKK--LIHRDIKLENIFLNCD-GKIVLGDFGTAMPFEKEREAFDYGWVG 330
Query: 88 TPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEY-PYSE-CKNPAQIFKKV 137
T +PE L + Y E+ DI+S G+ +L+M++ ++ P + P + K+
Sbjct: 331 TVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKI 383
|
Length = 501 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 3e-10
Identities = 36/102 (35%), Positives = 61/102 (59%), Gaps = 5/102 (4%)
Query: 29 WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ-PTARSVIG 87
+A +I GL LH I++RDLK +NI ++ +HG ++I DLGLA+ + + T + +G
Sbjct: 107 YAAEICCGLEDLHQER--IVYRDLKPENILLD-DHGHIRISDLGLAVHVPEGQTIKGRVG 163
Query: 88 TPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECK 128
T +MAPE+ + E Y D ++ G + EM+ + P+ + K
Sbjct: 164 TVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 3e-10
Identities = 36/98 (36%), Positives = 58/98 (59%), Gaps = 5/98 (5%)
Query: 29 WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ-PTARSVIG 87
+A +IL GL LH N ++RDLK +NI ++ ++G ++I DLGLA+ + + + R +G
Sbjct: 107 YAAEILCGLEDLHREN--TVYRDLKPENILLD-DYGHIRISDLGLAVKIPEGESIRGRVG 163
Query: 88 TPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPY 124
T +MAPE L + Y D + G I EM+ + P+
Sbjct: 164 TVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 3e-10
Identities = 35/125 (28%), Positives = 64/125 (51%), Gaps = 8/125 (6%)
Query: 1 MITELFTSGNLRQYRKKHKN-VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV 59
++ EL G LR Y + +K +D+ + ++ Q+ L YL S +HRD+ N+ V
Sbjct: 83 IVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR--FVHRDIAARNVLV 140
Query: 60 NGNHGEVKIGDLGLAIAMQQPT--ARSVIGTP-EFMAPE-LYEEEYNELVDIYSFGMCIL 115
+ VK+GD GL+ ++ + S P ++MAPE + + D++ FG+C+
Sbjct: 141 SSPDC-VKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMW 199
Query: 116 EMVTF 120
E++
Sbjct: 200 EILML 204
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 5e-10
Identities = 52/191 (27%), Positives = 95/191 (49%), Gaps = 24/191 (12%)
Query: 4 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNH 63
ELFT R++ + + ++ + +I+ L +LH II+RD+K +NI ++
Sbjct: 91 ELFTHLYQREHFTESE------VRVYIAEIVLALDHLHQLG--IIYRDIKLENILLDSE- 141
Query: 64 GEVKIGDLGLA---IAMQQPTARSVIGTPEFMAPELY---EEEYNELVDIYSFGMCILEM 117
G V + D GL+ +A ++ A S GT E+MAPE+ +++ VD +S G+ E+
Sbjct: 142 GHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFEL 201
Query: 118 VTFEYPYS---ECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASE-RL---S 170
+T P++ E + ++I +++ P K + + FI+K L + RL
Sbjct: 202 LTGASPFTVDGEQNSQSEISRRILKSKPP--FPKTMSAEARDFIQKLLEKDPKKRLGANG 259
Query: 171 AKDLLKDPFLQ 181
A ++ PF Q
Sbjct: 260 ADEIKNHPFFQ 270
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 5e-10
Identities = 40/96 (41%), Positives = 56/96 (58%), Gaps = 12/96 (12%)
Query: 32 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA-IAMQQPTARSV----I 86
QIL GL Y+HS N ++HRDLK N+ +N N ++KI D GLA IA + +
Sbjct: 114 QILRGLKYIHSAN--VLHRDLKPSNLLLNTN-CDLKICDFGLARIADPEHDHTGFLTEYV 170
Query: 87 GTPEFMAPE--LYEEEYNELVDIYSFGMCIL-EMVT 119
T + APE L + Y + +DI+S G CIL EM++
Sbjct: 171 ATRWYRAPEIMLNSKGYTKAIDIWSVG-CILAEMLS 205
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 6e-10
Identities = 41/114 (35%), Positives = 58/114 (50%), Gaps = 7/114 (6%)
Query: 10 NLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIG 69
+L Y +N+ I I R +L + YLH IIHRD+K +NIF+N + G+V +G
Sbjct: 168 DLYCYLAAKRNIAICDILAIERSVLRAIQYLH--ENRIIHRDIKAENIFIN-HPGDVCLG 224
Query: 70 DLGLA---IAMQQPTARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVT 119
D G A + + GT APEL + Y VDI+S G+ + EM T
Sbjct: 225 DFGAACFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMAT 278
|
Length = 391 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 7e-10
Identities = 60/208 (28%), Positives = 93/208 (44%), Gaps = 43/208 (20%)
Query: 32 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIG---T 88
QIL GL Y+HS + IIHRDLK N+ VN + E+KI D GLA + T + G T
Sbjct: 128 QILRGLKYIHSAD--IIHRDLKPSNLAVNED-CELKILDFGLA----RHTDDEMTGYVAT 180
Query: 89 PEFMAPELYEE--EYNELVDIYSFGMCILEMVTFE--YPYSECKNPAQIFKKVTSGIKPA 144
+ APE+ YN+ VDI+S G + E++T +P ++ + ++ ++
Sbjct: 181 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 240
Query: 145 SLAKVN--------------------------DPQIKGFIEKCLVPASE-RLSAKDLLKD 177
L K++ +P +EK LV S+ R++A L
Sbjct: 241 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300
Query: 178 P-FLQVEN-QKEPICDPLKLPIQSLKML 203
F Q + EP+ DP +S +L
Sbjct: 301 AYFAQYHDPDDEPVADPYDQSFESRDLL 328
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 8e-10
Identities = 58/210 (27%), Positives = 84/210 (40%), Gaps = 61/210 (29%)
Query: 19 KNVDIK--VIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 76
KNV IK + +L+GL Y+H + I+HRD+K NI + + G +K+ D GLA A
Sbjct: 112 KNVKFTLSEIKKVMKMLLNGLYYIHRNK--ILHRDMKAANILITKD-GILKLADFGLARA 168
Query: 77 MQQP--------TARSVIGTPEFMAPELY--EEEYNELVDIYSFGMCIL-EMVTFEYP-- 123
T R V T + PEL E +Y +D++ G CI+ EM T P
Sbjct: 169 FSLSKNSKPNRYTNRVV--TLWYRPPELLLGERDYGPPIDMWGAG-CIMAEMWT-RSPIM 224
Query: 124 --------------------------------YSECKNPAQIFKKVTSGIKPASLAKVND 151
+ + + P +KV +KP V D
Sbjct: 225 QGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKP----YVKD 280
Query: 152 PQIKGFIEKCLV--PASERLSAKDLLKDPF 179
P I+K LV P ++R+ A L F
Sbjct: 281 PHALDLIDKLLVLDP-AKRIDADTALNHDF 309
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 8e-10
Identities = 37/104 (35%), Positives = 62/104 (59%), Gaps = 13/104 (12%)
Query: 21 VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA----IA 76
+D +++K++ Q+L GL + HSHN ++HRDLK N+ +N N GE+K+ D GLA I
Sbjct: 96 IDPEIVKSFMFQLLKGLAFCHSHN--VLHRDLKPQNLLINKN-GELKLADFGLARAFGIP 152
Query: 77 MQQPTARSVIGTPEFMAPE--LYEEEYNELVDIYSFGMCIL-EM 117
++ +A V T + P+ + Y+ +D++S G CI E+
Sbjct: 153 VRCYSAEVV--TLWYRPPDVLFGAKLYSTSIDMWSAG-CIFAEL 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 8e-10
Identities = 44/112 (39%), Positives = 61/112 (54%), Gaps = 7/112 (6%)
Query: 10 NLRQYRKK--HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVK 67
+LR Y K + + IK+ RQ L GL +LH++ I+HRDLK +NI V + G+VK
Sbjct: 92 DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVT-SGGQVK 148
Query: 68 IGDLGLA-IAMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEM 117
+ D GLA I Q V+ T + APE L + Y VD++S G EM
Sbjct: 149 LADFGLARIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 9e-10
Identities = 36/102 (35%), Positives = 49/102 (48%), Gaps = 22/102 (21%)
Query: 31 RQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA-----------IAMQQ 79
QIL+GL LH +HRDL NIF+N + G KI D GLA ++ +
Sbjct: 126 LQILNGLNVLHKWY--FMHRDLSPANIFIN-SKGICKIADFGLARRYGYPPYSDTLSKDE 182
Query: 80 PTARSVIGTPE-----FMAPELY--EEEYNELVDIYSFGMCI 114
R T + + APEL E+Y+ VD++S G CI
Sbjct: 183 TMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVG-CI 223
|
Length = 335 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 36/93 (38%), Positives = 55/93 (59%), Gaps = 6/93 (6%)
Query: 29 WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TARSVI 86
+A ++ + YLHS N II+RDLK +NI ++ + G V + D GL +P T +
Sbjct: 101 YAAEVASAIGYLHSLN--IIYRDLKPENILLD-SQGHVVLTDFGLCKEGVEPEETTSTFC 157
Query: 87 GTPEFMAPE-LYEEEYNELVDIYSFGMCILEMV 118
GTPE++APE L +E Y+ VD + G + EM+
Sbjct: 158 GTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 35/121 (28%), Positives = 65/121 (53%), Gaps = 7/121 (5%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 60
++T+ + G L + +K K + +++ L +LH ++ I++RDLK +NI ++
Sbjct: 73 LVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYD--IVYRDLKPENILLD 130
Query: 61 GNHGEVKIGDLGLAIA--MQQPTARSVIGTPEFMAPELYEEE--YNELVDIYSFGMCILE 116
G + + D GL+ A T + GT E++APE+ +E Y + VD +S G+ + E
Sbjct: 131 AT-GHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFE 189
Query: 117 M 117
M
Sbjct: 190 M 190
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 1e-09
Identities = 37/127 (29%), Positives = 68/127 (53%), Gaps = 6/127 (4%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 60
++ E G+L + ++ + + + + +A +I L +LH II+RDLK DN+ ++
Sbjct: 73 LVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERG--IIYRDLKLDNVLLD 130
Query: 61 GNHGEVKIGDLGLAIAMQQP--TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEM 117
+ G +K+ D G+ P T + GTP ++APE+ EEY VD ++ G+ + EM
Sbjct: 131 AD-GHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEM 189
Query: 118 VTFEYPY 124
+ P+
Sbjct: 190 MAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 1e-09
Identities = 46/140 (32%), Positives = 71/140 (50%), Gaps = 10/140 (7%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIK--NWARQILHGLVYLHSHNPPIIHRDLKCDNIF 58
+ITE +G+L + K + + + + K + A QI G+ ++ N IHRDL+ NI
Sbjct: 77 IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN--YIHRDLRAANIL 134
Query: 59 VNGNHGEVKIGDLGLA--IAMQQPTARSVIGTP-EFMAPE-LYEEEYNELVDIYSFGMCI 114
V+ KI D GLA I + TAR P ++ APE + + D++SFG+ +
Sbjct: 135 VS-ETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILL 193
Query: 115 LEMVTF-EYPYSECKNPAQI 133
E+VT+ PY NP I
Sbjct: 194 TEIVTYGRIPYPGMTNPEVI 213
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 1e-09
Identities = 43/132 (32%), Positives = 64/132 (48%), Gaps = 12/132 (9%)
Query: 1 MITELFTSGNLRQY--RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIF 58
+ITE T GNL Y + V+ V+ A QI + YL N IHRDL N
Sbjct: 79 IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCL 136
Query: 59 VNGNHGEVKIGDLGLAIAMQQPTARSVIGTP---EFMAPE-LYEEEYNELVDIYSFGMCI 114
V G + VK+ D GL+ M T + G ++ APE L +++ D+++FG+ +
Sbjct: 137 V-GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLL 195
Query: 115 LEMVTF---EYP 123
E+ T+ YP
Sbjct: 196 WEIATYGMSPYP 207
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 2e-09
Identities = 38/132 (28%), Positives = 72/132 (54%), Gaps = 10/132 (7%)
Query: 1 MITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV 59
++T+L G+L + ++H+ ++D + + NW QI G+ YL H ++HR+L NI +
Sbjct: 85 LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR--MVHRNLAARNILL 142
Query: 60 NGNHGEVKIGDLGLAIAMQQPTAR---SVIGTP-EFMAPE-LYEEEYNELVDIYSFGMCI 114
+ V+I D G+A + + S TP ++MA E + Y D++S+G+ +
Sbjct: 143 KSDS-IVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTV 201
Query: 115 LEMVTF-EYPYS 125
EM+++ PY+
Sbjct: 202 WEMMSYGAEPYA 213
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 41/127 (32%), Positives = 69/127 (54%), Gaps = 11/127 (8%)
Query: 1 MITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV 59
++T+L G L Y +HK N+ +++ NW QI G++YL ++HRDL N+ V
Sbjct: 85 LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR--LVHRDLAARNVLV 142
Query: 60 NG-NHGEVKIGDLGLAIAMQ----QPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMC 113
NH VKI D GLA ++ + A ++MA E ++ ++ D++S+G+
Sbjct: 143 KSPNH--VKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVT 200
Query: 114 ILEMVTF 120
I E++TF
Sbjct: 201 IWELMTF 207
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 59.1 bits (144), Expect = 2e-09
Identities = 58/212 (27%), Positives = 93/212 (43%), Gaps = 52/212 (24%)
Query: 32 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA-------IAMQQPTARS 84
Q+L L Y+HS N +IHRDLK NI +N + VK+ D GLA + P
Sbjct: 115 QLLKALKYIHSGN--VIHRDLKPSNILLNSD-CRVKLADFGLARSLSELEENPENPVLTD 171
Query: 85 VIGTPEFMAPE--LYEEEYNELVDIYSFGMCIL-EMVTFE--YPYSECKNPAQIFKKVTS 139
+ T + APE L Y + VD++S G CIL EM+ + +P + N Q+ K +
Sbjct: 172 YVATRWYRAPEILLGSTRYTKGVDMWSVG-CILGEMLLGKPLFPGTSTLN--QLEKIIEV 228
Query: 140 GIKPAS--------------LAKVNDPQIKG--------------FIEKCLV--PASERL 169
P++ L + K ++K LV P ++RL
Sbjct: 229 IGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNP-NKRL 287
Query: 170 SAKDLLKDPFLQ--VENQKEPICD-PLKLPIQ 198
+A++ L+ P++ EP+ P+ +P+
Sbjct: 288 TAEEALEHPYVAQFHNPSDEPVLPYPITIPLD 319
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 41/116 (35%), Positives = 67/116 (57%), Gaps = 13/116 (11%)
Query: 32 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAI----AMQQPTARSVIG 87
QI+ L +HS ++HRDLK NIF+ G +K+GD G + ++ A S G
Sbjct: 177 QIVLALDEVHSRK--MMHRDLKSANIFLMPT-GIIKLGDFGFSKQYSDSVSLDVASSFCG 233
Query: 88 TPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQ--IFKKVTSG 140
TP ++APEL+E + Y++ D++S G+ + E++T P+ K P+Q I ++V G
Sbjct: 234 TPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPF---KGPSQREIMQQVLYG 286
|
Length = 478 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 54/192 (28%), Positives = 81/192 (42%), Gaps = 40/192 (20%)
Query: 26 IKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSV 85
+K + QIL GL YLHS I+HRD+K N+ VN N +KI D GLA + ++ +
Sbjct: 105 VKVFLYQILRGLKYLHSAG--ILHRDIKPGNLLVNSN-CVLKICDFGLARVEEPDESKHM 161
Query: 86 ---IGTPEFMAPELY--EEEYNELVDIYSFGMCI-------------------LEMVT-- 119
+ T + APE+ Y VDI+S G CI L+++T
Sbjct: 162 TQEVVTQYYRAPEILMGSRHYTSAVDIWSVG-CIFAELLGRRILFQAQSPIQQLDLITDL 220
Query: 120 -----FEYPYSECKNP-AQIFKKVTSGIKPASLAKVNDP---QIKGFIEKCLV-PASERL 169
E S C+ A I + L ++ + + + LV +R+
Sbjct: 221 LGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRI 280
Query: 170 SAKDLLKDPFLQ 181
SA D L P+L
Sbjct: 281 SAADALAHPYLD 292
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 3e-09
Identities = 35/92 (38%), Positives = 50/92 (54%), Gaps = 8/92 (8%)
Query: 30 ARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ----QPTARSV 85
ARQ+L + Y+H IIHRD+K +N+ VNG ++ +GD G A + P +
Sbjct: 266 ARQLLSAIDYIHGEG--IIHRDIKTENVLVNGPE-DICLGDFGAACFARGSWSTPFHYGI 322
Query: 86 IGTPEFMAPE-LYEEEYNELVDIYSFGMCILE 116
GT + APE L + Y VDI+S G+ I E
Sbjct: 323 AGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 3e-09
Identities = 34/99 (34%), Positives = 57/99 (57%), Gaps = 6/99 (6%)
Query: 29 WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA--MQQPTARSVI 86
+ +I+ L YLHS I++RDLK +N+ ++ + G +KI D GL T ++
Sbjct: 100 YGAEIVSALDYLHSGK--IVYRDLKLENLMLDKD-GHIKITDFGLCKEGITDAATMKTFC 156
Query: 87 GTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPY 124
GTPE++APE+ E+ +Y VD + G+ + EM+ P+
Sbjct: 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 3e-09
Identities = 37/114 (32%), Positives = 65/114 (57%), Gaps = 9/114 (7%)
Query: 32 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGL----AIAMQQPTARSVIG 87
Q+L L H H+ +IHRD+K NI + N G VK+GD G A + R+ G
Sbjct: 151 QVL--LAVHHVHSKHMIHRDIKSANILLCSN-GLVKLGDFGFSKMYAATVSDDVGRTFCG 207
Query: 88 TPEFMAPELYEEE-YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG 140
TP ++APE++ + Y++ D++S G+ + E++T + P+ + +N ++ K +G
Sbjct: 208 TPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPF-DGENMEEVMHKTLAG 260
|
Length = 496 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 4e-09
Identities = 39/138 (28%), Positives = 71/138 (51%), Gaps = 9/138 (6%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 60
+ E G+L + ++ + + + + ++ +I L YLH II+RDLK DN+ ++
Sbjct: 73 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLD 130
Query: 61 GNHGEVKIGDLGLAIAMQQP--TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEM 117
+ G +K+ D G+ +P T + GTP ++APE+ E+Y VD ++ G+ + EM
Sbjct: 131 -SEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEM 189
Query: 118 VTFEYPYS---ECKNPAQ 132
+ P+ NP Q
Sbjct: 190 MAGRSPFDIVGSSDNPDQ 207
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 4e-09
Identities = 33/96 (34%), Positives = 57/96 (59%), Gaps = 6/96 (6%)
Query: 32 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA--MQQPTARSVIGTP 89
+I+ L YLHS + +++RDLK +N+ ++ + G +KI D GL T ++ GTP
Sbjct: 103 EIVSALGYLHSCD--VVYRDLKLENLMLDKD-GHIKITDFGLCKEGISDGATMKTFCGTP 159
Query: 90 EFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPY 124
E++APE+ E+ +Y VD + G+ + EM+ P+
Sbjct: 160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 4e-09
Identities = 33/99 (33%), Positives = 57/99 (57%), Gaps = 5/99 (5%)
Query: 29 WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA--MQQPTARSVI 86
+ +I+ L YLHS +++RDLK +N+ ++ + G +KI D GL T ++
Sbjct: 100 YGAEIVSALDYLHSEKN-VVYRDLKLENLMLDKD-GHIKITDFGLCKEGIKDGATMKTFC 157
Query: 87 GTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPY 124
GTPE++APE+ E+ +Y VD + G+ + EM+ P+
Sbjct: 158 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 196
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 5e-09
Identities = 42/154 (27%), Positives = 78/154 (50%), Gaps = 13/154 (8%)
Query: 1 MITELFTSGNLRQY--RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIF 58
+ITE G+L + RK+ + ++ + +++ Q+ G+ +L S N IHRDL N+
Sbjct: 116 VITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNVL 173
Query: 59 VNGNHGEV-KIGDLGLAIAMQQPTARSVIGTP----EFMAPE-LYEEEYNELVDIYSFGM 112
+ HG++ KI D GLA + + V G ++MAPE ++ Y D++S+G+
Sbjct: 174 LT--HGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGI 231
Query: 113 CILEMVTF-EYPYSECKNPAQIFKKVTSGIKPAS 145
+ E+ + PY ++ +K + G + A
Sbjct: 232 LLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQ 265
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 56.8 bits (138), Expect = 5e-09
Identities = 44/181 (24%), Positives = 82/181 (45%), Gaps = 14/181 (7%)
Query: 9 GNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKI 68
G+L KK + +K RQ++ L LH HN IIH D+K +N+ + + +
Sbjct: 94 GDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHN--IIHNDIKLENVLYDRAKDRIYL 151
Query: 69 GDLGLAIAMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPY--- 124
D GL + P+ GT ++ +PE + Y+ D ++ G+ E++T ++P+
Sbjct: 152 CDYGLCKIIGTPSCYD--GTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKED 209
Query: 125 -SECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPA-SERLSA-KDLLKDPFLQ 181
E + + K+ K K F++ L + RL+ +++K PFL+
Sbjct: 210 EDEELDLESLLKRQQ---KKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLK 266
Query: 182 V 182
+
Sbjct: 267 I 267
|
Length = 267 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 6e-09
Identities = 32/87 (36%), Positives = 50/87 (57%), Gaps = 4/87 (4%)
Query: 41 HSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM--QQPTARSVIGTPEFMAPELYE 98
H H+ II+RDLK +NI ++ G +K+ D GL+ + A S GT E+MAPE+
Sbjct: 113 HLHSLGIIYRDLKPENILLD-EEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVN 171
Query: 99 EE-YNELVDIYSFGMCILEMVTFEYPY 124
+ + D +SFG+ + EM+T P+
Sbjct: 172 RRGHTQSADWWSFGVLMFEMLTGSLPF 198
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 7e-09
Identities = 56/203 (27%), Positives = 95/203 (46%), Gaps = 31/203 (15%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 60
+ E + G+L + ++ + + + + ++ +I L +LH II+RDLK DN+ ++
Sbjct: 73 FVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERG--IIYRDLKLDNVLLD 130
Query: 61 GNHGEVKIGDLGLAIAMQQP--TARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEM 117
G +K+ D G+ +P T + GTP ++APE L E+Y VD ++ G+ + EM
Sbjct: 131 AE-GHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEM 189
Query: 118 VTFEYPY---SECKNPAQ---------IFKKVTSGIK-PASLAKVNDPQIKGFIEKCLVP 164
+ P+ NP Q I +K I+ P SL+ +KGF+ K P
Sbjct: 190 MAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ---IRIPRSLSVKASSVLKGFLNK--DP 244
Query: 165 ASERLSAK------DLLKDPFLQ 181
ERL D+ PF +
Sbjct: 245 K-ERLGCHPQTGFRDIKSHPFFR 266
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 8e-09
Identities = 33/92 (35%), Positives = 46/92 (50%), Gaps = 8/92 (8%)
Query: 31 RQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM----QQPTARSVI 86
R++L L YLH IIHRD+K +NIF++ +GD G A + P
Sbjct: 192 RRLLEALAYLHGRG--IIHRDVKTENIFLD-EPENAVLGDFGAACKLDAHPDTPQCYGWS 248
Query: 87 GTPEFMAPELYE-EEYNELVDIYSFGMCILEM 117
GT E +PEL + Y DI+S G+ + EM
Sbjct: 249 GTLETNSPELLALDPYCAKTDIWSAGLVLFEM 280
|
Length = 392 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 8e-09
Identities = 43/154 (27%), Positives = 74/154 (48%), Gaps = 20/154 (12%)
Query: 41 HSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR--SVIGTPEFMAPEL-- 96
H H IHRD+K +NI + G VK+ D G++ + R + +GTP +MAPE+
Sbjct: 139 HLHVNKTIHRDVKGNNILLT-TEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIA 197
Query: 97 ----YEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDP 152
+ Y+ D++S G+ +E+ + P ++ +P + K+ P ++ P
Sbjct: 198 CEQQLDSTYDARCDVWSLGITAIELGDGDPPLADL-HPMRALFKIPRNPPP----TLHQP 252
Query: 153 QI-----KGFIEKCLVPASE-RLSAKDLLKDPFL 180
++ FI KCL E R + DLL+ F+
Sbjct: 253 ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 40/115 (34%), Positives = 67/115 (58%), Gaps = 9/115 (7%)
Query: 27 KNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGL---AIAMQQPTAR 83
+ +A +I L YLHS N I++RDLK +NI ++ + G V + D GL IA Q T
Sbjct: 99 RFYAAEIASALGYLHSIN--IVYRDLKPENILLD-SQGHVVLTDFGLCKEGIA-QSDTTT 154
Query: 84 SVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKV 137
+ GTPE++APE + ++ Y+ VD + G + EM+ + P C++ A+++ +
Sbjct: 155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEML-YGLPPFYCRDVAEMYDNI 208
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 43/175 (24%), Positives = 74/175 (42%), Gaps = 23/175 (13%)
Query: 40 LHS-HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM---QQPTARSVIGTPEFMAPE 95
+HS H +HRD+K +N+ ++ G +K+ D G A + + ++ +GTP+++APE
Sbjct: 115 IHSVHQMGYVHRDIKPENVLID-RTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPE 173
Query: 96 LYEE-------EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS---GIKPAS 145
+ Y D +S G+ EM+ P+ E A+ + + + +K
Sbjct: 174 VLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHE-GTSAKTYNNIMNFQRFLKFPE 232
Query: 146 LAKVNDPQIKGFIEKCLVPASERLSAKDLLKDPFL------QVENQKEPICDPLK 194
KV+ I+ L ERL + L PF + N P LK
Sbjct: 233 DPKVSS-DFLDLIQSLLCGQKERLGYEGLCCHPFFSKIDWNNIRNSLPPFVPTLK 286
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 47/165 (28%), Positives = 77/165 (46%), Gaps = 19/165 (11%)
Query: 32 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSV-----I 86
Q+L L Y+H+ N + HRDLK NI N + ++KI D GLA T ++ +
Sbjct: 111 QLLRALKYIHTAN--VFHRDLKPKNILANAD-CKLKICDFGLARVAFNDTPTAIFWTDYV 167
Query: 87 GTPEFMAPEL---YEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI-- 141
T + APEL + +Y +DI+S G CI V P KN +T +
Sbjct: 168 ATRWYRAPELCGSFFSKYTPAIDIWSIG-CIFAEVLTGKPLFPGKNVVHQLDLITDLLGT 226
Query: 142 -KPASLAKVNDPQIKGFI----EKCLVPASERLSAKDLLKDPFLQ 181
P ++++V + + + ++ +K VP S++ D L L+
Sbjct: 227 PSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLE 271
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 35/102 (34%), Positives = 58/102 (56%), Gaps = 5/102 (4%)
Query: 29 WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ-PTARSVIG 87
+A ++ GL L I++RDLK +NI ++ + G ++I DLGLA+ + + T R +G
Sbjct: 107 YAAELCCGLEDLQRER--IVYRDLKPENILLD-DRGHIRISDLGLAVQIPEGETVRGRVG 163
Query: 88 TPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECK 128
T +MAPE + E+Y D + G I EM+ + P+ + K
Sbjct: 164 TVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRK 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 1e-08
Identities = 49/132 (37%), Positives = 68/132 (51%), Gaps = 8/132 (6%)
Query: 32 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEF 91
Q+L GL Y+HS IIHRDLK N+ VN + E+KI D GLA V+ T +
Sbjct: 125 QMLCGLKYIHSAG--IIHRDLKPGNLAVNED-CELKILDFGLARHADAEMTGYVV-TRWY 180
Query: 92 MAPE--LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFK--KVTSGIKPASLA 147
APE L YN+ VDI+S G + EM+T + + Q+ + KVT P +
Sbjct: 181 RAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQ 240
Query: 148 KVNDPQIKGFIE 159
K+ D K +I+
Sbjct: 241 KLEDKAAKSYIK 252
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 2e-08
Identities = 38/132 (28%), Positives = 72/132 (54%), Gaps = 7/132 (5%)
Query: 9 GNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKI 68
G L + ++ D+ + + ++L L LH N +I+RDLK +NI ++ G + +
Sbjct: 78 GELFHHLQREGRFDLSRARFYTAELLCALENLHKFN--VIYRDLKPENILLD-YQGHIAL 134
Query: 69 GDLGLA-IAMQQP-TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYS 125
D GL + M+ + GTPE++APEL Y + VD ++ G+ + EM+T P+
Sbjct: 135 CDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFY 194
Query: 126 ECKNPAQIFKKV 137
+ +N ++++K+
Sbjct: 195 D-ENVNEMYRKI 205
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 53/196 (27%), Positives = 98/196 (50%), Gaps = 26/196 (13%)
Query: 4 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNH 63
ELFT + R+ K+ + ++ ++ +I+ L +LH II+RD+K +NI ++ N
Sbjct: 91 ELFTHLSQRERFKEQE------VQIYSGEIVLALEHLHKLG--IIYRDIKLENILLDSN- 141
Query: 64 GEVKIGDLGLA---IAMQQPTARSVIGTPEFMAPELY---EEEYNELVDIYSFGMCILEM 117
G V + D GL+ + A S GT E+MAP++ + +++ VD +S G+ + E+
Sbjct: 142 GHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYEL 201
Query: 118 VTFEYPYS---ECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERL---- 169
+T P++ E + A+I +++ P + K I++ L+ +RL
Sbjct: 202 LTGASPFTVDGEKNSQAEISRRILKSEPP--YPQEMSALAKDIIQRLLMKDPKKRLGCGP 259
Query: 170 -SAKDLLKDPFLQVEN 184
A ++ K PF Q N
Sbjct: 260 SDADEIKKHPFFQKIN 275
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 3e-08
Identities = 41/105 (39%), Positives = 55/105 (52%), Gaps = 6/105 (5%)
Query: 17 KHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 76
KH+ + I+ Q+L GL Y+H+ IIHRDLK N+ VN E+KI D GLA
Sbjct: 111 KHEKLSEDRIQFLVYQMLKGLKYIHAAG--IIHRDLKPGNLAVN-EDCELKILDFGLARQ 167
Query: 77 MQQPTARSVIGTPEFMAPE--LYEEEYNELVDIYSFGMCILEMVT 119
V+ T + APE L Y + VDI+S G + EM+T
Sbjct: 168 TDSEMTGYVV-TRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLT 211
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 3e-08
Identities = 33/100 (33%), Positives = 48/100 (48%), Gaps = 14/100 (14%)
Query: 32 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGE--VKIGDLGL--------AIAMQQPT 81
Q+L L +HN I+HRDLK NI V+ K+ D G+ + T
Sbjct: 87 QVLDALA--CAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLT 144
Query: 82 ARS-VIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 119
+ V+GTP + APE L E D+Y++G+ LE +T
Sbjct: 145 RTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLT 184
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 3e-08
Identities = 39/119 (32%), Positives = 61/119 (51%), Gaps = 8/119 (6%)
Query: 6 FTSGNLRQYRKKHKNV-DIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHG 64
+ +L+QY N+ + +K + Q+L GL Y H I+HRDLK N+ +N G
Sbjct: 84 YLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK--ILHRDLKPQNLLIN-EKG 140
Query: 65 EVKIGDLGLAIAMQQPTA--RSVIGTPEFMAPE--LYEEEYNELVDIYSFGMCILEMVT 119
E+K+ D GLA A PT + + T + P+ L EY+ +D++ G + EM T
Sbjct: 141 ELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMAT 199
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 3e-08
Identities = 41/142 (28%), Positives = 74/142 (52%), Gaps = 6/142 (4%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 60
++ E G + +++K V +A QI+ YL S N I++RDLK +N+ ++
Sbjct: 108 LVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLN--IVYRDLKPENLLLD 165
Query: 61 GNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 119
+ G +K+ D G A + T ++ GTPE++APE L + + D ++ G+ I E++
Sbjct: 166 KD-GFIKMTDFGFAKVVDTRT-YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILV 223
Query: 120 FEYPYSECKNPAQIFKKVTSGI 141
P+ P I++K+ GI
Sbjct: 224 GCPPFY-ANEPLLIYQKILEGI 244
|
Length = 340 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 4e-08
Identities = 42/123 (34%), Positives = 61/123 (49%), Gaps = 13/123 (10%)
Query: 16 KKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG---NHGEVKIGDLG 72
KK + ++K+ QIL G+ YLH++ ++HRDLK NI V G G VKI D+G
Sbjct: 100 KKPMQLPRSMVKSLLYQILDGIHYLHAN--WVLHRDLKPANILVMGEGPERGRVKIADMG 157
Query: 73 LAIAMQQPTA-----RSVIGTPEFMAPELY--EEEYNELVDIYSFGMCILEMVTFEYPYS 125
A P V+ T + APEL Y + +DI++ G E++T E P
Sbjct: 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE-PIF 216
Query: 126 ECK 128
C+
Sbjct: 217 HCR 219
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 4e-08
Identities = 51/164 (31%), Positives = 82/164 (50%), Gaps = 20/164 (12%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKV--IKNWARQILHGLVYLHSHNPPIIHRDLKCDNIF 58
++TE + G+L + K + +K+ + + A Q+ G+ Y+ N IHRDL+ NI
Sbjct: 77 IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN--YIHRDLRSANIL 134
Query: 59 VNGNHGEVKIGDLGLA--IAMQQPTARSVIGTP-EFMAPE--LYEEEYNELVDIYSFGMC 113
V G+ KI D GLA I + TAR P ++ APE LY + D++SFG+
Sbjct: 135 V-GDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGIL 192
Query: 114 ILEMVTF-EYPYSECKNPAQIFKKVTSGIK-------PASLAKV 149
+ E+VT PY N ++ ++V G + P SL ++
Sbjct: 193 LTELVTKGRVPYPGMNN-REVLEQVERGYRMPCPQDCPISLHEL 235
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 5e-08
Identities = 41/148 (27%), Positives = 67/148 (45%), Gaps = 29/148 (19%)
Query: 1 MITELFTSGNLRQYRKKH----------------KNVDIKVIKNWARQILHGLVYLHSHN 44
++ E GNLR + + + + K + ++A Q+ G+ +L S
Sbjct: 93 VVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK 152
Query: 45 PPIIHRDLKCDNIFVNGNHGEVKIGDLGLA-----IAMQQPTARSVIGTPEFMAPE-LYE 98
IHRDL N+ V +H +KI D GLA I + T + ++MAPE L++
Sbjct: 153 --CIHRDLAARNVLVTEDH-VMKIADFGLARDIHHIDYYRKTTNGRLPV-KWMAPEALFD 208
Query: 99 EEYNELVDIYSFGMCILEMVTF---EYP 123
Y D++SFG+ + E+ T YP
Sbjct: 209 RVYTHQSDVWSFGVLLWEIFTLGGSPYP 236
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 5e-08
Identities = 40/114 (35%), Positives = 58/114 (50%), Gaps = 13/114 (11%)
Query: 25 VIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG---NHGEVKIGDLGLAIAMQQPT 81
++K+ QIL G+ YLH++ ++HRDLK NI V G G VKI D+G A P
Sbjct: 109 MVKSLLYQILDGIHYLHAN--WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPL 166
Query: 82 A-----RSVIGTPEFMAPELY--EEEYNELVDIYSFGMCILEMVTFEYPYSECK 128
V+ T + APEL Y + +DI++ G E++T E P C+
Sbjct: 167 KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE-PIFHCR 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 5e-08
Identities = 50/201 (24%), Positives = 91/201 (45%), Gaps = 35/201 (17%)
Query: 40 LHS-HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-TARS--VIGTPEFMAPE 95
+HS H +HRD+K DN+ ++ N G +++ D G + M Q T +S +GTP++++PE
Sbjct: 115 IHSIHQLHYVHRDIKPDNVLLDMN-GHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPE 173
Query: 96 LYEE------EYNELVDIYSFGMCILEMVTFEYPY---SECKNPAQIFKKVTSGIKPASL 146
+ + +Y D +S G+C+ EM+ E P+ S + +I P+ +
Sbjct: 174 ILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHI 233
Query: 147 AKVNDPQIKGFIEKCLVPASERLSA---KDLLKDPFLQ------VENQKEPICDPLKLPI 197
V++ + K I++ + RL +D K F + + N + P + P
Sbjct: 234 TDVSE-EAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDWENIRNLEAPYIPDVSSP- 291
Query: 198 QSLKMLRLPMSGPSSMDIDSD 218
S S+ D+D D
Sbjct: 292 ----------SDTSNFDVDDD 302
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 6e-08
Identities = 48/197 (24%), Positives = 86/197 (43%), Gaps = 34/197 (17%)
Query: 43 HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA-MQQPTARS--VIGTPEFMAPELYEE 99
H +HRD+K DNI ++ N G +++ D G + M+ T +S +GTP++++PE+ +
Sbjct: 119 HQLHYVHRDIKPDNILMDMN-GHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA 177
Query: 100 ------EYNELVDIYSFGMCILEMVTFEYPY---SECKNPAQIFKKVTSGIKPASLAKVN 150
+Y D +S G+C+ EM+ E P+ S + +I PA + V+
Sbjct: 178 MEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVS 237
Query: 151 DPQIKGFIEKCLVPASERLSA---KDLLKDPFL------QVENQKEPICDPLKLPIQSLK 201
+ K I + + RL +D + PF + N + P + P +
Sbjct: 238 E-DAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDWDNIRNCEAPYIPEVSSPTDT-- 294
Query: 202 MLRLPMSGPSSMDIDSD 218
S+ D+D D
Sbjct: 295 ---------SNFDVDDD 302
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 6e-08
Identities = 38/115 (33%), Positives = 59/115 (51%), Gaps = 8/115 (6%)
Query: 10 NLRQYRKKHKNV-DIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKI 68
+L+QY N+ + +K + QIL GL Y H ++HRDLK N+ +N GE+K+
Sbjct: 89 DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK--VLHRDLKPQNLLIN-ERGELKL 145
Query: 69 GDLGLAIAMQQPTA--RSVIGTPEFMAPE--LYEEEYNELVDIYSFGMCILEMVT 119
D GLA A PT + + T + P+ L EY+ +D++ G EM +
Sbjct: 146 ADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMAS 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 7e-08
Identities = 44/132 (33%), Positives = 68/132 (51%), Gaps = 12/132 (9%)
Query: 1 MITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV 59
+IT+L G L Y ++HK N+ + + NW QI G+ YL ++HRDL N+ V
Sbjct: 85 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR--LVHRDLAARNVLV 142
Query: 60 NG-NHGEVKIGDLGLA--IAMQQPTARSVIG-TP-EFMAPE-LYEEEYNELVDIYSFGMC 113
H VKI D GLA + + + G P ++MA E + Y D++S+G+
Sbjct: 143 KTPQH--VKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVT 200
Query: 114 ILEMVTF-EYPY 124
+ E++TF PY
Sbjct: 201 VWELMTFGSKPY 212
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 8e-08
Identities = 37/115 (32%), Positives = 60/115 (52%), Gaps = 8/115 (6%)
Query: 10 NLRQYRKKHKN-VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKI 68
+L+QY N +++ +K + Q+L GL Y H ++HRDLK N+ +N GE+K+
Sbjct: 89 DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK--VLHRDLKPQNLLIN-ERGELKL 145
Query: 69 GDLGLAIAMQQPTA--RSVIGTPEFMAPE--LYEEEYNELVDIYSFGMCILEMVT 119
D GLA A PT + + T + P+ L +Y+ +D++ G EM T
Sbjct: 146 ADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMST 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 9e-08
Identities = 49/170 (28%), Positives = 80/170 (47%), Gaps = 19/170 (11%)
Query: 41 HSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGL---AIAMQQPTARSVIGTPEFMAPE-L 96
H H II+RDLK +NI ++ G VK+ D GL +I T + GT E+MAPE L
Sbjct: 115 HLHQQGIIYRDLKPENILLDAQ-GHVKLTDFGLCKESIHEGTVT-HTFCGTIEYMAPEIL 172
Query: 97 YEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG--IKPASLAKVNDPQI 154
+ + VD +S G + +M+T P++ +N + K+ G P L P+
Sbjct: 173 MRSGHGKAVDWWSLGALMYDMLTGAPPFT-AENRKKTIDKILKGKLNLPPYLT----PEA 227
Query: 155 KGFIEKCLV-PASERL-----SAKDLLKDPFLQVENQKEPICDPLKLPIQ 198
+ ++K L S RL A ++ PF + N + + ++ P +
Sbjct: 228 RDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNWDDLLARKVEPPFK 277
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 9e-08
Identities = 35/132 (26%), Positives = 68/132 (51%), Gaps = 12/132 (9%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 60
M+ E G+L + +V K K + +++ L +HS +IHRD+K DN+ ++
Sbjct: 120 MVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMG--LIHRDVKPDNMLLD 176
Query: 61 GNHGEVKIGDLGLAIAMQQP---TARSVIGTPEFMAPELYEEE-----YNELVDIYSFGM 112
HG +K+ D G + M + + +GTP++++PE+ + + Y D +S G+
Sbjct: 177 -KHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGV 235
Query: 113 CILEMVTFEYPY 124
+ EM+ + P+
Sbjct: 236 FLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 1e-07
Identities = 35/115 (30%), Positives = 58/115 (50%), Gaps = 8/115 (6%)
Query: 10 NLRQYRKKHKN-VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKI 68
+L+QY + + ++ + Q+L GL Y H ++HRDLK N+ ++ GE+K+
Sbjct: 88 DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR--VLHRDLKPQNLLIS-ERGELKL 144
Query: 69 GDLGLAIAMQQP--TARSVIGTPEFMAPE--LYEEEYNELVDIYSFGMCILEMVT 119
D GLA A P T + + T + P+ L EY+ +D++ G EM T
Sbjct: 145 ADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMAT 199
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 42/132 (31%), Positives = 67/132 (50%), Gaps = 8/132 (6%)
Query: 32 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEF 91
Q+L GL Y+HS IIHRDLK N+ VN + E++I D GLA + T +
Sbjct: 126 QLLRGLKYIHSAG--IIHRDLKPSNVAVNED-CELRILDFGLARQADDEMT-GYVATRWY 181
Query: 92 MAPE--LYEEEYNELVDIYSFGMCILEMVTFE--YPYSECKNPAQIFKKVTSGIKPASLA 147
APE L YN+ VDI+S G + E++ + +P ++ + + +V P L
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLK 241
Query: 148 KVNDPQIKGFIE 159
K++ + +I+
Sbjct: 242 KISSEHARKYIQ 253
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 2e-07
Identities = 41/144 (28%), Positives = 66/144 (45%), Gaps = 21/144 (14%)
Query: 1 MITELFTSGNLRQYRKKH-----------KNVDIKVIKNWARQILHGLVYLHSHNPPIIH 49
MI E +G+L Q+ +KH K++ + A QI G+ YL S N +H
Sbjct: 96 MIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN--FVH 153
Query: 50 RDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTP----EFMAPE-LYEEEYNEL 104
RDL N V N+ +KI D G++ + V G +MA E + ++
Sbjct: 154 RDLATRNCLVGKNY-TIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTK 212
Query: 105 VDIYSFGMCILEMVTF--EYPYSE 126
D+++FG+ + E++T E PY
Sbjct: 213 SDVWAFGVTLWEILTLCREQPYEH 236
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-07
Identities = 47/183 (25%), Positives = 89/183 (48%), Gaps = 31/183 (16%)
Query: 4 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNH 63
E+FT R + + ++ ++ +I+ L +LH I++RD+K +NI ++ +
Sbjct: 91 EMFTHLYQRDNFSEDE------VRFYSGEIILALEHLHKLG--IVYRDIKLENILLD-SE 141
Query: 64 GEVKIGDLGLA---IAMQQPTARSVIGTPEFMAPELYEEE--YNELVDIYSFGMCILEMV 118
G V + D GL+ ++ ++ S GT E+MAPE+ + + + VD +S G+ I E++
Sbjct: 142 GHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELL 201
Query: 119 TFEYPYS---ECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDLL 175
T P++ E +++ +++ DP FI P ++ L K L
Sbjct: 202 TGASPFTLEGERNTQSEVSRRILK----------CDPPFPSFIG----PEAQDLLHKLLR 247
Query: 176 KDP 178
KDP
Sbjct: 248 KDP 250
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 3e-07
Identities = 45/191 (23%), Positives = 74/191 (38%), Gaps = 55/191 (28%)
Query: 43 HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM------------------------- 77
H IHRD+K DNI ++ G +K+ D GL
Sbjct: 118 HKMGFIHRDIKPDNILID-RDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEE 176
Query: 78 --------------------QQPTARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILE 116
Q+ A S++GTP ++APE+ Y +L D +S G+ + E
Sbjct: 177 WSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236
Query: 117 MVTFEYPYSECKNPAQIFKKVT---SGIKPASLAKVNDPQIKGFIEKCLVPASERL---S 170
M+ + P+ PA+ KV + + S AK++ + I + A +RL
Sbjct: 237 MLVGQPPFLA-DTPAETQLKVINWETTLHIPSQAKLS-REASDLILRLCCGAEDRLGKNG 294
Query: 171 AKDLLKDPFLQ 181
A ++ PF +
Sbjct: 295 ADEIKAHPFFK 305
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 4e-07
Identities = 38/148 (25%), Positives = 72/148 (48%), Gaps = 10/148 (6%)
Query: 1 MITELFTSGNLRQYRKKHKNV-DIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV 59
++TE +G L Y ++ K + + + + + YL S+ IHRDL N V
Sbjct: 76 IVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG--FIHRDLAARNCLV 133
Query: 60 NGNHGEVKIGDLGLAIAMQQPTARSVIGTP---EFMAPELYE-EEYNELVDIYSFGMCIL 115
G VK+ D GLA + S GT ++ PE+++ ++ D++SFG+ +
Sbjct: 134 -GEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMW 192
Query: 116 EMVTF-EYPYSECKNPAQIFKKVTSGIK 142
E+ + + PY N +++ + V++G +
Sbjct: 193 EVFSEGKMPYERFSN-SEVVESVSAGYR 219
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 4e-07
Identities = 44/156 (28%), Positives = 75/156 (48%), Gaps = 15/156 (9%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIK--NWARQILHGLVYLHSHNPPIIHRDLKCDNIF 58
+ITE +G L +Y + H + + R I G+ YL N +HRDL NI
Sbjct: 83 IITEYMENGALDKYLRDHDG-EFSSYQLVGMLRGIAAGMKYLSDMN--YVHRDLAARNIL 139
Query: 59 VNGNHGEVKIGDLGLAIAMQQPTARSVIGTP-----EFMAPE-LYEEEYNELVDIYSFGM 112
VN N E K+ D GL+ ++ + + + APE + ++ D++SFG+
Sbjct: 140 VNSNL-ECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGI 198
Query: 113 CILEMVTF-EYPYSECKNPAQIFKKVTSGIK-PASL 146
+ E+++F E PY + N ++ K + G + PA +
Sbjct: 199 VMWEVMSFGERPYWDMSN-HEVMKAINDGFRLPAPM 233
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 4e-07
Identities = 37/122 (30%), Positives = 62/122 (50%), Gaps = 22/122 (18%)
Query: 37 LVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA-IAMQQPTA------------- 82
L YLH++ I+HRDLK DN+ + + G +K+ D GL+ I + T
Sbjct: 114 LEYLHNYG--IVHRDLKPDNLLIT-SMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170
Query: 83 ---RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVT 138
+ V GTPE++APE + + Y + VD ++ G+ + E + P+ P ++F +V
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG-DTPEELFGQVI 229
Query: 139 SG 140
S
Sbjct: 230 SD 231
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 4e-07
Identities = 45/140 (32%), Positives = 71/140 (50%), Gaps = 10/140 (7%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIK--NWARQILHGLVYLHSHNPPIIHRDLKCDNIF 58
+ITE G+L + K + + K +++ QI G+ ++ N IHRDL+ NI
Sbjct: 77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANIL 134
Query: 59 VNGNHGEVKIGDLGLA--IAMQQPTARSVIGTP-EFMAPE-LYEEEYNELVDIYSFGMCI 114
V+ + KI D GLA I + TAR P ++ APE + + D++SFG+ +
Sbjct: 135 VSASL-VCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILL 193
Query: 115 LEMVTF-EYPYSECKNPAQI 133
+E+VT+ PY NP I
Sbjct: 194 MEIVTYGRIPYPGMSNPEVI 213
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 5e-07
Identities = 39/127 (30%), Positives = 66/127 (51%), Gaps = 11/127 (8%)
Query: 1 MITELFTSGNLRQYRKKHKN-VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV 59
++T+L G L Y +++K+ + + + NW QI G+ YL ++HRDL N+ V
Sbjct: 85 LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR--LVHRDLAARNVLV 142
Query: 60 -NGNHGEVKIGDLGLA----IAMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMC 113
+ NH VKI D GLA I + A ++MA E + + D++S+G+
Sbjct: 143 KSPNH--VKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVT 200
Query: 114 ILEMVTF 120
+ E++TF
Sbjct: 201 VWELMTF 207
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 6e-07
Identities = 33/91 (36%), Positives = 51/91 (56%), Gaps = 7/91 (7%)
Query: 32 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TARSVIGTP 89
Q+L GL Y+H + I+HRDLK N+ ++ GE+K+ D GLA A P T S + T
Sbjct: 111 QLLRGLAYIHGQH--ILHRDLKPQNLLIS-YLGELKLADFGLARAKSIPSQTYSSEVVTL 167
Query: 90 EFMAPE--LYEEEYNELVDIYSFGMCILEMV 118
+ P+ L +Y+ +DI+ G +EM+
Sbjct: 168 WYRPPDVLLGATDYSSALDIWGAGCIFIEML 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 6e-07
Identities = 43/136 (31%), Positives = 68/136 (50%), Gaps = 10/136 (7%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIK--NWARQILHGLVYLHSHNPPIIHRDLKCDNIF 58
+ITE G+L + K + + + K +++ QI G+ Y+ N IHRDL+ N+
Sbjct: 78 IITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN--YIHRDLRAANVL 135
Query: 59 VNGNHGEVKIGDLGLA--IAMQQPTARSVIGTP-EFMAPELYE-EEYNELVDIYSFGMCI 114
V+ KI D GLA I + TAR P ++ APE + D++SFG+ +
Sbjct: 136 VS-ESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILL 194
Query: 115 LEMVTF-EYPYSECKN 129
E+VT+ + PY N
Sbjct: 195 YEIVTYGKIPYPGMSN 210
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 6e-07
Identities = 44/126 (34%), Positives = 67/126 (53%), Gaps = 11/126 (8%)
Query: 1 MITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIF 58
++TE G+L + K+ K + + + + A QI G+ Y+ N IHRDL+ NI
Sbjct: 77 IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN--YIHRDLRAANIL 134
Query: 59 VNGNHGEVKIGDLGLA--IAMQQPTARSVIGTP-EFMAPE--LYEEEYNELVDIYSFGMC 113
V G++ KI D GLA I + TAR P ++ APE LY + D++SFG+
Sbjct: 135 V-GDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGIL 192
Query: 114 ILEMVT 119
+ E+VT
Sbjct: 193 LTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 6e-07
Identities = 39/94 (41%), Positives = 51/94 (54%), Gaps = 15/94 (15%)
Query: 32 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPE- 90
Q+L G+ +LHS IIHRDLK NI V + +KI D GLA + S + TP
Sbjct: 126 QMLCGIKHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFGLA----RTAGTSFMMTPYV 178
Query: 91 ----FMAPE-LYEEEYNELVDIYSFGMCIL-EMV 118
+ APE + Y E VDI+S G CI+ EM+
Sbjct: 179 VTRYYRAPEVILGMGYKENVDIWSVG-CIMGEMI 211
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 6e-07
Identities = 37/133 (27%), Positives = 62/133 (46%), Gaps = 40/133 (30%)
Query: 43 HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ--------------PT------- 81
H IHRD+K DN+ ++ + G VK+ D GL +++ P+
Sbjct: 118 HQLGFIHRDIKPDNLLLD-SKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNM 176
Query: 82 ----------------ARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTFEYPY 124
A S +GTP+++APE++ + YN+L D +S G+ + EM+ YP
Sbjct: 177 NSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML-IGYPP 235
Query: 125 SECKNPAQIFKKV 137
+ P + +KKV
Sbjct: 236 FCSETPQETYKKV 248
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 7e-07
Identities = 39/148 (26%), Positives = 73/148 (49%), Gaps = 10/148 (6%)
Query: 1 MITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV 59
++TE ++G L Y ++H K + + + G+ YL S IHRDL N V
Sbjct: 76 IVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ--FIHRDLAARNCLV 133
Query: 60 NGNHGEVKIGDLGLAIAMQQPTARSVIGTP---EFMAPE-LYEEEYNELVDIYSFGMCIL 115
+ G VK+ D GL+ + S +G+ + PE L +++ D+++FG+ +
Sbjct: 134 DDQ-GCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMW 192
Query: 116 EMVTF-EYPYSECKNPAQIFKKVTSGIK 142
E+ + + PY N ++ +KV+ G++
Sbjct: 193 EVYSLGKMPYERFNN-SETVEKVSQGLR 219
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 9e-07
Identities = 38/118 (32%), Positives = 63/118 (53%), Gaps = 8/118 (6%)
Query: 6 FTSGNLRQYRKKHKN-VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHG 64
+ +L QY KH + + +K + Q+L GL Y+H I+HRDLK N+ ++ + G
Sbjct: 84 YVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY--ILHRDLKPQNLLIS-DTG 140
Query: 65 EVKIGDLGLAIAMQQP--TARSVIGTPEFMAPE--LYEEEYNELVDIYSFGMCILEMV 118
E+K+ D GLA A P T + + T + P+ L EY+ +D++ G +EM+
Sbjct: 141 ELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMI 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 36/133 (27%), Positives = 61/133 (45%), Gaps = 40/133 (30%)
Query: 43 HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ--------------PT------- 81
H IHRD+K DN+ ++ G VK+ D GL +++ P+
Sbjct: 118 HQLGFIHRDIKPDNLLLDAK-GHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNM 176
Query: 82 ----------------ARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTFEYPY 124
A S +GTP+++APE++ + YN+L D +S G+ + EM+ YP
Sbjct: 177 NSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML-IGYPP 235
Query: 125 SECKNPAQIFKKV 137
+ P + ++KV
Sbjct: 236 FCSETPQETYRKV 248
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 1e-06
Identities = 40/126 (31%), Positives = 65/126 (51%), Gaps = 11/126 (8%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKV--IKNWARQILHGLVYLHSHNPPIIHRDLKCDNIF 58
++TE + G+L + K +++ + + A QI G+ Y+ N +HRDL+ NI
Sbjct: 77 IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANIL 134
Query: 59 VNGNHGEVKIGDLGLA--IAMQQPTARSVIGTP-EFMAPE--LYEEEYNELVDIYSFGMC 113
V G + K+ D GLA I + TAR P ++ APE LY + D++SFG+
Sbjct: 135 V-GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGIL 192
Query: 114 ILEMVT 119
+ E+ T
Sbjct: 193 LTELTT 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 1e-06
Identities = 44/157 (28%), Positives = 73/157 (46%), Gaps = 20/157 (12%)
Query: 1 MITELFTSGNLRQYRKKHKN-------VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLK 53
+I EL G+L Y + + + +K + + + G VYL + IHRDL
Sbjct: 76 IIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH--FIHRDLA 133
Query: 54 CDNIFVNGNHGE----VKIGDLGLAIAMQQPTARSVIGTP----EFMAPE-LYEEEYNEL 104
N V+ + VKIGD GLA + + G +MAPE L + ++
Sbjct: 134 ARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQ 193
Query: 105 VDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSG 140
D++SFG+ + E++T + PY N ++ + VT+G
Sbjct: 194 SDVWSFGVLMWEILTLGQQPYPALNN-QEVLQHVTAG 229
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 2e-06
Identities = 44/190 (23%), Positives = 80/190 (42%), Gaps = 58/190 (30%)
Query: 40 LHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGL------------------------AI 75
+H IHRD+K DN+ ++ G +K+ D GL
Sbjct: 117 IHKLG--YIHRDIKPDNLLLDAK-GHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLD 173
Query: 76 AMQQPT----------------ARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMV 118
+ +P A S +GTP+++APE++ + YN+ D +S G+ + EM+
Sbjct: 174 FISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233
Query: 119 TFEYP--YSECKNPAQIFKKVTSGIKPASLAKVND----PQIKGFIEKCLVPASERL--- 169
YP S+ NP + ++K+ + + +L ++ P+ K I++ A RL
Sbjct: 234 V-GYPPFCSD--NPQETYRKIINWKE--TLQFPDEVPLSPEAKDLIKRLCCEAERRLGNN 288
Query: 170 SAKDLLKDPF 179
++ PF
Sbjct: 289 GVNEIKSHPF 298
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 48/170 (28%), Positives = 77/170 (45%), Gaps = 29/170 (17%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWAR----------------QILHGLVYLHSHN 44
+I E + GNLR+Y + + ++ + AR Q+ G+ YL S
Sbjct: 98 VIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK 157
Query: 45 PPIIHRDLKCDNIFVNGNHGEVKIGDLGLA-----IAMQQPTARSVIGTPEFMAPE-LYE 98
IHRDL N+ V N+ +KI D GLA I + T + ++MAPE L++
Sbjct: 158 --CIHRDLAARNVLVTENN-VMKIADFGLARDVNNIDYYKKTTNGRLPV-KWMAPEALFD 213
Query: 99 EEYNELVDIYSFGMCILEMVTF---EYPYSECKNPAQIFKKVTSGIKPAS 145
Y D++SFG+ + E+ T YP + ++ K+ KPA+
Sbjct: 214 RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPAN 263
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 39/135 (28%), Positives = 68/135 (50%), Gaps = 10/135 (7%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 60
++ EL G L ++ +K+K+V K I Q+ G+ YL N +HRDL N+ +
Sbjct: 72 LVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETN--FVHRDLAARNVLLV 129
Query: 61 GNHGEVKIGDLGLAIAMQQP----TARSVIGTP-EFMAPE-LYEEEYNELVDIYSFGMCI 114
H KI D GL+ A+ A++ P ++ APE + +++ D++SFG+ +
Sbjct: 130 TQH-YAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLM 188
Query: 115 LEMVTF-EYPYSECK 128
E ++ + PY K
Sbjct: 189 WEAFSYGQKPYKGMK 203
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 33/117 (28%), Positives = 59/117 (50%), Gaps = 17/117 (14%)
Query: 20 NVDIKVIKNWAR----QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 75
N DI + WAR +++ L +HS IHRD+K DN+ ++ G +K+ D G +
Sbjct: 136 NYDIP--EKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLD-KSGHLKLADFGTCM 190
Query: 76 AMQ---QPTARSVIGTPEFMAPELYEE-----EYNELVDIYSFGMCILEMVTFEYPY 124
M + +GTP++++PE+ + Y D +S G+ + EM+ + P+
Sbjct: 191 KMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 3e-06
Identities = 41/142 (28%), Positives = 66/142 (46%), Gaps = 26/142 (18%)
Query: 1 MITELFTSGNLRQYRKKHK----------------NVDIKVIKNWARQILHGLVYLHSHN 44
+I E + GNLR+Y + + + K + + A Q+ G+ YL S
Sbjct: 101 VIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK 160
Query: 45 PPIIHRDLKCDNIFVNGNHGEVKIGDLGLA-----IAMQQPTARSVIGTPEFMAPE-LYE 98
IHRDL N+ V ++ +KI D GLA I + T + ++MAPE L++
Sbjct: 161 --CIHRDLAARNVLVTEDN-VMKIADFGLARDIHHIDYYKKTTNGRLPV-KWMAPEALFD 216
Query: 99 EEYNELVDIYSFGMCILEMVTF 120
Y D++SFG+ + E+ T
Sbjct: 217 RIYTHQSDVWSFGVLLWEIFTL 238
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 3e-06
Identities = 37/133 (27%), Positives = 65/133 (48%), Gaps = 19/133 (14%)
Query: 9 GNLRQYRKKHKNVDIKVIK--------NWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 60
GNL+ + ++ + + + + A QI G+ YLH +IH+D+ N ++
Sbjct: 94 GNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG--VIHKDIAARNCVID 151
Query: 61 GNHGEVKIGDLGLAIAMQQPTARSVIGTPE-----FMAPE-LYEEEYNELVDIYSFGMCI 114
+VKI D L+ + P +G E +MA E L +EY+ D++SFG+ +
Sbjct: 152 -EELQVKITDNALSRDLF-PMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLL 209
Query: 115 LEMVTF-EYPYSE 126
E++T + PY E
Sbjct: 210 WELMTLGQTPYVE 222
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 3e-06
Identities = 38/144 (26%), Positives = 65/144 (45%), Gaps = 21/144 (14%)
Query: 1 MITELFTSGNLRQYRKKHK-----------NVDIKVIKNWARQILHGLVYLHSHNPPIIH 49
MITE +G+L Q+ +H+ + + A QI G+ YL S N +H
Sbjct: 96 MITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN--FVH 153
Query: 50 RDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-----TARSVIGTPEFMAPELYEEEYNEL 104
RDL N V N+ +KI D G++ + R+V+ + ++
Sbjct: 154 RDLATRNCLVGKNY-TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTA 212
Query: 105 VDIYSFGMCILEMVTF--EYPYSE 126
D+++FG+ + E++T E PYS+
Sbjct: 213 SDVWAFGVTLWEILTLCKEQPYSQ 236
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 3e-06
Identities = 36/143 (25%), Positives = 65/143 (45%), Gaps = 17/143 (11%)
Query: 1 MITELFTSGNLRQY---------RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRD 51
MI E G+L+Q+ + K + K QI G+ +L + +HRD
Sbjct: 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR--FVHRD 142
Query: 52 LKCDNIFVNGNHGEVKIGDLGLA---IAMQQPTARSVIGTPEFMAPE-LYEEEYNELVDI 107
L N V+ EVK+ L L+ + R+ + ++APE + E++++ D+
Sbjct: 143 LAARNCLVSSQR-EVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDV 201
Query: 108 YSFGMCILEMVTF-EYPYSECKN 129
+SFG+ + E+ T E P+ +
Sbjct: 202 WSFGVLMWEVFTQGELPFYGLSD 224
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 6e-06
Identities = 39/111 (35%), Positives = 55/111 (49%), Gaps = 11/111 (9%)
Query: 30 ARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTP 89
A QI G+VYL S + +HRDL N V G VKIGD G++ + V G
Sbjct: 128 ASQIASGMVYLASLH--FVHRDLATRNCLV-GQGLVVKIGDFGMSRDIYSTDYYRVGGRT 184
Query: 90 ----EFMAPE--LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQI 133
+M PE LY + E DI+SFG+ + E+ T+ + P+ + N I
Sbjct: 185 MLPIRWMPPESILYRKFTTE-SDIWSFGVVLWEIFTYGKQPWYQLSNTEAI 234
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 6e-06
Identities = 37/149 (24%), Positives = 74/149 (49%), Gaps = 21/149 (14%)
Query: 48 IHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-TARS--VIGTPEFMAPELYEE----- 99
+HRD+K DN+ ++ +G +++ D G + + T +S +GTP++++PE+ +
Sbjct: 124 VHRDIKPDNVLLD-KNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGK 182
Query: 100 -EYNELVDIYSFGMCILEMVTFEYP-YSECKNPAQIFKKVTSGIK----PASLAKVNDPQ 153
Y D +S G+C+ EM+ E P Y+E + + + K+ + + P + V++ +
Sbjct: 183 GRYGPECDWWSLGVCMYEMLYGETPFYAE--SLVETYGKIMNHKEHFQFPPDVTDVSE-E 239
Query: 154 IKGFIEKCLVPASERL---SAKDLLKDPF 179
K I + + RL +D PF
Sbjct: 240 AKDLIRRLICSPETRLGRNGLQDFKDHPF 268
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 7e-06
Identities = 35/136 (25%), Positives = 67/136 (49%), Gaps = 20/136 (14%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWAR----QILHGLVYLHSHNPPIIHRDLKCDN 56
M+ E G+L + V + WAR +++ L +HS IHRD+K DN
Sbjct: 120 MVMEYMPGGDLVNLMSNYD-----VPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDN 172
Query: 57 IFVNGNHGEVKIGDLGLAIAMQQP---TARSVIGTPEFMAPELYEEE-----YNELVDIY 108
+ ++ + G +K+ D G + M + + +GTP++++PE+ + + Y D +
Sbjct: 173 MLLDKS-GHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWW 231
Query: 109 SFGMCILEMVTFEYPY 124
S G+ + EM+ + P+
Sbjct: 232 SVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 8e-06
Identities = 36/131 (27%), Positives = 63/131 (48%), Gaps = 14/131 (10%)
Query: 1 MITELFTSGNLRQY---RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 57
++TE G+L Y R + + +A + G+ YL N +HRDL N+
Sbjct: 77 IVTEYMAKGSLVDYLRSRGRAVIT-LAQQLGFALDVCEGMEYLEEKN--FVHRDLAARNV 133
Query: 58 FVNGNHGEVKIGDLGLAIAMQ--QPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCI 114
V+ K+ D GLA Q + + + ++ APE L E++++ D++SFG+ +
Sbjct: 134 LVS-EDLVAKVSDFGLAKEASQGQDSGKLPV---KWTAPEALREKKFSTKSDVWSFGILL 189
Query: 115 LEMVTF-EYPY 124
E+ +F PY
Sbjct: 190 WEIYSFGRVPY 200
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 9e-06
Identities = 36/118 (30%), Positives = 61/118 (51%), Gaps = 10/118 (8%)
Query: 11 LRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGD 70
++ Y + + + + ++K ++ Q+ L Y+HS I HRDLK N+ ++ N +K+ D
Sbjct: 157 MKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF--ICHRDLKPQNLLIDPNTHTLKLCD 214
Query: 71 LGLA---IAMQQPTARSVIGTPEFMAPELY--EEEYNELVDIYSFGMCILEMVTFEYP 123
G A +A Q+ S I + + APEL Y +D++S G I EM+ YP
Sbjct: 215 FGSAKNLLAGQRSV--SYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMI-LGYP 269
|
Length = 440 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 9e-06
Identities = 38/146 (26%), Positives = 72/146 (49%), Gaps = 13/146 (8%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIK--NWARQILHGLVYLHSHNPPIIHRDLKCDNIF 58
++ EL + GNL + + + VI+ ++ + G+ YL S ++HRDL NI
Sbjct: 75 IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK--LVHRDLAARNIL 132
Query: 59 VNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEM 117
V+ + G K+ D GLA S + ++ APE L ++++ D++S+G+ + E+
Sbjct: 133 VSED-GVAKVSDFGLARVGSMGVDNSKLPV-KWTAPEALKHKKFSSKSDVWSYGVLLWEV 190
Query: 118 VTF-EYPYSECKNPAQIFKKVTSGIK 142
++ PY P K+V ++
Sbjct: 191 FSYGRAPY-----PKMSLKEVKECVE 211
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 42/137 (30%), Positives = 70/137 (51%), Gaps = 12/137 (8%)
Query: 32 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGE-VKIGDLGLAIAMQQPTARSVIGTP- 89
Q+ +G+ +L S N +HRDL N+ + G+ VKI D GLA + + + G+
Sbjct: 247 QVANGMEFLASKN--CVHRDLAARNVLIC--EGKLVKICDFGLARDIMRDSNYISKGSTF 302
Query: 90 ---EFMAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSGIKPA 144
++MAPE ++ Y L D++SFG+ + E+ T PY E Q + + G + A
Sbjct: 303 LPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMA 362
Query: 145 SLAKVNDPQIKGFIEKC 161
A +D +I ++KC
Sbjct: 363 KPAHASD-EIYEIMQKC 378
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.8 bits (113), Expect = 1e-05
Identities = 27/56 (48%), Positives = 35/56 (62%), Gaps = 3/56 (5%)
Query: 22 DIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM 77
DI VIK RQ+L GL LH I+HRD+K +N+ V + G+VKI D G A+ M
Sbjct: 307 DINVIKGVMRQVLTGLRKLHRIG--IVHRDIKPENLLVTVD-GQVKIIDFGAAVDM 359
|
Length = 507 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 1e-05
Identities = 41/147 (27%), Positives = 67/147 (45%), Gaps = 11/147 (7%)
Query: 1 MITELFTSGNLRQY-RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV 59
++ EL G+L + RKK + +K + + G+ YL S N IHRDL N V
Sbjct: 69 IVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN--CIHRDLAARNCLV 126
Query: 60 NGNHGEVKIGDLGLAIAMQQPTARSVIGTPE----FMAPE-LYEEEYNELVDIYSFGMCI 114
N+ +KI D G++ + G + + APE L Y D++S+G+ +
Sbjct: 127 GENN-VLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILL 185
Query: 115 LEMVTF-EYPYSECKNPAQIFKKVTSG 140
E + + PY N Q +++ SG
Sbjct: 186 WETFSLGDTPYPGMSN-QQTRERIESG 211
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 40/152 (26%), Positives = 67/152 (44%), Gaps = 21/152 (13%)
Query: 1 MITELFTSGNLRQY-RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV 59
+ITE +G+L ++ R+ + + R I G+ YL N +HRDL NI V
Sbjct: 82 IITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN--YVHRDLAARNILV 139
Query: 60 NGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFM---------APE-LYEEEYNELVDIYS 109
N ++ K+ D GL+ T APE + ++ D++S
Sbjct: 140 N-SNLVCKVSDFGLS-----RRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWS 193
Query: 110 FGMCILEMVTF-EYPYSECKNPAQIFKKVTSG 140
FG+ + E++++ E PY + N + K V G
Sbjct: 194 FGIVMWEVMSYGERPYWDMSN-QDVIKAVEDG 224
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 42/148 (28%), Positives = 68/148 (45%), Gaps = 29/148 (19%)
Query: 1 MITELFTSGNLRQY----------------RKKHKNVDIKVIKNWARQILHGLVYLHSHN 44
+I E GNLR++ + + + K + + A Q+ G+ YL S
Sbjct: 95 VIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR 154
Query: 45 PPIIHRDLKCDNIFVNGNHGEVKIGDLGLA-----IAMQQPTARSVIGTPEFMAPE-LYE 98
IHRDL N+ V ++ +KI D GLA I + T+ + ++MAPE L++
Sbjct: 155 --CIHRDLAARNVLVTEDN-VMKIADFGLARGVHDIDYYKKTSNGRLPV-KWMAPEALFD 210
Query: 99 EEYNELVDIYSFGMCILEMVTF---EYP 123
Y D++SFG+ + E+ T YP
Sbjct: 211 RVYTHQSDVWSFGILMWEIFTLGGSPYP 238
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 2e-05
Identities = 47/183 (25%), Positives = 79/183 (43%), Gaps = 16/183 (8%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLH-SHNPPIIHRDLKCDNIFV 59
+I E T G LR+ K K++ K + A GL L+ N P +++L + V
Sbjct: 99 LILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLV 156
Query: 60 NGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYE------EEYNELVDIYSFGMC 113
N ++KI GL + P ++V FM Y+ EY DIYS G+
Sbjct: 157 TEN-YKLKIICHGLEKILSSPPFKNV----NFMVYFSYKMLNDIFSEYTIKDDIYSLGVV 211
Query: 114 ILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAK 172
+ E+ T + P+ E +I+ + + L +IK +E C + +R + K
Sbjct: 212 LWEIFTGKIPF-ENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIK 270
Query: 173 DLL 175
++L
Sbjct: 271 EIL 273
|
Length = 283 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 2e-05
Identities = 39/150 (26%), Positives = 75/150 (50%), Gaps = 17/150 (11%)
Query: 1 MITELFTSGNLRQY-RKKHKNV-DIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIF 58
++TE G+L Y R + ++V + ++ + + YL ++N +HRDL N+
Sbjct: 77 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN--FVHRDLAARNVL 134
Query: 59 VNGNHGEVKIGDLGLA--IAMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCIL 115
V+ ++ K+ D GL + Q T + + ++ APE L E++++ D++SFG+ +
Sbjct: 135 VSEDN-VAKVSDFGLTKEASSTQDTGKLPV---KWTAPEALREKKFSTKSDVWSFGILLW 190
Query: 116 EMVTF---EYPYSECKNPAQIFKKVTSGIK 142
E+ +F YP K + +V G K
Sbjct: 191 EIYSFGRVPYPRIPLK---DVVPRVEKGYK 217
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 35/139 (25%), Positives = 63/139 (45%), Gaps = 17/139 (12%)
Query: 2 ITELFTSGNLRQYRKKHKNVDIK--VIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV 59
++ L G+ K H + I + +L+ L Y+HS IHR +K +I +
Sbjct: 77 VSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG--FIHRSVKASHILL 134
Query: 60 NGNHGEVKIGDLGLAIAM--QQPTARSVIGTPEF-------MAPELYEEE---YNELVDI 107
+G+ G+V + L +++M R V P+ ++PE+ ++ YNE DI
Sbjct: 135 SGD-GKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDI 193
Query: 108 YSFGMCILEMVTFEYPYSE 126
YS G+ E+ P+ +
Sbjct: 194 YSVGITACELANGHVPFKD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 3e-05
Identities = 50/176 (28%), Positives = 81/176 (46%), Gaps = 10/176 (5%)
Query: 18 HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA-IA 76
H +D + + Q+L G+ +LHS IIHRDLK NI V + +KI D GLA A
Sbjct: 117 HMELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFGLARTA 173
Query: 77 MQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFK 135
+ T + APE + Y E VDI+S G + E+V + + Q +
Sbjct: 174 CTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQ-WN 232
Query: 136 KVTSGIKPASLAKVN--DPQIKGFIEKCLVPASERLSAKDLLKDPFLQVENQKEPI 189
KV + S +N P ++ ++E P +S ++L D E++++ +
Sbjct: 233 KVIEQLGTPSAEFMNRLQPTVRNYVEN--RPQYPGISFEELFPDWIFPSESERDKL 286
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 3e-05
Identities = 38/119 (31%), Positives = 59/119 (49%), Gaps = 12/119 (10%)
Query: 30 ARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTP 89
A QI G+VYL S + +HRDL N V G VKIGD G++ + V G
Sbjct: 128 AVQIASGMVYLASQH--FVHRDLATRNCLV-GYDLVVKIGDFGMSRDVYTTDYYRVGGHT 184
Query: 90 ----EFMAPE--LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSGI 141
+M PE +Y + E D++SFG+ + E+ T+ + P+ N ++ + +T G
Sbjct: 185 MLPIRWMPPESIMYRKFTTE-SDVWSFGVVLWEIFTYGKQPWYGLSN-EEVIECITQGR 241
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 3e-05
Identities = 40/139 (28%), Positives = 67/139 (48%), Gaps = 13/139 (9%)
Query: 1 MITELFTSGNLRQY-RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV 59
+ITE +G L + R+ + + R I G+ YL N +HRDL NI V
Sbjct: 82 IITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMN--YVHRDLAARNILV 139
Query: 60 NGNHGEVKIGDLGLAIAMQQ----PTARSVIGTP---EFMAPE-LYEEEYNELVDIYSFG 111
N N K+ D GL+ ++ PT S +G + APE + ++ D++S+G
Sbjct: 140 NSNL-VCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYG 198
Query: 112 MCILEMVTF-EYPYSECKN 129
+ + E++++ E PY + N
Sbjct: 199 IVMWEVMSYGERPYWDMSN 217
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 3e-05
Identities = 58/263 (22%), Positives = 91/263 (34%), Gaps = 68/263 (25%)
Query: 43 HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM------------------------- 77
H IHRD+K DNI ++ + G +K+ D GL
Sbjct: 118 HKMGFIHRDIKPDNILIDLD-GHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDL 176
Query: 78 ------------------------QQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGM 112
Q+ A S++GTP ++APE L + Y +L D +S G+
Sbjct: 177 WDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236
Query: 113 CILEMVTFEYPYSECKNPAQIFKKVT---SGIKPASLAKVNDPQIKGFIEKCLVPASERL 169
+ EM+ + P+ P + KV + + K++ P+ I K A ERL
Sbjct: 237 ILFEMLVGQPPFL-APTPTETQLKVINWENTLHIPPQVKLS-PEAVDLITKLCCSAEERL 294
Query: 170 ---SAKDLLKDPFLQ-------VENQKEPICDPLKLPIQSLKMLRLPMSGPSSMDIDSDY 219
A D+ PF + Q P + P+ + P+ S + S
Sbjct: 295 GRNGADDIKAHPFFSEVDFSSDIRTQPAPYVPKISHPMDTSNF--DPVEEESPWNDASGD 352
Query: 220 KQLSLSTCTESNNGSPHCPVLEF 242
+ T N P EF
Sbjct: 353 STRTWDTLCSPNGKHPEHAFYEF 375
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 4e-05
Identities = 54/204 (26%), Positives = 93/204 (45%), Gaps = 36/204 (17%)
Query: 1 MITELFTSGNLRQY----------------RKKHKNVDIKVIKNWARQILHGLVYLHSHN 44
++ E + GNLR+Y + + + K + + A Q+ G+ YL S
Sbjct: 95 VLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK 154
Query: 45 PPIIHRDLKCDNIFVNGNHGEVKIGDLGLA-----IAMQQPTARSVIGTPEFMAPE-LYE 98
IHRDL N+ V ++ +KI D GLA I + T + ++MAPE L++
Sbjct: 155 --CIHRDLAARNVLVTEDN-VMKIADFGLARDVHNIDYYKKTTNGRLPV-KWMAPEALFD 210
Query: 99 EEYNELVDIYSFGMCILEMVTF---EYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIK 155
Y D++SFG+ + E+ T YP + ++ K+ KPA+ ++
Sbjct: 211 RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTH----ELY 266
Query: 156 GFIEKC--LVPASERLSAKDLLKD 177
+ +C VP S+R + K L++D
Sbjct: 267 MIMRECWHAVP-SQRPTFKQLVED 289
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 5e-05
Identities = 34/111 (30%), Positives = 58/111 (52%), Gaps = 11/111 (9%)
Query: 21 VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80
+ + + ++A QI G+ YL ++HRDL N+ V ++KI D GL+ + +
Sbjct: 124 LTMGDLISFAWQISRGMQYLAEMK--LVHRDLAARNVLV-AEGRKMKISDFGLSRDVYEE 180
Query: 81 TA---RSVIGTP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTF---EYP 123
+ RS P ++MA E L++ Y D++SFG+ + E+VT YP
Sbjct: 181 DSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP 231
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 6e-05
Identities = 37/146 (25%), Positives = 77/146 (52%), Gaps = 10/146 (6%)
Query: 1 MITELFTSGNLRQY-RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV 59
++TE +G L Y R++ + ++ + + + G+ YL ++ IHRDL N V
Sbjct: 76 IVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS--FIHRDLAARNCLV 133
Query: 60 NGNHGEVKIGDLGLA--IAMQQPTARSVIGTP-EFMAPELYE-EEYNELVDIYSFGMCIL 115
+ + G VK+ D G+ + + T+ S P ++ PE++ +Y+ D++SFG+ +
Sbjct: 134 S-STGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMW 192
Query: 116 EMVT-FEYPYSECKNPAQIFKKVTSG 140
E+ T + P+ E K+ ++ + ++ G
Sbjct: 193 EVFTEGKMPF-EKKSNYEVVEMISRG 217
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 6e-05
Identities = 38/170 (22%), Positives = 61/170 (35%), Gaps = 25/170 (14%)
Query: 29 WA--RQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVI 86
WA Q L L LH L + + + G +R
Sbjct: 20 WAVCLQCLGALRELHRQAKS--GNILLTWDGLLKLD---------GSVAFKTPEQSR--- 65
Query: 87 GTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP-- 143
P FMAPE+ + Y E DIYS G+ + E + +E PY+E + + I + + +G+
Sbjct: 66 PDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADD 125
Query: 144 ----ASLAKVND-PQIKGFIEKCLVPAS-ERLSAKDLLKDPFLQVENQKE 187
++L V+ + F+ C R +A L E
Sbjct: 126 PRDRSNLEGVSAARSFEDFMRLCASRLPQRREAANHYLAHCRALFAETLE 175
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 6e-05
Identities = 40/155 (25%), Positives = 72/155 (46%), Gaps = 22/155 (14%)
Query: 1 MITELFTSGNLRQYRKKHKNV-----DIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCD 55
++ E G+L+ Y + ++ + V++ A ++ GL++LH + IH DL
Sbjct: 72 LVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD--FIHSDLALR 129
Query: 56 NIFVNGNHGEVKIGDLGLAIAMQQP----TARSVIGTPEFMAPELYEEEYNELV------ 105
N + + VKIGD GLA+ T ++APEL E +L+
Sbjct: 130 NCQLTAD-LSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTK 188
Query: 106 --DIYSFGMCILEMVTF-EYPYSECKNPAQIFKKV 137
+I+S G+ + E+ T + PY + + Q+ K+V
Sbjct: 189 KSNIWSLGVTMWELFTAADQPYPDLSD-EQVLKQV 222
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 8e-05
Identities = 35/101 (34%), Positives = 52/101 (51%), Gaps = 18/101 (17%)
Query: 30 ARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--------IAMQQPT 81
A QI G+ YL SH+ +HRDL N V G VKI D GL+ +Q
Sbjct: 130 AIQIAAGMEYLSSHH--FVHRDLAARNCLV-GEGLTVKISDFGLSRDIYSADYYRVQ--- 183
Query: 82 ARSVIGTPEFMAPE--LYEEEYNELVDIYSFGMCILEMVTF 120
++S++ +M PE LY + E DI+SFG+ + E+ ++
Sbjct: 184 SKSLLPV-RWMPPEAILYGKFTTE-SDIWSFGVVLWEIFSY 222
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 9e-05
Identities = 44/156 (28%), Positives = 75/156 (48%), Gaps = 15/156 (9%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIK--NWARQILHGLVYLHSHNPPIIHRDLKCDNIF 58
++TE +G+L + +KH + VI+ R I G+ YL +HRDL NI
Sbjct: 82 IVTEYMENGSLDAFLRKH-DGQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNIL 138
Query: 59 VNGNHGEVKIGDLGLAIAMQQP-----TARSVIGTPEFMAPE-LYEEEYNELVDIYSFGM 112
VN N K+ D GL+ ++ T R + APE + ++ D++S+G+
Sbjct: 139 VNSNL-VCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGI 197
Query: 113 CILEMVTF-EYPYSECKNPAQIFKKVTSGIK-PASL 146
+ E++++ E PY E N + K + G + PA +
Sbjct: 198 VMWEVMSYGERPYWEMSN-QDVIKAIEEGYRLPAPM 232
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 1e-04
Identities = 30/79 (37%), Positives = 40/79 (50%), Gaps = 9/79 (11%)
Query: 24 KVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ----- 78
K+I+ RQIL L LHS I+HRD+K NI + G KI DLG A ++
Sbjct: 255 KIIQTIMRQILFALDGLHSTG--IVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINY 312
Query: 79 QPTARSVIGTPEFMAPELY 97
P + + P + APE Y
Sbjct: 313 IP--KEFLLDPRYAAPEQY 329
|
Length = 566 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 1e-04
Identities = 37/93 (39%), Positives = 49/93 (52%), Gaps = 13/93 (13%)
Query: 32 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPE- 90
Q+L G+ +LHS IIHRDLK NI V + +KI D GLA + S + TP
Sbjct: 134 QMLCGIKHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFGLA----RTAGTSFMMTPYV 186
Query: 91 ----FMAPE-LYEEEYNELVDIYSFGMCILEMV 118
+ APE + Y E VDI+S G + EM+
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 219
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.8 bits (104), Expect = 1e-04
Identities = 47/197 (23%), Positives = 85/197 (43%), Gaps = 42/197 (21%)
Query: 11 LRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGD 70
L Q R+ K + +V + +A ++L L YLH I++RDLK +NI ++ + G + + D
Sbjct: 91 LLQ-RQPGKCLSEEVARFYAAEVLLALEYLH--LLGIVYRDLKPENILLHES-GHIMLSD 146
Query: 71 LGLA-----------------------------IAMQQPTAR--SVIGTPEFMAPELYEE 99
L+ ++P+ R S +GT E++APE+
Sbjct: 147 FDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISG 206
Query: 100 E-YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLA-KVNDP-QIKG 156
+ + VD ++ G+ + EM+ P+ + N + F + K + +
Sbjct: 207 DGHGSAVDWWTLGILLYEMLYGTTPF-KGSNRDETFSNILK--KEVTFPGSPPVSSSARD 263
Query: 157 FIEKCLVP-ASERLSAK 172
I K LV S+RL +K
Sbjct: 264 LIRKLLVKDPSKRLGSK 280
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 35/120 (29%), Positives = 61/120 (50%), Gaps = 11/120 (9%)
Query: 32 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGE-VKIGDLGLAIAMQQPTARSVIGTP- 89
Q+ G+ +L S N +HRDL N+ + G+ VKI D GLA + + G+
Sbjct: 245 QVARGMEFLASKN--CVHRDLAARNVLLA--QGKIVKICDFGLARDIMHDSNYVSKGSTF 300
Query: 90 ---EFMAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSGIKPA 144
++MAPE +++ Y L D++S+G+ + E+ + PY + + K+ SG + A
Sbjct: 301 LPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMA 360
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 2e-04
Identities = 42/175 (24%), Positives = 77/175 (44%), Gaps = 32/175 (18%)
Query: 9 GNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKI 68
L Q + +N + +++ A +I G+ ++H HN +H DL N F+ + VK+
Sbjct: 84 SYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN--FLHSDLALRNCFLTSDL-TVKV 140
Query: 69 GDLGLAIAMQQP----TARSVIGTPEFMAPELYEEEYNELV--------DIYSFGMCILE 116
GD G+ + + T ++APEL E + L+ ++++ G+ + E
Sbjct: 141 GDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWE 200
Query: 117 MVTFE---YPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASER 168
+ FE PYS + ++ V + D Q+K F + +P SER
Sbjct: 201 L--FENAAQPYSHLSD-REVLNHV-----------IKDQQVKLFKPQLELPYSER 241
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 3e-04
Identities = 37/142 (26%), Positives = 64/142 (45%), Gaps = 21/142 (14%)
Query: 1 MITELFTSGNLRQYRKKHKNV-----DIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCD 55
++ E G+L+ Y + + D ++ A +I GL++LH +N IH DL
Sbjct: 72 LVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN--FIHSDLALR 129
Query: 56 NIFVNGNHGEVKIGDLGLAIAMQQP----TARSVIGTPEFMAPELYEEEYNELV------ 105
N + + VKIGD GL+ + T + ++APEL +E + L+
Sbjct: 130 NCLLTADL-TVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTK 188
Query: 106 --DIYSFGMCILEMVTF-EYPY 124
+++S G+ I E+ PY
Sbjct: 189 ESNVWSLGVTIWELFELGSQPY 210
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 42.8 bits (100), Expect = 3e-04
Identities = 38/93 (40%), Positives = 49/93 (52%), Gaps = 13/93 (13%)
Query: 32 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTP-- 89
Q+L G+ +LHS IIHRDLK NI V + +KI D GLA + S + TP
Sbjct: 127 QMLCGIKHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFGLA----RTAGTSFMMTPYV 179
Query: 90 ---EFMAPE-LYEEEYNELVDIYSFGMCILEMV 118
+ APE + Y E VDI+S G + EMV
Sbjct: 180 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 5e-04
Identities = 32/132 (24%), Positives = 50/132 (37%), Gaps = 51/132 (38%)
Query: 43 HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM------------------------- 77
H IHRD+K DNI ++ + G +K+ D GL
Sbjct: 118 HKMGFIHRDIKPDNILIDRD-GHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNE 176
Query: 78 ------------------------QQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGM 112
Q+ A S++GTP ++APE L Y +L D +S G+
Sbjct: 177 WGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236
Query: 113 CILEMVTFEYPY 124
+ EM+ + P+
Sbjct: 237 ILYEMLVGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 5e-04
Identities = 43/168 (25%), Positives = 71/168 (42%), Gaps = 37/168 (22%)
Query: 1 MITELFTSGNLRQYRKKHKNVD-------------------IKVIKNWARQILHGLVYLH 41
MITE +G+L Q+ H D + + A QI G+ YL
Sbjct: 96 MITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS 155
Query: 42 SHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM-----QQPTARSVIGTPEFMAPE- 95
S N +HRDL N V N +KI D G++ + + R+V+ +MA E
Sbjct: 156 SLN--FVHRDLATRNCLVGENL-TIKIADFGMSRNLYAGDYYRIQGRAVLPI-RWMAWEC 211
Query: 96 LYEEEYNELVDIYSFGMCILEMVTF--EYPYSE------CKNPAQIFK 135
+ ++ D+++FG+ + E++ E PY E +N + F+
Sbjct: 212 ILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFR 259
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 5e-04
Identities = 37/135 (27%), Positives = 62/135 (45%), Gaps = 14/135 (10%)
Query: 1 MITELFTSGNLRQY-RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV 59
++ E G L Y R + + + + G+ YL S N +IHRDL N V
Sbjct: 76 LVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN--VIHRDLAARNCLV 133
Query: 60 NGNHGEVKIGDLGLAIAMQQPTARSVIGTP---EFMAPELYE-EEYNELVDIYSFGMCIL 115
G + VK+ D G+ + S GT ++ +PE++ +Y+ D++SFG+ +
Sbjct: 134 -GENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMW 192
Query: 116 EMVTFEYPYSECKNP 130
E+ +SE K P
Sbjct: 193 EV------FSEGKTP 201
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 6e-04
Identities = 34/99 (34%), Positives = 51/99 (51%), Gaps = 14/99 (14%)
Query: 30 ARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ-------QPTA 82
A QI G+ YL SH +H+DL NI + G VKI DLGL+ + QP +
Sbjct: 130 AIQIAAGMEYLSSHF--FVHKDLAARNILI-GEQLHVKISDLGLSREIYSADYYRVQPKS 186
Query: 83 RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTF 120
I +M PE + +++ DI+SFG+ + E+ +F
Sbjct: 187 LLPI---RWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSF 222
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 7e-04
Identities = 33/108 (30%), Positives = 52/108 (48%), Gaps = 27/108 (25%)
Query: 32 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEF 91
Q+ G+ +L S IHRDL NI ++ N+ VKI D GL AR + P++
Sbjct: 181 QVARGMEFLASRK--CIHRDLAARNILLSENN-VVKICDFGL--------ARDIYKDPDY 229
Query: 92 ------------MAPE-LYEEEYNELVDIYSFGMCILEMVTF---EYP 123
MAPE ++++ Y D++SFG+ + E+ + YP
Sbjct: 230 VRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYP 277
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 8e-04
Identities = 37/144 (25%), Positives = 66/144 (45%), Gaps = 26/144 (18%)
Query: 32 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEF 91
Q+ G+ +L S IHRDL NI ++ N+ VKI D GL AR + P++
Sbjct: 182 QVARGMEFLASRK--CIHRDLAARNILLSENN-VVKICDFGL--------ARDIYKDPDY 230
Query: 92 ------------MAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKV 137
MAPE ++++ Y D++SFG+ + E+ + PY + + +++
Sbjct: 231 VRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRL 290
Query: 138 TSGIKPASLAKVNDPQIKGFIEKC 161
G + + + P+I + C
Sbjct: 291 KDGTRMRA-PENATPEIYRIMLAC 313
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 0.001
Identities = 20/38 (52%), Positives = 26/38 (68%), Gaps = 3/38 (7%)
Query: 37 LVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA 74
L YLH H IIHRDLK DN+ ++ N G +K+ D GL+
Sbjct: 117 LDYLHRHG--IIHRDLKPDNMLIS-NEGHIKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 35/125 (28%), Positives = 58/125 (46%), Gaps = 25/125 (20%)
Query: 32 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEF 91
Q+ G+ +L S IHRDL NI ++ N+ VKI D GL AR + P++
Sbjct: 187 QVAKGMEFLASRK--CIHRDLAARNILLSENN-VVKICDFGL--------ARDIYKDPDY 235
Query: 92 ------------MAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKV 137
MAPE +++ Y D++SFG+ + E+ + PY K + +++
Sbjct: 236 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 295
Query: 138 TSGIK 142
G +
Sbjct: 296 KEGTR 300
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.003
Identities = 37/160 (23%), Positives = 68/160 (42%), Gaps = 34/160 (21%)
Query: 4 ELFTSGNLRQYRKKHKN-------VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDN 56
EL G+L+ + ++++ + +K + AR + G YL ++ IHRD+ N
Sbjct: 89 ELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH--FIHRDIAARN 146
Query: 57 IFVN--GNHGEVKIGDLGLAIAMQQPTARSVIGTP------------EFMAPELYEEE-Y 101
+ G KI D G+A R + ++M PE + + +
Sbjct: 147 CLLTCKGPGRVAKIADFGMA--------RDIYRASYYRKGGRAMLPIKWMPPEAFLDGIF 198
Query: 102 NELVDIYSFGMCILEMVTFEY-PYSECKNPAQIFKKVTSG 140
D++SFG+ + E+ + Y PY N ++ + VT G
Sbjct: 199 TSKTDVWSFGVLLWEIFSLGYMPYPGRTN-QEVMEFVTGG 237
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 563 | |||
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 99.98 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.98 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.98 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 99.98 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 99.98 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.98 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 99.97 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 99.97 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 99.97 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.97 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.97 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.97 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.97 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.97 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.97 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.97 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.97 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 99.97 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.97 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.97 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.97 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.97 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.97 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.97 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.97 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.97 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.97 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.97 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 99.97 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.97 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.97 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.97 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.97 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 99.97 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.97 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.97 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.97 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 99.97 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.97 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.97 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.97 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.97 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 99.96 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.96 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.96 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.96 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.96 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.96 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.96 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 99.96 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.96 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.96 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.96 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.96 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.96 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.96 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.96 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.96 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.96 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.96 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 99.96 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.96 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.96 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.96 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.96 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.96 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.96 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 99.96 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.96 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.96 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.96 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.96 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.96 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 99.96 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.96 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.96 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 99.96 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.96 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.96 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.96 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.96 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.96 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.96 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.96 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.96 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.96 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.96 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.96 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.96 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.96 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.96 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.96 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 99.96 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.96 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.96 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.96 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.96 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.96 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.96 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.96 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.96 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.96 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.96 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.96 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 99.96 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.96 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.96 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 99.96 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.96 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.96 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 99.96 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.95 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.95 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.95 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.95 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.95 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.95 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.95 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.95 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.95 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.95 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 99.95 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.95 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.95 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.95 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.95 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.95 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.95 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.95 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.95 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.95 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.95 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.95 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.95 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.95 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.95 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.95 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.95 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.95 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.95 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.95 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.95 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.95 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.95 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.95 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.95 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.95 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.95 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.95 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.95 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.95 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.95 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.95 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.95 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.95 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.95 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.95 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 99.95 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.95 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.95 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.95 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.95 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.95 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.95 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.95 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.95 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.95 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.94 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.94 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.94 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.94 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.94 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.94 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.94 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.94 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.94 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.94 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.94 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.94 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.94 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.94 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.94 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.94 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.94 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.94 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.94 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.94 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.94 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.94 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.94 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.94 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.94 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.94 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.94 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.94 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.94 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.94 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.94 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.94 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.94 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.94 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.94 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.94 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.94 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.94 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.94 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.94 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.94 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.94 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.94 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.94 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.94 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.94 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.94 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.94 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.94 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.94 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.94 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.94 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.94 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.94 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.94 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.94 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.94 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.93 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.93 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.93 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.93 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.93 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.93 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.93 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.93 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.93 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.93 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.93 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.93 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.93 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.93 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.93 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.93 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.93 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.93 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.93 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.93 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.93 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.93 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.93 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.93 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.93 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.93 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.92 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.92 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.92 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.92 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.92 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 99.92 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.92 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.92 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 99.92 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.92 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.92 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.91 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.91 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.91 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.91 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.91 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.91 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.89 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.89 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.89 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.89 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.89 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.87 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.87 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.87 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.87 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.87 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.87 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.86 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.86 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.85 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.85 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.85 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.84 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.84 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.83 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.81 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.8 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.79 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.79 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.77 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.76 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.72 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.71 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.68 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.65 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.64 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.58 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.58 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.54 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.54 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.52 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.45 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.36 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.35 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.34 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.33 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.32 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.31 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.31 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.29 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.21 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.18 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.05 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 98.98 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 98.94 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.93 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 98.9 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 98.88 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 98.87 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 98.81 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 98.78 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.6 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 98.53 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.52 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 98.48 | |
| PF12202 | 38 | OSR1_C: Oxidative-stress-responsive kinase 1 C ter | 98.42 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.38 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 98.26 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.24 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 98.24 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.21 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.14 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.11 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 97.98 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 97.87 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 97.8 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.59 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 97.5 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 97.47 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 97.29 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 97.06 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 96.5 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 96.29 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 96.21 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.01 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 95.92 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 95.52 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 95.08 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 95.01 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 94.67 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 94.19 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 93.51 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 90.77 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 90.13 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 88.32 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 87.83 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 87.36 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 86.01 | |
| PLN02236 | 344 | choline kinase | 85.94 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 85.04 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 84.75 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 84.45 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 84.23 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 83.66 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 82.55 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 82.26 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 81.35 | |
| smart00587 | 196 | CHK ZnF_C4 abd HLH domain containing kinases domai | 81.26 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 81.22 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 80.96 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 80.17 |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-67 Score=568.03 Aligned_cols=326 Identities=59% Similarity=0.935 Sum_probs=273.5
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
||+|+|++|+|++|++++++++.+.++.|++|||+||.|||++.||||||||||+||||+++.|.|||+|+|+|...+..
T Consensus 120 ~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s 199 (632)
T KOG0584|consen 120 FITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS 199 (632)
T ss_pred eeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence 68999999999999999999999999999999999999999999999999999999999999999999999999999988
Q ss_pred CCccccCCCCccCcccccccCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHHHHHH
Q 008504 81 TARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEK 160 (563)
Q Consensus 81 ~~~~~~Gtp~Y~APEvl~~~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~LI~k 160 (563)
....++|||.|||||+++..|+..+||||||||++||+|+.+||..|.+++++|+++..|++|..+.++.+|++++||.+
T Consensus 200 ~aksvIGTPEFMAPEmYEE~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr~fIek 279 (632)
T KOG0584|consen 200 HAKSVIGTPEFMAPEMYEENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVREFIEK 279 (632)
T ss_pred ccceeccCccccChHHHhhhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHHHHHHH
Confidence 88899999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hcCCCCCCCCHHHHHcCccccccccCCCCCCCC----------CCchhhhhhccCCCCC--CCCcccCccccccCccccc
Q 008504 161 CLVPASERLSAKDLLKDPFLQVENQKEPICDPL----------KLPIQSLKMLRLPMSG--PSSMDIDSDYKQLSLSTCT 228 (563)
Q Consensus 161 cL~dP~kRpSa~ELLkHpff~~~~~~~~~~~~l----------~~p~~~~~~~~~~~s~--~~~~~id~~~~~~~~~~~~ 228 (563)
||...++|+|+.|||+||||+.....- ...+. .......+....+... ...+++..| .....+.
T Consensus 280 Cl~~~~~R~sa~eLL~d~Ff~~d~g~~-~~~~e~d~~~~~~~~~~~~~~~~~~~~~~~n~i~~~~~~~~D---~~e~v~~ 355 (632)
T KOG0584|consen 280 CLATKSERLSAKELLKDPFFDEDGGIV-ELAPEDDMSDPALSLSLRDEDGKKNKRPKANAIQFDYNLNTD---ESEEVAQ 355 (632)
T ss_pred HhcCchhccCHHHHhhChhhccccccc-cccchhhcccccccccccccchhhcCCcccccccceeecCCC---chhHHHH
Confidence 998899999999999999999875421 11111 0111111111111111 111111111 1111111
Q ss_pred CCCCC--CCCCCchhhhhccccccccccccCCCCC-ceEEEEeecCCCCCcceeeecccCCCCCHHHHHHHHHHccCCCc
Q 008504 229 ESNNG--SPHCPVLEFQRMHKNNEFRLRGTKNDDT-SVSLTLRIADSSGRVRNIHFLFYLDSDTALSVAGEMVEQLDLAD 305 (563)
Q Consensus 229 ~s~~~--s~~~~~~e~~~~~~~~~~~~~g~~~~~~-~i~L~LRi~d~~~~~~~I~F~F~~~~DTa~~vA~EmV~~~~i~~ 305 (563)
++... -......+..+..++..+.++|+.+++. .++|.|||+|+.|+.|||+|||++..|||.+||.|||+++.+++
T Consensus 356 em~~~~~~~edd~~~v~r~~~~~~~~ikgkr~~~~~~~~l~l~i~~~~g~~r~i~fpf~~~~dta~~Va~eMv~el~~~d 435 (632)
T KOG0584|consen 356 EMVEEEIVSEDDSREVARLLKDTVFSIKGKRNDRQTEISLELRIADEDGLVRNIHFPFDLEGDTAPSVAHEMVEELEITD 435 (632)
T ss_pred HHHHhccCCcchHHHHHHHhccceeeechhhhcccccceeEeeccCCCCCcccccCCCcCCCcchhHHHHHHHhhcCCcc
Confidence 11000 1111224566777888999999999777 99999999999999999999999999999999999999999999
Q ss_pred ccHHHHHHHHHHHHHHhCCCCCCCC
Q 008504 306 HDVAFIAEFIDYLIMKLLPGWKPSY 330 (563)
Q Consensus 306 ~D~~~iA~~i~~~i~~l~p~w~~~~ 330 (563)
+++..||+|||.+|.+|+|.|+...
T Consensus 436 q~v~~ia~mid~~i~~L~p~~~~~~ 460 (632)
T KOG0584|consen 436 QPVVNIAEMIDGEISALVPNWKAST 460 (632)
T ss_pred cchhhHHHHHhchhhhcCCccCCCC
Confidence 9999999999999999999998765
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=334.79 Aligned_cols=182 Identities=32% Similarity=0.555 Sum_probs=166.7
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHS-HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs-~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
|+||||++|+|.++++..+++++..+.+++.+|++||.|||. ++ ||||||||+||||+ ..|+|||||||.+..+..
T Consensus 155 I~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~--IIHRDIKPsNlLvN-skGeVKicDFGVS~~lvn 231 (364)
T KOG0581|consen 155 ICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERK--IIHRDIKPSNLLVN-SKGEVKICDFGVSGILVN 231 (364)
T ss_pred eehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccC--eeeccCCHHHeeec-cCCCEEeccccccHHhhh
Confidence 689999999999999999999999999999999999999995 88 99999999999998 568999999999998888
Q ss_pred CCCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCC----CCHHHHHHHHhcCCCCCccccCCChhH
Q 008504 80 PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSEC----KNPAQIFKKVTSGIKPASLAKVNDPQI 154 (563)
Q Consensus 80 ~~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~----~~~~~i~~~i~~~~~p~~l~~~~s~~l 154 (563)
....+++||..|||||.+.+ .|+.++||||||+.++|+++|++||... .....++..|..+.+|......+++++
T Consensus 232 S~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ef 311 (364)
T KOG0581|consen 232 SIANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSPEF 311 (364)
T ss_pred hhcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCHHH
Confidence 88889999999999999986 5999999999999999999999999762 466788888888877766666799999
Q ss_pred HHHHHHhcC-CCCCCCCHHHHHcCcccccccc
Q 008504 155 KGFIEKCLV-PASERLSAKDLLKDPFLQVENQ 185 (563)
Q Consensus 155 ~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~~ 185 (563)
++||..||+ +|.+||+++||++|||++....
T Consensus 312 ~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~ 343 (364)
T KOG0581|consen 312 RSFVSCCLRKDPSERPSAKQLLQHPFIKKFED 343 (364)
T ss_pred HHHHHHHhcCCcccCCCHHHHhcCHHHhhccc
Confidence 999999997 8999999999999999986543
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=321.00 Aligned_cols=182 Identities=27% Similarity=0.396 Sum_probs=160.7
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCC--CCcEEEecccchhhcc
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGN--HGEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~--~G~VKL~DFGlA~~~~ 78 (563)
|||||++||+|.+++-.++.+.+..-+.+++|++.||.|||++| |+||||||+|||+..+ .-.+||+|||+|+..+
T Consensus 253 mVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~G--I~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g 330 (475)
T KOG0615|consen 253 MVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQG--IIHRDIKPENILLSNDAEDCLLKITDFGLAKVSG 330 (475)
T ss_pred EEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcC--cccccCCcceEEeccCCcceEEEecccchhhccc
Confidence 69999999999999999999999999999999999999999999 9999999999999733 2479999999999886
Q ss_pred CC-CCccccCCCCccCccccccc----CCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCC--ccccCCC
Q 008504 79 QP-TARSVIGTPEFMAPELYEEE----YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPA--SLAKVND 151 (563)
Q Consensus 79 ~~-~~~~~~Gtp~Y~APEvl~~~----ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~--~l~~~~s 151 (563)
.. ...+.||||.|.|||++..+ +..++|+||+||++|.+++|.+||++......+.+.+.+|.... ..+...+
T Consensus 331 ~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~~Is 410 (475)
T KOG0615|consen 331 EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWDRIS 410 (475)
T ss_pred cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhhhhhh
Confidence 53 56788999999999999643 45699999999999999999999998766666888888887653 3445567
Q ss_pred hhHHHHHHHhcC-CCCCCCCHHHHHcCccccccc
Q 008504 152 PQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 184 (563)
Q Consensus 152 ~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~ 184 (563)
.+.++||.+||+ ||++|||+.|+|+||||+...
T Consensus 411 eea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 411 EEALDLINWMLVVDPENRPSADEALNHPWFKDAP 444 (475)
T ss_pred HHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence 899999999996 999999999999999998543
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=307.32 Aligned_cols=192 Identities=27% Similarity=0.495 Sum_probs=169.6
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC-
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ- 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~- 79 (563)
||+||+.||.|+-.|.+.+.+++..++.|+.+|+.||.|||++| ||||||||+|||++ .+|+|+|+|||+++....
T Consensus 102 lVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~g--IiyRDlKPENILLd-~~GHi~LtDFgL~k~~~~~ 178 (357)
T KOG0598|consen 102 LVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKG--IIYRDLKPENILLD-EQGHIKLTDFGLCKEDLKD 178 (357)
T ss_pred EEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHeeec-CCCcEEEeccccchhcccC
Confidence 69999999999999999999999999999999999999999999 99999999999998 679999999999975433
Q ss_pred -CCCccccCCCCccCccccc-ccCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHHH
Q 008504 80 -PTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 157 (563)
Q Consensus 80 -~~~~~~~Gtp~Y~APEvl~-~~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~L 157 (563)
....+++||+.|||||++. .+|+..+|+||||+++|+|++|..||.. .+...+++++..+..+ ..+...+.++++|
T Consensus 179 ~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~-~~~~~~~~~I~~~k~~-~~p~~ls~~ardl 256 (357)
T KOG0598|consen 179 GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYA-EDVKKMYDKILKGKLP-LPPGYLSEEARDL 256 (357)
T ss_pred CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcC-ccHHHHHHHHhcCcCC-CCCccCCHHHHHH
Confidence 3566789999999999885 5699999999999999999999999987 6677888888877633 3566688999999
Q ss_pred HHHhcC-CCCCCC----CHHHHHcCccccccccCCCCCCCCCCch
Q 008504 158 IEKCLV-PASERL----SAKDLLKDPFLQVENQKEPICDPLKLPI 197 (563)
Q Consensus 158 I~kcL~-dP~kRp----Sa~ELLkHpff~~~~~~~~~~~~l~~p~ 197 (563)
|+++|. +|.+|. .+.++-+||||...+|+......+..|.
T Consensus 257 l~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l~~k~l~PpF 301 (357)
T KOG0598|consen 257 LKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEKLLAKKLSPPF 301 (357)
T ss_pred HHHHhccCHHHhcCCCCChHHhhcCcccccCCHHHHHhcCCCCCe
Confidence 999997 899996 6999999999999999876665555444
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=308.71 Aligned_cols=182 Identities=32% Similarity=0.561 Sum_probs=155.8
Q ss_pred CEeccCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~-~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
|+|||+++|+|.+++.+.+ +|++..++.+++||++||.|||++| ||||||||+|||++...|.+||+|||++.....
T Consensus 93 i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g--~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 93 IFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKG--IVHCDIKPANILLDPSNGDVKLADFGLAKKLES 170 (313)
T ss_pred eeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence 5899999999999999987 7999999999999999999999999 999999999999985358999999999976652
Q ss_pred -----CCCccccCCCCccCcccccccCC--chhhHHHhHHHHHHHhhcCCCCCC-CCCHHHHHHHHhcCCCCCccccCCC
Q 008504 80 -----PTARSVIGTPEFMAPELYEEEYN--ELVDIYSFGMCILEMVTFEYPYSE-CKNPAQIFKKVTSGIKPASLAKVND 151 (563)
Q Consensus 80 -----~~~~~~~Gtp~Y~APEvl~~~ys--~ksDIwSLGviLyELlTG~~Pf~~-~~~~~~i~~~i~~~~~p~~l~~~~s 151 (563)
.......||+.|||||++..... .++|||||||++.||+||..||.. ......++........| .++...+
T Consensus 171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P-~ip~~ls 249 (313)
T KOG0198|consen 171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLP-EIPDSLS 249 (313)
T ss_pred ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCC-CCCcccC
Confidence 22446789999999999985433 499999999999999999999987 33444455555455334 7788899
Q ss_pred hhHHHHHHHhcC-CCCCCCCHHHHHcCcccccccc
Q 008504 152 PQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQ 185 (563)
Q Consensus 152 ~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~~ 185 (563)
+++++||.+|+. +|.+||||.++|+|||.+....
T Consensus 250 ~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 250 DEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI 284 (313)
T ss_pred HHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence 999999999997 8999999999999999986543
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=307.90 Aligned_cols=184 Identities=29% Similarity=0.493 Sum_probs=153.8
Q ss_pred CEeccCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhcc
Q 008504 1 MITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~--~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~ 78 (563)
+||.||.+|++.++++.. ..++|..|..+++++++||.|||.+| .||||||+.||||+ .+|.|||+|||.+..+-
T Consensus 101 vVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G--~IHRdvKAgnILi~-~dG~VkLadFgvsa~l~ 177 (516)
T KOG0582|consen 101 VVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG--HIHRDVKAGNILID-SDGTVKLADFGVSASLF 177 (516)
T ss_pred EeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC--ceecccccccEEEc-CCCcEEEcCceeeeeec
Confidence 589999999999999864 45999999999999999999999999 99999999999998 56999999999875442
Q ss_pred CC-----CC-ccccCCCCccCccccc---ccCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCC-------
Q 008504 79 QP-----TA-RSVIGTPEFMAPELYE---EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK------- 142 (563)
Q Consensus 79 ~~-----~~-~~~~Gtp~Y~APEvl~---~~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~------- 142 (563)
.. .. .+++|||+|||||++. .+|+.|+||||||++..||.+|..||........+...+....+
T Consensus 178 ~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~ 257 (516)
T KOG0582|consen 178 DSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGL 257 (516)
T ss_pred ccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccC
Confidence 21 12 5678999999999954 35999999999999999999999999986555566666555443
Q ss_pred CCccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCccccccccCC
Q 008504 143 PASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQKE 187 (563)
Q Consensus 143 p~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~~~~ 187 (563)
+....+..+..++.+|..||+ ||.+||||.++|+|+||+......
T Consensus 258 ~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~~ 303 (516)
T KOG0582|consen 258 DKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSKE 303 (516)
T ss_pred ChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccchh
Confidence 122233456789999999997 899999999999999998776544
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=297.04 Aligned_cols=191 Identities=29% Similarity=0.516 Sum_probs=171.4
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
|||||.+||.|+.++++.+++++..++.++.||+.||+|||+++ |++|||||+|||++ .+|.+||+|||+|+.....
T Consensus 121 mvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~--iiYRDLKPENiLlD-~~G~iKitDFGFAK~v~~r 197 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLD--IIYRDLKPENLLLD-QNGHIKITDFGFAKRVSGR 197 (355)
T ss_pred EEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcC--eeeccCChHHeeec-cCCcEEEEeccceEEecCc
Confidence 69999999999999999999999999999999999999999999 99999999999998 6699999999999877654
Q ss_pred CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHHHHH
Q 008504 81 TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIE 159 (563)
Q Consensus 81 ~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~LI~ 159 (563)
..+.||||.|+|||++.. +|+.++|.|+|||++|||+.|.+||.. .++.++|.+|..+... +|...++++++||+
T Consensus 198 -T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~-~~~~~iY~KI~~~~v~--fP~~fs~~~kdLl~ 273 (355)
T KOG0616|consen 198 -TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYD-DNPIQIYEKILEGKVK--FPSYFSSDAKDLLK 273 (355)
T ss_pred -EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcC-CChHHHHHHHHhCccc--CCcccCHHHHHHHH
Confidence 678899999999998874 599999999999999999999999987 6779999999988654 67888999999999
Q ss_pred HhcC-CCCCC-----CCHHHHHcCccccccccCCCCCCCCCCchh
Q 008504 160 KCLV-PASER-----LSAKDLLKDPFLQVENQKEPICDPLKLPIQ 198 (563)
Q Consensus 160 kcL~-dP~kR-----pSa~ELLkHpff~~~~~~~~~~~~l~~p~~ 198 (563)
++|+ |-.+| ....++..||||+...|.......+..|..
T Consensus 274 ~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~i~~r~ie~P~~ 318 (355)
T KOG0616|consen 274 KLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEAILQRKIEPPFE 318 (355)
T ss_pred HHHhhhhHhhhcCcCCCccccccCcccccccHHHHhhccccCCCC
Confidence 9996 88888 357899999999999887765555555543
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=310.32 Aligned_cols=178 Identities=28% Similarity=0.583 Sum_probs=159.4
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhcc--
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ-- 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~-- 78 (563)
||||||.||+|.+++.+.+++.+..++.+++||+.||+|||++| |+||||||+|||++.+.+.+||+|||++....
T Consensus 97 ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~g--i~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~~ 174 (370)
T KOG0583|consen 97 IVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRG--IVHRDLKPENILLDGNEGNLKLSDFGLSAISPGE 174 (370)
T ss_pred EEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEecCCCCCEEEeccccccccCCC
Confidence 69999999999999999999999999999999999999999999 99999999999999664899999999998772
Q ss_pred CCCCccccCCCCccCcccccc-c-C-CchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCC-ChhH
Q 008504 79 QPTARSVIGTPEFMAPELYEE-E-Y-NELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVN-DPQI 154 (563)
Q Consensus 79 ~~~~~~~~Gtp~Y~APEvl~~-~-y-s~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~-s~~l 154 (563)
.....+.+|++.|+|||++.+ . | +.++||||+|+++|.|++|++||.. .+...++.++..+... ++... ++++
T Consensus 175 ~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d-~~~~~l~~ki~~~~~~--~p~~~~S~~~ 251 (370)
T KOG0583|consen 175 DGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD-SNVPNLYRKIRKGEFK--IPSYLLSPEA 251 (370)
T ss_pred CCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC-ccHHHHHHHHhcCCcc--CCCCcCCHHH
Confidence 345678899999999999976 3 5 5799999999999999999999998 6667777777776543 45555 9999
Q ss_pred HHHHHHhcC-CCCCCCCHHHHHcCcccccc
Q 008504 155 KGFIEKCLV-PASERLSAKDLLKDPFLQVE 183 (563)
Q Consensus 155 ~~LI~kcL~-dP~kRpSa~ELLkHpff~~~ 183 (563)
+.||.+||. +|.+|+|+.+++.||||+..
T Consensus 252 ~~Li~~mL~~~P~~R~t~~~i~~h~w~~~~ 281 (370)
T KOG0583|consen 252 RSLIEKMLVPDPSTRITLLEILEHPWFQKE 281 (370)
T ss_pred HHHHHHHcCCCcccCCCHHHHhhChhhccC
Confidence 999999997 89999999999999999974
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=314.71 Aligned_cols=178 Identities=35% Similarity=0.627 Sum_probs=160.9
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC-
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ- 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~- 79 (563)
+|||||+||+|.+.+... .++|.++..++++++.||+|||.+| |||||||.+|||+. .+|.+||+|||++..+..
T Consensus 347 VVMEym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~g--IiHrDIKSDnILL~-~~g~vKltDFGFcaqi~~~ 422 (550)
T KOG0578|consen 347 VVMEYMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARG--IIHRDIKSDNILLT-MDGSVKLTDFGFCAQISEE 422 (550)
T ss_pred EEEeecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcc--eeeeccccceeEec-cCCcEEEeeeeeeeccccc
Confidence 489999999999998874 4999999999999999999999999 99999999999997 668999999999977653
Q ss_pred -CCCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHHH
Q 008504 80 -PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 157 (563)
Q Consensus 80 -~~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~L 157 (563)
....+.+|||.|||||++.. .|++++||||||++++||+-|++||........++.....|.+....+...++.+++|
T Consensus 423 ~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdF 502 (550)
T KOG0578|consen 423 QSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDF 502 (550)
T ss_pred cCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHH
Confidence 35667899999999999865 5999999999999999999999999875556677777778888778888999999999
Q ss_pred HHHhcC-CCCCCCCHHHHHcCccccc
Q 008504 158 IEKCLV-PASERLSAKDLLKDPFLQV 182 (563)
Q Consensus 158 I~kcL~-dP~kRpSa~ELLkHpff~~ 182 (563)
+.+||+ |+.+|++|.|||+||||+.
T Consensus 503 L~~cL~~dv~~RasA~eLL~HpFl~~ 528 (550)
T KOG0578|consen 503 LDRCLVVDVEQRASAKELLEHPFLKM 528 (550)
T ss_pred HHHHhhcchhcCCCHHHHhcChhhhh
Confidence 999997 9999999999999999954
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=315.45 Aligned_cols=176 Identities=34% Similarity=0.548 Sum_probs=160.2
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
||+|+|..|+|..++++++.++|.+++.+++||+.||.|||+++ |||||||..|||++.+ -+|||+|||+|..+...
T Consensus 95 ivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~--IiHRDLKLGNlfL~~~-~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 95 IVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLG--IIHRDLKLGNLFLNEN-MNVKIGDFGLATQLEYD 171 (592)
T ss_pred EEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcC--ceecccchhheeecCc-CcEEecccceeeeecCc
Confidence 68999999999999999999999999999999999999999999 9999999999999965 49999999999887643
Q ss_pred --CCccccCCCCccCccccc-ccCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHHH
Q 008504 81 --TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 157 (563)
Q Consensus 81 --~~~~~~Gtp~Y~APEvl~-~~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~L 157 (563)
...+.+|||.|.|||++. .+++..+||||+||++|.|++|++||.. .+....+.+|...... +|...+.++++|
T Consensus 172 ~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFet-k~vkety~~Ik~~~Y~--~P~~ls~~A~dL 248 (592)
T KOG0575|consen 172 GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFET-KTVKETYNKIKLNEYS--MPSHLSAEAKDL 248 (592)
T ss_pred ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCccc-chHHHHHHHHHhcCcc--cccccCHHHHHH
Confidence 456789999999999886 4699999999999999999999999987 6788889988877554 456888999999
Q ss_pred HHHhcC-CCCCCCCHHHHHcCccccc
Q 008504 158 IEKCLV-PASERLSAKDLLKDPFLQV 182 (563)
Q Consensus 158 I~kcL~-dP~kRpSa~ELLkHpff~~ 182 (563)
|.++|. +|.+|||++++|.|+||+.
T Consensus 249 I~~lL~~~P~~Rpsl~~vL~h~Ff~~ 274 (592)
T KOG0575|consen 249 IRKLLRPNPSERPSLDEVLDHPFFKS 274 (592)
T ss_pred HHHHhcCCcccCCCHHHHhcCHhhhC
Confidence 999998 8999999999999999953
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=310.34 Aligned_cols=182 Identities=29% Similarity=0.487 Sum_probs=162.9
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
||+||+++|+|.++|++.+.|++..++.++.||+.||+|||++| ||||||||+|||+++ +|++||+|||.|+.+...
T Consensus 151 FvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~G--IIHRDlKPENILLd~-dmhikITDFGsAK~l~~~ 227 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNG--IIHRDLKPENILLDK-DGHIKITDFGSAKILSPS 227 (604)
T ss_pred EEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeEcC-CCcEEEeeccccccCChh
Confidence 68999999999999999999999999999999999999999999 999999999999984 589999999999766321
Q ss_pred -------------C--CccccCCCCccCccccccc-CCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCC
Q 008504 81 -------------T--ARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPA 144 (563)
Q Consensus 81 -------------~--~~~~~Gtp~Y~APEvl~~~-ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~ 144 (563)
. ..+++||..|.+||++... .+..+|||+|||++|+|+.|.+||.+ .+.-.++++|..-..
T Consensus 228 ~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra-~NeyliFqkI~~l~y-- 304 (604)
T KOG0592|consen 228 QKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRA-ANEYLIFQKIQALDY-- 304 (604)
T ss_pred hccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcc-ccHHHHHHHHHHhcc--
Confidence 1 1458999999999999765 78899999999999999999999988 677788888877544
Q ss_pred ccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCccccccccCCC
Q 008504 145 SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQKEP 188 (563)
Q Consensus 145 ~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~~~~~ 188 (563)
.++...++.+++||+++|+ +|.+|+|+.+|.+||||...+|+..
T Consensus 305 ~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~nl 349 (604)
T KOG0592|consen 305 EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWENL 349 (604)
T ss_pred cCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhhh
Confidence 3566778999999999997 9999999999999999999988764
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=310.25 Aligned_cols=180 Identities=26% Similarity=0.492 Sum_probs=163.3
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhcc-C
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ-Q 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~-~ 79 (563)
+|.||++||.|++|+-+++++++.++.++++||+.|+.|||..+ |+||||||+|+|++.+ +.|||+|||+|..-. .
T Consensus 89 lvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~--icHRDLKpENlLLd~~-~nIKIADFGMAsLe~~g 165 (786)
T KOG0588|consen 89 LVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFN--ICHRDLKPENLLLDVK-NNIKIADFGMASLEVPG 165 (786)
T ss_pred EEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhc--ceeccCCchhhhhhcc-cCEeeeccceeecccCC
Confidence 58999999999999999999999999999999999999999999 9999999999999855 569999999996543 3
Q ss_pred CCCccccCCCCccCccccccc-C-CchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHHH
Q 008504 80 PTARSVIGTPEFMAPELYEEE-Y-NELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 157 (563)
Q Consensus 80 ~~~~~~~Gtp~Y~APEvl~~~-y-s~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~L 157 (563)
....+.||.|+|.|||++.+. | +.++||||+|||+|.|+||+.||.+ .|...++.++..|... +|...++++++|
T Consensus 166 klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD-dNir~LLlKV~~G~f~--MPs~Is~eaQdL 242 (786)
T KOG0588|consen 166 KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD-DNIRVLLLKVQRGVFE--MPSNISSEAQDL 242 (786)
T ss_pred ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC-ccHHHHHHHHHcCccc--CCCcCCHHHHHH
Confidence 456678999999999999865 4 7799999999999999999999996 7889999999999764 568889999999
Q ss_pred HHHhcC-CCCCCCCHHHHHcCccccccccC
Q 008504 158 IEKCLV-PASERLSAKDLLKDPFLQVENQK 186 (563)
Q Consensus 158 I~kcL~-dP~kRpSa~ELLkHpff~~~~~~ 186 (563)
|.+||. ||.+|+|..|+++|||++.....
T Consensus 243 Lr~ml~VDp~~RiT~~eI~kHP~l~g~~~~ 272 (786)
T KOG0588|consen 243 LRRMLDVDPSTRITTEEILKHPFLSGYTSL 272 (786)
T ss_pred HHHHhccCccccccHHHHhhCchhhcCCCC
Confidence 999996 99999999999999999876543
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=291.79 Aligned_cols=184 Identities=26% Similarity=0.513 Sum_probs=158.8
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCC--C---CcEEEecccchh
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGN--H---GEVKIGDLGLAI 75 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~--~---G~VKL~DFGlA~ 75 (563)
||||||.||+|.+|+++++.+++..++.++.||+.||++||+++ ||||||||+||||+.. . ..+||+|||+|+
T Consensus 86 lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~--IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR 163 (429)
T KOG0595|consen 86 LVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENN--IIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR 163 (429)
T ss_pred EEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence 69999999999999999999999999999999999999999999 9999999999999753 1 368999999999
Q ss_pred hccCC-CCccccCCCCccCcccc-cccCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCC-CCccccCCCh
Q 008504 76 AMQQP-TARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK-PASLAKVNDP 152 (563)
Q Consensus 76 ~~~~~-~~~~~~Gtp~Y~APEvl-~~~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~-p~~l~~~~s~ 152 (563)
.+... ...+.+|+|.|||||++ .++|+.|+|+||+|+|+|+|++|+.||.. .++.++...+..+.. ...++...+.
T Consensus 164 ~L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a-~t~~eL~~~~~k~~~~~~~~~~~~s~ 242 (429)
T KOG0595|consen 164 FLQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA-ETPKELLLYIKKGNEIVPVLPAELSN 242 (429)
T ss_pred hCCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc-cCHHHHHHHHhccccccCchhhhccC
Confidence 88754 45678999999999999 57799999999999999999999999987 456666666666543 3445555666
Q ss_pred hHHHHHHHhcC-CCCCCCCHHHHHcCccccccccCC
Q 008504 153 QIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQKE 187 (563)
Q Consensus 153 ~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~~~~ 187 (563)
...+++...|. +|.+|.+..+-+.|+|+.......
T Consensus 243 ~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p~~~ 278 (429)
T KOG0595|consen 243 PLRELLISLLQRNPKDRISFEDFFDHPFLAANPQDR 278 (429)
T ss_pred chhhhhhHHHhcCccccCchHHhhhhhhcccCcccc
Confidence 77788888886 899999999999999998665433
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=299.13 Aligned_cols=186 Identities=23% Similarity=0.446 Sum_probs=160.4
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC-
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ- 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~- 79 (563)
|||||++||++..+|.+.+.|++..++.|+.+++.|+..||.+| +|||||||+|+||+ ..|++||+||||+..+..
T Consensus 218 LiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~g--yIHRDIKPdNlLiD-~~GHiKLSDFGLs~gl~~~ 294 (550)
T KOG0605|consen 218 LIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLG--YIHRDIKPDNLLID-AKGHIKLSDFGLSTGLDKK 294 (550)
T ss_pred EEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcC--cccccCChhheeec-CCCCEeeccccccchhhhh
Confidence 69999999999999999999999999999999999999999999 99999999999998 669999999999842110
Q ss_pred ------------------------CC------------------------CccccCCCCccCcccccc-cCCchhhHHHh
Q 008504 80 ------------------------PT------------------------ARSVIGTPEFMAPELYEE-EYNELVDIYSF 110 (563)
Q Consensus 80 ------------------------~~------------------------~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSL 110 (563)
.. ..+.+|||.|||||++.+ +|+..+|+|||
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSL 374 (550)
T KOG0605|consen 295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSL 374 (550)
T ss_pred hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHH
Confidence 00 014579999999998865 59999999999
Q ss_pred HHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCC--ccccCCChhHHHHHHHhcCCCCCCCC---HHHHHcCcccccccc
Q 008504 111 GMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPA--SLAKVNDPQIKGFIEKCLVPASERLS---AKDLLKDPFLQVENQ 185 (563)
Q Consensus 111 GviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~--~l~~~~s~~l~~LI~kcL~dP~kRpS---a~ELLkHpff~~~~~ 185 (563)
|||+||||.|.+||.. .++.+.+++|....... +.....++++++||.+||.+|.+|.. +.||.+||||+..+|
T Consensus 375 G~ImyEmLvGyPPF~s-~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~d~~~RLG~~G~~EIK~HPfF~~v~W 453 (550)
T KOG0605|consen 375 GCIMYEMLVGYPPFCS-ETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLCDPENRLGSKGAEEIKKHPFFKGVDW 453 (550)
T ss_pred HHHHHHHHhCCCCCCC-CCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhcCHHHhcCcccHHHHhcCCccccCCc
Confidence 9999999999999987 78888888887765322 22334468999999999999999985 999999999999999
Q ss_pred CCCCC
Q 008504 186 KEPIC 190 (563)
Q Consensus 186 ~~~~~ 190 (563)
.....
T Consensus 454 ~~l~~ 458 (550)
T KOG0605|consen 454 DHLRE 458 (550)
T ss_pred chhhc
Confidence 87543
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=279.83 Aligned_cols=175 Identities=30% Similarity=0.523 Sum_probs=155.6
Q ss_pred CEeccCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCC--eEeccCccCceEEeCCCCcEEEecccch
Q 008504 1 MITELFTSGNLRQYRKK----HKNVDIKVIKNWARQILHGLVYLHSHNPP--IIHRDLKCDNIFVNGNHGEVKIGDLGLA 74 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k----~~~Lse~~i~~i~~QIL~aL~yLHs~gp~--IIHrDLKP~NILLd~~~G~VKL~DFGlA 74 (563)
||||||.+|+|.+.++. ++.++++.+|+++.|++.||..+|+.-|. |+||||||.|||++ .+|.|||+|||++
T Consensus 97 ivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~-~~gvvKLGDfGL~ 175 (375)
T KOG0591|consen 97 IVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLT-ANGVVKLGDFGLG 175 (375)
T ss_pred HHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEc-CCCceeeccchhH
Confidence 68999999999999874 45699999999999999999999995444 99999999999998 5589999999999
Q ss_pred hhccCC--CCccccCCCCccCccccc-ccCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCC
Q 008504 75 IAMQQP--TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVND 151 (563)
Q Consensus 75 ~~~~~~--~~~~~~Gtp~Y~APEvl~-~~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s 151 (563)
+.+... .+.+.+|||.||+||++. .+|+.++||||+||++|||+..+.||.+ .+-..+.++|.++..++.+...++
T Consensus 176 r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g-~n~~~L~~KI~qgd~~~~p~~~YS 254 (375)
T KOG0591|consen 176 RFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYG-DNLLSLCKKIEQGDYPPLPDEHYS 254 (375)
T ss_pred hHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccc-ccHHHHHHHHHcCCCCCCcHHHhh
Confidence 988654 356789999999999886 5699999999999999999999999998 588899999999988776668889
Q ss_pred hhHHHHHHHhcC-CCCCCCCHHHHHcCccccc
Q 008504 152 PQIKGFIEKCLV-PASERLSAKDLLKDPFLQV 182 (563)
Q Consensus 152 ~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~ 182 (563)
..++.+|..|+. ||..||+. +|+++.
T Consensus 255 ~~l~~li~~ci~vd~~~RP~t-----~~~v~d 281 (375)
T KOG0591|consen 255 TDLRELINMCIAVDPEQRPDT-----VPYVQD 281 (375)
T ss_pred hHHHHHHHHHccCCcccCCCc-----chHHHH
Confidence 999999999997 89999987 555554
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-33 Score=292.57 Aligned_cols=174 Identities=35% Similarity=0.569 Sum_probs=150.2
Q ss_pred CEeccCCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhcc
Q 008504 1 MITELFTSGNLRQYRKK--HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k--~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~ 78 (563)
|||||+++|+|.+++.+ .+.++...+..|+.||++||.|||+++| ||||||||+|||++.+.-++||+|||+++...
T Consensus 117 iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~-iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~ 195 (362)
T KOG0192|consen 117 IVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP-IIHRDLKSDNILVDLKGKTLKIADFGLSREKV 195 (362)
T ss_pred EEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC-eeecccChhhEEEcCCCCEEEECCCccceeec
Confidence 69999999999999987 5789999999999999999999999997 99999999999998542399999999997665
Q ss_pred C--CCCccccCCCCccCccccccc---CCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChh
Q 008504 79 Q--PTARSVIGTPEFMAPELYEEE---YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQ 153 (563)
Q Consensus 79 ~--~~~~~~~Gtp~Y~APEvl~~~---ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~ 153 (563)
. .......||+.|||||++++. |+.|+||||||+++|||+||+.||..... .+....+..+...+.++...++.
T Consensus 196 ~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-~~~~~~v~~~~~Rp~~p~~~~~~ 274 (362)
T KOG0192|consen 196 ISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-VQVASAVVVGGLRPPIPKECPPH 274 (362)
T ss_pred cccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-HHHHHHHHhcCCCCCCCccCCHH
Confidence 4 233346899999999999853 99999999999999999999999998665 55555555444444566668899
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHHc
Q 008504 154 IKGFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 154 l~~LI~kcL~-dP~kRpSa~ELLk 176 (563)
+..||.+||. +|.+||++.+++.
T Consensus 275 l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 275 LSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred HHHHHHHhCCCCCCcCCCHHHHHH
Confidence 9999999997 8999999999875
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=287.87 Aligned_cols=183 Identities=25% Similarity=0.493 Sum_probs=155.7
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC-
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ- 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~- 79 (563)
|||||+.+|+|.+++.+.+.+++..++.++.||+.||+|||++| |+||||||+|||++ .+|.+||+|||++.....
T Consensus 72 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--ivHrDlkp~NIll~-~~~~~kl~DfG~a~~~~~~ 148 (323)
T cd05571 72 FVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCD--VVYRDLKLENLMLD-KDGHIKITDFGLCKEGISD 148 (323)
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEEC-CCCCEEEeeCCCCcccccC
Confidence 68999999999999998889999999999999999999999999 99999999999998 557999999999865322
Q ss_pred -CCCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHHH
Q 008504 80 -PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 157 (563)
Q Consensus 80 -~~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~L 157 (563)
......+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.. .+.......+..+.. .++...++.+++|
T Consensus 149 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~-~~~~~~~~~~~~~~~--~~p~~~~~~~~~l 225 (323)
T cd05571 149 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILMEEI--RFPRTLSPEAKSL 225 (323)
T ss_pred CCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHHHHHH
Confidence 22344679999999998864 589999999999999999999999976 445555555554432 3455678899999
Q ss_pred HHHhcC-CCCCCC-----CHHHHHcCccccccccCCCC
Q 008504 158 IEKCLV-PASERL-----SAKDLLKDPFLQVENQKEPI 189 (563)
Q Consensus 158 I~kcL~-dP~kRp-----Sa~ELLkHpff~~~~~~~~~ 189 (563)
|.+||. +|.+|| ++.++++||||...++....
T Consensus 226 i~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~~~~~~~ 263 (323)
T cd05571 226 LAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINWQDVV 263 (323)
T ss_pred HHHHccCCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHH
Confidence 999997 899999 89999999999887665443
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=280.42 Aligned_cols=179 Identities=30% Similarity=0.512 Sum_probs=154.9
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
+||||+++|+|.+++.+.+.+++..++.++.||+.||+|||++| |+||||||+|||++ ..|.+||+|||++......
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~NIli~-~~~~~kl~Dfg~~~~~~~~ 154 (291)
T cd05612 78 MLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKE--IVYRDLKPENILLD-KEGHIKLTDFGFAKKLRDR 154 (291)
T ss_pred EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEEC-CCCCEEEEecCcchhccCC
Confidence 58999999999999999889999999999999999999999999 99999999999997 5689999999999765432
Q ss_pred CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHHHHH
Q 008504 81 TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIE 159 (563)
Q Consensus 81 ~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~LI~ 159 (563)
.....|++.|+|||++.+ .++.++|||||||++|+|++|+.||.. .+...++..+..+.. .++...++.+++||+
T Consensus 155 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~-~~~~~~~~~i~~~~~--~~~~~~~~~~~~li~ 230 (291)
T cd05612 155 -TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFD-DNPFGIYEKILAGKL--EFPRHLDLYAKDLIK 230 (291)
T ss_pred -cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCc--CCCccCCHHHHHHHH
Confidence 234578999999998865 488999999999999999999999987 456666666665543 345556889999999
Q ss_pred HhcC-CCCCCCC-----HHHHHcCccccccccC
Q 008504 160 KCLV-PASERLS-----AKDLLKDPFLQVENQK 186 (563)
Q Consensus 160 kcL~-dP~kRpS-----a~ELLkHpff~~~~~~ 186 (563)
+||. +|.+|++ +.++++||||+...+.
T Consensus 231 ~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~ 263 (291)
T cd05612 231 KLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWD 263 (291)
T ss_pred HHcCCCHHHccCCccCCHHHHhcCccccCCCHH
Confidence 9997 8999995 9999999999876654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=287.75 Aligned_cols=186 Identities=23% Similarity=0.434 Sum_probs=152.1
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
||||||+||+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ ..|.+||+|||+++.....
T Consensus 78 lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--ivHrDlKp~NILi~-~~~~vkL~DFGla~~~~~~ 154 (363)
T cd05628 78 LIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLG--FIHRDIKPDNLLLD-SKGHVKLSDFGLCTGLKKA 154 (363)
T ss_pred EEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEEC-CCCCEEEeeccCccccccc
Confidence 68999999999999998889999999999999999999999999 99999999999998 4589999999998643211
Q ss_pred C-------------------------------------CccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCC
Q 008504 81 T-------------------------------------ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEY 122 (563)
Q Consensus 81 ~-------------------------------------~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~ 122 (563)
. ....+||+.|+|||++.+ .++.++|||||||++|+|++|..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence 0 123579999999998864 58999999999999999999999
Q ss_pred CCCCCCCHHHHHHHHhcCCCCCccc--cCCChhHHHHHHHhcCC---CCCCCCHHHHHcCccccccccCCCCC
Q 008504 123 PYSECKNPAQIFKKVTSGIKPASLA--KVNDPQIKGFIEKCLVP---ASERLSAKDLLKDPFLQVENQKEPIC 190 (563)
Q Consensus 123 Pf~~~~~~~~i~~~i~~~~~p~~l~--~~~s~~l~~LI~kcL~d---P~kRpSa~ELLkHpff~~~~~~~~~~ 190 (563)
||.. ......+..+........++ ...++.+++||.+++.+ +..||++.|+++||||+..++.....
T Consensus 235 Pf~~-~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~hp~f~~~~~~~~~~ 306 (363)
T cd05628 235 PFCS-ETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTNPFFEGVDWEHIRE 306 (363)
T ss_pred CCCC-CCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCCCCCCCCCHHHHHh
Confidence 9986 45566666665533222222 23578999999997764 34578999999999999887765433
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=290.98 Aligned_cols=183 Identities=30% Similarity=0.458 Sum_probs=154.1
Q ss_pred CEeccCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~-~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
||||||+. +|.++++.+ +.|++..++.|++||++||+|+|.+| +.||||||+|||+.++ ..|||+|||+|+.+..
T Consensus 87 fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~G--fFHRDlKPENiLi~~~-~~iKiaDFGLARev~S 162 (538)
T KOG0661|consen 87 FVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHG--FFHRDLKPENILISGN-DVIKIADFGLAREVRS 162 (538)
T ss_pred eeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcC--cccccCChhheEeccc-ceeEeccccccccccc
Confidence 69999976 999999865 56999999999999999999999999 9999999999999865 4899999999988764
Q ss_pred -CCCccccCCCCccCccccc--ccCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCC--------------
Q 008504 80 -PTARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK-------------- 142 (563)
Q Consensus 80 -~~~~~~~Gtp~Y~APEvl~--~~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~-------------- 142 (563)
+....++.|.+|.|||++- +-|+.++|+|++|||++|+++.++.|.+....+++++...---.
T Consensus 163 kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~ 242 (538)
T KOG0661|consen 163 KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLAS 242 (538)
T ss_pred CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHH
Confidence 3455678999999999774 45999999999999999999999999998888888775432000
Q ss_pred ------C-------CccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCccccccccCC
Q 008504 143 ------P-------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQKE 187 (563)
Q Consensus 143 ------p-------~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~~~~ 187 (563)
| ..+-...++++.++|.+|+. ||.+||||.++|+||||+......
T Consensus 243 ~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~~~ 301 (538)
T KOG0661|consen 243 AMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRASG 301 (538)
T ss_pred HhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccccccc
Confidence 0 01112256789999999998 999999999999999999765443
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-32 Score=284.36 Aligned_cols=180 Identities=26% Similarity=0.486 Sum_probs=155.9
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
+||||+.+|+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++......
T Consensus 95 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~NIll~-~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 95 FLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKD--IIYRDLKPENLLLD-NKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred EEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEEC-CCCCEEEeeccCceEcCCC
Confidence 58999999999999999889999999999999999999999999 99999999999998 5689999999999765432
Q ss_pred CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHHHHH
Q 008504 81 TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIE 159 (563)
Q Consensus 81 ~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~LI~ 159 (563)
.....|++.|+|||++.+ .++.++|||||||++|+|++|..||.. ..+...+..+..+.. .++...+..+++||.
T Consensus 172 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~li~ 247 (329)
T PTZ00263 172 -TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFD-DTPFRIYEKILAGRL--KFPNWFDGRARDLVK 247 (329)
T ss_pred -cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCC-CCHHHHHHHHhcCCc--CCCCCCCHHHHHHHH
Confidence 234679999999998865 488999999999999999999999976 456667777766543 245567889999999
Q ss_pred HhcC-CCCCCCC-----HHHHHcCccccccccCC
Q 008504 160 KCLV-PASERLS-----AKDLLKDPFLQVENQKE 187 (563)
Q Consensus 160 kcL~-dP~kRpS-----a~ELLkHpff~~~~~~~ 187 (563)
+||. +|.+|++ +.+++.||||....+..
T Consensus 248 ~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~~~ 281 (329)
T PTZ00263 248 GLLQTDHTKRLGTLKGGVADVKNHPYFHGANWDK 281 (329)
T ss_pred HHhhcCHHHcCCCCCCCHHHHhcCCccCCCCHHH
Confidence 9997 8999997 79999999998765543
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.7e-33 Score=276.46 Aligned_cols=180 Identities=27% Similarity=0.491 Sum_probs=156.8
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
+|+|+|+.|.|++|+...-.++++..+++++|++.|+.|||.++ |+||||||+|||++.+ -++||+|||+++.+...
T Consensus 100 lVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~--IVHRDLKpENILlddn-~~i~isDFGFa~~l~~G 176 (411)
T KOG0599|consen 100 LVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARN--IVHRDLKPENILLDDN-MNIKISDFGFACQLEPG 176 (411)
T ss_pred hhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhh--hhhcccChhheeeccc-cceEEeccceeeccCCc
Confidence 58999999999999999889999999999999999999999999 9999999999999855 59999999999888754
Q ss_pred -CCccccCCCCccCccccc-------ccCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccc--cCC
Q 008504 81 -TARSVIGTPEFMAPELYE-------EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLA--KVN 150 (563)
Q Consensus 81 -~~~~~~Gtp~Y~APEvl~-------~~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~--~~~ 150 (563)
.....+|||.|+|||.+. .+|+..+|+|++|+|+|.|+.|.+||.. .....+.+.+..|......+ ...
T Consensus 177 ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwH-RkQmlMLR~ImeGkyqF~speWadi 255 (411)
T KOG0599|consen 177 EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWH-RKQMLMLRMIMEGKYQFRSPEWADI 255 (411)
T ss_pred hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhH-HHHHHHHHHHHhcccccCCcchhhc
Confidence 456789999999999875 2589999999999999999999999986 33445567788887654333 344
Q ss_pred ChhHHHHHHHhcC-CCCCCCCHHHHHcCccccccc
Q 008504 151 DPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 184 (563)
Q Consensus 151 s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~ 184 (563)
+...++||.+||+ ||.+|.|++|+|.||||++.-
T Consensus 256 s~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~ 290 (411)
T KOG0599|consen 256 SATVKDLISRLLQVDPTKRITAKEALAHPFFIQIA 290 (411)
T ss_pred cccHHHHHHHHHeeCchhcccHHHHhcChHHHHHH
Confidence 6789999999997 999999999999999996543
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-32 Score=282.01 Aligned_cols=181 Identities=24% Similarity=0.472 Sum_probs=154.6
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhcc--
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ-- 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~-- 78 (563)
|||||+++|+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++....
T Consensus 73 iv~Ey~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~--ivH~dlkp~NIli~-~~~~~kL~DfG~~~~~~~~ 149 (320)
T cd05590 73 FVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKG--IIYRDLKLDNVLLD-HEGHCKLADFGMCKEGIFN 149 (320)
T ss_pred EEEcCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEEC-CCCcEEEeeCCCCeecCcC
Confidence 68999999999999998889999999999999999999999999 99999999999998 55799999999986432
Q ss_pred CCCCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHHH
Q 008504 79 QPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 157 (563)
Q Consensus 79 ~~~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~L 157 (563)
........||+.|+|||++.+ .++.++|||||||++|+|++|+.||.. .+...++..+..+.. ..+...++.+++|
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~-~~~~~~~~~i~~~~~--~~~~~~~~~~~~l 226 (320)
T cd05590 150 GKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEA-ENEDDLFEAILNDEV--VYPTWLSQDAVDI 226 (320)
T ss_pred CCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCC-CCHHHHHHHHhcCCC--CCCCCCCHHHHHH
Confidence 222334579999999998864 488999999999999999999999986 455666666665433 2445678899999
Q ss_pred HHHhcC-CCCCCCCH------HHHHcCccccccccCC
Q 008504 158 IEKCLV-PASERLSA------KDLLKDPFLQVENQKE 187 (563)
Q Consensus 158 I~kcL~-dP~kRpSa------~ELLkHpff~~~~~~~ 187 (563)
|.+||. +|.+||++ .++++||||+...+..
T Consensus 227 i~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~~~ 263 (320)
T cd05590 227 LKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDWEK 263 (320)
T ss_pred HHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCCHHH
Confidence 999997 89999998 9999999998766543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.2e-32 Score=279.87 Aligned_cols=180 Identities=26% Similarity=0.462 Sum_probs=153.3
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC-
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ- 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~- 79 (563)
|||||+++|+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ ..|.+||+|||++.....
T Consensus 70 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~HrDlkp~Nili~-~~~~~kl~Dfg~~~~~~~~ 146 (312)
T cd05585 70 LVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFN--VIYRDLKPENILLD-YQGHIALCDFGLCKLNMKD 146 (312)
T ss_pred EEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHeEEC-CCCcEEEEECcccccCccC
Confidence 68999999999999998888999999999999999999999999 99999999999997 557999999999865322
Q ss_pred -CCCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHHH
Q 008504 80 -PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 157 (563)
Q Consensus 80 -~~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~L 157 (563)
.......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.. ......+..+.... ..++...++.+++|
T Consensus 147 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~-~~~~~~~~~~~~~~--~~~~~~~~~~~~~l 223 (312)
T cd05585 147 DDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYD-ENVNEMYRKILQEP--LRFPDGFDRDAKDL 223 (312)
T ss_pred CCccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCC-CCHHHHHHHHHcCC--CCCCCcCCHHHHHH
Confidence 22334579999999998865 489999999999999999999999986 44555666655442 33456678899999
Q ss_pred HHHhcC-CCCCCC---CHHHHHcCccccccccC
Q 008504 158 IEKCLV-PASERL---SAKDLLKDPFLQVENQK 186 (563)
Q Consensus 158 I~kcL~-dP~kRp---Sa~ELLkHpff~~~~~~ 186 (563)
|.+||. +|.+|| ++.++|.||||....+.
T Consensus 224 i~~~L~~dp~~R~~~~~~~e~l~hp~~~~~~~~ 256 (312)
T cd05585 224 LIGLLSRDPTRRLGYNGAQEIKNHPFFSQLSWK 256 (312)
T ss_pred HHHHcCCCHHHcCCCCCHHHHHcCCCcCCCCHH
Confidence 999997 899997 58999999999876543
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=3e-32 Score=285.16 Aligned_cols=180 Identities=26% Similarity=0.454 Sum_probs=155.9
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
|||||+.+|+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++.....
T Consensus 108 lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~-~~~~ikL~DFG~a~~~~~- 183 (340)
T PTZ00426 108 LVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLN--IVYRDLKPENLLLD-KDGFIKMTDFGFAKVVDT- 183 (340)
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEEC-CCCCEEEecCCCCeecCC-
Confidence 68999999999999999889999999999999999999999999 99999999999997 568999999999976543
Q ss_pred CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHHHHH
Q 008504 81 TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIE 159 (563)
Q Consensus 81 ~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~LI~ 159 (563)
......||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .++...++.+..+.. .++...++.++++|+
T Consensus 184 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~li~ 260 (340)
T PTZ00426 184 RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYA-NEPLLIYQKILEGII--YFPKFLDNNCKHLMK 260 (340)
T ss_pred CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCC-CCHHHHHHHHhcCCC--CCCCCCCHHHHHHHH
Confidence 2345679999999998865 488999999999999999999999986 455666667666543 245567889999999
Q ss_pred HhcC-CCCCCC-----CHHHHHcCccccccccCC
Q 008504 160 KCLV-PASERL-----SAKDLLKDPFLQVENQKE 187 (563)
Q Consensus 160 kcL~-dP~kRp-----Sa~ELLkHpff~~~~~~~ 187 (563)
+||. +|.+|+ ++.++++||||....+..
T Consensus 261 ~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~~ 294 (340)
T PTZ00426 261 KLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVS 294 (340)
T ss_pred HHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHHH
Confidence 9997 899995 899999999998766554
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.9e-32 Score=281.85 Aligned_cols=182 Identities=23% Similarity=0.430 Sum_probs=152.6
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
+||||+.+|+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++......
T Consensus 78 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--iiH~Dlkp~NIll~-~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 78 LVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLG--FIHRDIKPDNILID-ADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred EEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEEC-CCCCEEeecCCCCccCccc
Confidence 68999999999999998888999999999999999999999999 99999999999998 5579999999998755432
Q ss_pred C-------------------------------CccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCC
Q 008504 81 T-------------------------------ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECK 128 (563)
Q Consensus 81 ~-------------------------------~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~ 128 (563)
. .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 2 234578999999998865 48999999999999999999999998743
Q ss_pred CHHHHHHHHhcCCCCCccc--cCCChhHHHHHHHhcCCCCCCCC-HHHHHcCccccccccC
Q 008504 129 NPAQIFKKVTSGIKPASLA--KVNDPQIKGFIEKCLVPASERLS-AKDLLKDPFLQVENQK 186 (563)
Q Consensus 129 ~~~~i~~~i~~~~~p~~l~--~~~s~~l~~LI~kcL~dP~kRpS-a~ELLkHpff~~~~~~ 186 (563)
....+..+.........+ ...++.+++||.+||.+|.+||+ +.++++||||+...+.
T Consensus 235 -~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~dp~~R~~s~~~ll~hp~~~~~~~~ 294 (350)
T cd05573 235 -LQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLCDPEDRLGSFEEIKSHPFFKGIDWE 294 (350)
T ss_pred -HHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHccChhhcCCCHHHHhcCCCcCCCCHH
Confidence 455555555422221222 22588999999999999999999 9999999999876554
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-32 Score=279.48 Aligned_cols=181 Identities=25% Similarity=0.496 Sum_probs=153.1
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC-
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ- 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~- 79 (563)
|||||+++|+|..++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ ++|.+||+|||++.....
T Consensus 72 lv~E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~-~~~~~kL~Dfg~~~~~~~~ 148 (323)
T cd05595 72 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLD-KDGHIKITDFGLCKEGISD 148 (323)
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEEc-CCCCEEecccHHhccccCC
Confidence 68999999999999998888999999999999999999999999 99999999999998 567999999999865322
Q ss_pred -CCCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHHH
Q 008504 80 -PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 157 (563)
Q Consensus 80 -~~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~L 157 (563)
.......|++.|+|||++.+ .++.++|||||||++|+|++|+.||.. .+.......+..... .++...++.+++|
T Consensus 149 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~-~~~~~~~~~~~~~~~--~~p~~~~~~~~~l 225 (323)
T cd05595 149 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELILMEEI--RFPRTLSPEAKSL 225 (323)
T ss_pred CCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHhcCCC--CCCCCCCHHHHHH
Confidence 22334679999999998864 589999999999999999999999976 344555555444322 2455678999999
Q ss_pred HHHhcC-CCCCCC-----CHHHHHcCccccccccCC
Q 008504 158 IEKCLV-PASERL-----SAKDLLKDPFLQVENQKE 187 (563)
Q Consensus 158 I~kcL~-dP~kRp-----Sa~ELLkHpff~~~~~~~ 187 (563)
|.+||. +|.+|+ ++.++++||||....+..
T Consensus 226 i~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~~~~ 261 (323)
T cd05595 226 LAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQD 261 (323)
T ss_pred HHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCCHHH
Confidence 999997 899998 899999999998766544
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-32 Score=280.17 Aligned_cols=180 Identities=23% Similarity=0.396 Sum_probs=150.8
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
|||||+++|+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ ..|.+||+|||++.....
T Consensus 78 lv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~-~~~~~kL~Dfg~a~~~~~- 153 (333)
T cd05600 78 LAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELG--YIHRDLKPENFLID-ASGHIKLTDFGLSKGIVT- 153 (333)
T ss_pred EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEC-CCCCEEEEeCcCCccccc-
Confidence 68999999999999998888999999999999999999999999 99999999999998 568999999999975543
Q ss_pred CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccc------cCCChh
Q 008504 81 TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLA------KVNDPQ 153 (563)
Q Consensus 81 ~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~------~~~s~~ 153 (563)
......|++.|+|||++.+ .++.++|||||||++|+|++|..||.. .+....+..+.........+ ...+++
T Consensus 154 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~ 232 (333)
T cd05600 154 YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSG-STPNETWENLKYWKETLQRPVYDDPRFNLSDE 232 (333)
T ss_pred ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCC-CCHHHHHHHHHhccccccCCCCCccccccCHH
Confidence 3345679999999998864 589999999999999999999999986 44555555444322111111 134789
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHHcCcccccccc
Q 008504 154 IKGFIEKCLV-PASERLSAKDLLKDPFLQVENQ 185 (563)
Q Consensus 154 l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~~ 185 (563)
+.+||.+||. +|.+||++.++++||||....+
T Consensus 233 ~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~~~ 265 (333)
T cd05600 233 AWDLITKLINDPSRRFGSLEDIKNHPFFKEVDW 265 (333)
T ss_pred HHHHHHHHhhChhhhcCCHHHHHhCcccCCCCH
Confidence 9999999997 6899999999999999987544
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-32 Score=280.70 Aligned_cols=181 Identities=25% Similarity=0.489 Sum_probs=153.0
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC-
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ- 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~- 79 (563)
|||||+++|+|..++...+.+++..++.++.||+.||.|||++| |+||||||+|||++ ..|.+||+|||++.....
T Consensus 72 lv~Ey~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~NIll~-~~~~~kL~DfG~~~~~~~~ 148 (328)
T cd05593 72 FVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGK--IVYRDLKLENLMLD-KDGHIKITDFGLCKEGITD 148 (328)
T ss_pred EEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeEEC-CCCcEEEecCcCCccCCCc
Confidence 68999999999999998888999999999999999999999999 99999999999998 557999999999865322
Q ss_pred -CCCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHHH
Q 008504 80 -PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 157 (563)
Q Consensus 80 -~~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~L 157 (563)
.......||+.|+|||++.+ .++.++|||||||++|+|++|+.||... ........+..... .++...++.+.+|
T Consensus 149 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~-~~~~~~~~~~~~~~--~~p~~~~~~~~~l 225 (328)
T cd05593 149 AATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ-DHEKLFELILMEDI--KFPRTLSADAKSL 225 (328)
T ss_pred ccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCC-CHHHHHHHhccCCc--cCCCCCCHHHHHH
Confidence 22334579999999998864 5899999999999999999999999763 44455555443322 3456678899999
Q ss_pred HHHhcC-CCCCCC-----CHHHHHcCccccccccCC
Q 008504 158 IEKCLV-PASERL-----SAKDLLKDPFLQVENQKE 187 (563)
Q Consensus 158 I~kcL~-dP~kRp-----Sa~ELLkHpff~~~~~~~ 187 (563)
|.+||. +|.+|+ ++.++++||||...++..
T Consensus 226 i~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~~ 261 (328)
T cd05593 226 LSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNWQD 261 (328)
T ss_pred HHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCCCHHH
Confidence 999997 899997 899999999998766543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-32 Score=278.33 Aligned_cols=181 Identities=26% Similarity=0.461 Sum_probs=154.0
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhcc--
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ-- 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~-- 78 (563)
|||||+++|+|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++ ..|.+||+|||++....
T Consensus 78 lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~-~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 78 FVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLD-AEGHIKIADFGMCKENIFG 154 (324)
T ss_pred EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEEc-CCCCEEEeecCcceecCCC
Confidence 68999999999999998888999999999999999999999999 99999999999998 45799999999986432
Q ss_pred CCCCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHHH
Q 008504 79 QPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 157 (563)
Q Consensus 79 ~~~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~L 157 (563)
.......+||+.|+|||++.+ .++.++|||||||++|+|+||+.||.. ......+..+..... .++...++.+.+|
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~-~~~~~~~~~i~~~~~--~~~~~~~~~~~~l 231 (324)
T cd05587 155 GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDG-EDEDELFQSIMEHNV--SYPKSLSKEAVSI 231 (324)
T ss_pred CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHHHHHH
Confidence 223345579999999998865 489999999999999999999999986 445566666655432 3455678899999
Q ss_pred HHHhcC-CCCCCCCH-----HHHHcCccccccccCC
Q 008504 158 IEKCLV-PASERLSA-----KDLLKDPFLQVENQKE 187 (563)
Q Consensus 158 I~kcL~-dP~kRpSa-----~ELLkHpff~~~~~~~ 187 (563)
|.+||. +|.+|+++ .++++||||...++..
T Consensus 232 i~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~~~ 267 (324)
T cd05587 232 CKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDWEK 267 (324)
T ss_pred HHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCHHH
Confidence 999997 89999976 8999999998766543
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-32 Score=278.07 Aligned_cols=180 Identities=27% Similarity=0.507 Sum_probs=152.4
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhcc--
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ-- 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~-- 78 (563)
|||||+.+|+|..++.+.+.+++..++.++.||+.||+|||++| |+||||||+|||++ .+|.+||+|||++....
T Consensus 73 lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~ 149 (316)
T cd05620 73 FVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG--IIYRDLKLDNVMLD-RDGHIKIADFGMCKENVFG 149 (316)
T ss_pred EEECCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEEC-CCCCEEeCccCCCeecccC
Confidence 68999999999999998888999999999999999999999999 99999999999998 45799999999986432
Q ss_pred CCCCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHHH
Q 008504 79 QPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 157 (563)
Q Consensus 79 ~~~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~L 157 (563)
........|++.|+|||++.+ .++.++|||||||++|+|++|+.||.. .+...+...+.... ...+...++.+++|
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~-~~~~~~~~~~~~~~--~~~~~~~~~~~~~l 226 (316)
T cd05620 150 DNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHG-DDEDELFESIRVDT--PHYPRWITKESKDI 226 (316)
T ss_pred CCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCC--CCCCCCCCHHHHHH
Confidence 223345679999999998864 589999999999999999999999976 44555565555443 23455678899999
Q ss_pred HHHhcC-CCCCCCCH-HHHHcCccccccccC
Q 008504 158 IEKCLV-PASERLSA-KDLLKDPFLQVENQK 186 (563)
Q Consensus 158 I~kcL~-dP~kRpSa-~ELLkHpff~~~~~~ 186 (563)
|.+||. +|.+||++ .++++||||+...+.
T Consensus 227 i~~~l~~dP~~R~~~~~~~~~h~~f~~~~~~ 257 (316)
T cd05620 227 LEKLFERDPTRRLGVVGNIRGHPFFKTINWT 257 (316)
T ss_pred HHHHccCCHHHcCCChHHHHcCCCcCCCCHH
Confidence 999997 89999997 588999999876543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-32 Score=266.33 Aligned_cols=180 Identities=26% Similarity=0.498 Sum_probs=157.1
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeC--CCCcEEEecccchhhcc
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG--NHGEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~--~~G~VKL~DFGlA~~~~ 78 (563)
||+|+|+||+|..-|-++-.+++..+..+++||+.||.|+|.+| |||||+||+|+++-. +..-+||+|||+|..+.
T Consensus 87 lvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~--IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~ 164 (355)
T KOG0033|consen 87 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNG--IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN 164 (355)
T ss_pred EEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence 68999999999887777677999999999999999999999999 999999999999953 23469999999998776
Q ss_pred CC-CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCC--CCccccCCChhH
Q 008504 79 QP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK--PASLAKVNDPQI 154 (563)
Q Consensus 79 ~~-~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~--p~~l~~~~s~~l 154 (563)
.. ......|||.|||||+++. .|+..+|||+.|+++|-|+.|.+||.+ .....+++.|..+.. +.......++++
T Consensus 165 ~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~-~~~~rlye~I~~g~yd~~~~~w~~is~~A 243 (355)
T KOG0033|consen 165 DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD-EDQHRLYEQIKAGAYDYPSPEWDTVTPEA 243 (355)
T ss_pred CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCC-ccHHHHHHHHhccccCCCCcccCcCCHHH
Confidence 33 3456789999999999875 599999999999999999999999987 567889999988765 333455668899
Q ss_pred HHHHHHhcC-CCCCCCCHHHHHcCcccccc
Q 008504 155 KGFIEKCLV-PASERLSAKDLLKDPFLQVE 183 (563)
Q Consensus 155 ~~LI~kcL~-dP~kRpSa~ELLkHpff~~~ 183 (563)
++||++||. ||.+|+|+.|+|+|||+...
T Consensus 244 k~LvrrML~~dP~kRIta~EAL~HpWi~~r 273 (355)
T KOG0033|consen 244 KSLIRRMLTVNPKKRITADEALKHPWICNR 273 (355)
T ss_pred HHHHHHHhccChhhhccHHHHhCCchhcch
Confidence 999999996 99999999999999999754
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-32 Score=278.75 Aligned_cols=182 Identities=23% Similarity=0.416 Sum_probs=150.9
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
+||||+.+|+|.+++.+++.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++......
T Consensus 82 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nili~-~~~~~kl~DfG~~~~~~~~ 158 (332)
T cd05614 82 LILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLG--IVYRDIKLENILLD-SEGHVVLTDFGLSKEFLSE 158 (332)
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHeEEC-CCCCEEEeeCcCCcccccc
Confidence 58999999999999998888999999999999999999999999 99999999999998 4579999999998754322
Q ss_pred ---CCccccCCCCccCcccccc--cCCchhhHHHhHHHHHHHhhcCCCCCCC---CCHHHHHHHHhcCCCCCccccCCCh
Q 008504 81 ---TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSEC---KNPAQIFKKVTSGIKPASLAKVNDP 152 (563)
Q Consensus 81 ---~~~~~~Gtp~Y~APEvl~~--~ys~ksDIwSLGviLyELlTG~~Pf~~~---~~~~~i~~~i~~~~~p~~l~~~~s~ 152 (563)
......||+.|+|||++.+ .++.++|||||||++|+|+||..||... .....+...+.... ..++...++
T Consensus 159 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 236 (332)
T cd05614 159 EKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCD--PPFPSFIGP 236 (332)
T ss_pred CCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCC--CCCCCCCCH
Confidence 2234579999999998864 3788999999999999999999999642 22333444443322 234556788
Q ss_pred hHHHHHHHhcC-CCCCCC-----CHHHHHcCccccccccCC
Q 008504 153 QIKGFIEKCLV-PASERL-----SAKDLLKDPFLQVENQKE 187 (563)
Q Consensus 153 ~l~~LI~kcL~-dP~kRp-----Sa~ELLkHpff~~~~~~~ 187 (563)
.+++||.+||. +|.+|| ++.++++||||+...+..
T Consensus 237 ~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~~ 277 (332)
T cd05614 237 EAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEA 277 (332)
T ss_pred HHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCHHH
Confidence 99999999997 899999 899999999998765443
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-32 Score=278.29 Aligned_cols=182 Identities=24% Similarity=0.451 Sum_probs=155.2
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhcc--
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ-- 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~-- 78 (563)
|||||+++|+|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++....
T Consensus 78 lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~-~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 78 FVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLD-SEGHIKIADFGMCKENMWD 154 (323)
T ss_pred EEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEecCCCHHHeEEC-CCCcEEEccCCCceecCCC
Confidence 68999999999999998888999999999999999999999999 99999999999998 55799999999986432
Q ss_pred CCCCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHHH
Q 008504 79 QPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 157 (563)
Q Consensus 79 ~~~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~L 157 (563)
........||+.|+|||++.+ .++.++|||||||++|+|+||+.||.. .+...++..+..... .++...++.+++|
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~~l 231 (323)
T cd05616 155 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG-EDEDELFQSIMEHNV--AYPKSMSKEAVAI 231 (323)
T ss_pred CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCC--CCCCcCCHHHHHH
Confidence 223345679999999998864 589999999999999999999999987 455666666665433 2455678899999
Q ss_pred HHHhcC-CCCCCCC-----HHHHHcCccccccccCCC
Q 008504 158 IEKCLV-PASERLS-----AKDLLKDPFLQVENQKEP 188 (563)
Q Consensus 158 I~kcL~-dP~kRpS-----a~ELLkHpff~~~~~~~~ 188 (563)
|.+||. +|.+|++ ..++++||||+..++...
T Consensus 232 i~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~~~~ 268 (323)
T cd05616 232 CKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKL 268 (323)
T ss_pred HHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCHHHH
Confidence 999997 8999998 489999999987766543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-32 Score=278.20 Aligned_cols=181 Identities=24% Similarity=0.446 Sum_probs=154.5
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC-
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ- 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~- 79 (563)
|||||+++|+|..++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++.....
T Consensus 73 lv~E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~Nill~-~~~~~kL~Dfg~~~~~~~~ 149 (321)
T cd05591 73 FVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG--VIYRDLKLDNILLD-AEGHCKLADFGMCKEGILN 149 (321)
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEEC-CCCCEEEeecccceecccC
Confidence 69999999999999998889999999999999999999999999 99999999999998 557999999999864322
Q ss_pred -CCCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHHH
Q 008504 80 -PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 157 (563)
Q Consensus 80 -~~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~L 157 (563)
.......|++.|+|||++.+ .++.++|||||||++|+|++|+.||.. .+....+..+..+.. ..+...++++.+|
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~l 226 (321)
T cd05591 150 GVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEA-DNEDDLFESILHDDV--LYPVWLSKEAVSI 226 (321)
T ss_pred CccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHHHHHH
Confidence 22334578999999998865 589999999999999999999999987 455666666665433 2345568899999
Q ss_pred HHHhcC-CCCCCC-------CHHHHHcCccccccccCC
Q 008504 158 IEKCLV-PASERL-------SAKDLLKDPFLQVENQKE 187 (563)
Q Consensus 158 I~kcL~-dP~kRp-------Sa~ELLkHpff~~~~~~~ 187 (563)
|.+||. +|.+|+ ++.++++||||....+..
T Consensus 227 l~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~~~ 264 (321)
T cd05591 227 LKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDWVL 264 (321)
T ss_pred HHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCCCHHH
Confidence 999997 899999 999999999998766543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-32 Score=284.51 Aligned_cols=186 Identities=23% Similarity=0.457 Sum_probs=152.6
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
||||||+||+|.+++.+.+.+++..++.|+.||+.||.|||++| |+||||||+|||++ ..|.+||+|||++......
T Consensus 78 lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~g--ivHrDLkp~NIli~-~~~~vkL~DfG~~~~~~~~ 154 (360)
T cd05627 78 LIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLG--FIHRDIKPDNLLLD-AKGHVKLSDFGLCTGLKKA 154 (360)
T ss_pred EEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEEC-CCCCEEEeeccCCcccccc
Confidence 68999999999999998889999999999999999999999999 99999999999997 5689999999998643211
Q ss_pred -------------------------------------CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCC
Q 008504 81 -------------------------------------TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEY 122 (563)
Q Consensus 81 -------------------------------------~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~ 122 (563)
.....+||+.|+|||++.+ .++.++|||||||++|+|++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence 0123479999999998864 58999999999999999999999
Q ss_pred CCCCCCCHHHHHHHHhcCCCCCccc--cCCChhHHHHHHHhcCCCCCCC---CHHHHHcCccccccccCCCCC
Q 008504 123 PYSECKNPAQIFKKVTSGIKPASLA--KVNDPQIKGFIEKCLVPASERL---SAKDLLKDPFLQVENQKEPIC 190 (563)
Q Consensus 123 Pf~~~~~~~~i~~~i~~~~~p~~l~--~~~s~~l~~LI~kcL~dP~kRp---Sa~ELLkHpff~~~~~~~~~~ 190 (563)
||.. ..+...+..+........++ ...++.+++||.+|+.+|.+|+ ++.++++||||+..++.....
T Consensus 235 Pf~~-~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~p~~R~~~~~~~ei~~hp~f~~~~~~~~~~ 306 (360)
T cd05627 235 PFCS-ETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCTDSENRIGSNGVEEIKSHPFFEGVDWGHIRE 306 (360)
T ss_pred CCCC-CCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhccChhhcCCCCCHHHHhcCCCCCCCCHHHHhc
Confidence 9986 45555655555432221222 2357899999999888888888 589999999999887765433
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=275.82 Aligned_cols=180 Identities=29% Similarity=0.521 Sum_probs=147.8
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSH-NPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~-gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
+||||+++|+|.+++...+.+++..+..++.|++.||.|||+. + |+||||||+|||++ ..|.+||+|||++.....
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~--ivH~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~ 156 (331)
T cd06649 80 ICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQ--IMHRDVKPSNILVN-SRGEIKLCDFGVSGQLID 156 (331)
T ss_pred EEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCC--EEcCCCChhhEEEc-CCCcEEEccCcccccccc
Confidence 6899999999999999888899999999999999999999985 6 99999999999998 557999999999976655
Q ss_pred CCCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHH---------------------
Q 008504 80 PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKV--------------------- 137 (563)
Q Consensus 80 ~~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i--------------------- 137 (563)
.......|++.|+|||++.+ .++.++|||||||++|+|++|+.||.... ...+...+
T Consensus 157 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (331)
T cd06649 157 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPD-AKELEAIFGRPVVDGEEGEPHSISPRPRP 235 (331)
T ss_pred cccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHhcccccccccCCccccCccccc
Confidence 44555679999999998865 48999999999999999999999996532 22221111
Q ss_pred -------------------------hcCCCCCccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCccccccc
Q 008504 138 -------------------------TSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 184 (563)
Q Consensus 138 -------------------------~~~~~p~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~ 184 (563)
.....+.......++++++||.+||. +|.+|||+.++|+||||+...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 308 (331)
T cd06649 236 PGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSE 308 (331)
T ss_pred ccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhcc
Confidence 11111222223457889999999998 899999999999999998644
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-32 Score=280.17 Aligned_cols=180 Identities=26% Similarity=0.489 Sum_probs=152.2
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHS-HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs-~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
|||||+++|+|..++.+.+.+++..++.++.||+.||.|||+ +| |+||||||+|||++ .+|.+||+|||++.....
T Consensus 72 lv~E~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~--ivHrDikp~NIll~-~~~~~kL~Dfg~~~~~~~ 148 (325)
T cd05594 72 FVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLD-KDGHIKITDFGLCKEGIK 148 (325)
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCCCCeEEEC-CCCCEEEecCCCCeecCC
Confidence 699999999999999988889999999999999999999997 78 99999999999998 557999999999864322
Q ss_pred --CCCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHH
Q 008504 80 --PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKG 156 (563)
Q Consensus 80 --~~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~ 156 (563)
.......|++.|+|||++.+ .++.++|||||||++|+|+||..||.. .+.......+..... .++...++.+.+
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~ 225 (325)
T cd05594 149 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILMEEI--RFPRTLSPEAKS 225 (325)
T ss_pred CCcccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCC-CCHHHHHHHHhcCCC--CCCCCCCHHHHH
Confidence 22334579999999998864 589999999999999999999999976 344555555544322 345567889999
Q ss_pred HHHHhcC-CCCCCC-----CHHHHHcCccccccccC
Q 008504 157 FIEKCLV-PASERL-----SAKDLLKDPFLQVENQK 186 (563)
Q Consensus 157 LI~kcL~-dP~kRp-----Sa~ELLkHpff~~~~~~ 186 (563)
||.+||. +|.+|+ ++.++++||||....+.
T Consensus 226 li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~ 261 (325)
T cd05594 226 LLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQ 261 (325)
T ss_pred HHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCCCHH
Confidence 9999997 899997 99999999999876544
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=276.34 Aligned_cols=180 Identities=27% Similarity=0.515 Sum_probs=152.7
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC-
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ- 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~- 79 (563)
|||||++||+|.+++...+.+++..++.|+.||+.||.|||++| |+||||||+|||++ .++.+||+|||++.....
T Consensus 73 lv~e~~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dlkp~Nill~-~~~~~kL~Dfg~a~~~~~~ 149 (316)
T cd05592 73 FVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKG--IIYRDLKLDNVLLD-KDGHIKIADFGMCKENMNG 149 (316)
T ss_pred EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHeEEC-CCCCEEEccCcCCeECCCC
Confidence 68999999999999998889999999999999999999999999 99999999999997 557999999999865422
Q ss_pred -CCCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHHH
Q 008504 80 -PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 157 (563)
Q Consensus 80 -~~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~L 157 (563)
.......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.. .+...++..+..... .++...+..+++|
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~-~~~~~~~~~i~~~~~--~~~~~~~~~~~~l 226 (316)
T cd05592 150 EGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHG-EDEDELFDSILNDRP--HFPRWISKEAKDC 226 (316)
T ss_pred CCccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHHHHHH
Confidence 23344579999999998865 489999999999999999999999987 445556665554332 3456678899999
Q ss_pred HHHhcC-CCCCCCCH-HHHHcCccccccccC
Q 008504 158 IEKCLV-PASERLSA-KDLLKDPFLQVENQK 186 (563)
Q Consensus 158 I~kcL~-dP~kRpSa-~ELLkHpff~~~~~~ 186 (563)
|.+||. +|.+||++ .++++||||....+.
T Consensus 227 l~~~l~~~P~~R~~~~~~l~~h~~~~~~~~~ 257 (316)
T cd05592 227 LSKLFERDPTKRLGVDGDIRQHPFFRGIDWE 257 (316)
T ss_pred HHHHccCCHHHcCCChHHHHcCcccCCCCHH
Confidence 999997 89999986 589999999876554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=277.49 Aligned_cols=181 Identities=26% Similarity=0.429 Sum_probs=153.3
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC-
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ- 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~- 79 (563)
|||||+.+|+|..++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ ++|.+||+|||++.....
T Consensus 73 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~g--ivH~dikp~NIll~-~~~~~kl~Dfg~~~~~~~~ 149 (323)
T cd05575 73 FVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLN--IIYRDLKPENILLD-SQGHVVLTDFGLCKEGIEH 149 (323)
T ss_pred EEEcCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEEC-CCCcEEEeccCCCcccccC
Confidence 68999999999999998889999999999999999999999999 99999999999998 568999999999864322
Q ss_pred -CCCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHHH
Q 008504 80 -PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 157 (563)
Q Consensus 80 -~~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~L 157 (563)
.......|++.|+|||++.+ .++.++|||||||++|+|++|..||.. .+...++..+..+.. .++...++.+.++
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~--~~~~~~~~~~~~l 226 (323)
T cd05575 150 SKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYS-RDTAEMYDNILNKPL--RLKPNISVSARHL 226 (323)
T ss_pred CCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHHHHHH
Confidence 22334579999999998865 489999999999999999999999986 455666666655432 2344558899999
Q ss_pred HHHhcC-CCCCCCCH----HHHHcCccccccccCC
Q 008504 158 IEKCLV-PASERLSA----KDLLKDPFLQVENQKE 187 (563)
Q Consensus 158 I~kcL~-dP~kRpSa----~ELLkHpff~~~~~~~ 187 (563)
|.+||. +|.+||++ .++++||||....+..
T Consensus 227 i~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~~~~ 261 (323)
T cd05575 227 LEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINWDD 261 (323)
T ss_pred HHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCCHHH
Confidence 999997 89999987 6999999998766543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=280.80 Aligned_cols=182 Identities=24% Similarity=0.486 Sum_probs=150.9
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
||||||++|+|.+++.+.+.+++..++.|+.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++..+...
T Consensus 78 lv~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~-~~~~~kl~Dfg~~~~~~~~ 154 (364)
T cd05599 78 LIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLG--YIHRDIKPDNLLLD-AKGHIKLSDFGLCTGLKKS 154 (364)
T ss_pred EEECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEEC-CCCCEEEeecccceecccc
Confidence 68999999999999998888999999999999999999999999 99999999999998 5689999999998643211
Q ss_pred ----------------------------------------CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhh
Q 008504 81 ----------------------------------------TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT 119 (563)
Q Consensus 81 ----------------------------------------~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlT 119 (563)
.....+||+.|+|||++.+ .++.++|||||||++|+|++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 234 (364)
T cd05599 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234 (364)
T ss_pred ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence 0113469999999998864 58999999999999999999
Q ss_pred cCCCCCCCCCHHHHHHHHhcCCCCCccc--cCCChhHHHHHHHhcCCCCCCCC---HHHHHcCccccccccC
Q 008504 120 FEYPYSECKNPAQIFKKVTSGIKPASLA--KVNDPQIKGFIEKCLVPASERLS---AKDLLKDPFLQVENQK 186 (563)
Q Consensus 120 G~~Pf~~~~~~~~i~~~i~~~~~p~~l~--~~~s~~l~~LI~kcL~dP~kRpS---a~ELLkHpff~~~~~~ 186 (563)
|..||... +.......+.........+ ...++.+++||.+||.+|.+|++ +.+++.||||+...+.
T Consensus 235 G~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~~p~~R~~~~~~~~ll~h~~~~~~~~~ 305 (364)
T cd05599 235 GYPPFCSD-NPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCCEAERRLGNNGVNEIKSHPFFKGVDWE 305 (364)
T ss_pred CCCCCCCC-CHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHccCHhhcCCCCCHHHHhcCCCcCCCCHH
Confidence 99999873 4555555555433222222 24578999999999999999997 9999999999876554
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=271.68 Aligned_cols=185 Identities=25% Similarity=0.412 Sum_probs=150.2
Q ss_pred CEeccCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhcc
Q 008504 1 MITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~--~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~ 78 (563)
+|||||++|+|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++....
T Consensus 77 lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nill~-~~~~~kl~Dfg~~~~~~ 153 (285)
T cd05631 77 LVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER--IVYRDLKPENILLD-DRGHIRISDLGLAVQIP 153 (285)
T ss_pred EEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEEC-CCCCEEEeeCCCcEEcC
Confidence 589999999999888643 46999999999999999999999999 99999999999997 55799999999987654
Q ss_pred CC-CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCH---HHHHHHHhcCCCCCccccCCChh
Q 008504 79 QP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNP---AQIFKKVTSGIKPASLAKVNDPQ 153 (563)
Q Consensus 79 ~~-~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~---~~i~~~i~~~~~p~~l~~~~s~~ 153 (563)
.. ......|++.|+|||++.+ .++.++|||||||++|+|++|+.||...... ..+...+... ....+...++.
T Consensus 154 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~s~~ 231 (285)
T cd05631 154 EGETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKED--QEEYSEKFSED 231 (285)
T ss_pred CCCeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcc--cccCCccCCHH
Confidence 32 2234578999999998864 5899999999999999999999999864322 2222222222 22344556889
Q ss_pred HHHHHHHhcC-CCCCCCC-----HHHHHcCccccccccCCCCC
Q 008504 154 IKGFIEKCLV-PASERLS-----AKDLLKDPFLQVENQKEPIC 190 (563)
Q Consensus 154 l~~LI~kcL~-dP~kRpS-----a~ELLkHpff~~~~~~~~~~ 190 (563)
+.+||.+||. +|.+||+ +.++++||||+..++.....
T Consensus 232 ~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~~~~~ 274 (285)
T cd05631 232 AKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKRLEA 274 (285)
T ss_pred HHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCHHHHHh
Confidence 9999999997 8999997 99999999999877665433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-32 Score=296.87 Aligned_cols=192 Identities=27% Similarity=0.486 Sum_probs=165.7
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhcc--
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ-- 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~-- 78 (563)
+||||+.||++..++ +.+.+++..++.|+..|+.||.|||++| |||||||.+|||++ ..|.+||+|||+++...
T Consensus 446 fvmey~~Ggdm~~~~-~~~~F~e~rarfyaAev~l~L~fLH~~~--IIYRDlKLdNiLLD-~eGh~kiADFGlcKe~m~~ 521 (694)
T KOG0694|consen 446 FVMEYVAGGDLMHHI-HTDVFSEPRARFYAAEVVLGLQFLHENG--IIYRDLKLDNLLLD-TEGHVKIADFGLCKEGMGQ 521 (694)
T ss_pred EEEEecCCCcEEEEE-ecccccHHHHHHHHHHHHHHHHHHHhcC--ceeeecchhheEEc-ccCcEEecccccccccCCC
Confidence 699999999955543 3467999999999999999999999999 99999999999998 56899999999997543
Q ss_pred CCCCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHHH
Q 008504 79 QPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 157 (563)
Q Consensus 79 ~~~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~L 157 (563)
...+.+++|||.|||||++.+ .|+.++|+|+|||+||||+.|+.||.+ .+.++++..|..... ..|...+.++..+
T Consensus 522 g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~g-ddEee~FdsI~~d~~--~yP~~ls~ea~~i 598 (694)
T KOG0694|consen 522 GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPG-DDEEEVFDSIVNDEV--RYPRFLSKEAIAI 598 (694)
T ss_pred CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHhcCCC--CCCCcccHHHHHH
Confidence 345678999999999999975 599999999999999999999999998 677888887776543 3567788999999
Q ss_pred HHHhcC-CCCCCCC-----HHHHHcCccccccccCCCCCCCCCCchhh
Q 008504 158 IEKCLV-PASERLS-----AKDLLKDPFLQVENQKEPICDPLKLPIQS 199 (563)
Q Consensus 158 I~kcL~-dP~kRpS-----a~ELLkHpff~~~~~~~~~~~~l~~p~~~ 199 (563)
++++|. +|.+|.. +.+|.+||||+..+|.......++.|..+
T Consensus 599 l~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~r~i~PPf~P 646 (694)
T KOG0694|consen 599 MRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLNRRIKPPFVP 646 (694)
T ss_pred HHHHhccCcccccCCCCCCchhhhhCCccccCCHHHHhhccCCCCCCc
Confidence 999997 8999985 68999999999999988766666665443
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-32 Score=279.23 Aligned_cols=180 Identities=26% Similarity=0.423 Sum_probs=152.1
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhcc--
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ-- 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~-- 78 (563)
|||||+.+|+|..++.+.+.+++..++.++.||+.||+|||++| |+||||||+|||++ .++.+||+|||++....
T Consensus 73 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~--ivHrDlkp~Nili~-~~~~~kl~Dfg~a~~~~~~ 149 (330)
T cd05586 73 LVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYD--IVYRDLKPENILLD-ATGHIALCDFGLSKANLTD 149 (330)
T ss_pred EEEcCCCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEEC-CCCCEEEecCCcCcCCCCC
Confidence 68999999999999998889999999999999999999999999 99999999999998 55799999999986432
Q ss_pred CCCCccccCCCCccCcccccc--cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHH
Q 008504 79 QPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKG 156 (563)
Q Consensus 79 ~~~~~~~~Gtp~Y~APEvl~~--~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~ 156 (563)
.......+||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+..+.++.+..+.... .....++.+++
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~-~~~~~~~~~i~~~~~~~-~~~~~~~~~~~ 227 (330)
T cd05586 150 NKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYA-EDTQQMYRNIAFGKVRF-PKNVLSDEGRQ 227 (330)
T ss_pred CCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCC-CCHHHHHHHHHcCCCCC-CCccCCHHHHH
Confidence 223345679999999998854 478999999999999999999999976 45566666666553322 22346789999
Q ss_pred HHHHhcC-CCCCCC----CHHHHHcCcccccccc
Q 008504 157 FIEKCLV-PASERL----SAKDLLKDPFLQVENQ 185 (563)
Q Consensus 157 LI~kcL~-dP~kRp----Sa~ELLkHpff~~~~~ 185 (563)
||.+||. +|.+|| ++.++++||||....+
T Consensus 228 li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~~ 261 (330)
T cd05586 228 FVKGLLNRNPQHRLGAHRDAVELKEHPFFADIDW 261 (330)
T ss_pred HHHHHcCCCHHHCCCCCCCHHHHhcCccccCCCH
Confidence 9999997 899998 7999999999986554
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=275.30 Aligned_cols=180 Identities=28% Similarity=0.516 Sum_probs=152.9
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhcc--
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ-- 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~-- 78 (563)
|||||+++|+|.+++.....+++..++.++.||+.||.|||++| |+||||||+|||++ ..+.+||+|||++....
T Consensus 73 lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~--ivHrdikp~Nil~~-~~~~~kl~Dfg~~~~~~~~ 149 (316)
T cd05619 73 FVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG--IVYRDLKLDNILLD-TDGHIKIADFGMCKENMLG 149 (316)
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEEC-CCCCEEEccCCcceECCCC
Confidence 68999999999999998888999999999999999999999999 99999999999998 45799999999986432
Q ss_pred CCCCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHHH
Q 008504 79 QPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 157 (563)
Q Consensus 79 ~~~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~L 157 (563)
........||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+.......+..... ..+...+..+++|
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~-~~~~~~~~~i~~~~~--~~~~~~~~~~~~l 226 (316)
T cd05619 150 DAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHG-HDEEELFQSIRMDNP--CYPRWLTREAKDI 226 (316)
T ss_pred CCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCC--CCCccCCHHHHHH
Confidence 223345678999999998865 589999999999999999999999986 445566665554432 2445678899999
Q ss_pred HHHhcC-CCCCCCCHH-HHHcCccccccccC
Q 008504 158 IEKCLV-PASERLSAK-DLLKDPFLQVENQK 186 (563)
Q Consensus 158 I~kcL~-dP~kRpSa~-ELLkHpff~~~~~~ 186 (563)
|.+||. +|.+||++. ++++||||....+.
T Consensus 227 i~~~l~~~P~~R~~~~~~l~~h~~~~~~~~~ 257 (316)
T cd05619 227 LVKLFVREPERRLGVKGDIRQHPFFREIDWS 257 (316)
T ss_pred HHHHhccCHhhcCCChHHHHcCcccCCCCHH
Confidence 999997 899999996 89999999876654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=276.82 Aligned_cols=181 Identities=23% Similarity=0.435 Sum_probs=149.7
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhcc--
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ-- 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~-- 78 (563)
||||||++|+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ ..+.+||+|||++....
T Consensus 73 lv~e~~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nili~-~~~~~kL~Dfg~~~~~~~~ 149 (329)
T cd05588 73 FVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERG--IIYRDLKLDNVLLD-AEGHIKLTDYGMCKEGIRP 149 (329)
T ss_pred EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEEC-CCCCEEECcCccccccccC
Confidence 68999999999999988889999999999999999999999999 99999999999998 55799999999986422
Q ss_pred CCCCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCC--------CHHHHHHHHhcCCCCCccccC
Q 008504 79 QPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECK--------NPAQIFKKVTSGIKPASLAKV 149 (563)
Q Consensus 79 ~~~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~--------~~~~i~~~i~~~~~p~~l~~~ 149 (563)
.......+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.... ....+.+.+.... ..++..
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~p~~ 227 (329)
T cd05588 150 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ--IRIPRS 227 (329)
T ss_pred CCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC--CCCCCC
Confidence 222345679999999998865 48999999999999999999999996311 1122334444332 234566
Q ss_pred CChhHHHHHHHhcC-CCCCCCC------HHHHHcCccccccccC
Q 008504 150 NDPQIKGFIEKCLV-PASERLS------AKDLLKDPFLQVENQK 186 (563)
Q Consensus 150 ~s~~l~~LI~kcL~-dP~kRpS------a~ELLkHpff~~~~~~ 186 (563)
.++.+.++|.+||. +|.+|++ +.++++||||....+.
T Consensus 228 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~~ 271 (329)
T cd05588 228 LSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWD 271 (329)
T ss_pred CCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCHH
Confidence 78899999999997 8999987 7999999999765543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=274.19 Aligned_cols=180 Identities=25% Similarity=0.478 Sum_probs=153.2
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhcc--
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ-- 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~-- 78 (563)
+||||+++|+|..++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ ..+.+||+|||++....
T Consensus 73 lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~ 149 (318)
T cd05570 73 FVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERG--IIYRDLKLDNVLLD-SEGHIKIADFGMCKEGILG 149 (318)
T ss_pred EEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEccCCCHHHeEEC-CCCcEEecccCCCeecCcC
Confidence 58999999999999998889999999999999999999999999 99999999999998 55799999999986432
Q ss_pred CCCCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHHH
Q 008504 79 QPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 157 (563)
Q Consensus 79 ~~~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~L 157 (563)
.......+|++.|+|||++.+ .++.++|||||||++|+|++|+.||.. .+.......+..... ..+...++.+++|
T Consensus 150 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~-~~~~~~~~~i~~~~~--~~~~~~~~~~~~l 226 (318)
T cd05570 150 GVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEG-DDEDELFQSILEDEV--RYPRWLSKEAKSI 226 (318)
T ss_pred CCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCC-CCHHHHHHHHHcCCC--CCCCcCCHHHHHH
Confidence 222334578999999998865 589999999999999999999999976 445555555554432 2455678899999
Q ss_pred HHHhcC-CCCCCCCH-----HHHHcCccccccccC
Q 008504 158 IEKCLV-PASERLSA-----KDLLKDPFLQVENQK 186 (563)
Q Consensus 158 I~kcL~-dP~kRpSa-----~ELLkHpff~~~~~~ 186 (563)
|.+||. +|.+||++ .+++.||||+...+.
T Consensus 227 i~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~~~~ 261 (318)
T cd05570 227 LKSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDWD 261 (318)
T ss_pred HHHHccCCHHHcCCCCCCCHHHHhcCCCcCCCCHH
Confidence 999997 89999999 999999999876553
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=274.65 Aligned_cols=181 Identities=28% Similarity=0.423 Sum_probs=153.1
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC-
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ- 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~- 79 (563)
+||||+++|+|.+++.+.+.+.+..++.++.||+.||.|||++| |+||||||+|||++ ..|.+||+|||++.....
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~ 153 (323)
T cd05584 77 LILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQG--IIYRDLKPENILLD-AQGHVKLTDFGLCKESIHE 153 (323)
T ss_pred EEEeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEC-CCCCEEEeeCcCCeecccC
Confidence 58999999999999998888999999999999999999999999 99999999999998 558999999999864322
Q ss_pred -CCCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHHH
Q 008504 80 -PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 157 (563)
Q Consensus 80 -~~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~L 157 (563)
.......|++.|+|||++.+ .++.++|||||||++|+|++|+.||.. .+.......+..+.. .++...++.+++|
T Consensus 154 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~-~~~~~~~~~~~~~~~--~~~~~~~~~~~~l 230 (323)
T cd05584 154 GTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTA-ENRKKTIDKILKGKL--NLPPYLTPEARDL 230 (323)
T ss_pred CCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHHHHHH
Confidence 22334579999999998864 488999999999999999999999987 344455555555433 3455678899999
Q ss_pred HHHhcC-CCCCCC-----CHHHHHcCccccccccCC
Q 008504 158 IEKCLV-PASERL-----SAKDLLKDPFLQVENQKE 187 (563)
Q Consensus 158 I~kcL~-dP~kRp-----Sa~ELLkHpff~~~~~~~ 187 (563)
|.+||. +|.+|| ++.+++.||||....+..
T Consensus 231 i~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~~~~ 266 (323)
T cd05584 231 LKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNWDD 266 (323)
T ss_pred HHHHcccCHhHcCCCCCCCHHHHhcCCCcCCCCHHH
Confidence 999997 899999 899999999998765543
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=268.59 Aligned_cols=183 Identities=28% Similarity=0.499 Sum_probs=148.4
Q ss_pred CEeccCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhh
Q 008504 1 MITELFTSGNLRQYRKK----HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 76 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k----~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~ 76 (563)
|||||+++|+|..++.. .+.+++..++.++.||+.||.|||++| |+||||||+||+++ +.+.+||+|||++..
T Consensus 70 lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~-~~~~~~l~dfg~~~~ 146 (280)
T cd05608 70 LVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR--IIYRDLKPENVLLD-NDGNVRISDLGLAVE 146 (280)
T ss_pred EEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCCEEEeeCcccee
Confidence 58999999999988743 356999999999999999999999999 99999999999997 567999999999865
Q ss_pred ccCC--CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCH---HHHHHHHhcCCCCCccccCC
Q 008504 77 MQQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNP---AQIFKKVTSGIKPASLAKVN 150 (563)
Q Consensus 77 ~~~~--~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~---~~i~~~i~~~~~p~~l~~~~ 150 (563)
.... ......|++.|+|||++.+ .++.++|||||||++|+|++|+.||...... ......+... +...+...
T Consensus 147 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 224 (280)
T cd05608 147 LKDGQSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILND--SVTYPDKF 224 (280)
T ss_pred cCCCCccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhccc--CCCCcccC
Confidence 5432 2234578999999998864 5889999999999999999999999753321 2222222222 22344567
Q ss_pred ChhHHHHHHHhcC-CCCCCC-----CHHHHHcCccccccccCCC
Q 008504 151 DPQIKGFIEKCLV-PASERL-----SAKDLLKDPFLQVENQKEP 188 (563)
Q Consensus 151 s~~l~~LI~kcL~-dP~kRp-----Sa~ELLkHpff~~~~~~~~ 188 (563)
++.+++|+.+||. +|.+|| ++.++++||||+...+...
T Consensus 225 ~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~~~ 268 (280)
T cd05608 225 SPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQL 268 (280)
T ss_pred CHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCHhHH
Confidence 8899999999997 899999 8899999999987665543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=276.73 Aligned_cols=183 Identities=21% Similarity=0.403 Sum_probs=151.3
Q ss_pred CEeccCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~-~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
|||||+++|+|.+++.+. +.+++..++.++.||+.||.|||++| |+||||||+|||++ ..|.+||+|||++.....
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--i~H~Dlkp~NIll~-~~~~~kL~Dfg~a~~~~~ 154 (330)
T cd05601 78 LVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG--YVHRDIKPENVLID-RTGHIKLADFGSAARLTA 154 (330)
T ss_pred EEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEcccCchHheEEC-CCCCEEeccCCCCeECCC
Confidence 689999999999999876 67999999999999999999999999 99999999999998 568999999999976543
Q ss_pred CC---CccccCCCCccCccccc-------ccCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccc--
Q 008504 80 PT---ARSVIGTPEFMAPELYE-------EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLA-- 147 (563)
Q Consensus 80 ~~---~~~~~Gtp~Y~APEvl~-------~~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~-- 147 (563)
.. .....||+.|+|||++. ..++.++|||||||++|+|++|+.||... .....+..+.........+
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~ 233 (330)
T cd05601 155 NKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEG-TSAKTYNNIMNFQRFLKFPED 233 (330)
T ss_pred CCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCC-CHHHHHHHHHcCCCccCCCCC
Confidence 22 22347899999999875 24788999999999999999999999874 3444555554433222222
Q ss_pred cCCChhHHHHHHHhcCCCCCCCCHHHHHcCccccccccCC
Q 008504 148 KVNDPQIKGFIEKCLVPASERLSAKDLLKDPFLQVENQKE 187 (563)
Q Consensus 148 ~~~s~~l~~LI~kcL~dP~kRpSa~ELLkHpff~~~~~~~ 187 (563)
...++.+++||.+||.+|.+||++.+++.||||...++..
T Consensus 234 ~~~~~~~~~li~~ll~~p~~R~t~~~l~~h~~~~~~~~~~ 273 (330)
T cd05601 234 PKVSSDFLDLIQSLLCGQKERLGYEGLCCHPFFSKIDWNN 273 (330)
T ss_pred CCCCHHHHHHHHHHccChhhCCCHHHHhCCCCcCCCCHHH
Confidence 2457889999999999999999999999999998765543
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-32 Score=287.30 Aligned_cols=177 Identities=33% Similarity=0.537 Sum_probs=154.3
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
++||||.||++.+.++..+.+.+..+.-++++++.||.|||+++ .+|||||+.|||+..+ |.|||+|||++..+...
T Consensus 88 iiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~--kiHrDIKaanil~s~~-g~vkl~DfgVa~ql~~~ 164 (467)
T KOG0201|consen 88 IIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEK--KIHRDIKAANILLSES-GDVKLADFGVAGQLTNT 164 (467)
T ss_pred HHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcc--eecccccccceeEecc-CcEEEEecceeeeeech
Confidence 57999999999999998887899999999999999999999999 9999999999999855 99999999999776543
Q ss_pred --CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHHH
Q 008504 81 --TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 157 (563)
Q Consensus 81 --~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~L 157 (563)
...+++|||.|||||++.+ .|+.++||||||++++||++|.+||..+.. ......|. ...|+.+...+++.+++|
T Consensus 165 ~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP-mrvlflIp-k~~PP~L~~~~S~~~kEF 242 (467)
T KOG0201|consen 165 VKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP-MRVLFLIP-KSAPPRLDGDFSPPFKEF 242 (467)
T ss_pred hhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc-ceEEEecc-CCCCCccccccCHHHHHH
Confidence 3467899999999999986 699999999999999999999999987543 22222222 334556667889999999
Q ss_pred HHHhcC-CCCCCCCHHHHHcCccccc
Q 008504 158 IEKCLV-PASERLSAKDLLKDPFLQV 182 (563)
Q Consensus 158 I~kcL~-dP~kRpSa~ELLkHpff~~ 182 (563)
|..||. +|+.||+|.+||+|+|++.
T Consensus 243 V~~CL~k~P~~RpsA~~LLKh~FIk~ 268 (467)
T KOG0201|consen 243 VEACLDKNPEFRPSAKELLKHKFIKR 268 (467)
T ss_pred HHHHhhcCcccCcCHHHHhhhHHHHh
Confidence 999997 8999999999999999987
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=267.01 Aligned_cols=182 Identities=27% Similarity=0.492 Sum_probs=150.5
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
+||||+++|+|.+++..++.+++..++.++.||+.||.|||+++ |+||||||+||+++ .++.++|+|||++......
T Consensus 74 lv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dikp~Nil~~-~~~~~~l~dfg~~~~~~~~ 150 (279)
T cd05633 74 FILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRF--VVYRDLKPANILLD-EHGHVRISDLGLACDFSKK 150 (279)
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cCCCCCCHHHEEEC-CCCCEEEccCCcceecccc
Confidence 58999999999999998888999999999999999999999999 99999999999997 5579999999998655444
Q ss_pred CCccccCCCCccCcccccc--cCCchhhHHHhHHHHHHHhhcCCCCCCCCC--HHHHHHHHhcCCCCCccccCCChhHHH
Q 008504 81 TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKN--PAQIFKKVTSGIKPASLAKVNDPQIKG 156 (563)
Q Consensus 81 ~~~~~~Gtp~Y~APEvl~~--~ys~ksDIwSLGviLyELlTG~~Pf~~~~~--~~~i~~~i~~~~~p~~l~~~~s~~l~~ 156 (563)
......|++.|+|||.+.. .++.++|||||||++|+|++|..||..... ...+.. ... ..+..++...++.+++
T Consensus 151 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~ 228 (279)
T cd05633 151 KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR-MTL-TVNVELPDSFSPELKS 228 (279)
T ss_pred CccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHH-Hhh-cCCcCCccccCHHHHH
Confidence 4444578999999998753 478999999999999999999999975322 222211 111 1233445567889999
Q ss_pred HHHHhcC-CCCCCC-----CHHHHHcCccccccccCC
Q 008504 157 FIEKCLV-PASERL-----SAKDLLKDPFLQVENQKE 187 (563)
Q Consensus 157 LI~kcL~-dP~kRp-----Sa~ELLkHpff~~~~~~~ 187 (563)
+|.+||. +|.+|+ ++.++++||||+..++..
T Consensus 229 li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~~~ 265 (279)
T cd05633 229 LLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQ 265 (279)
T ss_pred HHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCCHhH
Confidence 9999997 899999 699999999999866544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-31 Score=264.05 Aligned_cols=177 Identities=19% Similarity=0.348 Sum_probs=140.9
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
|||||++++.|..+......+++..++.++.||+.||.|||++| |+||||||+||+++ ..+.+||+|||++......
T Consensus 77 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~ 153 (287)
T cd07848 77 LVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKND--IVHRDIKPENLLIS-HNDVLKLCDFGFARNLSEG 153 (287)
T ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEc-CCCcEEEeeccCccccccc
Confidence 68999999888777666667999999999999999999999999 99999999999997 5579999999999765432
Q ss_pred ---CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhc-CC--------------
Q 008504 81 ---TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS-GI-------------- 141 (563)
Q Consensus 81 ---~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~-~~-------------- 141 (563)
......|++.|+|||++.+ .++.++|||||||++|+|++|+.||............... +.
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07848 154 SNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR 233 (287)
T ss_pred ccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence 1234578999999998864 5899999999999999999999999864433322211110 00
Q ss_pred -----CCC---------ccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCccc
Q 008504 142 -----KPA---------SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 180 (563)
Q Consensus 142 -----~p~---------~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff 180 (563)
.+. ......++.+++||.+||. +|.+|||+.++|+||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 000 0112356789999999998 89999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=273.53 Aligned_cols=181 Identities=24% Similarity=0.438 Sum_probs=150.7
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhcc--
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ-- 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~-- 78 (563)
|||||+++|+|..++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ ..+.+||+|||++....
T Consensus 73 lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nili~-~~~~~kl~Dfg~~~~~~~~ 149 (327)
T cd05617 73 LVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERG--IIYRDLKLDNVLLD-ADGHIKLTDYGMCKEGLGP 149 (327)
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEe-CCCCEEEeccccceeccCC
Confidence 68999999999999998888999999999999999999999999 99999999999998 55799999999986432
Q ss_pred CCCCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCC------CCHHHHHHHHhcCCCCCccccCCC
Q 008504 79 QPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSEC------KNPAQIFKKVTSGIKPASLAKVND 151 (563)
Q Consensus 79 ~~~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~------~~~~~i~~~i~~~~~p~~l~~~~s 151 (563)
.......+||+.|+|||++.+ .++.++|||||||++|+|++|..||... .........+... +..++...+
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~p~~~~ 227 (327)
T cd05617 150 GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK--PIRIPRFLS 227 (327)
T ss_pred CCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC--CCCCCCCCC
Confidence 222345679999999998864 5899999999999999999999999532 1223344444333 333566678
Q ss_pred hhHHHHHHHhcC-CCCCCCC------HHHHHcCccccccccC
Q 008504 152 PQIKGFIEKCLV-PASERLS------AKDLLKDPFLQVENQK 186 (563)
Q Consensus 152 ~~l~~LI~kcL~-dP~kRpS------a~ELLkHpff~~~~~~ 186 (563)
+.+.++|.+||. +|.+|++ +.+++.||||....+.
T Consensus 228 ~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~~ 269 (327)
T cd05617 228 VKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWD 269 (327)
T ss_pred HHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCHH
Confidence 899999999997 8999998 5799999999876654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=279.21 Aligned_cols=182 Identities=23% Similarity=0.443 Sum_probs=148.0
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
|||||+++|+|.+++.+.+.+++..++.|+.||+.||.|||++| |+||||||+|||++ ..|.+||+|||+++.....
T Consensus 78 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~g--ivHrDlkp~NIll~-~~~~~kl~DfGla~~~~~~ 154 (377)
T cd05629 78 LIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLG--FIHRDIKPDNILID-RGGHIKLSDFGLSTGFHKQ 154 (377)
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEC-CCCCEEEeecccccccccc
Confidence 68999999999999998889999999999999999999999999 99999999999997 5689999999998532110
Q ss_pred -------------------------------------------------CCccccCCCCccCcccccc-cCCchhhHHHh
Q 008504 81 -------------------------------------------------TARSVIGTPEFMAPELYEE-EYNELVDIYSF 110 (563)
Q Consensus 81 -------------------------------------------------~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSL 110 (563)
.....+||+.|+|||++.+ .++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 234 (377)
T cd05629 155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234 (377)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence 0012469999999998864 58999999999
Q ss_pred HHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCcccc--CCChhHHHHHHHhcCCCCC---CCCHHHHHcCcccccccc
Q 008504 111 GMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAK--VNDPQIKGFIEKCLVPASE---RLSAKDLLKDPFLQVENQ 185 (563)
Q Consensus 111 GviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~--~~s~~l~~LI~kcL~dP~k---RpSa~ELLkHpff~~~~~ 185 (563)
||++|+|++|..||.. ......+..+........++. ..++.+++||.+||.+|.+ |+++.+++.||||+..++
T Consensus 235 Gvil~elltG~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~~~~~r~~r~~~~~~l~hp~~~~~~~ 313 (377)
T cd05629 235 GAIMFECLIGWPPFCS-ENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLITNAENRLGRGGAHEIKSHPFFRGVDW 313 (377)
T ss_pred chhhhhhhcCCCCCCC-CCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhcCHhhcCCCCCHHHHhcCCCcCCCCH
Confidence 9999999999999976 344555555554322222222 3578999999999986554 569999999999987654
Q ss_pred C
Q 008504 186 K 186 (563)
Q Consensus 186 ~ 186 (563)
.
T Consensus 314 ~ 314 (377)
T cd05629 314 D 314 (377)
T ss_pred H
Confidence 3
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-31 Score=269.45 Aligned_cols=181 Identities=27% Similarity=0.403 Sum_probs=142.7
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
+|||||. ++|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++ ..|.+||+|||++......
T Consensus 81 lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~-~~~~~kL~Dfg~~~~~~~~ 156 (338)
T cd07859 81 VVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTAN--VFHRDLKPKNILAN-ADCKLKICDFGLARVAFND 156 (338)
T ss_pred EEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEC-CCCcEEEccCccccccccc
Confidence 5899995 699999998888999999999999999999999999 99999999999998 5689999999998654321
Q ss_pred -----CCccccCCCCccCcccccc---cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHH--------------HHHh
Q 008504 81 -----TARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIF--------------KKVT 138 (563)
Q Consensus 81 -----~~~~~~Gtp~Y~APEvl~~---~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~--------------~~i~ 138 (563)
......|++.|+|||++.+ .++.++|||||||++|+|+||+.||.......... ..+.
T Consensus 157 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 236 (338)
T cd07859 157 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVR 236 (338)
T ss_pred cCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence 1134578999999998753 58999999999999999999999997643221110 0000
Q ss_pred c-----------CCCCCcc---ccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCcccccccc
Q 008504 139 S-----------GIKPASL---AKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQ 185 (563)
Q Consensus 139 ~-----------~~~p~~l---~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~~ 185 (563)
. ...+... ....++.+.+||.+||. +|.+|||+.++|+||||+....
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~ 298 (338)
T cd07859 237 NEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK 298 (338)
T ss_pred hhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence 0 0001000 11346788999999997 8999999999999999986443
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-31 Score=271.58 Aligned_cols=182 Identities=25% Similarity=0.446 Sum_probs=154.2
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC-
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ- 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~- 79 (563)
|||||+++|+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++.....
T Consensus 78 lv~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivHrDikp~Nill~-~~~~ikL~Dfg~~~~~~~~ 154 (323)
T cd05615 78 FVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRG--IIYRDLKLDNVMLD-SEGHIKIADFGMCKEHMVD 154 (323)
T ss_pred EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEEC-CCCCEEEeccccccccCCC
Confidence 58999999999999998889999999999999999999999999 99999999999998 557999999999865432
Q ss_pred -CCCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHHH
Q 008504 80 -PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 157 (563)
Q Consensus 80 -~~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~L 157 (563)
.......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.. .....+...+..... ..+...+..++++
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~l 231 (323)
T cd05615 155 GVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDG-EDEDELFQSIMEHNV--SYPKSLSKEAVSI 231 (323)
T ss_pred CccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCC--CCCccCCHHHHHH
Confidence 22334578999999998864 489999999999999999999999987 455666666655432 3455667899999
Q ss_pred HHHhcC-CCCCCCC-----HHHHHcCccccccccCCC
Q 008504 158 IEKCLV-PASERLS-----AKDLLKDPFLQVENQKEP 188 (563)
Q Consensus 158 I~kcL~-dP~kRpS-----a~ELLkHpff~~~~~~~~ 188 (563)
+.+||. +|.+|++ ..++++||||+...+...
T Consensus 232 i~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~~~~ 268 (323)
T cd05615 232 CKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDWDKL 268 (323)
T ss_pred HHHHcccCHhhCCCCCCCCHHHHhcCcccCCCCHHHH
Confidence 999997 8999997 589999999997765443
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-31 Score=278.01 Aligned_cols=181 Identities=22% Similarity=0.440 Sum_probs=150.2
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
||||||+||+|.+++... .+++..+..++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++......
T Consensus 120 lv~Ey~~gg~L~~~l~~~-~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~-~~~~~kL~DfG~~~~~~~~ 195 (370)
T cd05596 120 MVMEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLD-KSGHLKLADFGTCMKMDAN 195 (370)
T ss_pred EEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEc-CCCCEEEEeccceeeccCC
Confidence 689999999999998764 6899999999999999999999999 99999999999998 5689999999998765432
Q ss_pred ---CCccccCCCCccCcccccc-----cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCcccc--CC
Q 008504 81 ---TARSVIGTPEFMAPELYEE-----EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAK--VN 150 (563)
Q Consensus 81 ---~~~~~~Gtp~Y~APEvl~~-----~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~--~~ 150 (563)
.....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.. ......+..+........++. ..
T Consensus 196 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~ 274 (370)
T cd05596 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA-DSLVGTYSKIMDHKNSLTFPDDIEI 274 (370)
T ss_pred CcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCC-CCHHHHHHHHHcCCCcCCCCCcCCC
Confidence 2234579999999998753 378899999999999999999999987 445556666655433322332 45
Q ss_pred ChhHHHHHHHhcC-CCCC--CCCHHHHHcCccccccccC
Q 008504 151 DPQIKGFIEKCLV-PASE--RLSAKDLLKDPFLQVENQK 186 (563)
Q Consensus 151 s~~l~~LI~kcL~-dP~k--RpSa~ELLkHpff~~~~~~ 186 (563)
+..+++||.+||. +|.+ |+++.++++||||+...+.
T Consensus 275 s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~~~ 313 (370)
T cd05596 275 SKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQWT 313 (370)
T ss_pred CHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCCChh
Confidence 7899999999997 5776 9999999999999876553
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-31 Score=273.25 Aligned_cols=182 Identities=29% Similarity=0.469 Sum_probs=153.1
Q ss_pred CEeccCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhcc
Q 008504 1 MITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~--~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~ 78 (563)
||||||+||+|..+++++ +.+++..++.|+.+++.||+|||..| ||+|||||+||||. ++|+|.|+||.++....
T Consensus 154 l~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG--ivYRDLKPENILvr-edGHIMLsDFDLS~~~~ 230 (459)
T KOG0610|consen 154 LVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG--IVYRDLKPENILVR-EDGHIMLSDFDLSLRCP 230 (459)
T ss_pred EEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc--eeeccCCcceeEEe-cCCcEEeeeccccccCC
Confidence 689999999999999875 46999999999999999999999999 99999999999997 66999999998863110
Q ss_pred ----------------------------------C-C-----------------------CCccccCCCCccCcccccc-
Q 008504 79 ----------------------------------Q-P-----------------------TARSVIGTPEFMAPELYEE- 99 (563)
Q Consensus 79 ----------------------------------~-~-----------------------~~~~~~Gtp~Y~APEvl~~- 99 (563)
. . ...+++||-+|+|||++.+
T Consensus 231 ~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~ 310 (459)
T KOG0610|consen 231 VSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGE 310 (459)
T ss_pred CCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecC
Confidence 0 0 0124578999999999986
Q ss_pred cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHHHHHHhcC-CCCCCCC----HHHH
Q 008504 100 EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLS----AKDL 174 (563)
Q Consensus 100 ~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~LI~kcL~-dP~kRpS----a~EL 174 (563)
+.+.++|+|+|||++|||+.|..||.+..+.+.+...+.+...-+..+ ..+..+++||+++|+ ||.+|.. |.||
T Consensus 311 GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~-~vs~~akDLIr~LLvKdP~kRlg~~rGA~eI 389 (459)
T KOG0610|consen 311 GHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEP-EVSSAAKDLIRKLLVKDPSKRLGSKRGAAEI 389 (459)
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCC-cchhHHHHHHHHHhccChhhhhccccchHHh
Confidence 489999999999999999999999999666665555555544332222 456789999999997 8999998 9999
Q ss_pred HcCccccccccC
Q 008504 175 LKDPFLQVENQK 186 (563)
Q Consensus 175 LkHpff~~~~~~ 186 (563)
.+||||+..+|.
T Consensus 390 K~HpFF~gVnWa 401 (459)
T KOG0610|consen 390 KRHPFFEGVNWA 401 (459)
T ss_pred hcCccccCCChh
Confidence 999999999997
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-31 Score=273.69 Aligned_cols=181 Identities=23% Similarity=0.441 Sum_probs=149.3
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC-
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ- 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~- 79 (563)
|||||+++|+|..++.+.+.+++..++.++.||+.||.|||++| |+||||||+||+++ .+|.+||+|||++.....
T Consensus 73 lv~E~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dikp~Nili~-~~~~~kL~DfG~~~~~~~~ 149 (329)
T cd05618 73 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLD-SEGHIKLTDYGMCKEGLRP 149 (329)
T ss_pred EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEC-CCCCEEEeeCCccccccCC
Confidence 68999999999999998889999999999999999999999999 99999999999998 557999999999864322
Q ss_pred -CCCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCC--------CCHHHHHHHHhcCCCCCccccC
Q 008504 80 -PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSEC--------KNPAQIFKKVTSGIKPASLAKV 149 (563)
Q Consensus 80 -~~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~--------~~~~~i~~~i~~~~~p~~l~~~ 149 (563)
.......||+.|+|||++.+ .++.++|||||||++|+|++|+.||... .....+.+.+.... ..++..
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~--~~~p~~ 227 (329)
T cd05618 150 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ--IRIPRS 227 (329)
T ss_pred CCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC--CCCCCC
Confidence 22334679999999998865 4889999999999999999999999521 11222333333332 234566
Q ss_pred CChhHHHHHHHhcC-CCCCCCC------HHHHHcCccccccccC
Q 008504 150 NDPQIKGFIEKCLV-PASERLS------AKDLLKDPFLQVENQK 186 (563)
Q Consensus 150 ~s~~l~~LI~kcL~-dP~kRpS------a~ELLkHpff~~~~~~ 186 (563)
.+..+++||.+||. +|.+||+ +.++++||||+..++.
T Consensus 228 ~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~~ 271 (329)
T cd05618 228 LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWD 271 (329)
T ss_pred CCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCHH
Confidence 78899999999997 8999998 5899999999876553
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-31 Score=278.50 Aligned_cols=182 Identities=23% Similarity=0.416 Sum_probs=148.4
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
||||||++|+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ ..|.+||+|||++..+...
T Consensus 78 lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~--ivHrDlKp~NILl~-~~g~~kL~DFGla~~~~~~ 154 (382)
T cd05625 78 FVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMG--FIHRDIKPDNILID-RDGHIKLTDFGLCTGFRWT 154 (382)
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEC-CCCCEEEeECCCCcccccc
Confidence 69999999999999998888999999999999999999999999 99999999999998 5689999999997432100
Q ss_pred -------------------------------------------------CCccccCCCCccCcccccc-cCCchhhHHHh
Q 008504 81 -------------------------------------------------TARSVIGTPEFMAPELYEE-EYNELVDIYSF 110 (563)
Q Consensus 81 -------------------------------------------------~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSL 110 (563)
.....+||+.|+|||++.+ .|+.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (382)
T cd05625 155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 234 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence 0123478999999998864 59999999999
Q ss_pred HHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCc--cccCCChhHHHHHHHhcCCCCCCCC---HHHHHcCcccccccc
Q 008504 111 GMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPAS--LAKVNDPQIKGFIEKCLVPASERLS---AKDLLKDPFLQVENQ 185 (563)
Q Consensus 111 GviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~--l~~~~s~~l~~LI~kcL~dP~kRpS---a~ELLkHpff~~~~~ 185 (563)
||++|+|++|+.||... ++......+........ .....++++.++|.+|+.+|.+|++ +.++++||||+...+
T Consensus 235 Gvil~elltG~~Pf~~~-~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~p~~R~~~~~~~ei~~hp~f~~~~~ 313 (382)
T cd05625 235 GVILYEMLVGQPPFLAQ-TPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCRGPEDRLGKNGADEIKAHPFFKTIDF 313 (382)
T ss_pred hHHHHHHHhCCCCCCCC-CHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHccCHhHcCCCCCHHHHhcCCCcCCcCh
Confidence 99999999999999874 44444444443222211 2234678999999998889999987 999999999987654
Q ss_pred C
Q 008504 186 K 186 (563)
Q Consensus 186 ~ 186 (563)
.
T Consensus 314 ~ 314 (382)
T cd05625 314 S 314 (382)
T ss_pred H
Confidence 3
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=279.30 Aligned_cols=181 Identities=23% Similarity=0.413 Sum_probs=147.8
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
||||||++|+|.+++.+.+.+++..++.|+.||+.||+|||++| |+||||||+|||++ ..|.+||+|||++..+...
T Consensus 78 lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~-~~~~ikL~DFG~a~~~~~~ 154 (376)
T cd05598 78 FVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILID-RDGHIKLTDFGLCTGFRWT 154 (376)
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHEEEC-CCCCEEEEeCCCCcccccc
Confidence 68999999999999998888999999999999999999999999 99999999999998 5579999999997422100
Q ss_pred ---------------------------------------------CCccccCCCCccCcccccc-cCCchhhHHHhHHHH
Q 008504 81 ---------------------------------------------TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCI 114 (563)
Q Consensus 81 ---------------------------------------------~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviL 114 (563)
.....+||+.|+|||++.+ .++.++|||||||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 234 (376)
T cd05598 155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 234 (376)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence 0113479999999998865 589999999999999
Q ss_pred HHHhhcCCCCCCCCCHHHHHHHHhcCCCCC--ccccCCChhHHHHHHHhcCCCCCCC---CHHHHHcCcccccccc
Q 008504 115 LEMVTFEYPYSECKNPAQIFKKVTSGIKPA--SLAKVNDPQIKGFIEKCLVPASERL---SAKDLLKDPFLQVENQ 185 (563)
Q Consensus 115 yELlTG~~Pf~~~~~~~~i~~~i~~~~~p~--~l~~~~s~~l~~LI~kcL~dP~kRp---Sa~ELLkHpff~~~~~ 185 (563)
|+|++|+.||... .+......+....... ......++.+.+||.+|+.+|.+|+ ++.++++||||+...+
T Consensus 235 yell~G~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~~~p~~R~~~~t~~ell~h~~~~~~~~ 309 (376)
T cd05598 235 YEMLVGQPPFLAD-TPAETQLKVINWETTLHIPSQAKLSREASDLILRLCCGAEDRLGKNGADEIKAHPFFKGIDF 309 (376)
T ss_pred eehhhCCCCCCCC-CHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHhcCHhhcCCCCCHHHHhCCCCcCCCCH
Confidence 9999999999874 3444444443322211 1223467899999999888999999 9999999999987554
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-31 Score=271.10 Aligned_cols=179 Identities=28% Similarity=0.471 Sum_probs=150.4
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC-
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ- 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~- 79 (563)
|||||+++|+|..++.. +.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++.....
T Consensus 79 lv~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrdlkp~Nill~-~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 79 FVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENK--IVYRDLKLDNLLLD-TEGFVKIADFGLCKEGMGF 154 (324)
T ss_pred EEEcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEEC-CCCcEEeCcccCCccCCCC
Confidence 68999999999998865 57999999999999999999999999 99999999999998 557999999999864322
Q ss_pred -CCCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHHH
Q 008504 80 -PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 157 (563)
Q Consensus 80 -~~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~L 157 (563)
.......|++.|+|||++.+ .++.++|||||||++|+|++|+.||.. .+.......+..+.. ..+...++.+.+|
T Consensus 155 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~l 231 (324)
T cd05589 155 GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPG-DDEEEVFDSIVNDEV--RYPRFLSREAISI 231 (324)
T ss_pred CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCC--CCCCCCCHHHHHH
Confidence 22345679999999998865 488999999999999999999999986 345555555554432 2445678899999
Q ss_pred HHHhcC-CCCCCC-----CHHHHHcCccccccccC
Q 008504 158 IEKCLV-PASERL-----SAKDLLKDPFLQVENQK 186 (563)
Q Consensus 158 I~kcL~-dP~kRp-----Sa~ELLkHpff~~~~~~ 186 (563)
|.+||. +|.+|| ++.++++||||+...+.
T Consensus 232 i~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~~ 266 (324)
T cd05589 232 MRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINWD 266 (324)
T ss_pred HHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCCHH
Confidence 999997 899999 79999999999876544
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=283.13 Aligned_cols=179 Identities=34% Similarity=0.621 Sum_probs=158.8
Q ss_pred CEeccCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhcc
Q 008504 1 MITELFTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~--~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~ 78 (563)
|||+||+||+|.+.+++.+ .++++.+..|+.||+.||.|||+++ |+|||||+.|||++.+ +.|||+|||+|+.+.
T Consensus 81 Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~--iLHRDlK~~Nifltk~-~~VkLgDfGlaK~l~ 157 (426)
T KOG0589|consen 81 IVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR--VLHRDLKCANIFLTKD-KKVKLGDFGLAKILN 157 (426)
T ss_pred EEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh--hhcccchhhhhhcccc-CceeecchhhhhhcC
Confidence 6999999999999998654 5999999999999999999999999 9999999999999854 688999999999887
Q ss_pred CC--CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHH
Q 008504 79 QP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIK 155 (563)
Q Consensus 79 ~~--~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~ 155 (563)
.. ...+.+|||.||+||++.+ .|+.|+||||||||+|||++-+.+|.. .+...+..++..+.. ..++..++.+++
T Consensus 158 ~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a-~~m~~Li~ki~~~~~-~Plp~~ys~el~ 235 (426)
T KOG0589|consen 158 PEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKA-SNMSELILKINRGLY-SPLPSMYSSELR 235 (426)
T ss_pred CchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCc-cchHHHHHHHhhccC-CCCCccccHHHH
Confidence 65 5677899999999999986 599999999999999999999999988 566667777776663 346777889999
Q ss_pred HHHHHhcC-CCCCCCCHHHHHcCccccccc
Q 008504 156 GFIEKCLV-PASERLSAKDLLKDPFLQVEN 184 (563)
Q Consensus 156 ~LI~kcL~-dP~kRpSa~ELLkHpff~~~~ 184 (563)
.+|+.||. +|..||++.+||.+|.++..-
T Consensus 236 ~lv~~~l~~~P~~RPsa~~LL~~P~l~~~~ 265 (426)
T KOG0589|consen 236 SLVKSMLRKNPEHRPSALELLRRPHLLRYL 265 (426)
T ss_pred HHHHHHhhcCCccCCCHHHHhhChhhhhHH
Confidence 99999997 799999999999999887443
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=272.51 Aligned_cols=181 Identities=26% Similarity=0.431 Sum_probs=152.5
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC-
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ- 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~- 79 (563)
+||||+.+|+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++.....
T Consensus 73 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~g--iiHrDlkp~Nili~-~~~~~kl~DfG~a~~~~~~ 149 (325)
T cd05602 73 FVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLD-SQGHIVLTDFGLCKENIEH 149 (325)
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEEC-CCCCEEEccCCCCcccccC
Confidence 58999999999999998888999999999999999999999999 99999999999998 567999999999865322
Q ss_pred -CCCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHHH
Q 008504 80 -PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 157 (563)
Q Consensus 80 -~~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~L 157 (563)
.......||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+....+..+..... ......++.++++
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~-~~~~~~~~~i~~~~~--~~~~~~~~~~~~l 226 (325)
T cd05602 150 NGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS-RNTAEMYDNILNKPL--QLKPNITNSARHL 226 (325)
T ss_pred CCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCC-CCHHHHHHHHHhCCc--CCCCCCCHHHHHH
Confidence 22345679999999998865 488999999999999999999999986 445555555554322 2344567899999
Q ss_pred HHHhcC-CCCCCCCHH----HHHcCccccccccCC
Q 008504 158 IEKCLV-PASERLSAK----DLLKDPFLQVENQKE 187 (563)
Q Consensus 158 I~kcL~-dP~kRpSa~----ELLkHpff~~~~~~~ 187 (563)
|.+||+ +|.+|+++. ++++|+||....+..
T Consensus 227 i~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~~~~~ 261 (325)
T cd05602 227 LEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINWDD 261 (325)
T ss_pred HHHHcccCHHHCCCCCCCHHHHhcCcccCCCCHHH
Confidence 999997 899999865 899999998766544
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=273.25 Aligned_cols=180 Identities=25% Similarity=0.427 Sum_probs=152.9
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
|||||+++|+|.+++.+...+++..++.|+.||+.||.|||++| |+||||||+|||++ .++.+||+|||++......
T Consensus 75 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~-~~~~~kL~Dfg~~~~~~~~ 151 (318)
T cd05582 75 LILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLD-EEGHIKLTDFGLSKESIDH 151 (318)
T ss_pred EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHeEEC-CCCcEEEeeccCCcccCCC
Confidence 68999999999999998888999999999999999999999999 99999999999998 5579999999998654332
Q ss_pred --CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHHH
Q 008504 81 --TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 157 (563)
Q Consensus 81 --~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~L 157 (563)
......|++.|+|||++.+ .++.++|||||||++|+|++|+.||.. .........+..... .++...++.+++|
T Consensus 152 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~l 228 (318)
T cd05582 152 EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQG-KDRKETMTMILKAKL--GMPQFLSPEAQSL 228 (318)
T ss_pred CCceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHHHHHH
Confidence 2335678999999998864 588999999999999999999999986 344555555544432 2455678899999
Q ss_pred HHHhcC-CCCCCCC-----HHHHHcCccccccccC
Q 008504 158 IEKCLV-PASERLS-----AKDLLKDPFLQVENQK 186 (563)
Q Consensus 158 I~kcL~-dP~kRpS-----a~ELLkHpff~~~~~~ 186 (563)
|.+||. +|.+||+ +.+++.||||+...+.
T Consensus 229 i~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~~~ 263 (318)
T cd05582 229 LRALFKRNPANRLGAGPDGVEEIKRHPFFSTIDWN 263 (318)
T ss_pred HHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCCCHH
Confidence 999997 8999999 7889999999876543
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=273.13 Aligned_cols=180 Identities=26% Similarity=0.418 Sum_probs=151.0
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhcc--
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ-- 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~-- 78 (563)
|||||+.+|+|..++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ ++|.+||+|||++....
T Consensus 73 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~g--ivH~Dlkp~NIll~-~~~~~kL~DfG~~~~~~~~ 149 (325)
T cd05604 73 FVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSIN--IVYRDLKPENILLD-SQGHVVLTDFGLCKEGIAQ 149 (325)
T ss_pred EEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEEC-CCCCEEEeecCCcccCCCC
Confidence 68999999999999998889999999999999999999999999 99999999999997 56799999999986432
Q ss_pred CCCCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHHH
Q 008504 79 QPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 157 (563)
Q Consensus 79 ~~~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~L 157 (563)
........|++.|+|||++.+ .++.++|||||||++|+|++|..||.. .+...++..+..... ......+..+.++
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~-~~~~~~~~~~~~~~~--~~~~~~~~~~~~l 226 (325)
T cd05604 150 SDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYC-RDVAEMYDNILHKPL--VLRPGASLTAWSI 226 (325)
T ss_pred CCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCC-CCHHHHHHHHHcCCc--cCCCCCCHHHHHH
Confidence 222345579999999998865 488999999999999999999999986 445556665554432 2233467889999
Q ss_pred HHHhcC-CCCCCCCH----HHHHcCccccccccC
Q 008504 158 IEKCLV-PASERLSA----KDLLKDPFLQVENQK 186 (563)
Q Consensus 158 I~kcL~-dP~kRpSa----~ELLkHpff~~~~~~ 186 (563)
|.+||. +|.+||++ .++++||||....+.
T Consensus 227 l~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~~~~ 260 (325)
T cd05604 227 LEELLEKDRQRRLGAKEDFLEIQEHPFFESLSWT 260 (325)
T ss_pred HHHHhccCHHhcCCCCCCHHHHhcCCCcCCCCHH
Confidence 999997 89999876 699999999876543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-31 Score=270.62 Aligned_cols=181 Identities=24% Similarity=0.391 Sum_probs=152.4
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC-
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ- 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~- 79 (563)
|||||+++|+|..++.+.+.+++..++.|+.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++.....
T Consensus 73 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~-~~~~~kl~Dfg~~~~~~~~ 149 (321)
T cd05603 73 FVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLN--IIYRDLKPENILLD-SQGHVVLTDFGLCKEGVEP 149 (321)
T ss_pred EEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEEC-CCCCEEEccCCCCccCCCC
Confidence 68999999999999988888999999999999999999999999 99999999999998 558999999999865322
Q ss_pred -CCCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHHH
Q 008504 80 -PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 157 (563)
Q Consensus 80 -~~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~L 157 (563)
.......|++.|+|||++.+ .++.++|||||||++|+|++|..||.. .+....+..+.... ..++...+..+.++
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~-~~~~~~~~~i~~~~--~~~~~~~~~~~~~l 226 (321)
T cd05603 150 EETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYS-RDVSQMYDNILHKP--LQLPGGKTVAACDL 226 (321)
T ss_pred CCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCC-CCHHHHHHHHhcCC--CCCCCCCCHHHHHH
Confidence 22334578999999998864 489999999999999999999999987 45556666665543 23455667889999
Q ss_pred HHHhcC-CCCCCCCH----HHHHcCccccccccCC
Q 008504 158 IEKCLV-PASERLSA----KDLLKDPFLQVENQKE 187 (563)
Q Consensus 158 I~kcL~-dP~kRpSa----~ELLkHpff~~~~~~~ 187 (563)
|.+||. +|.+|+++ .++++|+||....+..
T Consensus 227 i~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~~~~~ 261 (321)
T cd05603 227 LVGLLHKDQRRRLGAKADFLEIKNHVFFSPINWDD 261 (321)
T ss_pred HHHHccCCHhhcCCCCCCHHHHhCCCCcCCCCHHH
Confidence 999997 89999875 5999999998766543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=276.19 Aligned_cols=180 Identities=23% Similarity=0.464 Sum_probs=147.5
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
||||||++|+|.+++... .+++..++.++.||+.||.|||++| |+||||||+|||++ ..|.+||+|||++......
T Consensus 120 lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~--IvHrDLKp~NILl~-~~~~~kL~DFG~a~~~~~~ 195 (370)
T cd05621 120 MVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMG--LIHRDVKPDNMLLD-KHGHLKLADFGTCMKMDET 195 (370)
T ss_pred EEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEEC-CCCCEEEEecccceecccC
Confidence 689999999999999764 6899999999999999999999999 99999999999998 5689999999999765432
Q ss_pred C---CccccCCCCccCcccccc-----cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCcccc--CC
Q 008504 81 T---ARSVIGTPEFMAPELYEE-----EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAK--VN 150 (563)
Q Consensus 81 ~---~~~~~Gtp~Y~APEvl~~-----~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~--~~ 150 (563)
. ....+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.. .+....+..+........++. ..
T Consensus 196 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~~~ 274 (370)
T cd05621 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYA-DSLVGTYSKIMDHKNSLNFPEDVEI 274 (370)
T ss_pred CceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCcccCCCCcccC
Confidence 1 235679999999998853 278899999999999999999999986 345555565554332222222 35
Q ss_pred ChhHHHHHHHhcCC-C--CCCCCHHHHHcCcccccccc
Q 008504 151 DPQIKGFIEKCLVP-A--SERLSAKDLLKDPFLQVENQ 185 (563)
Q Consensus 151 s~~l~~LI~kcL~d-P--~kRpSa~ELLkHpff~~~~~ 185 (563)
+..++++|.+||.+ + ..|+++.++++||||+...+
T Consensus 275 s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~~ 312 (370)
T cd05621 275 SKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQW 312 (370)
T ss_pred CHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCCCc
Confidence 78899999999974 3 34899999999999987544
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=265.31 Aligned_cols=179 Identities=26% Similarity=0.413 Sum_probs=140.5
Q ss_pred CEeccCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~-~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
+||||+. |+|.+++.++ +.+++..++.++.||+.||.|||++| |+||||||+|||++ ..|.+||+|||++.....
T Consensus 80 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~ 155 (303)
T cd07869 80 LVFEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY--ILHRDLKPQNLLIS-DTGELKLADFGLARAKSV 155 (303)
T ss_pred EEEECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEC-CCCCEEECCCCcceeccC
Confidence 5899996 6888887664 56999999999999999999999999 99999999999998 557999999999864432
Q ss_pred C--CCccccCCCCccCcccccc--cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcC--CC-----------
Q 008504 80 P--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG--IK----------- 142 (563)
Q Consensus 80 ~--~~~~~~Gtp~Y~APEvl~~--~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~--~~----------- 142 (563)
. ......+++.|+|||++.+ .++.++|||||||++|+|++|..||....+.......+... ..
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T cd07869 156 PSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSL 235 (303)
T ss_pred CCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhc
Confidence 1 2234578999999998754 47889999999999999999999998755543333222110 00
Q ss_pred ----CCccc-------------cCCChhHHHHHHHhcC-CCCCCCCHHHHHcCcccccc
Q 008504 143 ----PASLA-------------KVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 183 (563)
Q Consensus 143 ----p~~l~-------------~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~ 183 (563)
+.... ...++.+++||.+||. +|.+|||+.++|+||||+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~ 294 (303)
T cd07869 236 PHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL 294 (303)
T ss_pred cccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccC
Confidence 00000 0123578999999998 89999999999999999854
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=266.20 Aligned_cols=179 Identities=26% Similarity=0.482 Sum_probs=147.0
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
||+|||+..-|.++-+.-..++.+.++++++|++.|+.|+|+++ +|||||||+||||+ .+|.+||||||+|+.+..+
T Consensus 78 LVFE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n--~IHRDIKPENILit-~~gvvKLCDFGFAR~L~~p 154 (396)
T KOG0593|consen 78 LVFEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNN--CIHRDIKPENILIT-QNGVVKLCDFGFARTLSAP 154 (396)
T ss_pred EEeeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcC--eecccCChhheEEe-cCCcEEeccchhhHhhcCC
Confidence 69999998555544444456999999999999999999999999 99999999999998 5689999999999887643
Q ss_pred --CCccccCCCCccCcccccc--cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhc-----------------
Q 008504 81 --TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS----------------- 139 (563)
Q Consensus 81 --~~~~~~Gtp~Y~APEvl~~--~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~----------------- 139 (563)
....++.|.+|.|||++-+ +|+..+||||+||++.||++|++-|.+..+.++++.....
T Consensus 155 gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~ 234 (396)
T KOG0593|consen 155 GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPF 234 (396)
T ss_pred cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCc
Confidence 3345688999999998865 5999999999999999999999999998888888765432
Q ss_pred --CCCC------Ccccc---CCChhHHHHHHHhcC-CCCCCCCHHHHHcCccccc
Q 008504 140 --GIKP------ASLAK---VNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQV 182 (563)
Q Consensus 140 --~~~p------~~l~~---~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~ 182 (563)
|+.. ..+.. ..+..+.+|+++||. ||.+|++..++|.||||+.
T Consensus 235 F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~ 289 (396)
T KOG0593|consen 235 FHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDG 289 (396)
T ss_pred eeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHH
Confidence 1110 01111 123478899999997 9999999999999999954
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=269.53 Aligned_cols=179 Identities=28% Similarity=0.520 Sum_probs=145.9
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSH-NPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~-gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
|||||+.+|+|.+++.+.+.+++..++.++.||+.||.|||+. + |+||||||+|||++ +.|.+||+|||++.....
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~--ivH~dlkp~Nili~-~~~~~kL~Dfg~~~~~~~ 156 (333)
T cd06650 80 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVN-SRGEIKLCDFGVSGQLID 156 (333)
T ss_pred EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChhhEEEc-CCCCEEEeeCCcchhhhh
Confidence 6899999999999999888899999999999999999999974 7 99999999999997 557999999999976654
Q ss_pred CCCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHH------------------------
Q 008504 80 PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIF------------------------ 134 (563)
Q Consensus 80 ~~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~------------------------ 134 (563)
.......|++.|+|||++.+ .++.++|||||||++|+|++|+.||..... ..+.
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (333)
T cd06650 157 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDA-KELELMFGCPVEGDPAESETSPRPRPPG 235 (333)
T ss_pred hccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcch-hHHHHHhcCcccCCccccccCcccCCcc
Confidence 44445678999999998865 488999999999999999999999975221 1111
Q ss_pred --------------------HHHhcCCCCCccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCcccccc
Q 008504 135 --------------------KKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 183 (563)
Q Consensus 135 --------------------~~i~~~~~p~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~ 183 (563)
..+.....+.......+.++++||.+||. +|.+|||+.|+++||||+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 305 (333)
T cd06650 236 RPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 305 (333)
T ss_pred chhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence 11111111211222356789999999997 89999999999999999854
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=275.77 Aligned_cols=183 Identities=23% Similarity=0.392 Sum_probs=146.6
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
||||||++|+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ ..|.+||+|||++......
T Consensus 78 lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDlKp~Nili~-~~~~~kL~DFGl~~~~~~~ 154 (381)
T cd05626 78 FVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMG--FIHRDIKPDNILID-LDGHIKLTDFGLCTGFRWT 154 (381)
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCcHHHEEEC-CCCCEEEeeCcCCcccccc
Confidence 68999999999999999889999999999999999999999999 99999999999997 5589999999987432100
Q ss_pred -------------------------------------------------CCccccCCCCccCcccccc-cCCchhhHHHh
Q 008504 81 -------------------------------------------------TARSVIGTPEFMAPELYEE-EYNELVDIYSF 110 (563)
Q Consensus 81 -------------------------------------------------~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSL 110 (563)
.....+||+.|+|||++.+ .++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (381)
T cd05626 155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV 234 (381)
T ss_pred cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence 0123579999999998864 58999999999
Q ss_pred HHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCC--CCccccCCChhHHHHHHHhcC---CCCCCCCHHHHHcCcccccccc
Q 008504 111 GMCILEMVTFEYPYSECKNPAQIFKKVTSGIK--PASLAKVNDPQIKGFIEKCLV---PASERLSAKDLLKDPFLQVENQ 185 (563)
Q Consensus 111 GviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~--p~~l~~~~s~~l~~LI~kcL~---dP~kRpSa~ELLkHpff~~~~~ 185 (563)
||++|+|+||..||.... .......+..... ........++++++||.+|+. ++..|+++.+++.||||+...+
T Consensus 235 G~il~elltG~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~~~ 313 (381)
T cd05626 235 GVILFEMLVGQPPFLAPT-PTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVDF 313 (381)
T ss_pred hhHHHHHHhCCCCCcCCC-HHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCCCh
Confidence 999999999999998744 3333333332221 111223467899999999663 4566999999999999987665
Q ss_pred CC
Q 008504 186 KE 187 (563)
Q Consensus 186 ~~ 187 (563)
..
T Consensus 314 ~~ 315 (381)
T cd05626 314 SS 315 (381)
T ss_pred hH
Confidence 43
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=286.31 Aligned_cols=184 Identities=35% Similarity=0.596 Sum_probs=165.5
Q ss_pred CEeccCCCCCHHHHHH-hCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhc
Q 008504 1 MITELFTSGNLRQYRK-KHKNV--DIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM 77 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~-k~~~L--se~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~ 77 (563)
|.||-++||+|..+++ +.+++ ++.++..|.+||++||.|||.+. |+|||||-+|+||+.-.|.+||+|||-++.+
T Consensus 649 IFMEqVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~--IVHRDIKGDNVLvNTySGvlKISDFGTsKRL 726 (1226)
T KOG4279|consen 649 IFMEQVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK--IVHRDIKGDNVLVNTYSGVLKISDFGTSKRL 726 (1226)
T ss_pred EEeecCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc--eeeccccCCcEEEeeccceEEecccccchhh
Confidence 5799999999999987 46888 89999999999999999999999 9999999999999988899999999999877
Q ss_pred c--CCCCccccCCCCccCcccccc---cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCCh
Q 008504 78 Q--QPTARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDP 152 (563)
Q Consensus 78 ~--~~~~~~~~Gtp~Y~APEvl~~---~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~ 152 (563)
. .+...++.||..|||||++.. +|+.++|||||||++.||.||++||....++...+.++---...+.+|...+.
T Consensus 727 AginP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsa 806 (1226)
T KOG4279|consen 727 AGINPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSA 806 (1226)
T ss_pred ccCCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHH
Confidence 5 356678899999999999963 59999999999999999999999999888887777777666666678888899
Q ss_pred hHHHHHHHhcC-CCCCCCCHHHHHcCccccccccC
Q 008504 153 QIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQK 186 (563)
Q Consensus 153 ~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~~~ 186 (563)
+++.||.+|+. +|.+||+|.++|.+||++..+.+
T Consensus 807 eak~FilrcFepd~~~R~sA~~LL~DpFlq~~~kk 841 (1226)
T KOG4279|consen 807 EAKNFILRCFEPDPCDRPSAKDLLQDPFLQHNNKK 841 (1226)
T ss_pred HHHHHHHHHcCCCcccCccHHHhccCcccccCCCC
Confidence 99999999998 79999999999999999987544
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=261.72 Aligned_cols=176 Identities=31% Similarity=0.432 Sum_probs=140.8
Q ss_pred CEeccCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhcc
Q 008504 1 MITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~--~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~ 78 (563)
+||||+. |+|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||++ ..+.+||+|||++....
T Consensus 86 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--iiH~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~ 161 (290)
T cd07862 86 LVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVT-SSGQIKLADFGLARIYS 161 (290)
T ss_pred EEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEc-CCCCEEEccccceEecc
Confidence 5899996 6999999763 45899999999999999999999999 99999999999998 55799999999997654
Q ss_pred CC-CCccccCCCCccCccccc-ccCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCC--CC----------
Q 008504 79 QP-TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK--PA---------- 144 (563)
Q Consensus 79 ~~-~~~~~~Gtp~Y~APEvl~-~~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~--p~---------- 144 (563)
.. ......|++.|+|||++. ..++.++|||||||++|+|++|..||........+...+..... +.
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 241 (290)
T cd07862 162 FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPR 241 (290)
T ss_pred CCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcccc
Confidence 32 233457899999999885 45899999999999999999999999875443333222211000 00
Q ss_pred ------------ccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCccc
Q 008504 145 ------------SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 180 (563)
Q Consensus 145 ------------~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff 180 (563)
.+....++.+++||.+||. +|.+|||+.++|+||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 242 QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred hhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 0112346788999999997 89999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=282.20 Aligned_cols=181 Identities=26% Similarity=0.392 Sum_probs=144.7
Q ss_pred CEeccCCCCCHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhh
Q 008504 1 MITELFTSGNLRQYRK----KHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 76 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~----k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~ 76 (563)
+||||+++ +|.+++. ....+++..++.++.||+.||.|||++| |+||||||+|||++.+.+.+||+|||+++.
T Consensus 144 lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~--IiHrDLKp~NILl~~~~~~vkL~DFGla~~ 220 (440)
T PTZ00036 144 VVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF--ICHRDLKPQNLLIDPNTHTLKLCDFGSAKN 220 (440)
T ss_pred EEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCcCHHHEEEcCCCCceeeeccccchh
Confidence 58999975 7877765 3467999999999999999999999999 999999999999986656899999999976
Q ss_pred ccCC-CCccccCCCCccCcccccc--cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCC-----------
Q 008504 77 MQQP-TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK----------- 142 (563)
Q Consensus 77 ~~~~-~~~~~~Gtp~Y~APEvl~~--~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~----------- 142 (563)
+... ......|++.|+|||++.+ .|+.++|||||||++|+|++|.+||.+......+.+.+.....
T Consensus 221 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~ 300 (440)
T PTZ00036 221 LLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNP 300 (440)
T ss_pred ccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhch
Confidence 5432 2334678999999998754 5899999999999999999999999875554444333221100
Q ss_pred -------C--------CccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCccccccc
Q 008504 143 -------P--------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 184 (563)
Q Consensus 143 -------p--------~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~ 184 (563)
+ ..++...++++++||.+||. +|.+|||+.|+|+||||+...
T Consensus 301 ~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~ 358 (440)
T PTZ00036 301 NYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLR 358 (440)
T ss_pred hhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhh
Confidence 0 01223356789999999997 899999999999999997543
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=260.95 Aligned_cols=182 Identities=26% Similarity=0.495 Sum_probs=151.4
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
+||||+.||+|.+++.+.+.+++..++.|+.|++.||.|||+++ |+||||||+||+++ .++.+||+|||++......
T Consensus 74 ~v~e~~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~nili~-~~~~~kl~dfg~~~~~~~~ 150 (278)
T cd05606 74 FILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLD-EHGHVRISDLGLACDFSKK 150 (278)
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCCCCHHHEEEC-CCCCEEEccCcCccccCcc
Confidence 58999999999999988888999999999999999999999999 99999999999998 4579999999998765544
Q ss_pred CCccccCCCCccCcccccc--cCCchhhHHHhHHHHHHHhhcCCCCCCCC--CHHHHHHHHhcCCCCCccccCCChhHHH
Q 008504 81 TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECK--NPAQIFKKVTSGIKPASLAKVNDPQIKG 156 (563)
Q Consensus 81 ~~~~~~Gtp~Y~APEvl~~--~ys~ksDIwSLGviLyELlTG~~Pf~~~~--~~~~i~~~i~~~~~p~~l~~~~s~~l~~ 156 (563)
......|++.|+|||++.+ .++.++||||||+++|+|++|+.||.... ........... ....++...++.+.+
T Consensus 151 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~s~~~~~ 228 (278)
T cd05606 151 KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT--MAVELPDSFSPELRS 228 (278)
T ss_pred CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhc--cCCCCCCcCCHHHHH
Confidence 4445678999999999863 48899999999999999999999997642 22222222221 223345556889999
Q ss_pred HHHHhcC-CCCCCC-----CHHHHHcCccccccccCC
Q 008504 157 FIEKCLV-PASERL-----SAKDLLKDPFLQVENQKE 187 (563)
Q Consensus 157 LI~kcL~-dP~kRp-----Sa~ELLkHpff~~~~~~~ 187 (563)
+|.+||. +|.+|| ++.++++||||....+..
T Consensus 229 li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~~~ 265 (278)
T cd05606 229 LLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQM 265 (278)
T ss_pred HHHHHhhcCHHhccCCCCCCHHHHHhCccccCCCchH
Confidence 9999997 899999 999999999998766543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-30 Score=261.46 Aligned_cols=175 Identities=27% Similarity=0.445 Sum_probs=138.9
Q ss_pred CEeccCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~-~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
+||||+.+ +|.+++...+ .+++..++.++.||+.||+|||++| |+||||||+|||++ .+|.+||+|||++.....
T Consensus 80 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~-~~~~~kl~DfG~~~~~~~ 155 (288)
T cd07871 80 LVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK--ILHRDLKPQNLLIN-EKGELKLADFGLARAKSV 155 (288)
T ss_pred EEEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEC-CCCCEEECcCcceeeccC
Confidence 58999975 9999987654 4899999999999999999999999 99999999999997 557999999999865432
Q ss_pred C--CCccccCCCCccCcccccc--cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCC--C-----------
Q 008504 80 P--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI--K----------- 142 (563)
Q Consensus 80 ~--~~~~~~Gtp~Y~APEvl~~--~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~--~----------- 142 (563)
. ......+++.|+|||++.+ .++.++|||||||++|+|+||+.||........+ ..+.... .
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07871 156 PTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEEL-HLIFRLLGTPTEETWPGITSN 234 (288)
T ss_pred CCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHHhCCCChHHhhccccc
Confidence 2 2234568999999998754 4899999999999999999999999774333222 2221100 0
Q ss_pred --------CC-------ccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCccc
Q 008504 143 --------PA-------SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 180 (563)
Q Consensus 143 --------p~-------~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff 180 (563)
+. ......++++++||.+||. +|.+|||+.|+|+||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 235 EEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred hhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 00 0112346789999999998 89999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-30 Score=253.78 Aligned_cols=176 Identities=34% Similarity=0.596 Sum_probs=148.4
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
+|+||+++++|.+++.+.+.+++..++.++.|++.||.|||+.| |+||||+|+||+++ .++.++|+|||++......
T Consensus 81 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nilv~-~~~~~~l~dfg~~~~~~~~ 157 (263)
T cd06625 81 IFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNM--IVHRDIKGANILRD-SAGNVKLGDFGASKRLQTI 157 (263)
T ss_pred EEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEc-CCCCEEEeecccceecccc
Confidence 58999999999999998888999999999999999999999999 99999999999998 5679999999998654322
Q ss_pred C-----CccccCCCCccCccccccc-CCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhH
Q 008504 81 T-----ARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQI 154 (563)
Q Consensus 81 ~-----~~~~~Gtp~Y~APEvl~~~-ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l 154 (563)
. .....+++.|+|||++.+. ++.++||||||+++|+|++|+.||.......... .+.........+...+..+
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 236 (263)
T cd06625 158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIF-KIATQPTNPQLPSHVSPDA 236 (263)
T ss_pred ccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHH-HHhccCCCCCCCccCCHHH
Confidence 1 1234678899999988654 8899999999999999999999997744433333 3333333445666778899
Q ss_pred HHHHHHhcC-CCCCCCCHHHHHcCccc
Q 008504 155 KGFIEKCLV-PASERLSAKDLLKDPFL 180 (563)
Q Consensus 155 ~~LI~kcL~-dP~kRpSa~ELLkHpff 180 (563)
.++|.+||. +|.+|||+.++++||||
T Consensus 237 ~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 237 RNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred HHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 999999997 89999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=272.76 Aligned_cols=180 Identities=22% Similarity=0.430 Sum_probs=148.7
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
+|||||++|+|.+++... .+++..++.++.||+.||.|||++| |+||||||+|||++ ..|.+||+|||++......
T Consensus 120 lv~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NIll~-~~~~ikL~DfG~a~~~~~~ 195 (371)
T cd05622 120 MVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLD-KSGHLKLADFGTCMKMNKE 195 (371)
T ss_pred EEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHEEEC-CCCCEEEEeCCceeEcCcC
Confidence 589999999999999764 5899999999999999999999999 99999999999998 5689999999999765432
Q ss_pred ---CCccccCCCCccCcccccc-----cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCcc--ccCC
Q 008504 81 ---TARSVIGTPEFMAPELYEE-----EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASL--AKVN 150 (563)
Q Consensus 81 ---~~~~~~Gtp~Y~APEvl~~-----~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l--~~~~ 150 (563)
.....+||+.|+|||++.. .++.++|||||||++|+|++|..||.. .+....+..+........+ ....
T Consensus 196 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~ 274 (371)
T cd05622 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA-DSLVGTYSKIMNHKNSLTFPDDNDI 274 (371)
T ss_pred CcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCCcccCCCcCCC
Confidence 2235679999999998853 278899999999999999999999986 4556666666654332222 2346
Q ss_pred ChhHHHHHHHhcCCCC---CCCCHHHHHcCcccccccc
Q 008504 151 DPQIKGFIEKCLVPAS---ERLSAKDLLKDPFLQVENQ 185 (563)
Q Consensus 151 s~~l~~LI~kcL~dP~---kRpSa~ELLkHpff~~~~~ 185 (563)
+..+++||.+||.+|. .|+++.++++||||+...+
T Consensus 275 s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~~ 312 (371)
T cd05622 275 SKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQW 312 (371)
T ss_pred CHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCCh
Confidence 7899999999998543 3789999999999987554
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-30 Score=279.73 Aligned_cols=179 Identities=21% Similarity=0.327 Sum_probs=139.9
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEeccCccCceEEeCCC---------------C
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHS-HNPPIIHRDLKCDNIFVNGNH---------------G 64 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs-~gp~IIHrDLKP~NILLd~~~---------------G 64 (563)
||||++ |++|.+++.+++.+++..++.|+.||+.||.|||+ .| ||||||||+|||++... +
T Consensus 209 iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~g--IiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~ 285 (467)
T PTZ00284 209 IVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELH--LMHTDLKPENILMETSDTVVDPVTNRALPPDPC 285 (467)
T ss_pred EEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHEEEecCCcccccccccccCCCCc
Confidence 578887 77999999988899999999999999999999998 58 99999999999997432 1
Q ss_pred cEEEecccchhhccCCCCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhc--CC
Q 008504 65 EVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS--GI 141 (563)
Q Consensus 65 ~VKL~DFGlA~~~~~~~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~--~~ 141 (563)
.+||+|||.+..... .....+||+.|+|||++.+ .|+.++|||||||++|||++|+.||........+. .+.. +.
T Consensus 286 ~vkl~DfG~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~-~i~~~~g~ 363 (467)
T PTZ00284 286 RVRICDLGGCCDERH-SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLH-LMEKTLGR 363 (467)
T ss_pred eEEECCCCccccCcc-ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH-HHHHHcCC
Confidence 499999998754322 2345689999999998865 59999999999999999999999997644332221 1111 00
Q ss_pred CCCc--------------------------------------cccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCccccc
Q 008504 142 KPAS--------------------------------------LAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQV 182 (563)
Q Consensus 142 ~p~~--------------------------------------l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~ 182 (563)
.+.. .....++.+.+||.+||+ ||.+|||+.|+|+||||+.
T Consensus 364 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~~~ 443 (467)
T PTZ00284 364 LPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYVLK 443 (467)
T ss_pred CCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCccccc
Confidence 0000 001124568899999998 9999999999999999985
Q ss_pred cc
Q 008504 183 EN 184 (563)
Q Consensus 183 ~~ 184 (563)
..
T Consensus 444 ~~ 445 (467)
T PTZ00284 444 YY 445 (467)
T ss_pred cC
Confidence 43
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-30 Score=254.37 Aligned_cols=176 Identities=30% Similarity=0.542 Sum_probs=144.2
Q ss_pred CEeccCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhcc
Q 008504 1 MITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~--~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~ 78 (563)
+||||+.+|+|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+||+++ +.+.+||+|||++....
T Consensus 86 iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~--ivh~dl~~~nili~-~~~~~~l~Dfg~~~~~~ 162 (272)
T cd06637 86 LVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLD 162 (272)
T ss_pred EEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHEEEC-CCCCEEEccCCCceecc
Confidence 589999999999999864 35899999999999999999999999 99999999999998 55799999999987553
Q ss_pred CC--CCccccCCCCccCccccc------ccCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCC
Q 008504 79 QP--TARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVN 150 (563)
Q Consensus 79 ~~--~~~~~~Gtp~Y~APEvl~------~~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~ 150 (563)
.. ......|++.|+|||++. ..++.++|||||||++|+|++|+.||..... ......+.....+.......
T Consensus 163 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~ 241 (272)
T cd06637 163 RTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP-MRALFLIPRNPAPRLKSKKW 241 (272)
T ss_pred cccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCH-HHHHHHHhcCCCCCCCCCCc
Confidence 22 233457899999999874 2478899999999999999999999976433 33333333332333334456
Q ss_pred ChhHHHHHHHhcC-CCCCCCCHHHHHcCccc
Q 008504 151 DPQIKGFIEKCLV-PASERLSAKDLLKDPFL 180 (563)
Q Consensus 151 s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff 180 (563)
+..+++||.+||. +|.+|||+.++++||||
T Consensus 242 ~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 242 SKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred CHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 7899999999997 89999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=278.04 Aligned_cols=176 Identities=30% Similarity=0.501 Sum_probs=154.8
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
+|+|||.| +|+.++...+.++++.++.++.|++.||.|||+++ |+|||+||.|||+. ..|.+|+||||+|+.+...
T Consensus 78 vVte~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~r--ilhrd~kPqniLl~-~~~~~KlcdFg~Ar~m~~~ 153 (808)
T KOG0597|consen 78 VVTEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNR--ILHRDMKPQNILLE-KGGTLKLCDFGLARAMSTN 153 (808)
T ss_pred EEehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcC--cccccCCcceeeec-CCCceeechhhhhhhcccC
Confidence 58999987 99999999999999999999999999999999999 99999999999997 5689999999999887653
Q ss_pred --CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHHH
Q 008504 81 --TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 157 (563)
Q Consensus 81 --~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~L 157 (563)
....+.|||.|||||++++ .|+..+|+||+||++|||++|++||.. ....++.+.|..... .++...+..+..|
T Consensus 154 t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a-~si~~Lv~~I~~d~v--~~p~~~S~~f~nf 230 (808)
T KOG0597|consen 154 TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA-RSITQLVKSILKDPV--KPPSTASSSFVNF 230 (808)
T ss_pred ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH-HHHHHHHHHHhcCCC--CCcccccHHHHHH
Confidence 3456789999999999875 599999999999999999999999986 445566666665433 3345778899999
Q ss_pred HHHhcC-CCCCCCCHHHHHcCcccccc
Q 008504 158 IEKCLV-PASERLSAKDLLKDPFLQVE 183 (563)
Q Consensus 158 I~kcL~-dP~kRpSa~ELLkHpff~~~ 183 (563)
++.+|. ||.+|.|..+++.|||.+..
T Consensus 231 l~gLL~kdP~~RltW~~Ll~HpF~k~~ 257 (808)
T KOG0597|consen 231 LQGLLIKDPAQRLTWTDLLGHPFWKGK 257 (808)
T ss_pred HHHHhhcChhhcccHHHHhcChHHhhh
Confidence 999997 89999999999999999753
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-30 Score=260.17 Aligned_cols=183 Identities=27% Similarity=0.442 Sum_probs=148.4
Q ss_pred CEeccCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhcc
Q 008504 1 MITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~--~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~ 78 (563)
+||||+.+|+|..++... ..+++..+..++.||+.||.|||+.| |+||||||+||+++ +.+.++|+|||++....
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~-~~~~~~l~Dfg~~~~~~ 153 (285)
T cd05605 77 LVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER--IVYRDLKPENILLD-DYGHIRISDLGLAVEIP 153 (285)
T ss_pred EEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHEEEC-CCCCEEEeeCCCceecC
Confidence 689999999999988653 46999999999999999999999999 99999999999997 55799999999986653
Q ss_pred CC-CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHH---HHHHHHhcCCCCCccccCCChh
Q 008504 79 QP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPA---QIFKKVTSGIKPASLAKVNDPQ 153 (563)
Q Consensus 79 ~~-~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~---~i~~~i~~~~~p~~l~~~~s~~ 153 (563)
.. ......|++.|+|||++.+ .++.++|||||||++|+|++|+.||....... .+...+... +...+...++.
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 231 (285)
T cd05605 154 EGETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKED--QEEYSEKFSEA 231 (285)
T ss_pred CCCccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhc--ccccCcccCHH
Confidence 32 2234578999999998864 58899999999999999999999998643221 122222221 22344557789
Q ss_pred HHHHHHHhcC-CCCCCC-----CHHHHHcCccccccccCCC
Q 008504 154 IKGFIEKCLV-PASERL-----SAKDLLKDPFLQVENQKEP 188 (563)
Q Consensus 154 l~~LI~kcL~-dP~kRp-----Sa~ELLkHpff~~~~~~~~ 188 (563)
+++||.+||. +|.+|| ++.++++||||...+++..
T Consensus 232 ~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~ 272 (285)
T cd05605 232 ARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKRL 272 (285)
T ss_pred HHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHHHH
Confidence 9999999997 899999 9999999999987666543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-30 Score=290.81 Aligned_cols=183 Identities=25% Similarity=0.464 Sum_probs=161.2
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC-
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ- 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~- 79 (563)
||||||+||+|-.++.+..+++++.++.|+..|+.||.-||+.| +|||||||+|||++ ..|+|||+|||.+..+..
T Consensus 152 lVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mg--yVHRDiKPDNvLld-~~GHikLADFGsClkm~~d 228 (1317)
T KOG0612|consen 152 LVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMG--YVHRDIKPDNVLLD-KSGHIKLADFGSCLKMDAD 228 (1317)
T ss_pred EEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhcc--ceeccCCcceeEec-ccCcEeeccchhHHhcCCC
Confidence 69999999999999999999999999999999999999999999 99999999999998 669999999999877653
Q ss_pred CC--CccccCCCCccCccccc------ccCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccc--cC
Q 008504 80 PT--ARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLA--KV 149 (563)
Q Consensus 80 ~~--~~~~~Gtp~Y~APEvl~------~~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~--~~ 149 (563)
+. ....+|||.|.+||++. +.|+..+|+||+||++|||+.|..||+. ......|.+|..-.....+| ..
T Consensus 229 G~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa-dslveTY~KIm~hk~~l~FP~~~~ 307 (1317)
T KOG0612|consen 229 GTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA-DSLVETYGKIMNHKESLSFPDETD 307 (1317)
T ss_pred CcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH-HHHHHHHHHHhchhhhcCCCcccc
Confidence 32 33458999999999984 3499999999999999999999999987 56677888887654333333 44
Q ss_pred CChhHHHHHHHhcCCCCCCCC---HHHHHcCccccccccCC
Q 008504 150 NDPQIKGFIEKCLVPASERLS---AKDLLKDPFLQVENQKE 187 (563)
Q Consensus 150 ~s~~l~~LI~kcL~dP~kRpS---a~ELLkHpff~~~~~~~ 187 (563)
.++++++||.+++.+|..|.. +.++..||||....|..
T Consensus 308 VSeeakdLI~~ll~~~e~RLgrngiedik~HpFF~g~~W~~ 348 (1317)
T KOG0612|consen 308 VSEEAKDLIEALLCDREVRLGRNGIEDIKNHPFFEGIDWDN 348 (1317)
T ss_pred cCHHHHHHHHHHhcChhhhcccccHHHHHhCccccCCChhh
Confidence 789999999999999999988 99999999999999954
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-30 Score=265.70 Aligned_cols=183 Identities=19% Similarity=0.437 Sum_probs=148.2
Q ss_pred CEeccCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k-~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
|||||+.+|+|.+++.+ .+.+++..++.|+.||+.||.|||++| |+||||||+|||++ .++.+||+|||++.....
T Consensus 78 lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~--iiHrDlkp~Nili~-~~~~~kL~DfG~a~~~~~ 154 (332)
T cd05623 78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMD-MNGHIRLADFGSCLKLME 154 (332)
T ss_pred EEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEEC-CCCCEEEeecchheeccc
Confidence 68999999999999987 467999999999999999999999999 99999999999998 557999999999865432
Q ss_pred C---CCccccCCCCccCccccc------ccCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCcc---c
Q 008504 80 P---TARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASL---A 147 (563)
Q Consensus 80 ~---~~~~~~Gtp~Y~APEvl~------~~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l---~ 147 (563)
. ......||+.|+|||++. +.++.++|||||||++|+|++|+.||.. .+....+..+........+ .
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~ 233 (332)
T cd05623 155 DGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYA-ESLVETYGKIMNHKERFQFPAQV 233 (332)
T ss_pred CCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCC-CCHHHHHHHHhCCCccccCCCcc
Confidence 2 122357999999999875 3478899999999999999999999987 3455555555543322112 2
Q ss_pred cCCChhHHHHHHHhcC-C--CCCCCCHHHHHcCccccccccCC
Q 008504 148 KVNDPQIKGFIEKCLV-P--ASERLSAKDLLKDPFLQVENQKE 187 (563)
Q Consensus 148 ~~~s~~l~~LI~kcL~-d--P~kRpSa~ELLkHpff~~~~~~~ 187 (563)
...++.+++||.+||. + +..|+++.++++||||+...+..
T Consensus 234 ~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~~~~ 276 (332)
T cd05623 234 TDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDWDN 276 (332)
T ss_pred ccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCCHHH
Confidence 3457899999999996 3 34478999999999998766543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=252.06 Aligned_cols=182 Identities=27% Similarity=0.458 Sum_probs=154.2
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
+||||+++|+|.+++.+.+.+++..++.++.||+.||.|||+++ ++|+||+|+||+++ .++.++|+|||++......
T Consensus 70 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--~~h~dl~~~nilv~-~~~~~~l~df~~~~~~~~~ 146 (262)
T cd05572 70 MLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRG--IIYRDLKPENLLLD-SNGYVKLVDFGFAKKLKSG 146 (262)
T ss_pred EEEecCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEEc-CCCCEEEeeCCcccccCcc
Confidence 58999999999999998888999999999999999999999999 99999999999998 4579999999999766543
Q ss_pred -CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCC-CHHHHHHHHhcCCCCCccccCCChhHHHH
Q 008504 81 -TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECK-NPAQIFKKVTSGIKPASLAKVNDPQIKGF 157 (563)
Q Consensus 81 -~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~-~~~~i~~~i~~~~~p~~l~~~~s~~l~~L 157 (563)
......+++.|+|||.+.+ .++.++|+||||+++|+|++|..||.... ++...+..+..+......+...++.+++|
T Consensus 147 ~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (262)
T cd05572 147 QKTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDL 226 (262)
T ss_pred cccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHH
Confidence 2234568899999998754 58899999999999999999999997643 24555666554444444555558899999
Q ss_pred HHHhcC-CCCCCCC-----HHHHHcCcccccccc
Q 008504 158 IEKCLV-PASERLS-----AKDLLKDPFLQVENQ 185 (563)
Q Consensus 158 I~kcL~-dP~kRpS-----a~ELLkHpff~~~~~ 185 (563)
|.+||. +|.+||+ +.|+++||||+...+
T Consensus 227 i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~ 260 (262)
T cd05572 227 IKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFDW 260 (262)
T ss_pred HHHHccCChhhCcCCcccCHHHHhcChhhhCCCC
Confidence 999997 8999999 999999999987654
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-30 Score=257.22 Aligned_cols=181 Identities=25% Similarity=0.442 Sum_probs=145.3
Q ss_pred CEeccCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhcc
Q 008504 1 MITELFTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~--~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~ 78 (563)
+||||++||+|..++...+ .+++..+..++.||+.||.|||+.| |+||||||+||+++ +.+.++|+|||++....
T Consensus 70 lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~-~~~~~~l~Dfg~~~~~~ 146 (277)
T cd05607 70 LVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD--IVYRDMKPENVLLD-DQGNCRLSDLGLAVELK 146 (277)
T ss_pred EEEecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC--EEEccCChHhEEEc-CCCCEEEeeceeeeecC
Confidence 6899999999999886543 5899999999999999999999999 99999999999998 55799999999986654
Q ss_pred CCC-CccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCC---HHHHHHHHhcCCCCCccccCCChh
Q 008504 79 QPT-ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKN---PAQIFKKVTSGIKPASLAKVNDPQ 153 (563)
Q Consensus 79 ~~~-~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~---~~~i~~~i~~~~~p~~l~~~~s~~ 153 (563)
... .....|++.|+|||++.+ .++.++|||||||++|+|++|..||..... ...+.........+. .....+++
T Consensus 147 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 225 (277)
T cd05607 147 DGKTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKF-EHQNFTEE 225 (277)
T ss_pred CCceeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcccccc-ccccCCHH
Confidence 322 233468999999998864 489999999999999999999999975322 223333332222221 22346789
Q ss_pred HHHHHHHhcC-CCCCCCCH----HHHHcCcccccccc
Q 008504 154 IKGFIEKCLV-PASERLSA----KDLLKDPFLQVENQ 185 (563)
Q Consensus 154 l~~LI~kcL~-dP~kRpSa----~ELLkHpff~~~~~ 185 (563)
+++||.+||. +|.+||++ .++++||||+..++
T Consensus 226 ~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~~ 262 (277)
T cd05607 226 SKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINF 262 (277)
T ss_pred HHHHHHHHhccCHhhCCCCccchhhhhcChhhcCCCH
Confidence 9999999997 89999999 77889999987554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-30 Score=258.54 Aligned_cols=171 Identities=23% Similarity=0.325 Sum_probs=146.3
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSH-NPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~-gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
||||||++|+|.+++.+.+.+++.....++.|++.||.|||+. + ++||||||+||+++ ++|.+||+|||++.....
T Consensus 99 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~--~~Hrdlkp~nill~-~~~~~kl~dfg~~~~~~~ 175 (283)
T PHA02988 99 LILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTN--KPYKNLTSVSFLVT-ENYKLKIICHGLEKILSS 175 (283)
T ss_pred EEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCC--CCCCcCChhhEEEC-CCCcEEEcccchHhhhcc
Confidence 5899999999999999888899999999999999999999984 7 88999999999998 558999999999976543
Q ss_pred CCCccccCCCCccCcccccc---cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHH
Q 008504 80 PTARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKG 156 (563)
Q Consensus 80 ~~~~~~~Gtp~Y~APEvl~~---~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~ 156 (563)
.. ....|++.|+|||++.+ .++.++|||||||++|||++|+.||... +...++..+.........+...++.+++
T Consensus 176 ~~-~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~l~~ 253 (283)
T PHA02988 176 PP-FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENL-TTKEIYDLIINKNNSLKLPLDCPLEIKC 253 (283)
T ss_pred cc-ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCC-CHHHHHHHHHhcCCCCCCCCcCcHHHHH
Confidence 22 34568899999999864 6899999999999999999999999874 4556666665444444455567889999
Q ss_pred HHHHhcC-CCCCCCCHHHHHc
Q 008504 157 FIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 157 LI~kcL~-dP~kRpSa~ELLk 176 (563)
||.+||. +|.+|||+.++++
T Consensus 254 li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 254 IVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred HHHHHhcCCcccCcCHHHHHH
Confidence 9999997 8999999999986
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-30 Score=266.84 Aligned_cols=179 Identities=31% Similarity=0.459 Sum_probs=147.7
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhcc--
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ-- 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~-- 78 (563)
+|+|+|+ .+|.+.++.++.++...+..+++||++||.|+|+.| |+||||||.|+|++.+ ..+||+|||+|+...
T Consensus 103 iV~elMe-tDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAn--ViHRDLKPsNll~n~~-c~lKI~DFGLAR~~~~~ 178 (359)
T KOG0660|consen 103 LVFELME-TDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSAN--VIHRDLKPSNLLLNAD-CDLKICDFGLARYLDKF 178 (359)
T ss_pred EehhHHh-hHHHHHHHcCccccHHHHHHHHHHHHHhcchhhccc--ccccccchhheeeccC-CCEEeccccceeecccc
Confidence 5899994 599999999888999999999999999999999999 9999999999999855 689999999998774
Q ss_pred --CCCCccccCCCCccCccccc--ccCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHH--------------h--
Q 008504 79 --QPTARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKV--------------T-- 138 (563)
Q Consensus 79 --~~~~~~~~Gtp~Y~APEvl~--~~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i--------------~-- 138 (563)
.......+.|.+|.|||++. ..|+.++||||+|||+.||++|+.-|.+.....++.... .
T Consensus 179 ~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~ 258 (359)
T KOG0660|consen 179 FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSE 258 (359)
T ss_pred CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccH
Confidence 33345668899999999874 469999999999999999999999998755444432211 1
Q ss_pred -------c-CCCC-C---ccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCcccccc
Q 008504 139 -------S-GIKP-A---SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 183 (563)
Q Consensus 139 -------~-~~~p-~---~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~ 183 (563)
+ ...+ . .+-...++.+.+|+++||+ ||.+|+|++|+|.||||...
T Consensus 259 ~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~ 316 (359)
T KOG0660|consen 259 KARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPY 316 (359)
T ss_pred HHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhh
Confidence 0 0111 1 1123457899999999998 99999999999999999854
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.6e-30 Score=252.42 Aligned_cols=180 Identities=31% Similarity=0.583 Sum_probs=149.7
Q ss_pred CEeccCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEeccCccCceEEeCCCCcEEEecccchhhcc
Q 008504 1 MITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHS-HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~-~~Lse~~i~~i~~QIL~aL~yLHs-~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~ 78 (563)
+|+||+.+++|.+++... ..+++..+..++.||+.||.|||+ .| ++|+||||+||+++ +.|.++|+|||.+....
T Consensus 76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~--i~H~dl~~~ni~~~-~~~~~~l~d~g~~~~~~ 152 (265)
T cd06605 76 ICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK--IIHRDVKPSNILVN-SRGQIKLCDFGVSGQLV 152 (265)
T ss_pred EEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCC--eecCCCCHHHEEEC-CCCCEEEeecccchhhH
Confidence 589999999999999876 789999999999999999999999 99 99999999999998 46899999999986654
Q ss_pred CCCCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCC----CCHHHHHHHHhcCCCCCccccCCChh
Q 008504 79 QPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSEC----KNPAQIFKKVTSGIKPASLAKVNDPQ 153 (563)
Q Consensus 79 ~~~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~----~~~~~i~~~i~~~~~p~~l~~~~s~~ 153 (563)
........++..|+|||.+.+ .++.++||||||+++|+|++|..||... .......+.+.....+.......++.
T Consensus 153 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (265)
T cd06605 153 NSLAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPD 232 (265)
T ss_pred HHHhhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHH
Confidence 333333678899999998864 4889999999999999999999999764 23334444444444433333337889
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHHcCcccccc
Q 008504 154 IKGFIEKCLV-PASERLSAKDLLKDPFLQVE 183 (563)
Q Consensus 154 l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~ 183 (563)
+++||.+||. +|.+|||+.+++.||||+..
T Consensus 233 ~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~ 263 (265)
T cd06605 233 FQDFVNLCLIKDPRERPSYKELLEHPFIKKY 263 (265)
T ss_pred HHHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence 9999999997 89999999999999999753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=253.64 Aligned_cols=177 Identities=25% Similarity=0.432 Sum_probs=144.8
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
+||||+++|+|.+++...+.+++..++.++.||+.||.|||+.| ++||||||+||+++.+.+.++|+|||++......
T Consensus 86 iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~ 163 (267)
T PHA03390 86 LIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHN--IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP 163 (267)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEeCCCCeEEEecCccceecCCC
Confidence 58999999999999998888999999999999999999999999 9999999999999855449999999998655432
Q ss_pred CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHH-HHHHHhcCCCCCccccCCChhHHHHH
Q 008504 81 TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQ-IFKKVTSGIKPASLAKVNDPQIKGFI 158 (563)
Q Consensus 81 ~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~-i~~~i~~~~~p~~l~~~~s~~l~~LI 158 (563)
....+++.|+|||++.+ .++.++||||||+++|+|++|..||........ ..........+.......++.+++||
T Consensus 164 --~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 241 (267)
T PHA03390 164 --SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNANDFV 241 (267)
T ss_pred --ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHHHHHHH
Confidence 23468899999998864 588999999999999999999999975322211 11111111222234456789999999
Q ss_pred HHhcC-CCCCCCC-HHHHHcCcccc
Q 008504 159 EKCLV-PASERLS-AKDLLKDPFLQ 181 (563)
Q Consensus 159 ~kcL~-dP~kRpS-a~ELLkHpff~ 181 (563)
.+||+ +|.+||+ ++++|+||||.
T Consensus 242 ~~~l~~~p~~R~~~~~~~l~h~~~~ 266 (267)
T PHA03390 242 QSMLKYNINYRLTNYNEIIKHPFLK 266 (267)
T ss_pred HHHhccChhhCCchHHHHhcCCccc
Confidence 99998 8999996 69999999996
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=250.79 Aligned_cols=177 Identities=29% Similarity=0.474 Sum_probs=147.2
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC-
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ- 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~- 79 (563)
+||||+++|+|.+++.+.+.+++..+..++.||+.||.|||+.+ |+|+||+|+||+++ ..+.++|+|||++.....
T Consensus 79 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~~ 155 (265)
T cd06631 79 IFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNC--VVHRDIKGNNVMLM-PNGIIKLIDFGCARRLAWV 155 (265)
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHhEEEC-CCCeEEeccchhhHhhhhc
Confidence 58999999999999998888999999999999999999999999 99999999999998 567999999999865421
Q ss_pred -------CCCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCC
Q 008504 80 -------PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVND 151 (563)
Q Consensus 80 -------~~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s 151 (563)
.......|++.|+|||.+.+ .++.++|+|||||++|+|++|..||......................+...+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (265)
T cd06631 156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFS 235 (265)
T ss_pred cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCC
Confidence 11223468899999998864 4789999999999999999999999865444433333322222333555678
Q ss_pred hhHHHHHHHhcC-CCCCCCCHHHHHcCccc
Q 008504 152 PQIKGFIEKCLV-PASERLSAKDLLKDPFL 180 (563)
Q Consensus 152 ~~l~~LI~kcL~-dP~kRpSa~ELLkHpff 180 (563)
..+.+||.+||. +|.+||++.+++.||||
T Consensus 236 ~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 236 AAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred HHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 899999999997 89999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=279.26 Aligned_cols=177 Identities=27% Similarity=0.500 Sum_probs=150.8
Q ss_pred CEeccCCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhh
Q 008504 1 MITELFTSGNLRQYRKKH----KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 76 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~----~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~ 76 (563)
+||||+++|+|.+++..+ ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+++.
T Consensus 116 lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~--IiHrDLKP~NILl~-~~~~vkL~DFGls~~ 192 (496)
T PTZ00283 116 LVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH--MIHRDIKSANILLC-SNGLVKLGDFGFSKM 192 (496)
T ss_pred EEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEe-CCCCEEEEecccCee
Confidence 589999999999998753 46999999999999999999999999 99999999999998 457999999999875
Q ss_pred ccCC----CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCC
Q 008504 77 MQQP----TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVND 151 (563)
Q Consensus 77 ~~~~----~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s 151 (563)
.... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.. .+...++..+..+... .++...+
T Consensus 193 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~-~~~~~~~~~~~~~~~~-~~~~~~~ 270 (496)
T PTZ00283 193 YAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDG-ENMEEVMHKTLAGRYD-PLPPSIS 270 (496)
T ss_pred ccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHhcCCCC-CCCCCCC
Confidence 5322 2345679999999999875 489999999999999999999999986 4555666666555443 3455678
Q ss_pred hhHHHHHHHhcC-CCCCCCCHHHHHcCccccc
Q 008504 152 PQIKGFIEKCLV-PASERLSAKDLLKDPFLQV 182 (563)
Q Consensus 152 ~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~ 182 (563)
+.+++||.+||. +|.+||++.++++|||++.
T Consensus 271 ~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~ 302 (496)
T PTZ00283 271 PEMQEIVTALLSSDPKRRPSSSKLLNMPICKL 302 (496)
T ss_pred HHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence 899999999997 8999999999999999874
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=263.14 Aligned_cols=182 Identities=19% Similarity=0.433 Sum_probs=146.0
Q ss_pred CEeccCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k-~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
|||||+.+|+|.+++.+ ...+++..++.++.||+.||+|||++| |+||||||+|||++ ..|.+||+|||++.....
T Consensus 78 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~ 154 (331)
T cd05597 78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG--YVHRDIKPDNVLLD-KNGHIRLADFGSCLRLLA 154 (331)
T ss_pred EEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEECCCCHHHEEEC-CCCCEEEEECCceeecCC
Confidence 68999999999999986 457999999999999999999999999 99999999999997 558999999999865433
Q ss_pred CC---CccccCCCCccCccccc------ccCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCC---ccc
Q 008504 80 PT---ARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPA---SLA 147 (563)
Q Consensus 80 ~~---~~~~~Gtp~Y~APEvl~------~~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~---~l~ 147 (563)
.. .....||+.|+|||++. +.++.++|||||||++|+|++|+.||.. ....+.+..+....... ...
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~ 233 (331)
T cd05597 155 DGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA-ESLVETYGKIMNHKEHFQFPPDV 233 (331)
T ss_pred CCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC-CCHHHHHHHHHcCCCcccCCCcc
Confidence 21 12246899999999885 2478899999999999999999999976 34445555554332211 112
Q ss_pred cCCChhHHHHHHHhcCC---CCCCCCHHHHHcCccccccccC
Q 008504 148 KVNDPQIKGFIEKCLVP---ASERLSAKDLLKDPFLQVENQK 186 (563)
Q Consensus 148 ~~~s~~l~~LI~kcL~d---P~kRpSa~ELLkHpff~~~~~~ 186 (563)
...++.+++||.+||.. +..|+++.++++||||...++.
T Consensus 234 ~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~~~ 275 (331)
T cd05597 234 TDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDWD 275 (331)
T ss_pred CCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCCHH
Confidence 33678999999999963 3458899999999999876543
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=254.44 Aligned_cols=176 Identities=30% Similarity=0.429 Sum_probs=139.5
Q ss_pred CEeccCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhcc
Q 008504 1 MITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~--~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~ 78 (563)
+||||+. ++|.+++... ..+++..++.++.||+.||.|||++| |+||||||+||+++ +.+.+||+|||++....
T Consensus 84 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~-~~~~~kl~dfg~~~~~~ 159 (288)
T cd07863 84 LVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVT-SGGQVKLADFGLARIYS 159 (288)
T ss_pred EEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEC-CCCCEEECccCcccccc
Confidence 5899997 4899998764 35899999999999999999999999 99999999999997 55799999999997654
Q ss_pred CC-CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcC-C-C----C-------
Q 008504 79 QP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG-I-K----P------- 143 (563)
Q Consensus 79 ~~-~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~-~-~----p------- 143 (563)
.. ......|++.|+|||++.+ .++.++|||||||++|+|++|..||..........+..... . . +
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (288)
T cd07863 160 CQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPR 239 (288)
T ss_pred CcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccccc
Confidence 32 2234578999999998854 58999999999999999999999997644333222221100 0 0 0
Q ss_pred -----------CccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCccc
Q 008504 144 -----------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 180 (563)
Q Consensus 144 -----------~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff 180 (563)
.......+..+++||.+||. ||.+|||+.+++.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 240 GAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred cccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 00112345678999999997 89999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=251.57 Aligned_cols=176 Identities=30% Similarity=0.531 Sum_probs=143.4
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
+||||+++|+|.+++...+.+++..++.++.||+.||.|||++| |+|+||||+||+++ ..+.+||+|||++......
T Consensus 83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~-~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06645 83 ICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKG--KMHRDIKGANILLT-DNGHVKLADFGVSAQITAT 159 (267)
T ss_pred EEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEC-CCCCEEECcceeeeEccCc
Confidence 58999999999999998889999999999999999999999999 99999999999997 5579999999998654332
Q ss_pred --CCccccCCCCccCccccc----ccCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccc--cCCCh
Q 008504 81 --TARSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLA--KVNDP 152 (563)
Q Consensus 81 --~~~~~~Gtp~Y~APEvl~----~~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~--~~~s~ 152 (563)
......|++.|+|||++. +.++.++|+|||||++|+|++|..||..................+.... ...+.
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd06645 160 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSN 239 (267)
T ss_pred ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCH
Confidence 123457899999999873 3488899999999999999999999976443333333222222222221 13467
Q ss_pred hHHHHHHHhcC-CCCCCCCHHHHHcCcc
Q 008504 153 QIKGFIEKCLV-PASERLSAKDLLKDPF 179 (563)
Q Consensus 153 ~l~~LI~kcL~-dP~kRpSa~ELLkHpf 179 (563)
.+++||.+||. +|.+||++.++++|||
T Consensus 240 ~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 240 SFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred HHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 89999999997 8999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-30 Score=266.77 Aligned_cols=182 Identities=30% Similarity=0.445 Sum_probs=152.4
Q ss_pred CEeccCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhh
Q 008504 1 MITELFTSGNLRQYRKK----HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 76 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k----~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~ 76 (563)
|||||++. +|.++++. +..++.-.++-+++||++||+|||++| |+||||||.|||+|.+.|.+||||||.|+.
T Consensus 99 lVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~--IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 99 LVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG--ICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred HHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC--cccCCCChheEEEcCCCCeEEeccCCccee
Confidence 58999986 99999884 577999999999999999999999999 999999999999999999999999999987
Q ss_pred ccCC-CCccccCCCCccCcccccc--cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhc-C------------
Q 008504 77 MQQP-TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS-G------------ 140 (563)
Q Consensus 77 ~~~~-~~~~~~Gtp~Y~APEvl~~--~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~-~------------ 140 (563)
+... ...+++.+..|.|||++-+ .|+.+.||||.||++.||+-|++-|.+.....++...+.- |
T Consensus 176 L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~ 255 (364)
T KOG0658|consen 176 LVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNP 255 (364)
T ss_pred eccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCc
Confidence 7543 3456678999999998854 5999999999999999999999999986655555443321 0
Q ss_pred ---------CCCC----ccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCcccccccc
Q 008504 141 ---------IKPA----SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQ 185 (563)
Q Consensus 141 ---------~~p~----~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~~ 185 (563)
..+. .+....++++.+|+.++|+ +|.+|.++.|+|.||||+.-..
T Consensus 256 ~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~ 314 (364)
T KOG0658|consen 256 NYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRD 314 (364)
T ss_pred ccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhC
Confidence 0011 1334557899999999998 8999999999999999985443
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-30 Score=259.39 Aligned_cols=184 Identities=23% Similarity=0.378 Sum_probs=155.1
Q ss_pred CEeccCCCCCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeC--CCCcEEEecccchhh
Q 008504 1 MITELFTSGNLRQYRKKHKN--VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG--NHGEVKIGDLGLAIA 76 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~--Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~--~~G~VKL~DFGlA~~ 76 (563)
+|||.|+||.|+..+..++. ++++++..|++||..|+.|||+.+ |.||||||+|+|..+ .+..+||+|||+|+.
T Consensus 136 iVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n--IAHRDlKpENLLyt~t~~na~lKLtDfGFAK~ 213 (400)
T KOG0604|consen 136 IVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN--IAHRDLKPENLLYTTTSPNAPLKLTDFGFAKE 213 (400)
T ss_pred eeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc--hhhccCChhheeeecCCCCcceEecccccccc
Confidence 69999999999999988765 999999999999999999999999 999999999999964 345799999999987
Q ss_pred ccC-CCCccccCCCCccCccccc-ccCCchhhHHHhHHHHHHHhhcCCCCCCCC---CHHHHHHHHhcCCC--CCccccC
Q 008504 77 MQQ-PTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECK---NPAQIFKKVTSGIK--PASLAKV 149 (563)
Q Consensus 77 ~~~-~~~~~~~Gtp~Y~APEvl~-~~ys~ksDIwSLGviLyELlTG~~Pf~~~~---~~~~i~~~i~~~~~--p~~l~~~ 149 (563)
... ....+.+-||.|.|||++. .+|+..+|+||+||++|-|++|.+||.... -......+|..|.. |..-+..
T Consensus 214 t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~ 293 (400)
T KOG0604|consen 214 TQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSC 293 (400)
T ss_pred cCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhHhH
Confidence 653 3456678899999999996 569999999999999999999999997522 22345556666654 3334455
Q ss_pred CChhHHHHHHHhcC-CCCCCCCHHHHHcCccccccccC
Q 008504 150 NDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQK 186 (563)
Q Consensus 150 ~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~~~ 186 (563)
.+...+++|+++|. +|.+|.|+.+++.|||+......
T Consensus 294 VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~v 331 (400)
T KOG0604|consen 294 VSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAV 331 (400)
T ss_pred HHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccC
Confidence 67899999999997 99999999999999999865543
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=250.17 Aligned_cols=179 Identities=24% Similarity=0.468 Sum_probs=149.7
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
+||||+++|+|.+++...+.+++..+..++.||+.||.|||+++ ++||||+|+||+++ +.+.+||+|||++.....
T Consensus 74 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~- 149 (260)
T cd05611 74 LVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRG--IIHRDIKPENLLID-QTGHLKLTDFGLSRNGLE- 149 (260)
T ss_pred EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEC-CCCcEEEeecccceeccc-
Confidence 58999999999999998888999999999999999999999999 99999999999998 567999999999865433
Q ss_pred CCccccCCCCccCccccccc-CCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCC--CCccccCCChhHHHH
Q 008504 81 TARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK--PASLAKVNDPQIKGF 157 (563)
Q Consensus 81 ~~~~~~Gtp~Y~APEvl~~~-ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~--p~~l~~~~s~~l~~L 157 (563)
.....+++.|+|||.+.+. ++.++||||||+++|+|++|..||... +....+..+..+.. +.......++.+.++
T Consensus 150 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (260)
T cd05611 150 -NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAE-TPDAVFDNILSRRINWPEEVKEFCSPEAVDL 227 (260)
T ss_pred -cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCC-CHHHHHHHHHhcccCCCCcccccCCHHHHHH
Confidence 2344688999999988654 789999999999999999999999763 44555555444322 223344568899999
Q ss_pred HHHhcC-CCCCCCC---HHHHHcCcccccccc
Q 008504 158 IEKCLV-PASERLS---AKDLLKDPFLQVENQ 185 (563)
Q Consensus 158 I~kcL~-dP~kRpS---a~ELLkHpff~~~~~ 185 (563)
|.+||. +|.+||+ +.|+|.||||...+|
T Consensus 228 i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~~ 259 (260)
T cd05611 228 INRLLCMDPAKRLGANGYQEIKSHPFFKSINW 259 (260)
T ss_pred HHHHccCCHHHccCCCcHHHHHcChHhhcCCC
Confidence 999997 8999995 579999999987654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-29 Score=246.99 Aligned_cols=175 Identities=30% Similarity=0.614 Sum_probs=146.5
Q ss_pred CEeccCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhcc
Q 008504 1 MITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~--~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~ 78 (563)
+||||+++++|.+++... ..+++..++.++.|++.||.|||+.| |+||||||+||+++ ..+.++|+|||++....
T Consensus 77 lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~--i~H~di~p~nil~~-~~~~~~l~df~~~~~~~ 153 (257)
T cd08223 77 IVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH--ILHRDLKTQNVFLT-RTNIIKVGDLGIARVLE 153 (257)
T ss_pred EEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCchhEEEe-cCCcEEEecccceEEec
Confidence 589999999999999763 45899999999999999999999999 99999999999997 56799999999986553
Q ss_pred CC--CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHH
Q 008504 79 QP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIK 155 (563)
Q Consensus 79 ~~--~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~ 155 (563)
.. ......+++.|+|||++.+ .++.++||||||+++|+|++|+.||... +.......+..+..+ ..+...++.+.
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~ 231 (257)
T cd08223 154 NQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAK-DMNSLVYRIIEGKLP-PMPKDYSPELG 231 (257)
T ss_pred ccCCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCC-CHHHHHHHHHhcCCC-CCccccCHHHH
Confidence 22 2234568899999998864 4788999999999999999999999763 344444444444433 24456778999
Q ss_pred HHHHHhcC-CCCCCCCHHHHHcCccc
Q 008504 156 GFIEKCLV-PASERLSAKDLLKDPFL 180 (563)
Q Consensus 156 ~LI~kcL~-dP~kRpSa~ELLkHpff 180 (563)
+||.+||. +|.+||++.++++||||
T Consensus 232 ~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 232 ELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred HHHHHHhccCcccCCCHHHHhcCCCC
Confidence 99999997 89999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=276.54 Aligned_cols=177 Identities=29% Similarity=0.490 Sum_probs=149.4
Q ss_pred CEeccCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhh
Q 008504 1 MITELFTSGNLRQYRKK----HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 76 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k----~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~ 76 (563)
|||||+++|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++ ..+.+||+|||++..
T Consensus 142 lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~-~~~~~kL~DFgla~~ 218 (478)
T PTZ00267 142 LIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK--MMHRDLKSANIFLM-PTGIIKLGDFGFSKQ 218 (478)
T ss_pred EEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCcCHHhEEEC-CCCcEEEEeCcCcee
Confidence 69999999999988754 456999999999999999999999999 99999999999998 557999999999976
Q ss_pred ccCC----CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCC
Q 008504 77 MQQP----TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVND 151 (563)
Q Consensus 77 ~~~~----~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s 151 (563)
.... .....+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.. .....+...+..+..+ ..+...+
T Consensus 219 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~-~~~~~~~~~~~~~~~~-~~~~~~s 296 (478)
T PTZ00267 219 YSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKG-PSQREIMQQVLYGKYD-PFPCPVS 296 (478)
T ss_pred cCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCC-CCCccCC
Confidence 5432 1334579999999998864 489999999999999999999999976 3455555555554433 2345567
Q ss_pred hhHHHHHHHhcC-CCCCCCCHHHHHcCccccc
Q 008504 152 PQIKGFIEKCLV-PASERLSAKDLLKDPFLQV 182 (563)
Q Consensus 152 ~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~ 182 (563)
+.+++||.+||. +|.+||++.+++.|+|++.
T Consensus 297 ~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 297 SGMKALLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred HHHHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 899999999997 8999999999999999964
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=253.72 Aligned_cols=176 Identities=31% Similarity=0.524 Sum_probs=144.6
Q ss_pred CEeccCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhcc
Q 008504 1 MITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~--~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~ 78 (563)
+||||+.+|+|.+++... ..+++..++.++.||+.||.|||++| |+||||+|+||+++ +.+.++|+|||++....
T Consensus 96 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dl~~~nili~-~~~~~~l~dfg~~~~~~ 172 (282)
T cd06636 96 LVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK--VIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLD 172 (282)
T ss_pred EEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCCEEEeeCcchhhhh
Confidence 589999999999999763 45889999999999999999999999 99999999999997 56799999999986553
Q ss_pred CC--CCccccCCCCccCccccc------ccCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCC
Q 008504 79 QP--TARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVN 150 (563)
Q Consensus 79 ~~--~~~~~~Gtp~Y~APEvl~------~~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~ 150 (563)
.. ......|++.|+|||.+. ..++.++|||||||++|+|++|..||......... ..+.....+.......
T Consensus 173 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~ 251 (282)
T cd06636 173 RTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL-FLIPRNPPPKLKSKKW 251 (282)
T ss_pred ccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhh-hhHhhCCCCCCccccc
Confidence 22 233457899999999874 34788999999999999999999999764433333 2333333333334456
Q ss_pred ChhHHHHHHHhcC-CCCCCCCHHHHHcCccc
Q 008504 151 DPQIKGFIEKCLV-PASERLSAKDLLKDPFL 180 (563)
Q Consensus 151 s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff 180 (563)
+..+.+||.+||. +|.+||++.+||+||||
T Consensus 252 ~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 252 SKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred CHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 7899999999997 89999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-30 Score=252.55 Aligned_cols=177 Identities=34% Similarity=0.631 Sum_probs=144.0
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhc--c
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM--Q 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~--~ 78 (563)
+||||+.+++|.+++.+.+.+++..++.++.||+.||.+||++| |+|+||||+||+++ +++.++|+|||.+... .
T Consensus 75 ~v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~--i~H~dikp~NIl~~-~~~~~~l~Dfg~~~~~~~~ 151 (260)
T PF00069_consen 75 IVMEYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKG--IVHRDIKPENILLD-ENGEVKLIDFGSSVKLSEN 151 (260)
T ss_dssp EEEEEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTT--EEESSBSGGGEEES-TTSEEEESSGTTTEESTST
T ss_pred cccccccccccccccccccccccccccccccccccccccccccc--cccccccccccccc-ccccccccccccccccccc
Confidence 58999999999999998788999999999999999999999999 99999999999998 6689999999998643 2
Q ss_pred CCCCccccCCCCccCccccc--ccCCchhhHHHhHHHHHHHhhcCCCCCCCC--CHHHHHHHHhcCCCCCccc--cCCCh
Q 008504 79 QPTARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTFEYPYSECK--NPAQIFKKVTSGIKPASLA--KVNDP 152 (563)
Q Consensus 79 ~~~~~~~~Gtp~Y~APEvl~--~~ys~ksDIwSLGviLyELlTG~~Pf~~~~--~~~~i~~~i~~~~~p~~l~--~~~s~ 152 (563)
........+++.|+|||++. ..++.++||||||+++|+|++|..||.... +.................. ....+
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (260)
T PF00069_consen 152 NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSE 231 (260)
T ss_dssp TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHH
Confidence 23344567899999999987 458999999999999999999999998742 1222222222211111111 11137
Q ss_pred hHHHHHHHhcC-CCCCCCCHHHHHcCccc
Q 008504 153 QIKGFIEKCLV-PASERLSAKDLLKDPFL 180 (563)
Q Consensus 153 ~l~~LI~kcL~-dP~kRpSa~ELLkHpff 180 (563)
.++++|.+||. +|.+||++.++++||||
T Consensus 232 ~l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 232 ELRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 99999999997 89999999999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=254.53 Aligned_cols=181 Identities=29% Similarity=0.496 Sum_probs=153.7
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
+||||+++|+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||+|+|||++ .+|.+||+|||++......
T Consensus 78 ~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~--i~H~dl~p~nili~-~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 78 LVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLD--IVYRDLKPENLLLD-SDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEC-CCCCEEEeeCCCccccCCC
Confidence 58999999999999998889999999999999999999999999 99999999999998 4579999999998765443
Q ss_pred CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHHHHH
Q 008504 81 TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIE 159 (563)
Q Consensus 81 ~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~LI~ 159 (563)
.....+++.|+|||.+.+ .++.++||||||+++|+|++|..||... ......+.+..+.. .++...++.++++|.
T Consensus 155 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~--~~~~~~~~~l~~li~ 230 (290)
T cd05580 155 -TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDD-NPIQIYEKILEGKV--RFPSFFSPDAKDLIR 230 (290)
T ss_pred -CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhcCCc--cCCccCCHHHHHHHH
Confidence 334578999999998754 4788999999999999999999999763 34555555554432 244556889999999
Q ss_pred HhcC-CCCCCC-----CHHHHHcCccccccccCCC
Q 008504 160 KCLV-PASERL-----SAKDLLKDPFLQVENQKEP 188 (563)
Q Consensus 160 kcL~-dP~kRp-----Sa~ELLkHpff~~~~~~~~ 188 (563)
+||. +|.+|+ ++.++++||||+...+...
T Consensus 231 ~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~~ 265 (290)
T cd05580 231 NLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWIAL 265 (290)
T ss_pred HHccCCHHHccCcccCCHHHHHcCcccccCCHHHH
Confidence 9997 899999 9999999999987665443
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=268.96 Aligned_cols=180 Identities=28% Similarity=0.471 Sum_probs=155.8
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCC---CCcEEEecccchhhc
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGN---HGEVKIGDLGLAIAM 77 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~---~G~VKL~DFGlA~~~ 77 (563)
+|||+|.||.|++.+.+. .+++..+..+++||+.|+.|||+.| |+||||||+|+|+... .+.+|++|||++...
T Consensus 113 lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~g--vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~ 189 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLG--VVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFI 189 (382)
T ss_pred EEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCHHHeeeccccCCCCcEEEeeCCCceEc
Confidence 699999999999999876 4999999999999999999999999 9999999999999644 247999999999877
Q ss_pred cC-CCCccccCCCCccCccccc-ccCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCC--CCccccCCChh
Q 008504 78 QQ-PTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK--PASLAKVNDPQ 153 (563)
Q Consensus 78 ~~-~~~~~~~Gtp~Y~APEvl~-~~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~--p~~l~~~~s~~ 153 (563)
.. ......+|||.|+|||++. ..|+..+||||+|+++|.|++|..||.. .........+..+.. ........+..
T Consensus 190 ~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~-~~~~~~~~~i~~~~~~f~~~~w~~is~~ 268 (382)
T KOG0032|consen 190 KPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWG-ETEFEIFLAILRGDFDFTSEPWDDISES 268 (382)
T ss_pred cCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcC-CChhHHHHHHHcCCCCCCCCCccccCHH
Confidence 65 3456679999999999998 6799999999999999999999999987 445555667776654 23334455789
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHHcCccccccc
Q 008504 154 IKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 184 (563)
Q Consensus 154 l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~ 184 (563)
+++||.+||. ||.+|+|+.++|+|||++...
T Consensus 269 akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~ 300 (382)
T KOG0032|consen 269 AKDFIRKLLEFDPRKRLTAAQALQHPWIKSIG 300 (382)
T ss_pred HHHHHHHhcccCcccCCCHHHHhcCccccCCc
Confidence 9999999997 899999999999999998653
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=262.98 Aligned_cols=183 Identities=19% Similarity=0.454 Sum_probs=147.5
Q ss_pred CEeccCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k-~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
|||||+.||+|.+++.+ .+.+++..++.|+.||+.||.|||++| |+||||||+|||++ ..|.+||+|||++.....
T Consensus 78 lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~--iiHrDlkp~Nill~-~~~~~kl~DfG~a~~~~~ 154 (331)
T cd05624 78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH--YVHRDIKPDNVLLD-MNGHIRLADFGSCLKMNQ 154 (331)
T ss_pred EEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCchHHEEEc-CCCCEEEEeccceeeccC
Confidence 68999999999999987 467999999999999999999999999 99999999999998 557999999999866543
Q ss_pred CC---CccccCCCCccCcccccc------cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccc---
Q 008504 80 PT---ARSVIGTPEFMAPELYEE------EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLA--- 147 (563)
Q Consensus 80 ~~---~~~~~Gtp~Y~APEvl~~------~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~--- 147 (563)
.. .....|++.|+|||++.+ .++.++|||||||++|+|++|+.||.. .+....+..+........++
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~ 233 (331)
T cd05624 155 DGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA-ESLVETYGKIMNHEERFQFPSHI 233 (331)
T ss_pred CCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccC-CCHHHHHHHHHcCCCcccCCCcc
Confidence 22 123469999999998863 478899999999999999999999986 34455555554432211122
Q ss_pred cCCChhHHHHHHHhcCCCCC---CCCHHHHHcCccccccccCC
Q 008504 148 KVNDPQIKGFIEKCLVPASE---RLSAKDLLKDPFLQVENQKE 187 (563)
Q Consensus 148 ~~~s~~l~~LI~kcL~dP~k---RpSa~ELLkHpff~~~~~~~ 187 (563)
...+..+++||.+||..+.+ |+++.++++||||+..++..
T Consensus 234 ~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~~~~ 276 (331)
T cd05624 234 TDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDWEN 276 (331)
T ss_pred ccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCCHHH
Confidence 23478999999999974333 57999999999998766544
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-29 Score=249.58 Aligned_cols=177 Identities=35% Similarity=0.575 Sum_probs=145.8
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
+|+||+++++|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||+|+||+++ ..+.+||+|||++......
T Consensus 83 l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~--i~H~~l~p~nil~~-~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd06651 83 IFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM--IVHRDIKGANILRD-SAGNVKLGDFGASKRLQTI 159 (266)
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEC-CCCCEEEccCCCccccccc
Confidence 58999999999999998888999999999999999999999999 99999999999998 5579999999998654321
Q ss_pred -----CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhH
Q 008504 81 -----TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQI 154 (563)
Q Consensus 81 -----~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l 154 (563)
......++..|+|||.+.+ .++.++|||||||++|+|++|+.||........+..... ......++...++.+
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 238 (266)
T cd06651 160 CMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIAT-QPTNPQLPSHISEHA 238 (266)
T ss_pred cccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhc-CCCCCCCchhcCHHH
Confidence 1123457889999998864 478999999999999999999999987544444443333 323344556678889
Q ss_pred HHHHHHhcCCCCCCCCHHHHHcCcccc
Q 008504 155 KGFIEKCLVPASERLSAKDLLKDPFLQ 181 (563)
Q Consensus 155 ~~LI~kcL~dP~kRpSa~ELLkHpff~ 181 (563)
++||..|+.+|.+||++.++++||||+
T Consensus 239 ~~li~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 239 RDFLGCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred HHHHHHhcCChhhCcCHHHHhcCcccc
Confidence 999954445999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-30 Score=276.76 Aligned_cols=174 Identities=32% Similarity=0.512 Sum_probs=150.7
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
||||||..|.|...|+...++....+..|.++|+.|+.|||.+. |||||||.-||||..+ ..|||+|||-++.....
T Consensus 189 IiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hK--IIHRDLKSPNiLIs~~-d~VKIsDFGTS~e~~~~ 265 (904)
T KOG4721|consen 189 IIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHK--IIHRDLKSPNILISYD-DVVKISDFGTSKELSDK 265 (904)
T ss_pred EeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhh--HhhhccCCCceEeecc-ceEEeccccchHhhhhh
Confidence 69999999999999999999999999999999999999999999 9999999999999855 49999999999776543
Q ss_pred -CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHHHH
Q 008504 81 -TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFI 158 (563)
Q Consensus 81 -~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~LI 158 (563)
+.-.+.||..|||||++++ ..++|+|||||||+||||+||+.||.+....+ ++.-+-.+......+..++..++-||
T Consensus 266 STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA-IIwGVGsNsL~LpvPstcP~GfklL~ 344 (904)
T KOG4721|consen 266 STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA-IIWGVGSNSLHLPVPSTCPDGFKLLL 344 (904)
T ss_pred hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe-eEEeccCCcccccCcccCchHHHHHH
Confidence 4557899999999999975 48999999999999999999999998743322 32333334444456777888999999
Q ss_pred HHhcC-CCCCCCCHHHHHcCc
Q 008504 159 EKCLV-PASERLSAKDLLKDP 178 (563)
Q Consensus 159 ~kcL~-dP~kRpSa~ELLkHp 178 (563)
+.||. +|..||++.++|.|-
T Consensus 345 Kqcw~sKpRNRPSFrqil~Hl 365 (904)
T KOG4721|consen 345 KQCWNSKPRNRPSFRQILLHL 365 (904)
T ss_pred HHHHhcCCCCCccHHHHHHHH
Confidence 99997 899999999999885
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-29 Score=245.66 Aligned_cols=181 Identities=28% Similarity=0.493 Sum_probs=149.8
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
+||||+.+|+|.+++.+.+.+++..+..++.||+.||.|||+++ ++||||+|+||+++ .++.++|+|||++......
T Consensus 70 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~di~~~nil~~-~~~~~~l~dfg~~~~~~~~ 146 (265)
T cd05579 70 LVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNG--IIHRDLKPDNILID-SNGHLKLTDFGLSKVGLVR 146 (265)
T ss_pred EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcC--eecCCCCHHHeEEc-CCCCEEEEecccchhcccC
Confidence 58999999999999998888999999999999999999999999 99999999999998 4579999999998654322
Q ss_pred ----------CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccC
Q 008504 81 ----------TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKV 149 (563)
Q Consensus 81 ----------~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~ 149 (563)
......+++.|+|||.+.. .++.++|+||||+++|+|++|..||.. .........+..+..+......
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~ 225 (265)
T cd05579 147 RQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHG-ETPEEIFQNILNGKIEWPEDVE 225 (265)
T ss_pred cccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhcCCcCCCcccc
Confidence 1223467889999998754 478899999999999999999999976 3455556555554433222222
Q ss_pred CChhHHHHHHHhcC-CCCCCCCH---HHHHcCcccccccc
Q 008504 150 NDPQIKGFIEKCLV-PASERLSA---KDLLKDPFLQVENQ 185 (563)
Q Consensus 150 ~s~~l~~LI~kcL~-dP~kRpSa---~ELLkHpff~~~~~ 185 (563)
.++.+.+||.+||. +|.+|||+ .++|+||||...+|
T Consensus 226 ~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~~ 265 (265)
T cd05579 226 VSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGIDW 265 (265)
T ss_pred CCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCCCC
Confidence 37899999999997 89999999 99999999986543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-29 Score=248.51 Aligned_cols=175 Identities=32% Similarity=0.582 Sum_probs=146.3
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
+||||+++++|.+++...+.+++..++.++.|++.||.|||++| ++||||+|+||+++ +.+.+||+|||++......
T Consensus 83 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~--ivH~di~p~nil~~-~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06628 83 IFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRG--IIHRDIKGANILVD-NKGGIKISDFGISKKLEAN 159 (267)
T ss_pred EEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcC--cccccCCHHHEEEc-CCCCEEecccCCCcccccc
Confidence 58999999999999998888999999999999999999999999 99999999999997 5679999999998655421
Q ss_pred C--------CccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCC
Q 008504 81 T--------ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVND 151 (563)
Q Consensus 81 ~--------~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s 151 (563)
. .....|++.|+|||.+.+ .++.++|+|||||++|+|++|+.||........+ ..+..... ...+...+
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~~-~~~~~~~~ 237 (267)
T cd06628 160 SLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAI-FKIGENAS-PEIPSNIS 237 (267)
T ss_pred cccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHH-HHHhccCC-CcCCcccC
Confidence 1 112457889999998864 4888999999999999999999999875443333 33333322 23445667
Q ss_pred hhHHHHHHHhcC-CCCCCCCHHHHHcCccc
Q 008504 152 PQIKGFIEKCLV-PASERLSAKDLLKDPFL 180 (563)
Q Consensus 152 ~~l~~LI~kcL~-dP~kRpSa~ELLkHpff 180 (563)
..++++|.+||. +|.+||++.++++||||
T Consensus 238 ~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 238 SEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred HHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 899999999998 89999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-29 Score=255.55 Aligned_cols=179 Identities=30% Similarity=0.529 Sum_probs=145.6
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHS-HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs-~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
+||||+++|+|.+++.+.+.+++..++.++.||+.||.|||+ ++ ++||||||+|||++ .++.+||+|||++.....
T Consensus 76 lv~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~ 152 (308)
T cd06615 76 ICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHK--IMHRDVKPSNILVN-SRGEIKLCDFGVSGQLID 152 (308)
T ss_pred EEeeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC--EEECCCChHHEEEe-cCCcEEEccCCCcccccc
Confidence 589999999999999988889999999999999999999997 58 99999999999998 457999999999876554
Q ss_pred CCCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHh--------------------
Q 008504 80 PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVT-------------------- 138 (563)
Q Consensus 80 ~~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~-------------------- 138 (563)
.......+++.|+|||++.+ .++.++|+||||+++|+|++|+.||.... .......+.
T Consensus 153 ~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (308)
T cd06615 153 SMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPD-AKELEAMFGRPVSEGEAKESHRPVSGHPP 231 (308)
T ss_pred cccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcc-hhhHHHhhcCccccccccCCcccccCCCC
Confidence 44455678999999998864 48889999999999999999999986422 222221111
Q ss_pred ----------------cCCCCCccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCcccccc
Q 008504 139 ----------------SGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 183 (563)
Q Consensus 139 ----------------~~~~p~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~ 183 (563)
....+.......++.+++||.+||. +|.+||++.++++||||...
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 232 DSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred CccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence 1111111122356789999999997 89999999999999999753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.1e-29 Score=250.61 Aligned_cols=179 Identities=30% Similarity=0.546 Sum_probs=145.7
Q ss_pred CEeccCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k-~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
+|+||+.+|+|..++.+ .+.+++..+..++.||+.||.|||+.| |+||||||+||+++ .++.+||+|||++.....
T Consensus 79 ~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~--i~H~dlkp~nili~-~~~~~kl~dfg~~~~~~~ 155 (282)
T cd06643 79 ILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK--IIHRDLKAGNILFT-LDGDIKLADFGVSAKNTR 155 (282)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEc-cCCCEEEccccccccccc
Confidence 58999999999998765 467999999999999999999999999 99999999999997 557999999999865432
Q ss_pred C--CCccccCCCCccCccccc------ccCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCC-CCccccCC
Q 008504 80 P--TARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK-PASLAKVN 150 (563)
Q Consensus 80 ~--~~~~~~Gtp~Y~APEvl~------~~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~-p~~l~~~~ 150 (563)
. ......+++.|+|||++. ..++.++|||||||++|+|++|+.||.... .......+..... ....+...
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
T cd06643 156 TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELN-PMRVLLKIAKSEPPTLAQPSRW 234 (282)
T ss_pred cccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccC-HHHHHHHHhhcCCCCCCCcccc
Confidence 2 223456899999999873 237789999999999999999999998743 3333333333322 22234456
Q ss_pred ChhHHHHHHHhcC-CCCCCCCHHHHHcCcccccc
Q 008504 151 DPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 183 (563)
Q Consensus 151 s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~ 183 (563)
+..+++||.+||. +|.+||++.++++||||...
T Consensus 235 ~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 268 (282)
T cd06643 235 SSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVN 268 (282)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence 7899999999997 89999999999999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-29 Score=245.10 Aligned_cols=175 Identities=33% Similarity=0.600 Sum_probs=147.7
Q ss_pred CEeccCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhcc
Q 008504 1 MITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~--~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~ 78 (563)
+||||+++++|.+++... ..+++..++.++.||+.||.|||+.| ++||||||+||+++ ..+.++|+|||++....
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~--i~h~dl~~~nili~-~~~~~~l~df~~~~~~~ 152 (256)
T cd08529 76 IVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK--ILHRDIKSLNLFLD-AYDNVKIGDLGVAKLLS 152 (256)
T ss_pred EEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEe-CCCCEEEcccccceecc
Confidence 589999999999999874 56999999999999999999999999 99999999999998 45799999999987654
Q ss_pred CCC--CccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHH
Q 008504 79 QPT--ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIK 155 (563)
Q Consensus 79 ~~~--~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~ 155 (563)
... .....|++.|+|||++.+ .++.++|+|||||++|+|++|+.||... +.......+..+..+. .+...+..+.
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~ 230 (256)
T cd08529 153 DNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDAN-NQGALILKIIRGVFPP-VSQMYSQQLA 230 (256)
T ss_pred CccchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHcCCCCC-CccccCHHHH
Confidence 322 233468899999998864 4789999999999999999999999764 4555555555554433 3446778999
Q ss_pred HHHHHhcC-CCCCCCCHHHHHcCccc
Q 008504 156 GFIEKCLV-PASERLSAKDLLKDPFL 180 (563)
Q Consensus 156 ~LI~kcL~-dP~kRpSa~ELLkHpff 180 (563)
++|.+||. +|.+||++.++++|||+
T Consensus 231 ~~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 231 QLIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred HHHHHHccCCcccCcCHHHHhhCCCC
Confidence 99999997 89999999999999996
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-29 Score=258.61 Aligned_cols=153 Identities=25% Similarity=0.418 Sum_probs=124.4
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCCC----CccccCCCCccCcc
Q 008504 20 NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT----ARSVIGTPEFMAPE 95 (563)
Q Consensus 20 ~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~~----~~~~~Gtp~Y~APE 95 (563)
.+++..+..++.||+.||.|||++| |+||||||+|||++ .++.+||+|||+++...... .....+++.|+|||
T Consensus 170 ~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDiKp~Nil~~-~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE 246 (338)
T cd05102 170 PLTMEDLICYSFQVARGMEFLASRK--CIHRDLAARNILLS-ENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPE 246 (338)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCccceEEEc-CCCcEEEeecccccccccCcchhcccCCCCCccccCcH
Confidence 4788899999999999999999999 99999999999998 45799999999997543221 12234567899999
Q ss_pred cccc-cCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHHHHHHhcC-CCCCCCCHH
Q 008504 96 LYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAK 172 (563)
Q Consensus 96 vl~~-~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ 172 (563)
++.+ .++.++|||||||++|||++ |..||............+..+..+ ..+...++.+++||.+||. +|.+|||+.
T Consensus 247 ~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dp~~RPs~~ 325 (338)
T cd05102 247 SIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRM-RAPENATPEIYRIMLACWQGDPKERPTFS 325 (338)
T ss_pred HhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCC-CCCCCCCHHHHHHHHHHccCChhhCcCHH
Confidence 8754 58999999999999999997 999998755444555555544433 3455677899999999997 899999999
Q ss_pred HHHc
Q 008504 173 DLLK 176 (563)
Q Consensus 173 ELLk 176 (563)
++++
T Consensus 326 el~~ 329 (338)
T cd05102 326 ALVE 329 (338)
T ss_pred HHHH
Confidence 9986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-29 Score=255.36 Aligned_cols=177 Identities=28% Similarity=0.443 Sum_probs=134.3
Q ss_pred CEeccCCCCCHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEe---CCCCcEEE
Q 008504 1 MITELFTSGNLRQYRKKH---------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN---GNHGEVKI 68 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~---------~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd---~~~G~VKL 68 (563)
+||||+. ++|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||+. ...+.+||
T Consensus 77 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivHrDlkp~Nil~~~~~~~~~~~kl 153 (317)
T cd07868 77 LLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKI 153 (317)
T ss_pred EEEeccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEecCCCCcCcEEE
Confidence 5789985 5898887632 24899999999999999999999999 99999999999994 24578999
Q ss_pred ecccchhhccCC-----CCccccCCCCccCcccccc--cCCchhhHHHhHHHHHHHhhcCCCCCCCCCH---------HH
Q 008504 69 GDLGLAIAMQQP-----TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNP---------AQ 132 (563)
Q Consensus 69 ~DFGlA~~~~~~-----~~~~~~Gtp~Y~APEvl~~--~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~---------~~ 132 (563)
+|||++...... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||...... .+
T Consensus 154 ~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~ 233 (317)
T cd07868 154 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ 233 (317)
T ss_pred eecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHH
Confidence 999999765432 1234578999999998854 4899999999999999999999999642210 11
Q ss_pred HHHHHhc-CCC-----------C-----------------------CccccCCChhHHHHHHHhcC-CCCCCCCHHHHHc
Q 008504 133 IFKKVTS-GIK-----------P-----------------------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 133 i~~~i~~-~~~-----------p-----------------------~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLk 176 (563)
+...+.. +.. + .......+..+.+||.+||. ||.+|||+.|+|+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~ 313 (317)
T cd07868 234 LDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 313 (317)
T ss_pred HHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhc
Confidence 1111000 000 0 00001224568899999998 9999999999999
Q ss_pred Cccc
Q 008504 177 DPFL 180 (563)
Q Consensus 177 Hpff 180 (563)
||||
T Consensus 314 hp~f 317 (317)
T cd07868 314 DPYF 317 (317)
T ss_pred CCCC
Confidence 9998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=272.79 Aligned_cols=183 Identities=30% Similarity=0.490 Sum_probs=152.4
Q ss_pred CEeccCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k-~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
|+.|||.||-....+-. ...|.+.+|.-+++|+|.||.|||+++ |||||||..|||++ -+|.|+|+|||.+.....
T Consensus 106 iliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~--iIHRDLKAGNiL~T-ldGdirLADFGVSAKn~~ 182 (1187)
T KOG0579|consen 106 ILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQN--IIHRDLKAGNILLT-LDGDIRLADFGVSAKNKS 182 (1187)
T ss_pred EEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcc--hhhhhccccceEEE-ecCcEeeecccccccchh
Confidence 46899999999988765 457999999999999999999999999 99999999999998 568999999999854322
Q ss_pred --CCCccccCCCCccCccccc------ccCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCC
Q 008504 80 --PTARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVND 151 (563)
Q Consensus 80 --~~~~~~~Gtp~Y~APEvl~------~~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s 151 (563)
....+++|||+|||||++. ..|+.++||||||++|.||.-+.+|.+.......+.+......+....|..++
T Consensus 183 t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws 262 (1187)
T KOG0579|consen 183 TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWS 262 (1187)
T ss_pred HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhh
Confidence 2456789999999999763 35999999999999999999999998874444444444444444444566778
Q ss_pred hhHHHHHHHhcC-CCCCCCCHHHHHcCccccccccC
Q 008504 152 PQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQK 186 (563)
Q Consensus 152 ~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~~~ 186 (563)
..+++|+++||. +|..||++.+||+||||+.....
T Consensus 263 ~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~Sn 298 (1187)
T KOG0579|consen 263 RSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAPSN 298 (1187)
T ss_pred hHHHHHHHHHHhcCCccCCCHHHHhhCcccccCCcc
Confidence 899999999997 89999999999999999855443
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.9e-30 Score=270.05 Aligned_cols=180 Identities=23% Similarity=0.460 Sum_probs=149.5
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
||+|||..|.+...-.....+++.++++|++.++.||.|||.+| ||||||||+|+||+. .|+|||+|||.+......
T Consensus 187 lVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg--iiHRDIKPsNLLl~~-~g~VKIsDFGVs~~~~~~ 263 (576)
T KOG0585|consen 187 LVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQG--IIHRDIKPSNLLLSS-DGTVKISDFGVSNEFPQG 263 (576)
T ss_pred EEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEEcC-CCcEEeeccceeeecccC
Confidence 69999999988764333333999999999999999999999999 999999999999985 589999999998655221
Q ss_pred -------CCccccCCCCccCccccccc-----CCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCcccc
Q 008504 81 -------TARSVIGTPEFMAPELYEEE-----YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAK 148 (563)
Q Consensus 81 -------~~~~~~Gtp~Y~APEvl~~~-----ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~ 148 (563)
.....+|||.|+|||+..++ .+.+.||||+||+||.|+.|++||.+ .....++.+|...........
T Consensus 264 ~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~-~~~~~l~~KIvn~pL~fP~~p 342 (576)
T KOG0585|consen 264 SDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFD-DFELELFDKIVNDPLEFPENP 342 (576)
T ss_pred CccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCccc-chHHHHHHHHhcCcccCCCcc
Confidence 12236899999999987542 36789999999999999999999987 566778888877655433334
Q ss_pred CCChhHHHHHHHhcC-CCCCCCCHHHHHcCccccccc
Q 008504 149 VNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 184 (563)
Q Consensus 149 ~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~ 184 (563)
.....+++||++||. ||.+|++..++..|||.....
T Consensus 343 e~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g 379 (576)
T KOG0585|consen 343 EINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDG 379 (576)
T ss_pred cccHHHHHHHHHHhhcChhheeehhhheecceeccCC
Confidence 457899999999997 899999999999999997653
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-29 Score=252.12 Aligned_cols=177 Identities=28% Similarity=0.491 Sum_probs=142.8
Q ss_pred CEeccCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhh
Q 008504 1 MITELFTSGNLRQYRKK----HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 76 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k----~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~ 76 (563)
+||||+++|+|.++++. ...+++..++.++.|++.||.|||+++ ++||||||+||+++ ..+.+||+|||++..
T Consensus 101 lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~nili~-~~~~~kl~dfg~~~~ 177 (291)
T cd06639 101 LVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR--IIHRDVKGNNILLT-TEGGVKLVDFGVSAQ 177 (291)
T ss_pred EEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEc-CCCCEEEeecccchh
Confidence 58999999999998863 456999999999999999999999999 99999999999997 557899999999876
Q ss_pred ccCCC--CccccCCCCccCcccccc------cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCC-Cccc
Q 008504 77 MQQPT--ARSVIGTPEFMAPELYEE------EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP-ASLA 147 (563)
Q Consensus 77 ~~~~~--~~~~~Gtp~Y~APEvl~~------~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p-~~l~ 147 (563)
..... .....|++.|+|||++.. .++.++|||||||++|+|++|+.||........+. .+.....+ ...+
T Consensus 178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~ 256 (291)
T cd06639 178 LTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLF-KIPRNPPPTLLHP 256 (291)
T ss_pred cccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHH-HHhcCCCCCCCcc
Confidence 54321 234568899999998743 26789999999999999999999998743333333 33333222 1223
Q ss_pred cCCChhHHHHHHHhcC-CCCCCCCHHHHHcCcccc
Q 008504 148 KVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQ 181 (563)
Q Consensus 148 ~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~ 181 (563)
......+.+||.+||. +|.+||++.++++||||+
T Consensus 257 ~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 257 EKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred cccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 3455789999999997 899999999999999995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-29 Score=247.92 Aligned_cols=177 Identities=33% Similarity=0.567 Sum_probs=147.1
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
+||||+++|+|.+++.+.+.+++..+..++.|++.||.|||+++ |+|+||||+||+++ ..+.++|+|||++......
T Consensus 83 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~-~~~~~~l~Dfg~~~~~~~~ 159 (265)
T cd06652 83 IFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNM--IVHRDIKGANILRD-SVGNVKLGDFGASKRLQTI 159 (265)
T ss_pred EEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEec-CCCCEEECcCccccccccc
Confidence 48999999999999998888999999999999999999999999 99999999999997 5679999999998654321
Q ss_pred -----CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhH
Q 008504 81 -----TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQI 154 (563)
Q Consensus 81 -----~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l 154 (563)
......++..|+|||.+.+ .++.++|||||||++|+|++|+.||.......... ...........+...+..+
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 238 (265)
T cd06652 160 CLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIF-KIATQPTNPVLPPHVSDHC 238 (265)
T ss_pred cccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHH-HHhcCCCCCCCchhhCHHH
Confidence 1233468889999998754 48899999999999999999999998644344333 3333333333455567789
Q ss_pred HHHHHHhcCCCCCCCCHHHHHcCcccc
Q 008504 155 KGFIEKCLVPASERLSAKDLLKDPFLQ 181 (563)
Q Consensus 155 ~~LI~kcL~dP~kRpSa~ELLkHpff~ 181 (563)
.++|.+||.+|.+||++.++++|||+.
T Consensus 239 ~~~i~~~l~~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 239 RDFLKRIFVEAKLRPSADELLRHTFVH 265 (265)
T ss_pred HHHHHHHhcChhhCCCHHHHhcCcccC
Confidence 999999999999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.9e-29 Score=254.04 Aligned_cols=183 Identities=25% Similarity=0.415 Sum_probs=147.5
Q ss_pred CEeccCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhcc
Q 008504 1 MITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~--~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~ 78 (563)
|||||+.+|+|.+++.+. ..+++..++.++.||+.||.|||+.| ++||||||+||+++ .+|.++|+|||++....
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~-~~~~~~l~dfg~~~~~~ 154 (316)
T cd05574 78 LVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG--IVYRDLKPENILLH-ESGHIMLSDFDLSKQSD 154 (316)
T ss_pred EEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChHHeEEc-CCCCEEEeecchhhccc
Confidence 589999999999999864 56999999999999999999999999 99999999999998 45799999999985432
Q ss_pred CC-------------------------------CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCC
Q 008504 79 QP-------------------------------TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSE 126 (563)
Q Consensus 79 ~~-------------------------------~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~ 126 (563)
.. ......|+..|+|||++.+ .++.++||||||+++|+|++|..||..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~ 234 (316)
T cd05574 155 VEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKG 234 (316)
T ss_pred ccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCC
Confidence 11 0113467889999998864 488899999999999999999999987
Q ss_pred CCCHHHHHHHHhcCCCCCccccCCChhHHHHHHHhcC-CCCCCCC----HHHHHcCccccccccCC
Q 008504 127 CKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLS----AKDLLKDPFLQVENQKE 187 (563)
Q Consensus 127 ~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~LI~kcL~-dP~kRpS----a~ELLkHpff~~~~~~~ 187 (563)
.... ..+..+.............+..+++||.+||. +|.+||+ +.++|+||||+...+..
T Consensus 235 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~~~~ 299 (316)
T cd05574 235 SNRD-ETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWAL 299 (316)
T ss_pred CchH-HHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCChhh
Confidence 4443 33333333222222222257899999999997 8999999 99999999998766543
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=255.66 Aligned_cols=182 Identities=26% Similarity=0.460 Sum_probs=146.4
Q ss_pred CEeccCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhcc
Q 008504 1 MITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~--~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~ 78 (563)
+||||+.+|+|.+++... ..+++..+..++.|++.||.|||++| |+||||||+||+++ ..+.++|+|||++....
T Consensus 77 lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nil~~-~~~~~~l~Dfg~~~~~~ 153 (285)
T cd05630 77 LVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER--IVYRDLKPENILLD-DHGHIRISDLGLAVHVP 153 (285)
T ss_pred EEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEEC-CCCCEEEeeccceeecC
Confidence 589999999999998654 35999999999999999999999999 99999999999998 45799999999986543
Q ss_pred CC-CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCH--HHHHHHHhcCCCCCccccCCChhH
Q 008504 79 QP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNP--AQIFKKVTSGIKPASLAKVNDPQI 154 (563)
Q Consensus 79 ~~-~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~--~~i~~~i~~~~~p~~l~~~~s~~l 154 (563)
.. ......|++.|+|||++.+ .++.++||||||+++|+|++|+.||...... ........... +...+...++.+
T Consensus 154 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 232 (285)
T cd05630 154 EGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV-QEEYSEKFSPDA 232 (285)
T ss_pred CCccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhh-hhhcCccCCHHH
Confidence 22 2234578999999998864 5899999999999999999999999763321 11122221111 223445677899
Q ss_pred HHHHHHhcC-CCCCCCC-----HHHHHcCccccccccC
Q 008504 155 KGFIEKCLV-PASERLS-----AKDLLKDPFLQVENQK 186 (563)
Q Consensus 155 ~~LI~kcL~-dP~kRpS-----a~ELLkHpff~~~~~~ 186 (563)
++||.+||+ +|.+||| +.++++||||+...+.
T Consensus 233 ~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~~ 270 (285)
T cd05630 233 RSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINFK 270 (285)
T ss_pred HHHHHHHhhcCHHHccCCCCCchHHHHcChhhhccCHH
Confidence 999999998 8999999 9999999999865544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.9e-29 Score=260.46 Aligned_cols=175 Identities=32% Similarity=0.454 Sum_probs=138.5
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
+||||+.+ +|.+++.. .+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++......
T Consensus 106 lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~-~~~~~kL~DfG~a~~~~~~ 179 (364)
T cd07875 106 IVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTS 179 (364)
T ss_pred EEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEEC-CCCcEEEEeCCCccccCCC
Confidence 58999965 78887754 4899999999999999999999999 99999999999998 5579999999999765433
Q ss_pred -CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCC----------------
Q 008504 81 -TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK---------------- 142 (563)
Q Consensus 81 -~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~---------------- 142 (563)
......+++.|+|||++.+ .++.++|||||||++|+|++|+.||...... ..+..+.....
T Consensus 180 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (364)
T cd07875 180 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI-DQWNKVIEQLGTPCPEFMKKLQPTVRT 258 (364)
T ss_pred CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCCHHHHHhhhHHHHH
Confidence 2234578999999998865 5899999999999999999999999764332 22222211100
Q ss_pred -----C-------------------CccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCccccc
Q 008504 143 -----P-------------------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQV 182 (563)
Q Consensus 143 -----p-------------------~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~ 182 (563)
+ .......+..+++||.+||. ||.+|||+.++|+||||+.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~ 323 (364)
T cd07875 259 YVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 323 (364)
T ss_pred HHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence 0 00011224578999999998 9999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-30 Score=297.32 Aligned_cols=182 Identities=32% Similarity=0.549 Sum_probs=161.8
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
|.||||++|+|.+.+...+..++...+.+..|++.||+|||++| ||||||||.|||++ .+|.+|++|||.|..+...
T Consensus 1311 IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~g--IVHRDIK~aNI~Ld-~~g~iK~~DFGsa~ki~~~ 1387 (1509)
T KOG4645|consen 1311 IFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHG--IVHRDIKPANILLD-FNGLIKYGDFGSAVKIKNN 1387 (1509)
T ss_pred HHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcC--ceecCCCccceeee-cCCcEEeecccceeEecCc
Confidence 46999999999999998888999999999999999999999999 99999999999998 5589999999999766543
Q ss_pred C------CccccCCCCccCcccccc----cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCC
Q 008504 81 T------ARSVIGTPEFMAPELYEE----EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVN 150 (563)
Q Consensus 81 ~------~~~~~Gtp~Y~APEvl~~----~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~ 150 (563)
. .+...|||.|||||++.+ +...++|||||||++.||+||+.||....+..+++..+..|..|.. |...
T Consensus 1388 ~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~-P~~l 1466 (1509)
T KOG4645|consen 1388 AQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQI-PERL 1466 (1509)
T ss_pred hhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCC-chhh
Confidence 2 345689999999999964 3677999999999999999999999999999999999999988754 4558
Q ss_pred ChhHHHHHHHhcC-CCCCCCCHHHHHcCccccccccC
Q 008504 151 DPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQK 186 (563)
Q Consensus 151 s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~~~ 186 (563)
+++.++||..||. ||.+|+++.|||.|.|-+.....
T Consensus 1467 s~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~~d~ 1503 (1509)
T KOG4645|consen 1467 SSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSCTDE 1503 (1509)
T ss_pred hHhHHHHHHHHHhcCchhhhHHHHHHHhhcccccccc
Confidence 8999999999996 99999999999999998765443
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-29 Score=261.55 Aligned_cols=175 Identities=30% Similarity=0.527 Sum_probs=139.6
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
+||||+.+|+|... ...++..+..++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++......
T Consensus 149 lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~-~~~~~kL~DfG~~~~~~~~ 221 (353)
T PLN00034 149 VLLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRH--IVHRDIKPSNLLIN-SAKNVKIADFGVSRILAQT 221 (353)
T ss_pred EEEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEc-CCCCEEEcccccceecccc
Confidence 58999999998753 34678889999999999999999999 99999999999998 5579999999999765432
Q ss_pred --CCccccCCCCccCcccccc-----c-CCchhhHHHhHHHHHHHhhcCCCCCCCCC--HHHHHHHHhcCCCCCccccCC
Q 008504 81 --TARSVIGTPEFMAPELYEE-----E-YNELVDIYSFGMCILEMVTFEYPYSECKN--PAQIFKKVTSGIKPASLAKVN 150 (563)
Q Consensus 81 --~~~~~~Gtp~Y~APEvl~~-----~-ys~ksDIwSLGviLyELlTG~~Pf~~~~~--~~~i~~~i~~~~~p~~l~~~~ 150 (563)
......|++.|+|||++.. . .+.++|||||||++|+|++|+.||..... .......+.... +...+...
T Consensus 222 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 300 (353)
T PLN00034 222 MDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQ-PPEAPATA 300 (353)
T ss_pred cccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccC-CCCCCCcc
Confidence 2234578999999998742 2 35689999999999999999999974221 122222222222 22344566
Q ss_pred ChhHHHHHHHhcC-CCCCCCCHHHHHcCcccccc
Q 008504 151 DPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 183 (563)
Q Consensus 151 s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~ 183 (563)
+..+++||.+||. +|.+||++.|+|+||||...
T Consensus 301 ~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~ 334 (353)
T PLN00034 301 SREFRHFISCCLQREPAKRWSAMQLLQHPFILRA 334 (353)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcCcccccC
Confidence 7899999999997 89999999999999999864
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=267.08 Aligned_cols=177 Identities=26% Similarity=0.350 Sum_probs=147.0
Q ss_pred CEeccCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~-~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
||+|||+. +|.-++... -.|++.+++.|++||+.||.|||++| |+|||||+.||||| +.|.+||+|||+|+.+..
T Consensus 195 lVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~g--vlHRDIK~SNiLid-n~G~LKiaDFGLAr~y~~ 270 (560)
T KOG0600|consen 195 LVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRG--VLHRDIKGSNILID-NNGVLKIADFGLARFYTP 270 (560)
T ss_pred EEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcC--eeeccccccceEEc-CCCCEEeccccceeeccC
Confidence 69999988 999888763 46999999999999999999999999 99999999999998 779999999999987654
Q ss_pred CC---CccccCCCCccCcccccc--cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcC-CC----------C
Q 008504 80 PT---ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG-IK----------P 143 (563)
Q Consensus 80 ~~---~~~~~Gtp~Y~APEvl~~--~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~-~~----------p 143 (563)
.. ....+-|.+|.|||++-+ .|+.++|+||.|||+.||++|++.|.+....+|+-+...-. .+ |
T Consensus 271 ~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP 350 (560)
T KOG0600|consen 271 SGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLP 350 (560)
T ss_pred CCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCC
Confidence 32 345577999999998865 59999999999999999999999999877666654433211 00 0
Q ss_pred -------C--------ccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCcccc
Q 008504 144 -------A--------SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQ 181 (563)
Q Consensus 144 -------~--------~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~ 181 (563)
. ......++...+|+..+|. ||.+|.||.++|+|+||.
T Consensus 351 ~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~ 404 (560)
T KOG0600|consen 351 HATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFT 404 (560)
T ss_pred cccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccc
Confidence 0 0012346788999999997 999999999999999994
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.7e-29 Score=246.43 Aligned_cols=179 Identities=29% Similarity=0.544 Sum_probs=147.1
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
+|+||+.+++|.+++.+.+.+++..++.|+.||+.||.|||++| ++|+||+|+||+++.+...+||+|||++......
T Consensus 80 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~--i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~ 157 (268)
T cd06630 80 LFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQ--IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK 157 (268)
T ss_pred EEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEcccccccccccc
Confidence 58999999999999998888999999999999999999999999 9999999999999855457999999998665432
Q ss_pred C------CccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCC--HHHHHHHHhcCCCCCccccCCC
Q 008504 81 T------ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKN--PAQIFKKVTSGIKPASLAKVND 151 (563)
Q Consensus 81 ~------~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~--~~~i~~~i~~~~~p~~l~~~~s 151 (563)
. .....++..|+|||++.+ .++.++|+||||+++|+|++|..||..... .......+.........+...+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (268)
T cd06630 158 GTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLS 237 (268)
T ss_pred cccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhC
Confidence 1 123467889999998764 588999999999999999999999965322 2222222322333344556678
Q ss_pred hhHHHHHHHhcC-CCCCCCCHHHHHcCcccc
Q 008504 152 PQIKGFIEKCLV-PASERLSAKDLLKDPFLQ 181 (563)
Q Consensus 152 ~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~ 181 (563)
+.+.++|.+||. +|.+||++.++++||||+
T Consensus 238 ~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 238 PGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 899999999997 899999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.7e-29 Score=250.62 Aligned_cols=177 Identities=29% Similarity=0.565 Sum_probs=144.7
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
+||||+++|+|..+ ..+++..+..++.||+.||.|||++| |+|+||||+|||++ .++.++|+|||++......
T Consensus 76 lv~e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nill~-~~~~~~l~dfg~~~~~~~~ 148 (279)
T cd06619 76 ICTEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLK--ILHRDVKPSNMLVN-TRGQVKLCDFGVSTQLVNS 148 (279)
T ss_pred EEEecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCCHHHEEEC-CCCCEEEeeCCcceecccc
Confidence 58999999999765 35789999999999999999999999 99999999999998 5689999999999766554
Q ss_pred CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCC------HHHHHHHHhcCCCCCccccCCChh
Q 008504 81 TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKN------PAQIFKKVTSGIKPASLAKVNDPQ 153 (563)
Q Consensus 81 ~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~------~~~i~~~i~~~~~p~~l~~~~s~~ 153 (563)
......|++.|+|||++.+ .++.++|+|||||++|+|++|+.||..... .......+.....+.......++.
T Consensus 149 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (279)
T cd06619 149 IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEK 228 (279)
T ss_pred cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHH
Confidence 4555688999999998864 488999999999999999999999964221 123333333333333333446789
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHHcCccccccc
Q 008504 154 IKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 184 (563)
Q Consensus 154 l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~ 184 (563)
+++||.+||. +|.+||++.++++||||+..+
T Consensus 229 ~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~ 260 (279)
T cd06619 229 FVHFITQCMRKQPKERPAPENLMDHPFIVQYN 260 (279)
T ss_pred HHHHHHHHhhCChhhCCCHHHHhcCccccccc
Confidence 9999999997 899999999999999997653
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-30 Score=260.59 Aligned_cols=191 Identities=26% Similarity=0.484 Sum_probs=165.3
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhcc--
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ-- 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~-- 78 (563)
+||||..||.|+-+|.+.+.+++...+.+-..|+.||.|||+++ ||+||||.+|++++ .+|++||+|||+++.--
T Consensus 245 FVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~--ivYRDlKLENLlLD-kDGHIKitDFGLCKE~I~~ 321 (516)
T KOG0690|consen 245 FVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRN--IVYRDLKLENLLLD-KDGHIKITDFGLCKEEIKY 321 (516)
T ss_pred EEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCC--eeeeechhhhheec-cCCceEeeecccchhcccc
Confidence 69999999999999999889999999999999999999999999 99999999999998 66999999999996432
Q ss_pred CCCCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHHH
Q 008504 79 QPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 157 (563)
Q Consensus 79 ~~~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~L 157 (563)
.....+++|||.|+|||++.. .|+.++|+|.+||++|||++|+.||.. .+...++..|..... .+|...+++++.|
T Consensus 322 g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn-~dh~kLFeLIl~ed~--kFPr~ls~eAktL 398 (516)
T KOG0690|consen 322 GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYN-KDHEKLFELILMEDL--KFPRTLSPEAKTL 398 (516)
T ss_pred cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccc-cchhHHHHHHHhhhc--cCCccCCHHHHHH
Confidence 235678999999999999975 599999999999999999999999987 455666666655432 3577889999999
Q ss_pred HHHhcC-CCCCCCC-----HHHHHcCccccccccCCCCCCCCCCch
Q 008504 158 IEKCLV-PASERLS-----AKDLLKDPFLQVENQKEPICDPLKLPI 197 (563)
Q Consensus 158 I~kcL~-dP~kRpS-----a~ELLkHpff~~~~~~~~~~~~l~~p~ 197 (563)
+..+|. +|.+|.. |.|+.+|+||...+|.....+.+..|.
T Consensus 399 LsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki~PPf 444 (516)
T KOG0690|consen 399 LSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKKIEPPF 444 (516)
T ss_pred HHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhccCCCC
Confidence 999997 8999984 899999999999998765554444443
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-29 Score=261.73 Aligned_cols=176 Identities=31% Similarity=0.418 Sum_probs=137.5
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
+||||+.+ +|.+++. ..+++..+..++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++......
T Consensus 103 lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~--ivHrDlkp~NIl~~-~~~~~kl~Dfg~a~~~~~~ 176 (359)
T cd07876 103 LVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLARTACTN 176 (359)
T ss_pred EEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEC-CCCCEEEecCCCccccccC
Confidence 58999975 6777664 35899999999999999999999999 99999999999998 5589999999999654322
Q ss_pred -CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHh--------------------
Q 008504 81 -TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVT-------------------- 138 (563)
Q Consensus 81 -~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~-------------------- 138 (563)
......||+.|+|||++.+ .++.++|||||||++|+|++|+.||............+.
T Consensus 177 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (359)
T cd07876 177 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNY 256 (359)
T ss_pred ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHH
Confidence 2334578999999998865 589999999999999999999999986433221111100
Q ss_pred -cCCC--C----------------CccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCccccc
Q 008504 139 -SGIK--P----------------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQV 182 (563)
Q Consensus 139 -~~~~--p----------------~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~ 182 (563)
.... + .......++.+++||.+||. +|.+|||+.|+|+||||+.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 320 (359)
T cd07876 257 VENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV 320 (359)
T ss_pred HhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence 0000 0 00112235678999999998 8999999999999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.3e-29 Score=246.93 Aligned_cols=178 Identities=34% Similarity=0.556 Sum_probs=144.3
Q ss_pred CEeccCCCCCHHHHHHhC-CCC--CHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhc
Q 008504 1 MITELFTSGNLRQYRKKH-KNV--DIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM 77 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~-~~L--se~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~ 77 (563)
+|+||+++++|.+++... ..+ ++..+..++.||+.||+|||++| |+||||||+||+++...+.++|+|||++...
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~ 159 (268)
T cd06624 82 IFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 159 (268)
T ss_pred EEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCeEEEecchhheec
Confidence 589999999999999864 455 88999999999999999999999 9999999999999865679999999998654
Q ss_pred cCC--CCccccCCCCccCcccccc---cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCCh
Q 008504 78 QQP--TARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDP 152 (563)
Q Consensus 78 ~~~--~~~~~~Gtp~Y~APEvl~~---~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~ 152 (563)
... ......+++.|+|||.+.. .++.++|+||||+++|+|++|+.||.....................++...++
T Consensus 160 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (268)
T cd06624 160 AGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSA 239 (268)
T ss_pred ccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCH
Confidence 321 2223467899999998753 37889999999999999999999997644433332222221222345566778
Q ss_pred hHHHHHHHhcC-CCCCCCCHHHHHcCccc
Q 008504 153 QIKGFIEKCLV-PASERLSAKDLLKDPFL 180 (563)
Q Consensus 153 ~l~~LI~kcL~-dP~kRpSa~ELLkHpff 180 (563)
.+++|+.+||. +|.+|||+.+++.||||
T Consensus 240 ~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 240 EAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred HHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 99999999997 79999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.8e-29 Score=253.57 Aligned_cols=180 Identities=31% Similarity=0.543 Sum_probs=147.1
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
+||||+++|+|.+++.+ ..+++..+..++.|++.||.|||+.| |+||||||+||+++ .++.+||+|||++......
T Consensus 94 lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~g--i~H~dLkp~Nill~-~~~~~kl~dfg~~~~~~~~ 169 (296)
T cd06654 94 VVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPE 169 (296)
T ss_pred EeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEc-CCCCEEECccccchhcccc
Confidence 58999999999999875 46899999999999999999999999 99999999999997 5679999999998654332
Q ss_pred --CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHHH
Q 008504 81 --TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 157 (563)
Q Consensus 81 --~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~L 157 (563)
......+++.|+|||.+.+ .++.++|||||||++|+|++|+.||...............+..+...+...++.+.+|
T Consensus 170 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 249 (296)
T cd06654 170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDF 249 (296)
T ss_pred ccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHH
Confidence 1233478899999998865 4789999999999999999999999764433333333333332323344567889999
Q ss_pred HHHhcC-CCCCCCCHHHHHcCccccccc
Q 008504 158 IEKCLV-PASERLSAKDLLKDPFLQVEN 184 (563)
Q Consensus 158 I~kcL~-dP~kRpSa~ELLkHpff~~~~ 184 (563)
|.+||. +|.+||++.++++||||....
T Consensus 250 i~~~l~~~p~~Rpt~~eil~~~~~~~~~ 277 (296)
T cd06654 250 LNRCLDMDVEKRGSAKELLQHQFLKIAK 277 (296)
T ss_pred HHHHCcCCcccCcCHHHHhhChhhhccC
Confidence 999997 899999999999999998543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.4e-29 Score=244.53 Aligned_cols=176 Identities=35% Similarity=0.574 Sum_probs=143.2
Q ss_pred CEeccCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k-~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
+|+||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ ++||||+|+||+++ +.+.+||+|||++.....
T Consensus 75 l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~ni~~~-~~~~~~l~dfg~~~~~~~ 151 (256)
T cd06612 75 IVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK--KIHRDIKAGNILLN-EEGQAKLADFGVSGQLTD 151 (256)
T ss_pred EEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEC-CCCcEEEcccccchhccc
Confidence 58999999999999975 456899999999999999999999999 99999999999998 457999999999876544
Q ss_pred CC--CccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcC-CCCCccccCCChhHH
Q 008504 80 PT--ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG-IKPASLAKVNDPQIK 155 (563)
Q Consensus 80 ~~--~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~-~~p~~l~~~~s~~l~ 155 (563)
.. .....++..|+|||++.+ .++.++||||||+++|+|++|+.||......... ..+... ......+...+..+.
T Consensus 152 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 230 (256)
T cd06612 152 TMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI-FMIPNKPPPTLSDPEKWSPEFN 230 (256)
T ss_pred CccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh-hhhccCCCCCCCchhhcCHHHH
Confidence 32 233457889999998864 4889999999999999999999999764332222 222221 111222334567899
Q ss_pred HHHHHhcC-CCCCCCCHHHHHcCccc
Q 008504 156 GFIEKCLV-PASERLSAKDLLKDPFL 180 (563)
Q Consensus 156 ~LI~kcL~-dP~kRpSa~ELLkHpff 180 (563)
+||.+||. +|.+|||+.++|.||||
T Consensus 231 ~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 231 DFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred HHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 99999997 89999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-29 Score=254.79 Aligned_cols=179 Identities=27% Similarity=0.366 Sum_probs=150.1
Q ss_pred CEeccCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~-~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
||||||+. +|+.++.+-+ +|...+++.++.|+++||+|||.+. |+||||||+|+|++ +.|.+||+|||+|+.+..
T Consensus 154 ~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~w--ilHRDLK~SNLLm~-~~G~lKiaDFGLAR~ygs 229 (419)
T KOG0663|consen 154 IVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNW--ILHRDLKTSNLLLS-HKGILKIADFGLAREYGS 229 (419)
T ss_pred eeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhce--eEecccchhheeec-cCCcEEecccchhhhhcC
Confidence 69999987 9999998765 8999999999999999999999999 99999999999998 779999999999998876
Q ss_pred C--CCccccCCCCccCcccccc--cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCC------------
Q 008504 80 P--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP------------ 143 (563)
Q Consensus 80 ~--~~~~~~Gtp~Y~APEvl~~--~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p------------ 143 (563)
+ .....+-|.+|.|||++-+ .|+.++|+||+|||+.||+++++-|.+....+++.+.+..--.|
T Consensus 230 p~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp 309 (419)
T KOG0663|consen 230 PLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELP 309 (419)
T ss_pred CcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccc
Confidence 5 2445678999999998854 49999999999999999999999999877777766554321000
Q ss_pred ----------------CccccC-CChhHHHHHHHhcC-CCCCCCCHHHHHcCcccccc
Q 008504 144 ----------------ASLAKV-NDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 183 (563)
Q Consensus 144 ----------------~~l~~~-~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~ 183 (563)
..+... .+....+|+..+|. ||.+|.||.+.|+|.||...
T Consensus 310 ~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~ 367 (419)
T KOG0663|consen 310 AVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRET 367 (419)
T ss_pred hhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccC
Confidence 001111 34677899999997 99999999999999999853
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-29 Score=247.35 Aligned_cols=176 Identities=28% Similarity=0.525 Sum_probs=142.1
Q ss_pred CEeccCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhh
Q 008504 1 MITELFTSGNLRQYRKK----HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 76 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k----~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~ 76 (563)
+||||+++++|.+++.. ...+++..++.++.|++.||.|||+++ ++|+||+|+||+++. ++.+||+|||++..
T Consensus 86 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~~l~p~ni~~~~-~~~~~l~d~~~~~~ 162 (275)
T cd06608 86 LVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK--VIHRDIKGQNILLTK-NAEVKLVDFGVSAQ 162 (275)
T ss_pred EEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEEcc-CCeEEECCCcccee
Confidence 58999999999999875 357999999999999999999999999 999999999999984 57999999999865
Q ss_pred ccCC--CCccccCCCCccCcccccc------cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCC-ccc
Q 008504 77 MQQP--TARSVIGTPEFMAPELYEE------EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPA-SLA 147 (563)
Q Consensus 77 ~~~~--~~~~~~Gtp~Y~APEvl~~------~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~-~l~ 147 (563)
.... ......|++.|+|||++.. .++.++|||||||++|+|++|..||......... ..+.....+. ..+
T Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~ 241 (275)
T cd06608 163 LDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRAL-FKIPRNPPPTLKSP 241 (275)
T ss_pred cccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHH-HHhhccCCCCCCch
Confidence 4322 2234568899999998742 3678999999999999999999999764333333 3333333222 112
Q ss_pred cCCChhHHHHHHHhcC-CCCCCCCHHHHHcCccc
Q 008504 148 KVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 180 (563)
Q Consensus 148 ~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff 180 (563)
...+..+++||.+||. +|.+|||+.++++|||+
T Consensus 242 ~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 242 ENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred hhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 2356789999999997 89999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.9e-29 Score=244.97 Aligned_cols=180 Identities=33% Similarity=0.599 Sum_probs=151.7
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHS-HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs-~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
+||||+++++|.+++.....+++..++.++.||+.||.|||+ .+ ++||||+|+||+++ .++.++|+|||++.....
T Consensus 76 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~--~~H~~l~~~ni~~~-~~~~~~l~df~~~~~~~~ 152 (264)
T cd06623 76 IVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH--IIHRDIKPSNLLIN-SKGEVKIADFGISKVLEN 152 (264)
T ss_pred EEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCC--CccCCCCHHHEEEC-CCCCEEEccCccceeccc
Confidence 589999999999999988889999999999999999999999 99 99999999999998 457999999999876544
Q ss_pred CCCc--cccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCC--CHHHHHHHHhcCCCCCccccCCChhH
Q 008504 80 PTAR--SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECK--NPAQIFKKVTSGIKPASLAKVNDPQI 154 (563)
Q Consensus 80 ~~~~--~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~--~~~~i~~~i~~~~~p~~l~~~~s~~l 154 (563)
.... ...++..|+|||.+.. .++.++|+||||+++|+|+||..||.... ...+....+.....+.......+..+
T Consensus 153 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 232 (264)
T cd06623 153 TLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEF 232 (264)
T ss_pred CCCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHH
Confidence 3222 4567889999998864 47889999999999999999999997754 45555555554444333222267899
Q ss_pred HHHHHHhcC-CCCCCCCHHHHHcCcccccc
Q 008504 155 KGFIEKCLV-PASERLSAKDLLKDPFLQVE 183 (563)
Q Consensus 155 ~~LI~kcL~-dP~kRpSa~ELLkHpff~~~ 183 (563)
.++|.+||. +|.+||++.++++||||+..
T Consensus 233 ~~li~~~l~~~p~~R~~~~~ll~~~~~~~~ 262 (264)
T cd06623 233 RDFISACLQKDPKKRPSAAELLQHPFIKKA 262 (264)
T ss_pred HHHHHHHccCChhhCCCHHHHHhCHHHHhc
Confidence 999999997 79999999999999999754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-29 Score=260.10 Aligned_cols=177 Identities=31% Similarity=0.422 Sum_probs=138.1
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
+||||+.+ +|.+++.. .+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||+++.....
T Consensus 99 lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDikp~Nill~-~~~~~kl~Dfg~~~~~~~~ 172 (355)
T cd07874 99 LVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTS 172 (355)
T ss_pred EEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEEC-CCCCEEEeeCcccccCCCc
Confidence 58999975 77777754 4899999999999999999999999 99999999999997 5579999999999765433
Q ss_pred -CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhc-------------------
Q 008504 81 -TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS------------------- 139 (563)
Q Consensus 81 -~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~------------------- 139 (563)
......||+.|+|||++.+ .++.++|||||||++|+|++|+.||............+..
T Consensus 173 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (355)
T cd07874 173 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 252 (355)
T ss_pred cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHH
Confidence 2334578999999998865 5899999999999999999999999764322221111110
Q ss_pred --CCC-------C-----------CccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCcccccc
Q 008504 140 --GIK-------P-----------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 183 (563)
Q Consensus 140 --~~~-------p-----------~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~ 183 (563)
... + .......+..+++||.+||. +|.+|||+.|+|+||||+..
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~ 317 (355)
T cd07874 253 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVW 317 (355)
T ss_pred HhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcc
Confidence 000 0 00112234578999999997 89999999999999999744
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=7e-29 Score=261.43 Aligned_cols=179 Identities=30% Similarity=0.455 Sum_probs=143.2
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
+||||+. ++|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++ ..+.+||+|||++......
T Consensus 81 lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nili~-~~~~~kL~Dfg~a~~~~~~ 156 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAG--ILHRDIKPGNLLVN-SNCVLKICDFGLARVEEPD 156 (372)
T ss_pred EEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChHHEEEC-CCCCEEeccccceeecccC
Confidence 5899996 589999988888999999999999999999999999 99999999999998 5579999999998654322
Q ss_pred ---CCccccCCCCccCcccccc--cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhc----------------
Q 008504 81 ---TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS---------------- 139 (563)
Q Consensus 81 ---~~~~~~Gtp~Y~APEvl~~--~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~---------------- 139 (563)
......+++.|+|||++.+ .++.++|||||||++|+|++|+.||.... +......+..
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-~~~~~~~i~~~~g~~~~~~~~~~~~~ 235 (372)
T cd07853 157 ESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQS-PIQQLDLITDLLGTPSLEAMRSACEG 235 (372)
T ss_pred ccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCC-HHHHHHHHHHHcCCCCHHHHHHhhHH
Confidence 1223467899999998865 37899999999999999999999997643 2222222211
Q ss_pred --------CCCCC------ccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCccccccc
Q 008504 140 --------GIKPA------SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 184 (563)
Q Consensus 140 --------~~~p~------~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~ 184 (563)
...+. ......++.+.+||.+||. +|.+|||+.++|+||||+...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 295 (372)
T cd07853 236 ARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR 295 (372)
T ss_pred HHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence 11111 1123346789999999998 899999999999999998653
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.1e-29 Score=264.60 Aligned_cols=178 Identities=33% Similarity=0.405 Sum_probs=138.6
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC-
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ- 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~- 79 (563)
+|+||+. ++|..++...+.+++..++.|+.||+.||.|||++| |+||||||+|||++ ..|.+||+|||++.....
T Consensus 160 lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~--IvHrDiKP~NIll~-~~~~vkL~DFG~a~~~~~~ 235 (391)
T PHA03212 160 LILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENR--IIHRDIKAENIFIN-HPGDVCLGDFGAACFPVDI 235 (391)
T ss_pred EEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHhEEEc-CCCCEEEEeCCcccccccc
Confidence 5789985 699999988888999999999999999999999999 99999999999998 557999999999864322
Q ss_pred --CCCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCC-------HHHHHHHHh-----------
Q 008504 80 --PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKN-------PAQIFKKVT----------- 138 (563)
Q Consensus 80 --~~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~-------~~~i~~~i~----------- 138 (563)
.......||+.|+|||++.+ .++.++|||||||++|+|++|..||..... ..++...+.
T Consensus 236 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~ 315 (391)
T PHA03212 236 NANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPI 315 (391)
T ss_pred cccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCc
Confidence 22334579999999998864 589999999999999999999988753211 111111110
Q ss_pred --------------cCC--CCCccc-----cCCChhHHHHHHHhcC-CCCCCCCHHHHHcCccccc
Q 008504 139 --------------SGI--KPASLA-----KVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQV 182 (563)
Q Consensus 139 --------------~~~--~p~~l~-----~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~ 182 (563)
... .+...+ ...+..+.+||.+||. +|.+|||+.|+|+||||+.
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~ 381 (391)
T PHA03212 316 DAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQD 381 (391)
T ss_pred chhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhcc
Confidence 000 000000 1124578999999998 8999999999999999975
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.1e-29 Score=248.70 Aligned_cols=176 Identities=26% Similarity=0.495 Sum_probs=138.5
Q ss_pred CEeccCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k-~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
+|+||+. |+|.+++.. .+.+++..++.++.||+.||.|||++| |+||||||+||+++ ..+.+||+|||++.....
T Consensus 76 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dl~~~nil~~-~~~~~~l~dfg~~~~~~~ 151 (284)
T cd07839 76 LVFEYCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN--VLHRDLKPQNLLIN-KNGELKLADFGLARAFGI 151 (284)
T ss_pred EEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEc-CCCcEEECccchhhccCC
Confidence 5899997 588888765 567999999999999999999999999 99999999999998 457999999999875543
Q ss_pred C--CCccccCCCCccCcccccc--cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCC-------------
Q 008504 80 P--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK------------- 142 (563)
Q Consensus 80 ~--~~~~~~Gtp~Y~APEvl~~--~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~------------- 142 (563)
. ......+++.|+|||++.+ .++.++|||||||++|+|+||..||....+....+..+.....
T Consensus 152 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07839 152 PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKL 231 (284)
T ss_pred CCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhc
Confidence 2 1223467889999998754 3789999999999999999999987554444333332211100
Q ss_pred ------C--------CccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCccc
Q 008504 143 ------P--------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 180 (563)
Q Consensus 143 ------p--------~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff 180 (563)
+ .......++.+++||.+||. +|.+|||+.++++||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 232 PDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred ccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 0 00112346789999999997 89999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.2e-29 Score=247.78 Aligned_cols=181 Identities=31% Similarity=0.538 Sum_probs=150.2
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
+|+||+++|+|.+++... ++++..++.++.||+.||.|||+++ ++||||+|+||+++ +.|.++|+|||++......
T Consensus 76 ~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~-~~~~~~l~d~g~~~~~~~~ 151 (274)
T cd06609 76 IIMEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEG--KIHRDIKAANILLS-EEGDVKLADFGVSGQLTST 151 (274)
T ss_pred EEEEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEC-CCCCEEEcccccceeeccc
Confidence 589999999999999875 7999999999999999999999999 99999999999998 4679999999999766543
Q ss_pred --CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHHH
Q 008504 81 --TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 157 (563)
Q Consensus 81 --~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~L 157 (563)
......+++.|+|||.+.+ .++.++||||||+++|+|+||..||... ++......+.....+.......++.+.++
T Consensus 152 ~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (274)
T cd06609 152 MSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDL-HPMRVLFLIPKNNPPSLEGNKFSKPFKDF 230 (274)
T ss_pred ccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccC-chHHHHHHhhhcCCCCCcccccCHHHHHH
Confidence 2334578889999998864 4899999999999999999999999763 34444444444433332222267889999
Q ss_pred HHHhcC-CCCCCCCHHHHHcCccccccccC
Q 008504 158 IEKCLV-PASERLSAKDLLKDPFLQVENQK 186 (563)
Q Consensus 158 I~kcL~-dP~kRpSa~ELLkHpff~~~~~~ 186 (563)
|.+||. +|.+|||+.++++||||+.....
T Consensus 231 l~~~l~~~p~~Rpt~~~il~~~~~~~~~~~ 260 (274)
T cd06609 231 VSLCLNKDPKERPSAKELLKHKFIKKAKKT 260 (274)
T ss_pred HHHHhhCChhhCcCHHHHhhChhhcCCCcc
Confidence 999997 89999999999999999875543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=256.15 Aligned_cols=176 Identities=30% Similarity=0.462 Sum_probs=139.3
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
+++|++ +++|.++++. +.+++..++.++.||+.||.|||++| |+||||||+||+++ .++.+||+|||++......
T Consensus 97 ~~~~~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrdikp~Nil~~-~~~~~kl~Dfg~~~~~~~~ 171 (343)
T cd07878 97 LVTNLM-GADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSAG--IIHRDLKPSNVAVN-EDCELRILDFGLARQADDE 171 (343)
T ss_pred EEeecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecccCChhhEEEC-CCCCEEEcCCccceecCCC
Confidence 467877 7899988764 56999999999999999999999999 99999999999998 5579999999999765432
Q ss_pred CCccccCCCCccCcccccc--cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcC--CC--------------
Q 008504 81 TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG--IK-------------- 142 (563)
Q Consensus 81 ~~~~~~Gtp~Y~APEvl~~--~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~--~~-------------- 142 (563)
.....|++.|+|||++.+ .++.++|||||||++|+|++|+.||........ ...+... ..
T Consensus 172 -~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (343)
T cd07878 172 -MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQ-LKRIMEVVGTPSPEVLKKISSEHAR 249 (343)
T ss_pred -cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH-HHHHHHHhCCCCHHHHHhcchhhHH
Confidence 334578999999998865 488999999999999999999999976332222 2211110 00
Q ss_pred ---------C-C---ccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCcccccc
Q 008504 143 ---------P-A---SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 183 (563)
Q Consensus 143 ---------p-~---~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~ 183 (563)
+ . ......++.+.+||.+||. +|.+|||+.++|.||||...
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~ 304 (343)
T cd07878 250 KYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQY 304 (343)
T ss_pred HHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhcc
Confidence 0 0 0011235678999999997 89999999999999999764
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.8e-29 Score=249.04 Aligned_cols=176 Identities=27% Similarity=0.494 Sum_probs=142.4
Q ss_pred CEeccCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhh
Q 008504 1 MITELFTSGNLRQYRKK----HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 76 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k----~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~ 76 (563)
+||||+++|+|.+++.. ...+++..++.++.|++.||.|||+++ |+||||||+||+++ ..+.+||+|||++..
T Consensus 97 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~-~~~~~kl~dfg~~~~ 173 (286)
T cd06638 97 LVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK--TIHRDVKGNNILLT-TEGGVKLVDFGVSAQ 173 (286)
T ss_pred EEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC--ccccCCCHHhEEEC-CCCCEEEccCCceee
Confidence 58999999999998753 356899999999999999999999999 99999999999998 457899999999865
Q ss_pred ccCC--CCccccCCCCccCccccc------ccCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCC-CCccc
Q 008504 77 MQQP--TARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK-PASLA 147 (563)
Q Consensus 77 ~~~~--~~~~~~Gtp~Y~APEvl~------~~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~-p~~l~ 147 (563)
.... ......|++.|+|||++. ..++.++|||||||++|+|++|+.||........... +..... ....+
T Consensus 174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~ 252 (286)
T cd06638 174 LTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFK-IPRNPPPTLHQP 252 (286)
T ss_pred cccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhh-ccccCCCcccCC
Confidence 5432 223456899999999874 3378899999999999999999999987443333322 222222 22234
Q ss_pred cCCChhHHHHHHHhcC-CCCCCCCHHHHHcCccc
Q 008504 148 KVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 180 (563)
Q Consensus 148 ~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff 180 (563)
...+..+.+||.+||. +|.+|||+.++++|+||
T Consensus 253 ~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 253 ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred CCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 4456789999999997 89999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=249.04 Aligned_cols=183 Identities=30% Similarity=0.518 Sum_probs=147.3
Q ss_pred CEeccCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k-~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
+||||+++|+|..++.+ ...+++..++.++.||+.||.|||++| ++||||||+||+++ ..|.+||+|||++.....
T Consensus 86 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nili~-~~~~~kl~dfg~~~~~~~ 162 (292)
T cd06644 86 IMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK--IIHRDLKAGNVLLT-LDGDIKLADFGVSAKNVK 162 (292)
T ss_pred EEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCC--eeecCCCcceEEEc-CCCCEEEccCccceeccc
Confidence 58999999999988764 456999999999999999999999999 99999999999997 457999999998864332
Q ss_pred C--CCccccCCCCccCccccc------ccCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCC-CccccCC
Q 008504 80 P--TARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP-ASLAKVN 150 (563)
Q Consensus 80 ~--~~~~~~Gtp~Y~APEvl~------~~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p-~~l~~~~ 150 (563)
. ......+++.|+|||++. ..++.++|||||||++|+|++|..||.... .......+.....+ ...+...
T Consensus 163 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 241 (292)
T cd06644 163 TLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN-PMRVLLKIAKSEPPTLSQPSKW 241 (292)
T ss_pred cccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCcccc-HHHHHHHHhcCCCccCCCCccc
Confidence 2 223456889999999874 236789999999999999999999997643 44444444433322 2234455
Q ss_pred ChhHHHHHHHhcC-CCCCCCCHHHHHcCccccccccCC
Q 008504 151 DPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQKE 187 (563)
Q Consensus 151 s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~~~~ 187 (563)
+..+.+||.+||. +|.+||++.++++||||....+..
T Consensus 242 ~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~ 279 (292)
T cd06644 242 SMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSNR 279 (292)
T ss_pred CHHHHHHHHHHhcCCcccCcCHHHHhcCccccccccch
Confidence 6789999999997 899999999999999998655543
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=240.92 Aligned_cols=177 Identities=39% Similarity=0.643 Sum_probs=152.5
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
+|+||+++++|.+++.+.+.+++..++.++.|++.||.|||+.| ++|+||+|+||+++. .+.++|+|||.+......
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~~h~dl~p~ni~i~~-~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 78 IFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNG--IVHRDIKGANILVDS-DGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEcC-CCCEEEcccccEEecccc
Confidence 58999999999999998889999999999999999999999999 999999999999984 579999999998766544
Q ss_pred C----CccccCCCCccCccccccc-CCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHH
Q 008504 81 T----ARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIK 155 (563)
Q Consensus 81 ~----~~~~~Gtp~Y~APEvl~~~-ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~ 155 (563)
. .....++..|+|||.+.+. ++.++||||||+++|+|++|..||....+.......+.........+...+..++
T Consensus 155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 234 (260)
T cd06606 155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAK 234 (260)
T ss_pred cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHH
Confidence 3 3445788999999988654 8899999999999999999999998755455555555543444456666788999
Q ss_pred HHHHHhcC-CCCCCCCHHHHHcCccc
Q 008504 156 GFIEKCLV-PASERLSAKDLLKDPFL 180 (563)
Q Consensus 156 ~LI~kcL~-dP~kRpSa~ELLkHpff 180 (563)
+||.+||. +|.+||++.++++||||
T Consensus 235 ~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 235 DFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred HHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 99999997 89999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-29 Score=268.17 Aligned_cols=177 Identities=28% Similarity=0.461 Sum_probs=146.1
Q ss_pred CEeccCCCCCHHHHHHhCCCC-CHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKKHKNV-DIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~L-se~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
|||||=+ -+|.++|++.... +.-.++.|.+|+|.|+.++|.+| |||.||||.|+|+- .|.+||+|||+|..+..
T Consensus 437 mvmE~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~g--IVHSDLKPANFLlV--kG~LKLIDFGIA~aI~~ 511 (677)
T KOG0596|consen 437 MVMECGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHG--IVHSDLKPANFLLV--KGRLKLIDFGIANAIQP 511 (677)
T ss_pred EEeeccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhc--eeecCCCcccEEEE--eeeEEeeeechhcccCc
Confidence 6889764 4999999987653 33589999999999999999999 99999999999986 48999999999988766
Q ss_pred CCC----ccccCCCCccCcccccc------------cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCC
Q 008504 80 PTA----RSVIGTPEFMAPELYEE------------EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP 143 (563)
Q Consensus 80 ~~~----~~~~Gtp~Y~APEvl~~------------~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p 143 (563)
... .+.+||+.||+||.+.. +.+.++||||||||||+|+.|+.||....+....+..+......
T Consensus 512 DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~ 591 (677)
T KOG0596|consen 512 DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHE 591 (677)
T ss_pred cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCcc
Confidence 543 35689999999997731 25789999999999999999999998766555555555554333
Q ss_pred CccccCCChh-HHHHHHHhcC-CCCCCCCHHHHHcCccccc
Q 008504 144 ASLAKVNDPQ-IKGFIEKCLV-PASERLSAKDLLKDPFLQV 182 (563)
Q Consensus 144 ~~l~~~~s~~-l~~LI~kcL~-dP~kRpSa~ELLkHpff~~ 182 (563)
..++...... +.++++.||. ||.+|||+.+||+|||++.
T Consensus 592 Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 592 IEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred ccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence 3455555444 9999999997 9999999999999999984
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.4e-29 Score=248.42 Aligned_cols=183 Identities=27% Similarity=0.467 Sum_probs=149.3
Q ss_pred CEeccCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhcc
Q 008504 1 MITELFTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~--~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~ 78 (563)
+||||+++|+|.+++.+.+ .+++..++.++.|++.||.|||++| ++||||+|+||+++ +.+.+||+|||++....
T Consensus 70 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~Nil~~-~~~~~~l~dfg~~~~~~ 146 (277)
T cd05577 70 LVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR--IVYRDLKPENVLLD-DHGNVRISDLGLAVELK 146 (277)
T ss_pred EEEecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEC-CCCCEEEccCcchhhhc
Confidence 5899999999999998765 7999999999999999999999999 99999999999998 55799999999987654
Q ss_pred CC-CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCC---HHHHHHHHhcCCCCCccccCCChh
Q 008504 79 QP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKN---PAQIFKKVTSGIKPASLAKVNDPQ 153 (563)
Q Consensus 79 ~~-~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~---~~~i~~~i~~~~~p~~l~~~~s~~ 153 (563)
.. ......++..|+|||.+.+ .++.++||||||+++|+|++|+.||..... ...+...+.. .+...+...++.
T Consensus 147 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 224 (277)
T cd05577 147 GGKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLE--MAVEYPDKFSPE 224 (277)
T ss_pred cCCccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcccc--ccccCCccCCHH
Confidence 32 2234467889999998754 488899999999999999999999976332 2222222221 233345556889
Q ss_pred HHHHHHHhcC-CCCCCC-----CHHHHHcCccccccccCCC
Q 008504 154 IKGFIEKCLV-PASERL-----SAKDLLKDPFLQVENQKEP 188 (563)
Q Consensus 154 l~~LI~kcL~-dP~kRp-----Sa~ELLkHpff~~~~~~~~ 188 (563)
++++|.+||. +|.+|| ++.+++.||||...++...
T Consensus 225 ~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~~~~ 265 (277)
T cd05577 225 AKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWRRL 265 (277)
T ss_pred HHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCChhhh
Confidence 9999999997 899999 8999999999987766543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=244.08 Aligned_cols=176 Identities=32% Similarity=0.556 Sum_probs=143.4
Q ss_pred CEeccCCCCCHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhc
Q 008504 1 MITELFTSGNLRQYRKKH---KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM 77 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~---~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~ 77 (563)
+||||+.+++|.+++... ..+++..++.++.||+.||.|||++| |+||||+|+||+++. ++.++|+|||++...
T Consensus 76 iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~--i~h~~l~p~ni~~~~-~~~~~l~df~~~~~~ 152 (267)
T cd06610 76 LVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG--QIHRDIKAGNILLGE-DGSVKIADFGVSASL 152 (267)
T ss_pred EEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEcC-CCCEEEcccchHHHh
Confidence 589999999999999864 45999999999999999999999999 999999999999984 579999999998765
Q ss_pred cCCC------CccccCCCCccCcccccc--cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCcc---
Q 008504 78 QQPT------ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASL--- 146 (563)
Q Consensus 78 ~~~~------~~~~~Gtp~Y~APEvl~~--~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l--- 146 (563)
.... .....|++.|+|||++.. .++.++|+||||+++|+|++|+.||...... ..+........+...
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~ 231 (267)
T cd06610 153 ADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM-KVLMLTLQNDPPSLETGA 231 (267)
T ss_pred ccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh-hhHHHHhcCCCCCcCCcc
Confidence 4322 123468899999998754 4889999999999999999999999874433 333333333222111
Q ss_pred -ccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCccc
Q 008504 147 -AKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 180 (563)
Q Consensus 147 -~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff 180 (563)
....++.+++||.+||. +|.+||++.++++||||
T Consensus 232 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 232 DYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred ccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 12446789999999997 89999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.8e-29 Score=247.98 Aligned_cols=179 Identities=32% Similarity=0.588 Sum_probs=147.2
Q ss_pred CEeccCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~-~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
+||||+++|+|..++.+. +.+++..++.++.|++.||.|||++| |+|+||+|+||+++ ..+.++|+|||++.....
T Consensus 79 lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~nili~-~~~~~~l~d~g~~~~~~~ 155 (280)
T cd06611 79 ILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK--VIHRDLKAGNILLT-LDGDVKLADFGVSAKNKS 155 (280)
T ss_pred EEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEC-CCCCEEEccCccchhhcc
Confidence 589999999999998764 56999999999999999999999999 99999999999997 557999999998865432
Q ss_pred C--CCccccCCCCccCccccc------ccCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCC-CccccCC
Q 008504 80 P--TARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP-ASLAKVN 150 (563)
Q Consensus 80 ~--~~~~~~Gtp~Y~APEvl~------~~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p-~~l~~~~ 150 (563)
. ......+++.|+|||++. ..++.++|+||||+++|+|++|+.||... ........+..+..+ ...+...
T Consensus 156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 234 (280)
T cd06611 156 TLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHEL-NPMRVLLKILKSEPPTLDQPSKW 234 (280)
T ss_pred cccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccC-CHHHHHHHHhcCCCCCcCCcccC
Confidence 2 223456899999999874 23677999999999999999999999774 344444444444332 2234456
Q ss_pred ChhHHHHHHHhcC-CCCCCCCHHHHHcCcccccc
Q 008504 151 DPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 183 (563)
Q Consensus 151 s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~ 183 (563)
+..+.+||.+||. +|.+||++.++|+||||...
T Consensus 235 ~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 235 SSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred CHHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 7899999999997 89999999999999999865
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.8e-29 Score=264.26 Aligned_cols=181 Identities=25% Similarity=0.390 Sum_probs=142.3
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
+||||+. ++|.+++...+.+++..++.|+.||+.||.|||++| |+||||||+|||++ ..+.+||+|||++......
T Consensus 163 lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~g--ivHrDlkp~Nill~-~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 163 MVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRG--IIHRDVKTENIFLD-EPENAVLGDFGAACKLDAH 238 (392)
T ss_pred EEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEc-CCCCEEEccCccccccCcc
Confidence 5899985 699999987788999999999999999999999999 99999999999998 5579999999998755432
Q ss_pred C----CccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCH--HHHHHHHhc--------------
Q 008504 81 T----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNP--AQIFKKVTS-------------- 139 (563)
Q Consensus 81 ~----~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~--~~i~~~i~~-------------- 139 (563)
. .....||+.|+|||++.. .|+.++|||||||++|+|++|+.||.+.... ...+..+..
T Consensus 239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~ 318 (392)
T PHA03207 239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGS 318 (392)
T ss_pred cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccc
Confidence 1 234579999999998864 5899999999999999999999999653221 111111110
Q ss_pred ------------CCCC-Cccc-----cCCChhHHHHHHHhcC-CCCCCCCHHHHHcCcccccccc
Q 008504 140 ------------GIKP-ASLA-----KVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQ 185 (563)
Q Consensus 140 ------------~~~p-~~l~-----~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~~ 185 (563)
...+ ...+ ...+..+++||.+||. +|.+|||+.++|.||||+...+
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~ 383 (392)
T PHA03207 319 TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPI 383 (392)
T ss_pred hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccch
Confidence 0000 0111 1235678999999997 8999999999999999976443
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=241.59 Aligned_cols=175 Identities=30% Similarity=0.525 Sum_probs=148.9
Q ss_pred CEeccCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHH-----hCCCCeEeccCccCceEEeCCCCcEEEecc
Q 008504 1 MITELFTSGNLRQYRKK----HKNVDIKVIKNWARQILHGLVYLH-----SHNPPIIHRDLKCDNIFVNGNHGEVKIGDL 71 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k----~~~Lse~~i~~i~~QIL~aL~yLH-----s~gp~IIHrDLKP~NILLd~~~G~VKL~DF 71 (563)
+||||+++|+|.+++.. ...+++..++.++.||+.||.||| +.+ ++|+||+|+||+++ +.+.+||+||
T Consensus 78 ~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~--i~h~dl~p~nili~-~~~~~kl~d~ 154 (265)
T cd08217 78 IVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT--VLHRDLKPANIFLD-ANNNVKLGDF 154 (265)
T ss_pred EEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc--ceecCCCHHHEEEe-cCCCEEEecc
Confidence 58999999999999875 357999999999999999999999 888 99999999999998 5589999999
Q ss_pred cchhhccCCC--CccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCcccc
Q 008504 72 GLAIAMQQPT--ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAK 148 (563)
Q Consensus 72 GlA~~~~~~~--~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~ 148 (563)
|++....... .....+++.|+|||.+.+ .++.++|+||||+++|+|++|..||... ......+.+..+..+ .++.
T Consensus 155 g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~ 232 (265)
T cd08217 155 GLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTAR-NQLQLASKIKEGKFR-RIPY 232 (265)
T ss_pred cccccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCc-CHHHHHHHHhcCCCC-CCcc
Confidence 9997665432 334578999999998864 4788999999999999999999999874 355556666555433 3455
Q ss_pred CCChhHHHHHHHhcC-CCCCCCCHHHHHcCccc
Q 008504 149 VNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 180 (563)
Q Consensus 149 ~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff 180 (563)
..+..+.+++.+||. +|.+||++.++++|||+
T Consensus 233 ~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 233 RYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred ccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 667899999999997 89999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.8e-29 Score=255.37 Aligned_cols=179 Identities=22% Similarity=0.450 Sum_probs=139.4
Q ss_pred CEeccCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhcc
Q 008504 1 MITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~--~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~ 78 (563)
+||||+++|+|.+++..+ +.+++..++.++.||+.||.|||++| |+||||||+|||++ ..+.++++||+.+....
T Consensus 76 lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiH~dlkp~Nil~~-~~~~~~l~~~~~~~~~~ 152 (327)
T cd08227 76 VVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILIS-VDGKVYLSGLRSNLSMI 152 (327)
T ss_pred EEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCChhhEEEe-cCCcEEEcccchhhccc
Confidence 589999999999999753 45999999999999999999999999 99999999999998 45799999998654322
Q ss_pred CC---------CCccccCCCCccCcccccc---cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCC---
Q 008504 79 QP---------TARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP--- 143 (563)
Q Consensus 79 ~~---------~~~~~~Gtp~Y~APEvl~~---~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p--- 143 (563)
.. ......++..|+|||++.+ .++.++|||||||++|+|++|+.||.............. +..+
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~-~~~~~~~ 231 (327)
T cd08227 153 NHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLN-GTVPCLL 231 (327)
T ss_pred cccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhc-CCccccc
Confidence 11 1112346778999998864 488999999999999999999999976433322222221 1110
Q ss_pred -----------------------------------------CccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCcccc
Q 008504 144 -----------------------------------------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQ 181 (563)
Q Consensus 144 -----------------------------------------~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~ 181 (563)
.......++.+++||.+||. +|.+|||+.++++||||+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~ 311 (327)
T cd08227 232 DTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFK 311 (327)
T ss_pred cccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhh
Confidence 00112235789999999997 899999999999999997
Q ss_pred cc
Q 008504 182 VE 183 (563)
Q Consensus 182 ~~ 183 (563)
..
T Consensus 312 ~~ 313 (327)
T cd08227 312 QI 313 (327)
T ss_pred hc
Confidence 53
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=250.62 Aligned_cols=181 Identities=31% Similarity=0.565 Sum_probs=148.2
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
+|+||+.+|+|..++.+ ..+++..+..++.|++.||.|||++| ++||||||+||+++ ..+.+||+|||++......
T Consensus 93 lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~--i~H~dL~p~Nili~-~~~~~kl~dfg~~~~~~~~ 168 (296)
T cd06655 93 VVMEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQ--VIHRDIKSDNVLLG-MDGSVKLTDFGFCAQITPE 168 (296)
T ss_pred EEEEecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCCEEEccCccchhcccc
Confidence 58999999999999876 46999999999999999999999999 99999999999997 5689999999998655432
Q ss_pred C--CccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHHH
Q 008504 81 T--ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 157 (563)
Q Consensus 81 ~--~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~L 157 (563)
. .....+++.|+|||.+.+ .++.++|||||||++|+|++|+.||......................+...++.+++|
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 248 (296)
T cd06655 169 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDF 248 (296)
T ss_pred cccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHH
Confidence 1 233468899999998864 4889999999999999999999999874433333332222322333445567899999
Q ss_pred HHHhcC-CCCCCCCHHHHHcCcccccccc
Q 008504 158 IEKCLV-PASERLSAKDLLKDPFLQVENQ 185 (563)
Q Consensus 158 I~kcL~-dP~kRpSa~ELLkHpff~~~~~ 185 (563)
|.+||. +|.+||++.+++.||||+....
T Consensus 249 i~~~l~~dp~~Rpt~~~il~~~~~~~~~~ 277 (296)
T cd06655 249 LNRCLEMDVEKRGSAKELLQHPFLKLAKP 277 (296)
T ss_pred HHHHhhcChhhCCCHHHHhhChHhhhccc
Confidence 999997 8999999999999999985543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=250.64 Aligned_cols=179 Identities=30% Similarity=0.618 Sum_probs=145.9
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
+||||+++++|.+++.. +.+++..++.++.||+.||.|||++| |+||||||+||+++ +++.++|+|||++......
T Consensus 96 lv~e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~-~~~~~kL~dfg~~~~~~~~ 171 (292)
T cd06658 96 VVMEFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQG--VIHRDIKSDSILLT-SDGRIKLSDFGFCAQVSKE 171 (292)
T ss_pred EEEeCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEc-CCCCEEEccCcchhhcccc
Confidence 58999999999998865 56999999999999999999999999 99999999999997 4579999999998654322
Q ss_pred --CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCC-ccccCCChhHHH
Q 008504 81 --TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPA-SLAKVNDPQIKG 156 (563)
Q Consensus 81 --~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~-~l~~~~s~~l~~ 156 (563)
......|++.|+|||.+.+ .++.++||||||+++|+|++|+.||... ........+.....+. ......+..+++
T Consensus 172 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (292)
T cd06658 172 VPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNE-PPLQAMRRIRDNLPPRVKDSHKVSSVLRG 250 (292)
T ss_pred cccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhcCCCccccccccCHHHHH
Confidence 2234568899999998864 5889999999999999999999999763 3334444443332221 122345778999
Q ss_pred HHHHhcC-CCCCCCCHHHHHcCccccccc
Q 008504 157 FIEKCLV-PASERLSAKDLLKDPFLQVEN 184 (563)
Q Consensus 157 LI~kcL~-dP~kRpSa~ELLkHpff~~~~ 184 (563)
||.+||. +|.+|||+.++++||||....
T Consensus 251 li~~~l~~~P~~Rpt~~~il~~~~~~~~~ 279 (292)
T cd06658 251 FLDLMLVREPSQRATAQELLQHPFLKLAG 279 (292)
T ss_pred HHHHHccCChhHCcCHHHHhhChhhhccC
Confidence 9999997 899999999999999998544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=242.74 Aligned_cols=176 Identities=30% Similarity=0.541 Sum_probs=143.7
Q ss_pred CEeccCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~-~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
+||||+.+++|.+++... ..+++..++.++.|++.||.|||++| |+|+||+|+||+++ +.+.+||+|||++.....
T Consensus 77 l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~-~~~~~~l~d~g~~~~~~~ 153 (262)
T cd06613 77 IVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG--KIHRDIKGANILLT-EDGDVKLADFGVSAQLTA 153 (262)
T ss_pred EEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCChhhEEEC-CCCCEEECccccchhhhh
Confidence 589999999999999876 78999999999999999999999999 99999999999998 567999999999866543
Q ss_pred C--CCccccCCCCccCcccccc----cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCc--cccCCC
Q 008504 80 P--TARSVIGTPEFMAPELYEE----EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPAS--LAKVND 151 (563)
Q Consensus 80 ~--~~~~~~Gtp~Y~APEvl~~----~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~--l~~~~s 151 (563)
. ......++..|+|||.+.+ .++.++|+|||||++|+|+||..||..................+.. .....+
T Consensus 154 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (262)
T cd06613 154 TIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWS 233 (262)
T ss_pred hhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhh
Confidence 2 2234568889999998753 5788999999999999999999999875444433333222222211 122345
Q ss_pred hhHHHHHHHhcC-CCCCCCCHHHHHcCcc
Q 008504 152 PQIKGFIEKCLV-PASERLSAKDLLKDPF 179 (563)
Q Consensus 152 ~~l~~LI~kcL~-dP~kRpSa~ELLkHpf 179 (563)
..+++||.+||. +|.+|||+.+++.|+|
T Consensus 234 ~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 234 PVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred HHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 789999999997 8999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=253.72 Aligned_cols=181 Identities=31% Similarity=0.496 Sum_probs=148.3
Q ss_pred CEeccCCCCCHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhh
Q 008504 1 MITELFTSGNLRQYRKKHK----NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 76 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~----~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~ 76 (563)
||+||+.. +|.+|+...+ .++...++.+++||+.||+|||+++ |+||||||+||+|+ +.|.+||+|||+|+.
T Consensus 94 lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~--IlHRDLKPQNlLi~-~~G~lKlaDFGlAra 169 (323)
T KOG0594|consen 94 LVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG--ILHRDLKPQNLLIS-SSGVLKLADFGLARA 169 (323)
T ss_pred EEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCcceEEEC-CCCcEeeeccchHHH
Confidence 58999975 9999998765 5888999999999999999999999 99999999999998 479999999999987
Q ss_pred ccCC--CCccccCCCCccCcccccc--cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCC---------
Q 008504 77 MQQP--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP--------- 143 (563)
Q Consensus 77 ~~~~--~~~~~~Gtp~Y~APEvl~~--~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p--------- 143 (563)
..-+ ...+.++|.+|.|||++-+ .|+..+||||+|||++||++++.-|.+.....++......--.|
T Consensus 170 ~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~ 249 (323)
T KOG0594|consen 170 FSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVS 249 (323)
T ss_pred hcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCcc
Confidence 6533 3445688999999998754 49999999999999999999999998877666655443221000
Q ss_pred ---------------Cccc---cCCChhHHHHHHHhcC-CCCCCCCHHHHHcCcccccccc
Q 008504 144 ---------------ASLA---KVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQ 185 (563)
Q Consensus 144 ---------------~~l~---~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~~ 185 (563)
..+. ...++...+++.+||. +|.+|.|+..+|.||||+....
T Consensus 250 ~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~ 310 (323)
T KOG0594|consen 250 SLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPE 310 (323)
T ss_pred ccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccccc
Confidence 0000 1123588999999998 8999999999999999986543
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=241.23 Aligned_cols=176 Identities=38% Similarity=0.599 Sum_probs=147.4
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
+|+||+++++|.+++.+.+.+++..++.++.||+.||.|||+.| |+|+||+|+||+++ ..+.+||+|||++......
T Consensus 79 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~~~ni~~~-~~~~~kl~d~~~~~~~~~~ 155 (258)
T cd06632 79 IFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRN--TVHRDIKGANILVD-TNGVVKLADFGMAKQVVEF 155 (258)
T ss_pred EEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCCEEEccCccceecccc
Confidence 58999999999999998888999999999999999999999999 99999999999998 4579999999998665433
Q ss_pred C-CccccCCCCccCcccccc-c-CCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHHH
Q 008504 81 T-ARSVIGTPEFMAPELYEE-E-YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 157 (563)
Q Consensus 81 ~-~~~~~Gtp~Y~APEvl~~-~-ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~L 157 (563)
. .....+++.|+|||.+.. . ++.++|+||||+++|+|++|+.||........... +.........+...++.+++|
T Consensus 156 ~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l 234 (258)
T cd06632 156 SFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFK-IGRSKELPPIPDHLSDEAKDF 234 (258)
T ss_pred ccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHH-HHhcccCCCcCCCcCHHHHHH
Confidence 2 334568899999998753 3 78999999999999999999999987543333333 333223334555678899999
Q ss_pred HHHhcC-CCCCCCCHHHHHcCccc
Q 008504 158 IEKCLV-PASERLSAKDLLKDPFL 180 (563)
Q Consensus 158 I~kcL~-dP~kRpSa~ELLkHpff 180 (563)
|.+||. +|.+||++.+++.|||+
T Consensus 235 i~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 235 ILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred HHHHhhcCcccCcCHHHHhcCCCC
Confidence 999997 89999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-28 Score=246.08 Aligned_cols=180 Identities=30% Similarity=0.529 Sum_probs=146.8
Q ss_pred CEeccCCCCCHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEeccCccCceEEeCCCCcEEEecccchhh
Q 008504 1 MITELFTSGNLRQYRKKH---KNVDIKVIKNWARQILHGLVYLHS-HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 76 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~---~~Lse~~i~~i~~QIL~aL~yLHs-~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~ 76 (563)
+||||+++++|..++... ..+++..++.++.||+.||.|||+ ++ |+||||||+||+++. .+.+||+|||++..
T Consensus 76 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~~-~~~~~l~dfg~~~~ 152 (286)
T cd06622 76 MCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--IIHRDVKPTNVLVNG-NGQVKLCDFGVSGN 152 (286)
T ss_pred EEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC--EeeCCCCHHHEEECC-CCCEEEeecCCccc
Confidence 589999999999998863 379999999999999999999997 58 999999999999984 67999999999976
Q ss_pred ccCCCCccccCCCCccCcccccc-------cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHH--HHHHHHhcCCCCCccc
Q 008504 77 MQQPTARSVIGTPEFMAPELYEE-------EYNELVDIYSFGMCILEMVTFEYPYSECKNPA--QIFKKVTSGIKPASLA 147 (563)
Q Consensus 77 ~~~~~~~~~~Gtp~Y~APEvl~~-------~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~--~i~~~i~~~~~p~~l~ 147 (563)
..........+++.|+|||.+.+ .++.++|+|||||++|+|++|+.||....... .....+..+.. ...+
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~ 231 (286)
T cd06622 153 LVASLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDP-PTLP 231 (286)
T ss_pred ccCCccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCC-CCCC
Confidence 65444455678889999998743 25789999999999999999999997532221 12222333332 3344
Q ss_pred cCCChhHHHHHHHhcC-CCCCCCCHHHHHcCccccccc
Q 008504 148 KVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 184 (563)
Q Consensus 148 ~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~ 184 (563)
...++.+++||.+||. +|.+||++.+++.||||....
T Consensus 232 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~ 269 (286)
T cd06622 232 SGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYK 269 (286)
T ss_pred cccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhcc
Confidence 4578899999999997 899999999999999997654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-30 Score=259.08 Aligned_cols=183 Identities=31% Similarity=0.502 Sum_probs=155.2
Q ss_pred CEeccCCCCCHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRK-KHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~-k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
||||||..|+..+.++ ++++|++.++..+++..++||+|||... -||||||..|||++ ..|..||+|||.|..+..
T Consensus 105 IVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~--KIHRDIKAGNILLN-T~G~AKLADFGVAGQLTD 181 (502)
T KOG0574|consen 105 IVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLK--KIHRDIKAGNILLN-TDGIAKLADFGVAGQLTD 181 (502)
T ss_pred eehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHH--HHHhhcccccEEEc-ccchhhhhhccccchhhh
Confidence 6999999999999987 4678999999999999999999999998 89999999999998 458999999999977765
Q ss_pred C--CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHH
Q 008504 80 P--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKG 156 (563)
Q Consensus 80 ~--~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~ 156 (563)
. ...+++|||.|||||+++. +|+.++||||||+...||..|++||.+......++-.-+...+...-+..++.++.+
T Consensus 182 TMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~D 261 (502)
T KOG0574|consen 182 TMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFND 261 (502)
T ss_pred hHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHH
Confidence 3 3567899999999999975 699999999999999999999999987433333332223333333445667889999
Q ss_pred HHHHhcC-CCCCCCCHHHHHcCccccccccC
Q 008504 157 FIEKCLV-PASERLSAKDLLKDPFLQVENQK 186 (563)
Q Consensus 157 LI~kcL~-dP~kRpSa~ELLkHpff~~~~~~ 186 (563)
||++||. +|.+|.||.+|++|||++.....
T Consensus 262 Fi~~CLiK~PE~R~TA~~L~~H~FiknA~g~ 292 (502)
T KOG0574|consen 262 FIRSCLIKKPEERKTALRLCEHTFIKNAPGC 292 (502)
T ss_pred HHHHHhcCCHHHHHHHHHHhhhhhhcCCCcc
Confidence 9999997 79999999999999999876543
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=246.88 Aligned_cols=180 Identities=31% Similarity=0.550 Sum_probs=145.2
Q ss_pred CEeccCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeEeccCccCceEEeCCCCcEEEecccchh
Q 008504 1 MITELFTSGNLRQYRKK----HKNVDIKVIKNWARQILHGLVYLHSH-NPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 75 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k----~~~Lse~~i~~i~~QIL~aL~yLHs~-gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~ 75 (563)
+||||++ |+|.+++.. ...+++..++.++.||+.||.|||++ + ++||||||+||+++ ..+.+||+|||++.
T Consensus 77 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~--i~h~dlkp~nil~~-~~~~~kl~dfg~~~ 152 (283)
T cd06617 77 ICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS--VIHRDVKPSNVLIN-RNGQVKLCDFGISG 152 (283)
T ss_pred EEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEEC-CCCCEEEeeccccc
Confidence 5899996 688888764 24689999999999999999999997 8 99999999999998 45799999999987
Q ss_pred hccCCCC-ccccCCCCccCcccccc-----cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccC
Q 008504 76 AMQQPTA-RSVIGTPEFMAPELYEE-----EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKV 149 (563)
Q Consensus 76 ~~~~~~~-~~~~Gtp~Y~APEvl~~-----~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~ 149 (563)
....... ....++..|+|||.+.+ .++.++|+|||||++|+|++|+.||............+..+..+......
T Consensus 153 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd06617 153 YLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEK 232 (283)
T ss_pred ccccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCccc
Confidence 6543322 23468889999998753 36889999999999999999999997644443434444444333333345
Q ss_pred CChhHHHHHHHhcC-CCCCCCCHHHHHcCccccccc
Q 008504 150 NDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 184 (563)
Q Consensus 150 ~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~ 184 (563)
.+..+++||.+||. +|.+||++.+++.||||+...
T Consensus 233 ~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 268 (283)
T cd06617 233 FSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL 268 (283)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence 67899999999997 899999999999999998754
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=245.66 Aligned_cols=177 Identities=27% Similarity=0.463 Sum_probs=142.6
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
+||||+++++|..++.....+++..++.++.||+.||.|||++| ++||||||+||+++ +.|.+||+|||++......
T Consensus 77 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~--i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 77 LVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN--CIHRDVKPENILIT-KQGQIKLCDFGFARILTGP 153 (286)
T ss_pred EEEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCChhhEEEc-CCCcEEECccccceecCCC
Confidence 58999999999998887778999999999999999999999999 99999999999998 5579999999999765433
Q ss_pred C--CccccCCCCccCcccccc--cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhc--C--------------
Q 008504 81 T--ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS--G-------------- 140 (563)
Q Consensus 81 ~--~~~~~Gtp~Y~APEvl~~--~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~--~-------------- 140 (563)
. .....++..|+|||++.+ .++.++||||||+++|+|++|+.||.+............. .
T Consensus 154 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07847 154 GDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQF 233 (286)
T ss_pred cccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccc
Confidence 2 223467889999998754 4788999999999999999999999875544433322110 0
Q ss_pred ---C-CCCc--------cccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCccc
Q 008504 141 ---I-KPAS--------LAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 180 (563)
Q Consensus 141 ---~-~p~~--------l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff 180 (563)
. .+.. .....+..+.+||.+||. +|.+||++.+++.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 234 FKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred cccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 0 0000 011236788999999997 89999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=250.22 Aligned_cols=184 Identities=25% Similarity=0.408 Sum_probs=150.0
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
+||||++||+|.+++...+.+++..+..++.|++.||.|||++| ++||||||+||+++ ..|.+||+|||+++.....
T Consensus 78 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~NIll~-~~~~~~l~dfg~~~~~~~~ 154 (305)
T cd05609 78 MVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYG--IVHRDLKPDNLLIT-SMGHIKLTDFGLSKIGLMS 154 (305)
T ss_pred EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHEEEC-CCCCEEEeeCCCccccCcC
Confidence 58999999999999998888999999999999999999999999 99999999999997 5689999999987531100
Q ss_pred -----------------CCccccCCCCccCccccc-ccCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCC
Q 008504 81 -----------------TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK 142 (563)
Q Consensus 81 -----------------~~~~~~Gtp~Y~APEvl~-~~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~ 142 (563)
......+++.|+|||.+. ..++.++|+|||||++|+|++|..||.+. ...+....+..+..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~-~~~~~~~~~~~~~~ 233 (305)
T cd05609 155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD-TPEELFGQVISDDI 233 (305)
T ss_pred ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhccc
Confidence 011235788899999775 45899999999999999999999999863 45555555554432
Q ss_pred C-CccccCCChhHHHHHHHhcC-CCCCCCC---HHHHHcCccccccccCCC
Q 008504 143 P-ASLAKVNDPQIKGFIEKCLV-PASERLS---AKDLLKDPFLQVENQKEP 188 (563)
Q Consensus 143 p-~~l~~~~s~~l~~LI~kcL~-dP~kRpS---a~ELLkHpff~~~~~~~~ 188 (563)
+ .......++.+++||.+||. +|.+||+ +.++|+||||....+...
T Consensus 234 ~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~~~~ 284 (305)
T cd05609 234 EWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWNGL 284 (305)
T ss_pred CCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCHHHH
Confidence 2 22223567889999999997 8999998 899999999987666543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-28 Score=240.05 Aligned_cols=176 Identities=28% Similarity=0.511 Sum_probs=146.2
Q ss_pred CEeccCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhcc
Q 008504 1 MITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~--~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~ 78 (563)
+||||+++|+|.+++... ..+++..++.++.|++.||.|||++| |+|+||+|+||+++.+.+.+||+|||++....
T Consensus 76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~ 153 (256)
T cd08220 76 IVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL--ILHRDLKTQNILLDKHKMVVKIGDFGISKILS 153 (256)
T ss_pred EEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEccCCCceecC
Confidence 589999999999999864 35899999999999999999999999 99999999999998666678999999997654
Q ss_pred CCC-CccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHH
Q 008504 79 QPT-ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKG 156 (563)
Q Consensus 79 ~~~-~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~ 156 (563)
... .....+++.|+|||.+.+ .++.++||||||+++|+|++|..||..... ......+..+... ..+...++.+++
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~-~~~~~~~~~~~~~-~~~~~~~~~l~~ 231 (256)
T cd08220 154 SKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL-PALVLKIMSGTFA-PISDRYSPDLRQ 231 (256)
T ss_pred CCccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch-HHHHHHHHhcCCC-CCCCCcCHHHHH
Confidence 332 234568899999998864 478899999999999999999999977443 3444444433322 234456789999
Q ss_pred HHHHhcC-CCCCCCCHHHHHcCccc
Q 008504 157 FIEKCLV-PASERLSAKDLLKDPFL 180 (563)
Q Consensus 157 LI~kcL~-dP~kRpSa~ELLkHpff 180 (563)
+|.+||. +|.+|||+.+++.||||
T Consensus 232 li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 232 LILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred HHHHHccCChhhCCCHHHHhhCCCC
Confidence 9999997 89999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=251.30 Aligned_cols=178 Identities=26% Similarity=0.437 Sum_probs=139.9
Q ss_pred CEeccCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~-~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
+||||+.+ +|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||++ ..+.+||+|||++.....
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~ 156 (309)
T cd07872 81 LVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK--VLHRDLKPQNLLIN-ERGELKLADFGLARAKSV 156 (309)
T ss_pred EEEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEC-CCCCEEECccccceecCC
Confidence 58999975 888888764 45899999999999999999999999 99999999999998 457999999999865432
Q ss_pred C--CCccccCCCCccCcccccc--cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCC--------------
Q 008504 80 P--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI-------------- 141 (563)
Q Consensus 80 ~--~~~~~~Gtp~Y~APEvl~~--~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~-------------- 141 (563)
. ......+++.|+|||++.+ .++.++|||||||++|+|+||+.||........ ...+....
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 235 (309)
T cd07872 157 PTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDE-LHLIFRLLGTPTEETWPGISSN 235 (309)
T ss_pred CccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCHHHHhhhcch
Confidence 2 2234467899999998753 478999999999999999999999976433222 11111100
Q ss_pred -------CCC-------ccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCcccccc
Q 008504 142 -------KPA-------SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 183 (563)
Q Consensus 142 -------~p~-------~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~ 183 (563)
.+. ......++++++||.+||. +|.+|||+.|+|+||||+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 292 (309)
T cd07872 236 DEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL 292 (309)
T ss_pred hhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhc
Confidence 000 0112346789999999998 89999999999999999854
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-28 Score=245.46 Aligned_cols=176 Identities=31% Similarity=0.480 Sum_probs=138.8
Q ss_pred CEeccCCCCCHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhc
Q 008504 1 MITELFTSGNLRQYRKKH---KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM 77 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~---~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~ 77 (563)
+||||+. |+|.+++... +.+++..++.++.||+.||.|||++| |+||||||+||+++ ++|.+||+|||++...
T Consensus 76 ~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~ 151 (285)
T cd07861 76 LIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR--VLHRDLKPQNLLID-NKGVIKLADFGLARAF 151 (285)
T ss_pred EEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEEc-CCCcEEECcccceeec
Confidence 5899997 6899988653 46999999999999999999999999 99999999999997 5689999999998654
Q ss_pred cCC--CCccccCCCCccCcccccc--cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCC-----------
Q 008504 78 QQP--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK----------- 142 (563)
Q Consensus 78 ~~~--~~~~~~Gtp~Y~APEvl~~--~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~----------- 142 (563)
... ......+++.|+|||++.+ .++.++|||||||++|+|+||+.||..................
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (285)
T cd07861 152 GIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTS 231 (285)
T ss_pred CCCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchh
Confidence 322 1223456889999998754 4788999999999999999999999764433333222111000
Q ss_pred ---------------CCccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCccc
Q 008504 143 ---------------PASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 180 (563)
Q Consensus 143 ---------------p~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff 180 (563)
........++++++||.+||. +|.+|||+.+++.||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 232 LPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred hHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 001122357889999999997 89999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=245.50 Aligned_cols=176 Identities=30% Similarity=0.512 Sum_probs=141.3
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
+||||+++|+|.+++.+.+.+++..+..++.|++.||.|||++| |+||||+|+||+++ ..+.+||+|||++......
T Consensus 83 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nill~-~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06646 83 ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKG--KMHRDIKGANILLT-DNGDVKLADFGVAAKITAT 159 (267)
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEC-CCCCEEECcCccceeeccc
Confidence 58999999999999988888999999999999999999999999 99999999999997 5578999999998755432
Q ss_pred --CCccccCCCCccCccccc----ccCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCcc--ccCCCh
Q 008504 81 --TARSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASL--AKVNDP 152 (563)
Q Consensus 81 --~~~~~~Gtp~Y~APEvl~----~~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l--~~~~s~ 152 (563)
......+++.|+|||.+. ..++.++|+|||||++|+|++|+.||..................+... ....+.
T Consensus 160 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd06646 160 IAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSS 239 (267)
T ss_pred ccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCH
Confidence 123456889999999873 337889999999999999999999996533222222111111122111 123467
Q ss_pred hHHHHHHHhcC-CCCCCCCHHHHHcCcc
Q 008504 153 QIKGFIEKCLV-PASERLSAKDLLKDPF 179 (563)
Q Consensus 153 ~l~~LI~kcL~-dP~kRpSa~ELLkHpf 179 (563)
.+.+||.+||. +|.+||++.++|+|+|
T Consensus 240 ~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 240 TFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred HHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 89999999997 8999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=251.40 Aligned_cols=181 Identities=31% Similarity=0.551 Sum_probs=147.6
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
+||||+++|+|.+++.+ ..+++..+..++.|++.||.|||+.| |+||||||+|||++ ..|.++|+|||++......
T Consensus 93 lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~--i~H~dL~p~Nili~-~~~~~~l~Dfg~~~~~~~~ 168 (297)
T cd06656 93 VVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQ--VIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPE 168 (297)
T ss_pred EeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCCEEECcCccceEccCC
Confidence 58999999999999876 46899999999999999999999999 99999999999997 5689999999998654332
Q ss_pred C--CccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHHH
Q 008504 81 T--ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 157 (563)
Q Consensus 81 ~--~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~L 157 (563)
. .....+++.|+|||.+.+ .++.++|+|||||++|+|++|..||...............+..+...+...++.+++|
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 248 (297)
T cd06656 169 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDF 248 (297)
T ss_pred ccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHH
Confidence 1 223468899999998864 4889999999999999999999999764333333322222333333445567889999
Q ss_pred HHHhcC-CCCCCCCHHHHHcCcccccccc
Q 008504 158 IEKCLV-PASERLSAKDLLKDPFLQVENQ 185 (563)
Q Consensus 158 I~kcL~-dP~kRpSa~ELLkHpff~~~~~ 185 (563)
|.+||. +|.+||++.++++||||+....
T Consensus 249 i~~~l~~~p~~Rps~~~il~~~~~~~~~~ 277 (297)
T cd06656 249 LNRCLEMDVDRRGSAKELLQHPFLKLAKP 277 (297)
T ss_pred HHHHccCChhhCcCHHHHhcCchhccccc
Confidence 999997 8999999999999999986544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.5e-29 Score=252.76 Aligned_cols=177 Identities=28% Similarity=0.431 Sum_probs=133.4
Q ss_pred CEeccCCCCCHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEe---CCCCcEEE
Q 008504 1 MITELFTSGNLRQYRKKH---------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN---GNHGEVKI 68 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~---------~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd---~~~G~VKL 68 (563)
+||||+. ++|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||+. ...+.+||
T Consensus 77 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~~kl 153 (317)
T cd07867 77 LLFDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKI 153 (317)
T ss_pred EEEeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEccCCCCCCcEEE
Confidence 5899986 4888887532 24889999999999999999999999 99999999999994 24578999
Q ss_pred ecccchhhccCCC-----CccccCCCCccCcccccc--cCCchhhHHHhHHHHHHHhhcCCCCCCCCCH---------HH
Q 008504 69 GDLGLAIAMQQPT-----ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNP---------AQ 132 (563)
Q Consensus 69 ~DFGlA~~~~~~~-----~~~~~Gtp~Y~APEvl~~--~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~---------~~ 132 (563)
+|||+++...... .....+|+.|+|||++.+ .++.++|||||||++|+|+||+.||...... .+
T Consensus 154 ~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~ 233 (317)
T cd07867 154 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQ 233 (317)
T ss_pred eeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHH
Confidence 9999997654321 234578999999998854 4789999999999999999999999642210 11
Q ss_pred HHHHHhc-C--------------------------CC--------CCccccCCChhHHHHHHHhcC-CCCCCCCHHHHHc
Q 008504 133 IFKKVTS-G--------------------------IK--------PASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 133 i~~~i~~-~--------------------------~~--------p~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLk 176 (563)
....... + .. ........+..+.+||.+||. ||.+|||+.|+|+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~ 313 (317)
T cd07867 234 LDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQ 313 (317)
T ss_pred HHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhc
Confidence 1110000 0 00 000011234568899999998 8999999999999
Q ss_pred Cccc
Q 008504 177 DPFL 180 (563)
Q Consensus 177 Hpff 180 (563)
||||
T Consensus 314 hp~f 317 (317)
T cd07867 314 DPYF 317 (317)
T ss_pred CCCC
Confidence 9998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=248.65 Aligned_cols=181 Identities=27% Similarity=0.444 Sum_probs=146.6
Q ss_pred CEeccCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhcc
Q 008504 1 MITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~--~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~ 78 (563)
+||||+.+|+|..++... ..+++..+..++.|++.||.|||++| |+||||||+||+++ +.+.+||+|||++....
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--iiH~dikp~Nili~-~~~~~kl~Dfg~~~~~~ 153 (285)
T cd05632 77 LVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN--TVYRDLKPENILLD-DYGHIRISDLGLAVKIP 153 (285)
T ss_pred EEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEEC-CCCCEEEecCCcceecC
Confidence 589999999999988653 46999999999999999999999999 99999999999998 45799999999986543
Q ss_pred CC-CCccccCCCCccCccccc-ccCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHH---HHHHHhcCCCCCccccCCChh
Q 008504 79 QP-TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQ---IFKKVTSGIKPASLAKVNDPQ 153 (563)
Q Consensus 79 ~~-~~~~~~Gtp~Y~APEvl~-~~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~---i~~~i~~~~~p~~l~~~~s~~ 153 (563)
.. ......|++.|+|||++. ..++.++|+|||||++|+|++|..||........ +...+... ....+...++.
T Consensus 154 ~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 231 (285)
T cd05632 154 EGESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLET--EEVYSAKFSEE 231 (285)
T ss_pred CCCcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhcc--ccccCccCCHH
Confidence 22 223457899999999885 4589999999999999999999999986433221 22222222 12234456788
Q ss_pred HHHHHHHhcC-CCCCCCC-----HHHHHcCccccccccC
Q 008504 154 IKGFIEKCLV-PASERLS-----AKDLLKDPFLQVENQK 186 (563)
Q Consensus 154 l~~LI~kcL~-dP~kRpS-----a~ELLkHpff~~~~~~ 186 (563)
+.+|+.+||. +|.+||+ +.+++.|+||.....+
T Consensus 232 ~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~ 270 (285)
T cd05632 232 AKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFK 270 (285)
T ss_pred HHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCCHH
Confidence 9999999997 8999999 8999999999876554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-28 Score=236.39 Aligned_cols=176 Identities=34% Similarity=0.599 Sum_probs=144.1
Q ss_pred CEeccCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~-~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
+|+||+++++|.+++... +.+++..+..++.|++.||.|||.+| ++||||+|+||+++ +.+.++|+|||.+.....
T Consensus 74 l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--i~h~dl~p~ni~i~-~~~~~~l~d~~~~~~~~~ 150 (253)
T cd05122 74 IVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG--IIHRDIKAANILLT-SDGEVKLIDFGLSAQLSD 150 (253)
T ss_pred EEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC--EecCCCCHHHEEEc-cCCeEEEeeccccccccc
Confidence 589999999999999876 67999999999999999999999999 99999999999998 467999999999876654
Q ss_pred CC-CccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHHH
Q 008504 80 PT-ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 157 (563)
Q Consensus 80 ~~-~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~L 157 (563)
.. .....++..|+|||.+.+ .++.++|+||||+++|+|++|+.||..........................+..+.++
T Consensus 151 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (253)
T cd05122 151 TKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDF 230 (253)
T ss_pred cccccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHH
Confidence 33 345578899999998864 4788999999999999999999999874333333332222222211222237889999
Q ss_pred HHHhcC-CCCCCCCHHHHHcCcc
Q 008504 158 IEKCLV-PASERLSAKDLLKDPF 179 (563)
Q Consensus 158 I~kcL~-dP~kRpSa~ELLkHpf 179 (563)
|.+||. +|.+|||+.++++|||
T Consensus 231 i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 231 LKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred HHHHccCChhhCCCHHHHhcCCC
Confidence 999997 8999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.4e-29 Score=256.41 Aligned_cols=176 Identities=22% Similarity=0.458 Sum_probs=155.6
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
|||||..+|.|.+|+...+.|++.+++.+++||..|+.|+|.++ ++|||||.+|||++ .++++||+|||++..+...
T Consensus 130 ivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknr--VvHRDLKLENILLD-~N~NiKIADFGLSNly~~~ 206 (668)
T KOG0611|consen 130 IVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNR--VVHRDLKLENILLD-QNNNIKIADFGLSNLYADK 206 (668)
T ss_pred EEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhcc--ceecccchhheeec-CCCCeeeeccchhhhhccc
Confidence 69999999999999999999999999999999999999999999 99999999999998 4579999999999877654
Q ss_pred -CCccccCCCCccCccccccc-C-CchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHHH
Q 008504 81 -TARSVIGTPEFMAPELYEEE-Y-NELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 157 (563)
Q Consensus 81 -~~~~~~Gtp~Y~APEvl~~~-y-s~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~L 157 (563)
...++||+|-|.+||++++. | ++.+|.||||++||.|+.|.+||.+ .+...+.+.|..|.+.. ...+..+.-|
T Consensus 207 kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG-~Dhk~lvrQIs~GaYrE---P~~PSdA~gL 282 (668)
T KOG0611|consen 207 KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDG-RDHKRLVRQISRGAYRE---PETPSDASGL 282 (668)
T ss_pred cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCC-chHHHHHHHhhcccccC---CCCCchHHHH
Confidence 56789999999999999875 4 7899999999999999999999998 45667777888776542 1223468899
Q ss_pred HHHhcC-CCCCCCCHHHHHcCcccccc
Q 008504 158 IEKCLV-PASERLSAKDLLKDPFLQVE 183 (563)
Q Consensus 158 I~kcL~-dP~kRpSa~ELLkHpff~~~ 183 (563)
|+.||. +|.+|.|+.++-.|-|+.-.
T Consensus 283 IRwmLmVNP~RRATieDiAsHWWvNwg 309 (668)
T KOG0611|consen 283 IRWMLMVNPERRATIEDIASHWWVNWG 309 (668)
T ss_pred HHHHHhcCcccchhHHHHhhhheeecc
Confidence 999995 99999999999999998643
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=264.51 Aligned_cols=191 Identities=28% Similarity=0.489 Sum_probs=158.9
Q ss_pred CEeccCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhcc
Q 008504 1 MITELFTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~--~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~ 78 (563)
||+.+|.||+|.-+|.+.+ .+++..++.|+.+|+.||.+||..+ |++|||||+|||+| +.|+|+|+|+|+|..+.
T Consensus 262 lVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~--iVYRDLKPeNILLD-d~GhvRISDLGLAvei~ 338 (591)
T KOG0986|consen 262 LVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR--IVYRDLKPENILLD-DHGHVRISDLGLAVEIP 338 (591)
T ss_pred EEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc--eeeccCChhheeec-cCCCeEeeccceEEecC
Confidence 6899999999999998876 7999999999999999999999999 99999999999998 67999999999998876
Q ss_pred CCC-CccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCH---HHHHHHHhcCCCCCccccCCChh
Q 008504 79 QPT-ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNP---AQIFKKVTSGIKPASLAKVNDPQ 153 (563)
Q Consensus 79 ~~~-~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~---~~i~~~i~~~~~p~~l~~~~s~~ 153 (563)
... ....+||..|||||++.+ .|+...|+|+|||++|||+.|+.||...... +++-+.+.. .+..++...+++
T Consensus 339 ~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~--~~~ey~~kFS~e 416 (591)
T KOG0986|consen 339 EGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLE--DPEEYSDKFSEE 416 (591)
T ss_pred CCCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhc--chhhcccccCHH
Confidence 543 334499999999999975 4999999999999999999999999763321 122222222 244566788999
Q ss_pred HHHHHHHhcC-CCCCCC-----CHHHHHcCccccccccCCCCCCCCCCc
Q 008504 154 IKGFIEKCLV-PASERL-----SAKDLLKDPFLQVENQKEPICDPLKLP 196 (563)
Q Consensus 154 l~~LI~kcL~-dP~kRp-----Sa~ELLkHpff~~~~~~~~~~~~l~~p 196 (563)
+++|.+.+|. ||.+|. .++++.+||||+..+|......-+..|
T Consensus 417 akslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rleagml~PP 465 (591)
T KOG0986|consen 417 AKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRLEAGMLEPP 465 (591)
T ss_pred HHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHHhccCCCCC
Confidence 9999999997 899987 478999999999999876544333333
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-28 Score=245.75 Aligned_cols=181 Identities=25% Similarity=0.506 Sum_probs=146.9
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHS-HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs-~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
|||||+++|+|.+++.+.+.+++..++.++.|++.||.|||+ ++ ++||||+|+||+++ +.+.++|+|||++.....
T Consensus 80 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~-~~~~~~l~d~gl~~~~~~ 156 (284)
T cd06620 80 MCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHR--IMHRDIKPSNILVN-SRGQIKLCDFGVSGELIN 156 (284)
T ss_pred EEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcC--eeccCCCHHHEEEC-CCCcEEEccCCcccchhh
Confidence 689999999999999988889999999999999999999997 68 99999999999997 567999999999865544
Q ss_pred CCCccccCCCCccCccccc-ccCCchhhHHHhHHHHHHHhhcCCCCCCCCCH----------HHHHHHHhcCCCCCcccc
Q 008504 80 PTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNP----------AQIFKKVTSGIKPASLAK 148 (563)
Q Consensus 80 ~~~~~~~Gtp~Y~APEvl~-~~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~----------~~i~~~i~~~~~p~~l~~ 148 (563)
.......|+..|+|||++. +.++.++|||||||++|+|+||..||...... ......+.....+.....
T Consensus 157 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd06620 157 SIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSS 236 (284)
T ss_pred hccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCch
Confidence 3344567899999999875 45888999999999999999999999753321 122223332222222222
Q ss_pred CCChhHHHHHHHhcC-CCCCCCCHHHHHcCccccccc
Q 008504 149 VNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 184 (563)
Q Consensus 149 ~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~ 184 (563)
..+..+.+||.+||. +|.+|||+.|+++|+||....
T Consensus 237 ~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~ 273 (284)
T cd06620 237 DFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQAL 273 (284)
T ss_pred hcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 356789999999997 899999999999999997543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=264.10 Aligned_cols=171 Identities=26% Similarity=0.460 Sum_probs=145.6
Q ss_pred CEeccCCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhcc
Q 008504 1 MITELFTSGNLRQYRKK--HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k--~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~ 78 (563)
||||||+.|+|.+||+. ++.++......++.||++|++||++++ +|||||...||||+ ++..+||+|||+|+...
T Consensus 278 IVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~--~IHRDLAARNiLV~-~~~~vKIsDFGLAr~~~ 354 (468)
T KOG0197|consen 278 IVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN--YIHRDLAARNILVD-EDLVVKISDFGLARLIG 354 (468)
T ss_pred EEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC--ccchhhhhhheeec-cCceEEEcccccccccC
Confidence 69999999999999997 567999999999999999999999999 99999999999998 55799999999999554
Q ss_pred CCCCccccC---CCCccCccccc-ccCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCCCCccccCCChh
Q 008504 79 QPTARSVIG---TPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQ 153 (563)
Q Consensus 79 ~~~~~~~~G---tp~Y~APEvl~-~~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~ 153 (563)
+.......| ...|.|||.+. +.++.++|||||||+||||+| |+.||.+ ....+....+.+|.+.+. |..+++.
T Consensus 355 d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~-msn~ev~~~le~GyRlp~-P~~CP~~ 432 (468)
T KOG0197|consen 355 DDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPG-MSNEEVLELLERGYRLPR-PEGCPDE 432 (468)
T ss_pred CCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCC-CCHHHHHHHHhccCcCCC-CCCCCHH
Confidence 433222222 34799999886 679999999999999999998 7888887 556777788888877654 5567889
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHHc
Q 008504 154 IKGFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 154 l~~LI~kcL~-dP~kRpSa~ELLk 176 (563)
+.+++..||. +|.+|||+..+..
T Consensus 433 vY~lM~~CW~~~P~~RPtF~~L~~ 456 (468)
T KOG0197|consen 433 VYELMKSCWHEDPEDRPTFETLRE 456 (468)
T ss_pred HHHHHHHHhhCCcccCCCHHHHHH
Confidence 9999999997 8999999986653
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-29 Score=247.92 Aligned_cols=173 Identities=26% Similarity=0.543 Sum_probs=145.7
Q ss_pred CHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCCCCcc-ccC
Q 008504 10 NLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARS-VIG 87 (563)
Q Consensus 10 sL~~~L~k-~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~~~~~-~~G 87 (563)
.+..++++ .+++++..+-++...+++||.||..+. .|||||+||+|||++ ..|+|||||||++..+......+ ..|
T Consensus 176 C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH-~viHRDvKPSNILlD-e~GniKlCDFGIsGrlvdSkAhtrsAG 253 (391)
T KOG0983|consen 176 CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKH-GVIHRDVKPSNILLD-ERGNIKLCDFGISGRLVDSKAHTRSAG 253 (391)
T ss_pred HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhc-ceeecccCccceEEc-cCCCEEeecccccceeecccccccccC
Confidence 44455544 467999999999999999999998653 299999999999998 56899999999997776654443 478
Q ss_pred CCCccCccccc----ccCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccC-CChhHHHHHHHhc
Q 008504 88 TPEFMAPELYE----EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKV-NDPQIKGFIEKCL 162 (563)
Q Consensus 88 tp~Y~APEvl~----~~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~-~s~~l~~LI~kcL 162 (563)
.+.|||||.+. .+|+-.+||||||+.++||+||++||.++........++....+|...... .++.+++|+..||
T Consensus 254 C~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFSp~F~~fv~~CL 333 (391)
T KOG0983|consen 254 CAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFSPDFQSFVKDCL 333 (391)
T ss_pred CccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcCHHHHHHHHHHh
Confidence 99999999885 349999999999999999999999999998888888888776554433333 7899999999999
Q ss_pred C-CCCCCCCHHHHHcCccccccc
Q 008504 163 V-PASERLSAKDLLKDPFLQVEN 184 (563)
Q Consensus 163 ~-dP~kRpSa~ELLkHpff~~~~ 184 (563)
. |+.+||...+||+|||+....
T Consensus 334 ~kd~r~RP~Y~~Ll~h~Fi~~ye 356 (391)
T KOG0983|consen 334 TKDHRKRPKYNKLLEHPFIKRYE 356 (391)
T ss_pred hcCcccCcchHHHhcCcceeecc
Confidence 7 899999999999999997654
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-29 Score=268.88 Aligned_cols=178 Identities=31% Similarity=0.541 Sum_probs=152.6
Q ss_pred CEeccCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~-~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
||||||- |+-.+++.-+ +++.+-.|..|+.+.+.||+|||+++ .||||||..|||++ +.|.|||+|||.|....
T Consensus 103 LVMEYCl-GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~--~IHRDiKAGNILLs-e~g~VKLaDFGSAsi~~- 177 (948)
T KOG0577|consen 103 LVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--RIHRDIKAGNILLS-EPGLVKLADFGSASIMA- 177 (948)
T ss_pred HHHHHHh-ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhh--HHhhhccccceEec-CCCeeeeccccchhhcC-
Confidence 6899995 5888988754 57999999999999999999999999 99999999999998 66899999999996654
Q ss_pred CCCccccCCCCccCcccc----cccCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHH
Q 008504 80 PTARSVIGTPEFMAPELY----EEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIK 155 (563)
Q Consensus 80 ~~~~~~~Gtp~Y~APEvl----~~~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~ 155 (563)
...+++|||.|||||++ .+.|+-++||||||++..||.-.++|+.+......+|. |..+..|......++..++
T Consensus 178 -PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYH-IAQNesPtLqs~eWS~~F~ 255 (948)
T KOG0577|consen 178 -PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH-IAQNESPTLQSNEWSDYFR 255 (948)
T ss_pred -chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHH-HHhcCCCCCCCchhHHHHH
Confidence 35789999999999977 36799999999999999999999999987544444444 4555555555667788999
Q ss_pred HHHHHhcC-CCCCCCCHHHHHcCcccccccc
Q 008504 156 GFIEKCLV-PASERLSAKDLLKDPFLQVENQ 185 (563)
Q Consensus 156 ~LI~kcL~-dP~kRpSa~ELLkHpff~~~~~ 185 (563)
.||..||+ .|.+|||..++|+|+|+.....
T Consensus 256 ~Fvd~CLqKipqeRptse~ll~H~fv~R~Rp 286 (948)
T KOG0577|consen 256 NFVDSCLQKIPQERPTSEELLKHRFVLRERP 286 (948)
T ss_pred HHHHHHHhhCcccCCcHHHHhhcchhccCCC
Confidence 99999998 5999999999999999986543
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-28 Score=239.38 Aligned_cols=176 Identities=38% Similarity=0.682 Sum_probs=145.8
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
+|+||+++++|.+++.+.+.+++..++.++.|++.||.|||++| |+|+||+|+||+++. .+.+||+|||++......
T Consensus 76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~~~nil~~~-~~~~kl~d~g~~~~~~~~ 152 (264)
T cd06626 76 IFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHG--IVHRDIKPANIFLDH-NGVIKLGDFGCAVKLKNN 152 (264)
T ss_pred EEEecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECC-CCCEEEcccccccccCCC
Confidence 58999999999999998878999999999999999999999999 999999999999984 689999999998765432
Q ss_pred CC------ccccCCCCccCccccccc----CCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccC-
Q 008504 81 TA------RSVIGTPEFMAPELYEEE----YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKV- 149 (563)
Q Consensus 81 ~~------~~~~Gtp~Y~APEvl~~~----ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~- 149 (563)
.. ....+++.|+|||++.+. ++.++||||||+++|+|++|+.||............+..+..+ .++..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~ 231 (264)
T cd06626 153 TTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKP-PIPDSL 231 (264)
T ss_pred CCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCC-CCCccc
Confidence 11 134678899999988632 7889999999999999999999997654444444444433222 23333
Q ss_pred -CChhHHHHHHHhcC-CCCCCCCHHHHHcCccc
Q 008504 150 -NDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 180 (563)
Q Consensus 150 -~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff 180 (563)
.++.+.+||.+||. +|.+||++.+++.|||+
T Consensus 232 ~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 232 QLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred ccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 37889999999997 89999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-28 Score=243.73 Aligned_cols=172 Identities=24% Similarity=0.377 Sum_probs=143.4
Q ss_pred CEeccCCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCC
Q 008504 1 MITELFTSGNLRQYRKKH----------------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHG 64 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~----------------~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G 64 (563)
++|||+++|+|.+++... ..+++..++.++.||+.||.|||++| ++||||||+||+++ +++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nil~~-~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH--FVHRDLAARNCLVG-EGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccccceEEEc-CCC
Confidence 589999999999999864 45888999999999999999999999 99999999999998 557
Q ss_pred cEEEecccchhhccCCC----CccccCCCCccCccccc-ccCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHh
Q 008504 65 EVKIGDLGLAIAMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVT 138 (563)
Q Consensus 65 ~VKL~DFGlA~~~~~~~----~~~~~Gtp~Y~APEvl~-~~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~ 138 (563)
.+||+|||++....... .....+++.|+|||.+. +.++.++|||||||++|+|++ |..||.+ .....+...+.
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~-~~~~~~~~~i~ 240 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYG-FSNQEVIEMIR 240 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHH
Confidence 99999999986543221 22335678899999775 568999999999999999998 9999987 34566666666
Q ss_pred cCCCCCccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcC
Q 008504 139 SGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 177 (563)
Q Consensus 139 ~~~~p~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkH 177 (563)
.+..+. .+...++.+.+|+.+||. +|.+||++.+++++
T Consensus 241 ~~~~~~-~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 241 SRQLLP-CPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred cCCcCC-CcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 554433 455678899999999997 89999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-28 Score=241.52 Aligned_cols=175 Identities=31% Similarity=0.488 Sum_probs=147.2
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
+|+||+.+++|.+++.+...+++..+..|+.||+.||.|||++| ++|+||+|+||+++ +++.++|+|||++......
T Consensus 77 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~-~~~~~~l~d~~~~~~~~~~ 153 (258)
T cd05578 77 LVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKG--IIHRDIKPDNILLD-EQGHVHITDFNIATKVTPD 153 (258)
T ss_pred EEEeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEEc-CCCCEEEeecccccccCCC
Confidence 58999999999999988778999999999999999999999999 99999999999998 5579999999998665433
Q ss_pred -CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCC--HHHHHHHHhcCCCCCccccCCChhHHH
Q 008504 81 -TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKN--PAQIFKKVTSGIKPASLAKVNDPQIKG 156 (563)
Q Consensus 81 -~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~--~~~i~~~i~~~~~p~~l~~~~s~~l~~ 156 (563)
......|+..|+|||++.. .++.++|+||||+++|+|++|..||..... .......... .....+...+..+.+
T Consensus 154 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~ 231 (258)
T cd05578 154 TLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET--ADVLYPATWSTEAID 231 (258)
T ss_pred ccccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc--ccccCcccCcHHHHH
Confidence 2234568889999998864 478999999999999999999999986543 3333333332 223345556789999
Q ss_pred HHHHhcC-CCCCCCCH--HHHHcCccc
Q 008504 157 FIEKCLV-PASERLSA--KDLLKDPFL 180 (563)
Q Consensus 157 LI~kcL~-dP~kRpSa--~ELLkHpff 180 (563)
+|.+||. +|.+||++ .++++||||
T Consensus 232 ~i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 232 AINKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred HHHHHccCChhHcCCccHHHHhcCCCC
Confidence 9999997 89999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-28 Score=242.30 Aligned_cols=178 Identities=26% Similarity=0.395 Sum_probs=146.3
Q ss_pred CEeccCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~-~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
||+||++. +|...++.. ..++...++.|+.++++||+|||++. |+||||||.|+||+ .+|.+||+|||+|+.+..
T Consensus 78 lVfEfm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~--IlHRDlKPnNLLis-~~g~lKiADFGLAr~f~~ 153 (318)
T KOG0659|consen 78 LVFEFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKW--ILHRDLKPNNLLIS-SDGQLKIADFGLARFFGS 153 (318)
T ss_pred EEEEeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhh--hhcccCCccceEEc-CCCcEEeecccchhccCC
Confidence 68999976 999999854 56999999999999999999999999 99999999999998 568999999999998865
Q ss_pred CCC--ccccCCCCccCcccccc--cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCC--CCCc--------
Q 008504 80 PTA--RSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI--KPAS-------- 145 (563)
Q Consensus 80 ~~~--~~~~Gtp~Y~APEvl~~--~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~--~p~~-------- 145 (563)
+.. ...+-|.+|.|||++-+ .|+..+|+||.|||+.||+-|.+-|.+..+.+|+......-- .+..
T Consensus 154 p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lp 233 (318)
T KOG0659|consen 154 PNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLP 233 (318)
T ss_pred CCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccc
Confidence 432 22367999999998754 599999999999999999999888888777776654443210 0111
Q ss_pred ---------------cccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCccccc
Q 008504 146 ---------------LAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQV 182 (563)
Q Consensus 146 ---------------l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~ 182 (563)
+-...+..+.+|+.+||. +|.+|+++.|+|+|+||..
T Consensus 234 dY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~ 286 (318)
T KOG0659|consen 234 DYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKS 286 (318)
T ss_pred cHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhc
Confidence 112234577999999998 9999999999999999985
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-28 Score=242.74 Aligned_cols=177 Identities=25% Similarity=0.443 Sum_probs=139.9
Q ss_pred CEeccCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k-~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
+||||+ +++|.+++.. .+.+++..++.++.||+.||.|||++| ++|+||||+||+++. .+.++|+|||++.....
T Consensus 76 ~v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~~~~-~~~~~l~dfg~~~~~~~ 151 (286)
T cd07832 76 LVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG--IMHRDLKPANLLISA-DGVLKIADFGLARLFSE 151 (286)
T ss_pred EEeccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCHHHEEEcC-CCcEEEeeeeecccccC
Confidence 589999 9999999875 456999999999999999999999999 999999999999984 57999999999876544
Q ss_pred CC---CccccCCCCccCcccccc--cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCC-----------
Q 008504 80 PT---ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP----------- 143 (563)
Q Consensus 80 ~~---~~~~~Gtp~Y~APEvl~~--~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p----------- 143 (563)
.. .....++..|+|||++.+ .++.++||||||+++|+|++|..||....+.......+.....+
T Consensus 152 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07832 152 EEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSL 231 (286)
T ss_pred CCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCc
Confidence 32 234568899999998753 36899999999999999999988886643332222211110000
Q ss_pred ----------------CccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCcccc
Q 008504 144 ----------------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQ 181 (563)
Q Consensus 144 ----------------~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~ 181 (563)
.......+..+.+||.+||. +|.+||++.++|+||||.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 232 PDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred chhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 00112335789999999997 899999999999999984
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.4e-29 Score=262.85 Aligned_cols=194 Identities=26% Similarity=0.427 Sum_probs=176.1
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
|+||-|-||.|...++.++.|+....+.++.-+++|++|||++| ||+|||||+|.+++ +.|-+||.|||+|+.+...
T Consensus 497 mLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~--iIYRDLKPENllLd-~~Gy~KLVDFGFAKki~~g 573 (732)
T KOG0614|consen 497 MLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKG--IIYRDLKPENLLLD-NRGYLKLVDFGFAKKIGSG 573 (732)
T ss_pred hhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcC--ceeccCChhheeec-cCCceEEeehhhHHHhccC
Confidence 57899999999999999999999999999999999999999999 99999999999998 6799999999999888754
Q ss_pred -CCccccCCCCccCcccc-cccCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHHHH
Q 008504 81 -TARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFI 158 (563)
Q Consensus 81 -~~~~~~Gtp~Y~APEvl-~~~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~LI 158 (563)
..-+++|||.|.|||++ ..+.+.++|.||||+++|||++|.+||++ .++...|..|.+|+....+|........+||
T Consensus 574 ~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~-~dpmktYn~ILkGid~i~~Pr~I~k~a~~Li 652 (732)
T KOG0614|consen 574 RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSG-VDPMKTYNLILKGIDKIEFPRRITKTATDLI 652 (732)
T ss_pred CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCC-CchHHHHHHHHhhhhhhhcccccchhHHHHH
Confidence 56688999999999966 56689999999999999999999999998 7889999999999998889999999999999
Q ss_pred HHhcC-CCCCCCC-----HHHHHcCccccccccCCCCCCCCCCchh
Q 008504 159 EKCLV-PASERLS-----AKDLLKDPFLQVENQKEPICDPLKLPIQ 198 (563)
Q Consensus 159 ~kcL~-dP~kRpS-----a~ELLkHpff~~~~~~~~~~~~l~~p~~ 198 (563)
+++.. +|.+|.. +.+|-+|.||..-+|.......++.|..
T Consensus 653 k~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~L~pPi~ 698 (732)
T KOG0614|consen 653 KKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRTLPPPII 698 (732)
T ss_pred HHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhhhhccCCCCcc
Confidence 99876 7999986 8999999999999998776666665543
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.1e-28 Score=241.12 Aligned_cols=176 Identities=32% Similarity=0.558 Sum_probs=148.2
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
+|+||+++++|.+++...+.+++..++.|+.||+.||.|||++| ++|+||||+||+++ .++.++|+|||++......
T Consensus 83 ~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~--i~H~dl~p~ni~i~-~~~~~~l~dfg~~~~~~~~ 159 (264)
T cd06653 83 IFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNM--IVHRDIKGANILRD-SAGNVKLGDFGASKRIQTI 159 (264)
T ss_pred EEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEc-CCCCEEECccccccccccc
Confidence 58999999999999998788999999999999999999999999 99999999999998 4579999999999754321
Q ss_pred -----CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhH
Q 008504 81 -----TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQI 154 (563)
Q Consensus 81 -----~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l 154 (563)
......++..|+|||++.+ .++.++|+|||||++|+|++|+.||........+.+ +.....+..++...++.+
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-~~~~~~~~~~p~~~~~~~ 238 (264)
T cd06653 160 CMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFK-IATQPTKPMLPDGVSDAC 238 (264)
T ss_pred cccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHH-HHcCCCCCCCCcccCHHH
Confidence 1223568899999998865 478899999999999999999999987544444443 333333445666778899
Q ss_pred HHHHHHhcCCCCCCCCHHHHHcCccc
Q 008504 155 KGFIEKCLVPASERLSAKDLLKDPFL 180 (563)
Q Consensus 155 ~~LI~kcL~dP~kRpSa~ELLkHpff 180 (563)
+++|.+||.+|..||++.+++.|||.
T Consensus 239 ~~~i~~~l~~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 239 RDFLKQIFVEEKRRPTAEFLLRHPFV 264 (264)
T ss_pred HHHHHHHhcCcccCccHHHHhcCCCC
Confidence 99999999989999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.5e-28 Score=246.68 Aligned_cols=179 Identities=26% Similarity=0.448 Sum_probs=140.7
Q ss_pred CEeccCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~-~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
+||||+. ++|.+++.+. ..+++..++.++.||+.||.|||++| |+||||||+|||++ +++.+||+|||++.....
T Consensus 81 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--i~H~dlkp~Nil~~-~~~~~kl~dfg~~~~~~~ 156 (301)
T cd07873 81 LVFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK--VLHRDLKPQNLLIN-ERGELKLADFGLARAKSI 156 (301)
T ss_pred EEEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHHHEEEC-CCCcEEECcCcchhccCC
Confidence 5899997 5999988764 56999999999999999999999999 99999999999998 557999999999865432
Q ss_pred C--CCccccCCCCccCcccccc--cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCC--------------
Q 008504 80 P--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI-------------- 141 (563)
Q Consensus 80 ~--~~~~~~Gtp~Y~APEvl~~--~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~-------------- 141 (563)
. ......+++.|+|||++.+ .++.++|||||||++|+|+||+.||........ ...+....
T Consensus 157 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 235 (301)
T cd07873 157 PTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQ-LHFIFRILGTPTEETWPGILSN 235 (301)
T ss_pred CCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHcCCCChhhchhhhcc
Confidence 2 2233467889999998754 478899999999999999999999986433222 22111100
Q ss_pred -------CCC-------ccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCccccccc
Q 008504 142 -------KPA-------SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 184 (563)
Q Consensus 142 -------~p~-------~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~ 184 (563)
.+. ......++.+++||.+||. +|.+|||+.++|+||||+...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~ 293 (301)
T cd07873 236 EEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG 293 (301)
T ss_pred ccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 000 0112356789999999998 899999999999999997544
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-28 Score=240.85 Aligned_cols=169 Identities=21% Similarity=0.351 Sum_probs=139.5
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
|||||+++|+|.+++.+...+++..+..++.|++.||.|||++| |+||||||+||+++ ..+.++|+|||.+......
T Consensus 62 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nil~~-~~~~~~l~df~~~~~~~~~ 138 (237)
T cd05576 62 LVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREG--IVCRDLNPNNILLD-DRGHIQLTYFSRWSEVEDS 138 (237)
T ss_pred EEEecCCCCCHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEc-CCCCEEEecccchhccccc
Confidence 58999999999999988888999999999999999999999999 99999999999998 4579999999987655432
Q ss_pred CCccccCCCCccCccccc-ccCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHHHHH
Q 008504 81 TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIE 159 (563)
Q Consensus 81 ~~~~~~Gtp~Y~APEvl~-~~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~LI~ 159 (563)
.....++..|+|||.+. +.++.++|+||+|+++|+|++|..|+..... .. .......++...++.+++||.
T Consensus 139 -~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~--~~-----~~~~~~~~~~~~~~~~~~li~ 210 (237)
T cd05576 139 -CDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPS--GI-----NTHTTLNIPEWVSEEARSLLQ 210 (237)
T ss_pred -cccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCch--hc-----ccccccCCcccCCHHHHHHHH
Confidence 22345577899999886 4588999999999999999999988754211 11 111112244556789999999
Q ss_pred HhcC-CCCCCCCH-----HHHHcCccc
Q 008504 160 KCLV-PASERLSA-----KDLLKDPFL 180 (563)
Q Consensus 160 kcL~-dP~kRpSa-----~ELLkHpff 180 (563)
+||. +|.+||++ .++++||||
T Consensus 211 ~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 211 QLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred HHccCCHHHhcCCCccchHHHHcCCCC
Confidence 9997 89999985 999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.7e-28 Score=243.83 Aligned_cols=178 Identities=29% Similarity=0.440 Sum_probs=139.9
Q ss_pred CEeccCCCCCHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchh
Q 008504 1 MITELFTSGNLRQYRKKH-----KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 75 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~-----~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~ 75 (563)
+||||+.+ +|.+++... ..+++..++.++.||+.||.|||++| |+||||+|+||+++.+.+.+||+|||++.
T Consensus 83 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~~~nil~~~~~~~~kl~dfg~~~ 159 (295)
T cd07837 83 LVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG--VMHRDLKPQNLLVDKQKGLLKIADLGLGR 159 (295)
T ss_pred EEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEecCCCeEEEeecccce
Confidence 58999985 899988642 35899999999999999999999999 99999999999998647899999999986
Q ss_pred hccCC--CCccccCCCCccCcccccc--cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCC--------
Q 008504 76 AMQQP--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP-------- 143 (563)
Q Consensus 76 ~~~~~--~~~~~~Gtp~Y~APEvl~~--~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p-------- 143 (563)
..... ......+++.|+|||++.+ .++.++||||||+++|+|++|..||...............-..+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (295)
T cd07837 160 AFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGV 239 (295)
T ss_pred ecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcch
Confidence 54322 1223356889999998753 47899999999999999999999998754444333222110000
Q ss_pred -----------------CccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCcccc
Q 008504 144 -----------------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQ 181 (563)
Q Consensus 144 -----------------~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~ 181 (563)
.......++.+.+||.+||. +|.+||++.++|.||||+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 240 SKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred hhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 00012356789999999997 899999999999999995
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.9e-28 Score=244.61 Aligned_cols=179 Identities=31% Similarity=0.615 Sum_probs=148.1
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
+|+||+++++|.+++.. +++++..++.++.||+.||+|||++| |+||||+|+||+++ .++.++|+|||++......
T Consensus 93 ~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~~l~d~g~~~~~~~~ 168 (285)
T cd06648 93 VVMEFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQG--VIHRDIKSDSILLT-SDGRVKLSDFGFCAQVSKE 168 (285)
T ss_pred EEEeccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChhhEEEc-CCCcEEEcccccchhhccC
Confidence 58999999999999987 67999999999999999999999999 99999999999998 5579999999988654332
Q ss_pred --CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCc-cccCCChhHHH
Q 008504 81 --TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPAS-LAKVNDPQIKG 156 (563)
Q Consensus 81 --~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~-l~~~~s~~l~~ 156 (563)
......|++.|+|||.+.+ .++.++||||||+++|+|++|+.||.. .++......+.....+.. .....+..+.+
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 247 (285)
T cd06648 169 VPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFN-EPPLQAMKRIRDNLPPKLKNLHKVSPRLRS 247 (285)
T ss_pred CcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcC-CCHHHHHHHHHhcCCCCCcccccCCHHHHH
Confidence 2233568999999998864 488999999999999999999999976 344555555554432221 12235678999
Q ss_pred HHHHhcC-CCCCCCCHHHHHcCccccccc
Q 008504 157 FIEKCLV-PASERLSAKDLLKDPFLQVEN 184 (563)
Q Consensus 157 LI~kcL~-dP~kRpSa~ELLkHpff~~~~ 184 (563)
||.+||. +|.+||++.++++||||....
T Consensus 248 li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 276 (285)
T cd06648 248 FLDRMLVRDPAQRATAAELLNHPFLAKAG 276 (285)
T ss_pred HHHHHcccChhhCcCHHHHccCcccccCC
Confidence 9999997 899999999999999998644
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.7e-28 Score=238.07 Aligned_cols=175 Identities=27% Similarity=0.521 Sum_probs=147.2
Q ss_pred CEeccCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhcc
Q 008504 1 MITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~--~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~ 78 (563)
+||||+++|+|.+++.+. ..+++..+..++.|++.||.|||+.| ++||||+|+||+++ ..+.+||+|||++....
T Consensus 76 ~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~ni~~~-~~~~~kl~d~~~~~~~~ 152 (256)
T cd08221 76 IEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG--ILHRDIKTLNIFLT-KAGLIKLGDFGISKILG 152 (256)
T ss_pred EEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChHhEEEe-CCCCEEECcCcceEEcc
Confidence 589999999999999875 46899999999999999999999999 99999999999998 45799999999986554
Q ss_pred CCC--CccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHH
Q 008504 79 QPT--ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIK 155 (563)
Q Consensus 79 ~~~--~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~ 155 (563)
... .....+++.|+|||++.+ .++.++|+||||+++|+|++|..||.. .........+..+..+. .....+..+.
T Consensus 153 ~~~~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 230 (256)
T cd08221 153 SEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDA-TNPLNLVVKIVQGNYTP-VVSVYSSELI 230 (256)
T ss_pred cccccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHcCCCCC-CccccCHHHH
Confidence 322 334578999999998764 478899999999999999999999976 44555555555554332 3355678999
Q ss_pred HHHHHhcC-CCCCCCCHHHHHcCccc
Q 008504 156 GFIEKCLV-PASERLSAKDLLKDPFL 180 (563)
Q Consensus 156 ~LI~kcL~-dP~kRpSa~ELLkHpff 180 (563)
++|.+||. +|.+||++.++|+|||+
T Consensus 231 ~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 231 SLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred HHHHHHcccCcccCCCHHHHhhCcCC
Confidence 99999997 89999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.9e-28 Score=255.10 Aligned_cols=178 Identities=31% Similarity=0.487 Sum_probs=135.2
Q ss_pred CEeccCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k-~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
+||||+. |+|.+++.+ .+.+++..++.|+.||+.||.|||++| |+||||||+|||++ ..+.+||+|||++.....
T Consensus 134 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~-~~~~~kl~DfG~a~~~~~ 209 (357)
T PHA03209 134 MVLPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR--IIHRDVKTENIFIN-DVDQVCIGDLGAAQFPVV 209 (357)
T ss_pred EEEEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEC-CCCCEEEecCcccccccc
Confidence 5899995 588888865 467999999999999999999999999 99999999999998 557999999999864332
Q ss_pred -CCCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCC-CH---------HHHHHHHhc-CCCCCcc
Q 008504 80 -PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECK-NP---------AQIFKKVTS-GIKPASL 146 (563)
Q Consensus 80 -~~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~-~~---------~~i~~~i~~-~~~p~~l 146 (563)
.......||+.|+|||++.+ .++.++|||||||++|+|+++..|+.... .. ..+...+.. +..+..+
T Consensus 210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 289 (357)
T PHA03209 210 APAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEF 289 (357)
T ss_pred CcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhc
Confidence 22334578999999998864 58999999999999999998755543211 10 111111111 1111111
Q ss_pred c------------------------------cCCChhHHHHHHHhcC-CCCCCCCHHHHHcCccccc
Q 008504 147 A------------------------------KVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQV 182 (563)
Q Consensus 147 ~------------------------------~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~ 182 (563)
+ ...+..+.+||.+||. ||.+|||+.|+|+||||+.
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 290 PRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred CCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 1 1234567789999998 8999999999999999975
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.7e-28 Score=243.80 Aligned_cols=182 Identities=29% Similarity=0.525 Sum_probs=145.2
Q ss_pred CEeccCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhh
Q 008504 1 MITELFTSGNLRQYRKK----HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 76 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k----~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~ 76 (563)
+||||+++|+|.+++.. ...+++..+..++.||+.||.|||+.| ++|+||+|+||+++ ..+.++|+|||++..
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~--i~H~dl~~~nil~~-~~~~~~l~dfg~~~~ 154 (287)
T cd06621 78 IAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK--IIHRDIKPSNILLT-RKGQVKLCDFGVSGE 154 (287)
T ss_pred EEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEe-cCCeEEEeecccccc
Confidence 58999999999998753 345899999999999999999999999 99999999999998 457999999999865
Q ss_pred ccCCCCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCC----CCHHHHHHHHhcCCCCCc---cc-
Q 008504 77 MQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSEC----KNPAQIFKKVTSGIKPAS---LA- 147 (563)
Q Consensus 77 ~~~~~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~----~~~~~i~~~i~~~~~p~~---l~- 147 (563)
..........++..|+|||.+.+ .++.++|||||||++|+|++|..||... .........+.....+.. ..
T Consensus 155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd06621 155 LVNSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGN 234 (287)
T ss_pred ccccccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCC
Confidence 54433344567889999998764 5899999999999999999999999764 223334444333222111 11
Q ss_pred -cCCChhHHHHHHHhcC-CCCCCCCHHHHHcCcccccccc
Q 008504 148 -KVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQ 185 (563)
Q Consensus 148 -~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~~ 185 (563)
...++.+++||.+||. +|.+|||+.|+++||||+....
T Consensus 235 ~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~ 274 (287)
T cd06621 235 GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMK 274 (287)
T ss_pred CCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccccc
Confidence 2235689999999997 8999999999999999965443
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-28 Score=248.07 Aligned_cols=181 Identities=24% Similarity=0.458 Sum_probs=142.1
Q ss_pred CEeccCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhcc
Q 008504 1 MITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~--~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~ 78 (563)
++|||+.+|+|.+++.+. ..+++..++.+++||+.||.|||+++ |+||||||+||+++ ..|.+||+|||.+....
T Consensus 76 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~--ivH~dlk~~Nili~-~~~~~kl~d~~~~~~~~ 152 (314)
T cd08216 76 VVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG--FIHRSVKASHILLS-GDGKVVLSGLRYSVSMI 152 (314)
T ss_pred EEEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCcceEEEe-cCCceEEecCccceeec
Confidence 589999999999999864 45899999999999999999999999 99999999999998 55899999999885442
Q ss_pred CC---------CCccccCCCCccCcccccc---cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCC---
Q 008504 79 QP---------TARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP--- 143 (563)
Q Consensus 79 ~~---------~~~~~~Gtp~Y~APEvl~~---~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p--- 143 (563)
.. ......++..|+|||++.. .++.++|+|||||++|+|++|..||............+......
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 232 (314)
T cd08216 153 KHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLD 232 (314)
T ss_pred cccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccc
Confidence 11 1123356778999998854 48899999999999999999999998754444433333211100
Q ss_pred ----------------------------CccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCccccccc
Q 008504 144 ----------------------------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 184 (563)
Q Consensus 144 ----------------------------~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~ 184 (563)
.......+..+.+||.+||. +|.+|||+.++|+||||+...
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~ 302 (314)
T cd08216 233 KSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK 302 (314)
T ss_pred cCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence 00011123578899999997 899999999999999998554
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.7e-28 Score=242.30 Aligned_cols=179 Identities=33% Similarity=0.552 Sum_probs=145.1
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
+||||+++++|.+++.. +.+++..++.++.||+.||.|||+.| |+||||+|+||+++. .+.++|+|||++......
T Consensus 79 lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~p~ni~i~~-~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 79 IIMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVG--VIHRDIKAANILVTN-TGNVKLCDFGVAALLNQN 154 (277)
T ss_pred EEEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHHEEEcC-CCCEEEccCCceeecCCC
Confidence 58999999999999876 47999999999999999999999999 999999999999984 689999999998765432
Q ss_pred C--CccccCCCCccCcccccc--cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHH
Q 008504 81 T--ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKG 156 (563)
Q Consensus 81 ~--~~~~~Gtp~Y~APEvl~~--~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~ 156 (563)
. .....|++.|+|||.+.+ .++.++|+||||+++|+|++|..||.... .......+.....+.......+..+.+
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (277)
T cd06917 155 SSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVD-AFRAMMLIPKSKPPRLEDNGYSKLLRE 233 (277)
T ss_pred ccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCC-hhhhhhccccCCCCCCCcccCCHHHHH
Confidence 2 233468899999998754 36889999999999999999999997643 322222222222222222236789999
Q ss_pred HHHHhcC-CCCCCCCHHHHHcCccccccc
Q 008504 157 FIEKCLV-PASERLSAKDLLKDPFLQVEN 184 (563)
Q Consensus 157 LI~kcL~-dP~kRpSa~ELLkHpff~~~~ 184 (563)
||.+||. +|.+||++.++++|+||+...
T Consensus 234 ~i~~~l~~~p~~R~~~~~il~~~~~~~~~ 262 (277)
T cd06917 234 FVAACLDEEPKERLSAEELLKSKWIKAHS 262 (277)
T ss_pred HHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence 9999997 899999999999999997543
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-28 Score=255.12 Aligned_cols=193 Identities=25% Similarity=0.477 Sum_probs=168.9
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhh--cc
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA--MQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~--~~ 78 (563)
+||||+.||+|--.+++.+++.+..+..++..|+-||-|||++| ||+||||.+||++++ .|+|||+|||+++. ..
T Consensus 427 FVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kg--IiYRDLKLDNvmLd~-eGHiKi~DFGmcKEni~~ 503 (683)
T KOG0696|consen 427 FVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDS-EGHIKIADFGMCKENIFD 503 (683)
T ss_pred eEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCC--eeeeeccccceEecc-CCceEeeecccccccccC
Confidence 69999999999999999999999999999999999999999999 999999999999985 58999999999964 34
Q ss_pred CCCCccccCCCCccCccccc-ccCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHHH
Q 008504 79 QPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 157 (563)
Q Consensus 79 ~~~~~~~~Gtp~Y~APEvl~-~~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~L 157 (563)
..+.++++|||.|+|||++. +.|+.++|+||+|++||||+.|+.||.+ .+..++++.|.... ...++..+.++.++
T Consensus 504 ~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdG-eDE~elF~aI~ehn--vsyPKslSkEAv~i 580 (683)
T KOG0696|consen 504 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDG-EDEDELFQAIMEHN--VSYPKSLSKEAVAI 580 (683)
T ss_pred CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHHHcc--CcCcccccHHHHHH
Confidence 55678899999999999886 6799999999999999999999999988 56777787777653 34577788899999
Q ss_pred HHHhcC-CCCCCCC-----HHHHHcCccccccccCCCCCCCCCCchhh
Q 008504 158 IEKCLV-PASERLS-----AKDLLKDPFLQVENQKEPICDPLKLPIQS 199 (563)
Q Consensus 158 I~kcL~-dP~kRpS-----a~ELLkHpff~~~~~~~~~~~~l~~p~~~ 199 (563)
++..|. .|.+|.. -.++-.||||+...|......+++.|..+
T Consensus 581 ckg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~E~~eiqPPfkP 628 (683)
T KOG0696|consen 581 CKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKLERREIQPPFKP 628 (683)
T ss_pred HHHHhhcCCccccCCCCccccchhhCcchhhccHHHHhhccCCCCCCC
Confidence 999997 6999975 47899999999999987766666666544
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-28 Score=241.43 Aligned_cols=176 Identities=23% Similarity=0.461 Sum_probs=158.4
Q ss_pred CEeccCCCCCHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhcc
Q 008504 1 MITELFTSGNLRQYRK--KHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~--k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~ 78 (563)
|++||...|+|...|. ..+++++...+.+++|++.||.|+|..+ ||||||||+|+|+. ..|.+||+|||.+....
T Consensus 99 LilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~--VIhRdiKpenlLlg-~~~~lkiAdfGwsV~~p 175 (281)
T KOG0580|consen 99 LILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR--VIHRDIKPENLLLG-SAGELKIADFGWSVHAP 175 (281)
T ss_pred EEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC--cccCCCCHHHhccC-CCCCeeccCCCceeecC
Confidence 5899999999999999 6678999999999999999999999999 99999999999997 56899999999997776
Q ss_pred CCCCccccCCCCccCccccccc-CCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHHH
Q 008504 79 QPTARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 157 (563)
Q Consensus 79 ~~~~~~~~Gtp~Y~APEvl~~~-ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~L 157 (563)
.....+.+||..|.|||+.++. ++..+|+|++|++.||++.|..||... .....|+++.+-... ++...+..++++
T Consensus 176 ~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~-~~~etYkrI~k~~~~--~p~~is~~a~dl 252 (281)
T KOG0580|consen 176 SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQ-SHSETYKRIRKVDLK--FPSTISGGAADL 252 (281)
T ss_pred CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhh-hhHHHHHHHHHcccc--CCcccChhHHHH
Confidence 6677889999999999999864 899999999999999999999999874 477888888765432 346778899999
Q ss_pred HHHhcC-CCCCCCCHHHHHcCccccc
Q 008504 158 IEKCLV-PASERLSAKDLLKDPFLQV 182 (563)
Q Consensus 158 I~kcL~-dP~kRpSa~ELLkHpff~~ 182 (563)
|.+||. +|.+|.+..|++.|||+..
T Consensus 253 I~~ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 253 ISRLLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred HHHHhccCccccccHHHHhhhHHHHh
Confidence 999997 8999999999999999864
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.4e-28 Score=236.06 Aligned_cols=172 Identities=24% Similarity=0.420 Sum_probs=145.8
Q ss_pred CEeccCCCCCHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecc
Q 008504 1 MITELFTSGNLRQYRKKH---------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDL 71 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~---------~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DF 71 (563)
+||||+++|+|.+++... ..+++..++.++.||+.||.|||++| ++||||+|+||+++. ++.+||+||
T Consensus 73 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~nili~~-~~~~~l~df 149 (262)
T cd00192 73 LVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK--FVHRDLAARNCLVGE-DLVVKISDF 149 (262)
T ss_pred EEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC--cccCccCcceEEECC-CCcEEEccc
Confidence 589999999999999875 77999999999999999999999999 999999999999984 579999999
Q ss_pred cchhhccCCC----CccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCCCCc
Q 008504 72 GLAIAMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPAS 145 (563)
Q Consensus 72 GlA~~~~~~~----~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~ 145 (563)
|.+....... .....+++.|+|||.+.. .++.++||||||+++|+|++ |..||... ........+..+... .
T Consensus 150 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~-~~~~~~~~~~~~~~~-~ 227 (262)
T cd00192 150 GLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGL-SNEEVLEYLRKGYRL-P 227 (262)
T ss_pred ccccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHHcCCCC-C
Confidence 9997665422 334467889999998864 58999999999999999999 58999874 556666666654433 3
Q ss_pred cccCCChhHHHHHHHhcC-CCCCCCCHHHHHcC
Q 008504 146 LAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 177 (563)
Q Consensus 146 l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkH 177 (563)
.+...++.+.+++.+||. +|.+|||+.+++++
T Consensus 228 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 228 KPEYCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred CCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 445568899999999997 89999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-28 Score=265.85 Aligned_cols=172 Identities=23% Similarity=0.458 Sum_probs=148.4
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
+|||++.||-|.+-+...+.+. ..+..|+.||+.|+.|||++| |+||||||+|||+.++.|+++|+|||.++.....
T Consensus 393 ~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~g--vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 393 LVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQG--VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred eeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcC--eeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 5899999999888887766555 788899999999999999999 9999999999999657789999999999876654
Q ss_pred CCccccCCCCccCccccc-ccCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHHHHH
Q 008504 81 TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIE 159 (563)
Q Consensus 81 ~~~~~~Gtp~Y~APEvl~-~~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~LI~ 159 (563)
..+.+-|..|.|||++. .+|++++||||||++||+|++|+.||....+..++...+..+. +....+..+++||.
T Consensus 470 -~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~----~s~~vS~~AKdLl~ 544 (612)
T KOG0603|consen 470 -CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPK----FSECVSDEAKDLLQ 544 (612)
T ss_pred -hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCc----cccccCHHHHHHHH
Confidence 33445588999999886 4599999999999999999999999987655556666665443 33777899999999
Q ss_pred HhcC-CCCCCCCHHHHHcCccc
Q 008504 160 KCLV-PASERLSAKDLLKDPFL 180 (563)
Q Consensus 160 kcL~-dP~kRpSa~ELLkHpff 180 (563)
+||+ +|.+|+++.+++.||||
T Consensus 545 ~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 545 QLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred HhccCChhhCcChhhhccCcch
Confidence 9998 99999999999999999
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.8e-28 Score=245.67 Aligned_cols=179 Identities=33% Similarity=0.611 Sum_probs=146.4
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
+||||+++|+|..++.. ..+++..++.++.||+.||.|||++| ++||||||+||+++ .++.+||+|||++......
T Consensus 95 iv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dl~p~Nill~-~~~~~kL~dfg~~~~~~~~ 170 (297)
T cd06659 95 VLMEFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQG--VIHRDIKSDSILLT-LDGRVKLSDFGFCAQISKD 170 (297)
T ss_pred EEEecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHeEEc-cCCcEEEeechhHhhcccc
Confidence 58999999999998765 56999999999999999999999999 99999999999997 5689999999998655432
Q ss_pred --CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCC-CccccCCChhHHH
Q 008504 81 --TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP-ASLAKVNDPQIKG 156 (563)
Q Consensus 81 --~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p-~~l~~~~s~~l~~ 156 (563)
......|++.|+|||++.+ .++.++|||||||++|+|++|+.||... ........+.....+ .......+..+.+
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 249 (297)
T cd06659 171 VPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSD-SPVQAMKRLRDSPPPKLKNAHKISPVLRD 249 (297)
T ss_pred cccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhccCCCCccccCCCCHHHHH
Confidence 2234578999999998864 5889999999999999999999999763 334444444333221 1223345678999
Q ss_pred HHHHhcC-CCCCCCCHHHHHcCccccccc
Q 008504 157 FIEKCLV-PASERLSAKDLLKDPFLQVEN 184 (563)
Q Consensus 157 LI~kcL~-dP~kRpSa~ELLkHpff~~~~ 184 (563)
+|.+||. +|.+||++.++++||||....
T Consensus 250 ~i~~~l~~~P~~Rps~~~ll~~~~~~~~~ 278 (297)
T cd06659 250 FLERMLTREPQERATAQELLDHPFLLQTG 278 (297)
T ss_pred HHHHHhcCCcccCcCHHHHhhChhhccCC
Confidence 9999997 899999999999999998543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.7e-28 Score=243.01 Aligned_cols=181 Identities=37% Similarity=0.653 Sum_probs=148.1
Q ss_pred CEeccCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~-~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
+|+||+.+++|.+++..++ .+++..+..++.||+.||.|||+.| |+|+||+|+||+++ ..|.++|+|||++.....
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~g--i~H~dl~p~ni~i~-~~~~~~l~d~~~~~~~~~ 168 (286)
T cd06614 92 VVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN--VIHRDIKSDNILLS-KDGSVKLADFGFAAQLTK 168 (286)
T ss_pred EEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCChhhEEEc-CCCCEEECccchhhhhcc
Confidence 5899999999999999876 8999999999999999999999999 99999999999998 567999999999865433
Q ss_pred C--CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhc-CCCCCccccCCChhHH
Q 008504 80 P--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS-GIKPASLAKVNDPQIK 155 (563)
Q Consensus 80 ~--~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~-~~~p~~l~~~~s~~l~ 155 (563)
. ......+++.|+|||.+.+ .++.++|+||||+++|+|++|..||... .+......+.. ...+.......+..++
T Consensus 169 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 247 (286)
T cd06614 169 EKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLRE-PPLRALFLITTKGIPPLKNPEKWSPEFK 247 (286)
T ss_pred chhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhcCCCCCcchhhCCHHHH
Confidence 2 1233457889999998764 4889999999999999999999999764 33333333332 2222222333678899
Q ss_pred HHHHHhcC-CCCCCCCHHHHHcCcccccccc
Q 008504 156 GFIEKCLV-PASERLSAKDLLKDPFLQVENQ 185 (563)
Q Consensus 156 ~LI~kcL~-dP~kRpSa~ELLkHpff~~~~~ 185 (563)
+||.+||. +|.+||++.++++|+||....+
T Consensus 248 ~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 278 (286)
T cd06614 248 DFLNKCLVKDPEKRPSAEELLQHPFLKKACP 278 (286)
T ss_pred HHHHHHhccChhhCcCHHHHhhChHhhccCc
Confidence 99999997 8999999999999999987443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.9e-28 Score=235.34 Aligned_cols=175 Identities=32% Similarity=0.584 Sum_probs=148.0
Q ss_pred CEeccCCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhh
Q 008504 1 MITELFTSGNLRQYRKKH----KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 76 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~----~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~ 76 (563)
+|+||+++++|.+++.+. ..+++..+..++.||+.||.|||++| ++|+||+|+||+++ +.+.++|+|||++..
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--~~H~dl~~~nil~~-~~~~~~l~d~~~~~~ 152 (258)
T cd08215 76 IVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK--ILHRDIKPQNIFLT-SNGLVKLGDFGISKV 152 (258)
T ss_pred EEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHHeEEc-CCCcEEECCccceee
Confidence 589999999999999864 67999999999999999999999999 99999999999998 457999999999866
Q ss_pred ccCC--CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChh
Q 008504 77 MQQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQ 153 (563)
Q Consensus 77 ~~~~--~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~ 153 (563)
.... ......|++.|+|||.+.+ .++.++|+||+|+++|+|++|..||... ....+........ ...++...+..
T Consensus 153 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~ 230 (258)
T cd08215 153 LSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGE-NLLELALKILKGQ-YPPIPSQYSSE 230 (258)
T ss_pred cccCcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCC-cHHHHHHHHhcCC-CCCCCCCCCHH
Confidence 5443 2334578899999998754 4888999999999999999999999764 3555555554443 33345567789
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHHcCccc
Q 008504 154 IKGFIEKCLV-PASERLSAKDLLKDPFL 180 (563)
Q Consensus 154 l~~LI~kcL~-dP~kRpSa~ELLkHpff 180 (563)
+.++|.+||. +|.+||++.++|+||||
T Consensus 231 ~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 231 LRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred HHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 9999999997 89999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=237.46 Aligned_cols=171 Identities=24% Similarity=0.390 Sum_probs=143.6
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
+||||+++|+|.+++.+.+.+++..+..++.||+.||.|||++| |+||||||.||+++ +.+.+||+|||++......
T Consensus 72 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~nill~-~~~~~kl~Dfg~~~~~~~~ 148 (257)
T cd05116 72 LVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETN--FVHRDLAARNVLLV-TQHYAKISDFGLSKALGAD 148 (257)
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchhhEEEc-CCCeEEECCCccccccCCC
Confidence 58999999999999998888999999999999999999999999 99999999999998 4579999999998765432
Q ss_pred CC-----ccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCCCCccccCCChh
Q 008504 81 TA-----RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQ 153 (563)
Q Consensus 81 ~~-----~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~ 153 (563)
.. ....+++.|+|||.+.. .++.++|||||||++|||++ |..||.. .....+...+..+..+ ..+...++.
T Consensus 149 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~-~~~~~~~~~i~~~~~~-~~~~~~~~~ 226 (257)
T cd05116 149 ENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKG-MKGNEVTQMIESGERM-ECPQRCPPE 226 (257)
T ss_pred CCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHCCCCC-CCCCCCCHH
Confidence 21 11234578999998864 58889999999999999998 9999976 4455666667665543 345567889
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHHc
Q 008504 154 IKGFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 154 l~~LI~kcL~-dP~kRpSa~ELLk 176 (563)
+++||.+||. +|.+||++.+|.+
T Consensus 227 l~~li~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 227 MYDLMKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred HHHHHHHHhccCchhCcCHHHHHH
Confidence 9999999997 8999999998865
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-27 Score=242.69 Aligned_cols=179 Identities=25% Similarity=0.404 Sum_probs=141.5
Q ss_pred CEeccCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~-~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
+||||+ +|+|.+++.... .+++..++.++.||+.||.|||++| |+||||+|+|||++ .+|.++|+|||++.....
T Consensus 79 lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nill~-~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 79 LVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW--ILHRDLKPNNLLIA-SDGVLKLADFGLARSFGS 154 (298)
T ss_pred EEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCChhhEEEc-CCCCEEEccceeeeeccC
Confidence 589999 899999998766 7999999999999999999999999 99999999999998 558999999999976543
Q ss_pred C--CCccccCCCCccCcccccc--cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCC-CC-----------
Q 008504 80 P--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI-KP----------- 143 (563)
Q Consensus 80 ~--~~~~~~Gtp~Y~APEvl~~--~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~-~p----------- 143 (563)
. ......+++.|+|||.+.+ .++.++|||||||++|+|++|..||....... ....+.... .+
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 233 (298)
T cd07841 155 PNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID-QLGKIFEALGTPTEENWPGVTSL 233 (298)
T ss_pred CCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH-HHHHHHHHcCCCchhhhhhcccc
Confidence 2 2223356788999998753 47899999999999999999977776543322 222221110 00
Q ss_pred --------------CccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCccccccc
Q 008504 144 --------------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 184 (563)
Q Consensus 144 --------------~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~ 184 (563)
.......+..+.+||.+||. +|.+|||+.++|+||||+...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~ 289 (298)
T cd07841 234 PDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDP 289 (298)
T ss_pred cccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCC
Confidence 00112235688999999997 899999999999999998643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-28 Score=258.24 Aligned_cols=181 Identities=25% Similarity=0.459 Sum_probs=156.3
Q ss_pred CEeccCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~-~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
||+|+=.+|+|++||-++ ..+++..+++|+.||+.|+.|+|... ++||||||+|+.+-...|.|||.|||++..+..
T Consensus 94 LiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLH--VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P 171 (864)
T KOG4717|consen 94 LILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLH--VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP 171 (864)
T ss_pred EEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhh--hhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence 589999999999999876 56999999999999999999999999 999999999998888899999999999966654
Q ss_pred -CCCccccCCCCccCccccccc-C-CchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHH
Q 008504 80 -PTARSVIGTPEFMAPELYEEE-Y-NELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKG 156 (563)
Q Consensus 80 -~~~~~~~Gtp~Y~APEvl~~~-y-s~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~ 156 (563)
....+.+|...|.|||++-+. | .+++||||||||||-|++|+.||....+. +..-+|....+ ..|...+.++++
T Consensus 172 G~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDS-ETLTmImDCKY--tvPshvS~eCrd 248 (864)
T KOG4717|consen 172 GKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDS-ETLTMIMDCKY--TVPSHVSKECRD 248 (864)
T ss_pred cchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccch-hhhhhhhcccc--cCchhhhHHHHH
Confidence 345678999999999988664 6 46899999999999999999999885444 44445555443 356777889999
Q ss_pred HHHHhcC-CCCCCCCHHHHHcCccccccccC
Q 008504 157 FIEKCLV-PASERLSAKDLLKDPFLQVENQK 186 (563)
Q Consensus 157 LI~kcL~-dP~kRpSa~ELLkHpff~~~~~~ 186 (563)
||..||+ ||.+|.+.++|..|+|++..+..
T Consensus 249 LI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~ 279 (864)
T KOG4717|consen 249 LIQSMLVRDPKKRASLEEIVSTSWLQAGDRG 279 (864)
T ss_pred HHHHHHhcCchhhccHHHHhccccccCCCCC
Confidence 9999997 99999999999999999976643
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.1e-28 Score=240.42 Aligned_cols=174 Identities=24% Similarity=0.375 Sum_probs=137.3
Q ss_pred CEeccCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k-~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
+||||+. |+|.+++.. .+.+++..++.++.||+.||.|||++| ++||||+|+||+++. +.+||+|||++.....
T Consensus 77 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~p~ni~l~~--~~~kl~dfg~~~~~~~ 151 (282)
T cd07831 77 LVFELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG--IFHRDIKPENILIKD--DILKLADFGSCRGIYS 151 (282)
T ss_pred EEEecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEcC--CCeEEEeccccccccc
Confidence 5899997 588888775 357999999999999999999999999 999999999999985 8999999999976543
Q ss_pred CC-CccccCCCCccCccccc--ccCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCC---------------
Q 008504 80 PT-ARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI--------------- 141 (563)
Q Consensus 80 ~~-~~~~~Gtp~Y~APEvl~--~~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~--------------- 141 (563)
.. .....+++.|+|||.+. +.++.++|||||||++|+|++|..||.... .......+....
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd07831 152 KPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTN-ELDQIAKIHDVLGTPDAEVLKKFRKSR 230 (282)
T ss_pred CCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCC-HHHHHHHHHHHcCCCCHHHHHhhcccc
Confidence 22 23346789999999764 337889999999999999999999997633 222222221100
Q ss_pred -CCCc-----------cccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCccc
Q 008504 142 -KPAS-----------LAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 180 (563)
Q Consensus 142 -~p~~-----------l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff 180 (563)
.... .....+..+++||.+||. +|.+||++.++++||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 231 HMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred cccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 0000 112346889999999998 89999999999999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.5e-28 Score=237.34 Aligned_cols=175 Identities=27% Similarity=0.543 Sum_probs=146.0
Q ss_pred CEeccCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhcc
Q 008504 1 MITELFTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~--~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~ 78 (563)
+||||+.+++|.+++.... .+++..+..|+.|++.||.|||+++ ++|+||+|+||+++ ..+.++|+|||++....
T Consensus 76 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~l~~~nil~~-~~~~~~l~d~~~~~~~~ 152 (256)
T cd08218 76 IVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLT-KDGTIKLGDFGIARVLN 152 (256)
T ss_pred EEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEc-CCCCEEEeeccceeecC
Confidence 5899999999999997643 5899999999999999999999999 99999999999997 45799999999986554
Q ss_pred CCC--CccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHH
Q 008504 79 QPT--ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIK 155 (563)
Q Consensus 79 ~~~--~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~ 155 (563)
... .....|++.|+|||++.+ .++.++|+|||||++|+|++|..||... ........+..+..+. .+...+..+.
T Consensus 153 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~ 230 (256)
T cd08218 153 STVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAG-NMKNLVLKIIRGSYPP-VSSHYSYDLR 230 (256)
T ss_pred cchhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCC-CHHHHHHHHhcCCCCC-CcccCCHHHH
Confidence 321 223468889999998764 4788999999999999999999999763 4455555555554432 3455678999
Q ss_pred HHHHHhcC-CCCCCCCHHHHHcCccc
Q 008504 156 GFIEKCLV-PASERLSAKDLLKDPFL 180 (563)
Q Consensus 156 ~LI~kcL~-dP~kRpSa~ELLkHpff 180 (563)
++|.+||. +|.+||++.++++||||
T Consensus 231 ~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 231 NLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred HHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 99999997 89999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=239.07 Aligned_cols=177 Identities=31% Similarity=0.558 Sum_probs=144.2
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
+||||+.+|+|.+++.+.+.+++..++.++.||+.||.|||+++ ++||||+|+||+++ ..+.++|+|||++......
T Consensus 85 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~~~nil~~-~~~~~~l~d~~~~~~~~~~ 161 (272)
T cd06629 85 IFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKG--ILHRDLKADNLLVD-ADGICKISDFGISKKSDDI 161 (272)
T ss_pred EEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC--eeecCCChhhEEEc-CCCeEEEeecccccccccc
Confidence 58999999999999998888999999999999999999999999 99999999999998 5689999999998654322
Q ss_pred ----CCccccCCCCccCcccccc---cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCC---CCccccCC
Q 008504 81 ----TARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK---PASLAKVN 150 (563)
Q Consensus 81 ----~~~~~~Gtp~Y~APEvl~~---~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~---p~~l~~~~ 150 (563)
......++..|+|||.+.. .++.++|+||||+++|+|++|..||.................. +.......
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (272)
T cd06629 162 YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNL 241 (272)
T ss_pred ccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccccC
Confidence 1223467889999998753 3788999999999999999999999764443333332222211 22222345
Q ss_pred ChhHHHHHHHhcC-CCCCCCCHHHHHcCccc
Q 008504 151 DPQIKGFIEKCLV-PASERLSAKDLLKDPFL 180 (563)
Q Consensus 151 s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff 180 (563)
+..+++||.+||. +|.+||++.++|+||||
T Consensus 242 ~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 242 SPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred CHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 7899999999997 89999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=239.79 Aligned_cols=176 Identities=30% Similarity=0.502 Sum_probs=139.5
Q ss_pred CEeccCCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhcc
Q 008504 1 MITELFTSGNLRQYRKK--HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k--~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~ 78 (563)
+||||+. ++|..++.. ...+++..++.++.||+.||+|||+++ ++||||+|+||+++ .++.+||+|||++....
T Consensus 76 ~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~--i~H~~l~p~nill~-~~~~~~l~dfg~~~~~~ 151 (284)
T cd07860 76 LVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLIN-TEGAIKLADFGLARAFG 151 (284)
T ss_pred EEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEC-CCCCEEEeeccchhhcc
Confidence 5899996 689999875 356899999999999999999999999 99999999999998 55799999999986554
Q ss_pred CC--CCccccCCCCccCccccccc--CCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCC-----------
Q 008504 79 QP--TARSVIGTPEFMAPELYEEE--YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP----------- 143 (563)
Q Consensus 79 ~~--~~~~~~Gtp~Y~APEvl~~~--ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p----------- 143 (563)
.. ......+++.|+|||++.+. ++.++||||||+++|+|+||+.||..........+.+.....+
T Consensus 152 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07860 152 VPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSL 231 (284)
T ss_pred cCccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHH
Confidence 32 22234568899999987643 6889999999999999999999997654444333322211110
Q ss_pred ---------------CccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCccc
Q 008504 144 ---------------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 180 (563)
Q Consensus 144 ---------------~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff 180 (563)
.......++.++++|.+||. +|.+|||+.++++||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 232 PDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred HHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 00112356789999999997 89999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.6e-28 Score=264.46 Aligned_cols=181 Identities=28% Similarity=0.501 Sum_probs=146.0
Q ss_pred CEeccCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeC-CCCcEEEecccchhhc
Q 008504 1 MITELFTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG-NHGEVKIGDLGLAIAM 77 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~--~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~-~~G~VKL~DFGlA~~~ 77 (563)
||+|++. -+|.+|++.++ +|+...++.++.||+.||.+||+.| |||+||||+||||.. ....|||+|||.++..
T Consensus 265 iVfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~--IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 265 IVFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG--IIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred eeehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCChhheeeccCCcCceeEEeccccccc
Confidence 6899995 49999999764 6999999999999999999999999 999999999999953 2347999999999887
Q ss_pred cCCCCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhc-CCC-------------
Q 008504 78 QQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS-GIK------------- 142 (563)
Q Consensus 78 ~~~~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~-~~~------------- 142 (563)
..... +++.+..|.|||++-+ .|+.+.||||||||+.||++|.+.|.+....+++...+.- |.+
T Consensus 342 ~q~vy-tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~k 420 (586)
T KOG0667|consen 342 SQRVY-TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHK 420 (586)
T ss_pred CCcce-eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccce
Confidence 76554 7889999999998765 6999999999999999999998888875555554433211 000
Q ss_pred ---------------------------------------CC-------ccccCCChhHHHHHHHhcC-CCCCCCCHHHHH
Q 008504 143 ---------------------------------------PA-------SLAKVNDPQIKGFIEKCLV-PASERLSAKDLL 175 (563)
Q Consensus 143 ---------------------------------------p~-------~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL 175 (563)
|. .........+.+||++||. ||.+|+|+.++|
T Consensus 421 ff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal 500 (586)
T KOG0667|consen 421 FFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQAL 500 (586)
T ss_pred ehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHh
Confidence 00 0001223568999999998 999999999999
Q ss_pred cCcccccccc
Q 008504 176 KDPFLQVENQ 185 (563)
Q Consensus 176 kHpff~~~~~ 185 (563)
+||||.....
T Consensus 501 ~Hpfl~~~~~ 510 (586)
T KOG0667|consen 501 NHPFLTGTSL 510 (586)
T ss_pred cCcccccccc
Confidence 9999985443
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-27 Score=233.25 Aligned_cols=175 Identities=32% Similarity=0.526 Sum_probs=148.0
Q ss_pred CEeccCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhh
Q 008504 1 MITELFTSGNLRQYRKK----HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 76 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k----~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~ 76 (563)
+||||+++++|.+++.+ ...+++..++.++.|++.||.|||+.| ++|+||+|+||+++. .+.+||+|||++..
T Consensus 76 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~--i~h~~l~~~ni~~~~-~~~~kl~d~g~~~~ 152 (256)
T cd08530 76 IVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK--ILHRDLKSANILLVA-NDLVKIGDLGISKV 152 (256)
T ss_pred EEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEEec-CCcEEEeeccchhh
Confidence 58999999999999876 356899999999999999999999999 999999999999985 57999999999977
Q ss_pred ccCCCCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHH
Q 008504 77 MQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIK 155 (563)
Q Consensus 77 ~~~~~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~ 155 (563)
..........+++.|+|||.+.+ .++.++|+||||+++|+|++|+.||... +.......+..+..+. .+...+..++
T Consensus 153 ~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~ 230 (256)
T cd08530 153 LKKNMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEAR-SMQDLRYKVQRGKYPP-IPPIYSQDLQ 230 (256)
T ss_pred hccCCcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhcCCCCC-CchhhCHHHH
Confidence 65544444568899999998864 4788999999999999999999999874 4444445555444332 3446778999
Q ss_pred HHHHHhcC-CCCCCCCHHHHHcCccc
Q 008504 156 GFIEKCLV-PASERLSAKDLLKDPFL 180 (563)
Q Consensus 156 ~LI~kcL~-dP~kRpSa~ELLkHpff 180 (563)
++|.+||. +|.+||++.++++||++
T Consensus 231 ~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 231 NFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred HHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 99999997 89999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-27 Score=233.42 Aligned_cols=174 Identities=29% Similarity=0.508 Sum_probs=148.1
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
+||||+.+++|.+++...+.+++..+..++.||+.||.|||+.+ ++|+||+|+||+++ ..+.++|+|||++......
T Consensus 70 ~v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~--~~H~~l~p~ni~~~-~~~~~~l~d~~~~~~~~~~ 146 (250)
T cd05123 70 LVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLG--IIYRDLKPENILLD-ADGHIKLTDFGLAKELSSE 146 (250)
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcceEEEc-CCCcEEEeecCcceecccC
Confidence 58999999999999998888999999999999999999999999 99999999999998 5579999999998665432
Q ss_pred --CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHHH
Q 008504 81 --TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 157 (563)
Q Consensus 81 --~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~L 157 (563)
......++..|+|||.+.+ .++.++|+||||+++|+|++|..||... ........+.... ..++...+..+.+|
T Consensus 147 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~-~~~~~~~~~~~~~--~~~~~~~~~~l~~~ 223 (250)
T cd05123 147 GSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAE-DRKEIYEKILKDP--LRFPEFLSPEARDL 223 (250)
T ss_pred CCcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCC-CHHHHHHHHhcCC--CCCCCCCCHHHHHH
Confidence 2344567889999998764 4788999999999999999999999763 3355555555432 33555668899999
Q ss_pred HHHhcC-CCCCCCCH---HHHHcCccc
Q 008504 158 IEKCLV-PASERLSA---KDLLKDPFL 180 (563)
Q Consensus 158 I~kcL~-dP~kRpSa---~ELLkHpff 180 (563)
|++||. +|.+||++ .++++||||
T Consensus 224 i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 224 ISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred HHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 999997 89999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=234.94 Aligned_cols=176 Identities=29% Similarity=0.543 Sum_probs=144.3
Q ss_pred CEeccCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhcc
Q 008504 1 MITELFTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~--~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~ 78 (563)
+|+||+++++|.+++.+.. .+++..++.|+.||+.||.|||+++ ++|+||||+||+++.+...+||+|||.+....
T Consensus 76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~ 153 (257)
T cd08225 76 IVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK--ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN 153 (257)
T ss_pred EEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEcCCCCeEEecccccchhcc
Confidence 5899999999999997644 4799999999999999999999999 99999999999998654567999999987654
Q ss_pred CCC--CccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHH
Q 008504 79 QPT--ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIK 155 (563)
Q Consensus 79 ~~~--~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~ 155 (563)
... .....|++.|+|||.+.. .++.++|+||||+++|+|++|..||... +.......+..+..+ ......+..++
T Consensus 154 ~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~ 231 (257)
T cd08225 154 DSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN-NLHQLVLKICQGYFA-PISPNFSRDLR 231 (257)
T ss_pred CCcccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCc-cHHHHHHHHhcccCC-CCCCCCCHHHH
Confidence 332 223468899999998754 5889999999999999999999999764 334444444443332 22334567899
Q ss_pred HHHHHhcC-CCCCCCCHHHHHcCccc
Q 008504 156 GFIEKCLV-PASERLSAKDLLKDPFL 180 (563)
Q Consensus 156 ~LI~kcL~-dP~kRpSa~ELLkHpff 180 (563)
++|.+||. +|.+|||+.++++||||
T Consensus 232 ~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 232 SLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred HHHHHHhccChhhCcCHHHHhhCCCC
Confidence 99999997 89999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.9e-28 Score=242.97 Aligned_cols=182 Identities=26% Similarity=0.435 Sum_probs=149.4
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
+||||+++|+|.+++...+.+++..+..++.||+.||.|||++| ++||||+|+|||++ .++.+||+|||++......
T Consensus 82 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nil~~-~~~~~kl~dfg~~~~~~~~ 158 (290)
T cd05613 82 LILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLG--IIYRDIKLENILLD-SNGHVVLTDFGLSKEFHED 158 (290)
T ss_pred EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEEC-CCCCEEEeeCccceecccc
Confidence 58999999999999998888999999999999999999999999 99999999999998 4589999999998655332
Q ss_pred ---CCccccCCCCccCcccccc---cCCchhhHHHhHHHHHHHhhcCCCCCCCC---CHHHHHHHHhcCCCCCccccCCC
Q 008504 81 ---TARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTFEYPYSECK---NPAQIFKKVTSGIKPASLAKVND 151 (563)
Q Consensus 81 ---~~~~~~Gtp~Y~APEvl~~---~ys~ksDIwSLGviLyELlTG~~Pf~~~~---~~~~i~~~i~~~~~p~~l~~~~s 151 (563)
......|+..|+|||.+.. .++.++||||||+++|+|++|..||.... ....+...+..... ..+...+
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 236 (290)
T cd05613 159 EVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP--PYPQEMS 236 (290)
T ss_pred cccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCC--CCCccCC
Confidence 1224568899999998853 46789999999999999999999996422 22333333333322 2345578
Q ss_pred hhHHHHHHHhcC-CCCCCC-----CHHHHHcCccccccccCC
Q 008504 152 PQIKGFIEKCLV-PASERL-----SAKDLLKDPFLQVENQKE 187 (563)
Q Consensus 152 ~~l~~LI~kcL~-dP~kRp-----Sa~ELLkHpff~~~~~~~ 187 (563)
+.+.+|+.+||. +|.+|| ++.+++.||||+..++..
T Consensus 237 ~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~ 278 (290)
T cd05613 237 ALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDD 278 (290)
T ss_pred HHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCHHH
Confidence 899999999997 899997 899999999999877644
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=241.09 Aligned_cols=180 Identities=27% Similarity=0.491 Sum_probs=140.3
Q ss_pred CEeccCCCCCHHHHHH-----hCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeEeccCccCceEEeCCCCcEEEecccch
Q 008504 1 MITELFTSGNLRQYRK-----KHKNVDIKVIKNWARQILHGLVYLHSH-NPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA 74 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~-----k~~~Lse~~i~~i~~QIL~aL~yLHs~-gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA 74 (563)
++|||+.. +|.++.. ..+.+++..+..++.|++.||+|||+. + |+||||||+||+++ ..+.+||+|||++
T Consensus 80 ~~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~~-~~~~~kl~dfg~~ 155 (288)
T cd06616 80 ICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK--IIHRDVKPSNILLD-RNGNIKLCDFGIS 155 (288)
T ss_pred EEEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC--eeccCCCHHHEEEc-cCCcEEEeecchh
Confidence 47899864 6555432 246799999999999999999999974 8 99999999999998 4579999999999
Q ss_pred hhccCCC-CccccCCCCccCcccccc----cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCcc---
Q 008504 75 IAMQQPT-ARSVIGTPEFMAPELYEE----EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASL--- 146 (563)
Q Consensus 75 ~~~~~~~-~~~~~Gtp~Y~APEvl~~----~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l--- 146 (563)
....... .....|++.|+|||++.+ .++.++|||||||++|+|++|+.||............+..+..+...
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd06616 156 GQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSE 235 (288)
T ss_pred HHhccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcC
Confidence 7654332 233468899999998864 48899999999999999999999997654333333333333322211
Q ss_pred ccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCccccccc
Q 008504 147 AKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 184 (563)
Q Consensus 147 ~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~ 184 (563)
....++.+.+||.+||. +|.+|||+.++++||||+...
T Consensus 236 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~ 274 (288)
T cd06616 236 EREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYE 274 (288)
T ss_pred CCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchh
Confidence 22367889999999997 899999999999999998644
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=238.85 Aligned_cols=177 Identities=25% Similarity=0.452 Sum_probs=142.1
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
+||||+.++.|..++.+...+++..++.++.||+.||.|||.++ ++||||+|+||+++ +.+.+||+|||++......
T Consensus 77 iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~ni~~~-~~~~~kl~d~g~~~~~~~~ 153 (288)
T cd07833 77 LVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN--IIHRDIKPENILVS-ESGVLKLCDFGFARALRAR 153 (288)
T ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEC-CCCCEEEEeeecccccCCC
Confidence 58999999888877777777999999999999999999999999 99999999999998 4689999999998765433
Q ss_pred ---CCccccCCCCccCcccccc--cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhc--CCC-----------
Q 008504 81 ---TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS--GIK----------- 142 (563)
Q Consensus 81 ---~~~~~~Gtp~Y~APEvl~~--~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~--~~~----------- 142 (563)
......+++.|+|||++.+ .++.++||||||+++|+|++|+.||........+...... ...
T Consensus 154 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07833 154 PASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNP 233 (288)
T ss_pred ccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCc
Confidence 2234567889999998753 4789999999999999999999999765444333221110 000
Q ss_pred --------C--------CccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCccc
Q 008504 143 --------P--------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 180 (563)
Q Consensus 143 --------p--------~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff 180 (563)
. ...+...++.+++||++||. +|.+||++.++++||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 234 RFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred cccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 0 01223347889999999997 89999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-27 Score=236.97 Aligned_cols=174 Identities=34% Similarity=0.529 Sum_probs=145.8
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
+||||+.+|+|.+++.+.+.+++..++.|+.|++.||.|||++| ++|+||+|+||+++ .+|.++|+|||++......
T Consensus 79 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~--~~H~dl~~~ni~i~-~~~~~~l~df~~~~~~~~~ 155 (280)
T cd05581 79 FVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG--IIHRDLKPENILLD-KDMHIKITDFGTAKVLDPN 155 (280)
T ss_pred EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEEC-CCCCEEecCCccccccCCc
Confidence 58999999999999999889999999999999999999999999 99999999999997 5689999999998655432
Q ss_pred C----------------------CccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 008504 81 T----------------------ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKV 137 (563)
Q Consensus 81 ~----------------------~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i 137 (563)
. .....++..|+|||.+.. .++.++|+||||++++++++|+.||.... ....+..+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-~~~~~~~~ 234 (280)
T cd05581 156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN-EYLTFQKI 234 (280)
T ss_pred cccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc-HHHHHHHH
Confidence 1 123457889999998754 47889999999999999999999998743 33444444
Q ss_pred hcCCCCCccccCCChhHHHHHHHhcC-CCCCCCCH----HHHHcCccc
Q 008504 138 TSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSA----KDLLKDPFL 180 (563)
Q Consensus 138 ~~~~~p~~l~~~~s~~l~~LI~kcL~-dP~kRpSa----~ELLkHpff 180 (563)
.... ..++...++.+.+||.+||. +|.+||++ .++++||||
T Consensus 235 ~~~~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 235 LKLE--YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred HhcC--CCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 3322 22344557899999999997 89999999 999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.8e-28 Score=277.99 Aligned_cols=182 Identities=29% Similarity=0.474 Sum_probs=149.2
Q ss_pred CEeccCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCeEeccCccCceEEeCC---------
Q 008504 1 MITELFTSGNLRQYRKK----HKNVDIKVIKNWARQILHGLVYLHSHN-----PPIIHRDLKCDNIFVNGN--------- 62 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k----~~~Lse~~i~~i~~QIL~aL~yLHs~g-----p~IIHrDLKP~NILLd~~--------- 62 (563)
|||||+.+|+|.++|.. .+.+++..++.|+.||+.||.|||+.+ .+||||||||+||||+..
T Consensus 91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~ 170 (1021)
T PTZ00266 91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA 170 (1021)
T ss_pred EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence 68999999999999875 357999999999999999999999854 249999999999999531
Q ss_pred -------CCcEEEecccchhhccCC-CCccccCCCCccCccccc---ccCCchhhHHHhHHHHHHHhhcCCCCCCCCCHH
Q 008504 63 -------HGEVKIGDLGLAIAMQQP-TARSVIGTPEFMAPELYE---EEYNELVDIYSFGMCILEMVTFEYPYSECKNPA 131 (563)
Q Consensus 63 -------~G~VKL~DFGlA~~~~~~-~~~~~~Gtp~Y~APEvl~---~~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~ 131 (563)
.+.+||+|||++..+... ......||+.|+|||++. ..++.++|||||||++|+|+||..||.......
T Consensus 171 ~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~ 250 (1021)
T PTZ00266 171 QANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFS 250 (1021)
T ss_pred cccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHH
Confidence 235899999999765432 234557999999999874 248899999999999999999999998766666
Q ss_pred HHHHHHhcCCCCCccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCccccccc
Q 008504 132 QIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 184 (563)
Q Consensus 132 ~i~~~i~~~~~p~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~ 184 (563)
.+...+..+... .....++.+.+||..||. +|.+||++.++|.||||+...
T Consensus 251 qli~~lk~~p~l--pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~ 302 (1021)
T PTZ00266 251 QLISELKRGPDL--PIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVG 302 (1021)
T ss_pred HHHHHHhcCCCC--CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcC
Confidence 666665554322 223457899999999997 899999999999999997543
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=240.27 Aligned_cols=178 Identities=32% Similarity=0.549 Sum_probs=145.8
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
+||||+++|+|.+++.. +.+++..++.++.||+.||.|||++| ++|+||+|+||+++ +++.++|+|||++......
T Consensus 79 lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--ivH~dl~p~ni~i~-~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06642 79 IIMEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSER--KIHRDIKAANVLLS-EQGDVKLADFGVAGQLTDT 154 (277)
T ss_pred EEEEccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCC--eeccCCChheEEEe-CCCCEEEccccccccccCc
Confidence 58999999999999875 56999999999999999999999999 99999999999997 5679999999998655432
Q ss_pred C--CccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHHH
Q 008504 81 T--ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 157 (563)
Q Consensus 81 ~--~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~L 157 (563)
. .....++..|+|||.+.+ .++.++|+|||||++|+|++|..||... .+......+..+. +..+....+..+.++
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~~~~l 232 (277)
T cd06642 155 QIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDL-HPMRVLFLIPKNS-PPTLEGQYSKPFKEF 232 (277)
T ss_pred chhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCccc-chhhHHhhhhcCC-CCCCCcccCHHHHHH
Confidence 2 223467889999998865 4788999999999999999999999753 3333333333332 223444567789999
Q ss_pred HHHhcC-CCCCCCCHHHHHcCccccccc
Q 008504 158 IEKCLV-PASERLSAKDLLKDPFLQVEN 184 (563)
Q Consensus 158 I~kcL~-dP~kRpSa~ELLkHpff~~~~ 184 (563)
|.+||. +|.+||++.++++||||....
T Consensus 233 i~~~l~~~p~~Rp~~~~il~~~~~~~~~ 260 (277)
T cd06642 233 VEACLNKDPRFRPTAKELLKHKFITRYT 260 (277)
T ss_pred HHHHccCCcccCcCHHHHHHhHHHHHHh
Confidence 999997 899999999999999997544
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-27 Score=232.92 Aligned_cols=175 Identities=34% Similarity=0.600 Sum_probs=147.0
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
+||||+++++|.+++...+.+++..++.++.|++.||.|||++| |+||||+|+||+++. .+.++|+|||++......
T Consensus 76 ~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~~-~~~~~l~d~~~~~~~~~~ 152 (254)
T cd06627 76 IILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG--VIHRDIKAANILTTK-DGVVKLADFGVATKLNDV 152 (254)
T ss_pred EEEecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEECC-CCCEEEeccccceecCCC
Confidence 58999999999999998888999999999999999999999999 999999999999984 679999999999766543
Q ss_pred CC--ccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHHH
Q 008504 81 TA--RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 157 (563)
Q Consensus 81 ~~--~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~L 157 (563)
.. ....++..|+|||.+.+ .++.++|||+||+++|+|++|..||........... ...... ...+...+..++++
T Consensus 153 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~-~~~~~~-~~~~~~~~~~~~~~ 230 (254)
T cd06627 153 SKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFR-IVQDDH-PPLPEGISPELKDF 230 (254)
T ss_pred cccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHH-HhccCC-CCCCCCCCHHHHHH
Confidence 22 34568889999998754 378899999999999999999999976443333333 332222 23455667899999
Q ss_pred HHHhcC-CCCCCCCHHHHHcCccc
Q 008504 158 IEKCLV-PASERLSAKDLLKDPFL 180 (563)
Q Consensus 158 I~kcL~-dP~kRpSa~ELLkHpff 180 (563)
|.+||. +|.+||++.+++.||||
T Consensus 231 i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 231 LMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred HHHHHhCChhhCcCHHHHhcCCCC
Confidence 999997 89999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-27 Score=236.61 Aligned_cols=171 Identities=24% Similarity=0.428 Sum_probs=140.9
Q ss_pred CEeccCCCCCHHHHHHhCC--------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcE
Q 008504 1 MITELFTSGNLRQYRKKHK--------------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEV 66 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~--------------~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~V 66 (563)
+||||+++|+|.+++...+ .+++..+..++.||+.||.|||++| ++||||||+||+++ ..+.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~h~dlkp~nili~-~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH--FVHRDLATRNCLVG-YDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eeccccccceEEEc-CCCeE
Confidence 5899999999999997643 4789999999999999999999999 99999999999998 45899
Q ss_pred EEecccchhhccCCC----CccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcC
Q 008504 67 KIGDLGLAIAMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSG 140 (563)
Q Consensus 67 KL~DFGlA~~~~~~~----~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~ 140 (563)
||+|||++....... .....+++.|+|||++.+ .++.++|||||||++|+|++ |..||... ........+..+
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~-~~~~~~~~~~~~ 240 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGL-SNEEVIECITQG 240 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHHcC
Confidence 999999986543211 123345778999998864 58999999999999999998 99999764 445555555555
Q ss_pred CCCCccccCCChhHHHHHHHhcC-CCCCCCCHHHHHc
Q 008504 141 IKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 141 ~~p~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLk 176 (563)
..+. .+...+..+++||.+||. +|.+||++.|+++
T Consensus 241 ~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 241 RLLQ-RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred CcCC-CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 4433 345677899999999997 8999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-27 Score=239.84 Aligned_cols=175 Identities=28% Similarity=0.416 Sum_probs=139.1
Q ss_pred CEeccCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~-~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
|||||+. ++|.+++.... .+++..++.++.||+.||.|||++| ++||||||+|||++ +.|.+||+|||++.....
T Consensus 83 lv~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~-~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 83 MVMEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW--ILHRDLKTSNLLLN-NRGILKICDFGLAREYGS 158 (293)
T ss_pred EEehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEEC-CCCcEEEeecCceeeccC
Confidence 5899997 49999987644 5999999999999999999999999 99999999999998 558999999999876544
Q ss_pred C--CCccccCCCCccCcccccc--cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCC--------------
Q 008504 80 P--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI-------------- 141 (563)
Q Consensus 80 ~--~~~~~~Gtp~Y~APEvl~~--~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~-------------- 141 (563)
. ......+++.|+|||.+.+ .++.++|+||||+++|+|++|..||......... .++....
T Consensus 159 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 237 (293)
T cd07843 159 PLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQL-NKIFKLLGTPTEKIWPGFSEL 237 (293)
T ss_pred CccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHHHhCCCchHHHHHhhcc
Confidence 3 2233467889999998754 3688999999999999999999999764433222 2111100
Q ss_pred ---------------CCCccccC-CChhHHHHHHHhcC-CCCCCCCHHHHHcCccc
Q 008504 142 ---------------KPASLAKV-NDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 180 (563)
Q Consensus 142 ---------------~p~~l~~~-~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff 180 (563)
....++.. .++.+++||.+||. +|.+|||+.|+|.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 238 PGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred chhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 00111222 46789999999997 89999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=243.40 Aligned_cols=181 Identities=31% Similarity=0.557 Sum_probs=145.3
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
+|+||+++|+|.+++.+. .+++..+..++.|++.||.|||++| ++||||+|+||+++ ..+.+||+|||++......
T Consensus 93 lv~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~g--i~H~dL~p~Nili~-~~~~~kL~dfg~~~~~~~~ 168 (293)
T cd06647 93 VVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPE 168 (293)
T ss_pred EEEecCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC--EeeccCCHHHEEEc-CCCCEEEccCcceeccccc
Confidence 589999999999999764 5899999999999999999999999 99999999999997 5579999999988654322
Q ss_pred --CCccccCCCCccCccccc-ccCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHHH
Q 008504 81 --TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 157 (563)
Q Consensus 81 --~~~~~~Gtp~Y~APEvl~-~~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~L 157 (563)
......+++.|+|||.+. +.++.++|+||||+++|+|++|+.||...............+......+...+..+++|
T Consensus 169 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 248 (293)
T cd06647 169 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDF 248 (293)
T ss_pred ccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHH
Confidence 223346888999999875 45889999999999999999999999764333332222222222222333456789999
Q ss_pred HHHhcC-CCCCCCCHHHHHcCcccccccc
Q 008504 158 IEKCLV-PASERLSAKDLLKDPFLQVENQ 185 (563)
Q Consensus 158 I~kcL~-dP~kRpSa~ELLkHpff~~~~~ 185 (563)
|.+||. +|.+||++.+++.|+||+..+.
T Consensus 249 i~~~l~~~p~~Rp~~~~il~h~~~~~~~~ 277 (293)
T cd06647 249 LNRCLEMDVEKRGSAKELLQHPFLKIAKP 277 (293)
T ss_pred HHHHccCChhhCcCHHHHhcCHHHhcCcc
Confidence 999997 8999999999999999986543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=239.25 Aligned_cols=179 Identities=32% Similarity=0.552 Sum_probs=147.0
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
+||||+++|+|.+++.. +++++..+..++.|++.||.|||+.+ ++|+||+|+||+++ ..+.++|+|||++......
T Consensus 79 lv~e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~--ivH~dl~p~Nil~~-~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06640 79 IIMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEK--KIHRDIKAANVLLS-EQGDVKLADFGVAGQLTDT 154 (277)
T ss_pred EEEecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--ccCcCCChhhEEEc-CCCCEEEcccccceeccCC
Confidence 68999999999999876 56999999999999999999999999 99999999999998 5579999999998655432
Q ss_pred C--CccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHHH
Q 008504 81 T--ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 157 (563)
Q Consensus 81 ~--~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~L 157 (563)
. .....++..|+|||++.+ .++.++|+|||||++|+|+||..||.... +......+..+. +.......+..+.+|
T Consensus 155 ~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~-~~~~~~~~~~~~-~~~~~~~~~~~~~~l 232 (277)
T cd06640 155 QIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMH-PMRVLFLIPKNN-PPTLTGEFSKPFKEF 232 (277)
T ss_pred ccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcC-hHhHhhhhhcCC-CCCCchhhhHHHHHH
Confidence 2 223467889999998764 47899999999999999999999998643 333333333332 333445567889999
Q ss_pred HHHhcC-CCCCCCCHHHHHcCcccccccc
Q 008504 158 IEKCLV-PASERLSAKDLLKDPFLQVENQ 185 (563)
Q Consensus 158 I~kcL~-dP~kRpSa~ELLkHpff~~~~~ 185 (563)
|.+||. +|.+||++.++++||||.....
T Consensus 233 i~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 261 (277)
T cd06640 233 IDACLNKDPSFRPTAKELLKHKFIVKNAK 261 (277)
T ss_pred HHHHcccCcccCcCHHHHHhChHhhhcch
Confidence 999997 8999999999999999976544
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-27 Score=248.25 Aligned_cols=178 Identities=31% Similarity=0.425 Sum_probs=139.1
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
+||||+. |+|.+++... +++..++.++.||+.||.|||++| |+||||||+||+++ ..|.+||+|||++......
T Consensus 98 lv~e~~~-~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nil~~-~~~~~kL~Dfg~~~~~~~~ 171 (353)
T cd07850 98 LVMELMD-ANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTS 171 (353)
T ss_pred EEEeccC-CCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEC-CCCCEEEccCccceeCCCC
Confidence 5899996 5899988754 999999999999999999999999 99999999999998 4579999999999765433
Q ss_pred C-CccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCC----------------
Q 008504 81 T-ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK---------------- 142 (563)
Q Consensus 81 ~-~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~---------------- 142 (563)
. .....+++.|+|||++.+ .++.++|||||||++|+|++|+.||....... .+..+.....
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (353)
T cd07850 172 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHID-QWNKIIEQLGTPSDEFMSRLQPTVRN 250 (353)
T ss_pred CCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHhcCCCCHHHHHHhhhhhhH
Confidence 2 234467899999998764 58999999999999999999999997643222 1221111000
Q ss_pred -----C----Cc----------------cccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCcccccccc
Q 008504 143 -----P----AS----------------LAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQ 185 (563)
Q Consensus 143 -----p----~~----------------l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~~ 185 (563)
+ .. .....++.+++||.+||. +|.+|||+.|+|+||||+....
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~ 319 (353)
T cd07850 251 YVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYD 319 (353)
T ss_pred HhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccC
Confidence 0 00 011235578999999997 8999999999999999985433
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-27 Score=242.29 Aligned_cols=178 Identities=23% Similarity=0.358 Sum_probs=140.5
Q ss_pred CEeccCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k-~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
+||||+.+ +|.+++.. ...+++..++.++.||+.||.|||++| ++||||||+||+++ +.+.+||+|||++.....
T Consensus 85 lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~-~~~~~kL~dfg~~~~~~~ 160 (309)
T cd07845 85 LVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF--IIHRDLKVSNLLLT-DKGCLKIADFGLARTYGL 160 (309)
T ss_pred EEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEC-CCCCEEECccceeeecCC
Confidence 58999964 89888876 367999999999999999999999999 99999999999998 557999999999976543
Q ss_pred C--CCccccCCCCccCcccccc--cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCC-C-----------
Q 008504 80 P--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK-P----------- 143 (563)
Q Consensus 80 ~--~~~~~~Gtp~Y~APEvl~~--~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~-p----------- 143 (563)
. ......+++.|+|||++.+ .++.++|||||||++|+|++|+.||.... ....+..+..... +
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07845 161 PAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKS-EIEQLDLIIQLLGTPNESIWPGFSDL 239 (309)
T ss_pred ccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHhcCCCChhhchhhhcc
Confidence 2 2223345788999998754 47899999999999999999999998643 3333333222100 0
Q ss_pred -----Ccc-----------ccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCcccccc
Q 008504 144 -----ASL-----------AKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 183 (563)
Q Consensus 144 -----~~l-----------~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~ 183 (563)
... ....++.+.+||.+||. +|.+|||+.++|.||||+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~ 296 (309)
T cd07845 240 PLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEK 296 (309)
T ss_pred cccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccC
Confidence 000 01246788999999998 89999999999999999743
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.1e-27 Score=239.36 Aligned_cols=171 Identities=25% Similarity=0.449 Sum_probs=140.3
Q ss_pred CEeccCCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCC
Q 008504 1 MITELFTSGNLRQYRKKHK----------------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHG 64 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~----------------~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G 64 (563)
+||||+++|+|.+++..++ .+++..++.++.||+.||+|||++| |+||||||+|||++ .++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~Nil~~-~~~ 160 (291)
T cd05094 84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH--FVHRDLATRNCLVG-ANL 160 (291)
T ss_pred EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEEEc-cCC
Confidence 5899999999999997643 3899999999999999999999999 99999999999998 457
Q ss_pred cEEEecccchhhccCCC----CccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHh
Q 008504 65 EVKIGDLGLAIAMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVT 138 (563)
Q Consensus 65 ~VKL~DFGlA~~~~~~~----~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~ 138 (563)
.++|+|||++....... .....+++.|+|||.+.+ .++.++|||||||++|+|+| |..||... ........+.
T Consensus 161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~-~~~~~~~~~~ 239 (291)
T cd05094 161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQL-SNTEVIECIT 239 (291)
T ss_pred cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHh
Confidence 99999999986543321 223456788999998764 58899999999999999999 99998763 4444555555
Q ss_pred cCCCCCccccCCChhHHHHHHHhcC-CCCCCCCHHHHHc
Q 008504 139 SGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 139 ~~~~p~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLk 176 (563)
.+..+ ..+...+..+.+++.+||. +|.+||++.++++
T Consensus 240 ~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 240 QGRVL-ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred CCCCC-CCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 54433 2345567889999999997 8999999999976
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.4e-28 Score=270.72 Aligned_cols=174 Identities=22% Similarity=0.395 Sum_probs=142.1
Q ss_pred CEeccCCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhcc
Q 008504 1 MITELFTSGNLRQYRKK--HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k--~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~ 78 (563)
|.||||.||.|-+|+.+ +.+|++.+|++|+.|+++|+++||...|||||||||-+||||. .+|..||||||.|....
T Consensus 119 lLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls-~~g~~KLCDFGSatt~~ 197 (738)
T KOG1989|consen 119 LLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLS-ADGNYKLCDFGSATTKI 197 (738)
T ss_pred eehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEc-CCCCEEeCccccccccc
Confidence 68999999999999985 3569999999999999999999999999999999999999998 56899999999985432
Q ss_pred CCC-C-c---------cccCCCCccCccccc---c-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCC
Q 008504 79 QPT-A-R---------SVIGTPEFMAPELYE---E-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP 143 (563)
Q Consensus 79 ~~~-~-~---------~~~Gtp~Y~APEvl~---~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p 143 (563)
... . . ...-|+.|+|||++. + ..++|+|||+|||+||.|+.+..||...... .|..+...
T Consensus 198 ~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l-----aIlng~Y~ 272 (738)
T KOG1989|consen 198 LSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL-----AILNGNYS 272 (738)
T ss_pred CCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce-----eEEecccc
Confidence 221 1 0 124699999999874 3 4899999999999999999999999863221 24444443
Q ss_pred CccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCccc
Q 008504 144 ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 180 (563)
Q Consensus 144 ~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff 180 (563)
......++..+++||..||+ +|.+||++-+++.+-+.
T Consensus 273 ~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~ 310 (738)
T KOG1989|consen 273 FPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFE 310 (738)
T ss_pred CCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHH
Confidence 33334567799999999998 89999999999876554
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-27 Score=235.52 Aligned_cols=172 Identities=22% Similarity=0.377 Sum_probs=140.2
Q ss_pred CEeccCCCCCHHHHHHh------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccch
Q 008504 1 MITELFTSGNLRQYRKK------HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA 74 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k------~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA 74 (563)
+||||+.+|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++
T Consensus 83 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~-~~~~~kl~Dfg~~ 159 (272)
T cd05075 83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS--FIHRDLAARNCMLN-ENMNVCVADFGLS 159 (272)
T ss_pred EEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhheEEc-CCCCEEECCCCcc
Confidence 48999999999998842 234899999999999999999999999 99999999999997 5579999999999
Q ss_pred hhccCCC----CccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCCCCcccc
Q 008504 75 IAMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAK 148 (563)
Q Consensus 75 ~~~~~~~----~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~ 148 (563)
....... .....+++.|+|||.+.+ .++.++|||||||++|+|++ |+.||.. .....++..+..+..+. .+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~ 237 (272)
T cd05075 160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPG-VENSEIYDYLRQGNRLK-QPP 237 (272)
T ss_pred cccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHcCCCCC-CCC
Confidence 7654321 122245678999998864 48999999999999999999 7899976 44556666666654432 234
Q ss_pred CCChhHHHHHHHhcC-CCCCCCCHHHHHcC
Q 008504 149 VNDPQIKGFIEKCLV-PASERLSAKDLLKD 177 (563)
Q Consensus 149 ~~s~~l~~LI~kcL~-dP~kRpSa~ELLkH 177 (563)
..+..++++|.+||. +|.+|||+.+++++
T Consensus 238 ~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 238 DCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred CCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 456789999999997 89999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-27 Score=238.54 Aligned_cols=171 Identities=23% Similarity=0.415 Sum_probs=140.9
Q ss_pred CEeccCCCCCHHHHHHhCC-------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEE
Q 008504 1 MITELFTSGNLRQYRKKHK-------------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVK 67 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~-------------~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VK 67 (563)
+||||+++|+|.+++..++ .+++..++.++.||+.||+|||++| ++||||||+||+++ ..+.+|
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~--i~H~dlkp~Nili~-~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVG-ENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEEEc-cCCcEE
Confidence 5899999999999998654 3899999999999999999999999 99999999999998 557999
Q ss_pred EecccchhhccCCC----CccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCC
Q 008504 68 IGDLGLAIAMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGI 141 (563)
Q Consensus 68 L~DFGlA~~~~~~~----~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~ 141 (563)
|+|||++....... .....+++.|+|||.+.+ .++.++|||||||++|+|++ |..||... ........+..+.
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~-~~~~~~~~i~~~~ 239 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL-SNNEVIECITQGR 239 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHcCC
Confidence 99999987543221 122345678999998864 48899999999999999998 88998764 4455556666654
Q ss_pred CCCccccCCChhHHHHHHHhcC-CCCCCCCHHHHHc
Q 008504 142 KPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 142 ~p~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLk 176 (563)
.+ ..+...++.+.+|+.+||. +|.+|||+.+++.
T Consensus 240 ~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 240 VL-QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred cC-CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 33 2345567899999999998 8999999999854
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-27 Score=259.56 Aligned_cols=178 Identities=26% Similarity=0.419 Sum_probs=138.4
Q ss_pred CEeccCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~-~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
|||||+. |+|..++... +.+++..++.|+.||+.||.|||++| |+||||||+|||++ ..+.+||+|||+++....
T Consensus 237 lv~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDLKP~NILl~-~~~~vkL~DFGla~~~~~ 312 (461)
T PHA03211 237 LVLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEG--IIHRDIKTENVLVN-GPEDICLGDFGAACFARG 312 (461)
T ss_pred EEEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEECcCCHHHEEEC-CCCCEEEcccCCceeccc
Confidence 5889995 6999988764 46999999999999999999999999 99999999999998 457999999999976533
Q ss_pred CC----CccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCC-------CHHHHHHHHhcCCCC-Cc-
Q 008504 80 PT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECK-------NPAQIFKKVTSGIKP-AS- 145 (563)
Q Consensus 80 ~~----~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~-------~~~~i~~~i~~~~~p-~~- 145 (563)
.. .....||+.|+|||++.+ .++.++|||||||++|||++|..|+.... ...++.+.+...... ..
T Consensus 313 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~ 392 (461)
T PHA03211 313 SWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEF 392 (461)
T ss_pred ccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccC
Confidence 21 223569999999998865 48999999999999999999876543211 123343333322110 00
Q ss_pred ----------------------------cc--cCCChhHHHHHHHhcC-CCCCCCCHHHHHcCccccc
Q 008504 146 ----------------------------LA--KVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQV 182 (563)
Q Consensus 146 ----------------------------l~--~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~ 182 (563)
+. ...++.+++||.+||. ||.+|||+.|+|+||||+.
T Consensus 393 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 393 PQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred CCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 00 1234578999999998 9999999999999999974
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.5e-27 Score=233.66 Aligned_cols=170 Identities=22% Similarity=0.409 Sum_probs=141.2
Q ss_pred CEeccCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhcc
Q 008504 1 MITELFTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~--~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~ 78 (563)
+||||+++|+|.+++.+.+ .+++..+..++.||+.||+|||++| |+||||||+||+++ +++.+||+|||++....
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~-~~~~~kl~dfg~~~~~~ 153 (256)
T cd05082 77 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN--FVHRDLAARNVLVS-EDNVAKVSDFGLTKEAS 153 (256)
T ss_pred EEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccccchheEEEc-CCCcEEecCCccceecc
Confidence 5899999999999998654 4899999999999999999999999 99999999999997 56799999999986543
Q ss_pred CCCCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHH
Q 008504 79 QPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKG 156 (563)
Q Consensus 79 ~~~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~ 156 (563)
... ....++..|+|||++.+ .++.++|||||||++|+|++ |+.||.. .........+..+..+ ..+...++.+++
T Consensus 154 ~~~-~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 230 (256)
T cd05082 154 STQ-DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR-IPLKDVVPRVEKGYKM-DAPDGCPPVVYD 230 (256)
T ss_pred ccC-CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHhcCCCC-CCCCCCCHHHHH
Confidence 322 23344568999998864 48899999999999999998 9999976 4455666666555433 345567889999
Q ss_pred HHHHhcC-CCCCCCCHHHHHc
Q 008504 157 FIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 157 LI~kcL~-dP~kRpSa~ELLk 176 (563)
+|.+||. +|.+|||+.++++
T Consensus 231 li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 231 VMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred HHHHHhcCChhhCcCHHHHHH
Confidence 9999997 8999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=252.47 Aligned_cols=153 Identities=24% Similarity=0.418 Sum_probs=123.2
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCCCCc----cccCCCCccCcc
Q 008504 20 NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR----SVIGTPEFMAPE 95 (563)
Q Consensus 20 ~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~~~~----~~~Gtp~Y~APE 95 (563)
++++..+++|+.||+.||.|||++| |+||||||+|||++ +.+.+||+|||++......... ...+++.|+|||
T Consensus 208 ~l~~~~~~~i~~qi~~aL~yLH~~g--iiHrDLkp~Nil~~-~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE 284 (374)
T cd05106 208 PLDLDDLLRFSSQVAQGMDFLASKN--CIHRDVAARNVLLT-DGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPE 284 (374)
T ss_pred CcCHHHHHHHHHHHHHHHHHHHHCC--EEeccCchheEEEe-CCCeEEEeeceeeeeccCCcceeeccCCCCccceeCHH
Confidence 4788899999999999999999999 99999999999998 5679999999998755432211 223456799999
Q ss_pred ccc-ccCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHHHHHHhcC-CCCCCCCHH
Q 008504 96 LYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAK 172 (563)
Q Consensus 96 vl~-~~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ 172 (563)
++. ..++.++|||||||++|+|++ |..||............+..+.. ...+...++.++++|.+||. +|.+|||+.
T Consensus 285 ~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ 363 (374)
T cd05106 285 SIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQ-MSRPDFAPPEIYSIMKMCWNLEPTERPTFS 363 (374)
T ss_pred HhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccC-ccCCCCCCHHHHHHHHHHcCCChhhCcCHH
Confidence 875 458999999999999999997 99999875444444444444432 23445567899999999998 899999999
Q ss_pred HHHc
Q 008504 173 DLLK 176 (563)
Q Consensus 173 ELLk 176 (563)
++++
T Consensus 364 ~l~~ 367 (374)
T cd05106 364 QISQ 367 (374)
T ss_pred HHHH
Confidence 9976
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.8e-27 Score=235.73 Aligned_cols=171 Identities=19% Similarity=0.343 Sum_probs=139.7
Q ss_pred CEeccCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~-~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
|||||+++|+|.+++... ..+++..++.++.||+.||+|||++| ++||||||+|||++ .++.+|++|||.+.....
T Consensus 83 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~--iiH~dikp~nili~-~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 83 IVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG--YVHKGLAAHKVLVN-SDLVCKISGFRRLQEDKS 159 (266)
T ss_pred EEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeeccccHhhEEEc-CCCcEEECCCcccccccc
Confidence 689999999999999874 57999999999999999999999999 99999999999998 457999999998754322
Q ss_pred CC---CccccCCCCccCccccc-ccCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhH
Q 008504 80 PT---ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQI 154 (563)
Q Consensus 80 ~~---~~~~~Gtp~Y~APEvl~-~~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l 154 (563)
.. .....+++.|+|||.+. +.++.++|||||||++|++++ |..||... ......+.+..+..+ ..+...+..+
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~ 237 (266)
T cd05064 160 EAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDM-SGQDVIKAVEDGFRL-PAPRNCPNLL 237 (266)
T ss_pred cchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcC-CHHHHHHHHHCCCCC-CCCCCCCHHH
Confidence 11 11223467899999875 458999999999999999775 99999863 444555555555433 2455677899
Q ss_pred HHHHHHhcC-CCCCCCCHHHHHc
Q 008504 155 KGFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 155 ~~LI~kcL~-dP~kRpSa~ELLk 176 (563)
.+++.+||. +|.+||++.+|++
T Consensus 238 ~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 238 HQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred HHHHHHHcCCCchhCCCHHHHHH
Confidence 999999998 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-27 Score=237.01 Aligned_cols=176 Identities=30% Similarity=0.484 Sum_probs=139.2
Q ss_pred CEeccCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhcc
Q 008504 1 MITELFTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~--~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~ 78 (563)
+||||+. ++|.+++...+ .+++..++.++.||+.||.|||+++ ++||||+|+||+++. ++.++|+|||++....
T Consensus 75 iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~--~~H~dl~p~nil~~~-~~~~~l~df~~~~~~~ 150 (283)
T cd07835 75 LVFEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR--VLHRDLKPQNLLIDR-EGALKLADFGLARAFG 150 (283)
T ss_pred EEEeccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEcC-CCcEEEeecccccccC
Confidence 5899995 69999998766 7999999999999999999999999 999999999999984 6899999999986543
Q ss_pred CC--CCccccCCCCccCcccccc--cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCC------------
Q 008504 79 QP--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK------------ 142 (563)
Q Consensus 79 ~~--~~~~~~Gtp~Y~APEvl~~--~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~------------ 142 (563)
.. ......+++.|+|||++.+ .++.++||||||+++|+|++|+.||..........+.......
T Consensus 151 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd07835 151 VPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSL 230 (283)
T ss_pred CCccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhc
Confidence 22 1223356889999998754 3688999999999999999999999764333332222111000
Q ss_pred --------------CCccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCccc
Q 008504 143 --------------PASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 180 (563)
Q Consensus 143 --------------p~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff 180 (563)
........+..+.++|.+||. +|.+|||+.+++.||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 231 PDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred hhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 001123345789999999997 89999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.9e-27 Score=233.51 Aligned_cols=171 Identities=25% Similarity=0.430 Sum_probs=141.6
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
+||||+.+|+|.+++.+.+.+++..++.++.|++.||.|||.++ ++||||||+|||++ ..+.+||+|||++......
T Consensus 72 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~nili~-~~~~~kl~df~~~~~~~~~ 148 (257)
T cd05060 72 LVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKH--FVHRDLAARNVLLV-NRHQAKISDFGMSRALGAG 148 (257)
T ss_pred EEEEeCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcC--eeccCcccceEEEc-CCCcEEeccccccceeecC
Confidence 58999999999999998888999999999999999999999999 99999999999998 5579999999998765432
Q ss_pred CC-----ccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCCCCccccCCChh
Q 008504 81 TA-----RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQ 153 (563)
Q Consensus 81 ~~-----~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~ 153 (563)
.. ....++..|+|||.+.+ .++.++|||||||++|+|++ |..||... +.......+..+... ..+...++.
T Consensus 149 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~ 226 (257)
T cd05060 149 SDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEM-KGAEVIAMLESGERL-PRPEECPQE 226 (257)
T ss_pred CcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccC-CHHHHHHHHHcCCcC-CCCCCCCHH
Confidence 21 11123457999998764 58899999999999999998 89999774 445555555555432 345566789
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHHc
Q 008504 154 IKGFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 154 l~~LI~kcL~-dP~kRpSa~ELLk 176 (563)
++++|.+||. +|.+||++.++++
T Consensus 227 l~~li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 227 IYSIMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred HHHHHHHHhcCChhhCcCHHHHHH
Confidence 9999999997 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.8e-27 Score=237.40 Aligned_cols=177 Identities=29% Similarity=0.493 Sum_probs=140.2
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
+||||+++++|..+......+++..++.++.||+.||.|||+.| |+||||+|+||+++ .++.++|+|||++......
T Consensus 77 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~h~~l~p~ni~~~-~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07846 77 LVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN--IIHRDIKPENILVS-QSGVVKLCDFGFARTLAAP 153 (286)
T ss_pred EEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEC-CCCcEEEEeeeeeeeccCC
Confidence 58999999999998877777999999999999999999999999 99999999999997 5579999999998655332
Q ss_pred --CCccccCCCCccCcccccc--cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhc-----------------
Q 008504 81 --TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS----------------- 139 (563)
Q Consensus 81 --~~~~~~Gtp~Y~APEvl~~--~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~----------------- 139 (563)
......++..|+|||++.+ .++.++||||||+++|+|++|+.||...............
T Consensus 154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07846 154 GEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPL 233 (286)
T ss_pred ccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchH
Confidence 2223467889999998754 3788999999999999999999999754332222211110
Q ss_pred --CCC-CC--------ccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCccc
Q 008504 140 --GIK-PA--------SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 180 (563)
Q Consensus 140 --~~~-p~--------~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff 180 (563)
+.. +. ......+..+++|+.+||. +|.+||++.++++||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 234 FAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred hhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 000 00 0012346789999999997 89999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.8e-27 Score=238.72 Aligned_cols=182 Identities=26% Similarity=0.424 Sum_probs=147.5
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
+||||+.+|+|.+++.+.+.+++..++.++.|++.||.|||+.+ ++||||+|+||+++. ++.++|+|||++......
T Consensus 82 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--~~H~dl~p~nil~~~-~~~~~l~dfg~~~~~~~~ 158 (288)
T cd05583 82 LILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLG--IIYRDIKLENILLDS-EGHVVLTDFGLSKEFLAE 158 (288)
T ss_pred EEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECC-CCCEEEEECccccccccc
Confidence 58999999999999988788999999999999999999999999 999999999999984 579999999998654332
Q ss_pred C---CccccCCCCccCccccccc---CCchhhHHHhHHHHHHHhhcCCCCCCCC---CHHHHHHHHhcCCCCCccccCCC
Q 008504 81 T---ARSVIGTPEFMAPELYEEE---YNELVDIYSFGMCILEMVTFEYPYSECK---NPAQIFKKVTSGIKPASLAKVND 151 (563)
Q Consensus 81 ~---~~~~~Gtp~Y~APEvl~~~---ys~ksDIwSLGviLyELlTG~~Pf~~~~---~~~~i~~~i~~~~~p~~l~~~~s 151 (563)
. .....|++.|+|||.+.+. ++.++||||||+++|+|++|..||.... ....+.+.+..... ..+...+
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 236 (288)
T cd05583 159 EEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKP--PFPKTMS 236 (288)
T ss_pred cccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCC--CCCcccC
Confidence 1 2234688999999987543 6889999999999999999999996422 12233333333322 2345567
Q ss_pred hhHHHHHHHhcC-CCCCCCC---HHHHHcCccccccccCC
Q 008504 152 PQIKGFIEKCLV-PASERLS---AKDLLKDPFLQVENQKE 187 (563)
Q Consensus 152 ~~l~~LI~kcL~-dP~kRpS---a~ELLkHpff~~~~~~~ 187 (563)
+.++++|.+||. +|.+||| +.++|+||||+...+..
T Consensus 237 ~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~~~ 276 (288)
T cd05583 237 AEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWDD 276 (288)
T ss_pred HHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCHHH
Confidence 899999999997 8999998 67889999998776643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.2e-27 Score=237.40 Aligned_cols=179 Identities=23% Similarity=0.415 Sum_probs=143.1
Q ss_pred CEeccCCCCCHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEec
Q 008504 1 MITELFTSGNLRQYRKKH----------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGD 70 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~----------~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~D 70 (563)
+||||+++|+|.+++.+. ..++...+..++.||+.||.|||+++ |+||||||+||+++ .++.+||+|
T Consensus 86 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dikp~nili~-~~~~~~L~D 162 (288)
T cd05061 86 VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK--FVHRDLAARNCMVA-HDFTVKIGD 162 (288)
T ss_pred EEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCCChheEEEc-CCCcEEECc
Confidence 589999999999999753 23467788999999999999999999 99999999999998 457999999
Q ss_pred ccchhhccCCC----CccccCCCCccCccccc-ccCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCCCC
Q 008504 71 LGLAIAMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPA 144 (563)
Q Consensus 71 FGlA~~~~~~~----~~~~~Gtp~Y~APEvl~-~~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~p~ 144 (563)
||+++...... .....++..|+|||.+. +.++.++|||||||++|+|++ |..||.. .........+..+..+
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~-~~~~~~~~~~~~~~~~- 240 (288)
T cd05061 163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQG-LSNEQVLKFVMDGGYL- 240 (288)
T ss_pred CCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCC-
Confidence 99986543211 11224567899999876 458999999999999999998 7889876 3445555555444332
Q ss_pred ccccCCChhHHHHHHHhcC-CCCCCCCHHHHHc------Cccccccc
Q 008504 145 SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK------DPFLQVEN 184 (563)
Q Consensus 145 ~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLk------Hpff~~~~ 184 (563)
..+...++.++++|.+||. +|.+|||+.++++ ||||....
T Consensus 241 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~ 287 (288)
T cd05061 241 DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVS 287 (288)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCCC
Confidence 2334557899999999997 8999999999987 89987654
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.5e-27 Score=249.93 Aligned_cols=154 Identities=23% Similarity=0.391 Sum_probs=125.1
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCCCC----ccccCCCCccCcc
Q 008504 20 NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA----RSVIGTPEFMAPE 95 (563)
Q Consensus 20 ~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~~~----~~~~Gtp~Y~APE 95 (563)
.+++..+..|+.||+.||.|||++| |+||||||+|||++ +.+.+||+|||++........ ....++..|+|||
T Consensus 210 ~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nill~-~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE 286 (375)
T cd05104 210 ALDTEDLLSFSYQVAKGMSFLASKN--CIHRDLAARNILLT-HGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPE 286 (375)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCchhhEEEE-CCCcEEEecCccceeccCcccccccCCCCCCcceeChh
Confidence 4788899999999999999999999 99999999999998 457999999999975543221 1223456799999
Q ss_pred cccc-cCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHHHHHHhcC-CCCCCCCHH
Q 008504 96 LYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAK 172 (563)
Q Consensus 96 vl~~-~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ 172 (563)
++.+ .++.++|||||||++|+|++ |..||..........+.+..+..+ ..+...+.++++||.+||. +|.+||++.
T Consensus 287 ~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 365 (375)
T cd05104 287 SIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRM-LSPECAPSEMYDIMKSCWDADPLKRPTFK 365 (375)
T ss_pred HhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccC-CCCCCCCHHHHHHHHHHccCChhHCcCHH
Confidence 8864 58999999999999999998 889998755555666666655433 2345567899999999997 899999999
Q ss_pred HHHcC
Q 008504 173 DLLKD 177 (563)
Q Consensus 173 ELLkH 177 (563)
++++.
T Consensus 366 eil~~ 370 (375)
T cd05104 366 QIVQL 370 (375)
T ss_pred HHHHH
Confidence 99864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=4e-27 Score=234.96 Aligned_cols=173 Identities=24% Similarity=0.394 Sum_probs=135.5
Q ss_pred CEeccCCCCCHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchh
Q 008504 1 MITELFTSGNLRQYRKKHK-----NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 75 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~-----~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~ 75 (563)
+||||+++|+|.+++...+ ..++..++.++.||+.||+|||++| |+||||||+|||++. ++.+||+|||++.
T Consensus 72 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~-~~~~kl~dfg~~~ 148 (269)
T cd05042 72 LVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD--FIHSDLALRNCQLTA-DLSVKIGDYGLAL 148 (269)
T ss_pred EEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC--EecccccHhheEecC-CCcEEEecccccc
Confidence 5899999999999998643 2467888999999999999999999 999999999999984 5799999999985
Q ss_pred hccCC----CCccccCCCCccCcccccc--------cCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCC
Q 008504 76 AMQQP----TARSVIGTPEFMAPELYEE--------EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIK 142 (563)
Q Consensus 76 ~~~~~----~~~~~~Gtp~Y~APEvl~~--------~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~ 142 (563)
..... ......+++.|+|||++.. .++.++|||||||++|+|++ |..||....+.......+.....
T Consensus 149 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~ 228 (269)
T cd05042 149 EQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDI 228 (269)
T ss_pred ccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCc
Confidence 43221 1122345678999998742 36789999999999999999 78888765444433333333322
Q ss_pred ---CCccccCCChhHHHHHHHhcCCCCCCCCHHHHHc
Q 008504 143 ---PASLAKVNDPQIKGFIEKCLVPASERLSAKDLLK 176 (563)
Q Consensus 143 ---p~~l~~~~s~~l~~LI~kcL~dP~kRpSa~ELLk 176 (563)
........++.+.+++..||.+|.+|||+.++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~dp~~Rpt~~~v~~ 265 (269)
T cd05042 229 KLPKPQLDLKYSDRWYEVMQFCWLDPETRPTAEEVHE 265 (269)
T ss_pred cCCCCcccccCCHHHHHHHHHHhcCcccccCHHHHHH
Confidence 2233445678899999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.5e-27 Score=238.36 Aligned_cols=176 Identities=27% Similarity=0.486 Sum_probs=136.3
Q ss_pred CEeccCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k-~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
+||||+. ++|.+++.. .+.+++..++.++.||+.||.|||++| |+|+||||+|||++ ..+.+||+|||++.....
T Consensus 80 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nil~~-~~~~~~l~Dfg~~~~~~~ 155 (291)
T cd07870 80 FVFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH--ILHRDLKPQNLLIS-YLGELKLADFGLARAKSI 155 (291)
T ss_pred EEEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEEc-CCCcEEEeccccccccCC
Confidence 5899996 677777654 356889999999999999999999999 99999999999997 567999999999865432
Q ss_pred C--CCccccCCCCccCcccccc--cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhc--CCC-----------
Q 008504 80 P--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS--GIK----------- 142 (563)
Q Consensus 80 ~--~~~~~~Gtp~Y~APEvl~~--~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~--~~~----------- 142 (563)
. ......+++.|+|||.+.+ .++.++||||||+++|+|++|..||............+.. +.+
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (291)
T cd07870 156 PSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKL 235 (291)
T ss_pred CCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhc
Confidence 2 2233457899999998854 4788999999999999999999999765443332222211 000
Q ss_pred ------------CCcc-----ccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCccc
Q 008504 143 ------------PASL-----AKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 180 (563)
Q Consensus 143 ------------p~~l-----~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff 180 (563)
+... ....++.+.+|+.+||. +|.+|||+.+++.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 236 PNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred ccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 0000 00125688999999998 89999999999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=239.06 Aligned_cols=171 Identities=30% Similarity=0.550 Sum_probs=137.6
Q ss_pred CEeccCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhcc
Q 008504 1 MITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~--~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~ 78 (563)
+|||||++|+|.+++... ..+++..+..|+.||+.||.|||+++ ++|++|+++|||++. ++.+||+|||++....
T Consensus 78 lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~--iiH~~l~~~nill~~-~~~~Kl~~f~~~~~~~ 154 (259)
T PF07714_consen 78 LVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN--IIHGNLSPSNILLDS-NGQVKLSDFGLSRPIS 154 (259)
T ss_dssp EEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT--EEEST-SGGGEEEET-TTEEEEESTTTGEETT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccc--ccccccccccccccc-cccccccccccccccc
Confidence 589999999999999986 67999999999999999999999999 999999999999984 5799999999997652
Q ss_pred CCC----CccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCCCCccccCCCh
Q 008504 79 QPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDP 152 (563)
Q Consensus 79 ~~~----~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~ 152 (563)
... .........|+|||.+.. .++.++||||||+++|||++ |+.||... ....+...+..+..+. .+...+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~~~ 232 (259)
T PF07714_consen 155 EKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY-DNEEIIEKLKQGQRLP-IPDNCPK 232 (259)
T ss_dssp TSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS-CHHHHHHHHHTTEETT-SBTTSBH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccc-ccccccccccccccce-eccchhH
Confidence 211 122345678999999865 48999999999999999999 68999875 6666666666554433 4556788
Q ss_pred hHHHHHHHhcC-CCCCCCCHHHHHc
Q 008504 153 QIKGFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 153 ~l~~LI~kcL~-dP~kRpSa~ELLk 176 (563)
.+.++|.+||. +|.+||++.++++
T Consensus 233 ~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 233 DIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp HHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHh
Confidence 99999999997 8999999999975
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-27 Score=240.97 Aligned_cols=176 Identities=30% Similarity=0.498 Sum_probs=142.3
Q ss_pred CEeccCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k-~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
|||||+. |+|.+++.. .+.+++..+..++.||+.||.|||++| |+||||+|+||+++ .++.+||+|||++.....
T Consensus 92 lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~--i~H~dl~p~nIl~~-~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 92 LVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHE--RIHRDIKAGNILLT-EPGTVKLADFGSASLVSP 167 (307)
T ss_pred EEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEEC-CCCCEEEeecCcceecCC
Confidence 5899997 577777654 457999999999999999999999999 99999999999997 557999999999865432
Q ss_pred CCCccccCCCCccCccccc----ccCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHH
Q 008504 80 PTARSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIK 155 (563)
Q Consensus 80 ~~~~~~~Gtp~Y~APEvl~----~~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~ 155 (563)
.....+++.|+|||++. +.++.++||||||+++|+|+||..||.... .......+.....+.......+..++
T Consensus 168 --~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (307)
T cd06607 168 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-AMSALYHIAQNDSPTLSSNDWSDYFR 244 (307)
T ss_pred --CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCcc-HHHHHHHHhcCCCCCCCchhhCHHHH
Confidence 23456788999999873 348889999999999999999999997643 33333333333333333344677899
Q ss_pred HHHHHhcC-CCCCCCCHHHHHcCcccccc
Q 008504 156 GFIEKCLV-PASERLSAKDLLKDPFLQVE 183 (563)
Q Consensus 156 ~LI~kcL~-dP~kRpSa~ELLkHpff~~~ 183 (563)
++|.+||. +|.+||++.+++.||||...
T Consensus 245 ~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 273 (307)
T cd06607 245 NFVDSCLQKIPQDRPSSEELLKHRFVLRE 273 (307)
T ss_pred HHHHHHhcCChhhCcCHHHHhcChhhccc
Confidence 99999997 89999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.6e-27 Score=235.46 Aligned_cols=171 Identities=24% Similarity=0.419 Sum_probs=139.7
Q ss_pred CEeccCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~-~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
+++||+++|+|.+++..+ +.+++..+..++.||+.||.|||+++ |+||||||+|||++ +.+.+||+|||+++....
T Consensus 85 l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--iiH~dlkp~Nil~~-~~~~~kL~dfG~~~~~~~ 161 (279)
T cd05109 85 LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR--LVHRDLAARNVLVK-SPNHVKITDFGLARLLDI 161 (279)
T ss_pred EEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccccceEEEc-CCCcEEECCCCceeeccc
Confidence 589999999999999874 56999999999999999999999999 99999999999997 557999999999876543
Q ss_pred CCC----ccccCCCCccCccccc-ccCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCCCCccccCCChh
Q 008504 80 PTA----RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQ 153 (563)
Q Consensus 80 ~~~----~~~~Gtp~Y~APEvl~-~~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~ 153 (563)
... ....+++.|+|||.+. ..++.++|||||||++|||++ |..||.. .....+...+..+..+. .+...++.
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~ 239 (279)
T cd05109 162 DETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDG-IPAREIPDLLEKGERLP-QPPICTID 239 (279)
T ss_pred ccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHCCCcCC-CCccCCHH
Confidence 211 1123467899999875 458999999999999999998 8899875 34455555555544332 34456789
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHHc
Q 008504 154 IKGFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 154 l~~LI~kcL~-dP~kRpSa~ELLk 176 (563)
+.++|.+||. +|.+||++.+++.
T Consensus 240 ~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 240 VYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHH
Confidence 9999999997 8999999999984
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.1e-27 Score=232.86 Aligned_cols=172 Identities=23% Similarity=0.439 Sum_probs=141.0
Q ss_pred CEeccCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~-~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
+||||+++++|.+++..+ +.+++..++.++.||+.||.|||++| |+||||||+|||++ +.|.+||+|||++.....
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~ni~i~-~~~~~kl~dfg~~~~~~~ 152 (256)
T cd05059 76 IVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG--FIHRDLAARNCLVG-EDNVVKVSDFGLARYVLD 152 (256)
T ss_pred EEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--cccccccHhhEEEC-CCCcEEECCcccceeccc
Confidence 589999999999999764 46899999999999999999999999 99999999999998 567999999999865543
Q ss_pred CCCccc---cCCCCccCccccc-ccCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhH
Q 008504 80 PTARSV---IGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQI 154 (563)
Q Consensus 80 ~~~~~~---~Gtp~Y~APEvl~-~~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l 154 (563)
...... .++..|+|||.+. ..++.++||||||+++|+|++ |..||... ........+..+... ..+...++.+
T Consensus 153 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~ 230 (256)
T cd05059 153 DQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERF-SNSEVVESVSAGYRL-YRPKLAPTEV 230 (256)
T ss_pred ccccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCC-CHHHHHHHHHcCCcC-CCCCCCCHHH
Confidence 222222 2345799999886 458899999999999999999 79999763 445555666555433 3345678899
Q ss_pred HHHHHHhcC-CCCCCCCHHHHHcC
Q 008504 155 KGFIEKCLV-PASERLSAKDLLKD 177 (563)
Q Consensus 155 ~~LI~kcL~-dP~kRpSa~ELLkH 177 (563)
.+++.+||. +|.+|||+.++++.
T Consensus 231 ~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 231 YTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred HHHHHHHhcCChhhCcCHHHHHHH
Confidence 999999997 89999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.7e-27 Score=235.49 Aligned_cols=173 Identities=21% Similarity=0.409 Sum_probs=139.4
Q ss_pred CEeccCCCCCHHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCC--CCcEEEecc
Q 008504 1 MITELFTSGNLRQYRKKHK-------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGN--HGEVKIGDL 71 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~-------~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~--~G~VKL~DF 71 (563)
+||||+.+|+|.+++...+ .+++..+..++.||+.||.|||+++ ++||||||+||+++.+ ...+||+||
T Consensus 86 lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~nil~~~~~~~~~~kl~df 163 (277)
T cd05036 86 ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH--FIHRDIAARNCLLTCKGPGRVAKIADF 163 (277)
T ss_pred EEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchheEEEeccCCCcceEeccC
Confidence 5899999999999998653 4899999999999999999999999 9999999999999743 236999999
Q ss_pred cchhhccCCCC----ccccCCCCccCccccc-ccCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCCCCc
Q 008504 72 GLAIAMQQPTA----RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPAS 145 (563)
Q Consensus 72 GlA~~~~~~~~----~~~~Gtp~Y~APEvl~-~~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~ 145 (563)
|++........ .....++.|+|||++. ..++.++|||||||++|+|++ |..||... ....+...+.....+ .
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~-~~~~~~~~~~~~~~~-~ 241 (277)
T cd05036 164 GMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGR-TNQEVMEFVTGGGRL-D 241 (277)
T ss_pred ccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHHHcCCcC-C
Confidence 99976532211 1223356799999875 458999999999999999997 89999864 344455555544332 3
Q ss_pred cccCCChhHHHHHHHhcC-CCCCCCCHHHHHcC
Q 008504 146 LAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 177 (563)
Q Consensus 146 l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkH 177 (563)
.+...+..+.+|+.+||. +|.+||++.++++|
T Consensus 242 ~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 242 PPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 345567899999999997 89999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.5e-28 Score=262.70 Aligned_cols=172 Identities=33% Similarity=0.496 Sum_probs=147.4
Q ss_pred CEeccCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhcc-
Q 008504 1 MITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ- 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~-~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~- 78 (563)
||+-+|+|.+|+.++... .+|.....+.|++||++|+.|||.++ |||||||..|||+. +++.|||+|||++....
T Consensus 464 IiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~--IIHrDLKSnNIFl~-~~~kVkIgDFGLatvk~~ 540 (678)
T KOG0193|consen 464 IITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKN--IIHRDLKSNNIFLH-EDLKVKIGDFGLATVKTR 540 (678)
T ss_pred eeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhh--hhhhhccccceEEc-cCCcEEEecccceeeeee
Confidence 688999999999999853 46999999999999999999999999 99999999999997 55899999999995432
Q ss_pred ---CCCCccccCCCCccCccccc----ccCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCc---ccc
Q 008504 79 ---QPTARSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPAS---LAK 148 (563)
Q Consensus 79 ---~~~~~~~~Gtp~Y~APEvl~----~~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~---l~~ 148 (563)
........|...|||||+++ ..|++.+||||||+++|||+||..||. ..+.+++...+.+|...+. ...
T Consensus 541 w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~dqIifmVGrG~l~pd~s~~~s 619 (678)
T KOG0193|consen 541 WSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQNRDQIIFMVGRGYLMPDLSKIRS 619 (678)
T ss_pred eccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCChhheEEEecccccCccchhhhc
Confidence 22334456788999999886 349999999999999999999999999 6889999999998844333 334
Q ss_pred CCChhHHHHHHHhcC-CCCCCCCHHHHHc
Q 008504 149 VNDPQIKGFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 149 ~~s~~l~~LI~kcL~-dP~kRpSa~ELLk 176 (563)
..+.++++|+..||. ++++||.+.+||.
T Consensus 620 ~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 620 NCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred cCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 445699999999998 8999999999986
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.4e-27 Score=232.22 Aligned_cols=171 Identities=27% Similarity=0.433 Sum_probs=141.3
Q ss_pred CEeccCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhcc
Q 008504 1 MITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~--~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~ 78 (563)
+||||+++|+|.+++... ..+++..++.++.|++.||.|||++| ++||||||+||+++ +++.+||+|||++....
T Consensus 79 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~nil~~-~~~~~kl~df~~~~~~~ 155 (263)
T cd05052 79 IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVG-ENHLVKVADFGLSRLMT 155 (263)
T ss_pred EEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEc-CCCcEEeCCCccccccc
Confidence 589999999999999763 35899999999999999999999999 99999999999997 56799999999987654
Q ss_pred CCCCc---cccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCCCCccccCCChh
Q 008504 79 QPTAR---SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQ 153 (563)
Q Consensus 79 ~~~~~---~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~ 153 (563)
..... ...+++.|+|||.+.+ .++.++|||||||++|+|++ |..||.. ......+..+..+..+ ..+...++.
T Consensus 156 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~ 233 (263)
T cd05052 156 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLEKGYRM-ERPEGCPPK 233 (263)
T ss_pred cceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHCCCCC-CCCCCCCHH
Confidence 33211 1223567999998764 58899999999999999998 8999976 4556666666655433 345566789
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHHc
Q 008504 154 IKGFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 154 l~~LI~kcL~-dP~kRpSa~ELLk 176 (563)
+.++|.+||. +|.+||++.++++
T Consensus 234 ~~~li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 234 VYELMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred HHHHHHHHccCCcccCCCHHHHHH
Confidence 9999999997 8999999999976
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-27 Score=243.34 Aligned_cols=180 Identities=31% Similarity=0.456 Sum_probs=144.4
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
+||||+. ++|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++. ++.++|+|||++......
T Consensus 81 lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~g--i~H~dlkp~nili~~-~~~~~L~dfg~~~~~~~~ 156 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSAN--VIHRDLKPSNILVNS-NCDLKICDFGLARGVDPD 156 (330)
T ss_pred EEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcC-CCCEEEcccCceEeeccc
Confidence 5899997 589999988888999999999999999999999999 999999999999984 489999999999765443
Q ss_pred C-----CccccCCCCccCcccccc--cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCC--C--------
Q 008504 81 T-----ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK--P-------- 143 (563)
Q Consensus 81 ~-----~~~~~Gtp~Y~APEvl~~--~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~--p-------- 143 (563)
. .....+++.|+|||++.+ .++.++|+||||+++|+|++|..||.... ....+..+..... +
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~ 235 (330)
T cd07834 157 EDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRD-YIDQLNLIVEVLGTPSEEDLKFIT 235 (330)
T ss_pred ccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCC-HHHHHHHHHHhcCCCChhHhhhcc
Confidence 2 234567889999998864 47899999999999999999999997643 3332332222100 0
Q ss_pred -------------------CccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCcccccccc
Q 008504 144 -------------------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQ 185 (563)
Q Consensus 144 -------------------~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~~ 185 (563)
.......++.+.+||.+||. +|.+||++.++++||||+....
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 236 SEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred ccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 00112246789999999997 8999999999999999986543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.7e-27 Score=237.15 Aligned_cols=181 Identities=27% Similarity=0.425 Sum_probs=140.6
Q ss_pred CEeccCCCCCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhcc
Q 008504 1 MITELFTSGNLRQYRKKHKN--VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~--Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~ 78 (563)
+||||+. ++|.+++..... +++..++.++.||+.||+|||+++ ++||||+|+||+++..++.+||+|||++....
T Consensus 78 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~ 154 (294)
T PLN00009 78 LVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR--VLHRDLKPQNLLIDRRTNALKLADFGLARAFG 154 (294)
T ss_pred EEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCcceEEEECCCCEEEEcccccccccC
Confidence 5899996 588888876443 588999999999999999999999 99999999999998656689999999996543
Q ss_pred CC--CCccccCCCCccCcccccc--cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCC-----------
Q 008504 79 QP--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP----------- 143 (563)
Q Consensus 79 ~~--~~~~~~Gtp~Y~APEvl~~--~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p----------- 143 (563)
.. ......+++.|+|||.+.+ .++.++|||||||++|+|+||..||........+.+.......+
T Consensus 155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (294)
T PLN00009 155 IPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSL 234 (294)
T ss_pred CCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccc
Confidence 22 2233467889999998754 47889999999999999999999997644433333322110000
Q ss_pred ------------C---ccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCccccccc
Q 008504 144 ------------A---SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 184 (563)
Q Consensus 144 ------------~---~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~ 184 (563)
. ......++.++++|.+||. +|.+||++.++++||||....
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~ 291 (294)
T PLN00009 235 PDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLG 291 (294)
T ss_pred hhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHh
Confidence 0 0112346789999999997 899999999999999998644
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.2e-27 Score=238.44 Aligned_cols=175 Identities=26% Similarity=0.433 Sum_probs=135.4
Q ss_pred CEeccCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~-~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
+||||+. ++|.+++.+. ..+++..++.++.||+.||.|||++| ++|+||||+||+++ ..+.+||+|||++.....
T Consensus 96 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dl~p~nil~~-~~~~~kl~dfg~~~~~~~ 171 (310)
T cd07865 96 LVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNK--ILHRDMKAANILIT-KDGILKLADFGLARAFSL 171 (310)
T ss_pred EEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEC-CCCcEEECcCCCcccccC
Confidence 5899996 4888887754 36999999999999999999999999 99999999999997 557999999999865533
Q ss_pred CC------CccccCCCCccCcccccc--cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhc---CCCCC----
Q 008504 80 PT------ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS---GIKPA---- 144 (563)
Q Consensus 80 ~~------~~~~~Gtp~Y~APEvl~~--~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~---~~~p~---- 144 (563)
.. .....++..|+|||++.+ .++.++||||||+++|+|++|..||.... .......+.. ...+.
T Consensus 172 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 250 (310)
T cd07865 172 SKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNT-EQHQLTLISQLCGSITPEVWPG 250 (310)
T ss_pred CcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHhCCCChhhccc
Confidence 21 123457788999998754 36889999999999999999999997633 2221111111 10000
Q ss_pred -----------------------ccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCccc
Q 008504 145 -----------------------SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 180 (563)
Q Consensus 145 -----------------------~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff 180 (563)
......++.+++||.+||. +|.+|||+.++|+||||
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 251 VDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred ccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 0011235678899999997 89999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.4e-27 Score=235.31 Aligned_cols=172 Identities=25% Similarity=0.439 Sum_probs=138.6
Q ss_pred CEeccCCCCCHHHHHHhCC----------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEec
Q 008504 1 MITELFTSGNLRQYRKKHK----------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGD 70 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~----------~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~D 70 (563)
+||||+++|+|.+++.+.+ .++...+..++.|++.||.|||+.| ++||||||+||+++ ..+.++|+|
T Consensus 86 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~vH~dlkp~Nil~~-~~~~~~l~d 162 (277)
T cd05062 86 VIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVA-EDFTVKIGD 162 (277)
T ss_pred EEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCcchheEEEc-CCCCEEECC
Confidence 5899999999999997532 3577889999999999999999999 99999999999998 457999999
Q ss_pred ccchhhccCCC----CccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCCCC
Q 008504 71 LGLAIAMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPA 144 (563)
Q Consensus 71 FGlA~~~~~~~----~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~p~ 144 (563)
||++....... .....+++.|+|||.+.+ .++.++|||||||++|+|++ |..||.. .........+..+..+
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~-~~~~~~~~~~~~~~~~- 240 (277)
T cd05062 163 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG-MSNEQVLRFVMEGGLL- 240 (277)
T ss_pred CCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHcCCcC-
Confidence 99986543221 112345678999998864 58999999999999999999 6889876 3445555555444332
Q ss_pred ccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcC
Q 008504 145 SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 177 (563)
Q Consensus 145 ~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkH 177 (563)
..+...+..+++||.+||. +|.+|||+.+++++
T Consensus 241 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 241 DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 3445567889999999998 89999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.4e-27 Score=234.81 Aligned_cols=171 Identities=25% Similarity=0.436 Sum_probs=140.5
Q ss_pred CEeccCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~-~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
+|+||+++|+|.+++... +.+++..++.|+.||+.||.|||+++ ++||||||+||+++ .++.+||+|||+++....
T Consensus 85 ~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~nili~-~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 85 LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR--MVHRNLAARNILLK-SDSIVQIADFGVADLLYP 161 (279)
T ss_pred EEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEc-CCCcEEEcCCccceeccC
Confidence 589999999999999764 56999999999999999999999999 99999999999998 457999999999975432
Q ss_pred CC----CccccCCCCccCccccc-ccCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCCCCccccCCChh
Q 008504 80 PT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQ 153 (563)
Q Consensus 80 ~~----~~~~~Gtp~Y~APEvl~-~~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~ 153 (563)
.. .....++..|+|||.+. +.++.++|||||||++|||++ |..||.+. .+......+..+..+ ..+...+..
T Consensus 162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~ 239 (279)
T cd05111 162 DDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGM-RPHEVPDLLEKGERL-AQPQICTID 239 (279)
T ss_pred CCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHHHCCCcC-CCCCCCCHH
Confidence 21 12334667899999885 458999999999999999998 99999763 444445555554433 234456778
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHHc
Q 008504 154 IKGFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 154 l~~LI~kcL~-dP~kRpSa~ELLk 176 (563)
+..++.+||. +|.+|||+.++++
T Consensus 240 ~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 240 VYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred HHHHHHHHcCCCcccCcCHHHHHH
Confidence 9999999997 8999999999976
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.7e-27 Score=235.96 Aligned_cols=176 Identities=27% Similarity=0.481 Sum_probs=136.3
Q ss_pred CEeccCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~-~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
+||||+.+ +|.+++.+. ..+++..++.++.||+.||.|||++| |+||||||+|||++ ..|.+||+|||++.....
T Consensus 80 lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~dl~p~nil~~-~~~~~kl~dfg~~~~~~~ 155 (291)
T cd07844 80 LVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR--VLHRDLKPQNLLIS-ERGELKLADFGLARAKSV 155 (291)
T ss_pred EEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCHHHEEEc-CCCCEEECccccccccCC
Confidence 58999975 999998764 46899999999999999999999999 99999999999998 557999999999865432
Q ss_pred C--CCccccCCCCccCcccccc--cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCC---C----------
Q 008504 80 P--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI---K---------- 142 (563)
Q Consensus 80 ~--~~~~~~Gtp~Y~APEvl~~--~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~---~---------- 142 (563)
. ......+++.|+|||++.+ .++.++||||||+++|+|++|+.||............+.... .
T Consensus 156 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (291)
T cd07844 156 PSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSN 235 (291)
T ss_pred CCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhc
Confidence 1 1222356889999998753 478999999999999999999999976443322222111100 0
Q ss_pred ------------CCcc---ccCCC--hhHHHHHHHhcC-CCCCCCCHHHHHcCccc
Q 008504 143 ------------PASL---AKVND--PQIKGFIEKCLV-PASERLSAKDLLKDPFL 180 (563)
Q Consensus 143 ------------p~~l---~~~~s--~~l~~LI~kcL~-dP~kRpSa~ELLkHpff 180 (563)
+... ....+ ..+.++|.+||. +|.+|||+.+++.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 236 PEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred cccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 0000 01122 678899999997 89999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=8e-27 Score=230.53 Aligned_cols=172 Identities=29% Similarity=0.439 Sum_probs=141.0
Q ss_pred CEeccCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhcc
Q 008504 1 MITELFTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~--~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~ 78 (563)
+||||+++|+|.+++.+.. .+++..++.++.|++.||.|||++| ++||||||+||+++. ++.+||+|||++....
T Consensus 72 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~di~p~nil~~~-~~~~kl~dfg~~~~~~ 148 (257)
T cd05040 72 MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR--FIHRDLAARNILLAS-DDKVKIGDFGLMRALP 148 (257)
T ss_pred EEEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC--ccccccCcccEEEec-CCEEEecccccccccc
Confidence 5899999999999998754 6899999999999999999999999 999999999999984 4799999999987654
Q ss_pred CCC-----CccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCCCCccccCCC
Q 008504 79 QPT-----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVND 151 (563)
Q Consensus 79 ~~~-----~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s 151 (563)
... .....++..|+|||.+.. .++.++|||||||++|+|++ |..||... +..++.+.+.........+...+
T Consensus 149 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 227 (257)
T cd05040 149 QNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGL-SGSQILKKIDKEGERLERPEACP 227 (257)
T ss_pred ccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHhcCCcCCCCccCC
Confidence 321 112356778999998864 58999999999999999998 99999764 44445555543322333344567
Q ss_pred hhHHHHHHHhcC-CCCCCCCHHHHHc
Q 008504 152 PQIKGFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 152 ~~l~~LI~kcL~-dP~kRpSa~ELLk 176 (563)
..+.+++.+||. +|.+||++.+++.
T Consensus 228 ~~~~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 228 QDIYNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred HHHHHHHHHHCCCCcccCCCHHHHHH
Confidence 899999999997 8999999999975
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.9e-27 Score=244.11 Aligned_cols=181 Identities=27% Similarity=0.460 Sum_probs=142.4
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
+||||+. |+|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++......
T Consensus 85 lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~-~~~~~kl~dfg~~~~~~~~ 160 (334)
T cd07855 85 VVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLVN-EDCELRIGDFGMARGLSSS 160 (334)
T ss_pred EEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEc-CCCcEEecccccceeeccc
Confidence 5899995 699999988788999999999999999999999999 99999999999998 5689999999998654321
Q ss_pred C------CccccCCCCccCcccccc--cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHh--------------
Q 008504 81 T------ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVT-------------- 138 (563)
Q Consensus 81 ~------~~~~~Gtp~Y~APEvl~~--~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~-------------- 138 (563)
. .....++..|+|||.+.+ .++.++|||||||++|+|++|+.||........+.....
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~ 240 (334)
T cd07855 161 PTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIG 240 (334)
T ss_pred CcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhc
Confidence 1 123478899999998753 488999999999999999999999976432222111000
Q ss_pred ---------cCCC--CC---ccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCcccccccc
Q 008504 139 ---------SGIK--PA---SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQ 185 (563)
Q Consensus 139 ---------~~~~--p~---~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~~ 185 (563)
.... +. ......++.+++||.+||. +|.+||++.+++.||||.....
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~ 302 (334)
T cd07855 241 SDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHD 302 (334)
T ss_pred hhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccC
Confidence 0000 00 0112347889999999997 8999999999999999985443
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.5e-27 Score=230.57 Aligned_cols=171 Identities=22% Similarity=0.441 Sum_probs=140.7
Q ss_pred CEeccCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~-~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
+||||+++|+|.+++... +.+++..++.++.||+.||.|||++| |+||||||+||+++ .++.+||+|||.+.....
T Consensus 76 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~-~~~~~kl~d~g~~~~~~~ 152 (256)
T cd05114 76 IVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS--FIHRDLAARNCLVS-STGVVKVSDFGMTRYVLD 152 (256)
T ss_pred EEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcceEEEc-CCCeEEECCCCCccccCC
Confidence 589999999999999753 46899999999999999999999999 99999999999998 457999999999865433
Q ss_pred CCC---ccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhH
Q 008504 80 PTA---RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQI 154 (563)
Q Consensus 80 ~~~---~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l 154 (563)
... ....++..|+|||++.+ .++.++||||||+++|+|++ |+.||.. .+.......+..+..+ ..+...+..+
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~-~~~~~~~~~i~~~~~~-~~~~~~~~~~ 230 (256)
T cd05114 153 DEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEK-KSNYEVVEMISRGFRL-YRPKLASMTV 230 (256)
T ss_pred CceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHCCCCC-CCCCCCCHHH
Confidence 221 12234568999998864 58899999999999999999 8999976 3455556666655433 2345567889
Q ss_pred HHHHHHhcC-CCCCCCCHHHHHc
Q 008504 155 KGFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 155 ~~LI~kcL~-dP~kRpSa~ELLk 176 (563)
.+++.+||. +|.+||++.++++
T Consensus 231 ~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 231 YEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred HHHHHHHccCCcccCcCHHHHHH
Confidence 999999997 8999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-26 Score=232.92 Aligned_cols=176 Identities=30% Similarity=0.461 Sum_probs=140.3
Q ss_pred CEeccCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhcc
Q 008504 1 MITELFTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~--~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~ 78 (563)
+||||+ +|+|.+++.... .+++..+..++.|++.||.|||++| ++|+||+|+||+++ ..+.++|+|||++....
T Consensus 75 lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~dl~~~ni~i~-~~~~~~l~d~~~~~~~~ 150 (283)
T cd07830 75 FVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG--FFHRDLKPENLLVS-GPEVVKIADFGLAREIR 150 (283)
T ss_pred EEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEc-CCCCEEEeecccceecc
Confidence 589999 789999988764 7899999999999999999999999 99999999999998 56899999999997654
Q ss_pred CC-CCccccCCCCccCcccccc--cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCC------------
Q 008504 79 QP-TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP------------ 143 (563)
Q Consensus 79 ~~-~~~~~~Gtp~Y~APEvl~~--~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p------------ 143 (563)
.. ......++..|+|||++.+ .++.++|+||||+++|+|++|+.||..........+.......+
T Consensus 151 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd07830 151 SRPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLA 230 (283)
T ss_pred CCCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhh
Confidence 32 2234567889999998743 47899999999999999999999997654433332221110000
Q ss_pred ---------------CccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCccc
Q 008504 144 ---------------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 180 (563)
Q Consensus 144 ---------------~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff 180 (563)
.......+..+++||.+||. +|.+|||+.|++.||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 231 SKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred ccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 00011225789999999997 89999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.4e-27 Score=237.19 Aligned_cols=180 Identities=26% Similarity=0.539 Sum_probs=143.0
Q ss_pred CEeccCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEeccCccCceEEeCCCCcEEEecccchhhcc
Q 008504 1 MITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHS-HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k-~~~Lse~~i~~i~~QIL~aL~yLHs-~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~ 78 (563)
+||||+. ++|..++.. .+.+++..+..++.||+.||.|||+ +| |+||||+|+||+++ +++.+||+|||++..+.
T Consensus 91 ~v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~--i~H~dl~p~nill~-~~~~~kL~dfg~~~~~~ 166 (296)
T cd06618 91 ICMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHG--VIHRDVKPSNILLD-ASGNVKLCDFGISGRLV 166 (296)
T ss_pred EEeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC--EecCCCcHHHEEEc-CCCCEEECccccchhcc
Confidence 5899985 588887765 4579999999999999999999997 58 99999999999997 56799999999987654
Q ss_pred CCC-CccccCCCCccCcccccc-----cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCC-ccccCCC
Q 008504 79 QPT-ARSVIGTPEFMAPELYEE-----EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPA-SLAKVND 151 (563)
Q Consensus 79 ~~~-~~~~~Gtp~Y~APEvl~~-----~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~-~l~~~~s 151 (563)
... .....+++.|+|||.+.+ .++.++||||||+++|+|++|+.||.......+....+.....+. ......+
T Consensus 167 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (296)
T cd06618 167 DSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFS 246 (296)
T ss_pred CCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCCCC
Confidence 322 223357889999998853 378899999999999999999999976444344444444333222 1222357
Q ss_pred hhHHHHHHHhcC-CCCCCCCHHHHHcCccccccc
Q 008504 152 PQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 184 (563)
Q Consensus 152 ~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~ 184 (563)
..+++||.+||. +|.+||++.++++||||+...
T Consensus 247 ~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 280 (296)
T cd06618 247 PDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYE 280 (296)
T ss_pred HHHHHHHHHHccCChhhCCCHHHHhcChhhhccc
Confidence 889999999997 899999999999999998644
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.4e-27 Score=231.62 Aligned_cols=172 Identities=24% Similarity=0.462 Sum_probs=141.1
Q ss_pred CEeccCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~-~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
+||||+.+|+|.+++... ..+++..++.++.||+.||.|||++| ++|+||||.|||++ .++.+||+|||.+.....
T Consensus 76 lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~nili~-~~~~~kl~d~g~~~~~~~ 152 (256)
T cd05113 76 IVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ--FIHRDLAARNCLVD-DQGCVKVSDFGLSRYVLD 152 (256)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEc-CCCCEEECCCccceecCC
Confidence 589999999999999864 46899999999999999999999999 99999999999998 457999999999865433
Q ss_pred CCCc---cccCCCCccCccccc-ccCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhH
Q 008504 80 PTAR---SVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQI 154 (563)
Q Consensus 80 ~~~~---~~~Gtp~Y~APEvl~-~~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l 154 (563)
.... ...++..|+|||.+. ..++.++|||||||++|+|++ |..||.... .......+..+..+ ..+...+..+
T Consensus 153 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~ 230 (256)
T cd05113 153 DEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFN-NSETVEKVSQGLRL-YRPHLASEKV 230 (256)
T ss_pred CceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCC-HHHHHHHHhcCCCC-CCCCCCCHHH
Confidence 2211 123456799999886 458899999999999999998 999997643 44555555555443 2344567899
Q ss_pred HHHHHHhcC-CCCCCCCHHHHHcC
Q 008504 155 KGFIEKCLV-PASERLSAKDLLKD 177 (563)
Q Consensus 155 ~~LI~kcL~-dP~kRpSa~ELLkH 177 (563)
++++.+||. +|.+||++.+++.+
T Consensus 231 ~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 231 YAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred HHHHHHHcCCCcccCCCHHHHHHh
Confidence 999999997 89999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.6e-27 Score=232.89 Aligned_cols=173 Identities=24% Similarity=0.368 Sum_probs=134.8
Q ss_pred CEeccCCCCCHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchh
Q 008504 1 MITELFTSGNLRQYRKKHK-----NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 75 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~-----~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~ 75 (563)
+||||+++|+|.+++...+ .+++..++.++.|++.||.|||+.+ ++||||||+||+++. .+.+||+|||++.
T Consensus 72 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dlkp~nil~~~-~~~~kL~dfg~~~ 148 (269)
T cd05087 72 LVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN--FIHSDLALRNCLLTA-DLTVKIGDYGLSH 148 (269)
T ss_pred EEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEcC-CCcEEECCccccc
Confidence 5899999999999997532 4677888999999999999999999 999999999999984 5799999999986
Q ss_pred hccCCC----CccccCCCCccCcccccc--------cCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCC
Q 008504 76 AMQQPT----ARSVIGTPEFMAPELYEE--------EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIK 142 (563)
Q Consensus 76 ~~~~~~----~~~~~Gtp~Y~APEvl~~--------~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~ 142 (563)
...... .....+++.|+|||++.+ .++.++||||||+++|+|++ |..||............+.....
T Consensus 149 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~ 228 (269)
T cd05087 149 NKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQL 228 (269)
T ss_pred cccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccC
Confidence 443221 123456788999998753 25789999999999999996 99999875444433333322221
Q ss_pred ---CCccccCCChhHHHHHHHhcCCCCCCCCHHHHHc
Q 008504 143 ---PASLAKVNDPQIKGFIEKCLVPASERLSAKDLLK 176 (563)
Q Consensus 143 ---p~~l~~~~s~~l~~LI~kcL~dP~kRpSa~ELLk 176 (563)
........+..+.+++.+|+.+|.+|||+.+|++
T Consensus 229 ~~~~~~~~~~~~~~~~~l~~~c~~~P~~Rpt~~~l~~ 265 (269)
T cd05087 229 KLPKPRLKLPLSDRWYEVMQFCWLQPEQRPSAEEVHL 265 (269)
T ss_pred CCCCCccCCCCChHHHHHHHHHhcCcccCCCHHHHHH
Confidence 1222334567899999999989999999999985
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.4e-27 Score=239.95 Aligned_cols=172 Identities=27% Similarity=0.451 Sum_probs=140.5
Q ss_pred CEeccCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~-~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
+|+||+.+|+|.+++..+ ..+++..+..++.||+.||+|||++| |+||||||+|||++ +.+.+||+|||+++....
T Consensus 85 ~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--iiH~dlkp~Nill~-~~~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 85 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR--LVHRDLAARNVLVK-TPQHVKITDFGLAKLLGA 161 (316)
T ss_pred eeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEec-CCCcEEEccccccccccC
Confidence 589999999999999875 45899999999999999999999999 99999999999997 557999999999976543
Q ss_pred CCC----ccccCCCCccCccccc-ccCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCCCCccccCCChh
Q 008504 80 PTA----RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQ 153 (563)
Q Consensus 80 ~~~----~~~~Gtp~Y~APEvl~-~~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~ 153 (563)
... ....++..|+|||.+. ..++.++|||||||++|+|++ |..||.+ ....++...+..+... ..+...+..
T Consensus 162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~ 239 (316)
T cd05108 162 DEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG-IPASEISSILEKGERL-PQPPICTID 239 (316)
T ss_pred CCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHhCCCCC-CCCCCCCHH
Confidence 211 1223456899999875 458999999999999999998 9999976 3444555544444333 234556788
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHHcC
Q 008504 154 IKGFIEKCLV-PASERLSAKDLLKD 177 (563)
Q Consensus 154 l~~LI~kcL~-dP~kRpSa~ELLkH 177 (563)
+.++|.+||. +|.+||++.+++.+
T Consensus 240 ~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 240 VYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred HHHHHHHHccCChhhCcCHHHHHHH
Confidence 9999999997 89999999999986
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-26 Score=240.61 Aligned_cols=179 Identities=26% Similarity=0.389 Sum_probs=141.3
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
+||||+. |+|.+++.....+++..+..++.||+.||.|||++| |+||||+|+||+++ ..+.+||+|||++......
T Consensus 97 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~--i~H~dl~~~nill~-~~~~~kl~dfg~~~~~~~~ 172 (335)
T PTZ00024 97 LVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWY--FMHRDLSPANIFIN-SKGICKIADFGLARRYGYP 172 (335)
T ss_pred EEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHeEEC-CCCCEEECCccceeecccc
Confidence 5899997 699999988888999999999999999999999999 99999999999997 5579999999998654411
Q ss_pred ----------------CCccccCCCCccCcccccc--cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCC-
Q 008504 81 ----------------TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI- 141 (563)
Q Consensus 81 ----------------~~~~~~Gtp~Y~APEvl~~--~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~- 141 (563)
......+++.|+|||.+.+ .++.++|||||||++|+|++|..||........ ...+....
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~-~~~i~~~~~ 251 (335)
T PTZ00024 173 PYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQ-LGRIFELLG 251 (335)
T ss_pred cccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhC
Confidence 1112346788999998864 378999999999999999999999986443332 22221100
Q ss_pred --CC--------------------C---ccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCccccccc
Q 008504 142 --KP--------------------A---SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 184 (563)
Q Consensus 142 --~p--------------------~---~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~ 184 (563)
.. . ......+..+.+||.+||. +|.+||++.++|.||||+...
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~ 320 (335)
T PTZ00024 252 TPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDP 320 (335)
T ss_pred CCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCC
Confidence 00 0 0012336778999999998 899999999999999998543
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.9e-27 Score=244.02 Aligned_cols=154 Identities=23% Similarity=0.416 Sum_probs=124.8
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCCC----CccccCCCCccCcc
Q 008504 20 NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT----ARSVIGTPEFMAPE 95 (563)
Q Consensus 20 ~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~~----~~~~~Gtp~Y~APE 95 (563)
.+++..+..++.||+.||.|||++| |+||||||+||+++. ++.+||+|||++..+.... .....++..|+|||
T Consensus 169 ~l~~~~~~~~~~qi~~aL~~lH~~~--ivHrDikp~Nill~~-~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE 245 (337)
T cd05054 169 PLTLEDLISYSFQVARGMEFLASRK--CIHRDLAARNILLSE-NNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 245 (337)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEeC-CCcEEEeccccchhcccCcchhhccCCCCCccccCcH
Confidence 5889999999999999999999999 999999999999984 5799999999997653221 12334567899999
Q ss_pred ccc-ccCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHHHHHHhcC-CCCCCCCHH
Q 008504 96 LYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAK 172 (563)
Q Consensus 96 vl~-~~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ 172 (563)
++. ..++.++|||||||++|+|++ |..||............+..+..+ ..+...++.+.+++.+||+ +|.+||++.
T Consensus 246 ~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ 324 (337)
T cd05054 246 SIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRM-RAPEYATPEIYSIMLDCWHNNPEDRPTFS 324 (337)
T ss_pred HhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCC-CCCccCCHHHHHHHHHHccCChhhCcCHH
Confidence 775 458999999999999999998 999997644334444444444333 3345667899999999997 899999999
Q ss_pred HHHcC
Q 008504 173 DLLKD 177 (563)
Q Consensus 173 ELLkH 177 (563)
++++|
T Consensus 325 ell~~ 329 (337)
T cd05054 325 ELVEI 329 (337)
T ss_pred HHHHH
Confidence 99975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.3e-27 Score=238.26 Aligned_cols=179 Identities=32% Similarity=0.605 Sum_probs=145.4
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
+||||+++++|.+++.. +.+++..++.++.|++.||+|||++| ++||||+|+||+++ .++.++|+|||++......
T Consensus 94 lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~g--ivH~dl~p~Nilv~-~~~~~~l~dfg~~~~~~~~ 169 (292)
T cd06657 94 VVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQG--VIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKE 169 (292)
T ss_pred EEEecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEC-CCCCEEEcccccceecccc
Confidence 58999999999998765 56899999999999999999999999 99999999999998 4579999999988654332
Q ss_pred --CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCC-ccccCCChhHHH
Q 008504 81 --TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPA-SLAKVNDPQIKG 156 (563)
Q Consensus 81 --~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~-~l~~~~s~~l~~ 156 (563)
......|++.|+|||.+.+ .++.++|+||||+++|+|++|..||... ........+.....+. ......++.+.+
T Consensus 170 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 248 (292)
T cd06657 170 VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE-PPLKAMKMIRDNLPPKLKNLHKVSPSLKG 248 (292)
T ss_pred cccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhhCCcccCCcccCCHHHHH
Confidence 2233568899999998754 5789999999999999999999999763 3333334443332221 122345788999
Q ss_pred HHHHhcC-CCCCCCCHHHHHcCccccccc
Q 008504 157 FIEKCLV-PASERLSAKDLLKDPFLQVEN 184 (563)
Q Consensus 157 LI~kcL~-dP~kRpSa~ELLkHpff~~~~ 184 (563)
+|.+||. +|.+||++.+++.||||....
T Consensus 249 li~~~l~~~P~~R~~~~~ll~~~~~~~~~ 277 (292)
T cd06657 249 FLDRLLVRDPAQRATAAELLKHPFLAKAG 277 (292)
T ss_pred HHHHHHhCCcccCcCHHHHhcChHHhccC
Confidence 9999997 899999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.94 E-value=7e-27 Score=232.20 Aligned_cols=174 Identities=28% Similarity=0.462 Sum_probs=142.4
Q ss_pred CEeccCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhh
Q 008504 1 MITELFTSGNLRQYRKK----HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 76 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k----~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~ 76 (563)
+|+||+++|+|.+++.. ...+++..+..++.||+.||.|||++| ++|+||||+||+++ ..+.++|+|||++..
T Consensus 79 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~nil~~-~~~~~~l~d~g~~~~ 155 (267)
T cd08228 79 IVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR--VMHRDIKPANVFIT-ATGVVKLGDLGLGRF 155 (267)
T ss_pred EEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCCHHHEEEc-CCCCEEECcccccee
Confidence 58999999999998863 345899999999999999999999999 99999999999997 457999999999865
Q ss_pred ccCCC--CccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCC-CHHHHHHHHhcCCCCCccccCCCh
Q 008504 77 MQQPT--ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECK-NPAQIFKKVTSGIKPASLAKVNDP 152 (563)
Q Consensus 77 ~~~~~--~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~-~~~~i~~~i~~~~~p~~l~~~~s~ 152 (563)
..... .....+++.|+|||.+.+ .++.++|+||||+++|+|++|+.||.... +.......+.....+.......+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (267)
T cd08228 156 FSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSE 235 (267)
T ss_pred ccchhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCH
Confidence 54321 223468889999998754 58889999999999999999999986532 334555555554444444455678
Q ss_pred hHHHHHHHhcC-CCCCCCCHHHHHcC
Q 008504 153 QIKGFIEKCLV-PASERLSAKDLLKD 177 (563)
Q Consensus 153 ~l~~LI~kcL~-dP~kRpSa~ELLkH 177 (563)
.++++|.+||. +|.+||++.++++.
T Consensus 236 ~~~~li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 236 KLRELVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred HHHHHHHHHCCCCcccCcCHHHHHHH
Confidence 89999999997 89999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.2e-27 Score=236.94 Aligned_cols=172 Identities=23% Similarity=0.390 Sum_probs=139.4
Q ss_pred CEeccCCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCC
Q 008504 1 MITELFTSGNLRQYRKKHK----------------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHG 64 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~----------------~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G 64 (563)
+||||+++|+|.+++.+.+ .+++..++.++.||+.||+|||++| |+||||||+||+++ .++
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nill~-~~~ 156 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ--FIHRDLAARNVLVG-ENL 156 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCcCCcceEEEC-CCC
Confidence 5899999999999997643 4889999999999999999999999 99999999999997 457
Q ss_pred cEEEecccchhhccCCCCcc-ccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCC
Q 008504 65 EVKIGDLGLAIAMQQPTARS-VIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGI 141 (563)
Q Consensus 65 ~VKL~DFGlA~~~~~~~~~~-~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~ 141 (563)
.+||+|||++.......... ...+..|+|||.+.. .++.++|||||||++|+|++ |..||.. .........+..+.
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~-~~~~~~~~~~~~~~ 235 (297)
T cd05089 157 ASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCG-MTCAELYEKLPQGY 235 (297)
T ss_pred eEEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHhcCC
Confidence 99999999985432211111 223457999998764 58999999999999999997 9999976 44555566665554
Q ss_pred CCCccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcC
Q 008504 142 KPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 177 (563)
Q Consensus 142 ~p~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkH 177 (563)
.+ ..+...++.+++||.+||. +|.+||++.++++.
T Consensus 236 ~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 236 RM-EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred CC-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 32 3445677899999999997 89999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.1e-27 Score=229.63 Aligned_cols=167 Identities=23% Similarity=0.386 Sum_probs=133.9
Q ss_pred CEeccCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCC-------cEEEeccc
Q 008504 1 MITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHG-------EVKIGDLG 72 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~-~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G-------~VKL~DFG 72 (563)
+||||+++|+|.+++...+ .+++..+..++.||+.||.|||++| |+||||||+||+++.. + .+||+|||
T Consensus 77 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dlkp~Nill~~~-~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 77 MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKK--LVHGNVCGKNILVARY-GLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC--eecccCccceEEEecC-ccccCCceeEEeCCCC
Confidence 5899999999999998766 7999999999999999999999999 9999999999999743 4 69999999
Q ss_pred chhhccCCCCccccCCCCccCcccccc---cCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCCCCcccc
Q 008504 73 LAIAMQQPTARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAK 148 (563)
Q Consensus 73 lA~~~~~~~~~~~~Gtp~Y~APEvl~~---~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~ 148 (563)
++..... .....++..|+|||++.+ .++.++||||||+++|+|++ |..||.... ........... ...+.
T Consensus 154 ~a~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~-~~~~~~~~~~~---~~~~~ 227 (259)
T cd05037 154 IPITVLS--REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLS-SSEKERFYQDQ---HRLPM 227 (259)
T ss_pred ccccccc--ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCC-chhHHHHHhcC---CCCCC
Confidence 9876543 223456778999998864 48899999999999999999 578886643 22222222211 11122
Q ss_pred CCChhHHHHHHHhcC-CCCCCCCHHHHHc
Q 008504 149 VNDPQIKGFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 149 ~~s~~l~~LI~kcL~-dP~kRpSa~ELLk 176 (563)
.....+.++|.+||. +|.+|||+.++++
T Consensus 228 ~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 228 PDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred CCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 223789999999997 8999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=7e-27 Score=238.26 Aligned_cols=172 Identities=25% Similarity=0.381 Sum_probs=133.1
Q ss_pred CEeccCCCCCHHHHHHhCC-------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeC
Q 008504 1 MITELFTSGNLRQYRKKHK-------------------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG 61 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~-------------------~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~ 61 (563)
|||||+.+|+|.+++.... .+++..+..++.||+.||.|||++| |+||||||+|||++
T Consensus 96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--ivH~dlkp~Nill~- 172 (304)
T cd05096 96 MITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN--FVHRDLATRNCLVG- 172 (304)
T ss_pred EEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC--ccccCcchhheEEc-
Confidence 5899999999999987532 3677889999999999999999999 99999999999998
Q ss_pred CCCcEEEecccchhhccCCC----CccccCCCCccCccccc-ccCCchhhHHHhHHHHHHHhh--cCCCCCCCCCHHHHH
Q 008504 62 NHGEVKIGDLGLAIAMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT--FEYPYSECKNPAQIF 134 (563)
Q Consensus 62 ~~G~VKL~DFGlA~~~~~~~----~~~~~Gtp~Y~APEvl~-~~ys~ksDIwSLGviLyELlT--G~~Pf~~~~~~~~i~ 134 (563)
..+.+||+|||++....... .....+++.|+|||++. +.++.++|||||||++|+|++ +..||..... ....
T Consensus 173 ~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~-~~~~ 251 (304)
T cd05096 173 ENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTD-EQVI 251 (304)
T ss_pred CCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCcCCH-HHHH
Confidence 55799999999987553322 12234577899999875 458999999999999999987 5678876433 3332
Q ss_pred HHHhc----C--CCCCccccCCChhHHHHHHHhcC-CCCCCCCHHHHHc
Q 008504 135 KKVTS----G--IKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 135 ~~i~~----~--~~p~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLk 176 (563)
..+.. . ......+...+..+.+||.+||. +|.+|||+.++.+
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~ 300 (304)
T cd05096 252 ENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA 300 (304)
T ss_pred HHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence 22211 1 11111233456789999999997 8999999999953
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.1e-27 Score=233.45 Aligned_cols=176 Identities=30% Similarity=0.503 Sum_probs=138.7
Q ss_pred CEeccCCCCCHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhc
Q 008504 1 MITELFTSGNLRQYRKKH---KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM 77 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~---~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~ 77 (563)
|||||+.+ +|.+++... ..+++..+..++.||+.||.|||+.| ++||||||+||+++ +.+.++|+|||++...
T Consensus 75 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~h~dl~p~ni~~~-~~~~~~l~d~g~~~~~ 150 (284)
T cd07836 75 LVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR--VLHRDLKPQNLLIN-KRGELKLADFGLARAF 150 (284)
T ss_pred EEEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEC-CCCcEEEeecchhhhh
Confidence 68999985 899988764 35899999999999999999999999 99999999999998 5579999999998655
Q ss_pred cCC--CCccccCCCCccCcccccc--cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCC----------
Q 008504 78 QQP--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP---------- 143 (563)
Q Consensus 78 ~~~--~~~~~~Gtp~Y~APEvl~~--~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p---------- 143 (563)
... ......+++.|++||++.+ .++.++||||||+++|+|++|+.||..................+
T Consensus 151 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07836 151 GIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQ 230 (284)
T ss_pred cCCccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhc
Confidence 332 1223457889999998754 37889999999999999999999998754443322221110000
Q ss_pred -----C-----------ccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCccc
Q 008504 144 -----A-----------SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 180 (563)
Q Consensus 144 -----~-----------~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff 180 (563)
. ......++.++++|.+||+ +|.+||++.++++||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 231 LPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred CchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 0 0112346788999999997 89999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=229.22 Aligned_cols=171 Identities=22% Similarity=0.395 Sum_probs=137.3
Q ss_pred CEeccCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~-~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
|||||+.+|+|.+++.+. ..+++..++.++.|++.||.|||++| |+||||||+|||++ .++.+||+|||++.....
T Consensus 70 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~-~~~~~kl~dfg~~~~~~~ 146 (252)
T cd05084 70 IVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH--CIHRDLAARNCLVT-EKNVLKISDFGMSREEED 146 (252)
T ss_pred EEEeeccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEEc-CCCcEEECccccCccccc
Confidence 589999999999999764 45899999999999999999999999 99999999999997 557999999999865433
Q ss_pred CCCcc----ccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCCCCccccCCChh
Q 008504 80 PTARS----VIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQ 153 (563)
Q Consensus 80 ~~~~~----~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~ 153 (563)
..... ...+..|+|||.+.+ .++.++||||||+++|+|++ |..||... ........+...... ..+...+..
T Consensus 147 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~ 224 (252)
T cd05084 147 GVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANL-SNQQTREAIEQGVRL-PCPELCPDA 224 (252)
T ss_pred ccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccc-CHHHHHHHHHcCCCC-CCcccCCHH
Confidence 21111 122456999998764 58899999999999999998 88888753 344444444443332 345566789
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHHc
Q 008504 154 IKGFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 154 l~~LI~kcL~-dP~kRpSa~ELLk 176 (563)
+.+|+.+||. +|.+|||+.++++
T Consensus 225 ~~~li~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 225 VYRLMERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHH
Confidence 9999999997 8999999999975
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=230.49 Aligned_cols=171 Identities=25% Similarity=0.426 Sum_probs=139.5
Q ss_pred CEeccCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhcc
Q 008504 1 MITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~--~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~ 78 (563)
+||||+++|+|.+++... ..+++..++.++.||+.||+|||+++ ++||||||+||+++ ..+.+||+|||++....
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nili~-~~~~~~l~dfg~~~~~~ 154 (261)
T cd05072 78 IITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN--YIHRDLRAANVLVS-ESLMCKIADFGLARVIE 154 (261)
T ss_pred EEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEec-CCCcEEECCCccceecC
Confidence 589999999999999753 56899999999999999999999999 99999999999998 56799999999997654
Q ss_pred CCC---CccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCCCCccccCCChh
Q 008504 79 QPT---ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQ 153 (563)
Q Consensus 79 ~~~---~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~ 153 (563)
... .....++..|+|||.+.. .++.++|||||||++|+|+| |..||.. .........+..+.... .....+..
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~ 232 (261)
T cd05072 155 DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPG-MSNSDVMSALQRGYRMP-RMENCPDE 232 (261)
T ss_pred CCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCC-CCHHHHHHHHHcCCCCC-CCCCCCHH
Confidence 322 112245668999998764 48889999999999999998 8999976 34445555555544332 23456789
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHHc
Q 008504 154 IKGFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 154 l~~LI~kcL~-dP~kRpSa~ELLk 176 (563)
+.++|.+||. +|.+||+++++++
T Consensus 233 ~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 233 LYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred HHHHHHHHccCCcccCcCHHHHHH
Confidence 9999999997 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-26 Score=229.48 Aligned_cols=172 Identities=22% Similarity=0.378 Sum_probs=138.0
Q ss_pred CEeccCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~-~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
+||||+.+|+|.+++.+. ..+++..+..++.||+.||.|||+.+ ++||||||+|||++ +.+.+||+|||++.....
T Consensus 74 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlk~~nili~-~~~~~kl~dfg~~~~~~~ 150 (262)
T cd05058 74 VVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK--FVHRDLAARNCMLD-ESFTVKVADFGLARDIYD 150 (262)
T ss_pred EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEc-CCCcEEECCccccccccC
Confidence 589999999999999764 45788889999999999999999999 99999999999998 557999999999865432
Q ss_pred CC------CccccCCCCccCccccc-ccCCchhhHHHhHHHHHHHhhcC-CCCCCCCCHHHHHHHHhcCCCCCccccCCC
Q 008504 80 PT------ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFE-YPYSECKNPAQIFKKVTSGIKPASLAKVND 151 (563)
Q Consensus 80 ~~------~~~~~Gtp~Y~APEvl~-~~ys~ksDIwSLGviLyELlTG~-~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s 151 (563)
.. .....+++.|+|||.+. ..++.++|||||||++|+|++|. .||.. .+...+...+..+..+. .+...+
T Consensus 151 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~-~~~~~~~~~~~~~~~~~-~~~~~~ 228 (262)
T cd05058 151 KEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD-VDSFDITVYLLQGRRLL-QPEYCP 228 (262)
T ss_pred CcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHhcCCCCC-CCCcCC
Confidence 11 11234567899999875 45889999999999999999964 55554 45555565555554332 344557
Q ss_pred hhHHHHHHHhcC-CCCCCCCHHHHHcC
Q 008504 152 PQIKGFIEKCLV-PASERLSAKDLLKD 177 (563)
Q Consensus 152 ~~l~~LI~kcL~-dP~kRpSa~ELLkH 177 (563)
+.+.+++.+||. +|.+||++.++++.
T Consensus 229 ~~~~~li~~cl~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 229 DPLYEVMLSCWHPKPEMRPTFSELVSR 255 (262)
T ss_pred HHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 889999999997 89999999999863
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-26 Score=232.27 Aligned_cols=171 Identities=25% Similarity=0.439 Sum_probs=140.2
Q ss_pred CEeccCCCCCHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEec
Q 008504 1 MITELFTSGNLRQYRKKH----------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGD 70 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~----------~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~D 70 (563)
+||||+++|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++ ..+.+||+|
T Consensus 86 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~di~p~nill~-~~~~~kl~d 162 (277)
T cd05032 86 VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK--FVHRDLAARNCMVA-EDLTVKIGD 162 (277)
T ss_pred EEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccChheEEEc-CCCCEEECC
Confidence 589999999999999753 23678899999999999999999999 99999999999998 558999999
Q ss_pred ccchhhccCCC----CccccCCCCccCccccc-ccCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCCCC
Q 008504 71 LGLAIAMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPA 144 (563)
Q Consensus 71 FGlA~~~~~~~----~~~~~Gtp~Y~APEvl~-~~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~p~ 144 (563)
||+++...... .....++..|+|||.+. +.++.++|||||||++|+|++ |..||.. .......+.+..+..+
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~-~~~~~~~~~~~~~~~~- 240 (277)
T cd05032 163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQG-LSNEEVLKFVIDGGHL- 240 (277)
T ss_pred cccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCcc-CCHHHHHHHHhcCCCC-
Confidence 99987554321 12334678899999875 458899999999999999998 8999976 4455566666544332
Q ss_pred ccccCCChhHHHHHHHhcC-CCCCCCCHHHHHc
Q 008504 145 SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 145 ~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLk 176 (563)
..+...+..+.++|.+||. +|.+|||+.+++.
T Consensus 241 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 241 DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 3445568899999999998 8999999999985
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-26 Score=231.10 Aligned_cols=172 Identities=20% Similarity=0.354 Sum_probs=140.2
Q ss_pred CEeccCCCCCHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccch
Q 008504 1 MITELFTSGNLRQYRKKH------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA 74 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~------~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA 74 (563)
+|+||+++|+|..++... ..+++..++.++.|++.||.|||+++ |+||||||+||+++ +++.+||+|||++
T Consensus 84 ~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~--i~H~dlkp~Nil~~-~~~~~kl~dfg~~ 160 (273)
T cd05035 84 VILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN--FIHRDLAARNCMLR-EDMTVCVADFGLS 160 (273)
T ss_pred EEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccchheEEEC-CCCeEEECCccce
Confidence 578999999999998542 35899999999999999999999999 99999999999998 5579999999998
Q ss_pred hhccCCCC----ccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCCCCcccc
Q 008504 75 IAMQQPTA----RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAK 148 (563)
Q Consensus 75 ~~~~~~~~----~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~ 148 (563)
+....... ....++..|+|||.+.. .++.++|||||||++|||++ |..||... ....+...+..+..+ ..+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~ 238 (273)
T cd05035 161 KKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGV-ENHEIYDYLRHGNRL-KQPE 238 (273)
T ss_pred eeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHcCCCC-CCCc
Confidence 75533211 11234568999998764 48899999999999999999 88898763 445555666555433 3455
Q ss_pred CCChhHHHHHHHhcC-CCCCCCCHHHHHcC
Q 008504 149 VNDPQIKGFIEKCLV-PASERLSAKDLLKD 177 (563)
Q Consensus 149 ~~s~~l~~LI~kcL~-dP~kRpSa~ELLkH 177 (563)
..++.+.++|.+||. +|.+||++.+++++
T Consensus 239 ~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 239 DCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 677899999999998 89999999999874
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=231.30 Aligned_cols=171 Identities=19% Similarity=0.413 Sum_probs=140.5
Q ss_pred CEeccCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k-~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
+||||+++|+|.+++.. ...+++..++.++.||+.||.|||++| ++||||||+||+++ ..+.+||+|||++.....
T Consensus 71 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~-~~~~~kl~dfg~~~~~~~ 147 (257)
T cd05115 71 LVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN--FVHRDLAARNVLLV-NQHYAKISDFGLSKALGA 147 (257)
T ss_pred EEEEeCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcC--eeecccchheEEEc-CCCcEEeccCCccccccC
Confidence 58999999999999975 457999999999999999999999999 99999999999997 557999999999865433
Q ss_pred CCC-----ccccCCCCccCccccc-ccCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCCCCccccCCCh
Q 008504 80 PTA-----RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDP 152 (563)
Q Consensus 80 ~~~-----~~~~Gtp~Y~APEvl~-~~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~ 152 (563)
... ....+++.|+|||.+. +.++.++|||||||++|+|++ |..||... ........+..+..+ ..+...++
T Consensus 148 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~ 225 (257)
T cd05115 148 DDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKM-KGPEVMSFIEQGKRL-DCPAECPP 225 (257)
T ss_pred CccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcC-CHHHHHHHHHCCCCC-CCCCCCCH
Confidence 211 1112356899999876 458899999999999999996 99999874 445555666665443 34556788
Q ss_pred hHHHHHHHhcC-CCCCCCCHHHHHc
Q 008504 153 QIKGFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 153 ~l~~LI~kcL~-dP~kRpSa~ELLk 176 (563)
++.++|.+||. +|.+||++.++++
T Consensus 226 ~l~~li~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 226 EMYALMKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHH
Confidence 99999999998 8999999999865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.8e-27 Score=230.73 Aligned_cols=172 Identities=30% Similarity=0.531 Sum_probs=143.2
Q ss_pred CEeccCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhcc
Q 008504 1 MITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~--~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~ 78 (563)
+||||+++|+|.+++... ..+++..++.|+.||+.||.|||++| |+|+||||+||+++ ..+.++|+|||++....
T Consensus 75 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dl~p~nili~-~~~~~~l~dfg~~~~~~ 151 (255)
T cd08219 75 IVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR--VLHRDIKSKNIFLT-QNGKVKLGDFGSARLLT 151 (255)
T ss_pred EEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEEC-CCCcEEEcccCcceeec
Confidence 589999999999998753 45899999999999999999999999 99999999999997 55799999999986554
Q ss_pred CC--CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHH
Q 008504 79 QP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIK 155 (563)
Q Consensus 79 ~~--~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~ 155 (563)
.. ......|++.|+|||++.+ .++.++|+||||+++|+|++|..||.. .+.......+..+... ..+...+..++
T Consensus 152 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 229 (255)
T cd08219 152 SPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQA-NSWKNLILKVCQGSYK-PLPSHYSYELR 229 (255)
T ss_pred ccccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCC-CCHHHHHHHHhcCCCC-CCCcccCHHHH
Confidence 32 2234578899999998865 488999999999999999999999986 4445555555554433 24455678899
Q ss_pred HHHHHhcC-CCCCCCCHHHHHcC
Q 008504 156 GFIEKCLV-PASERLSAKDLLKD 177 (563)
Q Consensus 156 ~LI~kcL~-dP~kRpSa~ELLkH 177 (563)
+||.+||. +|.+||++.+++.-
T Consensus 230 ~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 230 SLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred HHHHHHHhCCcccCCCHHHHhhc
Confidence 99999997 89999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.8e-27 Score=242.55 Aligned_cols=178 Identities=31% Similarity=0.458 Sum_probs=142.3
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
+|+||+ +++|.+++.. .++++..++.++.||+.||.|||+.| |+||||||+||+++ +.|.+||+|||++......
T Consensus 97 lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nill~-~~~~~kL~dfg~~~~~~~~ 171 (343)
T cd07851 97 LVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAG--IIHRDLKPSNIAVN-EDCELKILDFGLARHTDDE 171 (343)
T ss_pred EEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEC-CCCCEEEcccccccccccc
Confidence 588998 6799999876 56999999999999999999999999 99999999999998 5689999999999765432
Q ss_pred CCccccCCCCccCcccccc--cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCC--C-------------
Q 008504 81 TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK--P------------- 143 (563)
Q Consensus 81 ~~~~~~Gtp~Y~APEvl~~--~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~--p------------- 143 (563)
.....+++.|+|||.+.+ .++.++|||||||++|+|++|+.||..... ...+..+..... +
T Consensus 172 -~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 249 (343)
T cd07851 172 -MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDH-IDQLKRIMNLVGTPDEELLQKISSESAR 249 (343)
T ss_pred -ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHhcCCCCHHHHhhccchhHH
Confidence 334567889999998754 478899999999999999999999976433 332332221110 0
Q ss_pred -----------C---ccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCcccccccc
Q 008504 144 -----------A---SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQ 185 (563)
Q Consensus 144 -----------~---~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~~ 185 (563)
. ......++.+.+||.+||. +|.+|||+.++++||||+....
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~ 306 (343)
T cd07851 250 NYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHD 306 (343)
T ss_pred HHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCC
Confidence 0 0112247789999999997 8999999999999999986543
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.1e-27 Score=243.07 Aligned_cols=178 Identities=26% Similarity=0.425 Sum_probs=138.9
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
+||||+. ++|.+++.. +.+++..++.++.||+.||.|||++| |+||||||+||+++..++.+||+|||++......
T Consensus 93 lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~g--ivH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~ 168 (342)
T cd07854 93 IVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPH 168 (342)
T ss_pred EEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEcCCCceEEECCcccceecCCc
Confidence 5899997 599998865 46999999999999999999999999 9999999999999866678999999998654321
Q ss_pred C-----CccccCCCCccCcccccc--cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcC-------------
Q 008504 81 T-----ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG------------- 140 (563)
Q Consensus 81 ~-----~~~~~Gtp~Y~APEvl~~--~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~------------- 140 (563)
. .....++..|+|||++.+ .++.++|||||||++|+|++|+.||............+...
T Consensus 169 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (342)
T cd07854 169 YSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLN 248 (342)
T ss_pred cccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhh
Confidence 1 122357889999997643 47889999999999999999999997643322222111110
Q ss_pred ----------CCC----CccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCccccc
Q 008504 141 ----------IKP----ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQV 182 (563)
Q Consensus 141 ----------~~p----~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~ 182 (563)
..+ .......+.++++||.+||. +|.+|||+.++|.||||+.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~ 305 (342)
T cd07854 249 VIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSC 305 (342)
T ss_pred hhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccc
Confidence 000 00112356789999999998 8999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.8e-27 Score=261.29 Aligned_cols=181 Identities=25% Similarity=0.357 Sum_probs=133.2
Q ss_pred CEeccCCCCCHHHHHHhCCC--------------------CCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEe
Q 008504 1 MITELFTSGNLRQYRKKHKN--------------------VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 60 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~--------------------Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd 60 (563)
||+||+.+|+|.+++..... .....+..++.||+.||.|||+++ |+||||||+|||++
T Consensus 212 LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g--IiHRDLKP~NILl~ 289 (566)
T PLN03225 212 LVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG--IVHRDVKPQNIIFS 289 (566)
T ss_pred EEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC--EEeCcCCHHHEEEe
Confidence 58999999999999875321 123457789999999999999999 99999999999998
Q ss_pred CCCCcEEEecccchhhccCC---CCccccCCCCccCcccccc-----------------------cCCchhhHHHhHHHH
Q 008504 61 GNHGEVKIGDLGLAIAMQQP---TARSVIGTPEFMAPELYEE-----------------------EYNELVDIYSFGMCI 114 (563)
Q Consensus 61 ~~~G~VKL~DFGlA~~~~~~---~~~~~~Gtp~Y~APEvl~~-----------------------~ys~ksDIwSLGviL 114 (563)
.+.+.+||+|||+++.+... ......+++.|+|||.+.. .++.++|||||||++
T Consensus 290 ~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL 369 (566)
T PLN03225 290 EGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIF 369 (566)
T ss_pred CCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHHHH
Confidence 66679999999999755322 2345678999999996521 234567999999999
Q ss_pred HHHhhcCCCCCCCCCHHHHHHHHhcCC-------------CCC------ccccCCChhHHHHHHHhcC-CCCCCCCHHHH
Q 008504 115 LEMVTFEYPYSECKNPAQIFKKVTSGI-------------KPA------SLAKVNDPQIKGFIEKCLV-PASERLSAKDL 174 (563)
Q Consensus 115 yELlTG~~Pf~~~~~~~~i~~~i~~~~-------------~p~------~l~~~~s~~l~~LI~kcL~-dP~kRpSa~EL 174 (563)
|||+++..|+.. ........+.... ... ..........++||.+||. ||.+|||+.++
T Consensus 370 ~el~~~~~~~~~--~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e~ 447 (566)
T PLN03225 370 LQMAFPNLRSDS--NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKAA 447 (566)
T ss_pred HHHHhCcCCCch--HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCCHHHH
Confidence 999998766543 2222222221110 000 0011123345689999997 89999999999
Q ss_pred HcCcccccccc
Q 008504 175 LKDPFLQVENQ 185 (563)
Q Consensus 175 LkHpff~~~~~ 185 (563)
|+||||+....
T Consensus 448 L~Hpff~~~~~ 458 (566)
T PLN03225 448 LAHPYFDREGL 458 (566)
T ss_pred hCCcCcCCCCc
Confidence 99999987554
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.94 E-value=7e-27 Score=242.82 Aligned_cols=178 Identities=28% Similarity=0.437 Sum_probs=141.4
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
||+||+. ++|.+++.+.+.+++..++.++.||+.||.|||+++ ++||||||+||+++ ..+.+||+|||++......
T Consensus 86 lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dlkp~Nil~~-~~~~~kL~Dfg~~~~~~~~ 161 (337)
T cd07858 86 IVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSAN--VLHRDLKPSNLLLN-ANCDLKICDFGLARTTSEK 161 (337)
T ss_pred EEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEc-CCCCEEECcCccccccCCC
Confidence 5899995 699999998888999999999999999999999999 99999999999997 4579999999999765432
Q ss_pred --CCccccCCCCccCccccc--ccCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhc-----------------
Q 008504 81 --TARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS----------------- 139 (563)
Q Consensus 81 --~~~~~~Gtp~Y~APEvl~--~~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~----------------- 139 (563)
......++..|+|||.+. ..++.++|||||||++|+|++|+.||....... ....+..
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd07858 162 GDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVH-QLKLITELLGSPSEEDLGFIRNEK 240 (337)
T ss_pred cccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHH-HHHHHHHHhCCCChHHhhhcCchh
Confidence 223446788999999875 348899999999999999999999997532211 1111100
Q ss_pred ------C----CCC--CccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCcccccc
Q 008504 140 ------G----IKP--ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 183 (563)
Q Consensus 140 ------~----~~p--~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~ 183 (563)
. ..+ .......++.+++||.+||. +|.+|||+.++++||||...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 241 ARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred hhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 0 000 01122457789999999998 89999999999999999754
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-26 Score=232.19 Aligned_cols=176 Identities=29% Similarity=0.491 Sum_probs=140.0
Q ss_pred CEeccCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k-~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
+|+||+.+ +|.+++.. ...+++..++.++.||+.||.|||+++ |+|+||+|+||+++ ..+.+||+|||.+.....
T Consensus 75 ~v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~-~~~~~~l~df~~~~~~~~ 150 (283)
T cd05118 75 LVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG--ILHRDLKPENLLIN-TEGVLKLADFGLARSFGS 150 (283)
T ss_pred EEEeccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCC--eeecCcCHHHEEEC-CCCcEEEeeeeeeEecCC
Confidence 58999975 88888876 457999999999999999999999999 99999999999998 457999999999866544
Q ss_pred CC--CccccCCCCccCcccccc--cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCC------------
Q 008504 80 PT--ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP------------ 143 (563)
Q Consensus 80 ~~--~~~~~Gtp~Y~APEvl~~--~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p------------ 143 (563)
.. .....++..|+|||.+.+ .++.++|+||||+++|+|+||+.||..................+
T Consensus 151 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd05118 151 PVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLA 230 (283)
T ss_pred CcccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhh
Confidence 32 223467889999998753 47899999999999999999999997754433332222111000
Q ss_pred ---------------CccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCccc
Q 008504 144 ---------------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 180 (563)
Q Consensus 144 ---------------~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff 180 (563)
.......+..+++||.+||. +|.+||++.+++.||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 231 RNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 00112346789999999997 89999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.5e-27 Score=241.89 Aligned_cols=182 Identities=24% Similarity=0.414 Sum_probs=139.8
Q ss_pred CEeccCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhcc
Q 008504 1 MITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~--~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~ 78 (563)
+|+||+.+|+|.+++.+. ..+++..++.++.||+.||+|||++| |+||||||+||+++ ..+.++++||+.+....
T Consensus 76 ~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivHrDlkp~Nill~-~~~~~~~~~~~~~~~~~ 152 (328)
T cd08226 76 VISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG--YIHRNIKASHILIS-GDGLVSLSGLSHLYSLV 152 (328)
T ss_pred EEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEe-CCCcEEEechHHHhhhh
Confidence 589999999999999874 35899999999999999999999999 99999999999998 55799999998653321
Q ss_pred CCC---------CccccCCCCccCcccccc---cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCC----
Q 008504 79 QPT---------ARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK---- 142 (563)
Q Consensus 79 ~~~---------~~~~~Gtp~Y~APEvl~~---~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~---- 142 (563)
... .....++..|+|||++.+ .++.++|||||||++|+|++|..||............+.....
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 232 (328)
T cd08226 153 RNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLD 232 (328)
T ss_pred ccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCcc
Confidence 110 011234567999998864 3789999999999999999999999875444433332221100
Q ss_pred ----------------------------------------CCccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCcccc
Q 008504 143 ----------------------------------------PASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQ 181 (563)
Q Consensus 143 ----------------------------------------p~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~ 181 (563)
........++.+.+||.+||. +|.+|||+.++|+||||.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~ 312 (328)
T cd08226 233 ITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFK 312 (328)
T ss_pred ccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHH
Confidence 000112235678999999997 899999999999999997
Q ss_pred cccc
Q 008504 182 VENQ 185 (563)
Q Consensus 182 ~~~~ 185 (563)
....
T Consensus 313 ~~~~ 316 (328)
T cd08226 313 QVKE 316 (328)
T ss_pred HHHH
Confidence 5543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.2e-27 Score=235.95 Aligned_cols=172 Identities=27% Similarity=0.447 Sum_probs=140.8
Q ss_pred CEeccCCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCC
Q 008504 1 MITELFTSGNLRQYRKKH----------------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHG 64 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~----------------~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G 64 (563)
+||||+.+|+|..++..+ +.+++..++.++.||+.||.|||+++ |+||||||+|||++ +++
T Consensus 93 li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~Nil~~-~~~ 169 (293)
T cd05053 93 VVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK--CIHRDLAARNVLVT-EDH 169 (293)
T ss_pred EEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--ccccccceeeEEEc-CCC
Confidence 589999999999999642 45899999999999999999999999 99999999999997 568
Q ss_pred cEEEecccchhhccCCC----CccccCCCCccCccccc-ccCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHh
Q 008504 65 EVKIGDLGLAIAMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVT 138 (563)
Q Consensus 65 ~VKL~DFGlA~~~~~~~----~~~~~Gtp~Y~APEvl~-~~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~ 138 (563)
.+||+|||++....... .....++..|+|||.+. ..++.++|||||||++|+|++ |..||.. ....+....+.
T Consensus 170 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~-~~~~~~~~~~~ 248 (293)
T cd05053 170 VMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG-IPVEELFKLLK 248 (293)
T ss_pred eEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCC-CCHHHHHHHHH
Confidence 99999999997654321 11123456799999875 458999999999999999997 8999976 44555666665
Q ss_pred cCCCCCccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcC
Q 008504 139 SGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 177 (563)
Q Consensus 139 ~~~~p~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkH 177 (563)
.+..+. .+...+..+.+|+.+||. +|.+|||+.+++++
T Consensus 249 ~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 249 EGYRME-KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred cCCcCC-CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 554432 344567899999999997 89999999999975
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=233.73 Aligned_cols=171 Identities=25% Similarity=0.453 Sum_probs=139.2
Q ss_pred CEeccCCCCCHHHHHHhCC---------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCc
Q 008504 1 MITELFTSGNLRQYRKKHK---------------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGE 65 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~---------------~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~ 65 (563)
+||||+.+|+|.+++..++ .+++..++.++.||+.||+|||++| ++||||||+|||++ +.+.
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~nil~~-~~~~ 160 (280)
T cd05092 84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH--FVHRDLATRNCLVG-QGLV 160 (280)
T ss_pred EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC--eecccccHhhEEEc-CCCC
Confidence 5899999999999998653 4889999999999999999999999 99999999999998 5679
Q ss_pred EEEecccchhhccCCC----CccccCCCCccCccccc-ccCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhc
Q 008504 66 VKIGDLGLAIAMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTS 139 (563)
Q Consensus 66 VKL~DFGlA~~~~~~~----~~~~~Gtp~Y~APEvl~-~~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~ 139 (563)
+||+|||++....... .....+++.|+|||.+. ..++.++|||||||++|+|++ |..||... ........+..
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~-~~~~~~~~~~~ 239 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQL-SNTEAIECITQ 239 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccC-CHHHHHHHHHc
Confidence 9999999986543221 11223467899999776 458999999999999999998 89999764 34444555555
Q ss_pred CCCCCccccCCChhHHHHHHHhcC-CCCCCCCHHHHHc
Q 008504 140 GIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 140 ~~~p~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLk 176 (563)
+..+ ..+...++.+++||.+||. +|.+||++.+++.
T Consensus 240 ~~~~-~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 240 GREL-ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred CccC-CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 5433 2345667899999999997 8999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-26 Score=229.14 Aligned_cols=171 Identities=25% Similarity=0.437 Sum_probs=139.7
Q ss_pred CEeccCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhcc
Q 008504 1 MITELFTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~--~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~ 78 (563)
+||||+.+|+|.+++.... .+++..+..++.|++.||.|||++| |+||||||+||+++ ..+.+||+|||++....
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~~l~dfg~~~~~~ 154 (261)
T cd05068 78 IVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN--YIHRDLAARNVLVG-ENNICKVADFGLARVIK 154 (261)
T ss_pred eeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCcceEEEc-CCCCEEECCcceEEEcc
Confidence 5899999999999998654 6999999999999999999999999 99999999999998 45799999999997655
Q ss_pred CCCCccccC---CCCccCcccccc-cCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCCCCccccCCChh
Q 008504 79 QPTARSVIG---TPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQ 153 (563)
Q Consensus 79 ~~~~~~~~G---tp~Y~APEvl~~-~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~ 153 (563)
........+ +..|+|||.+.+ .++.++||||||+++|+|++ |+.||... ........+...... ..+...+..
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~ 232 (261)
T cd05068 155 EDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGM-TNAEVLQQVDQGYRM-PCPPGCPKE 232 (261)
T ss_pred CCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHHcCCCC-CCCCcCCHH
Confidence 332222222 357999998764 58899999999999999999 99999763 445555555544332 234456789
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHHc
Q 008504 154 IKGFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 154 l~~LI~kcL~-dP~kRpSa~ELLk 176 (563)
+.+++.+||. +|.+||++.++++
T Consensus 233 ~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 233 LYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred HHHHHHHHhhcCcccCCCHHHHHH
Confidence 9999999997 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-26 Score=235.69 Aligned_cols=175 Identities=28% Similarity=0.429 Sum_probs=134.7
Q ss_pred CEeccCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k-~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
+||||+.+ +|..++.. ...+++..++.++.||++||.|||++| |+||||||+||+++ +++.+||+|||++.....
T Consensus 92 lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~--i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~ 167 (311)
T cd07866 92 MVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENH--ILHRDIKAANILID-NQGILKIADFGLARPYDG 167 (311)
T ss_pred EEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEC-CCCCEEECcCccchhccC
Confidence 57899875 67776654 457999999999999999999999999 99999999999998 558999999999865432
Q ss_pred CC-------------CccccCCCCccCcccccc--cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhc---CC
Q 008504 80 PT-------------ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS---GI 141 (563)
Q Consensus 80 ~~-------------~~~~~Gtp~Y~APEvl~~--~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~---~~ 141 (563)
.. .....+++.|+|||.+.+ .++.++|||||||++|+|++|+.||....... ....+.. ..
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~-~~~~~~~~~~~~ 246 (311)
T cd07866 168 PPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDID-QLHLIFKLCGTP 246 (311)
T ss_pred CCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCC
Confidence 21 112356888999998754 47899999999999999999999997643332 2222111 00
Q ss_pred CC----------------------Ccc---ccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCccc
Q 008504 142 KP----------------------ASL---AKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 180 (563)
Q Consensus 142 ~p----------------------~~l---~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff 180 (563)
.+ ... .....+.+.+||.+||. +|.+|||+.+++.||||
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 247 TEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred ChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 00 000 01223678899999997 89999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-26 Score=237.29 Aligned_cols=177 Identities=29% Similarity=0.537 Sum_probs=143.2
Q ss_pred CEeccCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k-~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
+||||+. |+|.+++.. ...+++..++.++.||+.||.|||++| ++||||+|+||+++ ..+.+||+|||++.....
T Consensus 98 lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dl~p~nili~-~~~~~kL~dfg~~~~~~~ 173 (313)
T cd06633 98 LVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLT-EPGQVKLADFGSASKSSP 173 (313)
T ss_pred EEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChhhEEEC-CCCCEEEeecCCCcccCC
Confidence 5899996 578777765 456999999999999999999999999 99999999999997 557999999998854322
Q ss_pred CCCccccCCCCccCccccc----ccCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHH
Q 008504 80 PTARSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIK 155 (563)
Q Consensus 80 ~~~~~~~Gtp~Y~APEvl~----~~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~ 155 (563)
.....|+..|+|||++. +.++.++|||||||++|+|++|..||.......... .+.....+.......+..++
T Consensus 174 --~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~ 250 (313)
T cd06633 174 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-HIAQNDSPTLQSNEWTDSFR 250 (313)
T ss_pred --CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH-HHHhcCCCCCCccccCHHHH
Confidence 23457889999999873 348889999999999999999999997744333333 33333333333445567899
Q ss_pred HHHHHhcC-CCCCCCCHHHHHcCccccccc
Q 008504 156 GFIEKCLV-PASERLSAKDLLKDPFLQVEN 184 (563)
Q Consensus 156 ~LI~kcL~-dP~kRpSa~ELLkHpff~~~~ 184 (563)
+||.+||. +|.+||++.+++.||||....
T Consensus 251 ~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~ 280 (313)
T cd06633 251 GFVDYCLQKIPQERPASAELLRHDFVRRDR 280 (313)
T ss_pred HHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 99999997 899999999999999998643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=237.19 Aligned_cols=172 Identities=28% Similarity=0.461 Sum_probs=140.4
Q ss_pred CEeccCCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCC
Q 008504 1 MITELFTSGNLRQYRKKHK----------------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHG 64 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~----------------~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G 64 (563)
+||||+.+|+|.+++..++ .+++..++.++.||+.||+|||++| ++||||||+||+++ .++
T Consensus 101 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~dlkp~Nill~-~~~ 177 (307)
T cd05098 101 VIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVT-EDN 177 (307)
T ss_pred EEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--cccccccHHheEEc-CCC
Confidence 5899999999999998642 4888999999999999999999999 99999999999998 457
Q ss_pred cEEEecccchhhccCCC----CccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHh
Q 008504 65 EVKIGDLGLAIAMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVT 138 (563)
Q Consensus 65 ~VKL~DFGlA~~~~~~~----~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~ 138 (563)
.+||+|||++....... .....+++.|+|||.+.+ .++.++|||||||++|+|++ |..||.. .........+.
T Consensus 178 ~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~-~~~~~~~~~~~ 256 (307)
T cd05098 178 VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG-VPVEELFKLLK 256 (307)
T ss_pred cEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCc-CCHHHHHHHHH
Confidence 99999999986553211 111234568999998764 48999999999999999998 7888865 45566666665
Q ss_pred cCCCCCccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcC
Q 008504 139 SGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 177 (563)
Q Consensus 139 ~~~~p~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkH 177 (563)
.+... ..+...+..+++||.+||. +|.+||++.+++++
T Consensus 257 ~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 257 EGHRM-DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred cCCCC-CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 55432 3455667899999999997 89999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-26 Score=236.23 Aligned_cols=172 Identities=23% Similarity=0.411 Sum_probs=140.7
Q ss_pred CEeccCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhcc
Q 008504 1 MITELFTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~--~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~ 78 (563)
+||||+.+|+|.+++.... .+++..+..++.||+.||.|||+++ |+|+||||+||+++ ..+.+||+|||++....
T Consensus 116 lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~-~~~~~~l~dfg~~~~~~ 192 (302)
T cd05055 116 VITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNVLLT-HGKIVKICDFGLARDIM 192 (302)
T ss_pred EEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eehhhhccceEEEc-CCCeEEECCCccccccc
Confidence 5899999999999997643 3899999999999999999999999 99999999999997 55799999999987554
Q ss_pred CCC----CccccCCCCccCccccc-ccCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCCCCccccCCCh
Q 008504 79 QPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDP 152 (563)
Q Consensus 79 ~~~----~~~~~Gtp~Y~APEvl~-~~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~ 152 (563)
... .....+++.|+|||.+. +.++.++|||||||++|+|++ |..||..........+.+..+..+ ..+...++
T Consensus 193 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 271 (302)
T cd05055 193 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRM-AQPEHAPA 271 (302)
T ss_pred CCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcC-CCCCCCCH
Confidence 321 11234567899999775 458999999999999999998 999998755444455555544333 33445678
Q ss_pred hHHHHHHHhcC-CCCCCCCHHHHHc
Q 008504 153 QIKGFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 153 ~l~~LI~kcL~-dP~kRpSa~ELLk 176 (563)
.+++|+.+||. +|.+|||+.++++
T Consensus 272 ~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 272 EIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred HHHHHHHHHcCCCchhCcCHHHHHH
Confidence 99999999997 8999999999986
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-26 Score=229.48 Aligned_cols=173 Identities=28% Similarity=0.473 Sum_probs=141.4
Q ss_pred CEeccCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhh
Q 008504 1 MITELFTSGNLRQYRKK----HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 76 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k----~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~ 76 (563)
+||||+.+++|.+++.. ...+++..++.++.||+.||.|||++| ++|+||||+||+++ .++.++|+|||++..
T Consensus 79 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~-~~~~~~l~dfg~~~~ 155 (267)
T cd08229 79 IVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFIT-ATGVVKLGDLGLGRF 155 (267)
T ss_pred EEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEc-CCCCEEECcchhhhc
Confidence 58999999999999874 356899999999999999999999999 99999999999998 457999999999876
Q ss_pred ccCCC--CccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCC-HHHHHHHHhcCCCCCccccCCCh
Q 008504 77 MQQPT--ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKN-PAQIFKKVTSGIKPASLAKVNDP 152 (563)
Q Consensus 77 ~~~~~--~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~-~~~i~~~i~~~~~p~~l~~~~s~ 152 (563)
..... .....+++.|+|||.+.+ .++.++|+||||+++|+|++|..||..... .....+.+.....+.......++
T Consensus 156 ~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (267)
T cd08229 156 FSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSE 235 (267)
T ss_pred cccCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccH
Confidence 54322 234568899999998854 488899999999999999999999975332 23444444444444444456778
Q ss_pred hHHHHHHHhcC-CCCCCCCHHHHHc
Q 008504 153 QIKGFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 153 ~l~~LI~kcL~-dP~kRpSa~ELLk 176 (563)
.++++|.+||. +|.+|||+.++++
T Consensus 236 ~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 236 ELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred HHHHHHHHhcCCCcccCCCHHHHHH
Confidence 99999999997 8999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-26 Score=228.90 Aligned_cols=174 Identities=31% Similarity=0.551 Sum_probs=143.7
Q ss_pred CEeccCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhh
Q 008504 1 MITELFTSGNLRQYRKK----HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 76 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k----~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~ 76 (563)
+||||+++++|.+++.. ...+++..++.++.|++.||.|||++| ++|+||+|+||+++ + +.+||+|||++..
T Consensus 79 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~~l~~~nili~-~-~~~~l~d~g~~~~ 154 (260)
T cd08222 79 IITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR--ILHRDLKAKNIFLK-N-NLLKIGDFGVSRL 154 (260)
T ss_pred EEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC--ccccCCChhheEee-c-CCEeecccCceee
Confidence 58999999999998864 356999999999999999999999999 99999999999997 3 5799999999865
Q ss_pred ccCC--CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChh
Q 008504 77 MQQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQ 153 (563)
Q Consensus 77 ~~~~--~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~ 153 (563)
.... ......|++.|+|||.+.+ .++.++|+||||+++|+|++|..||... ........+..+..+ ..+...+..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~ 232 (260)
T cd08222 155 LMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQ-NFLSVVLRIVEGPTP-SLPETYSRQ 232 (260)
T ss_pred cCCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCc-cHHHHHHHHHcCCCC-CCcchhcHH
Confidence 5332 2234567889999998754 4788999999999999999999999763 334444444444333 345566789
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHHcCccc
Q 008504 154 IKGFIEKCLV-PASERLSAKDLLKDPFL 180 (563)
Q Consensus 154 l~~LI~kcL~-dP~kRpSa~ELLkHpff 180 (563)
+.++|.+||. +|.+||++.++++||||
T Consensus 233 ~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 233 LNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred HHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 9999999997 89999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=231.86 Aligned_cols=175 Identities=27% Similarity=0.418 Sum_probs=139.0
Q ss_pred CEeccCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~-~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
+||||+++ +|..++.+. ..+++..++.++.||+.||+|||++| ++|+||+|+||+++ +++.+||+|||++.....
T Consensus 77 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~--~~h~dl~p~nil~~-~~~~~~l~d~g~~~~~~~ 152 (287)
T cd07840 77 MVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG--ILHRDIKGSNILIN-NDGVLKLADFGLARPYTK 152 (287)
T ss_pred EEeccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEEc-CCCCEEEccccceeeccC
Confidence 58999974 899988765 57999999999999999999999999 99999999999998 568999999999876544
Q ss_pred CC---CccccCCCCccCcccccc--cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCC---CC--------
Q 008504 80 PT---ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI---KP-------- 143 (563)
Q Consensus 80 ~~---~~~~~Gtp~Y~APEvl~~--~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~---~p-------- 143 (563)
.. .....++..|+|||.+.+ .++.++||||||+++|+|++|+.||....... ....+.... .+
T Consensus 153 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07840 153 RNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELE-QLEKIFELCGSPTDENWPGVSK 231 (287)
T ss_pred CCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCchhhcccccc
Confidence 32 223456788999997653 47899999999999999999999997644332 222221110 00
Q ss_pred ------------------CccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCccc
Q 008504 144 ------------------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 180 (563)
Q Consensus 144 ------------------~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff 180 (563)
..+....++.+.++|.+||. +|.+||++.++++||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 232 LPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred chhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 00112236789999999997 89999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-26 Score=232.35 Aligned_cols=172 Identities=25% Similarity=0.390 Sum_probs=140.5
Q ss_pred CEeccCCCCCHHHHHHhC-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCC
Q 008504 1 MITELFTSGNLRQYRKKH-----------------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNH 63 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~-----------------~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~ 63 (563)
+||||+.+|+|.+++... ..+++..+..++.||+.||.|||++| |+||||||+||+++ +.
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~nili~-~~ 160 (283)
T cd05090 84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF--FVHKDLAARNILIG-EQ 160 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC--eehhccccceEEEc-CC
Confidence 589999999999998632 24788999999999999999999999 99999999999998 45
Q ss_pred CcEEEecccchhhccCCC----CccccCCCCccCccccc-ccCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHH
Q 008504 64 GEVKIGDLGLAIAMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKV 137 (563)
Q Consensus 64 G~VKL~DFGlA~~~~~~~----~~~~~Gtp~Y~APEvl~-~~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i 137 (563)
+.+||+|||++....... .....++..|+|||.+. +.++.++|||||||++|+|++ |..||.. .....+...+
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~-~~~~~~~~~~ 239 (283)
T cd05090 161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYG-FSNQEVIEMV 239 (283)
T ss_pred CcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHH
Confidence 799999999997553221 22334567899999876 458999999999999999998 8889976 3445555655
Q ss_pred hcCCCCCccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcC
Q 008504 138 TSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 177 (563)
Q Consensus 138 ~~~~~p~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkH 177 (563)
.....+ ..+...++.++++|.+||. +|.+||++.+++++
T Consensus 240 ~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 240 RKRQLL-PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred HcCCcC-CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 554433 3455678899999999998 89999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-26 Score=228.44 Aligned_cols=171 Identities=27% Similarity=0.454 Sum_probs=141.1
Q ss_pred CEeccCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhcc
Q 008504 1 MITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~--~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~ 78 (563)
+||||+++|+|.+++.+. ..+++..++.++.||+.||.|||++| |+||||||+||+++ +++.+||+|||++....
T Consensus 79 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~h~dl~~~nilv~-~~~~~kl~d~g~~~~~~ 155 (261)
T cd05148 79 IITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN--SIHRDLAARNILVG-EDLVCKVADFGLARLIK 155 (261)
T ss_pred EEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccCcceEEEc-CCceEEEccccchhhcC
Confidence 589999999999999863 46899999999999999999999999 99999999999998 55799999999997654
Q ss_pred CCC--CccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhH
Q 008504 79 QPT--ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQI 154 (563)
Q Consensus 79 ~~~--~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l 154 (563)
... .....+++.|+|||.+.. .++.++||||||+++|+|++ |+.||.. ......+..+..+..+ ..+...++.+
T Consensus 156 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~ 233 (261)
T cd05148 156 EDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPG-MNNHEVYDQITAGYRM-PCPAKCPQEI 233 (261)
T ss_pred CccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCc-CCHHHHHHHHHhCCcC-CCCCCCCHHH
Confidence 322 112345678999998754 58899999999999999998 8999976 3455565666554333 3345667899
Q ss_pred HHHHHHhcC-CCCCCCCHHHHHc
Q 008504 155 KGFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 155 ~~LI~kcL~-dP~kRpSa~ELLk 176 (563)
.++|.+||. +|.+|||+.++++
T Consensus 234 ~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 234 YKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred HHHHHHHcCCCchhCcCHHHHHH
Confidence 999999997 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-26 Score=229.34 Aligned_cols=169 Identities=21% Similarity=0.354 Sum_probs=133.8
Q ss_pred CEeccCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCC-------cEEEeccc
Q 008504 1 MITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHG-------EVKIGDLG 72 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~-~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G-------~VKL~DFG 72 (563)
+||||+.+|+|.+++..++ .+++..++.++.||+.||+|||++| |+||||||+||+++.+.. .++++|||
T Consensus 76 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g 153 (258)
T cd05078 76 MVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKG--LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG 153 (258)
T ss_pred EEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCccceEEEecccccccCCCceEEecccc
Confidence 6899999999999998654 5899999999999999999999999 999999999999974422 37999999
Q ss_pred chhhccCCCCccccCCCCccCcccccc--cCCchhhHHHhHHHHHHHhhcC-CCCCCCCCHHHHHHHHhcCCCCCccccC
Q 008504 73 LAIAMQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFE-YPYSECKNPAQIFKKVTSGIKPASLAKV 149 (563)
Q Consensus 73 lA~~~~~~~~~~~~Gtp~Y~APEvl~~--~ys~ksDIwSLGviLyELlTG~-~Pf~~~~~~~~i~~~i~~~~~p~~l~~~ 149 (563)
++..... .....+++.|+|||++.+ .++.++||||||+++|+|++|. .||.. ............ ...++..
T Consensus 154 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~-~~~~~~~~~~~~---~~~~~~~ 227 (258)
T cd05078 154 ISITVLP--KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSA-LDSQKKLQFYED---RHQLPAP 227 (258)
T ss_pred cccccCC--chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhh-ccHHHHHHHHHc---cccCCCC
Confidence 9865432 223467889999998864 4789999999999999999995 56654 333322222221 1123344
Q ss_pred CChhHHHHHHHhcC-CCCCCCCHHHHHcC
Q 008504 150 NDPQIKGFIEKCLV-PASERLSAKDLLKD 177 (563)
Q Consensus 150 ~s~~l~~LI~kcL~-dP~kRpSa~ELLkH 177 (563)
....+.+||.+||. +|.+|||+.++++.
T Consensus 228 ~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 228 KWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred CcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 55789999999998 89999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-26 Score=221.03 Aligned_cols=177 Identities=36% Similarity=0.603 Sum_probs=150.6
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
+|+||+.+++|..++...+.++...+..++.+++.+|.|||+.+ ++|+||+|+||+++. .+.++|+|||.+......
T Consensus 64 l~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~i~~~ni~~~~-~~~~~l~d~~~~~~~~~~ 140 (244)
T smart00220 64 LVMEYCDGGDLFDLLKKRGRLSEDEARFYARQILSALEYLHSNG--IIHRDLKPENILLDE-DGHVKLADFGLARQLDPG 140 (244)
T ss_pred EEEeCCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHcC--eecCCcCHHHeEECC-CCcEEEccccceeeeccc
Confidence 58999999999999988777999999999999999999999999 999999999999984 479999999999766543
Q ss_pred -CCccccCCCCccCccccc-ccCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccC-CChhHHHH
Q 008504 81 -TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKV-NDPQIKGF 157 (563)
Q Consensus 81 -~~~~~~Gtp~Y~APEvl~-~~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~-~s~~l~~L 157 (563)
......+++.|++||.+. ..++.++|||+||+++|+|++|..||........+...+..+......... .+..+.++
T Consensus 141 ~~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 220 (244)
T smart00220 141 GLLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDL 220 (244)
T ss_pred cccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHH
Confidence 334557888999999886 458889999999999999999999998755666666666655444322222 66789999
Q ss_pred HHHhcC-CCCCCCCHHHHHcCccc
Q 008504 158 IEKCLV-PASERLSAKDLLKDPFL 180 (563)
Q Consensus 158 I~kcL~-dP~kRpSa~ELLkHpff 180 (563)
+.+||. +|.+||++.++++||||
T Consensus 221 i~~~l~~~p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 221 IRKLLVKDPEKRLTAEEALQHPFF 244 (244)
T ss_pred HHHHccCCchhccCHHHHhhCCCC
Confidence 999997 89999999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-26 Score=227.87 Aligned_cols=173 Identities=30% Similarity=0.504 Sum_probs=141.2
Q ss_pred CEeccCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhh
Q 008504 1 MITELFTSGNLRQYRKK----HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 76 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k----~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~ 76 (563)
+||||+++|+|..++.. ...+++..++.|+.||+.||.|||++| |+||||+|+||+++ ..|.++|+|||++..
T Consensus 79 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~nil~~-~~~~~~l~d~~~~~~ 155 (267)
T cd08224 79 IVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR--IMHRDIKPANVFIT-ATGVVKLGDLGLGRF 155 (267)
T ss_pred EEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecCCcChhhEEEC-CCCcEEEeccceeee
Confidence 58999999999999864 245899999999999999999999999 99999999999998 457999999999865
Q ss_pred ccCC--CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCC-CHHHHHHHHhcCCCCCccccCCCh
Q 008504 77 MQQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECK-NPAQIFKKVTSGIKPASLAKVNDP 152 (563)
Q Consensus 77 ~~~~--~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~-~~~~i~~~i~~~~~p~~l~~~~s~ 152 (563)
.... ......+++.|+|||.+.+ .++.++|+|||||++|+|++|+.||.... ........+..+..+.......+.
T Consensus 156 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (267)
T cd08224 156 FSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSE 235 (267)
T ss_pred ccCCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCH
Confidence 5432 2233568889999998754 48899999999999999999999996532 333444555555444333335677
Q ss_pred hHHHHHHHhcC-CCCCCCCHHHHHc
Q 008504 153 QIKGFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 153 ~l~~LI~kcL~-dP~kRpSa~ELLk 176 (563)
.++++|.+||. +|.+|||+.++++
T Consensus 236 ~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 236 ELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred HHHHHHHHHcCCCcccCCCHHHHHH
Confidence 89999999997 8999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=240.63 Aligned_cols=178 Identities=27% Similarity=0.455 Sum_probs=137.7
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
+|+||+. ++|.+++.. +.+++..++.++.||+.||.|||++| |+||||||+||+++ ..+.+||+|||++......
T Consensus 85 lv~e~~~-~~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~--ivH~dlkp~Nill~-~~~~~kl~dfg~~~~~~~~ 159 (336)
T cd07849 85 IVQELME-TDLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLN-TNCDLKICDFGLARIADPE 159 (336)
T ss_pred EEehhcc-cCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEC-CCCCEEECcccceeecccc
Confidence 5789996 488888765 57999999999999999999999999 99999999999997 5679999999998654322
Q ss_pred C-----CccccCCCCccCccccc--ccCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhc--------------
Q 008504 81 T-----ARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS-------------- 139 (563)
Q Consensus 81 ~-----~~~~~Gtp~Y~APEvl~--~~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~-------------- 139 (563)
. .....|++.|+|||.+. ..++.++|||||||++|+|++|+.||........ ...+..
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 238 (336)
T cd07849 160 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQ-LNLILGVLGTPSQEDLNCII 238 (336)
T ss_pred ccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHcCCCCHHHHHHhh
Confidence 1 12346889999999764 3488999999999999999999999976322111 111100
Q ss_pred ---------CC-C--CC---ccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCccccccc
Q 008504 140 ---------GI-K--PA---SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 184 (563)
Q Consensus 140 ---------~~-~--p~---~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~ 184 (563)
.. . .. ......++.+.+||.+||. +|.+|||+.++++||||....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 239 SLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred chhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 00 0 00 0112246789999999997 899999999999999998543
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-26 Score=236.12 Aligned_cols=171 Identities=27% Similarity=0.447 Sum_probs=139.5
Q ss_pred CEeccCCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCC
Q 008504 1 MITELFTSGNLRQYRKKH----------------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHG 64 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~----------------~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G 64 (563)
+||||+.+|+|.+++... ..+++..+..++.||+.||.|||++| |+||||||+|||++ +++
T Consensus 95 lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~dlkp~Nill~-~~~ 171 (314)
T cd05099 95 VIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR--CIHRDLAARNVLVT-EDN 171 (314)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC--eeeccccceeEEEc-CCC
Confidence 589999999999999763 24889999999999999999999999 99999999999997 557
Q ss_pred cEEEecccchhhccCCC----CccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHh
Q 008504 65 EVKIGDLGLAIAMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVT 138 (563)
Q Consensus 65 ~VKL~DFGlA~~~~~~~----~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~ 138 (563)
.+||+|||+++...... .....+++.|+|||++.+ .++.++|||||||++|+|++ |..||.. ......+..+.
T Consensus 172 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~-~~~~~~~~~~~ 250 (314)
T cd05099 172 VMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPG-IPVEELFKLLR 250 (314)
T ss_pred cEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHH
Confidence 99999999997654321 111234467999998754 58899999999999999999 8889976 45566666665
Q ss_pred cCCCCCccccCCChhHHHHHHHhcC-CCCCCCCHHHHHc
Q 008504 139 SGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 139 ~~~~p~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLk 176 (563)
.+... ..+...+..++++|.+||. +|.+||++.++++
T Consensus 251 ~~~~~-~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 251 EGHRM-DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred cCCCC-CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 55432 2344557789999999997 8999999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=236.17 Aligned_cols=177 Identities=32% Similarity=0.497 Sum_probs=134.7
Q ss_pred CEeccCCCCCHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeC---CCCcEEEeccc
Q 008504 1 MITELFTSGNLRQYRKKH-----KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG---NHGEVKIGDLG 72 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~-----~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~---~~G~VKL~DFG 72 (563)
|||||+.+ +|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+||+++. ..|.+||+|||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW--VLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 58999975 777776532 36899999999999999999999999 999999999999974 15799999999
Q ss_pred chhhccCCC-----CccccCCCCccCcccccc--cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHH--------HHHHHH
Q 008504 73 LAIAMQQPT-----ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPA--------QIFKKV 137 (563)
Q Consensus 73 lA~~~~~~~-----~~~~~Gtp~Y~APEvl~~--~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~--------~i~~~i 137 (563)
++....... .....+++.|+|||++.+ .++.++|||||||++|+|++|+.||....... .....+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERI 237 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHH
Confidence 987654321 223467889999997754 47899999999999999999999997532211 000000
Q ss_pred hc------------------------CCCCCccc-----------cCCChhHHHHHHHhcC-CCCCCCCHHHHHcCccc
Q 008504 138 TS------------------------GIKPASLA-----------KVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 180 (563)
Q Consensus 138 ~~------------------------~~~p~~l~-----------~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff 180 (563)
.. .......+ ...+..+.++|.+||. +|.+|||+.++++||||
T Consensus 238 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 238 FEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 00 00000000 1455689999999998 89999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-26 Score=230.43 Aligned_cols=172 Identities=22% Similarity=0.418 Sum_probs=134.0
Q ss_pred CEeccCCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhh
Q 008504 1 MITELFTSGNLRQYRKKH----KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 76 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~----~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~ 76 (563)
+||||+++|+|.+++.+. ..+++..++.++.||+.||.|||+++ ++||||||+|||++ ..+.+||+|||++..
T Consensus 72 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nil~~-~~~~~~l~Dfg~~~~ 148 (268)
T cd05086 72 LVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN--FLHSDLALRNCFLT-SDLTVKVGDYGIGPS 148 (268)
T ss_pred EEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--eeccCCccceEEEc-CCccEEecccccccc
Confidence 589999999999999864 34677888999999999999999999 99999999999997 457999999999754
Q ss_pred ccCC----CCccccCCCCccCcccccc--------cCCchhhHHHhHHHHHHHhhc-CCCCCCCCCHHHHHHHHhcCC--
Q 008504 77 MQQP----TARSVIGTPEFMAPELYEE--------EYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSGI-- 141 (563)
Q Consensus 77 ~~~~----~~~~~~Gtp~Y~APEvl~~--------~ys~ksDIwSLGviLyELlTG-~~Pf~~~~~~~~i~~~i~~~~-- 141 (563)
.... ......+++.|+|||++.. .++.++|||||||++|+|+++ ..||..... ...+..+..+.
T Consensus 149 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-~~~~~~~~~~~~~ 227 (268)
T cd05086 149 RYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD-REVLNHVIKDQQV 227 (268)
T ss_pred cCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHHhhccc
Confidence 2211 1223467889999998742 257799999999999999974 678876443 33333332221
Q ss_pred --CCCccccCCChhHHHHHHHhcCCCCCCCCHHHHHc
Q 008504 142 --KPASLAKVNDPQIKGFIEKCLVPASERLSAKDLLK 176 (563)
Q Consensus 142 --~p~~l~~~~s~~l~~LI~kcL~dP~kRpSa~ELLk 176 (563)
....+....++.+.+++.+||.+|.+||++.++++
T Consensus 228 ~~~~~~~~~~~~~~~~~l~~~c~~~P~~Rp~~~~i~~ 264 (268)
T cd05086 228 KLFKPQLELPYSERWYEVLQFCWLSPEKRATAEEVHR 264 (268)
T ss_pred ccCCCccCCCCcHHHHHHHHHHhhCcccCCCHHHHHH
Confidence 12233445678899999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-26 Score=232.19 Aligned_cols=177 Identities=34% Similarity=0.570 Sum_probs=146.6
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
+||||+++|+|.+++.. ..+++..+..++.|++.||.|||++| ++|+||+|+||+++ +.+.++|+|||++......
T Consensus 79 lv~e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~Ni~i~-~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06641 79 IIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLS-EHGEVKLADFGVAGQLTDT 154 (277)
T ss_pred EEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCC--eecCCCCHHhEEEC-CCCCEEEeecccceecccc
Confidence 58999999999999875 46999999999999999999999999 99999999999997 5579999999998654332
Q ss_pred --CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHHH
Q 008504 81 --TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 157 (563)
Q Consensus 81 --~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~L 157 (563)
......++..|+|||.+.+ .++.++|+|||||++|+|++|..||... ........+..+. +..+....+..+.++
T Consensus 155 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 232 (277)
T cd06641 155 QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSEL-HPMKVLFLIPKNN-PPTLEGNYSKPLKEF 232 (277)
T ss_pred hhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCcc-chHHHHHHHhcCC-CCCCCcccCHHHHHH
Confidence 1223467889999998764 4788999999999999999999999763 3444444443332 333455667899999
Q ss_pred HHHhcC-CCCCCCCHHHHHcCcccccc
Q 008504 158 IEKCLV-PASERLSAKDLLKDPFLQVE 183 (563)
Q Consensus 158 I~kcL~-dP~kRpSa~ELLkHpff~~~ 183 (563)
|.+||. +|.+||++.++++||||...
T Consensus 233 i~~~l~~~p~~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 233 VEACLNKEPSFRPTAKELLKHKFIVRF 259 (277)
T ss_pred HHHHccCChhhCcCHHHHHhCHHHhhh
Confidence 999997 89999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.4e-27 Score=219.69 Aligned_cols=160 Identities=24% Similarity=0.339 Sum_probs=127.3
Q ss_pred CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCCCCccccC
Q 008504 9 GNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIG 87 (563)
Q Consensus 9 GsL~~~L~k~-~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~~~~~~~G 87 (563)
|+|.+++..+ +.+++..++.|+.||+.||.|||+++ ||+|||++ .++.+|+ ||++...... ...|
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~--------kp~Nil~~-~~~~~~~--fG~~~~~~~~---~~~g 66 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA--------KSGNILLT-WDGLLKL--DGSVAFKTPE---QSRV 66 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC--------CcccEeEc-Cccceee--ccceEeeccc---cCCC
Confidence 7999999874 45999999999999999999999998 99999997 5578999 9998665432 2268
Q ss_pred CCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCc-----cccCCCh--hHHHHHH
Q 008504 88 TPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPAS-----LAKVNDP--QIKGFIE 159 (563)
Q Consensus 88 tp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~-----l~~~~s~--~l~~LI~ 159 (563)
++.|||||++.+ .|+.++|||||||++|+|+||+.||............+.....+.. ....... .+++||.
T Consensus 67 ~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 146 (176)
T smart00750 67 DPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMR 146 (176)
T ss_pred cccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHH
Confidence 999999998864 5899999999999999999999999764443444444433322211 1111222 6999999
Q ss_pred HhcC-CCCCCCCHHHHHcCccccc
Q 008504 160 KCLV-PASERLSAKDLLKDPFLQV 182 (563)
Q Consensus 160 kcL~-dP~kRpSa~ELLkHpff~~ 182 (563)
+||. +|.+||++.++++|+|+..
T Consensus 147 ~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 147 VCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred HHHhcccccccCHHHHHHHHHHHH
Confidence 9997 8999999999999999864
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.7e-26 Score=226.99 Aligned_cols=170 Identities=24% Similarity=0.420 Sum_probs=141.1
Q ss_pred CEeccCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhcc
Q 008504 1 MITELFTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~--~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~ 78 (563)
+||||+++|+|.+++.... .+++..++.++.|++.||.|||++| ++||||||+||+++ .++.+||+|||.+....
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~Nili~-~~~~~~l~d~g~~~~~~ 153 (256)
T cd05039 77 IVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN--FVHRDLAARNVLVS-EDLVAKVSDFGLAKEAS 153 (256)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccchhcccceEEEe-CCCCEEEcccccccccc
Confidence 5899999999999998765 6999999999999999999999999 99999999999998 55799999999997664
Q ss_pred CCCCccccCCCCccCccccc-ccCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHH
Q 008504 79 QPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKG 156 (563)
Q Consensus 79 ~~~~~~~~Gtp~Y~APEvl~-~~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~ 156 (563)
.... ....+..|+|||.+. +.++.++||||||+++|+|++ |..||.. .....+...+..+..+ ..+...++.+.+
T Consensus 154 ~~~~-~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 230 (256)
T cd05039 154 QGQD-SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR-IPLKDVVPHVEKGYRM-EAPEGCPPEVYK 230 (256)
T ss_pred cccc-cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCC-CCHHHHHHHHhcCCCC-CCccCCCHHHHH
Confidence 3222 233456799999775 458889999999999999997 9999976 3455555555554333 334556789999
Q ss_pred HHHHhcC-CCCCCCCHHHHHc
Q 008504 157 FIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 157 LI~kcL~-dP~kRpSa~ELLk 176 (563)
+|.+||. +|.+||++.++++
T Consensus 231 li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 231 VMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred HHHHHhccChhhCcCHHHHHH
Confidence 9999997 8999999999986
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-26 Score=236.79 Aligned_cols=176 Identities=31% Similarity=0.526 Sum_probs=143.3
Q ss_pred CEeccCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k-~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
+||||+. |+|.+++.. ...+++..++.++.|++.||.|||+++ ++||||+|+||+++ ..+.+||+|||++.....
T Consensus 92 lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nil~~-~~~~~kl~dfg~~~~~~~ 167 (308)
T cd06634 92 LVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLS-EPGLVKLGDFGSASIMAP 167 (308)
T ss_pred EEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHhEEEC-CCCcEEECCcccceeecC
Confidence 5899996 588887754 456999999999999999999999999 99999999999997 457999999999865443
Q ss_pred CCCccccCCCCccCccccc----ccCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHH
Q 008504 80 PTARSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIK 155 (563)
Q Consensus 80 ~~~~~~~Gtp~Y~APEvl~----~~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~ 155 (563)
.....+++.|+|||.+. +.++.++|||||||++|+|++|..||.......... .+..+..+.......+..++
T Consensus 168 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 244 (308)
T cd06634 168 --ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-HIAQNESPALQSGHWSEYFR 244 (308)
T ss_pred --cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHH-HHhhcCCCCcCcccccHHHH
Confidence 23456889999999873 347889999999999999999999997643333333 33444444444456778899
Q ss_pred HHHHHhcC-CCCCCCCHHHHHcCcccccc
Q 008504 156 GFIEKCLV-PASERLSAKDLLKDPFLQVE 183 (563)
Q Consensus 156 ~LI~kcL~-dP~kRpSa~ELLkHpff~~~ 183 (563)
+||.+||. +|.+||++.++++|||+...
T Consensus 245 ~li~~cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 245 NFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred HHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence 99999997 89999999999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.7e-26 Score=233.96 Aligned_cols=172 Identities=28% Similarity=0.447 Sum_probs=141.0
Q ss_pred CEeccCCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCC
Q 008504 1 MITELFTSGNLRQYRKKH----------------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHG 64 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~----------------~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G 64 (563)
+||||+.+|+|.+++.+. ..++...+..++.||+.||.|||++| |+||||||+||+++ ..+
T Consensus 98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g--ivH~dlkp~Nili~-~~~ 174 (304)
T cd05101 98 VIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK--CIHRDLAARNVLVT-ENN 174 (304)
T ss_pred EEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC--eeecccccceEEEc-CCC
Confidence 589999999999999864 24778889999999999999999999 99999999999997 557
Q ss_pred cEEEecccchhhccCCC----CccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHh
Q 008504 65 EVKIGDLGLAIAMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVT 138 (563)
Q Consensus 65 ~VKL~DFGlA~~~~~~~----~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~ 138 (563)
.+||+|||++....... .....+++.|+|||++.+ .++.++||||||+++|+|++ |..||.. .....+...+.
T Consensus 175 ~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~-~~~~~~~~~~~ 253 (304)
T cd05101 175 VMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG-IPVEELFKLLK 253 (304)
T ss_pred cEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCccc-CCHHHHHHHHH
Confidence 99999999997654321 122345678999998764 58999999999999999998 7888876 45666666666
Q ss_pred cCCCCCccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcC
Q 008504 139 SGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 177 (563)
Q Consensus 139 ~~~~p~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkH 177 (563)
.+... ..+...+..+++||.+||. +|.+||++.++++.
T Consensus 254 ~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 254 EGHRM-DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred cCCcC-CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 55433 2345567899999999997 89999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-26 Score=230.51 Aligned_cols=176 Identities=31% Similarity=0.429 Sum_probs=137.7
Q ss_pred CEeccCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhcc
Q 008504 1 MITELFTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~--~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~ 78 (563)
+||||+.+ +|.+++...+ .+++..++.++.||+.||.|||+++ ++|+||+|+||+++.+ +.+||+|||++....
T Consensus 83 l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~--i~h~~l~~~nili~~~-~~~~l~dfg~~~~~~ 158 (287)
T cd07838 83 LVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR--IVHRDLKPQNILVTSD-GQVKIADFGLARIYS 158 (287)
T ss_pred EEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhEEEccC-CCEEEeccCcceecc
Confidence 58999974 8999987643 4999999999999999999999999 9999999999999855 899999999986654
Q ss_pred CC-CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCC--------------
Q 008504 79 QP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK-------------- 142 (563)
Q Consensus 79 ~~-~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~-------------- 142 (563)
.. ......+++.|+|||++.+ .++.++|+|||||++|+|++|..||..........+.......
T Consensus 159 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (287)
T cd07838 159 FEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPR 238 (287)
T ss_pred CCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccch
Confidence 32 2223457889999998864 4888999999999999999999998764433322222211000
Q ss_pred -------CC---ccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCccc
Q 008504 143 -------PA---SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 180 (563)
Q Consensus 143 -------p~---~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff 180 (563)
+. ......++.+.+||.+||. +|.+||++.+++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 239 SSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred hhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 00 0011234678899999997 89999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-26 Score=230.28 Aligned_cols=171 Identities=25% Similarity=0.389 Sum_probs=136.9
Q ss_pred CEeccCCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCC
Q 008504 1 MITELFTSGNLRQYRKKHK----------------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHG 64 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~----------------~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G 64 (563)
+||||+++|+|.+++.+.+ .+++..++.++.|++.||+|||++| ++||||||+||+++ ..+
T Consensus 73 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nili~-~~~ 149 (270)
T cd05047 73 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVG-ENY 149 (270)
T ss_pred EEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccccceEEEc-CCC
Confidence 5899999999999997643 4789999999999999999999999 99999999999998 457
Q ss_pred cEEEecccchhhccCCC-CccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCC
Q 008504 65 EVKIGDLGLAIAMQQPT-ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGI 141 (563)
Q Consensus 65 ~VKL~DFGlA~~~~~~~-~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~ 141 (563)
.+||+|||++....... ......++.|+|||++.. .++.++|||||||++|+|++ |..||.. ......+..+..+.
T Consensus 150 ~~kl~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~-~~~~~~~~~~~~~~ 228 (270)
T cd05047 150 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG-MTCAELYEKLPQGY 228 (270)
T ss_pred eEEECCCCCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccc-cCHHHHHHHHhCCC
Confidence 99999999985332111 111223567999998754 58899999999999999997 9999976 34445555555443
Q ss_pred CCCccccCCChhHHHHHHHhcC-CCCCCCCHHHHHc
Q 008504 142 KPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 142 ~p~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLk 176 (563)
.. ..+...+..+.+++.+||. +|.+|||+.+++.
T Consensus 229 ~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 229 RL-EKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred CC-CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 32 2344567889999999997 8999999999986
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.6e-26 Score=227.31 Aligned_cols=171 Identities=25% Similarity=0.413 Sum_probs=139.1
Q ss_pred CEeccCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhcc
Q 008504 1 MITELFTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~--~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~ 78 (563)
+||||+.+|+|.+++.... .+++..+..++.||+.||.|||+.| ++||||||+||+++ +.+.++|+|||++....
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dl~~~Nill~-~~~~~~l~dfg~~~~~~ 153 (260)
T cd05069 77 IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN--YIHRDLRAANILVG-DNLVCKIADFGLARLIE 153 (260)
T ss_pred EEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEc-CCCeEEECCCccceEcc
Confidence 5899999999999997643 4899999999999999999999999 99999999999997 55799999999996553
Q ss_pred CCCC---ccccCCCCccCccccc-ccCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCCCCccccCCChh
Q 008504 79 QPTA---RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQ 153 (563)
Q Consensus 79 ~~~~---~~~~Gtp~Y~APEvl~-~~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~ 153 (563)
.... ....++..|+|||... +.++.++||||||+++|+|+| |..||... ........+..+..+ ..+...+..
T Consensus 154 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~ 231 (260)
T cd05069 154 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM-VNREVLEQVERGYRM-PCPQGCPES 231 (260)
T ss_pred CCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHcCCCC-CCCcccCHH
Confidence 3221 1234567899999876 458899999999999999999 89999874 344455555544332 234456789
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHHc
Q 008504 154 IKGFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 154 l~~LI~kcL~-dP~kRpSa~ELLk 176 (563)
++++|.+||. +|.+||+++++++
T Consensus 232 ~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 232 LHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred HHHHHHHHccCCcccCcCHHHHHH
Confidence 9999999997 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-26 Score=238.55 Aligned_cols=179 Identities=28% Similarity=0.450 Sum_probs=139.8
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
+++||+. ++|.+++.....+++..++.++.||+.||.|||++| |+||||||+|||++ ..+.+||+|||++......
T Consensus 83 ~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivH~dlkp~Nili~-~~~~~kl~Dfg~a~~~~~~ 158 (332)
T cd07857 83 LYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSAN--VLHRDLKPGNLLVN-ADCELKICDFGLARGFSEN 158 (332)
T ss_pred EEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHeEEc-CCCCEEeCcCCCceecccc
Confidence 3677775 699999988888999999999999999999999999 99999999999998 4579999999999654321
Q ss_pred C------CccccCCCCccCcccccc--cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHh--------------
Q 008504 81 T------ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVT-------------- 138 (563)
Q Consensus 81 ~------~~~~~Gtp~Y~APEvl~~--~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~-------------- 138 (563)
. .....|++.|+|||.+.+ .++.++||||||+++|+|++|..||............+.
T Consensus 159 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (332)
T cd07857 159 PGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIG 238 (332)
T ss_pred cccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhh
Confidence 1 223478999999997754 488999999999999999999999976332211111000
Q ss_pred c-----------CCCCC---ccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCcccccc
Q 008504 139 S-----------GIKPA---SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 183 (563)
Q Consensus 139 ~-----------~~~p~---~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~ 183 (563)
. ..... ......+..+++||.+||. +|.+|||+.+++.||||+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~ 298 (332)
T cd07857 239 SPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIW 298 (332)
T ss_pred hhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhh
Confidence 0 00000 1112246789999999997 89999999999999999654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.1e-26 Score=237.45 Aligned_cols=179 Identities=26% Similarity=0.356 Sum_probs=141.6
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
|||||+. ++|..++... .+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++......
T Consensus 86 lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~--i~H~dl~p~nill~-~~~~~kl~d~g~~~~~~~~ 160 (337)
T cd07852 86 LVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGN--VIHRDLKPSNILLN-SDCRVKLADFGLARSLSEL 160 (337)
T ss_pred EEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEc-CCCcEEEeeccchhccccc
Confidence 5899997 5999999875 7899999999999999999999999 99999999999998 5689999999998755322
Q ss_pred -------CCccccCCCCccCcccccc--cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCC----------
Q 008504 81 -------TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI---------- 141 (563)
Q Consensus 81 -------~~~~~~Gtp~Y~APEvl~~--~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~---------- 141 (563)
......|++.|+|||.+.+ .++.++||||||+++|+|++|+.||..........+......
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd07852 161 EENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESI 240 (337)
T ss_pred cccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHH
Confidence 1223468899999997743 478899999999999999999999976443332222111100
Q ss_pred ------------------CCCccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCccccccc
Q 008504 142 ------------------KPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 184 (563)
Q Consensus 142 ------------------~p~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~ 184 (563)
.........+..+.+||.+||. +|.+|||+.++++||||+...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~ 302 (337)
T cd07852 241 KSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFH 302 (337)
T ss_pred HhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhc
Confidence 0011112257789999999997 899999999999999998653
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.9e-26 Score=228.37 Aligned_cols=172 Identities=24% Similarity=0.425 Sum_probs=140.6
Q ss_pred CEeccCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~-~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
+||||+++|+|.+++... +.+++..+..++.|++.||.|||+++ |+||||||+|||++ ..+.++|+|||++.....
T Consensus 82 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~di~p~nili~-~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 82 IITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN--YVHRDLAARNILVN-SNLVCKVSDFGLSRRLED 158 (266)
T ss_pred EEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEc-CCCCEEECccchhhcccc
Confidence 589999999999999764 46999999999999999999999999 99999999999998 457999999999976642
Q ss_pred C--C--CccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCCCCccccCCChh
Q 008504 80 P--T--ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQ 153 (563)
Q Consensus 80 ~--~--~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~ 153 (563)
. . .....+++.|+|||.+.+ .++.++||||||+++|+|++ |..||... ........+..+... ..+...++.
T Consensus 159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~ 236 (266)
T cd05033 159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDM-SNQDVIKAVEDGYRL-PPPMDCPSA 236 (266)
T ss_pred cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHHcCCCC-CCCCCCCHH
Confidence 1 1 112234578999998864 58899999999999999998 99999764 344555555554332 234456789
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHHcC
Q 008504 154 IKGFIEKCLV-PASERLSAKDLLKD 177 (563)
Q Consensus 154 l~~LI~kcL~-dP~kRpSa~ELLkH 177 (563)
+.+|+.+||. +|.+||++.+++++
T Consensus 237 l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 237 LYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred HHHHHHHHcCCCcccCcCHHHHHHH
Confidence 9999999997 89999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-26 Score=231.86 Aligned_cols=172 Identities=24% Similarity=0.360 Sum_probs=137.2
Q ss_pred CEeccCCCCCHHHHHHhCC-----------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEe
Q 008504 1 MITELFTSGNLRQYRKKHK-----------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIG 69 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~-----------~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~ 69 (563)
+||||+.+++|.+++.+.. .+++..++.++.|++.||.|||++| |+||||||+||+++ +.+.++|+
T Consensus 96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~--i~H~dlkp~Nili~-~~~~~~l~ 172 (296)
T cd05051 96 MIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN--FVHRDLATRNCLVG-KNYTIKIA 172 (296)
T ss_pred EEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC--ccccccchhceeec-CCCceEEc
Confidence 5899999999999998765 6999999999999999999999999 99999999999998 45799999
Q ss_pred cccchhhccCCC----CccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhh--cCCCCCCCCCHHHHHHHHhcC--
Q 008504 70 DLGLAIAMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT--FEYPYSECKNPAQIFKKVTSG-- 140 (563)
Q Consensus 70 DFGlA~~~~~~~----~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlT--G~~Pf~~~~~~~~i~~~i~~~-- 140 (563)
|||++....... .....+++.|+|||.+.+ .++.++|||||||++|+|++ +..||.... .......+...
T Consensus 173 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~-~~~~~~~~~~~~~ 251 (296)
T cd05051 173 DFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT-DQQVIENAGHFFR 251 (296)
T ss_pred cccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC-hHHHHHHHHhccc
Confidence 999986543221 223355778999998764 68999999999999999998 678887643 33333333322
Q ss_pred ----CCCCccccCCChhHHHHHHHhcC-CCCCCCCHHHHHc
Q 008504 141 ----IKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 141 ----~~p~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLk 176 (563)
......+...+.++.++|.+||. +|.+|||+.++++
T Consensus 252 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 252 DDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred cccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 11112233456799999999997 8999999999965
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.7e-26 Score=230.97 Aligned_cols=171 Identities=27% Similarity=0.443 Sum_probs=134.4
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
+||||+++|+|.+++... .+++..++.++.|++.||.|||++| |+||||||+|||++ .++.+||+|||++......
T Consensus 85 lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~--i~H~dlkp~Nili~-~~~~~~l~dfg~~~~~~~~ 160 (283)
T cd05080 85 LIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQH--YIHRDLAARNVLLD-NDRLVKIGDFGLAKAVPEG 160 (283)
T ss_pred EEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCC--eeccccChheEEEc-CCCcEEEeecccccccCCc
Confidence 589999999999999874 5999999999999999999999999 99999999999997 4579999999998765432
Q ss_pred CC-----ccccCCCCccCccccc-ccCCchhhHHHhHHHHHHHhhcCCCCCCCCCHH--------------HHHHHHhcC
Q 008504 81 TA-----RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPA--------------QIFKKVTSG 140 (563)
Q Consensus 81 ~~-----~~~~Gtp~Y~APEvl~-~~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~--------------~i~~~i~~~ 140 (563)
.. ....++..|+|||.+. ..++.++||||||+++|+|+||..||....... .....+..+
T Consensus 161 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (283)
T cd05080 161 HEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERG 240 (283)
T ss_pred chhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcC
Confidence 11 1224566799999876 458899999999999999999999986422111 011111111
Q ss_pred CCCCccccCCChhHHHHHHHhcC-CCCCCCCHHHHHc
Q 008504 141 IKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 141 ~~p~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLk 176 (563)
.. ...+...+..+++++.+||. +|++|||+.+++.
T Consensus 241 ~~-~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 241 MR-LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred CC-CCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 11 12244567899999999998 8999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-26 Score=236.73 Aligned_cols=173 Identities=24% Similarity=0.382 Sum_probs=138.0
Q ss_pred CEeccCCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCC
Q 008504 1 MITELFTSGNLRQYRKKHK----------------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHG 64 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~----------------~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G 64 (563)
+||||+++|+|.+++.+.+ .+++..++.++.||+.||+|||++| |+||||||+|||++ ..+
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dlkp~Nili~-~~~ 161 (303)
T cd05088 85 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVG-ENY 161 (303)
T ss_pred EEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEec-CCC
Confidence 5899999999999997543 5789999999999999999999999 99999999999998 457
Q ss_pred cEEEecccchhhccCCC-CccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCC
Q 008504 65 EVKIGDLGLAIAMQQPT-ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGI 141 (563)
Q Consensus 65 ~VKL~DFGlA~~~~~~~-~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~ 141 (563)
.+||+|||++....... .....++..|+|||.+.+ .++.++|||||||++|+|+| |..||.. .........+..+.
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~-~~~~~~~~~~~~~~ 240 (303)
T cd05088 162 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG-MTCAELYEKLPQGY 240 (303)
T ss_pred cEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCccc-CChHHHHHHHhcCC
Confidence 99999999985332111 111223567999998764 47899999999999999998 9999976 34445555554443
Q ss_pred CCCccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCc
Q 008504 142 KPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDP 178 (563)
Q Consensus 142 ~p~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHp 178 (563)
.+ ..+...++.+.+||.+||. +|.+||++.+++.+.
T Consensus 241 ~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l 277 (303)
T cd05088 241 RL-EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 277 (303)
T ss_pred cC-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 22 2333457889999999997 899999999999863
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.94 E-value=4e-26 Score=226.63 Aligned_cols=171 Identities=25% Similarity=0.417 Sum_probs=138.9
Q ss_pred CEeccCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhcc
Q 008504 1 MITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~--~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~ 78 (563)
+||||+++|+|.+++... ..+++..++.++.|++.||.|||+++ |+||||||+||+++ +++.++|+|||++....
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~Nili~-~~~~~~l~dfg~~~~~~ 153 (260)
T cd05070 77 IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN--YIHRDLRSANILVG-DGLVCKIADFGLARLIE 153 (260)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEEe-CCceEEeCCceeeeecc
Confidence 589999999999999763 45899999999999999999999999 99999999999998 55799999999996654
Q ss_pred CCCC---ccccCCCCccCccccc-ccCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCCCCccccCCChh
Q 008504 79 QPTA---RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQ 153 (563)
Q Consensus 79 ~~~~---~~~~Gtp~Y~APEvl~-~~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~ 153 (563)
.... ....++..|+|||.+. ..++.++||||||+++|+|++ |..||... +.......+..+..+ ..+...+..
T Consensus 154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~ 231 (260)
T cd05070 154 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM-NNREVLEQVERGYRM-PCPQDCPIS 231 (260)
T ss_pred CcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHHcCCCC-CCCCcCCHH
Confidence 3221 1223456799999875 458899999999999999999 88999763 344455555544332 334566789
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHHc
Q 008504 154 IKGFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 154 l~~LI~kcL~-dP~kRpSa~ELLk 176 (563)
+++|+.+||. +|.+|||+.+++.
T Consensus 232 ~~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 232 LHELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred HHHHHHHHcccCcccCcCHHHHHH
Confidence 9999999997 8999999999874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.5e-26 Score=223.74 Aligned_cols=171 Identities=26% Similarity=0.470 Sum_probs=141.8
Q ss_pred CEeccCCCCCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhcc
Q 008504 1 MITELFTSGNLRQYRKKHKN--VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~--Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~ 78 (563)
+||||+++++|.+++..... +++..+..++.||+.||+|||+.+ ++||||||+||+++ +.+.++|+|||++....
T Consensus 78 ~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~--~~h~dl~~~nil~~-~~~~~~l~dfg~~~~~~ 154 (258)
T smart00219 78 IVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN--FIHRDLAARNCLVG-ENLVVKISDFGLSRDLY 154 (258)
T ss_pred EEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC--eeecccccceEEEc-cCCeEEEcccCCceecc
Confidence 58999999999999986554 999999999999999999999999 99999999999998 55799999999986554
Q ss_pred CCCCc---cccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCCCCccccCCChh
Q 008504 79 QPTAR---SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQ 153 (563)
Q Consensus 79 ~~~~~---~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~ 153 (563)
..... ...+++.|+|||.+.+ .++.++||||||+++|+|++ |..||.. .........+..+..+. .+...+..
T Consensus 155 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~ 232 (258)
T smart00219 155 DDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPG-MSNEEVLEYLKKGYRLP-KPENCPPE 232 (258)
T ss_pred cccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHhcCCCCC-CCCcCCHH
Confidence 32111 1236789999998854 48999999999999999998 7788876 45566666666655443 34447889
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHHc
Q 008504 154 IKGFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 154 l~~LI~kcL~-dP~kRpSa~ELLk 176 (563)
+.+++.+||. +|.+|||+.++++
T Consensus 233 ~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 233 IYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred HHHHHHHHCcCChhhCcCHHHHHh
Confidence 9999999998 8999999999986
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.3e-26 Score=227.58 Aligned_cols=176 Identities=34% Similarity=0.493 Sum_probs=138.5
Q ss_pred CEeccCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~-~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
+||||+. ++|.+++.+. ..+++..++.++.|++.||.|||++| |+||||+|+||+++ +.+.+||+|||++.....
T Consensus 75 ~v~e~~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~~l~~~ni~~~-~~~~~~l~d~g~~~~~~~ 150 (282)
T cd07829 75 LVFEYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR--ILHRDLKPQNILIN-RDGVLKLADFGLARAFGI 150 (282)
T ss_pred EEecCcC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChheEEEc-CCCCEEEecCCcccccCC
Confidence 5899997 5999999886 57999999999999999999999999 99999999999998 458999999999876543
Q ss_pred CC--CccccCCCCccCcccccc--cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhc----------------
Q 008504 80 PT--ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS---------------- 139 (563)
Q Consensus 80 ~~--~~~~~Gtp~Y~APEvl~~--~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~---------------- 139 (563)
.. .....++..|+|||.+.+ .++.++|||||||++|+|++|..||..........+....
T Consensus 151 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd07829 151 PLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLP 230 (282)
T ss_pred CccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccc
Confidence 22 223356778999998753 5888999999999999999999999764333222211110
Q ss_pred ---CCCCC-------ccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCccc
Q 008504 140 ---GIKPA-------SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 180 (563)
Q Consensus 140 ---~~~p~-------~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff 180 (563)
...+. ......+..+.++|.+||. +|.+||++.+++.||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 231 DYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred cccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 00000 0011226789999999997 89999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.4e-26 Score=234.59 Aligned_cols=177 Identities=29% Similarity=0.500 Sum_probs=143.6
Q ss_pred CEeccCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k-~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
|||||+.| +|.+++.. ..++++..+..++.||+.||.|||++| |+||||+|+||+++ +.+.+||+|||++.....
T Consensus 102 lv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--i~H~dL~p~Nil~~-~~~~~kl~dfg~~~~~~~ 177 (317)
T cd06635 102 LVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLT-EPGQVKLADFGSASIASP 177 (317)
T ss_pred EEEeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcccEEEC-CCCCEEEecCCCccccCC
Confidence 68999975 78777754 456999999999999999999999999 99999999999997 457999999998864432
Q ss_pred CCCccccCCCCccCccccc----ccCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHH
Q 008504 80 PTARSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIK 155 (563)
Q Consensus 80 ~~~~~~~Gtp~Y~APEvl~----~~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~ 155 (563)
.....+++.|+|||.+. +.++.++|||||||++|+|++|..||.... .......+..+..+.......++.++
T Consensus 178 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~ 254 (317)
T cd06635 178 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-AMSALYHIAQNESPTLQSNEWSDYFR 254 (317)
T ss_pred --cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCcc-HHHHHHHHHhccCCCCCCccccHHHH
Confidence 23456889999999863 358889999999999999999999997743 33333344444333334445678899
Q ss_pred HHHHHhcC-CCCCCCCHHHHHcCccccccc
Q 008504 156 GFIEKCLV-PASERLSAKDLLKDPFLQVEN 184 (563)
Q Consensus 156 ~LI~kcL~-dP~kRpSa~ELLkHpff~~~~ 184 (563)
+||.+||. +|.+||++.++++|+|+....
T Consensus 255 ~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 284 (317)
T cd06635 255 NFVDSCLQKIPQDRPTSEELLKHMFVLRER 284 (317)
T ss_pred HHHHHHccCCcccCcCHHHHHhChhhhccC
Confidence 99999997 899999999999999996543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.5e-26 Score=228.51 Aligned_cols=173 Identities=23% Similarity=0.408 Sum_probs=141.5
Q ss_pred CEeccCCCCCHHHHHHhCC---------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecc
Q 008504 1 MITELFTSGNLRQYRKKHK---------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDL 71 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~---------~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DF 71 (563)
+||||+++|+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+||+++ ..+.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dlkp~Nili~-~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR--FVHRDLAARNCLVS-SQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC--cccCcCccceEEEe-CCCcEEEccc
Confidence 5899999999999998765 6999999999999999999999999 99999999999998 4579999999
Q ss_pred cchhhccCC---CCccccCCCCccCccccc-ccCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCCCCcc
Q 008504 72 GLAIAMQQP---TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASL 146 (563)
Q Consensus 72 GlA~~~~~~---~~~~~~Gtp~Y~APEvl~-~~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~l 146 (563)
|++...... ......+++.|+|||.+. ..++.++||||||+++|+|++ |..||... ........+..+......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~-~~~~~~~~~~~~~~~~~~ 240 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGL-SDEEVLNRLQAGKLELPV 240 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCcccc-chHHHHHHHHcCCcCCCC
Confidence 998643221 122335577899999875 457889999999999999998 78899763 344455555544444444
Q ss_pred ccCCChhHHHHHHHhcC-CCCCCCCHHHHHcC
Q 008504 147 AKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 177 (563)
Q Consensus 147 ~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkH 177 (563)
+...+..+.++|.+||. +|.+||++.+++.+
T Consensus 241 ~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 241 PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 55667899999999997 89999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.1e-26 Score=225.09 Aligned_cols=170 Identities=22% Similarity=0.409 Sum_probs=139.4
Q ss_pred CEeccCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhcc
Q 008504 1 MITELFTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~--~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~ 78 (563)
+||||+.+|+|.+++.... .+++..+..++.|++.||.|||++| ++||||||+||+++ .++.+||+|||++....
T Consensus 75 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--~~H~dl~p~nili~-~~~~~kl~Dfg~~~~~~ 151 (254)
T cd05083 75 IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK--LVHRDLAARNILVS-EDGVAKVSDFGLARVGS 151 (254)
T ss_pred EEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEc-CCCcEEECCCccceecc
Confidence 5899999999999998643 5899999999999999999999999 99999999999997 45799999999986543
Q ss_pred CCCCccccCCCCccCccccc-ccCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHH
Q 008504 79 QPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKG 156 (563)
Q Consensus 79 ~~~~~~~~Gtp~Y~APEvl~-~~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~ 156 (563)
.. ......+..|+|||.+. +.++.++|+|||||++|+|++ |..||... ........+..+..+. .+...++.+.+
T Consensus 152 ~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 228 (254)
T cd05083 152 MG-VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKM-SLKEVKECVEKGYRME-PPEGCPADVYV 228 (254)
T ss_pred cc-CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccC-CHHHHHHHHhCCCCCC-CCCcCCHHHHH
Confidence 22 12233456899999876 458899999999999999997 89999763 4445555555554332 34456789999
Q ss_pred HHHHhcC-CCCCCCCHHHHHc
Q 008504 157 FIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 157 LI~kcL~-dP~kRpSa~ELLk 176 (563)
+|.+||. +|.+||++.+++.
T Consensus 229 li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 229 LMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred HHHHHcCCChhhCcCHHHHHH
Confidence 9999997 8999999999975
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.6e-26 Score=230.42 Aligned_cols=171 Identities=25% Similarity=0.427 Sum_probs=139.8
Q ss_pred CEeccCCCCCHHHHHHhC------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCc
Q 008504 1 MITELFTSGNLRQYRKKH------------------------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDN 56 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~------------------------~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~N 56 (563)
+|+||+.+|+|.+++... ..+++..++.++.|++.||.|||+++ |+||||||+|
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--ivH~dikp~n 157 (290)
T cd05045 80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK--LVHRDLAARN 157 (290)
T ss_pred EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC--eehhhhhhhe
Confidence 589999999999998742 24788999999999999999999999 9999999999
Q ss_pred eEEeCCCCcEEEecccchhhccCCC----CccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhh-cCCCCCCCCCH
Q 008504 57 IFVNGNHGEVKIGDLGLAIAMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNP 130 (563)
Q Consensus 57 ILLd~~~G~VKL~DFGlA~~~~~~~----~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~ 130 (563)
||++ +.+.+||+|||++....... .....++..|+|||.+.+ .++.++||||||+++|+|++ |..||.. ..+
T Consensus 158 ill~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~-~~~ 235 (290)
T cd05045 158 VLVA-EGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG-IAP 235 (290)
T ss_pred EEEc-CCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCC-CCH
Confidence 9997 55799999999986543221 112245678999997754 48999999999999999998 9999976 456
Q ss_pred HHHHHHHhcCCCCCccccCCChhHHHHHHHhcC-CCCCCCCHHHHHc
Q 008504 131 AQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 131 ~~i~~~i~~~~~p~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLk 176 (563)
..+...+..+..+. .+...+..+++||.+||. +|.+||++.++++
T Consensus 236 ~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 236 ERLFNLLKTGYRME-RPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred HHHHHHHhCCCCCC-CCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 66666665554332 345567899999999997 8999999999975
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.8e-26 Score=226.69 Aligned_cols=171 Identities=24% Similarity=0.399 Sum_probs=138.9
Q ss_pred CEeccCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhcc
Q 008504 1 MITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~--~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~ 78 (563)
+||||+++|+|.+++.+. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++ +++.+||+|||.+....
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~Nill~-~~~~~~L~dfg~~~~~~ 153 (262)
T cd05071 77 IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVG-ENLVCKVADFGLARLIE 153 (262)
T ss_pred EEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcccEEEc-CCCcEEeccCCceeecc
Confidence 589999999999999863 35899999999999999999999999 99999999999998 56799999999996554
Q ss_pred CCCC---ccccCCCCccCccccc-ccCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCCCCccccCCChh
Q 008504 79 QPTA---RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQ 153 (563)
Q Consensus 79 ~~~~---~~~~Gtp~Y~APEvl~-~~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~ 153 (563)
.... ....++..|+|||.+. ..++.++|||||||++|+|+| |..||... ........+..+... ......+..
T Consensus 154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~ 231 (262)
T cd05071 154 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM-VNREVLDQVERGYRM-PCPPECPES 231 (262)
T ss_pred ccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCC-ChHHHHHHHhcCCCC-CCccccCHH
Confidence 3221 1234567899999875 458999999999999999999 78888763 344555555444322 224456788
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHHc
Q 008504 154 IKGFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 154 l~~LI~kcL~-dP~kRpSa~ELLk 176 (563)
+.+||.+||. +|.+||++.+++.
T Consensus 232 l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 232 LHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred HHHHHHHHccCCcccCCCHHHHHH
Confidence 9999999997 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.94 E-value=8e-26 Score=222.47 Aligned_cols=172 Identities=23% Similarity=0.391 Sum_probs=139.3
Q ss_pred CEeccCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~-~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
+||||+++|+|.+++... ..+++..+..++.|++.||.|||++| ++||||||+||+++ .++.+||+|||++.....
T Consensus 69 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~~H~dl~p~nili~-~~~~~~l~d~g~~~~~~~ 145 (250)
T cd05085 69 IVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN--CIHRDLAARNCLVG-ENNVLKISDFGMSRQEDD 145 (250)
T ss_pred EEEECCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccChheEEEc-CCCeEEECCCccceeccc
Confidence 589999999999998753 45899999999999999999999999 99999999999997 567999999999865432
Q ss_pred CCC---ccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhH
Q 008504 80 PTA---RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQI 154 (563)
Q Consensus 80 ~~~---~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l 154 (563)
... ....+++.|+|||++.. .++.++||||||+++|++++ |..||... ........+..+... ..+...+..+
T Consensus 146 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~ 223 (250)
T cd05085 146 GIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGM-TNQQAREQVEKGYRM-SCPQKCPDDV 223 (250)
T ss_pred cccccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCC-CHHHHHHHHHcCCCC-CCCCCCCHHH
Confidence 211 11234567999998864 58899999999999999998 89999764 444555555544332 2344567899
Q ss_pred HHHHHHhcC-CCCCCCCHHHHHcC
Q 008504 155 KGFIEKCLV-PASERLSAKDLLKD 177 (563)
Q Consensus 155 ~~LI~kcL~-dP~kRpSa~ELLkH 177 (563)
.+|+.+||. +|.+||++.++++.
T Consensus 224 ~~li~~~l~~~p~~Rp~~~~l~~~ 247 (250)
T cd05085 224 YKVMQRCWDYKPENRPKFSELQKE 247 (250)
T ss_pred HHHHHHHcccCcccCCCHHHHHHH
Confidence 999999997 89999999999763
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.6e-26 Score=228.96 Aligned_cols=172 Identities=21% Similarity=0.317 Sum_probs=140.2
Q ss_pred CEeccCCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCC
Q 008504 1 MITELFTSGNLRQYRKKH----------------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHG 64 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~----------------~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G 64 (563)
+++||+.+++|.+++... ..+++..+..++.|++.||.|||++| |+||||||+||+++ +++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g--i~H~dlkp~Nil~~-~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH--VVHKDLATRNVLVF-DKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC--ccccccchhheEec-CCC
Confidence 478999999999998532 34888999999999999999999999 99999999999998 557
Q ss_pred cEEEecccchhhccCCC----CccccCCCCccCccccc-ccCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHh
Q 008504 65 EVKIGDLGLAIAMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVT 138 (563)
Q Consensus 65 ~VKL~DFGlA~~~~~~~----~~~~~Gtp~Y~APEvl~-~~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~ 138 (563)
.+||+|||+++...... .....+++.|+|||.+. +.++.++|||||||++|||++ |..||.. .....+...+.
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~-~~~~~~~~~i~ 240 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCG-YSNQDVIEMIR 240 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHH
Confidence 89999999987553321 12334577999999875 558999999999999999998 7888876 44556666666
Q ss_pred cCCCCCccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcC
Q 008504 139 SGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 177 (563)
Q Consensus 139 ~~~~p~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkH 177 (563)
.+... ..+...+..+.+|+.+||+ +|.+||++.+++..
T Consensus 241 ~~~~~-~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 241 NRQVL-PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred cCCcC-CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 55433 2345677889999999997 89999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.7e-26 Score=225.64 Aligned_cols=171 Identities=25% Similarity=0.437 Sum_probs=138.6
Q ss_pred CEeccCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~-~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
+||||+++|+|.+++... +.+++..+..++.|++.||.|||++| ++||||||+||+++ .++.+||+|||++.....
T Consensus 83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nili~-~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 83 IITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN--YVHRDLAARNILVN-SNLECKVSDFGLSRVLED 159 (268)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEEc-CCCcEEECCCccceeccc
Confidence 589999999999999764 57899999999999999999999999 99999999999998 457999999999865533
Q ss_pred CCCc-----cccCCCCccCccccc-ccCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCCCCccccCCCh
Q 008504 80 PTAR-----SVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDP 152 (563)
Q Consensus 80 ~~~~-----~~~Gtp~Y~APEvl~-~~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~ 152 (563)
.... ....++.|+|||++. +.++.++|||||||++|+|++ |..||... ........+..+... ......+.
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~-~~~~~~~~i~~~~~~-~~~~~~~~ 237 (268)
T cd05063 160 DPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDM-SNHEVMKAINDGFRL-PAPMDCPS 237 (268)
T ss_pred ccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcC-CHHHHHHHHhcCCCC-CCCCCCCH
Confidence 2111 112345799999876 458899999999999999997 99999763 345555555554332 22344578
Q ss_pred hHHHHHHHhcC-CCCCCCCHHHHHc
Q 008504 153 QIKGFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 153 ~l~~LI~kcL~-dP~kRpSa~ELLk 176 (563)
.+++++.+||. +|.+||++.++++
T Consensus 238 ~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 238 AVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred HHHHHHHHHcCCCcccCcCHHHHHH
Confidence 89999999997 8999999999985
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.1e-26 Score=237.74 Aligned_cols=179 Identities=28% Similarity=0.410 Sum_probs=139.0
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
+|+||+. ++|..++. ..+++..++.++.||+.||.|||++| |+||||||+||+++ ..|.+||+|||++.....
T Consensus 97 lv~e~~~-~~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dlkp~NIll~-~~~~~kL~dfg~~~~~~~- 169 (342)
T cd07879 97 LVMPYMQ-TDLQKIMG--HPLSEDKVQYLVYQMLCGLKYIHSAG--IIHRDLKPGNLAVN-EDCELKILDFGLARHADA- 169 (342)
T ss_pred EEecccc-cCHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCCEEEeeCCCCcCCCC-
Confidence 5789886 47877653 46999999999999999999999999 99999999999998 458999999999865432
Q ss_pred CCccccCCCCccCcccccc--cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCC-----------------
Q 008504 81 TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI----------------- 141 (563)
Q Consensus 81 ~~~~~~Gtp~Y~APEvl~~--~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~----------------- 141 (563)
......+++.|+|||.+.+ .++.++|||||||++|+|++|+.||....... .+..+....
T Consensus 170 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (342)
T cd07879 170 EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILKVTGVPGPEFVQKLEDKAAK 248 (342)
T ss_pred CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCCHHHHHHhcccchH
Confidence 2234567889999998754 47889999999999999999999998633222 222211100
Q ss_pred -----CC----Cc---cccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCccccccccCC
Q 008504 142 -----KP----AS---LAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQKE 187 (563)
Q Consensus 142 -----~p----~~---l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~~~~ 187 (563)
.+ .. .....++.+.+||.+||. +|.+||++.+++.||||+......
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~ 307 (342)
T cd07879 249 SYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDAD 307 (342)
T ss_pred HHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccccc
Confidence 00 00 011346778999999997 899999999999999998765543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.8e-26 Score=227.28 Aligned_cols=168 Identities=20% Similarity=0.362 Sum_probs=132.2
Q ss_pred CEeccCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCC-------cEEEeccc
Q 008504 1 MITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHG-------EVKIGDLG 72 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~-~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G-------~VKL~DFG 72 (563)
+||||+++|+|..++.+. ..+++..++.++.||+.||.|||+++ |+||||||+|||++. .+ .+|++|||
T Consensus 81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~-~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKD--LVHGNVCTKNILLAR-EGIDGECGPFIKLSDPG 157 (262)
T ss_pred EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCC--eECCCCCcccEEEec-CCccCCCCceeEeCCCC
Confidence 589999999999998764 56999999999999999999999999 999999999999973 33 38999999
Q ss_pred chhhccCCCCccccCCCCccCccccc--ccCCchhhHHHhHHHHHHHh-hcCCCCCCCCCHHHHHHHHhcCCCCCccccC
Q 008504 73 LAIAMQQPTARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMV-TFEYPYSECKNPAQIFKKVTSGIKPASLAKV 149 (563)
Q Consensus 73 lA~~~~~~~~~~~~Gtp~Y~APEvl~--~~ys~ksDIwSLGviLyELl-TG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~ 149 (563)
++..... .....++..|+|||.+. ..++.++|||||||++|+|+ +|..||.... ...... ...+... ....
T Consensus 158 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~-~~~~~~-~~~~~~~--~~~~ 231 (262)
T cd05077 158 IPITVLS--RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKT-LAEKER-FYEGQCM--LVTP 231 (262)
T ss_pred CCccccC--cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcc-hhHHHH-HHhcCcc--CCCC
Confidence 9855432 23346788999999875 34889999999999999998 5788886532 222222 1222111 1222
Q ss_pred CChhHHHHHHHhcC-CCCCCCCHHHHHcC
Q 008504 150 NDPQIKGFIEKCLV-PASERLSAKDLLKD 177 (563)
Q Consensus 150 ~s~~l~~LI~kcL~-dP~kRpSa~ELLkH 177 (563)
..+.+++||.+||. +|.+||++.+|+++
T Consensus 232 ~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 232 SCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred ChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 35689999999997 89999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.5e-26 Score=223.27 Aligned_cols=171 Identities=23% Similarity=0.395 Sum_probs=137.8
Q ss_pred CEeccCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k-~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
+||||+.+++|.+++.+ ...+++..+..++.|++.||.|||+++ ++||||+|+|||++ ..+.+||+|||++.....
T Consensus 69 ~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~--i~h~di~p~nili~-~~~~~~l~d~g~~~~~~~ 145 (251)
T cd05041 69 IVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN--CIHRDLAARNCLVG-ENNVLKISDFGMSREEEG 145 (251)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--EehhhcCcceEEEc-CCCcEEEeeccccccccC
Confidence 58999999999999976 456899999999999999999999999 99999999999997 557999999999865542
Q ss_pred CCC----ccccCCCCccCccccc-ccCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCCCCccccCCChh
Q 008504 80 PTA----RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQ 153 (563)
Q Consensus 80 ~~~----~~~~Gtp~Y~APEvl~-~~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~ 153 (563)
... ....++..|+|||.+. +.++.++|+||||+++|+|+| |..||... ........+.... ....+...+..
T Consensus 146 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~ 223 (251)
T cd05041 146 GIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGM-SNQQTRERIESGY-RMPAPQLCPEE 223 (251)
T ss_pred CcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccC-CHHHHHHHHhcCC-CCCCCccCCHH
Confidence 111 1122356799999876 458899999999999999999 78888763 3444444444432 22234566789
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHHc
Q 008504 154 IKGFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 154 l~~LI~kcL~-dP~kRpSa~ELLk 176 (563)
+.+||.+||. +|.+||++.++++
T Consensus 224 ~~~li~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 224 IYRLMLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred HHHHHHHHhccChhhCcCHHHHHH
Confidence 9999999997 8999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-26 Score=234.13 Aligned_cols=185 Identities=28% Similarity=0.451 Sum_probs=153.5
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCC--CcEEEecccchhhcc
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNH--GEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~--G~VKL~DFGlA~~~~ 78 (563)
||||-|.||+|...|.+++.+++.++.++++.|+.||.|||.+| |.||||||+|||....+ .-||||||.+...+.
T Consensus 153 LVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kg--IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k 230 (463)
T KOG0607|consen 153 LVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKG--IAHRDLKPENILCESPNKVSPVKICDFDLGSGIK 230 (463)
T ss_pred EEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcC--cccccCCccceeecCCCCcCceeeeccccccccc
Confidence 69999999999999999999999999999999999999999999 99999999999996332 258999998875432
Q ss_pred C---------CCCccccCCCCccCccccc---c---cCCchhhHHHhHHHHHHHhhcCCCCCCCCC--------------
Q 008504 79 Q---------PTARSVIGTPEFMAPELYE---E---EYNELVDIYSFGMCILEMVTFEYPYSECKN-------------- 129 (563)
Q Consensus 79 ~---------~~~~~~~Gtp~Y~APEvl~---~---~ys~ksDIwSLGviLyELlTG~~Pf~~~~~-------------- 129 (563)
. +...+.+|+..|||||+.. + .|+.++|.||||||+|-|+.|.+||.+.-.
T Consensus 231 ~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~C 310 (463)
T KOG0607|consen 231 LNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVC 310 (463)
T ss_pred cCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHH
Confidence 1 2234567888999999763 2 489999999999999999999999964110
Q ss_pred HHHHHHHHhcCCC--CCccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCccccccccCC
Q 008504 130 PAQIFKKVTSGIK--PASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQKE 187 (563)
Q Consensus 130 ~~~i~~~i~~~~~--p~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~~~~ 187 (563)
...++..|..|.. |..-+...+.+.+++|..+|. ++.+|.++.++++|||++......
T Consensus 311 Q~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~ek 371 (463)
T KOG0607|consen 311 QNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPEK 371 (463)
T ss_pred HHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchhc
Confidence 2456777888765 444455567899999999997 899999999999999998765543
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.6e-26 Score=230.09 Aligned_cols=175 Identities=26% Similarity=0.435 Sum_probs=136.8
Q ss_pred CEeccCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~-~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
+|+||+++ +|..++... ..+++..++.++.||+.||.|||++| |+||||||+||+++ +.+.+||+|||++.....
T Consensus 93 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~-~~~~~kl~dfg~~~~~~~ 168 (302)
T cd07864 93 LVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKN--FLHRDIKCSNILLN-NKGQIKLADFGLARLYNS 168 (302)
T ss_pred EEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEC-CCCcEEeCcccccccccC
Confidence 58999976 777777654 46999999999999999999999999 99999999999998 557999999999876543
Q ss_pred CC---CccccCCCCccCcccccc--cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhc---CCCCC-------
Q 008504 80 PT---ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS---GIKPA------- 144 (563)
Q Consensus 80 ~~---~~~~~Gtp~Y~APEvl~~--~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~---~~~p~------- 144 (563)
.. .....+++.|+|||.+.+ .++.++|||||||++|+|++|+.||....... ....+.. ...+.
T Consensus 169 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 247 (302)
T cd07864 169 EESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELA-QLELISRLCGSPCPAVWPDVIK 247 (302)
T ss_pred CcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCChhhcccccc
Confidence 22 122345778999998753 37889999999999999999999997633322 2222211 11110
Q ss_pred ------------------ccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCccc
Q 008504 145 ------------------SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 180 (563)
Q Consensus 145 ------------------~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff 180 (563)
......++.+.++|.+||. +|.+||++.+++.||||
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 248 LPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred cccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 0112347889999999997 89999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.6e-26 Score=223.44 Aligned_cols=172 Identities=21% Similarity=0.447 Sum_probs=140.4
Q ss_pred CEeccCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~-~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
+||||+.+|+|.+++... +.+++..++.++.|++.||.|||+++ ++||||||+||+++ .++.+||+|||++.....
T Consensus 76 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~dl~p~ni~i~-~~~~~~l~d~g~~~~~~~ 152 (256)
T cd05112 76 LVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN--VIHRDLAARNCLVG-ENQVVKVSDFGMTRFVLD 152 (256)
T ss_pred EEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccccceEEEc-CCCeEEECCCcceeeccc
Confidence 589999999999999764 46899999999999999999999999 99999999999997 557999999999865433
Q ss_pred CCCc---cccCCCCccCccccc-ccCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhH
Q 008504 80 PTAR---SVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQI 154 (563)
Q Consensus 80 ~~~~---~~~Gtp~Y~APEvl~-~~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l 154 (563)
.... ...++..|+|||.+. +.++.++||||||+++|+|++ |..||.. .........+..+..+ ..+...+..+
T Consensus 153 ~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~ 230 (256)
T cd05112 153 DQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYEN-RSNSEVVETINAGFRL-YKPRLASQSV 230 (256)
T ss_pred CcccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCc-CCHHHHHHHHhCCCCC-CCCCCCCHHH
Confidence 2211 223456899999886 458899999999999999998 8999976 3445555555554332 2345567899
Q ss_pred HHHHHHhcC-CCCCCCCHHHHHcC
Q 008504 155 KGFIEKCLV-PASERLSAKDLLKD 177 (563)
Q Consensus 155 ~~LI~kcL~-dP~kRpSa~ELLkH 177 (563)
.+|+.+||. +|.+||++.+++++
T Consensus 231 ~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 231 YELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred HHHHHHHcccChhhCCCHHHHHHh
Confidence 999999997 89999999999864
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.1e-26 Score=252.33 Aligned_cols=180 Identities=27% Similarity=0.445 Sum_probs=133.6
Q ss_pred CEeccCCCCCHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchh
Q 008504 1 MITELFTSGNLRQYRKKH-----KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 75 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~-----~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~ 75 (563)
+|+|++. ++|..++... .......++.|+.||+.||.|||++| ||||||||+|||++ ..|.+||+|||++.
T Consensus 240 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g--IiHrDLKP~NILl~-~~~~vkL~DFGla~ 315 (501)
T PHA03210 240 MITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK--LIHRDIKLENIFLN-CDGKIVLGDFGTAM 315 (501)
T ss_pred EEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEC-CCCCEEEEeCCCce
Confidence 4788885 5788877542 23456778899999999999999999 99999999999998 55799999999997
Q ss_pred hccCC---CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCC-CCCC-CCH-HHHHHHHhcCC-----CC
Q 008504 76 AMQQP---TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYP-YSEC-KNP-AQIFKKVTSGI-----KP 143 (563)
Q Consensus 76 ~~~~~---~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~P-f~~~-~~~-~~i~~~i~~~~-----~p 143 (563)
.+... ......|++.|+|||++.+ .|+.++|||||||++|||++|..+ |... ..+ .++.+.+.... .+
T Consensus 316 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p 395 (501)
T PHA03210 316 PFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFP 395 (501)
T ss_pred ecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHHhcccChhhcC
Confidence 65432 2234579999999998864 589999999999999999999864 4322 122 22222221100 00
Q ss_pred -------------------Ccc-----ccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCccccccc
Q 008504 144 -------------------ASL-----AKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 184 (563)
Q Consensus 144 -------------------~~l-----~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~ 184 (563)
..+ ....+..+.++|.+||. ||.+|||+.|+|.||||....
T Consensus 396 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~~ 461 (501)
T PHA03210 396 DPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAEE 461 (501)
T ss_pred CcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcCC
Confidence 000 01234567888999997 999999999999999997654
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.7e-26 Score=236.04 Aligned_cols=179 Identities=29% Similarity=0.415 Sum_probs=141.8
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
+||||+ +++|..++.. ..+++..++.++.||+.||.|||++| |+||||||+||+++ +.+.+||+|||++......
T Consensus 97 lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~g--i~H~dlkp~Nill~-~~~~~kl~dfg~~~~~~~~ 171 (343)
T cd07880 97 LVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAG--IIHRDLKPGNLAVN-EDCELKILDFGLARQTDSE 171 (343)
T ss_pred EEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEc-CCCCEEEeecccccccccC
Confidence 589998 7799988875 57999999999999999999999999 99999999999998 5579999999998755432
Q ss_pred CCccccCCCCccCcccccc--cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCC----------------
Q 008504 81 TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK---------------- 142 (563)
Q Consensus 81 ~~~~~~Gtp~Y~APEvl~~--~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~---------------- 142 (563)
.....+++.|+|||.+.+ .++.++|+||||+++|+|++|..||..................
T Consensus 172 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (343)
T cd07880 172 -MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKN 250 (343)
T ss_pred -ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHH
Confidence 234467899999998764 4788999999999999999999999864433222221110000
Q ss_pred ---------C---CccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCcccccccc
Q 008504 143 ---------P---ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQ 185 (563)
Q Consensus 143 ---------p---~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~~ 185 (563)
+ .......++.+.++|.+||. +|.+|||+.+++.||||+....
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~ 306 (343)
T cd07880 251 YVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHD 306 (343)
T ss_pred HHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcC
Confidence 0 01123456789999999997 8999999999999999986543
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.5e-26 Score=232.40 Aligned_cols=168 Identities=25% Similarity=0.330 Sum_probs=131.5
Q ss_pred EeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC-
Q 008504 2 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP- 80 (563)
Q Consensus 2 VmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~- 80 (563)
++|++. .++.+++......++..++.++.||+.||.|||+++ |+||||||+|||++ ..+.++|+|||+++.....
T Consensus 105 ~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiHrDiKp~Nill~-~~~~~~l~DFGla~~~~~~~ 180 (294)
T PHA02882 105 LLEKLV-ENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHG--ISHGDIKPENIMVD-GNNRGYIIDYGIASHFIIHG 180 (294)
T ss_pred EEehhc-cCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEc-CCCcEEEEEcCCceeeccCC
Confidence 456553 477777777666889999999999999999999999 99999999999997 4579999999999754311
Q ss_pred --------CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHH--------HHHhcCCCC
Q 008504 81 --------TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIF--------KKVTSGIKP 143 (563)
Q Consensus 81 --------~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~--------~~i~~~~~p 143 (563)
......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.......... ..+..+..
T Consensus 181 ~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~- 259 (294)
T PHA02882 181 KHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKCDFIKRLHEGKI- 259 (294)
T ss_pred cccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHHHHHHHhhhhhh-
Confidence 1123469999999998865 48999999999999999999999998753322221 22222211
Q ss_pred CccccCCChhHHHHHHHhcC-CCCCCCCHHHHHc
Q 008504 144 ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 144 ~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLk 176 (563)
.....++.+.+++..|+. +|.+||++.++++
T Consensus 260 --~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 260 --KIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred --ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 123346789999999997 8999999999975
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.7e-26 Score=226.61 Aligned_cols=171 Identities=24% Similarity=0.382 Sum_probs=140.5
Q ss_pred CEeccCCCCCHHHHHHhC--------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEeccc
Q 008504 1 MITELFTSGNLRQYRKKH--------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLG 72 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~--------~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFG 72 (563)
+++||+.+|+|.+++... ..+++..++.++.||+.||.|||+++ ++||||||+||+++ ..+.+||+|||
T Consensus 86 ~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--i~H~di~p~nil~~-~~~~~kl~d~g 162 (280)
T cd05043 86 VLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG--VIHKDIAARNCVID-EELQVKITDNA 162 (280)
T ss_pred EEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCHhhEEEc-CCCcEEECCCC
Confidence 478999999999999763 45899999999999999999999999 99999999999997 45799999999
Q ss_pred chhhccCCCC----ccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCCCCcc
Q 008504 73 LAIAMQQPTA----RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASL 146 (563)
Q Consensus 73 lA~~~~~~~~----~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~l 146 (563)
+++.+..... ....++..|+|||++.+ .++.++|||||||++|++++ |+.||.. .++..+...+..+.... .
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~-~~~~~~~~~~~~~~~~~-~ 240 (280)
T cd05043 163 LSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVE-IDPFEMAAYLKDGYRLA-Q 240 (280)
T ss_pred CcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCc-CCHHHHHHHHHcCCCCC-C
Confidence 9975532211 12345667999998864 48999999999999999999 9999976 35566666666554432 2
Q ss_pred ccCCChhHHHHHHHhcC-CCCCCCCHHHHHc
Q 008504 147 AKVNDPQIKGFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 147 ~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLk 176 (563)
+...++.+.+++.+||. +|.+|||+.++++
T Consensus 241 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 241 PINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred CCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 34457899999999997 8999999999985
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.2e-26 Score=224.05 Aligned_cols=171 Identities=25% Similarity=0.410 Sum_probs=139.7
Q ss_pred CEeccCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhcc
Q 008504 1 MITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~--~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~ 78 (563)
+||||+.+|+|.+++.+. ..+++..+..++.|++.||.|||++| ++||||||+||+++ +.+.++|+|||++....
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~--i~H~dl~p~ni~i~-~~~~~~l~dfg~~~~~~ 153 (260)
T cd05067 77 IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN--YIHRDLRAANILVS-ETLCCKIADFGLARLIE 153 (260)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHHhEEEc-CCCCEEEccCcceeecC
Confidence 589999999999998753 45899999999999999999999999 99999999999998 56799999999986554
Q ss_pred CCC---CccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCCCCccccCCChh
Q 008504 79 QPT---ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQ 153 (563)
Q Consensus 79 ~~~---~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~ 153 (563)
... .....++..|+|||++.. .++.++||||||+++|+|++ |+.||... +.......+..+... ..+...+.+
T Consensus 154 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~ 231 (260)
T cd05067 154 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGM-TNPEVIQNLERGYRM-PRPDNCPEE 231 (260)
T ss_pred CCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCC-ChHHHHHHHHcCCCC-CCCCCCCHH
Confidence 221 112345678999998864 47889999999999999999 99999874 344455555544333 334556789
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHHc
Q 008504 154 IKGFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 154 l~~LI~kcL~-dP~kRpSa~ELLk 176 (563)
++++|.+||. +|.+||++.+++.
T Consensus 232 ~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 232 LYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred HHHHHHHHccCChhhCCCHHHHHH
Confidence 9999999997 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.3e-26 Score=235.80 Aligned_cols=153 Identities=24% Similarity=0.415 Sum_probs=123.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCCC----CccccCCCCccCccc
Q 008504 21 VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT----ARSVIGTPEFMAPEL 96 (563)
Q Consensus 21 Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~~----~~~~~Gtp~Y~APEv 96 (563)
+++..+..++.||+.||+|||++| |+||||||+||+++ ..+.+||+|||++....... .....+++.|+|||.
T Consensus 176 ~~~~~~~~~~~qi~~al~~lH~~~--i~H~dikp~Nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 252 (343)
T cd05103 176 LTLEDLICYSFQVAKGMEFLASRK--CIHRDLAARNILLS-ENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPET 252 (343)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--eecCCCccCeEEEc-CCCcEEEEecccccccccCcchhhcCCCCCCcceECcHH
Confidence 678888999999999999999999 99999999999998 45799999999986543221 112345678999998
Q ss_pred cc-ccCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHHHHHHhcC-CCCCCCCHHH
Q 008504 97 YE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKD 173 (563)
Q Consensus 97 l~-~~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~E 173 (563)
+. ..++.++||||||+++|+|++ |..||............+..+..+ ..+...++.+.+++.+||. +|.+|||+.+
T Consensus 253 ~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~cl~~~p~~Rps~~e 331 (343)
T cd05103 253 IFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM-RAPDYTTPEMYQTMLDCWHGEPSQRPTFSE 331 (343)
T ss_pred hcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCC-CCCCCCCHHHHHHHHHHccCChhhCcCHHH
Confidence 75 458999999999999999997 899997755444555555544433 2344567899999999997 8999999999
Q ss_pred HHcC
Q 008504 174 LLKD 177 (563)
Q Consensus 174 LLkH 177 (563)
+++|
T Consensus 332 il~~ 335 (343)
T cd05103 332 LVEH 335 (343)
T ss_pred HHHH
Confidence 9986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.7e-26 Score=224.64 Aligned_cols=173 Identities=25% Similarity=0.413 Sum_probs=141.1
Q ss_pred CEeccCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEeccCccCceEEeCCCCcEEEecccchh
Q 008504 1 MITELFTSGNLRQYRKK----HKNVDIKVIKNWARQILHGLVYLHS-HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 75 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k----~~~Lse~~i~~i~~QIL~aL~yLHs-~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~ 75 (563)
+||||+++++|.+++.. ...+++..++.++.|++.||.|||+ .+ ++|+||+|+|||++ ..+.+||+|||++.
T Consensus 86 lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~--i~H~dl~~~nil~~-~~~~~~l~dfg~~~ 162 (269)
T cd08528 86 IVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR--IVHRDLTPNNIMLG-EDDKVTITDFGLAK 162 (269)
T ss_pred EEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc--eeecCCCHHHEEEC-CCCcEEEeccccee
Confidence 58999999999998743 3469999999999999999999996 67 99999999999997 55799999999997
Q ss_pred hccCC-CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChh
Q 008504 76 AMQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQ 153 (563)
Q Consensus 76 ~~~~~-~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~ 153 (563)
..... ......|+..|+|||.+.+ .++.++|+||||+++|+|++|+.||... ........+..+..........++.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (269)
T cd08528 163 QKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYST-NMLSLATKIVEAVYEPLPEGMYSED 241 (269)
T ss_pred ecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCccccc-CHHHHHHHHhhccCCcCCcccCCHH
Confidence 65433 2334568899999998864 4889999999999999999999999763 3444444444444433334456789
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHHcC
Q 008504 154 IKGFIEKCLV-PASERLSAKDLLKD 177 (563)
Q Consensus 154 l~~LI~kcL~-dP~kRpSa~ELLkH 177 (563)
+.+||.+||. +|.+||++.|+..+
T Consensus 242 l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 242 VTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred HHHHHHHHCCCCCccCCCHHHHHHH
Confidence 9999999997 89999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.5e-27 Score=229.71 Aligned_cols=176 Identities=23% Similarity=0.288 Sum_probs=136.7
Q ss_pred CEeccCCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhh
Q 008504 1 MITELFTSGNLRQYRKKH----KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 76 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~----~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~ 76 (563)
|+++|+..|+|.+.+... ..+++.++..|+.+|++||.+||+..||++||||||.||++.+ .+.++|.|||.++.
T Consensus 100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~-~~~~vl~D~GS~~~ 178 (302)
T KOG2345|consen 100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSD-SGLPVLMDLGSATQ 178 (302)
T ss_pred EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecC-CCceEEEeccCccc
Confidence 588999999999998752 3599999999999999999999999999999999999999974 58999999999865
Q ss_pred ccCCC-----------CccccCCCCccCcccccc----cCCchhhHHHhHHHHHHHhhcCCCCCCCCC-HHHHHHHHhcC
Q 008504 77 MQQPT-----------ARSVIGTPEFMAPELYEE----EYNELVDIYSFGMCILEMVTFEYPYSECKN-PAQIFKKVTSG 140 (563)
Q Consensus 77 ~~~~~-----------~~~~~Gtp~Y~APEvl~~----~ys~ksDIwSLGviLyELlTG~~Pf~~~~~-~~~i~~~i~~~ 140 (563)
..-.. ......|..|.|||++.- ..++++|||||||++|.|+.|..||..... ...+.-.+..+
T Consensus 179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~n~ 258 (302)
T KOG2345|consen 179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQNA 258 (302)
T ss_pred cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeeecc
Confidence 43110 012246889999999863 368899999999999999999999964110 00011112222
Q ss_pred CCCCccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcC
Q 008504 141 IKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 177 (563)
Q Consensus 141 ~~p~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkH 177 (563)
.....-...++..+.+||+.||+ ||.+||++.+++.+
T Consensus 259 q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 259 QISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred ccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 22222233378899999999997 99999999999864
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=224.65 Aligned_cols=172 Identities=25% Similarity=0.485 Sum_probs=139.2
Q ss_pred CEeccCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~-~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
+||||+++|+|.+++.+.+ .+++..++.++.||+.||.|||++| ++||||||+||+++ ..+.+||+|||++.....
T Consensus 83 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~~H~dl~p~nili~-~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 83 IVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR--FVHRDIAARNVLVS-SPDCVKLGDFGLSRYLED 159 (270)
T ss_pred EEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccChheEEEe-cCCCeEEccCceeeeccc
Confidence 5899999999999998744 5899999999999999999999999 99999999999998 457999999999865543
Q ss_pred CCC---ccccCCCCccCccccc-ccCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhH
Q 008504 80 PTA---RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQI 154 (563)
Q Consensus 80 ~~~---~~~~Gtp~Y~APEvl~-~~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l 154 (563)
... ....+++.|+|||.+. ..++.++||||||+++|+|++ |..||...... .....+..+... ..+...++.+
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~-~~~~~~~~~~~~-~~~~~~~~~~ 237 (270)
T cd05056 160 ESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN-DVIGRIENGERL-PMPPNCPPTL 237 (270)
T ss_pred ccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHHcCCcC-CCCCCCCHHH
Confidence 211 1223446799999875 458899999999999999986 99999875443 334444444333 2345567899
Q ss_pred HHHHHHhcC-CCCCCCCHHHHHcC
Q 008504 155 KGFIEKCLV-PASERLSAKDLLKD 177 (563)
Q Consensus 155 ~~LI~kcL~-dP~kRpSa~ELLkH 177 (563)
+++|.+||. +|.+|||+.+++..
T Consensus 238 ~~li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 238 YSLMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred HHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999997 89999999998863
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.2e-26 Score=223.44 Aligned_cols=171 Identities=26% Similarity=0.419 Sum_probs=138.7
Q ss_pred CEeccCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhcc
Q 008504 1 MITELFTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~--~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~ 78 (563)
+||||+++|+|.+++.... .+++..+..++.||+.||.|||++| ++|+||||+||+++ .++.+||+|||++....
T Consensus 78 ~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~--i~h~di~p~nili~-~~~~~~l~d~g~~~~~~ 154 (261)
T cd05034 78 IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN--YIHRDLAARNILVG-ENLVCKIADFGLARLIE 154 (261)
T ss_pred EEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcchheEEEc-CCCCEEECccccceecc
Confidence 5899999999999998653 6899999999999999999999999 99999999999997 55899999999986654
Q ss_pred CCCC---ccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCCCCccccCCChh
Q 008504 79 QPTA---RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQ 153 (563)
Q Consensus 79 ~~~~---~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~ 153 (563)
.... ....++..|+|||.+.+ .++.++|+||||+++|+|++ |+.||... ........+..+.... .+...+..
T Consensus 155 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~ 232 (261)
T cd05034 155 DDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGM-TNREVLEQVERGYRMP-RPPNCPEE 232 (261)
T ss_pred chhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHcCCCCC-CCCCCCHH
Confidence 3211 12234568999998864 48899999999999999998 99999763 4445555555543322 23344778
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHHc
Q 008504 154 IKGFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 154 l~~LI~kcL~-dP~kRpSa~ELLk 176 (563)
+++++.+||. +|.+||++.+++.
T Consensus 233 ~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 233 LYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred HHHHHHHHcccCcccCCCHHHHHH
Confidence 9999999997 8999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1e-25 Score=233.58 Aligned_cols=173 Identities=28% Similarity=0.449 Sum_probs=140.2
Q ss_pred CEeccCCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCC
Q 008504 1 MITELFTSGNLRQYRKKHK----------------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHG 64 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~----------------~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G 64 (563)
+||||+++|+|.+++.+.+ .++...+..++.||+.||.|||++| |+||||||+|||++ ..+
T Consensus 95 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--ivH~dlkp~Nill~-~~~ 171 (334)
T cd05100 95 VLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK--CIHRDLAARNVLVT-EDN 171 (334)
T ss_pred EEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--eeccccccceEEEc-CCC
Confidence 5899999999999997632 3788899999999999999999999 99999999999997 457
Q ss_pred cEEEecccchhhccCCC----CccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHh
Q 008504 65 EVKIGDLGLAIAMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVT 138 (563)
Q Consensus 65 ~VKL~DFGlA~~~~~~~----~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~ 138 (563)
.+||+|||+++...... .....++..|+|||++.+ .++.++||||||+++|+|++ |..||.. .........+.
T Consensus 172 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~-~~~~~~~~~~~ 250 (334)
T cd05100 172 VMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG-IPVEELFKLLK 250 (334)
T ss_pred cEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCC-CCHHHHHHHHH
Confidence 99999999987554321 111234567999998854 58899999999999999998 7888876 45566666665
Q ss_pred cCCCCCccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCc
Q 008504 139 SGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDP 178 (563)
Q Consensus 139 ~~~~p~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHp 178 (563)
.+..+ ..+...+..+.+||.+||. +|.+||++.+++++-
T Consensus 251 ~~~~~-~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l 290 (334)
T cd05100 251 EGHRM-DKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDL 290 (334)
T ss_pred cCCCC-CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence 55433 2344557789999999997 899999999999863
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=227.12 Aligned_cols=169 Identities=23% Similarity=0.368 Sum_probs=132.9
Q ss_pred CEeccCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCC------CCcEEEecccc
Q 008504 1 MITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGN------HGEVKIGDLGL 73 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k-~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~------~G~VKL~DFGl 73 (563)
|||||+++|+|..++.+ .+.+++..+..++.||+.||+|||+++ |+||||||+||+++.. .+.+||+|||+
T Consensus 93 lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~ 170 (274)
T cd05076 93 MVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKN--LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGV 170 (274)
T ss_pred EEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCC--ccCCCCCcccEEEeccCcccCccceeeecCCcc
Confidence 68999999999999975 467999999999999999999999999 9999999999999732 22489999998
Q ss_pred hhhccCCCCccccCCCCccCcccccc--cCCchhhHHHhHHHHHHHh-hcCCCCCCCCCHHHHHHHHhcCCCCCccccCC
Q 008504 74 AIAMQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMV-TFEYPYSECKNPAQIFKKVTSGIKPASLAKVN 150 (563)
Q Consensus 74 A~~~~~~~~~~~~Gtp~Y~APEvl~~--~ys~ksDIwSLGviLyELl-TG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~ 150 (563)
+...... ....+++.|+|||.+.+ .++.++|||||||++|+|+ +|..||.... +........... ..+...
T Consensus 171 ~~~~~~~--~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~-~~~~~~~~~~~~---~~~~~~ 244 (274)
T cd05076 171 SFTALSR--EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERT-PSEKERFYEKKH---RLPEPS 244 (274)
T ss_pred ccccccc--cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccC-hHHHHHHHHhcc---CCCCCC
Confidence 7543221 22357888999998854 4789999999999999995 6899997643 222222222211 122334
Q ss_pred ChhHHHHHHHhcC-CCCCCCCHHHHHcC
Q 008504 151 DPQIKGFIEKCLV-PASERLSAKDLLKD 177 (563)
Q Consensus 151 s~~l~~LI~kcL~-dP~kRpSa~ELLkH 177 (563)
.+.+.++|.+||. +|.+|||+.++|++
T Consensus 245 ~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 245 CKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred ChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 5689999999997 89999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.9e-26 Score=228.04 Aligned_cols=173 Identities=25% Similarity=0.464 Sum_probs=135.1
Q ss_pred CEeccCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~-~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
+||||++||+|.+++.+. ..+++..+..++.||+.||.|||++| ++||||||+||+++ .++.+||+|||++.....
T Consensus 85 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~g--i~H~dlkp~Nil~~-~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVE-SEHQVKIGDFGLTKAIET 161 (284)
T ss_pred EEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccchheEEEc-CCCCEEECCCcccccccc
Confidence 589999999999999765 35899999999999999999999999 99999999999997 457999999999876543
Q ss_pred CC-----CccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCC--------------CHHHHHHHHhc
Q 008504 80 PT-----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECK--------------NPAQIFKKVTS 139 (563)
Q Consensus 80 ~~-----~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~--------------~~~~i~~~i~~ 139 (563)
.. .....++..|+|||++.+ .++.++|||||||++|+|+|+..|+.... ........+..
T Consensus 162 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (284)
T cd05079 162 DKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEE 241 (284)
T ss_pred CccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHc
Confidence 21 123456778999998754 58899999999999999999876643211 11111222222
Q ss_pred CCCCCccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcC
Q 008504 140 GIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 177 (563)
Q Consensus 140 ~~~p~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkH 177 (563)
+... ..+...+..+.+||.+||. +|.+||++.+++++
T Consensus 242 ~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 242 GKRL-PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred CccC-CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 2222 2344567899999999997 89999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-25 Score=226.64 Aligned_cols=171 Identities=20% Similarity=0.345 Sum_probs=137.6
Q ss_pred CEeccCCCCCHHHHHHhCC----------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceE
Q 008504 1 MITELFTSGNLRQYRKKHK----------------------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIF 58 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~----------------------~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NIL 58 (563)
+||||+++|+|.+++.... .+++..++.++.||+.||.|||.++ ++||||||+|||
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~--i~H~dl~p~nil 162 (288)
T cd05050 85 LLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK--FVHRDLATRNCL 162 (288)
T ss_pred EEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--eecccccHhheE
Confidence 5899999999999997532 3788899999999999999999999 999999999999
Q ss_pred EeCCCCcEEEecccchhhccCCC----CccccCCCCccCccccc-ccCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHH
Q 008504 59 VNGNHGEVKIGDLGLAIAMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQ 132 (563)
Q Consensus 59 Ld~~~G~VKL~DFGlA~~~~~~~----~~~~~Gtp~Y~APEvl~-~~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~ 132 (563)
++ .++.++|+|||++....... ......++.|+|||.+. ..++.++|||||||++|+|++ |..||.. .....
T Consensus 163 ~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~-~~~~~ 240 (288)
T cd05050 163 VG-ENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYG-MAHEE 240 (288)
T ss_pred ec-CCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCC-CCHHH
Confidence 97 55799999999986543221 11223456799999875 458999999999999999998 7788876 34555
Q ss_pred HHHHHhcCCCCCccccCCChhHHHHHHHhcC-CCCCCCCHHHHHc
Q 008504 133 IFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 133 i~~~i~~~~~p~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLk 176 (563)
....+..+.... .+...+..+.+||.+||. +|.+|||+.|+++
T Consensus 241 ~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 241 VIYYVRDGNVLS-CPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred HHHHHhcCCCCC-CCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 555555544332 234567899999999997 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.4e-26 Score=247.22 Aligned_cols=183 Identities=23% Similarity=0.417 Sum_probs=149.4
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhcc--
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ-- 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~-- 78 (563)
|||+|++||++-.+|-+-+-|.+..++.|+..+..|+++.|..| +|||||||+||||| .+|+|||.||||+.-++
T Consensus 706 FVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmG--FIHRDiKPDNILID-rdGHIKLTDFGLCTGfRWT 782 (1034)
T KOG0608|consen 706 FVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILID-RDGHIKLTDFGLCTGFRWT 782 (1034)
T ss_pred EEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhcc--ceecccCccceEEc-cCCceeeeeccccccceec
Confidence 69999999999999999999999999999999999999999999 99999999999998 56999999999985321
Q ss_pred -CCC-----------------------------------------CccccCCCCccCccccc-ccCCchhhHHHhHHHHH
Q 008504 79 -QPT-----------------------------------------ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCIL 115 (563)
Q Consensus 79 -~~~-----------------------------------------~~~~~Gtp~Y~APEvl~-~~ys~ksDIwSLGviLy 115 (563)
+.. ....+||+.|+|||++. .+|+..+|+||.|||||
T Consensus 783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~ 862 (1034)
T KOG0608|consen 783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY 862 (1034)
T ss_pred cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence 000 11457999999999885 56999999999999999
Q ss_pred HHhhcCCCCCCCCCHHHHHHHHhcCC--CCCccccCCChhHHHHHHHhcCCCCCCCC---HHHHHcCccccccccCC
Q 008504 116 EMVTFEYPYSECKNPAQIFKKVTSGI--KPASLAKVNDPQIKGFIEKCLVPASERLS---AKDLLKDPFLQVENQKE 187 (563)
Q Consensus 116 ELlTG~~Pf~~~~~~~~i~~~i~~~~--~p~~l~~~~s~~l~~LI~kcL~dP~kRpS---a~ELLkHpff~~~~~~~ 187 (563)
||+.|+.||.... +.....++.... .........++++.++|.++...+..|.. ++++..||||+..++..
T Consensus 863 em~~g~~pf~~~t-p~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~sad~RLGkng~d~vKaHpfFkgIDfss 938 (1034)
T KOG0608|consen 863 EMLVGQPPFLADT-PGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCCSADSRLGKNGADQVKAHPFFKGIDFSS 938 (1034)
T ss_pred HHhhCCCCccCCC-CCcceeeeeehhhccccccccccCHHHHHHHHHHhcChhhhhcccchhhhhcCccccccchHh
Confidence 9999999997633 322222222211 12223455688999999999988888874 78899999999887765
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-25 Score=222.98 Aligned_cols=171 Identities=28% Similarity=0.469 Sum_probs=137.4
Q ss_pred CEeccCCCCCHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCC-----cEEE
Q 008504 1 MITELFTSGNLRQYRKKH-------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHG-----EVKI 68 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~-------~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G-----~VKL 68 (563)
+||||+++|+|.+++.+. ..+++..+..++.||+.||.|||+.+ ++|+||||+||+++. .+ .++|
T Consensus 76 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~~-~~~~~~~~~~l 152 (269)
T cd05044 76 IIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH--FIHRDLAARNCLVSE-KGYDADRVVKI 152 (269)
T ss_pred EEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC--cccCCCChheEEEec-CCCCCCcceEE
Confidence 589999999999999742 34788999999999999999999999 999999999999984 34 7999
Q ss_pred ecccchhhccCCC----CccccCCCCccCccccc-ccCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCC
Q 008504 69 GDLGLAIAMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIK 142 (563)
Q Consensus 69 ~DFGlA~~~~~~~----~~~~~Gtp~Y~APEvl~-~~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~ 142 (563)
+|||++....... .....++..|+|||.+. +.++.++|||||||++|+|++ |..||... +.......+..+..
T Consensus 153 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~-~~~~~~~~~~~~~~ 231 (269)
T cd05044 153 GDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPAL-NNQEVLQHVTAGGR 231 (269)
T ss_pred CCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCccc-CHHHHHHHHhcCCc
Confidence 9999986543221 12234567899999876 458999999999999999998 99999763 34445555544332
Q ss_pred CCccccCCChhHHHHHHHhcC-CCCCCCCHHHHHc
Q 008504 143 PASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 143 p~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLk 176 (563)
. ..+...+..+.+||.+||. +|.+||++.++++
T Consensus 232 ~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 232 L-QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred c-CCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 2 2344567889999999997 8999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-25 Score=229.12 Aligned_cols=172 Identities=28% Similarity=0.474 Sum_probs=139.1
Q ss_pred CEeccCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~-~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
+|+||+++|+|.+++..++ .+++..+..++.||+.||.|||+++ |+||||||+||+++ +++.+||+|||++.....
T Consensus 85 ~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dikp~Nill~-~~~~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR--LVHRDLAARNVLVK-SPNHVKITDFGLARLLEG 161 (303)
T ss_pred eeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcC--eeccccccceeeec-CCCceEEccccccccccC
Confidence 5899999999999998754 5899999999999999999999999 99999999999997 457999999999976542
Q ss_pred CC----CccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCCCCccccCCChh
Q 008504 80 PT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQ 153 (563)
Q Consensus 80 ~~----~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~ 153 (563)
.. .....++..|+|||.+.+ .++.++|||||||++|+|++ |..||.+. ........+..+..+ ..+...+..
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~ 239 (303)
T cd05110 162 DEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI-PTREIPDLLEKGERL-PQPPICTID 239 (303)
T ss_pred cccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHCCCCC-CCCCCCCHH
Confidence 21 112345678999998764 58899999999999999997 88999763 334444444444333 234456788
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHHcC
Q 008504 154 IKGFIEKCLV-PASERLSAKDLLKD 177 (563)
Q Consensus 154 l~~LI~kcL~-dP~kRpSa~ELLkH 177 (563)
+.+++.+||. +|.+||++.++++.
T Consensus 240 ~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 240 VYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999999997 89999999999874
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.2e-25 Score=223.97 Aligned_cols=171 Identities=27% Similarity=0.457 Sum_probs=140.7
Q ss_pred CEeccCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~-~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
+||||+++|+|.+++.+. ..+++..+..|+.||+.||+|||+++ |+||||||+||+++ ..+.+||+|||++.....
T Consensus 85 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~di~p~nil~~-~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 85 LITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR--LVHRDLAARNVLVK-TPQHVKITDFGLAKLLDV 161 (279)
T ss_pred EEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--EEecccCcceEEEc-CCCeEEECCCcccccccC
Confidence 589999999999999874 46999999999999999999999999 99999999999997 557999999999976543
Q ss_pred CCC----ccccCCCCccCccccc-ccCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCCCCccccCCChh
Q 008504 80 PTA----RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQ 153 (563)
Q Consensus 80 ~~~----~~~~Gtp~Y~APEvl~-~~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~ 153 (563)
... ....++..|+|||.+. ..++.++|+||||+++|++++ |..||... ....+...+..+... ..+...+..
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~ 239 (279)
T cd05057 162 DEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGI-PAVEIPDLLEKGERL-PQPPICTID 239 (279)
T ss_pred cccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCC-CHHHHHHHHhCCCCC-CCCCCCCHH
Confidence 211 1112356799999875 458899999999999999998 99999773 556666666655432 334567789
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHHc
Q 008504 154 IKGFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 154 l~~LI~kcL~-dP~kRpSa~ELLk 176 (563)
+.+++.+||. +|.+||++.++++
T Consensus 240 ~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 240 VYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred HHHHHHHHcCCChhhCCCHHHHHH
Confidence 9999999997 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-25 Score=222.99 Aligned_cols=171 Identities=23% Similarity=0.429 Sum_probs=138.9
Q ss_pred CEeccCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~-~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
+||||+++|+|.+++.+. +.+++..+..++.||+.||.|||++| ++||||||+||+++ .++.++|+|||++.....
T Consensus 82 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~h~dlkp~nili~-~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 82 IVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILVN-SNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeehhhchhcEEEC-CCCeEEeCCCCccccccc
Confidence 589999999999999864 46899999999999999999999999 99999999999997 457999999999876543
Q ss_pred CCC-----ccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCCCCccccCCCh
Q 008504 80 PTA-----RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDP 152 (563)
Q Consensus 80 ~~~-----~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~ 152 (563)
... ....++..|+|||.+.+ .++.++|+||||+++|++++ |..||... ........+..+..+ ..+...++
T Consensus 159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~ 236 (267)
T cd05066 159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEM-SNQDVIKAIEEGYRL-PAPMDCPA 236 (267)
T ss_pred ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccC-CHHHHHHHHhCCCcC-CCCCCCCH
Confidence 211 11123567999998864 58999999999999999886 99999764 344555555555332 22344578
Q ss_pred hHHHHHHHhcC-CCCCCCCHHHHHc
Q 008504 153 QIKGFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 153 ~l~~LI~kcL~-dP~kRpSa~ELLk 176 (563)
.+++++.+||. +|.+||++.++++
T Consensus 237 ~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 237 ALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred HHHHHHHHHcccCchhCCCHHHHHH
Confidence 89999999997 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.7e-26 Score=261.47 Aligned_cols=176 Identities=33% Similarity=0.566 Sum_probs=143.8
Q ss_pred CEeccCCCCCHHHHHHhCCCC-CHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhcc-
Q 008504 1 MITELFTSGNLRQYRKKHKNV-DIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ- 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~L-se~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~- 78 (563)
|=||||+.-+|++++.++... ....++++++||+.||.|+|++| ||||||||.|||++ ..+.|||+|||+|+...
T Consensus 673 IQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~g--iIHRDLKP~NIFLd-~~~~VKIGDFGLAt~~~~ 749 (1351)
T KOG1035|consen 673 IQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQG--IIHRDLKPRNIFLD-SRNSVKIGDFGLATDLKE 749 (1351)
T ss_pred EEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCc--eeeccCCcceeEEc-CCCCeeecccccchhhhh
Confidence 348999998999988876654 57889999999999999999999 99999999999999 45699999999997511
Q ss_pred ---------C----------CCCccccCCCCccCcccccc----cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHH
Q 008504 79 ---------Q----------PTARSVIGTPEFMAPELYEE----EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFK 135 (563)
Q Consensus 79 ---------~----------~~~~~~~Gtp~Y~APEvl~~----~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~ 135 (563)
. ......+||.-|+|||++.+ .|+.|+|+|||||+++||+ +||........+..
T Consensus 750 ~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~---yPF~TsMERa~iL~ 826 (1351)
T KOG1035|consen 750 NLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEML---YPFGTSMERASILT 826 (1351)
T ss_pred hhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHh---ccCCchHHHHHHHH
Confidence 0 01234589999999999853 5999999999999999998 57877666666667
Q ss_pred HHhcCCCCCc--cccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCccccc
Q 008504 136 KVTSGIKPAS--LAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQV 182 (563)
Q Consensus 136 ~i~~~~~p~~--l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~ 182 (563)
.+..+..|.. +....-+.-..+|..||. ||++||||.|||++-||..
T Consensus 827 ~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~llpp 876 (1351)
T KOG1035|consen 827 NLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNSELLPP 876 (1351)
T ss_pred hcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhhccCCCc
Confidence 7776666554 112223567889999998 9999999999999999974
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=241.44 Aligned_cols=153 Identities=25% Similarity=0.405 Sum_probs=123.9
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCCC----CccccCCCCccCcc
Q 008504 20 NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT----ARSVIGTPEFMAPE 95 (563)
Q Consensus 20 ~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~~----~~~~~Gtp~Y~APE 95 (563)
.+++..+..++.||+.||.|||+++ |+||||||+|||++ ..+.+||+|||++....... .....+++.|+|||
T Consensus 233 ~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dikp~Nill~-~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE 309 (400)
T cd05105 233 GLTTLDLLSFTYQVARGMEFLASKN--CVHRDLAARNVLLA-QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPE 309 (400)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChHhEEEe-CCCEEEEEeCCcceeccccccccccCCcCCCcceEChh
Confidence 4788889999999999999999999 99999999999998 45799999999987543221 22335678899999
Q ss_pred cccc-cCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHHHHHHhcC-CCCCCCCHH
Q 008504 96 LYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAK 172 (563)
Q Consensus 96 vl~~-~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ 172 (563)
++.+ .++.++|||||||++|+|++ |..||.........+..+..+..+ ..+...+..++++|.+||. +|.+||++.
T Consensus 310 ~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 388 (400)
T cd05105 310 SIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRM-AKPDHATQEVYDIMVKCWNSEPEKRPSFL 388 (400)
T ss_pred hhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHHhcCCCC-CCCccCCHHHHHHHHHHCccCHhHCcCHH
Confidence 8754 58999999999999999997 899998754445555555555433 2345567899999999997 899999999
Q ss_pred HHHc
Q 008504 173 DLLK 176 (563)
Q Consensus 173 ELLk 176 (563)
++.+
T Consensus 389 ~l~~ 392 (400)
T cd05105 389 HLSD 392 (400)
T ss_pred HHHH
Confidence 8876
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-25 Score=227.14 Aligned_cols=172 Identities=27% Similarity=0.399 Sum_probs=133.6
Q ss_pred CEeccCCCCCHHHHHHhCC------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEE
Q 008504 1 MITELFTSGNLRQYRKKHK------------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKI 68 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~------------~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL 68 (563)
+||||+.+|+|.+++.... .+++..+..++.||+.||.|||++| ++||||||+||+++ +++.+||
T Consensus 94 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~Nill~-~~~~~kl 170 (295)
T cd05097 94 MITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN--FVHRDLATRNCLVG-NHYTIKI 170 (295)
T ss_pred EEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC--eeccccChhhEEEc-CCCcEEe
Confidence 5899999999999996532 3788999999999999999999999 99999999999998 5579999
Q ss_pred ecccchhhccCCC----CccccCCCCccCccccc-ccCCchhhHHHhHHHHHHHhh--cCCCCCCCCCHHHHHHHHhc--
Q 008504 69 GDLGLAIAMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT--FEYPYSECKNPAQIFKKVTS-- 139 (563)
Q Consensus 69 ~DFGlA~~~~~~~----~~~~~Gtp~Y~APEvl~-~~ys~ksDIwSLGviLyELlT--G~~Pf~~~~~~~~i~~~i~~-- 139 (563)
+|||++....... .....+++.|+|||.+. +.++.++|||||||++|+|++ +..||.... .......+..
T Consensus 171 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~-~~~~~~~~~~~~ 249 (295)
T cd05097 171 ADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS-DEQVIENTGEFF 249 (295)
T ss_pred cccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccC-hHHHHHHHHHhh
Confidence 9999986543221 11224467899999775 458999999999999999998 567887633 3333322211
Q ss_pred ----CCCCCccccCCChhHHHHHHHhcC-CCCCCCCHHHHHc
Q 008504 140 ----GIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 140 ----~~~p~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLk 176 (563)
.......+...++.+.+||.+||. +|.+||++.++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 250 RNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred hhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 111122334567899999999997 8999999999975
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-25 Score=233.91 Aligned_cols=176 Identities=29% Similarity=0.411 Sum_probs=137.5
Q ss_pred EeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCCC
Q 008504 2 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT 81 (563)
Q Consensus 2 VmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~~ 81 (563)
+++++ +++|.+++.. +.+++..++.++.||+.||.|||++| |+||||||+||+++ .+|.+||+|||++..... .
T Consensus 100 v~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~-~~~~~kl~dfg~~~~~~~-~ 173 (345)
T cd07877 100 VTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTDD-E 173 (345)
T ss_pred Eehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEc-CCCCEEEecccccccccc-c
Confidence 56665 7899988765 46999999999999999999999999 99999999999998 557999999999865433 2
Q ss_pred CccccCCCCccCcccccc--cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcC-------------------
Q 008504 82 ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG------------------- 140 (563)
Q Consensus 82 ~~~~~Gtp~Y~APEvl~~--~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~------------------- 140 (563)
.....+++.|+|||.+.+ .++.++|||||||++|+|++|+.||....... ....+...
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (345)
T cd07877 174 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID-QLKLILRLVGTPGAELLKKISSESARN 252 (345)
T ss_pred ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHHhhcccHhHHH
Confidence 234567899999998754 47889999999999999999999997533222 21111110
Q ss_pred -------CCCC---ccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCccccccc
Q 008504 141 -------IKPA---SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 184 (563)
Q Consensus 141 -------~~p~---~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~ 184 (563)
.... ......++.+.+||.+||. +|.+||++.+++.||||+...
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~ 307 (345)
T cd07877 253 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 307 (345)
T ss_pred HHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcC
Confidence 0000 0011346789999999997 899999999999999998643
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-25 Score=224.48 Aligned_cols=172 Identities=27% Similarity=0.438 Sum_probs=132.4
Q ss_pred CEeccCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~-~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
+||||+++|+|.+++.+. ..+++..++.++.||+.||.|||++| |+||||||+||+++ .++.+||+|||++.....
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~--i~H~dlkp~nili~-~~~~~~l~dfg~~~~~~~ 160 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR--YVHRDLATRNILVE-SENRVKIGDFGLTKVLPQ 160 (284)
T ss_pred EEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHhhEEEC-CCCeEEECCCcccccccC
Confidence 589999999999999764 46899999999999999999999999 99999999999997 457999999999976543
Q ss_pred CCC-----ccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCH---------------HHHHHHHh
Q 008504 80 PTA-----RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNP---------------AQIFKKVT 138 (563)
Q Consensus 80 ~~~-----~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~---------------~~i~~~i~ 138 (563)
... ....++..|+|||++.+ .++.++|||||||++|+|++|..|+...... ..+...+.
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05081 161 DKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLK 240 (284)
T ss_pred CCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHh
Confidence 221 11123446999998864 4889999999999999999987765431110 00111122
Q ss_pred cCCCCCccccCCChhHHHHHHHhcC-CCCCCCCHHHHHc
Q 008504 139 SGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 139 ~~~~p~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLk 176 (563)
.... ...+...+..+.+||.+||. +|.+|||+.++++
T Consensus 241 ~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 241 NNGR-LPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred cCCc-CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 2211 12234456789999999997 8999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-25 Score=226.13 Aligned_cols=172 Identities=25% Similarity=0.396 Sum_probs=132.9
Q ss_pred CEeccCCCCCHHHHHHhCC-----------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEe
Q 008504 1 MITELFTSGNLRQYRKKHK-----------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIG 69 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~-----------~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~ 69 (563)
+||||+.+|+|.+++.+.. .+++..+..++.||+.||+|||++| ++||||||+|||++ ..+.++|+
T Consensus 96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dlkp~Nili~-~~~~~~l~ 172 (296)
T cd05095 96 MITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN--FVHRDLATRNCLVG-KNYTIKIA 172 (296)
T ss_pred EEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--eecccCChheEEEc-CCCCEEec
Confidence 5899999999999997643 3677899999999999999999999 99999999999997 55799999
Q ss_pred cccchhhccCCCC----ccccCCCCccCccccc-ccCCchhhHHHhHHHHHHHhh--cCCCCCCCCCHHHHHHHHhc---
Q 008504 70 DLGLAIAMQQPTA----RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT--FEYPYSECKNPAQIFKKVTS--- 139 (563)
Q Consensus 70 DFGlA~~~~~~~~----~~~~Gtp~Y~APEvl~-~~ys~ksDIwSLGviLyELlT--G~~Pf~~~~~~~~i~~~i~~--- 139 (563)
|||++..+..... ....+++.|+|||... +.++.++|||||||++|+|++ |..||.... ..........
T Consensus 173 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~-~~~~~~~~~~~~~ 251 (296)
T cd05095 173 DFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLS-DEQVIENTGEFFR 251 (296)
T ss_pred cCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccC-hHHHHHHHHHHHh
Confidence 9999875533221 1223457899999654 568999999999999999998 678887633 2332222111
Q ss_pred -C--CCCCccccCCChhHHHHHHHhcC-CCCCCCCHHHHHc
Q 008504 140 -G--IKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 140 -~--~~p~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLk 176 (563)
. ......+...++.+++||.+||. +|.+||++.++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 252 DQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred hccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 0 01111233456899999999997 8999999999875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.9e-26 Score=263.42 Aligned_cols=174 Identities=19% Similarity=0.220 Sum_probs=131.2
Q ss_pred EeccCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeC------------------C
Q 008504 2 ITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG------------------N 62 (563)
Q Consensus 2 VmEy~~gGsL~~~L~k-~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~------------------~ 62 (563)
++||+ +++|.+++.. ...+++..++.+++||+.||.|||++| |+||||||+||||+. .
T Consensus 58 ~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g--IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~ 134 (793)
T PLN00181 58 ALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQG--IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDE 134 (793)
T ss_pred hhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCC--eeeccCCchhEEEcccCcEEEeeccccCcccccc
Confidence 57877 6699999975 356999999999999999999999999 999999999999952 2
Q ss_pred CCcEEEecccchhhccCC------------------CCccccCCCCccCccccc-ccCCchhhHHHhHHHHHHHhhcCCC
Q 008504 63 HGEVKIGDLGLAIAMQQP------------------TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYP 123 (563)
Q Consensus 63 ~G~VKL~DFGlA~~~~~~------------------~~~~~~Gtp~Y~APEvl~-~~ys~ksDIwSLGviLyELlTG~~P 123 (563)
.+.+||+|||+++..... .....+||+.|||||++. ..|+.++|||||||++|||++|..|
T Consensus 135 ~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~ 214 (793)
T PLN00181 135 DATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSS 214 (793)
T ss_pred cCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCc
Confidence 345677777776532110 001135789999999875 4599999999999999999999888
Q ss_pred CCCCCCHHHHHHHHhcCCCCCccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCccccc
Q 008504 124 YSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQV 182 (563)
Q Consensus 124 f~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~ 182 (563)
+... ......+.....+.... ...+....++.+||. +|.+||++.|+|+||||..
T Consensus 215 ~~~~---~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~ 270 (793)
T PLN00181 215 REEK---SRTMSSLRHRVLPPQIL-LNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINE 270 (793)
T ss_pred hhhH---HHHHHHHHHhhcChhhh-hcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhh
Confidence 7531 22222222222222111 124567889999997 8999999999999999975
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.93 E-value=3e-25 Score=221.47 Aligned_cols=171 Identities=22% Similarity=0.406 Sum_probs=136.8
Q ss_pred CEeccCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k-~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
+||||+++|+|.+++.. .+.+++..++.++.|++.||.|||++| ++||||||+||+++ .++.+||+|||++.....
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g--~~H~dl~p~nili~-~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 82 IITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMN--YVHRDLAARNILVN-SNLVCKVSDFGLSRFLED 158 (269)
T ss_pred EEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccChheEEEc-CCCcEEECCCcccccccc
Confidence 58999999999999986 356899999999999999999999999 99999999999998 457999999999865433
Q ss_pred CCC----cccc---CCCCccCccccc-ccCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCCCCccccCC
Q 008504 80 PTA----RSVI---GTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVN 150 (563)
Q Consensus 80 ~~~----~~~~---Gtp~Y~APEvl~-~~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~ 150 (563)
... .... .+..|+|||.+. ..++.++|||||||++|||++ |..||... ........+...... ..+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~-~~~~~~~~i~~~~~~-~~~~~~ 236 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM-SNQDVINAIEQDYRL-PPPMDC 236 (269)
T ss_pred CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCC-CHHHHHHHHHcCCcC-CCcccC
Confidence 211 1111 134799999886 458999999999999999886 99999763 344555555443322 223455
Q ss_pred ChhHHHHHHHhcC-CCCCCCCHHHHHc
Q 008504 151 DPQIKGFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 151 s~~l~~LI~kcL~-dP~kRpSa~ELLk 176 (563)
+..+.+++.+||. +|.+||++.+++.
T Consensus 237 ~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 237 PTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 7889999999997 8999999999985
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.2e-25 Score=220.52 Aligned_cols=171 Identities=23% Similarity=0.426 Sum_probs=138.0
Q ss_pred CEeccCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhcc
Q 008504 1 MITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~--~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~ 78 (563)
+||||+++|+|.+++.+. ..+++..+..++.||+.||.|||++| ++||||||+||+++ ..+.+||+|||++....
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~ni~i~-~~~~~~l~d~~~~~~~~ 153 (260)
T cd05073 77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVS-ASLVCKIADFGLARVIE 153 (260)
T ss_pred EEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEc-CCCcEEECCCcceeecc
Confidence 589999999999999763 45788999999999999999999999 99999999999997 55799999999986554
Q ss_pred CCCC---ccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCCCCccccCCChh
Q 008504 79 QPTA---RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQ 153 (563)
Q Consensus 79 ~~~~---~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~ 153 (563)
.... ....++..|+|||++.. .++.++|+|||||++|+++| |..||... ........+..+... ..+...+..
T Consensus 154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~ 231 (260)
T cd05073 154 DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM-SNPEVIRALERGYRM-PRPENCPEE 231 (260)
T ss_pred CCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHhCCCCC-CCcccCCHH
Confidence 3211 12234567999998864 47889999999999999999 89999864 344444555544332 234456789
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHHc
Q 008504 154 IKGFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 154 l~~LI~kcL~-dP~kRpSa~ELLk 176 (563)
+.+++.+||. +|.+||++.++++
T Consensus 232 ~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 232 LYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred HHHHHHHHcccCcccCcCHHHHHH
Confidence 9999999997 8999999998864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-26 Score=249.27 Aligned_cols=180 Identities=28% Similarity=0.454 Sum_probs=155.5
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC-
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ- 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~- 79 (563)
+||||+.+|.+++|+.+++++.+..++.++.|++.|++|||+++ |+|||||++|||++.+ -.+||+|||++..+..
T Consensus 132 lV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~--ivHrdLk~eNilL~~~-mnikIaDfgfS~~~~~~ 208 (596)
T KOG0586|consen 132 LVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKN--IVHRDLKAENILLDEN-MNIKIADFGFSTFFDYG 208 (596)
T ss_pred EEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcc--eeccccchhhcccccc-cceeeeccccceeeccc
Confidence 69999999999999999999999999999999999999999999 9999999999999865 4799999999987764
Q ss_pred CCCccccCCCCccCccccccc--CCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHHH
Q 008504 80 PTARSVIGTPEFMAPELYEEE--YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 157 (563)
Q Consensus 80 ~~~~~~~Gtp~Y~APEvl~~~--ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~L 157 (563)
....+.+|++.|.|||++.+. .++.+|+||+|+++|.|+.|..||.+ .+...+...+..+.. .++...+-++.++
T Consensus 209 ~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG-~~lk~Lr~rvl~gk~--rIp~~ms~dce~l 285 (596)
T KOG0586|consen 209 LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDG-QNLKELRPRVLRGKY--RIPFYMSCDCEDL 285 (596)
T ss_pred ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCC-cccccccchheeeee--cccceeechhHHH
Confidence 456788999999999999764 47899999999999999999999987 344444444444433 2455566789999
Q ss_pred HHHhcC-CCCCCCCHHHHHcCccccccccC
Q 008504 158 IEKCLV-PASERLSAKDLLKDPFLQVENQK 186 (563)
Q Consensus 158 I~kcL~-dP~kRpSa~ELLkHpff~~~~~~ 186 (563)
|.++|. +|.+|++.+++.+|.|.......
T Consensus 286 Lrk~lvl~Pskr~~~dqim~~~W~n~~~~~ 315 (596)
T KOG0586|consen 286 LRKFLVLNPSKRGPCDQIMKDRWRNDLLEA 315 (596)
T ss_pred HHHhhccCccccCCHHHhhhhcccchhhhh
Confidence 999998 89999999999999999765544
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-25 Score=235.00 Aligned_cols=182 Identities=29% Similarity=0.455 Sum_probs=150.7
Q ss_pred EeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeC--CCCcEEEecccchhhccC
Q 008504 2 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG--NHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 2 VmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~--~~G~VKL~DFGlA~~~~~ 79 (563)
|+|||+|.+|.-||++++-+++++++.|+.||+.||.||....|||||-||||.|||+-. ..|.+||.|||+++.+..
T Consensus 546 VLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdd 625 (775)
T KOG1151|consen 546 VLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDD 625 (775)
T ss_pred eeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhhhccC
Confidence 789999999999999999999999999999999999999999999999999999999842 236899999999998765
Q ss_pred CCC---------ccccCCCCccCccccc-c----cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhc---CCC
Q 008504 80 PTA---------RSVIGTPEFMAPELYE-E----EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS---GIK 142 (563)
Q Consensus 80 ~~~---------~~~~Gtp~Y~APEvl~-~----~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~---~~~ 142 (563)
... ....||.+|++||.+- + +.+.++||||+|||+|.++.|+.||........+....+- ...
T Consensus 626 dSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlkAtEV 705 (775)
T KOG1151|consen 626 DSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILKATEV 705 (775)
T ss_pred CccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhcceec
Confidence 322 2346899999999773 2 3788999999999999999999999875555444433211 111
Q ss_pred CCccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCcccccc
Q 008504 143 PASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 183 (563)
Q Consensus 143 p~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~ 183 (563)
........++++++||++||. .-.+|..+.+|-.||||...
T Consensus 706 qFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh 747 (775)
T KOG1151|consen 706 QFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPH 747 (775)
T ss_pred cCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccch
Confidence 222345668899999999998 68899999999999999753
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.5e-25 Score=252.09 Aligned_cols=99 Identities=25% Similarity=0.465 Sum_probs=77.6
Q ss_pred cCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcC-CCCCccccCCChhHHHHHHHhcC
Q 008504 86 IGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG-IKPASLAKVNDPQIKGFIEKCLV 163 (563)
Q Consensus 86 ~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~-~~p~~l~~~~s~~l~~LI~kcL~ 163 (563)
+||+.|+|||++.+ .|+.++|||||||++|||+||+.||.. ......+..+... ..........+..+.+++.+||.
T Consensus 541 vGT~~Y~APE~l~~~~~~~~~DiwSlG~il~ElltG~~pf~~-~~~~~~~~~il~~~~~~p~~~~~~~~~~~~~l~~lL~ 619 (669)
T cd05610 541 LGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFND-ETPQQVFQNILNRDIPWPEGEEKLSVNAQNAIEILLT 619 (669)
T ss_pred eeCccccCHHHcCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHcc
Confidence 45889999997754 589999999999999999999999987 3455555554433 22222233457789999999997
Q ss_pred -CCCCCCCHHHHHcCcccccccc
Q 008504 164 -PASERLSAKDLLKDPFLQVENQ 185 (563)
Q Consensus 164 -dP~kRpSa~ELLkHpff~~~~~ 185 (563)
+|.+||++.++|+||||....+
T Consensus 620 ~dP~~R~ta~e~l~h~~~~~~~~ 642 (669)
T cd05610 620 MDPTKRAGLKELKQHPLFHGVDW 642 (669)
T ss_pred cChhHCcCHHHHHhCHhhcCCCH
Confidence 8999999999999999976543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-25 Score=226.15 Aligned_cols=181 Identities=33% Similarity=0.529 Sum_probs=141.0
Q ss_pred CEeccCCCCCHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCC---CCcEEEeccc
Q 008504 1 MITELFTSGNLRQYRKKH-----KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGN---HGEVKIGDLG 72 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~-----~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~---~G~VKL~DFG 72 (563)
|++||.+. +|.+.|+-+ +.++...++.++.||+.|+.|||++- |+||||||.||+|.++ .|.|||+|||
T Consensus 105 l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW--vlHRDLKPaNIlvmgdgperG~VKIaDlG 181 (438)
T KOG0666|consen 105 LLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW--VLHRDLKPANILVMGDGPERGRVKIADLG 181 (438)
T ss_pred EEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh--eeeccCCcceEEEeccCCccCeeEeeccc
Confidence 58999987 999998743 35999999999999999999999999 9999999999999754 4899999999
Q ss_pred chhhccCCC-----CccccCCCCccCcccccc--cCCchhhHHHhHHHHHHHhhcCCCCCCCC------CH---HHHHHH
Q 008504 73 LAIAMQQPT-----ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECK------NP---AQIFKK 136 (563)
Q Consensus 73 lA~~~~~~~-----~~~~~Gtp~Y~APEvl~~--~ys~ksDIwSLGviLyELlTG~~Pf~~~~------~~---~~i~~~ 136 (563)
+++.+..+- ...++-|.+|.|||++-+ .|+.++|||++|||+.||+|.++.|.+.. ++ .++.+.
T Consensus 182 laR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rI 261 (438)
T KOG0666|consen 182 LARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRI 261 (438)
T ss_pred HHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHH
Confidence 999876542 334577999999998854 59999999999999999999888775421 11 111111
Q ss_pred Hhc-CCC-----------CC----------------------ccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCcccc
Q 008504 137 VTS-GIK-----------PA----------------------SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQ 181 (563)
Q Consensus 137 i~~-~~~-----------p~----------------------~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~ 181 (563)
..- |.+ |. ...+..++...+|+.++|. ||.+|+|+.++|+|+||.
T Consensus 262 f~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~ 341 (438)
T KOG0666|consen 262 FEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYFT 341 (438)
T ss_pred HHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccccc
Confidence 100 000 00 0012235668899999997 999999999999999998
Q ss_pred ccc
Q 008504 182 VEN 184 (563)
Q Consensus 182 ~~~ 184 (563)
...
T Consensus 342 ~d~ 344 (438)
T KOG0666|consen 342 EDP 344 (438)
T ss_pred cCC
Confidence 653
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.8e-25 Score=228.95 Aligned_cols=177 Identities=32% Similarity=0.487 Sum_probs=138.1
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
+|+||+ +++|..+++. .++++..+..++.||+.||.|||++| |+||||+|+||+++ ..+.+||+|||++.....
T Consensus 87 lv~e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~--iiH~dl~p~Nili~-~~~~~~l~dfg~~~~~~~- 160 (328)
T cd07856 87 FVTELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAG--VVHRDLKPSNILIN-ENCDLKICDFGLARIQDP- 160 (328)
T ss_pred EEeehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEeEC-CCCCEEeCccccccccCC-
Confidence 589998 5699988875 46899999999999999999999999 99999999999998 567999999999865433
Q ss_pred CCccccCCCCccCcccccc--cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHh---------------cC---
Q 008504 81 TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVT---------------SG--- 140 (563)
Q Consensus 81 ~~~~~~Gtp~Y~APEvl~~--~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~---------------~~--- 140 (563)
......+++.|+|||.+.+ .++.++|||||||++|+|++|+.||.... .......+. ..
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (328)
T cd07856 161 QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKD-HVNQFSIITDLLGTPPDDVINTICSENTL 239 (328)
T ss_pred CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHhCCCCHHHHHhccchhhH
Confidence 2234467889999998754 58999999999999999999999997532 211111000 00
Q ss_pred ------C--CCC---ccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCccccccc
Q 008504 141 ------I--KPA---SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 184 (563)
Q Consensus 141 ------~--~p~---~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~ 184 (563)
. .+. ......++.++++|.+||. +|.+||++.+++.||||....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~ 295 (328)
T cd07856 240 RFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYH 295 (328)
T ss_pred HHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCcccccc
Confidence 0 000 0112346789999999997 899999999999999997543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.7e-25 Score=218.26 Aligned_cols=172 Identities=21% Similarity=0.355 Sum_probs=136.9
Q ss_pred CEeccCCCCCHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccch
Q 008504 1 MITELFTSGNLRQYRKKH------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA 74 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~------~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA 74 (563)
+++||+.+|+|.+++... ..++...++.++.||+.||+|||++| |+||||||+||+++ ..+.+||+|||++
T Consensus 84 ~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~nili~-~~~~~kl~dfg~~ 160 (273)
T cd05074 84 VILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN--FIHRDLAARNCMLN-ENMTVCVADFGLS 160 (273)
T ss_pred EEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccchhhEEEc-CCCCEEECccccc
Confidence 367899999999987532 24789999999999999999999999 99999999999997 5579999999998
Q ss_pred hhccCCC----CccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCCCCcccc
Q 008504 75 IAMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAK 148 (563)
Q Consensus 75 ~~~~~~~----~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~ 148 (563)
....... .....+++.|++||.+.+ .++.++|||||||++|+|++ |..||.. .+...++..+..+.... .+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~ 238 (273)
T cd05074 161 KKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAG-VENSEIYNYLIKGNRLK-QPP 238 (273)
T ss_pred ccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCC-CCHHHHHHHHHcCCcCC-CCC
Confidence 7553221 122345678999998764 47889999999999999999 8888876 44455555555443322 233
Q ss_pred CCChhHHHHHHHhcC-CCCCCCCHHHHHcC
Q 008504 149 VNDPQIKGFIEKCLV-PASERLSAKDLLKD 177 (563)
Q Consensus 149 ~~s~~l~~LI~kcL~-dP~kRpSa~ELLkH 177 (563)
..+..+.+++.+||. +|.+||++.+++++
T Consensus 239 ~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 239 DCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 456799999999997 89999999999863
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.8e-25 Score=221.03 Aligned_cols=172 Identities=27% Similarity=0.477 Sum_probs=135.3
Q ss_pred CEeccCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~-~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
+||||+++|+|.+++...+ .+++..+..++.||+.||.|||++| ++||||||+||+++ .++.++|+|||++.....
T Consensus 85 lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05038 85 LIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR--YIHRDLAARNILVE-SEDLVKISDFGLAKVLPE 161 (284)
T ss_pred EEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEc-CCCCEEEccccccccccc
Confidence 5899999999999998754 6999999999999999999999999 99999999999998 458999999999976552
Q ss_pred CCC-----ccccCCCCccCccccc-ccCCchhhHHHhHHHHHHHhhcCCCCCCCCCH--------------HHHHHHHhc
Q 008504 80 PTA-----RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNP--------------AQIFKKVTS 139 (563)
Q Consensus 80 ~~~-----~~~~Gtp~Y~APEvl~-~~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~--------------~~i~~~i~~ 139 (563)
... ....++..|+|||.+. ..++.++||||||+++|+|++|..|+...... ......+..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (284)
T cd05038 162 DKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKE 241 (284)
T ss_pred CCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHc
Confidence 211 1123455799999775 45888999999999999999999998653211 112222222
Q ss_pred CCCCCccccCCChhHHHHHHHhcC-CCCCCCCHHHHHc
Q 008504 140 GIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 140 ~~~p~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLk 176 (563)
... ...+...+..+.+|+.+||. +|.+|||+.++++
T Consensus 242 ~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 242 GER-LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred CCc-CCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 222 22234456789999999997 8999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-25 Score=228.18 Aligned_cols=191 Identities=23% Similarity=0.406 Sum_probs=155.7
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhcc--
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ-- 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~-- 78 (563)
+|.||++||+|--.+.++++++++.++.+...|+.||.|||++| ||+||||.+|+|++. .|.+||.|+|+++.--
T Consensus 328 fvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rg--iiyrdlkldnvllda-eghikltdygmcke~l~~ 404 (593)
T KOG0695|consen 328 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERG--IIYRDLKLDNVLLDA-EGHIKLTDYGMCKEGLGP 404 (593)
T ss_pred EEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcC--eeeeeccccceEEcc-CCceeecccchhhcCCCC
Confidence 58999999999999999999999999999999999999999999 999999999999985 5899999999996532
Q ss_pred CCCCccccCCCCccCccccccc-CCchhhHHHhHHHHHHHhhcCCCCCC--CCCH-----HHHHHHHhcCCCCCccccCC
Q 008504 79 QPTARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTFEYPYSE--CKNP-----AQIFKKVTSGIKPASLAKVN 150 (563)
Q Consensus 79 ~~~~~~~~Gtp~Y~APEvl~~~-ys~ksDIwSLGviLyELlTG~~Pf~~--~~~~-----~~i~~~i~~~~~p~~l~~~~ 150 (563)
.....+++|||.|.|||++++. |+..+|+|+||++++||+.|+.||.- ..++ .-+++.+.... ..++...
T Consensus 405 gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekq--iriprsl 482 (593)
T KOG0695|consen 405 GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQ--IRIPRSL 482 (593)
T ss_pred CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhc--cccccee
Confidence 2356688999999999999875 99999999999999999999999952 2222 23444444322 2345555
Q ss_pred ChhHHHHHHHhcC-CCCCCCC------HHHHHcCccccccccCCCCCCCCCCc
Q 008504 151 DPQIKGFIEKCLV-PASERLS------AKDLLKDPFLQVENQKEPICDPLKLP 196 (563)
Q Consensus 151 s~~l~~LI~kcL~-dP~kRpS------a~ELLkHpff~~~~~~~~~~~~l~~p 196 (563)
+-.+..+++..|. ||.+|.. +.++..|+||+...|.-...+....|
T Consensus 483 svkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~leqk~v~pp 535 (593)
T KOG0695|consen 483 SVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLLEQKQVLPP 535 (593)
T ss_pred ehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHHhhcccCCC
Confidence 6667788888886 8999864 78999999999888876544444333
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.1e-25 Score=235.43 Aligned_cols=153 Identities=26% Similarity=0.407 Sum_probs=124.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC----CCccccCCCCccCccc
Q 008504 21 VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP----TARSVIGTPEFMAPEL 96 (563)
Q Consensus 21 Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~----~~~~~~Gtp~Y~APEv 96 (563)
+++..+..++.||+.||.|||+.+ |+||||||+|||++ +.+.+||+|||++...... ......+++.|+|||.
T Consensus 236 l~~~~~~~~~~qi~~aL~~LH~~~--ivHrdlkp~NiLl~-~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~ 312 (401)
T cd05107 236 LSYMDLVGFSYQVANGMEFLASKN--CVHRDLAARNVLIC-EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPES 312 (401)
T ss_pred CCHHHHHHHHHHHHHHHHHHhcCC--cCcccCCcceEEEe-CCCEEEEEecCcceecccccccccCCCcCCCCceeChHH
Confidence 567788999999999999999999 99999999999998 4579999999998754321 1123356788999998
Q ss_pred ccc-cCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHHHHHHhcC-CCCCCCCHHH
Q 008504 97 YEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKD 173 (563)
Q Consensus 97 l~~-~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~E 173 (563)
+.+ .++.++|||||||++|||++ |..||............+..+..+ ..+...+..+.+||.+||. +|.+||++.+
T Consensus 313 ~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~~~~~-~~p~~~~~~l~~li~~cl~~~P~~RPs~~e 391 (401)
T cd05107 313 IFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRM-AKPAHASDEIYEIMQKCWEEKFEIRPDFSQ 391 (401)
T ss_pred hcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHcCCCC-CCCCCCCHHHHHHHHHHcCCChhHCcCHHH
Confidence 764 48899999999999999998 889998755555555555555433 2345567899999999997 8999999999
Q ss_pred HHcC
Q 008504 174 LLKD 177 (563)
Q Consensus 174 LLkH 177 (563)
|++.
T Consensus 392 ll~~ 395 (401)
T cd05107 392 LVHL 395 (401)
T ss_pred HHHH
Confidence 9864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.6e-26 Score=234.16 Aligned_cols=179 Identities=21% Similarity=0.381 Sum_probs=140.4
Q ss_pred CEeccCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeC----------C------
Q 008504 1 MITELFTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG----------N------ 62 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~--~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~----------~------ 62 (563)
||+|.+ |-++++|++.++ +++...++.+.+||+.+++|||+.+ ++|-||||+|||+.. .
T Consensus 168 ivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k--l~HTDLKPENILfvss~~~~~~~~k~~~~~~r 244 (415)
T KOG0671|consen 168 IVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK--LTHTDLKPENILFVSSEYFKTYNPKKKVCFIR 244 (415)
T ss_pred EEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc--eeecCCChheEEEeccceEEEeccCCccceec
Confidence 588988 459999999754 6999999999999999999999999 999999999999831 1
Q ss_pred ---CCcEEEecccchhhccCCCCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHH--HHHH
Q 008504 63 ---HGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQ--IFKK 136 (563)
Q Consensus 63 ---~G~VKL~DFGlA~~~~~~~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~--i~~~ 136 (563)
.-.|+|+|||.|+...+.. ...+.|..|.|||++-+ +++..+||||+||||+|++||...|....+.+. +++.
T Consensus 245 ~~ks~~I~vIDFGsAtf~~e~h-s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMer 323 (415)
T KOG0671|consen 245 PLKSTAIKVIDFGSATFDHEHH-STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMER 323 (415)
T ss_pred cCCCcceEEEecCCcceeccCc-ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHH
Confidence 1258999999997655443 56788999999998765 799999999999999999999999876554442 2333
Q ss_pred HhcCCCCC----------------ccc----------------------c---CCChhHHHHHHHhcC-CCCCCCCHHHH
Q 008504 137 VTSGIKPA----------------SLA----------------------K---VNDPQIKGFIEKCLV-PASERLSAKDL 174 (563)
Q Consensus 137 i~~~~~p~----------------~l~----------------------~---~~s~~l~~LI~kcL~-dP~kRpSa~EL 174 (563)
+....+.. .++ . ....++.+||++||. ||.+|+|+.|+
T Consensus 324 IlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EA 403 (415)
T KOG0671|consen 324 ILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREA 403 (415)
T ss_pred hhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHH
Confidence 32211100 000 0 012368899999997 99999999999
Q ss_pred HcCcccccc
Q 008504 175 LKDPFLQVE 183 (563)
Q Consensus 175 LkHpff~~~ 183 (563)
|.||||+..
T Consensus 404 L~HpFF~~~ 412 (415)
T KOG0671|consen 404 LSHPFFARL 412 (415)
T ss_pred hcCHHhhcC
Confidence 999999753
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-25 Score=236.93 Aligned_cols=175 Identities=27% Similarity=0.440 Sum_probs=132.9
Q ss_pred CEeccCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCC-CCeEeccCccCceEEeCCCCcEEEecccchhhc
Q 008504 1 MITELFTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHN-PPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM 77 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~--~Lse~~i~~i~~QIL~aL~yLHs~g-p~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~ 77 (563)
||+|||++|+|.++|.... .++|....+|+.++++||+|||... |+|||||||+.|||+| .+...||+|||+|+..
T Consensus 149 LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD-~~~~aKlsDFGLa~~~ 227 (361)
T KOG1187|consen 149 LVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLD-EDFNAKLSDFGLAKLG 227 (361)
T ss_pred EEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeEC-CCCCEEccCccCcccC
Confidence 6999999999999998654 8999999999999999999999965 5899999999999999 4579999999999665
Q ss_pred cC-CCCc-cc-cCCCCccCccccc-ccCCchhhHHHhHHHHHHHhhcCCCCCCCC--CHHHH----HHHHhcCCC----C
Q 008504 78 QQ-PTAR-SV-IGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECK--NPAQI----FKKVTSGIK----P 143 (563)
Q Consensus 78 ~~-~~~~-~~-~Gtp~Y~APEvl~-~~ys~ksDIwSLGviLyELlTG~~Pf~~~~--~~~~i----~~~i~~~~~----p 143 (563)
.. .... .. .||..|+|||++. +..+.++||||||++++||+||+.|..... ....+ ...+..+.. .
T Consensus 228 ~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD 307 (361)
T KOG1187|consen 228 PEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVD 307 (361)
T ss_pred CccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeC
Confidence 43 2221 22 7999999999886 568999999999999999999998876422 11111 122222211 1
Q ss_pred Cccc-cCCC--hh---HHHHHHHhcC-CCCCCCCHHHHHc
Q 008504 144 ASLA-KVND--PQ---IKGFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 144 ~~l~-~~~s--~~---l~~LI~kcL~-dP~kRpSa~ELLk 176 (563)
+.+. ...+ .. +..+..+|+. +|.+||++.++++
T Consensus 308 ~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 308 PRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred CCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 1111 2222 22 4556778997 7999999999754
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.1e-25 Score=255.40 Aligned_cols=171 Identities=22% Similarity=0.419 Sum_probs=142.0
Q ss_pred CEeccCCCCCHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccc
Q 008504 1 MITELFTSGNLRQYRKKH-------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGL 73 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~-------~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGl 73 (563)
|++|||.||+|..||++. ..++...+..++.||++|+.||++++ +|||||.++|+|++.. ..|||+|||+
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~--fvHRDLAaRNCLL~~~-r~VKIaDFGl 848 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH--FVHRDLAARNCLLDER-RVVKIADFGL 848 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC--CcCcchhhhheeeccc-CcEEEcccch
Confidence 689999999999999875 34999999999999999999999999 9999999999999865 7999999999
Q ss_pred hhhccCCCCccccC----CCCccCccccc-ccCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCCCCccc
Q 008504 74 AIAMQQPTARSVIG----TPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLA 147 (563)
Q Consensus 74 A~~~~~~~~~~~~G----tp~Y~APEvl~-~~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~ 147 (563)
|+.+-........+ ...|||||.+. +.++.|+|||||||++||++| |..||.+..+.+.+......+ .-..+
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg--RL~~P 926 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG--RLDPP 926 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC--ccCCC
Confidence 98554332222222 35799999886 669999999999999999999 678998855444444344555 33456
Q ss_pred cCCChhHHHHHHHhcC-CCCCCCCHHHHHc
Q 008504 148 KVNDPQIKGFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 148 ~~~s~~l~~LI~kcL~-dP~kRpSa~ELLk 176 (563)
..++..+.++|..||. +|.+||++..|++
T Consensus 927 ~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 927 SYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred CCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 7778888999999997 8999999999998
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.4e-25 Score=226.29 Aligned_cols=176 Identities=31% Similarity=0.390 Sum_probs=140.9
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
+|||||. ++|.+.+. -.++.+.++.++.|++.|+.|||+.| |+||||||+||+++ ..+.+||.|||+|+.....
T Consensus 98 ~v~e~m~-~nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~--IihRdLkPsnivv~-~~~~lKi~dfg~ar~e~~~ 171 (369)
T KOG0665|consen 98 LVMELMD-ANLCQVIL--MELDHETISYILYQMLCGIKHLHSAG--IIHRDLKPSNIVVN-SDCTLKILDFGLARTEDTD 171 (369)
T ss_pred HHHHhhh-hHHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcc--eeecccCcccceec-chhheeeccchhhcccCcc
Confidence 5899996 49999887 45889999999999999999999999 99999999999998 5579999999999765544
Q ss_pred -CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCC-----------------
Q 008504 81 -TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI----------------- 141 (563)
Q Consensus 81 -~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~----------------- 141 (563)
....++.|..|.|||++-+ +|.+.+||||+||++.||++|..-|.+.....+..+.+..-.
T Consensus 172 ~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~y 251 (369)
T KOG0665|consen 172 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNY 251 (369)
T ss_pred cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHH
Confidence 3455688999999997754 599999999999999999999998887444444333222100
Q ss_pred ---------------CCC-------ccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCccccc
Q 008504 142 ---------------KPA-------SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQV 182 (563)
Q Consensus 142 ---------------~p~-------~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~ 182 (563)
.|. ..+......+++++.+||. +|++|.+++++|+||||+.
T Consensus 252 v~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~v 315 (369)
T KOG0665|consen 252 VENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKV 315 (369)
T ss_pred hhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeee
Confidence 000 0011223578999999997 9999999999999999983
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.7e-25 Score=246.56 Aligned_cols=170 Identities=25% Similarity=0.403 Sum_probs=142.5
Q ss_pred CEeccCCCCCHHHHHHhCC--------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcE
Q 008504 1 MITELFTSGNLRQYRKKHK--------------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEV 66 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~--------------~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~V 66 (563)
||+|||..|+|.+||+.+. .++..+...|+.||+.|+.||-++. ++||||-.+|+||. ++-.|
T Consensus 566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~--FVHRDLATRNCLVg-e~l~V 642 (774)
T KOG1026|consen 566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH--FVHRDLATRNCLVG-ENLVV 642 (774)
T ss_pred EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc--ccccchhhhhceec-cceEE
Confidence 6899999999999997531 2889999999999999999999999 99999999999997 44599
Q ss_pred EEecccchhhccCCCCcccc----CCCCccCcccc-cccCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcC
Q 008504 67 KIGDLGLAIAMQQPTARSVI----GTPEFMAPELY-EEEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSG 140 (563)
Q Consensus 67 KL~DFGlA~~~~~~~~~~~~----Gtp~Y~APEvl-~~~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~ 140 (563)
||+|||+++..-....+... -..+|||||.+ .++|+.++|||||||+|||+++ |+.||.+..+ ++..+.+..+
T Consensus 643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn-~EVIe~i~~g 721 (774)
T KOG1026|consen 643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN-QEVIECIRAG 721 (774)
T ss_pred EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch-HHHHHHHHcC
Confidence 99999999765332222222 24589999955 6889999999999999999997 7899998554 5566677777
Q ss_pred CCCCccccCCChhHHHHHHHhcC-CCCCCCCHHHHH
Q 008504 141 IKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLL 175 (563)
Q Consensus 141 ~~p~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL 175 (563)
.. -.-+..++.++.+|+..||+ .|.+||++.||-
T Consensus 722 ~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 722 QL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred Cc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 66 45678889999999999998 799999999984
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.5e-25 Score=248.37 Aligned_cols=177 Identities=29% Similarity=0.525 Sum_probs=153.2
Q ss_pred CEeccCCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhcc
Q 008504 1 MITELFTSGNLRQYRKK--HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k--~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~ 78 (563)
||||||.||+.-+++++ ..++.|..+..|++.++.||.+||.+. +||||||-.|||++ ..|.|||+|||++..+.
T Consensus 98 LVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk--viHRDikG~NiLLT-~e~~VKLvDFGvSaQld 174 (953)
T KOG0587|consen 98 LVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK--VIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLD 174 (953)
T ss_pred EEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc--eeeecccCceEEEe-ccCcEEEeeeeeeeeee
Confidence 69999999999999986 456999999999999999999999999 99999999999998 45899999999997765
Q ss_pred C--CCCccccCCCCccCcccccc------cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCcc-ccC
Q 008504 79 Q--PTARSVIGTPEFMAPELYEE------EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASL-AKV 149 (563)
Q Consensus 79 ~--~~~~~~~Gtp~Y~APEvl~~------~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l-~~~ 149 (563)
. ....+.+|||.|||||++.. .|+..+|+||||++..||.-|.+|+.+ ..+......+....+|... +..
T Consensus 175 sT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~D-mHPmraLF~IpRNPPPkLkrp~k 253 (953)
T KOG0587|consen 175 STVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCD-MHPMRALFLIPRNPPPKLKRPKK 253 (953)
T ss_pred cccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccC-cchhhhhccCCCCCCccccchhh
Confidence 4 34567899999999998852 378899999999999999999999987 4555555555555555443 667
Q ss_pred CChhHHHHHHHhcC-CCCCCCCHHHHHcCcccc
Q 008504 150 NDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQ 181 (563)
Q Consensus 150 ~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~ 181 (563)
++.++.+||..||. +..+||+..++|+|||+.
T Consensus 254 Ws~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~ 286 (953)
T KOG0587|consen 254 WSKKFNDFISTCLVKDYEQRPSTEELLKHPFIT 286 (953)
T ss_pred HHHHHHHHHHHHHhhccccCcchhhhccCCccc
Confidence 78899999999997 899999999999999998
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.1e-25 Score=252.71 Aligned_cols=174 Identities=28% Similarity=0.412 Sum_probs=133.1
Q ss_pred CEeccCCCCCHHHHHHhC-----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEe
Q 008504 1 MITELFTSGNLRQYRKKH-----------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIG 69 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~-----------~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~ 69 (563)
+||||++||+|.+++... ..++...+..++.||+.||+|||++| |+||||||+||+++ ..|.+||+
T Consensus 79 LVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G--IIHRDLKPeNILLd-~dg~vKLi 155 (932)
T PRK13184 79 YTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG--VLHRDLKPDNILLG-LFGEVVIL 155 (932)
T ss_pred EEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchheEEEc-CCCCEEEE
Confidence 589999999999998641 23566788999999999999999999 99999999999997 55799999
Q ss_pred cccchhhccCC--------------------CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCC
Q 008504 70 DLGLAIAMQQP--------------------TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECK 128 (563)
Q Consensus 70 DFGlA~~~~~~--------------------~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~ 128 (563)
|||++...... .....+||+.|+|||++.+ .++.++|||||||++|+|+||+.||....
T Consensus 156 DFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~ 235 (932)
T PRK13184 156 DWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKK 235 (932)
T ss_pred ecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcc
Confidence 99999654110 0112468999999998864 58999999999999999999999997633
Q ss_pred CHHHHHHHHhcCCCCCccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcC
Q 008504 129 NPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 177 (563)
Q Consensus 129 ~~~~i~~~i~~~~~p~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkH 177 (563)
......................++.+.+++.+||. +|.+|++..+.+.+
T Consensus 236 ~~ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 236 GRKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred hhhhhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 22222221111111111123457889999999997 89999887666654
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.7e-25 Score=238.71 Aligned_cols=172 Identities=25% Similarity=0.391 Sum_probs=144.4
Q ss_pred CEeccCCCCCHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKKHKN-VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~-Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
||||+|.||+|.+||++.+. ++..+...++.+.+.||+|||+++ +|||||-.+|+|++ ..+.+||+|||+++.-..
T Consensus 238 ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~--~IHRDIAARNcL~~-~~~~vKISDFGLs~~~~~ 314 (474)
T KOG0194|consen 238 LVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKN--CIHRDIAARNCLYS-KKGVVKISDFGLSRAGSQ 314 (474)
T ss_pred EEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCC--CcchhHhHHHheec-CCCeEEeCccccccCCcc
Confidence 69999999999999999874 999999999999999999999999 99999999999997 445789999999865432
Q ss_pred CC-Cc-cccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHH
Q 008504 80 PT-AR-SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIK 155 (563)
Q Consensus 80 ~~-~~-~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~ 155 (563)
.. .. ...-...|+|||.+.. -|++++|||||||++||+++ |..||.+ ....++..++.....+...+...+..+.
T Consensus 315 ~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g-~~~~~v~~kI~~~~~r~~~~~~~p~~~~ 393 (474)
T KOG0194|consen 315 YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPG-MKNYEVKAKIVKNGYRMPIPSKTPKELA 393 (474)
T ss_pred eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCC-CCHHHHHHHHHhcCccCCCCCCCHHHHH
Confidence 11 11 1123468999998875 59999999999999999998 7889988 4566777777554455556667888999
Q ss_pred HHHHHhcC-CCCCCCCHHHHHc
Q 008504 156 GFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 156 ~LI~kcL~-dP~kRpSa~ELLk 176 (563)
.++.+||. +|.+||++.++.+
T Consensus 394 ~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 394 KVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred HHHHHhccCChhhccCHHHHHH
Confidence 99999997 8999999999876
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-25 Score=238.92 Aligned_cols=179 Identities=28% Similarity=0.462 Sum_probs=149.7
Q ss_pred CEeccCCCCCHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCC--CCcEEEecccchhhc
Q 008504 1 MITELFTSGNLRQYRK-KHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGN--HGEVKIGDLGLAIAM 77 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~-k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~--~G~VKL~DFGlA~~~ 77 (563)
+|||-+.|.-|.-.|. ..+++++..-+.++.||+.||.|||-+| |+|+||||+|||+... ..++||||||+|+.+
T Consensus 640 VVMEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn--IvHCDLKPENVLLas~~~FPQvKlCDFGfARiI 717 (888)
T KOG4236|consen 640 VVMEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN--IVHCDLKPENVLLASASPFPQVKLCDFGFARII 717 (888)
T ss_pred EEehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc--eeeccCCchheeeccCCCCCceeeccccceeec
Confidence 4899996644444444 3578999999999999999999999999 9999999999999643 348999999999998
Q ss_pred cCC-CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcC--CCCCccccCCChh
Q 008504 78 QQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG--IKPASLAKVNDPQ 153 (563)
Q Consensus 78 ~~~-~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~--~~p~~l~~~~s~~ 153 (563)
++. ..++.+|||.|+|||+++. +|+..-|+||.|+|+|.-+.|.+||.+..+ +...|... ..|...+...++.
T Consensus 718 gEksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd---IndQIQNAaFMyPp~PW~eis~~ 794 (888)
T KOG4236|consen 718 GEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED---INDQIQNAAFMYPPNPWSEISPE 794 (888)
T ss_pred chhhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc---hhHHhhccccccCCCchhhcCHH
Confidence 764 5678899999999999975 599999999999999999999999987433 33344332 3455666777899
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHHcCccccccc
Q 008504 154 IKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 184 (563)
Q Consensus 154 l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~ 184 (563)
+.+||..+|+ +-.+|.|++..|.|||+|...
T Consensus 795 AidlIn~LLqVkm~kRysvdk~lsh~Wlq~yq 826 (888)
T KOG4236|consen 795 AIDLINNLLQVKMRKRYSVDKSLSHPWLQDYQ 826 (888)
T ss_pred HHHHHHHHHHHHHHHhcchHhhccchhhhcch
Confidence 9999999997 899999999999999998653
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.3e-24 Score=212.16 Aligned_cols=179 Identities=24% Similarity=0.392 Sum_probs=141.9
Q ss_pred CEeccCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~-~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
|||.+|+. +|.-++... .+++...+++++++++.||.|+|... |+|||+||.|+||++ +|.+||+|||+++.+..
T Consensus 101 lVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k--ilHRDmKaaNvLIt~-dgilklADFGlar~fs~ 176 (376)
T KOG0669|consen 101 LVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNK--ILHRDMKAANVLITK-DGILKLADFGLARAFST 176 (376)
T ss_pred eeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhh--HHhhcccHhhEEEcC-CceEEeeccccccceec
Confidence 58889976 899888865 57999999999999999999999999 999999999999984 58999999999976543
Q ss_pred C------CCccccCCCCccCcccccc--cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHH--HHhcCCCCCc----
Q 008504 80 P------TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFK--KVTSGIKPAS---- 145 (563)
Q Consensus 80 ~------~~~~~~Gtp~Y~APEvl~~--~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~--~i~~~~~p~~---- 145 (563)
. .....+-|.+|.+||.+-+ .|+++.|||..|||+.||+|+.+-+.+..+..++.. .+.....+..
T Consensus 177 ~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~ 256 (376)
T KOG0669|consen 177 SKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNV 256 (376)
T ss_pred ccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCc
Confidence 2 1223456999999997754 599999999999999999999988887544443321 1111111111
Q ss_pred --------------------------cccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCcccccc
Q 008504 146 --------------------------LAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 183 (563)
Q Consensus 146 --------------------------l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~ 183 (563)
-+-..+++..+|+.++|. ||.+|+.++++|.|.||..+
T Consensus 257 d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kd 321 (376)
T KOG0669|consen 257 DNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKD 321 (376)
T ss_pred ccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcC
Confidence 112235688999999998 99999999999999999754
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.4e-25 Score=220.51 Aligned_cols=184 Identities=28% Similarity=0.465 Sum_probs=149.2
Q ss_pred CEeccCCCCCHHHHHH-----hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchh
Q 008504 1 MITELFTSGNLRQYRK-----KHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 75 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~-----k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~ 75 (563)
|.||+|. .+|..+.+ +...+++..+-.|..-.+.||.||-..- .|||||+||+|||++ ..|.|||||||++.
T Consensus 140 iCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l-kiIHRDvKPSNILld-r~G~vKLCDFGIcG 216 (361)
T KOG1006|consen 140 ICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL-KIIHRDVKPSNILLD-RHGDVKLCDFGICG 216 (361)
T ss_pred eeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh-hhhhccCChhheEEe-cCCCEeeecccchH
Confidence 4588885 47776544 3467999999999999999999998653 399999999999998 55899999999997
Q ss_pred hccCCCCccc-cCCCCccCccccc---ccCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCcccc---
Q 008504 76 AMQQPTARSV-IGTPEFMAPELYE---EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAK--- 148 (563)
Q Consensus 76 ~~~~~~~~~~-~Gtp~Y~APEvl~---~~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~--- 148 (563)
.+......+. .|...|||||.+. .+|+-++||||||++|||+.||.+||..-.+..+....+..|.+|.....
T Consensus 217 qLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~ 296 (361)
T KOG1006|consen 217 QLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKEC 296 (361)
T ss_pred hHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccc
Confidence 7766554443 6888999999885 34999999999999999999999999876666556666666666543332
Q ss_pred -CCChhHHHHHHHhcC-CCCCCCCHHHHHcCccccccccCC
Q 008504 149 -VNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQKE 187 (563)
Q Consensus 149 -~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~~~~ 187 (563)
..+..+..||..||. |.+.||...+|+++||+.......
T Consensus 297 ~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~~~~ 337 (361)
T KOG1006|consen 297 VHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYAVEG 337 (361)
T ss_pred cccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhhhcC
Confidence 247789999999997 899999999999999998655443
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=232.07 Aligned_cols=179 Identities=27% Similarity=0.346 Sum_probs=132.4
Q ss_pred CEeccCCCCCHHHHHHhC------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCc
Q 008504 1 MITELFTSGNLRQYRKKH------------------------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDN 56 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~------------------------~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~N 56 (563)
|||||+++|+|.+++... ..+++..++.++.|++.||.|||+++ |+||||||+|
T Consensus 262 LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~--ivHrDLKp~N 339 (507)
T PLN03224 262 LVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIG--IVHRDIKPEN 339 (507)
T ss_pred EEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCchHh
Confidence 689999999999988642 12456788999999999999999999 9999999999
Q ss_pred eEEeCCCCcEEEecccchhhccCCC-Cc--cccCCCCccCccccccc---------------------C--CchhhHHHh
Q 008504 57 IFVNGNHGEVKIGDLGLAIAMQQPT-AR--SVIGTPEFMAPELYEEE---------------------Y--NELVDIYSF 110 (563)
Q Consensus 57 ILLd~~~G~VKL~DFGlA~~~~~~~-~~--~~~Gtp~Y~APEvl~~~---------------------y--s~ksDIwSL 110 (563)
||++. .+.+||+|||++....... .. ...+++.|+|||.+... | ..+.||||+
T Consensus 340 ILl~~-~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSl 418 (507)
T PLN03224 340 LLVTV-DGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTA 418 (507)
T ss_pred EEECC-CCcEEEEeCcCccccccCCccCccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhH
Confidence 99984 5799999999986543221 11 22347899999976421 1 134799999
Q ss_pred HHHHHHHhhcCC-CCCCCCC----------HHHHHHHHhcCCCCCccccCCChhHHHHHHHhcC-CC---CCCCCHHHHH
Q 008504 111 GMCILEMVTFEY-PYSECKN----------PAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PA---SERLSAKDLL 175 (563)
Q Consensus 111 GviLyELlTG~~-Pf~~~~~----------~~~i~~~i~~~~~p~~l~~~~s~~l~~LI~kcL~-dP---~kRpSa~ELL 175 (563)
||++|+|+++.. ||..... ....++.+.............++..++|+.+||. +| .+|+|+.|+|
T Consensus 419 Gvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL 498 (507)
T PLN03224 419 GVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQAL 498 (507)
T ss_pred HHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHh
Confidence 999999999975 6643211 1111222222222233344567899999999996 33 6899999999
Q ss_pred cCccccc
Q 008504 176 KDPFLQV 182 (563)
Q Consensus 176 kHpff~~ 182 (563)
+||||..
T Consensus 499 ~Hp~f~~ 505 (507)
T PLN03224 499 SHRFFLP 505 (507)
T ss_pred CCCCcCC
Confidence 9999964
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.5e-25 Score=233.53 Aligned_cols=179 Identities=26% Similarity=0.402 Sum_probs=145.2
Q ss_pred CEeccCCCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhc
Q 008504 1 MITELFTSGNLRQYRKKHK---NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM 77 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~---~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~ 77 (563)
||+|-+ .-+|++.|++.+ .|....++.|+.|++.||..|-.+| |+|.||||+||||+.....+||||||.|...
T Consensus 511 lVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~--vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~ 587 (752)
T KOG0670|consen 511 LVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG--VLHADIKPDNILVNESKNILKLCDFGSASFA 587 (752)
T ss_pred EEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC--eeecccCccceEeccCcceeeeccCcccccc
Confidence 578877 459999999865 4999999999999999999999999 9999999999999987778999999999877
Q ss_pred cCCCCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHH-HhcCCCCC-----------
Q 008504 78 QQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKK-VTSGIKPA----------- 144 (563)
Q Consensus 78 ~~~~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~-i~~~~~p~----------- 144 (563)
.......+.-+..|.|||++-+ .|+...|+||.||+||||+||+..|++..+...+... -..|..|.
T Consensus 588 ~eneitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dq 667 (752)
T KOG0670|consen 588 SENEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQ 667 (752)
T ss_pred ccccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhh
Confidence 7666666666788999998876 5999999999999999999999999987665543211 11111110
Q ss_pred --------------------------------ccc-------cCC------ChhHHHHHHHhcC-CCCCCCCHHHHHcCc
Q 008504 145 --------------------------------SLA-------KVN------DPQIKGFIEKCLV-PASERLSAKDLLKDP 178 (563)
Q Consensus 145 --------------------------------~l~-------~~~------s~~l~~LI~kcL~-dP~kRpSa~ELLkHp 178 (563)
.+. ... -.++++|+.+||. ||.+|.|..++|+||
T Consensus 668 HFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~Hp 747 (752)
T KOG0670|consen 668 HFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKHP 747 (752)
T ss_pred hcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcCC
Confidence 000 000 1368999999998 999999999999999
Q ss_pred cccc
Q 008504 179 FLQV 182 (563)
Q Consensus 179 ff~~ 182 (563)
||+.
T Consensus 748 Fi~~ 751 (752)
T KOG0670|consen 748 FITE 751 (752)
T ss_pred cccC
Confidence 9974
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.4e-23 Score=197.63 Aligned_cols=179 Identities=25% Similarity=0.442 Sum_probs=139.7
Q ss_pred CEeccCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k-~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
+|+|||.. +|..|... ++.++.+.++.++.|+++||.|+|+++ +.||||||.|++|+ .+|.+||+|||+++.++-
T Consensus 78 lvfe~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshn--vlhrdlkpqnllin-~ngelkladfglarafgi 153 (292)
T KOG0662|consen 78 LVFEFCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHN--VLHRDLKPQNLLIN-RNGELKLADFGLARAFGI 153 (292)
T ss_pred EeHHHhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhh--hhhccCCcceEEec-cCCcEEecccchhhhcCC
Confidence 58999965 99998875 678999999999999999999999999 99999999999998 558999999999988775
Q ss_pred CC--CccccCCCCccCccccccc--CCchhhHHHhHHHHHHHhhc-CCCCCCCCCHHHHHHHHhc-CCC-CCcc------
Q 008504 80 PT--ARSVIGTPEFMAPELYEEE--YNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTS-GIK-PASL------ 146 (563)
Q Consensus 80 ~~--~~~~~Gtp~Y~APEvl~~~--ys~ksDIwSLGviLyELlTG-~~Pf~~~~~~~~i~~~i~~-~~~-p~~l------ 146 (563)
+. ....+-|.+|.+|.++-+. |+...|+||.|||+.|+... ++.|.+..-..++.+.... |.+ ...+
T Consensus 154 pvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~l 233 (292)
T KOG0662|consen 154 PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKL 233 (292)
T ss_pred ceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccC
Confidence 53 2234678999999988653 99999999999999999875 4456664444444333221 100 0000
Q ss_pred ---------c---------cCCChhHHHHHHHhcC-CCCCCCCHHHHHcCcccccc
Q 008504 147 ---------A---------KVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 183 (563)
Q Consensus 147 ---------~---------~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~ 183 (563)
+ ......-+++++++|. +|.+|++++++|+||||...
T Consensus 234 pdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~ 289 (292)
T KOG0662|consen 234 PDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF 289 (292)
T ss_pred CCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence 0 0112356899999997 89999999999999999753
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.8e-23 Score=232.27 Aligned_cols=172 Identities=24% Similarity=0.422 Sum_probs=145.0
Q ss_pred CEeccCCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCC
Q 008504 1 MITELFTSGNLRQYRKKHK----------------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHG 64 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~----------------~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G 64 (563)
+|+||+..|+|..|+++.+ .++...+..++.||+.|++||++.. +|||||-++|||+..+ .
T Consensus 379 ~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~--~vHRDLAaRNVLi~~~-~ 455 (609)
T KOG0200|consen 379 VIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP--CVHRDLAARNVLITKN-K 455 (609)
T ss_pred EEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC--ccchhhhhhhEEecCC-C
Confidence 5899999999999998765 3899999999999999999999999 9999999999999854 5
Q ss_pred cEEEecccchhhccCCCCcc---ccC--CCCccCcccccc-cCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHH
Q 008504 65 EVKIGDLGLAIAMQQPTARS---VIG--TPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKV 137 (563)
Q Consensus 65 ~VKL~DFGlA~~~~~~~~~~---~~G--tp~Y~APEvl~~-~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i 137 (563)
.+||+|||+++......... ..+ ...|||||.+.. .|+.++||||||+++||++| |..||.+......+++.+
T Consensus 456 ~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~l 535 (609)
T KOG0200|consen 456 VIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEFL 535 (609)
T ss_pred EEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHHH
Confidence 99999999998554432222 122 235999998875 59999999999999999998 678998865567778888
Q ss_pred hcCCCCCccccCCChhHHHHHHHhcC-CCCCCCCHHHHHc
Q 008504 138 TSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 138 ~~~~~p~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLk 176 (563)
..|.+.. .|..+++++.++++.||. +|.+||++.++.+
T Consensus 536 ~~G~r~~-~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 536 KEGNRME-QPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred hcCCCCC-CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 8887654 456668999999999997 8999999999875
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.5e-23 Score=226.81 Aligned_cols=171 Identities=26% Similarity=0.485 Sum_probs=142.2
Q ss_pred CEeccCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~-~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
||||+++-|.|+.|++.++ .++...+..++.||+.||+|||+.. ++||||..+|||+... ..|||+|||+++.+..
T Consensus 467 ivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkr--fVHRDIAaRNiLVsSp-~CVKLaDFGLSR~~ed 543 (974)
T KOG4257|consen 467 IVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKR--FVHRDIAARNILVSSP-QCVKLADFGLSRYLED 543 (974)
T ss_pred EEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhc--hhhhhhhhhheeecCc-ceeeecccchhhhccc
Confidence 6999999999999999765 5999999999999999999999999 9999999999999855 4999999999988765
Q ss_pred CCCcc-ccC--CCCccCccccc-ccCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhH
Q 008504 80 PTARS-VIG--TPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQI 154 (563)
Q Consensus 80 ~~~~~-~~G--tp~Y~APEvl~-~~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l 154 (563)
...+. ..| ..-|||||-++ ..++.++|||-||||+||++. |..||.+-.+.+.+. .+..|.+++ .|..++|.+
T Consensus 544 ~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~-~iEnGeRlP-~P~nCPp~L 621 (974)
T KOG4257|consen 544 DAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIG-HIENGERLP-CPPNCPPAL 621 (974)
T ss_pred cchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEE-EecCCCCCC-CCCCCChHH
Confidence 43221 122 34799999886 569999999999999999876 789998866655443 344454443 566788999
Q ss_pred HHHHHHhcC-CCCCCCCHHHHHc
Q 008504 155 KGFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 155 ~~LI~kcL~-dP~kRpSa~ELLk 176 (563)
..|+.+||. +|.+||++.+|..
T Consensus 622 YslmskcWayeP~kRPrftei~~ 644 (974)
T KOG4257|consen 622 YSLMSKCWAYEPSKRPRFTEIKA 644 (974)
T ss_pred HHHHHHHhccCcccCCcHHHHHH
Confidence 999999998 9999999888754
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.9e-23 Score=201.61 Aligned_cols=179 Identities=23% Similarity=0.385 Sum_probs=143.4
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
||+||..+.+.+++. +.++...++.++.|++.||.|||+.| |+|||+||.|++|+.....++|+|+|+|......
T Consensus 112 LiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~G--ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~ 186 (338)
T KOG0668|consen 112 LIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMG--IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
T ss_pred hHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcC--cccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence 578888887777654 45889999999999999999999999 9999999999999987778999999999887665
Q ss_pred CCcc-ccCCCCccCccccc--ccCCchhhHHHhHHHHHHHhhcCCCCC-CCCCHHHHHHHHhc-----------------
Q 008504 81 TARS-VIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTFEYPYS-ECKNPAQIFKKVTS----------------- 139 (563)
Q Consensus 81 ~~~~-~~Gtp~Y~APEvl~--~~ys~ksDIwSLGviLyELlTG~~Pf~-~~~~~~~i~~~i~~----------------- 139 (563)
.... .+.+..|--||++- +.|+.+-|+|||||++..|+..+-||. +..+..++.+...-
T Consensus 187 ~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~L 266 (338)
T KOG0668|consen 187 KEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDL 266 (338)
T ss_pred ceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCC
Confidence 4433 35677889999885 458999999999999999999998875 45566665543211
Q ss_pred --------CCC---------CCccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCccccccc
Q 008504 140 --------GIK---------PASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 184 (563)
Q Consensus 140 --------~~~---------p~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~ 184 (563)
+.. +..-....++++.+|+.++|. |..+|+||+|++.||||....
T Consensus 267 dp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~ 329 (338)
T KOG0668|consen 267 DPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVR 329 (338)
T ss_pred ChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHH
Confidence 000 011122346899999999998 999999999999999997544
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-23 Score=233.87 Aligned_cols=177 Identities=28% Similarity=0.362 Sum_probs=135.3
Q ss_pred CEeccCCCCCHHHHHHhC-CCCCH---HHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCC----CCcEEEeccc
Q 008504 1 MITELFTSGNLRQYRKKH-KNVDI---KVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGN----HGEVKIGDLG 72 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~-~~Lse---~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~----~G~VKL~DFG 72 (563)
|..|+|.. +|.+++... ..+.. -..+..+.|+++||++||+.+ ||||||||.||||... ...++|+|||
T Consensus 580 IalELC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~--iVHRDLkPQNILI~~~~~~~~~ra~iSDfg 656 (903)
T KOG1027|consen 580 IALELCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK--IVHRDLKPQNILISVPSADGTLRAKISDFG 656 (903)
T ss_pred EEehHhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc--cccccCCCceEEEEccCCCcceeEEecccc
Confidence 46789975 999999874 11111 345778999999999999999 9999999999999752 2478999999
Q ss_pred chhhccCCC-----CccccCCCCccCccccccc-CCchhhHHHhHHHHHHHhhc-CCCCCCCCCHHHHHHHHhcCCCCCc
Q 008504 73 LAIAMQQPT-----ARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSGIKPAS 145 (563)
Q Consensus 73 lA~~~~~~~-----~~~~~Gtp~Y~APEvl~~~-ys~ksDIwSLGviLyELlTG-~~Pf~~~~~~~~i~~~i~~~~~p~~ 145 (563)
+++.+.... .....||-.|+|||++... -+.++|||||||++|+.++| ..||... .+.....+........
T Consensus 657 lsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~--~~R~~NIl~~~~~L~~ 734 (903)
T KOG1027|consen 657 LSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDS--LERQANILTGNYTLVH 734 (903)
T ss_pred cccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCch--HHhhhhhhcCccceee
Confidence 998775432 3345799999999999754 56799999999999999997 8999752 2222222222222223
Q ss_pred cccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCccccc
Q 008504 146 LAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQV 182 (563)
Q Consensus 146 l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~ 182 (563)
+....+.++++||.+|+. +|..||+|.++|.||||-.
T Consensus 735 L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~ 772 (903)
T KOG1027|consen 735 LEPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWD 772 (903)
T ss_pred eccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCC
Confidence 333333389999999998 8999999999999999953
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1e-22 Score=196.92 Aligned_cols=142 Identities=32% Similarity=0.557 Sum_probs=121.0
Q ss_pred CEeccCCCCCHHHHH----HhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhh
Q 008504 1 MITELFTSGNLRQYR----KKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 76 (563)
Q Consensus 1 LVmEy~~gGsL~~~L----~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~ 76 (563)
|.||.|. .+|..|. ++.+.+++..+-+|+..++.||.|||++= .+||||+||.||||+ ..|+|||||||++..
T Consensus 122 IcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL-~vIHRDvKPsNiLIn-~~GqVKiCDFGIsG~ 198 (282)
T KOG0984|consen 122 ICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL-SVIHRDVKPSNILIN-YDGQVKICDFGISGY 198 (282)
T ss_pred EeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh-hhhhccCCcceEEEc-cCCcEEEccccccee
Confidence 4578885 4887764 45678999999999999999999999984 399999999999998 568999999999988
Q ss_pred ccCCCCcc-ccCCCCccCccccc-----ccCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCc
Q 008504 77 MQQPTARS-VIGTPEFMAPELYE-----EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPAS 145 (563)
Q Consensus 77 ~~~~~~~~-~~Gtp~Y~APEvl~-----~~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~ 145 (563)
+.+....+ ..|...|||||.+. .+|+-++||||||+.+.||.++++||..-..+.+..+.+.....|..
T Consensus 199 L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep~P~L 273 (282)
T KOG0984|consen 199 LVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEPSPQL 273 (282)
T ss_pred ehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCCCCCC
Confidence 77766665 46888999999885 25899999999999999999999999988888888888887665543
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.4e-22 Score=215.02 Aligned_cols=171 Identities=28% Similarity=0.440 Sum_probs=145.9
Q ss_pred CEeccCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhcc
Q 008504 1 MITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~--~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~ 78 (563)
||+|||..|+|.+||+.. ..++.-.+..++.||..|+.||..++ +|||||...|+||..+ ..||++|||+++.+.
T Consensus 340 IiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn--FIHRDLAARNCLVgEn-hiVKvADFGLsRlMt 416 (1157)
T KOG4278|consen 340 IITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGEN-HIVKVADFGLSRLMT 416 (1157)
T ss_pred EEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh--hhhhhhhhhhcccccc-ceEEeeccchhhhhc
Confidence 689999999999999863 34888888999999999999999999 9999999999999754 599999999999887
Q ss_pred CCCCccccC---CCCccCccccc-ccCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCCCCccccCCChh
Q 008504 79 QPTARSVIG---TPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQ 153 (563)
Q Consensus 79 ~~~~~~~~G---tp~Y~APEvl~-~~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~ 153 (563)
........| ..-|.|||-+. +.++.|+|||+|||+|||+.| |-.||.+ .+..+.|..+..+.+.. -+.-+++.
T Consensus 417 gDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPG-idlSqVY~LLEkgyRM~-~PeGCPpk 494 (1157)
T KOG4278|consen 417 GDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYGLLEKGYRMD-GPEGCPPK 494 (1157)
T ss_pred CCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCC-ccHHHHHHHHhcccccc-CCCCCCHH
Confidence 655443333 34699999775 569999999999999999998 6678887 56788888888887654 46677889
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHHc
Q 008504 154 IKGFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 154 l~~LI~kcL~-dP~kRpSa~ELLk 176 (563)
+.+|+..||+ .|.+||++.|+-+
T Consensus 495 VYeLMraCW~WsPsDRPsFaeiHq 518 (1157)
T KOG4278|consen 495 VYELMRACWNWSPSDRPSFAEIHQ 518 (1157)
T ss_pred HHHHHHHHhcCCcccCccHHHHHH
Confidence 9999999998 9999999988754
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.8e-22 Score=220.60 Aligned_cols=176 Identities=27% Similarity=0.422 Sum_probs=148.5
Q ss_pred CEeccCCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhcc
Q 008504 1 MITELFTSGNLRQYRKK--HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k--~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~ 78 (563)
||||+++.|+|.+.|++ ...|-...+..|+.||+.|+.||.+++ +|||||...||++-. ...|||+|||+.+.+.
T Consensus 187 MV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr--lvHRDLAARNlllas-prtVKI~DFGLmRaLg 263 (1039)
T KOG0199|consen 187 MVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR--LVHRDLAARNLLLAS-PRTVKICDFGLMRALG 263 (1039)
T ss_pred HHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh--hhhhhhhhhhheecc-cceeeeecccceeccC
Confidence 68999999999999987 345889999999999999999999999 999999999999975 4599999999998876
Q ss_pred CCCCccc-----cCCCCccCccccc-ccCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCCCCccccCCC
Q 008504 79 QPTARSV-----IGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVND 151 (563)
Q Consensus 79 ~~~~~~~-----~Gtp~Y~APEvl~-~~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s 151 (563)
....... .-...|+|||.++ ..++.++|||+|||++|||+| |+.||.++ ...++.+.+..+.+. .-++.++
T Consensus 264 ~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~-~g~qIL~~iD~~erL-pRPk~cs 341 (1039)
T KOG0199|consen 264 ENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGC-RGIQILKNIDAGERL-PRPKYCS 341 (1039)
T ss_pred CCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCC-CHHHHHHhccccccC-CCCCCCh
Confidence 5432211 2245799999886 569999999999999999998 58999984 678888888866543 3467788
Q ss_pred hhHHHHHHHhcC-CCCCCCCHHHHHcCcccc
Q 008504 152 PQIKGFIEKCLV-PASERLSAKDLLKDPFLQ 181 (563)
Q Consensus 152 ~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~ 181 (563)
..+.++++.||. +|.+|||+..|...-++.
T Consensus 342 edIY~imk~cWah~paDRptFsair~~~~l~ 372 (1039)
T KOG0199|consen 342 EDIYQIMKNCWAHNPADRPTFSAIREDLVLA 372 (1039)
T ss_pred HHHHHHHHHhccCCccccccHHHHHHhHHHH
Confidence 999999999998 899999999997665554
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.7e-22 Score=222.18 Aligned_cols=128 Identities=31% Similarity=0.554 Sum_probs=112.1
Q ss_pred CEeccCCCCCHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEe-CCCC--cEEEecccch
Q 008504 1 MITELFTSGNLRQYRKK---HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN-GNHG--EVKIGDLGLA 74 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k---~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd-~~~G--~VKL~DFGlA 74 (563)
+|||||.||+|+.++.+ ..+|++.+++.++..+..||.|||.+| |+||||||.||++. +.+| .-||+|||.|
T Consensus 94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~--IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG--IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC--ceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 68999999999999975 457999999999999999999999999 99999999999884 2223 4699999999
Q ss_pred hhccCC-CCccccCCCCccCccccc--ccCCchhhHHHhHHHHHHHhhcCCCCCCCCCH
Q 008504 75 IAMQQP-TARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTFEYPYSECKNP 130 (563)
Q Consensus 75 ~~~~~~-~~~~~~Gtp~Y~APEvl~--~~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~ 130 (563)
+.+.+. ...+++||+.|.+||+++ +.|+..+|.|||||++|+++||..||-....+
T Consensus 172 rel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p 230 (732)
T KOG4250|consen 172 RELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP 230 (732)
T ss_pred ccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence 888654 566789999999999998 45899999999999999999999999653333
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.3e-22 Score=216.66 Aligned_cols=172 Identities=26% Similarity=0.383 Sum_probs=136.3
Q ss_pred CEeccCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhcc
Q 008504 1 MITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~--~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~ 78 (563)
+||||++.|+|.+|+.++ +.+.-+...+++.||+.|++||.+.+ ++||||.+.|+|++++ +++||+|||+++.+-
T Consensus 612 mI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n--fVHrd~a~rNcLv~~e-~~iKiadfgmsR~ly 688 (807)
T KOG1094|consen 612 MITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN--FVHRDLATRNCLVDGE-FTIKIADFGMSRNLY 688 (807)
T ss_pred HHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc--hhhccccccceeecCc-ccEEecCcccccccc
Confidence 589999999999999988 33455667779999999999999999 9999999999999866 699999999998654
Q ss_pred CCCCccc----cCCCCccCccc-ccccCCchhhHHHhHHHHHHHhh--cCCCCCCCCCHHHHHHHHhcCC---C---CCc
Q 008504 79 QPTARSV----IGTPEFMAPEL-YEEEYNELVDIYSFGMCILEMVT--FEYPYSECKNPAQIFKKVTSGI---K---PAS 145 (563)
Q Consensus 79 ~~~~~~~----~Gtp~Y~APEv-l~~~ys~ksDIwSLGviLyELlT--G~~Pf~~~~~~~~i~~~i~~~~---~---p~~ 145 (563)
....... +-...|||+|. +.++++.++|+|+||+++||+++ .+.||....+ +++......-. . -..
T Consensus 689 sg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~-e~vven~~~~~~~~~~~~~l~ 767 (807)
T KOG1094|consen 689 SGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD-EQVVENAGEFFRDQGRQVVLS 767 (807)
T ss_pred cCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH-HHHHHhhhhhcCCCCcceecc
Confidence 3333222 33568999994 46889999999999999999875 5789987443 44433322211 1 123
Q ss_pred cccCCChhHHHHHHHhcC-CCCCCCCHHHHHc
Q 008504 146 LAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 146 l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLk 176 (563)
.|..++..+.++|.+||. +-.+||+++++..
T Consensus 768 ~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 768 RPPACPQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred CCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 456778889999999997 8999999999854
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.3e-23 Score=226.13 Aligned_cols=171 Identities=24% Similarity=0.456 Sum_probs=143.9
Q ss_pred CEeccCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~-~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
||+|||++|+|..||+++ +.|+.-++..+++.|+.|+.||-..| ++||||..+||||+.+ -.+|++|||+++.+.+
T Consensus 707 IiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~--YVHRDLAARNILVNsn-LvCKVsDFGLSRvled 783 (996)
T KOG0196|consen 707 IITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMN--YVHRDLAARNILVNSN-LVCKVSDFGLSRVLED 783 (996)
T ss_pred EEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcC--chhhhhhhhheeeccc-eEEEeccccceeeccc
Confidence 689999999999999875 56999999999999999999999999 9999999999999965 4899999999997754
Q ss_pred CC--CccccC---CCCccCccccc-ccCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCCCCccccCCCh
Q 008504 80 PT--ARSVIG---TPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDP 152 (563)
Q Consensus 80 ~~--~~~~~G---tp~Y~APEvl~-~~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~ 152 (563)
.. ..+..| ...|.|||.+. .+++.++||||||++|||.++ |+.||.+..+ .+..+.|..+.+.+ .|-.++.
T Consensus 784 d~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN-QdVIkaIe~gyRLP-pPmDCP~ 861 (996)
T KOG0196|consen 784 DPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-QDVIKAIEQGYRLP-PPMDCPA 861 (996)
T ss_pred CCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch-HHHHHHHHhccCCC-CCCCCcH
Confidence 33 222222 35899999885 679999999999999999765 8999998554 55566677776543 3556778
Q ss_pred hHHHHHHHhcC-CCCCCCCHHHHHc
Q 008504 153 QIKGFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 153 ~l~~LI~kcL~-dP~kRpSa~ELLk 176 (563)
.+.+|+..||+ +-.+||.+.+|+.
T Consensus 862 aL~qLMldCWqkdR~~RP~F~qiV~ 886 (996)
T KOG0196|consen 862 ALYQLMLDCWQKDRNRRPKFAQIVS 886 (996)
T ss_pred HHHHHHHHHHHHHhhcCCCHHHHHH
Confidence 99999999998 7999999999987
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=7.7e-22 Score=232.33 Aligned_cols=170 Identities=22% Similarity=0.341 Sum_probs=123.0
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSH-NPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~-gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
+||||+++|+|.++++. +++..+..++.||+.||+|||.+ .++|+||||||+||+++.+ +..++. ||.......
T Consensus 760 lv~Ey~~~g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~-~~~~~~-~~~~~~~~~ 834 (968)
T PLN00113 760 LIHEYIEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGK-DEPHLR-LSLPGLLCT 834 (968)
T ss_pred EEEeCCCCCcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCC-CceEEE-ecccccccc
Confidence 69999999999999963 89999999999999999999944 2339999999999999844 566665 555433221
Q ss_pred CCCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCC----HHHHHHHHhcCC-----CCCccc--
Q 008504 80 PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKN----PAQIFKKVTSGI-----KPASLA-- 147 (563)
Q Consensus 80 ~~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~----~~~i~~~i~~~~-----~p~~l~-- 147 (563)
.....+++.|+|||++.+ .|+.++|||||||++|||+||+.||..... .....+...... ..+...
T Consensus 835 --~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (968)
T PLN00113 835 --DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGD 912 (968)
T ss_pred --CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCC
Confidence 123367899999998864 599999999999999999999999853211 111111111000 000010
Q ss_pred ----cCCChhHHHHHHHhcC-CCCCCCCHHHHHcC
Q 008504 148 ----KVNDPQIKGFIEKCLV-PASERLSAKDLLKD 177 (563)
Q Consensus 148 ----~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkH 177 (563)
.....++.+++.+||. +|.+|||+.|+++.
T Consensus 913 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 913 VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred CCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 0111256788999997 89999999999874
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.9e-22 Score=201.43 Aligned_cols=178 Identities=29% Similarity=0.475 Sum_probs=135.4
Q ss_pred EeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCCC
Q 008504 2 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT 81 (563)
Q Consensus 2 VmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~~ 81 (563)
|+|+|.+ +|...|-.-..++...++-+++||++||.|||+.+ |.||||||.|+|++.+ -.+||||||+++......
T Consensus 135 ~TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~--ILHRDIKPGNLLVNSN-CvLKICDFGLARvee~d~ 210 (449)
T KOG0664|consen 135 LTELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTAN--ILHRDIKPGNLLVNSN-CILKICDFGLARTWDQRD 210 (449)
T ss_pred HHHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcc--hhhccCCCccEEeccC-ceEEecccccccccchhh
Confidence 4566644 77777766678999999999999999999999999 9999999999999854 689999999998665432
Q ss_pred C---ccccCCCCccCcccccc--cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhc-----------------
Q 008504 82 A---RSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS----------------- 139 (563)
Q Consensus 82 ~---~~~~Gtp~Y~APEvl~~--~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~----------------- 139 (563)
. ...+-|-.|.|||++.+ .|+.++||||.|||+.|++..+..|.. .++.+....+..
T Consensus 211 ~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQA-q~PiqQL~lItdLLGTPs~EaMr~ACEGA 289 (449)
T KOG0664|consen 211 RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQA-AGPIEQLQMIIDLLGTPSQEAMKYACEGA 289 (449)
T ss_pred hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhc-cChHHHHHHHHHHhCCCcHHHHHHHhhhh
Confidence 2 22355789999998865 599999999999999999999888876 334333332221
Q ss_pred -------CCCCCccccC--------CChhHHHHHHHhcC-CCCCCCCHHHHHcCccccccc
Q 008504 140 -------GIKPASLAKV--------NDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 184 (563)
Q Consensus 140 -------~~~p~~l~~~--------~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~ 184 (563)
+.+++.++.. ...+...++.++|. +|.+|.+..+.+.|+++...+
T Consensus 290 k~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R 350 (449)
T KOG0664|consen 290 KNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGR 350 (449)
T ss_pred HHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccc
Confidence 2222222211 12355667777777 899999999999999987544
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.1e-22 Score=216.67 Aligned_cols=180 Identities=30% Similarity=0.533 Sum_probs=153.0
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
+.||||.||+|.+.-.-.+++++.++...++..++||+|||+.| -+|||||-.||+++ +.|.||++|||.+..+...
T Consensus 89 icMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~g--k~hRdiKGanillt-d~gDvklaDfgvsaqitat 165 (829)
T KOG0576|consen 89 ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQG--KIHRDIKGANILLT-DEGDVKLADFGVSAQITAT 165 (829)
T ss_pred EEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCC--cccccccccceeec-ccCceeecccCchhhhhhh
Confidence 57999999999998887889999999999999999999999999 99999999999998 6689999999999776543
Q ss_pred --CCccccCCCCccCcccc----cccCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCcc--ccCCCh
Q 008504 81 --TARSVIGTPEFMAPELY----EEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASL--AKVNDP 152 (563)
Q Consensus 81 --~~~~~~Gtp~Y~APEvl----~~~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l--~~~~s~ 152 (563)
..+.++|||.|||||+- .++|+.++|||++|+...|+.-.+.|.........++-.-..+..|+.+ .....+
T Consensus 166 i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~ 245 (829)
T KOG0576|consen 166 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSE 245 (829)
T ss_pred hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchH
Confidence 45678999999999976 3679999999999999999999998876633334444444555555443 344578
Q ss_pred hHHHHHHHhcC-CCCCCCCHHHHHcCcccccc
Q 008504 153 QIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 183 (563)
Q Consensus 153 ~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~ 183 (563)
.+.+|++.+|. +|.+||++..+|.|||....
T Consensus 246 ~fh~fvK~altknpKkRptaeklL~h~fvs~~ 277 (829)
T KOG0576|consen 246 FFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT 277 (829)
T ss_pred HHHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence 89999999996 79999999999999999754
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.9e-21 Score=178.14 Aligned_cols=142 Identities=37% Similarity=0.657 Sum_probs=125.9
Q ss_pred CEeccCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~-~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
+|+||+.+++|.+++... ..++...++.++.+++.+|.+||++| ++|+||+|.||+++...+.++|+|||.+.....
T Consensus 68 ~~~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~ 145 (215)
T cd00180 68 LVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNG--IIHRDLKPENILLDSDNGKVKLADFGLSKLLTS 145 (215)
T ss_pred EEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHhhEEEeCCCCcEEEecCCceEEccC
Confidence 589999999999999876 57999999999999999999999999 999999999999985257999999999976654
Q ss_pred CC--CccccCCCCccCcccccc--cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHH
Q 008504 80 PT--ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIK 155 (563)
Q Consensus 80 ~~--~~~~~Gtp~Y~APEvl~~--~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~ 155 (563)
.. .....+...|++||.+.. .++.+.|+|++|+++++| ..+.
T Consensus 146 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------~~~~ 191 (215)
T cd00180 146 DKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------PELK 191 (215)
T ss_pred CcchhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------HHHH
Confidence 43 344567889999998865 678899999999999999 6789
Q ss_pred HHHHHhcC-CCCCCCCHHHHHcCc
Q 008504 156 GFIEKCLV-PASERLSAKDLLKDP 178 (563)
Q Consensus 156 ~LI~kcL~-dP~kRpSa~ELLkHp 178 (563)
+++.+|+. +|.+||++.++++|+
T Consensus 192 ~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 192 DLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred HHHHHHhhCCcccCcCHHHHhhCC
Confidence 99999997 899999999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.4e-21 Score=204.06 Aligned_cols=172 Identities=28% Similarity=0.490 Sum_probs=131.9
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-------CCCeEeccCccCceEEeCCCCcEEEecccc
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSH-------NPPIIHRDLKCDNIFVNGNHGEVKIGDLGL 73 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~-------gp~IIHrDLKP~NILLd~~~G~VKL~DFGl 73 (563)
||+||.+.|+|.+||+.+ .+++....+++.-+++||+|||+- .|+|+|||||..||||. ++++..|+|||+
T Consensus 285 LVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK-~DlTccIaDFGL 362 (534)
T KOG3653|consen 285 LVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVK-NDLTCCIADFGL 362 (534)
T ss_pred EEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEc-cCCcEEeeccce
Confidence 699999999999999985 699999999999999999999985 35899999999999997 668999999999
Q ss_pred hhhccCC----CCccccCCCCccCcccccccCC-------chhhHHHhHHHHHHHhhcC------------CCCCC----
Q 008504 74 AIAMQQP----TARSVIGTPEFMAPELYEEEYN-------ELVDIYSFGMCILEMVTFE------------YPYSE---- 126 (563)
Q Consensus 74 A~~~~~~----~~~~~~Gtp~Y~APEvl~~~ys-------~ksDIwSLGviLyELlTG~------------~Pf~~---- 126 (563)
|..+... .....+||..|||||++++..+ .+.||||+|.++|||++.- .||..
T Consensus 363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~ 442 (534)
T KOG3653|consen 363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGN 442 (534)
T ss_pred eEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcC
Confidence 9766432 2334689999999999986432 2589999999999999752 23321
Q ss_pred CCCHHHHHHHHhcCCCCCccccC-----CChhHHHHHHHhcC-CCCCCCCHHHH
Q 008504 127 CKNPAQIFKKVTSGIKPASLAKV-----NDPQIKGFIEKCLV-PASERLSAKDL 174 (563)
Q Consensus 127 ~~~~~~i~~~i~~~~~p~~l~~~-----~s~~l~~LI~kcL~-dP~kRpSa~EL 174 (563)
....+++...+......+.++.. ....+++.++.||. ||..|.||.=+
T Consensus 443 hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv 496 (534)
T KOG3653|consen 443 HPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCV 496 (534)
T ss_pred CCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHH
Confidence 11223344444443333333322 13468999999997 99999997644
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.7e-21 Score=201.57 Aligned_cols=178 Identities=27% Similarity=0.486 Sum_probs=137.6
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhcc--
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ-- 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~-- 78 (563)
+|+||++.-...++... ++...++.+++.++.||.++|.+| ||||||||.|++.+...+.-.|+|||+|....
T Consensus 112 ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~G--IvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~ 186 (418)
T KOG1167|consen 112 IVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNG--IVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGY 186 (418)
T ss_pred EEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccC--ccccCCCccccccccccCCceEEechhHHHHHhh
Confidence 58999999999998765 779999999999999999999999 99999999999999888899999999996110
Q ss_pred -------C-------C-C-----------------------------CccccCCCCccCccccc--ccCCchhhHHHhHH
Q 008504 79 -------Q-------P-T-----------------------------ARSVIGTPEFMAPELYE--EEYNELVDIYSFGM 112 (563)
Q Consensus 79 -------~-------~-~-----------------------------~~~~~Gtp~Y~APEvl~--~~ys~ksDIwSLGv 112 (563)
. . . .....||+.|.|||++. +..++++||||.|+
T Consensus 187 ~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GV 266 (418)
T KOG1167|consen 187 QQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGV 266 (418)
T ss_pred hhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccc
Confidence 0 0 0 00235899999999885 45788999999999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHH-HHH-------------hcCC-----------------------------------CC
Q 008504 113 CILEMVTFEYPYSECKNPAQIF-KKV-------------TSGI-----------------------------------KP 143 (563)
Q Consensus 113 iLyELlTG~~Pf~~~~~~~~i~-~~i-------------~~~~-----------------------------------~p 143 (563)
|++.++++++||....+..... ..+ ..|. ..
T Consensus 267 I~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~ 346 (418)
T KOG1167|consen 267 ILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTER 346 (418)
T ss_pred eeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceee
Confidence 9999999999996543321111 000 0000 00
Q ss_pred CccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCcccccc
Q 008504 144 ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 183 (563)
Q Consensus 144 ~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~ 183 (563)
.......+..+.+|+.+||. +|.+|.||+++|+||||...
T Consensus 347 ~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~ 387 (418)
T KOG1167|consen 347 EIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEA 387 (418)
T ss_pred ccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcch
Confidence 11112334588999999997 99999999999999999843
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.6e-20 Score=197.77 Aligned_cols=174 Identities=30% Similarity=0.516 Sum_probs=133.0
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC------CCCeEeccCccCceEEeCCCCcEEEecccch
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSH------NPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA 74 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~------gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA 74 (563)
||++|-+.|+|++||.+ ..++.+...+++..++.||++||.. .|.|.|||||..||||. ++|..-|+|+|+|
T Consensus 286 LvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVK-kn~~C~IADLGLA 363 (513)
T KOG2052|consen 286 LVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK-KNGTCCIADLGLA 363 (513)
T ss_pred EeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEc-cCCcEEEeeceee
Confidence 69999999999999998 6799999999999999999999974 36799999999999997 6689999999999
Q ss_pred hhccCC------CCccccCCCCccCcccccccC-------CchhhHHHhHHHHHHHhhc----------CCCCCCC----
Q 008504 75 IAMQQP------TARSVIGTPEFMAPELYEEEY-------NELVDIYSFGMCILEMVTF----------EYPYSEC---- 127 (563)
Q Consensus 75 ~~~~~~------~~~~~~Gtp~Y~APEvl~~~y-------s~ksDIwSLGviLyELlTG----------~~Pf~~~---- 127 (563)
...... .....+||..|||||++.... -..+||||||.++||++.. +.||.+.
T Consensus 364 v~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~D 443 (513)
T KOG2052|consen 364 VRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSD 443 (513)
T ss_pred EEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCC
Confidence 654432 234568999999999996532 2358999999999999752 5788652
Q ss_pred CCHHHHHHHHhcCCCCCccccCC--Ch---hHHHHHHHhcC-CCCCCCCHHHHHc
Q 008504 128 KNPAQIFKKVTSGIKPASLAKVN--DP---QIKGFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 128 ~~~~~i~~~i~~~~~p~~l~~~~--s~---~l~~LI~kcL~-dP~kRpSa~ELLk 176 (563)
...+++.+.+.-....+.++... ++ .+.++|+.||. +|.-|.||--+.+
T Consensus 444 Ps~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKK 498 (513)
T KOG2052|consen 444 PSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKK 498 (513)
T ss_pred CCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence 22344444443333333333322 23 45677999996 8999999876644
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.4e-20 Score=208.79 Aligned_cols=171 Identities=29% Similarity=0.473 Sum_probs=142.8
Q ss_pred CEeccCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~-~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
||++|+++|+|.+|++.+ .++-.+....|+.||++|+.|||.++ ++||||-.+||||.. ...|||.|||+++.+..
T Consensus 774 lvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qr--lVHrdLaaRNVLVks-P~hvkitdfgla~ll~~ 850 (1177)
T KOG1025|consen 774 LVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQR--LVHRDLAARNVLVKS-PNHVKITDFGLAKLLAP 850 (1177)
T ss_pred HHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcc--hhhhhhhhhheeecC-CCeEEEEecchhhccCc
Confidence 588999999999999875 46999999999999999999999999 999999999999984 45999999999987754
Q ss_pred CCCc----cccCCCCccCccccc-ccCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCCCCccccCCChh
Q 008504 80 PTAR----SVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQ 153 (563)
Q Consensus 80 ~~~~----~~~Gtp~Y~APEvl~-~~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~ 153 (563)
.... ...-.+.|||-|.+. ..|+.++|||||||++||++| |..||.+ ...+++-..+..+.+ -..+...+..
T Consensus 851 d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~g-i~~~eI~dlle~geR-LsqPpiCtiD 928 (1177)
T KOG1025|consen 851 DEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDG-IPAEEIPDLLEKGER-LSQPPICTID 928 (1177)
T ss_pred ccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCC-CCHHHhhHHHhcccc-CCCCCCccHH
Confidence 3211 112245688888775 569999999999999999998 6889887 556777777777766 4456777889
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHHc
Q 008504 154 IKGFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 154 l~~LI~kcL~-dP~kRpSa~ELLk 176 (563)
+.-++.+||. |+..||+++++..
T Consensus 929 Vy~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 929 VYMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred HHHHHHHHhccCcccCccHHHHHH
Confidence 9999999996 9999999988764
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.3e-20 Score=211.62 Aligned_cols=180 Identities=24% Similarity=0.430 Sum_probs=145.7
Q ss_pred EeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC-
Q 008504 2 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP- 80 (563)
Q Consensus 2 VmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~- 80 (563)
+||||++ +|+.++...+.+....+..+++|++.||+|||+.| |.||||||+|++++ ..|.+||+|||.+.....+
T Consensus 399 ~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~G--iahrdlK~enll~~-~~g~lki~Dfg~~~vf~~~~ 474 (601)
T KOG0590|consen 399 SMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMG--LAHRDLKLENLLVT-ENGILKIIDFGAASVFRYPW 474 (601)
T ss_pred hhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcC--ceeccCccccEEEe-cCCceEEeecCcceeeccCc
Confidence 3899999 99999998888999999999999999999999999 99999999999998 5579999999999765432
Q ss_pred -----CCccccCCCCccCccccccc-CC-chhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhc------CCCCCccc
Q 008504 81 -----TARSVIGTPEFMAPELYEEE-YN-ELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS------GIKPASLA 147 (563)
Q Consensus 81 -----~~~~~~Gtp~Y~APEvl~~~-ys-~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~------~~~p~~l~ 147 (563)
.....+|+..|+|||++.+. |. ..+||||.|+++..|++|++||.........+..... ...+..+.
T Consensus 475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~ 554 (601)
T KOG0590|consen 475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLL 554 (601)
T ss_pred chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHH
Confidence 23356899999999988754 64 4799999999999999999999754333322111110 11123344
Q ss_pred cCCChhHHHHHHHhcC-CCCCCCCHHHHHcCcccccccc
Q 008504 148 KVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQ 185 (563)
Q Consensus 148 ~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~~ 185 (563)
...+...+.+|.+||+ +|.+|.|+.+|++.+||+....
T Consensus 555 ~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~ 593 (601)
T KOG0590|consen 555 SLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIEC 593 (601)
T ss_pred HhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcce
Confidence 5556788999999998 8999999999999999986543
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.7e-19 Score=191.76 Aligned_cols=57 Identities=37% Similarity=0.598 Sum_probs=50.9
Q ss_pred CEeccCCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEE
Q 008504 1 MITELFTSGNLRQYRKK--HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV 59 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k--~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILL 59 (563)
||+|++ |-+|..+|++ ++.++...++.|++|||.||.|||... .|||-||||+|||+
T Consensus 163 MVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec-gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 163 MVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC-GIIHTDLKPENVLL 221 (590)
T ss_pred EEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc-CccccCCCcceeee
Confidence 689999 5588888875 578999999999999999999999864 39999999999998
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.79 E-value=5.5e-19 Score=169.32 Aligned_cols=139 Identities=34% Similarity=0.549 Sum_probs=118.4
Q ss_pred CEeccCCCCCHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKKHKN-VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~-Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
+|+||+.+++|.+++..... +++..+..++.|++.+|.|||+++ ++|+||+|.||+++.+ +.++|+|||.+.....
T Consensus 74 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~di~~~ni~v~~~-~~~~l~d~g~~~~~~~ 150 (225)
T smart00221 74 LVMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLG--IVHRDLKPENILLGMD-GLVKLADFGLARFIHR 150 (225)
T ss_pred EEEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCC-CCEEEeeCceeeEecC
Confidence 58999999999999998777 899999999999999999999999 9999999999999854 7999999999876654
Q ss_pred C---CCccccCCCCccCccccc--ccCCchhhHHHhHHHHHHHhhcCCCCCC-CCCHHHHHHHHhcCCC
Q 008504 80 P---TARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTFEYPYSE-CKNPAQIFKKVTSGIK 142 (563)
Q Consensus 80 ~---~~~~~~Gtp~Y~APEvl~--~~ys~ksDIwSLGviLyELlTG~~Pf~~-~~~~~~i~~~i~~~~~ 142 (563)
. ......++..|++||.+. ..++.++|+|+||+++++|++|+.||.. ..+...+.+.+..+..
T Consensus 151 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 219 (225)
T smart00221 151 DLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGVP 219 (225)
T ss_pred cccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCCc
Confidence 3 223456788999999873 3477799999999999999999999976 4555577777776653
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=6.5e-19 Score=183.18 Aligned_cols=170 Identities=22% Similarity=0.335 Sum_probs=141.0
Q ss_pred EeccCCCCCHHHHHHh--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccc
Q 008504 2 ITELFTSGNLRQYRKK--------HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGL 73 (563)
Q Consensus 2 VmEy~~gGsL~~~L~k--------~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGl 73 (563)
++.++.-|+|+.|+.. -+.++..++..++.|+..|++|||++| |||.||..+|.+|+ +.-+|||+|=.+
T Consensus 366 ~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~--ViHkDiAaRNCvId-d~LqVkltDsaL 442 (563)
T KOG1024|consen 366 LYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG--VIHKDIAARNCVID-DQLQVKLTDSAL 442 (563)
T ss_pred EEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC--cccchhhhhcceeh-hheeEEeccchh
Confidence 5678888999999983 134778888999999999999999999 99999999999998 446999999988
Q ss_pred hhhccCCCCc----cccCCCCccCccccc-ccCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCCCCccc
Q 008504 74 AIAMQQPTAR----SVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLA 147 (563)
Q Consensus 74 A~~~~~~~~~----~~~Gtp~Y~APEvl~-~~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~ 147 (563)
++.+-..... ..-....||+||.+. ..|+.++|+||||+++|||+| |+.||.+ .+|.+....+..|.+.. .|
T Consensus 443 SRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~Pyae-IDPfEm~~ylkdGyRla-QP 520 (563)
T KOG1024|consen 443 SRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAE-IDPFEMEHYLKDGYRLA-QP 520 (563)
T ss_pred ccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccc-cCHHHHHHHHhccceec-CC
Confidence 8754322111 112345799999886 459999999999999999998 7899987 67899999999887654 35
Q ss_pred cCCChhHHHHHHHhcC-CCCCCCCHHHHHc
Q 008504 148 KVNDPQIKGFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 148 ~~~s~~l~~LI~kcL~-dP~kRpSa~ELLk 176 (563)
-.++.++..++..||. .|++||++.|+..
T Consensus 521 ~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 521 FNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred CCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 5677899999999997 8999999999864
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.5e-19 Score=179.28 Aligned_cols=177 Identities=23% Similarity=0.369 Sum_probs=131.4
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEe-CCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN-GNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd-~~~G~VKL~DFGlA~~~~~ 79 (563)
+++||++.|+|..-+.. .++-+...++++.|+++|+.|+|+.+ ++|||||.+||||- .+.-.|||||||+.+..+.
T Consensus 99 F~qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHskn--lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~ 175 (378)
T KOG1345|consen 99 FVQEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKN--LVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT 175 (378)
T ss_pred EeeccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccc--hhhcccccceEEEecCCccEEEeeecccccccCc
Confidence 58999999999988776 45899999999999999999999999 99999999999984 3445899999999865433
Q ss_pred CCCccccCCCCccCccccc----cc--CCchhhHHHhHHHHHHHhhcCCCCCCCCCHH---HHHHHHhcCCCC--Ccccc
Q 008504 80 PTARSVIGTPEFMAPELYE----EE--YNELVDIYSFGMCILEMVTFEYPYSECKNPA---QIFKKVTSGIKP--ASLAK 148 (563)
Q Consensus 80 ~~~~~~~Gtp~Y~APEvl~----~~--ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~---~i~~~i~~~~~p--~~l~~ 148 (563)
.. ...--+..|.+||+.. +. ..+..|||.||+++|.++||.+||....... ..+.+...+..+ +..-+
T Consensus 176 tV-~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~ 254 (378)
T KOG1345|consen 176 TV-KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKFN 254 (378)
T ss_pred ee-hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhhc
Confidence 21 1222356789999663 22 5788999999999999999999997532222 222333333322 12223
Q ss_pred CCChhHHHHHHHhcC-CCCCC---CCHHHHHcCcccc
Q 008504 149 VNDPQIKGFIEKCLV-PASER---LSAKDLLKDPFLQ 181 (563)
Q Consensus 149 ~~s~~l~~LI~kcL~-dP~kR---pSa~ELLkHpff~ 181 (563)
..++.+..+.++-|. ++.+| .++....+..|..
T Consensus 255 ~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E 291 (378)
T KOG1345|consen 255 PFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKE 291 (378)
T ss_pred ccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHH
Confidence 456788888889887 68888 5666666666653
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.6e-17 Score=161.81 Aligned_cols=182 Identities=30% Similarity=0.408 Sum_probs=145.4
Q ss_pred CEeccCCCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhc
Q 008504 1 MITELFTSGNLRQYRKKHK---NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM 77 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~---~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~ 77 (563)
++++|+.+++|.+++.... .+....+..++.|++.++.|+|+.+ ++||||||+||+++.....++++|||.+...
T Consensus 75 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~--~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~ 152 (384)
T COG0515 75 LVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG--IIHRDIKPENILLDRDGRVVKLIDFGLAKLL 152 (384)
T ss_pred EEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeecCCCCeEEEeccCcceec
Confidence 5899999999998888765 7999999999999999999999999 9999999999999854337999999998755
Q ss_pred cCC--------CCccccCCCCccCcccccc----cCCchhhHHHhHHHHHHHhhcCCCCCCCCC---HHHHHHHHhcCCC
Q 008504 78 QQP--------TARSVIGTPEFMAPELYEE----EYNELVDIYSFGMCILEMVTFEYPYSECKN---PAQIFKKVTSGIK 142 (563)
Q Consensus 78 ~~~--------~~~~~~Gtp~Y~APEvl~~----~ys~ksDIwSLGviLyELlTG~~Pf~~~~~---~~~i~~~i~~~~~ 142 (563)
... ......|+..|++||.+.+ .+....|+|++|++++++++|..||..... .......+.....
T Consensus 153 ~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 232 (384)
T COG0515 153 PDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPT 232 (384)
T ss_pred CCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCC
Confidence 432 2356689999999998864 578899999999999999999999876543 3455555544443
Q ss_pred C-CccccCC------ChhHHHHHHHhcC-CCCCCCCHHHHHcCccccccc
Q 008504 143 P-ASLAKVN------DPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 184 (563)
Q Consensus 143 p-~~l~~~~------s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~ 184 (563)
+ ....... ...+.+++.+|+. +|..|.+..+...++|.....
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~ 282 (384)
T COG0515 233 PSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLK 282 (384)
T ss_pred cccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCcc
Confidence 3 1111111 1478999999997 799999999999987665443
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.2e-18 Score=184.82 Aligned_cols=122 Identities=30% Similarity=0.467 Sum_probs=110.1
Q ss_pred EeccC-CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 2 ITELF-TSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 2 VmEy~-~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
+||-- +|-+|++||..++.+++.+++.|++|++.|+++||++| |||||||-+|+.+++ +|.+||+|||.+......
T Consensus 647 ~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~--ivhrdikdenvivd~-~g~~klidfgsaa~~ksg 723 (772)
T KOG1152|consen 647 ETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQG--IVHRDIKDENVIVDS-NGFVKLIDFGSAAYTKSG 723 (772)
T ss_pred EecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccC--ceecccccccEEEec-CCeEEEeeccchhhhcCC
Confidence 34433 34599999999999999999999999999999999999 999999999999985 489999999999888888
Q ss_pred CCccccCCCCccCccccccc-C-CchhhHHHhHHHHHHHhhcCCCCCC
Q 008504 81 TARSVIGTPEFMAPELYEEE-Y-NELVDIYSFGMCILEMVTFEYPYSE 126 (563)
Q Consensus 81 ~~~~~~Gtp~Y~APEvl~~~-y-s~ksDIwSLGviLyELlTG~~Pf~~ 126 (563)
....++||..|.|||++.+. | +..-|||++|+++|.++..+.||.+
T Consensus 724 pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 724 PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 88889999999999999865 4 6789999999999999999999974
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=3.9e-18 Score=186.54 Aligned_cols=175 Identities=21% Similarity=0.338 Sum_probs=148.5
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
++++|..||.|...+.+...+.+...+.+...++-+++++|+.+ |+|||+|++||+++. .|.+++.|||+++..-..
T Consensus 74 l~ld~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~--iiyrd~k~enilld~-~Ghi~~tdfglske~v~~ 150 (612)
T KOG0603|consen 74 LILDFLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLG--IAYRDYKLENVLLLL-EGHIKLTDFGLSKEAVKE 150 (612)
T ss_pred HhhhhcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhH--HHHhcccccceeecc-cCccccCCchhhhHhHhh
Confidence 46788999999999998888999999999999999999999999 999999999999985 589999999999766543
Q ss_pred CCccccCCCCccCcccccccCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHHHHHH
Q 008504 81 TARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEK 160 (563)
Q Consensus 81 ~~~~~~Gtp~Y~APEvl~~~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~LI~k 160 (563)
... +||..|||||+++ +...++|.||||+++++|+||..||.. .+.+.|..... ..+....+.+++++..
T Consensus 151 ~~~--cgt~eymApEI~~-gh~~a~D~ws~gvl~felltg~~pf~~-----~~~~~Il~~~~--~~p~~l~~~a~~~~~~ 220 (612)
T KOG0603|consen 151 KIA--CGTYEYRAPEIIN-GHLSAADWWSFGVLAFELLTGTLPFGG-----DTMKRILKAEL--EMPRELSAEARSLFRQ 220 (612)
T ss_pred hhc--ccchhhhhhHhhh-ccCCcccchhhhhhHHHHhhCCCCCch-----HHHHHHhhhcc--CCchhhhHHHHHHHHH
Confidence 333 8999999999998 677899999999999999999999976 44444444322 2456667889999999
Q ss_pred hcC-CCCCCCC-----HHHHHcCccccccccCCC
Q 008504 161 CLV-PASERLS-----AKDLLKDPFLQVENQKEP 188 (563)
Q Consensus 161 cL~-dP~kRpS-----a~ELLkHpff~~~~~~~~ 188 (563)
++. +|..|.- +.++++|+||+...|...
T Consensus 221 l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~~l 254 (612)
T KOG0603|consen 221 LFKRNPENRLGAGPDGVDEIKQHEFFQSIDWNEL 254 (612)
T ss_pred HHhhCHHHHhccCcchhHHHhccchheeeeHhhH
Confidence 996 7888874 689999999998887743
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.68 E-value=2e-17 Score=178.08 Aligned_cols=170 Identities=27% Similarity=0.511 Sum_probs=133.9
Q ss_pred CEeccCCCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhc
Q 008504 1 MITELFTSGNLRQYRKKHK---NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM 77 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~---~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~ 77 (563)
|.|++|..++|.++|.... ..+....+.|+.|+..|+.| ++ .+|||+||.||++. .+..+||+|||+....
T Consensus 333 I~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~--~ihrdlkp~nif~~-~d~q~kIgDFgl~ts~ 406 (516)
T KOG1033|consen 333 IQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG--LIHRDLKPSNIFFS-DDDQLKIGDFGLVTSQ 406 (516)
T ss_pred hhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc--chhhhccccccccc-cchhhhhhhhhheeec
Confidence 5689999999999997543 36778899999999999999 88 99999999999996 5568999999998655
Q ss_pred cCCC--------CccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCCCCccc
Q 008504 78 QQPT--------ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLA 147 (563)
Q Consensus 78 ~~~~--------~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~ 147 (563)
.... ....+||..||+||.+.+ .|+.++|||+||++++|+++ ...++. .......+..+..|+...
T Consensus 407 ~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e----r~~t~~d~r~g~ip~~~~ 482 (516)
T KOG1033|consen 407 DKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE----RIATLTDIRDGIIPPEFL 482 (516)
T ss_pred ccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH----HHHhhhhhhcCCCChHHh
Confidence 4322 224579999999998874 59999999999999999997 333332 233444556666654333
Q ss_pred cCCChhHHHHHHHhcC-CCCCCCCHHHHHcCcccc
Q 008504 148 KVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQ 181 (563)
Q Consensus 148 ~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~ 181 (563)
.. .|.-..|+..+|. .|.+||++.+.-.|+|.+
T Consensus 483 ~d-~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~~ 516 (516)
T KOG1033|consen 483 QD-YPEEYTLLQQLLSPSPEERPSAIEVALHEFLQ 516 (516)
T ss_pred hc-CcHHHHHHHHhcCCCcccCchHHHHhhhhhcC
Confidence 33 3567799999997 799999888888787763
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.7e-16 Score=181.27 Aligned_cols=150 Identities=30% Similarity=0.491 Sum_probs=123.4
Q ss_pred HHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC-----------------CCCccccCCCCccCccc
Q 008504 34 LHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ-----------------PTARSVIGTPEFMAPEL 96 (563)
Q Consensus 34 L~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~-----------------~~~~~~~Gtp~Y~APEv 96 (563)
+.+++|||+.| |+|||+||+|.+|+ .-|.+|++|||+.+..-. -..+.++|||.|.|||+
T Consensus 153 vla~Eylh~yg--ivhrdlkpdnllIT-~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeV 229 (1205)
T KOG0606|consen 153 VLAVEYLHSYG--IVHRDLKPDNLLIT-SMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEV 229 (1205)
T ss_pred hHHhHhhccCC--eecCCCCCCcceee-ecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhh
Confidence 78999999999 99999999999998 668999999999853210 01235689999999997
Q ss_pred c-cccCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCC-CCccccCCChhHHHHHHHhcC-CCCCCC---C
Q 008504 97 Y-EEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK-PASLAKVNDPQIKGFIEKCLV-PASERL---S 170 (563)
Q Consensus 97 l-~~~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~-p~~l~~~~s~~l~~LI~kcL~-dP~kRp---S 170 (563)
+ .++|+..+|+|++|+|+|+.+.|..||.+ ..+++++..+..... ...-.....++++++|.++|+ +|..|. .
T Consensus 230 ilrqgygkpvdwwamGiIlyeFLVgcvpffG-dtpeelfg~visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~g 308 (1205)
T KOG0606|consen 230 ILRQGYGKPVDWWAMGIILYEFLVGCVPFFG-DTPEELFGQVISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGG 308 (1205)
T ss_pred hhhhccCCCccHHHHHHHHHHHheeeeeccC-CCHHHHHhhhhhhhccccccCcCCCHHHHHHHHHHHHhChHhhcccch
Confidence 7 56799999999999999999999999988 677887777665432 222245567899999999996 788885 6
Q ss_pred HHHHHcCccccccccCC
Q 008504 171 AKDLLKDPFLQVENQKE 187 (563)
Q Consensus 171 a~ELLkHpff~~~~~~~ 187 (563)
+-++.+|+||+..+|..
T Consensus 309 a~evk~h~ff~~LDw~~ 325 (1205)
T KOG0606|consen 309 ALEVKQHGFFQLLDWKS 325 (1205)
T ss_pred hhhhhhccceeecccch
Confidence 88999999999888874
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.64 E-value=2.6e-16 Score=161.26 Aligned_cols=173 Identities=36% Similarity=0.594 Sum_probs=129.1
Q ss_pred CEeccCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhh
Q 008504 1 MITELFTSGNLRQYRKK----HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 76 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k----~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~ 76 (563)
|++|||..|+|.+||++ ++.+....+++|+.||+.||.|||+..|||+|+++.++.||+. .+|.|||+--.....
T Consensus 149 Fiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq-~ngLIkig~~ap~s~ 227 (458)
T KOG1266|consen 149 FITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQ-HNGLIKIGSVAPDST 227 (458)
T ss_pred EEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeec-CCceEEecccCcccc
Confidence 58999999999999985 4569999999999999999999999999999999999999998 668999865332211
Q ss_pred c------cCCCCccccCCCCccCccccc-ccCCchhhHHHhHHHHHHHhhcCCCCCCCCCH---HHHHHHHhcCCCCCcc
Q 008504 77 M------QQPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNP---AQIFKKVTSGIKPASL 146 (563)
Q Consensus 77 ~------~~~~~~~~~Gtp~Y~APEvl~-~~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~---~~i~~~i~~~~~p~~l 146 (563)
. .........+.+.|.+||.-. .+.+.++|||+||++.++|..++..-.+.... +.....+.
T Consensus 228 h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i-------- 299 (458)
T KOG1266|consen 228 HPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVI-------- 299 (458)
T ss_pred chhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhhe--------
Confidence 0 011111234678899999654 34677899999999999999987654332111 11111111
Q ss_pred ccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCccccc
Q 008504 147 AKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQV 182 (563)
Q Consensus 147 ~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~ 182 (563)
....++.-+.+|.+|+. .|..||+++++|.||.+-.
T Consensus 300 ~~len~lqr~~i~kcl~~eP~~rp~ar~llfHpllfe 336 (458)
T KOG1266|consen 300 IGLENGLQRGSITKCLEGEPNGRPDARLLLFHPLLFE 336 (458)
T ss_pred eeccCccccCcCcccccCCCCCCcchhhhhcCceeee
Confidence 12223455789999998 7999999999999998653
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.8e-14 Score=150.25 Aligned_cols=174 Identities=20% Similarity=0.239 Sum_probs=127.7
Q ss_pred CEeccCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCC----CcEEEecccch
Q 008504 1 MITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNH----GEVKIGDLGLA 74 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~--~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~----G~VKL~DFGlA 74 (563)
|||+++ |.+|.++.+.. +.++..++..++.|++.+|.+||+.| ++||||||+|+.+.... ..+.|.|||++
T Consensus 98 iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G--~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 98 IVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG--FIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred EEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC--cccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 588888 67999988654 47999999999999999999999999 99999999999996432 36999999999
Q ss_pred h--hcc-CC--------C-CccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHH--HHHHHhc
Q 008504 75 I--AMQ-QP--------T-ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQ--IFKKVTS 139 (563)
Q Consensus 75 ~--~~~-~~--------~-~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~--i~~~i~~ 139 (563)
+ ... .. . ...+.||..|+++.+..+ ..+.+.|+||++.++.+++.|..||........ .+.....
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~ 254 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPR 254 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhh
Confidence 8 321 11 1 123469999999997764 489999999999999999999999976443222 2222222
Q ss_pred CCCCCccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcC
Q 008504 140 GIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 177 (563)
Q Consensus 140 ~~~p~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkH 177 (563)
...........+.++..+...+-. +...+|....+...
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 255 KLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred hhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 211111223344566666665554 67888887777654
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.58 E-value=8.1e-15 Score=153.31 Aligned_cols=176 Identities=21% Similarity=0.332 Sum_probs=126.1
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCC---CcEEEecccchhhc
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNH---GEVKIGDLGLAIAM 77 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~---G~VKL~DFGlA~~~ 77 (563)
+||.-+.. +|++|+-.+ ..+....+-++.|+++|+.|||.+| |.|||||.+|||+.-++ ..+.|+|||.+-.-
T Consensus 320 lvMkrY~~-tLr~yl~~~-~~s~r~~~~~laQlLEav~hL~~hg--vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd 395 (598)
T KOG4158|consen 320 LVMKRYRQ-TLREYLWTR-HRSYRTGRVILAQLLEAVTHLHKHG--VAHRDLKSDNILLELDDDEIPQLVVADFGCCLAD 395 (598)
T ss_pred Eehhcchh-hHHHHHhcC-CCchHHHHHHHHHHHHHHHHHHHcc--chhhcccccceEEEecCCCCcEEEEcccceeeec
Confidence 45666654 899998764 4777888889999999999999999 99999999999994322 25789999987321
Q ss_pred cC-----C---CCccccCCCCccCccccccc-------CCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCC
Q 008504 78 QQ-----P---TARSVIGTPEFMAPELYEEE-------YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK 142 (563)
Q Consensus 78 ~~-----~---~~~~~~Gtp~Y~APEvl~~~-------ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~ 142 (563)
.. + ..-..-|.-..||||+.... .-.++|.|+.|.+.||+++...||+......--....... .
T Consensus 396 ~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~-q 474 (598)
T KOG4158|consen 396 DNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQES-Q 474 (598)
T ss_pred cccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhh-h
Confidence 11 1 11123477789999988531 2358999999999999999999997622111111111222 2
Q ss_pred CCccccCCChhHHHHHHHhcC-CCCCCCCH---HHHHcCcccc
Q 008504 143 PASLAKVNDPQIKGFIEKCLV-PASERLSA---KDLLKDPFLQ 181 (563)
Q Consensus 143 p~~l~~~~s~~l~~LI~kcL~-dP~kRpSa---~ELLkHpff~ 181 (563)
.+.++...++.+++++..+|+ +|++|+++ ..+|+-..+.
T Consensus 475 LPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~LsLw~ 517 (598)
T KOG4158|consen 475 LPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVLNLSLWR 517 (598)
T ss_pred CCCCcccCChHHHHHHHHHhcCCccccCCccHHHhHHHHHHhc
Confidence 334677788999999999997 89999984 4455443333
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.54 E-value=4.2e-15 Score=152.95 Aligned_cols=155 Identities=17% Similarity=0.220 Sum_probs=99.0
Q ss_pred EeccCCCCCHHHHHH---hCC----CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccch
Q 008504 2 ITELFTSGNLRQYRK---KHK----NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA 74 (563)
Q Consensus 2 VmEy~~gGsL~~~L~---k~~----~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA 74 (563)
+|+-+ .++|.+++. ... .+.......+..|+++.+++||++| ++|+||+|+|+|++ .+|.++|+||+..
T Consensus 117 l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G--lVHgdi~~~nfll~-~~G~v~Lg~F~~~ 192 (288)
T PF14531_consen 117 LMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG--LVHGDIKPENFLLD-QDGGVFLGDFSSL 192 (288)
T ss_dssp EEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT--EEEST-SGGGEEE--TTS-EEE--GGGE
T ss_pred ccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc--eEecccceeeEEEc-CCCCEEEcChHHH
Confidence 44555 358877754 221 1334445566799999999999999 99999999999998 5699999999887
Q ss_pred hhccCCCCccccCCCCccCcccccc---------cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCc
Q 008504 75 IAMQQPTARSVIGTPEFMAPELYEE---------EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPAS 145 (563)
Q Consensus 75 ~~~~~~~~~~~~Gtp~Y~APEvl~~---------~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~ 145 (563)
...+..... ...+..|.|||.... .++.+.|.|+||+++|.|+++..||..... ...... ...
T Consensus 193 ~r~g~~~~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~-~~~~~~------~f~ 264 (288)
T PF14531_consen 193 VRAGTRYRC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSP-EADPEW------DFS 264 (288)
T ss_dssp EETTEEEEG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGG-GSTSGG------GGT
T ss_pred eecCceeec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCc-cccccc------cch
Confidence 554432221 344578999997632 378899999999999999999999975321 110000 011
Q ss_pred cccCCChhHHHHHHHhcC-CCCCC
Q 008504 146 LAKVNDPQIKGFIEKCLV-PASER 168 (563)
Q Consensus 146 l~~~~s~~l~~LI~kcL~-dP~kR 168 (563)
.-...+..++.||..+|+ +|.+|
T Consensus 265 ~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 265 RCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp TSS---HHHHHHHHHHT-SSGGGS
T ss_pred hcCCcCHHHHHHHHHHccCCcccC
Confidence 111456789999999997 78877
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.54 E-value=3.6e-15 Score=170.70 Aligned_cols=168 Identities=21% Similarity=0.285 Sum_probs=126.4
Q ss_pred EeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhc--cC
Q 008504 2 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM--QQ 79 (563)
Q Consensus 2 VmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~--~~ 79 (563)
|-+|+.+ +|.+.+..++-+..-+.+.|+.||+.||.-+|..| |+|||||.+||||+. -+-+.|+||..-+.. ..
T Consensus 99 vRqyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~g--VcHGDIKsENILiTS-WNW~~LtDFAsFKPtYLPe 174 (1431)
T KOG1240|consen 99 VRQYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLG--VCHGDIKSENILITS-WNWLYLTDFASFKPTYLPE 174 (1431)
T ss_pred HHHHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcC--ccccccccceEEEee-echhhhhcccccCCccCCC
Confidence 3456655 88888888888999999999999999999999999 999999999999984 458999999865422 11
Q ss_pred --CCCc-----cccCCCCccCcccccc-----------c-CCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhc
Q 008504 80 --PTAR-----SVIGTPEFMAPELYEE-----------E-YNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTS 139 (563)
Q Consensus 80 --~~~~-----~~~Gtp~Y~APEvl~~-----------~-ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~ 139 (563)
+... +-....+|.|||.+.. . .+++.||||+||++.||++ |++||. ..++...-..
T Consensus 175 DNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~----LSQL~aYr~~ 250 (1431)
T KOG1240|consen 175 DNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT----LSQLLAYRSG 250 (1431)
T ss_pred CCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc----HHHHHhHhcc
Confidence 1111 1123458999997632 1 4678999999999999988 467773 3444443333
Q ss_pred CCC--CCccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcC
Q 008504 140 GIK--PASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 177 (563)
Q Consensus 140 ~~~--p~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkH 177 (563)
+.. ...+.++.+..++.||..|++ +|++|.+|++.|+.
T Consensus 251 ~~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 251 NADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred CccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 211 123455667789999999997 99999999999985
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.52 E-value=2.7e-14 Score=155.73 Aligned_cols=173 Identities=25% Similarity=0.409 Sum_probs=132.0
Q ss_pred CEeccCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCe-EeccCccCceEEeCCCCcEEEecccchhhcc
Q 008504 1 MITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPI-IHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k-~~~Lse~~i~~i~~QIL~aL~yLHs~gp~I-IHrDLKP~NILLd~~~G~VKL~DFGlA~~~~ 78 (563)
+|.+||..|+|.+.+.. .-.++......+++.|+.||.|||..- | .|+.|+..|.+++.. -.+||.|||+.....
T Consensus 24 ~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~s~nClvd~~-w~lklt~~Gl~~~~~ 100 (484)
T KOG1023|consen 24 VIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALKSSNCLVDSR-WVLKLTDFGLNSLLE 100 (484)
T ss_pred EEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeeccccceeeee-EEEEechhhhccccc
Confidence 37899999999999987 456889999999999999999999876 5 999999999999855 599999999986553
Q ss_pred C----CCCccccCCCCccCccccccc--------CCchhhHHHhHHHHHHHhhcCCCCCCC---CCHHHHHHHHhc-CCC
Q 008504 79 Q----PTARSVIGTPEFMAPELYEEE--------YNELVDIYSFGMCILEMVTFEYPYSEC---KNPAQIFKKVTS-GIK 142 (563)
Q Consensus 79 ~----~~~~~~~Gtp~Y~APEvl~~~--------ys~ksDIwSLGviLyELlTG~~Pf~~~---~~~~~i~~~i~~-~~~ 142 (563)
. .......-...|.|||+++.. .+.+.||||||++++|+++...||... ..+.++..++.. +..
T Consensus 101 ~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~~~~~~ 180 (484)
T KOG1023|consen 101 ETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDLRNLVEDPDEIILRVKKGGSN 180 (484)
T ss_pred ccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCccccccccCChHHHHHHHHhcCCC
Confidence 2 111111234579999988652 467899999999999999999999752 223455555555 222
Q ss_pred ---CCcccc-CCChhHHHHHHHhcC-CCCCCCCHHHHHc
Q 008504 143 ---PASLAK-VNDPQIKGFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 143 ---p~~l~~-~~s~~l~~LI~kcL~-dP~kRpSa~ELLk 176 (563)
|..... ...+.+..++..||. +|.+||++.++-.
T Consensus 181 ~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~ 219 (484)
T KOG1023|consen 181 PFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS 219 (484)
T ss_pred CcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence 211111 334578999999997 8999999888754
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.45 E-value=2.2e-13 Score=136.93 Aligned_cols=168 Identities=18% Similarity=0.327 Sum_probs=129.5
Q ss_pred CEeccCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEE--Eecccchhh
Q 008504 1 MITELFTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVK--IGDLGLAIA 76 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~--~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VK--L~DFGlA~~ 76 (563)
+|..||+.|+|+..+.... .++..++.+++..|++|++|||+..|-|.---|....++|+.+ -+.+ .+|--++..
T Consensus 264 ~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmided-ltarismad~kfsfq 342 (448)
T KOG0195|consen 264 IISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDED-LTARISMADTKFSFQ 342 (448)
T ss_pred EeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecch-hhhheecccceeeee
Confidence 4788999999999998754 3788899999999999999999999755566788889999844 2444 344333311
Q ss_pred ccCCCCccccCCCCccCccccccc----CCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCCh
Q 008504 77 MQQPTARSVIGTPEFMAPELYEEE----YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDP 152 (563)
Q Consensus 77 ~~~~~~~~~~Gtp~Y~APEvl~~~----ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~ 152 (563)
.. ...-.|.||+||.+..+ .-.++|+|||++++||+.|.+.||.+....+--.+....|.++. ++.-.++
T Consensus 343 --e~---gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~-ippgis~ 416 (448)
T KOG0195|consen 343 --EV---GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVH-IPPGISR 416 (448)
T ss_pred --cc---ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhcccccc-CCCCccH
Confidence 11 11237899999988643 34589999999999999999999998766666666667776654 4455667
Q ss_pred hHHHHHHHhcC-CCCCCCCHHHHH
Q 008504 153 QIKGFIEKCLV-PASERLSAKDLL 175 (563)
Q Consensus 153 ~l~~LI~kcL~-dP~kRpSa~ELL 175 (563)
.+..|+.-|+. ||.+||.++.++
T Consensus 417 hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 417 HMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred HHHHHHHHHhcCCCCcCCCcceeh
Confidence 89999999997 899999987654
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.36 E-value=2.6e-12 Score=132.28 Aligned_cols=138 Identities=20% Similarity=0.387 Sum_probs=112.9
Q ss_pred CEeccCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeC----CCCcEEEecccchh
Q 008504 1 MITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG----NHGEVKIGDLGLAI 75 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k-~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~----~~G~VKL~DFGlA~ 75 (563)
||+|++ |-+|.++..- .++|+.+++.-++.|++.-++|+|++. +|.|||||+|+||.. +...|.|+|||+|+
T Consensus 101 LVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~--LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK 177 (449)
T KOG1165|consen 101 LVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKD--LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAK 177 (449)
T ss_pred hhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcc--eeecccCccceeecCCCCCCCceEEEEeccchh
Confidence 688988 6799998874 456999999999999999999999999 999999999999942 22368999999998
Q ss_pred hccCCC---------CccccCCCCccCcccc-cccCCchhhHHHhHHHHHHHhhcCCCCCCC--CCHHHHHHHHhcCC
Q 008504 76 AMQQPT---------ARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVTFEYPYSEC--KNPAQIFKKVTSGI 141 (563)
Q Consensus 76 ~~~~~~---------~~~~~Gtp~Y~APEvl-~~~ys~ksDIwSLGviLyELlTG~~Pf~~~--~~~~~i~~~i~~~~ 141 (563)
...++. ..+..||..||+-.-- ....+..-|+=|||-++.+.+.|..||.+. .+..+.|++|-...
T Consensus 178 ~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~K 255 (449)
T KOG1165|consen 178 EYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETK 255 (449)
T ss_pred hhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcccc
Confidence 876543 3356799999997633 345788899999999999999999999874 34566677765543
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.35 E-value=9.4e-13 Score=127.84 Aligned_cols=75 Identities=16% Similarity=0.270 Sum_probs=65.9
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYL-HSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yL-Hs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
|||||++|++|...+.+.+.++...+..++.|++.+|.|| |+.| |+||||||+||+++ + +.++|+|||++.....
T Consensus 94 iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~g--iiHrDlkP~NIli~-~-~~v~LiDFG~a~~~~~ 169 (190)
T cd05147 94 LVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCR--LVHADLSEYNLLYH-D-GKLYIIDVSQSVEHDH 169 (190)
T ss_pred EEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEE-C-CcEEEEEccccccCCC
Confidence 6999999988876655567899999999999999999999 7999 99999999999998 3 6899999999965443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.34 E-value=1e-12 Score=139.91 Aligned_cols=88 Identities=23% Similarity=0.304 Sum_probs=70.3
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccC-ccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDL-KCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDL-KP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
||||||+|++|... .. .. ...++.|++.||.|||++| |+|||| ||+|||++ .++.+||+|||+++.+..
T Consensus 95 LVmE~~~G~~L~~~-~~---~~---~~~~~~~i~~aL~~lH~~g--IiHrDL~KP~NILv~-~~~~ikLiDFGlA~~~~~ 164 (365)
T PRK09188 95 LVRGWTEGVPLHLA-RP---HG---DPAWFRSAHRALRDLHRAG--ITHNDLAKPQNWLMG-PDGEAAVIDFQLASVFRR 164 (365)
T ss_pred EEEEccCCCCHHHh-Cc---cc---hHHHHHHHHHHHHHHHHCC--CeeCCCCCcceEEEc-CCCCEEEEECccceeccc
Confidence 68999999999732 11 11 1568899999999999999 999999 99999997 457999999999975543
Q ss_pred CC----------CccccCCCCccCccccc
Q 008504 80 PT----------ARSVIGTPEFMAPELYE 98 (563)
Q Consensus 80 ~~----------~~~~~Gtp~Y~APEvl~ 98 (563)
.. .....+++.|+|||.+.
T Consensus 165 ~~~~~~~~~~~d~~~~~~~~~~~~pe~~~ 193 (365)
T PRK09188 165 RGALYRIAAYEDLRHLLKHKRTYAPDALT 193 (365)
T ss_pred CcchhhhhhhhhhhhhhccCccCCcccCC
Confidence 21 12456888999999885
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.33 E-value=1.7e-13 Score=154.52 Aligned_cols=179 Identities=25% Similarity=0.345 Sum_probs=143.2
Q ss_pred CEeccCCCCCHHHHH-HhCC-CCCHHHHHHHHHHHHHHHHHHH-hCCCCeEeccCccCceEEeCCCC-cEEEecccchhh
Q 008504 1 MITELFTSGNLRQYR-KKHK-NVDIKVIKNWARQILHGLVYLH-SHNPPIIHRDLKCDNIFVNGNHG-EVKIGDLGLAIA 76 (563)
Q Consensus 1 LVmEy~~gGsL~~~L-~k~~-~Lse~~i~~i~~QIL~aL~yLH-s~gp~IIHrDLKP~NILLd~~~G-~VKL~DFGlA~~ 76 (563)
++++|..||++...+ .... ..+...+..++.|+..+|.|+| ..+ +.||||||+|.+++. .+ .++++|||+|..
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~--~~h~~ikP~n~~l~~-s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG--VTHRDIKPSNSLLDE-SGSALKIADFGLATA 174 (601)
T ss_pred cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc--cccCCCCCccchhcc-CCCcccCCCchhhcc
Confidence 467899999999988 5554 6888899999999999999999 889 999999999999984 46 899999999976
Q ss_pred ccC-CC----CccccC-CCCccCcccccc--cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCC--CCCcc
Q 008504 77 MQQ-PT----ARSVIG-TPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI--KPASL 146 (563)
Q Consensus 77 ~~~-~~----~~~~~G-tp~Y~APEvl~~--~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~--~p~~l 146 (563)
... .. ....+| ++.|+|||...+ ......|+||.|+++..+++|..|+.........+....... .....
T Consensus 175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (601)
T KOG0590|consen 175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLP 254 (601)
T ss_pred ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCc
Confidence 654 22 233478 999999998876 357889999999999999999999976433333222222221 12334
Q ss_pred ccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCccccc
Q 008504 147 AKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQV 182 (563)
Q Consensus 147 ~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~ 182 (563)
....+....+++.+++. +|..|.+..++-.+||+..
T Consensus 255 ~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 255 WNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred cccCChhhhhcccccccCCchhccccccccccccccc
Confidence 45566788999999996 8999999999999999987
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.32 E-value=2.7e-12 Score=127.40 Aligned_cols=160 Identities=21% Similarity=0.322 Sum_probs=122.2
Q ss_pred CEeccCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEe--CCCCcEEEecccchhhc
Q 008504 1 MITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN--GNHGEVKIGDLGLAIAM 77 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k-~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd--~~~G~VKL~DFGlA~~~ 77 (563)
|||+++ |.+|.++..- .+.++.+++.-++-|++.-++|+|.++ +|||||||+|+|.. .....+.|+|||+|+.+
T Consensus 88 lVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~--fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 88 LVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRN--FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred eeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhc--cccccCCccceeeccccccceEEEEeccchhhh
Confidence 689998 6799998763 457999999999999999999999999 99999999999983 23347999999999866
Q ss_pred cCCC---------CccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCC--CHHHHHHHHhcCCC---
Q 008504 78 QQPT---------ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECK--NPAQIFKKVTSGIK--- 142 (563)
Q Consensus 78 ~~~~---------~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~--~~~~i~~~i~~~~~--- 142 (563)
.... .....||..|.+-...-+ ..+..-|+=|+|.++..+..|..||.+.. +..+.+.+|.....
T Consensus 165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ 244 (341)
T KOG1163|consen 165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTP 244 (341)
T ss_pred ccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCC
Confidence 4322 334578999988664433 35778899999999999999999998743 34556666654332
Q ss_pred CCccccCCChhHHHHHHHhcC
Q 008504 143 PASLAKVNDPQIKGFIEKCLV 163 (563)
Q Consensus 143 p~~l~~~~s~~l~~LI~kcL~ 163 (563)
+..+-.-.+.++.-.+.-|-.
T Consensus 245 ie~LC~G~P~EF~myl~Y~R~ 265 (341)
T KOG1163|consen 245 IEVLCKGFPAEFAMYLNYCRG 265 (341)
T ss_pred HHHHhCCCcHHHHHHHHHHhh
Confidence 233344456777777777753
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.31 E-value=3.7e-12 Score=125.92 Aligned_cols=116 Identities=19% Similarity=0.162 Sum_probs=87.6
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccC-ccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDL-KCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDL-KP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
++|||+.|++|.+.+.. . ...++.|++.+|.++|++| |+|||| ||.|||++ .+|.++|+|||++.....
T Consensus 75 lvmeyI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~G--IvHrDL~kp~NILv~-~~g~i~LIDFG~A~~~~~ 144 (218)
T PRK12274 75 LDRSYLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCG--VAHNDLAKEANWLVQ-EDGSPAVIDFQLAVRGNP 144 (218)
T ss_pred EEEeeecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCc--CccCCCCCcceEEEc-CCCCEEEEECCCceecCC
Confidence 58999999999765422 1 2357889999999999999 999999 79999997 557999999999974433
Q ss_pred CCC------c---------cccCCCCccCccccc--ccCC-chhhHHHhHHHHHHHhhcCCCCCC
Q 008504 80 PTA------R---------SVIGTPEFMAPELYE--EEYN-ELVDIYSFGMCILEMVTFEYPYSE 126 (563)
Q Consensus 80 ~~~------~---------~~~Gtp~Y~APEvl~--~~ys-~ksDIwSLGviLyELlTG~~Pf~~ 126 (563)
... . -...++.|+.|+... ...+ ...+.++.|+-+|.++|+..|+..
T Consensus 145 ~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 145 RARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred cchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 221 0 112577888887332 2233 567888999999999999988754
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.31 E-value=3.3e-12 Score=123.39 Aligned_cols=75 Identities=19% Similarity=0.268 Sum_probs=64.5
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHS-HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs-~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
|||||++|+++.........++...+..++.|++.+|.+||+ +| |+||||||+||+++ .+.++|+|||++.....
T Consensus 94 lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~g--ivHrDlkP~NIll~--~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 94 LVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAG--LVHGDLSEYNILYH--DGKPYIIDVSQAVELDH 169 (190)
T ss_pred EEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCChhhEEEE--CCCEEEEEcccceecCC
Confidence 689999998665443344678999999999999999999999 99 99999999999997 47999999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.29 E-value=4.3e-12 Score=147.44 Aligned_cols=120 Identities=23% Similarity=0.334 Sum_probs=104.7
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEe------CCCCcEEEecccch
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN------GNHGEVKIGDLGLA 74 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd------~~~G~VKL~DFGlA 74 (563)
||+||.+.|+|.+++...+.+++..+..++.|++..|..||.++ |||+||||+|++|. .+..-++|+|||.+
T Consensus 771 lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~--IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~s 848 (974)
T KOG1166|consen 771 LVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMG--IIHGDIKPDNFLLRREICADSDSKGLYLIDFGRS 848 (974)
T ss_pred eeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcc--eecccCCcceeEeecccCCCCcccceEEEecccc
Confidence 68999999999999998899999999999999999999999999 99999999999994 12235899999998
Q ss_pred hhcc---CC-CCccccCCCCccCccccccc-CCchhhHHHhHHHHHHHhhcCC
Q 008504 75 IAMQ---QP-TARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTFEY 122 (563)
Q Consensus 75 ~~~~---~~-~~~~~~Gtp~Y~APEvl~~~-ys~ksDIwSLGviLyELlTG~~ 122 (563)
..+. .. .....++|-.|-.+|+..+. ++..+|.|.|+.+++.|+.|++
T Consensus 849 iDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 849 IDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred eeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 6543 22 33455788899999999875 8999999999999999999964
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.21 E-value=6.3e-12 Score=125.96 Aligned_cols=97 Identities=22% Similarity=0.280 Sum_probs=73.7
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
|||||++|.+|.++.. +++ ....+++.+|..||.+| ++|||+||.||+++ .+| ++|+|||........
T Consensus 120 lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~~g--i~H~Dikp~Nili~-~~g-i~liDfg~~~~~~e~ 187 (232)
T PRK10359 120 MLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQHG--MVSGDPHKGNFIVS-KNG-LRIIDLSGKRCTAQR 187 (232)
T ss_pred EEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHHcC--CccCCCChHHEEEe-CCC-EEEEECCCcccccch
Confidence 5899999999998732 333 24569999999999999 99999999999998 456 999999987554322
Q ss_pred CCccccCCCCccCcccccccCCchhhHHHhHHHHHHHh
Q 008504 81 TARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMV 118 (563)
Q Consensus 81 ~~~~~~Gtp~Y~APEvl~~~ys~ksDIwSLGviLyELl 118 (563)
..... =+++..|+.++|+|+||+.+..+.
T Consensus 188 ~a~d~---------~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 188 KAKDR---------IDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred hhHHH---------HHHHhHhcccccccceeEeehHHH
Confidence 11100 022345778999999999887664
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.18 E-value=1.9e-11 Score=140.50 Aligned_cols=184 Identities=23% Similarity=0.394 Sum_probs=151.4
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhcc--
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ-- 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~-- 78 (563)
||++|..+|+|...+.+-+..+....+.++..+..+++|||+.. +.|||++|.|+++. ..|..++.+||......
T Consensus 881 L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~--r~h~~~~p~~~l~~-~~gh~~l~~~~t~~~vg~~ 957 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSL--RKHRDLKPDSLLIA-YDGHRPLTDFGTLSKVGLI 957 (1205)
T ss_pred hhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccch--hhcccccccchhhc-ccCCcccCccccccccccc
Confidence 57899999999999999888999999999999999999999998 99999999999996 56899999998432110
Q ss_pred -----C--------------C------------CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCC
Q 008504 79 -----Q--------------P------------TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSE 126 (563)
Q Consensus 79 -----~--------------~------------~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~ 126 (563)
. . ......||+.|.+||...+ .....+|+|++|+++++.++|..||..
T Consensus 958 ~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na 1037 (1205)
T KOG0606|consen 958 PPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNA 1037 (1205)
T ss_pred cCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCC
Confidence 0 0 0123468999999997765 478889999999999999999999987
Q ss_pred CCCHHHHHHHHhcCCCCC-ccccCCChhHHHHHHHhcC-CCCCCCCHH---HHHcCccccccccCCC
Q 008504 127 CKNPAQIFKKVTSGIKPA-SLAKVNDPQIKGFIEKCLV-PASERLSAK---DLLKDPFLQVENQKEP 188 (563)
Q Consensus 127 ~~~~~~i~~~i~~~~~p~-~l~~~~s~~l~~LI~kcL~-dP~kRpSa~---ELLkHpff~~~~~~~~ 188 (563)
..+.+++..+..+..+. .-+...++.+++++.+.|. +|.+|..+. ++-.|+||+...|...
T Consensus 1038 -~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~~~l 1103 (1205)
T KOG0606|consen 1038 -ETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDWENL 1103 (1205)
T ss_pred -cchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCcccc
Confidence 56777777766665543 3445567899999999997 899999887 9999999999887653
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.05 E-value=2.1e-10 Score=115.39 Aligned_cols=76 Identities=22% Similarity=0.298 Sum_probs=65.6
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
|||||+.|++|..+......+....+..++.||+.+|.+||.+| .|+||||||+||+++ .+.++|+|||.+.....
T Consensus 125 lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g-~iiH~Dikp~NIli~--~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 125 LVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEG-ELVHGDLSEYNILVH--DGKVVIIDVSQSVELDH 200 (237)
T ss_pred EEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcC-CEEeCCCChhhEEEE--CCCEEEEEChhhhccCC
Confidence 69999999998877655556777788999999999999999997 599999999999998 46899999999865443
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.98 E-value=8.2e-10 Score=109.32 Aligned_cols=69 Identities=22% Similarity=0.227 Sum_probs=56.1
Q ss_pred CEecc--CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHH-HHHHhCCCCeEeccCccCceEEeC---CCCcEEEecccch
Q 008504 1 MITEL--FTSGNLRQYRKKHKNVDIKVIKNWARQILHGL-VYLHSHNPPIIHRDLKCDNIFVNG---NHGEVKIGDLGLA 74 (563)
Q Consensus 1 LVmEy--~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL-~yLHs~gp~IIHrDLKP~NILLd~---~~G~VKL~DFGlA 74 (563)
+|+|| +.+|+|.+++++. .+++. ..++.|++.++ .|||+++ |+||||||+|||++. ..+.++|+||+.+
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~--IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNR--IVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 47999 5589999999774 57666 46788888888 9999999 999999999999973 2247999995443
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=98.94 E-value=1.4e-09 Score=105.36 Aligned_cols=68 Identities=26% Similarity=0.342 Sum_probs=61.2
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhh
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 76 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~ 76 (563)
+||||++|++|.+++..... ....++.+++.+|.+||..| ++|||++|.|||++ .+.++|+|||.+..
T Consensus 76 lv~e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~--i~H~Dl~p~Nil~~--~~~~~liDf~~a~~ 143 (211)
T PRK14879 76 IVMEYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAG--IIHGDLTTSNMILS--GGKIYLIDFGLAEF 143 (211)
T ss_pred EEEEEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCC--cccCCCCcccEEEE--CCCEEEEECCcccC
Confidence 58999999999999876432 88899999999999999999 99999999999998 46899999998854
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.93 E-value=8.6e-10 Score=121.15 Aligned_cols=176 Identities=27% Similarity=0.317 Sum_probs=136.2
Q ss_pred eccCCCCCHHHHHHhCCC-CCHHHHHHHHHHHHH----HHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhc
Q 008504 3 TELFTSGNLRQYRKKHKN-VDIKVIKNWARQILH----GLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM 77 (563)
Q Consensus 3 mEy~~gGsL~~~L~k~~~-Lse~~i~~i~~QIL~----aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~ 77 (563)
+|+|. .+|..|...... ++...++..+.+... ||..+|+.+ ++|-|+||.||+...+....+++|||+...+
T Consensus 197 tE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~--~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i 273 (524)
T KOG0601|consen 197 TELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN--IVHDDLKPANIFTTSDWTSCKLTDFGLVSKI 273 (524)
T ss_pred ecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCc--ccccccchhheecccccceeecCCcceeEEc
Confidence 57774 688888876544 899999999999999 999999999 9999999999999866468999999998776
Q ss_pred cCCCC-------ccccCCCCccCcccccccCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCC
Q 008504 78 QQPTA-------RSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVN 150 (563)
Q Consensus 78 ~~~~~-------~~~~Gtp~Y~APEvl~~~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~ 150 (563)
..... ....|...|++||..++-++...|||++|.++.+..++..++....+. .+..+..+..+..+-...
T Consensus 274 ~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~--~W~~~r~~~ip~e~~~~~ 351 (524)
T KOG0601|consen 274 SDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNS--SWSQLRQGYIPLEFCEGG 351 (524)
T ss_pred cCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCC--CccccccccCchhhhcCc
Confidence 54331 122577889999999999999999999999999999987665443111 112222333333333344
Q ss_pred ChhHHHHHHHhcC-CCCCCCCHHHHHcCcccccc
Q 008504 151 DPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 183 (563)
Q Consensus 151 s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~ 183 (563)
+..+...+..++. +|..|++++.++.|+++...
T Consensus 352 s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~ 385 (524)
T KOG0601|consen 352 SSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK 385 (524)
T ss_pred chhhhhHHHHhcCcchhhhhHHHHHhccccccch
Confidence 5566678888887 79999999999999999743
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=98.90 E-value=1.8e-09 Score=103.85 Aligned_cols=65 Identities=25% Similarity=0.360 Sum_probs=58.1
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhh
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 76 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~ 76 (563)
|||||++|++|.+++..... .++.|++.+|.+||+.| ++|||++|.||+++ .+.++++|||++..
T Consensus 74 lv~e~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~g--i~H~Dl~~~Nil~~--~~~~~liDfg~a~~ 138 (199)
T TIGR03724 74 IVMEYIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAG--IVHGDLTTSNIIVR--DDKLYLIDFGLGKY 138 (199)
T ss_pred EEEEEECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCC--eecCCCCcceEEEE--CCcEEEEECCCCcC
Confidence 58999999999998866432 88999999999999999 99999999999998 47999999998854
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=98.88 E-value=1.8e-09 Score=104.62 Aligned_cols=70 Identities=24% Similarity=0.274 Sum_probs=59.5
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
+||||++|++|..+... .....++.+|+.++.++|..| |+||||||.||+++. ++.++|+|||++.....
T Consensus 108 lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~g--i~H~Dl~p~Nill~~-~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 108 VVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHG--IIHGDLSEFNILVDD-DEKIYIIDWPQMVSTDH 177 (198)
T ss_pred EEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCC--CCcCCCCcccEEEcC-CCcEEEEECCccccCCC
Confidence 58999999999876431 346678999999999999999 999999999999984 67999999999855443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=98.87 E-value=3.2e-09 Score=106.86 Aligned_cols=68 Identities=16% Similarity=0.232 Sum_probs=58.0
Q ss_pred CEeccCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhh
Q 008504 1 MITELFTS-GNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 76 (563)
Q Consensus 1 LVmEy~~g-GsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~ 76 (563)
|||||++| ++|.+++.. ..+++.. +.||+.+|.+||.+| |+||||||.|||++. ++.++|+|||.+..
T Consensus 123 lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~G--I~HrDlkp~NILv~~-~~~v~LIDfg~~~~ 191 (239)
T PRK01723 123 ILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAG--VYHADLNAHNILLDP-DGKFWLIDFDRGEL 191 (239)
T ss_pred EEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCC--CCCCCCCchhEEEcC-CCCEEEEECCCccc
Confidence 58999997 699999876 4566553 578999999999999 999999999999984 46899999998854
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=98.81 E-value=4.7e-09 Score=117.25 Aligned_cols=65 Identities=22% Similarity=0.313 Sum_probs=58.4
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhc
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM 77 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~ 77 (563)
|||||++|++|.+++. ....++.|++.+|.|||++| |+||||||+||+++ .+.++|+|||+++..
T Consensus 413 lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~g--iiHrDlkp~NILl~--~~~~~liDFGla~~~ 477 (535)
T PRK09605 413 IVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAG--IVHGDLTTSNFIVR--DDRLYLIDFGLGKYS 477 (535)
T ss_pred EEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCC--CccCCCChHHEEEE--CCcEEEEeCcccccC
Confidence 6899999999999986 35678999999999999999 99999999999994 468999999998653
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=98.78 E-value=7.1e-09 Score=98.55 Aligned_cols=73 Identities=23% Similarity=0.279 Sum_probs=57.2
Q ss_pred CEeccCCCCCHHHH-HHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEeccCccCceEEeCCCCcEEEecccchhhcc
Q 008504 1 MITELFTSGNLRQY-RKKHKNVDIKVIKNWARQILHGLVYLHS-HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~-L~k~~~Lse~~i~~i~~QIL~aL~yLHs-~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~ 78 (563)
|||||+++|.+... +... ... ..++.++.+++.++.++|. +| |+||||||+||+++ .+.++|+|||.+....
T Consensus 92 lv~e~~~g~~~~~~~l~~~-~~~-~~~~~~~~~~~~~l~~lh~~~~--ivH~Dl~p~Nili~--~~~~~liDfg~a~~~~ 165 (187)
T cd05119 92 LVMEFIGGDGIPAPRLKDV-RLL-EDPEELYDQILELMRKLYREAG--LVHGDLSEYNILVD--DGKVYIIDVPQAVEID 165 (187)
T ss_pred EEEEEeCCCCccChhhhhh-hhc-ccHHHHHHHHHHHHHHHhhccC--cCcCCCChhhEEEE--CCcEEEEECccccccc
Confidence 58999999543321 1111 111 6788999999999999999 99 99999999999998 5799999999996554
Q ss_pred C
Q 008504 79 Q 79 (563)
Q Consensus 79 ~ 79 (563)
.
T Consensus 166 ~ 166 (187)
T cd05119 166 H 166 (187)
T ss_pred C
Confidence 3
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.60 E-value=2.8e-08 Score=111.10 Aligned_cols=152 Identities=18% Similarity=0.283 Sum_probs=107.9
Q ss_pred HHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCCCCc-----------cccCCCCccCccccc
Q 008504 30 ARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR-----------SVIGTPEFMAPELYE 98 (563)
Q Consensus 30 ~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~~~~-----------~~~Gtp~Y~APEvl~ 98 (563)
+.++..||.|+|.+- .+||++|.|++|+++. .|.+||+.|+++.....+... .......|.|||++.
T Consensus 105 l~~v~dgl~flh~sA-k~VH~ni~p~~i~~na-~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSA-KVVHGNIQPEAIVVNA-NGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhccCc-ceeecccchhheeecc-CcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 445568999999874 5999999999999984 589999999988544331111 123456899999886
Q ss_pred cc-CCchhhHHHhHHHHHHHhhc-CCCCCCCCCHHHHHHH--HhcCCCCCccccCCChhHHHHHHHhcC-CCCCCCCHHH
Q 008504 99 EE-YNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKK--VTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKD 173 (563)
Q Consensus 99 ~~-ys~ksDIwSLGviLyELlTG-~~Pf~~~~~~~~i~~~--i~~~~~p~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~E 173 (563)
.. .+.++|+||+|+++|.+..| +.-+.. .+....+.. ...+..........+.++++=+.+++. ++..||++.+
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a-~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~ 261 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAA-NGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDL 261 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhc-cCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhh
Confidence 54 68899999999999999944 443432 211111111 111112223345667899999999996 8999999999
Q ss_pred HHcCccccccc
Q 008504 174 LLKDPFLQVEN 184 (563)
Q Consensus 174 LLkHpff~~~~ 184 (563)
++.-|||+...
T Consensus 262 l~~~~ff~D~~ 272 (700)
T KOG2137|consen 262 LLSIPFFSDPG 272 (700)
T ss_pred hhcccccCCch
Confidence 99999997543
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=98.53 E-value=1.4e-07 Score=92.67 Aligned_cols=75 Identities=19% Similarity=0.265 Sum_probs=59.3
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYL-HSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yL-Hs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
|||||+.++.+..-.-+...++...+..+..|++.+|..| |..| |+|+||++.||++. .|.+.|+|||.+.....
T Consensus 101 lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~g--lVHGDLs~~NIL~~--~~~v~iIDF~qav~~~h 176 (197)
T cd05146 101 LVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECN--LVHADLSEYNMLWH--DGKVWFIDVSQSVEPTH 176 (197)
T ss_pred EEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEE--CCcEEEEECCCceeCCC
Confidence 6999997754433222233566777888899999999999 8999 99999999999997 36899999998865543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.52 E-value=3.9e-08 Score=108.29 Aligned_cols=170 Identities=21% Similarity=0.205 Sum_probs=121.2
Q ss_pred eccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCCCC
Q 008504 3 TELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA 82 (563)
Q Consensus 3 mEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~~~ 82 (563)
-|||.++++...+.--..+++...+++..|++.++.++|+.. ++|+|++|+||++..+.+..+++|||....+.....
T Consensus 345 ~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~--~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~~ 422 (524)
T KOG0601|consen 345 LEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKL--FVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSSG 422 (524)
T ss_pred hhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchh--hhcccccccceeeccchhhhhccccccccccceecc
Confidence 489999998887765566899999999999999999999999 999999999999974447889999998865322111
Q ss_pred ccccCCCCcc-Ccccccc--cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHHHHH
Q 008504 83 RSVIGTPEFM-APELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIE 159 (563)
Q Consensus 83 ~~~~Gtp~Y~-APEvl~~--~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~LI~ 159 (563)
. ..+.-.++ .+|++.. .+..++|+++||.-+.+.+++..--.. ......+..+..+. .+... .+++.+.+
T Consensus 423 ~-~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~----~~~~~~i~~~~~p~-~~~~~-~~~q~~~k 495 (524)
T KOG0601|consen 423 V-FHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSES----GVQSLTIRSGDTPN-LPGLK-LQLQVLLK 495 (524)
T ss_pred c-ccccccccccchhhccccccccccccccccccccccccCcccCcc----cccceeeecccccC-CCchH-Hhhhhhhh
Confidence 1 12233344 2554433 378899999999999999998532211 11222333343332 22222 57777888
Q ss_pred HhcC-CCCCCCCHHHHHcCcccc
Q 008504 160 KCLV-PASERLSAKDLLKDPFLQ 181 (563)
Q Consensus 160 kcL~-dP~kRpSa~ELLkHpff~ 181 (563)
.++. ++..||.+.++..|.-|.
T Consensus 496 v~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 496 VMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred hhcCCccccchhhhhhcccchhh
Confidence 8876 788999999999887664
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=98.48 E-value=1.7e-07 Score=83.54 Aligned_cols=67 Identities=24% Similarity=0.215 Sum_probs=56.3
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC-CCeEeccCccCceEEeCCCCcEEEecccchh
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHN-PPIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 75 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~g-p~IIHrDLKP~NILLd~~~G~VKL~DFGlA~ 75 (563)
++|||+.++.+..+ +......++.+++.+|.+||... ++++|+||+|.||+++. .+.+++.|||.+.
T Consensus 70 ~v~e~~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~-~~~~~l~Df~~~~ 137 (155)
T cd05120 70 LLMEWIEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDD-GKILGIIDWEYAG 137 (155)
T ss_pred EEEEecCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEEC-CcEEEEEeccccc
Confidence 58899998877765 55677888999999999999852 12999999999999984 5799999999874
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PF12202 OSR1_C: Oxidative-stress-responsive kinase 1 C terminal; InterPro: IPR024678 Oxidative-stress-responsive kinase 1 (OSR1) is involved in the signalling cascade which activates Na/K/2Cl co-transporter during osmotic stress | Back alignment and domain information |
|---|
Probab=98.42 E-value=2.7e-07 Score=66.15 Aligned_cols=32 Identities=41% Similarity=0.534 Sum_probs=27.5
Q ss_pred eEEEEeecCCCC------CcceeeecccCCCCCHHHHH
Q 008504 263 VSLTLRIADSSG------RVRNIHFLFYLDSDTALSVA 294 (563)
Q Consensus 263 i~L~LRi~d~~~------~~~~I~F~F~~~~DTa~~vA 294 (563)
|.|+||++|+++ +.++|+|+|++++|+|++||
T Consensus 1 i~l~Lrv~d~kK~~~k~ken~aI~F~F~~~~D~~e~VA 38 (38)
T PF12202_consen 1 INLRLRVRDPKKRKGKHKENEAIEFEFDLGKDTAEEVA 38 (38)
T ss_dssp EEEEEEEC-TTSSSSS--TCEEEEEEEETTT--HHHHH
T ss_pred CcEEEEEeccccccCccccCccEEEEEecCCCcccccC
Confidence 689999999998 88999999999999999998
|
This entry represents the CCT domain found in OSR1, STE20/SPS1-related kinase and in WNK activators []. This domain is found in eukaryotes, and is approximately 40 amino acids in length. There is a single completely conserved residue F that may be functionally important. ; PDB: 2V3S_A 2LRU_A. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.38 E-value=2.5e-06 Score=91.29 Aligned_cols=152 Identities=22% Similarity=0.329 Sum_probs=108.9
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhcc-CCCCccccCCCCccCcccc
Q 008504 19 KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ-QPTARSVIGTPEFMAPELY 97 (563)
Q Consensus 19 ~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~-~~~~~~~~Gtp~Y~APEvl 97 (563)
+..++..+.+.++.|+.+.+-||.+| ..-+|+.++|+|+. +.+.|.|.|=..-.... .......+|.++|.+||.-
T Consensus 112 P~~~w~fllrvaRnlA~aFA~lH~~G--h~vGDVn~~~~lVs-d~~~V~LVdsDsfqi~~ng~~~~cpVg~~eftPPElQ 188 (637)
T COG4248 112 PHCAWDFLLRVARNLASAFATLHEHG--HVVGDVNQNSFLVS-DDSKVVLVDSDSFQINANGTLHLCPVGVSEFTPPELQ 188 (637)
T ss_pred CccccHHHHHHHHHHHHHHHHHHhcC--CcccccCccceeee-cCceEEEEcccceeeccCCceEecccCccccCCHHHh
Confidence 45788999999999999999999999 99999999999997 66899998844322212 2223456899999999976
Q ss_pred c-c-----cCCchhhHHHhHHHHHHHhhc-CCCCCCCC------CHHH--HH-------HHHhcCCCC--Cc-cccCCCh
Q 008504 98 E-E-----EYNELVDIYSFGMCILEMVTF-EYPYSECK------NPAQ--IF-------KKVTSGIKP--AS-LAKVNDP 152 (563)
Q Consensus 98 ~-~-----~ys~ksDIwSLGviLyELlTG-~~Pf~~~~------~~~~--i~-------~~i~~~~~p--~~-l~~~~s~ 152 (563)
. + .-+...|.|.||+++++++.| +.||.+.. ++-+ +. .+-..+.++ .. .....++
T Consensus 189 ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp 268 (637)
T COG4248 189 TLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAYASDQRRGLKPPPRSIPLSMLPP 268 (637)
T ss_pred ccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeeechhccCCCCCCCCCCChhhcCH
Confidence 4 1 246789999999999999987 89997631 1111 10 011111221 11 1234578
Q ss_pred hHHHHHHHhcCC---CCCCCCHHH
Q 008504 153 QIKGFIEKCLVP---ASERLSAKD 173 (563)
Q Consensus 153 ~l~~LI~kcL~d---P~kRpSa~E 173 (563)
.++.|..+|+.+ +.-|||++.
T Consensus 269 ~vqAlF~qaF~~~~~~~~RP~a~a 292 (637)
T COG4248 269 DVQALFQQAFTESGVATPRPTAKA 292 (637)
T ss_pred HHHHHHHHHhcccCCCCCCCCHHH
Confidence 999999999964 568999653
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=98.26 E-value=7.5e-07 Score=82.92 Aligned_cols=65 Identities=25% Similarity=0.158 Sum_probs=51.8
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCC---CeEeccCccCceEEeCCCCcEEEecccchh
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNP---PIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 75 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp---~IIHrDLKP~NILLd~~~G~VKL~DFGlA~ 75 (563)
+||||++|.++... ......++.+++.+|+.||..+. .++|+|++|.||+++ .+.++++||+.+.
T Consensus 68 lv~e~i~G~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~--~~~~~liDf~~a~ 135 (170)
T cd05151 68 LITEFIEGSELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD--DGRLWLIDWEYAG 135 (170)
T ss_pred EEEEecCCCccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE--CCeEEEEeccccc
Confidence 58999999888653 11123467899999999999871 249999999999998 3589999999874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.24 E-value=1.6e-06 Score=84.18 Aligned_cols=65 Identities=25% Similarity=0.370 Sum_probs=55.8
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhh
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 76 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~ 76 (563)
|+|||.+|-.|++++... ...+++.+-.-+.-||..| |+|+||+++||++.+ +.+.++|||++..
T Consensus 76 I~me~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~g--ivHGDLTtsNiIl~~--~~i~~IDfGLg~~ 140 (204)
T COG3642 76 IVMEYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAG--IVHGDLTTSNIILSG--GRIYFIDFGLGEF 140 (204)
T ss_pred EEEEEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcC--eecCCCccceEEEeC--CcEEEEECCcccc
Confidence 689999999999999875 2456777777888899999 999999999999973 3599999999864
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=98.24 E-value=1.2e-06 Score=95.92 Aligned_cols=72 Identities=22% Similarity=0.265 Sum_probs=56.1
Q ss_pred CEeccCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHH-HHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhcc
Q 008504 1 MITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILH-GLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~-~~Lse~~i~~i~~QIL~-aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~ 78 (563)
|||||++|++|.++.... ..++ ...++.+++. .+..+|..| ++|+|++|.||+++ .+|.++|+|||++..+.
T Consensus 235 LvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g--~~H~D~hPgNilv~-~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 235 LTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDG--FFHADLHPGNIFVL-KDGKIIALDFGIVGRLS 308 (437)
T ss_pred EEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCC--ceeCCCCcccEEEC-CCCcEEEEeCCCeeECC
Confidence 699999999999887532 1232 3345556655 478899999 99999999999997 55899999999985543
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.21 E-value=3e-06 Score=87.09 Aligned_cols=73 Identities=19% Similarity=0.222 Sum_probs=62.9
Q ss_pred CEeccCCCC-CHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeC------CCCcEEEecc
Q 008504 1 MITELFTSG-NLRQYRKK--HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG------NHGEVKIGDL 71 (563)
Q Consensus 1 LVmEy~~gG-sL~~~L~k--~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~------~~G~VKL~DF 71 (563)
||||++++- +|.+++.. ....+......++.+++..+.-||..| |+|+||++.|||++. ..+.+.|+||
T Consensus 112 LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~G--i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl 189 (268)
T PRK15123 112 IITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAG--INHRDCYICHFLLHLPFPGREEDLKLSVIDL 189 (268)
T ss_pred EEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCc--CccCCCChhhEEEeccccCCCCCceEEEEEC
Confidence 689999886 89999864 345677788899999999999999999 999999999999974 2458999999
Q ss_pred cchh
Q 008504 72 GLAI 75 (563)
Q Consensus 72 GlA~ 75 (563)
+.+.
T Consensus 190 ~r~~ 193 (268)
T PRK15123 190 HRAQ 193 (268)
T ss_pred Cccc
Confidence 9874
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.14 E-value=4.4e-06 Score=82.09 Aligned_cols=74 Identities=24% Similarity=0.312 Sum_probs=64.6
Q ss_pred CEeccCCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCC--CcEEEecccchhh
Q 008504 1 MITELFTSG-NLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNH--GEVKIGDLGLAIA 76 (563)
Q Consensus 1 LVmEy~~gG-sL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~--G~VKL~DFGlA~~ 76 (563)
||||++++- +|.+++......+......++.++...+.-||.+| |+|+|+++.|||++.+. ..+.++||+.+..
T Consensus 94 lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH~~g--i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 94 LITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLHDAG--IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred EEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHHHCc--CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 589999884 89999988666888889999999999999999999 99999999999998543 2689999998754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.11 E-value=6.7e-06 Score=79.92 Aligned_cols=75 Identities=21% Similarity=0.356 Sum_probs=60.7
Q ss_pred CEeccCCC-CCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcE--EEecccchh
Q 008504 1 MITELFTS-GNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEV--KIGDLGLAI 75 (563)
Q Consensus 1 LVmEy~~g-GsL~~~L~k~~--~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~V--KL~DFGlA~ 75 (563)
|+|||++| .++++|+.... .........++++|-..+.-||..+ |||+||..+||++..+.+.+ .++|||++.
T Consensus 87 i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd--iiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 87 IYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND--IIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred EEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC--eecccccccceEEecCCCcCceEEEeecchh
Confidence 68999976 48999987642 2334444789999999999999999 99999999999997655554 899999985
Q ss_pred hc
Q 008504 76 AM 77 (563)
Q Consensus 76 ~~ 77 (563)
..
T Consensus 165 ~s 166 (229)
T KOG3087|consen 165 VS 166 (229)
T ss_pred cc
Confidence 43
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=97.98 E-value=5.8e-06 Score=92.55 Aligned_cols=69 Identities=16% Similarity=0.218 Sum_probs=52.1
Q ss_pred CEeccCCCCCHHHH--HHhCC----CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCC---CcEEEecc
Q 008504 1 MITELFTSGNLRQY--RKKHK----NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNH---GEVKIGDL 71 (563)
Q Consensus 1 LVmEy~~gGsL~~~--L~k~~----~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~---G~VKL~DF 71 (563)
|||||+.|+.|.++ +...+ .+.+..+..++.|++ ..| ++|+|+||.||+++.+. +.++++||
T Consensus 238 LvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif-------~~G--ffHaDpHPGNIlv~~~g~~~~~i~llDF 308 (537)
T PRK04750 238 MVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF-------RDG--FFHADMHPGNIFVSYDPPENPRYIALDF 308 (537)
T ss_pred EEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-------hCC--eeeCCCChHHeEEecCCCCCCeEEEEec
Confidence 69999999999875 33333 255555666666665 478 99999999999997432 28999999
Q ss_pred cchhhcc
Q 008504 72 GLAIAMQ 78 (563)
Q Consensus 72 GlA~~~~ 78 (563)
|++..+.
T Consensus 309 Givg~l~ 315 (537)
T PRK04750 309 GIVGSLN 315 (537)
T ss_pred ceEEECC
Confidence 9986553
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.87 E-value=4.4e-05 Score=85.83 Aligned_cols=111 Identities=27% Similarity=0.329 Sum_probs=78.4
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLH-SHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLH-s~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
||+|-+ -.|..++++. ....+..-+.||+.||.||| ..+ ++|++|.-+.|||+ ..|..||++|-++.....
T Consensus 86 lvTErV--~Pl~~~lk~l---~~~~v~~Gl~qIl~AL~FL~~d~~--lvHgNv~~~SVfVn-~~GeWkLggle~v~~~~~ 157 (690)
T KOG1243|consen 86 LVTERV--RPLETVLKEL---GKEEVCLGLFQILAALSFLNDDCN--LVHGNVCKDSVFVN-ESGEWKLGGLELVSKASG 157 (690)
T ss_pred EEeecc--ccHHHHHHHh---HHHHHHHHHHHHHHHHHHHhccCC--eeeccEeeeeEEEc-CCCcEEEeeeEEEecccc
Confidence 355555 3566677663 36677788999999999998 455 99999999999998 568999999988754332
Q ss_pred CC--CccccCCCCccCcccccccCCchhhHHHhHHHHHHHhhc
Q 008504 80 PT--ARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTF 120 (563)
Q Consensus 80 ~~--~~~~~Gtp~Y~APEvl~~~ys~ksDIwSLGviLyELlTG 120 (563)
.. .....-.-.|..|+.+... .-..|.|-|||++++++.|
T Consensus 158 ~~~~~~~~~~~~s~~~P~~~~~s-~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 158 FNAPAKSLYLIESFDDPEEIDPS-EWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred CCcccccchhhhcccChhhcCcc-ccchhhhhHHHHHHHHhCc
Confidence 21 1111222235555543211 1357999999999999998
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=97.80 E-value=1.1e-05 Score=78.79 Aligned_cols=72 Identities=28% Similarity=0.408 Sum_probs=49.7
Q ss_pred CEeccCC--CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHH-HHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhc
Q 008504 1 MITELFT--SGNLRQYRKKHKNVDIKVIKNWARQILHGLVY-LHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM 77 (563)
Q Consensus 1 LVmEy~~--gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~y-LHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~ 77 (563)
|||||+. |..+..+.... ++......++.+++..+.. +|..| |+|+||.+.||+++. +.+.|+|||.+...
T Consensus 83 ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~g--ivHGDLs~~NIlv~~--~~~~iIDf~qav~~ 156 (188)
T PF01163_consen 83 IVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHKAG--IVHGDLSEYNILVDD--GKVYIIDFGQAVDS 156 (188)
T ss_dssp EEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCTT--EEESS-STTSEEEET--TCEEE--GTTEEET
T ss_pred EEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHhcC--ceecCCChhhEEeec--ceEEEEecCcceec
Confidence 6999998 65665543322 2255667788888885555 57999 999999999999983 38999999988554
Q ss_pred c
Q 008504 78 Q 78 (563)
Q Consensus 78 ~ 78 (563)
.
T Consensus 157 ~ 157 (188)
T PF01163_consen 157 S 157 (188)
T ss_dssp T
T ss_pred C
Confidence 4
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.59 E-value=0.00024 Score=84.25 Aligned_cols=168 Identities=25% Similarity=0.376 Sum_probs=118.6
Q ss_pred eccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccC---ceEEeCCCCcEEEe--cccchhhc
Q 008504 3 TELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCD---NIFVNGNHGEVKIG--DLGLAIAM 77 (563)
Q Consensus 3 mEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~---NILLd~~~G~VKL~--DFGlA~~~ 77 (563)
.|||++-++...+..-+.++...++.+..++++||.|+|+.. ..|.-|... +--+++. +.+.++ ||+.....
T Consensus 265 ~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~--l~~v~L~~s~~~~~~~~~e-~~~~~sl~~~~ss~~l 341 (1351)
T KOG1035|consen 265 QEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLS--LEHVVLSASSSKESTVDGE-GVVAISLSDFDSSKPL 341 (1351)
T ss_pred HhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhc--cceeEEecccccccccCcc-ceeecchhhhcccccC
Confidence 478888999999998889999999999999999999999997 677666555 3333322 356666 88877655
Q ss_pred cCCC-CccccCCCCccCccccccc---CCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChh
Q 008504 78 QQPT-ARSVIGTPEFMAPELYEEE---YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQ 153 (563)
Q Consensus 78 ~~~~-~~~~~Gtp~Y~APEvl~~~---ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~ 153 (563)
.... .........+.+||....+ .....|+|.+|.....+..|..+-.....+ ...++......
T Consensus 342 ~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~~~~------------~~~l~~~~~~~ 409 (1351)
T KOG1035|consen 342 PDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEKSAVP------------VSLLDVLSTSE 409 (1351)
T ss_pred CCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHhhhhhcCcccccccch------------hhhhccccchh
Confidence 4432 2223445567788877544 334569999999999999886543221110 11112222226
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHHcCcccccccc
Q 008504 154 IKGFIEKCLV-PASERLSAKDLLKDPFLQVENQ 185 (563)
Q Consensus 154 l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~~ 185 (563)
..++..+|+. ++.+|+++.+++.|+|......
T Consensus 410 ~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~~~ 442 (1351)
T KOG1035|consen 410 LLDALPKCLDEDSEERLSALELLTHPFLRFPTD 442 (1351)
T ss_pred hhhhhhhhcchhhhhccchhhhhhchhcccccc
Confidence 7888999997 7999999999999999975543
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=97.50 E-value=0.0009 Score=73.77 Aligned_cols=150 Identities=17% Similarity=0.270 Sum_probs=104.8
Q ss_pred CEeccCCC-CCHHHHHH---------------hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCC
Q 008504 1 MITELFTS-GNLRQYRK---------------KHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHG 64 (563)
Q Consensus 1 LVmEy~~g-GsL~~~L~---------------k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G 64 (563)
||++|.++ ++|.++-- ++.+.++..+|.|+.||..||.++|+.| +.-+-|.|.+|+++++.
T Consensus 354 lvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG--LAck~L~~~kIlv~G~~- 430 (655)
T KOG3741|consen 354 LVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG--LACKTLDLKKILVTGKM- 430 (655)
T ss_pred EEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC--ceeecccHhHeEeeCcc-
Confidence 57888876 47777532 2245889999999999999999999999 98899999999999764
Q ss_pred cEEEecccchhhccCCCCccccCCCCccCcccccccCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHH-HHHHhcCCCC
Q 008504 65 EVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQI-FKKVTSGIKP 143 (563)
Q Consensus 65 ~VKL~DFGlA~~~~~~~~~~~~Gtp~Y~APEvl~~~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i-~~~i~~~~~p 143 (563)
+++|...|....+..... +.+++ ..+-|.-.||.+++.|.||..--......... ..
T Consensus 431 RIriS~C~i~Dvl~~d~~------------~~le~--~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~-------- 488 (655)
T KOG3741|consen 431 RIRISGCGIMDVLQEDPT------------EPLES--QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLT-------- 488 (655)
T ss_pred eEEEecccceeeecCCCC------------cchhH--HhhhhHHHHHHHHHHHhhcccccccccchHHHHHH--------
Confidence 788888777654433220 11211 23568889999999999995432211112211 11
Q ss_pred CccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcC
Q 008504 144 ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 177 (563)
Q Consensus 144 ~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkH 177 (563)
.+...++.+++++|.-+.. .+.+ .++.+++.|
T Consensus 489 -~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 489 -RITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred -HhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 2334556788999988876 4555 788888875
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=97.47 E-value=0.00011 Score=70.77 Aligned_cols=74 Identities=23% Similarity=0.309 Sum_probs=57.8
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHN------------------------------------ 44 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~g------------------------------------ 44 (563)
+||||++|++|...+.. ..+++.....++.+++.+|.+||+..
T Consensus 77 ~v~e~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (223)
T cd05154 77 YVMERVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPP 155 (223)
T ss_pred EEEEEeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccH
Confidence 58999999888776532 45777888888888888888888531
Q ss_pred ------------------CCeEeccCccCceEEeCC-CCcEEEecccchh
Q 008504 45 ------------------PPIIHRDLKCDNIFVNGN-HGEVKIGDLGLAI 75 (563)
Q Consensus 45 ------------------p~IIHrDLKP~NILLd~~-~G~VKL~DFGlA~ 75 (563)
..++|+|++|.||+++.+ .+.+.|+||+.+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 156 AMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 237999999999999853 4568999999874
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.00023 Score=71.28 Aligned_cols=63 Identities=24% Similarity=0.354 Sum_probs=50.5
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchh
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 75 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~ 75 (563)
|||||++|..|.++.. +++ .+...|..++.-||..| +.|+|.+|.|++++ + +.++++||+..+
T Consensus 120 ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G--~~HGD~hpgNFlv~-~-~~i~iID~~~k~ 182 (229)
T PF06176_consen 120 LLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHG--FYHGDPHPGNFLVS-N-NGIRIIDTQGKR 182 (229)
T ss_pred EEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcC--CccCCCCcCcEEEE-C-CcEEEEECcccc
Confidence 5899999988877642 333 24466778899999999 99999999999997 3 469999998654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.06 E-value=0.0014 Score=65.42 Aligned_cols=72 Identities=18% Similarity=0.212 Sum_probs=59.8
Q ss_pred CEeccCCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCc--EEEecccchh
Q 008504 1 MITELFTS-GNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGE--VKIGDLGLAI 75 (563)
Q Consensus 1 LVmEy~~g-GsL~~~L~k~--~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~--VKL~DFGlA~ 75 (563)
||+|-+.| -+|.+++.+. .+.+......++.+|+..+.-||..| +.|+|+-+.|||++.+ |. |+++||.-++
T Consensus 102 LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~G--v~Hgdly~khIll~~~-g~~~v~lIDlEk~r 178 (216)
T PRK09902 102 LVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVN--RQHGCCYVRHIYVKTE-GKAEAGFLDLEKSR 178 (216)
T ss_pred EEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHhheeecCC-CCeeEEEEEhhccc
Confidence 57886653 4899988763 34678888899999999999999999 9999999999999743 45 9999997664
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.50 E-value=0.0027 Score=65.40 Aligned_cols=69 Identities=23% Similarity=0.340 Sum_probs=52.6
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhc
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM 77 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~ 77 (563)
+||||++|-.|.... ++.+....++..|+.-+.-+-..| |||+|+.+-||+++ ++|.+.++||--+...
T Consensus 184 VvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~G--iVHGDlSefNIlV~-~dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 184 VVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRG--IVHGDLSEFNILVT-EDGDIVVIDWPQAVPI 252 (304)
T ss_pred eeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcC--ccccCCchheEEEe-cCCCEEEEeCcccccC
Confidence 589999996666432 244555666677777666666888 99999999999998 5589999999776443
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.29 E-value=0.00056 Score=76.90 Aligned_cols=153 Identities=23% Similarity=0.285 Sum_probs=104.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC-CCccccCCCCccCccccc-
Q 008504 21 VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-TARSVIGTPEFMAPELYE- 98 (563)
Q Consensus 21 Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~-~~~~~~Gtp~Y~APEvl~- 98 (563)
+.+-+...+++.-+++|++||+.. -+|+| ||+.. .+.+|.++|+....+... ...+..+++.++|||+..
T Consensus 333 ~~~~~~~~~~r~et~~l~~l~~~~--~~~~d----~~l~s--~~~~~~~~~~v~~~L~~~~~~~t~~~~~~~~~pev~~~ 404 (829)
T KOG0576|consen 333 LEQYQFAYPLRKETRPLAELHSSY--KVHRD----NILGS--EEEVKLLDFAVPPQLTRTMKPRTAIGTPEPLAPEVIQE 404 (829)
T ss_pred hhhhhhhhhhhhhccccccccccc--ccCcc----ccccc--ccccccccccCCcccCcccccccCCCCCCCCCchhhcc
Confidence 334455566777778999999986 58888 77765 368999999998766543 456678999999999765
Q ss_pred ccCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCC-CCCccc-cCCChhH-HHHHHHhcC-CCCCCCCHHHH
Q 008504 99 EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI-KPASLA-KVNDPQI-KGFIEKCLV-PASERLSAKDL 174 (563)
Q Consensus 99 ~~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~-~p~~l~-~~~s~~l-~~LI~kcL~-dP~kRpSa~EL 174 (563)
+.+....|+|++|.-..+|.-|..|-.. +......+..+. .+.... ....+.. +++...|+. .|..|+....+
T Consensus 405 ~~~~~~p~~~~~~~~~~~~ap~~pPr~~---P~~~~~~~g~~p~s~~L~~~~aw~~~~~~~~~~~~~~g~P~~pkv~mga 481 (829)
T KOG0576|consen 405 NTIDGCPDSGSLAVSAIQMAPGLPPRSS---PPAVLPMIGNGPNSPMLTDKSAWSPVFHRDFPAPCLNGLPPTPKVHMGA 481 (829)
T ss_pred cccccCCCccCCCcchhhcCCCCCCCCC---CccccCCCCCCCCccccchhhhcCcccccCCcccccCCCCCCCcchhhH
Confidence 5589999999999988888888776543 111111111111 010001 1112222 247788887 69999999999
Q ss_pred HcCccccccc
Q 008504 175 LKDPFLQVEN 184 (563)
Q Consensus 175 LkHpff~~~~ 184 (563)
+.|.+|..-.
T Consensus 482 cfsKvfngCp 491 (829)
T KOG0576|consen 482 CFSKVFNGCP 491 (829)
T ss_pred HHHHHhccCc
Confidence 9999997543
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.21 E-value=0.0027 Score=71.14 Aligned_cols=69 Identities=26% Similarity=0.385 Sum_probs=58.8
Q ss_pred CCCceEEEEeecCCCC----CcceeeecccCCCCCHHHHHHHHHHccCCCcccHHHHHHHHHHHHHHhCCCCC
Q 008504 259 DDTSVSLTLRIADSSG----RVRNIHFLFYLDSDTALSVAGEMVEQLDLADHDVAFIAEFIDYLIMKLLPGWK 327 (563)
Q Consensus 259 ~~~~i~L~LRi~d~~~----~~~~I~F~F~~~~DTa~~vA~EmV~~~~i~~~D~~~iA~~i~~~i~~l~p~w~ 327 (563)
.+..++|.||..|.++ ..+.|+|.|++..|+++.||+|||+++++++.|...+|..|...+..+--...
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~n~i~~~~~~~~D~~e~v~~em~~~~~~~edd~~~v~r~~~~~~~~ikgkr~ 387 (632)
T KOG0584|consen 315 SDPALSLSLRDEDGKKNKRPKANAIQFDYNLNTDESEEVAQEMVEEEIVSEDDSREVARLLKDTVFSIKGKRN 387 (632)
T ss_pred ccccccccccccchhhcCCcccccccceeecCCCchhHHHHHHHHhccCCcchHHHHHHHhccceeeechhhh
Confidence 3455667788888763 35689999999999999999999999999999999999999998888776554
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.01 E-value=0.0016 Score=79.22 Aligned_cols=178 Identities=14% Similarity=0.048 Sum_probs=120.7
Q ss_pred EeccCCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCC---CCeEeccCccCceEEeCCCCcEEEecccch
Q 008504 2 ITELFTSGNLRQYRKKH----KNVDIKVIKNWARQILHGLVYLHSHN---PPIIHRDLKCDNIFVNGNHGEVKIGDLGLA 74 (563)
Q Consensus 2 VmEy~~gGsL~~~L~k~----~~Lse~~i~~i~~QIL~aL~yLHs~g---p~IIHrDLKP~NILLd~~~G~VKL~DFGlA 74 (563)
+++|+.+|.++..|-+. ..++..-+....++.+.+..-+|+.. -..+|++||+-|.+|..+. .||++++|+.
T Consensus 1309 r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny-~v~~gk~gLd 1387 (2724)
T KOG1826|consen 1309 RSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNY-NVKLGKGGLD 1387 (2724)
T ss_pred HHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCC-cccccccccc
Confidence 46788899999988653 44566666666666577777777652 2468999999999998775 8999999999
Q ss_pred hhccC--CCCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCC
Q 008504 75 IAMQQ--PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVND 151 (563)
Q Consensus 75 ~~~~~--~~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s 151 (563)
+.... ...+...+++.|+.|++.+. .++.++|+|..|+-+|+...|..+|-.. .....+.+........++...+
T Consensus 1388 KIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~fi~f--lq~~Lkgiidn~tf~sIe~l~p 1465 (2724)
T KOG1826|consen 1388 KIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYFIFF--LQPALKGIIDNHTFFSIEKLKP 1465 (2724)
T ss_pred cccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHHHHH--HHHHHcCcccccccccccccCC
Confidence 83332 23445677888999998865 4777899999999999999887776321 1112222222333334445544
Q ss_pred hhHHHHHHHhc-CCCCCCCCHHHHHcCccccc
Q 008504 152 PQIKGFIEKCL-VPASERLSAKDLLKDPFLQV 182 (563)
Q Consensus 152 ~~l~~LI~kcL-~dP~kRpSa~ELLkHpff~~ 182 (563)
.+.-.....+| -+-..||.-...+.-+.|..
T Consensus 1466 gdaNve~~~~Ll~K~~~rp~q~isls~d~~a~ 1497 (2724)
T KOG1826|consen 1466 GDANVEALHRLLWKYMERPGQYISLSRDHFAV 1497 (2724)
T ss_pred CcccHHHHHHHHHHhhhcchhhhhcccccccc
Confidence 44444444444 35677888888888777653
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.92 E-value=0.0074 Score=61.56 Aligned_cols=75 Identities=21% Similarity=0.346 Sum_probs=54.5
Q ss_pred CEeccCCCCCHH-HHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEeccCccCceEEeCCCCcEEEecccchhhcc
Q 008504 1 MITELFTSGNLR-QYRKKHKNVDIKVIKNWARQILHGLVYLHS-HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~-~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs-~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~ 78 (563)
|||||+...-+. -.|+. -.+....+..+..++++.+.-|-. .+ ++|+||+.-|||+. .|.+.|+|||-|....
T Consensus 143 LvMEfIg~~g~pAP~LkD-v~~e~~e~~~~~~~~v~~~~~l~~~a~--LVHgDLSEyNiL~~--~~~p~iID~~QaV~~~ 217 (268)
T COG1718 143 LVMEFIGDDGLPAPRLKD-VPLELEEAEGLYEDVVEYMRRLYKEAG--LVHGDLSEYNILVH--DGEPYIIDVSQAVTID 217 (268)
T ss_pred EEEEeccCCCCCCCCccc-CCcCchhHHHHHHHHHHHHHHHHHhcC--cccccchhhheEEE--CCeEEEEECccccccC
Confidence 688888553110 01111 123444688889999999998887 78 99999999999997 4699999999986655
Q ss_pred CC
Q 008504 79 QP 80 (563)
Q Consensus 79 ~~ 80 (563)
.+
T Consensus 218 hp 219 (268)
T COG1718 218 HP 219 (268)
T ss_pred CC
Confidence 43
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.52 E-value=0.021 Score=64.08 Aligned_cols=72 Identities=19% Similarity=0.301 Sum_probs=52.2
Q ss_pred CEeccCCCCCHHHHH--HhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhcc
Q 008504 1 MITELFTSGNLRQYR--KKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L--~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~ 78 (563)
|+|||+.|-.+.++. +. ..++.+.+.....++. +..+-..| +.|.|.+|.||+++.+ |.+.+.|||+...+.
T Consensus 243 LtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f--~~q~~~dg--ffHaDpHpGNi~v~~~-g~i~~lDfGi~g~l~ 316 (517)
T COG0661 243 LTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAF--LRQLLRDG--FFHADPHPGNILVRSD-GRIVLLDFGIVGRLD 316 (517)
T ss_pred EEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHH--HHHHHhcC--ccccCCCccceEEecC-CcEEEEcCcceecCC
Confidence 689999999998884 44 4566555444333332 22333468 9999999999999854 899999999986544
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=95.08 E-value=0.035 Score=54.14 Aligned_cols=75 Identities=23% Similarity=0.151 Sum_probs=57.7
Q ss_pred CEeccCCCCCHHH---HHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCC-CeEeccCccCceEEeCCCCcEEEecccchhh
Q 008504 1 MITELFTSGNLRQ---YRKKHKNVDIKVIKNWARQILHGLVYLHSHNP-PIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 76 (563)
Q Consensus 1 LVmEy~~gGsL~~---~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp-~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~ 76 (563)
+|+||...+++.. .+.+.-.-++..+.+++.+++..+.+|+..-. .+.-.|++++|+-++ ++|.+|++|...+..
T Consensus 33 ~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~lcDv~~~nfgv~-~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 33 YVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFFYLCDVSPDNFGVN-DDGRLKLIDLDDVFV 111 (188)
T ss_pred EEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcEEEeecchHHeEEe-CCCcEEEEechhcch
Confidence 3788888775542 12222347899999999999999999987321 388899999999998 568999999987643
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.01 E-value=0.036 Score=62.37 Aligned_cols=74 Identities=18% Similarity=0.179 Sum_probs=52.6
Q ss_pred CEeccCCCCCHHH--HHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeC---CCCcEEEecccchh
Q 008504 1 MITELFTSGNLRQ--YRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG---NHGEVKIGDLGLAI 75 (563)
Q Consensus 1 LVmEy~~gGsL~~--~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~---~~G~VKL~DFGlA~ 75 (563)
|+||||+|..+.+ ++.++ +++...+..-+.+... .-|-..| ++|+|=+|.||++.. .++.+.+.|||+..
T Consensus 279 LtME~~~G~~i~Dl~~i~~~-gi~~~~i~~~l~~~~~--~qIf~~G--ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~ 353 (538)
T KOG1235|consen 279 LTMEYVDGIKINDLDAIDKR-GISPHDILNKLVEAYL--EQIFKTG--FFHADPHPGNILVRPNPEGDEEIVLLDHGLYA 353 (538)
T ss_pred EEEEecCCccCCCHHHHHHc-CCCHHHHHHHHHHHHH--HHHHhcC--CccCCCCCCcEEEecCCCCCccEEEEcccccc
Confidence 6899999987755 45554 4666655444444332 2344567 999999999999983 35689999999986
Q ss_pred hccC
Q 008504 76 AMQQ 79 (563)
Q Consensus 76 ~~~~ 79 (563)
.+..
T Consensus 354 ~is~ 357 (538)
T KOG1235|consen 354 VISH 357 (538)
T ss_pred cccH
Confidence 6544
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=94.67 E-value=0.064 Score=51.61 Aligned_cols=29 Identities=38% Similarity=0.509 Sum_probs=20.2
Q ss_pred CeEeccCccCceEEeCCCCcEEEecccch
Q 008504 46 PIIHRDLKCDNIFVNGNHGEVKIGDLGLA 74 (563)
Q Consensus 46 ~IIHrDLKP~NILLd~~~G~VKL~DFGlA 74 (563)
.++|+|+.|.||+++..++.+-|+||+.+
T Consensus 167 ~~~HgD~~~~Nil~~~~~~~i~iID~e~a 195 (239)
T PF01636_consen 167 VLIHGDLHPGNILVDPSDGRIGIIDFEDA 195 (239)
T ss_dssp EEE-SS-SGGGEEEESSTTEEEE--GTT-
T ss_pred EEEEeccccccceeeeccceeEEEecccc
Confidence 49999999999999845567789999876
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=94.19 E-value=0.09 Score=52.33 Aligned_cols=29 Identities=28% Similarity=0.170 Sum_probs=24.5
Q ss_pred CCeEeccCccCceEEeCCCCcEEEecccch
Q 008504 45 PPIIHRDLKCDNIFVNGNHGEVKIGDLGLA 74 (563)
Q Consensus 45 p~IIHrDLKP~NILLd~~~G~VKL~DFGlA 74 (563)
|.++|+|+.|.||++++ .+.+.|+||+.+
T Consensus 163 ~~l~HgD~~~~Nil~~~-~~~~~iIDwe~a 191 (244)
T cd05150 163 LVVTHGDACLPNIIVDP-GKFSGFIDLGRL 191 (244)
T ss_pred eEEECCCCCCccEEEeC-CcEEEEEEcccc
Confidence 34899999999999984 456789999876
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=93.51 E-value=0.21 Score=49.92 Aligned_cols=30 Identities=27% Similarity=0.371 Sum_probs=24.7
Q ss_pred CCCeEeccCccCceEEeCCCCcEEEecccchh
Q 008504 44 NPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 75 (563)
Q Consensus 44 gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~ 75 (563)
.+.++|+|+.|.||++++ .+ +.|+||+.+.
T Consensus 152 ~~~~~HgD~~~~Nii~~~-~~-~~iIDwe~a~ 181 (226)
T TIGR02172 152 TSTCLHGDFQIGNLITSG-KG-TYWIDLGDFG 181 (226)
T ss_pred CCceEecCCCCCcEEEcC-CC-cEEEechhcC
Confidence 335899999999999974 45 9999999773
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=90.77 E-value=0.45 Score=48.92 Aligned_cols=29 Identities=24% Similarity=0.304 Sum_probs=25.1
Q ss_pred CeEeccCccCceEEeCC---CCcEEEecccch
Q 008504 46 PIIHRDLKCDNIFVNGN---HGEVKIGDLGLA 74 (563)
Q Consensus 46 ~IIHrDLKP~NILLd~~---~G~VKL~DFGlA 74 (563)
.++|+|+.+.||+++.+ .+.+.++||..+
T Consensus 180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya 211 (302)
T cd05156 180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYA 211 (302)
T ss_pred eEEecCCCcCeEEecCCCCCCCcEEEEeeCCC
Confidence 48999999999999853 368999999887
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=90.13 E-value=0.38 Score=47.42 Aligned_cols=30 Identities=33% Similarity=0.323 Sum_probs=25.5
Q ss_pred CeEeccCccCceEEeCCCCcEEEecccchh
Q 008504 46 PIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 75 (563)
Q Consensus 46 ~IIHrDLKP~NILLd~~~G~VKL~DFGlA~ 75 (563)
.++|+|+.+.||+++++++.+.|+||..+.
T Consensus 171 ~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 171 VFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred EEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 389999999999998534689999998773
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=88.32 E-value=0.94 Score=46.48 Aligned_cols=27 Identities=26% Similarity=0.417 Sum_probs=23.5
Q ss_pred CeEeccCccCceEEeCCCCcEEEecccch
Q 008504 46 PIIHRDLKCDNIFVNGNHGEVKIGDLGLA 74 (563)
Q Consensus 46 ~IIHrDLKP~NILLd~~~G~VKL~DFGlA 74 (563)
.++|+|+.+.||+++. +.+.|+||+.+
T Consensus 188 ~liHgD~~~~Nil~~~--~~i~lIDfd~~ 214 (313)
T TIGR02906 188 GFCHQDYAYHNILLKD--NEVYVIDFDYC 214 (313)
T ss_pred ceEcCCCCcccEEEeC--CcEEEEECccc
Confidence 4999999999999984 57899999865
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=87.83 E-value=0.56 Score=46.60 Aligned_cols=27 Identities=26% Similarity=0.335 Sum_probs=22.8
Q ss_pred eEeccCccCceEEeCCCCcEEEecccch
Q 008504 47 IIHRDLKCDNIFVNGNHGEVKIGDLGLA 74 (563)
Q Consensus 47 IIHrDLKP~NILLd~~~G~VKL~DFGlA 74 (563)
++|+|+.+.||+++ +.+..-|+||+.+
T Consensus 166 l~HGD~~~~Nvlv~-~~~i~giIDw~~a 192 (235)
T cd05155 166 WFHGDLAPGNLLVQ-DGRLSAVIDFGCL 192 (235)
T ss_pred EEeCCCCCCcEEEE-CCCEEEEEeCccc
Confidence 89999999999997 3334569999987
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=87.36 E-value=1.5 Score=47.59 Aligned_cols=84 Identities=21% Similarity=0.309 Sum_probs=57.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCCCCccccCCCCccCccccccc
Q 008504 21 VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEE 100 (563)
Q Consensus 21 Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~~~~~~~Gtp~Y~APEvl~~~ 100 (563)
-..+++..++.+.+..+.-+...- ++-||||.-+||+|+ .|+|-|+||-+++..... ..+--..+--|-.+.|.
T Consensus 318 ~~~~e~lsff~s~~sil~~lekkf-~fehrnlt~~niLId--~GnvtLIDfklsRl~~~q---~~isy~rldhp~lF~G~ 391 (488)
T COG5072 318 DRSEEELSFFWSCISILDILEKKF-PFEHRNLTLDNILID--EGNVTLIDFKLSRLSYSQ---GIISYNRLDHPDLFNGV 391 (488)
T ss_pred ccHHHHHHHHHHHHHHHhhhhhcC-Ccccccccccceeee--cCceEEEEeeeeecccCC---ceeeccccCchhhhcCc
Confidence 456788889998888887777765 589999999999998 589999999999732111 11111223344455555
Q ss_pred CCchhhHHHh
Q 008504 101 YNELVDIYSF 110 (563)
Q Consensus 101 ys~ksDIwSL 110 (563)
-+..-+||-+
T Consensus 392 dd~QFeIYrl 401 (488)
T COG5072 392 DDYQFEIYRL 401 (488)
T ss_pred cceeeeHHHH
Confidence 4556667654
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=86.01 E-value=1.1 Score=46.53 Aligned_cols=28 Identities=32% Similarity=0.469 Sum_probs=24.0
Q ss_pred CeEeccCccCceEEeCCCCcEEEecccch
Q 008504 46 PIIHRDLKCDNIFVNGNHGEVKIGDLGLA 74 (563)
Q Consensus 46 ~IIHrDLKP~NILLd~~~G~VKL~DFGlA 74 (563)
.++|+|+++.||+++.+ +.+.|+||+.+
T Consensus 188 ~l~HgD~~~~Nvl~~~~-~~~~vIDfd~~ 215 (307)
T TIGR00938 188 GVIHADLFPDNVLFDGD-SVKGVIDFYFA 215 (307)
T ss_pred ccCCCCCCcCcEEEECC-ceEEEeecccc
Confidence 49999999999999854 55689999977
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=85.94 E-value=0.97 Score=48.12 Aligned_cols=30 Identities=27% Similarity=0.391 Sum_probs=25.7
Q ss_pred CeEeccCccCceEEeCCCCcEEEecccchh
Q 008504 46 PIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 75 (563)
Q Consensus 46 ~IIHrDLKP~NILLd~~~G~VKL~DFGlA~ 75 (563)
.++|+|+++.||+++..++.+.|+||..+.
T Consensus 201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 201 GFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred eEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 389999999999998555689999998773
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=85.04 E-value=0.64 Score=45.40 Aligned_cols=29 Identities=41% Similarity=0.574 Sum_probs=19.5
Q ss_pred eEeccCccCceEEeCCCCcEEEecccchh
Q 008504 47 IIHRDLKCDNIFVNGNHGEVKIGDLGLAI 75 (563)
Q Consensus 47 IIHrDLKP~NILLd~~~G~VKL~DFGlA~ 75 (563)
++|+||.|.||+++..++.++|+||..+.
T Consensus 145 ~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 145 FCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred EeeccCccccEEeccCCCeEEEecHHHHh
Confidence 88999999999994466899999998773
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=84.75 E-value=1.5 Score=45.42 Aligned_cols=28 Identities=32% Similarity=0.420 Sum_probs=23.2
Q ss_pred CeEeccCccCceEEeCCCCcEEEecccch
Q 008504 46 PIIHRDLKCDNIFVNGNHGEVKIGDLGLA 74 (563)
Q Consensus 46 ~IIHrDLKP~NILLd~~~G~VKL~DFGlA 74 (563)
.+||+|+.|.||+++++ ..+-|+||+.+
T Consensus 188 ~liHgD~~~~Nil~~~~-~~~~iIDf~~~ 215 (319)
T PRK05231 188 GVIHADLFRDNVLFEGD-RLSGFIDFYFA 215 (319)
T ss_pred ccCCCCCCCCcEEEECC-ceEEEEecccc
Confidence 39999999999999833 34579999987
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=84.45 E-value=1.3 Score=45.20 Aligned_cols=28 Identities=32% Similarity=0.441 Sum_probs=23.7
Q ss_pred CeEeccCccCceEEeCCCCcEEEecccch
Q 008504 46 PIIHRDLKCDNIFVNGNHGEVKIGDLGLA 74 (563)
Q Consensus 46 ~IIHrDLKP~NILLd~~~G~VKL~DFGlA 74 (563)
.++|+|+.|.||+++. ++.+.|+||+.+
T Consensus 176 ~l~HgD~~~~Nil~~~-~~~~~iIDfe~a 203 (296)
T cd05153 176 GVIHADLFRDNVLFDG-DELSGVIDFYFA 203 (296)
T ss_pred cCCccCcCcccEEEeC-CceEEEeehhhh
Confidence 3999999999999984 445689999877
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=84.23 E-value=0.77 Score=49.08 Aligned_cols=67 Identities=25% Similarity=0.350 Sum_probs=47.5
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhh
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 76 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~ 76 (563)
+|||++.|-.|.+...- .+ +..+...+..-+.-|..+| +||+|..--||++. +.+.++++||--...
T Consensus 185 Vvmelv~g~Pl~~v~~v---~d---~~~ly~~lm~~Iv~la~~G--lIHgDFNEFNimv~-dd~~i~vIDFPQmvS 251 (465)
T KOG2268|consen 185 VVMELVDGYPLRQVRHV---ED---PPTLYDDLMGLIVRLANHG--LIHGDFNEFNIMVK-DDDKIVVIDFPQMVS 251 (465)
T ss_pred eHHHhhcccceeeeeec---CC---hHHHHHHHHHHHHHHHHcC--ceecccchheeEEe-cCCCEEEeechHhhc
Confidence 36777777666654321 22 2344455555666788999 99999999999998 457899999976543
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=83.66 E-value=1 Score=45.85 Aligned_cols=40 Identities=30% Similarity=0.408 Sum_probs=33.6
Q ss_pred HHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccch
Q 008504 34 LHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA 74 (563)
Q Consensus 34 L~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA 74 (563)
+.+|.-.|+..+..+|+|-.|+||+-+ ..|.+||.|-+..
T Consensus 151 i~~L~~fH~~~~~~lHGD~np~NiM~D-~~G~lKlVDP~~L 190 (308)
T PF07387_consen 151 IKDLMDFHSENQHCLHGDCNPDNIMCD-KFGYLKLVDPVCL 190 (308)
T ss_pred HHHHHHhhccCCCeecCCCChhheeec-CCCCEEecChhhh
Confidence 567888897766799999999999998 5689999997643
|
The function of this family is unknown. |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=82.55 E-value=3.8 Score=40.52 Aligned_cols=55 Identities=27% Similarity=0.335 Sum_probs=37.9
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCC-C--cEEEec
Q 008504 9 GNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNH-G--EVKIGD 70 (563)
Q Consensus 9 GsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~-G--~VKL~D 70 (563)
-||.+|+++ +.++. .+...+ -.-..||-.++ |+.+||+|.||++.... | .+.|+|
T Consensus 108 ~TL~~~l~~-~~~~~-~~~~~L---~~f~~~l~~~~--Iv~~dl~~~NIv~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 108 PTLEDYLKE-GGLTE-ELRQAL---DEFKRYLLDHH--IVIRDLNPHNIVVQRRDSGEFRLVLID 165 (199)
T ss_pred ccHHHHHHc-CCccH-HHHHHH---HHHHHHHHHcC--CeecCCCcccEEEEecCCCceEEEEEe
Confidence 478999865 45666 443333 34456777888 99999999999996322 2 466666
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=82.26 E-value=1.9 Score=44.52 Aligned_cols=52 Identities=15% Similarity=0.197 Sum_probs=37.4
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchh
Q 008504 23 IKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 75 (563)
Q Consensus 23 e~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~ 75 (563)
...+...+..+-.++.-++..---++|+|+.|+|++.++ .|.++|+||..|.
T Consensus 131 ~~~~~~~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~-~~~l~LIDWEyAg 182 (269)
T COG0510 131 NHLLRKKLKELRRALEEVPKDDLVPCHNDLNPGNLLLTD-KGGLFLIDWEYAG 182 (269)
T ss_pred hHHHHHHHHHHHHHhhhcCCCceeeecCCCCccceEEcC-CCcEEEEecccCC
Confidence 344555566666666666655112899999999999984 4799999998763
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=81.35 E-value=1.2 Score=45.96 Aligned_cols=30 Identities=20% Similarity=0.259 Sum_probs=23.9
Q ss_pred CeEeccCccCceEEeCCCCcEEEecccchh
Q 008504 46 PIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 75 (563)
Q Consensus 46 ~IIHrDLKP~NILLd~~~G~VKL~DFGlA~ 75 (563)
.++|+|++|.||+++.+....-|+||+.+.
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~ 215 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAK 215 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcc
Confidence 489999999999998432235699999874
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain | Back alignment and domain information |
|---|
Probab=81.26 E-value=2.8 Score=40.76 Aligned_cols=30 Identities=30% Similarity=0.437 Sum_probs=24.2
Q ss_pred CeEeccCccCceEEeCCC-C---cEEEecccchh
Q 008504 46 PIIHRDLKCDNIFVNGNH-G---EVKIGDLGLAI 75 (563)
Q Consensus 46 ~IIHrDLKP~NILLd~~~-G---~VKL~DFGlA~ 75 (563)
.++|||+.+.||++..+. | .+.|+||..+.
T Consensus 121 vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~ 154 (196)
T smart00587 121 VLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSH 154 (196)
T ss_pred EEeeCCCCccceeeccCCCCCccceEEEecccCC
Confidence 389999999999997432 3 68999998773
|
subfamily of choline kinases |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=81.22 E-value=0.91 Score=51.05 Aligned_cols=81 Identities=17% Similarity=0.115 Sum_probs=54.0
Q ss_pred CchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCC---------ccccCCChhHHHHHHHhcC-CCCCCCCH
Q 008504 102 NELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPA---------SLAKVNDPQIKGFIEKCLV-PASERLSA 171 (563)
Q Consensus 102 s~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~---------~l~~~~s~~l~~LI~kcL~-dP~kRpSa 171 (563)
.+|+|||++|.++.++.-|...+....+.+.......-...+. .+.-..+..+..+..+|+- .|..||..
T Consensus 109 ~pKsdVwsl~~i~~el~L~~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~ 188 (725)
T KOG1093|consen 109 GPKSDVWSLGFIILELYLGISLEAELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLP 188 (725)
T ss_pred CcchhhhhHHHHHHHHHHhhHHHHHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccch
Confidence 3699999999999999998766654333332222111111111 1122345667888899996 79999999
Q ss_pred HHHHcCccccc
Q 008504 172 KDLLKDPFLQV 182 (563)
Q Consensus 172 ~ELLkHpff~~ 182 (563)
.++.+++-|..
T Consensus 189 ~~~~k~~i~~e 199 (725)
T KOG1093|consen 189 MELSKRCSFTE 199 (725)
T ss_pred hHHhcCccHHH
Confidence 99999998853
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=80.96 E-value=1.1 Score=44.95 Aligned_cols=28 Identities=29% Similarity=0.394 Sum_probs=23.7
Q ss_pred CeEeccCccCceEEeCCCCcEEEecccchh
Q 008504 46 PIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 75 (563)
Q Consensus 46 ~IIHrDLKP~NILLd~~~G~VKL~DFGlA~ 75 (563)
.++|+|+.|.||+++++ + +.|+||..+.
T Consensus 147 ~l~H~Dl~~~Nil~~~~-~-~~lIDwE~a~ 174 (256)
T TIGR02721 147 APLHMDVHAYNLVVTPQ-G-LKLIDWEYAS 174 (256)
T ss_pred eeecCCCCcCcEEEeCC-C-CEEEeccccC
Confidence 48999999999999843 4 7899998773
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=80.17 E-value=1.4 Score=43.24 Aligned_cols=28 Identities=21% Similarity=0.336 Sum_probs=23.6
Q ss_pred CeEeccCccCceEEeCCCCcEEEecccchh
Q 008504 46 PIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 75 (563)
Q Consensus 46 ~IIHrDLKP~NILLd~~~G~VKL~DFGlA~ 75 (563)
..+|+|+.|.||+++ ++| ++|+||+.+.
T Consensus 78 ~p~H~D~~~~N~~~~-~~~-~~lIDwe~a~ 105 (188)
T PRK10271 78 APLHMDVHAGNLVHS-ASG-LRLIDWEYAG 105 (188)
T ss_pred eeecCCCCCccEEEE-CCC-EEEEeCCccc
Confidence 369999999999997 444 9999999874
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 563 | ||||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-60 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-21 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-21 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-20 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-19 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-18 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 4e-18 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 5e-18 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 6e-18 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 6e-18 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 7e-18 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-17 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-17 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 6e-17 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 9e-17 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 9e-17 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 9e-17 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 4e-16 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-16 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 6e-16 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 8e-16 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 8e-16 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-15 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-15 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-15 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-15 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-15 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 4e-15 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 5e-15 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 5e-15 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 6e-15 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-15 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-15 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-14 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-14 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-14 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-14 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-14 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-14 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-14 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-14 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-14 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-14 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-14 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 4e-14 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 4e-14 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-14 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 5e-14 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 5e-14 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 6e-14 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 6e-14 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 6e-14 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 6e-14 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 7e-14 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 7e-14 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 9e-14 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 9e-14 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 9e-14 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 9e-14 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-13 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-13 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-13 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-13 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-13 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-13 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-13 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 3e-13 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-13 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-13 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-13 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-13 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-13 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-13 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-13 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-13 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 4e-13 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-13 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 4e-13 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 5e-13 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-13 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 5e-13 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-13 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 6e-13 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-13 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-13 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 9e-13 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-12 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-12 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-12 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-12 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-12 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-12 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-12 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-12 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-12 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 3e-12 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-12 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-12 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-12 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-12 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-12 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-12 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-12 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-12 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-12 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-12 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 4e-12 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 5e-12 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 5e-12 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 5e-12 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 5e-12 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 5e-12 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 5e-12 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 6e-12 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 6e-12 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 6e-12 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 6e-12 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 6e-12 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 6e-12 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-12 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-12 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 6e-12 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 6e-12 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 6e-12 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 6e-12 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 7e-12 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 7e-12 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-12 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 7e-12 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 7e-12 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 7e-12 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 7e-12 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 7e-12 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 7e-12 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 7e-12 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 7e-12 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 7e-12 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 8e-12 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 8e-12 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 8e-12 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 8e-12 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 8e-12 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 9e-12 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-11 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-11 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-11 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-11 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-11 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-11 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-11 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-11 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-11 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-11 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-11 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-11 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-11 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-11 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-11 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-11 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-11 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-11 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-11 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-11 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-11 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 4e-11 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-11 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 5e-11 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 5e-11 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-11 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 5e-11 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 6e-11 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 6e-11 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-11 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 6e-11 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 8e-11 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 8e-11 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 8e-11 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 8e-11 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 8e-11 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 8e-11 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 9e-11 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 9e-11 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 9e-11 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-10 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-10 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-10 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-10 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-10 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-10 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-10 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-10 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-10 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-10 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-10 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-10 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-10 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-10 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-10 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-10 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-10 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-10 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-10 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-10 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-10 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-10 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-10 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-10 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-10 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-10 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-10 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-10 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-10 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-10 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-10 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-10 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-10 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-10 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-10 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-10 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-10 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-10 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-10 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-10 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-10 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-10 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-10 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-10 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-10 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 4e-10 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 4e-10 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 4e-10 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 4e-10 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 4e-10 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 4e-10 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 4e-10 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 4e-10 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 4e-10 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 4e-10 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 5e-10 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 5e-10 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 5e-10 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 6e-10 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 6e-10 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 6e-10 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 6e-10 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 6e-10 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 6e-10 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 7e-10 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 8e-10 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 8e-10 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 9e-10 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 9e-10 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-09 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-09 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-09 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-09 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-09 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-09 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-09 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-09 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-09 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-09 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-09 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-09 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-09 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-09 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-09 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-09 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-09 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-09 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-09 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-09 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-09 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-09 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-09 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-09 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-09 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-09 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-09 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-09 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-09 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-09 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-09 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-09 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-09 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-09 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-09 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-09 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-09 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-09 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-09 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-09 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-09 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-09 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-09 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-09 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 4e-09 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 5e-09 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-09 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 5e-09 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 5e-09 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-09 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 5e-09 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 5e-09 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 5e-09 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 5e-09 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 6e-09 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 6e-09 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 6e-09 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 7e-09 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 7e-09 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 8e-09 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 8e-09 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 8e-09 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 9e-09 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 9e-09 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-08 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-08 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-08 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-08 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-08 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-08 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-08 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-08 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-08 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-08 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-08 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-08 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-08 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-08 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-08 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-08 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-08 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-08 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-08 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-08 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-08 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-08 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-08 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-08 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-08 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 2e-08 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-08 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-08 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-08 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-08 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-08 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-08 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-08 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-08 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-08 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-08 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-08 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-08 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-08 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-08 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-08 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-08 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-08 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-08 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-08 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-08 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-08 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-08 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-08 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 3e-08 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-08 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-08 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-08 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-08 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-08 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-08 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-08 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-08 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-08 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-08 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-08 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-08 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-08 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-08 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-08 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-08 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-08 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-08 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-08 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-08 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-08 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-08 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-08 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-08 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 3e-08 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-08 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-08 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-08 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-08 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-08 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-08 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-08 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-08 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-08 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-08 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 4e-08 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 4e-08 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-08 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-08 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 4e-08 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 4e-08 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-08 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 4e-08 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 4e-08 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-08 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 4e-08 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 4e-08 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-08 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 4e-08 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 4e-08 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 4e-08 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-08 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 4e-08 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 4e-08 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 4e-08 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 4e-08 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-08 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-08 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-08 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 4e-08 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 4e-08 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 4e-08 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 4e-08 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 4e-08 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 5e-08 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 5e-08 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 5e-08 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 5e-08 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 5e-08 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-08 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 5e-08 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 5e-08 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 5e-08 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-08 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 5e-08 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-08 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-08 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 5e-08 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 5e-08 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 5e-08 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 5e-08 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 5e-08 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 5e-08 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 5e-08 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 5e-08 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-08 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 5e-08 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 5e-08 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 5e-08 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 5e-08 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 5e-08 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-08 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 5e-08 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 5e-08 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 5e-08 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 6e-08 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 6e-08 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 6e-08 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 6e-08 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 6e-08 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 6e-08 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 6e-08 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 6e-08 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 6e-08 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 6e-08 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 6e-08 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 6e-08 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 6e-08 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 6e-08 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 6e-08 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 7e-08 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 7e-08 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 7e-08 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 7e-08 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 7e-08 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 8e-08 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-08 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 8e-08 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 9e-08 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 9e-08 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 9e-08 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 9e-08 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-08 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 9e-08 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 9e-08 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 9e-08 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 9e-08 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 9e-08 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 9e-08 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 9e-08 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 9e-08 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 9e-08 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 9e-08 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 9e-08 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-07 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-07 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-07 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-07 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-07 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-07 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-07 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-07 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-07 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-07 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-07 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-07 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-07 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-07 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-07 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-07 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-07 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-07 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-07 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-07 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-07 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-07 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-07 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-07 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-07 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-07 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-07 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-07 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-07 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-07 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-07 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-07 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-07 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-07 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-07 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-07 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-07 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-07 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-07 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-07 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-07 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-07 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-07 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-07 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-07 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-07 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-07 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-07 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-07 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-07 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-07 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-07 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-07 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-07 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-07 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-07 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-07 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-07 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-07 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-07 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-07 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-07 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-07 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-07 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-07 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-07 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-07 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-07 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-07 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-07 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-07 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-07 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-07 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-07 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-07 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-07 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-07 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-07 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-07 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-07 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-07 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-07 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-07 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-07 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-07 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 3e-07 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-07 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-07 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 3e-07 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-07 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-07 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-07 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 3e-07 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-07 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-07 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 4e-07 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 4e-07 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 4e-07 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 4e-07 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 4e-07 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 4e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 5e-07 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 5e-07 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 5e-07 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 5e-07 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 5e-07 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-07 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 6e-07 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 6e-07 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 6e-07 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 6e-07 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 7e-07 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 7e-07 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 7e-07 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 7e-07 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 7e-07 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 7e-07 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 8e-07 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 8e-07 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 8e-07 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 8e-07 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 8e-07 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 8e-07 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 8e-07 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 8e-07 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 8e-07 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 9e-07 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 9e-07 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 9e-07 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-06 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-06 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-06 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-06 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-06 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-06 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-06 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-06 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-06 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-06 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-06 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-06 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-06 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-06 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-06 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-06 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-06 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-06 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-06 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-06 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-06 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-06 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-06 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-06 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-06 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-06 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-06 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-06 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-06 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-06 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-06 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-06 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-06 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-06 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-06 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-06 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-06 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-06 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-06 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-06 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-06 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-06 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-06 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-06 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-06 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-06 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 2e-06 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-06 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-06 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 2e-06 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-06 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-06 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-06 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-06 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-06 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-06 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-06 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-06 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-06 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 3e-06 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 3e-06 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 3e-06 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-06 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-06 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 3e-06 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-06 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-06 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-06 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-06 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-06 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 4e-06 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 4e-06 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 4e-06 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 4e-06 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 4e-06 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 4e-06 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-06 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 4e-06 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 4e-06 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-06 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-06 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 4e-06 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 5e-06 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 5e-06 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 5e-06 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 5e-06 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 5e-06 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 5e-06 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-06 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 5e-06 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-06 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 5e-06 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-06 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 5e-06 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 5e-06 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 5e-06 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 5e-06 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-06 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 5e-06 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 5e-06 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 5e-06 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 5e-06 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-06 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 5e-06 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 5e-06 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-06 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-06 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-06 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 6e-06 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 6e-06 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 6e-06 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 6e-06 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 6e-06 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 6e-06 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 6e-06 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 6e-06 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-06 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 8e-06 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 8e-06 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 8e-06 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 8e-06 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 8e-06 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 8e-06 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 8e-06 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-06 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 9e-06 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 9e-06 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 9e-06 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 9e-06 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 9e-06 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 9e-06 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 9e-06 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-06 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 9e-06 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 9e-06 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-05 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-05 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-05 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-05 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-05 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-05 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-05 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-05 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-05 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-05 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-05 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-05 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-05 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-05 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-05 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-05 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-05 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-05 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-05 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-05 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-05 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-05 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-05 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-05 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-05 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-05 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-05 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-05 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-05 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-05 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-05 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-05 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 3e-05 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 3e-05 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-05 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-05 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-05 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-05 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-05 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-05 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-05 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 4e-05 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 5e-05 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 5e-05 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 5e-05 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 5e-05 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 5e-05 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 6e-05 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 6e-05 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 6e-05 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 6e-05 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 7e-05 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 7e-05 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 7e-05 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 7e-05 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 7e-05 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 7e-05 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 7e-05 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 7e-05 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 7e-05 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 8e-05 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 8e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 9e-05 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 9e-05 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-04 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-04 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-04 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-04 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-04 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-04 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-04 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-04 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-04 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-04 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-04 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-04 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 1e-04 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-04 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-04 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-04 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-04 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-04 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-04 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-04 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-04 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-04 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-04 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-04 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-04 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-04 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-04 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-04 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-04 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-04 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-04 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-04 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-04 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-04 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-04 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-04 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-04 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 3e-04 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-04 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 3e-04 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-04 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 4e-04 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-04 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 4e-04 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-04 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-04 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 4e-04 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 4e-04 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 4e-04 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 4e-04 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 4e-04 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 4e-04 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 4e-04 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 5e-04 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 5e-04 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 5e-04 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 5e-04 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 5e-04 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 5e-04 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 5e-04 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 5e-04 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 6e-04 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 6e-04 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 6e-04 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 6e-04 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 7e-04 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 7e-04 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 7e-04 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 8e-04 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 8e-04 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 8e-04 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 8e-04 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 9e-04 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 9e-04 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 9e-04 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 9e-04 |
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 320 bits (823), Expect = e-106
Identities = 110/182 (60%), Positives = 138/182 (75%), Gaps = 1/182 (0%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 60
++TEL TSG L+ Y K+ K + IKV+++W RQIL GL +LH+ PPIIHRDLKCDNIF+
Sbjct: 106 LVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT 165
Query: 61 GNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTF 120
G G VKIGDLGLA + A++VIGTPEFMAPE+YEE+Y+E VD+Y+FGMC+LEM T
Sbjct: 166 GPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATS 225
Query: 121 EYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPF 179
EYPYSEC+N AQI+++VTSG+KPAS KV P++K IE C+ ER S KDLL F
Sbjct: 226 EYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAF 285
Query: 180 LQ 181
Q
Sbjct: 286 FQ 287
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 1e-45
Identities = 47/184 (25%), Positives = 80/184 (43%), Gaps = 11/184 (5%)
Query: 1 MITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV 59
+ TE +L+Q+ + ++ + + R L L +LHS ++H D+K NIF+
Sbjct: 134 LQTE-LCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG--LVHLDVKPANIFL 190
Query: 60 NGNHGEVKIGDLGLAIAMQQPT-ARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMV 118
G K+GD GL + + G P +MAPEL + Y D++S G+ ILE+
Sbjct: 191 GPR-GRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVA 249
Query: 119 TFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKD 177
+ Q+ + A L +++ + L P R +A+ LL
Sbjct: 250 CNMELPHGGEGWQQLRQGYLPPEFTAGL----SSELRSVLVMMLEPDPKLRATAEALLAL 305
Query: 178 PFLQ 181
P L+
Sbjct: 306 PVLR 309
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 5e-44
Identities = 60/169 (35%), Positives = 86/169 (50%), Gaps = 8/169 (4%)
Query: 25 VIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IAMQQPTA 82
I + +QIL GL YLH + I+HRD+K DN+ +N G +KI D G + +A P
Sbjct: 123 TIGFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCT 180
Query: 83 RSVIGTPEFMAPE---LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS 139
+ GT ++MAPE Y + DI+S G I+EM T + P+ E P KV
Sbjct: 181 ETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGM 240
Query: 140 GIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQKE 187
+ + + K FI KC P +R A DLL D FL+V ++K+
Sbjct: 241 FKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKKK 289
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 2e-43
Identities = 49/192 (25%), Positives = 85/192 (44%), Gaps = 16/192 (8%)
Query: 1 MITELFTSGNLRQYRKKHKNVDI--KVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIF 58
+ E G L Q+ +K + + + QI G+ Y+HS +I+RDLK NIF
Sbjct: 97 IQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK--LINRDLKPSNIF 154
Query: 59 VNGNHGEVKIGDLGLAIAMQQPTAR-SVIGTPEFMAPELYEEE-YNELVDIYSFGMCILE 116
+ +VKIGD GL +++ R GT +M+PE + Y + VD+Y+ G+ + E
Sbjct: 155 LVDT-KQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAE 213
Query: 117 MVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLL 175
++ E F + GI D + K ++K L +R + ++L
Sbjct: 214 LLHVCDTAFETSK---FFTDLRDGIISDIF----DKKEKTLLQKLLSKKPEDRPNTSEIL 266
Query: 176 KDPFLQVENQKE 187
+ + + E
Sbjct: 267 RTLTVW-KKSPE 277
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 3e-43
Identities = 49/167 (29%), Positives = 79/167 (47%), Gaps = 8/167 (4%)
Query: 1 MITELFTSGNLRQY---RKKHKNVDIKVIKNWARQILHGLVYLHSHNP-PIIHRDLKCDN 56
++ E G+L + +W Q G+ YLHS P +IHRDLK N
Sbjct: 76 LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPN 135
Query: 57 IFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCIL 115
+ + +KI D G A +Q + G+ +MAPE++E Y+E D++S+G+ +
Sbjct: 136 LLLVAGGTVLKICDFGTACDIQT-HMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILW 194
Query: 116 EMVTFEYPYSECKNPAQ-IFKKVTSGIKPASLAKVNDPQIKGFIEKC 161
E++T P+ E PA I V +G +P L K I+ + +C
Sbjct: 195 EVITRRKPFDEIGGPAFRIMWAVHNGTRP-PLIKNLPKPIESLMTRC 240
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 4e-43
Identities = 48/187 (25%), Positives = 90/187 (48%), Gaps = 11/187 (5%)
Query: 1 MITELFTSGNLRQYRKKHKNVDI--KVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIF 58
++ + G+L + K V I +W QI L ++H I+HRD+K NIF
Sbjct: 100 IVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIF 157
Query: 59 VNGNHGEVKIGDLGLAIAMQQPT--ARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCIL 115
+ + G V++GD G+A + AR+ IGTP +++PE+ E + YN DI++ G +
Sbjct: 158 LTKD-GTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLY 216
Query: 116 EMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDL 174
E+ T ++ + E + + K+ SG ++ ++ + + +R S +
Sbjct: 217 ELCTLKHAF-EAGSMKNLVLKIISG-SFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSI 274
Query: 175 LKDPFLQ 181
L+ F+
Sbjct: 275 LEKGFIA 281
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 5e-43
Identities = 51/199 (25%), Positives = 93/199 (46%), Gaps = 16/199 (8%)
Query: 1 MITELFTSGNL----RQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPP---IIHRDLK 53
++ E G+L + K+ + +D + + Q+ L H + ++HRDLK
Sbjct: 84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLK 143
Query: 54 CDNIFVNGNHGEVKIGDLGLAIAMQQPT--ARSVIGTPEFMAPELYEEE-YNELVDIYSF 110
N+F++G VK+GD GLA + T A++ +GTP +M+PE YNE DI+S
Sbjct: 144 PANVFLDGK-QNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSL 202
Query: 111 GMCIL-EMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASER 168
G C+L E+ P+ + ++ K+ G K + ++ I + L R
Sbjct: 203 G-CLLYELCALMPPF-TAFSQKELAGKIREG-KFRRIPYRYSDELNEIITRMLNLKDYHR 259
Query: 169 LSAKDLLKDPFLQVENQKE 187
S +++L++P + +
Sbjct: 260 PSVEEILENPLILEHHHHH 278
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 9e-43
Identities = 50/167 (29%), Positives = 85/167 (50%), Gaps = 8/167 (4%)
Query: 1 MITELFTSGNLRQY---RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 57
++TE + G+L + + +D + + A + G+ YLH+ NPPI+HR+LK N+
Sbjct: 111 IVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNL 170
Query: 58 FVNGNHGEVKIGDLGLAIAMQQ--PTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCI 114
V+ VK+ D GL+ +++S GTPE+MAPE+ E NE D+YSFG+ +
Sbjct: 171 LVD-KKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVIL 229
Query: 115 LEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKC 161
E+ T + P+ + + + + +PQ+ IE C
Sbjct: 230 WELATLQQPWGNLNPAQVVAAVGFKCKRL-EIPRNLNPQVAAIIEGC 275
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 1e-42
Identities = 66/216 (30%), Positives = 94/216 (43%), Gaps = 28/216 (12%)
Query: 1 MITELFTSGNLRQY-RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV 59
+ E +G L ++ N RQIL L Y+HS IIHRDLK NIF+
Sbjct: 92 IQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQG--IIHRDLKPMNIFI 149
Query: 60 NGNHGEVKIGDLGLAIAMQQPTAR----------------SVIGTPEFMAPELYEE--EY 101
+ + VKIGD GLA + + S IGT ++A E+ + Y
Sbjct: 150 DES-RNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHY 208
Query: 102 NELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK--PASLAKVNDPQIKGFIE 159
NE +D+YS G+ EM+ YP+S I KK+ S P K I
Sbjct: 209 NEKIDMYSLGIIFFEMI---YPFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIR 265
Query: 160 KCLVP-ASERLSAKDLLKDPFLQVENQKEPICDPLK 194
+ ++R A+ LL +L V++Q E I + LK
Sbjct: 266 LLIDHDPNKRPGARTLLNSGWLPVKHQDEVIKEALK 301
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 1e-41
Identities = 48/171 (28%), Positives = 76/171 (44%), Gaps = 12/171 (7%)
Query: 1 MITELFTSGNLRQY-RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV 59
M+ E G+L K + V I G+ Y+ + NPPI+HRDL+ NIF+
Sbjct: 98 MVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFL 157
Query: 60 NGNHGE----VKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEE---YNELVDIYSFGM 112
K+ D GL+ + ++G ++MAPE E Y E D YSF M
Sbjct: 158 QSLDENAPVCAKVADFGLS-QQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAM 216
Query: 113 CILEMVTFEYPYSECKNP--AQIFKKVTSGIKPASLAKVNDPQIKGFIEKC 161
+ ++T E P+ E I G++P ++ + P+++ IE C
Sbjct: 217 ILYTILTGEGPFDEYSYGKIKFINMIREEGLRP-TIPEDCPPRLRNVIELC 266
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 151 bits (382), Expect = 2e-41
Identities = 52/199 (26%), Positives = 86/199 (43%), Gaps = 26/199 (13%)
Query: 2 ITELFTSGNLRQY---RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIF 58
+L NL+ + R ++ + V + QI + +LHS ++HRDLK NIF
Sbjct: 139 QMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG--LMHRDLKPSNIF 196
Query: 59 VNGNHGEVKIGDLGLAIAMQQPTAR--------------SVIGTPEFMAPELYEEE-YNE 103
+ VK+GD GL AM Q +GT +M+PE Y+
Sbjct: 197 FTMD-DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSH 255
Query: 104 LVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV 163
VDI+S G+ + E++ Y +S +I V + P + PQ ++ L
Sbjct: 256 KVDIFSLGLILFELL---YSFSTQMERVRIITDVRNLKFPLLFTQKY-PQEHMMVQDMLS 311
Query: 164 P-ASERLSAKDLLKDPFLQ 181
P +ER A D++++ +
Sbjct: 312 PSPTERPEATDIIENAIFE 330
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 1e-40
Identities = 45/176 (25%), Positives = 83/176 (47%), Gaps = 8/176 (4%)
Query: 11 LRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGD 70
++ ++K+ + + + + + Q+ L ++HS ++HRD+K N+F+ G VK+GD
Sbjct: 123 IKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFITAT-GVVKLGD 179
Query: 71 LGLAIAMQQPT--ARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTFEYPY-SE 126
LGL T A S++GTP +M+PE E YN DI+S G + EM + P+ +
Sbjct: 180 LGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 239
Query: 127 CKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQ 181
N + KK+ P + +++ + C+ P +R +
Sbjct: 240 KMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRM 295
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 4e-40
Identities = 50/200 (25%), Positives = 84/200 (42%), Gaps = 26/200 (13%)
Query: 1 MITELFTSGNLRQY---RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 57
+ +L NL+ + R + + V + QI + +LHS ++HRDLK NI
Sbjct: 92 IQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG--LMHRDLKPSNI 149
Query: 58 FVNGNHGEVKIGDLGLAIAMQQPTAR--------------SVIGTPEFMAPELYEEE-YN 102
F + VK+GD GL AM Q +GT +M+PE Y+
Sbjct: 150 FFTMD-DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYS 208
Query: 103 ELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCL 162
VDI+S G+ + E++ YP+S + V + P + P ++ L
Sbjct: 209 HKVDIFSLGLILFELL---YPFSTQMERVRTLTDVRNLKFPPLFTQKY-PCEYVMVQDML 264
Query: 163 VP-ASERLSAKDLLKDPFLQ 181
P ER A +++++ +
Sbjct: 265 SPSPMERPEAINIIENAVFE 284
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 5e-40
Identities = 45/170 (26%), Positives = 76/170 (44%), Gaps = 11/170 (6%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNP-PIIHRDLKCDNIFV 59
++ E G L + + + ++ NWA QI G+ YLH PIIHRDLK NI +
Sbjct: 83 LVMEFARGGPLNRVLSGKR-IPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILI 141
Query: 60 N-------GNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSFG 111
++ +KI D GLA + T S G +MAPE+ +++ D++S+G
Sbjct: 142 LQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYG 201
Query: 112 MCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKC 161
+ + E++T E P+ A + + + + +E C
Sbjct: 202 VLLWELLTGEVPFRGIDGLAVAYGVAMNKLAL-PIPSTCPEPFAKLMEDC 250
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 8e-40
Identities = 44/202 (21%), Positives = 80/202 (39%), Gaps = 12/202 (5%)
Query: 9 GNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKI 68
G+L Q K+ + + Q L GL YLH+ I+H D+K DN+ ++ + +
Sbjct: 135 GSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR--ILHGDVKADNVLLSSDGSRAAL 192
Query: 69 GDLGLA-------IAMQQPTARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTF 120
D G A + T + GT MAPE+ + + VDI+S +L M+
Sbjct: 193 CDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 252
Query: 121 EYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPF 179
+P+++ K + + P I++ L R SA +L +
Sbjct: 253 CHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVG 312
Query: 180 LQVENQKEPICDPLKLPIQSLK 201
++ + + P K + +
Sbjct: 313 KALQ-EVGGLKSPWKGEYKEPR 333
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 1e-39
Identities = 34/167 (20%), Positives = 70/167 (41%), Gaps = 11/167 (6%)
Query: 1 MITELFTSGNLRQY--RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIF 58
+IT G+L + VD +A + G+ +LH+ P I L ++
Sbjct: 86 LITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVM 145
Query: 59 VNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEE----YNELVDIYSFGMCI 114
++ +I + + Q P + P ++APE +++ D++SF + +
Sbjct: 146 ID-EDMTARISMADVKFSFQSPG---RMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLL 201
Query: 115 LEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKC 161
E+VT E P+++ N K G++P ++ P + ++ C
Sbjct: 202 WELVTREVPFADLSNMEIGMKVALEGLRP-TIPPGISPHVSKLMKIC 247
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 6e-39
Identities = 41/179 (22%), Positives = 77/179 (43%), Gaps = 23/179 (12%)
Query: 1 MITELFTSGNLRQY-RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV 59
+IT L L R +D+ + A++I+ G+ YLH+ I+H+DLK N+F
Sbjct: 106 IITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG--ILHKDLKSKNVFY 163
Query: 60 NGNHGEVKIGDLGLA-------IAMQQPTARSVIGTPEFMAPEL----------YEEEYN 102
++G+V I D GL ++ R G +APE+ + ++
Sbjct: 164 --DNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFS 221
Query: 103 ELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKC 161
+ D+++ G E+ E+P+ + I ++ +G+KP +I + C
Sbjct: 222 KHSDVFALGTIWYELHAREWPFKT-QPAEAIIWQMGTGMKPNLSQIGMGKEISDILLFC 279
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 8e-39
Identities = 48/254 (18%), Positives = 104/254 (40%), Gaps = 29/254 (11%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI-FV 59
M+ E + +L + KK K++D K++ + +L + +H H I+H DLK N V
Sbjct: 86 MVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV 142
Query: 60 NGNHGEVKIGDLGLAIAMQQPT----ARSVIGTPEFMAPEL------------YEEEYNE 103
+G +K+ D G+A MQ T S +GT +M PE + + +
Sbjct: 143 DGM---LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISP 199
Query: 104 LVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV 163
D++S G + M + P+ + N + + + ++ ++ CL
Sbjct: 200 KSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLK 259
Query: 164 P-ASERLSAKDLLKDPFLQVENQKEPICDPLKLPIQSLKMLRLPMSGPSSMDIDSDYKQL 222
+R+S +LL P++Q++ ++ + + ++ + ++ + +
Sbjct: 260 RDPKQRISIPELLAHPYVQIQTHPVN-----QMAKGTTEEMKYVLGQLVGLNSPNSILKA 314
Query: 223 SLSTCTESNNGSPH 236
+ + + G H
Sbjct: 315 AKTLYEHYSGGESH 328
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 9e-39
Identities = 53/173 (30%), Positives = 87/173 (50%), Gaps = 15/173 (8%)
Query: 1 MITELFTSGNLRQY-RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV 59
++T+ +L + ++K + + ARQ G+ YLH+ + IIHRDLK +NIF+
Sbjct: 96 IVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS--IIHRDLKSNNIFL 153
Query: 60 NGNHGEVKIGDLGLAIAMQQ----PTARSVIGTPEFMAPELYEEE----YNELVDIYSFG 111
VKIGD GLA + + G+ +MAPE+ + Y+ D+Y+FG
Sbjct: 154 -HEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFG 212
Query: 112 MCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKV---NDPQIKGFIEKC 161
+ + E++T + PYS N QI + V G L+KV ++K + +C
Sbjct: 213 IVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAEC 265
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 4e-38
Identities = 49/207 (23%), Positives = 90/207 (43%), Gaps = 26/207 (12%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI-FV 59
M+ E + +L + KK K++D K++ + +L + +H H I+H DLK N V
Sbjct: 105 MVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV 161
Query: 60 NGNHGEVKIGDLGLAIAMQQPT----ARSVIGTPEFMAPELYEEE------------YNE 103
+G +K+ D G+A MQ T S +GT +M PE ++ +
Sbjct: 162 DGM---LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISP 218
Query: 104 LVDIYSFGMCIL-EMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCL 162
D++S G CIL M + P+ + N + + + ++ ++ CL
Sbjct: 219 KSDVWSLG-CILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCL 277
Query: 163 VP-ASERLSAKDLLKDPFLQVENQKEP 188
+R+S +LL P++Q++
Sbjct: 278 KRDPKQRISIPELLAHPYVQIQTHPVN 304
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 8e-38
Identities = 52/222 (23%), Positives = 95/222 (42%), Gaps = 28/222 (12%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI-FV 59
M+ E + +L + KK K++D K++ + +L + +H H I+H DLK N V
Sbjct: 133 MVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV 189
Query: 60 NGNHGEVKIGDLGLAIAMQQPT----ARSVIGTPEFMAPELYEEE------------YNE 103
+G +K+ D G+A MQ T S +G +M PE ++ +
Sbjct: 190 DGM---LKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISP 246
Query: 104 LVDIYSFGMCIL-EMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCL 162
D++S G CIL M + P+ + N + + + ++ ++ CL
Sbjct: 247 KSDVWSLG-CILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCL 305
Query: 163 VP-ASERLSAKDLLKDPFLQVENQKEPICDPLKLPIQSLKML 203
+R+S +LL P++Q Q P+ K + +K +
Sbjct: 306 KRDPKQRISIPELLAHPYVQ--IQTHPVNQMAKGTTEEMKYV 345
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 2e-37
Identities = 38/197 (19%), Positives = 75/197 (38%), Gaps = 30/197 (15%)
Query: 11 LRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGN-------- 62
+ + + +K+ Q+ GL Y+HS + ++H D+K NIF++
Sbjct: 102 ISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS--LVHMDIKPSNIFISRTSIPNAASE 159
Query: 63 ----------HGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEE--YNELVDIYSF 110
KIGDLG + + + G F+A E+ +E + DI++
Sbjct: 160 EGDEDDWASNKVMFKIGDLGH--VTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFAL 217
Query: 111 GMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERL 169
+ ++ E + ++ G P + +V + ++ + P R
Sbjct: 218 ALTVVCAAGAEPLPRN----GDQWHEIRQGRLP-RIPQVLSQEFTELLKVMIHPDPERRP 272
Query: 170 SAKDLLKDPFLQVENQK 186
SA L+K L ++K
Sbjct: 273 SAMALVKHSVLLSASRK 289
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 9e-34
Identities = 52/215 (24%), Positives = 86/215 (40%), Gaps = 41/215 (19%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHS------HNPPIIHRDLKC 54
+IT+ +G+L Y K +D K + A + GL +LH+ P I HRDLK
Sbjct: 112 LITDYHENGSLYDYLKSTT-LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKS 170
Query: 55 DNIFVNGNHGEVKIGDLGLAIAMQQPTAR------SVIGTPEFMAPELYEE-------EY 101
NI V N G I DLGLA+ T + +GT +M PE+ +E +
Sbjct: 171 KNILVKKN-GTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQS 229
Query: 102 NELVDIYSFGMCILEMVT----------FEYPYSECKNPAQIFKKVTSG---------IK 142
+ D+YSFG+ + E+ ++ PY + ++ +
Sbjct: 230 YIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFP 289
Query: 143 PASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLK 176
+ Q+ + +C + RL+A + K
Sbjct: 290 NRWSSDECLRQMGKLMTECWAHNPASRLTALRVKK 324
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 3e-33
Identities = 53/215 (24%), Positives = 85/215 (39%), Gaps = 41/215 (19%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHS------HNPPIIHRDLKC 54
+IT G+L Y + +D I GL +LH P I HRDLK
Sbjct: 83 LITHYHEMGSLYDYLQLTT-LDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKS 141
Query: 55 DNIFVNGNHGEVKIGDLGLAIAMQQPTAR------SVIGTPEFMAPELYEE-------EY 101
NI V N G+ I DLGLA+ Q T + +GT +MAPE+ +E +
Sbjct: 142 KNILVKKN-GQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDS 200
Query: 102 NELVDIYSFGMCILEMVT----------FEYPYSECKNPAQIFKKVTSG---------IK 142
+ VDI++FG+ + E+ ++ P+ + F+ + I
Sbjct: 201 YKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIP 260
Query: 143 PASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLK 176
+ + +++C S RL+A + K
Sbjct: 261 NRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 4e-33
Identities = 55/158 (34%), Positives = 87/158 (55%), Gaps = 13/158 (8%)
Query: 31 RQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IAMQQPTARSVIGT 88
R+ L L +LHS+ +IHRD+K DNI + + G VK+ D G I +Q +++GT
Sbjct: 123 RECLQALEFLHSNQ--VIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRSTMVGT 179
Query: 89 PEFMAPEL-YEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQ-IFKKVTSGIKPASL 146
P +MAPE+ + Y VDI+S G+ +EM+ E PY +NP + ++ T+G L
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN-ENPLRALYLIATNG--TPEL 236
Query: 147 AKVND--PQIKGFIEKCL-VPASERLSAKDLLKDPFLQ 181
+ F+ +CL + +R SAK+LL+ FL+
Sbjct: 237 QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLK 274
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 7e-33
Identities = 50/185 (27%), Positives = 87/185 (47%), Gaps = 11/185 (5%)
Query: 11 LRQYRKKHKNVDIKVIKNWARQILHGLVYLHS-HNPPIIHRDLKCDNIFVNGNHGEVKIG 69
+Q K + + ++ A I+ L +LHS + +IHRD+K N+ +N G+VK+
Sbjct: 96 YKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINAL-GQVKMC 152
Query: 70 DLGLAIAMQQPTAR-SVIGTPEFMAPE-----LYEEEYNELVDIYSFGMCILEMVTFEYP 123
D G++ + A+ G +MAPE L ++ Y+ DI+S G+ ++E+ +P
Sbjct: 153 DFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFP 212
Query: 124 YSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQV 182
Y P Q K+V P A + F +CL + ER + +L++ PF +
Sbjct: 213 YDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL 272
Query: 183 ENQKE 187
K
Sbjct: 273 HESKG 277
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 9e-33
Identities = 57/158 (36%), Positives = 86/158 (54%), Gaps = 13/158 (8%)
Query: 31 RQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IAMQQPTARSVIGT 88
+L L YLH+ +IHRD+K D+I + + G VK+ D G I+ P +S++GT
Sbjct: 148 EAVLQALAYLHAQG--VIHRDIKSDSILLTLD-GRVKLSDFGFCAQISKDVPKRKSLVGT 204
Query: 89 PEFMAPEL-YEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQ-IFKKVTSGIKPASL 146
P +MAPE+ Y VDI+S G+ ++EMV E PY +P Q + + S P L
Sbjct: 205 PYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFS-DSPVQAMKRLRDSP--PPKL 261
Query: 147 AKVND--PQIKGFIEKCLVP-ASERLSAKDLLKDPFLQ 181
+ P ++ F+E+ LV ER +A++LL PFL
Sbjct: 262 KNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLL 299
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-32
Identities = 56/187 (29%), Positives = 92/187 (49%), Gaps = 21/187 (11%)
Query: 31 RQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR--SVIGT 88
R+IL GL +LH H +IHRD+K N+ + + EVK+ D G++ + + R + IGT
Sbjct: 136 REILRGLSHLHQHK--VIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRTVGRRNTFIGT 192
Query: 89 PEFMAPE------LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPA----QIFKKVT 138
P +MAPE + Y+ D++S G+ +EM P + +P I +
Sbjct: 193 PYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD-MHPMRALFLIPRNPA 251
Query: 139 SGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQKEPICDPLKLPI 197
+K +K + + FIE CLV S+R + + L+K PF++ + + + LK I
Sbjct: 252 PRLKSKKWSK----KFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNERQVRIQLKDHI 307
Query: 198 QSLKMLR 204
K R
Sbjct: 308 DRTKKKR 314
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 3e-32
Identities = 45/197 (22%), Positives = 89/197 (45%), Gaps = 13/197 (6%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 60
+ EL + + ++ + +++ I+ L YL + +IHRD+K NI ++
Sbjct: 101 IAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG-VIHRDVKPSNILLD 159
Query: 61 GNHGEVKIGDLGLAIAMQQPTAR-SVIGTPEFMAPE------LYEEEYNELVDIYSFGMC 113
G++K+ D G++ + A+ G +MAPE + +Y+ D++S G+
Sbjct: 160 ER-GQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGIS 218
Query: 114 ILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVND--PQIKGFIEKCLV-PASERLS 170
++E+ T ++PY CK ++ KV +P L + F++ CL +R
Sbjct: 219 LVELATGQFPYKNCKTDFEVLTKVLQE-EPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPK 277
Query: 171 AKDLLKDPFLQVENQKE 187
LL+ F++ E
Sbjct: 278 YNKLLEHSFIKRYETLE 294
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 4e-32
Identities = 59/168 (35%), Positives = 91/168 (54%), Gaps = 11/168 (6%)
Query: 31 RQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR--SVIGT 88
R+IL GL YLHS IHRD+K N+ ++ HGEVK+ D G+A + + + +GT
Sbjct: 126 REILKGLDYLHSEK--KIHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRNTFVGT 182
Query: 89 PEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQ-IFKKVTSGIKPASL 146
P +MAPE+ ++ Y+ DI+S G+ +E+ E P+SE +P + +F + P +L
Sbjct: 183 PFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSE-LHPMKVLFLIPKN--NPPTL 239
Query: 147 AKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQKEPICDPL 193
+K F+E CL S R +AK+LLK F+ +K L
Sbjct: 240 EGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTSYLTEL 287
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 6e-32
Identities = 49/170 (28%), Positives = 80/170 (47%), Gaps = 24/170 (14%)
Query: 31 RQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA-------IAMQQPTAR 83
R++L GL YLH + IHRD+K NI + + G V+I D G++ + +
Sbjct: 128 REVLEGLEYLHKNG--QIHRDVKAGNILLGED-GSVQIADFGVSAFLATGGDITRNKVRK 184
Query: 84 SVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQ----IFKKV 137
+ +GTP +MAPE+ E+ Y+ DI+SFG+ +E+ T PY + P + +
Sbjct: 185 TFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHK-YPPMKVLMLTLQND 243
Query: 138 TSGIKPASLAKVND----PQIKGFIEKCLV--PASERLSAKDLLKDPFLQ 181
++ K + I CL P +R +A +LL+ F Q
Sbjct: 244 PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDP-EKRPTAAELLRHKFFQ 292
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 7e-32
Identities = 48/215 (22%), Positives = 82/215 (38%), Gaps = 41/215 (19%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHS------HNPPIIHRDLKC 54
++++ G+L Y ++ V ++ + A GL +LH P I HRDLK
Sbjct: 117 LVSDYHEHGSLFDYLNRYT-VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKS 175
Query: 55 DNIFVNGNHGEVKIGDLGLAIAMQQPT------ARSVIGTPEFMAPELYEE-------EY 101
NI V N G I DLGLA+ T +GT +MAPE+ ++ E
Sbjct: 176 KNILVKKN-GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFES 234
Query: 102 NELVDIYSFGMCILEMVT----------FEYPYSECKNPAQIFKKVTSG---------IK 142
+ DIY+ G+ E+ ++ PY + +++ I
Sbjct: 235 FKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIP 294
Query: 143 PASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLK 176
+ + + +C + RL+A + K
Sbjct: 295 NRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 329
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-31
Identities = 26/186 (13%), Positives = 57/186 (30%), Gaps = 25/186 (13%)
Query: 9 GNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKI 68
L + HK++ Q++ L LH + ++H L+ +I ++ G V +
Sbjct: 191 EVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LVHTYLRPVDIVLDQR-GGVFL 247
Query: 69 GDLGLAIAMQQPTARSVIGTPEFMAPELYEEE------------YNELVDIYSFGMCILE 116
+ + F PEL D ++ G+ I
Sbjct: 248 TGFEHLVRDGARV--VSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYW 305
Query: 117 MVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLL 175
+ + P ++ + + K ++ +E L +RL +
Sbjct: 306 IWCADLPITK-DAALGGSEWIFRSCKNIP------QPVRALLEGFLRYPKEDRLLPLQAM 358
Query: 176 KDPFLQ 181
+ P +
Sbjct: 359 ETPEYE 364
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 1e-31
Identities = 45/186 (24%), Positives = 82/186 (44%), Gaps = 16/186 (8%)
Query: 14 YRKKHKNVDIKVIKNWARQILHGLVYLHS-HNPPIIHRDLKCDNIFVNGNHGEVKIGDLG 72
Y + +++ + L +L IIHRD+K NI ++ G +K+ D G
Sbjct: 115 YSVLDDVIPEEILGKITLATVKALNHLKENLK--IIHRDIKPSNILLD-RSGNIKLCDFG 171
Query: 73 LAIAMQQPTARSV-IGTPEFMAPE-----LYEEEYNELVDIYSFGMCILEMVTFEYPYSE 126
++ + A++ G +MAPE + Y+ D++S G+ + E+ T +PY +
Sbjct: 172 ISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPK 231
Query: 127 CKNPAQIFKKVTSGIKPASLAKVND----PQIKGFIEKCLV-PASERLSAKDLLKDPFLQ 181
+ +V G P L+ + P F+ CL S+R K+LLK PF+
Sbjct: 232 WNSVFDQLTQVVKG-DPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFIL 290
Query: 182 VENQKE 187
+ ++
Sbjct: 291 MYEERA 296
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-31
Identities = 52/173 (30%), Positives = 84/173 (48%), Gaps = 18/173 (10%)
Query: 31 RQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IAMQQPTARSVIGT 88
RQ+L L +LHS IIHRDLK N+ + G++++ D G++ S IGT
Sbjct: 124 RQMLEALNFLHSKR--IIHRDLKAGNVLMT-LEGDIRLADFGVSAKNLKTLQKRDSFIGT 180
Query: 89 PEFMAPE------LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQ-IFKKVTSGI 141
P +MAPE + + Y+ DI+S G+ ++EM E P+ E NP + + K S
Sbjct: 181 PYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL-NPMRVLLKIAKSD- 238
Query: 142 KPASLAKVND--PQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQKEPICD 191
P +L + + + F++ L R SA LL+ PF+ + + +
Sbjct: 239 -PPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNKALRE 290
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 5e-31
Identities = 55/158 (34%), Positives = 83/158 (52%), Gaps = 13/158 (8%)
Query: 31 RQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IAMQQPTARSVIGT 88
+ L GL YLH IHRD+K NI +N G K+ D G+A + +VIGT
Sbjct: 132 QSTLKGLEYLHFMR--KIHRDIKAGNILLN-TEGHAKLADFGVAGQLTDTMAKRNTVIGT 188
Query: 89 PEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQ-IFKKVTSGIKPASL 146
P +MAPE + E YN + DI+S G+ +EM + PY++ +P + IF T+ P +
Sbjct: 189 PFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYAD-IHPMRAIFMIPTNP--PPTF 245
Query: 147 AKVND--PQIKGFIEKCLVP-ASERLSAKDLLKDPFLQ 181
K F+++CLV +R +A LL+ PF++
Sbjct: 246 RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVR 283
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 9e-31
Identities = 51/158 (32%), Positives = 80/158 (50%), Gaps = 15/158 (9%)
Query: 31 RQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPE 90
L GL YLHSHN +IHRD+K NI ++ G VK+GD G A M A S +GTP
Sbjct: 161 HGALQGLAYLHSHN--MIHRDVKAGNILLS-EPGLVKLGDFGSASIMAP--ANSFVGTPY 215
Query: 91 FMAPE----LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQ-IFKKVTSGIKPAS 145
+MAPE + E +Y+ VD++S G+ +E+ + P N ++ + +
Sbjct: 216 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-NAMSALYHIAQNE--SPA 272
Query: 146 LAKVN-DPQIKGFIEKCL-VPASERLSAKDLLKDPFLQ 181
L + + F++ CL +R +++ LLK F+
Sbjct: 273 LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL 310
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-29
Identities = 45/200 (22%), Positives = 93/200 (46%), Gaps = 12/200 (6%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 60
+I E G + + +K D + + ++ + L Y HS +IHRD+K +N+ +
Sbjct: 86 LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLL- 142
Query: 61 GNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT 119
G+ GE+KI D G ++ + GT +++ PE+ E ++E VD++S G+ E +
Sbjct: 143 GSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLV 202
Query: 120 FEYPYSECKNPAQIFKKVTSG-IK-PASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLK 176
+ P+ E + +K+++ P + + I + L S+R +++L+
Sbjct: 203 GKPPF-EANTYQETYKRISRVEFTFPDFV----TEGARDLISRLLKHNPSQRPMLREVLE 257
Query: 177 DPFLQVENQKEPICDPLKLP 196
P++ + K C +
Sbjct: 258 HPWITANSSKPSNCQNKESA 277
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 2e-29
Identities = 47/179 (26%), Positives = 67/179 (37%), Gaps = 21/179 (11%)
Query: 1 MITELFTSGNLRQY-RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV 59
ITE G LR + ++A+ I G+ YLHS N IIHRDL N V
Sbjct: 84 FITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN--IIHRDLNSHNCLV 141
Query: 60 NGNHGEVKIGDLGLA----------------IAMQQPTARSVIGTPEFMAPE-LYEEEYN 102
N V + D GLA + +V+G P +MAPE + Y+
Sbjct: 142 RENK-NVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYD 200
Query: 103 ELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKC 161
E VD++SFG+ + E++ + F G P +C
Sbjct: 201 EKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNCPPSFFPITVRC 259
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 118 bits (296), Expect = 6e-29
Identities = 25/181 (13%), Positives = 56/181 (30%), Gaps = 20/181 (11%)
Query: 11 LRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGD 70
L + HK++ Q++ L LH + ++H L+ +I ++ G V +
Sbjct: 198 LLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LVHTYLRPVDIVLDQR-GGVFLTG 254
Query: 71 LGLAIAMQQPT---ARSVIGTPEFMAPELY------EEEYNELVDIYSFGMCILEMVTFE 121
+ PE A + D ++ G+ I + +
Sbjct: 255 FEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314
Query: 122 YPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFL 180
P ++ + + K ++ +E L +RL ++ P
Sbjct: 315 LPNTD-DAALGGSEWIFRSCKNIP------QPVRALLEGFLRYPKEDRLLPLQAMETPEY 367
Query: 181 Q 181
+
Sbjct: 368 E 368
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 7e-29
Identities = 61/209 (29%), Positives = 100/209 (47%), Gaps = 22/209 (10%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 60
++ EL +L + K+ K + + + RQI+ G YLH + +IHRDLK N+F+N
Sbjct: 92 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLN 149
Query: 61 GNHGEVKIGDLGLAIAMQQPTAR--SVIGTPEFMAPE-LYEEEYNELVDIYSFGMCIL-E 116
+ EVKIGD GLA ++ R + GTP ++APE L ++ ++ VD++S G CI+
Sbjct: 150 ED-LEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIG-CIMYT 207
Query: 117 MVTFEYPYSECKNPAQIFKKVTSGI--KPASLAKVNDPQIKGFIEKCLVP-ASERLSAKD 173
++ P E + + ++ P + P I+K L + R + +
Sbjct: 208 LLV-GKPPFETSCLKETYLRIKKNEYSIPKHIN----PVAASLIQKMLQTDPTARPTINE 262
Query: 174 LLKDPFLQVENQKEPICDPLKLPIQSLKM 202
LL D F P +LPI L +
Sbjct: 263 LLNDEFFTSG------YIPARLPITCLTI 285
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 4e-28
Identities = 55/231 (23%), Positives = 92/231 (39%), Gaps = 47/231 (20%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHS-HNPPIIHRDLKCDNIFV 59
+ E G+L Q KK + +++ + ++ GL YL H I+HRD+K NI V
Sbjct: 108 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILV 165
Query: 60 NGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMV 118
N + GE+K+ D G++ + A S +GT +M+PE L Y+ DI+S G+ ++EM
Sbjct: 166 N-SRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMA 224
Query: 119 TFEYPYSECKNPAQIFKKVTSGIKPASLAK------------------------------ 148
YP A+
Sbjct: 225 VGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYI 284
Query: 149 VND-----------PQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQKE 187
VN+ + + F+ KCL+ +ER K L+ F++ + +E
Sbjct: 285 VNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEE 335
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 6e-28
Identities = 67/230 (29%), Positives = 109/230 (47%), Gaps = 23/230 (10%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 60
++ EL +L + K+ K + + + RQI+ G YLH + +IHRDLK N+F+N
Sbjct: 118 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLN 175
Query: 61 GNHGEVKIGDLGLAIAMQQPTAR--SVIGTPEFMAPE-LYEEEYNELVDIYSFGMCIL-E 116
+ EVKIGD GLA ++ R + GTP ++APE L ++ ++ VD++S G CI+
Sbjct: 176 ED-LEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIG-CIMYT 233
Query: 117 MVTFEYPYSECKNPAQIFKKVTSGI--KPASLAKVNDPQIKGFIEKCLVP-ASERLSAKD 173
++ P E + + ++ P + P I+K L + R + +
Sbjct: 234 LLV-GKPPFETSCLKETYLRIKKNEYSIPKHIN----PVAASLIQKMLQTDPTARPTINE 288
Query: 174 LLKDPFLQVENQKEPICDPLKLPIQSLKMLRLPMSGPSSMDIDSDYKQLS 223
LL D F P +LPI L + PSS+D + K L+
Sbjct: 289 LLNDEFFTSG------YIPARLPITCLTIPPRFSIAPSSLDPSNR-KPLT 331
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 9e-28
Identities = 44/212 (20%), Positives = 83/212 (39%), Gaps = 30/212 (14%)
Query: 1 MITELFTSGNLRQYRKKHKNVDI---KVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 57
+I E G+L ++ N R ++ G+ +L + I+HR++K NI
Sbjct: 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNI 143
Query: 58 FVNGN---HGEVKIGDLGLAIAMQQPT-ARSVIGTPEFMAPELYE---------EEYNEL 104
K+ D G A ++ S+ GT E++ P++YE ++Y
Sbjct: 144 MRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGAT 203
Query: 105 VDIYSFGMCIL-EMVT----FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIE 159
VD++S G T F P+ + ++ K+ +G +++ V +
Sbjct: 204 VDLWSIG-VTFYHAATGSLPF-RPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDW 261
Query: 160 KCLVPASERLS--AKDLLKDPF---LQVENQK 186
+P S LS + LL L+ + +K
Sbjct: 262 SGDMPVSCSLSRGLQVLLTPVLANILEADQEK 293
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 2e-27
Identities = 42/212 (19%), Positives = 70/212 (33%), Gaps = 28/212 (13%)
Query: 1 MITELFTSGNLRQY----RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDN 56
++ F G L + K + I I GL +H+ HRDLK N
Sbjct: 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA--KGYAHRDLKPTN 164
Query: 57 IFVNGNHGEVKIGDLGLA-IAMQQPTARSVI----------GTPEFMAPELYEEE----Y 101
I + G+ + DLG A T + APEL+ +
Sbjct: 165 ILLGDE-GQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVI 223
Query: 102 NELVDIYSFGMCIL-EMVTFEYPY-SECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIE 159
+E D++S G C+L M+ E PY + + V + + + + + +
Sbjct: 224 DERTDVWSLG-CVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRHS-SALWQLLN 281
Query: 160 KCLVP-ASERLSAKDLLKDP-FLQVENQKEPI 189
+ +R LL LQ +
Sbjct: 282 SMMTVDPHQRPHIPLLLSQLEALQPPAPGQHT 313
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-27
Identities = 49/203 (24%), Positives = 97/203 (47%), Gaps = 14/203 (6%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 60
++ E G L + +KH D + + ++ L Y H +IHRD+K +N+ +
Sbjct: 91 LMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERK--VIHRDIKPENLLM- 147
Query: 61 GNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT 119
G GE+KI D G ++ R++ GT +++ PE+ E + ++E VD++ G+ E +
Sbjct: 148 GYKGELKIADFGWSVHAPSLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLV 207
Query: 120 FEYPYSECKNPAQIFKKVTSG-IK-PASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLK 176
P+ + + + +++ + +K P L K I K L +RL K +++
Sbjct: 208 GMPPF-DSPSHTETHRRIVNVDLKFPPFL----SDGSKDLISKLLRYHPPQRLPLKGVME 262
Query: 177 DPFLQVENQKEPICDPLKLPIQS 199
P+++ N + + P+ QS
Sbjct: 263 HPWVK-ANSR-RVLPPVYQSTQS 283
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 4e-27
Identities = 37/238 (15%), Positives = 73/238 (30%), Gaps = 61/238 (25%)
Query: 31 RQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR------- 83
+ +L L Y+H +HR +K +I ++ + G+V + L ++M R
Sbjct: 135 QGVLKALDYIHHMG--YVHRSVKASHILISVD-GKVYLSGLRSNLSMISHGQRQRVVHDF 191
Query: 84 --SVIGTPEFMAPELYEEE---YNELVDIYSFGMCILEMVTFEYPYSEC----------K 128
+ +++PE+ ++ Y+ DIYS G+ E+ P+ +
Sbjct: 192 PKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLN 251
Query: 129 NPAQIFKKVTSGIKPASLAKVND---------------------------------PQIK 155
++ + P
Sbjct: 252 GTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFH 311
Query: 156 GFIEKCLVP-ASERLSAKDLLKDPFLQVENQKEPICDPLKLPIQSLKMLRLPMSGPSS 212
F+E+CL R SA LL F + K + L ++ + + S
Sbjct: 312 HFVEQCLQRNPDARPSASTLLNHSFFK--QIKRRASEALPELLRPVTPITNFEGSQSQ 367
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 5e-27
Identities = 49/214 (22%), Positives = 81/214 (37%), Gaps = 41/214 (19%)
Query: 2 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHS--------HNPPIIHRDLK 53
IT G+L + K + V + + A + GL YLH H P I HRD+K
Sbjct: 100 ITAFHEKGSLSDFLKANV-VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIK 158
Query: 54 CDNIFVNGNHGEVKIGDLGLAI----AMQQPTARSVIGTPEFMAPEL------YEEEYNE 103
N+ + N I D GLA+ +GT +MAPE+ ++ +
Sbjct: 159 SKNVLLKNN-LTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFL 217
Query: 104 LVDIYSFGMCILEMVT----FEYPYSECKNPAQ----------------IFKKVTSGIKP 143
+D+Y+ G+ + E+ + + P E P + + KK ++
Sbjct: 218 RIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRD 277
Query: 144 ASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLK 176
+ IE+C A RLSA + +
Sbjct: 278 YWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 7e-27
Identities = 44/211 (20%), Positives = 82/211 (38%), Gaps = 28/211 (13%)
Query: 1 MITELFTSGNLRQYRKKHKNVDI---KVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 57
+I E G+L ++ N R ++ G+ +L + I+HR++K NI
Sbjct: 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNI 143
Query: 58 FVNGN---HGEVKIGDLGLAIAMQQPT-ARSVIGTPEFMAPELYE---------EEYNEL 104
K+ D G A ++ S+ GT E++ P++YE ++Y
Sbjct: 144 MRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGAT 203
Query: 105 VDIYSFGMCIL-EMVT----FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIE 159
VD++S G T F P+ + ++ K+ +G +++ V +
Sbjct: 204 VDLWSIG-VTFYHAATGSLPF-RPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDW 261
Query: 160 KCLVPASERLS--AKDLLKDPFLQVENQKEP 188
+P S LS + LL P L + +
Sbjct: 262 SGDMPVSCSLSRGLQVLLT-PVLANILEADQ 291
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 8e-27
Identities = 28/182 (15%), Positives = 55/182 (30%), Gaps = 16/182 (8%)
Query: 11 LRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGD 70
L + I + Q++ L S ++H DN+F+ G + +GD
Sbjct: 181 LDFVYVFRGDEGILALHILTAQLIRLAANLQSKG--LVHGHFTPDNLFI-MPDGRLMLGD 237
Query: 71 LGLAIAMQQPTARSVIGTPEFMAPELY----EEEYNELVDIYSFGMCILEMVTFEYPYSE 126
+ + T P AP + + ++ + G+ I + P+
Sbjct: 238 VSALWKV--GTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGL 295
Query: 127 CKN--PAQIFKKVTSGIKPASLAKVNDPQI----KGFIEKCLVP-ASERLSAKDLLKDPF 179
+ SLA + + K I + L RL + ++ P
Sbjct: 296 VTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPE 355
Query: 180 LQ 181
Sbjct: 356 FL 357
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-26
Identities = 57/213 (26%), Positives = 85/213 (39%), Gaps = 13/213 (6%)
Query: 1 MITELFTSGNLRQYRKKHKNVDI---KVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 57
+ E G+LR+Y + +N I+ I L YLH + IIHRDLK +NI
Sbjct: 95 LAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR--IIHRDLKPENI 152
Query: 58 --FVNGNHGEVKIGDLGLAIAMQQPT-ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMC 113
KI DLG A + Q +GT +++APEL E ++Y VD +SFG
Sbjct: 153 VLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTL 212
Query: 114 ILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKD 173
E +T P+ P Q KV + + F P
Sbjct: 213 AFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAG 272
Query: 174 LLKDPFLQ---VENQKEPICDPLKLPIQSLKML 203
L+ +LQ + +Q++ DP + + L
Sbjct: 273 KLE-RWLQCMLMWHQRQRGTDPQNPNVGCFQAL 304
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 4e-26
Identities = 53/208 (25%), Positives = 82/208 (39%), Gaps = 20/208 (9%)
Query: 1 MITELFTSGNLRQY-RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV 59
+ EL + L++Y +K +Q GL +LHS N I+HRDLK NI +
Sbjct: 95 IAIEL-CAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN--IVHRDLKPHNILI 151
Query: 60 NGNHGE----VKIGDLGLAIAMQQP-----TARSVIGTPEFMAPELYEEE----YNELVD 106
+ + I D GL + V GT ++APE+ E+ VD
Sbjct: 152 SMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVD 211
Query: 107 IYSFGMCILEMVTFEY-PYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP- 164
I+S G +++ P+ + + K D + IEK +
Sbjct: 212 IFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMD 271
Query: 165 ASERLSAKDLLKDPFLQ-VENQKEPICD 191
+R SAK +LK PF +E Q + D
Sbjct: 272 PQKRPSAKHVLKHPFFWSLEKQLQFFQD 299
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 8e-26
Identities = 45/224 (20%), Positives = 78/224 (34%), Gaps = 44/224 (19%)
Query: 1 MITELFTSGNLRQYRKKHKNVDI---KVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 57
++ G L ++ KK ++ + Q + ++H PPIIHRDLK +N+
Sbjct: 110 LLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENL 169
Query: 58 FVNGNHGEVKIGDLGLAIAMQQPTARSV--------------IGTPEFMAPELYE----E 99
++ G +K+ D G A + S TP + PE+ +
Sbjct: 170 LLSNQ-GTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNF 228
Query: 100 EYNELVDIYSFGMCIL-EMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQ----- 153
E DI++ G CIL + ++P+ E +I K + P
Sbjct: 229 PIGEKQDIWALG-CILYLLCFRQHPF-EDGAKLRIVN-----------GKYSIPPHDTQY 275
Query: 154 --IKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQKEPICDPLK 194
I L ERLS +++ + P+
Sbjct: 276 TVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPKSPIT 319
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 38/200 (19%), Positives = 72/200 (36%), Gaps = 30/200 (15%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKN-----WARQILHGLVYLHSHNPPIIHRDLKCD 55
++ EL++ G L +KN KV+ +A ++L+ + +H IIH D+K D
Sbjct: 144 LVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE--IIHGDIKPD 201
Query: 56 NIFVNG----------NHGEVKIGDLGLAIAMQQP----TARSVIGTPEFMAPE-LYEEE 100
N + + + DLG +I M+ + T F E L +
Sbjct: 202 NFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKP 261
Query: 101 YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEK 160
+N +D + + M+ Y + + + + + + F
Sbjct: 262 WNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLP-------HLDMWNEFFHV 314
Query: 161 CL-VPASERLSAKDLLKDPF 179
L +P L + DLL+
Sbjct: 315 MLNIPDCHHLPSLDLLRQKL 334
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 5e-25
Identities = 50/211 (23%), Positives = 96/211 (45%), Gaps = 11/211 (5%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI-FV 59
++ E + G L + +Q+L G+ YLH HN I+HRDLK +N+
Sbjct: 113 LVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN--IVHRDLKPENLLLE 170
Query: 60 N-GNHGEVKIGDLGLAIAMQQ-PTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEM 117
+ +KI D GL+ + + +GT ++APE+ ++Y+E D++S G+ + +
Sbjct: 171 SKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRKKYDEKCDVWSIGVILFIL 230
Query: 118 VTFEYPYSECKNPAQIFKKVTSGI---KPASLAKVNDPQIKGFIEKCLVP-ASERLSAKD 173
+ P+ + +I +KV G V K I++ L + R+SA+
Sbjct: 231 LAGYPPFG-GQTDQEILRKVEKGKYTFDSPEWKNV-SEGAKDLIKQMLQFDSQRRISAQQ 288
Query: 174 LLKDPFLQVENQKEPICDPLKLPIQSLKMLR 204
L+ P+++ K+ L +++ +R
Sbjct: 289 ALEHPWIKEMCSKKESGIELPSLANAIENMR 319
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 7e-25
Identities = 52/223 (23%), Positives = 94/223 (42%), Gaps = 32/223 (14%)
Query: 1 MITELFTSGNLRQYRKKHKNVD--------IKVIKNWARQILHGLVYLHSHNPPIIHRDL 52
+I E + ++ ++ + +D I+VIK + +L+ Y+H+ I HRD+
Sbjct: 120 IIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN-ICHRDV 178
Query: 53 KCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEE---YNELVDIYS 109
K NI + +G VK+ D G + M + GT EFM PE + E VDI+S
Sbjct: 179 KPSNILM-DKNGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWS 237
Query: 110 FGMCILEMVTFEYPYSECKNPAQIFKKVTSG-----------------IKPASLAKVNDP 152
G+C+ M P+S + ++F + + K
Sbjct: 238 LGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSN 297
Query: 153 QIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQKEPICDPLK 194
+ F++ L +ER++++D LK +L + E + + K
Sbjct: 298 EDIDFLKLFLRKNPAERITSEDALKHEWLA-DTNIEDLREFSK 339
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 9e-25
Identities = 60/223 (26%), Positives = 105/223 (47%), Gaps = 28/223 (12%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 60
++ EL G L +K + K + Q+L + YLH + IIHRDLK +N+ ++
Sbjct: 91 IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLS 148
Query: 61 GNHGE--VKIGDLGLAIAMQQPTA-RSVIGTPEFMAPE----LYEEEYNELVDIYSFGMC 113
+ +KI D G + + + + R++ GTP ++APE + YN VD +S G
Sbjct: 149 SQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLG-V 207
Query: 114 ILEMVTFEY-------PYSECKNPAQIFKKVTSGI---KPASLAKVNDPQIKGFIEKCLV 163
IL + P+SE + + ++TSG P A+V++ ++K LV
Sbjct: 208 IL------FICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEK-ALDLVKKLLV 260
Query: 164 P-ASERLSAKDLLKDPFLQVENQKEPICDPLKLPIQSLKMLRL 205
R + ++ L+ P+LQ E+ K D L +S + ++
Sbjct: 261 VDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEENESTALPQV 303
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 9e-25
Identities = 57/207 (27%), Positives = 96/207 (46%), Gaps = 28/207 (13%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV- 59
++ EL G L +K + K + Q+L + YLH + IIHRDLK +N+ +
Sbjct: 216 IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLS 273
Query: 60 -NGNHGEVKIGDLGLAIAMQQPTA-RSVIGTPEFMAPE----LYEEEYNELVDIYSFGMC 113
+KI D G + + + + R++ GTP ++APE + YN VD +S G
Sbjct: 274 SQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLG-V 332
Query: 114 ILEMVTFEY-------PYSECKNPAQIFKKVTSGI---KPASLAKVNDPQIKGFIEKCLV 163
IL + P+SE + + ++TSG P A+V++ ++K LV
Sbjct: 333 IL------FICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEK-ALDLVKKLLV 385
Query: 164 P-ASERLSAKDLLKDPFLQVENQKEPI 189
R + ++ L+ P+LQ E+ K
Sbjct: 386 VDPKARFTTEEALRHPWLQDEDMKRKF 412
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 40/144 (27%), Positives = 63/144 (43%), Gaps = 27/144 (18%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHS-------HNPPIIHRDLK 53
++ E + +G+L +Y H D A + GL YLH+ + P I HRDL
Sbjct: 89 LVMEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLN 147
Query: 54 CDNIFVNGNHGEVKIGDLGLAIAM----------QQPTARSVIGTPEFMAPELYE----- 98
N+ V + G I D GL++ + + A S +GT +MAPE+ E
Sbjct: 148 SRNVLVKND-GTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNL 206
Query: 99 ---EEYNELVDIYSFGMCILEMVT 119
E + VD+Y+ G+ E+
Sbjct: 207 RDXESALKQVDMYALGLIYWEIFM 230
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 43/173 (24%), Positives = 70/173 (40%), Gaps = 20/173 (11%)
Query: 31 RQILHGLVYLHSHNPPIIHRDLKCDNI-FVNGNHGEVKIGDLGLAIAMQQPTA------R 83
RQI L YLH+ I HRD+K +N F E+K+ D GL+ +
Sbjct: 175 RQIFSALHYLHNQG--ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMT 232
Query: 84 SVIGTPEFMAPEL---YEEEYNELVDIYSFGMCIL-EMVTFEYPYSECKNPAQIFKKVTS 139
+ GTP F+APE+ E Y D +S G +L ++ P+ N A +V +
Sbjct: 233 TKAGTPYFVAPEVLNTTNESYGPKCDAWSAG-VLLHLLLMGAVPF-PGVNDADTISQVLN 290
Query: 140 G---IKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQKEP 188
+ + ++ + + L ER A L+ P++ + K
Sbjct: 291 KKLCFENPNYNVLSP-LARDLLSNLLNRNVDERFDAMRALQHPWISQFSDKIY 342
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 7e-24
Identities = 60/211 (28%), Positives = 100/211 (47%), Gaps = 11/211 (5%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI-FV 59
++ EL+T G L K K +Q+ G+ Y+H HN I+HRDLK +NI
Sbjct: 98 IVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLE 155
Query: 60 N-GNHGEVKIGDLGLAIAMQQ-PTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEM 117
+ ++KI D GL+ QQ + IGT ++APE+ Y+E D++S G+ + +
Sbjct: 156 SKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYIL 215
Query: 118 VTFEYPYSECKNPAQIFKKVTSGI---KPASLAKVNDPQIKGFIEKCLVP-ASERLSAKD 173
++ P+ KN I K+V +G ++D K I K L S R++A
Sbjct: 216 LSGTPPFYG-KNEYDILKRVETGKYAFDLPQWRTISD-DAKDLIRKMLTFHPSLRITATQ 273
Query: 174 LLKDPFLQVENQKEPICDPLKLPIQSLKMLR 204
L+ P++Q + + P L ++ +R
Sbjct: 274 CLEHPWIQKYSSETPTISDLPSLESAMTNIR 304
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 7e-24
Identities = 49/189 (25%), Positives = 91/189 (48%), Gaps = 17/189 (8%)
Query: 1 MITELFTSGNLRQY-RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV 59
++ E+ +G + +Y + + K +++ QI+ G++YLHSH I+HRDL N+ +
Sbjct: 88 LVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG--ILHRDLTLSNLLL 145
Query: 60 NGNHGEVKIGDLGLAIAMQQPTAR--SVIGTPEFMAPE-LYEEEYNELVDIYSFGMCIL- 115
N +KI D GLA ++ P + ++ GTP +++PE + D++S G C+
Sbjct: 146 TRN-MNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLG-CMFY 203
Query: 116 EMVTFEYPYSECKNPAQIFKKVTSGI--KPASLAKVNDPQIKGFIEKCLVP-ASERLSAK 172
++ P+ + KV P+ L+ + K I + L ++RLS
Sbjct: 204 TLLIGRPPF-DTDTVKNTLNKVVLADYEMPSFLS----IEAKDLIHQLLRRNPADRLSLS 258
Query: 173 DLLKDPFLQ 181
+L PF+
Sbjct: 259 SVLDHPFMS 267
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-23
Identities = 55/211 (26%), Positives = 98/211 (46%), Gaps = 12/211 (5%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI-FV 59
++ E++T G L K RQ+L G+ Y+H + I+HRDLK +N+
Sbjct: 103 LVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK--IVHRDLKPENLLLE 160
Query: 60 N-GNHGEVKIGDLGLAIAMQQ-PTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEM 117
+ ++I D GL+ + + IGT ++APE+ Y+E D++S G+ + +
Sbjct: 161 SKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYIL 220
Query: 118 VTFEYPYSECKNPAQIFKKVTSGI---KPASLAKVNDPQIKGFIEKCLVP-ASERLSAKD 173
++ P++ N I KKV G + KV++ K I K L S R+SA+D
Sbjct: 221 LSGCPPFNG-ANEYDILKKVEKGKYTFELPQWKKVSE-SAKDLIRKMLTYVPSMRISARD 278
Query: 174 LLKDPFLQVENQKEPICDPLKLPIQSLKMLR 204
L ++Q +++ D ++ +R
Sbjct: 279 ALDHEWIQTYTKEQISVDV-PSLDNAILNIR 308
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 3e-23
Identities = 58/212 (27%), Positives = 98/212 (46%), Gaps = 14/212 (6%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI-FV 59
++TE + G L + D N +QIL G+ YLH HN I+HRD+K +NI
Sbjct: 123 LVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHN--IVHRDIKPENILLE 180
Query: 60 N-GNHGEVKIGDLGLAIAMQQ-PTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCIL-E 116
N + +KI D GL+ + R +GT ++APE+ +++YNE D++S G I+
Sbjct: 181 NKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKKKYNEKCDVWSCG-VIMYI 239
Query: 117 MVTFEYPYSECKNPAQIFKKVTSGI---KPASLAKVNDPQIKGFIEKCLVP-ASERLSAK 172
++ P+ +N I KKV G + + K I+ L ++R +A+
Sbjct: 240 LLCGYPPFGG-QNDQDIIKKVEKGKYYFDFNDWKNI-SDEAKELIKLMLTYDYNKRCTAE 297
Query: 173 DLLKDPFLQVENQKEPICDPLKLPIQSLKMLR 204
+ L +++ D K +L +R
Sbjct: 298 EALNSRWIKKYANNINKSD-QKTLCGALSNMR 328
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 4e-23
Identities = 41/198 (20%), Positives = 83/198 (41%), Gaps = 15/198 (7%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 60
++ EL T G L + + + +L + Y H N + HRDLK +N
Sbjct: 83 LVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN--VAHRDLKPENFLFL 140
Query: 61 GNHGE--VKIGDLGLAIAMQQPTA-RSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEM 117
+ + +K+ D GLA + R+ +GTP +++P++ E Y D +S G ++ +
Sbjct: 141 TDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGLYGPECDEWSAG-VMMYV 199
Query: 118 VTFEYP--YSECKNPAQIFKKVTSGI---KPASLAKVNDPQIKGFIEKCLVP-ASERLSA 171
+ YP + +++ K+ G V+ Q + I + L +R+++
Sbjct: 200 LLCGYPPFSAP--TDSEVMLKIREGTFTFPEKDWLNVSP-QAESLIRRLLTKSPKQRITS 256
Query: 172 KDLLKDPFLQVENQKEPI 189
L+ + + + P
Sbjct: 257 LQALEHEWFEKQLSSSPR 274
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 1e-22
Identities = 46/194 (23%), Positives = 92/194 (47%), Gaps = 22/194 (11%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 60
M+ +L G+LR + +++ + + +K + +++ L YL + IIHRD+K DNI ++
Sbjct: 92 MVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQR--IIHRDMKPDNILLD 149
Query: 61 GNHGEVKIGDLGLAIAMQQPT-ARSVIGTPEFMAPELYEEE----YNELVDIYSFGMCIL 115
HG V I D +A + + T ++ GT +MAPE++ Y+ VD +S G+
Sbjct: 150 -EHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAY 208
Query: 116 EMVT----FEYPYSECKNPAQIFKKVTSGIK--PASLAKVNDPQIKGFIEKCLVP-ASER 168
E++ + S + +I + + P++ ++ ++K L P +R
Sbjct: 209 ELLRGRRPYHIRSST--SSKEIVHTFETTVVTYPSAW----SQEMVSLLKKLLEPNPDQR 262
Query: 169 L-SAKDLLKDPFLQ 181
D+ P++
Sbjct: 263 FSQLSDVQNFPYMN 276
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 1e-22
Identities = 61/196 (31%), Positives = 95/196 (48%), Gaps = 15/196 (7%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 60
++ EL+T G L K K +Q+ G+ Y+H HN I+HRDLK +NI +
Sbjct: 98 IVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLE 155
Query: 61 GNHGE--VKIGDLGLAIAMQQPTA-RSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEM 117
+ +KI D GL+ QQ T + IGT ++APE+ Y+E D++S G IL +
Sbjct: 156 SKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAG-VILYI 214
Query: 118 VTFEYP--YSECKNPAQIFKKVTSGI---KPASLAKVNDPQIKGFIEKCLVP-ASERLSA 171
+ P Y + N I K+V +G ++D K I K L S R++A
Sbjct: 215 LLSGTPPFYGK--NEYDILKRVETGKYAFDLPQWRTISD-DAKDLIRKMLTFHPSLRITA 271
Query: 172 KDLLKDPFLQVENQKE 187
L+ P++Q + +E
Sbjct: 272 TQCLEHPWIQKYSSEE 287
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 1e-22
Identities = 47/185 (25%), Positives = 85/185 (45%), Gaps = 19/185 (10%)
Query: 31 RQILHGLVYLHSHNPPIIHRDLKCDNIFV---NGNHGEVKIGDLGLAIAMQQPTA-RSVI 86
+QIL G+ YLH+ I H DLK +NI + N +K+ D GLA ++ +++
Sbjct: 122 KQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF 179
Query: 87 GTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYP--YSECKNPAQIFKKVTSGI-- 141
GTPEF+APE + E D++S G I ++ + + +TS
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIG-VITYILLSGASPFLGD--TKQETLANITSVSYD 236
Query: 142 -KPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQKEPICDPLKLPIQS 199
+ ++ K FI K LV +RL+ ++ L+ P++ + ++ + + +
Sbjct: 237 FDEEFFSHTSE-LAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQA--MVRRESVVN 293
Query: 200 LKMLR 204
L+ R
Sbjct: 294 LENFR 298
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 2e-22
Identities = 43/198 (21%), Positives = 83/198 (41%), Gaps = 28/198 (14%)
Query: 1 MITELFTSGNL----RQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDN 56
++ E G L + + K + + +Q+++ L Y HS + ++H+DLK +N
Sbjct: 97 IVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH--VVHKDLKPEN 154
Query: 57 I-FVN-GNHGEVKIGDLGLAIAMQQPTA-RSVIGTPEFMAPELYEEEYNELVDIYSFGMC 113
I F + H +KI D GLA + + GT +MAPE+++ + DI+S G
Sbjct: 155 ILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKRDVTFKCDIWSAG-V 213
Query: 114 ILEMVTFEYP--YSECKNPAQIFKKVTSGI-------KPASLAKVNDPQIKGFIEKCLVP 164
++ + + ++ +K T +P + PQ +++ L
Sbjct: 214 VMYFLLTGCLPFTGT--SLEEVQQKATYKEPNYAVECRPLT------PQAVDLLKQMLTK 265
Query: 165 -ASERLSAKDLLKDPFLQ 181
R SA +L + +
Sbjct: 266 DPERRPSAAQVLHHEWFK 283
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 99.1 bits (247), Expect = 2e-22
Identities = 43/217 (19%), Positives = 78/217 (35%), Gaps = 39/217 (17%)
Query: 4 ELF----TSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV 59
L + + K K + + RQI G+ +LHS IIHRDLK NI V
Sbjct: 94 NLQDLVESKNVSDENLKLQKEYNPISL---LRQIASGVAHLHSLK--IIHRDLKPQNILV 148
Query: 60 N------------GNHGEVKIGDLGLAIAMQ------QPTARSVIGTPEFMAPEL----- 96
+ + + I D GL + + + GT + APEL
Sbjct: 149 STSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESN 208
Query: 97 ---YEEEYNELVDIYSFGMCILEMVTFEYP--YSECKNPAQIFKKVTSGIKPASLAKVN- 150
+ +DI+S G +++ + + I + + S + L +
Sbjct: 209 NLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSL 268
Query: 151 DPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQK 186
+ I + + +R +A +L+ P +++K
Sbjct: 269 IAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPKSKK 305
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 4e-22
Identities = 48/173 (27%), Positives = 81/173 (46%), Gaps = 15/173 (8%)
Query: 31 RQILHGLVYLHSHNPPIIHRDLKCDNI-FVNGNHGEVKIGDLGLAIAMQQPTA-RSVIGT 88
+QI G+ ++H I+H DLK +NI VN + ++KI D GLA + + GT
Sbjct: 194 KQICEGIRHMHQMY--ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGT 251
Query: 89 PEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYP--YSECKNPAQIFKKVTSGI---K 142
PEF+APE + + + D++S G+ I M+ + N A+ + + +
Sbjct: 252 PEFLAPEVVNYDFVSFPTDMWSVGV-IAYMLLSGLSPFLGD--NDAETLNNILACRWDLE 308
Query: 143 PASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQKEPICDPLK 194
+++ + K FI K L+ S R+SA + LK P+L + K
Sbjct: 309 DEEFQDISE-EAKEFISKLLIKEKSWRISASEALKHPWLSDHKLHSRLSAQKK 360
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 5e-22
Identities = 48/233 (20%), Positives = 86/233 (36%), Gaps = 49/233 (21%)
Query: 10 NLRQYRKKHKN-VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKI 68
+ +++ V ++K+ Q L + + H HN IHRD+K +NI + H +K+
Sbjct: 87 TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN--CIHRDVKPENILIT-KHSVIKL 143
Query: 69 GDLGLAIAMQQPTARSVIGTPEFM-----APELY--EEEYNELVDIYSFGMCIL-EMVTF 120
D G A + P+ E +PEL + +Y VD+++ G C+ E+++
Sbjct: 144 CDFGFARLLTGPSDYY---DDEVATRWYRSPELLVGDTQYGPPVDVWAIG-CVFAELLSG 199
Query: 121 EYPY----SE----------------------CKNPAQIFKKVTSGIKPASLAKV---ND 151
P S+ N K+ L
Sbjct: 200 V-PLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNIS 258
Query: 152 PQIKGFIEKCLV--PASERLSAKDLLKDPFLQVENQKEPICDPLKLPIQSLKM 202
G ++ CL P ERL+ + LL P+ + + E + P ++L
Sbjct: 259 YPALGLLKGCLHMDPT-ERLTCEQLLHHPYFENIREIEDLAKEHDKPAENLYF 310
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 6e-22
Identities = 45/147 (30%), Positives = 73/147 (49%), Gaps = 11/147 (7%)
Query: 1 MITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV 59
+IT+L G L Y ++HK N+ + + NW QI G+ YL ++HRDL N+ V
Sbjct: 93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLV 150
Query: 60 NGNHGEVKIGDLGLA--IAMQQPTARSVIG-TP-EFMAPE-LYEEEYNELVDIYSFGMCI 114
VKI D GLA + ++ + G P ++MA E + Y D++S+G+ +
Sbjct: 151 KTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTV 209
Query: 115 LEMVTF-EYPYSECKNPAQIFKKVTSG 140
E++TF PY ++I + G
Sbjct: 210 WELMTFGSKPYDGIPA-SEISSILEKG 235
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 6e-22
Identities = 46/184 (25%), Positives = 84/184 (45%), Gaps = 15/184 (8%)
Query: 4 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNH 63
E L +Y + H + + N+ QIL G+ + H I+HRD+K NI + ++
Sbjct: 91 EYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMR--IVHRDIKPQNILI-DSN 147
Query: 64 GEVKIGDLGLAIAMQQPT---ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT 119
+KI D G+A A+ + + V+GT ++ +PE + E +E DIYS G+ + EM+
Sbjct: 148 KTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLV 207
Query: 120 FEYPYSECKNPAQI-FKKVTSGIKPASLAKVND---PQIKGFIEKCLV--PASERLSAKD 173
E P++ + I K + + P V + I + A+ + ++
Sbjct: 208 GEPPFNG-ETAVSIAIKHIQDSV-PNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQE 265
Query: 174 LLKD 177
+ D
Sbjct: 266 MKDD 269
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 7e-22
Identities = 57/229 (24%), Positives = 92/229 (40%), Gaps = 49/229 (21%)
Query: 10 NLRQYRKKHKN-VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKI 68
+ + N +D +V++ + QI++G+ + HSHN IIHRD+K +NI V+ G VK+
Sbjct: 109 TILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN--IIHRDIKPENILVS-QSGVVKL 165
Query: 69 GDLGLAIAMQQPTARSVIGTPEFM-----APELY--EEEYNELVDIYSFGMCIL-EMVTF 120
D G A + P E APEL + +Y + VD+++ G C++ EM
Sbjct: 166 CDFGFARTLAAPGEVY---DDEVATRWYRAPELLVGDVKYGKAVDVWAIG-CLVTEMFMG 221
Query: 121 EYPY----SE----------------------CKNP---AQIFKKVTSGIKPASLAKVND 151
E P S+ KNP ++
Sbjct: 222 E-PLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLS 280
Query: 152 PQIKGFIEKCLV--PASERLSAKDLLKDPFLQVENQKEPICDPLKLPIQ 198
+ +KCL P +R +LL F Q++ E L+L +Q
Sbjct: 281 EVVIDLAKKCLHIDPD-KRPFCAELLHHDFFQMDGFAERFSQELQLKVQ 328
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 1e-21
Identities = 47/194 (24%), Positives = 86/194 (44%), Gaps = 17/194 (8%)
Query: 1 MITELFTSGNL--RQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI- 57
+I E G L R + + + R I + +LHSHN I HRD+K +N+
Sbjct: 103 IIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN--IAHRDVKPENLL 160
Query: 58 FVNGNHG-EVKIGDLGLAIAMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCIL 115
+ + +K+ D G A Q ++ TP ++APE L E+Y++ D++S G I+
Sbjct: 161 YTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLG-VIM 219
Query: 116 EMVTFEYP--YSECKN--PAQIFKKVTSG---IKPASLAKVNDPQIKGFIEKCLVP-ASE 167
++ +P YS + +++ G ++V++ K I L +E
Sbjct: 220 YILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSE-DAKQLIRLLLKTDPTE 278
Query: 168 RLSAKDLLKDPFLQ 181
RL+ + P++
Sbjct: 279 RLTITQFMNHPWIN 292
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 97.3 bits (242), Expect = 2e-21
Identities = 47/189 (24%), Positives = 90/189 (47%), Gaps = 15/189 (7%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 60
I +L G+L + +H ++ +A +I+ GL ++H+ +++RDLK NI ++
Sbjct: 269 FILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLD 326
Query: 61 GNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPE--LYEEEYNELVDIYSFGMCILEMV 118
HG V+I DLGLA + + +GT +MAPE Y+ D +S G + +++
Sbjct: 327 -EHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385
Query: 119 TFEYPY--SECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERL-----S 170
P+ + K+ +I + + L P+++ +E L + RL
Sbjct: 386 RGHSPFRQHKTKDKHEIDRMTLTM--AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRG 443
Query: 171 AKDLLKDPF 179
A+++ + PF
Sbjct: 444 AQEVKESPF 452
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 2e-21
Identities = 41/165 (24%), Positives = 71/165 (43%), Gaps = 15/165 (9%)
Query: 31 RQILHGLVYLHSHNPPIIHRDLKCDNI-FVNGNHGEVKIGDLGLAIAMQQPTA-RSVIGT 88
RQ GL ++H H+ I+H D+K +NI VKI D GLA + + T
Sbjct: 156 RQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTAT 213
Query: 89 PEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYP--YSECKNPAQIFKKVTSGI---K 142
EF APE + E D+++ G + ++ E + + + V
Sbjct: 214 AEFAAPEIVDREPVGFYTDMWAIG-VLGYVLLSGLSPFAGE--DDLETLQNVKRCDWEFD 270
Query: 143 PASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQK 186
+ + V+ + K FI+ L +RL+ D L+ P+L+ ++
Sbjct: 271 EDAFSSVSP-EAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSN 314
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 2e-21
Identities = 44/173 (25%), Positives = 81/173 (46%), Gaps = 17/173 (9%)
Query: 31 RQILHGLVYLHSHNPPIIHRDLKCDNIFV---NGNHGEVKIGDLGLAIAMQQPTA-RSVI 86
+QIL G+ YLH+ I H DLK +NI + N +K+ D GLA ++ +++
Sbjct: 122 KQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF 179
Query: 87 GTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYP--YSECKNPAQIFKKVTSGI-- 141
GTPEF+APE + E D++S G I ++ + + +T+
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIG-VITYILLSGASPFLGD--TKQETLANITAVSYD 236
Query: 142 -KPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQKEPICDP 192
++ ++ K FI K LV +RL+ ++ L+ P++ + ++ +
Sbjct: 237 FDEEFFSQTSE-LAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMVRR 288
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 3e-21
Identities = 46/169 (27%), Positives = 78/169 (46%), Gaps = 33/169 (19%)
Query: 31 RQILHGLVYLHSHNPPIIHRDLKCDNIFV--NGNHGEVKIGDLGLAIAMQQPTARSVIGT 88
+Q+L + YLH + I+HRDLK +N+ + ++ I D GL+ Q + GT
Sbjct: 113 QQVLSAVKYLHENG--IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGT 170
Query: 89 PEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYP--YSECKNPAQIFKKVTSGI---- 141
P ++APE L ++ Y++ VD +S G I ++ YP Y E +++F+K+ G
Sbjct: 171 PGYVAPEVLAQKPYSKAVDCWSIG-VITYILLCGYPPFYEE--TESKLFEKIKEGYYEFE 227
Query: 142 --------KPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQ 181
+ A K FI L +ER + + L P++
Sbjct: 228 SPFWDDISESA----------KDFICHLLEKDPNERYTCEKALSHPWID 266
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 5e-21
Identities = 47/186 (25%), Positives = 87/186 (46%), Gaps = 21/186 (11%)
Query: 31 RQILHGLVYLHSHNPPIIHRDLKCDNI-FVNGNH--GEVKIGDLGLAIAMQQPTA-RSVI 86
+QIL+G+ YLHS I H DLK +NI ++ N +KI D GLA + +++
Sbjct: 121 KQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF 178
Query: 87 GTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYP--YSECKNPAQIFKKVTSGI-- 141
GTPEF+APE + E D++S G I ++ + + V++
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIG-VITYILLSGASPFLGD--TKQETLANVSAVNYE 235
Query: 142 -KPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQKEPICDPLKLPIQS 199
+ + + K FI + LV +R++ +D L+ P+++ ++ ++ L +
Sbjct: 236 FEDEYFSNTSA-LAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQ----ALSRKASA 290
Query: 200 LKMLRL 205
+ M +
Sbjct: 291 VNMEKF 296
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 92.2 bits (230), Expect = 5e-21
Identities = 41/167 (24%), Positives = 76/167 (45%), Gaps = 17/167 (10%)
Query: 31 RQILHGLVYLHSHNPPIIHRDLKCDNIFV---NGNHGEVKIGDLGLAIAMQQPTA-RSVI 86
+QIL G+ YLHS I H DLK +NI + N + +K+ D G+A ++ +++
Sbjct: 115 KQILDGVHYLHSKR--IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF 172
Query: 87 GTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYP--YSECKNPAQIFKKVTSGI-- 141
GTPEF+APE + E D++S G I ++ E + +++
Sbjct: 173 GTPEFVAPEIVNYEPLGLEADMWSIG-VITYILLSGASPFLGE--TKQETLTNISAVNYD 229
Query: 142 -KPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQK 186
+ ++ K FI + LV R++ L+ +++ ++
Sbjct: 230 FDEEYFSNTSE-LAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRR 275
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 6e-21
Identities = 54/190 (28%), Positives = 85/190 (44%), Gaps = 28/190 (14%)
Query: 4 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNH 63
EL Y +K + D + + +I+ L YLH IIHRDLK +NI +N
Sbjct: 116 ELLK------YIRKIGSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLN-ED 166
Query: 64 GEVKIGDLGLA----IAMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMV 118
++I D G A +Q A S +GT ++++PE L E+ + D+++ G I ++V
Sbjct: 167 MHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 226
Query: 119 TFEYPYSECKNPAQIFKKVTSG-IK-PASLAKVNDPQIKGFIEKCLVP-ASERL------ 169
P+ N IF+K+ P P+ + +EK LV A++RL
Sbjct: 227 AGLPPF-RAGNEYLIFQKIIKLEYDFPEKF----FPKARDLVEKLLVLDATKRLGCEEME 281
Query: 170 SAKDLLKDPF 179
L PF
Sbjct: 282 GYGPLKAHPF 291
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 6e-21
Identities = 50/231 (21%), Positives = 109/231 (47%), Gaps = 16/231 (6%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 60
+I E + G + Y H + K ++ RQI+ + Y H I+HRDLK +N+ ++
Sbjct: 91 LIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR--IVHRDLKAENLLLD 148
Query: 61 GNHGEVKIGDLGLAIAMQQPTA-RSVIGTPEFMAPELYE-EEYN-ELVDIYSFGMCILEM 117
+ +KI D G + + G P + APEL++ ++Y+ VD++S G+ + +
Sbjct: 149 AD-MNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTL 207
Query: 118 VTFEYPYSECKNPAQIFKKVTSGI--KPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDL 174
V+ P+ +N ++ ++V G P ++ + +++ LV +R + + +
Sbjct: 208 VSGSLPFDG-QNLKELRERVLRGKYRIPFYMS----TDCENLLKRFLVLNPIKRGTLEQI 262
Query: 175 LKDPFLQVENQKEPICDPLKLPIQSLKMLRLPMSGPSSMDIDSDYKQLSLS 225
+KD ++ ++++ + ++ + R+ + M + Q SLS
Sbjct: 263 MKDRWINAGHEEDELKPFVEPELDISDQKRIDIM--VGMGYSQEEIQESLS 311
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 6e-21
Identities = 55/216 (25%), Positives = 97/216 (44%), Gaps = 23/216 (10%)
Query: 1 MITELFTSGNL--RQYRKKHKNVDI--KVIKNWARQILHGLVYLHSHNPPIIHRDLKCDN 56
M+ E +L ++ V ++ RQIL L Y H +N IIHRD+K
Sbjct: 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN--IIHRDVKPHC 160
Query: 57 I-FVN-GNHGEVKIGDLGLAIAMQQP--TARSVIGTPEFMAPE-LYEEEYNELVDIYSFG 111
+ + N VK+G G+AI + + A +GTP FMAPE + E Y + VD++ G
Sbjct: 161 VLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCG 220
Query: 112 MCILEMVTFEYP--YSECKNPAQIFKKVTSGI---KPASLAKVNDPQIKGFIEKCLVP-A 165
IL ++ Y ++F+ + G P + +++ K + + L+
Sbjct: 221 -VILFILLSGCLPFYGT---KERLFEGIIKGKYKMNPRQWSHISE-SAKDLVRRMLMLDP 275
Query: 166 SERLSAKDLLKDPFLQVENQKEPICDPLKLPIQSLK 201
+ER++ + L P+L+ E + L ++ L+
Sbjct: 276 AERITVYEALNHPWLK-ERDRYAYKIHLPETVEQLR 310
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 91.4 bits (228), Expect = 1e-20
Identities = 46/209 (22%), Positives = 88/209 (42%), Gaps = 46/209 (22%)
Query: 11 LRQYRKKHKNV-DIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIG 69
L++Y D +++K++ Q+L GL + HS N ++HRDLK N+ +N +GE+K+
Sbjct: 87 LKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLIN-RNGELKLA 143
Query: 70 DLGLAIAMQQPTARSVIGTPEFM-----APELY--EEEYNELVDIYSFGMCIL-EMVTFE 121
+ GLA A P R + E + P++ + Y+ +D++S G CI E+
Sbjct: 144 NFGLARAFGIPV-RCY--SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAG-CIFAELANAG 199
Query: 122 YPY----SE----------------------CKNP-AQIFKKVTSGIKPASLAKVNDPQI 154
P K P + + + ++ +
Sbjct: 200 RPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATG 259
Query: 155 KGFIEKCLV--PASERLSAKDLLKDPFLQ 181
+ ++ L P +R+SA++ L+ P+
Sbjct: 260 RDLLQNLLKCNPV-QRISAEEALQHPYFS 287
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 1e-20
Identities = 37/184 (20%), Positives = 79/184 (42%), Gaps = 16/184 (8%)
Query: 31 RQILHGLVYLHSHNPPIIHRDLKCDNI-FVNGNHGEVKIGDLGLAIAMQQPTA-RSVIGT 88
Q+ L +LHSHN I H D++ +NI + +KI + G A ++ R +
Sbjct: 109 HQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTA 166
Query: 89 PEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYP--YSECKNPAQIFKKVTSGI---K 142
PE+ APE + + D++S G ++ ++ +E QI + + +
Sbjct: 167 PEYYAPEVHQHDVVSTATDMWSLG-TLVYVLLSGINPFLAE--TNQQIIENIMNAEYTFD 223
Query: 143 PASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQKEPICDPLKLPIQSLK 201
+ +++ + F+++ LV R++A + L+ P+L+ + + ++
Sbjct: 224 EEAFKEISI-EAMDFVDRLLVKERKSRMTASEALQHPWLK-QKIERVSTKVIRTLKHRRY 281
Query: 202 MLRL 205
L
Sbjct: 282 YHTL 285
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 1e-20
Identities = 44/166 (26%), Positives = 80/166 (48%), Gaps = 26/166 (15%)
Query: 31 RQILHGLVYLHSHNPPIIHRDLKCDNI-FVN-GNHGEVKIGDLGLAIAMQ-QPTARSVIG 87
+QIL + Y HS+ I+HR+LK +N+ + VK+ D GLAI + G
Sbjct: 112 QQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAG 169
Query: 88 TPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEY-------PYSECKNPAQIFKKVTS 139
TP +++PE L ++ Y++ VDI++ G IL Y P+ + ++ +++ ++ +
Sbjct: 170 TPGYLSPEVLKKDPYSKPVDIWACG-VIL------YILLVGYPPFWD-EDQHRLYAQIKA 221
Query: 140 GI---KPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQ 181
G V + K I+ L +R++A LK P++
Sbjct: 222 GAYDYPSPEWDTVTP-EAKSLIDSMLTVNPKKRITADQALKVPWIC 266
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 94.5 bits (235), Expect = 1e-20
Identities = 50/214 (23%), Positives = 89/214 (41%), Gaps = 19/214 (8%)
Query: 1 MITELFTSGNL-RQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI-F 58
MI E + G L + +H + + RQ+ GL ++H +N +H DLK +NI F
Sbjct: 231 MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMF 288
Query: 59 VNGNHGEVKIGDLGLAIAMQQPTA-RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILE 116
E+K+ D GL + + + GT EF APE + D++S G +
Sbjct: 289 TTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVG-VLSY 347
Query: 117 MVTFEYP--YSECKNPAQIFKKVTSGI---KPASLAKVNDPQIKGFIEKCLVP-ASERLS 170
++ E N + + V S ++ + +++ K FI K L+ + R++
Sbjct: 348 ILLSGLSPFGGE--NDDETLRNVKSCDWNMDDSAFSGISE-DGKDFIRKLLLADPNTRMT 404
Query: 171 AKDLLKDPFLQVENQKEPICDPLKLPIQSLKMLR 204
L+ P+L N ++P +R
Sbjct: 405 IHQALEHPWLTPGNAPGRD---SQIPSSRYTKIR 435
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 45/168 (26%), Positives = 75/168 (44%), Gaps = 17/168 (10%)
Query: 31 RQILHGLVYLHSHNPPIIHRDLKCDNIFV---NGNHGEVKIGDLGLAIAMQ--QPTARSV 85
I + YLH+ ++HRDLK NI +GN ++I D G A ++ +
Sbjct: 123 FTITKTVEYLHAQG--VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTP 180
Query: 86 IGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYP--YSECK-NPAQIFKKVTSG- 140
T F+APE L + Y+ DI+S G +L + Y + P +I ++ SG
Sbjct: 181 CYTANFVAPEVLERQGYDAACDIWSLG-VLLYTMLTGYTPFANGPDDTPEEILARIGSGK 239
Query: 141 --IKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQ 185
+ V+D K + K L +RL+A +L+ P++ +Q
Sbjct: 240 FSLSGGYWNSVSD-TAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQ 286
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 2e-20
Identities = 39/121 (32%), Positives = 63/121 (52%), Gaps = 18/121 (14%)
Query: 11 LRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN----GNHGEV 66
L++Y K+ +V ++VIK++ Q+++G+ + HS +HRDLK N+ ++ +
Sbjct: 119 LKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRR--CLHRDLKPQNLLLSVSDASETPVL 176
Query: 67 KIGDLGLAIAMQQPTARSVIGTPEFM-----APELY--EEEYNELVDIYSFGMCIL-EMV 118
KIGD GLA A P + T E + PE+ Y+ VDI+S CI EM+
Sbjct: 177 KIGDFGLARAFGIPIRQF---THEIITLWYRPPEILLGSRHYSTSVDIWSIA-CIWAEML 232
Query: 119 T 119
Sbjct: 233 M 233
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 2e-20
Identities = 48/200 (24%), Positives = 80/200 (40%), Gaps = 38/200 (19%)
Query: 31 RQILHGLVYLHSHNPPIIHRDLKCDNI-FVNGNHG-EVKIGDLGLAIAMQ---------Q 79
+ + L +LH+ I HRDLK +NI + N VKI D L ++
Sbjct: 118 QDVASALDFLHNKG--IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPIST 175
Query: 80 PTARSVIGTPEFMAPE------LYEEEYNELVDIYSFG--MCIL------------EMVT 119
P + G+ E+MAPE Y++ D++S G + IL
Sbjct: 176 PELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCG 235
Query: 120 FEYPYSECKNPAQIFKKVTSGI---KPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLL 175
++ + +F+ + G A ++ K I K LV A +RLSA +L
Sbjct: 236 WDRGEACPACQNMLFESIQEGKYEFPDKDWAHISC-AAKDLISKLLVRDAKQRLSAAQVL 294
Query: 176 KDPFLQVENQKEPICDPLKL 195
+ P++Q + + P+ L
Sbjct: 295 QHPWVQGCAPENTLPTPMVL 314
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 2e-20
Identities = 43/184 (23%), Positives = 74/184 (40%), Gaps = 14/184 (7%)
Query: 4 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNH 63
E LR + K L + H + IIHRD+K NI +
Sbjct: 96 EYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMI-SAT 152
Query: 64 GEVKIGDLGLAIAMQQPTAR-----SVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEM 117
VK+ D G+A A+ +VIGT ++++PE + + D+YS G + E+
Sbjct: 153 NAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEV 212
Query: 118 VTFEYPYSECKNPAQI-FKKVTSGIKPASLAKVNDPQ-IKGFIEKCLV--PASERLSAKD 173
+T E P++ +P + ++ V P S + + K L P + +A +
Sbjct: 213 LTGEPPFTG-DSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAE 271
Query: 174 LLKD 177
+ D
Sbjct: 272 MRAD 275
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 3e-20
Identities = 36/147 (24%), Positives = 71/147 (48%), Gaps = 11/147 (7%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 60
++ E+ G L +Y +++++V K I Q+ G+ YL N +HRDL N+ +
Sbjct: 94 LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLV 151
Query: 61 GNHGEVKIGDLGLA--IAMQQPTARSVIGT--P-EFMAPE-LYEEEYNELVDIYSFGMCI 114
H KI D GL+ + + ++ P ++ APE + +++ D++SFG+ +
Sbjct: 152 TQH-YAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLM 210
Query: 115 LEMVTF-EYPYSECKNPAQIFKKVTSG 140
E ++ + PY K ++ + G
Sbjct: 211 WEAFSYGQKPYRGMKGS-EVTAMLEKG 236
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 93.8 bits (233), Expect = 3e-20
Identities = 31/122 (25%), Positives = 54/122 (44%), Gaps = 8/122 (6%)
Query: 4 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNH 63
E +L++ + + V + I + +IL L YLHS +++ DLK +NI +
Sbjct: 164 EYVGGQSLKRSKGQKLPVA-EAI-AYLLEILPALSYLHSIG--LVYNDLKPENIML--TE 217
Query: 64 GEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTFEYP 123
++K+ DLG + + GTP F APE+ DIY+ G + +
Sbjct: 218 EQLKLIDLGAVSRINSFGY--LYGTPGFQAPEIVRTGPTVATDIYTVGRTLAALTLDLPT 275
Query: 124 YS 125
+
Sbjct: 276 RN 277
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 4e-20
Identities = 41/149 (27%), Positives = 68/149 (45%), Gaps = 11/149 (7%)
Query: 1 MITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV 59
++ E SG LR + ++H+ +D + ++ QI G+ YL S +HRDL NI V
Sbjct: 103 LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR--CVHRDLAARNILV 160
Query: 60 NGNHGEVKIGDLGLAIAMQQP----TARSVIGTPEF-MAPE-LYEEEYNELVDIYSFGMC 113
+ VKI D GLA + R +P F APE L + ++ D++SFG+
Sbjct: 161 -ESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVV 219
Query: 114 ILEMVTF-EYPYSECKNPAQIFKKVTSGI 141
+ E+ T+ + S ++
Sbjct: 220 LYELFTYCDKSCSPSAEFLRMMGCERDVP 248
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 4e-20
Identities = 47/179 (26%), Positives = 83/179 (46%), Gaps = 17/179 (9%)
Query: 31 RQILHGLVYLHSHNPPIIHRDLKCDNI-FVNGN-HGEVKIGDLGLAIAMQQPTA-RSVIG 87
+QIL G+ YLH +N I+H DLK NI + G++KI D G++ + R ++G
Sbjct: 138 KQILEGVYYLHQNN--IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMG 195
Query: 88 TPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYP--YSECKNPAQIFKKVTSGI--- 141
TPE++APE L + D+++ G+ I M+ E + + + ++
Sbjct: 196 TPEYLAPEILNYDPITTATDMWNIGI-IAYMLLTHTSPFVGE--DNQETYLNISQVNVDY 252
Query: 142 KPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQKEPICDPLKLPIQS 199
+ + V+ FI+ LV +R +A+ L +LQ + E + P + S
Sbjct: 253 SEETFSSVSQ-LATDFIQSLLVKNPEKRPTAEICLSHSWLQ-QWDFENLFHPEETSSSS 309
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 4e-20
Identities = 45/147 (30%), Positives = 73/147 (49%), Gaps = 11/147 (7%)
Query: 1 MITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV 59
+IT+L G L Y ++HK N+ + + NW QI G+ YL ++HRDL N+ V
Sbjct: 93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLV 150
Query: 60 NGNHGEVKIGDLGLA--IAMQQPTARSVIG-TP-EFMAPE-LYEEEYNELVDIYSFGMCI 114
VKI D GLA + ++ + G P ++MA E + Y D++S+G+ +
Sbjct: 151 KTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTV 209
Query: 115 LEMVTF-EYPYSECKNPAQIFKKVTSG 140
E++TF PY ++I + G
Sbjct: 210 WELMTFGSKPYDGIPA-SEISSILEKG 235
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 5e-20
Identities = 46/171 (26%), Positives = 81/171 (47%), Gaps = 15/171 (8%)
Query: 31 RQILHGLVYLHSHNPPIIHRDLKCDNI-FVN-GNHGEVKIGDLGLAIAMQQPTA-RSVIG 87
+QIL + YLH + I+HRDLK +N+ + +KI D GL+ ++ ++V G
Sbjct: 155 KQILEAVAYLHENG--IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCG 212
Query: 88 TPEFMAPE-LYEEEYNELVDIYSFG--MCILEMVTFEYPYSECKNPAQIFKKVTSGI--- 141
TP + APE L Y VD++S G IL + FE P+ + + +F+++ +
Sbjct: 213 TPGYCAPEILRGCAYGPEVDMWSVGIITYIL-LCGFE-PFYDERGDQFMFRRILNCEYYF 270
Query: 142 KPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQKEPICD 191
+V+ K + K +V +RL+ L+ P++ + D
Sbjct: 271 ISPWWDEVSL-NAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAANFVHMD 320
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 6e-20
Identities = 37/147 (25%), Positives = 59/147 (40%), Gaps = 11/147 (7%)
Query: 1 MITELFTSGNLRQY-RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV 59
++ EL G+ + R + + +K + G+ YL S IHRDL N V
Sbjct: 189 IVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC--CIHRDLAARNCLV 246
Query: 60 NGNHGEVKIGDLGLAIAMQQPTARSVIGTPEF----MAPE-LYEEEYNELVDIYSFGMCI 114
+ +KI D G++ + G + APE L Y+ D++SFG+ +
Sbjct: 247 TEKN-VLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILL 305
Query: 115 LEMVTF-EYPYSECKNPAQIFKKVTSG 140
E + PY N Q + V G
Sbjct: 306 WETFSLGASPYPNLSN-QQTREFVEKG 331
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 7e-20
Identities = 47/191 (24%), Positives = 82/191 (42%), Gaps = 22/191 (11%)
Query: 31 RQILHGLVYLHSHNPPIIHRDLKCDNI-FVNGNHG-EVKIGDLGLAIAMQ--QPTARSVI 86
R+++ + ++H ++HRDLK +N+ F + N E+KI D G A ++
Sbjct: 113 RKLVSAVSHMHDVG--VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC 170
Query: 87 GTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYP--YSE-----CKNPAQIFKKVT 138
T + APE L + Y+E D++S G IL + S C + +I KK+
Sbjct: 171 FTLHYAAPELLNQNGYDESCDLWSLG-VILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIK 229
Query: 139 SG---IKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQ--KEPICDP 192
G + + V+ + K I+ L ++RL L + +LQ +Q P+ P
Sbjct: 230 KGDFSFEGEAWKNVSQ-EAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNPLMTP 288
Query: 193 LKLPIQSLKML 203
L +
Sbjct: 289 DILGSSGAAVH 299
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 7e-20
Identities = 59/219 (26%), Positives = 90/219 (41%), Gaps = 41/219 (18%)
Query: 11 LRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGD 70
R Y K + + + +IK + Q+L L Y+HS I HRD+K N+ ++ G +K+ D
Sbjct: 128 SRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG--ICHRDIKPQNLLLDPPSGVLKLID 185
Query: 71 LGLA-IAMQQPTARSVIGTPEFMAPELY--EEEYNELVDIYSFGMCIL-EMVT------- 119
G A I + S I + + APEL Y +DI+S G C++ E++
Sbjct: 186 FGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTG-CVMAELMQGQPLFPG 244
Query: 120 ----------FEY---PYSE---CKNPAQIFKKVTSGIKPASLAKV----NDPQIKGFIE 159
+ P E NP + K I+P +KV P I
Sbjct: 245 ESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQ-IRPHPFSKVFRPRTPPDAIDLIS 303
Query: 160 KCLV--PASERLSAKDLLKDPF---LQVENQKEPICDPL 193
+ L P S RL+A + L PF L+ + P L
Sbjct: 304 RLLEYTP-SARLTAIEALCHPFFDELRTGEARMPNGREL 341
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 1e-19
Identities = 37/147 (25%), Positives = 77/147 (52%), Gaps = 11/147 (7%)
Query: 1 MITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV 59
++T+ G+L + ++H+ + +++ NW QI G+ YL H ++HR+L N+ +
Sbjct: 91 LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG--MVHRNLAARNVLL 148
Query: 60 NGNHGEVKIGDLGLAIAMQQP---TARSVIGTP-EFMAPE-LYEEEYNELVDIYSFGMCI 114
+V++ D G+A + S TP ++MA E ++ +Y D++S+G+ +
Sbjct: 149 KSPS-QVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTV 207
Query: 115 LEMVTF-EYPYSECKNPAQIFKKVTSG 140
E++TF PY+ + A++ + G
Sbjct: 208 WELMTFGAEPYAGLRL-AEVPDLLEKG 233
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 1e-19
Identities = 47/186 (25%), Positives = 87/186 (46%), Gaps = 27/186 (14%)
Query: 31 RQILHGLVYLHSHNPPIIHRDLKCDNI-FVN-GNHGEVKIGDLGLAIAMQQPTA-RSVIG 87
+QIL + Y HS+ I+HR+LK +N+ + VK+ D GLAI + A G
Sbjct: 135 QQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAG 192
Query: 88 TPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEY-------PYSECKNPAQIFKKVTS 139
TP +++PE L ++ Y++ VDI++ G IL Y P+ + ++ +++ ++ +
Sbjct: 193 TPGYLSPEVLKKDPYSKPVDIWACG-VIL------YILLVGYPPFWD-EDQHRLYAQIKA 244
Query: 140 GI---KPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQKEPICDPLKL 195
G V + K I+ L +R++A LK P++ ++ +
Sbjct: 245 GAYDYPSPEWDTVTP-EAKSLIDSMLTVNPKKRITADQALKVPWIC-NRERVASAIHRQD 302
Query: 196 PIQSLK 201
+ LK
Sbjct: 303 TVDCLK 308
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 91.4 bits (227), Expect = 1e-19
Identities = 43/143 (30%), Positives = 72/143 (50%), Gaps = 11/143 (7%)
Query: 4 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNH 63
++ ++ + + + QI+ GL +LH N II+RDLK +N+ ++ +
Sbjct: 271 DIRY--HIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN--IIYRDLKPENVLLD-DD 325
Query: 64 GEVKIGDLGLA--IAMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTF 120
G V+I DLGLA + Q + GTP FMAPE L EEY+ VD ++ G+ + EM+
Sbjct: 326 GNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAA 385
Query: 121 EYPY---SECKNPAQIFKKVTSG 140
P+ E ++ ++V
Sbjct: 386 RGPFRARGEKVENKELKQRVLEQ 408
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 1e-19
Identities = 39/236 (16%), Positives = 85/236 (36%), Gaps = 56/236 (23%)
Query: 11 LRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGD 70
L+ + + +++ + +I + Q+ + ++HS I HRD+K N+ VN +K+ D
Sbjct: 128 LKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG--ICHRDIKPQNLLVNSKDNTLKLCD 185
Query: 71 LGLAIAMQQPTARSVIGTPEFM----------APELY--EEEYNELVDIYSFGMCIL-EM 117
G A+ +I + E APEL EY +D++S G C+ E+
Sbjct: 186 FGS--------AKKLIPS-EPSVAYICSRFYRAPELMLGATEYTPSIDLWSIG-CVFGEL 235
Query: 118 VTFE--YPYSECKN------------PAQIFKKVTSG--------IKPASLAKV----ND 151
+ + + + + ++ +K K+
Sbjct: 236 ILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTP 295
Query: 152 PQIKGFIEKCLV--PASERLSAKDLLKDPFLQV--ENQKEPICDPLKLPIQSLKML 203
+E+ L P R++ + + PF + + + + P + +
Sbjct: 296 SLAIDLLEQILRYEP-DLRINPYEAMAHPFFDHLRNSYESEVKNNSNFPHGVNQNI 350
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 1e-19
Identities = 36/164 (21%), Positives = 73/164 (44%), Gaps = 24/164 (14%)
Query: 28 NWAR----QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA---IAMQQP 80
AR +++ + +H + +HRD+K DNI ++ +G +++ D G +
Sbjct: 175 EMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMD-MNGHIRLADFGSCLKLMEDGTV 231
Query: 81 TARSVIGTPEFMAPELYEEE------YNELVDIYSFGMCILEMVTFEYP-YSECKNPAQI 133
+ +GTP++++PE+ + Y D +S G+C+ EM+ E P Y+E + +
Sbjct: 232 QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAE--SLVET 289
Query: 134 FKKVTSGIK----PASLAKVNDPQIKGFIEKCLVPASERLSAKD 173
+ K+ + + P + V K I + + RL
Sbjct: 290 YGKIMNHKERFQFPTQVTDV-SENAKDLIRRLICSREHRLGQNG 332
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 1e-19
Identities = 40/118 (33%), Positives = 62/118 (52%), Gaps = 16/118 (13%)
Query: 11 LRQYRKKHKNV-DIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIG 69
L++ ++K IK + Q+L G+ + H H I+HRDLK N+ +N + G +K+
Sbjct: 105 LKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR--ILHRDLKPQNLLIN-SDGALKLA 161
Query: 70 DLGLAIAMQQPTARSVIGTPEFM-----APELY--EEEYNELVDIYSFGMCIL-EMVT 119
D GLA A P T E + AP++ ++Y+ VDI+S G CI EM+T
Sbjct: 162 DFGLARAFGIPVRSY---THEVVTLWYRAPDVLMGSKKYSTSVDIWSIG-CIFAEMIT 215
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 2e-19
Identities = 45/176 (25%), Positives = 75/176 (42%), Gaps = 31/176 (17%)
Query: 31 RQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA-RSVIGTP 89
R +L + LH N I+HRDLK +NI ++ + +K+ D G + + R V GTP
Sbjct: 131 RALLEVICALHKLN--IVHRDLKPENILLDDD-MNIKLTDFGFSCQLDPGEKLREVCGTP 187
Query: 90 EFMAPE-------LYEEEYNELVDIYSFGMCILEMVTFEY-------PYSECKNPAQIFK 135
++APE Y + VD++S G I+ Y P+ + + +
Sbjct: 188 SYLAPEIIECSMNDNHPGYGKEVDMWSTG-VIM------YTLLAGSPPFWH-RKQMLMLR 239
Query: 136 KVTSGI---KPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQKE 187
+ SG +D K + + LV +R +A++ L PF Q +E
Sbjct: 240 MIMSGNYQFGSPEWDDYSDTV-KDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEE 294
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 2e-19
Identities = 40/170 (23%), Positives = 77/170 (45%), Gaps = 23/170 (13%)
Query: 28 NWAR----QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--- 80
WAR +++ L +HS IHRD+K DN+ ++ G +K+ D G + M +
Sbjct: 168 KWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLD-KSGHLKLADFGTCMKMNKEGMV 224
Query: 81 TARSVIGTPEFMAPEL-----YEEEYNELVDIYSFGMCILEMVTFEYP-YSECKNPAQIF 134
+ +GTP++++PE+ + Y D +S G+ + EM+ + P Y++ + +
Sbjct: 225 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD--SLVGTY 282
Query: 135 KKVTSGIKPASLAKVND--PQIKGFIEKCLVPASERL---SAKDLLKDPF 179
K+ + + ND + K I L RL +++ + F
Sbjct: 283 SKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLF 332
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 89.5 bits (222), Expect = 2e-19
Identities = 40/119 (33%), Positives = 58/119 (48%), Gaps = 14/119 (11%)
Query: 12 RQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG---NHGEVKI 68
+ KK + ++K+ QIL G+ YLH++ ++HRDLK NI V G G VKI
Sbjct: 116 SKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKI 173
Query: 69 GDLGLAIAMQQPTARSVIGTPEFM-----APELY--EEEYNELVDIYSFGMCIL-EMVT 119
D+G A P P + APEL Y + +DI++ G CI E++T
Sbjct: 174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIG-CIFAELLT 231
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 2e-19
Identities = 32/157 (20%), Positives = 63/157 (40%), Gaps = 28/157 (17%)
Query: 1 MITELFTSGNLRQYRKKHKN-VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV 59
++ E G+L Y KK+KN ++I A+Q+ + +L + +IH ++ NI +
Sbjct: 89 LVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENT--LIHGNVCAKNILL 146
Query: 60 N-------GNHGEVKIGDLGLAIAMQQPTARSVIGTPEF------MAPE--LYEEEYNEL 104
GN +K+ D G+ + +V+ + PE + N
Sbjct: 147 IREEDRKTGNPPFIKLSDPGI--------SITVLPKDILQERIPWVPPECIENPKNLNLA 198
Query: 105 VDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSG 140
D +SFG + E+ + + P S + + +
Sbjct: 199 TDKWSFGTTLWEICSGGDKPLSALDS-QRKLQFYEDR 234
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 3e-19
Identities = 37/146 (25%), Positives = 70/146 (47%), Gaps = 10/146 (6%)
Query: 1 MITELFTSGNLRQY-RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV 59
+I EL+ G L Y + ++ + + ++ QI + YL S N +HRD+ NI V
Sbjct: 89 IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN--CVHRDIAVRNILV 146
Query: 60 NGNHGEVKIGDLGLAIAMQQPTARSVIGT--P-EFMAPE-LYEEEYNELVDIYSFGMCIL 115
VK+GD GL+ ++ T P ++M+PE + + D++ F +C+
Sbjct: 147 ASPE-CVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMW 205
Query: 116 EMVTF-EYPYSECKNPAQIFKKVTSG 140
E+++F + P+ +N + + G
Sbjct: 206 EILSFGKQPFFWLEN-KDVIGVLEKG 230
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 3e-19
Identities = 45/187 (24%), Positives = 87/187 (46%), Gaps = 28/187 (14%)
Query: 31 RQILHGLVYLHSHNPPIIHRDLKCDNI-FVN-GNHGEVKIGDLGLAIAMQQPTA--RSVI 86
+QIL +++ H ++HR+LK +N+ + VK+ D GLAI ++
Sbjct: 117 QQILEAVLHCHQMG--VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA 174
Query: 87 GTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEY-------PYSECKNPAQIFKKVT 138
GTP +++PE L ++ Y + VD+++ G IL Y P+ + ++ ++++++
Sbjct: 175 GTPGYLSPEVLRKDPYGKPVDLWACG-VIL------YILLVGYPPFWD-EDQHRLYQQIK 226
Query: 139 SGI---KPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQKEPICDPLK 194
+G V + K I K L S+R++A + LK P++ C +
Sbjct: 227 AGAYDFPSPEWDTVTP-EAKDLINKMLTINPSKRITAAEALKHPWIS-HRSTVASCMHRQ 284
Query: 195 LPIQSLK 201
+ LK
Sbjct: 285 ETVDCLK 291
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 3e-19
Identities = 41/188 (21%), Positives = 83/188 (44%), Gaps = 12/188 (6%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 60
M+ EL G + + + + + + ++ G+ YLH IIHRD+K N+ V
Sbjct: 115 MVFELVNQGPVMEVPTLKP-LSEDQARFYFQDLIKGIEYLHYQK--IIHRDIKPSNLLVG 171
Query: 61 GNHGEVKIGDLGLAIAMQQPTA--RSVIGTPEFMAPEL---YEEEYN-ELVDIYSFGMCI 114
+ G +KI D G++ + A + +GTP FMAPE + ++ + +D+++ G+ +
Sbjct: 172 ED-GHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230
Query: 115 LEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKD 173
V + P+ + + + K+ S +K I + L R+ +
Sbjct: 231 YCFVFGQCPFMD-ERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPE 289
Query: 174 LLKDPFLQ 181
+ P++
Sbjct: 290 IKLHPWVT 297
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 90.3 bits (224), Expect = 3e-19
Identities = 43/146 (29%), Positives = 73/146 (50%), Gaps = 10/146 (6%)
Query: 1 MITELFTSGNLRQYRKKHKN-VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV 59
+I EL T G LR + + K +D+ + +A Q+ L YL S +HRD+ N+ V
Sbjct: 467 IIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLV 524
Query: 60 NGNHGEVKIGDLGLAIAMQQPTARSVIGT--P-EFMAPE-LYEEEYNELVDIYSFGMCIL 115
+ N VK+GD GL+ M+ T P ++MAPE + + D++ FG+C+
Sbjct: 525 SSND-CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMW 583
Query: 116 EMVTF-EYPYSECKNPAQIFKKVTSG 140
E++ P+ KN + ++ +G
Sbjct: 584 EILMHGVKPFQGVKNN-DVIGRIENG 608
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 87.2 bits (217), Expect = 4e-19
Identities = 39/118 (33%), Positives = 61/118 (51%), Gaps = 16/118 (13%)
Query: 11 LRQYRKKHKNV-DIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIG 69
L++ + + K++ Q+L+G+ Y H ++HRDLK N+ +N GE+KI
Sbjct: 86 LKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLIN-REGELKIA 142
Query: 70 DLGLAIAMQQPTARSVIGTPEFM-----APELY--EEEYNELVDIYSFGMCIL-EMVT 119
D GLA A P R T E + AP++ ++Y+ +DI+S G CI EMV
Sbjct: 143 DFGLARAFGIPV-RKY--THEIVTLWYRAPDVLMGSKKYSTTIDIWSVG-CIFAEMVN 196
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 87.6 bits (218), Expect = 4e-19
Identities = 42/118 (35%), Positives = 56/118 (47%), Gaps = 17/118 (14%)
Query: 11 LRQYRKKHKNV--DIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKI 68
L Y K + IK+ Q+L GL +LHSH ++HRDLK NI V + G++K+
Sbjct: 105 LTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVT-SSGQIKL 161
Query: 69 GDLGLAIAMQQPTARSVIGTPEFM-----APE-LYEEEYNELVDIYSFGMCIL-EMVT 119
D GLA A T + APE L + Y VD++S G CI EM
Sbjct: 162 ADFGLARIYSFQMAL----TSVVVTLWYRAPEVLLQSSYATPVDLWSVG-CIFAEMFR 214
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 4e-19
Identities = 44/127 (34%), Positives = 64/127 (50%), Gaps = 10/127 (7%)
Query: 1 MITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV 59
+I E G+LR Y +KHK +D + + QI G+ YL + IHRDL NI V
Sbjct: 90 LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILV 147
Query: 60 NGNHGEVKIGDLGLA--IAMQQPTARSVIGT--PEF-MAPE-LYEEEYNELVDIYSFGMC 113
N VKIGD GL + + + P F APE L E +++ D++SFG+
Sbjct: 148 -ENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVV 206
Query: 114 ILEMVTF 120
+ E+ T+
Sbjct: 207 LYELFTY 213
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 5e-19
Identities = 43/187 (22%), Positives = 89/187 (47%), Gaps = 22/187 (11%)
Query: 31 RQILHGLVYLHSHNPPIIHRDLKCDNI-FVNGNHG-EVKIGDLGLAIAMQ-QPTARSVIG 87
+ I + YLHS N I HRD+K +N+ + + +K+ D G A + +
Sbjct: 168 KSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY 225
Query: 88 TPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYP--YSECKNPAQ--IFKKVTSGI- 141
TP ++APE L E+Y++ D++S G I+ ++ YP YS + ++ G
Sbjct: 226 TPYYVAPEVLGPEKYDKSCDMWSLG-VIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY 284
Query: 142 --KPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQKEPICDPLKLPIQ 198
++V++ ++K I L ++R++ + + P++ ++ K P + P+
Sbjct: 285 EFPNPEWSEVSE-EVKMLIRNLLKTEPTQRMTITEFMNHPWIM-QSTKVP-----QTPLH 337
Query: 199 SLKMLRL 205
+ ++L+
Sbjct: 338 TSRVLKE 344
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 5e-19
Identities = 44/118 (37%), Positives = 59/118 (50%), Gaps = 17/118 (14%)
Query: 11 LRQY--RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKI 68
LR Y + + + IK+ RQ L GL +LH++ I+HRDLK +NI V + G VK+
Sbjct: 105 LRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVT-SGGTVKL 161
Query: 69 GDLGLAIAMQQPTARSVIGTPEFM-----APE-LYEEEYNELVDIYSFGMCIL-EMVT 119
D GLA A TP + APE L + Y VD++S G CI EM
Sbjct: 162 ADFGLARIYSYQMAL----TPVVVTLWYRAPEVLLQSTYATPVDMWSVG-CIFAEMFR 214
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 6e-19
Identities = 51/215 (23%), Positives = 77/215 (35%), Gaps = 56/215 (26%)
Query: 26 IKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSV 85
IK + +L+GL Y+H + I+HRD+K N+ + G +K+ D GLA A
Sbjct: 126 IKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQP 182
Query: 86 IG-TPE-----FMAPELY--EEEYNELVDIYSFGMCIL-EMVT----------------- 119
T + PEL E +Y +D++ G CI+ EM T
Sbjct: 183 NRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAG-CIMAEMWTRSPIMQGNTEQHQLALI 241
Query: 120 ---------------FEYP-YSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV 163
Y Y + + +KV +K DP I+K LV
Sbjct: 242 SQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVR----DPYALDLIDKLLV 297
Query: 164 --PASERLSAKDLLKDPFLQVENQKEPICDPLKLP 196
PA +R+ + D L F D +
Sbjct: 298 LDPA-QRIDSDDALNHDFF---WSDPMPSDLKGML 328
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 6e-19
Identities = 42/145 (28%), Positives = 66/145 (45%), Gaps = 12/145 (8%)
Query: 1 MITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV 59
M+TEL G+L +KH+ + + + +A Q+ G+ YL S IHRDL N+ +
Sbjct: 97 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLL 154
Query: 60 NGNHGEVKIGDLGLA--IAMQQPTARSVIGT--P-EFMAPE-LYEEEYNELVDIYSFGMC 113
VKIGD GL + P + APE L ++ D + FG+
Sbjct: 155 ATRD-LVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVT 213
Query: 114 ILEMVTF-EYPYSECKNPAQIFKKV 137
+ EM T+ + P+ +QI K+
Sbjct: 214 LWEMFTYGQEPWIGLNG-SQILHKI 237
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 86.8 bits (216), Expect = 6e-19
Identities = 54/185 (29%), Positives = 97/185 (52%), Gaps = 24/185 (12%)
Query: 4 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNH 63
ELF+ LR+ ++ V K +A ++ L YLHS + II+RDLK +NI ++ N
Sbjct: 92 ELFS--LLRKSQR----FPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLDKN- 142
Query: 64 GEVKIGDLGLAIAMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEY 122
G +KI D G A + T ++ GTP+++APE + + YN+ +D +SFG+ I EM+
Sbjct: 143 GHIKITDFGFAKYVPDVT-YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYT 201
Query: 123 PYSECKNPAQIFKKVTSG-IK-PASLAKVNDPQIKGFIEKCLVP-ASERL-----SAKDL 174
P+ N + ++K+ + ++ P + +K + + + S+RL +D+
Sbjct: 202 PF-YDSNTMKTYEKILNAELRFPPFF----NEDVKDLLSRLITRDLSQRLGNLQNGTEDV 256
Query: 175 LKDPF 179
P+
Sbjct: 257 KNHPW 261
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 88.7 bits (220), Expect = 7e-19
Identities = 43/147 (29%), Positives = 71/147 (48%), Gaps = 11/147 (7%)
Query: 1 MITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIF 58
++TE + G+L + K K + + + + A QI G+ Y+ N +HRDL+ NI
Sbjct: 255 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANIL 312
Query: 59 VNGNHGEVKIGDLGLAIAMQQP--TARSVIGTP-EFMAPE-LYEEEYNELVDIYSFGMCI 114
V G + K+ D GLA ++ TAR P ++ APE + D++SFG+ +
Sbjct: 313 V-GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILL 371
Query: 115 LEMVTF-EYPYSECKNPAQIFKKVTSG 140
E+ T PY N ++ +V G
Sbjct: 372 TELTTKGRVPYPGMVNR-EVLDQVERG 397
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 7e-19
Identities = 43/146 (29%), Positives = 74/146 (50%), Gaps = 10/146 (6%)
Query: 1 MITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV 59
+I EL T G LR + + K ++D+ + +A Q+ L YL S +HRD+ N+ V
Sbjct: 92 IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLV 149
Query: 60 NGNHGEVKIGDLGLAIAMQQPTARSVIGT--P-EFMAPE-LYEEEYNELVDIYSFGMCIL 115
+ N VK+GD GL+ M+ T P ++MAPE + + D++ FG+C+
Sbjct: 150 SSND-CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMW 208
Query: 116 EMVTF-EYPYSECKNPAQIFKKVTSG 140
E++ P+ KN + ++ +G
Sbjct: 209 EILMHGVKPFQGVKN-NDVIGRIENG 233
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 7e-19
Identities = 40/147 (27%), Positives = 70/147 (47%), Gaps = 12/147 (8%)
Query: 1 MITELFTSGNLRQY-RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV 59
++TE ++G L Y R K ++ + + G+ +L SH IHRDL N V
Sbjct: 80 IVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ--FIHRDLAARNCLV 137
Query: 60 NGNHGEVKIGDLGLAIAMQQPTARSVIGTPEF----MAPE-LYEEEYNELVDIYSFGMCI 114
VK+ D G+ + S +GT +F APE + +Y+ D+++FG+ +
Sbjct: 138 -DRDLCVKVSDFGMTRYVLDDQYVSSVGT-KFPVKWSAPEVFHYFKYSSKSDVWAFGILM 195
Query: 115 LEMVTF-EYPYSECKNPAQIFKKVTSG 140
E+ + + PY N +++ KV+ G
Sbjct: 196 WEVFSLGKMPYDLYTN-SEVVLKVSQG 221
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 8e-19
Identities = 48/170 (28%), Positives = 88/170 (51%), Gaps = 19/170 (11%)
Query: 4 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNH 63
E+F+ +LR+ + + +A QI+ YLHS + +I+RDLK +N+ ++
Sbjct: 127 EMFS--HLRRIGR----FSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLID-QQ 177
Query: 64 GEVKIGDLGLAIAMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEY 122
G +++ D G A ++ T ++ GTPE +APE + + YN+ VD ++ G+ I EM
Sbjct: 178 GYIQVTDFGFAKRVKGRT-WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYP 236
Query: 123 PYSECKNPAQIFKKVTSG-IK-PASLAKVNDPQIKGFIEKCLVP-ASERL 169
P+ P QI++K+ SG ++ P+ +K + L ++R
Sbjct: 237 PF-FADQPIQIYEKIVSGKVRFPSHF----SSDLKDLLRNLLQVDLTKRF 281
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 8e-19
Identities = 44/161 (27%), Positives = 74/161 (45%), Gaps = 26/161 (16%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 60
++ E G+LR Y +H + + + +A+QI G+ YLH+ + IHRDL N+ +
Sbjct: 112 LVMEYVPLGSLRDYLPRHS-IGLAQLLLFAQQICEGMAYLHAQH--YIHRDLAARNVLL- 167
Query: 61 GNHGEVKIGDLGLAIAMQQP----TARSVIGTPEF-MAPE-LYEEEYNELVDIYSFGMCI 114
N VKIGD GLA A+ + R +P F APE L E ++ D++SFG+ +
Sbjct: 168 DNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTL 227
Query: 115 LEMVTF---------------EYPYSECKNPAQIFKKVTSG 140
E++T + ++ + + G
Sbjct: 228 YELLTHCDSSQSPPTKFLELIGIAQGQMTV-LRLTELLERG 267
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 8e-19
Identities = 41/174 (23%), Positives = 79/174 (45%), Gaps = 27/174 (15%)
Query: 28 NWAR----QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--- 80
AR +I+ + +H +HRD+K DNI ++ G +++ D G + ++
Sbjct: 162 EMARFYLAEIVMAIDSVHRLG--YVHRDIKPDNILLD-RCGHIRLADFGSCLKLRADGTV 218
Query: 81 TARSVIGTPEFMAPEL--------YEEEYNELVDIYSFGMCILEMVTFEYP-YSECKNPA 131
+ +GTP++++PE+ Y D ++ G+ EM + P Y++ + A
Sbjct: 219 RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYAD--STA 276
Query: 132 QIFKKVTSGIKPASLAKVND---PQIKGFIEKCLVPASERL---SAKDLLKDPF 179
+ + K+ + SL V++ + + FI++ L P RL A D PF
Sbjct: 277 ETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLCPPETRLGRGGAGDFRTHPF 330
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 88.8 bits (220), Expect = 9e-19
Identities = 42/147 (28%), Positives = 71/147 (48%), Gaps = 11/147 (7%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIK--NWARQILHGLVYLHSHNPPIIHRDLKCDNIF 58
++TE + G+L + K +++ + + A QI G+ Y+ N +HRDL+ NI
Sbjct: 338 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANIL 395
Query: 59 VNGNHGEVKIGDLGLAIAMQQP--TARSVIGTP-EFMAPE-LYEEEYNELVDIYSFGMCI 114
V G + K+ D GLA ++ TAR P ++ APE + D++SFG+ +
Sbjct: 396 V-GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILL 454
Query: 115 LEMVTF-EYPYSECKNPAQIFKKVTSG 140
E+ T PY N ++ +V G
Sbjct: 455 TELTTKGRVPYPGMVNR-EVLDQVERG 480
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 1e-18
Identities = 44/127 (34%), Positives = 64/127 (50%), Gaps = 10/127 (7%)
Query: 1 MITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV 59
+I E G+LR Y +KHK +D + + QI G+ YL + IHRDL NI V
Sbjct: 121 LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILV 178
Query: 60 NGNHGEVKIGDLGLA--IAMQQPTARSVIGT--PEF-MAPE-LYEEEYNELVDIYSFGMC 113
N VKIGD GL + + + P F APE L E +++ D++SFG+
Sbjct: 179 -ENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVV 237
Query: 114 ILEMVTF 120
+ E+ T+
Sbjct: 238 LYELFTY 244
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 1e-18
Identities = 32/148 (21%), Positives = 68/148 (45%), Gaps = 12/148 (8%)
Query: 1 MITELFTSGNLRQY-RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV 59
++ E+ G L ++ K + + + + Q+ G+ YL N +HRDL N+ +
Sbjct: 86 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLL 143
Query: 60 NGNHGEVKIGDLGLA--IAMQQPTARSVIGT--P-EFMAPE-LYEEEYNELVDIYSFGMC 113
H KI D GL+ + + P ++ APE + +++ D++S+G+
Sbjct: 144 VNRH-YAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVT 202
Query: 114 ILEMVTF-EYPYSECKNPAQIFKKVTSG 140
+ E +++ + PY + K ++ + G
Sbjct: 203 MWEALSYGQKPYKKMKG-PEVMAFIEQG 229
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 1e-18
Identities = 44/127 (34%), Positives = 71/127 (55%), Gaps = 10/127 (7%)
Query: 1 MITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV 59
+I E SG+L++Y K+K +++K +A QI G+ YL S +HRDL N+ V
Sbjct: 102 LIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLV 159
Query: 60 NGNHGEVKIGDLGLAIAMQQP----TARSVIGTPEF-MAPE-LYEEEYNELVDIYSFGMC 113
H +VKIGD GL A++ T + +P F APE L + ++ D++SFG+
Sbjct: 160 ESEH-QVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVT 218
Query: 114 ILEMVTF 120
+ E++T+
Sbjct: 219 LHELLTY 225
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 1e-18
Identities = 35/147 (23%), Positives = 66/147 (44%), Gaps = 12/147 (8%)
Query: 1 MITELFTSGNLRQYRKKHKN-VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV 59
++TE G L Y + + + + + G+ YL +IHRDL N V
Sbjct: 80 LVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLV 137
Query: 60 NGNHGEVKIGDLGLAIAMQQPTARSVIGTPEF----MAPE-LYEEEYNELVDIYSFGMCI 114
G + +K+ D G+ + S GT +F +PE Y+ D++SFG+ +
Sbjct: 138 -GENQVIKVSDFGMTRFVLDDQYTSSTGT-KFPVKWASPEVFSFSRYSSKSDVWSFGVLM 195
Query: 115 LEMVTF-EYPYSECKNPAQIFKKVTSG 140
E+ + + PY N +++ + +++G
Sbjct: 196 WEVFSEGKIPYENRSN-SEVVEDISTG 221
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 1e-18
Identities = 44/227 (19%), Positives = 81/227 (35%), Gaps = 57/227 (25%)
Query: 11 LRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGD 70
R Y + + + + +K + Q+ L Y+HS I HRD+K N+ ++ + +K+ D
Sbjct: 143 ARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCD 200
Query: 71 LGLAIAMQQPTARSVIGTPEFM----------APELY--EEEYNELVDIYSFGMCIL-EM 117
G A+ ++ E APEL +Y +D++S G C+L E+
Sbjct: 201 FGS--------AKQLVRG-EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAG-CVLAEL 250
Query: 118 VTFE--YPYSECKN------------PAQIFKKVTSG--------IKPASLAKV----ND 151
+ + +P + + +++ IK KV
Sbjct: 251 LLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTP 310
Query: 152 PQIKGFIEKCLV--PASERLSAKDLLKDPFLQV---ENQKEPICDPL 193
P+ + L P + RL+ + F N K P
Sbjct: 311 PEAIALCSRLLEYTP-TARLTPLEACAHSFFDELRDPNVKLPNGRDT 356
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 1e-18
Identities = 47/149 (31%), Positives = 75/149 (50%), Gaps = 12/149 (8%)
Query: 30 ARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IAMQQPTARSVIG 87
A +I L YLHS N I++RDLK +NI ++ G + + D GL T + G
Sbjct: 145 AAEIASALGYLHSLN--IVYRDLKPENILLDSQ-GHIVLTDFGLCKENIEHNSTTSTFCG 201
Query: 88 TPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASL 146
TPE++APE L+++ Y+ VD + G + EM+ P+ +N A+++ + + KP L
Sbjct: 202 TPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPF-YSRNTAEMYDNILN--KPLQL 258
Query: 147 AKVNDPQIKGFIEKCLV--PASERLSAKD 173
+ +E L +RL AKD
Sbjct: 259 KPNITNSARHLLEGLLQKDRT-KRLGAKD 286
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 1e-18
Identities = 48/162 (29%), Positives = 84/162 (51%), Gaps = 16/162 (9%)
Query: 29 WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-TARSVIG 87
+A +I GL LH I++RDLK +NI ++ +HG ++I DLGLA+ + + T + +G
Sbjct: 291 YAAEICCGLEDLHRER--IVYRDLKPENILLD-DHGHIRISDLGLAVHVPEGQTIKGRVG 347
Query: 88 TPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI--KPA 144
T +MAPE + E Y D ++ G + EM+ + P+ + + ++V + P
Sbjct: 348 TVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPF-QQRKKKIKREEVERLVKEVPE 406
Query: 145 SLAKVNDPQIKGFIEKCLV--PASERL-----SAKDLLKDPF 179
++ PQ + + L PA ERL SA+++ + P
Sbjct: 407 EYSERFSPQARSLCSQLLCKDPA-ERLGCRGGSAREVKEHPL 447
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 2e-18
Identities = 37/112 (33%), Positives = 56/112 (50%), Gaps = 7/112 (6%)
Query: 32 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA-IAMQQP-TARSVIGTP 89
+I L +LH II+RDLK +NI +N G VK+ D GL ++ + GT
Sbjct: 129 EISMALGHLHQKG--IIYRDLKPENIMLNHQ-GHVKLTDFGLCKESIHDGTVTHTFCGTI 185
Query: 90 EFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG 140
E+MAPE L +N VD +S G + +M+T P+ +N + K+
Sbjct: 186 EYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPF-TGENRKKTIDKILKC 236
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 2e-18
Identities = 35/109 (32%), Positives = 60/109 (55%), Gaps = 7/109 (6%)
Query: 32 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA-IAMQQP-TARSVIGTP 89
++ L +LHS II+RDLK +NI ++ G +K+ D GL+ ++ A S GT
Sbjct: 134 ELALALDHLHSLG--IIYRDLKPENILLDEE-GHIKLTDFGLSKESIDHEKKAYSFCGTV 190
Query: 90 EFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKV 137
E+MAPE + + + D +SFG+ + EM+T P+ + K+ + +
Sbjct: 191 EYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPF-QGKDRKETMTMI 238
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 2e-18
Identities = 46/154 (29%), Positives = 80/154 (51%), Gaps = 13/154 (8%)
Query: 32 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA-IAMQQP-TARSVIGTP 89
+I+ GL +LHS I++RDLK DNI ++ + G +KI D G+ M + GTP
Sbjct: 126 EIILGLQFLHSKG--IVYRDLKLDNILLDKD-GHIKIADFGMCKENMLGDAKTNTFCGTP 182
Query: 90 EFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAK 148
+++APE L ++YN VD +SFG+ + EM+ + P+ ++ ++F + +
Sbjct: 183 DYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF-HGQDEEELFHSIRM--DNPFYPR 239
Query: 149 VNDPQIKGFIEKCLV--PASERL-SAKDLLKDPF 179
+ + K + K V P +RL D+ + P
Sbjct: 240 WLEKEAKDLLVKLFVREPE-KRLGVRGDIRQHPL 272
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 2e-18
Identities = 61/232 (26%), Positives = 97/232 (41%), Gaps = 65/232 (28%)
Query: 32 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IAMQQPTARSVIGTP 89
Q L + LH N +IHRDLK N+ +N N ++K+ D GLA I G
Sbjct: 120 QTLRAVKVLHGSN--VIHRDLKPSNLLINSN-CDLKVCDFGLARIIDESAADNSEPTGQQ 176
Query: 90 EFM----------APE--LYEEEYNELVDIYSFGMCIL-EMVT----------------- 119
M APE L +Y+ +D++S G CIL E+
Sbjct: 177 SGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCG-CILAELFLRRPIFPGRDYRHQLLLI 235
Query: 120 FEY---PYSE-----CKNP-AQIFKKVTSGIKPASLAKV---NDPQIKGFIEKCLV--PA 165
F P+S+ ++P A+ + K A L K+ +P+ +++ LV P
Sbjct: 236 FGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDP- 294
Query: 166 SERLSAKDLLKDPFLQV--ENQKEPICDPL------------KLPIQSLKML 203
++R++AK+ L+ P+LQ + EP +P+ L + LK L
Sbjct: 295 AKRITAKEALEHPYLQTYHDPNDEPEGEPIPPSFFEFDHYKEALTTKDLKKL 346
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 2e-18
Identities = 42/147 (28%), Positives = 71/147 (48%), Gaps = 11/147 (7%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIK--NWARQILHGLVYLHSHNPPIIHRDLKCDNIF 58
+ITE T GNL Y ++ ++ + A QI + YL N IHR+L N
Sbjct: 293 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRNLAARNCL 350
Query: 59 VNGNHGEVKIGDLGLAIAMQQP--TARSVIGTP-EFMAPE-LYEEEYNELVDIYSFGMCI 114
V G + VK+ D GL+ M TA + P ++ APE L +++ D+++FG+ +
Sbjct: 351 V-GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLL 409
Query: 115 LEMVTF-EYPYSECKNPAQIFKKVTSG 140
E+ T+ PY +Q+++ +
Sbjct: 410 WEIATYGMSPYPGIDL-SQVYELLEKD 435
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 2e-18
Identities = 40/170 (23%), Positives = 75/170 (44%), Gaps = 31/170 (18%)
Query: 31 RQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA-RSVIGTP 89
R +L + +LH++N I+HRDLK +NI ++ N ++++ D G + ++ R + GTP
Sbjct: 207 RSLLEAVSFLHANN--IVHRDLKPENILLDDN-MQIRLSDFGFSCHLEPGEKLRELCGTP 263
Query: 90 EFMAPE-------LYEEEYNELVDIYSFGMCILEMVTFEY-------PYSECKNPAQIFK 135
++APE Y + VD+++ G IL + P+ + + +
Sbjct: 264 GYLAPEILKCSMDETHPGYGKEVDLWACG-VIL------FTLLAGSPPFWH-RRQILMLR 315
Query: 136 KVTSGI---KPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQ 181
+ G + K I + L RL+A+ L+ PF +
Sbjct: 316 MIMEGQYQFSSPEWDDRSSTV-KDLISRLLQVDPEARLTAEQALQHPFFE 364
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 2e-18
Identities = 38/118 (32%), Positives = 59/118 (50%), Gaps = 16/118 (13%)
Query: 11 LRQYRKKHKNV-DIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIG 69
L+QY N+ ++ +K + Q+L GL Y H ++HRDLK N+ +N GE+K+
Sbjct: 86 LKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK--VLHRDLKPQNLLIN-ERGELKLA 142
Query: 70 DLGLAIAMQQPTARSVIGTPEFM-----APELY--EEEYNELVDIYSFGMCIL-EMVT 119
D GLA A PT E + P++ +Y+ +D++ G CI EM T
Sbjct: 143 DFGLARAKSIPTKTY---DNEVVTLWYRPPDILLGSTDYSTQIDMWGVG-CIFYEMAT 196
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 3e-18
Identities = 37/147 (25%), Positives = 67/147 (45%), Gaps = 12/147 (8%)
Query: 1 MITELFTSGNLRQY-RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV 59
+ITE +G L Y R+ + + + + + YL S +HRDL N V
Sbjct: 96 IITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLV 153
Query: 60 NGNHGEVKIGDLGLAIAMQQPTARSVIGTPEF----MAPE-LYEEEYNELVDIYSFGMCI 114
+ G VK+ D GL+ + S +G+ +F PE L +++ DI++FG+ +
Sbjct: 154 -NDQGVVKVSDFGLSRYVLDDEYTSSVGS-KFPVRWSPPEVLMYSKFSSKSDIWAFGVLM 211
Query: 115 LEMVTF-EYPYSECKNPAQIFKKVTSG 140
E+ + + PY N ++ + + G
Sbjct: 212 WEIYSLGKMPYERFTN-SETAEHIAQG 237
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 3e-18
Identities = 34/119 (28%), Positives = 64/119 (53%), Gaps = 14/119 (11%)
Query: 32 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA---IAMQQPTARSVIGT 88
+I+ L +LH II+RD+K +NI ++ ++G V + D GL+ +A + A GT
Sbjct: 167 EIVLALEHLHKLG--IIYRDIKLENILLD-SNGHVVLTDFGLSKEFVADETERAYDFCGT 223
Query: 89 PEFMAPELYEEE---YNELVDIYSFGMCILEMVT----FEYPYSECKNPAQIFKKVTSG 140
E+MAP++ +++ VD +S G+ + E++T F E + A+I +++
Sbjct: 224 IEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPF-TVDGEKNSQAEISRRILKS 281
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 4e-18
Identities = 37/106 (34%), Positives = 59/106 (55%), Gaps = 15/106 (14%)
Query: 22 DIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT 81
++ ++K + Q+L GL + H + I+HRDLK N+ +N G++K+GD GLA A P
Sbjct: 106 ELNLVKYFQWQLLQGLAFCHENK--ILHRDLKPQNLLIN-KRGQLKLGDFGLARAFGIPV 162
Query: 82 ARSVIGTPEFM-----APELY--EEEYNELVDIYSFGMCIL-EMVT 119
+ E + AP++ Y+ +DI+S G CIL EM+T
Sbjct: 163 NTF---SSEVVTLWYRAPDVLMGSRTYSTSIDIWSCG-CILAEMIT 204
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 5e-18
Identities = 46/197 (23%), Positives = 85/197 (43%), Gaps = 18/197 (9%)
Query: 31 RQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVI---- 86
Q++ GL YLHS I+H+D+K N+ + G +KI LG+A A+ A
Sbjct: 116 CQLIDGLEYLHSQG--IVHKDIKPGNLLLTTG-GTLKISALGVAEALHPFAADDTCRTSQ 172
Query: 87 GTPEFMAPELY--EEEYN-ELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI-- 141
G+P F PE+ + ++ VDI+S G+ + + T YP+ E N ++F+ + G
Sbjct: 173 GSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPF-EGDNIYKLFENIGKGSYA 231
Query: 142 KPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQKEPICDPLKLPIQSL 200
P P + ++ L ++R S + + + + + ++ P+ +
Sbjct: 232 IPGDC----GPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPVPIPPSPDTK 287
Query: 201 KMLRLPMSGPSSMDIDS 217
R P D+
Sbjct: 288 DRWRSMTVVPYLEDLHG 304
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 6e-18
Identities = 36/205 (17%), Positives = 86/205 (41%), Gaps = 19/205 (9%)
Query: 1 MITELFT-SGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV 59
+I E +L + + + ++ +++ Q+L + + H+ ++HRD+K +NI +
Sbjct: 125 LILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILI 182
Query: 60 NGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYE-EEYN-ELVDIYSFGMCILEM 117
+ N GE+K+ D G ++ GT + PE Y+ ++S G+ + +M
Sbjct: 183 DLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDM 242
Query: 118 VTFEYPYSECKNPAQIFKKVTSGI--KPASLAKVNDPQIKGFIEKCLVPA-SERLSAKDL 174
V + P+ +++ G ++ + + I CL S+R + +++
Sbjct: 243 VCGDIPFEH-------DEEIIRGQVFFRQRVS----SECQHLIRWCLALRPSDRPTFEEI 291
Query: 175 LKDPFLQVENQKEPICDPLKLPIQS 199
P++Q + + +
Sbjct: 292 QNHPWMQDVLLPQETAEIHLHSLSP 316
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 86.6 bits (214), Expect = 6e-18
Identities = 46/160 (28%), Positives = 82/160 (51%), Gaps = 17/160 (10%)
Query: 30 ARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TARSVIG 87
A +I GL +L S II+RDLK DN+ ++ G +KI D G+ T ++ G
Sbjct: 448 AAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSE-GHIKIADFGMCKENIWDGVTTKTFCG 504
Query: 88 TPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG--IKPA 144
TP+++APE + + Y + VD ++FG+ + EM+ + P+ E ++ ++F+ + P
Sbjct: 505 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPF-EGEDEDELFQSIMEHNVAYPK 563
Query: 145 SLAKVNDPQIKGFIEKCLVPASERL-----SAKDLLKDPF 179
S++K KG + K +RL +D+ + F
Sbjct: 564 SMSKEAVAICKGLMTKH---PGKRLGCGPEGERDIKEHAF 600
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 8e-18
Identities = 48/214 (22%), Positives = 91/214 (42%), Gaps = 24/214 (11%)
Query: 1 MITELFTSGN-LRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV 59
++ E L Y + + + + Q++ + + HS ++HRD+K +NI +
Sbjct: 115 LVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRG--VVHRDIKDENILI 172
Query: 60 NGNHGEVKIGDLGLAIAMQQPTARSVI-GTPEFMAPELYE-EEYN-ELVDIYSFGMCIL- 115
+ G K+ D G A+ + GT + PE +Y+ ++S G+ +L
Sbjct: 173 DLRRGCAKLIDFGSG-ALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGI-LLY 230
Query: 116 EMVTFEYPYSECKNPAQIFKKVTSGI--KPASLAKVNDPQIKGFIEKCLVPA-SERLSAK 172
+MV + P+ +++ PA ++ P I +CL P S R S +
Sbjct: 231 DMVCGDIPFER-------DQEILEAELHFPAHVS----PDCCALIRRCLAPKPSSRPSLE 279
Query: 173 DLLKDPFLQVENQKEPICDPLKLPIQSLKMLRLP 206
++L DP++Q + P+ +P K L LP
Sbjct: 280 EILLDPWMQTPAEDVPL-NPSKGGPAPLAWSLLP 312
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 9e-18
Identities = 38/148 (25%), Positives = 66/148 (44%), Gaps = 12/148 (8%)
Query: 1 MITELFTSGNLRQYRKKHKN-VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV 59
++TE +G+L + + H I + R + G+ YL +HRDL N+ V
Sbjct: 127 IVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG--YVHRDLAARNVLV 184
Query: 60 NGNHGEVKIGDLGLA--IAMQQPTARSVIGT--P-EFMAPE-LYEEEYNELVDIYSFGMC 113
+ N K+ D GL+ + A + G P + APE + ++ D++SFG+
Sbjct: 185 DSNL-VCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVV 243
Query: 114 ILEMVTF-EYPYSECKNPAQIFKKVTSG 140
+ E++ + E PY N + V G
Sbjct: 244 MWEVLAYGERPYWNMTN-RDVISSVEEG 270
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 50/197 (25%), Positives = 83/197 (42%), Gaps = 43/197 (21%)
Query: 32 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPE- 90
Q+L GL Y+HS N ++HRDLK N+F+N +KIGD GLA M + +
Sbjct: 128 QLLRGLKYIHSAN--VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGL 185
Query: 91 ----FMAPE--LYEEEYNELVDIYSFGMCIL-EMVT----F------------------- 120
+ +P L Y + +D+++ G CI EM+T F
Sbjct: 186 VTKWYRSPRLLLSPNNYTKAIDMWAAG-CIFAEMLTGKTLFAGAHELEQMQLILESIPVV 244
Query: 121 -EYPYSECKNPAQIFKKVTSGIKPASLAKV---NDPQIKGFIEKCLV--PASERLSAKDL 174
E E + ++ + L ++ + F+E+ L P +RL+A++
Sbjct: 245 HEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSP-MDRLTAEEA 303
Query: 175 LKDPFLQV--ENQKEPI 189
L P++ + EPI
Sbjct: 304 LSHPYMSIYSFPMDEPI 320
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 1e-17
Identities = 43/160 (26%), Positives = 85/160 (53%), Gaps = 17/160 (10%)
Query: 30 ARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA-IAMQQP-TARSVIG 87
+I+ L YLHS + +++RD+K +N+ ++ + G +KI D GL + T ++ G
Sbjct: 111 GAEIVSALEYLHSRD--VVYRDIKLENLMLDKD-GHIKITDFGLCKEGISDGATMKTFCG 167
Query: 88 TPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG-IK-PA 144
TPE++APE L + +Y VD + G+ + EM+ P+ ++ ++F+ + I+ P
Sbjct: 168 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-YNQDHERLFELILMEEIRFPR 226
Query: 145 SLAKVNDPQIKGFIEKCLVPASERL-----SAKDLLKDPF 179
+L+ + G ++K +RL AK++++ F
Sbjct: 227 TLSPEAKSLLAGLLKKD---PKQRLGGGPSDAKEVMEHRF 263
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 85.0 bits (210), Expect = 1e-17
Identities = 31/148 (20%), Positives = 68/148 (45%), Gaps = 12/148 (8%)
Query: 1 MITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV 59
++ E+ G L ++ + + + + Q+ G+ YL N +HR+L N+ +
Sbjct: 412 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRNLAARNVLL 469
Query: 60 NGNHGEVKIGDLGLA--IAMQQPTARSVIGT--P-EFMAPE-LYEEEYNELVDIYSFGMC 113
H KI D GL+ + + P ++ APE + +++ D++S+G+
Sbjct: 470 VNRH-YAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVT 528
Query: 114 ILEMVTF-EYPYSECKNPAQIFKKVTSG 140
+ E +++ + PY + K P ++ + G
Sbjct: 529 MWEALSYGQKPYKKMKGP-EVMAFIEQG 555
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 2e-17
Identities = 40/174 (22%), Positives = 66/174 (37%), Gaps = 21/174 (12%)
Query: 10 NLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIG 69
+L ++ + RQI L H+ HRD+K +NI V+ + +
Sbjct: 120 DLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAG--ATHRDVKPENILVSAD-DFAYLV 176
Query: 70 DLGLAIAMQQPT---ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCIL-EMVTFEYPY 124
D G+A A + +GT +MAPE + DIY+ C+L E +T PY
Sbjct: 177 DFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALT-CVLYECLTGSPPY 235
Query: 125 SECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDLLKDP 178
+ + + I S P I A + + A+ + K+P
Sbjct: 236 QG-DQLSVMGAHINQAIPRPSTV---RPGIP--------VAFDAVIARGMAKNP 277
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 2e-17
Identities = 46/148 (31%), Positives = 71/148 (47%), Gaps = 13/148 (8%)
Query: 1 MITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIF 58
+ITE T GNL Y ++ + V V+ A QI + YL N IHRDL N
Sbjct: 86 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCL 143
Query: 59 VNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEF----MAPE-LYEEEYNELVDIYSFGMC 113
V NH VK+ D GL+ M T + G +F APE L +++ D+++FG+
Sbjct: 144 VGENH-LVKVADFGLSRLMTGDTYTAHAGA-KFPIKWTAPESLAYNKFSIKSDVWAFGVL 201
Query: 114 ILEMVTF-EYPYSECKNPAQIFKKVTSG 140
+ E+ T+ PY +Q+++ +
Sbjct: 202 LWEIATYGMSPYPGIDL-SQVYELLEKD 228
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 2e-17
Identities = 40/118 (33%), Positives = 59/118 (50%), Gaps = 16/118 (13%)
Query: 11 LRQYRKKHKNV-DIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIG 69
L K + V IK + L GL YLH H I+HRDLK +N+ ++ +G +K+
Sbjct: 98 LEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLD-ENGVLKLA 154
Query: 70 DLGLAIAMQQPTARSVIGTPEFM-----APELY--EEEYNELVDIYSFGMCIL-EMVT 119
D GLA + P R+ T + + APEL Y VD+++ G CIL E++
Sbjct: 155 DFGLAKSFGSPN-RAY--THQVVTRWYRAPELLFGARMYGVGVDMWAVG-CILAELLL 208
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 2e-17
Identities = 34/149 (22%), Positives = 62/149 (41%), Gaps = 13/149 (8%)
Query: 1 MITELFTSGNLRQY-RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV 59
++ G+L Q+ R +N +K + ++ Q+ G+ YL +HRDL N +
Sbjct: 100 VLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK--FVHRDLAARNCML 157
Query: 60 NGNHGEVKIGDLGLA--IAMQQPTARSVIGTPEF----MAPE-LYEEEYNELVDIYSFGM 112
+ + VK+ D GLA I ++ + A E L + D++SFG+
Sbjct: 158 DESF-TVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGV 216
Query: 113 CILEMVTF-EYPYSECKNPAQIFKKVTSG 140
+ E++T PY + + G
Sbjct: 217 LLWELLTRGAPPYRHIDP-FDLTHFLAQG 244
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 45/158 (28%), Positives = 82/158 (51%), Gaps = 17/158 (10%)
Query: 32 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA-IAMQQP-TARSVIGTP 89
+I GL +L S II+RDLK DN+ ++ G +KI D G+ + T ++ GTP
Sbjct: 129 EIAIGLFFLQSKG--IIYRDLKLDNVMLDSE-GHIKIADFGMCKENIWDGVTTKTFCGTP 185
Query: 90 EFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG--IKPASL 146
+++APE + + Y + VD ++FG+ + EM+ + P+ E ++ ++F+ + P S+
Sbjct: 186 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPF-EGEDEDELFQSIMEHNVAYPKSM 244
Query: 147 AKVNDPQIKGFIEKCLVPASERL-----SAKDLLKDPF 179
+K KG + K +RL +D+ + F
Sbjct: 245 SKEAVAICKGLMTKH---PGKRLGCGPEGERDIKEHAF 279
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 2e-17
Identities = 56/236 (23%), Positives = 89/236 (37%), Gaps = 59/236 (25%)
Query: 1 MITELFTSGNLRQYRKKHKNV--DIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIF 58
M+ E+ NL KK+++ + +K ++Q+L GL Y+H IIH D+K +N+
Sbjct: 107 MVFEV-LGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC-GIIHTDIKPENVL 164
Query: 59 V-----NGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGM 112
+ N ++KI DLG A + + I T E+ +PE L + DI+S
Sbjct: 165 MEIVDSPENLIQIKIADLGNACWYDE-HYTNSIQTREYRSPEVLLGAPWGCGADIWSTAC 223
Query: 113 CILEMVT----FE--------------------------YPYSECKNPAQIFK-----KV 137
I E++T FE Y K F +
Sbjct: 224 LIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRN 283
Query: 138 TSGIKPASLAKV----------NDPQIKGFIEKCLV--PASERLSAKDLLKDPFLQ 181
S +K L V +I F+ L P +R A L+ P+L+
Sbjct: 284 ISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDP-RKRADAGGLVNHPWLK 338
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 3e-17
Identities = 46/147 (31%), Positives = 73/147 (49%), Gaps = 11/147 (7%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIK--NWARQILHGLVYLHSHNPPIIHRDLKCDNIF 58
+ITE +G+L + K + + + K + A QI G+ ++ N IHRDL+ NI
Sbjct: 84 IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANIL 141
Query: 59 VNGNHGEVKIGDLGLA--IAMQQPTARSVIGTP-EFMAPE-LYEEEYNELVDIYSFGMCI 114
V+ KI D GLA I + TAR P ++ APE + + D++SFG+ +
Sbjct: 142 VSDTL-SCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILL 200
Query: 115 LEMVTF-EYPYSECKNPAQIFKKVTSG 140
E+VT PY NP ++ + + G
Sbjct: 201 TEIVTHGRIPYPGMTNP-EVIQNLERG 226
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 3e-17
Identities = 35/108 (32%), Positives = 59/108 (54%), Gaps = 7/108 (6%)
Query: 32 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA-IAMQQP-TARSVIGTP 89
+I+ L++LH II+RDLK DN+ ++ G K+ D G+ + T + GTP
Sbjct: 132 EIISALMFLHDKG--IIYRDLKLDNVLLDHE-GHCKLADFGMCKEGICNGVTTATFCGTP 188
Query: 90 EFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKK 136
+++APE L E Y VD ++ G+ + EM+ P+ E +N +F+
Sbjct: 189 DYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPF-EAENEDDLFEA 235
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 4e-17
Identities = 39/149 (26%), Positives = 64/149 (42%), Gaps = 13/149 (8%)
Query: 1 MITELFTSGNLRQY-RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV 59
++ G+LR + R + N +K + + Q+ G+ YL S +HRDL N +
Sbjct: 104 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK--FVHRDLAARNCML 161
Query: 60 NGNHGEVKIGDLGLAIAMQQPTARSVIGTPEF------MAPE-LYEEEYNELVDIYSFGM 112
+ VK+ D GLA M SV MA E L +++ D++SFG+
Sbjct: 162 DEKF-TVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGV 220
Query: 113 CILEMVTF-EYPYSECKNPAQIFKKVTSG 140
+ E++T PY + I + G
Sbjct: 221 LLWELMTRGAPPYPDVNT-FDITVYLLQG 248
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 4e-17
Identities = 62/225 (27%), Positives = 86/225 (38%), Gaps = 70/225 (31%)
Query: 32 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEF 91
QIL GL Y+HS + IIHRDLK N+ VN + E+KI D GL AR T +
Sbjct: 140 QILRGLKYIHSAD--IIHRDLKPSNLAVNED-CELKILDFGL--------ARH---TADE 185
Query: 92 M----------APE--LYEEEYNELVDIYSFGMCIL-EMVTFEYPYSECKNPAQIFKKVT 138
M APE L YN+ VDI+S G CI+ E++T + K +
Sbjct: 186 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG-CIMAELLTGR-TLFPGTDHIDQLKLIL 243
Query: 139 SGI---KPASLAKVNDPQIKGFI--------------------------EKCLV--PASE 167
+ L K++ + +I EK LV +
Sbjct: 244 RLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDS-DK 302
Query: 168 RLSAKDLLKDPFLQV--ENQKEPICDPL-------KLPIQSLKML 203
R++A L + + EP+ DP L I K L
Sbjct: 303 RITAAQALAHAYFAQYHDPDDEPVADPYDQSLESRDLLIDEWKSL 347
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 5e-17
Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 12/148 (8%)
Query: 1 MITELFTSGNLRQYRKKHKN-VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV 59
++TE +G+L + +KH + + R I G+ YL +HRDL NI +
Sbjct: 123 IVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILI 180
Query: 60 NGNHGEVKIGDLGLA--IAMQQPTARSVIGT--P-EFMAPE-LYEEEYNELVDIYSFGMC 113
N N K+ D GL + A + G P + +PE + ++ D++S+G+
Sbjct: 181 NSNL-VCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIV 239
Query: 114 ILEMVTF-EYPYSECKNPAQIFKKVTSG 140
+ E++++ E PY E N + K V G
Sbjct: 240 LWEVMSYGERPYWEMSN-QDVIKAVDEG 266
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 5e-17
Identities = 44/147 (29%), Positives = 75/147 (51%), Gaps = 11/147 (7%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIK--NWARQILHGLVYLHSHNPPIIHRDLKCDNIF 58
+ITE G+L + K + + K +++ QI G+ ++ N IHRDL+ NI
Sbjct: 259 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANIL 316
Query: 59 VNGNHGEVKIGDLGLAIAMQQP--TARSVIGTP-EFMAPE-LYEEEYNELVDIYSFGMCI 114
V+ + KI D GLA ++ TAR P ++ APE + + D++SFG+ +
Sbjct: 317 VSASL-VCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILL 375
Query: 115 LEMVTF-EYPYSECKNPAQIFKKVTSG 140
+E+VT+ PY NP ++ + + G
Sbjct: 376 MEIVTYGRIPYPGMSNP-EVIRALERG 401
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 5e-17
Identities = 53/215 (24%), Positives = 86/215 (40%), Gaps = 50/215 (23%)
Query: 32 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEF 91
Q+L GL Y+H+ IIHRDLK N+ VN + E+KI D GLA V+ T +
Sbjct: 136 QMLKGLRYIHAAG--IIHRDLKPGNLAVNED-CELKILDFGLARQADSEMTGYVV-TRWY 191
Query: 92 MAPE--LYEEEYNELVDIYSFGMCIL-EMVTFEYPYSECKNPAQIFKKVTSGI---KPAS 145
APE L Y + VDI+S G CI+ EM+T + + + K++
Sbjct: 192 RAPEVILNWMRYTQTVDIWSVG-CIMAEMITGK-TLFKGSDHLDQLKEIMKVTGTPPAEF 249
Query: 146 LAKVNDPQIKGFI--------------------------EKCLV--PASERLSAKDLLKD 177
+ ++ + K ++ EK LV +R++A + L
Sbjct: 250 VQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDA-EQRVTAGEALAH 308
Query: 178 PFLQV--ENQKEPICDPL-------KLPIQSLKML 203
P+ + + + EP + K +
Sbjct: 309 PYFESLHDTEDEPQVQKYDDSFDDVDRTLDEWKRV 343
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 6e-17
Identities = 54/220 (24%), Positives = 87/220 (39%), Gaps = 53/220 (24%)
Query: 32 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPE- 90
QIL GL Y+HS N ++HRDLK N+ +N ++KI D GLA + T
Sbjct: 136 QILRGLKYIHSAN--VLHRDLKPSNLLLNTT-CDLKICDFGLARVADPDHDHTGFLTEYV 192
Query: 91 ----FMAPE--LYEEEYNELVDIYSFGMCIL-EMVTFE--YPYSECKN------------ 129
+ APE L + Y + +DI+S G CIL EM++ +P +
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVG-CILAEMLSNRPIFPGKHYLDQLNHILGILGSP 251
Query: 130 PAQIFKKVTS-----------GIKPASLAKV---NDPQIKGFIEKCLV--PASERLSAKD 173
+ + + ++ D + ++K L P +R+ +
Sbjct: 252 SQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNP-HKRIEVEQ 310
Query: 174 LLKDPFLQV--ENQKEPICDPL--------KLPIQSLKML 203
L P+L+ + EPI + LP + LK L
Sbjct: 311 ALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKEL 350
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 7e-17
Identities = 40/193 (20%), Positives = 75/193 (38%), Gaps = 49/193 (25%)
Query: 32 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA---IAMQQPTARSVIGT 88
+IL L Y HS I+HRD+K N+ ++ H ++++ D GLA Q+ R + +
Sbjct: 138 EILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR--VAS 193
Query: 89 PEFMAPE--LYEEEYNELVDIYSFGMCIL-EMVT-------------------------- 119
F PE + + Y+ +D++S G C+L M+
Sbjct: 194 RYFKGPELLVDYQMYDYSLDMWSLG-CMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED 252
Query: 120 -FEYPYSECKNPAQIF--------KKVTSGIKPASLAKVNDPQIKGFIEKCLV--PASER 168
++Y F +K + + P+ F++K L R
Sbjct: 253 LYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQ-SR 311
Query: 169 LSAKDLLKDPFLQ 181
L+A++ ++ P+
Sbjct: 312 LTAREAMEHPYFY 324
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 8e-17
Identities = 58/232 (25%), Positives = 87/232 (37%), Gaps = 70/232 (30%)
Query: 32 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPE- 90
Q+L G+ +LHS IIHRDLK NI V + +KI D GLA + S + TP
Sbjct: 135 QMLCGIKHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFGLA----RTAGTSFMMTPYV 187
Query: 91 ----FMAPE-LYEEEYNELVDIYSFGMCIL-EMVT----F-------------------- 120
+ APE + Y E VDI+S G CI+ EM+ F
Sbjct: 188 VTRYYRAPEVILGMGYKENVDIWSVG-CIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPC 246
Query: 121 ----------------EYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV- 163
P + ++F V + K+ Q + + K LV
Sbjct: 247 PEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLF-PADSEHNKLKASQARDLLSKMLVI 305
Query: 164 -PASERLSAKDLLKDPFLQV--ENQKEPICDPL---------KLPIQSLKML 203
S+R+S + L+ P++ V + + P + I+ K L
Sbjct: 306 DA-SKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEWKEL 356
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 8e-17
Identities = 46/239 (19%), Positives = 75/239 (31%), Gaps = 76/239 (31%)
Query: 11 LRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGD 70
R Y ++ +IK + Q++ + LH + + HRD+K N+ VN G +K+ D
Sbjct: 116 CRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCD 175
Query: 71 LGLAIAMQQPTARSVIGTPEFM----------APELY--EEEYNELVDIYSFGMCIL-EM 117
G A+ + + E APEL + Y VDI+S G CI EM
Sbjct: 176 FGS--------AKKLSPS-EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVG-CIFAEM 225
Query: 118 VT--------------------------------------FEYPYSECKNPAQIFKKVTS 139
+ + S+ + +F +
Sbjct: 226 MLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSL 285
Query: 140 GIKPASLAKVNDPQIKGFIEKCLV--PASERLSAKDLLKDPFLQV---ENQKEPICDPL 193
+ D + L P ER+ + L P+ K P L
Sbjct: 286 KDAKEAY----D-----LLSALLQYLP-EERMKPYEALCHPYFDELHDPATKLPNNKDL 334
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 40/148 (27%), Positives = 71/148 (47%), Gaps = 12/148 (8%)
Query: 1 MITELFTSGNLRQYRKKHKN-VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV 59
+ITE +G L ++ ++ + + R I G+ YL + N +HRDL NI V
Sbjct: 123 IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILV 180
Query: 60 NGNHGEVKIGDLGLA--IAMQQPTARSVIGT--P-EFMAPE-LYEEEYNELVDIYSFGMC 113
++ K+ D GL+ + + G P + APE + ++ D++SFG+
Sbjct: 181 -NSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIV 239
Query: 114 ILEMVTF-EYPYSECKNPAQIFKKVTSG 140
+ E++T+ E PY E N ++ K + G
Sbjct: 240 MWEVMTYGERPYWELSN-HEVMKAINDG 266
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 1e-16
Identities = 34/106 (32%), Positives = 55/106 (51%), Gaps = 6/106 (5%)
Query: 30 ARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TARSVIG 87
+ +I L YLH II+RDLK DN+ ++ G +K+ D G+ +P T + G
Sbjct: 116 SAEISLALNYLHERG--IIYRDLKLDNVLLDSE-GHIKLTDYGMCKEGLRPGDTTSTFCG 172
Query: 88 TPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQ 132
TP ++APE L E+Y VD ++ G+ + EM+ P+ +
Sbjct: 173 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDN 218
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 39/226 (17%), Positives = 69/226 (30%), Gaps = 69/226 (30%)
Query: 32 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEF 91
IL GL LH ++HRDL NI + N ++ I D L AR
Sbjct: 142 HILLGLHVLHEAG--VVHRDLHPGNILLADN-NDITICDFNL--------ARE-DTADAN 189
Query: 92 M----------APE--LYEEEYNELVDIYSFGMCIL-EMVTFEYPYSECKNPAQIFKKVT 138
APE + + + +LVD++S G C++ EM + K+
Sbjct: 190 KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAG-CVMAEMFNRK-ALFRGSTFYNQLNKIV 247
Query: 139 SGI---KPASLAKVNDPQIKGFI---------------------------EKCLV--PAS 166
+ K + + P + ++ K L P
Sbjct: 248 EVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNP-Q 306
Query: 167 ERLSAKDLLKDPFLQV--ENQKEPICDPL-------KLPIQSLKML 203
R+S + L+ P+ + + + + +
Sbjct: 307 RRISTEQALRHPYFESLFDPLDLTEGLSERFHFDESVTDVYDMHKI 352
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 59/216 (27%), Positives = 87/216 (40%), Gaps = 51/216 (23%)
Query: 32 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEF 91
Q+L GL Y+HS ++HRDLK N+ VN + E+KI D GLA V+ T +
Sbjct: 134 QMLKGLKYIHSAG--VVHRDLKPGNLAVNED-CELKILDFGLARHADAEMTGYVV-TRWY 189
Query: 92 MAPE--LYEEEYNELVDIYSFGMCIL-EMVTFEYPYSECKNPAQIFKKVTSGI---KPAS 145
APE L YN+ VDI+S G CI+ EM+T + + K+ ++
Sbjct: 190 RAPEVILSWMHYNQTVDIWSVG-CIMAEMLTGK-TLFKGKDYLDQLTQILKVTGVPGTEF 247
Query: 146 LAKVNDPQIKGFI--------------------------EKCLV--PASERLSAKDLLKD 177
+ K+ND K +I EK L +RL+A L
Sbjct: 248 VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDV-DKRLTAAQALTH 306
Query: 178 PFLQV--ENQKEPICDP--------LKLPIQSLKML 203
PF + + ++E KL + K
Sbjct: 307 PFFEPFRDPEEETEAQQPFDDSLEHEKLTVDEWKQH 342
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 2e-16
Identities = 49/213 (23%), Positives = 88/213 (41%), Gaps = 15/213 (7%)
Query: 31 RQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVI---- 86
Q++ G+VYLH I HRD+K +N+ ++ +KI D GLA + ++
Sbjct: 112 HQLMAGVVYLHGIG--ITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMC 168
Query: 87 GTPEFMAPELYE-EEYN-ELVDIYSFGMCILEMVTFEYPYSECKNPAQI-FKKVTSGIKP 143
GT ++APEL + E++ E VD++S G+ + M+ E P+ + + Q
Sbjct: 169 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL 228
Query: 144 ASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQV---ENQKEPICDPLKLPIQS 199
K+ D + K LV S R++ D+ KD + + K P +
Sbjct: 229 NPWKKI-DSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESP 287
Query: 200 LKMLRLPMSGPSSMDIDSDYKQLSLSTCTESNN 232
+ S ++S + E ++
Sbjct: 288 SGFSKHIQSNLDFSPVNSASRTPGSGWSKEHHH 320
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 3e-16
Identities = 34/106 (32%), Positives = 55/106 (51%), Gaps = 6/106 (5%)
Query: 30 ARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TARSVIG 87
+ +I L YLH II+RDLK DN+ ++ G +K+ D G+ +P T + G
Sbjct: 159 SAEISLALNYLHERG--IIYRDLKLDNVLLDSE-GHIKLTDYGMCKEGLRPGDTTSTFCG 215
Query: 88 TPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQ 132
TP ++APE L E+Y VD ++ G+ + EM+ P+ +
Sbjct: 216 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDN 261
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 3e-16
Identities = 52/237 (21%), Positives = 102/237 (43%), Gaps = 17/237 (7%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 60
+I E + G L + + + +Q+L G+ Y HS I HRDLK +N ++
Sbjct: 93 IIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQ--ICHRDLKLENTLLD 150
Query: 61 GNH-GEVKIGDLGLAIAMQQPTA-RSVIGTPEFMAPELYE-EEYN-ELVDIYSFGMCILE 116
G+ +KI D G + + + +S +GTP ++APE+ +EY+ ++ D++S G+ +
Sbjct: 151 GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYV 210
Query: 117 MVTFEYPYSECKNPAQIFKKVTSGIK------PASLAKVNDPQIKGFIEKCLVP-ASERL 169
M+ YP+ E + ++K I P + P+ I + V + R+
Sbjct: 211 MLVGAYPF-EDPEEPRDYRKTIQRILSVKYSIPDDIRI--SPECCHLISRIFVADPATRI 267
Query: 170 SAKDLLKDPFLQVENQKEPICDPLKLPIQSLKMLRLPMSGPSSMDIDSDYKQLSLST 226
S ++ + N + + Q + + S + M I S+ ++
Sbjct: 268 SIPEIKTHSWFLK-NLPADLMNESNTGSQFQEPEQPMQSLDTIMQIISEATIPAVRN 323
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 3e-16
Identities = 49/190 (25%), Positives = 88/190 (46%), Gaps = 16/190 (8%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 60
M+ E + G L Y KH V+ + +QIL + Y H H ++HRDLK +N+ ++
Sbjct: 88 MVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM--VVHRDLKPENVLLD 145
Query: 61 GNHGEVKIGDLGLAIAMQQPTA--RSVIGTPEFMAPELYE-EEYN-ELVDIYSFGMCILE 116
+ KI D GL+ M R+ G+P + APE+ Y VDI+S G+ +
Sbjct: 146 AH-MNAKIADFGLS-NMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYA 203
Query: 117 MVTFEYPYSECKNPAQIFKKVTSGI--KPASLAKVNDPQIKGFIEKCLVP-ASERLSAKD 173
++ P+ + ++ +FKK+ G+ P L + + L +R + KD
Sbjct: 204 LLCGTLPFDD-EHVPTLFKKIRGGVFYIPEYLN----RSVATLLMHMLQVDPLKRATIKD 258
Query: 174 LLKDPFLQVE 183
+ + + + +
Sbjct: 259 IREHEWFKQD 268
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 4e-16
Identities = 38/149 (25%), Positives = 65/149 (43%), Gaps = 13/149 (8%)
Query: 1 MITELFTSGNLRQY-RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV 59
++ G+LR + R + N +K + + Q+ G+ +L S +HRDL N +
Sbjct: 168 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCML 225
Query: 60 NGNHGEVKIGDLGLAIAMQQPTARSVIGTPE------FMAPE-LYEEEYNELVDIYSFGM 112
+ VK+ D GLA M SV +MA E L +++ D++SFG+
Sbjct: 226 DEKF-TVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGV 284
Query: 113 CILEMVTF-EYPYSECKNPAQIFKKVTSG 140
+ E++T PY + I + G
Sbjct: 285 LLWELMTRGAPPYPDVNT-FDITVYLLQG 312
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 4e-16
Identities = 44/158 (27%), Positives = 75/158 (47%), Gaps = 10/158 (6%)
Query: 31 RQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVI---- 86
Q++ G+VYLH I HRD+K +N+ ++ +KI D GLA + ++
Sbjct: 112 HQLMAGVVYLHGIG--ITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMC 168
Query: 87 GTPEFMAPE-LYEEEYN-ELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPA 144
GT ++APE L E++ E VD++S G+ + M+ E P+ + + Q +
Sbjct: 169 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL 228
Query: 145 SLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQ 181
+ K D + K LV S R++ D+ KD +
Sbjct: 229 NPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN 266
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 6e-16
Identities = 44/158 (27%), Positives = 84/158 (53%), Gaps = 16/158 (10%)
Query: 32 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA-IAMQQP-TARSVIGTP 89
+I+ L YLHS +++RDLK +N+ ++ + G +KI D GL ++ T ++ GTP
Sbjct: 256 EIVSALDYLHSEKN-VVYRDLKLENLMLDKD-GHIKITDFGLCKEGIKDGATMKTFCGTP 313
Query: 90 EFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG-IK-PASL 146
E++APE L + +Y VD + G+ + EM+ P+ ++ ++F+ + I+ P +L
Sbjct: 314 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-YNQDHEKLFELILMEEIRFPRTL 372
Query: 147 AKVNDPQIKGFIEKCLVPASERL-----SAKDLLKDPF 179
+ G ++K +RL AK++++ F
Sbjct: 373 GPEAKSLLSGLLKKD---PKQRLGGGSEDAKEIMQHRF 407
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 7e-16
Identities = 51/190 (26%), Positives = 94/190 (49%), Gaps = 17/190 (8%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 60
M+ E + G L Y + K + + + +QI+ + Y H H I+HRDLK +N+ ++
Sbjct: 86 MVIE-YAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK--IVHRDLKPENLLLD 142
Query: 61 GNHGEVKIGDLGLAIAMQQPTA--RSVIGTPEFMAPELYE-EEYN-ELVDIYSFGMCILE 116
N VKI D GL+ + ++ G+P + APE+ + Y VD++S G+ +
Sbjct: 143 DN-LNVKIADFGLS-NIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYV 200
Query: 117 MVTFEYPYSECKNPAQIFKKVTSGI--KPASLAKVNDPQIKGFIEKCLVP-ASERLSAKD 173
M+ P+ + + +FKKV S + P L P + I + +V +R++ ++
Sbjct: 201 MLVGRLPFDD-EFIPNLFKKVNSCVYVMPDFL----SPGAQSLIRRMIVADPMQRITIQE 255
Query: 174 LLKDPFLQVE 183
+ +DP+ V
Sbjct: 256 IRRDPWFNVN 265
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 8e-16
Identities = 35/150 (23%), Positives = 66/150 (44%), Gaps = 21/150 (14%)
Query: 1 MITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIF 58
++TE G+L Y + + + ++ + + YL +N +HRDL N+
Sbjct: 92 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVL 149
Query: 59 VNGNHGEVKIGDLGLA--IAMQQPTARSVIGTPEF----MAPE-LYEEEYNELVDIYSFG 111
V+ ++ K+ D GL + Q T + APE L E++++ D++SFG
Sbjct: 150 VSEDN-VAKVSDFGLTKEASSTQDTGK-------LPVKWTAPEALREKKFSTKSDVWSFG 201
Query: 112 MCILEMVTF-EYPYSECKNPAQIFKKVTSG 140
+ + E+ +F PY + +V G
Sbjct: 202 ILLWEIYSFGRVPYPRIPL-KDVVPRVEKG 230
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 9e-16
Identities = 49/235 (20%), Positives = 95/235 (40%), Gaps = 26/235 (11%)
Query: 1 MITELFTSGN-LRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV 59
++ E SG L + +H +D + RQ++ + YL + IIHRD+K +NI +
Sbjct: 106 LVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKD--IIHRDIKDENIVI 163
Query: 60 NGNHGEVKIGDLGLAIAMQQ-PTARSVIGTPEFMAPELYE-EEYN-ELVDIYSFGMCILE 116
+ +K+ D G A +++ + GT E+ APE+ Y ++++S G+ +
Sbjct: 164 AED-FTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYT 222
Query: 117 MVTFEYPYSECKNPAQIFKKVTSGI--KPASLAKVNDPQIKGFIEKCLVP-ASERLSAKD 173
+V E P+ E ++ P ++ ++ + L P R + +
Sbjct: 223 LVFEENPFCE-------LEETVEAAIHPPYLVS----KELMSLVSGLLQPVPERRTTLEK 271
Query: 174 LLKDPFLQ-----VENQKEPICDPLKLPIQSLKMLRLPMSGPSSMDIDSDYKQLS 223
L+ DP++ + E + K L L M S D+ +
Sbjct: 272 LVTDPWVTQPVNLADYTWEEVFRVNKPESGVLSAASLEMGNRSLSDVAQAQELCG 326
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 1e-15
Identities = 36/160 (22%), Positives = 67/160 (41%), Gaps = 32/160 (20%)
Query: 1 MITELFTSGNLRQYRKKHK------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKC 54
+I G+L + + N+ ++ + + I G+ YL S N IHRDL
Sbjct: 108 VILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN--FIHRDLAA 165
Query: 55 DNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEF------------MAPE-LYEEEY 101
N + + V + D GL+ R + + +A E L + Y
Sbjct: 166 RNCMLAEDM-TVCVADFGLS--------RKIYSGDYYRQGCASKLPVKWLALESLADNLY 216
Query: 102 NELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSG 140
D+++FG+ + E++T + PY+ +N A+I+ + G
Sbjct: 217 TVHSDVWAFGVTMWEIMTRGQTPYAGIEN-AEIYNYLIGG 255
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 1e-15
Identities = 34/151 (22%), Positives = 66/151 (43%), Gaps = 23/151 (15%)
Query: 1 MITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIF 58
++TE G+L Y + + + ++ + + YL +N +HRDL N+
Sbjct: 264 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVL 321
Query: 59 VNGNHGEVKIGDLGLAIAMQQPTARSVIGTPE-------FMAPE-LYEEEYNELVDIYSF 110
V+ ++ K+ D GL + T + + APE L E++++ D++SF
Sbjct: 322 VSEDN-VAKVSDFGL--------TKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSF 372
Query: 111 GMCILEMVTF-EYPYSECKNPAQIFKKVTSG 140
G+ + E+ +F PY + +V G
Sbjct: 373 GILLWEIYSFGRVPYPRIPL-KDVVPRVEKG 402
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 1e-15
Identities = 40/168 (23%), Positives = 71/168 (42%), Gaps = 39/168 (23%)
Query: 1 MITELFTSGNLRQY-RKKHKNVDIKVIKN-------------WARQILHGLVYLHSHNPP 46
+ITE G+L + R+K + ++ ++ Q+ G+ +L S N
Sbjct: 127 VITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN-- 184
Query: 47 IIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEF------------MAP 94
IHRD+ N+ + N KIGD GL AR ++ + MAP
Sbjct: 185 CIHRDVAARNVLL-TNGHVAKIGDFGL--------ARDIMNDSNYIVKGNARLPVKWMAP 235
Query: 95 E-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSG 140
E +++ Y D++S+G+ + E+ + PY ++ +K V G
Sbjct: 236 ESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDG 283
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 1e-15
Identities = 43/164 (26%), Positives = 68/164 (41%), Gaps = 36/164 (21%)
Query: 1 MITELFTSGNLRQY----------RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHR 50
+I EL T G+L+ Y + + A +I G+ YL+++ +HR
Sbjct: 105 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHR 162
Query: 51 DLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEF------------MAPE-LY 97
DL N V + VKIGD G+ R + T + M+PE L
Sbjct: 163 DLAARNCMVAEDF-TVKIGDFGM--------TRDIYETDYYRKGGKGLLPVRWMSPESLK 213
Query: 98 EEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSG 140
+ + D++SFG+ + E+ T E PY N Q+ + V G
Sbjct: 214 DGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN-EQVLRFVMEG 256
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 2e-15
Identities = 38/172 (22%), Positives = 67/172 (38%), Gaps = 43/172 (25%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKN------------------WARQILHGLVYLHS 42
+ITE G+L + ++ ++ I + ++ Q+ G+ +L S
Sbjct: 104 VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS 163
Query: 43 HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEF----------- 91
N IHRDL NI + KI D GL AR + +
Sbjct: 164 KN--CIHRDLAARNILLTHGR-ITKICDFGL--------ARDIKNDSNYVVKGNARLPVK 212
Query: 92 -MAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSG 140
MAPE ++ Y D++S+G+ + E+ + PY ++ +K + G
Sbjct: 213 WMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEG 264
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 78.0 bits (192), Expect = 2e-15
Identities = 61/237 (25%), Positives = 85/237 (35%), Gaps = 80/237 (33%)
Query: 32 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEF 91
Q+L G+ +LHS IIHRDLK NI V + +KI D GL AR+ GT
Sbjct: 172 QMLCGIKHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFGL--------ART-AGTSFM 219
Query: 92 M----------APE-LYEEEYNELVDIYSFGMCIL-EMVT----F--------------- 120
M APE + Y E VDI+S G CI+ EMV F
Sbjct: 220 MTPYVVTRYYRAPEVILGMGYKENVDIWSVG-CIMGEMVRHKILFPGRDYIDQWNKVIEQ 278
Query: 121 ---------------------EYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIE 159
P ++F + K+ Q + +
Sbjct: 279 LGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFP-ADSEHNKLKASQARDLLS 337
Query: 160 KCLV--PASERLSAKDLLKDPFLQV---ENQKEPICDPL--------KLPIQSLKML 203
K LV PA +R+S D L+ P++ V + E + + I+ K L
Sbjct: 338 KMLVIDPA-KRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKEL 393
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 2e-15
Identities = 41/170 (24%), Positives = 69/170 (40%), Gaps = 41/170 (24%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKN----------------WARQILHGLVYLHSHN 44
+I E GNL Y + +N + ++ Q+ G+ +L S
Sbjct: 109 VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK 168
Query: 45 PPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEF------------M 92
IHRDL NI ++ + VKI D GL AR + P++ M
Sbjct: 169 --CIHRDLAARNILLSEKN-VVKICDFGL--------ARDIYKDPDYVRKGDARLPLKWM 217
Query: 93 APE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSG 140
APE +++ Y D++SFG+ + E+ + PY K + +++ G
Sbjct: 218 APETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 267
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 2e-15
Identities = 56/251 (22%), Positives = 90/251 (35%), Gaps = 67/251 (26%)
Query: 1 MITELFTSGNLRQYRKKHKNV--DIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI- 57
M EL S NL + KK+K + +++ +A IL L LH + IIH DLK +NI
Sbjct: 176 MTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR--IIHCDLKPENIL 232
Query: 58 FVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCIL- 115
+K+ D G + Q + I + + APE + Y +D++S G CIL
Sbjct: 233 LKQQGRSGIKVIDFGSSCYEHQRVY-TYIQSRFYRAPEVILGARYGMPIDMWSLG-CILA 290
Query: 116 EMVT--------------------------------------FE---YPYSECKNPAQIF 134
E++T YP
Sbjct: 291 ELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDG 350
Query: 135 KKVTSGIKP---------------ASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDP 178
V +G + +L +DP F+++CL + R++ L+ P
Sbjct: 351 SVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHP 410
Query: 179 FLQVENQKEPI 189
+L+ K P
Sbjct: 411 WLRRRLPKPPT 421
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 3e-15
Identities = 52/258 (20%), Positives = 87/258 (33%), Gaps = 94/258 (36%)
Query: 32 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA-------------IAMQ 78
Q++ + YLHS ++HRD+K NI +N VK+ D GL+
Sbjct: 117 QLIKVIKYLHSGG--LLHRDMKPSNILLNAE-CHVKVADFGLSRSFVNIRRVTNNIPLSI 173
Query: 79 QPTARSVIGTPEFM----------APE--LYEEEYNELVDIYSFGMCIL-EMVT----F- 120
+ + APE L +Y + +D++S G CIL E++ F
Sbjct: 174 NENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLG-CILGEILCGKPIFP 232
Query: 121 --------------------------------EY----------PYSECKNPAQIFKKVT 138
S ++ +K +
Sbjct: 233 GSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLL 292
Query: 139 SGIKPASLAKVNDPQIKGFIEKCLV--PASERLSAKDLLKDPFLQV--ENQKEPICDP-- 192
I P + + + ++K L P ++R+SA D LK PF+ + +EP CD
Sbjct: 293 LKINPKADC---NEEALDLLDKLLQFNP-NKRISANDALKHPFVSIFHNPNEEPNCDHII 348
Query: 193 -------LKLPIQSLKML 203
+K I + L
Sbjct: 349 TIPINDNVKHSIDDYRNL 366
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 3e-15
Identities = 42/170 (24%), Positives = 73/170 (42%), Gaps = 42/170 (24%)
Query: 1 MITELFTSGNLRQYRKKH----------------KNVDIKVIKNWARQILHGLVYLHSHN 44
M+ E G+L ++ + H + + + + A QI G+VYL S +
Sbjct: 94 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH 153
Query: 45 PPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEF------------M 92
+HRDL N V N VKIGD G+ +R V T + M
Sbjct: 154 --FVHRDLATRNCLVGANL-LVKIGDFGM--------SRDVYSTDYYRVGGHTMLPIRWM 202
Query: 93 APE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSG 140
PE + ++ D++SFG+ + E+ T+ + P+ + N ++ + +T G
Sbjct: 203 PPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN-TEVIECITQG 251
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 4e-15
Identities = 31/160 (19%), Positives = 63/160 (39%), Gaps = 32/160 (20%)
Query: 1 MITELFTSGNLRQYRKKHK------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKC 54
+I G+L Y + ++ ++ + + I G+ YL + N +HRDL
Sbjct: 118 VILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN--FLHRDLAA 175
Query: 55 DNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEF------------MAPE-LYEEEY 101
N + + V + D GL ++ + + +A E L + Y
Sbjct: 176 RNCMLRDDM-TVCVADFGL--------SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVY 226
Query: 102 NELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSG 140
D+++FG+ + E+ T PY +N +++ + G
Sbjct: 227 TSKSDVWAFGVTMWEIATRGMTPYPGVQN-HEMYDYLLHG 265
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 6e-15
Identities = 35/96 (36%), Positives = 50/96 (52%), Gaps = 20/96 (20%)
Query: 36 GLVYLHSH-NPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARS-----VIGTP 89
GL YLH H +P IIHRD+K NI ++ E +GD GLA M + V GT
Sbjct: 143 GLAYLHDHCDPKIIHRDVKAANILLDEEF-EAVVGDFGLAKLM--DYKDTHVTTAVRGTI 199
Query: 90 EFMAPELYEEEY------NELVDIYSFGMCILEMVT 119
+AP EY +E D++ +G+ +LE++T
Sbjct: 200 GHIAP-----EYLSTGKSSEKTDVFGYGVMLLELIT 230
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 6e-15
Identities = 37/170 (21%), Positives = 66/170 (38%), Gaps = 42/170 (24%)
Query: 1 MITELFTSGNLRQYRKKH----------------KNVDIKVIKNWARQILHGLVYLHSHN 44
MI + G+L ++ ++ + QI G+ YL SH+
Sbjct: 89 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH 148
Query: 45 PPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEF------------M 92
++H+DL N+ V VKI DLGL R V + M
Sbjct: 149 --VVHKDLATRNVLVYDKL-NVKISDLGLF--------REVYAADYYKLLGNSLLPIRWM 197
Query: 93 APE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSG 140
APE + +++ DI+S+G+ + E+ ++ PY N + + + +
Sbjct: 198 APEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-QDVVEMIRNR 246
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 75.6 bits (186), Expect = 9e-15
Identities = 52/190 (27%), Positives = 92/190 (48%), Gaps = 16/190 (8%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 60
M+ E + G L Y K+ +D K + +QIL G+ Y H H ++HRDLK +N+ ++
Sbjct: 93 MVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHM--VVHRDLKPENVLLD 150
Query: 61 GNHGEVKIGDLGLAIAMQQPTA--RSVIGTPEFMAPELYE-EEYN-ELVDIYSFGMCILE 116
+ KI D GL+ M R+ G+P + APE+ Y VDI+S G+ +
Sbjct: 151 AH-MNAKIADFGLS-NMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYA 208
Query: 117 MVTFEYPYSECKNPAQIFKKVTSGI--KPASLAKVNDPQIKGFIEKCLVP-ASERLSAKD 173
++ P+ + + +FKK+ GI P L +P + ++ L +R + KD
Sbjct: 209 LLCGTLPFDD-DHVPTLFKKICDGIFYTPQYL----NPSVISLLKHMLQVDPMKRATIKD 263
Query: 174 LLKDPFLQVE 183
+ + + + +
Sbjct: 264 IREHEWFKQD 273
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 1e-14
Identities = 37/124 (29%), Positives = 61/124 (49%), Gaps = 8/124 (6%)
Query: 1 MITELFTSGNLRQYRKKHKN--VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI- 57
++ E+ S NL + V + + + +A+Q+ L++L + IIH DLK +NI
Sbjct: 133 LVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENIL 191
Query: 58 FVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCIL- 115
N +KI D G + + Q I + + +PE L Y+ +D++S G CIL
Sbjct: 192 LCNPKRSAIKIVDFGSSCQLGQRIY-QYIQSRFYRSPEVLLGMPYDLAIDMWSLG-CILV 249
Query: 116 EMVT 119
EM T
Sbjct: 250 EMHT 253
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 1e-14
Identities = 39/177 (22%), Positives = 65/177 (36%), Gaps = 48/177 (27%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKN-----------------------WARQILHGL 37
+I E G+L Y + + + +A Q+ G+
Sbjct: 126 LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGM 185
Query: 38 VYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEF------ 91
+L + +HRDL N+ V VKI D GL AR ++ +
Sbjct: 186 EFLEFKS--CVHRDLAARNVLVTHGK-VVKICDFGL--------ARDIMSDSNYVVRGNA 234
Query: 92 ------MAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSG 140
MAPE L+E Y D++S+G+ + E+ + PY A +K + +G
Sbjct: 235 RLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNG 291
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 1e-14
Identities = 39/155 (25%), Positives = 68/155 (43%), Gaps = 18/155 (11%)
Query: 1 MITELFTSGNLRQYRKKH-------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLK 53
++ EL G+L+ + ++ ++ + + + AR I G YL ++ IHRD+
Sbjct: 110 ILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIA 167
Query: 54 CDNIFVN--GNHGEVKIGDLGLAIAMQQPTARSVIGTPEF----MAPE-LYEEEYNELVD 106
N + G KIGD G+A + + + G M PE E + D
Sbjct: 168 ARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTD 227
Query: 107 IYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSG 140
+SFG+ + E+ + PY N ++ + VTSG
Sbjct: 228 TWSFGVLLWEIFSLGYMPYPSKSN-QEVLEFVTSG 261
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 1e-14
Identities = 35/127 (27%), Positives = 48/127 (37%), Gaps = 36/127 (28%)
Query: 32 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA----------------- 74
+L G+ Y+HS I+HRDLK N VN + VK+ D GLA
Sbjct: 164 NLLVGVKYVHSAG--ILHRDLKPANCLVNQD-CSVKVCDFGLARTVDYPENGNSQLPISP 220
Query: 75 --IAMQQPTARSVIGTPEFM----------APE--LYEEEYNELVDIYSFGMCIL-EMVT 119
M T + APE L +E Y E +D++S G CI E++
Sbjct: 221 REDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIG-CIFAELLN 279
Query: 120 FEYPYSE 126
Sbjct: 280 MIKENVA 286
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 2e-14
Identities = 49/268 (18%), Positives = 81/268 (30%), Gaps = 101/268 (37%)
Query: 32 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--------------IAM 77
+L G ++H IIHRDLK N +N + VK+ D GLA +
Sbjct: 137 NLLLGENFIHESG--IIHRDLKPANCLLNQD-CSVKVCDFGLARTINSEKDTNIVNDLEE 193
Query: 78 QQPTARSVIGTPEFM----------APE--LYEEEYNELVDIYSFGMCIL-EMVTFEY-- 122
+ + + APE L +E Y + +DI+S G CI E++
Sbjct: 194 NEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTG-CIFAELLNMLQSH 252
Query: 123 -----------PYSECKNPAQIFKKVTSGIK-----------------PASLAKVNDPQI 154
P S C + K L +N P++
Sbjct: 253 INDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEV 312
Query: 155 KGFI--------------------------EKCLV--PASERLSAKDLLKDPFLQV--EN 184
+I E L P ++R++ L P+L+ +
Sbjct: 313 IKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNP-NKRITIDQALDHPYLKDVRKK 371
Query: 185 QKEPICDP---------LKLPIQSLKML 203
+ E + L L+ +
Sbjct: 372 KLENFSTKKIILPFDDWMVLSETQLRYI 399
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 2e-14
Identities = 38/161 (23%), Positives = 67/161 (41%), Gaps = 25/161 (15%)
Query: 1 MITELFTSGNLRQYRKKH---------------KNVDIKVIKNWARQILHGLVYLHSHNP 45
M+ E G+L ++ + H + + + A Q+ G+VYL +
Sbjct: 120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH- 178
Query: 46 PIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEF----MAPE-LYEEE 100
+HRDL N V VKIGD G++ + V G M PE + +
Sbjct: 179 -FVHRDLATRNCLVGQGL-VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRK 236
Query: 101 YNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSG 140
+ D++SFG+ + E+ T+ + P+ + N + +T G
Sbjct: 237 FTTESDVWSFGVVLWEIFTYGKQPWYQLSN-TEAIDCITQG 276
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 3e-14
Identities = 44/170 (25%), Positives = 69/170 (40%), Gaps = 42/170 (24%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKN----------------WARQILHGLVYLHSHN 44
+I E + GNLR+Y + + ++ + Q+ G+ YL S
Sbjct: 118 VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK 177
Query: 45 PPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEF------------M 92
IHRDL N+ V N+ +KI D GL AR + + M
Sbjct: 178 --CIHRDLAARNVLVTENN-VMKIADFGL--------ARDINNIDYYKKTTNGRLPVKWM 226
Query: 93 APE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSG 140
APE L++ Y D++SFG+ + E+ T PY ++FK + G
Sbjct: 227 APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV-EELFKLLKEG 275
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 4e-14
Identities = 44/170 (25%), Positives = 69/170 (40%), Gaps = 42/170 (24%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKN----------------WARQILHGLVYLHSHN 44
+I E + GNLR+Y + + ++ + Q+ G+ YL S
Sbjct: 164 VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK 223
Query: 45 PPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEF------------M 92
IHRDL N+ V N+ +KI D GLA R + + M
Sbjct: 224 --CIHRDLAARNVLVTENN-VMKIADFGLA--------RDINNIDYYKKTTNGRLPVKWM 272
Query: 93 APE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSG 140
APE L++ Y D++SFG+ + E+ T PY ++FK + G
Sbjct: 273 APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV-EELFKLLKEG 321
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 5e-14
Identities = 39/155 (25%), Positives = 68/155 (43%), Gaps = 18/155 (11%)
Query: 1 MITELFTSGNLRQYRKKHK-------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLK 53
++ EL G+L+ + ++ + ++ + + + AR I G YL ++ IHRD+
Sbjct: 151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIA 208
Query: 54 CDNIFVN--GNHGEVKIGDLGLAIAMQQPTARSVIGTPEF----MAPE-LYEEEYNELVD 106
N + G KIGD G+A + + G M PE E + D
Sbjct: 209 ARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTD 268
Query: 107 IYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSG 140
+SFG+ + E+ + PY N ++ + VTSG
Sbjct: 269 TWSFGVLLWEIFSLGYMPYPSKSN-QEVLEFVTSG 302
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 8e-14
Identities = 45/170 (26%), Positives = 70/170 (41%), Gaps = 42/170 (24%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKN----------------WARQILHGLVYLHSHN 44
+I E + GNLR+Y + + ++ N A Q+ G+ YL S
Sbjct: 152 VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK 211
Query: 45 PPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEF------------M 92
IHRDL N+ V ++ +KI D GLA R + + M
Sbjct: 212 --CIHRDLAARNVLVTEDN-VMKIADFGLA--------RDIHHIDYYKKTTNGRLPVKWM 260
Query: 93 APE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSG 140
APE L++ Y D++SFG+ + E+ T PY ++FK + G
Sbjct: 261 APEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV-EELFKLLKEG 309
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 9e-14
Identities = 42/178 (23%), Positives = 69/178 (38%), Gaps = 50/178 (28%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKN------------------------WARQILHG 36
+I E G+LR + ++ + V + + +A QI G
Sbjct: 103 LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQG 162
Query: 37 LVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEF----- 91
+ YL ++HRDL NI V ++KI D GL +R V +
Sbjct: 163 MQYLAEMK--LVHRDLAARNILVAEGR-KMKISDFGL--------SRDVYEEDSYVKRSQ 211
Query: 92 -------MAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSG 140
MA E L++ Y D++SFG+ + E+VT PY ++F + +G
Sbjct: 212 GRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP-ERLFNLLKTG 268
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 70.7 bits (173), Expect = 2e-13
Identities = 34/127 (26%), Positives = 58/127 (45%), Gaps = 25/127 (19%)
Query: 28 NWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIG 87
++ Q+ G+ +L S IHRDL NI ++ + VKI D GL AR +
Sbjct: 197 CYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKN-VVKICDFGL--------ARDIYK 245
Query: 88 TPEF------------MAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQI 133
P++ MAPE +++ Y D++SFG+ + E+ + PY K +
Sbjct: 246 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 305
Query: 134 FKKVTSG 140
+++ G
Sbjct: 306 CRRLKEG 312
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 3e-13
Identities = 39/159 (24%), Positives = 66/159 (41%), Gaps = 23/159 (14%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNW----------------ARQILHGLVYLHSHN 44
+ E GNL + +K + ++ A + G+ YL
Sbjct: 103 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ 162
Query: 45 PPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTP-EFMAPE-LYEEEYN 102
IHRDL NI V N+ KI D GL+ + +++ P +MA E L Y
Sbjct: 163 --FIHRDLAARNILVGENY-VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYT 219
Query: 103 ELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSG 140
D++S+G+ + E+V+ PY A++++K+ G
Sbjct: 220 TNSDVWSYGVLLWEIVSLGGTPYCGMTC-AELYEKLPQG 257
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 4e-13
Identities = 41/217 (18%), Positives = 85/217 (39%), Gaps = 43/217 (19%)
Query: 1 MITELFTSGNL--RQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI- 57
++ E G L R + + + + I + YLHS N I HRD+K +N+
Sbjct: 92 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLL 149
Query: 58 FVN-GNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILE 116
+ + + +K+ D G A E E+Y++ D++S G I+
Sbjct: 150 YTSKRPNAILKLTDFGF-------------------AKETTGEKYDKSCDMWSLG-VIMY 189
Query: 117 MVTFEYP--YSECKNPAQ--IFKKVTSGIKPASLAKVNDPQI----KGFIEKCLVP-ASE 167
++ YP YS + ++ G ++ K I L ++
Sbjct: 190 ILLCGYPPFYSNHGLAISPGMKTRIRMG--QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQ 247
Query: 168 RLSAKDLLKDPFLQVENQKEPICDPLKLPIQSLKMLR 204
R++ + + P++ ++ K P + P+ + ++L+
Sbjct: 248 RMTITEFMNHPWIM-QSTKVP-----QTPLHTSRVLK 278
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 6e-13
Identities = 34/178 (19%), Positives = 64/178 (35%), Gaps = 50/178 (28%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNW------------------------ARQILHG 36
++ E G+L ++ + + + + ARQ+ G
Sbjct: 127 LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAG 186
Query: 37 LVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEF----- 91
+ YL +HRDL N V N VKI D GL+ R++ +
Sbjct: 187 MAYLSERK--FVHRDLATRNCLVGENM-VVKIADFGLS--------RNIYSADYYKADGN 235
Query: 92 -------MAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSG 140
M PE ++ Y D++++G+ + E+ ++ PY + ++ V G
Sbjct: 236 DAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH-EEVIYYVRDG 292
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 68.3 bits (168), Expect = 7e-13
Identities = 33/88 (37%), Positives = 46/88 (52%), Gaps = 7/88 (7%)
Query: 36 GLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IAMQQPTARS--VIGTPEF 91
G+ +LH IHRD+K NI ++ KI D GLA T + ++GT +
Sbjct: 145 GINFLH--ENHHIHRDIKSANILLDEAF-TAKISDFGLARASEKFAQTVMTSRIVGTTAY 201
Query: 92 MAPELYEEEYNELVDIYSFGMCILEMVT 119
MAPE E DIYSFG+ +LE++T
Sbjct: 202 MAPEALRGEITPKSDIYSFGVVLLEIIT 229
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 2e-12
Identities = 31/91 (34%), Positives = 46/91 (50%), Gaps = 12/91 (13%)
Query: 36 GLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP------TARSVIGTP 89
GL YLH IIHRD+K NI ++ N KI D G++ + T V GT
Sbjct: 151 GLHYLH--TRAIIHRDVKSINILLDENF-VPKITDFGISKKGTELDQTHLSTV--VKGTL 205
Query: 90 EFMAPELYEEEY-NELVDIYSFGMCILEMVT 119
++ PE + + E D+YSFG+ + E++
Sbjct: 206 GYIDPEYFIKGRLTEKSDVYSFGVVLFEVLC 236
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 1e-11
Identities = 46/253 (18%), Positives = 91/253 (35%), Gaps = 71/253 (28%)
Query: 1 MITELFTSGNLRQYRKKHKNV--DIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIF 58
++ EL + + K++ + + I+ A QI + +LHS+ + H DLK +NI
Sbjct: 94 IVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK--LTHTDLKPENIL 150
Query: 59 VNGNHG------------------EVKIGDLGLAIAMQQPTARSVIGTPEFMAPE-LYEE 99
+ ++K+ D G A + +++ T + APE +
Sbjct: 151 FVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDE-HHSTLVSTRHYRAPEVILAL 209
Query: 100 EYNELVDIYSFGMCIL-EMVT-------------------------------------FE 121
+++ D++S G CIL E F
Sbjct: 210 GWSQPCDVWSIG-CILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFH 268
Query: 122 YPYSECKNPAQIFKKVTSGIKP----ASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLK 176
+ + + + V+ KP V ++ I+K L ++R++ ++ LK
Sbjct: 269 HDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALK 328
Query: 177 DPFLQVENQKEPI 189
PF + K+ I
Sbjct: 329 HPFFDL--LKKSI 339
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 3e-11
Identities = 48/255 (18%), Positives = 82/255 (32%), Gaps = 81/255 (31%)
Query: 1 MITELFTSGNLRQYRKKHKNV--DIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIF 58
+I E +L + ++ I+ IK + +IL L YL + + H DLK +NI
Sbjct: 113 LIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS--LTHTDLKPENIL 169
Query: 59 VNGNHG------------------------EVKIGDLGLAIAMQQPTARSVIGTPEFMAP 94
++ + +K+ D G A S+I T ++ AP
Sbjct: 170 LDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD-YHGSIINTRQYRAP 228
Query: 95 E-LYEEEYNELVDIYSFGMCIL-EMVT--------------------------------- 119
E + ++ D++SFG C+L E+ T
Sbjct: 229 EVILNLGWDVSSDMWSFG-CVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEAT 287
Query: 120 ------------FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-AS 166
+ + E + K V P + F+ L +
Sbjct: 288 KTNGSKYVNKDELKLAWPENASSINSIKHVKKC-LPLYK-IIKHELFCDFLYSILQIDPT 345
Query: 167 ERLSAKDLLKDPFLQ 181
R S +LLK FL+
Sbjct: 346 LRPSPAELLKHKFLE 360
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 4e-11
Identities = 43/262 (16%), Positives = 88/262 (33%), Gaps = 69/262 (26%)
Query: 1 MITELFTSGNLRQYRKKHKNV--DIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIF 58
+ EL N ++ K++ + +++ A Q+ H L +LH + + H DLK +NI
Sbjct: 99 IAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ--LTHTDLKPENIL 155
Query: 59 VNGN------------------HGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPE-LYEE 99
+ + +++ D G A +++ T + PE + E
Sbjct: 156 FVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSAT-FDHEHHTTIVATRHYRPPEVILEL 214
Query: 100 EYNELVDIYSFGMCIL-EMVT----F---------------------------------- 120
+ + D++S G CIL E F
Sbjct: 215 GWAQPCDVWSIG-CILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFY 273
Query: 121 --EYPYSECKNPAQIFKKVTSGIKPASLAK-VNDPQIKGFIEKCLVP-ASERLSAKDLLK 176
+ E + + K+ +K L + Q+ + + L ++R++ + L
Sbjct: 274 KGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALL 333
Query: 177 DPFLQVENQKEPICDPLKLPIQ 198
PF +E + P +
Sbjct: 334 HPFFAGLTPEERSFHTSRNPSR 355
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 62.2 bits (151), Expect = 1e-10
Identities = 52/269 (19%), Positives = 84/269 (31%), Gaps = 101/269 (37%)
Query: 10 NLRQYRKKHKN--VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV-------- 59
+L ++ K + + +K +Q+L GL YLH+ IIH D+K +NI +
Sbjct: 130 HLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKC-RIIHTDIKPENILLSVNEQYIR 188
Query: 60 ----------------------------------------NGNHGEVKIGDLGLAIAMQQ 79
N +VKI DLG A + +
Sbjct: 189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK 248
Query: 80 PTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPY-------------- 124
I T ++ + E L YN DI+S E+ T +Y +
Sbjct: 249 HF-TEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDH 307
Query: 125 ----------------SECKNPAQIFK-----KVTSGIKPASLAKV----------NDPQ 153
K + F K + +KP L +V
Sbjct: 308 IALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAG 367
Query: 154 IKGFIEKCLV--PASERLSAKDLLKDPFL 180
F+ L P +R +A + L+ P+L
Sbjct: 368 FTDFLLPMLELIP-EKRATAAECLRHPWL 395
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 21/102 (20%), Positives = 41/102 (40%), Gaps = 13/102 (12%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 60
M+ E +L++ ++ + ++L L Y+H + +H D+K N+ +
Sbjct: 129 MVMERLGI-DLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENE--YVHGDIKAANLLLG 185
Query: 61 -GNHGEVKIGDLGLA---------IAMQQPTARSVIGTPEFM 92
N +V + D GL+ Q+ + GT EF
Sbjct: 186 YKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFT 227
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 1e-07
Identities = 17/73 (23%), Positives = 33/73 (45%), Gaps = 12/73 (16%)
Query: 30 ARQILHGLVYLHSHNPPIIHRDLKCDNIFVN-GNHGEVKIGDLGLA---------IAMQQ 79
A ++L L +LH + +H ++ +NIFV+ + +V + G A +A +
Sbjct: 165 ACRLLDALEFLHENE--YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVE 222
Query: 80 PTARSVIGTPEFM 92
+ G EF+
Sbjct: 223 GSRSPHEGDLEFI 235
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 49.4 bits (118), Expect = 1e-06
Identities = 10/105 (9%), Positives = 25/105 (23%), Gaps = 27/105 (25%)
Query: 29 WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGT 88
+ + H + + V+ + G+V + M +
Sbjct: 134 AMQSLAAAADAAHRAG--VALSIDHPSRVRVSID-GDVVLAYPA---TMPDANPQD---- 183
Query: 89 PEFMAPELYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQI 133
DI G + ++ +P E + +
Sbjct: 184 -----------------DIRGIGASLYALLVNRWPLPEAGVRSGL 211
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 2e-06
Identities = 23/73 (31%), Positives = 32/73 (43%), Gaps = 12/73 (16%)
Query: 30 ARQILHGLVYLHSHNPPIIHRDLKCDNIFVN-GNHGEVKIGDLGLA---------IAMQQ 79
+ +IL L Y+H H +H D+K N+ +N N +V + D GLA A
Sbjct: 158 SLRILDILEYIHEHE--YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAA 215
Query: 80 PTARSVIGTPEFM 92
R GT EF
Sbjct: 216 DPKRCHDGTIEFT 228
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 48.7 bits (115), Expect = 3e-06
Identities = 35/188 (18%), Positives = 55/188 (29%), Gaps = 33/188 (17%)
Query: 18 HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN----------------- 60
K + K+ Q+ L + HRDL N+ +
Sbjct: 155 TKLSSLATAKSILHQLTASLAVAE-ASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSST 213
Query: 61 -GNHG-EVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMV 118
+ G +V I D L+ + V+ M +L+ + + DIY
Sbjct: 214 IPSCGLQVSIIDYTLSRLERDGI---VVFCDVSMDEDLFTGDGDYQFDIYRLMKKENNNR 270
Query: 119 TFEY-PYSECK-----NPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAK 172
EY PYS + + K +I+ F L + SA
Sbjct: 271 WGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS----SAT 326
Query: 173 DLLKDPFL 180
DLL L
Sbjct: 327 DLLCQHSL 334
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 8e-06
Identities = 23/95 (24%), Positives = 38/95 (40%), Gaps = 14/95 (14%)
Query: 10 NLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV--NGNHGEV 66
+L + +K + A Q++ + Y+HS N IHRD+K DN + V
Sbjct: 90 SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLV 147
Query: 67 KIGDLGLAIAMQQP---------TARSVIGTPEFM 92
I D GLA + +++ GT +
Sbjct: 148 YIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 182
|
| >2lru_A Serine/threonine-protein kinase WNK1; autoinhibitory domain, PF2 domain, transferase; NMR {Rattus norvegicus} Length = 98 | Back alignment and structure |
|---|
Score = 42.7 bits (100), Expect = 2e-05
Identities = 23/83 (27%), Positives = 37/83 (44%), Gaps = 9/83 (10%)
Query: 251 FRLRGTKNDD---TSVSLTLRIADS---SGRVRN---IHFLFYLDSDTALSVAGEMVEQL 301
R+ + DD ++ L LRI D G+ ++ I F F L+ D VA EMVE
Sbjct: 11 VRVELAEEDDGEKIAIKLWLRIEDIKKLKGKYKDNEAIEFSFDLERDVPEDVAQEMVESG 70
Query: 302 DLADHDVAFIAEFIDYLIMKLLP 324
+ + D +A+ I + +
Sbjct: 71 YVCEGDHKTMAKAIKDRVSLIKR 93
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 43.8 bits (103), Expect = 1e-04
Identities = 19/77 (24%), Positives = 38/77 (49%), Gaps = 6/77 (7%)
Query: 1 MITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV 59
++ +L +L + + +K + A Q+++ + ++HS + +HRD+K DN +
Sbjct: 80 LVMDLLGP-SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLM 136
Query: 60 --NGNHGEVKIGDLGLA 74
+V I D GLA
Sbjct: 137 GLGRRANQVYIIDFGLA 153
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 2e-04
Identities = 21/79 (26%), Positives = 36/79 (45%), Gaps = 8/79 (10%)
Query: 1 MITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV 59
M+ EL +L + +K + A Q++ + Y+HS N +I+RD+K +N +
Sbjct: 82 MVLELLGP-SLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN--LIYRDVKPENFLI 138
Query: 60 ----NGNHGEVKIGDLGLA 74
N + I D LA
Sbjct: 139 GRPGNKTQQVIHIIDFALA 157
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 5e-04
Identities = 13/70 (18%), Positives = 32/70 (45%), Gaps = 7/70 (10%)
Query: 10 NLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGE--- 65
+L + +K + A+Q+L + +H + +++RD+K DN + + +
Sbjct: 91 SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNAN 148
Query: 66 -VKIGDLGLA 74
+ + D G+
Sbjct: 149 MIYVVDFGMV 158
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 42.1 bits (98), Expect = 6e-04
Identities = 77/597 (12%), Positives = 161/597 (26%), Gaps = 178/597 (29%)
Query: 19 KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIF----VNGNHG-EVKIGDLGL 73
N D K +++ + IL H +F + + +
Sbjct: 31 DNFDCKDVQDMPKSILSKEEIDHIIMSK--DAVSGTLRLFWTLLSKQEEMVQKFVEE--- 85
Query: 74 AIAMQQPTARSVIGTPEFMAPELYEEEYNELVD-IYSFGMCILEM-VTFEYPYSECKNPA 131
+ + S I T E P + Y E D +Y+ + V+ PY + +
Sbjct: 86 VLRINYKFLMSPIKT-EQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQAL 144
Query: 132 QIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDLLKD-PF----LQVENQK 186
++PA ++ + G + + A + + + F L ++N
Sbjct: 145 L-------ELRPAKNVLIDG--VLGSGKTWV--ALDVCLSYKVQCKMDFKIFWLNLKNCN 193
Query: 187 EPICDPLKLPIQSLKMLRLPMSGPSSMDIDSDYKQLSLSTCTESNNGSPHCPVLEFQRMH 246
P + + +Q L ID ++ S + + +
Sbjct: 194 SP--ETVLEMLQKL-----------LYQIDPNWTSRSDHSSNIKLR-------IHSIQAE 233
Query: 247 KNNEFRLRGTKN-----DDTSVSLTLRIADSSGRV----RNIHFLFYLDSDTALSVAGEM 297
+ + +N + + + S ++ R ++
Sbjct: 234 LRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTR--------FKQVTDFLSAAT 285
Query: 298 VEQLDLADHDVAFIAE-----FIDYLIMKL--LPGWKPSYDYSSSGALSFYSVSP----I 346
+ L H + + + YL + LP L + +P I
Sbjct: 286 TTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLP----------REVL---TTNPRRLSI 332
Query: 347 LGNGKTSTPSPWDAMGAGVPSEFVVKQDVVSGPTRNPSQDLAPAQGENLHDNAGGGGISS 406
+ + WD ++ + D L I
Sbjct: 333 IAESIRDGLATWD-------------------NWKHVNCD-------KLTT------IIE 360
Query: 407 PSLAKLEDQESQS---SVASDIFVDDTSTKNDKASEFSDYSTDRSYKDLNGYVSELELGD 463
SL LE E + ++ +F + S D D+ V++L
Sbjct: 361 SSLNVLEPAEYRKMFDRLS--VFPPSA---HIPTILLSLIWFDVIKSDVMVVVNKLH--- 412
Query: 464 LCYDECKLQGNYSEDGEDILLYQFVKNSKLTFPNLSTVL------------SLTSSYSSL 511
YS L+ + K S ++ P++ L S+ Y+
Sbjct: 413 ----------KYS------LVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIP 456
Query: 512 SLTGKDVDELKMEIDAIEAQYEHWFQELS------KMKEEALEASRK----RWMAKK 558
D D + +D QY ++ + + E R++ +K
Sbjct: 457 KTFDSD-DLIPPYLD----QY--FYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQK 506
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 41.8 bits (97), Expect = 7e-04
Identities = 43/320 (13%), Positives = 84/320 (26%), Gaps = 81/320 (25%)
Query: 269 IADSSGRVRNIHFLFYLDSDTALSVAGEMVEQLDLADHDVAFIAEFIDYLIMKLLPGWKP 328
I S V LF+ + + VE++ ++ F+ I +P
Sbjct: 54 IIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYK--FLMSPIKTEQR------QP 105
Query: 329 SYDYSSSGALSFYSVSPILGNGKTSTPSPWDAMGAGVPSEFVVKQDVVSGPTRNPSQDLA 388
S + + + + V + R +L
Sbjct: 106 SMMTR----MYIEQRDRLYNDNQVFAKYN-------VSRLQPYLK------LRQALLELR 148
Query: 389 PAQGENLHDNAGGGGISSPSLAK--LEDQESQSSVASDIF------VDDTS--------- 431
PA+ + G G +A + Q + IF +
Sbjct: 149 PAKNVLID---GVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKL 205
Query: 432 ----TKNDKASEFSDYSTDRSYKDLNGYVSELELGDLCYDECKLQGNYSEDGEDILLYQF 487
N + + + + L L Y+ C L +L
Sbjct: 206 LYQIDPNWTSRSDHSSNIKLRIHSIQAELRRL-LKSKPYENCLL----------VL--LN 252
Query: 488 VKNSKL--TFPNLSTVLSLTSSYSSL--SLTGKDVDELKMEIDAIEAQYEHWFQELSKMK 543
V+N+K F +L LT+ + + L+ + + +H L+
Sbjct: 253 VQNAKAWNAFNLSCKIL-LTTRFKQVTDFLSAATTTHISL---------DHHSMTLT--P 300
Query: 544 EEALEASRKRW--MAKKRLP 561
+E K + + LP
Sbjct: 301 DEVKSLLLK-YLDCRPQDLP 319
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 563 | |||
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 99.98 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 99.98 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 99.98 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 99.98 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 99.98 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 99.98 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 99.98 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 99.98 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 99.98 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 99.98 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 99.98 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 99.98 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 99.98 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.98 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 99.98 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.98 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 99.98 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.98 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 99.98 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 99.98 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 99.98 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.98 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.97 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 99.97 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 99.97 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.97 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 99.97 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 99.97 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.97 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.97 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.97 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.97 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.97 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 99.97 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.97 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 99.97 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 99.97 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 99.97 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 99.97 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 99.97 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.97 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.97 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 99.97 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.97 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 99.97 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.97 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 99.97 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.97 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.97 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.97 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 99.97 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 99.97 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 99.97 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 99.97 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.97 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.97 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 99.97 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 99.97 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.97 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 99.97 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.97 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 99.97 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 99.97 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.97 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 99.97 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.97 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.97 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 99.97 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.97 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.97 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 99.97 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.97 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.97 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.97 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.97 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 99.97 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.97 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 99.97 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.97 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.97 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.97 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.97 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.97 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 99.97 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 99.97 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.97 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 99.97 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 99.97 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.97 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.97 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 99.97 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 99.97 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 99.97 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.97 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.97 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.97 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 99.97 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 99.97 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 99.97 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 99.97 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 99.97 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 99.96 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 99.96 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 99.96 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.96 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 99.96 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 99.96 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 99.96 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 99.96 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 99.96 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.96 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 99.96 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 99.96 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.96 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 99.96 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 99.96 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.96 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 99.96 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.96 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 99.96 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.96 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.96 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.96 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.96 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 99.96 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 99.96 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 99.96 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 99.96 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.96 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.96 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.96 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.96 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 99.96 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 99.96 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.96 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.96 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.96 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 99.96 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.96 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 99.96 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 99.96 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 99.96 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.96 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 99.96 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.96 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 99.96 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 99.96 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 99.96 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 99.96 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.96 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.96 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.96 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 99.96 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.96 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 99.96 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.96 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 99.96 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.96 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 99.96 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 99.96 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 99.96 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.96 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.96 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.96 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 99.95 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.95 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.95 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 99.95 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 99.95 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.95 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 99.95 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.95 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.95 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.95 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.95 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.95 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.95 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.95 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.94 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.93 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.9 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.86 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.65 | |
| 2v3s_A | 96 | Serine/threonine-protein kinase OSR1; ATP-binding, | 99.59 | |
| 2lru_A | 98 | Serine/threonine-protein kinase WNK1; autoinhibito | 99.19 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.41 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.08 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 98.63 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 97.99 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 97.73 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 97.61 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 97.43 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.29 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 96.66 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 96.07 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 95.61 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 94.27 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 94.25 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 93.79 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 90.47 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 90.05 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 83.7 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 83.57 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 82.82 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 80.66 |
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=376.25 Aligned_cols=183 Identities=61% Similarity=1.068 Sum_probs=170.1
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
||||||+||+|.+++.+.+.+++..++.|+.||+.||+|||++|++||||||||+||||++.+|.+||+|||+|+.....
T Consensus 106 lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~ 185 (290)
T 3fpq_A 106 LVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS 185 (290)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred EEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCC
Confidence 68999999999999999899999999999999999999999999889999999999999866789999999999876666
Q ss_pred CCccccCCCCccCcccccccCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHHHHHH
Q 008504 81 TARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEK 160 (563)
Q Consensus 81 ~~~~~~Gtp~Y~APEvl~~~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~LI~k 160 (563)
...+.+|||.|||||++.+.|+.++|||||||++|||+||+.||.+..+...++..+..+..+..++...++++++||.+
T Consensus 186 ~~~~~~GTp~YmAPE~~~~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~ 265 (290)
T 3fpq_A 186 FAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEG 265 (290)
T ss_dssp SBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHH
T ss_pred ccCCcccCccccCHHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHHHHHHHHH
Confidence 66778999999999999989999999999999999999999999887888899999999888888888889999999999
Q ss_pred hcC-CCCCCCCHHHHHcCcccccc
Q 008504 161 CLV-PASERLSAKDLLKDPFLQVE 183 (563)
Q Consensus 161 cL~-dP~kRpSa~ELLkHpff~~~ 183 (563)
||. ||.+|||+.|+|+||||+..
T Consensus 266 ~L~~dP~~R~s~~e~l~Hp~~~~~ 289 (290)
T 3fpq_A 266 CIRQNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp HSCSSGGGSCCHHHHHTSGGGC--
T ss_pred HccCChhHCcCHHHHhcCccccCC
Confidence 997 89999999999999999853
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-42 Score=352.54 Aligned_cols=182 Identities=24% Similarity=0.402 Sum_probs=159.6
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC-
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ- 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~- 79 (563)
||||||+||+|.+++.+.+.+++..++.|+.||+.||.|||++| |+||||||+|||++ .+|.+||+|||+|+....
T Consensus 103 ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~-~~g~vKl~DFGla~~~~~~ 179 (304)
T 3ubd_A 103 LILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLD-EEGHIKLTDFGLSKESIDH 179 (304)
T ss_dssp EEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEEC-TTSCEEEESSEEEEC----
T ss_pred EEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHeEEc-CCCCEEecccccceeccCC
Confidence 69999999999999999899999999999999999999999999 99999999999998 558999999999976532
Q ss_pred -CCCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHHH
Q 008504 80 -PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 157 (563)
Q Consensus 80 -~~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~L 157 (563)
....+.+||+.|||||++.+ .|+.++|||||||++|||+||+.||.+ .+..+++..+..+..+ ++...++++++|
T Consensus 180 ~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~-~~~~~~~~~i~~~~~~--~p~~~s~~~~~l 256 (304)
T 3ubd_A 180 EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQG-KDRKETMTMILKAKLG--MPQFLSPEAQSL 256 (304)
T ss_dssp -CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCC--CCTTSCHHHHHH
T ss_pred CccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCC-cCHHHHHHHHHcCCCC--CCCcCCHHHHHH
Confidence 33456789999999999865 599999999999999999999999987 5677777777766443 466788999999
Q ss_pred HHHhcC-CCCCCCC-----HHHHHcCccccccccCCC
Q 008504 158 IEKCLV-PASERLS-----AKDLLKDPFLQVENQKEP 188 (563)
Q Consensus 158 I~kcL~-dP~kRpS-----a~ELLkHpff~~~~~~~~ 188 (563)
|.+||. ||.+||| ++|+++||||+..+|...
T Consensus 257 i~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw~~l 293 (304)
T 3ubd_A 257 LRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKL 293 (304)
T ss_dssp HHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCHHHH
T ss_pred HHHHcccCHHHCCCCCcCCHHHHHcCccccCCCHHHH
Confidence 999997 8999998 589999999998776543
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=352.12 Aligned_cols=182 Identities=29% Similarity=0.465 Sum_probs=161.6
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC-
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ- 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~- 79 (563)
||||||+||+|.+++.+.+.+++..++.|+.||+.||.|||++| |+||||||+|||++ .+|.+||+|||+|+.+..
T Consensus 109 ivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDlKPeNILl~-~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 109 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLN-EDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTSCEEECCCTTCEECCTT
T ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEEc-CCCCEEEEEcCCceecCCC
Confidence 69999999999999999899999999999999999999999999 99999999999998 558999999999987642
Q ss_pred ---CCCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHH
Q 008504 80 ---PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIK 155 (563)
Q Consensus 80 ---~~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~ 155 (563)
....+.+||+.|||||++.+ .|+.++|||||||++|+|+||+.||.+ .+...++..+..+.. .++...+++++
T Consensus 186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~ 262 (311)
T 4aw0_A 186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA-GNEGLIFAKIIKLEY--DFPEKFFPKAR 262 (311)
T ss_dssp TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCC--CCCTTCCHHHH
T ss_pred CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCC--CCCcccCHHHH
Confidence 23456799999999999975 599999999999999999999999987 567777777777654 34567789999
Q ss_pred HHHHHhcC-CCCCCCCHHH------HHcCccccccccCCC
Q 008504 156 GFIEKCLV-PASERLSAKD------LLKDPFLQVENQKEP 188 (563)
Q Consensus 156 ~LI~kcL~-dP~kRpSa~E------LLkHpff~~~~~~~~ 188 (563)
+||.+||. ||.+|||+.| +++||||+..+|...
T Consensus 263 dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~l 302 (311)
T 4aw0_A 263 DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 302 (311)
T ss_dssp HHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTG
T ss_pred HHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHHh
Confidence 99999997 8999999887 689999998888654
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=351.25 Aligned_cols=178 Identities=33% Similarity=0.616 Sum_probs=156.0
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
||||||+||+|.+++.+ +++++..++.|+.||+.||.|||++| ||||||||+||||+ .+|.+||+|||+|+.+...
T Consensus 148 ivmEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~-~~g~vKl~DFGla~~~~~~ 223 (346)
T 4fih_A 148 VVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKE 223 (346)
T ss_dssp EEECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTCCEEECCCTTCEECCSS
T ss_pred EEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEC-CCCCEEEecCcCceecCCC
Confidence 69999999999999987 56999999999999999999999999 99999999999998 5689999999999876433
Q ss_pred --CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCC-CccccCCChhHHH
Q 008504 81 --TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP-ASLAKVNDPQIKG 156 (563)
Q Consensus 81 --~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p-~~l~~~~s~~l~~ 156 (563)
...+.+||+.|||||++.+ .|+.++|||||||++|||++|+.||.+ .+....+..+..+..+ ...+...++++++
T Consensus 224 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~-~~~~~~~~~i~~~~~~~~~~~~~~s~~~~d 302 (346)
T 4fih_A 224 VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN-EPPLKAMKMIRDNLPPRLKNLHKVSPSLKG 302 (346)
T ss_dssp SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT-SCHHHHHHHHHHSSCCCCSCGGGSCHHHHH
T ss_pred CCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC-cCHHHHHHHHHcCCCCCCCccccCCHHHHH
Confidence 3456799999999999875 599999999999999999999999987 5666677777665443 2334567899999
Q ss_pred HHHHhcC-CCCCCCCHHHHHcCcccccc
Q 008504 157 FIEKCLV-PASERLSAKDLLKDPFLQVE 183 (563)
Q Consensus 157 LI~kcL~-dP~kRpSa~ELLkHpff~~~ 183 (563)
||.+||. ||.+|||+.|+|+||||+..
T Consensus 303 li~~~L~~dP~~R~ta~e~l~Hp~~~~~ 330 (346)
T 4fih_A 303 FLDRLLVRDPAQRATAAELLKHPFLAKA 330 (346)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred HHHHHcCCChhHCcCHHHHhcCHhhcCC
Confidence 9999997 89999999999999999854
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=338.71 Aligned_cols=175 Identities=28% Similarity=0.572 Sum_probs=146.8
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
|||||| +|+|.+++.+++++++..++.|++||+.||+|||++| |+||||||+|||++ .+|.+||+|||+|+.....
T Consensus 90 ivmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDiKP~NILl~-~~~~vkl~DFGla~~~~~~ 165 (275)
T 3hyh_A 90 MVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK--IVHRDLKPENLLLD-EHLNVKIADFGLSNIMTDG 165 (275)
T ss_dssp EEEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEEC-TTCCEEECCSSCC------
T ss_pred EEEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCChHHeEEC-CCCCEEEeecCCCeecCCC
Confidence 699999 6899999999999999999999999999999999999 99999999999998 5589999999999766543
Q ss_pred -CCccccCCCCccCccccccc-C-CchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHHH
Q 008504 81 -TARSVIGTPEFMAPELYEEE-Y-NELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 157 (563)
Q Consensus 81 -~~~~~~Gtp~Y~APEvl~~~-y-s~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~L 157 (563)
...+.+||+.|||||++.+. | +.++|||||||++|+|+||+.||.+ .+...+++.+..+..+ ++...++++++|
T Consensus 166 ~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~-~~~~~~~~~i~~~~~~--~p~~~s~~~~~l 242 (275)
T 3hyh_A 166 NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDD-ESIPVLFKNISNGVYT--LPKFLSPGAAGL 242 (275)
T ss_dssp ---------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCC--CCTTSCHHHHHH
T ss_pred CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHcCCCC--CCCCCCHHHHHH
Confidence 34567899999999999754 4 6899999999999999999999987 5677777887776543 456788999999
Q ss_pred HHHhcC-CCCCCCCHHHHHcCccccc
Q 008504 158 IEKCLV-PASERLSAKDLLKDPFLQV 182 (563)
Q Consensus 158 I~kcL~-dP~kRpSa~ELLkHpff~~ 182 (563)
|.+||. ||.+|||+.|+|+||||+.
T Consensus 243 i~~~L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 243 IKRMLIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp HHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred HHHHccCChhHCcCHHHHHcCccccc
Confidence 999997 8999999999999999974
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=349.40 Aligned_cols=178 Identities=26% Similarity=0.517 Sum_probs=155.5
Q ss_pred CEeccCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhcc
Q 008504 1 MITELFTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~--~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~ 78 (563)
||||||+||+|.++|...+ .+++..++.|+.||+.||.|||++| ||||||||+||||+ .+|.+||+|||+|+...
T Consensus 100 iVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~-~~g~vKl~DFGla~~~~ 176 (350)
T 4b9d_A 100 IVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLT-KDGTVQLGDFGIARVLN 176 (350)
T ss_dssp EEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CEETTCCGGGEEEC-TTCCEEECSTTEESCCC
T ss_pred EEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEEC-CCCCEEEcccccceeec
Confidence 6999999999999997643 5799999999999999999999999 99999999999998 56899999999997664
Q ss_pred CC--CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHH
Q 008504 79 QP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIK 155 (563)
Q Consensus 79 ~~--~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~ 155 (563)
.. .....+||+.|||||++.+ .|+.++|||||||++|||+||+.||.+ .+..+++..+..+..+. .+...+++++
T Consensus 177 ~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~-~~~~~~~~~i~~~~~~~-~~~~~s~~~~ 254 (350)
T 4b9d_A 177 STVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEA-GSMKNLVLKIISGSFPP-VSLHYSYDLR 254 (350)
T ss_dssp HHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHHTCCCC-CCTTSCHHHH
T ss_pred CCcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC-cCHHHHHHHHHcCCCCC-CCccCCHHHH
Confidence 32 2345689999999999975 599999999999999999999999987 56677777777765543 4556789999
Q ss_pred HHHHHhcC-CCCCCCCHHHHHcCcccccc
Q 008504 156 GFIEKCLV-PASERLSAKDLLKDPFLQVE 183 (563)
Q Consensus 156 ~LI~kcL~-dP~kRpSa~ELLkHpff~~~ 183 (563)
+||.+||. ||.+|||+.|+|+||||+..
T Consensus 255 ~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 283 (350)
T 4b9d_A 255 SLVSQLFKRNPRDRPSVNSILEKGFIAKR 283 (350)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHTSHHHHTT
T ss_pred HHHHHHccCChhHCcCHHHHhcCHHhhcC
Confidence 99999997 89999999999999999754
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=353.17 Aligned_cols=178 Identities=33% Similarity=0.616 Sum_probs=155.7
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
||||||+||+|.++++. +++++..++.|++||+.||.|||++| ||||||||+||||+ .+|.|||+|||+|+.+...
T Consensus 225 iVmEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~--IiHRDiKp~NILl~-~~g~vKl~DFGla~~~~~~ 300 (423)
T 4fie_A 225 VVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKE 300 (423)
T ss_dssp EEEECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSTTTEEEC-TTCCEEECCCTTCEECCSS
T ss_pred EEEeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEEc-CCCCEEEecCccceECCCC
Confidence 69999999999999976 56999999999999999999999999 99999999999998 5689999999999876432
Q ss_pred --CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCC-CccccCCChhHHH
Q 008504 81 --TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP-ASLAKVNDPQIKG 156 (563)
Q Consensus 81 --~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p-~~l~~~~s~~l~~ 156 (563)
...+.+||+.|||||++.+ .|+.++|||||||++|||++|+.||.+ .+...++..+..+..+ .......++++++
T Consensus 301 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~-~~~~~~~~~i~~~~~~~~~~~~~~s~~~~d 379 (423)
T 4fie_A 301 VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN-EPPLKAMKMIRDNLPPRLKNLHKVSPSLKG 379 (423)
T ss_dssp CCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT-SCHHHHHHHHHHSCCCCCSCTTSSCHHHHH
T ss_pred CccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC-cCHHHHHHHHHcCCCCCCcccccCCHHHHH
Confidence 3456799999999999875 599999999999999999999999987 5666667777665443 2334567899999
Q ss_pred HHHHhcC-CCCCCCCHHHHHcCcccccc
Q 008504 157 FIEKCLV-PASERLSAKDLLKDPFLQVE 183 (563)
Q Consensus 157 LI~kcL~-dP~kRpSa~ELLkHpff~~~ 183 (563)
||.+||. ||.+|||+.|+|+||||+..
T Consensus 380 li~~~L~~dP~~R~ta~ell~Hp~~~~~ 407 (423)
T 4fie_A 380 FLDRLLVRDPAQRATAAELLKHPFLAKA 407 (423)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred HHHHHcCCChhHCcCHHHHhcCHHhcCC
Confidence 9999997 89999999999999999854
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=345.33 Aligned_cols=180 Identities=28% Similarity=0.391 Sum_probs=150.3
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
||||||+||+|.+++++.+.+++..++.|+.||+.||.|||++| ||||||||+||||+.+...+||+|||+|+.+...
T Consensus 127 ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~ 204 (336)
T 4g3f_A 127 IFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR--ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD 204 (336)
T ss_dssp EEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCCGGGEEECTTSCCEEECCCTTCEEC---
T ss_pred EEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCC
Confidence 69999999999999999899999999999999999999999999 9999999999999854336999999999765432
Q ss_pred -------CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCC-CccccCCC
Q 008504 81 -------TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP-ASLAKVND 151 (563)
Q Consensus 81 -------~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p-~~l~~~~s 151 (563)
.....+||+.|||||++.+ .|+.++|||||||++|||+||+.||.+.. ...+...+..+..+ ..++...+
T Consensus 205 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~~s 283 (336)
T 4g3f_A 205 GLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYF-RGPLCLKIASEPPPIREIPPSCA 283 (336)
T ss_dssp ---------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTC-CSCCHHHHHHSCCGGGGSCTTSC
T ss_pred CcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC-HHHHHHHHHcCCCCchhcCccCC
Confidence 1234589999999999875 49999999999999999999999998743 33344445444433 34566788
Q ss_pred hhHHHHHHHhcC-CCCCCCCHHHH-------------HcCcccccc
Q 008504 152 PQIKGFIEKCLV-PASERLSAKDL-------------LKDPFLQVE 183 (563)
Q Consensus 152 ~~l~~LI~kcL~-dP~kRpSa~EL-------------LkHpff~~~ 183 (563)
+.+++||.+||. ||.+|||+.|+ |+|||+...
T Consensus 284 ~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~ 329 (336)
T 4g3f_A 284 PLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEY 329 (336)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSC
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCC
Confidence 999999999997 89999999998 468887643
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=331.59 Aligned_cols=178 Identities=19% Similarity=0.351 Sum_probs=143.3
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
||||||+||+|.++++ .+++..++.|++||+.||+|||++| |+||||||+|||++.+.|.+||+|||+|+.....
T Consensus 97 lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~g--IiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~ 171 (361)
T 4f9c_A 97 IAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFG--IVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDT 171 (361)
T ss_dssp EEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTTCEECTTC
T ss_pred EEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCc
Confidence 6899999999999984 5999999999999999999999999 9999999999999877689999999999644321
Q ss_pred ------------------------------CCccccCCCCccCcccccc--cCCchhhHHHhHHHHHHHhhcCCCCCCCC
Q 008504 81 ------------------------------TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECK 128 (563)
Q Consensus 81 ------------------------------~~~~~~Gtp~Y~APEvl~~--~ys~ksDIwSLGviLyELlTG~~Pf~~~~ 128 (563)
...+.+||+.|+|||++.+ .|+.++||||+||++|+|+||+.||....
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~ 251 (361)
T 4f9c_A 172 KIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKAS 251 (361)
T ss_dssp SCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCC
Confidence 1224579999999998864 48999999999999999999999997655
Q ss_pred CHHHHHHHHhcC----------------------------------------------------CCCCccccCCChhHHH
Q 008504 129 NPAQIFKKVTSG----------------------------------------------------IKPASLAKVNDPQIKG 156 (563)
Q Consensus 129 ~~~~i~~~i~~~----------------------------------------------------~~p~~l~~~~s~~l~~ 156 (563)
+.......+... ..........++++++
T Consensus 252 ~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~D 331 (361)
T 4f9c_A 252 DDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYD 331 (361)
T ss_dssp SHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHH
T ss_pred CHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHH
Confidence 543333222110 0000112345788999
Q ss_pred HHHHhcC-CCCCCCCHHHHHcCcccccc
Q 008504 157 FIEKCLV-PASERLSAKDLLKDPFLQVE 183 (563)
Q Consensus 157 LI~kcL~-dP~kRpSa~ELLkHpff~~~ 183 (563)
||.+||. ||.+|||+.|+|+||||+..
T Consensus 332 Ll~~lL~~dP~~R~ta~eaL~Hp~f~~i 359 (361)
T 4f9c_A 332 LLDKLLDLNPASRITAEEALLHPFFKDM 359 (361)
T ss_dssp HHHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred HHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 9999998 99999999999999999854
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=358.58 Aligned_cols=189 Identities=25% Similarity=0.458 Sum_probs=164.2
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
||||||+||+|.++|.+.+.+++..++.|+.||+.||.|||++| ||||||||+||||+ .+|.+||+|||+|+.+...
T Consensus 269 lVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~g--IiHRDLKPeNILld-~~G~vKL~DFGlA~~~~~~ 345 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLD-EHGHVRISDLGLACDFSKK 345 (689)
T ss_dssp EEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEECSSC
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHeEEe-CCCCEEecccceeeecCCC
Confidence 69999999999999999999999999999999999999999999 99999999999998 5689999999999887776
Q ss_pred CCccccCCCCccCccccc-c-cCCchhhHHHhHHHHHHHhhcCCCCCCC--CCHHHHHHHHhcCCCCCccccCCChhHHH
Q 008504 81 TARSVIGTPEFMAPELYE-E-EYNELVDIYSFGMCILEMVTFEYPYSEC--KNPAQIFKKVTSGIKPASLAKVNDPQIKG 156 (563)
Q Consensus 81 ~~~~~~Gtp~Y~APEvl~-~-~ys~ksDIwSLGviLyELlTG~~Pf~~~--~~~~~i~~~i~~~~~p~~l~~~~s~~l~~ 156 (563)
...+.+|||.|||||++. + .|+.++|||||||++|||++|..||.+. .....+...+..... .++...++++++
T Consensus 346 ~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~--~~p~~~S~~a~d 423 (689)
T 3v5w_A 346 KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV--ELPDSFSPELRS 423 (689)
T ss_dssp CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCC--CCCTTSCHHHHH
T ss_pred CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCC--CCCccCCHHHHH
Confidence 677889999999999985 3 5999999999999999999999999753 234455555555433 345678899999
Q ss_pred HHHHhcC-CCCCCCC-----HHHHHcCccccccccCCCCCCCCC
Q 008504 157 FIEKCLV-PASERLS-----AKDLLKDPFLQVENQKEPICDPLK 194 (563)
Q Consensus 157 LI~kcL~-dP~kRpS-----a~ELLkHpff~~~~~~~~~~~~l~ 194 (563)
||.+||. ||.+|++ +.|+++||||+..+|.......+.
T Consensus 424 LI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~~l~~~~~~ 467 (689)
T 3v5w_A 424 LLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYP 467 (689)
T ss_dssp HHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHHHHHTTCSC
T ss_pred HHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHHHHHcCCCC
Confidence 9999997 8999998 899999999999888765433333
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-38 Score=322.72 Aligned_cols=174 Identities=31% Similarity=0.482 Sum_probs=146.4
Q ss_pred CEeccCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~-~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
||||||+||+|.+++... +++++..+..|+.||+.||+|||+++ ||||||||+||||+ .++.+||+|||+|+....
T Consensus 108 iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~--IiHRDlKp~NILl~-~~~~~Ki~DFGla~~~~~ 184 (307)
T 3omv_A 108 IVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKN--IIHRDMKSNNIFLH-EGLTVKIGDFGLATVKSR 184 (307)
T ss_dssp EEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCCSSSEEEE-TTEEEEECCCSSCBC---
T ss_pred EEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCccCHHHEEEC-CCCcEEEeeccCceeccc
Confidence 699999999999999864 57999999999999999999999999 99999999999998 557999999999976542
Q ss_pred C----CCccccCCCCccCcccccc----cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCC---cccc
Q 008504 80 P----TARSVIGTPEFMAPELYEE----EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPA---SLAK 148 (563)
Q Consensus 80 ~----~~~~~~Gtp~Y~APEvl~~----~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~---~l~~ 148 (563)
. .....+||+.|||||++.+ .|+.++|||||||++|||+||+.||.+..+...+...+..+..++ ..+.
T Consensus 185 ~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~ 264 (307)
T 3omv_A 185 WSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYK 264 (307)
T ss_dssp ---------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCT
T ss_pred CCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccc
Confidence 2 2345689999999998852 489999999999999999999999998777777777777665443 3345
Q ss_pred CCChhHHHHHHHhcC-CCCCCCCHHHHHcC
Q 008504 149 VNDPQIKGFIEKCLV-PASERLSAKDLLKD 177 (563)
Q Consensus 149 ~~s~~l~~LI~kcL~-dP~kRpSa~ELLkH 177 (563)
..++.+++||.+||. +|.+|||+.|++++
T Consensus 265 ~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 294 (307)
T 3omv_A 265 NCPKAMKRLVADCVKKVKEERPLFPQILSS 294 (307)
T ss_dssp TSCHHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred cchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 568899999999997 89999999987643
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-38 Score=321.33 Aligned_cols=178 Identities=26% Similarity=0.416 Sum_probs=138.1
Q ss_pred CEeccCCCCCHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhc
Q 008504 1 MITELFTSGNLRQYRKKHKN---VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM 77 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~---Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~ 77 (563)
||||||+||+|.+++...+. .++..++.|+.||+.||+|||++| ||||||||+|||++ .+|.+||+|||+|+..
T Consensus 92 ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~--IiHRDlKp~NILl~-~~~~vKl~DFGla~~~ 168 (299)
T 4g31_A 92 IQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG--LMHRDLKPSNIFFT-MDDVVKVGDFGLVTAM 168 (299)
T ss_dssp EEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTCCEEECCCCCC---
T ss_pred EEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc--CccccCcHHHeEEC-CCCcEEEccCccceec
Confidence 58999999999999997655 455678999999999999999999 99999999999998 4589999999999765
Q ss_pred cCCC--------------CccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCC
Q 008504 78 QQPT--------------ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK 142 (563)
Q Consensus 78 ~~~~--------------~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~ 142 (563)
.... ....+||+.|||||++.+ .|+.++|||||||++|||++ ||............+.....
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~~~~~~~~ 245 (299)
T 4g31_A 169 DQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTDVRNLKF 245 (299)
T ss_dssp -----------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHTTCC
T ss_pred CCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHHHHhcCCC
Confidence 4321 123579999999999875 59999999999999999996 88653223334444454444
Q ss_pred CCccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCcccccccc
Q 008504 143 PASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQ 185 (563)
Q Consensus 143 p~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~~ 185 (563)
|..+ ...++.+++||.+||. +|.+|||+.|+|+||||+..++
T Consensus 246 p~~~-~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~~ 288 (299)
T 4g31_A 246 PPLF-TQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDF 288 (299)
T ss_dssp CHHH-HHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC--
T ss_pred CCCC-cccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCCC
Confidence 4332 3345678899999997 8999999999999999986543
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=329.63 Aligned_cols=178 Identities=28% Similarity=0.434 Sum_probs=146.8
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC-
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ- 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~- 79 (563)
||||||. |+|.+++.+.+.+++..++.|++||+.||.|||++| ||||||||+|||++ ..|.+||+|||+|+.+..
T Consensus 136 ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NIl~~-~~~~~Ki~DFGla~~~~~~ 211 (398)
T 4b99_A 136 VVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQ--VIHRDLKPSNLLVN-ENCELKIGDFGMARGLCTS 211 (398)
T ss_dssp EEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTCCEEECCCTTCBCC---
T ss_pred EEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCc--CcCCCcCccccccC-CCCCEEEeecceeeecccC
Confidence 6999996 689999999899999999999999999999999999 99999999999998 568999999999976532
Q ss_pred -----CCCccccCCCCccCcccccc--cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcC--CCCC------
Q 008504 80 -----PTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG--IKPA------ 144 (563)
Q Consensus 80 -----~~~~~~~Gtp~Y~APEvl~~--~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~--~~p~------ 144 (563)
....+.+||+.|||||++.+ .|+.++||||+||++|||++|+.||.+.. ....+..+... ..+.
T Consensus 212 ~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~-~~~~l~~I~~~~g~p~~~~~~~~ 290 (398)
T 4b99_A 212 PAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKN-YVHQLQLIMMVLGTPSPAVIQAV 290 (398)
T ss_dssp ----CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSS-HHHHHHHHHHHHCCCCGGGTC--
T ss_pred ccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCC-HHHHHHHHHHhcCCCChHHhhhh
Confidence 23446799999999998764 47999999999999999999999998743 44333333221 1110
Q ss_pred ---------------------ccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCcccccc
Q 008504 145 ---------------------SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 183 (563)
Q Consensus 145 ---------------------~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~ 183 (563)
......++++++||.+||. ||.+|||+.|+|+||||+..
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 351 (398)
T 4b99_A 291 GAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKY 351 (398)
T ss_dssp ---CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTT
T ss_pred hhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcC
Confidence 0112357889999999998 99999999999999999864
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=317.31 Aligned_cols=176 Identities=23% Similarity=0.403 Sum_probs=151.1
Q ss_pred CEeccCCCCCHHHHHHhC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEE
Q 008504 1 MITELFTSGNLRQYRKKH-------------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVK 67 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~-------------~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VK 67 (563)
||||||++|+|.++|.++ ..+++..+..|+.||+.||.|||+++ ||||||||+|||++ .++.+|
T Consensus 92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDlKp~NILl~-~~~~~K 168 (299)
T 4asz_A 92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVG-ENLLVK 168 (299)
T ss_dssp EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-GGGCEE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccCHhhEEEC-CCCcEE
Confidence 699999999999999864 36999999999999999999999999 99999999999998 457999
Q ss_pred EecccchhhccCCC----CccccCCCCccCccccc-ccCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCC
Q 008504 68 IGDLGLAIAMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGI 141 (563)
Q Consensus 68 L~DFGlA~~~~~~~----~~~~~Gtp~Y~APEvl~-~~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~ 141 (563)
|+|||+|+...... .....||+.|||||++. +.|+.++|||||||++|||+| |+.||.+ .+..++...+..+.
T Consensus 169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~-~~~~~~~~~i~~~~ 247 (299)
T 4asz_A 169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQ-LSNNEVIECITQGR 247 (299)
T ss_dssp ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT-SCHHHHHHHHHHTC
T ss_pred ECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHcCC
Confidence 99999997654321 23346899999999886 469999999999999999999 8999987 45677777787776
Q ss_pred CCCccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCcccccc
Q 008504 142 KPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 183 (563)
Q Consensus 142 ~p~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~ 183 (563)
.+. .+...++++.+||.+||. +|.+|||+.++ |+|++..
T Consensus 248 ~~~-~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~~~ 287 (299)
T 4asz_A 248 VLQ-RPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQNL 287 (299)
T ss_dssp CCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHHHH
T ss_pred CCC-CCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHHHH
Confidence 543 456778999999999997 89999999999 4577643
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-37 Score=322.72 Aligned_cols=173 Identities=25% Similarity=0.422 Sum_probs=150.7
Q ss_pred CEeccCCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCC
Q 008504 1 MITELFTSGNLRQYRKKH----------------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHG 64 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~----------------~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G 64 (563)
||||||++|+|.++|++. ..+++..+..|+.||+.||.|||+++ ||||||||+|||++ +++
T Consensus 146 iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~--iiHRDLK~~NILl~-~~~ 222 (353)
T 4ase_A 146 VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLS-EKN 222 (353)
T ss_dssp EEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-GGG
T ss_pred EEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC--eecCccCccceeeC-CCC
Confidence 689999999999999863 34899999999999999999999999 99999999999998 457
Q ss_pred cEEEecccchhhccCCC----CccccCCCCccCccccc-ccCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHh
Q 008504 65 EVKIGDLGLAIAMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVT 138 (563)
Q Consensus 65 ~VKL~DFGlA~~~~~~~----~~~~~Gtp~Y~APEvl~-~~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~ 138 (563)
.+||+|||+|+.+.... .....||+.|||||++. +.|+.++|||||||++|||+| |+.||.+......+.+.+.
T Consensus 223 ~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i~ 302 (353)
T 4ase_A 223 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 302 (353)
T ss_dssp CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHH
T ss_pred CEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHH
Confidence 99999999998664322 23457899999999886 459999999999999999998 8999988766777777777
Q ss_pred cCCCCCccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcC
Q 008504 139 SGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 177 (563)
Q Consensus 139 ~~~~p~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkH 177 (563)
.+..+. .+...++++++||.+||. +|.+|||+.||++|
T Consensus 303 ~g~~~~-~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 303 EGTRMR-APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp HTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCCCC-CCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 776543 456778999999999997 89999999999997
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=314.26 Aligned_cols=172 Identities=24% Similarity=0.422 Sum_probs=142.6
Q ss_pred CEeccCCCCCHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCc
Q 008504 1 MITELFTSGNLRQYRKKH---------------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGE 65 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~---------------~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~ 65 (563)
||||||++|+|.+++.++ +++++..+..|+.||+.||.|||+++ ||||||||+||||+ .++.
T Consensus 120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLKp~NILl~-~~~~ 196 (329)
T 4aoj_A 120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH--FVHRDLATRNCLVG-QGLV 196 (329)
T ss_dssp EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEE-TTTE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHhhEEEC-CCCc
Confidence 699999999999999764 35999999999999999999999999 99999999999998 5579
Q ss_pred EEEecccchhhccCC----CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhc
Q 008504 66 VKIGDLGLAIAMQQP----TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTS 139 (563)
Q Consensus 66 VKL~DFGlA~~~~~~----~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~ 139 (563)
+||+|||+++..... ......||+.|||||++.+ .|+.++|||||||++|||+| |+.||.+ .+..++...+..
T Consensus 197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~-~~~~~~~~~i~~ 275 (329)
T 4aoj_A 197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQ-LSNTEAIDCITQ 275 (329)
T ss_dssp EEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCS-SCHHHHHHHHHH
T ss_pred EEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCC-CCHHHHHHHHHc
Confidence 999999999765432 2234579999999998865 59999999999999999999 8999987 456677777777
Q ss_pred CCCCCccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcC
Q 008504 140 GIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 177 (563)
Q Consensus 140 ~~~p~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkH 177 (563)
+..+ ..+...++++++||.+||. +|.+|||+.|++++
T Consensus 276 g~~~-~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 276 GREL-ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp TCCC-CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred CCCC-CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 7554 3456778999999999997 89999999999864
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-36 Score=298.96 Aligned_cols=183 Identities=61% Similarity=1.068 Sum_probs=168.1
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
|||||+++|+|.+++.+.+.+++..++.|+.||+.||.|||++|++|+||||||+|||++...+.+||+|||++......
T Consensus 106 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~ 185 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS 185 (290)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred EEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccccc
Confidence 58999999999999998888999999999999999999999998889999999999999866789999999999776665
Q ss_pred CCccccCCCCccCcccccccCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHHHHHH
Q 008504 81 TARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEK 160 (563)
Q Consensus 81 ~~~~~~Gtp~Y~APEvl~~~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~LI~k 160 (563)
......|++.|+|||++.+.++.++|||||||++|+|++|+.||............+..+..+...+...++.+++||.+
T Consensus 186 ~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 265 (290)
T 1t4h_A 186 FAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEG 265 (290)
T ss_dssp SBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHH
T ss_pred ccccccCCcCcCCHHHHhccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCHHHHHHHHH
Confidence 55667899999999999888999999999999999999999999988888888888888888878888888999999999
Q ss_pred hcC-CCCCCCCHHHHHcCcccccc
Q 008504 161 CLV-PASERLSAKDLLKDPFLQVE 183 (563)
Q Consensus 161 cL~-dP~kRpSa~ELLkHpff~~~ 183 (563)
||. +|.+|||+.++|+||||+..
T Consensus 266 ~l~~dp~~Rps~~ell~h~~f~~~ 289 (290)
T 1t4h_A 266 CIRQNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp HSCSSGGGSCCHHHHHTSGGGC--
T ss_pred HccCChhhCCCHHHHhhCcccccC
Confidence 998 89999999999999999853
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=312.12 Aligned_cols=172 Identities=23% Similarity=0.337 Sum_probs=148.5
Q ss_pred CEeccCCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCC
Q 008504 1 MITELFTSGNLRQYRKKH----------------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHG 64 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~----------------~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G 64 (563)
||||||++|+|.++|..+ ..+++..+..|+.||+.||.|||+++ ||||||||+||||+ +++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLK~~NILl~-~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH--VVHKDLATRNVLVY-DKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-GGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCccccceEEC-CCC
Confidence 699999999999999753 35899999999999999999999999 99999999999998 557
Q ss_pred cEEEecccchhhccCC----CCccccCCCCccCccccc-ccCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHh
Q 008504 65 EVKIGDLGLAIAMQQP----TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVT 138 (563)
Q Consensus 65 ~VKL~DFGlA~~~~~~----~~~~~~Gtp~Y~APEvl~-~~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~ 138 (563)
.+||+|||+++..... ......||+.|||||++. +.|+.++|||||||++|||+| |+.||.+ .+..++...+.
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~-~~~~~~~~~i~ 261 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCG-YSNQDVVEMIR 261 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT-CCHHHHHHHHH
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCC-CCHHHHHHHHH
Confidence 9999999999765322 234567999999999886 569999999999999999998 8999987 45677777777
Q ss_pred cCCCCCccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcC
Q 008504 139 SGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 177 (563)
Q Consensus 139 ~~~~p~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkH 177 (563)
.+..++ .+..+++.+.+||.+||. +|.+|||+.||+++
T Consensus 262 ~~~~~~-~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 262 NRQVLP-CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp TTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCCCC-CcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 776543 456678999999999997 89999999999874
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-36 Score=334.58 Aligned_cols=182 Identities=27% Similarity=0.406 Sum_probs=157.2
Q ss_pred CEeccCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCC-CCcEEEecccchhhcc
Q 008504 1 MITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGN-HGEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k-~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~-~G~VKL~DFGlA~~~~ 78 (563)
||||||+||+|.+++.+ ++.+++..++.|++||+.||.|||++| |+||||||+|||++.+ .|.+||+|||+++.+.
T Consensus 231 iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~--iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~ 308 (573)
T 3uto_A 231 MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 308 (573)
T ss_dssp EEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCSSCEECC
T ss_pred EEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhccccCCCCCCEEEeeccceeEcc
Confidence 69999999999999964 467999999999999999999999999 9999999999999743 4799999999998765
Q ss_pred CC-CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCC--CCccccCCChhH
Q 008504 79 QP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK--PASLAKVNDPQI 154 (563)
Q Consensus 79 ~~-~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~--p~~l~~~~s~~l 154 (563)
.. .....+||+.|||||++.+ .|+.++|||||||++|+|++|..||.+ .+..+.+..+..+.. +.......++.+
T Consensus 309 ~~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 387 (573)
T 3uto_A 309 PKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG-ENDDETLRNVKSCDWNMDDSAFSGISEDG 387 (573)
T ss_dssp TTSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC-SSHHHHHHHHHTTCCCCCSGGGTTSCHHH
T ss_pred CCCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC-cCHHHHHHHHHhCCCCCCcccccCCCHHH
Confidence 43 3445689999999999875 499999999999999999999999987 456666777766543 333445678999
Q ss_pred HHHHHHhcC-CCCCCCCHHHHHcCcccccccc
Q 008504 155 KGFIEKCLV-PASERLSAKDLLKDPFLQVENQ 185 (563)
Q Consensus 155 ~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~~ 185 (563)
++||.+||. ||.+|||+.|+|+||||+...+
T Consensus 388 ~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~ 419 (573)
T 3uto_A 388 KDFIRKLLLADPNTRMTIHQALEHPWLTPGNA 419 (573)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCC
T ss_pred HHHHHHHccCChhHCcCHHHHhcCcCcCCCCC
Confidence 999999997 8999999999999999987654
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-35 Score=307.74 Aligned_cols=183 Identities=25% Similarity=0.472 Sum_probs=156.0
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC-
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ- 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~- 79 (563)
||||||.||+|.+++.+.+.+++..++.|+.||+.||.|||++| |+||||||+|||++ ..|.+||+|||+++....
T Consensus 101 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NILl~-~~g~ikL~DFG~a~~~~~~ 177 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKG--IIYRDLKLDNVLLD-HEGHCKLADFGMCKEGICN 177 (353)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTSCEEECCCTTCBCSCC-
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCCHHHEEEC-CCCCEEEccccceeecccC
Confidence 68999999999999999889999999999999999999999999 99999999999998 558999999999975332
Q ss_pred -CCCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHHH
Q 008504 80 -PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 157 (563)
Q Consensus 80 -~~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~L 157 (563)
......+||+.|+|||++.+ .|+.++|||||||++|+|++|+.||.. .+...++..+..+... ++...++.+++|
T Consensus 178 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~-~~~~~~~~~i~~~~~~--~p~~~~~~~~~l 254 (353)
T 3txo_A 178 GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEA-ENEDDLFEAILNDEVV--YPTWLHEDATGI 254 (353)
T ss_dssp --------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCC--CCTTSCHHHHHH
T ss_pred CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCCC--CCCCCCHHHHHH
Confidence 23445689999999998865 499999999999999999999999987 5667777777766443 455678899999
Q ss_pred HHHhcC-CCCCCCCH------HHHHcCccccccccCCCC
Q 008504 158 IEKCLV-PASERLSA------KDLLKDPFLQVENQKEPI 189 (563)
Q Consensus 158 I~kcL~-dP~kRpSa------~ELLkHpff~~~~~~~~~ 189 (563)
|.+||. +|.+||++ .++++||||+..+|....
T Consensus 255 i~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~~l~ 293 (353)
T 3txo_A 255 LKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQLN 293 (353)
T ss_dssp HHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCHHHHH
T ss_pred HHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCHHHHh
Confidence 999997 89999998 999999999988776543
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=301.16 Aligned_cols=182 Identities=25% Similarity=0.490 Sum_probs=158.4
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC-
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ- 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~- 79 (563)
|||||++||+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ ..|.+||+|||+++....
T Consensus 82 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~-~~g~vkL~DFG~a~~~~~~ 158 (337)
T 1o6l_A 82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLD-KDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTSCEEECCCTTCBCSCCT
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCCHHHEEEC-CCCCEEEeeccchhhcccC
Confidence 68999999999999998889999999999999999999999999 99999999999998 558999999999975322
Q ss_pred -CCCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHHH
Q 008504 80 -PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 157 (563)
Q Consensus 80 -~~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~L 157 (563)
......+||+.|+|||++.+ .|+.++|||||||++|+|++|+.||.. .+...++..+..... .++...++.+++|
T Consensus 159 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~~l 235 (337)
T 1o6l_A 159 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELILMEEI--RFPRTLSPEAKSL 235 (337)
T ss_dssp TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCC--CCCTTSCHHHHHH
T ss_pred CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHHHHHH
Confidence 23456789999999998865 589999999999999999999999987 456666666665433 3456678999999
Q ss_pred HHHhcC-CCCCCC-----CHHHHHcCccccccccCCC
Q 008504 158 IEKCLV-PASERL-----SAKDLLKDPFLQVENQKEP 188 (563)
Q Consensus 158 I~kcL~-dP~kRp-----Sa~ELLkHpff~~~~~~~~ 188 (563)
|.+||. +|.+|| ++.++++||||+..+|...
T Consensus 236 i~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~~~~ 272 (337)
T 1o6l_A 236 LAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDV 272 (337)
T ss_dssp HHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHH
T ss_pred HHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCHHHH
Confidence 999997 899999 9999999999998777544
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-34 Score=291.35 Aligned_cols=180 Identities=31% Similarity=0.544 Sum_probs=154.2
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
||||||.+|+|.+++.+. .+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++......
T Consensus 94 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~ 169 (297)
T 3fxz_A 94 VVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPE 169 (297)
T ss_dssp EEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTCCEEECCCTTCEECCST
T ss_pred EEEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEEC-CCCCEEEeeCCCceecCCc
Confidence 589999999999999875 6999999999999999999999999 99999999999998 5579999999998765432
Q ss_pred --CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHHH
Q 008504 81 --TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 157 (563)
Q Consensus 81 --~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~L 157 (563)
......||+.|+|||++.+ .++.++|||||||++|+|++|+.||...............+......+...++.+++|
T Consensus 170 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 249 (297)
T 3fxz_A 170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDF 249 (297)
T ss_dssp TCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHH
T ss_pred ccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHH
Confidence 2345689999999998864 5899999999999999999999999875544455555555554445566778899999
Q ss_pred HHHhcC-CCCCCCCHHHHHcCccccccc
Q 008504 158 IEKCLV-PASERLSAKDLLKDPFLQVEN 184 (563)
Q Consensus 158 I~kcL~-dP~kRpSa~ELLkHpff~~~~ 184 (563)
|.+||. +|.+|||+.|+|+||||+...
T Consensus 250 i~~~l~~dp~~Rps~~ell~h~~~~~~~ 277 (297)
T 3fxz_A 250 LNRCLEMDVEKRGSAKELLQHQFLKIAK 277 (297)
T ss_dssp HHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred HHHHccCChhHCcCHHHHhhChhhcccC
Confidence 999998 899999999999999998543
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-34 Score=295.42 Aligned_cols=179 Identities=24% Similarity=0.477 Sum_probs=156.1
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
|||||+++|+|.+++..++.+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++......
T Consensus 91 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~NIll~-~~~~~kl~DFG~a~~~~~~ 167 (328)
T 3fe3_A 91 LIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR--IVHRDLKAENLLLD-ADMNIKIADFGFSNEFTVG 167 (328)
T ss_dssp EEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTSCEEECSTTCCGGGSSS
T ss_pred EEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCCHHHEEEc-CCCCEEEeeccCceecCCC
Confidence 68999999999999998889999999999999999999999999 99999999999998 4579999999999765432
Q ss_pred -CCccccCCCCccCccccccc-C-CchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHHH
Q 008504 81 -TARSVIGTPEFMAPELYEEE-Y-NELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 157 (563)
Q Consensus 81 -~~~~~~Gtp~Y~APEvl~~~-y-s~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~L 157 (563)
.....+||+.|+|||++.+. + +.++|||||||++|+|++|+.||.+ .+...+...+..+... .+...++.+.+|
T Consensus 168 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~~--~p~~~s~~~~~l 244 (328)
T 3fe3_A 168 GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG-QNLKELRERVLRGKYR--IPFYMSTDCENL 244 (328)
T ss_dssp CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCC--CCTTSCHHHHHH
T ss_pred CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCC--CCCCCCHHHHHH
Confidence 34456899999999988654 4 5799999999999999999999987 5666777777666443 455678999999
Q ss_pred HHHhcC-CCCCCCCHHHHHcCcccccccc
Q 008504 158 IEKCLV-PASERLSAKDLLKDPFLQVENQ 185 (563)
Q Consensus 158 I~kcL~-dP~kRpSa~ELLkHpff~~~~~ 185 (563)
|.+||. +|.+|||+.|+|+||||+....
T Consensus 245 i~~~L~~dP~~R~t~~eil~h~~~~~~~~ 273 (328)
T 3fe3_A 245 LKRFLVLNPIKRGTLEQIMKDRWINAGHE 273 (328)
T ss_dssp HHHHCCSSTTTSCCHHHHTTCTTTTTTCT
T ss_pred HHHHCCCChhHCcCHHHHhcCHhhcCCCc
Confidence 999998 8999999999999999986543
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-34 Score=295.21 Aligned_cols=181 Identities=28% Similarity=0.511 Sum_probs=158.1
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
|||||++||+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++.....
T Consensus 83 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~-~~g~~kL~Dfg~a~~~~~- 158 (318)
T 1fot_A 83 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLD-KNGHIKITDFGFAKYVPD- 158 (318)
T ss_dssp EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEEC-TTSCEEECCCSSCEECSS-
T ss_pred EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChheEEEc-CCCCEEEeecCcceecCC-
Confidence 68999999999999999889999999999999999999999999 99999999999998 558999999999976543
Q ss_pred CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHHHHH
Q 008504 81 TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIE 159 (563)
Q Consensus 81 ~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~LI~ 159 (563)
.....+||+.|+|||++.+ .|+.++|||||||++|+|++|+.||.. .+....+..+..+.. .++...++.+++||.
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~li~ 235 (318)
T 1fot_A 159 VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD-SNTMKTYEKILNAEL--RFPPFFNEDVKDLLS 235 (318)
T ss_dssp CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHCCC--CCCTTSCHHHHHHHH
T ss_pred ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCC--CCCCCCCHHHHHHHH
Confidence 2345689999999998865 589999999999999999999999987 455666666665543 245567889999999
Q ss_pred HhcC-CCCCCC-----CHHHHHcCccccccccCCC
Q 008504 160 KCLV-PASERL-----SAKDLLKDPFLQVENQKEP 188 (563)
Q Consensus 160 kcL~-dP~kRp-----Sa~ELLkHpff~~~~~~~~ 188 (563)
+||. +|.+|| ++.++++||||+...+...
T Consensus 236 ~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~~~~ 270 (318)
T 1fot_A 236 RLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKL 270 (318)
T ss_dssp HHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHHH
T ss_pred HHhccCHHHcCCCcCCCHHHHhcCccccCCCHHHH
Confidence 9997 899999 9999999999998776543
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=301.21 Aligned_cols=182 Identities=24% Similarity=0.438 Sum_probs=158.6
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhcc--
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ-- 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~-- 78 (563)
|||||++||+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||+++...
T Consensus 98 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~-~~g~vkL~DFG~a~~~~~~ 174 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLD-SEGHIKIADFGMCKENIWD 174 (353)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTSCEEECCCTTCBCCCCT
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEEc-CCCcEEEEeCCcccccccC
Confidence 69999999999999998888999999999999999999999999 99999999999998 55899999999997532
Q ss_pred CCCCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHHH
Q 008504 79 QPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 157 (563)
Q Consensus 79 ~~~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~L 157 (563)
.......+||+.|+|||++.+ .|+.++|||||||++|+|++|+.||.. .+...++..+...... ++...++.+++|
T Consensus 175 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~-~~~~~~~~~i~~~~~~--~p~~~s~~~~~l 251 (353)
T 2i0e_A 175 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG-EDEDELFQSIMEHNVA--YPKSMSKEAVAI 251 (353)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCC--CCTTSCHHHHHH
T ss_pred CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCC-CCHHHHHHHHHhCCCC--CCCCCCHHHHHH
Confidence 223456789999999998864 589999999999999999999999987 5666777777665432 456678999999
Q ss_pred HHHhcC-CCCCCC-----CHHHHHcCccccccccCCC
Q 008504 158 IEKCLV-PASERL-----SAKDLLKDPFLQVENQKEP 188 (563)
Q Consensus 158 I~kcL~-dP~kRp-----Sa~ELLkHpff~~~~~~~~ 188 (563)
|.+||. +|.+|| ++.++++||||+..+|...
T Consensus 252 i~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~~l 288 (353)
T 2i0e_A 252 CKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKL 288 (353)
T ss_dssp HHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCHHHH
T ss_pred HHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCHHHH
Confidence 999997 899999 4799999999998777554
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=302.68 Aligned_cols=184 Identities=27% Similarity=0.504 Sum_probs=160.0
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhcc--
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ-- 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~-- 78 (563)
||||||+||+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||+++...
T Consensus 95 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~-~~g~vkL~DFG~a~~~~~~ 171 (345)
T 1xjd_A 95 FVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLD-KDGHIKIADFGMCKENMLG 171 (345)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTSCEEECCCTTCBCCCCT
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCChhhEEEC-CCCCEEEeEChhhhhcccC
Confidence 69999999999999998888999999999999999999999999 99999999999998 55899999999997543
Q ss_pred CCCCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHHH
Q 008504 79 QPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 157 (563)
Q Consensus 79 ~~~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~L 157 (563)
.......+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.. .+...++..+..+.. .++...++.+++|
T Consensus 172 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~~l 248 (345)
T 1xjd_A 172 DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG-QDEEELFHSIRMDNP--FYPRWLEKEAKDL 248 (345)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCC--CCCTTSCHHHHHH
T ss_pred CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCC-CCHHHHHHHHHhCCC--CCCcccCHHHHHH
Confidence 233456789999999998865 589999999999999999999999987 556677777766543 2456678999999
Q ss_pred HHHhcC-CCCCCCCHH-HHHcCccccccccCCCCC
Q 008504 158 IEKCLV-PASERLSAK-DLLKDPFLQVENQKEPIC 190 (563)
Q Consensus 158 I~kcL~-dP~kRpSa~-ELLkHpff~~~~~~~~~~ 190 (563)
|.+||. +|.+||++. ++++||||+..+|.....
T Consensus 249 i~~lL~~dp~~R~~~~~~i~~hp~f~~~~w~~l~~ 283 (345)
T 1xjd_A 249 LVKLFVREPEKRLGVRGDIRQHPLFREINWEELER 283 (345)
T ss_dssp HHHHSCSSGGGSBTTBSCGGGSGGGTTCCHHHHHT
T ss_pred HHHHhcCCHhHcCCChHHHHcCccccCCCHHHHhh
Confidence 999997 899999998 999999999887765433
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=297.19 Aligned_cols=175 Identities=26% Similarity=0.401 Sum_probs=134.5
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC------CCCeEeccCccCceEEeCCCCcEEEecccch
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSH------NPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA 74 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~------gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA 74 (563)
||||||++|+|.++++++ ++++..+.+++.|++.||+|||++ .++||||||||+||||+ .++.+||+|||++
T Consensus 78 lV~Ey~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~-~~~~~Ki~DFGla 155 (303)
T 3hmm_A 78 LVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK-KNGTCCIADLGLA 155 (303)
T ss_dssp EEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEEC-TTSCEEECCCTTC
T ss_pred EEecCCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEEC-CCCCEEEEeCCCC
Confidence 699999999999999874 699999999999999999999987 22399999999999998 5589999999999
Q ss_pred hhccCCC------CccccCCCCccCcccccc-------cCCchhhHHHhHHHHHHHhhcCCCCCCC--------------
Q 008504 75 IAMQQPT------ARSVIGTPEFMAPELYEE-------EYNELVDIYSFGMCILEMVTFEYPYSEC-------------- 127 (563)
Q Consensus 75 ~~~~~~~------~~~~~Gtp~Y~APEvl~~-------~ys~ksDIwSLGviLyELlTG~~Pf~~~-------------- 127 (563)
+...... ....+||+.|||||++.+ .|+.++|||||||++|||+||..||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~ 235 (303)
T 3hmm_A 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccccc
Confidence 7654321 224579999999999864 3678999999999999999997665321
Q ss_pred CCHHHHHHHHhcCCCCCccccCC-----ChhHHHHHHHhcC-CCCCCCCHHHHHcC
Q 008504 128 KNPAQIFKKVTSGIKPASLAKVN-----DPQIKGFIEKCLV-PASERLSAKDLLKD 177 (563)
Q Consensus 128 ~~~~~i~~~i~~~~~p~~l~~~~-----s~~l~~LI~kcL~-dP~kRpSa~ELLkH 177 (563)
.....+.+.+......+.++... ...+.+||.+||. +|.+|||+.|+++.
T Consensus 236 ~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 291 (303)
T 3hmm_A 236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred chHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 12234444444433322222221 2468899999997 89999999999864
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-34 Score=305.88 Aligned_cols=184 Identities=23% Similarity=0.419 Sum_probs=156.3
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhcc--
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ-- 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~-- 78 (563)
||||||+||+|..++.+.+.+++..++.|+.||+.||.|||++| |+||||||+|||++ ..|.+||+|||+++...
T Consensus 130 lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~-~~g~ikL~DFGla~~~~~~ 206 (396)
T 4dc2_A 130 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLD-SEGHIKLTDYGMCKEGLRP 206 (396)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTSCEEECCCTTCBCCCCT
T ss_pred EEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEEC-CCCCEEEeecceeeecccC
Confidence 69999999999999998889999999999999999999999999 99999999999998 55899999999997532
Q ss_pred CCCCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCC--------CCHHHHHHHHhcCCCCCccccC
Q 008504 79 QPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSEC--------KNPAQIFKKVTSGIKPASLAKV 149 (563)
Q Consensus 79 ~~~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~--------~~~~~i~~~i~~~~~p~~l~~~ 149 (563)
.......+||+.|+|||++.+ .|+.++|||||||++|+|++|+.||... .....++..+..... .++..
T Consensus 207 ~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~--~~p~~ 284 (396)
T 4dc2_A 207 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI--RIPRS 284 (396)
T ss_dssp TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC--CCCTT
T ss_pred CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc--CCCCc
Confidence 234556789999999998875 5899999999999999999999999642 123345555555433 34566
Q ss_pred CChhHHHHHHHhcC-CCCCCCCH------HHHHcCccccccccCCCC
Q 008504 150 NDPQIKGFIEKCLV-PASERLSA------KDLLKDPFLQVENQKEPI 189 (563)
Q Consensus 150 ~s~~l~~LI~kcL~-dP~kRpSa------~ELLkHpff~~~~~~~~~ 189 (563)
.++.+++||.+||. +|.+||++ .++++||||+..+|....
T Consensus 285 ~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w~~l~ 331 (396)
T 4dc2_A 285 LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMME 331 (396)
T ss_dssp SCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCHHHHH
T ss_pred CCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCHHHHH
Confidence 78999999999997 89999985 899999999988776543
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-34 Score=298.31 Aligned_cols=181 Identities=25% Similarity=0.448 Sum_probs=159.4
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
|||||++||+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||+++.....
T Consensus 118 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~-~~g~~kL~DFg~a~~~~~~ 194 (350)
T 1rdq_E 118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp EEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEECSSC
T ss_pred EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCccceEEEC-CCCCEEEcccccceeccCC
Confidence 68999999999999998889999999999999999999999999 99999999999998 5589999999999765443
Q ss_pred CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHHHHH
Q 008504 81 TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIE 159 (563)
Q Consensus 81 ~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~LI~ 159 (563)
....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.. .+...++..+..+.. .++...++.+++||.
T Consensus 195 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~li~ 270 (350)
T 1rdq_E 195 -TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA-DQPIQIYEKIVSGKV--RFPSHFSSDLKDLLR 270 (350)
T ss_dssp -BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCC--CCCTTCCHHHHHHHH
T ss_pred -cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHHHHHHHH
Confidence 345689999999998864 589999999999999999999999987 566777777776643 345667899999999
Q ss_pred HhcC-CCCCCCC-----HHHHHcCccccccccCCC
Q 008504 160 KCLV-PASERLS-----AKDLLKDPFLQVENQKEP 188 (563)
Q Consensus 160 kcL~-dP~kRpS-----a~ELLkHpff~~~~~~~~ 188 (563)
+||. +|.+||+ +.++++||||+..+|...
T Consensus 271 ~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w~~~ 305 (350)
T 1rdq_E 271 NLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAI 305 (350)
T ss_dssp HHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHH
T ss_pred HHhhcCHHhccCCccCCHHHHHhCcCcCCCCHHHH
Confidence 9997 8999998 999999999998776543
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-34 Score=295.62 Aligned_cols=182 Identities=23% Similarity=0.433 Sum_probs=154.5
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhcc--
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ-- 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~-- 78 (563)
|||||++||+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||+++...
T Consensus 87 lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~-~~g~~kL~DFG~a~~~~~~ 163 (345)
T 3a8x_A 87 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLD-SEGHIKLTDYGMCKEGLRP 163 (345)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTSCEEECCGGGCBCSCCT
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEEC-CCCCEEEEeccccccccCC
Confidence 69999999999999998889999999999999999999999999 99999999999998 55899999999997532
Q ss_pred CCCCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCC--------CCHHHHHHHHhcCCCCCccccC
Q 008504 79 QPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSEC--------KNPAQIFKKVTSGIKPASLAKV 149 (563)
Q Consensus 79 ~~~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~--------~~~~~i~~~i~~~~~p~~l~~~ 149 (563)
.......+||+.|+|||++.+ .|+.++|||||||++|+|++|+.||... .....++..+..... .++..
T Consensus 164 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~--~~p~~ 241 (345)
T 3a8x_A 164 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI--RIPRS 241 (345)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC--CCCTT
T ss_pred CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC--CCCCC
Confidence 223456689999999998865 5899999999999999999999999642 223345555555432 34566
Q ss_pred CChhHHHHHHHhcC-CCCCCCCH------HHHHcCccccccccCC
Q 008504 150 NDPQIKGFIEKCLV-PASERLSA------KDLLKDPFLQVENQKE 187 (563)
Q Consensus 150 ~s~~l~~LI~kcL~-dP~kRpSa------~ELLkHpff~~~~~~~ 187 (563)
.++.+++||.+||. +|.+||++ .++++||||+..+|..
T Consensus 242 ~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w~~ 286 (345)
T 3a8x_A 242 LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDM 286 (345)
T ss_dssp SCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCHHH
T ss_pred CCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCHHH
Confidence 78999999999997 89999995 8999999999877654
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=296.37 Aligned_cols=181 Identities=26% Similarity=0.458 Sum_probs=156.0
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCC---cEEEecccchhhc
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHG---EVKIGDLGLAIAM 77 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G---~VKL~DFGlA~~~ 77 (563)
||||||+||+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++.+.+ .+||+|||++...
T Consensus 92 lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~ 169 (361)
T 2yab_A 92 LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169 (361)
T ss_dssp EEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCTTSSSCCEEECCCSSCEEC
T ss_pred EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEeCCCCCccCEEEEecCCceEc
Confidence 68999999999999998889999999999999999999999999 999999999999974432 7999999999766
Q ss_pred cCC-CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCC--CccccCCChh
Q 008504 78 QQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP--ASLAKVNDPQ 153 (563)
Q Consensus 78 ~~~-~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p--~~l~~~~s~~ 153 (563)
... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+ .+....+..+..+... .......++.
T Consensus 170 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 248 (361)
T 2yab_A 170 EDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG-DTKQETLANITAVSYDFDEEFFSQTSEL 248 (361)
T ss_dssp CTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCC-SSHHHHHHHHHTTCCCCCHHHHTTSCHH
T ss_pred CCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhcCCCCCchhccCCCHH
Confidence 543 3445689999999998875 589999999999999999999999987 4566666666665432 2334567889
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHHcCccccccc
Q 008504 154 IKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 184 (563)
Q Consensus 154 l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~ 184 (563)
+++||.+||. +|.+|||+.|+|+||||+...
T Consensus 249 ~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~ 280 (361)
T 2yab_A 249 AKDFIRKLLVKETRKRLTIQEALRHPWITPVD 280 (361)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHHTSTTTSCSS
T ss_pred HHHHHHHHCCCChhHCcCHHHHhcCcCcCCCc
Confidence 9999999997 899999999999999998544
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-34 Score=304.04 Aligned_cols=182 Identities=25% Similarity=0.479 Sum_probs=156.2
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHS-HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs-~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
||||||++|+|.+++.+.+.+++..++.++.||+.||.|||+ +| |+||||||+|||++ .+|.+||+|||+++....
T Consensus 225 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~g--iiHrDlkp~NIll~-~~~~~kl~DFG~a~~~~~ 301 (446)
T 4ejn_A 225 FVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLD-KDGHIKITDFGLCKEGIK 301 (446)
T ss_dssp EEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTC--CCCCCCCGGGEEEC-SSSCEEECCCCCCCTTCC
T ss_pred EEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCC--EEECCCCHHHEEEC-CCCCEEEccCCCceeccC
Confidence 699999999999999988899999999999999999999998 89 99999999999998 457999999999975432
Q ss_pred --CCCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHH
Q 008504 80 --PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKG 156 (563)
Q Consensus 80 --~~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~ 156 (563)
......+||+.|+|||++.+ .|+.++|||||||++|+|++|+.||.. .+...+...+...... ++...++.+++
T Consensus 302 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~-~~~~~~~~~i~~~~~~--~p~~~~~~~~~ 378 (446)
T 4ejn_A 302 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILMEEIR--FPRTLGPEAKS 378 (446)
T ss_dssp -----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCC--CCTTSCHHHHH
T ss_pred CCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCC-CCHHHHHHHHHhCCCC--CCccCCHHHHH
Confidence 23445789999999998864 599999999999999999999999987 4556666666554332 45567899999
Q ss_pred HHHHhcC-CCCCCC-----CHHHHHcCccccccccCCC
Q 008504 157 FIEKCLV-PASERL-----SAKDLLKDPFLQVENQKEP 188 (563)
Q Consensus 157 LI~kcL~-dP~kRp-----Sa~ELLkHpff~~~~~~~~ 188 (563)
||.+||. +|.+|| ++.|+++||||+..++...
T Consensus 379 li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~~~~ 416 (446)
T 4ejn_A 379 LLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHV 416 (446)
T ss_dssp HHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHH
T ss_pred HHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCHHHH
Confidence 9999997 899999 9999999999998776543
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-34 Score=298.79 Aligned_cols=184 Identities=26% Similarity=0.426 Sum_probs=159.4
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC-
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ- 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~- 79 (563)
|||||+.||+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||+++....
T Consensus 116 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~-~~g~ikL~DFG~a~~~~~~ 192 (373)
T 2r5t_A 116 FVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLD-SQGHIVLTDFGLCKENIEH 192 (373)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTSCEEECCCCBCGGGBCC
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEEC-CCCCEEEeeCccccccccC
Confidence 69999999999999998889999999999999999999999999 99999999999998 558999999999976432
Q ss_pred -CCCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHHH
Q 008504 80 -PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 157 (563)
Q Consensus 80 -~~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~L 157 (563)
......+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.. .+...++..+..... .++...++.+++|
T Consensus 193 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~-~~~~~~~~~i~~~~~--~~~~~~~~~~~~l 269 (373)
T 2r5t_A 193 NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS-RNTAEMYDNILNKPL--QLKPNITNSARHL 269 (373)
T ss_dssp CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCC-SBHHHHHHHHHHSCC--CCCSSSCHHHHHH
T ss_pred CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHHhccc--CCCCCCCHHHHHH
Confidence 34456789999999998865 489999999999999999999999987 456667777666532 3455678899999
Q ss_pred HHHhcC-CCCCCCCH----HHHHcCccccccccCCCCC
Q 008504 158 IEKCLV-PASERLSA----KDLLKDPFLQVENQKEPIC 190 (563)
Q Consensus 158 I~kcL~-dP~kRpSa----~ELLkHpff~~~~~~~~~~ 190 (563)
|.+||. +|.+||++ .++++||||+..+|.....
T Consensus 270 i~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w~~l~~ 307 (373)
T 2r5t_A 270 LEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWDDLIN 307 (373)
T ss_dssp HHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCHHHHHT
T ss_pred HHHHcccCHHhCCCCCCCHHHHhCCccccCCCHHHHHh
Confidence 999997 89999986 7999999999888765433
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-34 Score=303.64 Aligned_cols=184 Identities=21% Similarity=0.402 Sum_probs=155.0
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
||||||+||+|.+++.+ ..+++..++.++.||+.||.|||++| |+||||||+|||++ ..|.+||+|||+++.....
T Consensus 146 lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~-~~g~ikL~DFG~a~~~~~~ 221 (410)
T 3v8s_A 146 MVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLD-KSGHLKLADFGTCMKMNKE 221 (410)
T ss_dssp EEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEECCTT
T ss_pred EEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeeEC-CCCCEEEeccceeEeeccC
Confidence 69999999999999987 46999999999999999999999999 99999999999998 5589999999999766543
Q ss_pred C---CccccCCCCccCccccccc-----CCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCC--CCccccCC
Q 008504 81 T---ARSVIGTPEFMAPELYEEE-----YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK--PASLAKVN 150 (563)
Q Consensus 81 ~---~~~~~Gtp~Y~APEvl~~~-----ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~--p~~l~~~~ 150 (563)
. ....+||+.|+|||++.+. |+.++|||||||++|+|++|+.||.. .+....+..+..+.. ........
T Consensus 222 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~~~ 300 (410)
T 3v8s_A 222 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA-DSLVGTYSKIMNHKNSLTFPDDNDI 300 (410)
T ss_dssp SEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHTHHHHCCCCTTCCC
T ss_pred CcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCC-CChhhHHHHHHhccccccCCCcccc
Confidence 2 3467899999999988632 78999999999999999999999987 556666666655321 11223356
Q ss_pred ChhHHHHHHHhcC-CCCC--CCCHHHHHcCccccccccCCCC
Q 008504 151 DPQIKGFIEKCLV-PASE--RLSAKDLLKDPFLQVENQKEPI 189 (563)
Q Consensus 151 s~~l~~LI~kcL~-dP~k--RpSa~ELLkHpff~~~~~~~~~ 189 (563)
++.+++||.+||. +|.+ |+++.|+++||||+..+|....
T Consensus 301 s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~~~~ 342 (410)
T 3v8s_A 301 SKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWET 342 (410)
T ss_dssp CHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCCSTT
T ss_pred cHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCHHHHh
Confidence 8899999999998 5777 9999999999999988776543
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-33 Score=317.23 Aligned_cols=188 Identities=23% Similarity=0.433 Sum_probs=163.2
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhcc--
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ-- 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~-- 78 (563)
|||||++||+|.+++.+.+.+++..++.|+.||+.||.|||++| |+||||||+||||+ .+|.+||+|||+++...
T Consensus 419 lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--IiHrDLKp~NILl~-~~g~ikL~DFGla~~~~~~ 495 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLD-SEGHIKIADFGMCKENIWD 495 (674)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTS--EECCCCCSTTEEEC-SSSCEEECCCTTCEECCCT
T ss_pred EEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeccCChhhEEEc-CCCcEEEeecceeeccccC
Confidence 69999999999999999889999999999999999999999999 99999999999998 55899999999997532
Q ss_pred CCCCccccCCCCccCccccc-ccCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHHH
Q 008504 79 QPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 157 (563)
Q Consensus 79 ~~~~~~~~Gtp~Y~APEvl~-~~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~L 157 (563)
.......+||+.|+|||++. ..|+.++|||||||++|||++|+.||.. .+...++..+..... .++...++++++|
T Consensus 496 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~~l 572 (674)
T 3pfq_A 496 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG-EDEDELFQSIMEHNV--AYPKSMSKEAVAI 572 (674)
T ss_dssp TCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHSSCC--CCCTTSCHHHHHH
T ss_pred CcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCC-CCHHHHHHHHHhCCC--CCCccCCHHHHHH
Confidence 23345678999999999886 4599999999999999999999999987 566777777776543 3456778999999
Q ss_pred HHHhcC-CCCCCCCH-----HHHHcCccccccccCCCCCCCCC
Q 008504 158 IEKCLV-PASERLSA-----KDLLKDPFLQVENQKEPICDPLK 194 (563)
Q Consensus 158 I~kcL~-dP~kRpSa-----~ELLkHpff~~~~~~~~~~~~l~ 194 (563)
|.+||. +|.+||++ .+|++||||+..+|.......+.
T Consensus 573 i~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~~l~~~~~~ 615 (674)
T 3pfq_A 573 CKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQ 615 (674)
T ss_dssp HHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHHHHTTTCSC
T ss_pred HHHHccCCHHHCCCCCCCcHHHHhcCccccCCCHHHHHhCCCC
Confidence 999997 89999997 99999999998887654443333
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=289.17 Aligned_cols=181 Identities=28% Similarity=0.400 Sum_probs=152.1
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC-
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ- 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~- 79 (563)
||||||.+|+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++.....
T Consensus 98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~ 174 (327)
T 3a62_A 98 LILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKG--IIYRDLKPENIMLN-HQGHVKLTDFGLCKESIHD 174 (327)
T ss_dssp EEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEEC-TTSCEEECCCSCC------
T ss_pred EEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEcccCCHHHeEEC-CCCcEEEEeCCcccccccC
Confidence 68999999999999998888999999999999999999999999 99999999999998 558999999999865432
Q ss_pred -CCCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHHH
Q 008504 80 -PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 157 (563)
Q Consensus 80 -~~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~L 157 (563)
.......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.. .+.......+..... .++...++.+++|
T Consensus 175 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~l 251 (327)
T 3a62_A 175 GTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTG-ENRKKTIDKILKCKL--NLPPYLTQEARDL 251 (327)
T ss_dssp ----CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHHTCC--CCCTTSCHHHHHH
T ss_pred CccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhCCC--CCCCCCCHHHHHH
Confidence 22345689999999998864 589999999999999999999999987 445555555555433 2445678899999
Q ss_pred HHHhcC-CCCCCC-----CHHHHHcCccccccccCC
Q 008504 158 IEKCLV-PASERL-----SAKDLLKDPFLQVENQKE 187 (563)
Q Consensus 158 I~kcL~-dP~kRp-----Sa~ELLkHpff~~~~~~~ 187 (563)
|.+||. +|.+|| ++.++++||||+..++..
T Consensus 252 i~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~~~ 287 (327)
T 3a62_A 252 LKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEE 287 (327)
T ss_dssp HHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCHHH
T ss_pred HHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCHHH
Confidence 999997 899999 899999999999776654
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-33 Score=279.13 Aligned_cols=180 Identities=23% Similarity=0.442 Sum_probs=151.4
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
+||||+++|+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+||+++ .+|.+||+|||++......
T Consensus 86 lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~dlkp~Nili~-~~~~~~l~Dfg~~~~~~~~ 162 (279)
T 3fdn_A 86 LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLG-SAGELKIADFGWSVHAPSS 162 (279)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT--CEECCCCGGGEEEC-TTSCEEECSCCEESCC---
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHhEEEc-CCCCEEEEeccccccCCcc
Confidence 58999999999999998888999999999999999999999999 99999999999997 5579999999998665554
Q ss_pred CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHHHHH
Q 008504 81 TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIE 159 (563)
Q Consensus 81 ~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~LI~ 159 (563)
......|++.|+|||++.+ .++.++||||||+++|+|++|..||.. .........+..... ..+...++.+++||.
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~-~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~ 239 (279)
T 3fdn_A 163 RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA-NTYQETYKRISRVEF--TFPDFVTEGARDLIS 239 (279)
T ss_dssp -----CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHTCC--CCCTTSCHHHHHHHH
T ss_pred cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCC-CcHHHHHHHHHhCCC--CCCCcCCHHHHHHHH
Confidence 4556689999999998865 478899999999999999999999986 455555555555433 245567889999999
Q ss_pred HhcC-CCCCCCCHHHHHcCccccccccC
Q 008504 160 KCLV-PASERLSAKDLLKDPFLQVENQK 186 (563)
Q Consensus 160 kcL~-dP~kRpSa~ELLkHpff~~~~~~ 186 (563)
+||. +|.+|||+.|+|+||||+.....
T Consensus 240 ~~l~~~p~~Rps~~e~l~h~~~~~~~~~ 267 (279)
T 3fdn_A 240 RLLKHNPSQRPMLREVLEHPWITANSSK 267 (279)
T ss_dssp HHCCSSGGGSCCHHHHHHCHHHHHHCSS
T ss_pred HHhccChhhCCCHHHHhhCccccCCccC
Confidence 9997 89999999999999999876543
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-33 Score=300.39 Aligned_cols=184 Identities=21% Similarity=0.426 Sum_probs=153.9
Q ss_pred CEeccCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~-~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
||||||+||+|.+++.+. ..+++..++.|+.||+.||.|||++| |+||||||+|||++ ..|.+||+|||+++....
T Consensus 138 lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILld-~~g~vkL~DFGla~~~~~ 214 (412)
T 2vd5_A 138 LVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG--YVHRDIKPDNILLD-RCGHIRLADFGSCLKLRA 214 (412)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEECCT
T ss_pred EEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccCHHHeeec-CCCCEEEeechhheeccC
Confidence 699999999999999875 47999999999999999999999999 99999999999998 558999999999976644
Q ss_pred CC---CccccCCCCccCccccc--------ccCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCC---CCCc
Q 008504 80 PT---ARSVIGTPEFMAPELYE--------EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI---KPAS 145 (563)
Q Consensus 80 ~~---~~~~~Gtp~Y~APEvl~--------~~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~---~p~~ 145 (563)
.. ....+||+.|+|||++. +.|+.++|||||||++|||++|+.||.. .+....+..+.... ..+.
T Consensus 215 ~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~-~~~~~~~~~i~~~~~~~~~p~ 293 (412)
T 2vd5_A 215 DGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYA-DSTAETYGKIVHYKEHLSLPL 293 (412)
T ss_dssp TSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHTHHHHCCCC-
T ss_pred CCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCC-CCHHHHHHHHHhcccCcCCCc
Confidence 32 23468999999999886 3589999999999999999999999987 45566665555421 1222
Q ss_pred cccCCChhHHHHHHHhcCCCCCC---CCHHHHHcCccccccccCCC
Q 008504 146 LAKVNDPQIKGFIEKCLVPASER---LSAKDLLKDPFLQVENQKEP 188 (563)
Q Consensus 146 l~~~~s~~l~~LI~kcL~dP~kR---pSa~ELLkHpff~~~~~~~~ 188 (563)
.....++++++||.+||.+|.+| +++.|+++||||+..+|...
T Consensus 294 ~~~~~s~~~~dli~~lL~~p~~Rlgr~~~~ei~~Hpff~~i~w~~l 339 (412)
T 2vd5_A 294 VDEGVPEEARDFIQRLLCPPETRLGRGGAGDFRTHPFFFGLDWDGL 339 (412)
T ss_dssp ---CCCHHHHHHHHTTSSCGGGCTTTTTHHHHHTSGGGTTCCSTTS
T ss_pred cccCCCHHHHHHHHHHcCChhhcCCCCCHHHHhcCCCcCCCCHHHH
Confidence 33567899999999999988877 69999999999998888764
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-33 Score=288.45 Aligned_cols=181 Identities=26% Similarity=0.405 Sum_probs=154.9
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCC---CcEEEecccchhhc
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNH---GEVKIGDLGLAIAM 77 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~---G~VKL~DFGlA~~~ 77 (563)
||||||.||+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||+.... +.+||+|||++...
T Consensus 93 lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~g--ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 93 VVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQG--VVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp EEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 69999999999999999889999999999999999999999999 99999999999985443 35999999999765
Q ss_pred cCC--CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCC--CCHHHHHHHHhcCCCCC--ccccCC
Q 008504 78 QQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSEC--KNPAQIFKKVTSGIKPA--SLAKVN 150 (563)
Q Consensus 78 ~~~--~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~--~~~~~i~~~i~~~~~p~--~l~~~~ 150 (563)
... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||... .....+...+..+.... ..+...
T Consensus 171 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 250 (342)
T 2qr7_A 171 RAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSV 250 (342)
T ss_dssp BCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTS
T ss_pred cCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccC
Confidence 432 3345688999999998875 4899999999999999999999999753 45667777777665432 233557
Q ss_pred ChhHHHHHHHhcC-CCCCCCCHHHHHcCcccccc
Q 008504 151 DPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 183 (563)
Q Consensus 151 s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~ 183 (563)
++.+++||.+||. +|.+|||+.++|+||||...
T Consensus 251 s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~ 284 (342)
T 2qr7_A 251 SDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW 284 (342)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTG
T ss_pred CHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCc
Confidence 8899999999997 89999999999999999754
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=303.12 Aligned_cols=184 Identities=19% Similarity=0.433 Sum_probs=154.3
Q ss_pred CEeccCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k-~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
||||||.||+|.+++.+ .+.+++..++.|+.||+.||.|||++| |+||||||+|||++ .+|.+||+|||+++....
T Consensus 151 lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILl~-~~g~vkL~DFGla~~~~~ 227 (437)
T 4aw2_A 151 LVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMD-MNGHIRLADFGSCLKLME 227 (437)
T ss_dssp EEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEECCT
T ss_pred EEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeeEc-CCCCEEEcchhhhhhccc
Confidence 69999999999999987 578999999999999999999999999 99999999999998 558999999999976543
Q ss_pred CC---CccccCCCCccCccccc------ccCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCC---CCCccc
Q 008504 80 PT---ARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI---KPASLA 147 (563)
Q Consensus 80 ~~---~~~~~Gtp~Y~APEvl~------~~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~---~p~~l~ 147 (563)
.. ....+||+.|+|||++. +.|+.++|||||||++|||++|+.||.. .+....+..+.... ..+...
T Consensus 228 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~ 306 (437)
T 4aw2_A 228 DGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYA-ESLVETYGKIMNHKERFQFPTQV 306 (437)
T ss_dssp TSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHTHHHHCCCCSSC
T ss_pred CCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCC-CChhHHHHhhhhccccccCCccc
Confidence 22 23468999999999885 3589999999999999999999999987 45566666654321 111222
Q ss_pred cCCChhHHHHHHHhcC-CCCC--CCCHHHHHcCccccccccCCC
Q 008504 148 KVNDPQIKGFIEKCLV-PASE--RLSAKDLLKDPFLQVENQKEP 188 (563)
Q Consensus 148 ~~~s~~l~~LI~kcL~-dP~k--RpSa~ELLkHpff~~~~~~~~ 188 (563)
...++.+++||.+||. +|.+ |+++.|+++||||+..+|...
T Consensus 307 ~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~~l 350 (437)
T 4aw2_A 307 TDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDNI 350 (437)
T ss_dssp CCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTTTG
T ss_pred ccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHHHH
Confidence 3468899999999997 5666 999999999999999888764
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-33 Score=286.03 Aligned_cols=180 Identities=27% Similarity=0.448 Sum_probs=152.2
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCC----cEEEecccchhh
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHG----EVKIGDLGLAIA 76 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G----~VKL~DFGlA~~ 76 (563)
|||||+++|+|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++.+ + .+||+|||++..
T Consensus 91 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIll~~~-~~~~~~~kl~Dfg~a~~ 167 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDR-NVPKPRIKIIDFGLAHK 167 (326)
T ss_dssp EEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCS-SSSSCCEEECCCTTCEE
T ss_pred EEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCC--eEcCCCCHHHEEEecC-CCCCCCEEEEECCCCeE
Confidence 58999999999999998888999999999999999999999999 9999999999999743 4 799999999976
Q ss_pred ccC-CCCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCC--CCccccCCCh
Q 008504 77 MQQ-PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK--PASLAKVNDP 152 (563)
Q Consensus 77 ~~~-~~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~--p~~l~~~~s~ 152 (563)
... .......||+.|+|||++.+ .++.++|||||||++|+|++|..||... ........+..... +.......++
T Consensus 168 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (326)
T 2y0a_A 168 IDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD-TKQETLANVSAVNYEFEDEYFSNTSA 246 (326)
T ss_dssp CCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS-SHHHHHHHHHHTCCCCCHHHHTTSCH
T ss_pred CCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCC-CHHHHHHHHHhcCCCcCccccccCCH
Confidence 643 23345679999999998864 5899999999999999999999999873 44445554444332 2223355678
Q ss_pred hHHHHHHHhcC-CCCCCCCHHHHHcCccccccc
Q 008504 153 QIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 184 (563)
Q Consensus 153 ~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~ 184 (563)
.+++||.+||. +|.+|||+.++|+||||+...
T Consensus 247 ~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 279 (326)
T 2y0a_A 247 LAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD 279 (326)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCCS
T ss_pred HHHHHHHHHccCChhhCCCHHHHhcCCCccCCc
Confidence 99999999997 899999999999999998544
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-33 Score=297.51 Aligned_cols=185 Identities=25% Similarity=0.456 Sum_probs=157.7
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC-
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ- 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~- 79 (563)
|||||+.||+|.+++.+.+.+++..++.|+.||+.||.|||++| |+||||||+|||++ ..|.+||+|||++.....
T Consensus 92 lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~-~~g~vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 92 MVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQR--IIHRDMKPDNILLD-EHGHVHITDFNIAAMLPRE 168 (384)
T ss_dssp EEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEECCTT
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEEC-CCCCEEEeccceeeeccCC
Confidence 58999999999999999889999999999999999999999999 99999999999998 558999999999976643
Q ss_pred CCCccccCCCCccCcccccc----cCCchhhHHHhHHHHHHHhhcCCCCCCC--CCHHHHHHHHhcCCCCCccccCCChh
Q 008504 80 PTARSVIGTPEFMAPELYEE----EYNELVDIYSFGMCILEMVTFEYPYSEC--KNPAQIFKKVTSGIKPASLAKVNDPQ 153 (563)
Q Consensus 80 ~~~~~~~Gtp~Y~APEvl~~----~ys~ksDIwSLGviLyELlTG~~Pf~~~--~~~~~i~~~i~~~~~p~~l~~~~s~~ 153 (563)
......+||+.|+|||++.. .|+.++|||||||++|+|++|+.||... .....+...+..... ..+...++.
T Consensus 169 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~--~~p~~~s~~ 246 (384)
T 4fr4_A 169 TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVV--TYPSAWSQE 246 (384)
T ss_dssp CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCC--CCCTTSCHH
T ss_pred CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhccc--CCCCcCCHH
Confidence 33456789999999998852 4899999999999999999999999742 334455555544433 345567899
Q ss_pred HHHHHHHhcC-CCCCCCC-HHHHHcCccccccccCCCCC
Q 008504 154 IKGFIEKCLV-PASERLS-AKDLLKDPFLQVENQKEPIC 190 (563)
Q Consensus 154 l~~LI~kcL~-dP~kRpS-a~ELLkHpff~~~~~~~~~~ 190 (563)
+.+||.+||. +|.+||+ +.++++||||+..+|.....
T Consensus 247 ~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w~~~~~ 285 (384)
T 4fr4_A 247 MVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINWDAVFQ 285 (384)
T ss_dssp HHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCHHHHHT
T ss_pred HHHHHHHHhcCCHhHhcccHHHHHcChhhhcCCHHHHHh
Confidence 9999999997 8999998 99999999999888765433
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-33 Score=276.59 Aligned_cols=182 Identities=22% Similarity=0.358 Sum_probs=154.6
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEe--CCCCcEEEecccchhhcc
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN--GNHGEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd--~~~G~VKL~DFGlA~~~~ 78 (563)
+||||+++|+|.+++...+.+++..++.++.||+.||.|||++| |+||||||+||++. ...+.+||+|||++....
T Consensus 83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 83 LVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN--VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp EEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred EEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 58999999999999998888999999999999999999999999 99999999999992 245799999999997654
Q ss_pred CC-CCccccCCCCccCcccccccCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCc--cccCCChhHH
Q 008504 79 QP-TARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPAS--LAKVNDPQIK 155 (563)
Q Consensus 79 ~~-~~~~~~Gtp~Y~APEvl~~~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~--l~~~~s~~l~ 155 (563)
.. ......||+.|+|||++.+.++.++||||||+++|+|++|+.||... ........+..+..... .....++.++
T Consensus 161 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (277)
T 3f3z_A 161 PGKMMRTKVGTPYYVSPQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSAP-TDSEVMLKIREGTFTFPEKDWLNVSPQAE 239 (277)
T ss_dssp TTSCBCCCCSCTTTCCHHHHTTCBCTTHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHHCCCCCCHHHHTTSCHHHH
T ss_pred CccchhccCCCCCccChHHhcccCCchhhehhHHHHHHHHHHCCCCCCCC-CHHHHHHHHHhCCCCCCchhhhcCCHHHH
Confidence 33 33456799999999999888999999999999999999999999874 45555555555543321 2235688999
Q ss_pred HHHHHhcC-CCCCCCCHHHHHcCcccccccc
Q 008504 156 GFIEKCLV-PASERLSAKDLLKDPFLQVENQ 185 (563)
Q Consensus 156 ~LI~kcL~-dP~kRpSa~ELLkHpff~~~~~ 185 (563)
+||.+||. +|.+|||+.++|+||||+....
T Consensus 240 ~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~ 270 (277)
T 3f3z_A 240 SLIRRLLTKSPKQRITSLQALEHEWFEKQLS 270 (277)
T ss_dssp HHHHHHTCSSTTTSCCHHHHTTSHHHHHHHC
T ss_pred HHHHHHccCChhhCcCHHHHhcCHHHhcccc
Confidence 99999998 8999999999999999986443
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-33 Score=299.13 Aligned_cols=180 Identities=24% Similarity=0.445 Sum_probs=156.0
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeC--CCCcEEEecccchhhcc
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG--NHGEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~--~~G~VKL~DFGlA~~~~ 78 (563)
||||||.||+|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++. ..+.+||+|||++....
T Consensus 87 lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~g--ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~ 164 (444)
T 3soa_A 87 LIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG--VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE 164 (444)
T ss_dssp EEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred EEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence 68999999999999999899999999999999999999999999 999999999999974 34789999999997665
Q ss_pred CC--CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCC--ccccCCChh
Q 008504 79 QP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPA--SLAKVNDPQ 153 (563)
Q Consensus 79 ~~--~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~--~l~~~~s~~ 153 (563)
.. ......||+.|+|||++.+ .|+.++|||||||++|+|++|..||.. .+...++..+..+.... ......++.
T Consensus 165 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 243 (444)
T 3soa_A 165 GEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWD-EDQHRLYQQIKAGAYDFPSPEWDTVTPE 243 (444)
T ss_dssp TTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHHTCCCCCTTTTTTSCHH
T ss_pred CCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCC-ccHHHHHHHHHhCCCCCCccccccCCHH
Confidence 33 2345689999999999875 599999999999999999999999987 45666777776665432 223456889
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHHcCcccccc
Q 008504 154 IKGFIEKCLV-PASERLSAKDLLKDPFLQVE 183 (563)
Q Consensus 154 l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~ 183 (563)
+++||.+||. +|.+|||+.|+|+||||+..
T Consensus 244 ~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~ 274 (444)
T 3soa_A 244 AKDLINKMLTINPSKRITAAEALKHPWISHR 274 (444)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred HHHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence 9999999997 89999999999999999754
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-33 Score=288.73 Aligned_cols=181 Identities=25% Similarity=0.398 Sum_probs=152.9
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
||||||++|+|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++ ..+.+||+|||++......
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~-~~~~~kl~Dfg~a~~~~~~ 158 (323)
T 3tki_A 82 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLD-ERDNLKISDFGLATVFRYN 158 (323)
T ss_dssp EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTCCEEECCCTTCEECEET
T ss_pred EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccchHHEEEe-CCCCEEEEEeeccceeccC
Confidence 58999999999999988888999999999999999999999999 99999999999998 5579999999999754321
Q ss_pred ----CCccccCCCCccCccccccc--CCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhH
Q 008504 81 ----TARSVIGTPEFMAPELYEEE--YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQI 154 (563)
Q Consensus 81 ----~~~~~~Gtp~Y~APEvl~~~--ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l 154 (563)
......||+.|+|||++.+. ++.++|||||||++|+|++|+.||.........+................++.+
T Consensus 159 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (323)
T 3tki_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP 238 (323)
T ss_dssp TEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHH
T ss_pred CcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHH
Confidence 23356899999999988653 477999999999999999999999875554444544444444333345678899
Q ss_pred HHHHHHhcC-CCCCCCCHHHHHcCccccccc
Q 008504 155 KGFIEKCLV-PASERLSAKDLLKDPFLQVEN 184 (563)
Q Consensus 155 ~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~ 184 (563)
.+||.+||. +|.+|||+.|+++||||+...
T Consensus 239 ~~li~~~L~~dP~~R~t~~eil~h~~~~~~~ 269 (323)
T 3tki_A 239 LALLHKILVENPSARITIPDIKKDRWYNKPL 269 (323)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred HHHHHHHccCChhhCcCHHHHhhChhhcccc
Confidence 999999997 899999999999999998643
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-33 Score=287.37 Aligned_cols=178 Identities=25% Similarity=0.453 Sum_probs=149.9
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
|||| +.+|+|.+++.+.+.+++..++.|+.||+.||.|||++| |+||||||+|||++ ++.+||+|||++......
T Consensus 86 lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~--iiHrDikp~NIll~--~~~~kl~DFG~a~~~~~~ 160 (343)
T 3dbq_A 86 MVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV--DGMLKLIDFGIANQMQPD 160 (343)
T ss_dssp EEEC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEE--TTEEEECCCSSSCCC---
T ss_pred EEEe-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEE--CCcEEEeecccccccCcc
Confidence 5899 567899999999999999999999999999999999999 99999999999997 468999999999765432
Q ss_pred C----CccccCCCCccCccccc------------ccCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCC
Q 008504 81 T----ARSVIGTPEFMAPELYE------------EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPA 144 (563)
Q Consensus 81 ~----~~~~~Gtp~Y~APEvl~------------~~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~ 144 (563)
. .....||+.|+|||++. ..++.++|||||||++|+|++|+.||............+.......
T Consensus 161 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 240 (343)
T 3dbq_A 161 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI 240 (343)
T ss_dssp ---------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCC
T ss_pred cccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCccc
Confidence 2 23557999999999885 3588999999999999999999999987666655566666555555
Q ss_pred ccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCcccccc
Q 008504 145 SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 183 (563)
Q Consensus 145 ~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~ 183 (563)
..+...++.+.+||.+||. +|.+|||+.++|+||||+..
T Consensus 241 ~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 280 (343)
T 3dbq_A 241 EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 280 (343)
T ss_dssp CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred CCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccccc
Confidence 6677778899999999998 89999999999999999853
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-33 Score=283.31 Aligned_cols=174 Identities=26% Similarity=0.432 Sum_probs=147.3
Q ss_pred CEeccCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~-~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
|||||+ +|+|.+++... ..+++..++.|+.||+.||.|||++| |+||||||+|||++ .++.+||+|||++.....
T Consensus 134 lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~-~~~~~kl~DFG~a~~~~~ 209 (311)
T 3p1a_A 134 LQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG--LVHLDVKPANIFLG-PRGRCKLGDFGLLVELGT 209 (311)
T ss_dssp EEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-GGGCEEECCCTTCEECC-
T ss_pred EEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEC-CCCCEEEccceeeeeccc
Confidence 589999 67999988764 46999999999999999999999999 99999999999997 457999999999876543
Q ss_pred C-CCccccCCCCccCcccccccCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHHHH
Q 008504 80 P-TARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFI 158 (563)
Q Consensus 80 ~-~~~~~~Gtp~Y~APEvl~~~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~LI 158 (563)
. ......||+.|+|||++.+.++.++|||||||++|+|++|..|+.. ......+..+..+..++...++.+++||
T Consensus 210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~el~~g~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~l~~li 285 (311)
T 3p1a_A 210 AGAGEVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELPHG----GEGWQQLRQGYLPPEFTAGLSSELRSVL 285 (311)
T ss_dssp -----CCCCCGGGCCGGGGGTCCSTHHHHHHHHHHHHHHHHTCCCCSS----HHHHHHHTTTCCCHHHHTTSCHHHHHHH
T ss_pred CCCCcccCCCccccCHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCC----ccHHHHHhccCCCcccccCCCHHHHHHH
Confidence 3 2334579999999999988999999999999999999999776654 2334455556666666677889999999
Q ss_pred HHhcC-CCCCCCCHHHHHcCccccc
Q 008504 159 EKCLV-PASERLSAKDLLKDPFLQV 182 (563)
Q Consensus 159 ~kcL~-dP~kRpSa~ELLkHpff~~ 182 (563)
.+||. +|.+|||+.++|+||||+.
T Consensus 286 ~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 286 VMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp HHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred HHHcCCChhhCcCHHHHHhCccccC
Confidence 99998 8999999999999999974
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-33 Score=282.16 Aligned_cols=183 Identities=25% Similarity=0.368 Sum_probs=144.4
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCC--CcEEEecccchhhcc
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNH--GEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~--G~VKL~DFGlA~~~~ 78 (563)
|||||+++|+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++.+. +.+||+|||++....
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 165 (316)
T 2ac3_A 88 LVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKG--IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165 (316)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred EEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence 68999999999999998888999999999999999999999999 99999999999997442 239999999986543
Q ss_pred CC---------CCccccCCCCccCccccc------ccCCchhhHHHhHHHHHHHhhcCCCCCCCCC--------------
Q 008504 79 QP---------TARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTFEYPYSECKN-------------- 129 (563)
Q Consensus 79 ~~---------~~~~~~Gtp~Y~APEvl~------~~ys~ksDIwSLGviLyELlTG~~Pf~~~~~-------------- 129 (563)
.. ......||+.|+|||++. ..++.++|||||||++|+|++|+.||.....
T Consensus 166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 245 (316)
T 2ac3_A 166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC 245 (316)
T ss_dssp ----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHH
T ss_pred cCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhH
Confidence 21 122346999999999885 3489999999999999999999999976432
Q ss_pred HHHHHHHHhcCCCCCc--cccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCcccccccc
Q 008504 130 PAQIFKKVTSGIKPAS--LAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQ 185 (563)
Q Consensus 130 ~~~i~~~i~~~~~p~~--l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~~ 185 (563)
...+...+..+..... .....++.+++||.+||. +|.+|||+.|+|+||||+....
T Consensus 246 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~ 304 (316)
T 2ac3_A 246 QNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAP 304 (316)
T ss_dssp HHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC----
T ss_pred HHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCCC
Confidence 2334555555543221 123567899999999997 8999999999999999986543
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-33 Score=278.15 Aligned_cols=179 Identities=25% Similarity=0.408 Sum_probs=145.2
Q ss_pred CEeccCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeC--CCCcEEEecccch
Q 008504 1 MITELFTSGNLRQYRKK----HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG--NHGEVKIGDLGLA 74 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k----~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~--~~G~VKL~DFGlA 74 (563)
+||||+++|+|.+++.. .+.+++..++.++.||+.||.|||++| |+||||||+||+++. ..+.+||+|||++
T Consensus 97 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a 174 (285)
T 3is5_A 97 IVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH--VVHKDLKPENILFQDTSPHSPIKIIDFGLA 174 (285)
T ss_dssp EEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEESSSSTTCCEEECCCCCC
T ss_pred EEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCCCHHHEEEecCCCCCCEEEEeeecc
Confidence 58999999999999854 367999999999999999999999999 999999999999953 3468999999999
Q ss_pred hhccCC-CCccccCCCCccCcccccccCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCC-CccccCCCh
Q 008504 75 IAMQQP-TARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP-ASLAKVNDP 152 (563)
Q Consensus 75 ~~~~~~-~~~~~~Gtp~Y~APEvl~~~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p-~~l~~~~s~ 152 (563)
...... ......|++.|+|||++.+.++.++|||||||++|+|++|+.||... ........+...... .......++
T Consensus 175 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~il~~ll~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (285)
T 3is5_A 175 ELFKSDEHSTNAAGTALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGT-SLEEVQQKATYKEPNYAVECRPLTP 253 (285)
T ss_dssp CC----------CTTGGGCCHHHHTTCCCHHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHHCCCCCCC--CCCCH
T ss_pred eecCCcccCcCcccccCcCChHHhccCCCcccCeehHHHHHHHHHhCCCCCCCC-CHHHHHhhhccCCcccccccCcCCH
Confidence 765432 23456789999999999888999999999999999999999999873 444444444433322 222234678
Q ss_pred hHHHHHHHhcC-CCCCCCCHHHHHcCccccc
Q 008504 153 QIKGFIEKCLV-PASERLSAKDLLKDPFLQV 182 (563)
Q Consensus 153 ~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~ 182 (563)
.+.+||.+||. +|.+|||+.|+|+||||+.
T Consensus 254 ~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 254 QAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp HHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 99999999998 8999999999999999975
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-33 Score=287.86 Aligned_cols=181 Identities=23% Similarity=0.389 Sum_probs=153.5
Q ss_pred CEeccCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCC-CCcEEEecccchhhcc
Q 008504 1 MITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGN-HGEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~-~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~-~G~VKL~DFGlA~~~~ 78 (563)
||||||+||+|.+++...+ .+++..++.++.||+.||.|||++| |+||||||+|||++.. .+.+||+|||++....
T Consensus 78 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g--ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~ 155 (321)
T 1tki_A 78 MIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155 (321)
T ss_dssp EEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred EEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEccCCCCCEEEEECCCCeECC
Confidence 5899999999999998654 6999999999999999999999999 9999999999999852 5799999999997664
Q ss_pred CC-CCccccCCCCccCccccccc-CCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCC--ccccCCChhH
Q 008504 79 QP-TARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPA--SLAKVNDPQI 154 (563)
Q Consensus 79 ~~-~~~~~~Gtp~Y~APEvl~~~-ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~--~l~~~~s~~l 154 (563)
.. ......||+.|+|||++.+. ++.++|||||||++|+|++|..||.. .....+...+..+.... ......++.+
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 234 (321)
T 1tki_A 156 PGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLA-ETNQQIIENIMNAEYTFDEEAFKEISIEA 234 (321)
T ss_dssp TTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHTCCCCCHHHHTTSCHHH
T ss_pred CCCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcC-CCHHHHHHHHHcCCCCCChhhhccCCHHH
Confidence 43 23445799999999998755 79999999999999999999999987 45556666666554432 2234568899
Q ss_pred HHHHHHhcC-CCCCCCCHHHHHcCccccccc
Q 008504 155 KGFIEKCLV-PASERLSAKDLLKDPFLQVEN 184 (563)
Q Consensus 155 ~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~ 184 (563)
++||.+||. +|.+|||+.|+|+||||+...
T Consensus 235 ~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~ 265 (321)
T 1tki_A 235 MDFVDRLLVKERKSRMTASEALQHPWLKQKI 265 (321)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred HHHHHHHcCCChhHCcCHHHHhcChhhccCc
Confidence 999999997 899999999999999998643
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-33 Score=277.55 Aligned_cols=179 Identities=22% Similarity=0.415 Sum_probs=143.5
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
|||||+.++.+..+....+.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++......
T Consensus 78 lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--ivH~dikp~Nil~~-~~~~~kl~Dfg~~~~~~~~ 154 (292)
T 3o0g_A 78 LVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLIN-RNGELKLANFGLARAFGIP 154 (292)
T ss_dssp EEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEECCSC
T ss_pred EEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEc-CCCCEEEeecccceecCCc
Confidence 68999986444444445678999999999999999999999999 99999999999998 4579999999999765432
Q ss_pred --CCccccCCCCccCcccccc-c-CCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCC--CC-----------
Q 008504 81 --TARSVIGTPEFMAPELYEE-E-YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI--KP----------- 143 (563)
Q Consensus 81 --~~~~~~Gtp~Y~APEvl~~-~-ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~--~p----------- 143 (563)
......||+.|+|||++.+ . ++.++|||||||++|+|++|..||............+.... ..
T Consensus 155 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 234 (292)
T 3o0g_A 155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred cccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccc
Confidence 2344578999999998864 3 79999999999999999999988765566555554443210 00
Q ss_pred --------------CccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCccccc
Q 008504 144 --------------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQV 182 (563)
Q Consensus 144 --------------~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~ 182 (563)
.......++.+++||.+||. +|.+|||+.|+|+||||+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 288 (292)
T 3o0g_A 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred cccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCccccc
Confidence 01112356889999999998 8999999999999999985
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-33 Score=281.41 Aligned_cols=176 Identities=24% Similarity=0.442 Sum_probs=148.3
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
|||||+++|+|.+++. .+.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++......
T Consensus 115 lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~ 190 (298)
T 2zv2_A 115 MVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQK--IIHRDIKPSNLLVG-EDGHIKIADFGVSNEFKGS 190 (298)
T ss_dssp EEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTSCEEECCCTTCEECSSS
T ss_pred EEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEC-CCCCEEEecCCCccccccc
Confidence 5899999999998754 457999999999999999999999999 99999999999998 4579999999999765432
Q ss_pred --CCccccCCCCccCccccccc----CCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhH
Q 008504 81 --TARSVIGTPEFMAPELYEEE----YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQI 154 (563)
Q Consensus 81 --~~~~~~Gtp~Y~APEvl~~~----ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l 154 (563)
......||+.|+|||++.+. ++.++|||||||++|+|++|+.||.. .........+.............++.+
T Consensus 191 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l 269 (298)
T 2zv2_A 191 DALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD-ERIMCLHSKIKSQALEFPDQPDIAEDL 269 (298)
T ss_dssp SCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCCCCSSSCCCHHH
T ss_pred cccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC-ccHHHHHHHHhcccCCCCCccccCHHH
Confidence 22345799999999998643 47889999999999999999999987 345555555555544433345678899
Q ss_pred HHHHHHhcC-CCCCCCCHHHHHcCcccc
Q 008504 155 KGFIEKCLV-PASERLSAKDLLKDPFLQ 181 (563)
Q Consensus 155 ~~LI~kcL~-dP~kRpSa~ELLkHpff~ 181 (563)
++||.+||. +|.+|||+.|+|+||||+
T Consensus 270 ~~li~~~l~~dp~~R~s~~e~l~hp~~~ 297 (298)
T 2zv2_A 270 KDLITRMLDKNPESRIVVPEIKLHPWVT 297 (298)
T ss_dssp HHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred HHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence 999999997 899999999999999996
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-33 Score=279.24 Aligned_cols=179 Identities=29% Similarity=0.425 Sum_probs=144.1
Q ss_pred CEeccCCCCCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhcc
Q 008504 1 MITELFTSGNLRQYRKKHKN--VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~--Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~ 78 (563)
+||||+. |+|.+++..... +++..++.++.||+.||.|||++| |+||||||+|||++ ..+.+||+|||++....
T Consensus 96 lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~~-~~~~~kl~Dfg~a~~~~ 171 (308)
T 3g33_A 96 LVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVT-SGGTVKLADFGLARIYS 171 (308)
T ss_dssp EEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCTTTEEEC-TTSCEEECSCSCTTTST
T ss_pred EEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEc-CCCCEEEeeCccccccC
Confidence 5899997 599999998654 999999999999999999999999 99999999999997 55799999999997665
Q ss_pred CC-CCccccCCCCccCccccc-ccCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcC--CCC-C---------
Q 008504 79 QP-TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG--IKP-A--------- 144 (563)
Q Consensus 79 ~~-~~~~~~Gtp~Y~APEvl~-~~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~--~~p-~--------- 144 (563)
.. ......||+.|+|||++. ..++.++|||||||++|+|++|+.||..... ......+... ..+ .
T Consensus 172 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~ 250 (308)
T 3g33_A 172 YQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE-ADQLGKIFDLIGLPPEDDWPRDVSLP 250 (308)
T ss_dssp TCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSH-HHHHHHHHHHHCCCCTTTSCSSCSSC
T ss_pred CCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCChhhccchhhcc
Confidence 33 334568999999999885 4589999999999999999999999987443 3333333211 110 0
Q ss_pred -------------ccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCccccccc
Q 008504 145 -------------SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 184 (563)
Q Consensus 145 -------------~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~ 184 (563)
......++.+.+||.+||. +|.+|||+.|+|+||||+...
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~ 304 (308)
T 3g33_A 251 RGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDE 304 (308)
T ss_dssp GGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC----
T ss_pred ccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCC
Confidence 0112456889999999998 899999999999999998654
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-33 Score=289.78 Aligned_cols=180 Identities=24% Similarity=0.466 Sum_probs=154.3
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCC--CCcEEEecccchhhcc
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGN--HGEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~--~G~VKL~DFGlA~~~~ 78 (563)
||||||.||+|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++.+ .+.+||+|||++....
T Consensus 105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~ 182 (362)
T 2bdw_A 105 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 182 (362)
T ss_dssp EEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT
T ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEEEeecCcceEec
Confidence 58999999999999998888999999999999999999999999 9999999999999743 3469999999997665
Q ss_pred CC-CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCC--CccccCCChhH
Q 008504 79 QP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP--ASLAKVNDPQI 154 (563)
Q Consensus 79 ~~-~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p--~~l~~~~s~~l 154 (563)
.. ......||+.|+|||++.+ .|+.++|||||||++|+|++|..||.. .+...++..+..+... .......++.+
T Consensus 183 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 261 (362)
T 2bdw_A 183 DSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD-EDQHRLYAQIKAGAYDYPSPEWDTVTPEA 261 (362)
T ss_dssp TCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCCCTTGGGGSCHHH
T ss_pred CCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhCCCCCCcccccCCCHHH
Confidence 43 2345689999999998875 599999999999999999999999987 4556666666665432 22234568899
Q ss_pred HHHHHHhcC-CCCCCCCHHHHHcCcccccc
Q 008504 155 KGFIEKCLV-PASERLSAKDLLKDPFLQVE 183 (563)
Q Consensus 155 ~~LI~kcL~-dP~kRpSa~ELLkHpff~~~ 183 (563)
++||.+||. +|.+|||+.++|+||||+..
T Consensus 262 ~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 291 (362)
T 2bdw_A 262 KSLIDSMLTVNPKKRITADQALKVPWICNR 291 (362)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred HHHHHHHcCCChhhCcCHHHHhcCcccCCC
Confidence 999999997 89999999999999999754
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-32 Score=281.98 Aligned_cols=178 Identities=33% Similarity=0.615 Sum_probs=151.0
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
|||||+++|+|.+++.+ ..+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++......
T Consensus 119 lv~e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~-~~~~~kl~Dfg~~~~~~~~ 194 (321)
T 2c30_A 119 VLMEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQG--VIHRDIKSDSILLT-LDGRVKLSDFGFCAQISKD 194 (321)
T ss_dssp EEECCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTCCEEECCCTTCEECCSS
T ss_pred EEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEC-CCCcEEEeeeeeeeecccC
Confidence 58999999999999875 56999999999999999999999999 99999999999998 4579999999998765432
Q ss_pred --CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCC-ccccCCChhHHH
Q 008504 81 --TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPA-SLAKVNDPQIKG 156 (563)
Q Consensus 81 --~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~-~l~~~~s~~l~~ 156 (563)
......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.. .........+.....+. ......++.+++
T Consensus 195 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 273 (321)
T 2c30_A 195 VPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFS-DSPVQAMKRLRDSPPPKLKNSHKVSPVLRD 273 (321)
T ss_dssp SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT-SCHHHHHHHHHHSSCCCCTTGGGSCHHHHH
T ss_pred ccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhcCCCCCcCccccCCHHHHH
Confidence 2345689999999998865 489999999999999999999999987 44555555555544332 233456789999
Q ss_pred HHHHhcC-CCCCCCCHHHHHcCcccccc
Q 008504 157 FIEKCLV-PASERLSAKDLLKDPFLQVE 183 (563)
Q Consensus 157 LI~kcL~-dP~kRpSa~ELLkHpff~~~ 183 (563)
||.+||. +|.+|||+.++|+||||...
T Consensus 274 li~~~l~~dp~~Rps~~ell~hp~~~~~ 301 (321)
T 2c30_A 274 FLERMLVRDPQERATAQELLDHPFLLQT 301 (321)
T ss_dssp HHHHHSCSSTTTSCCHHHHHTSGGGGGC
T ss_pred HHHHHccCChhhCcCHHHHhcChhhccC
Confidence 9999997 89999999999999999754
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-32 Score=298.66 Aligned_cols=183 Identities=31% Similarity=0.506 Sum_probs=157.1
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeC--CCCcEEEecccchhhcc
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG--NHGEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~--~~G~VKL~DFGlA~~~~ 78 (563)
||||||.+|+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++. ..+.+||+|||++....
T Consensus 98 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 175 (486)
T 3mwu_A 98 IVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (486)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence 58999999999999988889999999999999999999999999 999999999999963 34579999999997665
Q ss_pred CC-CCccccCCCCccCcccccccCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCc--cccCCChhHH
Q 008504 79 QP-TARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPAS--LAKVNDPQIK 155 (563)
Q Consensus 79 ~~-~~~~~~Gtp~Y~APEvl~~~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~--l~~~~s~~l~ 155 (563)
.. .....+||+.|+|||++.+.|+.++|||||||++|+|++|..||.. .+...+...+..+..... .....++.++
T Consensus 176 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 254 (486)
T 3mwu_A 176 QNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYG-KNEYDILKRVETGKYAFDLPQWRTISDDAK 254 (486)
T ss_dssp CC----CCTTGGGGCCGGGGGSCCCHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCSCSGGGGGSCHHHH
T ss_pred CCCccCCCcCCCCCCCHHHhCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCCCCCcccCCCCHHHH
Confidence 43 3345679999999999998999999999999999999999999987 456666777766654332 2345688999
Q ss_pred HHHHHhcC-CCCCCCCHHHHHcCccccccccC
Q 008504 156 GFIEKCLV-PASERLSAKDLLKDPFLQVENQK 186 (563)
Q Consensus 156 ~LI~kcL~-dP~kRpSa~ELLkHpff~~~~~~ 186 (563)
+||.+||. +|.+|||+.++|+||||+.....
T Consensus 255 ~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~~ 286 (486)
T 3mwu_A 255 DLIRKMLTFHPSLRITATQCLEHPWIQKYSSE 286 (486)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHHCHHHHHTCCC
T ss_pred HHHHHHcCCChhhCcCHHHHhcCHhhccCccc
Confidence 99999998 89999999999999999865443
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-33 Score=286.79 Aligned_cols=183 Identities=24% Similarity=0.405 Sum_probs=147.6
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeC--CCCcEEEecccchhhcc
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG--NHGEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~--~~G~VKL~DFGlA~~~~ 78 (563)
|||||+++|+|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++. ..+.+||+|||++....
T Consensus 125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~ 202 (349)
T 2w4o_A 125 LVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENG--IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202 (349)
T ss_dssp EEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence 68999999999999998888999999999999999999999999 999999999999973 35799999999997654
Q ss_pred CC-CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCC--CccccCCChhH
Q 008504 79 QP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP--ASLAKVNDPQI 154 (563)
Q Consensus 79 ~~-~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p--~~l~~~~s~~l 154 (563)
.. ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.........+..+...... .......++.+
T Consensus 203 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 282 (349)
T 2w4o_A 203 HQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNA 282 (349)
T ss_dssp ----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHH
T ss_pred cccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHH
Confidence 33 2345679999999998875 58999999999999999999999998766666666666655432 22334567899
Q ss_pred HHHHHHhcC-CCCCCCCHHHHHcCcccccccc
Q 008504 155 KGFIEKCLV-PASERLSAKDLLKDPFLQVENQ 185 (563)
Q Consensus 155 ~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~~ 185 (563)
++||.+||. +|.+|||+.++|+||||+....
T Consensus 283 ~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 314 (349)
T 2w4o_A 283 KDLVRKLIVLDPKKRLTTFQALQHPWVTGKAA 314 (349)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHSTTTTSTTC
T ss_pred HHHHHHHccCChhhCcCHHHHhcCcccCCCcc
Confidence 999999997 8999999999999999986443
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-33 Score=292.37 Aligned_cols=178 Identities=25% Similarity=0.454 Sum_probs=151.5
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
|||| +.+|+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ .+.+||+|||++......
T Consensus 133 lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~--~~~~kl~DFG~a~~~~~~ 207 (390)
T 2zmd_A 133 MVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV--DGMLKLIDFGIANQMQPD 207 (390)
T ss_dssp EEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCCGGGEEES--SSCEEECCCSSSCCC---
T ss_pred EEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEEE--CCeEEEEecCccccccCC
Confidence 5899 568899999999889999999999999999999999999 99999999999995 379999999999765432
Q ss_pred C----CccccCCCCccCcccccc------------cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCC
Q 008504 81 T----ARSVIGTPEFMAPELYEE------------EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPA 144 (563)
Q Consensus 81 ~----~~~~~Gtp~Y~APEvl~~------------~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~ 144 (563)
. ....+||+.|+|||++.+ .|+.++|||||||++|+|++|+.||............+.......
T Consensus 208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~ 287 (390)
T 2zmd_A 208 TTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI 287 (390)
T ss_dssp ------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCC
T ss_pred CccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccC
Confidence 1 235679999999998854 589999999999999999999999987666655666666555555
Q ss_pred ccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCcccccc
Q 008504 145 SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 183 (563)
Q Consensus 145 ~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~ 183 (563)
..+...+..+++||.+||. +|.+|||+.|+|+||||+..
T Consensus 288 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 327 (390)
T 2zmd_A 288 EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 327 (390)
T ss_dssp CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred CCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCcccc
Confidence 5666778899999999997 89999999999999999854
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-33 Score=288.33 Aligned_cols=183 Identities=28% Similarity=0.530 Sum_probs=150.1
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSH-NPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~-gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
|||||+++|+|.+++.+.+.+++..++.++.||+.||.|||+. | |+||||||+|||++ .++.+||+|||++.....
T Consensus 108 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~ 184 (360)
T 3eqc_A 108 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVN-SRGEIKLCDFGVSGQLID 184 (360)
T ss_dssp EEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEEC-TTCCEEECCCCCCHHHHH
T ss_pred EEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCC--EEcCCccHHHEEEC-CCCCEEEEECCCCccccc
Confidence 6899999999999999888999999999999999999999995 8 99999999999998 457999999999976544
Q ss_pred CCCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHH-------------------------
Q 008504 80 PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQI------------------------- 133 (563)
Q Consensus 80 ~~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i------------------------- 133 (563)
.......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.... ....
T Consensus 185 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (360)
T 3eqc_A 185 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD-AKELELMFGCQVEGDAAETPPRPRTPGRP 263 (360)
T ss_dssp HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCC-HHHHHHHHC--------------------
T ss_pred ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHhcccccccCCCCCCCcccCCCc
Confidence 44455689999999998865 48999999999999999999999997632 2221
Q ss_pred -----------------HHHHhcCCCCCccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCccccccccCC
Q 008504 134 -----------------FKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQKE 187 (563)
Q Consensus 134 -----------------~~~i~~~~~p~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~~~~ 187 (563)
...+.....+.......++.+++||.+||. +|.+|||+.++|+||||+......
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~ 335 (360)
T 3eqc_A 264 LNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEE 335 (360)
T ss_dssp ----------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHHHSC
T ss_pred ccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcchHhh
Confidence 222223333333344567899999999997 899999999999999998765443
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-32 Score=274.27 Aligned_cols=178 Identities=23% Similarity=0.431 Sum_probs=153.6
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
+||||+++|+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+||+++ .+|.+||+|||++......
T Consensus 91 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~kl~Dfg~~~~~~~~ 167 (284)
T 2vgo_A 91 LMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERK--VIHRDIKPENLLMG-YKGELKIADFGWSVHAPSL 167 (284)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEEC-TTCCEEECCCTTCEECSSS
T ss_pred EEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEEc-CCCCEEEecccccccCccc
Confidence 58999999999999998888999999999999999999999999 99999999999997 5579999999998766554
Q ss_pred CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHHHHH
Q 008504 81 TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIE 159 (563)
Q Consensus 81 ~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~LI~ 159 (563)
......|++.|+|||++.+ .++.++||||||+++|+|++|..||... ........+..... .++...++.+++||.
T Consensus 168 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~-~~~~~~~~~~~~~~--~~~~~~~~~~~~li~ 244 (284)
T 2vgo_A 168 RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSP-SHTETHRRIVNVDL--KFPPFLSDGSKDLIS 244 (284)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS-SHHHHHHHHHTTCC--CCCTTSCHHHHHHHH
T ss_pred ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCC-CHhHHHHHHhcccc--CCCCcCCHHHHHHHH
Confidence 4556689999999998875 4899999999999999999999999873 44445555544332 244567889999999
Q ss_pred HhcC-CCCCCCCHHHHHcCccccccc
Q 008504 160 KCLV-PASERLSAKDLLKDPFLQVEN 184 (563)
Q Consensus 160 kcL~-dP~kRpSa~ELLkHpff~~~~ 184 (563)
+||. +|.+|||+.++++||||+...
T Consensus 245 ~~l~~~p~~Rps~~~ll~h~~~~~~~ 270 (284)
T 2vgo_A 245 KLLRYHPPQRLPLKGVMEHPWVKANS 270 (284)
T ss_dssp HHSCSSGGGSCCHHHHHTCHHHHHHC
T ss_pred HHhhcCHhhCCCHHHHhhCHHHHhhc
Confidence 9997 899999999999999998644
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-33 Score=298.79 Aligned_cols=182 Identities=29% Similarity=0.469 Sum_probs=158.5
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEe--CCCCcEEEecccchhhcc
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN--GNHGEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd--~~~G~VKL~DFGlA~~~~ 78 (563)
||||||.+|+|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++ ...+.+||+|||++....
T Consensus 103 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 180 (484)
T 3nyv_A 103 LVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK--IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE 180 (484)
T ss_dssp EEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc
Confidence 58999999999999999899999999999999999999999999 99999999999995 245789999999998765
Q ss_pred CC-CCccccCCCCccCcccccccCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCc--cccCCChhHH
Q 008504 79 QP-TARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPAS--LAKVNDPQIK 155 (563)
Q Consensus 79 ~~-~~~~~~Gtp~Y~APEvl~~~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~--l~~~~s~~l~ 155 (563)
.. .....+||+.|+|||++.+.|+.++|||||||++|+|++|..||.. .+...+...+..+..... .....++.++
T Consensus 181 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 259 (484)
T 3nyv_A 181 ASKKMKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNG-ANEYDILKKVEKGKYTFELPQWKKVSESAK 259 (484)
T ss_dssp CCCSHHHHTTGGGTCCHHHHHTCCCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCCCCSGGGGGSCHHHH
T ss_pred cccccccCCCCccccCceeecCCCCCcceeHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHcCCCCCCCcccccCCHHHH
Confidence 43 2345579999999999988999999999999999999999999987 456667777776654332 2345688999
Q ss_pred HHHHHhcC-CCCCCCCHHHHHcCcccccccc
Q 008504 156 GFIEKCLV-PASERLSAKDLLKDPFLQVENQ 185 (563)
Q Consensus 156 ~LI~kcL~-dP~kRpSa~ELLkHpff~~~~~ 185 (563)
+||.+||. +|.+|||+.++|+||||+....
T Consensus 260 ~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~ 290 (484)
T 3nyv_A 260 DLIRKMLTYVPSMRISARDALDHEWIQTYTK 290 (484)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC
T ss_pred HHHHHHCCCChhHCcCHHHHhhChhhccccc
Confidence 99999998 8999999999999999986543
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-32 Score=271.98 Aligned_cols=182 Identities=24% Similarity=0.464 Sum_probs=153.6
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCC--CCcEEEecccchhhcc
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGN--HGEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~--~G~VKL~DFGlA~~~~ 78 (563)
+||||+.+|+|.+++...+.+++..++.++.||+.||.|||++| |+||||||+||+++.+ .+.+||+|||++....
T Consensus 82 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 159 (284)
T 3kk8_A 82 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 159 (284)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence 58999999999999998888999999999999999999999999 9999999999999743 2359999999997655
Q ss_pred CCC-CccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCC--CccccCCChhH
Q 008504 79 QPT-ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP--ASLAKVNDPQI 154 (563)
Q Consensus 79 ~~~-~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p--~~l~~~~s~~l 154 (563)
... .....|++.|+|||++.+ .++.++||||||+++|+|++|+.||.. .........+..+... .......++.+
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T 3kk8_A 160 DSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD-EDQHRLYAQIKAGAYDYPSPEWDTVTPEA 238 (284)
T ss_dssp SSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCCCTTTTTTSCHHH
T ss_pred cCccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCC-CchhHHHHHHHhccccCCchhhcccCHHH
Confidence 432 344679999999998865 489999999999999999999999987 4555556555555432 22334568899
Q ss_pred HHHHHHhcC-CCCCCCCHHHHHcCcccccccc
Q 008504 155 KGFIEKCLV-PASERLSAKDLLKDPFLQVENQ 185 (563)
Q Consensus 155 ~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~~ 185 (563)
++||.+||. +|.+|||+.++|+||||+....
T Consensus 239 ~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 270 (284)
T 3kk8_A 239 KSLIDSMLTVNPKKRITADQALKVPWICNRER 270 (284)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCC
T ss_pred HHHHHHHcccChhhCCCHHHHhcCccccCChh
Confidence 999999998 8999999999999999986544
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-32 Score=297.85 Aligned_cols=180 Identities=26% Similarity=0.471 Sum_probs=156.5
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCC--CCcEEEecccchhhcc
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGN--HGEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~--~G~VKL~DFGlA~~~~ 78 (563)
||||||.+|+|.+++.....+++..++.|+.||+.||.|||++| |+||||||+|||++.. .+.+||+|||++....
T Consensus 113 lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~ 190 (494)
T 3lij_A 113 LVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN--IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE 190 (494)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTCCEEECCCTTCEECB
T ss_pred EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChhhEEEeCCCCCCcEEEEECCCCeECC
Confidence 58999999999999998889999999999999999999999999 9999999999999643 4569999999997665
Q ss_pred CC-CCccccCCCCccCcccccccCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCC--ccccCCChhHH
Q 008504 79 QP-TARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPA--SLAKVNDPQIK 155 (563)
Q Consensus 79 ~~-~~~~~~Gtp~Y~APEvl~~~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~--~l~~~~s~~l~ 155 (563)
.. .....+||+.|+|||++.+.|+.++|||||||++|+|++|..||.. .....+...+..+.... ......++.++
T Consensus 191 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 269 (494)
T 3lij_A 191 NQKKMKERLGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGYPPFGG-QTDQEILRKVEKGKYTFDSPEWKNVSEGAK 269 (494)
T ss_dssp TTBCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCCCSGGGTTSCHHHH
T ss_pred CCccccccCCCcCeeCHHHHcccCCCchhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCCCCchhcccCCHHHH
Confidence 43 3345689999999999988899999999999999999999999987 45666777776665432 22345688999
Q ss_pred HHHHHhcC-CCCCCCCHHHHHcCcccccc
Q 008504 156 GFIEKCLV-PASERLSAKDLLKDPFLQVE 183 (563)
Q Consensus 156 ~LI~kcL~-dP~kRpSa~ELLkHpff~~~ 183 (563)
+||.+||. +|.+|||+.++|+||||+..
T Consensus 270 ~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 298 (494)
T 3lij_A 270 DLIKQMLQFDSQRRISAQQALEHPWIKEM 298 (494)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred HHHHHHCCCChhhCccHHHHhcCcccccC
Confidence 99999997 89999999999999999864
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-32 Score=283.00 Aligned_cols=182 Identities=25% Similarity=0.390 Sum_probs=136.9
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCC--CcEEEecccchhhcc
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNH--GEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~--G~VKL~DFGlA~~~~ 78 (563)
||||||++|+|.+++.+.+.+++..++.|+.||+.||.|||++| |+||||||+|||++.+. ..+||+|||++....
T Consensus 83 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~ 160 (325)
T 3kn6_A 83 LVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVG--VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKP 160 (325)
T ss_dssp EEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEC----CEEEECCCTTCEECC
T ss_pred EEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCHHHEEEecCCCcccEEEeccccceecC
Confidence 68999999999999999999999999999999999999999999 99999999999997432 279999999997554
Q ss_pred CC--CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCC------CCHHHHHHHHhcCCCCCc--cc
Q 008504 79 QP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSEC------KNPAQIFKKVTSGIKPAS--LA 147 (563)
Q Consensus 79 ~~--~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~------~~~~~i~~~i~~~~~p~~--l~ 147 (563)
.. .....+||+.|+|||++.+ .|+.++|||||||++|+|++|+.||... .....+...+..+..... ..
T Consensus 161 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (325)
T 3kn6_A 161 PDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAW 240 (325)
T ss_dssp C----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHH
T ss_pred CCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccc
Confidence 32 2345678999999998865 5899999999999999999999999753 233456666666544322 22
Q ss_pred cCCChhHHHHHHHhcC-CCCCCCCHHHHHcCccccccc
Q 008504 148 KVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 184 (563)
Q Consensus 148 ~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~ 184 (563)
...++.+++||.+||. +|.+|||+.++++||||+...
T Consensus 241 ~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~ 278 (325)
T 3kn6_A 241 KNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGS 278 (325)
T ss_dssp HTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTC
T ss_pred cCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCc
Confidence 4568899999999997 899999999999999998654
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-32 Score=285.92 Aligned_cols=177 Identities=24% Similarity=0.516 Sum_probs=151.7
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
|||||+.||+|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++......
T Consensus 177 lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~g--i~H~Dlkp~NIl~~-~~~~ikl~DfG~~~~~~~~ 253 (365)
T 2y7j_A 177 LVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANN--IVHRDLKPENILLD-DNMQIRLSDFGFSCHLEPG 253 (365)
T ss_dssp EEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTCCEEECCCTTCEECCTT
T ss_pred EEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEC-CCCCEEEEecCcccccCCC
Confidence 68999999999999998888999999999999999999999999 99999999999998 5589999999998766532
Q ss_pred -CCccccCCCCccCcccccc-------cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCc--cccCC
Q 008504 81 -TARSVIGTPEFMAPELYEE-------EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPAS--LAKVN 150 (563)
Q Consensus 81 -~~~~~~Gtp~Y~APEvl~~-------~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~--l~~~~ 150 (563)
......||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .........+..+..... .....
T Consensus 254 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~ 332 (365)
T 2y7j_A 254 EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWH-RRQILMLRMIMEGQYQFSSPEWDDR 332 (365)
T ss_dssp CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCCCHHHHSSS
T ss_pred cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhCCCCCCCcccccC
Confidence 3345689999999998852 478899999999999999999999987 445555555655544322 22456
Q ss_pred ChhHHHHHHHhcC-CCCCCCCHHHHHcCcccc
Q 008504 151 DPQIKGFIEKCLV-PASERLSAKDLLKDPFLQ 181 (563)
Q Consensus 151 s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~ 181 (563)
++.+.+||.+||. +|.+|||+.++|+||||+
T Consensus 333 ~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~ 364 (365)
T 2y7j_A 333 SSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364 (365)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence 7889999999997 899999999999999997
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-32 Score=282.58 Aligned_cols=183 Identities=28% Similarity=0.411 Sum_probs=144.1
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeC----CCCcEEEecccchhh
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG----NHGEVKIGDLGLAIA 76 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~----~~G~VKL~DFGlA~~ 76 (563)
|||||+. |+|.+++.+.+.+++..++.|+.||+.||.|||++| |+||||||+|||++. ..+.+||+|||++..
T Consensus 110 lv~e~~~-~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~ 186 (329)
T 3gbz_A 110 LIFEYAE-NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRR--CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA 186 (329)
T ss_dssp EEEECCS-EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEC-----CCEEEECCTTHHHH
T ss_pred EEEecCC-CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--EECCCCCHHHEEEecCCCCccceEEECcCCCccc
Confidence 6899998 599999999989999999999999999999999999 999999999999952 345699999999976
Q ss_pred ccCC--CCccccCCCCccCcccccc--cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCC--------
Q 008504 77 MQQP--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPA-------- 144 (563)
Q Consensus 77 ~~~~--~~~~~~Gtp~Y~APEvl~~--~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~-------- 144 (563)
.... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||........+...+.....+.
T Consensus 187 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (329)
T 3gbz_A 187 FGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVT 266 (329)
T ss_dssp HC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred cCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhh
Confidence 6432 2334578999999998864 489999999999999999999999987544444433332111100
Q ss_pred -------------------ccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCccccccccC
Q 008504 145 -------------------SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQK 186 (563)
Q Consensus 145 -------------------~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~~~ 186 (563)
.+....++.+++||.+||. +|.+|||+.|+|+||||+..++.
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 328 (329)
T 3gbz_A 267 ALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDFD 328 (329)
T ss_dssp GSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCSC
T ss_pred hhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCCC
Confidence 0112256889999999998 89999999999999999977653
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-32 Score=274.67 Aligned_cols=179 Identities=27% Similarity=0.436 Sum_probs=141.8
Q ss_pred CEeccCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~-~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
|||||+.+ +|.+++... +.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++.....
T Consensus 77 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~ 152 (288)
T 1ob3_A 77 LVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLIN-REGELKIADFGLARAFGI 152 (288)
T ss_dssp EEEECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTSCEEECCTTHHHHHCC
T ss_pred EEEEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEc-CCCCEEEeECccccccCc
Confidence 58999975 999999864 67999999999999999999999999 99999999999998 557999999999976643
Q ss_pred C--CCccccCCCCccCcccccc--cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhc-CCC-C----------
Q 008504 80 P--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS-GIK-P---------- 143 (563)
Q Consensus 80 ~--~~~~~~Gtp~Y~APEvl~~--~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~-~~~-p---------- 143 (563)
. ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||............... +.. .
T Consensus 153 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T 1ob3_A 153 PVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232 (288)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred cccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccc
Confidence 2 2334578999999998854 4899999999999999999999999875443333332211 000 0
Q ss_pred --------------CccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCcccccc
Q 008504 144 --------------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 183 (563)
Q Consensus 144 --------------~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~ 183 (563)
.......++.+++||.+||. +|.+|||+.|+|+||||+..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 287 (288)
T 1ob3_A 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287 (288)
T ss_dssp TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred ccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 01123457889999999998 89999999999999999854
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.98 E-value=1.1e-32 Score=286.78 Aligned_cols=183 Identities=24% Similarity=0.397 Sum_probs=152.4
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
|||||+++|+|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||+++.....
T Consensus 136 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~-~~~~~kl~DfG~a~~~~~~ 212 (355)
T 1vzo_A 136 LILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLD-SNGHVVLTDFGLSKEFVAD 212 (355)
T ss_dssp EEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTSCEEESCSSEEEECCGG
T ss_pred EEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCcEEEeeCCCCeecccC
Confidence 68999999999999998888999999999999999999999999 99999999999998 5579999999999754321
Q ss_pred ---CCccccCCCCccCcccccc---cCCchhhHHHhHHHHHHHhhcCCCCCCC---CCHHHHHHHHhcCCCCCccccCCC
Q 008504 81 ---TARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTFEYPYSEC---KNPAQIFKKVTSGIKPASLAKVND 151 (563)
Q Consensus 81 ---~~~~~~Gtp~Y~APEvl~~---~ys~ksDIwSLGviLyELlTG~~Pf~~~---~~~~~i~~~i~~~~~p~~l~~~~s 151 (563)
.....+||+.|+|||++.+ .++.++|||||||++|+|++|+.||... .....+...+..... ..+...+
T Consensus 213 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 290 (355)
T 1vzo_A 213 ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP--PYPQEMS 290 (355)
T ss_dssp GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCC--CCCTTSC
T ss_pred CCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCC--CCCcccC
Confidence 2334579999999999864 3789999999999999999999999642 233445555444432 2445667
Q ss_pred hhHHHHHHHhcC-CCCCCC-----CHHHHHcCccccccccCCC
Q 008504 152 PQIKGFIEKCLV-PASERL-----SAKDLLKDPFLQVENQKEP 188 (563)
Q Consensus 152 ~~l~~LI~kcL~-dP~kRp-----Sa~ELLkHpff~~~~~~~~ 188 (563)
+.+++||.+||. +|.+|| ++.++++||||+..++...
T Consensus 291 ~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~~~l 333 (355)
T 1vzo_A 291 ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDL 333 (355)
T ss_dssp HHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHH
T ss_pred HHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCChhHh
Confidence 899999999997 899999 9999999999998766543
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=99.98 E-value=1.2e-32 Score=291.96 Aligned_cols=181 Identities=20% Similarity=0.357 Sum_probs=143.0
Q ss_pred CEeccCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCC--CCcEEEecccchhh
Q 008504 1 MITELFTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGN--HGEVKIGDLGLAIA 76 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~--~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~--~G~VKL~DFGlA~~ 76 (563)
||||||.||+|.+++...+ .+++..++.|+.||+.||.|||++| |+||||||+|||++.. .+.+||+|||+++.
T Consensus 136 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~ 213 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 213 (400)
T ss_dssp EEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCcceEEEecCCCCccEEEEecccccc
Confidence 5899999999999998754 5999999999999999999999999 9999999999999853 57899999999976
Q ss_pred ccCC-CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCH---HHHHHHHhcCCC--CCccccC
Q 008504 77 MQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNP---AQIFKKVTSGIK--PASLAKV 149 (563)
Q Consensus 77 ~~~~-~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~---~~i~~~i~~~~~--p~~l~~~ 149 (563)
.... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|+.||...... ......+..+.. +......
T Consensus 214 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 293 (400)
T 1nxk_A 214 TTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE 293 (400)
T ss_dssp CC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTTTT
T ss_pred cCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCccccc
Confidence 5432 2345688999999999864 5999999999999999999999999763321 112333333332 2222345
Q ss_pred CChhHHHHHHHhcC-CCCCCCCHHHHHcCcccccc
Q 008504 150 NDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 183 (563)
Q Consensus 150 ~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~ 183 (563)
.++.+++||.+||. +|.+|||+.++|+||||...
T Consensus 294 ~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 328 (400)
T 1nxk_A 294 VSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 328 (400)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred CCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence 68899999999997 89999999999999999854
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.5e-32 Score=280.19 Aligned_cols=180 Identities=26% Similarity=0.423 Sum_probs=143.7
Q ss_pred CEeccCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~-~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
|||||+.+ +|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++.....
T Consensus 96 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIl~~-~~~~~kl~Dfg~a~~~~~ 171 (311)
T 3niz_A 96 LVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR--ILHRDLKPQNLLIN-SDGALKLADFGLARAFGI 171 (311)
T ss_dssp EEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECCCTTCEETTS
T ss_pred EEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCchHhEEEC-CCCCEEEccCcCceecCC
Confidence 68999985 888888764 45999999999999999999999999 99999999999998 457999999999976543
Q ss_pred C--CCccccCCCCccCcccccc--cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHh--cCCCCCc--------
Q 008504 80 P--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVT--SGIKPAS-------- 145 (563)
Q Consensus 80 ~--~~~~~~Gtp~Y~APEvl~~--~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~--~~~~p~~-------- 145 (563)
. ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.............. ....+..
T Consensus 172 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 251 (311)
T 3niz_A 172 PVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELP 251 (311)
T ss_dssp CCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSH
T ss_pred CcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccc
Confidence 2 2334578999999998854 489999999999999999999999987554443332221 1111111
Q ss_pred -----------------cccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCccccccc
Q 008504 146 -----------------LAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 184 (563)
Q Consensus 146 -----------------l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~ 184 (563)
.....++++++||.+||. ||.+|||+.|+|+||||+..+
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 308 (311)
T 3niz_A 252 LWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD 308 (311)
T ss_dssp HHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSC
T ss_pred hhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCC
Confidence 112346789999999998 899999999999999998654
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=1e-32 Score=273.03 Aligned_cols=181 Identities=25% Similarity=0.398 Sum_probs=151.2
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
+||||+++|+|.+++.....+++..++.++.||+.||.|||++| |+||||||+||+++ .+|.+||+|||++......
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~kl~dfg~~~~~~~~ 158 (276)
T 2yex_A 82 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLD-ERDNLKISDFGLATVFRYN 158 (276)
T ss_dssp EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTCCEEECCCTTCEECEET
T ss_pred EEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCChHHEEEc-cCCCEEEeeCCCccccCCC
Confidence 58999999999999988788999999999999999999999999 99999999999998 5579999999998654321
Q ss_pred ----CCccccCCCCccCccccccc--CCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhH
Q 008504 81 ----TARSVIGTPEFMAPELYEEE--YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQI 154 (563)
Q Consensus 81 ----~~~~~~Gtp~Y~APEvl~~~--ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l 154 (563)
......|++.|+|||++.+. ++.++||||||+++|+|++|+.||.........+..+.............++.+
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (276)
T 2yex_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP 238 (276)
T ss_dssp TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHH
T ss_pred cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHH
Confidence 23445789999999998653 477999999999999999999999875544444444444333333344568899
Q ss_pred HHHHHHhcC-CCCCCCCHHHHHcCccccccc
Q 008504 155 KGFIEKCLV-PASERLSAKDLLKDPFLQVEN 184 (563)
Q Consensus 155 ~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~ 184 (563)
++||.+||. +|.+|||+.++++||||+...
T Consensus 239 ~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 269 (276)
T 2yex_A 239 LALLHKILVENPSARITIPDIKKDRWYNKPL 269 (276)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred HHHHHHHCCCCchhCCCHHHHhcCccccChh
Confidence 999999997 899999999999999998543
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.2e-32 Score=278.02 Aligned_cols=185 Identities=24% Similarity=0.416 Sum_probs=142.9
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
|||||+.+++|.+++...+.+++..++.++.||+.||.|||++| |+||||||+||+++ ..+.+||+|||++......
T Consensus 79 lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~--ivH~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~ 155 (311)
T 4agu_A 79 LVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN--CIHRDVKPENILIT-KHSVIKLCDFGFARLLTGP 155 (311)
T ss_dssp EEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEECC--
T ss_pred EEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCChhhEEEc-CCCCEEEeeCCCchhccCc
Confidence 58999999999999998888999999999999999999999999 99999999999998 5579999999999765432
Q ss_pred --CCccccCCCCccCcccccc--cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhc--C--------------
Q 008504 81 --TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS--G-------------- 140 (563)
Q Consensus 81 --~~~~~~Gtp~Y~APEvl~~--~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~--~-------------- 140 (563)
......||+.|+|||++.+ .++.++|||||||++|+|++|..||............... .
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (311)
T 4agu_A 156 SDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQY 235 (311)
T ss_dssp ----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGG
T ss_pred ccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccc
Confidence 2334578999999998864 5899999999999999999999999875443333221110 0
Q ss_pred ---CC-CC--c------cccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCccccccccCCC
Q 008504 141 ---IK-PA--S------LAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQKEP 188 (563)
Q Consensus 141 ---~~-p~--~------l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~~~~~ 188 (563)
.. +. . .....++.+.+||.+||. +|.+|||+.++|+||||+...+...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~ 296 (311)
T 4agu_A 236 FSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIED 296 (311)
T ss_dssp GTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC----
T ss_pred cccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCHHH
Confidence 00 00 0 012356789999999998 8999999999999999997665443
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=99.98 E-value=2e-32 Score=282.81 Aligned_cols=176 Identities=26% Similarity=0.375 Sum_probs=142.6
Q ss_pred CEeccCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeC-----------------
Q 008504 1 MITELFTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG----------------- 61 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~--~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~----------------- 61 (563)
|||||+ +|+|.+++...+ .+++..++.++.||+.||.|||++| |+||||||+|||++.
T Consensus 113 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~ 189 (360)
T 3llt_A 113 LIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS--LTHTDLKPENILLDDPYFEKSLITVRRVTDGK 189 (360)
T ss_dssp EEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCTTCCEEEEEEECTTTCC
T ss_pred EEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCcccEEEccccccccccchhcccccc
Confidence 589999 899999998754 5999999999999999999999999 999999999999963
Q ss_pred -------CCCcEEEecccchhhccCCCCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHH
Q 008504 62 -------NHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQI 133 (563)
Q Consensus 62 -------~~G~VKL~DFGlA~~~~~~~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i 133 (563)
..+.+||+|||++..... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.... ....
T Consensus 190 ~~~~~~~~~~~~kl~DFG~a~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-~~~~ 267 (360)
T 3llt_A 190 KIQIYRTKSTGIKLIDFGCATFKSD-YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHE-HMEH 267 (360)
T ss_dssp EEEEEEESCCCEEECCCTTCEETTS-CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSS-HHHH
T ss_pred cccccccCCCCEEEEeccCceecCC-CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCc-HHHH
Confidence 267899999999975443 2345689999999998864 59999999999999999999999998743 3333
Q ss_pred HHHHhcCCCCC--------------------------------------------ccccCCChhHHHHHHHhcC-CCCCC
Q 008504 134 FKKVTSGIKPA--------------------------------------------SLAKVNDPQIKGFIEKCLV-PASER 168 (563)
Q Consensus 134 ~~~i~~~~~p~--------------------------------------------~l~~~~s~~l~~LI~kcL~-dP~kR 168 (563)
...+.....+. ......++.+.+||.+||. ||.+|
T Consensus 268 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 347 (360)
T 3llt_A 268 LAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLR 347 (360)
T ss_dssp HHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGS
T ss_pred HHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhC
Confidence 33222211100 0111224678899999998 89999
Q ss_pred CCHHHHHcCcccc
Q 008504 169 LSAKDLLKDPFLQ 181 (563)
Q Consensus 169 pSa~ELLkHpff~ 181 (563)
||+.|+|+||||+
T Consensus 348 pta~elL~hp~f~ 360 (360)
T 3llt_A 348 PSPAELLKHKFLE 360 (360)
T ss_dssp CCHHHHTTSGGGC
T ss_pred CCHHHHhcCcccC
Confidence 9999999999996
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.4e-32 Score=286.36 Aligned_cols=182 Identities=21% Similarity=0.431 Sum_probs=144.3
Q ss_pred CEeccCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhcc
Q 008504 1 MITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~--~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~ 78 (563)
||||||++|+|.+++... +.+++..++.++.||+.||.|||++| |+||||||+|||++ ..|.+||+|||.+....
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~NIll~-~~~~~kl~dfg~~~~~~ 179 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILIS-VDGKVYLSGLRSNLSMI 179 (389)
T ss_dssp EEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTCCEEECCGGGCEECE
T ss_pred EEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEc-CCCCEEEcccccceeec
Confidence 689999999999999876 67999999999999999999999999 99999999999998 55799999999875432
Q ss_pred C---------CCCccccCCCCccCcccccc---cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCC----
Q 008504 79 Q---------PTARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK---- 142 (563)
Q Consensus 79 ~---------~~~~~~~Gtp~Y~APEvl~~---~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~---- 142 (563)
. .......||+.|+|||++.+ .|+.++|||||||++|+|++|+.||.+..........+.....
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 259 (389)
T 3gni_B 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLD 259 (389)
T ss_dssp ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----------
T ss_pred cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccc
Confidence 1 11233478999999998865 5899999999999999999999999875444433332211100
Q ss_pred ---------------------------------------CCccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCccccc
Q 008504 143 ---------------------------------------PASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQV 182 (563)
Q Consensus 143 ---------------------------------------p~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~ 182 (563)
....+...++.+++||.+||. +|.+|||+.|+|+||||+.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~ 339 (389)
T 3gni_B 260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ 339 (389)
T ss_dssp ----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGG
T ss_pred ccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHH
Confidence 111334567889999999998 8999999999999999987
Q ss_pred ccc
Q 008504 183 ENQ 185 (563)
Q Consensus 183 ~~~ 185 (563)
...
T Consensus 340 ~~~ 342 (389)
T 3gni_B 340 IKR 342 (389)
T ss_dssp C--
T ss_pred Hhh
Confidence 654
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=99.98 E-value=2.2e-32 Score=285.75 Aligned_cols=181 Identities=24% Similarity=0.419 Sum_probs=139.3
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCC-CcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNH-GEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~-G~VKL~DFGlA~~~~~ 79 (563)
||||||.+|+|.+++.+.+.+++..++.|+.||+.||.|||++| |+||||||+|||++.+. +.+||+|||+++....
T Consensus 93 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~--ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~ 170 (361)
T 3uc3_A 93 IIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 170 (361)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCCceEEEeecCccccccc
Confidence 68999999999999998889999999999999999999999999 99999999999997432 3599999999864332
Q ss_pred -CCCccccCCCCccCcccccc-cCCc-hhhHHHhHHHHHHHhhcCCCCCCCCC---HHHHHHHHhcCCCCCccccCCChh
Q 008504 80 -PTARSVIGTPEFMAPELYEE-EYNE-LVDIYSFGMCILEMVTFEYPYSECKN---PAQIFKKVTSGIKPASLAKVNDPQ 153 (563)
Q Consensus 80 -~~~~~~~Gtp~Y~APEvl~~-~ys~-ksDIwSLGviLyELlTG~~Pf~~~~~---~~~i~~~i~~~~~p~~l~~~~s~~ 153 (563)
.......||+.|+|||++.+ .++. ++|||||||++|+|++|+.||..... .......+.............++.
T Consensus 171 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 250 (361)
T 3uc3_A 171 HSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPE 250 (361)
T ss_dssp ----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHH
T ss_pred cCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHH
Confidence 23345679999999998864 4544 48999999999999999999976332 234444444443333333456889
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHHcCcccccc
Q 008504 154 IKGFIEKCLV-PASERLSAKDLLKDPFLQVE 183 (563)
Q Consensus 154 l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~ 183 (563)
+++||.+||. +|.+|||+.|+++||||...
T Consensus 251 ~~~li~~~L~~dP~~Rps~~ell~hp~f~~~ 281 (361)
T 3uc3_A 251 CCHLISRIFVADPATRISIPEIKTHSWFLKN 281 (361)
T ss_dssp HHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred HHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence 9999999997 89999999999999999754
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=99.98 E-value=3.1e-32 Score=277.90 Aligned_cols=181 Identities=27% Similarity=0.459 Sum_probs=153.1
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCC---cEEEecccchhhc
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHG---EVKIGDLGLAIAM 77 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G---~VKL~DFGlA~~~ 77 (563)
+||||+++|+|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++.+.. .+||+|||++...
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~ 169 (321)
T 2a2a_A 92 LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169 (321)
T ss_dssp EEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCTTSSSCCEEECCCTTCEEC
T ss_pred EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChHHEEEecCCCCcCCEEEccCccceec
Confidence 58999999999999998888999999999999999999999999 999999999999974432 7999999999766
Q ss_pred cCC-CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCC--CccccCCChh
Q 008504 78 QQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP--ASLAKVNDPQ 153 (563)
Q Consensus 78 ~~~-~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p--~~l~~~~s~~ 153 (563)
... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .........+...... .......++.
T Consensus 170 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 248 (321)
T 2a2a_A 170 EDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG-DTKQETLANITSVSYDFDEEFFSHTSEL 248 (321)
T ss_dssp CTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCC-SSHHHHHHHHHTTCCCCCHHHHTTCCHH
T ss_pred CccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhcccccChhhhcccCHH
Confidence 543 2345679999999998864 589999999999999999999999987 3455555555554332 2233566889
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHHcCccccccc
Q 008504 154 IKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 184 (563)
Q Consensus 154 l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~ 184 (563)
+++||.+||. +|.+|||+.++|+||||+...
T Consensus 249 ~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~ 280 (321)
T 2a2a_A 249 AKDFIRKLLVKETRKRLTIQEALRHPWITPVD 280 (321)
T ss_dssp HHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSS
T ss_pred HHHHHHHHcCCChhhCcCHHHHhcCccccCCC
Confidence 9999999997 899999999999999997543
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=99.98 E-value=2.2e-32 Score=276.21 Aligned_cols=181 Identities=25% Similarity=0.414 Sum_probs=154.4
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEe--CCCCcEEEecccchhhcc
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN--GNHGEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd--~~~G~VKL~DFGlA~~~~ 78 (563)
+||||+++|+|.+++...+.+++..++.++.||+.||.|||++| |+||||||+||++. ...+.+||+|||++....
T Consensus 83 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 160 (304)
T 2jam_A 83 LVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENG--IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160 (304)
T ss_dssp EEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred EEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence 58999999999999988888999999999999999999999999 99999999999993 245799999999997655
Q ss_pred CCCCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCC--CccccCCChhHH
Q 008504 79 QPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP--ASLAKVNDPQIK 155 (563)
Q Consensus 79 ~~~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p--~~l~~~~s~~l~ 155 (563)
........|++.|+|||++.+ .++.++|||||||++|+|++|..||.. .....+...+..+... .......++.++
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 239 (304)
T 2jam_A 161 NGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYE-ETESKLFEKIKEGYYEFESPFWDDISESAK 239 (304)
T ss_dssp CBTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTT-SCHHHHHHHHHHCCCCCCTTTTTTSCHHHH
T ss_pred CCccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHcCCCCCCccccccCCHHHH
Confidence 444445679999999998865 489999999999999999999999987 4455666666665432 233455688999
Q ss_pred HHHHHhcC-CCCCCCCHHHHHcCccccccc
Q 008504 156 GFIEKCLV-PASERLSAKDLLKDPFLQVEN 184 (563)
Q Consensus 156 ~LI~kcL~-dP~kRpSa~ELLkHpff~~~~ 184 (563)
+||.+||. +|.+|||+.++|+||||+...
T Consensus 240 ~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (304)
T 2jam_A 240 DFICHLLEKDPNERYTCEKALSHPWIDGNT 269 (304)
T ss_dssp HHHHHHHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred HHHHHHcCCChhHCcCHHHHhcCccccCCC
Confidence 99999997 899999999999999998543
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=99.98 E-value=2.8e-32 Score=296.79 Aligned_cols=181 Identities=29% Similarity=0.460 Sum_probs=157.5
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCC--CcEEEecccchhhcc
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNH--GEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~--G~VKL~DFGlA~~~~ 78 (563)
||||||+||+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++.+. ..+||+|||++....
T Consensus 123 lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 200 (504)
T 3q5i_A 123 LVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHN--IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFS 200 (504)
T ss_dssp EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESSTTCCSSEEECCCTTCEECC
T ss_pred EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCcHHHEEEecCCCCccEEEEECCCCEEcC
Confidence 68999999999999998889999999999999999999999999 99999999999997443 269999999997665
Q ss_pred CC-CCccccCCCCccCcccccccCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCc--cccCCChhHH
Q 008504 79 QP-TARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPAS--LAKVNDPQIK 155 (563)
Q Consensus 79 ~~-~~~~~~Gtp~Y~APEvl~~~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~--l~~~~s~~l~ 155 (563)
.. ......||+.|+|||++.+.|+.++|||||||++|+|++|..||.. .+...+...+..+..... .....++.++
T Consensus 201 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 279 (504)
T 3q5i_A 201 KDYKLRDRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPPFGG-QNDQDIIKKVEKGKYYFDFNDWKNISDEAK 279 (504)
T ss_dssp TTSCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCCCCHHHHTTSCHHHH
T ss_pred CCCccccccCCcCCCCHHHhccCCCchHHHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCCCCCccccCCCCHHHH
Confidence 43 3445689999999999998899999999999999999999999987 556677777777654332 2345688999
Q ss_pred HHHHHhcC-CCCCCCCHHHHHcCccccccc
Q 008504 156 GFIEKCLV-PASERLSAKDLLKDPFLQVEN 184 (563)
Q Consensus 156 ~LI~kcL~-dP~kRpSa~ELLkHpff~~~~ 184 (563)
+||.+||. +|.+|||+.|+|+||||+...
T Consensus 280 ~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 309 (504)
T 3q5i_A 280 ELIKLMLTYDYNKRCTAEEALNSRWIKKYA 309 (504)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHTSHHHHHTC
T ss_pred HHHHHHcCCChhHCCCHHHHhcCHhhhhch
Confidence 99999998 899999999999999998643
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=99.98 E-value=3.6e-33 Score=290.13 Aligned_cols=176 Identities=28% Similarity=0.529 Sum_probs=147.6
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
|||||+ +|+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ ..+.+||+|||++......
T Consensus 86 lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~-~~~~~kl~DFG~s~~~~~~ 161 (336)
T 3h4j_B 86 MVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK--IVHRDLKPENLLLD-DNLNVKIADFGLSNIMTDG 161 (336)
T ss_dssp EEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHT--CCCCCCSTTTEEEC-TTCCEEECCSSCTBTTTTS
T ss_pred EEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCchhhEEEc-CCCCEEEEEeccceeccCC
Confidence 589999 7899999988889999999999999999999999999 99999999999998 5579999999999765443
Q ss_pred -CCccccCCCCccCccccccc-C-CchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHHH
Q 008504 81 -TARSVIGTPEFMAPELYEEE-Y-NELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 157 (563)
Q Consensus 81 -~~~~~~Gtp~Y~APEvl~~~-y-s~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~L 157 (563)
.....+||+.|+|||++.+. + +.++|||||||++|+|++|+.||..... ..+...+..+ ....+...++.+++|
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~-~~~~~~i~~~--~~~~p~~~s~~~~~l 238 (336)
T 3h4j_B 162 NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFI-PNLFKKVNSC--VYVMPDFLSPGAQSL 238 (336)
T ss_dssp BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSS-TTCBCCCCSS--CCCCCTTSCHHHHHH
T ss_pred cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccH-HHHHHHHHcC--CCCCcccCCHHHHHH
Confidence 34456899999999998754 3 7899999999999999999999976322 2222222222 223456678999999
Q ss_pred HHHhcC-CCCCCCCHHHHHcCcccccc
Q 008504 158 IEKCLV-PASERLSAKDLLKDPFLQVE 183 (563)
Q Consensus 158 I~kcL~-dP~kRpSa~ELLkHpff~~~ 183 (563)
|.+||. +|.+|||+.|+++||||+..
T Consensus 239 i~~~L~~dP~~Rpt~~eil~hp~~~~~ 265 (336)
T 3h4j_B 239 IRRMIVADPMQRITIQEIRRDPWFNVN 265 (336)
T ss_dssp HHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred HHHHcCCChhHCcCHHHHHhChhhccC
Confidence 999997 89999999999999999853
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.98 E-value=1.6e-32 Score=273.57 Aligned_cols=181 Identities=27% Similarity=0.501 Sum_probs=143.2
Q ss_pred CEeccCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeEeccCccCceEEeCCCCcEEEecccchh
Q 008504 1 MITELFTSGNLRQYRKK----HKNVDIKVIKNWARQILHGLVYLHSH-NPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 75 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k----~~~Lse~~i~~i~~QIL~aL~yLHs~-gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~ 75 (563)
|||||+. |+|.+++.. .+.+++..++.++.||+.||.|||++ | |+||||||+||+++ ..+.+||+|||++.
T Consensus 83 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dlkp~Nil~~-~~~~~kl~Dfg~~~ 158 (290)
T 3fme_A 83 ICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLIN-ALGQVKMCDFGISG 158 (290)
T ss_dssp EEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC--CCCCCCSGGGCEEC-TTCCEEBCCC----
T ss_pred EEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEEC-CCCCEEEeecCCcc
Confidence 5899997 588877653 56799999999999999999999998 9 99999999999998 45799999999997
Q ss_pred hccCCC-CccccCCCCccCccccc-----ccCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccC
Q 008504 76 AMQQPT-ARSVIGTPEFMAPELYE-----EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKV 149 (563)
Q Consensus 76 ~~~~~~-~~~~~Gtp~Y~APEvl~-----~~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~ 149 (563)
...... .....||+.|+|||++. ..++.++|||||||++|+|++|+.||..................+......
T Consensus 159 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (290)
T 3fme_A 159 YLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADK 238 (290)
T ss_dssp -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTT
T ss_pred cccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCccccc
Confidence 654432 23347899999999862 348899999999999999999999998766666665555555555555566
Q ss_pred CChhHHHHHHHhcC-CCCCCCCHHHHHcCcccccccc
Q 008504 150 NDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQ 185 (563)
Q Consensus 150 ~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~~ 185 (563)
.++.+.+||.+||. +|.+|||+.++++||||+....
T Consensus 239 ~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~~~ 275 (290)
T 3fme_A 239 FSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHES 275 (290)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHH
T ss_pred CCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccCcc
Confidence 78899999999998 8999999999999999986543
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.5e-32 Score=281.76 Aligned_cols=185 Identities=24% Similarity=0.404 Sum_probs=150.6
Q ss_pred CEeccCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeC--CCCcEEEecccchhh
Q 008504 1 MITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG--NHGEVKIGDLGLAIA 76 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~--~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~--~~G~VKL~DFGlA~~ 76 (563)
|||||+.+|+|.+++... +.+++..++.++.||+.||.|||++| |+||||||+|||++. ..+.+||+|||++..
T Consensus 106 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g--ivH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~ 183 (327)
T 3lm5_A 106 LILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN--IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK 183 (327)
T ss_dssp EEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESCBTTBCCEEECCGGGCEE
T ss_pred EEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCChHHEEEecCCCCCcEEEeeCccccc
Confidence 589999999999998653 67999999999999999999999999 999999999999975 257999999999976
Q ss_pred ccCC-CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCC--CCCccccCCCh
Q 008504 77 MQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI--KPASLAKVNDP 152 (563)
Q Consensus 77 ~~~~-~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~--~p~~l~~~~s~ 152 (563)
.... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||... ........+.... .+.......++
T Consensus 184 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~ 262 (327)
T 3lm5_A 184 IGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGE-DNQETYLNISQVNVDYSEETFSSVSQ 262 (327)
T ss_dssp C---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHHTCCCCCTTTTTTSCH
T ss_pred cCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CchHHHHHHHhcccccCchhhcccCH
Confidence 6443 2345679999999998864 5899999999999999999999999874 4444444444332 23333455678
Q ss_pred hHHHHHHHhcC-CCCCCCCHHHHHcCccccccccCCC
Q 008504 153 QIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQKEP 188 (563)
Q Consensus 153 ~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~~~~~ 188 (563)
.+++||.+||. +|.+|||+.++|+||||+..++...
T Consensus 263 ~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~~~ 299 (327)
T 3lm5_A 263 LATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENL 299 (327)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTTCC
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhCCHhhcccccccc
Confidence 99999999998 8999999999999999998776553
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=3e-32 Score=272.26 Aligned_cols=183 Identities=32% Similarity=0.530 Sum_probs=148.9
Q ss_pred CEeccCCCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhc
Q 008504 1 MITELFTSGNLRQYRKKHK---NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM 77 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~---~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~ 77 (563)
+||||+++|+|.+++.... .+++..++.++.||+.||.|||++| |+||||||+||+++...+.+||+|||++...
T Consensus 96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~ 173 (295)
T 2clq_A 96 IFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLINTYSGVLKISDFGTSKRL 173 (295)
T ss_dssp EEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTCCEEECCTTTCEES
T ss_pred EEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC--EEccCCChhhEEEECCCCCEEEeeccccccc
Confidence 5899999999999998752 4679999999999999999999999 9999999999999865789999999999765
Q ss_pred cCC--CCccccCCCCccCcccccc---cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCCh
Q 008504 78 QQP--TARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDP 152 (563)
Q Consensus 78 ~~~--~~~~~~Gtp~Y~APEvl~~---~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~ 152 (563)
... ......|++.|+|||++.+ .++.++||||||+++|+|++|+.||.....................++...++
T Consensus 174 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (295)
T 2clq_A 174 AGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSA 253 (295)
T ss_dssp CC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCH
T ss_pred CCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCH
Confidence 432 2345578999999998864 27899999999999999999999997654444333332222223345666789
Q ss_pred hHHHHHHHhcC-CCCCCCCHHHHHcCcccccccc
Q 008504 153 QIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQ 185 (563)
Q Consensus 153 ~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~~ 185 (563)
.+++||.+||. +|.+|||+.++|+||||+....
T Consensus 254 ~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 287 (295)
T 2clq_A 254 EAKAFILKCFEPDPDKRACANDLLVDEFLKVSSK 287 (295)
T ss_dssp HHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC---
T ss_pred HHHHHHHHHccCChhhCCCHHHHhcChhhhhccc
Confidence 99999999997 8999999999999999986543
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=99.98 E-value=2.3e-32 Score=283.91 Aligned_cols=180 Identities=27% Similarity=0.472 Sum_probs=149.8
Q ss_pred CEeccCCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCC--CCcEEEecccch
Q 008504 1 MITELFTSGNLRQYRKKH----KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGN--HGEVKIGDLGLA 74 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~----~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~--~G~VKL~DFGlA 74 (563)
||||||+||+|.+++.+. ..+++..++.++.||+.||.|||++| |+||||||+|||++.+ .+.+||+|||++
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN--IIHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChHHeEEecCCCCCcEEEecCcce
Confidence 689999999999888643 35899999999999999999999999 9999999999999743 235999999999
Q ss_pred hhccCCC--CccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCC--ccccC
Q 008504 75 IAMQQPT--ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPA--SLAKV 149 (563)
Q Consensus 75 ~~~~~~~--~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~--~l~~~ 149 (563)
....... ....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.. ....++..+..+.... .....
T Consensus 181 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~--~~~~~~~~i~~~~~~~~~~~~~~ 258 (351)
T 3c0i_A 181 IQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYG--TKERLFEGIIKGKYKMNPRQWSH 258 (351)
T ss_dssp EECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCS--SHHHHHHHHHHTCCCCCHHHHTT
T ss_pred eEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCC--cHHHHHHHHHcCCCCCCcccccc
Confidence 7665432 345679999999998865 489999999999999999999999986 3455556565554322 22245
Q ss_pred CChhHHHHHHHhcC-CCCCCCCHHHHHcCccccccc
Q 008504 150 NDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 184 (563)
Q Consensus 150 ~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~ 184 (563)
.++.+++||.+||. +|.+|||+.++|+||||+...
T Consensus 259 ~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~ 294 (351)
T 3c0i_A 259 ISESAKDLVRRMLMLDPAERITVYEALNHPWLKERD 294 (351)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTHH
T ss_pred CCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCCc
Confidence 67899999999997 899999999999999998644
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=6.4e-32 Score=270.73 Aligned_cols=181 Identities=26% Similarity=0.470 Sum_probs=152.5
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
|||||+++|+|.+++...+.+++..++.++.||+.||.|||++| |+||||||+||+++ .+|.+||+|||++......
T Consensus 101 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~kl~dfg~~~~~~~~ 177 (298)
T 1phk_A 101 LVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLD-DDMNIKLTDFGFSCQLDPG 177 (298)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTCCEEECCCTTCEECCTT
T ss_pred EEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEc-CCCcEEEecccchhhcCCC
Confidence 58999999999999998888999999999999999999999999 99999999999998 5579999999999765432
Q ss_pred -CCccccCCCCccCccccc-------ccCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCc--cccCC
Q 008504 81 -TARSVIGTPEFMAPELYE-------EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPAS--LAKVN 150 (563)
Q Consensus 81 -~~~~~~Gtp~Y~APEvl~-------~~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~--l~~~~ 150 (563)
......|++.|+|||++. ..++.++||||||+++|+|++|..||.. .........+..+..... .....
T Consensus 178 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (298)
T 1phk_A 178 EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH-RKQMLMLRMIMSGNYQFGSPEWDDY 256 (298)
T ss_dssp CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCCCTTTGGGS
T ss_pred cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcC-ccHHHHHHHHhcCCcccCccccccc
Confidence 334567899999999874 2478899999999999999999999987 345555555555443222 22456
Q ss_pred ChhHHHHHHHhcC-CCCCCCCHHHHHcCcccccccc
Q 008504 151 DPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQ 185 (563)
Q Consensus 151 s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~~ 185 (563)
++.+++||.+||. +|.+|||+.++|+||||+....
T Consensus 257 ~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~ 292 (298)
T 1phk_A 257 SDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVV 292 (298)
T ss_dssp CHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC-
T ss_pred CHHHHHHHHHHccCCcccCCCHHHHHhChHhhhccc
Confidence 7899999999997 8999999999999999986544
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.98 E-value=2.5e-32 Score=286.46 Aligned_cols=178 Identities=22% Similarity=0.360 Sum_probs=142.6
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC-
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ- 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~- 79 (563)
||||||. |+|.+++.. +.+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||+++....
T Consensus 88 lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~-~~~~~kl~DFG~a~~~~~~ 162 (388)
T 3oz6_A 88 LVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGG--LLHRDMKPSNILLN-AECHVKVADFGLSRSFVNI 162 (388)
T ss_dssp EEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECCCTTCEESSSC
T ss_pred EEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHeEEc-CCCCEEecCCccccccccc
Confidence 6899997 599999987 57999999999999999999999999 99999999999998 457999999999975422
Q ss_pred ----------------------CCCccccCCCCccCcccccc--cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHH
Q 008504 80 ----------------------PTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFK 135 (563)
Q Consensus 80 ----------------------~~~~~~~Gtp~Y~APEvl~~--~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~ 135 (563)
......+||+.|+|||++.+ .|+.++|||||||++|+|++|+.||.+.....++..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~ 242 (388)
T 3oz6_A 163 RRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLER 242 (388)
T ss_dssp CCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred ccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 11234579999999998864 589999999999999999999999987544433333
Q ss_pred HHhcCCCCC--------------------------------------------ccccCCChhHHHHHHHhcC-CCCCCCC
Q 008504 136 KVTSGIKPA--------------------------------------------SLAKVNDPQIKGFIEKCLV-PASERLS 170 (563)
Q Consensus 136 ~i~~~~~p~--------------------------------------------~l~~~~s~~l~~LI~kcL~-dP~kRpS 170 (563)
.+.....|. ......++.+.+||.+||. +|.+|||
T Consensus 243 i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t 322 (388)
T 3oz6_A 243 IIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRIS 322 (388)
T ss_dssp HHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCC
T ss_pred HHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCC
Confidence 221110010 0011457899999999998 8999999
Q ss_pred HHHHHcCcccccc
Q 008504 171 AKDLLKDPFLQVE 183 (563)
Q Consensus 171 a~ELLkHpff~~~ 183 (563)
+.|+|+||||+..
T Consensus 323 ~~e~l~Hp~~~~~ 335 (388)
T 3oz6_A 323 ANDALKHPFVSIF 335 (388)
T ss_dssp HHHHTTSTTTTTT
T ss_pred HHHHhCCHHHHHh
Confidence 9999999999754
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=4.1e-32 Score=268.60 Aligned_cols=175 Identities=23% Similarity=0.363 Sum_probs=142.8
Q ss_pred CEeccCCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeC---------------
Q 008504 1 MITELFTSGNLRQYRKKH----KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG--------------- 61 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~----~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~--------------- 61 (563)
|||||+++|+|.+++.+. +.+++..++.++.||+.||.|||++| |+||||||+|||++.
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 88 IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS--LVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC----------------
T ss_pred EEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeecCCCHHHEEEcCCCCCccccccccccc
Confidence 589999999999999864 67999999999999999999999999 999999999999973
Q ss_pred ---CCCcEEEecccchhhccCCCCccccCCCCccCccccccc--CCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 008504 62 ---NHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEE--YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKK 136 (563)
Q Consensus 62 ---~~G~VKL~DFGlA~~~~~~~~~~~~Gtp~Y~APEvl~~~--ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~ 136 (563)
..+.+||+|||++...... ....||+.|+|||++.+. ++.++|||||||++|+|++|..|+... .....
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~----~~~~~ 239 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSP--QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG----DQWHE 239 (289)
T ss_dssp ----CCCEEECCCTTCEETTCS--CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS----HHHHH
T ss_pred ccCCceEEEEcccccccccCCc--cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch----hHHHH
Confidence 2347999999999765543 234689999999998754 567999999999999999998776542 22333
Q ss_pred HhcCCCCCccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCccccccc
Q 008504 137 VTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 184 (563)
Q Consensus 137 i~~~~~p~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~ 184 (563)
+..+..+ .++...++.+++||.+||. +|.+|||+.++|+||||+...
T Consensus 240 ~~~~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 287 (289)
T 1x8b_A 240 IRQGRLP-RIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSAS 287 (289)
T ss_dssp HHTTCCC-CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC----
T ss_pred HHcCCCC-CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhhc
Confidence 4444333 3456678999999999997 899999999999999998643
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=4.9e-32 Score=276.66 Aligned_cols=180 Identities=28% Similarity=0.507 Sum_probs=145.5
Q ss_pred CEeccCCCCCHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccch
Q 008504 1 MITELFTSGNLRQYRKKH------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA 74 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~------~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA 74 (563)
|||||+. |+|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++
T Consensus 80 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~-~~~~~kl~Dfg~~ 155 (317)
T 2pmi_A 80 LVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK--ILHRDLKPQNLLIN-KRGQLKLGDFGLA 155 (317)
T ss_dssp EEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECCCSSC
T ss_pred EEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCChHHeEEc-CCCCEEECcCccc
Confidence 6899998 5999998753 35999999999999999999999999 99999999999998 5579999999999
Q ss_pred hhccCC--CCccccCCCCccCcccccc--cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhc--CCCC-----
Q 008504 75 IAMQQP--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS--GIKP----- 143 (563)
Q Consensus 75 ~~~~~~--~~~~~~Gtp~Y~APEvl~~--~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~--~~~p----- 143 (563)
...... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||..... ......+.. +..+
T Consensus 156 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~ 234 (317)
T 2pmi_A 156 RAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTND-EEQLKLIFDIMGTPNESLWP 234 (317)
T ss_dssp EETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHHHCSCCTTTCG
T ss_pred eecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCChhHhh
Confidence 765432 2345578999999998864 489999999999999999999999987443 333333221 1000
Q ss_pred -------------------------CccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCcccccccc
Q 008504 144 -------------------------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQ 185 (563)
Q Consensus 144 -------------------------~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~~ 185 (563)
.......++.+++||.+||. +|.+|||+.|+|+||||+....
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 302 (317)
T 2pmi_A 235 SVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYH 302 (317)
T ss_dssp GGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC
T ss_pred hhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccc
Confidence 01112457789999999998 8999999999999999986544
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.7e-32 Score=276.28 Aligned_cols=180 Identities=29% Similarity=0.545 Sum_probs=146.6
Q ss_pred CEeccCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhcc
Q 008504 1 MITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~--~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~ 78 (563)
|||||+.+|+|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++....
T Consensus 104 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~-~~~~~kl~Dfg~~~~~~ 180 (326)
T 2x7f_A 104 LVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLD 180 (326)
T ss_dssp EEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEC-TTCCEEECCCTTTC---
T ss_pred EEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCcHHHEEEc-CCCCEEEeeCcCceecC
Confidence 589999999999999875 56999999999999999999999999 99999999999998 55799999999987654
Q ss_pred CC--CCccccCCCCccCccccc------ccCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCC
Q 008504 79 QP--TARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVN 150 (563)
Q Consensus 79 ~~--~~~~~~Gtp~Y~APEvl~------~~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~ 150 (563)
.. ......|++.|+|||++. ..++.++|||||||++|+|++|..||... ........+.....+.......
T Consensus 181 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~ 259 (326)
T 2x7f_A 181 RTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM-HPMRALFLIPRNPAPRLKSKKW 259 (326)
T ss_dssp ----------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTS-CHHHHHHHHHHSCCCCCSCSCS
T ss_pred cCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCC-cHHHHHHHhhcCccccCCcccc
Confidence 32 233457899999999884 34889999999999999999999999874 4444444455554554455667
Q ss_pred ChhHHHHHHHhcC-CCCCCCCHHHHHcCccccccc
Q 008504 151 DPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 184 (563)
Q Consensus 151 s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~ 184 (563)
++.+++||.+||. +|.+||++.++++||||+...
T Consensus 260 ~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 294 (326)
T 2x7f_A 260 SKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQP 294 (326)
T ss_dssp CHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCT
T ss_pred CHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCc
Confidence 8899999999997 899999999999999998543
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.97 E-value=4e-32 Score=295.69 Aligned_cols=177 Identities=29% Similarity=0.517 Sum_probs=154.5
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
||||||++|+|.+++.+++.+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++......
T Consensus 93 lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDLkp~NIll~-~~~~vkL~DFG~a~~~~~~ 169 (476)
T 2y94_A 93 MVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHM--VVHRDLKPENVLLD-AHMNAKIADFGLSNMMSDG 169 (476)
T ss_dssp EEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEEC-TTCCEEECCCSSCEECCTT
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CCcccccHHHEEEe-cCCCeEEEeccchhhcccc
Confidence 68999999999999998889999999999999999999999999 99999999999998 4579999999999766543
Q ss_pred -CCccccCCCCccCccccccc-C-CchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHHH
Q 008504 81 -TARSVIGTPEFMAPELYEEE-Y-NELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 157 (563)
Q Consensus 81 -~~~~~~Gtp~Y~APEvl~~~-y-s~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~L 157 (563)
.....+||+.|+|||++.+. + +.++|||||||++|+|++|+.||... +...++..+..+... .+...++.+++|
T Consensus 170 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~-~~~~~~~~i~~~~~~--~p~~~s~~~~~L 246 (476)
T 2y94_A 170 EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDD-HVPTLFKKICDGIFY--TPQYLNPSVISL 246 (476)
T ss_dssp CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCS-SSHHHHHHHHTTCCC--CCTTCCHHHHHH
T ss_pred ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCC-CHHHHHHHHhcCCcC--CCccCCHHHHHH
Confidence 34456899999999998764 3 78999999999999999999999874 455666666666443 355678899999
Q ss_pred HHHhcC-CCCCCCCHHHHHcCcccccc
Q 008504 158 IEKCLV-PASERLSAKDLLKDPFLQVE 183 (563)
Q Consensus 158 I~kcL~-dP~kRpSa~ELLkHpff~~~ 183 (563)
|.+||. +|.+|||+.++++||||+..
T Consensus 247 i~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 247 LKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp HHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred HHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 999997 89999999999999999853
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=4.7e-32 Score=287.15 Aligned_cols=181 Identities=25% Similarity=0.409 Sum_probs=151.8
Q ss_pred CEeccCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeC-CCCcEEEecccchhhcc
Q 008504 1 MITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG-NHGEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~-~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~-~~G~VKL~DFGlA~~~~ 78 (563)
||||||.+|+|.+++...+ .+++..++.++.||+.||.|||++| |+||||||+|||++. ..+.+||+|||++....
T Consensus 125 lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~ 202 (387)
T 1kob_A 125 LILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLN 202 (387)
T ss_dssp EEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred EEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccchHHeEEecCCCCceEEEecccceecC
Confidence 6899999999999997654 6999999999999999999999999 999999999999974 34689999999997665
Q ss_pred CC-CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCC--CCccccCCChhH
Q 008504 79 QP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK--PASLAKVNDPQI 154 (563)
Q Consensus 79 ~~-~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~--p~~l~~~~s~~l 154 (563)
.. ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+.......+..... +.......++.+
T Consensus 203 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 281 (387)
T 1kob_A 203 PDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG-EDDLETLQNVKRCDWEFDEDAFSSVSPEA 281 (387)
T ss_dssp TTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC-SSHHHHHHHHHHCCCCCCSSTTTTSCHHH
T ss_pred CCcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCCCCccccccCCHHH
Confidence 43 2334579999999998865 489999999999999999999999987 344555555554432 222334568899
Q ss_pred HHHHHHhcC-CCCCCCCHHHHHcCccccccc
Q 008504 155 KGFIEKCLV-PASERLSAKDLLKDPFLQVEN 184 (563)
Q Consensus 155 ~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~ 184 (563)
++||.+||. +|.+|||+.++|+||||+...
T Consensus 282 ~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 312 (387)
T 1kob_A 282 KDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 312 (387)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred HHHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence 999999997 899999999999999998654
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=2.5e-32 Score=278.09 Aligned_cols=179 Identities=21% Similarity=0.368 Sum_probs=144.9
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
|||||+.+++|.+++.. +++..++.++.||+.||.|||++| |+||||||+|||++.+.+.+||+|||++......
T Consensus 110 lv~e~~~~~~l~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~ 184 (330)
T 3nsz_A 110 LVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 184 (330)
T ss_dssp EEEECCCCCCHHHHGGG---CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred EEEeccCchhHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence 58999999999999854 999999999999999999999999 9999999999999866558999999999765432
Q ss_pred -CCccccCCCCccCcccccc--cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhc-------------CCC--
Q 008504 81 -TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS-------------GIK-- 142 (563)
Q Consensus 81 -~~~~~~Gtp~Y~APEvl~~--~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~-------------~~~-- 142 (563)
......|++.|+|||++.+ .++.++|||||||++|+|++|+.||............+.. ...
T Consensus 185 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 264 (330)
T 3nsz_A 185 QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 264 (330)
T ss_dssp CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCC
T ss_pred CccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcccc
Confidence 3345678999999998864 4899999999999999999999999654443322221111 100
Q ss_pred --------------------CCccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCccccccc
Q 008504 143 --------------------PASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 184 (563)
Q Consensus 143 --------------------p~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~ 184 (563)
........++.+++||.+||. +|.+|||+.|+|+||||+...
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~ 327 (330)
T 3nsz_A 265 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 327 (330)
T ss_dssp CTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred ccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhc
Confidence 011122367899999999998 899999999999999998654
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.8e-32 Score=302.43 Aligned_cols=183 Identities=27% Similarity=0.445 Sum_probs=156.3
Q ss_pred CEeccCCCCCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhcc
Q 008504 1 MITELFTSGNLRQYRKKHKN--VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~--Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~ 78 (563)
|||||++||+|.+++...+. +++..++.|+.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++....
T Consensus 261 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g--IvHrDLKPeNILld-~~g~vKL~DFGla~~~~ 337 (576)
T 2acx_A 261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER--IVYRDLKPENILLD-DHGHIRISDLGLAVHVP 337 (576)
T ss_dssp EEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTSCEEECCCTTCEECC
T ss_pred EEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCchheEEEe-CCCCeEEEecccceecc
Confidence 69999999999999987543 999999999999999999999999 99999999999998 55899999999997665
Q ss_pred CC-CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCC---CHHHHHHHHhcCCCCCccccCCChh
Q 008504 79 QP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECK---NPAQIFKKVTSGIKPASLAKVNDPQ 153 (563)
Q Consensus 79 ~~-~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~---~~~~i~~~i~~~~~p~~l~~~~s~~ 153 (563)
.. .....+||+.|+|||++.+ .|+.++|||||||++|+|++|+.||.... ....+...+.... ..++...++.
T Consensus 338 ~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~--~~~p~~~s~~ 415 (576)
T 2acx_A 338 EGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVP--EEYSERFSPQ 415 (576)
T ss_dssp TTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCC--CCCCTTSCHH
T ss_pred cCccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhccc--ccCCccCCHH
Confidence 43 2345689999999998865 59999999999999999999999997642 3455555555442 2345677899
Q ss_pred HHHHHHHhcC-CCCCCC-----CHHHHHcCccccccccCCC
Q 008504 154 IKGFIEKCLV-PASERL-----SAKDLLKDPFLQVENQKEP 188 (563)
Q Consensus 154 l~~LI~kcL~-dP~kRp-----Sa~ELLkHpff~~~~~~~~ 188 (563)
+++||.+||. +|.+|| ++.|+++||||+..+|...
T Consensus 416 ~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w~~l 456 (576)
T 2acx_A 416 ARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRL 456 (576)
T ss_dssp HHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCHHHH
T ss_pred HHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCHHHH
Confidence 9999999997 899999 8999999999998777543
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-32 Score=292.12 Aligned_cols=183 Identities=28% Similarity=0.459 Sum_probs=148.0
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCC--CCcEEEecccchhhcc
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGN--HGEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~--~G~VKL~DFGlA~~~~ 78 (563)
||||||.+|+|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++.+ .+.+||+|||+++...
T Consensus 216 lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~ 293 (419)
T 3i6u_A 216 IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG 293 (419)
T ss_dssp EEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC
T ss_pred EEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecCCCcceEEEeecccceecC
Confidence 68999999999999998889999999999999999999999999 9999999999999733 3469999999998765
Q ss_pred CC-CCccccCCCCccCccccc----ccCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCC--ccccCCC
Q 008504 79 QP-TARSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPA--SLAKVND 151 (563)
Q Consensus 79 ~~-~~~~~~Gtp~Y~APEvl~----~~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~--~l~~~~s 151 (563)
.. .....+||+.|+|||++. ..|+.++|||||||++|+|++|..||........+...+..+.... ......+
T Consensus 294 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 373 (419)
T 3i6u_A 294 ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVS 373 (419)
T ss_dssp -----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHHTTSC
T ss_pred CCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhhcccC
Confidence 43 234568999999999874 3588899999999999999999999987555444555555554322 2234568
Q ss_pred hhHHHHHHHhcC-CCCCCCCHHHHHcCcccccccc
Q 008504 152 PQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQ 185 (563)
Q Consensus 152 ~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~~ 185 (563)
+.+++||.+||. +|.+|||+.++|+||||+....
T Consensus 374 ~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~ 408 (419)
T 3i6u_A 374 EKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDM 408 (419)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCHHH
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhCCcccCChhH
Confidence 899999999998 8999999999999999986543
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=9e-32 Score=272.05 Aligned_cols=182 Identities=31% Similarity=0.541 Sum_probs=150.9
Q ss_pred CEeccCCCCCHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRK-KHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~-k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
|||||+.+|+|.+++. ....+++..++.++.||+.||.|||++| |+||||||+||+++ .+|.+||+|||++.....
T Consensus 101 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~kl~dfg~~~~~~~ 177 (314)
T 3com_A 101 IVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR--KIHRDIKAGNILLN-TEGHAKLADFGVAGQLTD 177 (314)
T ss_dssp EEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTCCEEECCCTTCEECBT
T ss_pred EEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCcCHHHEEEC-CCCCEEEeecccchhhhh
Confidence 5899999999999997 4567999999999999999999999999 99999999999998 457999999999976543
Q ss_pred C--CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHH
Q 008504 80 P--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKG 156 (563)
Q Consensus 80 ~--~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~ 156 (563)
. ......|++.|+|||++.+ .++.++||||||+++|+|++|+.||......................+...++.+.+
T Consensus 178 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 257 (314)
T 3com_A 178 TMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTD 257 (314)
T ss_dssp TBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHH
T ss_pred hccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHH
Confidence 3 2334578999999998865 489999999999999999999999987443333333222222223345566889999
Q ss_pred HHHHhcC-CCCCCCCHHHHHcCcccccccc
Q 008504 157 FIEKCLV-PASERLSAKDLLKDPFLQVENQ 185 (563)
Q Consensus 157 LI~kcL~-dP~kRpSa~ELLkHpff~~~~~ 185 (563)
||.+||. +|.+|||+.++|+||||+....
T Consensus 258 li~~~l~~dp~~Rpt~~~ll~~~~~~~~~~ 287 (314)
T 3com_A 258 FVKQCLVKSPEQRATATQLLQHPFVRSAKG 287 (314)
T ss_dssp HHHHHTCSCTTTSCCHHHHTTSHHHHTCCC
T ss_pred HHHHHccCChhhCcCHHHHHhCHHHhcCCc
Confidence 9999997 8999999999999999986543
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.7e-32 Score=283.58 Aligned_cols=181 Identities=22% Similarity=0.348 Sum_probs=147.0
Q ss_pred CEeccCCCCCHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhh
Q 008504 1 MITELFTSGNLRQYRK----KHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 76 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~----k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~ 76 (563)
|||||+++ +|.+++. ..+.+++..++.++.||+.||.|||++| |+||||||+|||++..++.+||+|||++..
T Consensus 115 lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~ 191 (383)
T 3eb0_A 115 VIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG--ICHRDIKPQNLLVNSKDNTLKLCDFGSAKK 191 (383)
T ss_dssp EEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCCGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCc--CccCccCHHHEEEcCCCCcEEEEECCCCcc
Confidence 58999984 7776664 4578999999999999999999999999 999999999999986678999999999976
Q ss_pred ccCC-CCccccCCCCccCcccccc--cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCC----------
Q 008504 77 MQQP-TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP---------- 143 (563)
Q Consensus 77 ~~~~-~~~~~~Gtp~Y~APEvl~~--~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p---------- 143 (563)
.... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+......+...+.....+
T Consensus 192 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~ 271 (383)
T 3eb0_A 192 LIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNP 271 (383)
T ss_dssp CCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCT
T ss_pred cCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCc
Confidence 5432 3445678999999998764 48999999999999999999999998755444444333211000
Q ss_pred ----------------CccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCccccccc
Q 008504 144 ----------------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 184 (563)
Q Consensus 144 ----------------~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~ 184 (563)
..++...++.+++||.+||. +|.+|||+.|+|+||||+...
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 329 (383)
T 3eb0_A 272 HYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLR 329 (383)
T ss_dssp TC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGHHHH
T ss_pred ccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCHHHHHHH
Confidence 01234467889999999998 899999999999999998643
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.6e-32 Score=273.64 Aligned_cols=179 Identities=22% Similarity=0.378 Sum_probs=143.0
Q ss_pred CEeccCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCC----------------
Q 008504 1 MITELFTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGN---------------- 62 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~--~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~---------------- 62 (563)
|||||+ +|+|.+++...+ .+++..++.++.||+.||.|||++| |+||||||+|||++..
T Consensus 94 lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~ 170 (339)
T 1z57_A 94 IVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK--LTHTDLKPENILFVQSDYTEAYNPKIKRDERT 170 (339)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCCCEEEEEC----CEEEE
T ss_pred EEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEEEeccccccccCCcccccccc
Confidence 589999 889999998765 6899999999999999999999999 9999999999999742
Q ss_pred --CCcEEEecccchhhccCCCCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 008504 63 --HGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS 139 (563)
Q Consensus 63 --~G~VKL~DFGlA~~~~~~~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~ 139 (563)
.+.+||+|||++..... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||...... .....+..
T Consensus 171 ~~~~~~kl~Dfg~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-~~~~~~~~ 248 (339)
T 1z57_A 171 LINPDIKVVDFGSATYDDE-HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSK-EHLAMMER 248 (339)
T ss_dssp ESCCCEEECCCSSCEETTS-CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHH-HHHHHHHH
T ss_pred ccCCCceEeeCcccccCcc-ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHH
Confidence 46799999999975443 2345678999999998865 5899999999999999999999999874333 22222211
Q ss_pred --CCCCCc----------------------------------------cccCCChhHHHHHHHhcC-CCCCCCCHHHHHc
Q 008504 140 --GIKPAS----------------------------------------LAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 140 --~~~p~~----------------------------------------l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLk 176 (563)
+..+.. .....++.+.+||.+||. +|.+|||+.|+|+
T Consensus 249 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 328 (339)
T 1z57_A 249 ILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALK 328 (339)
T ss_dssp HHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred HhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhc
Confidence 111100 011123578999999998 8999999999999
Q ss_pred Cccccccc
Q 008504 177 DPFLQVEN 184 (563)
Q Consensus 177 Hpff~~~~ 184 (563)
||||+..+
T Consensus 329 hp~f~~~~ 336 (339)
T 1z57_A 329 HPFFDLLK 336 (339)
T ss_dssp SGGGGGGG
T ss_pred CHHHHHHh
Confidence 99998643
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.7e-32 Score=269.49 Aligned_cols=184 Identities=29% Similarity=0.530 Sum_probs=142.7
Q ss_pred CEeccCCCCCHHHHHHh--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEeccc
Q 008504 1 MITELFTSGNLRQYRKK--------HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLG 72 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k--------~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFG 72 (563)
+||||+++|+|.+++.. .+.+++..++.++.||+.||.|||++| |+||||||+||+++ .+|.+||+|||
T Consensus 90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~kl~dfg 166 (303)
T 2vwi_A 90 LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG--QIHRDVKAGNILLG-EDGSVQIADFG 166 (303)
T ss_dssp EEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEC-TTCCEEECCCH
T ss_pred EEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCCChhhEEEc-CCCCEEEEecc
Confidence 58999999999999974 456999999999999999999999999 99999999999998 45799999999
Q ss_pred chhhccCC-------CCccccCCCCccCcccccc--cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCC
Q 008504 73 LAIAMQQP-------TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP 143 (563)
Q Consensus 73 lA~~~~~~-------~~~~~~Gtp~Y~APEvl~~--~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p 143 (563)
++...... ......|++.|+|||++.+ .++.++|||||||++|+|++|+.||...................
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 246 (303)
T 2vwi_A 167 VSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPS 246 (303)
T ss_dssp HHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCC
T ss_pred chheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCc
Confidence 99765422 1234578999999998864 58999999999999999999999998754444333333222111
Q ss_pred -------CccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCccccccccCC
Q 008504 144 -------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQKE 187 (563)
Q Consensus 144 -------~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~~~~ 187 (563)
.......++.+++||.+||. +|.+|||+.++++||||+....++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~ 298 (303)
T 2vwi_A 247 LETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNKE 298 (303)
T ss_dssp TTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC-------
T ss_pred cccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCCCc
Confidence 12234567899999999998 899999999999999998765543
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.3e-32 Score=271.31 Aligned_cols=181 Identities=28% Similarity=0.487 Sum_probs=147.0
Q ss_pred CEeccCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k-~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
+||||+++|+|.+++.. .+.+++..++.++.||+.||.|||++| |+||||||+||+++ .+|.+||+|||++.....
T Consensus 93 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~ 169 (302)
T 2j7t_A 93 IMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR--IIHRDLKAGNVLMT-LEGDIRLADFGVSAKNLK 169 (302)
T ss_dssp EEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEC-TTSCEEECCCHHHHHHHH
T ss_pred EEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEEC-CCCCEEEEECCCCccccc
Confidence 58999999999999876 567999999999999999999999999 99999999999998 457999999999754321
Q ss_pred --CCCccccCCCCccCccccc------ccCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCC-CCccccCC
Q 008504 80 --PTARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK-PASLAKVN 150 (563)
Q Consensus 80 --~~~~~~~Gtp~Y~APEvl~------~~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~-p~~l~~~~ 150 (563)
.......|++.|+|||++. ..++.++||||||+++|+|++|..||.... .......+..... ....+...
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 248 (302)
T 2j7t_A 170 TLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN-PMRVLLKIAKSDPPTLLTPSKW 248 (302)
T ss_dssp HHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSC-HHHHHHHHHHSCCCCCSSGGGS
T ss_pred cccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCC-HHHHHHHHhccCCcccCCcccc
Confidence 1223457899999999873 348899999999999999999999998744 4444444443333 23345566
Q ss_pred ChhHHHHHHHhcC-CCCCCCCHHHHHcCcccccccc
Q 008504 151 DPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQ 185 (563)
Q Consensus 151 s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~~ 185 (563)
+..+.+||.+||. +|.+|||+.++++||||+....
T Consensus 249 ~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~ 284 (302)
T 2j7t_A 249 SVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITS 284 (302)
T ss_dssp CHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCCC
T ss_pred CHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhcc
Confidence 8899999999997 8999999999999999986543
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=99.97 E-value=6.8e-33 Score=289.99 Aligned_cols=170 Identities=16% Similarity=0.195 Sum_probs=137.6
Q ss_pred CEeccCCCCCHHHHHHhCCCCCH-------HHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccc
Q 008504 1 MITELFTSGNLRQYRKKHKNVDI-------KVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGL 73 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse-------~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGl 73 (563)
|||||+ +|+|.+++.+.+.+++ ..++.|+.||+.||.|||++| |+||||||+|||++ .+|.+||+|||+
T Consensus 177 lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrDikp~NIll~-~~~~~kL~DFG~ 252 (377)
T 3byv_A 177 FLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LVHTYLRPVDIVLD-QRGGVFLTGFEH 252 (377)
T ss_dssp EEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEC-TTCCEEECCGGG
T ss_pred EEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEc-CCCCEEEEechh
Confidence 589999 6899999987655655 888899999999999999999 99999999999998 458999999999
Q ss_pred hhhccCCCCccccCCCCccCcccccc------------cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCC
Q 008504 74 AIAMQQPTARSVIGTPEFMAPELYEE------------EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI 141 (563)
Q Consensus 74 A~~~~~~~~~~~~Gtp~Y~APEvl~~------------~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~ 141 (563)
++.... ......| +.|+|||++.+ .|+.++|||||||++|+|++|+.||..... ......+..
T Consensus 253 a~~~~~-~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~-~~~~~~~~~-- 327 (377)
T 3byv_A 253 LVRDGA-RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAA-LGGSEWIFR-- 327 (377)
T ss_dssp CEETTC-EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC-------CCSGGGGS--
T ss_pred heecCC-cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCccccc-ccchhhhhh--
Confidence 975433 2345567 99999998864 489999999999999999999999976321 111111111
Q ss_pred CCCccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCcccccc
Q 008504 142 KPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 183 (563)
Q Consensus 142 ~p~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~ 183 (563)
.....++.+++||.+||. +|.+|||+.++|+||||+..
T Consensus 328 ----~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~ 366 (377)
T 3byv_A 328 ----SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL 366 (377)
T ss_dssp ----SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHH
T ss_pred ----hccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHH
Confidence 124567899999999998 89999999999999999754
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.2e-32 Score=267.88 Aligned_cols=177 Identities=27% Similarity=0.502 Sum_probs=144.8
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
|||||+.+++|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+||+++ .++.+||+|||++......
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~~l~dfg~~~~~~~~ 164 (276)
T 2h6d_A 88 MVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM--VVHRDLKPENVLLD-AHMNAKIADFGLSNMMSDG 164 (276)
T ss_dssp EEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHC--SSCCCCCGGGEEEC-TTSCEEECCCCGGGCCCC-
T ss_pred EEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChhhEEEC-CCCCEEEeecccccccCCC
Confidence 58999999999999998888999999999999999999999999 99999999999998 4579999999999765443
Q ss_pred -CCccccCCCCccCccccccc-C-CchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHHH
Q 008504 81 -TARSVIGTPEFMAPELYEEE-Y-NELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 157 (563)
Q Consensus 81 -~~~~~~Gtp~Y~APEvl~~~-y-s~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~L 157 (563)
......|++.|+|||++.+. + +.++||||||+++|+|++|+.||.. .........+..+... .+...++.+.+|
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~~~~~--~~~~~~~~l~~l 241 (276)
T 2h6d_A 165 EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDD-EHVPTLFKKIRGGVFY--IPEYLNRSVATL 241 (276)
T ss_dssp ------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCC--CCTTSCHHHHHH
T ss_pred cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCC-CcHHHHHHHhhcCccc--CchhcCHHHHHH
Confidence 23345789999999998764 3 6899999999999999999999987 4555666666655432 345668899999
Q ss_pred HHHhcC-CCCCCCCHHHHHcCcccccc
Q 008504 158 IEKCLV-PASERLSAKDLLKDPFLQVE 183 (563)
Q Consensus 158 I~kcL~-dP~kRpSa~ELLkHpff~~~ 183 (563)
|.+||. +|.+|||+.++++||||+..
T Consensus 242 i~~~l~~~p~~Rps~~~~l~h~~~~~~ 268 (276)
T 2h6d_A 242 LMHMLQVDPLKRATIKDIREHEWFKQD 268 (276)
T ss_dssp HHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred HHHHccCChhhCCCHHHHHhChhhccC
Confidence 999997 89999999999999999753
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.6e-32 Score=269.52 Aligned_cols=178 Identities=26% Similarity=0.505 Sum_probs=127.3
Q ss_pred CEeccCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~-~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
|||||+++|+|.+++... +.+++..++.++.||+.||.|||++| |+||||||+||+++ .++.+||+|||++.....
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nili~-~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 88 LVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG--ILHRDLTLSNLLLT-RNMNIKIADFGLATQLKM 164 (278)
T ss_dssp EEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSSCCGGGEEEC-TTCCEEECCCTTCEECC-
T ss_pred EEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEc-CCCCEEEEeecceeeccC
Confidence 589999999999999875 67999999999999999999999999 99999999999998 557999999999976543
Q ss_pred C--CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHH
Q 008504 80 P--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKG 156 (563)
Q Consensus 80 ~--~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~ 156 (563)
. ......|++.|+|||++.+ .++.++||||||+++|+|++|+.||........ ...+... ....+...++.+++
T Consensus 165 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~--~~~~~~~~~~~~~~ 241 (278)
T 3cok_A 165 PHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT-LNKVVLA--DYEMPSFLSIEAKD 241 (278)
T ss_dssp ---------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------CCSS--CCCCCTTSCHHHHH
T ss_pred CCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH-HHHHhhc--ccCCccccCHHHHH
Confidence 2 2234578999999998865 488999999999999999999999976433222 2222211 12345567889999
Q ss_pred HHHHhcC-CCCCCCCHHHHHcCccccccc
Q 008504 157 FIEKCLV-PASERLSAKDLLKDPFLQVEN 184 (563)
Q Consensus 157 LI~kcL~-dP~kRpSa~ELLkHpff~~~~ 184 (563)
||.+||. +|.+|||+.++|+||||....
T Consensus 242 li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 270 (278)
T 3cok_A 242 LIHQLLRRNPADRLSLSSVLDHPFMSRNS 270 (278)
T ss_dssp HHHHHSCSSGGGSCCHHHHTTSTTTC---
T ss_pred HHHHHcccCHhhCCCHHHHhcCccccCCC
Confidence 9999997 899999999999999998644
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=99.97 E-value=8e-32 Score=298.01 Aligned_cols=183 Identities=28% Similarity=0.468 Sum_probs=155.6
Q ss_pred CEeccCCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhh
Q 008504 1 MITELFTSGNLRQYRKKH----KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 76 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~----~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~ 76 (563)
|||||++||+|.+++.+. +.+++..++.|+.||+.||.|||++| |+||||||+|||++ .+|.+||+|||+++.
T Consensus 262 lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g--IvHrDLKP~NILl~-~~g~vkL~DFGla~~ 338 (543)
T 3c4z_A 262 LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN--IIYRDLKPENVLLD-DDGNVRISDLGLAVE 338 (543)
T ss_dssp EEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTSCEEECCCTTCEE
T ss_pred EEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC--CcccCCChHHEEEe-CCCCEEEeecceeee
Confidence 699999999999999864 36999999999999999999999999 99999999999998 568999999999976
Q ss_pred ccCCC--CccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCC---CHHHHHHHHhcCCCCCccccCC
Q 008504 77 MQQPT--ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECK---NPAQIFKKVTSGIKPASLAKVN 150 (563)
Q Consensus 77 ~~~~~--~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~---~~~~i~~~i~~~~~p~~l~~~~ 150 (563)
..... ....+||+.|+|||++.+ .|+.++|||||||++|+|++|+.||.... ....+...+..... .++...
T Consensus 339 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~--~~p~~~ 416 (543)
T 3c4z_A 339 LKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAV--TYPDKF 416 (543)
T ss_dssp CCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCC--CCCTTS
T ss_pred ccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhccc--CCCccc
Confidence 65432 334589999999998875 59999999999999999999999997642 34566666655433 245667
Q ss_pred ChhHHHHHHHhcC-CCCCCCC-----HHHHHcCccccccccCCC
Q 008504 151 DPQIKGFIEKCLV-PASERLS-----AKDLLKDPFLQVENQKEP 188 (563)
Q Consensus 151 s~~l~~LI~kcL~-dP~kRpS-----a~ELLkHpff~~~~~~~~ 188 (563)
++.+++||.+||. +|.+||+ +.++++||||+..+|...
T Consensus 417 s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w~~l 460 (543)
T 3c4z_A 417 SPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQL 460 (543)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCHHHH
T ss_pred CHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCHHHH
Confidence 8999999999997 8999995 589999999998776543
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.2e-32 Score=278.95 Aligned_cols=182 Identities=26% Similarity=0.395 Sum_probs=144.0
Q ss_pred CEeccCCCCCHHHHHHh----------------------------------------CCCCCHHHHHHHHHHHHHHHHHH
Q 008504 1 MITELFTSGNLRQYRKK----------------------------------------HKNVDIKVIKNWARQILHGLVYL 40 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k----------------------------------------~~~Lse~~i~~i~~QIL~aL~yL 40 (563)
||||||++|+|.+++.. ...+++..++.++.||+.||.||
T Consensus 105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L 184 (345)
T 3hko_A 105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL 184 (345)
T ss_dssp EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence 68999999999999852 11246788999999999999999
Q ss_pred HhCCCCeEeccCccCceEEeCCC-CcEEEecccchhhccCC------CCccccCCCCccCccccc---ccCCchhhHHHh
Q 008504 41 HSHNPPIIHRDLKCDNIFVNGNH-GEVKIGDLGLAIAMQQP------TARSVIGTPEFMAPELYE---EEYNELVDIYSF 110 (563)
Q Consensus 41 Hs~gp~IIHrDLKP~NILLd~~~-G~VKL~DFGlA~~~~~~------~~~~~~Gtp~Y~APEvl~---~~ys~ksDIwSL 110 (563)
|++| |+||||||+|||++.+. +.+||+|||++...... ......||+.|+|||++. ..++.++|||||
T Consensus 185 H~~~--ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diwsl 262 (345)
T 3hko_A 185 HNQG--ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSA 262 (345)
T ss_dssp HHTT--EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHH
T ss_pred HHCC--ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHH
Confidence 9999 99999999999997432 28999999999754321 123457999999999885 458899999999
Q ss_pred HHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCC--CccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCcccccccc
Q 008504 111 GMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP--ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQ 185 (563)
Q Consensus 111 GviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p--~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~~ 185 (563)
||++|+|++|+.||...... .....+...... .......++.+++||.+||. +|.+|||+.++|+||||+...+
T Consensus 263 G~il~el~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~~ 339 (345)
T 3hko_A 263 GVLLHLLLMGAVPFPGVNDA-DTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSD 339 (345)
T ss_dssp HHHHHHHHHSSCSSCCSSHH-HHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTSS
T ss_pred HHHHHHHHHCCCCCCCCChH-HHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccChH
Confidence 99999999999999875444 444444433322 22233468899999999997 8999999999999999986543
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-31 Score=274.39 Aligned_cols=181 Identities=26% Similarity=0.436 Sum_probs=141.0
Q ss_pred CEeccCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~-~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
|||||+. |+|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||++ ..|.+||+|||++.....
T Consensus 77 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~-~~~~~kl~Dfg~a~~~~~ 152 (324)
T 3mtl_A 77 LVFEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK--VLHRDLKPQNLLIN-ERGELKLADFGLARAKSI 152 (324)
T ss_dssp EEEECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCCGGGEEEC-TTCCEEECSSSEEECC--
T ss_pred EEecccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCcCHHHEEEC-CCCCEEEccCcccccccC
Confidence 6899997 5999998875 45999999999999999999999999 99999999999998 457999999999975543
Q ss_pred C--CCccccCCCCccCcccccc--cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhc---CCCCCc-------
Q 008504 80 P--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS---GIKPAS------- 145 (563)
Q Consensus 80 ~--~~~~~~Gtp~Y~APEvl~~--~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~---~~~p~~------- 145 (563)
. ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.... .......+.. ...+..
T Consensus 153 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~ 231 (324)
T 3mtl_A 153 PTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGST-VEEQLHFIFRILGTPTEETWPGILSN 231 (324)
T ss_dssp ----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS-HHHHHHHHHHHHCCCCTTTSTTGGGC
T ss_pred CccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHhCCCChHhchhhhcc
Confidence 2 2334578999999998864 48999999999999999999999998744 3333332222 111111
Q ss_pred ------------------cccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCccccccccC
Q 008504 146 ------------------LAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQK 186 (563)
Q Consensus 146 ------------------l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~~~ 186 (563)
.....++.+++||.+||. +|.+|||+.|+|+||||......
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 291 (324)
T 3mtl_A 232 EEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGER 291 (324)
T ss_dssp HHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCST
T ss_pred hhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccc
Confidence 112356789999999998 89999999999999999876543
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.7e-32 Score=284.30 Aligned_cols=181 Identities=27% Similarity=0.337 Sum_probs=150.5
Q ss_pred CEeccCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEe-CCCCcEEEecccchhhcc
Q 008504 1 MITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN-GNHGEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~-~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd-~~~G~VKL~DFGlA~~~~ 78 (563)
|||||+++|+|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||+. ...+.+||+|||++....
T Consensus 163 lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~ 240 (373)
T 2x4f_A 163 LVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY--ILHLDLKPENILCVNRDAKQIKIIDFGLARRYK 240 (373)
T ss_dssp EEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEETTTTEEEECCCSSCEECC
T ss_pred EEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEecCCCCcEEEEeCCCceecC
Confidence 699999999999988764 46999999999999999999999999 99999999999984 245789999999997665
Q ss_pred CC-CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCC--CCccccCCChhH
Q 008504 79 QP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK--PASLAKVNDPQI 154 (563)
Q Consensus 79 ~~-~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~--p~~l~~~~s~~l 154 (563)
.. ......||+.|+|||++.+ .++.++|||||||++|+|++|..||... +.......+..... +.......++.+
T Consensus 241 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 319 (373)
T 2x4f_A 241 PREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGD-NDAETLNNILACRWDLEDEEFQDISEEA 319 (373)
T ss_dssp TTCBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCS-SHHHHHHHHHHTCCCSCSGGGTTSCHHH
T ss_pred CccccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhccCCCChhhhccCCHHH
Confidence 43 2344579999999998864 4899999999999999999999999874 44444444444332 222334568899
Q ss_pred HHHHHHhcC-CCCCCCCHHHHHcCccccccc
Q 008504 155 KGFIEKCLV-PASERLSAKDLLKDPFLQVEN 184 (563)
Q Consensus 155 ~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~ 184 (563)
++||.+||. +|.+|||+.|+|+||||+...
T Consensus 320 ~~li~~~L~~dp~~Rps~~e~l~hp~~~~~~ 350 (373)
T 2x4f_A 320 KEFISKLLIKEKSWRISASEALKHPWLSDHK 350 (373)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHSHHHHCHH
T ss_pred HHHHHHHcCCChhhCCCHHHHhcCcCcCCCc
Confidence 999999997 899999999999999998654
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.9e-32 Score=269.89 Aligned_cols=182 Identities=31% Similarity=0.516 Sum_probs=155.2
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCC--CCcEEEecccchhhcc
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGN--HGEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~--~G~VKL~DFGlA~~~~ 78 (563)
+||||+.+++|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+||+++.+ .+.+||+|||++....
T Consensus 98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~ 175 (287)
T 2wei_A 98 IVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (287)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred EEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence 58999999999999988888999999999999999999999999 9999999999999743 3479999999997665
Q ss_pred CC-CCccccCCCCccCcccccccCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCcc--ccCCChhHH
Q 008504 79 QP-TARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASL--AKVNDPQIK 155 (563)
Q Consensus 79 ~~-~~~~~~Gtp~Y~APEvl~~~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l--~~~~s~~l~ 155 (563)
.. ......|++.|+|||++.+.++.++||||||+++|+|++|..||.. .+...+...+..+...... ....++.++
T Consensus 176 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (287)
T 2wei_A 176 QNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYG-KNEYDILKRVETGKYAFDLPQWRTISDDAK 254 (287)
T ss_dssp CCSSCSCHHHHHTTCCHHHHTTCCCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCCCCSGGGTTSCHHHH
T ss_pred CCCccccccCcccccChHHhcCCCCCchhhHhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCCCCCchhhhhcCHHHH
Confidence 43 2334468899999999988899999999999999999999999987 4556666666666543322 245688999
Q ss_pred HHHHHhcC-CCCCCCCHHHHHcCcccccccc
Q 008504 156 GFIEKCLV-PASERLSAKDLLKDPFLQVENQ 185 (563)
Q Consensus 156 ~LI~kcL~-dP~kRpSa~ELLkHpff~~~~~ 185 (563)
+||.+||. +|.+|||+.++|+||||+....
T Consensus 255 ~li~~~l~~dp~~Rps~~ell~hp~~~~~~~ 285 (287)
T 2wei_A 255 DLIRKMLTFHPSLRITATQCLEHPWIQKYSS 285 (287)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHSHHHHHHCC
T ss_pred HHHHHHcccChhhCcCHHHHhcCHHHhcccc
Confidence 99999998 8999999999999999986543
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.97 E-value=9.1e-32 Score=284.21 Aligned_cols=183 Identities=26% Similarity=0.372 Sum_probs=145.9
Q ss_pred CEeccCCCCCHHHHH---HhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhc
Q 008504 1 MITELFTSGNLRQYR---KKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM 77 (563)
Q Consensus 1 LVmEy~~gGsL~~~L---~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~ 77 (563)
|||||+.++.+..+. ...+.+++..++.|+.||+.||.|||++| |+||||||+|||++...+.+||+|||+++..
T Consensus 115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~ 192 (394)
T 4e7w_A 115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG--ICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192 (394)
T ss_dssp EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence 589999875444332 23567999999999999999999999999 9999999999999866789999999999765
Q ss_pred cC-CCCccccCCCCccCcccccc--cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcC-C------------
Q 008504 78 QQ-PTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG-I------------ 141 (563)
Q Consensus 78 ~~-~~~~~~~Gtp~Y~APEvl~~--~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~-~------------ 141 (563)
.. .......||+.|+|||++.+ .|+.++|||||||++|+|++|+.||.+.....++...+... .
T Consensus 193 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~ 272 (394)
T 4e7w_A 193 IAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPN 272 (394)
T ss_dssp CTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGG
T ss_pred cCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChh
Confidence 43 23345688999999998854 48999999999999999999999998755444443332210 0
Q ss_pred ---------CC----CccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCcccccccc
Q 008504 142 ---------KP----ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQ 185 (563)
Q Consensus 142 ---------~p----~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~~ 185 (563)
.+ ..++...++.+++||.+||. +|.+|||+.|+|+||||+...+
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 330 (394)
T 4e7w_A 273 YMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRT 330 (394)
T ss_dssp GSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTS
T ss_pred hhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcc
Confidence 00 01223367899999999998 8999999999999999987654
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.2e-32 Score=274.81 Aligned_cols=175 Identities=29% Similarity=0.443 Sum_probs=141.9
Q ss_pred CEeccCCCCCHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhc
Q 008504 1 MITELFTSGNLRQYRKKHKN---VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM 77 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~---Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~ 77 (563)
||||||++|+|.+++.+... .++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++...
T Consensus 138 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~-~~~~~kL~DfG~a~~~ 214 (332)
T 3qd2_B 138 IQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG--LMHRDLKPSNIFFT-MDDVVKVGDFGLVTAM 214 (332)
T ss_dssp EEEECCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECCCTTCEEC
T ss_pred EEEEecCCCCHHHHHhcccCccchhhHHHHHHHHHHHHHHHHHHhCC--eeecCCCcccEEEe-CCCCEEEeecCccccc
Confidence 58999999999999987644 566779999999999999999999 99999999999998 5579999999999765
Q ss_pred cCC--------------CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCC
Q 008504 78 QQP--------------TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK 142 (563)
Q Consensus 78 ~~~--------------~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~ 142 (563)
... ......||+.|+|||++.+ .++.++|||||||++|+|++|..|+.. .......+.....
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~---~~~~~~~~~~~~~ 291 (332)
T 3qd2_B 215 DQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME---RVRIITDVRNLKF 291 (332)
T ss_dssp SCC--------------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH---HHHHHHHHHTTCC
T ss_pred ccchhhccccccccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH---HHHHHHHhhccCC
Confidence 432 1233579999999998865 589999999999999999998766532 3334444444433
Q ss_pred CCccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCccccc
Q 008504 143 PASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQV 182 (563)
Q Consensus 143 p~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~ 182 (563)
+. .....++.+++||.+||. +|.+|||+.|+|+||||+.
T Consensus 292 ~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 292 PL-LFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFEN 331 (332)
T ss_dssp CH-HHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCC
T ss_pred Cc-ccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhc
Confidence 32 223345788999999998 8999999999999999974
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.2e-32 Score=279.99 Aligned_cols=182 Identities=23% Similarity=0.372 Sum_probs=126.7
Q ss_pred CEeccCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCC--CCcEEEecccchhh
Q 008504 1 MITELFTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGN--HGEVKIGDLGLAIA 76 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~--~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~--~G~VKL~DFGlA~~ 76 (563)
||||||++|+|.+++.+.+ .+++..++.++.||+.||.|||++| |+||||||+|||++.+ .+.+||+|||++..
T Consensus 103 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~--ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~ 180 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN--IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE 180 (336)
T ss_dssp EEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEEecCCCceEEEecccccee
Confidence 5899999999999998764 6999999999999999999999999 9999999999999742 45699999999976
Q ss_pred ccCCCCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHH---HHHHHhcCC--CCCccccCC
Q 008504 77 MQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQ---IFKKVTSGI--KPASLAKVN 150 (563)
Q Consensus 77 ~~~~~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~---i~~~i~~~~--~p~~l~~~~ 150 (563)
..........||+.|+|||++.+ .++.++|||||||++|+|++|..||........ ....+..+. .+.......
T Consensus 181 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (336)
T 3fhr_A 181 TTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEV 260 (336)
T ss_dssp C----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTTTSTTC
T ss_pred ccccccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchhhccC
Confidence 66555556788999999998854 589999999999999999999999976332211 111111111 122223456
Q ss_pred ChhHHHHHHHhcC-CCCCCCCHHHHHcCccccccc
Q 008504 151 DPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 184 (563)
Q Consensus 151 s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~ 184 (563)
++.+++||.+||. +|.+|||+.++|+||||+...
T Consensus 261 ~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 295 (336)
T 3fhr_A 261 SEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSM 295 (336)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGG
T ss_pred CHHHHHHHHHHCCCChhHCcCHHHHhcCccccccc
Confidence 8899999999997 899999999999999998643
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-31 Score=280.01 Aligned_cols=178 Identities=30% Similarity=0.457 Sum_probs=146.0
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
|||||+ +++|.+++.. +.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||+++....
T Consensus 107 lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~-~~~~~kl~Dfg~a~~~~~- 180 (367)
T 1cm8_A 107 LVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVN-EDCELKILDFGLARQADS- 180 (367)
T ss_dssp EEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECCCTTCEECCS-
T ss_pred EEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCHHHEEEc-CCCCEEEEeeeccccccc-
Confidence 589999 8899999987 57999999999999999999999999 99999999999998 457999999999976543
Q ss_pred CCccccCCCCccCcccccc--cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhc-CCCC--------------
Q 008504 81 TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS-GIKP-------------- 143 (563)
Q Consensus 81 ~~~~~~Gtp~Y~APEvl~~--~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~-~~~p-------------- 143 (563)
.....++|+.|+|||++.+ .|+.++|||||||++|+|++|+.||.+.....++...+.. +..+
T Consensus 181 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~ 260 (367)
T 1cm8_A 181 EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKN 260 (367)
T ss_dssp SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHH
T ss_pred ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHH
Confidence 2345678999999998864 5899999999999999999999999874433333222211 1110
Q ss_pred -------------CccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCccccccc
Q 008504 144 -------------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 184 (563)
Q Consensus 144 -------------~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~ 184 (563)
.......++.+.+||.+||. ||.+|||+.++|+||||+...
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~ 315 (367)
T 1cm8_A 261 YMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 315 (367)
T ss_dssp HHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred HHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence 11223457899999999998 899999999999999998643
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-31 Score=271.48 Aligned_cols=178 Identities=25% Similarity=0.461 Sum_probs=147.8
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
|||| +.+|+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ + +.+||+|||++......
T Consensus 105 lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~-~-~~~kL~Dfg~~~~~~~~ 179 (313)
T 3cek_A 105 MVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV-D-GMLKLIDFGIANQMQPD 179 (313)
T ss_dssp EEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEE-T-TEEEECCCSSSCC----
T ss_pred EEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEEE-C-CeEEEeeccccccccCc
Confidence 5899 567899999999889999999999999999999999999 99999999999997 3 79999999999765432
Q ss_pred C----CccccCCCCccCcccccc------------cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCC
Q 008504 81 T----ARSVIGTPEFMAPELYEE------------EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPA 144 (563)
Q Consensus 81 ~----~~~~~Gtp~Y~APEvl~~------------~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~ 144 (563)
. .....|++.|+|||++.+ .++.++|||||||++|+|++|+.||............+.......
T Consensus 180 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 259 (313)
T 3cek_A 180 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI 259 (313)
T ss_dssp ----------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCC
T ss_pred cccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhccccc
Confidence 2 234578999999998854 588899999999999999999999987666555555555554444
Q ss_pred ccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCcccccc
Q 008504 145 SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 183 (563)
Q Consensus 145 ~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~ 183 (563)
..+...+..+++||.+||. +|.+|||+.++|+||||+..
T Consensus 260 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 299 (313)
T 3cek_A 260 EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 299 (313)
T ss_dssp CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC
T ss_pred CCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCC
Confidence 5566678899999999997 89999999999999999853
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-31 Score=286.33 Aligned_cols=179 Identities=27% Similarity=0.431 Sum_probs=142.4
Q ss_pred CEeccCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCc--EEEecccchhh
Q 008504 1 MITELFTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGE--VKIGDLGLAIA 76 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~--~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~--VKL~DFGlA~~ 76 (563)
|||||+. |+|.+++...+ .+++..++.|+.||+.||.|||++| |+||||||+|||++.+ +. +||+|||++..
T Consensus 176 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NILl~~~-~~~~vkL~DFG~a~~ 251 (429)
T 3kvw_A 176 MTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR--IIHCDLKPENILLKQQ-GRSGIKVIDFGSSCY 251 (429)
T ss_dssp EEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT--EECSCCSGGGEEESST-TSCCEEECCCTTCEE
T ss_pred EEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEccC-CCcceEEeeccccee
Confidence 5899996 69999998754 4999999999999999999999999 9999999999999844 55 99999999965
Q ss_pred ccCCCCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhc-CCCCC----------
Q 008504 77 MQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS-GIKPA---------- 144 (563)
Q Consensus 77 ~~~~~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~-~~~p~---------- 144 (563)
... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||........+...+.. +..+.
T Consensus 252 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~ 330 (429)
T 3kvw_A 252 EHQ-RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAK 330 (429)
T ss_dssp TTC-CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHH
T ss_pred cCC-cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhh
Confidence 443 3345689999999998865 5999999999999999999999999875443333222211 00000
Q ss_pred ---------------------------------------------ccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCc
Q 008504 145 ---------------------------------------------SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDP 178 (563)
Q Consensus 145 ---------------------------------------------~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHp 178 (563)
.+....++.+++||.+||. ||.+|||+.|+|+||
T Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~Hp 410 (429)
T 3kvw_A 331 NFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHP 410 (429)
T ss_dssp HHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHTST
T ss_pred hccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhCCh
Confidence 0112336789999999998 899999999999999
Q ss_pred cccccc
Q 008504 179 FLQVEN 184 (563)
Q Consensus 179 ff~~~~ 184 (563)
||+...
T Consensus 411 w~~~~~ 416 (429)
T 3kvw_A 411 WLRRRL 416 (429)
T ss_dssp TTC---
T ss_pred hhccCC
Confidence 998654
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.6e-32 Score=278.05 Aligned_cols=182 Identities=30% Similarity=0.496 Sum_probs=154.1
Q ss_pred CEeccCCCCCHHHH------HHh--CCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEeccCccCceEEeCCCCcEEEecc
Q 008504 1 MITELFTSGNLRQY------RKK--HKNVDIKVIKNWARQILHGLVYLHS-HNPPIIHRDLKCDNIFVNGNHGEVKIGDL 71 (563)
Q Consensus 1 LVmEy~~gGsL~~~------L~k--~~~Lse~~i~~i~~QIL~aL~yLHs-~gp~IIHrDLKP~NILLd~~~G~VKL~DF 71 (563)
+||||+++|+|.++ +.+ ...+++..++.++.||+.||.|||+ +| |+||||||+|||++ .++.+||+||
T Consensus 120 lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dl~p~Nil~~-~~~~~kl~df 196 (348)
T 2pml_X 120 IIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMD-KNGRVKLSDF 196 (348)
T ss_dssp EEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC--EECCCCCGGGEEEC-TTSCEEECCC
T ss_pred EEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC--EeecCCChHhEEEc-CCCcEEEecc
Confidence 58999999999998 665 5679999999999999999999999 99 99999999999998 5579999999
Q ss_pred cchhhccCCCCccccCCCCccCccccccc--CCc-hhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCcc--
Q 008504 72 GLAIAMQQPTARSVIGTPEFMAPELYEEE--YNE-LVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASL-- 146 (563)
Q Consensus 72 GlA~~~~~~~~~~~~Gtp~Y~APEvl~~~--ys~-ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l-- 146 (563)
|++............|++.|+|||++.+. ++. ++|||||||++|+|++|..||............+..+......
T Consensus 197 g~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~ 276 (348)
T 2pml_X 197 GESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDR 276 (348)
T ss_dssp TTCEECBTTEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHTSCCCCCCCSS
T ss_pred ccccccccccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCcCCccch
Confidence 99977655555566899999999998754 555 9999999999999999999998766656677666665433221
Q ss_pred ---------------ccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCcccccccc
Q 008504 147 ---------------AKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQ 185 (563)
Q Consensus 147 ---------------~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~~ 185 (563)
....++.+++||.+||. +|.+|||+.++|+||||+..++
T Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~~ 331 (348)
T 2pml_X 277 NHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNI 331 (348)
T ss_dssp SSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCCH
T ss_pred hhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCCH
Confidence 14568899999999998 8999999999999999986543
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.5e-32 Score=275.79 Aligned_cols=183 Identities=28% Similarity=0.469 Sum_probs=151.3
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCC--CcEEEecccchhhcc
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNH--GEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~--G~VKL~DFGlA~~~~ 78 (563)
+||||+.+|+|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++.+. +.+||+|||++....
T Consensus 91 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 168 (322)
T 2ycf_A 91 IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG 168 (322)
T ss_dssp EEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSSSCCEEECCCTTCEECC
T ss_pred EEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEecCCCCCeEEEccCccceecc
Confidence 58999999999999998889999999999999999999999999 99999999999997432 359999999997654
Q ss_pred CCC-CccccCCCCccCccccc----ccCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCC--CccccCCC
Q 008504 79 QPT-ARSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP--ASLAKVND 151 (563)
Q Consensus 79 ~~~-~~~~~Gtp~Y~APEvl~----~~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p--~~l~~~~s 151 (563)
... .....||+.|+|||++. ..++.++|||||||++|+|++|..||........+...+..+... .......+
T Consensus 169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (322)
T 2ycf_A 169 ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVS 248 (322)
T ss_dssp CCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHHTTSC
T ss_pred cccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhhhhcC
Confidence 432 23457899999999873 458899999999999999999999997654443444444444332 22234567
Q ss_pred hhHHHHHHHhcC-CCCCCCCHHHHHcCcccccccc
Q 008504 152 PQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQ 185 (563)
Q Consensus 152 ~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~~ 185 (563)
+.+.+||.+||. +|.+|||+.++|+||||+....
T Consensus 249 ~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~~~ 283 (322)
T 2ycf_A 249 EKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDM 283 (322)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCHHH
T ss_pred HHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCHHH
Confidence 899999999997 8999999999999999986543
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.97 E-value=3e-31 Score=269.15 Aligned_cols=182 Identities=31% Similarity=0.447 Sum_probs=146.8
Q ss_pred CEeccCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhcc
Q 008504 1 MITELFTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~--~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~ 78 (563)
|||||+. |+|.+++.... .+++..++.++.||+.||.|||++| |+||||||+||+++ ..|.+||+|||++....
T Consensus 96 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g--i~H~dlkp~Nili~-~~~~~kl~Dfg~~~~~~ 171 (326)
T 1blx_A 96 LVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVT-SSGQIKLADFGLARIYS 171 (326)
T ss_dssp EEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTCCEEECSCCSCCCCC
T ss_pred EEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHHHeEEc-CCCCEEEecCccccccc
Confidence 5899998 69999998754 4999999999999999999999999 99999999999998 55799999999996554
Q ss_pred CC-CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhc-CCC-------------
Q 008504 79 QP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS-GIK------------- 142 (563)
Q Consensus 79 ~~-~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~-~~~------------- 142 (563)
.. ......|++.|+|||++.+ .++.++|||||||++|+|++|+.||............+.. +..
T Consensus 172 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 251 (326)
T 1blx_A 172 FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPR 251 (326)
T ss_dssp GGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCG
T ss_pred CCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccccccch
Confidence 32 2334578999999998864 5899999999999999999999999875433333222211 000
Q ss_pred ----------CCccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCccccccccC
Q 008504 143 ----------PASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQK 186 (563)
Q Consensus 143 ----------p~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~~~ 186 (563)
........++.+++||.+||. +|.+|||+.++|+||||+.....
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~ 306 (326)
T 1blx_A 252 QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERC 306 (326)
T ss_dssp GGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred hhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccchh
Confidence 011224467889999999997 89999999999999999866543
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-31 Score=276.19 Aligned_cols=171 Identities=23% Similarity=0.408 Sum_probs=145.4
Q ss_pred CEeccCCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSG-NLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gG-sL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
|||||+.+| +|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++.....
T Consensus 106 lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~-~~~~~kL~Dfg~a~~~~~ 182 (335)
T 3dls_A 106 LVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKD--IIHRDIKDENIVIA-EDFTIKLIDFGSAAYLER 182 (335)
T ss_dssp EEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTSCEEECCCTTCEECCT
T ss_pred EEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEEeccCHHHEEEc-CCCcEEEeecccceECCC
Confidence 589999777 99999999889999999999999999999999999 99999999999998 458999999999976654
Q ss_pred C-CCccccCCCCccCccccccc-C-CchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHH
Q 008504 80 P-TARSVIGTPEFMAPELYEEE-Y-NELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKG 156 (563)
Q Consensus 80 ~-~~~~~~Gtp~Y~APEvl~~~-y-s~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~ 156 (563)
. ......||+.|+|||++.+. + +.++|||||||++|+|++|..||..... ... .....+...++.+++
T Consensus 183 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-------~~~--~~~~~~~~~~~~l~~ 253 (335)
T 3dls_A 183 GKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE-------TVE--AAIHPPYLVSKELMS 253 (335)
T ss_dssp TCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG-------GTT--TCCCCSSCCCHHHHH
T ss_pred CCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH-------HHh--hccCCCcccCHHHHH
Confidence 3 33456799999999988654 4 7899999999999999999999975211 111 112234457889999
Q ss_pred HHHHhcC-CCCCCCCHHHHHcCcccccc
Q 008504 157 FIEKCLV-PASERLSAKDLLKDPFLQVE 183 (563)
Q Consensus 157 LI~kcL~-dP~kRpSa~ELLkHpff~~~ 183 (563)
||.+||. +|.+|||+.++++||||+..
T Consensus 254 li~~~L~~dP~~Rps~~ell~hp~~~~~ 281 (335)
T 3dls_A 254 LVSGLLQPVPERRTTLEKLVTDPWVTQP 281 (335)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred HHHHHccCChhhCcCHHHHhcCccccCC
Confidence 9999998 89999999999999999753
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-31 Score=279.02 Aligned_cols=176 Identities=31% Similarity=0.519 Sum_probs=148.9
Q ss_pred CEeccCCCCCHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRK-KHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~-k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
|||||+. |+|.+++. ..+.+++..++.++.||+.||.|||++| |+||||||+|||++ ..|.+||+|||++.....
T Consensus 131 lv~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~-~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 131 LVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLS-EPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp EEEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEE-TTTEEEECCCTTCBSSSS
T ss_pred EEEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEC-CCCCEEEeeccCceecCC
Confidence 6899997 58888875 4567999999999999999999999999 99999999999998 558999999999976543
Q ss_pred CCCccccCCCCccCccccc----ccCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHH
Q 008504 80 PTARSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIK 155 (563)
Q Consensus 80 ~~~~~~~Gtp~Y~APEvl~----~~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~ 155 (563)
.....||+.|+|||++. +.++.++|||||||++|+|++|+.||..... ......+..+..+.......++.++
T Consensus 207 --~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~ 283 (348)
T 1u5q_A 207 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-MSALYHIAQNESPALQSGHWSEYFR 283 (348)
T ss_dssp --BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-HHHHHHHHHSCCCCCCCTTSCHHHH
T ss_pred --CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHhcCCCCCCCCCCCHHHH
Confidence 34567999999999873 4589999999999999999999999987443 3344444455455445566788999
Q ss_pred HHHHHhcC-CCCCCCCHHHHHcCcccccc
Q 008504 156 GFIEKCLV-PASERLSAKDLLKDPFLQVE 183 (563)
Q Consensus 156 ~LI~kcL~-dP~kRpSa~ELLkHpff~~~ 183 (563)
+||.+||. +|.+|||+.++|+||||...
T Consensus 284 ~li~~~l~~dP~~Rps~~~ll~h~~~~~~ 312 (348)
T 1u5q_A 284 NFVDSCLQKIPQDRPTSEVLLKHRFVLRE 312 (348)
T ss_dssp HHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred HHHHHHcccChhhCcCHHHHhhChhhhcc
Confidence 99999997 89999999999999999754
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.2e-32 Score=275.70 Aligned_cols=183 Identities=22% Similarity=0.365 Sum_probs=146.9
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
|||||++||+|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++......
T Consensus 93 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~-~~~~~kl~Dfg~a~~~~~~ 169 (311)
T 3ork_A 93 IVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMIS-ATNAVKVMDFGIARAIADS 169 (311)
T ss_dssp EEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEE-TTSCEEECCCSCC------
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEc-CCCCEEEeeccCccccccc
Confidence 58999999999999998889999999999999999999999999 99999999999998 4579999999999765432
Q ss_pred -----CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCC-ccccCCChh
Q 008504 81 -----TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPA-SLAKVNDPQ 153 (563)
Q Consensus 81 -----~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~-~l~~~~s~~ 153 (563)
......||+.|+|||++.+ .++.++|||||||++|+|++|+.||............+.....+. ......++.
T Consensus 170 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (311)
T 3ork_A 170 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSAD 249 (311)
T ss_dssp ------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTCCHH
T ss_pred ccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCCCCHH
Confidence 1234578999999998865 589999999999999999999999987444444444444433322 233456889
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHHcCccccccccC
Q 008504 154 IKGFIEKCLV-PASERLSAKDLLKDPFLQVENQK 186 (563)
Q Consensus 154 l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~~~ 186 (563)
+.+||.+||. +|.+||++.++|.|+|++.....
T Consensus 250 l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~ 283 (311)
T 3ork_A 250 LDAVVLKALAKNPENRYQTAAEMRADLVRVHNGE 283 (311)
T ss_dssp HHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcCC
Confidence 9999999997 89999999999999999865543
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=99.97 E-value=9.6e-32 Score=267.49 Aligned_cols=183 Identities=23% Similarity=0.416 Sum_probs=150.1
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCC---CcEEEecccchhhc
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNH---GEVKIGDLGLAIAM 77 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~---G~VKL~DFGlA~~~ 77 (563)
+||||+++++|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+||+++.+. +.+||+|||++...
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~ 162 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKR--IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI 162 (283)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChHHEEEecCCCCCCceEEEecccceec
Confidence 58999999999999998888999999999999999999999999 99999999999997432 27999999999765
Q ss_pred cCC-CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCC--CccccCCChh
Q 008504 78 QQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP--ASLAKVNDPQ 153 (563)
Q Consensus 78 ~~~-~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p--~~l~~~~s~~ 153 (563)
... ......|++.|+|||++.+ .++.++||||||+++|+|++|..||... ........+...... .......++.
T Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (283)
T 3bhy_A 163 EAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGE-TKQETLTNISAVNYDFDEEYFSNTSEL 241 (283)
T ss_dssp C--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCS-SHHHHHHHHHTTCCCCCHHHHTTCCHH
T ss_pred cCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCc-chHHHHHHhHhcccCCcchhcccCCHH
Confidence 432 2334578999999998864 5899999999999999999999999873 445555555444332 2233556789
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHHcCccccccccC
Q 008504 154 IKGFIEKCLV-PASERLSAKDLLKDPFLQVENQK 186 (563)
Q Consensus 154 l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~~~ 186 (563)
+++||.+||. +|.+|||+.++|+||||+.....
T Consensus 242 ~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~ 275 (283)
T 3bhy_A 242 AKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRR 275 (283)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHC
T ss_pred HHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHH
Confidence 9999999997 89999999999999999865543
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-31 Score=274.39 Aligned_cols=180 Identities=20% Similarity=0.363 Sum_probs=141.2
Q ss_pred CEeccCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEe------------------
Q 008504 1 MITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN------------------ 60 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~--~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd------------------ 60 (563)
|||||+ +|+|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||+.
T Consensus 99 lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~ 175 (355)
T 2eu9_A 99 IAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ--LTHTDLKPENILFVNSEFETLYNEHKSCEEKS 175 (355)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEESCCCEEEEECCC-CCCEEE
T ss_pred EEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEecccccccccccccccccc
Confidence 589999 66777777764 36999999999999999999999999 99999999999993
Q ss_pred CCCCcEEEecccchhhccCCCCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 008504 61 GNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS 139 (563)
Q Consensus 61 ~~~G~VKL~DFGlA~~~~~~~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~ 139 (563)
...+.+||+|||++..... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||......... ..+..
T Consensus 176 ~~~~~~kl~Dfg~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~-~~~~~ 253 (355)
T 2eu9_A 176 VKNTSIRVADFGSATFDHE-HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHL-VMMEK 253 (355)
T ss_dssp ESCCCEEECCCTTCEETTS-CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-HHHHH
T ss_pred cCCCcEEEeecCccccccc-cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHH
Confidence 1457899999999975443 2345679999999998864 5899999999999999999999999874433222 21111
Q ss_pred --CCCCCc----------------------------------------cccCCChhHHHHHHHhcC-CCCCCCCHHHHHc
Q 008504 140 --GIKPAS----------------------------------------LAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 140 --~~~p~~----------------------------------------l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLk 176 (563)
+..|.. .....++.+.+||.+||. +|.+|||+.|+|+
T Consensus 254 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 333 (355)
T 2eu9_A 254 ILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALL 333 (355)
T ss_dssp HHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred HcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 111100 000113478899999997 8999999999999
Q ss_pred Ccccccccc
Q 008504 177 DPFLQVENQ 185 (563)
Q Consensus 177 Hpff~~~~~ 185 (563)
||||+....
T Consensus 334 hp~f~~~~~ 342 (355)
T 2eu9_A 334 HPFFAGLTP 342 (355)
T ss_dssp SGGGGGCCH
T ss_pred ChhhcCCCh
Confidence 999987554
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-32 Score=287.01 Aligned_cols=179 Identities=13% Similarity=0.178 Sum_probs=139.5
Q ss_pred CEeccCCCCCHHHHHHhC-CCCCHHHH------HHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccc
Q 008504 1 MITELFTSGNLRQYRKKH-KNVDIKVI------KNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGL 73 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~-~~Lse~~i------~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGl 73 (563)
||||||. |+|.+++... ..+....+ ..++.||+.||+|||++| |+||||||+|||++ .+|.+||+|||+
T Consensus 165 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~--ivHrDikp~NIll~-~~~~~kL~DFG~ 240 (371)
T 3q60_A 165 LLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG--LVHGHFTPDNLFIM-PDGRLMLGDVSA 240 (371)
T ss_dssp EEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT--EEETTCSGGGEEEC-TTSCEEECCGGG
T ss_pred EEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC--CccCcCCHHHEEEC-CCCCEEEEecce
Confidence 6899998 8999999863 33555555 677799999999999999 99999999999998 558999999999
Q ss_pred hhhccCCCCccccCCCCccCcccccc---cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHH-HHHHH---HhcC--CCCC
Q 008504 74 AIAMQQPTARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTFEYPYSECKNPA-QIFKK---VTSG--IKPA 144 (563)
Q Consensus 74 A~~~~~~~~~~~~Gtp~Y~APEvl~~---~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~-~i~~~---i~~~--~~p~ 144 (563)
++...... ....+|+.|+|||++.+ .|+.++|||||||++|+|++|+.||....... ..+.. .... ....
T Consensus 241 a~~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (371)
T 3q60_A 241 LWKVGTRG-PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAF 319 (371)
T ss_dssp EEETTCEE-EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTCCCBCCTTSCCCCSCCC
T ss_pred eeecCCCc-cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCcccccchhhhhhhhccccccch
Confidence 97654322 24566799999998864 58999999999999999999999997642110 00000 0001 1111
Q ss_pred ccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCccccccc
Q 008504 145 SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 184 (563)
Q Consensus 145 ~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~ 184 (563)
......++.+++||.+||. +|.+|||+.++|+||||+...
T Consensus 320 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 360 (371)
T 3q60_A 320 GSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQ 360 (371)
T ss_dssp TTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHH
T ss_pred hhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHH
Confidence 1223568899999999997 899999999999999998654
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-31 Score=272.56 Aligned_cols=179 Identities=33% Similarity=0.592 Sum_probs=144.2
Q ss_pred CEeccCCCCCHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhc
Q 008504 1 MITELFTSGNLRQYRKKHKN---VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM 77 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~---Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~ 77 (563)
|||||+.+|+|.+++.+.+. +++..++.++.||+.||.|||++|++|+||||||+|||++ .++.+||+|||++...
T Consensus 111 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~-~~~~~kL~Dfg~a~~~ 189 (309)
T 3p86_A 111 IVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVD-KKYTVKVCDFGLSRLK 189 (309)
T ss_dssp EEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEEC-TTCCEEECCCC-----
T ss_pred EEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEe-CCCcEEECCCCCCccc
Confidence 58999999999999987654 9999999999999999999999998899999999999998 5579999999999754
Q ss_pred cCC--CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhH
Q 008504 78 QQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQI 154 (563)
Q Consensus 78 ~~~--~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l 154 (563)
... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.. .+.......+.........+...++.+
T Consensus 190 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l 268 (309)
T 3p86_A 190 ASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGN-LNPAQVVAAVGFKCKRLEIPRNLNPQV 268 (309)
T ss_dssp ------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTT-SCHHHHHHHHHHSCCCCCCCTTSCHHH
T ss_pred cccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhcCCCCCCCccCCHHH
Confidence 432 2345679999999998865 489999999999999999999999987 455555555554545555677788999
Q ss_pred HHHHHHhcC-CCCCCCCHHHHHc--Ccccc
Q 008504 155 KGFIEKCLV-PASERLSAKDLLK--DPFLQ 181 (563)
Q Consensus 155 ~~LI~kcL~-dP~kRpSa~ELLk--Hpff~ 181 (563)
.+||.+||. +|.+|||+.++++ +++++
T Consensus 269 ~~li~~~l~~dP~~Rps~~~ll~~L~~~~~ 298 (309)
T 3p86_A 269 AAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298 (309)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 999999997 8999999999998 45554
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-31 Score=287.26 Aligned_cols=182 Identities=25% Similarity=0.371 Sum_probs=138.3
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
|||||+ +|+|.+++...+.+++..++.|+.||+.||.|||++| |+||||||+||||+ .++.+||+|||+++.....
T Consensus 134 lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--iiHrDlKp~NILl~-~~~~~kl~DFGla~~~~~~ 209 (458)
T 3rp9_A 134 VVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAG--ILHRDLKPANCLVN-QDCSVKVCDFGLARTVDYP 209 (458)
T ss_dssp EEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTCCEEECCCTTCBCTTSC
T ss_pred EEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCC--cCCCCCChhhEEEC-CCCCEeecccccchhccCc
Confidence 589998 5799999999888999999999999999999999999 99999999999998 5579999999999765321
Q ss_pred -----------------------------CCccccCCCCccCcccc-c-ccCCchhhHHHhHHHHHHHhh----------
Q 008504 81 -----------------------------TARSVIGTPEFMAPELY-E-EEYNELVDIYSFGMCILEMVT---------- 119 (563)
Q Consensus 81 -----------------------------~~~~~~Gtp~Y~APEvl-~-~~ys~ksDIwSLGviLyELlT---------- 119 (563)
.....+||+.|+|||++ . ..|+.++|||||||++|||++
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~ 289 (458)
T 3rp9_A 210 ENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHA 289 (458)
T ss_dssp TTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGG
T ss_pred cccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccc
Confidence 12345789999999976 3 459999999999999999999
Q ss_pred -cCCCCCCCCC--------------------HHHHHHHHh-cCCC---------------------------CCccccCC
Q 008504 120 -FEYPYSECKN--------------------PAQIFKKVT-SGIK---------------------------PASLAKVN 150 (563)
Q Consensus 120 -G~~Pf~~~~~--------------------~~~i~~~i~-~~~~---------------------------p~~l~~~~ 150 (563)
|+.+|.+... ..++..... .+.+ ........
T Consensus 290 ~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 369 (458)
T 3rp9_A 290 DRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPAS 369 (458)
T ss_dssp GCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTS
T ss_pred cccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCC
Confidence 5666654221 011100000 0000 01112234
Q ss_pred ChhHHHHHHHhcC-CCCCCCCHHHHHcCccccccccC
Q 008504 151 DPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQK 186 (563)
Q Consensus 151 s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~~~ 186 (563)
++.+.+||.+||. ||.+|||+.|+|+||||+...+.
T Consensus 370 s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~ 406 (458)
T 3rp9_A 370 SADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIA 406 (458)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCG
T ss_pred CHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCC
Confidence 7899999999998 99999999999999999976554
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-31 Score=284.04 Aligned_cols=181 Identities=18% Similarity=0.316 Sum_probs=145.4
Q ss_pred CEeccCCCCCHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhh
Q 008504 1 MITELFTSGNLRQYRK----KHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 76 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~----k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~ 76 (563)
|||||+.+ +|.+++. ....+++..++.++.||+.||.|||++| |+||||||+||||+.+.+.+||+|||+++.
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NILl~~~~~~~kl~DFG~a~~ 206 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 206 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChhhEEEeCCCCeEEeccchhhhh
Confidence 58999986 6666554 3567999999999999999999999999 999999999999986667899999999976
Q ss_pred ccCC-CCccccCCCCccCcccccc--cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcC-------------
Q 008504 77 MQQP-TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG------------- 140 (563)
Q Consensus 77 ~~~~-~~~~~~Gtp~Y~APEvl~~--~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~------------- 140 (563)
.... .....+||+.|+|||++.+ .|+.++|||||||++|||++|+.||.+.....++...+...
T Consensus 207 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~ 286 (420)
T 1j1b_A 207 LVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP 286 (420)
T ss_dssp CCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCS
T ss_pred cccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhCh
Confidence 5432 3345688999999998854 58999999999999999999999998755444443333210
Q ss_pred -CCCCc------------cccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCccccccc
Q 008504 141 -IKPAS------------LAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 184 (563)
Q Consensus 141 -~~p~~------------l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~ 184 (563)
..... +....++.+++||.+||. +|.+|||+.|+|+||||+...
T Consensus 287 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 344 (420)
T 1j1b_A 287 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 344 (420)
T ss_dssp CCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred hhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccc
Confidence 00000 123457899999999998 899999999999999997654
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-31 Score=275.33 Aligned_cols=179 Identities=25% Similarity=0.422 Sum_probs=142.4
Q ss_pred CEeccCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k-~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
|||||+.+ +|.+++.. .+.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++.....
T Consensus 101 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~-~~~~~kl~Dfg~a~~~~~ 176 (351)
T 3mi9_A 101 LVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLIT-RDGVLKLADFGLARAFSL 176 (351)
T ss_dssp EEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEECCC
T ss_pred EEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEc-CCCCEEEccchhcccccc
Confidence 58999985 77777765 367999999999999999999999999 99999999999998 557999999999976542
Q ss_pred C------CCccccCCCCccCcccccc--cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhc---CCCCCcccc
Q 008504 80 P------TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS---GIKPASLAK 148 (563)
Q Consensus 80 ~------~~~~~~Gtp~Y~APEvl~~--~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~---~~~p~~l~~ 148 (563)
. ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.... .......+.. ...+..++.
T Consensus 177 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~ 255 (351)
T 3mi9_A 177 AKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT-EQHQLALISQLCGSITPEVWPN 255 (351)
T ss_dssp CSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS-HHHHHHHHHHHHCCCCTTTSTT
T ss_pred cccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCChhhccc
Confidence 1 2234578999999998864 48999999999999999999999998743 3333332221 222111111
Q ss_pred C---------------------------CChhHHHHHHHhcC-CCCCCCCHHHHHcCccccccc
Q 008504 149 V---------------------------NDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 184 (563)
Q Consensus 149 ~---------------------------~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~ 184 (563)
. .++.+++||.+||. ||.+|||+.|+|+||||+...
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 319 (351)
T 3mi9_A 256 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDP 319 (351)
T ss_dssp GGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSS
T ss_pred cccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCC
Confidence 1 26779999999998 899999999999999997543
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-31 Score=279.71 Aligned_cols=178 Identities=25% Similarity=0.416 Sum_probs=140.6
Q ss_pred CEeccCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHh--CCCCeEeccCccCceEEeC-CCCcEEEecccchh
Q 008504 1 MITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHS--HNPPIIHRDLKCDNIFVNG-NHGEVKIGDLGLAI 75 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~--~~Lse~~i~~i~~QIL~aL~yLHs--~gp~IIHrDLKP~NILLd~-~~G~VKL~DFGlA~ 75 (563)
|||||+. |+|.+++... +.+++..++.++.||+.||.|||+ .| |+||||||+|||++. ..+.+||+|||++.
T Consensus 133 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~--ivHrDlkp~NIll~~~~~~~~kL~DFG~a~ 209 (382)
T 2vx3_A 133 LVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELS--IIHCDLKPENILLCNPKRSAIKIVDFGSSC 209 (382)
T ss_dssp EEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTC--EECCCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred EEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCC--EEcCCCCcccEEEecCCCCcEEEEeccCce
Confidence 6899996 5999999875 469999999999999999999995 56 999999999999953 35789999999997
Q ss_pred hccCCCCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhc--CCCCCcc------
Q 008504 76 AMQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS--GIKPASL------ 146 (563)
Q Consensus 76 ~~~~~~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~--~~~p~~l------ 146 (563)
..... .....||+.|+|||++.+ .++.++|||||||++|+|+||+.||....... ....+.. +..+...
T Consensus 210 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~ 287 (382)
T 2vx3_A 210 QLGQR-IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVD-QMNKIVEVLGIPPAHILDQAPK 287 (382)
T ss_dssp ETTCC-CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCSCCHHHHTTCTT
T ss_pred ecccc-cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHHHhhHH
Confidence 66443 345689999999998865 58999999999999999999999998744333 3333221 1110000
Q ss_pred ---------------------------ccC---------------------------CChhHHHHHHHhcC-CCCCCCCH
Q 008504 147 ---------------------------AKV---------------------------NDPQIKGFIEKCLV-PASERLSA 171 (563)
Q Consensus 147 ---------------------------~~~---------------------------~s~~l~~LI~kcL~-dP~kRpSa 171 (563)
+.. ..+.+++||.+||. ||.+|||+
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpta 367 (382)
T 2vx3_A 288 ARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQP 367 (382)
T ss_dssp HHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCCH
T ss_pred HHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCCH
Confidence 000 01368999999998 89999999
Q ss_pred HHHHcCcccccc
Q 008504 172 KDLLKDPFLQVE 183 (563)
Q Consensus 172 ~ELLkHpff~~~ 183 (563)
.|+|+||||+..
T Consensus 368 ~e~L~hp~f~~~ 379 (382)
T 2vx3_A 368 YYALQHSFFKKT 379 (382)
T ss_dssp HHHTTSGGGCC-
T ss_pred HHHhcCcccccC
Confidence 999999999864
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-31 Score=267.53 Aligned_cols=177 Identities=29% Similarity=0.502 Sum_probs=151.6
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC-
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ- 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~- 79 (563)
+||||+.+++|.+++...+.+++..++.++.||+.||.|||++| |+||||||+||+++ .++.+||+|||++.....
T Consensus 92 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~kl~dfg~~~~~~~~ 168 (294)
T 2rku_A 92 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYD 168 (294)
T ss_dssp EEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECCCTTCEECCST
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEc-CCCCEEEEeccCceecccC
Confidence 58999999999999998889999999999999999999999999 99999999999998 557999999999976542
Q ss_pred -CCCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHHH
Q 008504 80 -PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 157 (563)
Q Consensus 80 -~~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~L 157 (563)
.......|++.|+|||++.+ .++.++||||||+++|+|++|+.||... .....+..+..... ..+...++.+.+|
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~-~~~~~~~~~~~~~~--~~~~~~~~~~~~l 245 (294)
T 2rku_A 169 GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS-CLKETYLRIKKNEY--SIPKHINPVAASL 245 (294)
T ss_dssp TCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCS-SHHHHHHHHHTTCC--CCCTTSCHHHHHH
T ss_pred ccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhhccC--CCccccCHHHHHH
Confidence 22344578999999998865 4889999999999999999999999873 44445555544432 2455678899999
Q ss_pred HHHhcC-CCCCCCCHHHHHcCcccccc
Q 008504 158 IEKCLV-PASERLSAKDLLKDPFLQVE 183 (563)
Q Consensus 158 I~kcL~-dP~kRpSa~ELLkHpff~~~ 183 (563)
|.+||. +|.+|||+.++++||||+..
T Consensus 246 i~~~l~~~p~~Rps~~~ll~~~~~~~~ 272 (294)
T 2rku_A 246 IQKMLQTDPTARPTINELLNDEFFTSG 272 (294)
T ss_dssp HHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred HHHHcccChhhCcCHHHHhhChheecC
Confidence 999997 89999999999999999754
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4e-31 Score=282.59 Aligned_cols=183 Identities=25% Similarity=0.353 Sum_probs=139.4
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
|||||+. |+|.++++..+.+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||+++.....
T Consensus 107 lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~g--ivHrDlkp~NILl~-~~~~~kL~DFGla~~~~~~ 182 (432)
T 3n9x_A 107 IVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESG--IIHRDLKPANCLLN-QDCSVKVCDFGLARTINSE 182 (432)
T ss_dssp EEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECCCTTCEEC---
T ss_pred EEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCHHHeEEC-CCCCEEEccCCCccccccc
Confidence 5899996 599999998888999999999999999999999999 99999999999998 5589999999999765432
Q ss_pred ------------------------CCccccCCCCccCcccc-c-ccCCchhhHHHhHHHHHHHhhcCCC-----------
Q 008504 81 ------------------------TARSVIGTPEFMAPELY-E-EEYNELVDIYSFGMCILEMVTFEYP----------- 123 (563)
Q Consensus 81 ------------------------~~~~~~Gtp~Y~APEvl-~-~~ys~ksDIwSLGviLyELlTG~~P----------- 123 (563)
.....+||+.|+|||++ . ..|+.++|||||||++|||++|..|
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~ 262 (432)
T 3n9x_A 183 KDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPL 262 (432)
T ss_dssp ----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCS
T ss_pred ccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccccccc
Confidence 12456899999999976 3 4599999999999999999985333
Q ss_pred CCCCCC-----------------HHHH-----------------------HHHHhcCCC--CC---ccccCCChhHHHHH
Q 008504 124 YSECKN-----------------PAQI-----------------------FKKVTSGIK--PA---SLAKVNDPQIKGFI 158 (563)
Q Consensus 124 f~~~~~-----------------~~~i-----------------------~~~i~~~~~--p~---~l~~~~s~~l~~LI 158 (563)
|.+... ..++ ...+..... +. ......++.+.+||
T Consensus 263 f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl 342 (432)
T 3n9x_A 263 FPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLL 342 (432)
T ss_dssp CCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHH
T ss_pred CCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHH
Confidence 322110 0111 111111100 00 01134678999999
Q ss_pred HHhcC-CCCCCCCHHHHHcCccccccccCC
Q 008504 159 EKCLV-PASERLSAKDLLKDPFLQVENQKE 187 (563)
Q Consensus 159 ~kcL~-dP~kRpSa~ELLkHpff~~~~~~~ 187 (563)
.+||. ||.+|||+.|+|+||||+...+..
T Consensus 343 ~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~ 372 (432)
T 3n9x_A 343 ESMLKFNPNKRITIDQALDHPYLKDVRKKK 372 (432)
T ss_dssp HHHSCSSTTTSCCHHHHHTCGGGTTTCCTT
T ss_pred HHHhcCCcccCCCHHHHhcChhhhhccCcc
Confidence 99998 899999999999999999766543
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.2e-31 Score=265.63 Aligned_cols=178 Identities=25% Similarity=0.481 Sum_probs=149.4
Q ss_pred CEeccCCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhcc
Q 008504 1 MITELFTSGNLRQYRKK--HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k--~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~ 78 (563)
|||||+.+| |.+++.. .+.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++....
T Consensus 85 lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~NIl~~-~~~~~kl~dfg~~~~~~ 160 (305)
T 2wtk_C 85 MVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG--IVHKDIKPGNLLLT-TGGTLKISALGVAEALH 160 (305)
T ss_dssp EEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTCCEEECCCTTCEECC
T ss_pred EEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEc-CCCcEEeeccccccccC
Confidence 589999876 8888775 456999999999999999999999999 99999999999998 55799999999997654
Q ss_pred CC----CCccccCCCCccCccccccc---CCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCC
Q 008504 79 QP----TARSVIGTPEFMAPELYEEE---YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVND 151 (563)
Q Consensus 79 ~~----~~~~~~Gtp~Y~APEvl~~~---ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s 151 (563)
.. ......|++.|+|||++.+. ++.++||||||+++|+|++|+.||.. .+.......+..+.. ..+...+
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~-~~~~~~~~~i~~~~~--~~~~~~~ 237 (305)
T 2wtk_C 161 PFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG-DNIYKLFENIGKGSY--AIPGDCG 237 (305)
T ss_dssp TTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHHCCC--CCCSSSC
T ss_pred ccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCC-chHHHHHHHHhcCCC--CCCCccC
Confidence 21 22345689999999988642 47899999999999999999999987 455666666666543 2455678
Q ss_pred hhHHHHHHHhcC-CCCCCCCHHHHHcCcccccccc
Q 008504 152 PQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQ 185 (563)
Q Consensus 152 ~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~~ 185 (563)
+.+.+||.+||. +|.+|||+.++++||||+....
T Consensus 238 ~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 272 (305)
T 2wtk_C 238 PPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHP 272 (305)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCC
T ss_pred HHHHHHHHHHccCChhhCCCHHHHhcCcccccCCC
Confidence 899999999997 8999999999999999986544
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-31 Score=274.05 Aligned_cols=178 Identities=29% Similarity=0.496 Sum_probs=152.2
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC-
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ- 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~- 79 (563)
|||||+.+++|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++.....
T Consensus 118 lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~-~~~~~kl~Dfg~~~~~~~~ 194 (335)
T 2owb_A 118 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYD 194 (335)
T ss_dssp EEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEC-TTCCEEECCCTTCEECCST
T ss_pred EEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--CEecCCCchhEEEc-CCCCEEEeeccCceecccC
Confidence 58999999999999998888999999999999999999999999 99999999999998 557999999999976542
Q ss_pred -CCCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHHH
Q 008504 80 -PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 157 (563)
Q Consensus 80 -~~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~L 157 (563)
.......|++.|+|||++.+ .++.++|||||||++|+|++|+.||... .....+..+..... .++...++.+++|
T Consensus 195 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~-~~~~~~~~~~~~~~--~~~~~~~~~~~~l 271 (335)
T 2owb_A 195 GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS-CLKETYLRIKKNEY--SIPKHINPVAASL 271 (335)
T ss_dssp TCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCS-SHHHHHHHHHHTCC--CCCTTSCHHHHHH
T ss_pred cccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCC-CHHHHHHHHhcCCC--CCCccCCHHHHHH
Confidence 22344579999999998865 4889999999999999999999999873 44445555544432 2455678899999
Q ss_pred HHHhcC-CCCCCCCHHHHHcCccccccc
Q 008504 158 IEKCLV-PASERLSAKDLLKDPFLQVEN 184 (563)
Q Consensus 158 I~kcL~-dP~kRpSa~ELLkHpff~~~~ 184 (563)
|.+||. +|.+|||+.++|+||||....
T Consensus 272 i~~~l~~dp~~Rps~~ell~~~~~~~~~ 299 (335)
T 2owb_A 272 IQKMLQTDPTARPTINELLNDEFFTSGY 299 (335)
T ss_dssp HHHHTCSSGGGSCCGGGGGGSHHHHTSC
T ss_pred HHHHccCChhHCcCHHHHhcCccccCCC
Confidence 999997 899999999999999998543
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-31 Score=273.45 Aligned_cols=172 Identities=21% Similarity=0.385 Sum_probs=147.5
Q ss_pred CEeccCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTS-GNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~g-GsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
+||||+.+ ++|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++.+.+.+||+|||++.....
T Consensus 125 lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~ 202 (320)
T 3a99_A 125 LILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKD 202 (320)
T ss_dssp EEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCCTTCEECCS
T ss_pred EEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--cEeCCCCHHHEEEeCCCCCEEEeeCcccccccc
Confidence 58999986 899999998889999999999999999999999999 999999999999986668999999999987766
Q ss_pred CCCccccCCCCccCccccccc--CCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHHH
Q 008504 80 PTARSVIGTPEFMAPELYEEE--YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 157 (563)
Q Consensus 80 ~~~~~~~Gtp~Y~APEvl~~~--ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~L 157 (563)
.......||+.|+|||++.+. ++.++|||||||++|+|++|+.||.. .... ..+. ...+...++.+++|
T Consensus 203 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~---~~~~----~~~~--~~~~~~~~~~~~~l 273 (320)
T 3a99_A 203 TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH---DEEI----IRGQ--VFFRQRVSSECQHL 273 (320)
T ss_dssp SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS---HHHH----HHCC--CCCSSCCCHHHHHH
T ss_pred ccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCC---hhhh----hccc--ccccccCCHHHHHH
Confidence 555567899999999988643 46889999999999999999999965 2221 1221 12345668899999
Q ss_pred HHHhcC-CCCCCCCHHHHHcCcccccc
Q 008504 158 IEKCLV-PASERLSAKDLLKDPFLQVE 183 (563)
Q Consensus 158 I~kcL~-dP~kRpSa~ELLkHpff~~~ 183 (563)
|.+||. +|.+|||+.++++||||+..
T Consensus 274 i~~~l~~dp~~Rps~~~ll~hp~~~~~ 300 (320)
T 3a99_A 274 IRWCLALRPSDRPTFEEIQNHPWMQDV 300 (320)
T ss_dssp HHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred HHHHccCChhhCcCHHHHhcCHhhcCc
Confidence 999997 89999999999999999854
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.4e-32 Score=276.23 Aligned_cols=181 Identities=27% Similarity=0.458 Sum_probs=144.1
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
|||||+.+++|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++ ..|.+||+|||++......
T Consensus 101 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~ 177 (331)
T 4aaa_A 101 LVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN--IIHRDIKPENILVS-QSGVVKLCDFGFARTLAAP 177 (331)
T ss_dssp EEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTSCEEECCCTTC------
T ss_pred EEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC--EEccCcChheEEEc-CCCcEEEEeCCCceeecCC
Confidence 58999999999999888888999999999999999999999999 99999999999998 4579999999999765432
Q ss_pred --CCccccCCCCccCcccccc--cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhc-----------------
Q 008504 81 --TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS----------------- 139 (563)
Q Consensus 81 --~~~~~~Gtp~Y~APEvl~~--~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~----------------- 139 (563)
......|++.|+|||++.+ .++.++|||||||++|+|++|+.||............+..
T Consensus 178 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (331)
T 4aaa_A 178 GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPV 257 (331)
T ss_dssp ------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGG
T ss_pred ccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccc
Confidence 2344578999999998865 4899999999999999999999999875544433332211
Q ss_pred --CCCCC---------ccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCccccccc
Q 008504 140 --GIKPA---------SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 184 (563)
Q Consensus 140 --~~~p~---------~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~ 184 (563)
+.... ......++.+.+||.+||. +|.+|||+.|+|+||||+...
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 314 (331)
T 4aaa_A 258 FAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDG 314 (331)
T ss_dssp GTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGGG
T ss_pred cccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccCC
Confidence 00000 0112357889999999998 899999999999999998654
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.5e-31 Score=272.74 Aligned_cols=182 Identities=24% Similarity=0.327 Sum_probs=142.4
Q ss_pred CEeccCCCCCHHHHH----HhCCCCCHHHHHHHHHHHHHHHHHHH--hCCCCeEeccCccCceEEeCCCCcEEEecccch
Q 008504 1 MITELFTSGNLRQYR----KKHKNVDIKVIKNWARQILHGLVYLH--SHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA 74 (563)
Q Consensus 1 LVmEy~~gGsL~~~L----~k~~~Lse~~i~~i~~QIL~aL~yLH--s~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA 74 (563)
|||||+.+ +|...+ .....+++..++.++.||+.||.||| ++| |+||||||+|||++..++.+||+|||++
T Consensus 103 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~--ivH~Dlkp~NIll~~~~~~~kl~Dfg~a 179 (360)
T 3e3p_A 103 VVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN--VCHRDIKPHNVLVNEADGTLKLCDFGSA 179 (360)
T ss_dssp EEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC--CBCSCCCGGGEEEETTTTEEEECCCTTC
T ss_pred EEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC--eecCcCCHHHEEEeCCCCcEEEeeCCCc
Confidence 58999987 444433 35677999999999999999999999 888 9999999999999865789999999999
Q ss_pred hhccCC-CCccccCCCCccCcccccc--cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCC--------
Q 008504 75 IAMQQP-TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP-------- 143 (563)
Q Consensus 75 ~~~~~~-~~~~~~Gtp~Y~APEvl~~--~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p-------- 143 (563)
...... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||............+.....+
T Consensus 180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (360)
T 3e3p_A 180 KKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKL 259 (360)
T ss_dssp BCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred eecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhc
Confidence 766543 2345578999999998853 38999999999999999999999998744333332222110000
Q ss_pred ---------------------CccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCcccccccc
Q 008504 144 ---------------------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQ 185 (563)
Q Consensus 144 ---------------------~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~~ 185 (563)
.......++.+++||.+||. +|.+|||+.|+|+||||+....
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 323 (360)
T 3e3p_A 260 NPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHD 323 (360)
T ss_dssp CTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGC
T ss_pred ccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCC
Confidence 00111135689999999998 8999999999999999987544
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.5e-31 Score=265.18 Aligned_cols=178 Identities=34% Similarity=0.508 Sum_probs=140.6
Q ss_pred CEeccCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~-~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
+||||+++|+|.+++...+ .+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++.....
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dlkp~Nil~~-~~~~~kl~dfg~~~~~~~ 168 (303)
T 1zy4_A 92 IQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQG--IIHRDLKPMNIFID-ESRNVKIGDFGLAKNVHR 168 (303)
T ss_dssp EEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTSCEEECCCCCCSCTTC
T ss_pred EEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCC--eecccCCHHhEEEc-CCCCEEEeeCcchhhccc
Confidence 5899999999999998644 5889999999999999999999999 99999999999997 557999999999865532
Q ss_pred C----------------CCccccCCCCccCcccccc--cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCC
Q 008504 80 P----------------TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI 141 (563)
Q Consensus 80 ~----------------~~~~~~Gtp~Y~APEvl~~--~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~ 141 (563)
. ......|++.|+|||++.+ .++.++|||||||++|+|++ ||............+....
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~~~~~~~ 245 (303)
T 1zy4_A 169 SLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKKLRSVS 245 (303)
T ss_dssp -------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHSTT
T ss_pred ccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHHhccccc
Confidence 1 1234568999999999864 58999999999999999998 6654333344445444432
Q ss_pred --CCCccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCccccccc
Q 008504 142 --KPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 184 (563)
Q Consensus 142 --~p~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~ 184 (563)
.+.......++.+++||.+||. +|.+|||+.++++||||+...
T Consensus 246 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (303)
T 1zy4_A 246 IEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKH 291 (303)
T ss_dssp CCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCCC
T ss_pred cccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCCC
Confidence 2334455566789999999997 899999999999999997543
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-31 Score=289.50 Aligned_cols=176 Identities=32% Similarity=0.438 Sum_probs=134.6
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
||||||.+ +|.+++.. .+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||+++.....
T Consensus 144 lv~E~~~~-~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDlkp~NIll~-~~~~~kl~DFG~a~~~~~~ 217 (464)
T 3ttj_A 144 LVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTS 217 (464)
T ss_dssp EEEECCSE-EHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTSCEEECCCCCC-----C
T ss_pred EEEeCCCC-CHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChHhEEEe-CCCCEEEEEEEeeeecCCC
Confidence 68999976 57776643 4999999999999999999999999 99999999999998 4579999999999766543
Q ss_pred -CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhc-CCCC--------------
Q 008504 81 -TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS-GIKP-------------- 143 (563)
Q Consensus 81 -~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~-~~~p-------------- 143 (563)
.....+||+.|+|||++.+ .|+.++|||||||++|+|++|+.||.+.....++...+.. +.+.
T Consensus 218 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~ 297 (464)
T 3ttj_A 218 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 297 (464)
T ss_dssp CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHH
T ss_pred cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhH
Confidence 3345689999999998865 5999999999999999999999999875433333322211 1000
Q ss_pred ---------CccccC---------------CChhHHHHHHHhcC-CCCCCCCHHHHHcCccccc
Q 008504 144 ---------ASLAKV---------------NDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQV 182 (563)
Q Consensus 144 ---------~~l~~~---------------~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~ 182 (563)
..++.. .++.+++||.+||. ||.+|||+.|+|+||||+.
T Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~ 361 (464)
T 3ttj_A 298 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 361 (464)
T ss_dssp HTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred hhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhh
Confidence 000000 04578999999998 9999999999999999984
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-31 Score=277.07 Aligned_cols=177 Identities=27% Similarity=0.412 Sum_probs=136.8
Q ss_pred CEeccCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhC-CCCeEeccCccCceEEeCCC--------------
Q 008504 1 MITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSH-NPPIIHRDLKCDNIFVNGNH-------------- 63 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~--~~Lse~~i~~i~~QIL~aL~yLHs~-gp~IIHrDLKP~NILLd~~~-------------- 63 (563)
|||||+ +|+|.+++.+. +.+++..++.|+.||+.||.|||++ | |+||||||+|||++.+.
T Consensus 122 lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g--ivHrDikp~NIll~~~~~~~~~~~~~~~~~~ 198 (397)
T 1wak_A 122 MVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQ 198 (397)
T ss_dssp EEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECCCCSGGGEEECCCHHHHHHHHHHHC---
T ss_pred EEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHeeEeccchhhhhhhhhhHHHh
Confidence 589999 56776666553 5699999999999999999999998 9 99999999999997432
Q ss_pred ----------------------------------CcEEEecccchhhccCCCCccccCCCCccCcccccc-cCCchhhHH
Q 008504 64 ----------------------------------GEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEE-EYNELVDIY 108 (563)
Q Consensus 64 ----------------------------------G~VKL~DFGlA~~~~~~~~~~~~Gtp~Y~APEvl~~-~ys~ksDIw 108 (563)
..+||+|||++...... .....||+.|+|||++.+ .++.++|||
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Diw 277 (397)
T 1wak_A 199 RSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-FTEDIQTRQYRSLEVLIGSGYNTPADIW 277 (397)
T ss_dssp ------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-SCSCCSCGGGCCHHHHHTSCCCTHHHHH
T ss_pred hcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-CccCCCCCcccCChhhcCCCCCcHHHHH
Confidence 27999999999765433 344578999999998865 489999999
Q ss_pred HhHHHHHHHhhcCCCCCCCCC-----HHHHHHHHhc--CCCCC-------------------------------------
Q 008504 109 SFGMCILEMVTFEYPYSECKN-----PAQIFKKVTS--GIKPA------------------------------------- 144 (563)
Q Consensus 109 SLGviLyELlTG~~Pf~~~~~-----~~~i~~~i~~--~~~p~------------------------------------- 144 (563)
||||++|+|+||+.||..... .......+.. +..+.
T Consensus 278 slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (397)
T 1wak_A 278 STACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEK 357 (397)
T ss_dssp HHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHT
T ss_pred HHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHhhhhh
Confidence 999999999999999975332 1111111110 11100
Q ss_pred -ccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCcccc
Q 008504 145 -SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQ 181 (563)
Q Consensus 145 -~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~ 181 (563)
..+...++.+++||.+||. +|.+|||+.|+|+||||+
T Consensus 358 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 396 (397)
T 1wak_A 358 YEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN 396 (397)
T ss_dssp SCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGG
T ss_pred cccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcccc
Confidence 0011123568899999998 899999999999999996
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-31 Score=264.10 Aligned_cols=181 Identities=26% Similarity=0.467 Sum_probs=149.5
Q ss_pred CEeccCCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCC---CCeEeccCccCceEEeCCCCcEEEecccc
Q 008504 1 MITELFTSGNLRQYRKKH----KNVDIKVIKNWARQILHGLVYLHSHN---PPIIHRDLKCDNIFVNGNHGEVKIGDLGL 73 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~----~~Lse~~i~~i~~QIL~aL~yLHs~g---p~IIHrDLKP~NILLd~~~G~VKL~DFGl 73 (563)
+||||+++|+|.+++... ..+++..++.++.||+.||.|||++| .+|+||||||+|||++ ..+.+||+|||+
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~-~~~~~kl~dfg~ 162 (279)
T 2w5a_A 84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLD-GKQNVKLGDFGL 162 (279)
T ss_dssp EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEEC-SSSCEEECCCCH
T ss_pred EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEc-CCCCEEEecCch
Confidence 589999999999999753 34999999999999999999999987 3499999999999998 557999999999
Q ss_pred hhhccCCC--CccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCC
Q 008504 74 AIAMQQPT--ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVN 150 (563)
Q Consensus 74 A~~~~~~~--~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~ 150 (563)
+....... .....|++.|+|||++.+ .++.++||||||+++|+|++|+.||.. .....+...+..+..+ .++...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~-~~~~~~~~~i~~~~~~-~~~~~~ 240 (279)
T 2w5a_A 163 ARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA-FSQKELAGKIREGKFR-RIPYRY 240 (279)
T ss_dssp HHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCC-CCCTTS
T ss_pred heeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcc-cCHHHHHHHHhhcccc-cCCccc
Confidence 97665432 223578999999998865 589999999999999999999999987 3456666666666543 345567
Q ss_pred ChhHHHHHHHhcC-CCCCCCCHHHHHcCccccccc
Q 008504 151 DPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 184 (563)
Q Consensus 151 s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~ 184 (563)
++.+++||.+||. +|.+|||+.++|+|+|+....
T Consensus 241 ~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~ 275 (279)
T 2w5a_A 241 SDELNEIITRMLNLKDYHRPSVEEILENPLILEHH 275 (279)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGG
T ss_pred CHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhc
Confidence 8899999999997 899999999999999997543
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.6e-31 Score=269.52 Aligned_cols=180 Identities=24% Similarity=0.408 Sum_probs=143.0
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
+||||+. |+|.+++.. +.+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++......
T Consensus 91 lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~Nil~~-~~~~~kl~Dfg~a~~~~~~ 165 (353)
T 2b9h_A 91 IIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSN--VIHRDLKPSNLLIN-SNCDLKVCDFGLARIIDES 165 (353)
T ss_dssp EEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEC-TTCCEEECCCTTCEECC--
T ss_pred EEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEc-CCCcEEEEecccccccccc
Confidence 5899997 599999987 57999999999999999999999999 99999999999998 4579999999999755421
Q ss_pred C------------CccccCCCCccCccccc--ccCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhc-CCCC--
Q 008504 81 T------------ARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS-GIKP-- 143 (563)
Q Consensus 81 ~------------~~~~~Gtp~Y~APEvl~--~~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~-~~~p-- 143 (563)
. .....||+.|+|||++. ..++.++|||||||++|+|++|+.||............... +...
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 245 (353)
T 2b9h_A 166 AADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSD 245 (353)
T ss_dssp --------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCST
T ss_pred cccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchh
Confidence 1 12347899999999874 45899999999999999999999999874433322221110 0000
Q ss_pred --------------------------CccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCcccccccc
Q 008504 144 --------------------------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQ 185 (563)
Q Consensus 144 --------------------------~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~~ 185 (563)
.......++.+++||.+||. +|.+|||+.++|+||||+....
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 314 (353)
T 2b9h_A 246 NDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHD 314 (353)
T ss_dssp TTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred ccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCC
Confidence 01123467899999999997 8999999999999999986544
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.4e-31 Score=265.45 Aligned_cols=178 Identities=34% Similarity=0.560 Sum_probs=151.2
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
|||||+++|+|.+++.. +.+++..++.++.||+.||.|||++| |+||||||+||+++ .+|.+||+|||++......
T Consensus 97 lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~kl~Dfg~~~~~~~~ 172 (303)
T 3a7i_A 97 IIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLS-EHGEVKLADFGVAGQLTDT 172 (303)
T ss_dssp EEEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEECBTT
T ss_pred EEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChheEEEC-CCCCEEEeecccceecCcc
Confidence 58999999999999875 57999999999999999999999999 99999999999998 5579999999999765433
Q ss_pred --CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHHH
Q 008504 81 --TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 157 (563)
Q Consensus 81 --~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~L 157 (563)
......|++.|+|||++.+ .++.++||||||+++|+|++|+.||... ........+..+.. ...+...++.+++|
T Consensus 173 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~l~~l 250 (303)
T 3a7i_A 173 QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL-HPMKVLFLIPKNNP-PTLEGNYSKPLKEF 250 (303)
T ss_dssp BCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS-CHHHHHHHHHHSCC-CCCCSSCCHHHHHH
T ss_pred ccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCc-CHHHHHHHhhcCCC-CCCccccCHHHHHH
Confidence 2344578999999998864 5889999999999999999999999873 44455455544433 33556678899999
Q ss_pred HHHhcC-CCCCCCCHHHHHcCccccccc
Q 008504 158 IEKCLV-PASERLSAKDLLKDPFLQVEN 184 (563)
Q Consensus 158 I~kcL~-dP~kRpSa~ELLkHpff~~~~ 184 (563)
|.+||. +|.+|||+.++++||||....
T Consensus 251 i~~~l~~dp~~Rps~~~ll~~~~~~~~~ 278 (303)
T 3a7i_A 251 VEACLNKEPSFRPTAKELLKHKFILRNA 278 (303)
T ss_dssp HHHHCCSSGGGSCCHHHHTTCHHHHHHC
T ss_pred HHHHcCCChhhCcCHHHHhhChhhhcCC
Confidence 999997 899999999999999997543
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-31 Score=274.95 Aligned_cols=182 Identities=26% Similarity=0.407 Sum_probs=140.0
Q ss_pred CEeccCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhC-CCCeEeccCccCceEEeC-----CCCcEEEeccc
Q 008504 1 MITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSH-NPPIIHRDLKCDNIFVNG-----NHGEVKIGDLG 72 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~--~~Lse~~i~~i~~QIL~aL~yLHs~-gp~IIHrDLKP~NILLd~-----~~G~VKL~DFG 72 (563)
|||||+ +|+|.+++.+. +.+++..++.++.||+.||.|||++ | |+||||||+|||++. ..+.+||+|||
T Consensus 107 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~--ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg 183 (373)
T 1q8y_A 107 MVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLG 183 (373)
T ss_dssp EEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGGEEEEEEETTTTEEEEEECCCT
T ss_pred EEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChHHeEEeccCCCcCcceEEEcccc
Confidence 589999 88999999874 4599999999999999999999998 9 999999999999952 33479999999
Q ss_pred chhhccCCCCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCC-----HHHHHHHHhc--CCCCC
Q 008504 73 LAIAMQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKN-----PAQIFKKVTS--GIKPA 144 (563)
Q Consensus 73 lA~~~~~~~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~-----~~~i~~~i~~--~~~p~ 144 (563)
++...... .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||..... .......+.. +..|.
T Consensus 184 ~a~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~ 262 (373)
T 1q8y_A 184 NACWYDEH-YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPS 262 (373)
T ss_dssp TCEETTBC-CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCH
T ss_pred cccccCCC-CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCH
Confidence 99765432 334578999999998865 489999999999999999999999975321 1111111110 10000
Q ss_pred --------------------------------------ccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCcccccccc
Q 008504 145 --------------------------------------SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQ 185 (563)
Q Consensus 145 --------------------------------------~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~~ 185 (563)
.++...++.+++||.+||. +|.+|||+.|+|+||||+....
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 342 (373)
T 1q8y_A 263 YLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLG 342 (373)
T ss_dssp HHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCTT
T ss_pred HHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhChhhhcccC
Confidence 0112234678999999998 8999999999999999986543
Q ss_pred C
Q 008504 186 K 186 (563)
Q Consensus 186 ~ 186 (563)
.
T Consensus 343 ~ 343 (373)
T 1q8y_A 343 M 343 (373)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=5.2e-31 Score=272.27 Aligned_cols=180 Identities=23% Similarity=0.368 Sum_probs=144.6
Q ss_pred CEeccCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~-~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
|||||+.+ +|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++.....
T Consensus 89 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~-~~~~~kl~Dfg~a~~~~~ 164 (346)
T 1ua2_A 89 LVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLD-ENGVLKLADFGLAKSFGS 164 (346)
T ss_dssp EEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTCCEEECCCGGGSTTTS
T ss_pred EEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCCHHHEEEc-CCCCEEEEecccceeccC
Confidence 58999986 899988765 46999999999999999999999999 99999999999998 557999999999976643
Q ss_pred C--CCccccCCCCccCcccccc--cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhc-CCC-CCc--------
Q 008504 80 P--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS-GIK-PAS-------- 145 (563)
Q Consensus 80 ~--~~~~~~Gtp~Y~APEvl~~--~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~-~~~-p~~-------- 145 (563)
. ......||+.|+|||++.+ .++.++|||||||++|+|++|..||........+...... +.. ...
T Consensus 165 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 244 (346)
T 1ua2_A 165 PNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP 244 (346)
T ss_dssp CCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSST
T ss_pred CcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCc
Confidence 2 2345678999999998854 4899999999999999999999999874433333322221 111 000
Q ss_pred ---------------cccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCccccccc
Q 008504 146 ---------------LAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 184 (563)
Q Consensus 146 ---------------l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~ 184 (563)
.....++.+++||.+||. +|.+|||+.|+|+||||+...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~ 299 (346)
T 1ua2_A 245 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP 299 (346)
T ss_dssp TCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred ccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCC
Confidence 113346789999999997 899999999999999998654
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.3e-31 Score=268.07 Aligned_cols=174 Identities=22% Similarity=0.404 Sum_probs=146.9
Q ss_pred CEecc-CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITEL-FTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy-~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
+|||| +.+|+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+||+++..++.+||+|||++.....
T Consensus 115 ~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~~~ 192 (312)
T 2iwi_A 115 LVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRG--VVHRDIKDENILIDLRRGCAKLIDFGSGALLHD 192 (312)
T ss_dssp EEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHT--EECCCCSGGGEEEETTTTEEEECCCSSCEECCS
T ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChhhEEEeCCCCeEEEEEcchhhhccc
Confidence 58898 789999999998888999999999999999999999999 999999999999985668999999999987766
Q ss_pred CCCccccCCCCccCccccccc-C-CchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHHH
Q 008504 80 PTARSVIGTPEFMAPELYEEE-Y-NELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 157 (563)
Q Consensus 80 ~~~~~~~Gtp~Y~APEvl~~~-y-s~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~L 157 (563)
.......|++.|+|||++.+. + +.++|||||||++|+|++|+.||... ..+. ... ..++...++.+++|
T Consensus 193 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~---~~~~----~~~--~~~~~~~~~~~~~l 263 (312)
T 2iwi_A 193 EPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD---QEIL----EAE--LHFPAHVSPDCCAL 263 (312)
T ss_dssp SCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH---HHHH----HTC--CCCCTTSCHHHHHH
T ss_pred CcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh---HHHh----hhc--cCCcccCCHHHHHH
Confidence 555667899999999988643 4 45899999999999999999999752 2221 111 22345678899999
Q ss_pred HHHhcC-CCCCCCCHHHHHcCcccccccc
Q 008504 158 IEKCLV-PASERLSAKDLLKDPFLQVENQ 185 (563)
Q Consensus 158 I~kcL~-dP~kRpSa~ELLkHpff~~~~~ 185 (563)
|.+||. +|.+|||+.++++||||+....
T Consensus 264 i~~~l~~~p~~Rps~~e~l~~~~~~~~~~ 292 (312)
T 2iwi_A 264 IRRCLAPKPSSRPSLEEILLDPWMQTPAE 292 (312)
T ss_dssp HHHHTCSSTTTSCCHHHHHHSTTTCC---
T ss_pred HHHHccCChhhCcCHHHHhcChhhcCchh
Confidence 999997 8999999999999999986544
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.9e-31 Score=266.31 Aligned_cols=179 Identities=25% Similarity=0.420 Sum_probs=144.1
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
+||||+. |+|.+++.+ +.+++..++.++.||+.||.|||++| |+||||||+|||++.+++.+||+|||++......
T Consensus 99 lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~ 174 (320)
T 2i6l_A 99 IVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPH 174 (320)
T ss_dssp EEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTTEEEECCCTTCBCC---
T ss_pred EEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCeEEEccCccccccCCC
Confidence 5899997 699999865 67999999999999999999999999 9999999999999866679999999999765321
Q ss_pred -----CCccccCCCCccCccccc--ccCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCC----------
Q 008504 81 -----TARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP---------- 143 (563)
Q Consensus 81 -----~~~~~~Gtp~Y~APEvl~--~~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p---------- 143 (563)
......+++.|+|||++. ..++.++|||||||++|+|++|+.||..... ......+......
T Consensus 175 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 253 (320)
T 2i6l_A 175 YSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHE-LEQMQLILESIPVVHEEDRQELL 253 (320)
T ss_dssp -----CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHSCCCCHHHHHHHH
T ss_pred cccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHhcCCCchhhhhhhh
Confidence 223456799999999875 4589999999999999999999999987443 3333332221110
Q ss_pred ------------------CccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCccccccc
Q 008504 144 ------------------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 184 (563)
Q Consensus 144 ------------------~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~ 184 (563)
.......++.+++||.+||. +|.+|||+.++|+||||+...
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 313 (320)
T 2i6l_A 254 SVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYS 313 (320)
T ss_dssp TTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTC
T ss_pred hcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCccccccc
Confidence 11223467899999999997 899999999999999998543
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=6.8e-31 Score=273.22 Aligned_cols=178 Identities=26% Similarity=0.414 Sum_probs=143.3
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
+||||+. |+|.+++.. +.+++..++.|+.||+.||.|||++| |+||||||+|||++ .++.+||+|||++......
T Consensus 107 iv~e~~~-~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~-~~~~~kl~Dfg~a~~~~~~ 181 (364)
T 3qyz_A 107 IVQDLME-TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLN-TTCDLKICDFGLARVADPD 181 (364)
T ss_dssp EEEECCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECCCTTCEECCGG
T ss_pred EEEcccC-cCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChHhEEEC-CCCCEEEEeCcceEecCCC
Confidence 5899997 599999977 46999999999999999999999999 99999999999998 5579999999999755422
Q ss_pred -----CCccccCCCCccCcccccc--cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhc-CCC----------
Q 008504 81 -----TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS-GIK---------- 142 (563)
Q Consensus 81 -----~~~~~~Gtp~Y~APEvl~~--~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~-~~~---------- 142 (563)
......||+.|+|||++.+ .++.++|||||||++|+|++|+.||........+...+.. +..
T Consensus 182 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 261 (364)
T 3qyz_A 182 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 261 (364)
T ss_dssp GCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCC
T ss_pred CCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 1234589999999997643 3899999999999999999999999875443333222210 000
Q ss_pred ------------C-----CccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCcccccc
Q 008504 143 ------------P-----ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 183 (563)
Q Consensus 143 ------------p-----~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~ 183 (563)
. .......++.+.+||.+||. +|.+|||+.|+|+||||+..
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 320 (364)
T 3qyz_A 262 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 320 (364)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTT
T ss_pred hhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhc
Confidence 0 01123457889999999998 89999999999999999864
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=3e-31 Score=278.19 Aligned_cols=178 Identities=29% Similarity=0.414 Sum_probs=130.3
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
+||||+ +++|.+++.. +.+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||+++.....
T Consensus 111 lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~-~~~~~kL~DFG~a~~~~~~ 185 (367)
T 2fst_X 111 LVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTADE 185 (367)
T ss_dssp EEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTCCEEECC----------
T ss_pred EEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHhhEEEC-CCCCEEEeecccccccccc
Confidence 588998 7899999876 67999999999999999999999999 99999999999998 5579999999999765432
Q ss_pred CCccccCCCCccCcccccc--cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhc-CCC---------------
Q 008504 81 TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS-GIK--------------- 142 (563)
Q Consensus 81 ~~~~~~Gtp~Y~APEvl~~--~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~-~~~--------------- 142 (563)
.....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.....++...+.. +.+
T Consensus 186 -~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~ 264 (367)
T 2fst_X 186 -MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 264 (367)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHH
T ss_pred -CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHH
Confidence 345688999999998864 5899999999999999999999999874433332222110 000
Q ss_pred ---------CC---ccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCccccccc
Q 008504 143 ---------PA---SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 184 (563)
Q Consensus 143 ---------p~---~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~ 184 (563)
.. ......++.+++||.+||. ||.+|||+.++|+||||+...
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~ 319 (367)
T 2fst_X 265 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 319 (367)
T ss_dssp HHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred HHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhcc
Confidence 00 0112346889999999998 899999999999999998643
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.8e-31 Score=277.91 Aligned_cols=182 Identities=26% Similarity=0.414 Sum_probs=134.8
Q ss_pred CEeccCCCCCHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEe---CCCCcEEE
Q 008504 1 MITELFTSGNLRQYRKKH---------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN---GNHGEVKI 68 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~---------~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd---~~~G~VKL 68 (563)
|||||+. |+|.+++... ..+++..++.|+.||+.||.|||++| |+||||||+||||. ...+.+||
T Consensus 97 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 97 LLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeCCCcCHHHeEEecCCCCCCcEEE
Confidence 5899997 5888887632 24999999999999999999999999 99999999999993 24579999
Q ss_pred ecccchhhccCC-----CCccccCCCCccCcccccc--cCCchhhHHHhHHHHHHHhhcCCCCCCCCC---------HHH
Q 008504 69 GDLGLAIAMQQP-----TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKN---------PAQ 132 (563)
Q Consensus 69 ~DFGlA~~~~~~-----~~~~~~Gtp~Y~APEvl~~--~ys~ksDIwSLGviLyELlTG~~Pf~~~~~---------~~~ 132 (563)
+|||++...... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|+.||..... ..+
T Consensus 174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 253 (405)
T 3rgf_A 174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ 253 (405)
T ss_dssp CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHH
T ss_pred EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHH
Confidence 999999765432 2335688999999998865 489999999999999999999999975332 122
Q ss_pred HHHHHhc-CCCCC-cc---------------------------------ccCCChhHHHHHHHhcC-CCCCCCCHHHHHc
Q 008504 133 IFKKVTS-GIKPA-SL---------------------------------AKVNDPQIKGFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 133 i~~~i~~-~~~p~-~l---------------------------------~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLk 176 (563)
+...+.. +..+. .+ ....++.+.+||.+||. ||.+|||+.|+|+
T Consensus 254 l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~ 333 (405)
T 3rgf_A 254 LDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 333 (405)
T ss_dssp HHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 2221111 11100 00 01126788999999998 8999999999999
Q ss_pred Ccccccccc
Q 008504 177 DPFLQVENQ 185 (563)
Q Consensus 177 Hpff~~~~~ 185 (563)
||||+....
T Consensus 334 hp~f~~~~~ 342 (405)
T 3rgf_A 334 DPYFLEDPL 342 (405)
T ss_dssp SGGGTSSSC
T ss_pred ChhhccCCC
Confidence 999986543
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-30 Score=257.66 Aligned_cols=175 Identities=28% Similarity=0.463 Sum_probs=139.8
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCC-CeEeccCccCceEEeC-------CCCcEEEeccc
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNP-PIIHRDLKCDNIFVNG-------NHGEVKIGDLG 72 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp-~IIHrDLKP~NILLd~-------~~G~VKL~DFG 72 (563)
+||||+++|+|.+++.. +.+++..++.++.||+.||.|||++|. +|+||||||+|||++. ..+.+||+|||
T Consensus 83 lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg 161 (271)
T 3dtc_A 83 LVMEFARGGPLNRVLSG-KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG 161 (271)
T ss_dssp EEEECCTTEEHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred EEEEcCCCCCHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence 58999999999999864 679999999999999999999999983 4889999999999974 25789999999
Q ss_pred chhhccCCCCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCC
Q 008504 73 LAIAMQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVND 151 (563)
Q Consensus 73 lA~~~~~~~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s 151 (563)
++............|++.|+|||++.+ .++.++||||||+++|+|++|+.||.... .......+.........+...+
T Consensus 162 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 240 (271)
T 3dtc_A 162 LAREWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGID-GLAVAYGVAMNKLALPIPSTCP 240 (271)
T ss_dssp C-------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSC-HHHHHHHHHTSCCCCCCCTTCC
T ss_pred cccccccccccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHhhhcCCCCCCCCcccC
Confidence 997766555556689999999998865 48999999999999999999999998743 4444444444444455667778
Q ss_pred hhHHHHHHHhcC-CCCCCCCHHHHHcC
Q 008504 152 PQIKGFIEKCLV-PASERLSAKDLLKD 177 (563)
Q Consensus 152 ~~l~~LI~kcL~-dP~kRpSa~ELLkH 177 (563)
+.+.+||.+||. +|.+|||+.++++|
T Consensus 241 ~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 241 EPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 999999999997 89999999999875
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.7e-31 Score=270.54 Aligned_cols=153 Identities=24% Similarity=0.416 Sum_probs=129.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCCC----CccccCCCCccCccc
Q 008504 21 VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT----ARSVIGTPEFMAPEL 96 (563)
Q Consensus 21 Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~~----~~~~~Gtp~Y~APEv 96 (563)
+++..++.|+.||+.||.|||++| |+||||||+|||++ ..+.+||+|||++....... .....||+.|+|||+
T Consensus 190 l~~~~~~~~~~ql~~aL~~LH~~~--ivH~Dikp~NIll~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~ 266 (359)
T 3vhe_A 190 LTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLS-EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPET 266 (359)
T ss_dssp BCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-GGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHH
T ss_pred cCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEc-CCCcEEEEeccceeeecccccchhccccCCCceeEChhh
Confidence 899999999999999999999999 99999999999998 45799999999997653321 234567889999998
Q ss_pred cc-ccCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHHHHHHhcC-CCCCCCCHHH
Q 008504 97 YE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKD 173 (563)
Q Consensus 97 l~-~~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~E 173 (563)
+. ..++.++|||||||++|+|+| |..||............+..+... ..+...++.+.++|.+||. +|.+|||+.+
T Consensus 267 ~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dP~~Rps~~e 345 (359)
T 3vhe_A 267 IFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM-RAPDYTTPEMYQTMLDCWHGEPSQRPTFSE 345 (359)
T ss_dssp HHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred hcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCC-CCCCCCCHHHHHHHHHHccCChhhCCCHHH
Confidence 86 458999999999999999998 999998866666666666655433 3456678899999999998 8999999999
Q ss_pred HHcC
Q 008504 174 LLKD 177 (563)
Q Consensus 174 LLkH 177 (563)
+++|
T Consensus 346 ll~~ 349 (359)
T 3vhe_A 346 LVEH 349 (359)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9986
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.5e-31 Score=268.66 Aligned_cols=176 Identities=21% Similarity=0.375 Sum_probs=141.3
Q ss_pred CEeccCCCCCHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEE----eCCCCcEEEecccc
Q 008504 1 MITELFTSGNLRQYRKKHKN---VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV----NGNHGEVKIGDLGL 73 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~---Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILL----d~~~G~VKL~DFGl 73 (563)
|||||+++|+|.+++..... +++..++.++.||+.||.|||++| |+||||||+|||+ + ..+.+||+|||+
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~-~~~~~kL~Dfg~ 162 (319)
T 4euu_A 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGED-GQSVYKLTDFGA 162 (319)
T ss_dssp EEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEECTT-SCEEEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEeccCC-CCceEEEccCCC
Confidence 58999999999999986443 999999999999999999999999 9999999999998 4 346799999999
Q ss_pred hhhccCC-CCccccCCCCccCccccc---------ccCCchhhHHHhHHHHHHHhhcCCCCCCCCC---HHHHHHHHhcC
Q 008504 74 AIAMQQP-TARSVIGTPEFMAPELYE---------EEYNELVDIYSFGMCILEMVTFEYPYSECKN---PAQIFKKVTSG 140 (563)
Q Consensus 74 A~~~~~~-~~~~~~Gtp~Y~APEvl~---------~~ys~ksDIwSLGviLyELlTG~~Pf~~~~~---~~~i~~~i~~~ 140 (563)
+...... ......||+.|+|||++. ..++.++|||||||++|+|++|+.||..... .......+..+
T Consensus 163 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (319)
T 4euu_A 163 ARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (319)
T ss_dssp CEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH
T ss_pred ceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC
Confidence 9766443 334567999999999874 4589999999999999999999999964332 23333333333
Q ss_pred CCCC-----------------------ccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCcc
Q 008504 141 IKPA-----------------------SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPF 179 (563)
Q Consensus 141 ~~p~-----------------------~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpf 179 (563)
.++. .+....++.+.+||.+||. ||.+|||+.|+|+||-
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (319)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence 2211 1112234578999999997 8999999999999984
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-30 Score=265.41 Aligned_cols=181 Identities=21% Similarity=0.367 Sum_probs=137.0
Q ss_pred CEeccCCCCCHHHHHHhCC------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccch
Q 008504 1 MITELFTSGNLRQYRKKHK------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA 74 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~------~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA 74 (563)
+||||+.+|+|.+++.... .+++..++.|+.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++
T Consensus 108 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--ivH~Dikp~NIli~-~~~~~kl~Dfg~a 184 (323)
T 3qup_A 108 VILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN--FIHRDLAARNCMLA-EDMTVCVADFGLS 184 (323)
T ss_dssp EEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-TTSCEEECCCCC-
T ss_pred EEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC--cccCCCCcceEEEc-CCCCEEEeecccc
Confidence 5899999999999997532 5999999999999999999999999 99999999999998 4579999999999
Q ss_pred hhccCCC----CccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCCCCcccc
Q 008504 75 IAMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAK 148 (563)
Q Consensus 75 ~~~~~~~----~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~ 148 (563)
....... .....+++.|+|||++.+ .++.++|||||||++|+|++ |..||... ....+...+..+..+ ..+.
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~ 262 (323)
T 3qup_A 185 RKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGI-ENAEIYNYLIGGNRL-KQPP 262 (323)
T ss_dssp ----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-CGGGHHHHHHTTCCC-CCCT
T ss_pred ccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCcccc-ChHHHHHHHhcCCCC-CCCC
Confidence 7654321 123356788999998865 48999999999999999999 89999874 444555555554433 2345
Q ss_pred CCChhHHHHHHHhcC-CCCCCCC-------HHHHHcCccccccccC
Q 008504 149 VNDPQIKGFIEKCLV-PASERLS-------AKDLLKDPFLQVENQK 186 (563)
Q Consensus 149 ~~s~~l~~LI~kcL~-dP~kRpS-------a~ELLkHpff~~~~~~ 186 (563)
..++.+++||.+||. +|.+||| +.+++.|||+......
T Consensus 263 ~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~ 308 (323)
T 3qup_A 263 ECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQD 308 (323)
T ss_dssp TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC---------
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCC
Confidence 667899999999997 8999999 7888899999865443
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-30 Score=271.65 Aligned_cols=172 Identities=28% Similarity=0.456 Sum_probs=144.9
Q ss_pred CEeccCCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCC
Q 008504 1 MITELFTSGNLRQYRKKHK----------------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHG 64 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~----------------~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G 64 (563)
|||||+.+|+|.+++...+ .+++..++.++.||+.||.|||++| |+||||||+|||++ .+|
T Consensus 164 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~-~~~ 240 (370)
T 2psq_A 164 VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVT-ENN 240 (370)
T ss_dssp EEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEC-TTC
T ss_pred EEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccchhhEEEC-CCC
Confidence 5899999999999998753 4899999999999999999999999 99999999999998 558
Q ss_pred cEEEecccchhhccCC----CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHh
Q 008504 65 EVKIGDLGLAIAMQQP----TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVT 138 (563)
Q Consensus 65 ~VKL~DFGlA~~~~~~----~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~ 138 (563)
.+||+|||++...... ......+++.|+|||++.+ .|+.++|||||||++|+|+| |..||.. .....+...+.
T Consensus 241 ~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~-~~~~~~~~~~~ 319 (370)
T 2psq_A 241 VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG-IPVEELFKLLK 319 (370)
T ss_dssp CEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-CCGGGHHHHHH
T ss_pred CEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHh
Confidence 9999999999755432 1223457889999998864 58999999999999999999 9999987 34555666666
Q ss_pred cCCCCCccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcC
Q 008504 139 SGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 177 (563)
Q Consensus 139 ~~~~p~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkH 177 (563)
.+..+ ..+...++.+.+||.+||. +|.+|||+.|++++
T Consensus 320 ~~~~~-~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 320 EGHRM-DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp TTCCC-CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCCC-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 65443 3455678899999999997 89999999999874
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=5.7e-31 Score=275.11 Aligned_cols=175 Identities=31% Similarity=0.446 Sum_probs=132.0
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
||||||.+ +|.+++. ..+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++......
T Consensus 107 lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIl~~-~~~~~kl~Dfg~a~~~~~~ 180 (371)
T 2xrw_A 107 IVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTS 180 (371)
T ss_dssp EEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTSCEEECCCCC-------
T ss_pred EEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEEc-CCCCEEEEEeecccccccc
Confidence 58999975 8988886 45999999999999999999999999 99999999999998 5579999999999765433
Q ss_pred -CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCc-------------
Q 008504 81 -TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPAS------------- 145 (563)
Q Consensus 81 -~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~------------- 145 (563)
......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.. ....+..+........
T Consensus 181 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 259 (371)
T 2xrw_A 181 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD-HIDQWNKVIEQLGTPCPEFMKKLQPTVRT 259 (371)
T ss_dssp ---------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHC-CCCCCHHHHTTSCHHHHH
T ss_pred cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHhCCCCHHHHHHhhhHHHH
Confidence 2345679999999998865 58999999999999999999999998744 3333333332211000
Q ss_pred ---------------------cc------cCCChhHHHHHHHhcC-CCCCCCCHHHHHcCccccc
Q 008504 146 ---------------------LA------KVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQV 182 (563)
Q Consensus 146 ---------------------l~------~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~ 182 (563)
.+ ...++.+++||.+||. ||.+|||+.|+|+||||+.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 324 (371)
T 2xrw_A 260 YVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 324 (371)
T ss_dssp HHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred HHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhh
Confidence 00 0014578999999998 8999999999999999974
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-30 Score=261.26 Aligned_cols=181 Identities=24% Similarity=0.491 Sum_probs=141.9
Q ss_pred CEeccCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeEeccCccCceEEeCCCCcEEEecccchhhcc
Q 008504 1 MITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSH-NPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k-~~~Lse~~i~~i~~QIL~aL~yLHs~-gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~ 78 (563)
|||||+ ++.+..++.. .+.+++..++.++.||+.||.|||++ | |+||||||+|||++ .++.+||+|||++....
T Consensus 101 lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dlkp~Nil~~-~~~~~kl~dfg~~~~~~ 176 (318)
T 2dyl_A 101 IAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLD-ERGQIKLCDFGISGRLV 176 (318)
T ss_dssp EEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHC--CCCCCCCGGGEEEC-TTSCEEECCCTTC----
T ss_pred EEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCC--EEeCCCCHHHEEEC-CCCCEEEEECCCchhcc
Confidence 589999 5677766654 56799999999999999999999995 9 99999999999998 55799999999996654
Q ss_pred CC-CCccccCCCCccCccccc------ccCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCc-cccCC
Q 008504 79 QP-TARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPAS-LAKVN 150 (563)
Q Consensus 79 ~~-~~~~~~Gtp~Y~APEvl~------~~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~-l~~~~ 150 (563)
.. ......|++.|+|||++. ..++.++|||||||++|+|++|+.||............+..+..+.. .....
T Consensus 177 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (318)
T 2dyl_A 177 DDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGF 256 (318)
T ss_dssp ----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSSCC
T ss_pred CCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccCCC
Confidence 32 233457899999999884 34889999999999999999999999876666666666655544322 22346
Q ss_pred ChhHHHHHHHhcC-CCCCCCCHHHHHcCcccccccc
Q 008504 151 DPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQ 185 (563)
Q Consensus 151 s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~~ 185 (563)
++.+.+||.+||. +|.+||++.++++||||+....
T Consensus 257 ~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~ 292 (318)
T 2dyl_A 257 SGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYET 292 (318)
T ss_dssp CHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHHH
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhccc
Confidence 8899999999997 8999999999999999986543
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.4e-30 Score=253.44 Aligned_cols=171 Identities=19% Similarity=0.347 Sum_probs=142.8
Q ss_pred CEeccCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhcc
Q 008504 1 MITELFTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~--~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~ 78 (563)
|||||+++|+|.+++...+ .+++..++.|+.||+.||.|||++|++|+||||||+||+++ .+|.++|+|||++....
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~-~~~~~~l~~~~~~~~~~ 164 (271)
T 3kmu_A 86 LITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMID-EDMTARISMADVKFSFQ 164 (271)
T ss_dssp EEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEEC-TTSCEEEEGGGSCCTTS
T ss_pred eeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEc-CCcceeEEeccceeeec
Confidence 5899999999999999765 48999999999999999999999998899999999999998 55799999988875432
Q ss_pred CCCCccccCCCCccCccccccc----CCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhH
Q 008504 79 QPTARSVIGTPEFMAPELYEEE----YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQI 154 (563)
Q Consensus 79 ~~~~~~~~Gtp~Y~APEvl~~~----ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l 154 (563)
. ....||+.|+|||++.+. ++.++|||||||++|+|++|+.||.... .......+.........+...++.+
T Consensus 165 ~---~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (271)
T 3kmu_A 165 S---PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLS-NMEIGMKVALEGLRPTIPPGISPHV 240 (271)
T ss_dssp C---TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSC-HHHHHHHHHHSCCCCCCCTTCCHHH
T ss_pred c---cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccC-hHHHHHHHHhcCCCCCCCCCCCHHH
Confidence 2 345789999999988643 3448999999999999999999998744 4444444444434445566788999
Q ss_pred HHHHHHhcC-CCCCCCCHHHHHc
Q 008504 155 KGFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 155 ~~LI~kcL~-dP~kRpSa~ELLk 176 (563)
.+||.+||. +|.+|||+.++++
T Consensus 241 ~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 241 SKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHcCCChhhCcCHHHHHH
Confidence 999999998 8999999999986
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.1e-30 Score=255.96 Aligned_cols=174 Identities=27% Similarity=0.477 Sum_probs=144.7
Q ss_pred CEeccCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCc-----EEEecccch
Q 008504 1 MITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGE-----VKIGDLGLA 74 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~-~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~-----VKL~DFGlA 74 (563)
|||||+++|+|.+++.+. ..+++..++.++.||+.||.|||++|++|+||||||+|||++.+ +. +||+|||++
T Consensus 98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~-~~~~~~~~kl~Dfg~~ 176 (287)
T 4f0f_A 98 MVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSL-DENAPVCAKVADFGLS 176 (287)
T ss_dssp EEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCC-CTTCSCCEEECCCTTC
T ss_pred EEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEecc-CCCCceeEEeCCCCcc
Confidence 589999999999988754 46999999999999999999999999889999999999999743 44 999999999
Q ss_pred hhccCCCCccccCCCCccCccccc---ccCCchhhHHHhHHHHHHHhhcCCCCCCCCCHH-HHHHHHhcCCCCCccccCC
Q 008504 75 IAMQQPTARSVIGTPEFMAPELYE---EEYNELVDIYSFGMCILEMVTFEYPYSECKNPA-QIFKKVTSGIKPASLAKVN 150 (563)
Q Consensus 75 ~~~~~~~~~~~~Gtp~Y~APEvl~---~~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~-~i~~~i~~~~~p~~l~~~~ 150 (563)
..... ......||+.|+|||++. ..++.++|||||||++|+|++|+.||....... .....+.........+...
T Consensus 177 ~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (287)
T 4f0f_A 177 QQSVH-SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPEDC 255 (287)
T ss_dssp BCCSS-CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCCCCCTTS
T ss_pred ccccc-cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCCCCCccc
Confidence 65433 234467899999999883 347899999999999999999999998644333 3344444444444566777
Q ss_pred ChhHHHHHHHhcC-CCCCCCCHHHHHc
Q 008504 151 DPQIKGFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 151 s~~l~~LI~kcL~-dP~kRpSa~ELLk 176 (563)
++.+++||.+||. +|.+|||+.++++
T Consensus 256 ~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 256 PPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 8999999999998 8999999999986
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-30 Score=262.27 Aligned_cols=179 Identities=25% Similarity=0.436 Sum_probs=142.5
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
|||||++||+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++......
T Consensus 88 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~ 164 (294)
T 4eqm_A 88 LVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMR--IVHRDIKPQNILID-SNKTLKIFDFGIAKALSET 164 (294)
T ss_dssp EEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTSCEEECCCSSSTTC---
T ss_pred EEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCCEEEEeCCCccccccc
Confidence 58999999999999999889999999999999999999999999 99999999999998 4579999999999765432
Q ss_pred ---CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCC--CccccCCChhH
Q 008504 81 ---TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP--ASLAKVNDPQI 154 (563)
Q Consensus 81 ---~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p--~~l~~~~s~~l 154 (563)
......||+.|+|||++.+ .++.++||||||+++|+|+||+.||..........+.+...... .......++.+
T Consensus 165 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 244 (294)
T 4eqm_A 165 SLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSL 244 (294)
T ss_dssp ----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHH
T ss_pred cccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHH
Confidence 2234579999999998865 48899999999999999999999998754444444444433322 12345567899
Q ss_pred HHHHHHhcC-CCCCCCCHHHHHcCccccc
Q 008504 155 KGFIEKCLV-PASERLSAKDLLKDPFLQV 182 (563)
Q Consensus 155 ~~LI~kcL~-dP~kRpSa~ELLkHpff~~ 182 (563)
.++|.+||. +|.+||+..+.+.+.|...
T Consensus 245 ~~li~~~l~~dp~~R~~~~~~l~~~l~~~ 273 (294)
T 4eqm_A 245 SNVILRATEKDKANRYKTIQEMKDDLSSV 273 (294)
T ss_dssp HHHHHHHSCSSGGGSCSSHHHHHHHHHTS
T ss_pred HHHHHHHhcCCHhHccccHHHHHHHHHHH
Confidence 999999997 8999997666666666543
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-30 Score=269.40 Aligned_cols=179 Identities=26% Similarity=0.386 Sum_probs=135.9
Q ss_pred CEeccCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~-~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
|||||+. |+|.+++... ..+++..++.|+.||+.||.|||++| |+||||||+|||++ ..+.+||+|||++.....
T Consensus 111 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~-~~~~~kl~Dfg~~~~~~~ 186 (362)
T 3pg1_A 111 LVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAG--VVHRDLHPGNILLA-DNNDITICDFNLAREDTA 186 (362)
T ss_dssp EEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTCCEEECCTTC------
T ss_pred EEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCc--CEecCCChHHEEEc-CCCCEEEEecCccccccc
Confidence 5899998 5888888754 46999999999999999999999999 99999999999997 557999999999975443
Q ss_pred C-CCccccCCCCccCcccccc--cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCC-------------
Q 008504 80 P-TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP------------- 143 (563)
Q Consensus 80 ~-~~~~~~Gtp~Y~APEvl~~--~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p------------- 143 (563)
. ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||............+.....+
T Consensus 187 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 266 (362)
T 3pg1_A 187 DANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSA 266 (362)
T ss_dssp ---------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHH
T ss_pred ccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHhhhccchhh
Confidence 2 2344578999999998864 58999999999999999999999998744333222221110000
Q ss_pred ----------------CccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCcccccc
Q 008504 144 ----------------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 183 (563)
Q Consensus 144 ----------------~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~ 183 (563)
.......++.+.+||.+||. +|.+|||+.++|+||||+..
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 323 (362)
T 3pg1_A 267 RDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESL 323 (362)
T ss_dssp HHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTT
T ss_pred hHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhc
Confidence 01123447789999999998 89999999999999999864
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-30 Score=270.38 Aligned_cols=177 Identities=29% Similarity=0.407 Sum_probs=139.2
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
+||||+. |+|.+++. ..+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++......
T Consensus 124 lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~-~~~~~kL~Dfg~a~~~~~~ 197 (371)
T 4exu_A 124 LVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVN-EDCELKILDFGLARHADAE 197 (371)
T ss_dssp EEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTCCEEECSTTCC------
T ss_pred EEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCcCHHHeEEC-CCCCEEEEecCcccccccC
Confidence 5899997 68988874 45999999999999999999999999 99999999999998 5579999999999765432
Q ss_pred CCccccCCCCccCcccccc--cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcC-CCC--------------
Q 008504 81 TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG-IKP-------------- 143 (563)
Q Consensus 81 ~~~~~~Gtp~Y~APEvl~~--~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~-~~p-------------- 143 (563)
.....||+.|+|||++.+ .++.++|||||||++|+|++|+.||........+...+... ..+
T Consensus 198 -~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 276 (371)
T 4exu_A 198 -MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKS 276 (371)
T ss_dssp ---CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHH
T ss_pred -cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhh
Confidence 345678999999998865 58999999999999999999999998744333332222111 000
Q ss_pred -------------CccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCccccccc
Q 008504 144 -------------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 184 (563)
Q Consensus 144 -------------~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~ 184 (563)
.......++.+++||.+||. +|.+|||+.|+|+||||+...
T Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 331 (371)
T 4exu_A 277 YIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR 331 (371)
T ss_dssp HHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred hhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCC
Confidence 01123457899999999998 899999999999999998543
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.97 E-value=4.1e-30 Score=256.91 Aligned_cols=173 Identities=21% Similarity=0.320 Sum_probs=139.5
Q ss_pred CEeccCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEe--CCCCcEEEecccchhhc
Q 008504 1 MITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN--GNHGEVKIGDLGLAIAM 77 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k-~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd--~~~G~VKL~DFGlA~~~ 77 (563)
|||||+ +|+|.+++.. .+.+++..++.++.||+.||.|||++| |+||||||+|||++ ...+.+||+|||++...
T Consensus 82 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 158 (296)
T 3uzp_A 82 MVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred EEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence 589999 8999999984 457999999999999999999999999 99999999999994 35679999999999765
Q ss_pred cCCC---------CccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCC--HHHHHHHHhcC---CC
Q 008504 78 QQPT---------ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKN--PAQIFKKVTSG---IK 142 (563)
Q Consensus 78 ~~~~---------~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~--~~~i~~~i~~~---~~ 142 (563)
.... .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||..... ....+..+... ..
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 3uzp_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred cccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc
Confidence 4332 235579999999998875 589999999999999999999999976322 11222222211 11
Q ss_pred CCccccCCChhHHHHHHHhcC-CCCCCCCHHHHHc
Q 008504 143 PASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 143 p~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLk 176 (563)
........++.+.+||.+||. +|.+|||+.++++
T Consensus 239 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 239 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 122335567899999999997 8999999999986
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.5e-31 Score=267.57 Aligned_cols=182 Identities=25% Similarity=0.488 Sum_probs=128.4
Q ss_pred CEeccCCCCCHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeEeccCccCceEEeCCCCcEEEecccch
Q 008504 1 MITELFTSGNLRQYRKK-----HKNVDIKVIKNWARQILHGLVYLHSH-NPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA 74 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k-----~~~Lse~~i~~i~~QIL~aL~yLHs~-gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA 74 (563)
|||||+.+ +|.+++.. ...+++..++.++.|++.||.|||++ | |+||||||+|||++ .++.+||+|||++
T Consensus 98 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~--ivH~dlkp~NIll~-~~~~~kl~Dfg~~ 173 (327)
T 3aln_A 98 ICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK--IIHRDIKPSNILLD-RSGNIKLCDFGIS 173 (327)
T ss_dssp EEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS--CCCSCCCGGGEEEE-TTTEEEECCCSSS
T ss_pred EEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC--EeECCCCHHHEEEc-CCCCEEEccCCCc
Confidence 58999985 88888763 56799999999999999999999999 9 99999999999998 5579999999999
Q ss_pred hhccCCC-CccccCCCCccCccccc-----ccCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCC---c
Q 008504 75 IAMQQPT-ARSVIGTPEFMAPELYE-----EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPA---S 145 (563)
Q Consensus 75 ~~~~~~~-~~~~~Gtp~Y~APEvl~-----~~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~---~ 145 (563)
....... .....|++.|+|||++. ..++.++|||||||++|+|++|+.||............+..+..+. .
T Consensus 174 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 253 (327)
T 3aln_A 174 GQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNS 253 (327)
T ss_dssp CC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCCCC
T ss_pred eecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCCc
Confidence 7654332 23347899999999883 3489999999999999999999999976433333333333332221 1
Q ss_pred cccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCccccccccC
Q 008504 146 LAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQK 186 (563)
Q Consensus 146 l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~~~ 186 (563)
.....++.+.+||.+||. +|.+|||+.++++||||......
T Consensus 254 ~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~~ 295 (327)
T 3aln_A 254 EEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEER 295 (327)
T ss_dssp SSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHHS
T ss_pred ccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhHhh
Confidence 223567899999999997 89999999999999999865543
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=3.6e-30 Score=263.96 Aligned_cols=175 Identities=24% Similarity=0.350 Sum_probs=146.7
Q ss_pred CEeccCCCCCHHHHHHhCC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCce
Q 008504 1 MITELFTSGNLRQYRKKHK-----------------------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 57 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~-----------------------~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NI 57 (563)
|||||+++|+|.+++...+ .+++..++.++.||+.||.|||++| |+||||||+||
T Consensus 126 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NI 203 (344)
T 1rjb_A 126 LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVHRDLAARNV 203 (344)
T ss_dssp EEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--EEETTCSGGGE
T ss_pred EEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChhhE
Confidence 5899999999999998653 3799999999999999999999999 99999999999
Q ss_pred EEeCCCCcEEEecccchhhccCCC----CccccCCCCccCccccc-ccCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHH
Q 008504 58 FVNGNHGEVKIGDLGLAIAMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPA 131 (563)
Q Consensus 58 LLd~~~G~VKL~DFGlA~~~~~~~----~~~~~Gtp~Y~APEvl~-~~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~ 131 (563)
|++ .++.+||+|||++....... .....||+.|+|||++. +.++.++|||||||++|+|+| |..||.......
T Consensus 204 ll~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~ 282 (344)
T 1rjb_A 204 LVT-HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA 282 (344)
T ss_dssp EEE-TTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH
T ss_pred EEc-CCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHH
Confidence 998 55799999999997654322 22345788999999885 458999999999999999998 999998866556
Q ss_pred HHHHHHhcCCCCCccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCcc
Q 008504 132 QIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPF 179 (563)
Q Consensus 132 ~i~~~i~~~~~p~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpf 179 (563)
.....+..+..+ ..+...++.+.+||.+||. +|.+|||+.++++|..
T Consensus 283 ~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~ 330 (344)
T 1rjb_A 283 NFYKLIQNGFKM-DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 330 (344)
T ss_dssp HHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHhcCCCC-CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence 666655555433 3455678899999999998 8999999999998754
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.6e-30 Score=258.55 Aligned_cols=173 Identities=15% Similarity=0.240 Sum_probs=140.1
Q ss_pred CEeccCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCC----CcEEEecccchh
Q 008504 1 MITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNH----GEVKIGDLGLAI 75 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~-~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~----G~VKL~DFGlA~ 75 (563)
|||||+ +|+|.+++...+ .+++..++.++.||+.||.|||++| |+||||||+|||++.+. +.+||+|||++.
T Consensus 83 lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~ 159 (298)
T 1csn_A 83 LVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159 (298)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred EEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence 589999 999999998754 5999999999999999999999999 99999999999997431 239999999997
Q ss_pred hccCCC---------CccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCC--CHHHHHHHHhcCC--
Q 008504 76 AMQQPT---------ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECK--NPAQIFKKVTSGI-- 141 (563)
Q Consensus 76 ~~~~~~---------~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~--~~~~i~~~i~~~~-- 141 (563)
...... .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.... .....+..+....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 239 (298)
T 1csn_A 160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 239 (298)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred ccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccC
Confidence 654321 234579999999998865 48999999999999999999999997632 3344444333221
Q ss_pred -CCCccccCCChhHHHHHHHhcC-CCCCCCCHHHHHc
Q 008504 142 -KPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 142 -~p~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLk 176 (563)
.........++.+++||.+||. +|.+||++.++++
T Consensus 240 ~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~ 276 (298)
T 1csn_A 240 TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 276 (298)
T ss_dssp SCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred ccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence 1222334567899999999996 8999999999986
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.3e-31 Score=266.16 Aligned_cols=171 Identities=29% Similarity=0.450 Sum_probs=138.3
Q ss_pred CEeccCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k-~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
|||||+.+|+|.+++.. .+.+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++.....
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~ 160 (310)
T 3s95_A 84 FITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN--IIHRDLNSHNCLVR-ENKNVVVADFGLARLMVD 160 (310)
T ss_dssp EEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEC-TTSCEEECCCTTCEECC-
T ss_pred EEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCcCeEEEC-CCCCEEEeecccceeccc
Confidence 58999999999999987 567999999999999999999999999 99999999999998 557999999999975533
Q ss_pred CCC----------------ccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHH-----HHHHH
Q 008504 80 PTA----------------RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQ-----IFKKV 137 (563)
Q Consensus 80 ~~~----------------~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~-----i~~~i 137 (563)
... ....||+.|+|||++.+ .++.++|||||||++|+|++|..||........ .....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~ 240 (310)
T 3s95_A 161 EKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFL 240 (310)
T ss_dssp -------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHH
T ss_pred ccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccc
Confidence 211 14579999999998875 489999999999999999999999865321110 00111
Q ss_pred hcCCCCCccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCcccc
Q 008504 138 TSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQ 181 (563)
Q Consensus 138 ~~~~~p~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~ 181 (563)
. ...+...++.+.+||.+||. +|.+|||+.++++ +++
T Consensus 241 ~-----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~--~L~ 278 (310)
T 3s95_A 241 D-----RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH--WLE 278 (310)
T ss_dssp H-----HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH--HHH
T ss_pred c-----ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH--HHH
Confidence 1 11234567789999999998 8999999999987 554
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.3e-30 Score=258.90 Aligned_cols=172 Identities=26% Similarity=0.426 Sum_probs=144.7
Q ss_pred CEeccCCCCCHHHHHHhCCC------------------------CCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCc
Q 008504 1 MITELFTSGNLRQYRKKHKN------------------------VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDN 56 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~------------------------Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~N 56 (563)
+||||+.+|+|.+++...+. +++..++.++.||+.||.|||++| |+||||||+|
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dikp~N 180 (314)
T 2ivs_A 103 LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK--LVHRDLAARN 180 (314)
T ss_dssp EEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGG
T ss_pred EEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC--Ccccccchhe
Confidence 58999999999999987543 899999999999999999999999 9999999999
Q ss_pred eEEeCCCCcEEEecccchhhccCCC----CccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhh-cCCCCCCCCCH
Q 008504 57 IFVNGNHGEVKIGDLGLAIAMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNP 130 (563)
Q Consensus 57 ILLd~~~G~VKL~DFGlA~~~~~~~----~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~ 130 (563)
||++ .++.+||+|||++....... .....+++.|+|||++.+ .++.++|||||||++|+|++ |..||.. ...
T Consensus 181 Ili~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~-~~~ 258 (314)
T 2ivs_A 181 ILVA-EGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG-IPP 258 (314)
T ss_dssp EEEE-TTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT-CCG
T ss_pred EEEc-CCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCC-CCH
Confidence 9998 55799999999997654321 223457788999998864 48999999999999999999 9999986 344
Q ss_pred HHHHHHHhcCCCCCccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcC
Q 008504 131 AQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 177 (563)
Q Consensus 131 ~~i~~~i~~~~~p~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkH 177 (563)
..+...+..+..+ ..+...++.+.+||.+||. +|.+|||+.+++++
T Consensus 259 ~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 259 ERLFNLLKTGHRM-ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp GGHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHhhcCCcC-CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 5555666555433 3455678899999999997 89999999999875
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5e-30 Score=254.07 Aligned_cols=172 Identities=19% Similarity=0.446 Sum_probs=145.7
Q ss_pred CEeccCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~-~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
+||||+++|+|.+++... +.+++..++.++.||+.||.|||++| |+||||||+||+++ .++.+||+|||++.....
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~-~~~~~kl~Dfg~~~~~~~ 158 (269)
T 4hcu_A 82 LVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVG-ENQVIKVSDFGMTRFVLD 158 (269)
T ss_dssp EEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-GGGCEEECCTTGGGGBCC
T ss_pred EEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCC--eecCCcchheEEEc-CCCCEEeccccccccccc
Confidence 589999999999999764 45999999999999999999999999 99999999999997 457999999999976543
Q ss_pred C---CCccccCCCCccCccccc-ccCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhH
Q 008504 80 P---TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQI 154 (563)
Q Consensus 80 ~---~~~~~~Gtp~Y~APEvl~-~~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l 154 (563)
. ......+++.|+|||++. ..++.++||||||+++|+|++ |..||.. .........+..+..+ ..+...++.+
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~ 236 (269)
T 4hcu_A 159 DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN-RSNSEVVEDISTGFRL-YKPRLASTHV 236 (269)
T ss_dssp HHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHHTTCCC-CCCTTSCHHH
T ss_pred cccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCC-CCHHHHHHHHhcCccC-CCCCcCCHHH
Confidence 2 223345678899999886 458999999999999999999 8999987 4556666666665433 3455668899
Q ss_pred HHHHHHhcC-CCCCCCCHHHHHcC
Q 008504 155 KGFIEKCLV-PASERLSAKDLLKD 177 (563)
Q Consensus 155 ~~LI~kcL~-dP~kRpSa~ELLkH 177 (563)
.+||.+||. +|.+|||+.++++|
T Consensus 237 ~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 237 YQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHccCCcccCcCHHHHHHH
Confidence 999999997 89999999999986
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.9e-30 Score=269.97 Aligned_cols=179 Identities=22% Similarity=0.385 Sum_probs=149.8
Q ss_pred CEeccCCCCCHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeC--CCCcEEEecc
Q 008504 1 MITELFTSGNLRQYRKKH-------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG--NHGEVKIGDL 71 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~-------~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~--~~G~VKL~DF 71 (563)
||||||.+|+|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||++. +...+||+||
T Consensus 151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~~~~kL~DF 228 (367)
T 3l9p_A 151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDF 228 (367)
T ss_dssp EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCEEECCC
T ss_pred EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEEecCCCCceEEECCC
Confidence 689999999999999864 35999999999999999999999999 999999999999973 2235999999
Q ss_pred cchhhccC----CCCccccCCCCccCccccc-ccCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCCCCc
Q 008504 72 GLAIAMQQ----PTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPAS 145 (563)
Q Consensus 72 GlA~~~~~----~~~~~~~Gtp~Y~APEvl~-~~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~ 145 (563)
|+++.... .......||+.|+|||++. ..++.++|||||||++|+|++ |..||.. .....+...+..+..+ .
T Consensus 229 G~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~-~~~~~~~~~i~~~~~~-~ 306 (367)
T 3l9p_A 229 GMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS-KSNQEVLEFVTSGGRM-D 306 (367)
T ss_dssp HHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-CCHHHHHHHHHTTCCC-C
T ss_pred ccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCC-C
Confidence 99975421 2233457899999999885 459999999999999999998 9999987 4566666777666543 2
Q ss_pred cccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCcccccc
Q 008504 146 LAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 183 (563)
Q Consensus 146 l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~ 183 (563)
.+...++.+.+||.+||. +|.+|||+.++++|.++...
T Consensus 307 ~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~ 345 (367)
T 3l9p_A 307 PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 345 (367)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence 355668899999999997 89999999999999887543
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=99.96 E-value=6.2e-30 Score=254.80 Aligned_cols=172 Identities=23% Similarity=0.429 Sum_probs=145.8
Q ss_pred CEeccCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k-~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
+||||+.+|+|.+++.. .+.+++..++.++.||+.||.|||++| |+||||||+||+++ .++.+||+|||++.....
T Consensus 96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nili~-~~~~~kl~Dfg~~~~~~~ 172 (283)
T 3gen_A 96 IITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVN-DQGVVKVSDFGLSRYVLD 172 (283)
T ss_dssp EEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEEC-TTSCEEECSTTGGGGBCC
T ss_pred EEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCccceEEEc-CCCCEEEccccccccccc
Confidence 58999999999999987 567999999999999999999999999 99999999999998 557999999999976543
Q ss_pred C---CCccccCCCCccCccccc-ccCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhH
Q 008504 80 P---TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQI 154 (563)
Q Consensus 80 ~---~~~~~~Gtp~Y~APEvl~-~~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l 154 (563)
. ......+++.|+|||++. ..++.++||||||+++|+|+| |+.||.. .........+..+... ..+...++.+
T Consensus 173 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~l 250 (283)
T 3gen_A 173 DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYER-FTNSETAEHIAQGLRL-YRPHLASEKV 250 (283)
T ss_dssp HHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTT-SCHHHHHHHHHTTCCC-CCCTTCCHHH
T ss_pred cccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccc-cChhHHHHHHhcccCC-CCCCcCCHHH
Confidence 2 122345678899999886 458999999999999999998 9999987 4455666666655433 3455668899
Q ss_pred HHHHHHhcC-CCCCCCCHHHHHcC
Q 008504 155 KGFIEKCLV-PASERLSAKDLLKD 177 (563)
Q Consensus 155 ~~LI~kcL~-dP~kRpSa~ELLkH 177 (563)
.+||.+||. +|.+|||+.++++|
T Consensus 251 ~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 251 YTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp HHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHccCChhHCcCHHHHHHH
Confidence 999999997 89999999999986
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=4.1e-30 Score=258.07 Aligned_cols=173 Identities=32% Similarity=0.535 Sum_probs=138.8
Q ss_pred CEeccCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k-~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
+||||+.+|+|.+++.. ...+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++.....
T Consensus 96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~Dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~ 172 (289)
T 3og7_A 96 IVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS--IIHRDLKSNNIFLH-EDNTVKIGDFGLATEKSR 172 (289)
T ss_dssp EEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEE-TTTEEEECCCC-------
T ss_pred EEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccccCccceEEEC-CCCCEEEccceecccccc
Confidence 58999999999999964 356999999999999999999999999 99999999999998 457999999999965432
Q ss_pred ----CCCccccCCCCccCccccc----ccCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCc---ccc
Q 008504 80 ----PTARSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPAS---LAK 148 (563)
Q Consensus 80 ----~~~~~~~Gtp~Y~APEvl~----~~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~---l~~ 148 (563)
.......||+.|+|||++. ..++.++|||||||++|+|++|+.||........+...+..+..... ...
T Consensus 173 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (289)
T 3og7_A 173 WSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRS 252 (289)
T ss_dssp -----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCT
T ss_pred ccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhccc
Confidence 1223457899999999884 34788999999999999999999999987777777777766654433 334
Q ss_pred CCChhHHHHHHHhcC-CCCCCCCHHHHHc
Q 008504 149 VNDPQIKGFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 149 ~~s~~l~~LI~kcL~-dP~kRpSa~ELLk 176 (563)
..++.+++||.+||. +|.+|||+.++++
T Consensus 253 ~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 253 NCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 567899999999997 8999999999986
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=5.8e-30 Score=264.47 Aligned_cols=177 Identities=29% Similarity=0.417 Sum_probs=138.6
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
+||||+. |+|.+++.. .+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++......
T Consensus 106 lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~NIl~~-~~~~~kl~Dfg~~~~~~~~ 179 (353)
T 3coi_A 106 LVMPFMQ-TDLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVN-EDCELKILDFGLARHADAE 179 (353)
T ss_dssp EEEECCS-EEGGGTTTS--CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEEC-TTCCEEECSTTCTTC----
T ss_pred EEecccc-CCHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEeEC-CCCcEEEeecccccCCCCC
Confidence 5899997 599888753 5999999999999999999999999 99999999999998 5579999999999765432
Q ss_pred CCccccCCCCccCcccccc--cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhc-CC----------------
Q 008504 81 TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS-GI---------------- 141 (563)
Q Consensus 81 ~~~~~~Gtp~Y~APEvl~~--~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~-~~---------------- 141 (563)
.....||+.|+|||++.+ .++.++|||||||++|+|++|+.||........+...+.. +.
T Consensus 180 -~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 258 (353)
T 3coi_A 180 -MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKS 258 (353)
T ss_dssp -----CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHH
T ss_pred -ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHH
Confidence 334578999999998864 5899999999999999999999999874433222221110 00
Q ss_pred -----------CCCccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCccccccc
Q 008504 142 -----------KPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 184 (563)
Q Consensus 142 -----------~p~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~ 184 (563)
.........++.+++||.+||. +|.+|||+.++|+||||+...
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~ 313 (353)
T 3coi_A 259 YIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR 313 (353)
T ss_dssp HHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred HHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhcc
Confidence 0011223457899999999997 899999999999999998543
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.6e-30 Score=263.36 Aligned_cols=172 Identities=27% Similarity=0.389 Sum_probs=137.7
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC----------CCCeEeccCccCceEEeCCCCcEEEec
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSH----------NPPIIHRDLKCDNIFVNGNHGEVKIGD 70 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~----------gp~IIHrDLKP~NILLd~~~G~VKL~D 70 (563)
||||||++|+|.++++.. .+++..++.++.||+.||.|||++ | |+||||||+|||++ ..+.+||+|
T Consensus 99 lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~--ivH~Dlkp~Nill~-~~~~~kL~D 174 (322)
T 3soc_A 99 LITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA--ISHRDIKSKNVLLK-NNLTACIAD 174 (322)
T ss_dssp EEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE--EECSCCSGGGEEEC-TTCCEEECC
T ss_pred EEEecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC--EEeCCCChHhEEEC-CCCeEEEcc
Confidence 589999999999999874 599999999999999999999999 8 99999999999998 557999999
Q ss_pred ccchhhccCCC----CccccCCCCccCcccccc------cCCchhhHHHhHHHHHHHhhcCCCCCCCC------------
Q 008504 71 LGLAIAMQQPT----ARSVIGTPEFMAPELYEE------EYNELVDIYSFGMCILEMVTFEYPYSECK------------ 128 (563)
Q Consensus 71 FGlA~~~~~~~----~~~~~Gtp~Y~APEvl~~------~ys~ksDIwSLGviLyELlTG~~Pf~~~~------------ 128 (563)
||+++...... .....||+.|+|||++.+ .++.++|||||||++|+|+||+.||....
T Consensus 175 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~ 254 (322)
T 3soc_A 175 FGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIG 254 (322)
T ss_dssp CTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHC
T ss_pred CCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhc
Confidence 99997654321 234579999999998864 46778999999999999999999996532
Q ss_pred ---CHHHHHHHHhcCCCCCccccCC-----ChhHHHHHHHhcC-CCCCCCCHHHHHc
Q 008504 129 ---NPAQIFKKVTSGIKPASLAKVN-----DPQIKGFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 129 ---~~~~i~~~i~~~~~p~~l~~~~-----s~~l~~LI~kcL~-dP~kRpSa~ELLk 176 (563)
....+...+........++... ++.+.+||.+||. +|.+|||+.++++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 255 QHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 2233333333333322222211 2459999999998 8999999999986
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=7.6e-30 Score=261.95 Aligned_cols=171 Identities=20% Similarity=0.384 Sum_probs=142.6
Q ss_pred CEeccCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~-~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
|||||+++|+|.+++... +.+++..++.|+.||+.||.|||++| |+||||||+|||++ .++.+||+|||++.....
T Consensus 127 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~-~~~~~kl~Dfg~a~~~~~ 203 (325)
T 3kul_A 127 IVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG--YVHRDLAARNVLVD-SNLVCKVSDFGLSRVLED 203 (325)
T ss_dssp EEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTCCEEECCCSSCEECC-
T ss_pred EEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEEC-CCCCEEECCCCccccccc
Confidence 689999999999999764 57999999999999999999999999 99999999999998 557999999999976543
Q ss_pred CC-----CccccCCCCccCccccc-ccCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCCCCccccCCCh
Q 008504 80 PT-----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDP 152 (563)
Q Consensus 80 ~~-----~~~~~Gtp~Y~APEvl~-~~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~ 152 (563)
.. .....+|+.|+|||++. ..++.++|||||||++|+|++ |..||.. .....+...+..+... ..+...++
T Consensus 204 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~ 281 (325)
T 3kul_A 204 DPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWN-MTNRDVISSVEEGYRL-PAPMGCPH 281 (325)
T ss_dssp ---CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT-SCHHHHHHHHHTTCCC-CCCTTCCH
T ss_pred CccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCccc-CCHHHHHHHHHcCCCC-CCCCCcCH
Confidence 21 12234577899999886 458999999999999999999 9999987 4555666666665433 24556788
Q ss_pred hHHHHHHHhcC-CCCCCCCHHHHHc
Q 008504 153 QIKGFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 153 ~l~~LI~kcL~-dP~kRpSa~ELLk 176 (563)
.+.+||.+||. +|.+|||+.++++
T Consensus 282 ~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 282 ALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHccCChhhCcCHHHHHH
Confidence 99999999997 8999999999986
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.7e-30 Score=256.98 Aligned_cols=172 Identities=27% Similarity=0.501 Sum_probs=134.5
Q ss_pred CEeccCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~-~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
+||||+.+|+|.+++...+ .+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++.....
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~ 168 (281)
T 1mp8_A 92 IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVS-SNDCVKLGDFGLSRYMED 168 (281)
T ss_dssp EEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEE-ETTEEEECC---------
T ss_pred EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHEEEC-CCCCEEECccccccccCc
Confidence 5899999999999998654 6999999999999999999999999 99999999999998 457999999999976543
Q ss_pred CC---CccccCCCCccCccccc-ccCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhH
Q 008504 80 PT---ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQI 154 (563)
Q Consensus 80 ~~---~~~~~Gtp~Y~APEvl~-~~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l 154 (563)
.. .....+++.|+|||++. ..++.++|||||||++|+|++ |..||.... .......+..+..+ ..+...++.+
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~-~~~~~~~i~~~~~~-~~~~~~~~~l 246 (281)
T 1mp8_A 169 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK-NNDVIGRIENGERL-PMPPNCPPTL 246 (281)
T ss_dssp ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCC-GGGHHHHHHTTCCC-CCCTTCCHHH
T ss_pred ccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCC-HHHHHHHHHcCCCC-CCCCCCCHHH
Confidence 22 22335678999999886 458999999999999999997 899998743 34445555554433 3455678899
Q ss_pred HHHHHHhcC-CCCCCCCHHHHHcC
Q 008504 155 KGFIEKCLV-PASERLSAKDLLKD 177 (563)
Q Consensus 155 ~~LI~kcL~-dP~kRpSa~ELLkH 177 (563)
.+||.+||. +|.+|||+.+++++
T Consensus 247 ~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 247 YSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHccCChhhCcCHHHHHHH
Confidence 999999997 89999999999874
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=6.5e-30 Score=252.71 Aligned_cols=172 Identities=23% Similarity=0.417 Sum_probs=143.9
Q ss_pred CEeccCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~-~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
+||||+++|+|.+++...+ .+++..++.++.||+.||.|||++| |+||||||+||+++ .++.+||+|||++.....
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~~-~~~~~~l~Dfg~~~~~~~ 156 (268)
T 3sxs_A 80 IVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ--FIHRDLAARNCLVD-RDLCVKVSDFGMTRYVLD 156 (268)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCSGGGEEEC-TTCCEEECCTTCEEECCT
T ss_pred EEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCcceEEEC-CCCCEEEccCccceecch
Confidence 5899999999999998754 5999999999999999999999999 99999999999998 557999999999976544
Q ss_pred CCC---ccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhH
Q 008504 80 PTA---RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQI 154 (563)
Q Consensus 80 ~~~---~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l 154 (563)
... ....+++.|+|||++.+ .++.++||||||+++|+|++ |..||... ........+..+... ..+...++.+
T Consensus 157 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~l 234 (268)
T 3sxs_A 157 DQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLY-TNSEVVLKVSQGHRL-YRPHLASDTI 234 (268)
T ss_dssp TCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTS-CHHHHHHHHHTTCCC-CCCTTSCHHH
T ss_pred hhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCcccc-ChHHHHHHHHcCCCC-CCCCcChHHH
Confidence 322 22345678999998865 58999999999999999999 99999874 445555555554432 3355568899
Q ss_pred HHHHHHhcC-CCCCCCCHHHHHcC
Q 008504 155 KGFIEKCLV-PASERLSAKDLLKD 177 (563)
Q Consensus 155 ~~LI~kcL~-dP~kRpSa~ELLkH 177 (563)
.+||.+||. +|.+|||+.+++++
T Consensus 235 ~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 235 YQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp HHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999998 89999999999986
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=8.1e-30 Score=267.39 Aligned_cols=172 Identities=28% Similarity=0.452 Sum_probs=146.8
Q ss_pred CEeccCCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCC
Q 008504 1 MITELFTSGNLRQYRKKHK----------------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHG 64 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~----------------~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G 64 (563)
|||||+.+|+|.+++...+ .+++..++.|+.||+.||.|||++| |+||||||+|||++ ..+
T Consensus 152 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~-~~~ 228 (382)
T 3tt0_A 152 VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVT-EDN 228 (382)
T ss_dssp EEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTC
T ss_pred EEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCcceEEEc-CCC
Confidence 6899999999999998754 4999999999999999999999999 99999999999998 457
Q ss_pred cEEEecccchhhccCC----CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHh
Q 008504 65 EVKIGDLGLAIAMQQP----TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVT 138 (563)
Q Consensus 65 ~VKL~DFGlA~~~~~~----~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~ 138 (563)
.+||+|||++...... ......+|+.|+|||++.+ .++.++|||||||++|+|++ |..||.. .....+...+.
T Consensus 229 ~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~-~~~~~~~~~~~ 307 (382)
T 3tt0_A 229 VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG-VPVEELFKLLK 307 (382)
T ss_dssp CEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-CCHHHHHHHHH
T ss_pred cEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHH
Confidence 9999999999765432 2233456789999998865 48999999999999999999 9999987 45666777776
Q ss_pred cCCCCCccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcC
Q 008504 139 SGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 177 (563)
Q Consensus 139 ~~~~p~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkH 177 (563)
.+..+. .+...++.+.+||.+||. +|.+|||+.+++++
T Consensus 308 ~~~~~~-~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 308 EGHRMD-KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp TTCCCC-CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCCCC-CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 665433 455678899999999997 89999999999985
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.96 E-value=8.5e-30 Score=254.20 Aligned_cols=173 Identities=21% Similarity=0.321 Sum_probs=138.8
Q ss_pred CEeccCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEe--CCCCcEEEecccchhhc
Q 008504 1 MITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN--GNHGEVKIGDLGLAIAM 77 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k-~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd--~~~G~VKL~DFGlA~~~ 77 (563)
|||||+ +|+|.+++.. .+.+++..++.++.||+.||.|||++| |+||||||+|||++ ...+.+||+|||++...
T Consensus 82 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 82 MVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp EEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred EEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 589999 9999999985 467999999999999999999999999 99999999999993 25679999999999765
Q ss_pred cCCC---------CccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCH--HHHHHHHhcC---CC
Q 008504 78 QQPT---------ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNP--AQIFKKVTSG---IK 142 (563)
Q Consensus 78 ~~~~---------~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~--~~i~~~i~~~---~~ 142 (563)
.... .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||...... ...+..+... ..
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch
Confidence 4321 234578999999998865 5899999999999999999999999763321 1122222111 11
Q ss_pred CCccccCCChhHHHHHHHhcC-CCCCCCCHHHHHc
Q 008504 143 PASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 143 p~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLk 176 (563)
........++.+.+||.+||. +|.+|||+.++++
T Consensus 239 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 239 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred hhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 112234567899999999997 8999999999987
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.6e-30 Score=263.44 Aligned_cols=172 Identities=22% Similarity=0.434 Sum_probs=142.7
Q ss_pred CEeccCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~-~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
+||||+.+|+|.+++... +.+++..++.|+.||+.||.|||++| |+||||||+|||++ ..|.+||+|||+++....
T Consensus 91 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~-~~~~~kl~Dfg~a~~~~~ 167 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG--MVHRNLAARNVLLK-SPSQVQVADFGVADLLPP 167 (325)
T ss_dssp EEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTT--CCCSCCSSTTEEES-SSSCEEECSCSGGGGSCC
T ss_pred EEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCC--CCCCccchheEEEC-CCCeEEECCCCcccccCc
Confidence 589999999999999875 57999999999999999999999999 99999999999997 557999999999987643
Q ss_pred CC----CccccCCCCccCccccc-ccCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCCCCccccCCChh
Q 008504 80 PT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQ 153 (563)
Q Consensus 80 ~~----~~~~~Gtp~Y~APEvl~-~~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~ 153 (563)
.. .....+++.|+|||++. +.++.++|||||||++|+|+| |..||... ........+..+... ..+...++.
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~ 245 (325)
T 3kex_A 168 DDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGL-RLAEVPDLLEKGERL-AQPQICTID 245 (325)
T ss_dssp CTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS-CTTHHHHHHHTTCBC-CCCTTBCTT
T ss_pred ccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCcccc-CHHHHHHHHHcCCCC-CCCCcCcHH
Confidence 22 23446788999999886 458999999999999999999 99999874 344455555554332 334556778
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHHcC
Q 008504 154 IKGFIEKCLV-PASERLSAKDLLKD 177 (563)
Q Consensus 154 l~~LI~kcL~-dP~kRpSa~ELLkH 177 (563)
+.+||.+||. +|.+|||+.++++|
T Consensus 246 ~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 246 VYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp TTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999999997 89999999999987
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=7e-30 Score=260.91 Aligned_cols=172 Identities=20% Similarity=0.323 Sum_probs=144.4
Q ss_pred CEeccCCCCCHHHHHHhC------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCc
Q 008504 1 MITELFTSGNLRQYRKKH------------------------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDN 56 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~------------------------~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~N 56 (563)
|||||+++|+|.+++... +.+++..++.++.||+.||.|||++| |+||||||+|
T Consensus 127 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~N 204 (343)
T 1luf_A 127 LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHRDLATRN 204 (343)
T ss_dssp EEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGG
T ss_pred EEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcce
Confidence 589999999999999874 56999999999999999999999999 9999999999
Q ss_pred eEEeCCCCcEEEecccchhhccCC----CCccccCCCCccCccccc-ccCCchhhHHHhHHHHHHHhh-cCCCCCCCCCH
Q 008504 57 IFVNGNHGEVKIGDLGLAIAMQQP----TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNP 130 (563)
Q Consensus 57 ILLd~~~G~VKL~DFGlA~~~~~~----~~~~~~Gtp~Y~APEvl~-~~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~ 130 (563)
||++ .++.+||+|||++...... ......+++.|+|||++. ..++.++|||||||++|+|++ |..||.. ...
T Consensus 205 Il~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~-~~~ 282 (343)
T 1luf_A 205 CLVG-ENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG-MAH 282 (343)
T ss_dssp EEEC-GGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT-SCH
T ss_pred EEEC-CCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCC-CCh
Confidence 9998 4579999999999765322 223446788999999886 458999999999999999999 9999987 455
Q ss_pred HHHHHHHhcCCCCCccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcC
Q 008504 131 AQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 177 (563)
Q Consensus 131 ~~i~~~i~~~~~p~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkH 177 (563)
..+...+..+..+ ..+...++.+.+||.+||. +|.+|||+.+++++
T Consensus 283 ~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 329 (343)
T 1luf_A 283 EEVIYYVRDGNIL-ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329 (343)
T ss_dssp HHHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHhCCCcC-CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 6666666665443 3455678899999999997 89999999999863
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=3.8e-30 Score=259.51 Aligned_cols=173 Identities=25% Similarity=0.444 Sum_probs=146.7
Q ss_pred CEeccCCCCCHHHHHHhCCC----------------CCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCC
Q 008504 1 MITELFTSGNLRQYRKKHKN----------------VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHG 64 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~----------------Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G 64 (563)
+||||+++|+|.+++...+. +++..++.++.||+.||.|||++| |+||||||+|||++ ..+
T Consensus 109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dikp~Nil~~-~~~ 185 (316)
T 2xir_A 109 VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLS-EKN 185 (316)
T ss_dssp EEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-GGG
T ss_pred EEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC--cccccCccceEEEC-CCC
Confidence 58999999999999987654 899999999999999999999999 99999999999997 457
Q ss_pred cEEEecccchhhccCCC----CccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHh
Q 008504 65 EVKIGDLGLAIAMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVT 138 (563)
Q Consensus 65 ~VKL~DFGlA~~~~~~~----~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~ 138 (563)
.+||+|||++....... .....||+.|+|||++.+ .++.++|||||||++|+|+| |..||............+.
T Consensus 186 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~ 265 (316)
T 2xir_A 186 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 265 (316)
T ss_dssp CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHH
T ss_pred CEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHHHhc
Confidence 99999999997654322 223467889999998864 58999999999999999998 9999987665666666666
Q ss_pred cCCCCCccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcC
Q 008504 139 SGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 177 (563)
Q Consensus 139 ~~~~p~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkH 177 (563)
.+... ..+...++.+.++|.+||. +|.+|||+.++++|
T Consensus 266 ~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 266 EGTRM-RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp HTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCccC-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 55433 3455678899999999998 89999999999986
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.7e-30 Score=257.09 Aligned_cols=172 Identities=30% Similarity=0.470 Sum_probs=135.9
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCeEeccCccCceEEeCCCCcEEEeccc
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLH--------SHNPPIIHRDLKCDNIFVNGNHGEVKIGDLG 72 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLH--------s~gp~IIHrDLKP~NILLd~~~G~VKL~DFG 72 (563)
|||||+++|+|.++++. ..+++..++.++.||+.||.||| ++| |+||||||+|||++ .++.+||+|||
T Consensus 83 lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dlkp~Nill~-~~~~~kl~Dfg 158 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA--IAHRDLKSKNILVK-KNGQCCIADLG 158 (301)
T ss_dssp EEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE--EECSCCCGGGEEEC-TTSCEEECCCT
T ss_pred EehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC--eecCCCChHhEEEc-CCCCEEEeeCC
Confidence 58999999999999965 57999999999999999999999 888 99999999999998 55799999999
Q ss_pred chhhccCCC------CccccCCCCccCcccccc-------cCCchhhHHHhHHHHHHHhhc----------CCCCCCCC-
Q 008504 73 LAIAMQQPT------ARSVIGTPEFMAPELYEE-------EYNELVDIYSFGMCILEMVTF----------EYPYSECK- 128 (563)
Q Consensus 73 lA~~~~~~~------~~~~~Gtp~Y~APEvl~~-------~ys~ksDIwSLGviLyELlTG----------~~Pf~~~~- 128 (563)
++....... .....||+.|+|||++.+ .++.++|||||||++|+|+|| ..||....
T Consensus 159 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~ 238 (301)
T 3q4u_A 159 LAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVP 238 (301)
T ss_dssp TCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred CeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCC
Confidence 996554322 233479999999998864 345799999999999999999 88886522
Q ss_pred ---CHHHHHHHHhcCCCCCccc-----cCCChhHHHHHHHhcC-CCCCCCCHHHHHc
Q 008504 129 ---NPAQIFKKVTSGIKPASLA-----KVNDPQIKGFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 129 ---~~~~i~~~i~~~~~p~~l~-----~~~s~~l~~LI~kcL~-dP~kRpSa~ELLk 176 (563)
........+.........+ ...++.+.+||.+||. +|.+|||+.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 239 NDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred CCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 2223333332222222222 1234679999999997 8999999999986
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=7.7e-30 Score=256.94 Aligned_cols=173 Identities=23% Similarity=0.411 Sum_probs=145.5
Q ss_pred CEeccCCCCCHHHHHHhCC------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCC
Q 008504 1 MITELFTSGNLRQYRKKHK------------------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGN 62 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~------------------~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~ 62 (563)
+||||+++|+|.+++...+ .+++..++.++.||+.||.|||++| |+||||||+|||++ .
T Consensus 104 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~-~ 180 (313)
T 1t46_A 104 VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNILLT-H 180 (313)
T ss_dssp EEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEE-T
T ss_pred EEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCccceEEEc-C
Confidence 5899999999999998754 4899999999999999999999999 99999999999998 5
Q ss_pred CCcEEEecccchhhccCCC----CccccCCCCccCccccc-ccCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHH
Q 008504 63 HGEVKIGDLGLAIAMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKK 136 (563)
Q Consensus 63 ~G~VKL~DFGlA~~~~~~~----~~~~~Gtp~Y~APEvl~-~~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~ 136 (563)
++.+||+|||++....... .....+++.|+|||++. ..++.++|||||||++|+|+| |..||............
T Consensus 181 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~ 260 (313)
T 1t46_A 181 GRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM 260 (313)
T ss_dssp TTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHH
T ss_pred CCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHHH
Confidence 5799999999997664432 22345678899999875 458999999999999999999 99999876655555555
Q ss_pred HhcCCCCCccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcC
Q 008504 137 VTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 177 (563)
Q Consensus 137 i~~~~~p~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkH 177 (563)
+..+..+ ..+...++.+++||.+||. +|.+|||+.+++++
T Consensus 261 ~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 261 IKEGFRM-LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp HHHTCCC-CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hccCCCC-CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 5555433 2345668899999999997 89999999999974
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=6.6e-30 Score=260.77 Aligned_cols=179 Identities=27% Similarity=0.399 Sum_probs=136.1
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---------CCCeEeccCccCceEEeCCCCcEEEecc
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSH---------NPPIIHRDLKCDNIFVNGNHGEVKIGDL 71 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~---------gp~IIHrDLKP~NILLd~~~G~VKL~DF 71 (563)
||||||++|+|.+++... ..++..++.++.||+.||.|||++ | |+||||||+|||++ ..|.+||+||
T Consensus 89 lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~--ivH~Dikp~Nill~-~~~~~kL~DF 164 (336)
T 3g2f_A 89 LVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA--ISHRDLNSRNVLVK-NDGTCVISDF 164 (336)
T ss_dssp EEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC--EECSSCSGGGEEEC-TTSCEEECCC
T ss_pred EEEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccc--eeecccccceEEEc-CCCcEEEeec
Confidence 589999999999999875 469999999999999999999999 8 99999999999998 5579999999
Q ss_pred cchhhccCC----------CCccccCCCCccCcccccc--------cCCchhhHHHhHHHHHHHhhcCCCCCCCCC----
Q 008504 72 GLAIAMQQP----------TARSVIGTPEFMAPELYEE--------EYNELVDIYSFGMCILEMVTFEYPYSECKN---- 129 (563)
Q Consensus 72 GlA~~~~~~----------~~~~~~Gtp~Y~APEvl~~--------~ys~ksDIwSLGviLyELlTG~~Pf~~~~~---- 129 (563)
|++...... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.....
T Consensus 165 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~ 244 (336)
T 3g2f_A 165 GLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEY 244 (336)
T ss_dssp TTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCC
T ss_pred cceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHH
Confidence 999755321 1224579999999998864 467899999999999999999777643211
Q ss_pred -------------HHHHHHHHhcCCCCCccccCC------ChhHHHHHHHhcC-CCCCCCCHHHHHc------Ccccccc
Q 008504 130 -------------PAQIFKKVTSGIKPASLAKVN------DPQIKGFIEKCLV-PASERLSAKDLLK------DPFLQVE 183 (563)
Q Consensus 130 -------------~~~i~~~i~~~~~p~~l~~~~------s~~l~~LI~kcL~-dP~kRpSa~ELLk------Hpff~~~ 183 (563)
.......+........++... ++.+++||.+||. +|.+|||+.|+++ ++|-++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~~~ 324 (336)
T 3g2f_A 245 QMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNK 324 (336)
T ss_dssp CCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC--
T ss_pred HHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHhcc
Confidence 112222222222222223222 2479999999998 8999999999954 5666543
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=99.96 E-value=3.7e-30 Score=267.64 Aligned_cols=173 Identities=22% Similarity=0.322 Sum_probs=137.9
Q ss_pred CEeccCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeC-CCCcEEEecccchhhcc
Q 008504 1 MITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG-NHGEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~-~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~-~~G~VKL~DFGlA~~~~ 78 (563)
|||||| ||+|.+++... +.+++..++.|+.||+.||.|||++| |+||||||+|||++. ..+.+||+|||+++.+.
T Consensus 129 lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~--iiHrDlkp~Nill~~~~~~~~kl~DFG~a~~~~ 205 (364)
T 3op5_A 129 MIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHE--YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYC 205 (364)
T ss_dssp EEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEESSCTTCEEECCCTTCEESS
T ss_pred EEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eEEecCCHHHEEEecCCCCeEEEEECCcceecc
Confidence 689999 99999999876 67999999999999999999999999 999999999999972 34799999999996543
Q ss_pred CC---------CCccccCCCCccCccccccc-CCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCC---C--
Q 008504 79 QP---------TARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK---P-- 143 (563)
Q Consensus 79 ~~---------~~~~~~Gtp~Y~APEvl~~~-ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~---p-- 143 (563)
.. ......||+.|+|||++.+. ++.++|||||||++|+|+||+.||.................. +
T Consensus 206 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 285 (364)
T 3op5_A 206 PEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYRENIASL 285 (364)
T ss_dssp GGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHCHHHH
T ss_pred cCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHHHHHHHHhhhhHHHH
Confidence 21 11344699999999988754 899999999999999999999999853332222211111100 0
Q ss_pred ---CccccCCChhHHHHHHHhcC-CCCCCCCHHHHHc
Q 008504 144 ---ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 144 ---~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLk 176 (563)
.......++.+.+||..||. +|.+||++.+|++
T Consensus 286 ~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 286 MDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 00114557899999999997 8999999999986
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-29 Score=257.42 Aligned_cols=173 Identities=29% Similarity=0.514 Sum_probs=136.5
Q ss_pred CEeccCCCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHh---CCCCeEeccCccCceEEeCCCCcEEEecccch
Q 008504 1 MITELFTSGNLRQYRKKHK---NVDIKVIKNWARQILHGLVYLHS---HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA 74 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~---~Lse~~i~~i~~QIL~aL~yLHs---~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA 74 (563)
|||||+++|+|.+++...+ .++...++.|+.||+.||.|||+ +| |+||||||+|||++.+...+||+|||++
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~--ivH~dlkp~NIll~~~~~~~kl~Dfg~~ 153 (307)
T 2eva_A 76 LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA--LIHRDLKPPNLLLVAGGTVLKICDFGTA 153 (307)
T ss_dssp EEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSC--CCCCCCSGGGEEEETTTTEEEECCCCC-
T ss_pred EEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCC--eecCCCChhHEEEeCCCCEEEEcccccc
Confidence 5899999999999998765 37899999999999999999999 77 9999999999999855334899999999
Q ss_pred hhccCCCCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCH-HHHHHHHhcCCCCCccccCCCh
Q 008504 75 IAMQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNP-AQIFKKVTSGIKPASLAKVNDP 152 (563)
Q Consensus 75 ~~~~~~~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~-~~i~~~i~~~~~p~~l~~~~s~ 152 (563)
...... .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||...... ..+...+..+..+ ......++
T Consensus 154 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 231 (307)
T 2eva_A 154 CDIQTH-MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRP-PLIKNLPK 231 (307)
T ss_dssp ------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCC-CCBTTCCH
T ss_pred cccccc-cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCC-CcccccCH
Confidence 755432 234468999999998865 5899999999999999999999999764333 3344444444433 34456788
Q ss_pred hHHHHHHHhcC-CCCCCCCHHHHHcC
Q 008504 153 QIKGFIEKCLV-PASERLSAKDLLKD 177 (563)
Q Consensus 153 ~l~~LI~kcL~-dP~kRpSa~ELLkH 177 (563)
.+++||.+||. +|.+|||+.+++++
T Consensus 232 ~l~~li~~~l~~dp~~Rps~~ell~~ 257 (307)
T 2eva_A 232 PIESLMTRCWSKDPSQRPSMEEIVKI 257 (307)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 99999999997 89999999999983
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=8.6e-30 Score=261.14 Aligned_cols=172 Identities=27% Similarity=0.460 Sum_probs=143.3
Q ss_pred CEeccCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~-~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
+|+||+.+|+|.+++... +.+++..++.|+.||+.||.|||++| |+||||||+|||++ .++.+||+|||+++....
T Consensus 93 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIll~-~~~~~kl~Dfg~a~~~~~ 169 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVK-TPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp EEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEE-ETTEEEECCTTHHHHHTT
T ss_pred EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCChheEEEC-CCCCEEEccCcceeEccC
Confidence 589999999999999874 56999999999999999999999999 99999999999998 457999999999976643
Q ss_pred CC----CccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCCCCccccCCChh
Q 008504 80 PT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQ 153 (563)
Q Consensus 80 ~~----~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~ 153 (563)
.. .....+|+.|+|||++.+ .++.++|||||||++|+|+| |+.||... ....+...+..+... ..+...+..
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~ 247 (327)
T 3poz_A 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERL-PQPPICTID 247 (327)
T ss_dssp TCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-CGGGHHHHHHTTCCC-CCCTTBCHH
T ss_pred CcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCC-CHHHHHHHHHcCCCC-CCCccCCHH
Confidence 22 223356889999998864 58999999999999999999 99999863 444555555555433 244556789
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHHcC
Q 008504 154 IKGFIEKCLV-PASERLSAKDLLKD 177 (563)
Q Consensus 154 l~~LI~kcL~-dP~kRpSa~ELLkH 177 (563)
+.+||.+||. +|.+||++.+++++
T Consensus 248 ~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 248 VYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp HHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred HHHHHHHHcCCChhhCCCHHHHHHH
Confidence 9999999998 89999999999986
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-29 Score=259.46 Aligned_cols=172 Identities=24% Similarity=0.388 Sum_probs=143.5
Q ss_pred CEeccCCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCC
Q 008504 1 MITELFTSGNLRQYRKKHK----------------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHG 64 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~----------------~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G 64 (563)
|||||+++|+|.+++.+.+ .+++..++.++.||+.||.|||++| |+||||||+|||++ .++
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~-~~~ 179 (327)
T 1fvr_A 103 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVG-ENY 179 (327)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-GGG
T ss_pred EEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCccceEEEc-CCC
Confidence 5899999999999998764 6999999999999999999999999 99999999999997 457
Q ss_pred cEEEecccchhhccCC-CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCC
Q 008504 65 EVKIGDLGLAIAMQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGI 141 (563)
Q Consensus 65 ~VKL~DFGlA~~~~~~-~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~ 141 (563)
.+||+|||++...... ......+++.|+|||++.+ .++.++|||||||++|+|++ |..||.. .....+...+..+.
T Consensus 180 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~-~~~~~~~~~~~~~~ 258 (327)
T 1fvr_A 180 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG-MTCAELYEKLPQGY 258 (327)
T ss_dssp CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHGGGTC
T ss_pred eEEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCC-CcHHHHHHHhhcCC
Confidence 9999999998643321 2233456889999998864 48999999999999999998 9999987 45566666666654
Q ss_pred CCCccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcC
Q 008504 142 KPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 177 (563)
Q Consensus 142 ~p~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkH 177 (563)
.+ ..+...++.+++||.+||. +|.+|||+.+++++
T Consensus 259 ~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 259 RL-EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp CC-CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CC-CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 33 2345567899999999997 89999999999986
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.96 E-value=1e-29 Score=252.12 Aligned_cols=172 Identities=28% Similarity=0.503 Sum_probs=144.8
Q ss_pred CEeccCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhcc
Q 008504 1 MITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~--~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~ 78 (563)
+||||+++|+|.+++.+. ..+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++....
T Consensus 97 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~ 173 (284)
T 2a19_B 97 IQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK--LINRDLKPSNIFLV-DTKQVKIGDFGLVTSLK 173 (284)
T ss_dssp EEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEE-ETTEEEECCCTTCEESS
T ss_pred EEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHEEEc-CCCCEEECcchhheecc
Confidence 589999999999999764 57999999999999999999999999 99999999999998 45799999999987665
Q ss_pred CC-CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHH
Q 008504 79 QP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKG 156 (563)
Q Consensus 79 ~~-~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~ 156 (563)
.. ......|++.|+|||++.+ .++.++||||||+++|+|++|..||.. .......+..+. ++...++.+++
T Consensus 174 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~---~~~~~~~~~~~~----~~~~~~~~~~~ 246 (284)
T 2a19_B 174 NDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE---TSKFFTDLRDGI----ISDIFDKKEKT 246 (284)
T ss_dssp CCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH---HHHHHHHHHTTC----CCTTSCHHHHH
T ss_pred ccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh---HHHHHHHhhccc----ccccCCHHHHH
Confidence 43 2344578999999998865 489999999999999999999988753 233334444332 34556789999
Q ss_pred HHHHhcC-CCCCCCCHHHHHcCccccc
Q 008504 157 FIEKCLV-PASERLSAKDLLKDPFLQV 182 (563)
Q Consensus 157 LI~kcL~-dP~kRpSa~ELLkHpff~~ 182 (563)
||.+||. +|.+|||+.++++|.+.-.
T Consensus 247 li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 247 LLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 9999997 8999999999999987654
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.3e-30 Score=267.32 Aligned_cols=173 Identities=20% Similarity=0.312 Sum_probs=138.1
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCC-CcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNH-GEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~-G~VKL~DFGlA~~~~~ 79 (563)
|||||+ +|+|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++.+. +.+||+|||+++.+..
T Consensus 129 lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~ 205 (345)
T 2v62_A 129 MVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENE--YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCP 205 (345)
T ss_dssp EEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEESSSTTSEEECCCTTCEESSG
T ss_pred EEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCcCHHHEEEccCCCCcEEEEeCCCceeccc
Confidence 689999 9999999988788999999999999999999999999 99999999999998431 3999999999965532
Q ss_pred C---------CCccccCCCCccCccccccc-CCchhhHHHhHHHHHHHhhcCCCCCCC-CCHHHHHHHHhc--CCCCCcc
Q 008504 80 P---------TARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTFEYPYSEC-KNPAQIFKKVTS--GIKPASL 146 (563)
Q Consensus 80 ~---------~~~~~~Gtp~Y~APEvl~~~-ys~ksDIwSLGviLyELlTG~~Pf~~~-~~~~~i~~~i~~--~~~p~~l 146 (563)
. ......||+.|+|||++.+. ++.++|||||||++|+|++|+.||... ............ ...+...
T Consensus 206 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (345)
T 2v62_A 206 NGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTNLLDELPQSV 285 (345)
T ss_dssp GGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHHHHHHHTTTHHH
T ss_pred ccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHHHHhhcccccHHH
Confidence 1 11345799999999988754 899999999999999999999999542 222222211111 1111111
Q ss_pred -----ccCCChhHHHHHHHhcC-CCCCCCCHHHHHc
Q 008504 147 -----AKVNDPQIKGFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 147 -----~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLk 176 (563)
....++.+++||.+||. +|.+||++.++++
T Consensus 286 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 321 (345)
T 2v62_A 286 LKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK 321 (345)
T ss_dssp HHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 11567899999999997 8999999999987
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2e-29 Score=252.86 Aligned_cols=171 Identities=21% Similarity=0.357 Sum_probs=145.3
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
+||||+.+|+|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++......
T Consensus 94 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nil~~-~~~~~kl~Dfg~~~~~~~~ 170 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLV-TQHYAKISDFGLSKALRAD 170 (291)
T ss_dssp EEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEE-ETTEEEECCCTTCEECCTT
T ss_pred EEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCC--eEcCCCCcceEEEe-CCCcEEEccCCcceeeccC
Confidence 58999999999999999888999999999999999999999999 99999999999998 4579999999999765432
Q ss_pred CC-----ccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCCCCccccCCChh
Q 008504 81 TA-----RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQ 153 (563)
Q Consensus 81 ~~-----~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~ 153 (563)
.. ....+++.|+|||++.+ .++.++||||||+++|+|++ |+.||.. .....+...+..+..+ ..+...++.
T Consensus 171 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~ 248 (291)
T 1xbb_A 171 ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG-MKGSEVTAMLEKGERM-GCPAGCPRE 248 (291)
T ss_dssp CSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTT-CCHHHHHHHHHTTCCC-CCCTTCCHH
T ss_pred CCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCCC-CCCCCCCHH
Confidence 21 12346788999998864 58899999999999999999 9999987 4556666666665443 345567889
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHHc
Q 008504 154 IKGFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 154 l~~LI~kcL~-dP~kRpSa~ELLk 176 (563)
+.++|.+||. +|.+||++.++++
T Consensus 249 l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 249 MYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHcCCChhhCcCHHHHHH
Confidence 9999999997 8999999999986
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2e-29 Score=248.26 Aligned_cols=172 Identities=19% Similarity=0.455 Sum_probs=145.1
Q ss_pred CEeccCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~-~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
+||||+++|+|.+++... +.+++..++.++.||+.||.|||++| |+||||||+||+++ .++.+||+|||++.....
T Consensus 80 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nili~-~~~~~kl~dfg~~~~~~~ 156 (267)
T 3t9t_A 80 LVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVG-ENQVIKVSDFGMTRFVLD 156 (267)
T ss_dssp EEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEEC-GGGCEEECCTTGGGGBCC
T ss_pred EEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEEC-CCCCEEEccccccccccc
Confidence 589999999999999875 56999999999999999999999999 99999999999997 457999999999976543
Q ss_pred C---CCccccCCCCccCccccc-ccCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhH
Q 008504 80 P---TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQI 154 (563)
Q Consensus 80 ~---~~~~~~Gtp~Y~APEvl~-~~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l 154 (563)
. ......+++.|+|||++. ..++.++||||||+++|+|++ |..||.. .........+..+..+ ..+...++.+
T Consensus 157 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~-~~~~~~~~~i~~~~~~-~~~~~~~~~l 234 (267)
T 3t9t_A 157 DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN-RSNSEVVEDISTGFRL-YKPRLASTHV 234 (267)
T ss_dssp HHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHHTTCCC-CCCTTSCHHH
T ss_pred ccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCC-CCHHHHHHHHhcCCcC-CCCccCcHHH
Confidence 2 122345678899999886 458999999999999999999 8999987 4556666666665433 3355668899
Q ss_pred HHHHHHhcC-CCCCCCCHHHHHcC
Q 008504 155 KGFIEKCLV-PASERLSAKDLLKD 177 (563)
Q Consensus 155 ~~LI~kcL~-dP~kRpSa~ELLkH 177 (563)
.+||.+||. +|.+|||+.+++++
T Consensus 235 ~~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 235 YQIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHccCChhhCcCHHHHHHH
Confidence 999999997 89999999999874
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-29 Score=256.93 Aligned_cols=172 Identities=24% Similarity=0.425 Sum_probs=143.7
Q ss_pred CEeccCCCCCHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEec
Q 008504 1 MITELFTSGNLRQYRKKH----------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGD 70 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~----------~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~D 70 (563)
+||||+.+|+|.+++... ..+++..++.++.||+.||.|||++| |+||||||+||+++ .+|.+||+|
T Consensus 105 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~NIli~-~~~~~kl~D 181 (322)
T 1p4o_A 105 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVA-EDFTVKIGD 181 (322)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGGEEEC-TTCCEEECC
T ss_pred EEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--CccCCCccceEEEc-CCCeEEECc
Confidence 589999999999999753 45799999999999999999999999 99999999999998 557999999
Q ss_pred ccchhhccCCC----CccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCCCC
Q 008504 71 LGLAIAMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPA 144 (563)
Q Consensus 71 FGlA~~~~~~~----~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~p~ 144 (563)
||++....... .....+++.|+|||++.+ .++.++|||||||++|+|++ |..||.. .........+..+..+
T Consensus 182 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~-~~~~~~~~~~~~~~~~- 259 (322)
T 1p4o_A 182 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG-LSNEQVLRFVMEGGLL- 259 (322)
T ss_dssp TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTT-SCHHHHHHHHHTTCCC-
T ss_pred CccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCcccc-CCHHHHHHHHHcCCcC-
Confidence 99997553321 223456889999998864 58999999999999999999 8899977 4555666666555433
Q ss_pred ccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcC
Q 008504 145 SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 177 (563)
Q Consensus 145 ~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkH 177 (563)
..+...++.+++||.+||. +|.+|||+.++++|
T Consensus 260 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 260 DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 2345677899999999998 89999999999986
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=8.4e-30 Score=254.23 Aligned_cols=169 Identities=21% Similarity=0.362 Sum_probs=138.0
Q ss_pred CEeccCCCCCHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCc--------EEEecc
Q 008504 1 MITELFTSGNLRQYRKKHKN-VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGE--------VKIGDL 71 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~-Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~--------VKL~DF 71 (563)
|||||+.+|+|.+++.+.+. +++..++.++.||+.||.|||++| |+||||||+|||++.+ +. +||+||
T Consensus 89 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~-~~~~~~~~~~~kl~Df 165 (289)
T 4fvq_A 89 LVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENT--LIHGNVCAKNILLIRE-EDRKTGNPPFIKLSDP 165 (289)
T ss_dssp EEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEEEC-CBGGGTBCCEEEECCC
T ss_pred EEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCC--eECCCcCcceEEEecC-CcccccccceeeeccC
Confidence 58999999999999988655 999999999999999999999999 9999999999999744 44 999999
Q ss_pred cchhhccCCCCccccCCCCccCcccccc--cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccC
Q 008504 72 GLAIAMQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKV 149 (563)
Q Consensus 72 GlA~~~~~~~~~~~~Gtp~Y~APEvl~~--~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~ 149 (563)
|++..... .....|++.|+|||++.+ .++.++|||||||++|+|++|..|+................. ..+..
T Consensus 166 g~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~---~~~~~ 240 (289)
T 4fvq_A 166 GISITVLP--KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRH---QLPAP 240 (289)
T ss_dssp CSCTTTSC--HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC---CCCCC
T ss_pred cccccccC--ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhccC---CCCCC
Confidence 99865432 233467899999998864 489999999999999999996655544345544444433322 23344
Q ss_pred CChhHHHHHHHhcC-CCCCCCCHHHHHcC
Q 008504 150 NDPQIKGFIEKCLV-PASERLSAKDLLKD 177 (563)
Q Consensus 150 ~s~~l~~LI~kcL~-dP~kRpSa~ELLkH 177 (563)
.++.+++||.+||. +|.+|||+.++++|
T Consensus 241 ~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 241 KAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp SSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 56789999999998 89999999999985
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-29 Score=259.61 Aligned_cols=171 Identities=22% Similarity=0.329 Sum_probs=138.4
Q ss_pred CEeccCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCc-----EEEecccch
Q 008504 1 MITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGE-----VKIGDLGLA 74 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k-~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~-----VKL~DFGlA 74 (563)
|||||+ +|+|.+++.. .+.+++..++.++.||+.||.|||++| |+||||||+|||++.+ +. +||+|||++
T Consensus 82 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--iiHrDlkp~Nill~~~-~~~~~~~~kl~DFg~a 157 (330)
T 2izr_A 82 MVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN--LIYRDVKPENFLIGRP-GNKTQQVIHIIDFALA 157 (330)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECCG-GGTCTTSEEECCCTTC
T ss_pred EEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeeccC-CCCCCceEEEEEcccc
Confidence 689999 9999999987 467999999999999999999999999 9999999999999743 55 999999999
Q ss_pred hhccCCC---------CccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCC--CHHHHHHHHhcCCC
Q 008504 75 IAMQQPT---------ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECK--NPAQIFKKVTSGIK 142 (563)
Q Consensus 75 ~~~~~~~---------~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~--~~~~i~~~i~~~~~ 142 (563)
....... .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.... .....+..+.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~ 237 (330)
T 2izr_A 158 KEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKR 237 (330)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHH
T ss_pred eeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhc
Confidence 7654322 235689999999998875 48999999999999999999999998642 33344444433221
Q ss_pred C---CccccCCChhHHHHHHHhcC-CCCCCCCHHHHHc
Q 008504 143 P---ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 143 p---~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLk 176 (563)
+ ....... +.+++||.+||. +|.+||++.++++
T Consensus 238 ~~~~~~~~~~~-p~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 238 ATPIEVLCENF-PEMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp HSCHHHHTTTC-HHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred cCCHHHHhccC-hHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 1 1111223 499999999997 8999999998886
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.7e-29 Score=251.84 Aligned_cols=172 Identities=23% Similarity=0.449 Sum_probs=140.7
Q ss_pred CEeccCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~-~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
+||||+.+|+|.+++.+. ..+++..++.++.||+.||.|||++| |+||||||+||+++ .++.+||+|||++.....
T Consensus 89 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~ 165 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN--CVHRDIAVRNILVA-SPECVKLGDFGLSRYIED 165 (281)
T ss_dssp EEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEE-ETTEEEECCCCGGGCC--
T ss_pred EEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEEC-CCCcEEeCccCCCccccc
Confidence 589999999999999764 45999999999999999999999999 99999999999998 457999999999976543
Q ss_pred CC---CccccCCCCccCccccc-ccCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhH
Q 008504 80 PT---ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQI 154 (563)
Q Consensus 80 ~~---~~~~~Gtp~Y~APEvl~-~~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l 154 (563)
.. .....+++.|+|||++. ..++.++||||||+++|+|++ |+.||..... ......+..+... ..+...++.+
T Consensus 166 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~-~~~~~~~~~~~~~-~~~~~~~~~l 243 (281)
T 3cc6_A 166 EDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN-KDVIGVLEKGDRL-PKPDLCPPVL 243 (281)
T ss_dssp -------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCG-GGHHHHHHHTCCC-CCCTTCCHHH
T ss_pred ccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCCh-HHHHHHHhcCCCC-CCCCCCCHHH
Confidence 22 22345678999999886 458999999999999999998 9999976433 3344444444332 2345678899
Q ss_pred HHHHHHhcC-CCCCCCCHHHHHcC
Q 008504 155 KGFIEKCLV-PASERLSAKDLLKD 177 (563)
Q Consensus 155 ~~LI~kcL~-dP~kRpSa~ELLkH 177 (563)
.+||.+||. +|.+|||+.+++++
T Consensus 244 ~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 244 YTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHccCCchhCcCHHHHHHH
Confidence 999999997 89999999999875
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-29 Score=257.25 Aligned_cols=173 Identities=30% Similarity=0.497 Sum_probs=134.5
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC--------CCCeEeccCccCceEEeCCCCcEEEeccc
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSH--------NPPIIHRDLKCDNIFVNGNHGEVKIGDLG 72 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~--------gp~IIHrDLKP~NILLd~~~G~VKL~DFG 72 (563)
|||||+++|+|.++++.. .+++..++.++.||+.||.|||++ | |+||||||+|||++ .++.+||+|||
T Consensus 112 lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dikp~Nill~-~~~~~kl~Dfg 187 (337)
T 3mdy_A 112 LITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA--IAHRDLKSKNILVK-KNGTCCIADLG 187 (337)
T ss_dssp EEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC--EECSCCCGGGEEEC-TTSCEEECCCT
T ss_pred EEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC--EEecccchHHEEEC-CCCCEEEEeCC
Confidence 589999999999999774 699999999999999999999999 8 99999999999998 55799999999
Q ss_pred chhhccCCC------CccccCCCCccCccccccc-CCc------hhhHHHhHHHHHHHhhc----------CCCCCCCC-
Q 008504 73 LAIAMQQPT------ARSVIGTPEFMAPELYEEE-YNE------LVDIYSFGMCILEMVTF----------EYPYSECK- 128 (563)
Q Consensus 73 lA~~~~~~~------~~~~~Gtp~Y~APEvl~~~-ys~------ksDIwSLGviLyELlTG----------~~Pf~~~~- 128 (563)
++....... .....||+.|+|||++.+. +.. ++|||||||++|+|+|| +.||....
T Consensus 188 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~ 267 (337)
T 3mdy_A 188 LAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVP 267 (337)
T ss_dssp TCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred CceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcC
Confidence 996553322 1245799999999988654 333 49999999999999999 77775422
Q ss_pred ---CHHHHHHHHhcCCCCCcccc-----CCChhHHHHHHHhcC-CCCCCCCHHHHHcC
Q 008504 129 ---NPAQIFKKVTSGIKPASLAK-----VNDPQIKGFIEKCLV-PASERLSAKDLLKD 177 (563)
Q Consensus 129 ---~~~~i~~~i~~~~~p~~l~~-----~~s~~l~~LI~kcL~-dP~kRpSa~ELLkH 177 (563)
........+.........+. ..++.+.+||.+||. +|.+|||+.++++|
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 268 SDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred CCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 12223333322222222222 234579999999998 89999999999985
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-29 Score=252.06 Aligned_cols=172 Identities=27% Similarity=0.399 Sum_probs=143.5
Q ss_pred CEeccCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~-~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
+||||+.+|+|.+++.+. +.+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++.....
T Consensus 97 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nili~-~~~~~kl~Dfg~~~~~~~ 173 (291)
T 1u46_A 97 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLA-TRDLVKIGDFGLMRALPQ 173 (291)
T ss_dssp EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEE-ETTEEEECCCTTCEECCC
T ss_pred eeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEEc-CCCCEEEccccccccccc
Confidence 589999999999999864 56999999999999999999999999 99999999999998 457999999999976543
Q ss_pred CC-----CccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCCCCccccCCCh
Q 008504 80 PT-----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDP 152 (563)
Q Consensus 80 ~~-----~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~ 152 (563)
.. .....+++.|+|||++.+ .++.++||||||+++|+|++ |+.||.. .+.......+.........+...++
T Consensus 174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (291)
T 1u46_A 174 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG-LNGSQILHKIDKEGERLPRPEDCPQ 252 (291)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHHTSCCCCCCCTTCCH
T ss_pred cccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCccc-CCHHHHHHHHHccCCCCCCCcCcCH
Confidence 22 223457788999998864 48999999999999999999 9999987 4555666666555444445566788
Q ss_pred hHHHHHHHhcC-CCCCCCCHHHHHc
Q 008504 153 QIKGFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 153 ~l~~LI~kcL~-dP~kRpSa~ELLk 176 (563)
.++++|.+||. +|.+|||+.++++
T Consensus 253 ~l~~li~~~l~~~p~~Rps~~~l~~ 277 (291)
T 1u46_A 253 DIYNVMVQCWAHKPEDRPTFVALRD 277 (291)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHccCCcccCcCHHHHHH
Confidence 99999999997 8999999999997
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=3e-29 Score=250.93 Aligned_cols=172 Identities=20% Similarity=0.360 Sum_probs=144.3
Q ss_pred CEeccCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k-~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
+||||+.+|+|.+++.. .+.+++..++.|+.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++.....
T Consensus 100 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nili~-~~~~~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 100 VLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK--FVHRDLAARNCMLD-ESFTVKVADFGLARDILD 176 (298)
T ss_dssp EEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-TTCCEEECCTTSSCTTTT
T ss_pred EEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEc-CCCcEEeCcCCCcccccC
Confidence 58999999999999987 456999999999999999999999999 99999999999998 557999999999965432
Q ss_pred ------CCCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCCh
Q 008504 80 ------PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDP 152 (563)
Q Consensus 80 ------~~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~ 152 (563)
.......+++.|+|||.+.+ .++.++|||||||++|+|++|..|+............+..+... ..+...++
T Consensus 177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 255 (298)
T 3pls_A 177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRL-PQPEYCPD 255 (298)
T ss_dssp GGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCC-CCCTTCCH
T ss_pred CcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCC-CCCccchH
Confidence 12234567889999998865 58999999999999999999766665556666666666665443 34556788
Q ss_pred hHHHHHHHhcC-CCCCCCCHHHHHc
Q 008504 153 QIKGFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 153 ~l~~LI~kcL~-dP~kRpSa~ELLk 176 (563)
.+.+||.+||. +|.+|||+.++++
T Consensus 256 ~l~~li~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 256 SLYQVMQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHccCChhhCcCHHHHHH
Confidence 99999999998 8999999999987
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=1.8e-29 Score=252.78 Aligned_cols=174 Identities=20% Similarity=0.382 Sum_probs=146.2
Q ss_pred CEeccCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~-~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
+||||+.+|+|.+++... ..+++..++.++.||+.||.|||++| |+||||||+||+++ ..+.+||+|||++.....
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~-~~~~~kl~Dfg~~~~~~~ 162 (287)
T 1u59_A 86 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLV-NRHYAKISDFGLSKALGA 162 (287)
T ss_dssp EEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEE-ETTEEEECCCTTCEECTT
T ss_pred EEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCchheEEEc-CCCCEEECcccceeeecc
Confidence 589999999999999754 56999999999999999999999999 99999999999998 557999999999976543
Q ss_pred CC-----CccccCCCCccCccccc-ccCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCCCCccccCCCh
Q 008504 80 PT-----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDP 152 (563)
Q Consensus 80 ~~-----~~~~~Gtp~Y~APEvl~-~~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~ 152 (563)
.. .....+++.|+|||++. ..++.++|||||||++|+|++ |+.||.... .......+..+..+ ..+...++
T Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~-~~~~~~~i~~~~~~-~~~~~~~~ 240 (287)
T 1u59_A 163 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK-GPEVMAFIEQGKRM-ECPPECPP 240 (287)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC-THHHHHHHHTTCCC-CCCTTCCH
T ss_pred CcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC-HHHHHHHHhcCCcC-CCCCCcCH
Confidence 21 22335688999999886 458999999999999999998 999998744 44555566655443 34556789
Q ss_pred hHHHHHHHhcC-CCCCCCCHHHHHcCcc
Q 008504 153 QIKGFIEKCLV-PASERLSAKDLLKDPF 179 (563)
Q Consensus 153 ~l~~LI~kcL~-dP~kRpSa~ELLkHpf 179 (563)
.+++||.+||. +|.+||++.++++|.+
T Consensus 241 ~l~~li~~~l~~~p~~Rps~~~l~~~l~ 268 (287)
T 1u59_A 241 ELYALMSDCWIYKWEDRPDFLTVEQRMR 268 (287)
T ss_dssp HHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 99999999997 8999999999998754
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=99.96 E-value=2.6e-29 Score=257.64 Aligned_cols=172 Identities=28% Similarity=0.455 Sum_probs=145.2
Q ss_pred CEeccCCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCC
Q 008504 1 MITELFTSGNLRQYRKKHK----------------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHG 64 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~----------------~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G 64 (563)
|||||+.+|+|.+++...+ .+++..++.++.||+.||.|||++| |+||||||+|||++ .++
T Consensus 118 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~-~~~ 194 (334)
T 2pvf_A 118 VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVT-ENN 194 (334)
T ss_dssp EEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTC
T ss_pred EEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCccceEEEc-CCC
Confidence 5899999999999998754 3899999999999999999999999 99999999999998 557
Q ss_pred cEEEecccchhhccCCC----CccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHh
Q 008504 65 EVKIGDLGLAIAMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVT 138 (563)
Q Consensus 65 ~VKL~DFGlA~~~~~~~----~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~ 138 (563)
.+||+|||++....... .....+++.|+|||++.+ .++.++|||||||++|+|++ |..||.. .....+...+.
T Consensus 195 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~-~~~~~~~~~~~ 273 (334)
T 2pvf_A 195 VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG-IPVEELFKLLK 273 (334)
T ss_dssp CEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT-CCHHHHHHHHH
T ss_pred CEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCc-CCHHHHHHHHh
Confidence 99999999997654322 223456788999998864 58999999999999999999 9999987 45566666666
Q ss_pred cCCCCCccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcC
Q 008504 139 SGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 177 (563)
Q Consensus 139 ~~~~p~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkH 177 (563)
.+..+ ..+...++.+++||.+||. +|.+|||+.+++++
T Consensus 274 ~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 274 EGHRM-DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp HTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCCC-CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 65443 3445678899999999997 89999999999975
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-29 Score=255.73 Aligned_cols=171 Identities=26% Similarity=0.445 Sum_probs=142.8
Q ss_pred CEeccCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~-~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
+||||+.+|+|.+++...+ .+++..++.++.||+.||.|||++| |+||||||+|||++ +|.+||+|||++.....
T Consensus 106 iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~NIl~~--~~~~~l~Dfg~~~~~~~ 181 (319)
T 2y4i_B 106 IITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG--ILHKDLKSKNVFYD--NGKVVITDFGLFSISGV 181 (319)
T ss_dssp EECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSTTEEEC----CCEECCCSCCC----
T ss_pred EEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChhhEEEe--CCCEEEeecCCcccccc
Confidence 5899999999999998754 6999999999999999999999999 99999999999997 46999999999765421
Q ss_pred -------CCCccccCCCCccCcccccc----------cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCC
Q 008504 80 -------PTARSVIGTPEFMAPELYEE----------EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK 142 (563)
Q Consensus 80 -------~~~~~~~Gtp~Y~APEvl~~----------~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~ 142 (563)
.......|++.|+|||++.+ .++.++|||||||++|+|++|+.||.. .........+..+..
T Consensus 182 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~-~~~~~~~~~~~~~~~ 260 (319)
T 2y4i_B 182 LQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT-QPAEAIIWQMGTGMK 260 (319)
T ss_dssp ------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSS-CCHHHHHHHHHTTCC
T ss_pred ccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHhccCCC
Confidence 12233468999999998853 378899999999999999999999987 455666666666666
Q ss_pred CCccccCCChhHHHHHHHhcC-CCCCCCCHHHHHc
Q 008504 143 PASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 143 p~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLk 176 (563)
+.......+..+.+||.+||. +|.+|||+.++++
T Consensus 261 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 295 (319)
T 2y4i_B 261 PNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMD 295 (319)
T ss_dssp CCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred CCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 655555677899999999997 8999999999997
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=7.6e-30 Score=273.72 Aligned_cols=180 Identities=28% Similarity=0.344 Sum_probs=135.3
Q ss_pred CEeccCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCC--C--CcEEEecccchh
Q 008504 1 MITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGN--H--GEVKIGDLGLAI 75 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~-~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~--~--G~VKL~DFGlA~ 75 (563)
||||||. |+|.+++.... .+.+..++.|+.||+.||.|||++| |+||||||+|||++.+ . ..+||+|||++.
T Consensus 95 lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~ 171 (432)
T 3p23_A 95 IAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN--IVHRDLKPHNILISMPNAHGKIKAMISDFGLCK 171 (432)
T ss_dssp EEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTT--CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEE
T ss_pred EEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCc--CEeCCCCHHHEEEecCCCCCceeEEEeccccee
Confidence 6899996 59999998754 4666677899999999999999999 9999999999999522 2 258899999997
Q ss_pred hccCC-----CCccccCCCCccCccccc----ccCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCCC-C
Q 008504 76 AMQQP-----TARSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKP-A 144 (563)
Q Consensus 76 ~~~~~-----~~~~~~Gtp~Y~APEvl~----~~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~p-~ 144 (563)
..... ......||+.|+|||++. ..++.++|||||||++|+|++ |..||..... ......+...... .
T Consensus 172 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~-~~~~~~~~~~~~~~~ 250 (432)
T 3p23_A 172 KLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ-RQANILLGACSLDCL 250 (432)
T ss_dssp CC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT-HHHHHHTTCCCCTTS
T ss_pred eccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH-HHHHHHhccCCcccc
Confidence 65432 233467999999999986 347789999999999999999 8999965332 2222222211111 1
Q ss_pred ccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCccccccc
Q 008504 145 SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 184 (563)
Q Consensus 145 ~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~ 184 (563)
......++.+++||.+||. +|.+|||+.++++||||....
T Consensus 251 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~~ 291 (432)
T 3p23_A 251 HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLE 291 (432)
T ss_dssp CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCHH
T ss_pred CccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccChH
Confidence 1122234568999999998 899999999999999997543
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.8e-29 Score=260.98 Aligned_cols=172 Identities=18% Similarity=0.314 Sum_probs=139.8
Q ss_pred CEeccCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCC--cEEEecccchhh
Q 008504 1 MITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHG--EVKIGDLGLAIA 76 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~--~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G--~VKL~DFGlA~~ 76 (563)
|||||+ +|+|.+++... +.+++..++.++.||+.||.|||++| |+||||||+|||++. .+ .+||+|||++..
T Consensus 135 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dikp~NIl~~~-~~~~~~kl~Dfg~a~~ 210 (352)
T 2jii_A 135 LVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE--YVHGNVTAENIFVDP-EDQSQVTLAGYGFAFR 210 (352)
T ss_dssp EEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCCGGGEEEET-TEEEEEEECCGGGCBC
T ss_pred EEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCHHHEEEcC-CCCceEEEecCcceee
Confidence 689999 99999999986 78999999999999999999999999 999999999999984 45 899999999965
Q ss_pred ccCC---------CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCC-CHHHHHHHHh---cCCC
Q 008504 77 MQQP---------TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECK-NPAQIFKKVT---SGIK 142 (563)
Q Consensus 77 ~~~~---------~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~-~~~~i~~~i~---~~~~ 142 (563)
.... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.... ....+..... ....
T Consensus 211 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 290 (352)
T 2jii_A 211 YCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPG 290 (352)
T ss_dssp SSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHSCC
T ss_pred ccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCHHHHHHHHHhccCChh
Confidence 4321 1234479999999998875 58999999999999999999999998654 3333333222 1111
Q ss_pred CC----ccccCCChhHHHHHHHhcC-CCCCCCCHHHHHc
Q 008504 143 PA----SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 143 p~----~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLk 176 (563)
.. ......++.+++||.+||. +|.+|||+.++++
T Consensus 291 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 291 PFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN 329 (352)
T ss_dssp CEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred hhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence 11 0112457899999999997 8999999999987
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-29 Score=253.98 Aligned_cols=172 Identities=27% Similarity=0.427 Sum_probs=135.6
Q ss_pred CEeccCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~-~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
|||||+++|+|.+++...+ .+++..++.++.||+.||.|||++| |+||||||+|||++ ..+.+||+|||++.....
T Consensus 90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~-~~~~~kl~Dfg~~~~~~~ 166 (295)
T 3ugc_A 90 LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVE-NENRVKIGDFGLTKVLPQ 166 (295)
T ss_dssp EEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEE-ETTEEEECCCCSCC----
T ss_pred EEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHhhEEEc-CCCeEEEccCcccccccC
Confidence 5899999999999998754 4999999999999999999999999 99999999999998 457999999999976543
Q ss_pred CC-----CccccCCCCccCccccc-ccCCchhhHHHhHHHHHHHhhcCCCCCCCCCH---------------HHHHHHHh
Q 008504 80 PT-----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNP---------------AQIFKKVT 138 (563)
Q Consensus 80 ~~-----~~~~~Gtp~Y~APEvl~-~~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~---------------~~i~~~i~ 138 (563)
.. .....+++.|+|||++. ..++.++||||||+++|+|+||..||...... ......+.
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (295)
T 3ugc_A 167 DKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 246 (295)
T ss_dssp ---------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHH
T ss_pred CcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHh
Confidence 21 22335677899999886 45899999999999999999999998641100 01222222
Q ss_pred cCCCCCccccCCChhHHHHHHHhcC-CCCCCCCHHHHHc
Q 008504 139 SGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 139 ~~~~p~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLk 176 (563)
.+.. ...+...++.+.+||.+||. +|.+|||+.++++
T Consensus 247 ~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 247 NNGR-LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp TTCC-CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ccCc-CCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 2222 23455678899999999998 8999999999986
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.1e-29 Score=257.29 Aligned_cols=179 Identities=22% Similarity=0.393 Sum_probs=148.7
Q ss_pred CEeccCCCCCHHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeC--CCCcEEEecc
Q 008504 1 MITELFTSGNLRQYRKKHK-------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG--NHGEVKIGDL 71 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~-------~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~--~~G~VKL~DF 71 (563)
|||||+++|+|.+++...+ .+++..++.++.||+.||.|||++| |+||||||+|||++. +.+.+||+||
T Consensus 110 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--i~H~dlkp~NIli~~~~~~~~~kl~Df 187 (327)
T 2yfx_A 110 ILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDF 187 (327)
T ss_dssp EEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCEEECCC
T ss_pred EEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eecCcCCHhHEEEecCCCcceEEECcc
Confidence 5899999999999998753 4999999999999999999999999 999999999999973 3346999999
Q ss_pred cchhhccCC----CCccccCCCCccCccccc-ccCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCCCCc
Q 008504 72 GLAIAMQQP----TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPAS 145 (563)
Q Consensus 72 GlA~~~~~~----~~~~~~Gtp~Y~APEvl~-~~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~ 145 (563)
|++...... ......|++.|+|||++. ..++.++|||||||++|+|+| |..||.. .........+..+..+ .
T Consensus 188 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~-~~~~~~~~~~~~~~~~-~ 265 (327)
T 2yfx_A 188 GMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS-KSNQEVLEFVTSGGRM-D 265 (327)
T ss_dssp HHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-CCHHHHHHHHHTTCCC-C
T ss_pred ccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCC-cCHHHHHHHHhcCCCC-C
Confidence 999755322 223456789999999885 458999999999999999998 8999976 4555666666665443 3
Q ss_pred cccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCcccccc
Q 008504 146 LAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 183 (563)
Q Consensus 146 l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~ 183 (563)
.+...++.+.+||.+||. +|.+||++.++++|.|+...
T Consensus 266 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 266 PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence 455678899999999998 89999999999999987543
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.9e-29 Score=264.39 Aligned_cols=171 Identities=22% Similarity=0.363 Sum_probs=142.4
Q ss_pred CEeccCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~-~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
|||||+++|+|.+++...+ .+++..+..++.||+.||+|||++| |+||||||+|||++ .++.+||+|||+++....
T Consensus 189 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nil~~-~~~~~kl~DfG~s~~~~~ 265 (377)
T 3cbl_A 189 IVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC--CIHRDLAARNCLVT-EKNVLKISDFGMSREEAD 265 (377)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTCCEEECCGGGCEECTT
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cCCcccCHHHEEEc-CCCcEEECcCCCceecCC
Confidence 6899999999999998654 5999999999999999999999999 99999999999997 557999999999975433
Q ss_pred CCC----ccccCCCCccCccccc-ccCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCCCCccccCCChh
Q 008504 80 PTA----RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQ 153 (563)
Q Consensus 80 ~~~----~~~~Gtp~Y~APEvl~-~~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~ 153 (563)
... ....+++.|+|||++. +.++.++|||||||++|||+| |..||... ...+....+..+... ..+...++.
T Consensus 266 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~ 343 (377)
T 3cbl_A 266 GVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNL-SNQQTREFVEKGGRL-PCPELCPDA 343 (377)
T ss_dssp SEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTS-CHHHHHHHHHTTCCC-CCCTTCCHH
T ss_pred CceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHcCCCC-CCCCCCCHH
Confidence 211 1123467899999886 458999999999999999998 99999874 455555556555433 345667889
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHHc
Q 008504 154 IKGFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 154 l~~LI~kcL~-dP~kRpSa~ELLk 176 (563)
+.+||.+||. +|.+|||+.++++
T Consensus 344 l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 344 VFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHcCCCchhCcCHHHHHH
Confidence 9999999997 8999999999986
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=3.4e-29 Score=251.27 Aligned_cols=171 Identities=25% Similarity=0.398 Sum_probs=139.0
Q ss_pred CEeccCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k-~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
+||||+.+|+|.+++.+ ...+++..++.|+.||+.||.|||++| |+||||||+||+++ .++.+||+|||++.....
T Consensus 104 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~--i~H~dikp~Nil~~-~~~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK--FVHRDLAARNCMLD-EKFTVKVADFGLARDMYD 180 (298)
T ss_dssp EEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-TTCCEEECSCGGGCCCSC
T ss_pred EEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEEC-CCCCEEECcccccccccc
Confidence 58999999999999986 456999999999999999999999999 99999999999998 557999999999975533
Q ss_pred C------CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhc-CCCCCCCCCHHHHHHHHhcCCCCCccccCCC
Q 008504 80 P------TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSGIKPASLAKVND 151 (563)
Q Consensus 80 ~------~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG-~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s 151 (563)
. ......+++.|+|||++.+ .++.++||||||+++|+|++| .+||.. .+.......+..+..+ ..+...+
T Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~-~~~~~~~ 258 (298)
T 3f66_A 181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD-VNTFDITVYLLQGRRL-LQPEYCP 258 (298)
T ss_dssp GGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-SCTTTHHHHHHTTCCC-CCCTTCC
T ss_pred cchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCcc-CCHHHHHHHHhcCCCC-CCCccCC
Confidence 2 1223457789999998864 589999999999999999995 555654 4444444445544433 3355668
Q ss_pred hhHHHHHHHhcC-CCCCCCCHHHHHc
Q 008504 152 PQIKGFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 152 ~~l~~LI~kcL~-dP~kRpSa~ELLk 176 (563)
+.+.++|.+||. +|.+|||+.++++
T Consensus 259 ~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 259 DPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 899999999997 8999999999987
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=99.96 E-value=2.6e-29 Score=270.06 Aligned_cols=170 Identities=22% Similarity=0.415 Sum_probs=141.8
Q ss_pred CEeccCCCCCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhcc
Q 008504 1 MITELFTSGNLRQYRKKHKN--VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~--Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~ 78 (563)
||||||++|+|.+++.+.+. +++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||+++...
T Consensus 264 iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill~-~~~~~kl~DfG~a~~~~ 340 (450)
T 1k9a_A 264 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVS-EDNVAKVSDFGLTKEAS 340 (450)
T ss_dssp EEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEC-TTSCEEECCCTTCEECC
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEEC-CCCCEEEeeCCCccccc
Confidence 68999999999999987543 799999999999999999999999 99999999999998 55799999999997543
Q ss_pred CCCCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHH
Q 008504 79 QPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKG 156 (563)
Q Consensus 79 ~~~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~ 156 (563)
.. .....+++.|+|||++.+ .++.++|||||||++|||+| |+.||.... ..+....+..+..+ ..+...++.+.+
T Consensus 341 ~~-~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~-~~~~~~~i~~~~~~-~~p~~~~~~l~~ 417 (450)
T 1k9a_A 341 ST-QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-LKDVVPRVEKGYKM-DAPDGCPPAVYD 417 (450)
T ss_dssp -------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSC-TTTHHHHHHTTCCC-CCCTTCCHHHHH
T ss_pred cc-ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC-HHHHHHHHHcCCCC-CCCCcCCHHHHH
Confidence 32 223367889999998864 58999999999999999998 999998743 34455566666443 345667899999
Q ss_pred HHHHhcC-CCCCCCCHHHHHc
Q 008504 157 FIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 157 LI~kcL~-dP~kRpSa~ELLk 176 (563)
||.+||. +|.+|||+.++++
T Consensus 418 li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 418 VMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp HHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHcCCChhHCcCHHHHHH
Confidence 9999997 8999999999975
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.2e-29 Score=268.20 Aligned_cols=178 Identities=25% Similarity=0.332 Sum_probs=131.7
Q ss_pred CEeccCCCCCHHHHHHhCCCCC-------HHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCC-----------
Q 008504 1 MITELFTSGNLRQYRKKHKNVD-------IKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGN----------- 62 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Ls-------e~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~----------- 62 (563)
||||||. |+|.+++...+... +..++.++.||+.||.|||++| |+||||||+|||++..
T Consensus 86 lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~~~~~~~~~~ 162 (434)
T 2rio_A 86 IALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGA 162 (434)
T ss_dssp EEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEECCHHHHSCCTTCC
T ss_pred EEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecCcccccccccCC
Confidence 5899996 69999998764332 3345789999999999999999 9999999999999732
Q ss_pred -CCcEEEecccchhhccCCC------CccccCCCCccCcccccc--------cCCchhhHHHhHHHHHHHhh-cCCCCCC
Q 008504 63 -HGEVKIGDLGLAIAMQQPT------ARSVIGTPEFMAPELYEE--------EYNELVDIYSFGMCILEMVT-FEYPYSE 126 (563)
Q Consensus 63 -~G~VKL~DFGlA~~~~~~~------~~~~~Gtp~Y~APEvl~~--------~ys~ksDIwSLGviLyELlT-G~~Pf~~ 126 (563)
.+.+||+|||++....... .....||+.|+|||++.+ .++.++|||||||++|+|+| |..||..
T Consensus 163 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~ 242 (434)
T 2rio_A 163 ENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD 242 (434)
T ss_dssp CSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCS
T ss_pred CceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCC
Confidence 3489999999997664321 224579999999998853 48899999999999999999 8999976
Q ss_pred CCCHHHHHHHHhcCCCCCcccc----CCChhHHHHHHHhcC-CCCCCCCHHHHHcCcccccc
Q 008504 127 CKNPAQIFKKVTSGIKPASLAK----VNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 183 (563)
Q Consensus 127 ~~~~~~i~~~i~~~~~p~~l~~----~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~ 183 (563)
...... ..+........... ..++.+++||.+||. +|.+|||+.++++||||...
T Consensus 243 ~~~~~~--~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~~ 302 (434)
T 2rio_A 243 KYSRES--NIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPK 302 (434)
T ss_dssp TTTHHH--HHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSCH
T ss_pred chhhHH--HHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCCc
Confidence 433322 11222111111111 124689999999997 89999999999999999643
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-29 Score=258.65 Aligned_cols=173 Identities=23% Similarity=0.405 Sum_probs=143.9
Q ss_pred CEeccCCCCCHHHHHHhC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcE
Q 008504 1 MITELFTSGNLRQYRKKH--------------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEV 66 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~--------------~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~V 66 (563)
|||||+++|+|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+
T Consensus 127 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~-~~~~~ 203 (333)
T 2i1m_A 127 VITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN--CIHRDVAARNVLLT-NGHVA 203 (333)
T ss_dssp EEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGCEEE-GGGEE
T ss_pred EEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC--cccCCcccceEEEC-CCCeE
Confidence 589999999999999753 35899999999999999999999999 99999999999998 45799
Q ss_pred EEecccchhhccCCC----CccccCCCCccCccccc-ccCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcC
Q 008504 67 KIGDLGLAIAMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSG 140 (563)
Q Consensus 67 KL~DFGlA~~~~~~~----~~~~~Gtp~Y~APEvl~-~~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~ 140 (563)
||+|||++....... .....+++.|+|||++. ..++.++|||||||++|+|+| |..||............+..+
T Consensus 204 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~ 283 (333)
T 2i1m_A 204 KIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDG 283 (333)
T ss_dssp EBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHHHT
T ss_pred EECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHhcC
Confidence 999999997553322 22345678899999876 458999999999999999998 899998765555555555554
Q ss_pred CCCCccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcC
Q 008504 141 IKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 177 (563)
Q Consensus 141 ~~p~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkH 177 (563)
..+ ..+...++.+.+||.+||. +|.+|||+.+++++
T Consensus 284 ~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 320 (333)
T 2i1m_A 284 YQM-AQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF 320 (333)
T ss_dssp CCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCC-CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence 333 3455668899999999997 89999999999873
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.6e-29 Score=254.22 Aligned_cols=172 Identities=20% Similarity=0.341 Sum_probs=137.8
Q ss_pred CEeccCCCCCHHHHHHh------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccch
Q 008504 1 MITELFTSGNLRQYRKK------HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA 74 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k------~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA 74 (563)
+||||+.+|+|.+++.. .+.+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++
T Consensus 118 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NIli~-~~~~~kl~Dfg~~ 194 (313)
T 3brb_A 118 VILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN--FLHRDLAARNCMLR-DDMTVCVADFGLS 194 (313)
T ss_dssp EEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCSGGGEEEC-TTSCEEECSCSCC
T ss_pred EEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEc-CCCcEEEeecCcc
Confidence 58999999999999953 356999999999999999999999999 99999999999998 4579999999999
Q ss_pred hhccCCC----CccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCCCCcccc
Q 008504 75 IAMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAK 148 (563)
Q Consensus 75 ~~~~~~~----~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~ 148 (563)
....... .....+++.|+|||++.+ .++.++|||||||++|+|++ |..||... ........+..+..+ ..+.
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~ 272 (313)
T 3brb_A 195 KKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGV-QNHEMYDYLLHGHRL-KQPE 272 (313)
T ss_dssp ----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTC-CGGGHHHHHHTTCCC-CCBT
T ss_pred eecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccC-CHHHHHHHHHcCCCC-CCCc
Confidence 7654321 223456889999998864 48999999999999999999 88899774 444455555555433 3455
Q ss_pred CCChhHHHHHHHhcC-CCCCCCCHHHHHcC
Q 008504 149 VNDPQIKGFIEKCLV-PASERLSAKDLLKD 177 (563)
Q Consensus 149 ~~s~~l~~LI~kcL~-dP~kRpSa~ELLkH 177 (563)
..++.+.+||.+||. +|.+|||+.+++++
T Consensus 273 ~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 273 DCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp TCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred cccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 677899999999997 89999999999874
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.7e-29 Score=255.52 Aligned_cols=177 Identities=24% Similarity=0.370 Sum_probs=137.1
Q ss_pred CEeccCCCCCHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhC---CCCeEeccCccCceEEeCCCCcEEEecccc
Q 008504 1 MITELFTSGNLRQYRKKHK----NVDIKVIKNWARQILHGLVYLHSH---NPPIIHRDLKCDNIFVNGNHGEVKIGDLGL 73 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~----~Lse~~i~~i~~QIL~aL~yLHs~---gp~IIHrDLKP~NILLd~~~G~VKL~DFGl 73 (563)
|||||+.+|+|.+++.... .+++..++.++.||+.||.|||++ | |+||||||+|||++ .++.+||+|||+
T Consensus 104 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~--ivH~Dlkp~Nil~~-~~~~~kl~Dfg~ 180 (326)
T 3uim_A 104 LVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK--IIHRDVKAANILLD-EEFEAVVGDFGL 180 (326)
T ss_dssp EEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC--EECCCCSGGGEEEC-TTCCEEECCCSS
T ss_pred EEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEeCCCchhhEEEC-CCCCEEeccCcc
Confidence 5899999999999998653 499999999999999999999999 8 99999999999998 557999999999
Q ss_pred hhhccCCC---CccccCCCCccCccccc-ccCCchhhHHHhHHHHHHHhhcCCCCCCC----CCHHHHHHHHhcCCCCC-
Q 008504 74 AIAMQQPT---ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSEC----KNPAQIFKKVTSGIKPA- 144 (563)
Q Consensus 74 A~~~~~~~---~~~~~Gtp~Y~APEvl~-~~ys~ksDIwSLGviLyELlTG~~Pf~~~----~~~~~i~~~i~~~~~p~- 144 (563)
+....... .....||+.|+|||++. ..++.++|||||||++|+|++|+.||... .........+.......
T Consensus 181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (326)
T 3uim_A 181 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 260 (326)
T ss_dssp CEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCC
T ss_pred ccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchh
Confidence 97654322 23446999999999885 45899999999999999999999999520 11111111111111111
Q ss_pred -----------ccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCccc
Q 008504 145 -----------SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 180 (563)
Q Consensus 145 -----------~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff 180 (563)
.......+.+.+||.+||. +|.+|||+.++++|-.-
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 261 LEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp STTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred hhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 1111113578999999997 89999999999997643
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=99.96 E-value=3.7e-29 Score=268.96 Aligned_cols=171 Identities=23% Similarity=0.435 Sum_probs=144.3
Q ss_pred CEeccCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhcc
Q 008504 1 MITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~--~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~ 78 (563)
||||||.+|+|.+++... ..+++..+..++.||+.||.|||++| |+||||||+|||++ .++.+||+|||+++...
T Consensus 259 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill~-~~~~~kl~DFG~a~~~~ 335 (454)
T 1qcf_A 259 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVS-ASLVCKIADFGLARVIE 335 (454)
T ss_dssp EEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEEC-TTCCEEECSTTGGGGBC
T ss_pred EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCHHHEEEC-CCCcEEEeeCCCceEcC
Confidence 689999999999999854 36999999999999999999999999 99999999999998 55799999999997654
Q ss_pred CCC---CccccCCCCccCccccc-ccCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCCCCccccCCChh
Q 008504 79 QPT---ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQ 153 (563)
Q Consensus 79 ~~~---~~~~~Gtp~Y~APEvl~-~~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~ 153 (563)
... .....+++.|+|||++. +.++.++|||||||++|||+| |+.||... ...++...+..+.... .+...++.
T Consensus 336 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~-~~~~~~~~i~~~~~~~-~~~~~~~~ 413 (454)
T 1qcf_A 336 DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM-SNPEVIRALERGYRMP-RPENCPEE 413 (454)
T ss_dssp CHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC-CHHHHHHHHHHTCCCC-CCTTSCHH
T ss_pred CCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHcCCCCC-CCCCCCHH
Confidence 321 22334677899999886 569999999999999999999 99999874 4556666666664433 34567889
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHHc
Q 008504 154 IKGFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 154 l~~LI~kcL~-dP~kRpSa~ELLk 176 (563)
+.+||.+||. +|.+|||+.++++
T Consensus 414 l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 414 LYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHccCChhHCcCHHHHHH
Confidence 9999999997 8999999999976
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.1e-29 Score=256.74 Aligned_cols=171 Identities=27% Similarity=0.459 Sum_probs=138.2
Q ss_pred CEeccCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~-~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
+|+||+.+|+|.+++... +.+++..++.|+.||+.||.|||++| |+||||||+|||++ ..+.+||+|||++.....
T Consensus 93 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~-~~~~~kL~DfG~a~~~~~ 169 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVK-TPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp EEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEE-ETTEEEECCTTC------
T ss_pred EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC--CcCCCCCHHHEEEc-CCCCEEEccCcceeEccC
Confidence 589999999999999874 56999999999999999999999999 99999999999998 457999999999976543
Q ss_pred CC----CccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCCCCccccCCChh
Q 008504 80 PT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQ 153 (563)
Q Consensus 80 ~~----~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~ 153 (563)
.. .....+++.|+|||++.+ .++.++|||||||++|+|++ |..||.. .....+...+..+... ..+...++.
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~ 247 (327)
T 3lzb_A 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG-IPASEISSILEKGERL-PQPPICTID 247 (327)
T ss_dssp ----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCGGGHHHHHHTTCCC-CCCTTBCHH
T ss_pred ccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCC-CCHHHHHHHHHcCCCC-CCCccCCHH
Confidence 21 223356788999998864 58999999999999999999 9999987 3444555555555433 345567889
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHHc
Q 008504 154 IKGFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 154 l~~LI~kcL~-dP~kRpSa~ELLk 176 (563)
+.+||.+||. +|.+|||+.++++
T Consensus 248 l~~li~~~l~~dp~~Rps~~ell~ 271 (327)
T 3lzb_A 248 VYMIMRKCWMIDADSRPKFRELII 271 (327)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHcCCChhHCcCHHHHHH
Confidence 9999999998 8999999999997
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=4.7e-29 Score=247.96 Aligned_cols=171 Identities=25% Similarity=0.420 Sum_probs=143.7
Q ss_pred CEeccCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhcc
Q 008504 1 MITELFTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~--~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~ 78 (563)
+||||+.+|+|.+++.... .+++..++.++.||+.||.|||++| |+||||||+||+++ ..+.+||+|||++....
T Consensus 84 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~~-~~~~~kl~Dfg~~~~~~ 160 (279)
T 1qpc_A 84 IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVS-DTLSCKIADFGLARLIE 160 (279)
T ss_dssp EEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTSCEEECCCTTCEECS
T ss_pred EEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHhhEEEc-CCCCEEECCCccccccc
Confidence 5899999999999997543 6999999999999999999999999 99999999999998 55799999999997654
Q ss_pred CCC---CccccCCCCccCccccc-ccCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCCCCccccCCChh
Q 008504 79 QPT---ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQ 153 (563)
Q Consensus 79 ~~~---~~~~~Gtp~Y~APEvl~-~~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~ 153 (563)
... .....+++.|+|||++. +.++.++||||||+++|+|++ |+.||.. .........+..+..+ ..+...++.
T Consensus 161 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~ 238 (279)
T 1qpc_A 161 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG-MTNPEVIQNLERGYRM-VRPDNCPEE 238 (279)
T ss_dssp SSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTT-CCHHHHHHHHHTTCCC-CCCTTCCHH
T ss_pred CcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcc-cCHHHHHHHHhcccCC-CCcccccHH
Confidence 322 22345678899999886 458999999999999999999 8999987 4455566666655433 334567889
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHHc
Q 008504 154 IKGFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 154 l~~LI~kcL~-dP~kRpSa~ELLk 176 (563)
+.+||.+||. +|.+|||+.++++
T Consensus 239 l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 239 LYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHhccChhhCCCHHHHHH
Confidence 9999999997 8999999999987
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.1e-29 Score=251.59 Aligned_cols=163 Identities=20% Similarity=0.359 Sum_probs=129.5
Q ss_pred CEeccCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCC--CCcEEEecccchhh
Q 008504 1 MITELFTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGN--HGEVKIGDLGLAIA 76 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~--~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~--~G~VKL~DFGlA~~ 76 (563)
|||||+++|+|.+++...+ .+++..++.++.||+.||.|||++| |+||||||+|||++.. .+.+||+|||++..
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 169 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 169 (299)
T ss_dssp EEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEecCCCCCcEEEeccccccc
Confidence 5899999999999998764 6999999999999999999999999 9999999999999853 57899999998854
Q ss_pred ccCCCCccccCCCCccCcccccccCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCC----C--CCccccCC
Q 008504 77 MQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI----K--PASLAKVN 150 (563)
Q Consensus 77 ~~~~~~~~~~Gtp~Y~APEvl~~~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~----~--p~~l~~~~ 150 (563)
.. ...++.++|||||||++|+|++|+.||..... ........... . +.......
T Consensus 170 ~~-------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (299)
T 3m2w_A 170 TT-------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG-LAISPGMKTRIRMGQYEFPNPEWSEV 229 (299)
T ss_dssp CT-------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC--------CCSCCSSCTTCCSSCHHHHTTS
T ss_pred cc-------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcc-hhhhHHHHHHHhhccccCCchhcccC
Confidence 32 13478899999999999999999999976322 11111111111 1 11111456
Q ss_pred ChhHHHHHHHhcC-CCCCCCCHHHHHcCcccccccc
Q 008504 151 DPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQ 185 (563)
Q Consensus 151 s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~~ 185 (563)
++.+++||.+||. +|.+|||+.++|+||||+....
T Consensus 230 ~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~ 265 (299)
T 3m2w_A 230 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 265 (299)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGG
T ss_pred CHHHHHHHHHHcccChhhCCCHHHHhcChhhccccc
Confidence 8899999999997 8999999999999999986543
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.7e-29 Score=250.00 Aligned_cols=170 Identities=22% Similarity=0.410 Sum_probs=137.4
Q ss_pred CEeccCCCCCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhcc
Q 008504 1 MITELFTSGNLRQYRKKHKN--VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~--Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~ 78 (563)
+||||+++|+|.+++.+.+. +++..++.++.||+.||.|||++| |+||||||+||+++ .++.+||+|||++....
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~-~~~~~~l~Dfg~~~~~~ 168 (278)
T 1byg_A 92 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVS-EDNVAKVSDFGLTKEAS 168 (278)
T ss_dssp EEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-TTSCEEECCCCC-----
T ss_pred EEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCcceEEEe-CCCcEEEeecccccccc
Confidence 58999999999999987543 899999999999999999999999 99999999999998 55799999999987554
Q ss_pred CCCCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHH
Q 008504 79 QPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKG 156 (563)
Q Consensus 79 ~~~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~ 156 (563)
.. .....+++.|+|||++.+ .++.++||||||+++|+|++ |..||... ........+..+..+ ..+...++.+.+
T Consensus 169 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~l~~ 245 (278)
T 1byg_A 169 ST-QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPRVEKGYKM-DAPDGCPPAVYE 245 (278)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS-CGGGHHHHHTTTCCC-CCCTTCCHHHHH
T ss_pred cc-ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHhcCCCC-CCcccCCHHHHH
Confidence 32 223467889999998864 58999999999999999998 99999863 444555555555433 345567889999
Q ss_pred HHHHhcC-CCCCCCCHHHHHc
Q 008504 157 FIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 157 LI~kcL~-dP~kRpSa~ELLk 176 (563)
+|.+||. +|.+|||+.++++
T Consensus 246 li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 246 VMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp HHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHhcCChhhCCCHHHHHH
Confidence 9999997 8999999999986
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.5e-29 Score=254.89 Aligned_cols=172 Identities=24% Similarity=0.403 Sum_probs=123.2
Q ss_pred CEeccCCCCCHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhc
Q 008504 1 MITELFTSGNLRQYRKK---HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM 77 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k---~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~ 77 (563)
+||||+. |+|.+++.. .+.+++..++.++.||+.||.|||++|++|+||||||+|||++ ..+.+||+|||++...
T Consensus 111 lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~-~~~~~kl~Dfg~~~~~ 188 (337)
T 3ll6_A 111 LLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLS-NQGTIKLCDFGSATTI 188 (337)
T ss_dssp EEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEEC-TTSCEEBCCCTTCBCC
T ss_pred EEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEEC-CCCCEEEecCccceec
Confidence 5899996 799999875 5679999999999999999999999988899999999999998 5579999999999765
Q ss_pred cCCCC--------------ccccCCCCccCccccc----ccCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 008504 78 QQPTA--------------RSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS 139 (563)
Q Consensus 78 ~~~~~--------------~~~~Gtp~Y~APEvl~----~~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~ 139 (563)
..... ....||+.|+|||++. ..++.++|||||||++|+|++|+.||...... . +..
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-~----~~~ 263 (337)
T 3ll6_A 189 SHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL-R----IVN 263 (337)
T ss_dssp SSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---------------
T ss_pred cccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH-H----hhc
Confidence 43211 1346899999999873 34889999999999999999999999753221 1 112
Q ss_pred CCCCCccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCcc
Q 008504 140 GIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPF 179 (563)
Q Consensus 140 ~~~p~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpf 179 (563)
+..........++.+.+||.+||. +|.+|||+.++++|-.
T Consensus 264 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 304 (337)
T 3ll6_A 264 GKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304 (337)
T ss_dssp --CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred CcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 222223344556789999999998 8999999999999754
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.4e-29 Score=249.92 Aligned_cols=172 Identities=27% Similarity=0.460 Sum_probs=139.6
Q ss_pred CEeccCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k-~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
+||||+++|+|.+++.+ .+.+++..++.++.||+.||.|||++| |+||||||+|||++ ..+.+||+|||++.....
T Consensus 102 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~-~~~~~kl~Dfg~~~~~~~ 178 (302)
T 4e5w_A 102 LIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVE-SEHQVKIGDFGLTKAIET 178 (302)
T ss_dssp EEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEE-ETTEEEECCCTTCEECCT
T ss_pred EEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCC--cccCCCchheEEEc-CCCCEEECcccccccccC
Confidence 58999999999999954 467999999999999999999999999 99999999999998 457999999999976543
Q ss_pred CC-----CccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCC--------------CCHHHHHHHHhc
Q 008504 80 PT-----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSEC--------------KNPAQIFKKVTS 139 (563)
Q Consensus 80 ~~-----~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~--------------~~~~~i~~~i~~ 139 (563)
.. .....||+.|+|||++.+ .++.++||||||+++|+|+||..|+... .........+..
T Consensus 179 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (302)
T 4e5w_A 179 DKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKE 258 (302)
T ss_dssp TCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHT
T ss_pred CCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHhc
Confidence 22 234467888999998864 5889999999999999999998876321 112223333333
Q ss_pred CCCCCccccCCChhHHHHHHHhcC-CCCCCCCHHHHHc
Q 008504 140 GIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 140 ~~~p~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLk 176 (563)
+.. ...+...++.+.+||.+||. +|.+|||+.++++
T Consensus 259 ~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 259 GKR-LPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp TCC-CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred cCC-CCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 332 33455678899999999998 8999999999986
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=8.1e-29 Score=250.30 Aligned_cols=173 Identities=28% Similarity=0.482 Sum_probs=135.8
Q ss_pred CEeccCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhh
Q 008504 1 MITELFTSGNLRQYRKK----HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 76 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k----~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~ 76 (563)
+||||+.+|+|.+++.. ...+++..++.++.||+.||.|||++| |+||||||+||+++ .+|.+||+|||++..
T Consensus 109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIl~~-~~~~~kl~Dfg~~~~ 185 (310)
T 2wqm_A 109 IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFIT-ATGVVKLGDLGLGRF 185 (310)
T ss_dssp EEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTSCEEECCC-----
T ss_pred EEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCcHHHEEEc-CCCCEEEEeccceee
Confidence 58999999999999874 456999999999999999999999999 99999999999998 557999999999876
Q ss_pred ccCC--CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCC-CHHHHHHHHhcCCCCCccccCCCh
Q 008504 77 MQQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECK-NPAQIFKKVTSGIKPASLAKVNDP 152 (563)
Q Consensus 77 ~~~~--~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~-~~~~i~~~i~~~~~p~~l~~~~s~ 152 (563)
.... ......|++.|+|||++.+ .++.++||||||+++|+|++|..||.... ........+.....+.......++
T Consensus 186 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (310)
T 2wqm_A 186 FSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSE 265 (310)
T ss_dssp -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCH
T ss_pred ecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCH
Confidence 5432 2234578999999998864 58999999999999999999999997533 344555666665555444566788
Q ss_pred hHHHHHHHhcC-CCCCCCCHHHHHc
Q 008504 153 QIKGFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 153 ~l~~LI~kcL~-dP~kRpSa~ELLk 176 (563)
.+++||.+||. +|.+|||+.++++
T Consensus 266 ~l~~li~~~l~~dp~~Rps~~~il~ 290 (310)
T 2wqm_A 266 ELRQLVNMCINPDPEKRPDVTYVYD 290 (310)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHcCCChhhCCCHHHHHH
Confidence 99999999997 8999999999987
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.3e-29 Score=253.66 Aligned_cols=172 Identities=22% Similarity=0.285 Sum_probs=134.9
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
+||||+++|+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++......
T Consensus 111 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~NIl~~-~~~~~kl~Dfg~~~~~~~~ 187 (309)
T 2h34_A 111 VDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAG--ATHRDVKPENILVS-ADDFAYLVDFGIASATTDE 187 (309)
T ss_dssp EEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTSCEEECSCCC-------
T ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCc--CCcCCCChHHEEEc-CCCCEEEecCccCcccccc
Confidence 58999999999999998888999999999999999999999999 99999999999998 4579999999998765432
Q ss_pred C---CccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCC-CCccccCCChhHH
Q 008504 81 T---ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK-PASLAKVNDPQIK 155 (563)
Q Consensus 81 ~---~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~-p~~l~~~~s~~l~ 155 (563)
. .....|++.|+|||++.+ .++.++||||||+++|+|++|+.||... ........+..... +...+...++.++
T Consensus 188 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 266 (309)
T 2h34_A 188 KLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGD-QLSVMGAHINQAIPRPSTVRPGIPVAFD 266 (309)
T ss_dssp ---------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSC-HHHHHHHHHHSCCCCGGGTSTTCCTHHH
T ss_pred ccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCc-hHHHHHHHhccCCCCccccCCCCCHHHH
Confidence 2 234578999999998864 4889999999999999999999999863 33334344443332 3344556788999
Q ss_pred HHHHHhcC-CCCCCC-CHHHHHc
Q 008504 156 GFIEKCLV-PASERL-SAKDLLK 176 (563)
Q Consensus 156 ~LI~kcL~-dP~kRp-Sa~ELLk 176 (563)
+||.+||. +|.+|| ++.++++
T Consensus 267 ~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 267 AVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp HHHHHHTCSSGGGSCSSHHHHHH
T ss_pred HHHHHhccCCHHHHHHhHHHHHH
Confidence 99999997 899999 7888875
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=8.9e-29 Score=254.53 Aligned_cols=172 Identities=24% Similarity=0.421 Sum_probs=139.4
Q ss_pred CEeccCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~-~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
|||||+.+|+|.+++... +.+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++.....
T Consensus 123 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~-~~~~~kl~Dfg~~~~~~~ 199 (333)
T 1mqb_A 123 IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVN-SNLVCKVSDFGLSRVLED 199 (333)
T ss_dssp EEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTCCEEECCCCC------
T ss_pred EEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChheEEEC-CCCcEEECCCCcchhhcc
Confidence 689999999999999865 57999999999999999999999999 99999999999998 557999999999976543
Q ss_pred CC-----CccccCCCCccCccccc-ccCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCCCCccccCCCh
Q 008504 80 PT-----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDP 152 (563)
Q Consensus 80 ~~-----~~~~~Gtp~Y~APEvl~-~~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~ 152 (563)
.. .....+++.|+|||++. ..++.++|||||||++|+|++ |..||.. .....+...+..+..+. .+...++
T Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~-~~~~~~~~~~~~~~~~~-~~~~~~~ 277 (333)
T 1mqb_A 200 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE-LSNHEVMKAINDGFRLP-TPMDCPS 277 (333)
T ss_dssp -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHHTTCCCC-CCTTCBH
T ss_pred ccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCccc-CCHHHHHHHHHCCCcCC-CcccCCH
Confidence 21 11234578899999886 458999999999999999999 9999987 34556666666654432 3445678
Q ss_pred hHHHHHHHhcC-CCCCCCCHHHHHcC
Q 008504 153 QIKGFIEKCLV-PASERLSAKDLLKD 177 (563)
Q Consensus 153 ~l~~LI~kcL~-dP~kRpSa~ELLkH 177 (563)
.+.+||.+||. +|.+||++.+++++
T Consensus 278 ~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 278 AIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999997 89999999999874
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=5.9e-29 Score=247.94 Aligned_cols=171 Identities=26% Similarity=0.408 Sum_probs=143.2
Q ss_pred CEeccCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhcc
Q 008504 1 MITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~--~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~ 78 (563)
+||||+.+|+|.+++... ..+++..++.++.||+.||.|||++| |+||||||+||+++ .++.+||+|||++....
T Consensus 86 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~-~~~~~~l~Dfg~~~~~~ 162 (288)
T 3kfa_A 86 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVG-ENHLVKVADFGLSRLMT 162 (288)
T ss_dssp EEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT--CCCSCCSGGGEEEC-GGGCEEECCCCGGGTSC
T ss_pred EEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC--ccCCCCCcceEEEc-CCCCEEEccCccceecc
Confidence 589999999999999874 44999999999999999999999999 99999999999997 45799999999997665
Q ss_pred CCCC---ccccCCCCccCccccc-ccCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCCCCccccCCChh
Q 008504 79 QPTA---RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQ 153 (563)
Q Consensus 79 ~~~~---~~~~Gtp~Y~APEvl~-~~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~ 153 (563)
.... ....+++.|+|||++. ..++.++||||||+++|+|++ |..||.. .........+...... ..+...++.
T Consensus 163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~ 240 (288)
T 3kfa_A 163 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLEKDYRM-ERPEGCPEK 240 (288)
T ss_dssp SSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-CCGGGHHHHHHTTCCC-CCCTTCCHH
T ss_pred CCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHhccCCC-CCCCCCCHH
Confidence 4322 2335678899999886 458999999999999999999 8999976 3445555555554333 345567889
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHHc
Q 008504 154 IKGFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 154 l~~LI~kcL~-dP~kRpSa~ELLk 176 (563)
+.+||.+||. +|.+|||+.++++
T Consensus 241 l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 241 VYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHhCCChhhCcCHHHHHH
Confidence 9999999998 8999999999986
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.7e-29 Score=255.73 Aligned_cols=173 Identities=21% Similarity=0.252 Sum_probs=136.7
Q ss_pred CEeccCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhh
Q 008504 1 MITELFTSGNLRQYRKK----HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 76 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k----~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~ 76 (563)
+||||+.+|+|.+++.. ...+++..++.++.||+.||.|||++| |+||||||+|||++ ..+.+||+|||++..
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dlkp~NIl~~-~~~~~kl~dfg~~~~ 183 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG--YAHRDLKPTNILLG-DEGQPVLMDLGSMNQ 183 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTSCEEECCCSSCEE
T ss_pred EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEc-CCCCEEEEecCcchh
Confidence 58999999999999986 467999999999999999999999999 99999999999997 557999999998754
Q ss_pred ccCCC-----------CccccCCCCccCcccccc----cCCchhhHHHhHHHHHHHhhcCCCCCCCC-CHHHHHHHHhcC
Q 008504 77 MQQPT-----------ARSVIGTPEFMAPELYEE----EYNELVDIYSFGMCILEMVTFEYPYSECK-NPAQIFKKVTSG 140 (563)
Q Consensus 77 ~~~~~-----------~~~~~Gtp~Y~APEvl~~----~ys~ksDIwSLGviLyELlTG~~Pf~~~~-~~~~i~~~i~~~ 140 (563)
..... .....|++.|+|||++.+ .++.++|||||||++|+|++|+.||.... ........+...
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~ 263 (317)
T 2buj_A 184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQ 263 (317)
T ss_dssp SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC
T ss_pred cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhcc
Confidence 42211 112357999999998853 26899999999999999999999995310 001112222222
Q ss_pred CCCCccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcC
Q 008504 141 IKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 177 (563)
Q Consensus 141 ~~p~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkH 177 (563)
.........++.+.+||.+||. +|.+|||+.+++++
T Consensus 264 -~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 264 -LSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp ---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -CCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 2222334567899999999997 89999999999986
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=7.3e-29 Score=260.38 Aligned_cols=171 Identities=22% Similarity=0.424 Sum_probs=133.1
Q ss_pred CEeccCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~-~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
|||||+++|+|.+++.+.+ .+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++.....
T Consensus 123 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~-~~~~~kl~Dfg~a~~~~~ 199 (373)
T 2qol_A 123 IVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILIN-SNLVCKVSDFGLGRVLED 199 (373)
T ss_dssp EEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTCCEEECCC--------
T ss_pred EEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEEc-CCCCEEECcCcccccccc
Confidence 6899999999999998754 6999999999999999999999999 99999999999998 457999999999976543
Q ss_pred CC-----CccccCCCCccCccccc-ccCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCCCCccccCCCh
Q 008504 80 PT-----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDP 152 (563)
Q Consensus 80 ~~-----~~~~~Gtp~Y~APEvl~-~~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~ 152 (563)
.. .....+++.|+|||++. ..++.++|||||||++|+|++ |+.||... ....+...+..+.... .+...+.
T Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~-~~~~~~~~i~~~~~~~-~~~~~~~ 277 (373)
T 2qol_A 200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM-SNQDVIKAVDEGYRLP-PPMDCPA 277 (373)
T ss_dssp --------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTC-CHHHHHHHHHTTEECC-CCTTCBH
T ss_pred CCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHcCCCCC-CCccccH
Confidence 21 11224567899999886 458999999999999999998 99999873 4556666665553322 2445678
Q ss_pred hHHHHHHHhcC-CCCCCCCHHHHHc
Q 008504 153 QIKGFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 153 ~l~~LI~kcL~-dP~kRpSa~ELLk 176 (563)
.+.+||.+||. +|.+||++.++++
T Consensus 278 ~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 278 ALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHhCcChhhCcCHHHHHH
Confidence 99999999997 8999999999987
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.5e-29 Score=251.48 Aligned_cols=174 Identities=25% Similarity=0.383 Sum_probs=138.9
Q ss_pred CEeccCCCCCHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhc
Q 008504 1 MITELFTSGNLRQYRKK---HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM 77 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k---~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~ 77 (563)
+||||+++|+|.+++.. .+.+++..++.++.||+.||.|||++| |+||||||+||+++ .++.+||+|||++...
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~Nili~-~~~~~kl~Dfg~~~~~ 183 (307)
T 2nru_A 107 LVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH--HIHRDIKSANILLD-EAFTAKISDFGLARAS 183 (307)
T ss_dssp EEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEC-TTCCEEECCCTTCEEC
T ss_pred EEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHEEEc-CCCcEEEeeccccccc
Confidence 58999999999999974 356999999999999999999999999 99999999999998 5579999999998755
Q ss_pred cCCC----CccccCCCCccCcccccccCCchhhHHHhHHHHHHHhhcCCCCCCCCCHH---HHHHHHhcCCC--------
Q 008504 78 QQPT----ARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPA---QIFKKVTSGIK-------- 142 (563)
Q Consensus 78 ~~~~----~~~~~Gtp~Y~APEvl~~~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~---~i~~~i~~~~~-------- 142 (563)
.... .....|++.|+|||++.+.++.++||||||+++|+|++|..||....... .+...+.....
T Consensus 184 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (307)
T 2nru_A 184 EKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDK 263 (307)
T ss_dssp CSCSSCEECSSCCSCGGGCCHHHHTTEECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCS
T ss_pred ccccccccccccCCCcCcCChHHhcCCCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccc
Confidence 4321 23457899999999998889999999999999999999999997643321 22222222111
Q ss_pred -CCccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcC
Q 008504 143 -PASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 177 (563)
Q Consensus 143 -p~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkH 177 (563)
....+...+..+.++|.+||. +|.+|||+.+++++
T Consensus 264 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 264 KMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp SCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred cccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 011122234578999999997 89999999999864
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.6e-29 Score=261.08 Aligned_cols=169 Identities=21% Similarity=0.289 Sum_probs=131.5
Q ss_pred CEeccCCCCCHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCC----------CCc
Q 008504 1 MITELFTSGNLRQYRKK-----HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGN----------HGE 65 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k-----~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~----------~G~ 65 (563)
||||||++|+|.+++.. .+.+++..++.|+.||+.||.|||++| |+||||||+|||++.. .+.
T Consensus 144 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~--ivHrDiKp~NIll~~~~~~~~~~~~~~~~ 221 (365)
T 3e7e_A 144 LVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE--IIHGDIKPDNFILGNGFLEQDDEDDLSAG 221 (365)
T ss_dssp EEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECGGGTCC------CTT
T ss_pred EEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEecccccCccccccccCC
Confidence 69999999999999974 457999999999999999999999999 9999999999999741 579
Q ss_pred EEEecccchhhcc----CCCCccccCCCCccCccccccc-CCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcC
Q 008504 66 VKIGDLGLAIAMQ----QPTARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG 140 (563)
Q Consensus 66 VKL~DFGlA~~~~----~~~~~~~~Gtp~Y~APEvl~~~-ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~ 140 (563)
+||+|||+++.+. .......+||+.|+|||++.+. |+.++|||||||++|+|+||+.||........ ....
T Consensus 222 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~----~~~~ 297 (365)
T 3e7e_A 222 LALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC----KPEG 297 (365)
T ss_dssp EEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE----EECS
T ss_pred EEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce----eech
Confidence 9999999996543 1123456799999999988754 89999999999999999999999964211000 0000
Q ss_pred CCCCccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCc
Q 008504 141 IKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDP 178 (563)
Q Consensus 141 ~~p~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHp 178 (563)
... ....+..+.+++.+||. +|.+|++..+.+.+.
T Consensus 298 ~~~---~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~ 333 (365)
T 3e7e_A 298 LFR---RLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQK 333 (365)
T ss_dssp CCT---TCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHH
T ss_pred hcc---ccCcHHHHHHHHHHHcCCCCCCcchHHHHHHHH
Confidence 000 11235678999999997 788886544444433
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=7.3e-29 Score=260.84 Aligned_cols=172 Identities=23% Similarity=0.384 Sum_probs=133.5
Q ss_pred CEeccCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~-~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
|||||+.+|+|.+++.+. ..+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||+++....
T Consensus 168 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~-~~~~~kL~DFG~a~~~~~ 244 (373)
T 3c1x_A 168 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLD-EKFTVKVADFGLARDMYD 244 (373)
T ss_dssp EEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTCCEEECCC--------
T ss_pred EEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EecCccchheEEEC-CCCCEEEeeccccccccc
Confidence 589999999999999865 45899999999999999999999999 99999999999998 557999999999975533
Q ss_pred CC------CccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCCCCccccCCC
Q 008504 80 PT------ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVND 151 (563)
Q Consensus 80 ~~------~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s 151 (563)
.. .....+++.|+|||++.+ .++.++|||||||++|+|+| |..||.... .......+..+..+ ..+...+
T Consensus 245 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~-~~~~~~~~~~~~~~-~~p~~~~ 322 (373)
T 3c1x_A 245 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-TFDITVYLLQGRRL-LQPEYCP 322 (373)
T ss_dssp -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC-SSCHHHHHHTTCCC-CCCTTCC
T ss_pred cccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCC-HHHHHHHHHcCCCC-CCCCCCC
Confidence 21 123456788999998864 58999999999999999999 677776533 33344445554433 3355678
Q ss_pred hhHHHHHHHhcC-CCCCCCCHHHHHcC
Q 008504 152 PQIKGFIEKCLV-PASERLSAKDLLKD 177 (563)
Q Consensus 152 ~~l~~LI~kcL~-dP~kRpSa~ELLkH 177 (563)
+.+.++|.+||. +|.+|||+.+++++
T Consensus 323 ~~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 323 DPLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 899999999997 89999999999874
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-29 Score=269.62 Aligned_cols=169 Identities=18% Similarity=0.242 Sum_probs=135.2
Q ss_pred EeccCCCCCHHHHHHh-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccch
Q 008504 2 ITELFTSGNLRQYRKK-------HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA 74 (563)
Q Consensus 2 VmEy~~gGsL~~~L~k-------~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA 74 (563)
+|+++ +|+|.+++.. .+.+++..+..++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++
T Consensus 183 ~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--iiHrDiKp~NILl~-~~~~~kL~DFG~a 258 (413)
T 3dzo_A 183 LYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LVHTYLRPVDIVLD-QRGGVFLTGFEHL 258 (413)
T ss_dssp EEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEC-TTCCEEECCGGGC
T ss_pred Eeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcccceEEEe-cCCeEEEEeccce
Confidence 45544 6799999852 234888899999999999999999999 99999999999998 4578999999998
Q ss_pred hhccCCCCccccCCCCccCcccc----------cc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCC
Q 008504 75 IAMQQPTARSVIGTPEFMAPELY----------EE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP 143 (563)
Q Consensus 75 ~~~~~~~~~~~~Gtp~Y~APEvl----------~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p 143 (563)
+..... ....+| +.|+|||++ .. .|+.++|||||||++|+|+||+.||.... .......+...
T Consensus 259 ~~~~~~-~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~-~~~~~~~~~~~--- 332 (413)
T 3dzo_A 259 VRDGAS-AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDA-ALGGSEWIFRS--- 332 (413)
T ss_dssp EETTEE-ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTG-GGSCSGGGGSS---
T ss_pred eecCCc-cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcc-hhhhHHHHHhh---
Confidence 765433 345577 999999988 32 37889999999999999999999997632 21111111111
Q ss_pred CccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCcccccc
Q 008504 144 ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 183 (563)
Q Consensus 144 ~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~ 183 (563)
....++.+++||.+||. +|.+||++.++++||||+..
T Consensus 333 ---~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~ 370 (413)
T 3dzo_A 333 ---CKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL 370 (413)
T ss_dssp ---CCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred ---cccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHH
Confidence 12456899999999998 89999999999999999754
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=7.9e-29 Score=253.00 Aligned_cols=173 Identities=27% Similarity=0.447 Sum_probs=138.8
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCeEeccCccCceEEeCCCCcEEEeccc
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLH--------SHNPPIIHRDLKCDNIFVNGNHGEVKIGDLG 72 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLH--------s~gp~IIHrDLKP~NILLd~~~G~VKL~DFG 72 (563)
+||||+++|+|.+++.+ ..+++..++.++.||+.||.||| ++| |+||||||+|||++ .++.+||+|||
T Consensus 117 lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dlkp~NIll~-~~~~~kL~Dfg 192 (342)
T 1b6c_B 117 LVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA--IAHRDLKSKNILVK-KNGTCCIADLG 192 (342)
T ss_dssp EEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE--EECSCCSGGGEEEC-TTSCEEECCCT
T ss_pred EEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC--eeeCCCCHHHEEEC-CCCCEEEEECC
Confidence 58999999999999987 46999999999999999999999 888 99999999999998 45799999999
Q ss_pred chhhccCCC------CccccCCCCccCccccccc-------CCchhhHHHhHHHHHHHhhc----------CCCCCCCC-
Q 008504 73 LAIAMQQPT------ARSVIGTPEFMAPELYEEE-------YNELVDIYSFGMCILEMVTF----------EYPYSECK- 128 (563)
Q Consensus 73 lA~~~~~~~------~~~~~Gtp~Y~APEvl~~~-------ys~ksDIwSLGviLyELlTG----------~~Pf~~~~- 128 (563)
++....... .....||+.|+|||++.+. ++.++|||||||++|+|+|| ..||....
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~ 272 (342)
T 1b6c_B 193 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 272 (342)
T ss_dssp TCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred CceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCc
Confidence 997654332 2345799999999988653 34789999999999999999 78886532
Q ss_pred ---CHHHHHHHHhcCCCCCcccc-----CCChhHHHHHHHhcC-CCCCCCCHHHHHcC
Q 008504 129 ---NPAQIFKKVTSGIKPASLAK-----VNDPQIKGFIEKCLV-PASERLSAKDLLKD 177 (563)
Q Consensus 129 ---~~~~i~~~i~~~~~p~~l~~-----~~s~~l~~LI~kcL~-dP~kRpSa~ELLkH 177 (563)
....+...+........++. .....+.+||.+||. +|.+|||+.++++|
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 273 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred CcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 23444444444333222222 123578999999997 89999999999985
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=6e-29 Score=253.86 Aligned_cols=173 Identities=23% Similarity=0.407 Sum_probs=140.9
Q ss_pred CEeccCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k-~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
|||||+++|+|.+++.. .+.+++..++.|+.||+.||.|||++| |+||||||+|||++ .++.+||+|||++.....
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~-~~~~~kl~Dfg~~~~~~~ 179 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR--CVHRDLAARNILVE-SEAHVKIADFGLAKLLPL 179 (327)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEE-ETTEEEECCGGGCEECCT
T ss_pred EEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChhhEEEC-CCCCEEEcccccceeccc
Confidence 58999999999999987 456999999999999999999999999 99999999999998 457999999999976543
Q ss_pred CC-----CccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCC--------------HHHHHHHHhc
Q 008504 80 PT-----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKN--------------PAQIFKKVTS 139 (563)
Q Consensus 80 ~~-----~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~--------------~~~i~~~i~~ 139 (563)
.. .....|++.|+|||++.+ .++.++|||||||++|+|++|..||..... .......+..
T Consensus 180 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (327)
T 3lxl_A 180 DKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEE 259 (327)
T ss_dssp TCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHT
T ss_pred CCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhc
Confidence 22 223467888999998865 489999999999999999999999854211 1222333333
Q ss_pred CCCCCccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcC
Q 008504 140 GIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 177 (563)
Q Consensus 140 ~~~p~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkH 177 (563)
+.. ...+...++.+++||.+||. +|.+|||+.+++++
T Consensus 260 ~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 260 GQR-LPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp TCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccC-CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 332 33456678899999999997 89999999999764
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.95 E-value=9.8e-29 Score=269.47 Aligned_cols=173 Identities=18% Similarity=0.336 Sum_probs=140.5
Q ss_pred CEeccCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEe--CCCCcEEEecccchhhc
Q 008504 1 MITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN--GNHGEVKIGDLGLAIAM 77 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k-~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd--~~~G~VKL~DFGlA~~~ 77 (563)
|||||+ +|+|.+++.. .+.+++..++.|+.||+.||.|||++| |+||||||+||||+ ...+.+||+|||+++..
T Consensus 80 lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (483)
T 3sv0_A 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (483)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred EEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCcceEEEecCCCCCeEEEEeCCcceec
Confidence 689999 8999999985 567999999999999999999999999 99999999999994 25679999999999765
Q ss_pred cCCC---------CccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCC--HHHHHHHHhcCC---C
Q 008504 78 QQPT---------ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKN--PAQIFKKVTSGI---K 142 (563)
Q Consensus 78 ~~~~---------~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~--~~~i~~~i~~~~---~ 142 (563)
.... .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||..... ....+..+.... .
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (483)
T 3sv0_A 157 RDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATS 236 (483)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSC
T ss_pred cCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccccc
Confidence 4322 125679999999998865 589999999999999999999999976432 233333332221 1
Q ss_pred CCccccCCChhHHHHHHHhcC-CCCCCCCHHHHHc
Q 008504 143 PASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 143 p~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLk 176 (563)
...+....++++.+||.+||. +|.+||++.+|++
T Consensus 237 ~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp HHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 122335567899999999997 8999999988765
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-28 Score=276.35 Aligned_cols=171 Identities=21% Similarity=0.357 Sum_probs=144.8
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
||||||.+|+|.+++...+.+++..++.|+.||+.||.|||++| |+||||||+||||+ ..+.+||+|||+++.+...
T Consensus 446 lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~--iiHrDLkp~NILl~-~~~~~kL~DFGla~~~~~~ 522 (635)
T 4fl3_A 446 LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLV-TQHYAKISDFGLSKALRAD 522 (635)
T ss_dssp EEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEE-ETTEEEECCTTHHHHTTC-
T ss_pred EEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeCCCCChHhEEEe-CCCCEEEEEcCCccccccC
Confidence 68999999999999999889999999999999999999999999 99999999999998 4579999999999866432
Q ss_pred C-----CccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCCCCccccCCChh
Q 008504 81 T-----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQ 153 (563)
Q Consensus 81 ~-----~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~ 153 (563)
. .....+++.|+|||++.+ .++.++|||||||++|||++ |+.||.. .....+...+..+..+ ..+...++.
T Consensus 523 ~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~-~~~~~~~~~i~~~~~~-~~p~~~~~~ 600 (635)
T 4fl3_A 523 ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG-MKGSEVTAMLEKGERM-GCPAGCPRE 600 (635)
T ss_dssp ------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT-CCHHHHHHHHHTTCCC-CCCTTCCHH
T ss_pred ccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCC-CCCCCCCHH
Confidence 2 122346788999998865 59999999999999999998 9999987 4556666777666543 345567889
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHHc
Q 008504 154 IKGFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 154 l~~LI~kcL~-dP~kRpSa~ELLk 176 (563)
+.+||.+||. +|.+||++.++++
T Consensus 601 l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 601 MYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHH
Confidence 9999999998 8999999999975
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-29 Score=258.55 Aligned_cols=176 Identities=24% Similarity=0.351 Sum_probs=136.6
Q ss_pred CEeccCCCCCHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhh
Q 008504 1 MITELFTSGNLRQYRKKHK----NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 76 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~----~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~ 76 (563)
+||||+++|+|.+++.... .+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++..
T Consensus 112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~-~~~~~kl~Dfg~~~~ 188 (321)
T 2qkw_B 112 LIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA--IIHRDVKSINILLD-ENFVPKITDFGISKK 188 (321)
T ss_dssp EEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCSTTEEEC-TTCCEEECCCTTCEE
T ss_pred EEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC--eecCCCCHHHEEEC-CCCCEEEeecccccc
Confidence 5899999999999987543 5999999999999999999999999 99999999999998 557999999999975
Q ss_pred ccCC----CCccccCCCCccCccccc-ccCCchhhHHHhHHHHHHHhhcCCCCCCCCCH-----HHH-HHHHhcCCC---
Q 008504 77 MQQP----TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNP-----AQI-FKKVTSGIK--- 142 (563)
Q Consensus 77 ~~~~----~~~~~~Gtp~Y~APEvl~-~~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~-----~~i-~~~i~~~~~--- 142 (563)
.... ......||+.|+|||++. +.++.++|||||||++|+|++|+.||...... ... ......+..
T Consensus 189 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (321)
T 2qkw_B 189 GTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQI 268 (321)
T ss_dssp CSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSS
T ss_pred cccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHh
Confidence 4321 123346899999999885 56899999999999999999999999753221 111 111111111
Q ss_pred --C---CccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCcc
Q 008504 143 --P---ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPF 179 (563)
Q Consensus 143 --p---~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpf 179 (563)
+ .......+..+.++|.+||. +|.+|||+.++++|..
T Consensus 269 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 311 (321)
T 2qkw_B 269 VDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311 (321)
T ss_dssp SSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred cChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 1 11112224578999999997 8999999999998653
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.9e-28 Score=266.87 Aligned_cols=171 Identities=26% Similarity=0.408 Sum_probs=143.6
Q ss_pred CEeccCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhcc
Q 008504 1 MITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~--~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~ 78 (563)
||||||.+|+|.+++.+. ..+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||+++...
T Consensus 293 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~-~~~~~kl~DFG~a~~~~ 369 (495)
T 1opk_A 293 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRNLAARNCLVG-ENHLVKVADFGLSRLMT 369 (495)
T ss_dssp EEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-GGGCEEECCTTCEECCT
T ss_pred EEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChhhEEEC-CCCcEEEeecccceecc
Confidence 689999999999999864 45999999999999999999999999 99999999999997 45799999999997654
Q ss_pred CCC---CccccCCCCccCccccc-ccCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCCCCccccCCChh
Q 008504 79 QPT---ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQ 153 (563)
Q Consensus 79 ~~~---~~~~~Gtp~Y~APEvl~-~~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~ 153 (563)
... .....+++.|+|||++. +.++.++|||||||++|+|+| |..||... ...++...+..+... ..+...++.
T Consensus 370 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~ 447 (495)
T 1opk_A 370 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI-DLSQVYELLEKDYRM-ERPEGCPEK 447 (495)
T ss_dssp TCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC-CGGGHHHHHHTTCCC-CCCTTCCHH
T ss_pred CCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHcCCCC-CCCCCCCHH
Confidence 322 12234567899999886 458999999999999999999 89999874 445556666655443 345567889
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHHc
Q 008504 154 IKGFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 154 l~~LI~kcL~-dP~kRpSa~ELLk 176 (563)
+.+||.+||. +|.+|||+.++++
T Consensus 448 l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 448 VYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHcCcChhHCcCHHHHHH
Confidence 9999999997 8999999999986
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-28 Score=251.72 Aligned_cols=171 Identities=26% Similarity=0.439 Sum_probs=138.9
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
|||||+++|+|.+++.+. .+++..++.++.||+.||.|||++| |+||||||+|||++ ..+.+||+|||++......
T Consensus 112 lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~--ivH~Dikp~Nil~~-~~~~~kl~Dfg~a~~~~~~ 187 (318)
T 3lxp_A 112 LVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQH--YIHRDLAARNVLLD-NDRLVKIGDFGLAKAVPEG 187 (318)
T ss_dssp EEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTCCEEECCGGGCEECCTT
T ss_pred EEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEEc-CCCCEEECCcccccccccc
Confidence 589999999999999775 4999999999999999999999999 99999999999998 5579999999999766442
Q ss_pred C-----CccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCH--------------HHHHHHHhcC
Q 008504 81 T-----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNP--------------AQIFKKVTSG 140 (563)
Q Consensus 81 ~-----~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~--------------~~i~~~i~~~ 140 (563)
. .....+++.|+|||++.+ .++.++|||||||++|+|+||..||...... ......+..+
T Consensus 188 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (318)
T 3lxp_A 188 HEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERG 267 (318)
T ss_dssp CSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTT
T ss_pred ccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcc
Confidence 2 233467888999998865 5889999999999999999999998642111 1122222333
Q ss_pred CCCCccccCCChhHHHHHHHhcC-CCCCCCCHHHHHc
Q 008504 141 IKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 141 ~~p~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLk 176 (563)
. ....+...++.+.+||.+||. +|.+|||+.++++
T Consensus 268 ~-~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 268 E-RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp C-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred c-CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 2 333456678899999999998 8999999999985
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=1.6e-28 Score=264.14 Aligned_cols=171 Identities=24% Similarity=0.398 Sum_probs=140.2
Q ss_pred CEeccCCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhcc
Q 008504 1 MITELFTSGNLRQYRKK--HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k--~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~ 78 (563)
||||||++|+|.+++.. .+.+++..+..++.||+.||.|||++| |+||||||+|||++ .++.+||+|||+++...
T Consensus 255 iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~Nill~-~~~~~kl~DfG~a~~~~ 331 (452)
T 1fmk_A 255 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVG-ENLVCKVADFGLARLIE 331 (452)
T ss_dssp EEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-GGGCEEECCCCTTC---
T ss_pred EEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEEC-CCCCEEECCCccceecC
Confidence 68999999999999974 356999999999999999999999999 99999999999997 55799999999997654
Q ss_pred CCC---CccccCCCCccCccccc-ccCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCCCCccccCCChh
Q 008504 79 QPT---ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQ 153 (563)
Q Consensus 79 ~~~---~~~~~Gtp~Y~APEvl~-~~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~ 153 (563)
... .....+++.|+|||++. +.++.++|||||||++|+|++ |+.||.+ ....++...+..+.... .+...++.
T Consensus 332 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~-~~~~~~~~~i~~~~~~~-~~~~~~~~ 409 (452)
T 1fmk_A 332 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG-MVNREVLDQVERGYRMP-CPPECPES 409 (452)
T ss_dssp -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT-CCHHHHHHHHHTTCCCC-CCTTSCHH
T ss_pred CCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCCC-CCCCCCHH
Confidence 322 22335678899999886 458999999999999999999 8999987 45566666666665432 34567889
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHHc
Q 008504 154 IKGFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 154 l~~LI~kcL~-dP~kRpSa~ELLk 176 (563)
+.+||.+||. +|.+|||+.++++
T Consensus 410 l~~li~~cl~~dP~~Rpt~~~l~~ 433 (452)
T 1fmk_A 410 LHDLMCQCWRKEPEERPTFEYLQA 433 (452)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHccCChhhCcCHHHHHH
Confidence 9999999997 8999999999987
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=7.3e-29 Score=261.65 Aligned_cols=174 Identities=20% Similarity=0.376 Sum_probs=138.5
Q ss_pred CEeccCCCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEE----eCCCCcEEEecccc
Q 008504 1 MITELFTSGNLRQYRKKHK---NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV----NGNHGEVKIGDLGL 73 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~---~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILL----d~~~G~VKL~DFGl 73 (563)
||||||++|+|.+++.... .+++..++.++.||+.||.|||++| |+||||||+|||+ + ..+.+||+|||+
T Consensus 86 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~-~~~~~kL~DFG~ 162 (396)
T 4eut_A 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGED-GQSVYKLTDFGA 162 (396)
T ss_dssp EEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEECTT-SCEEEEECCGGG
T ss_pred EEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EEECCcCHHHEEEeecCC-CceeEEEecCCC
Confidence 5899999999999997643 3999999999999999999999999 9999999999998 4 345799999999
Q ss_pred hhhccCC-CCccccCCCCccCccccc---------ccCCchhhHHHhHHHHHHHhhcCCCCCCCC---CHHHHHHHHhcC
Q 008504 74 AIAMQQP-TARSVIGTPEFMAPELYE---------EEYNELVDIYSFGMCILEMVTFEYPYSECK---NPAQIFKKVTSG 140 (563)
Q Consensus 74 A~~~~~~-~~~~~~Gtp~Y~APEvl~---------~~ys~ksDIwSLGviLyELlTG~~Pf~~~~---~~~~i~~~i~~~ 140 (563)
+...... ......||+.|+|||++. ..++.++|||||||++|+|++|+.||.... ........+..+
T Consensus 163 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~ 242 (396)
T 4eut_A 163 ARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (396)
T ss_dssp CEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHS
T ss_pred ceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcC
Confidence 9765443 234567999999999875 357889999999999999999999996422 223444444444
Q ss_pred CCCCc-----------------------cccCCChhHHHHHHHhcC-CCCCCCCHHHHHcC
Q 008504 141 IKPAS-----------------------LAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 177 (563)
Q Consensus 141 ~~p~~-----------------------l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkH 177 (563)
.++.. +....++.+.+||.+||. ||.+||++.+++++
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~ 303 (396)
T 4eut_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303 (396)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred CCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence 33211 112234578999999997 89999999998654
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=4.4e-28 Score=271.12 Aligned_cols=176 Identities=19% Similarity=0.387 Sum_probs=143.5
Q ss_pred CEeccCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~-~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
||||||.+|+|.+++... ..+++..++.++.||+.||.|||++| |+||||||+||||+ ..+.+||+|||+++....
T Consensus 412 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiHrDlkp~NILl~-~~~~vkL~DFGla~~~~~ 488 (613)
T 2ozo_A 412 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRNLAARNVLLV-NRHYAKISDFGLSKALGA 488 (613)
T ss_dssp EEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEE-ETTEEEECCCSTTTTCC-
T ss_pred EEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCcCCHHHEEEc-CCCcEEEeeccCcccccC
Confidence 699999999999999754 45999999999999999999999999 99999999999998 457999999999976543
Q ss_pred CC-----CccccCCCCccCccccc-ccCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCCCCccccCCCh
Q 008504 80 PT-----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDP 152 (563)
Q Consensus 80 ~~-----~~~~~Gtp~Y~APEvl~-~~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~ 152 (563)
.. .....+++.|+|||++. +.++.++|||||||++|||++ |+.||.... ..++...+..+... ..+...++
T Consensus 489 ~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~-~~~~~~~i~~~~~~-~~p~~~~~ 566 (613)
T 2ozo_A 489 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK-GPEVMAFIEQGKRM-ECPPECPP 566 (613)
T ss_dssp -------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-SHHHHHHHHTTCCC-CCCTTCCH
T ss_pred CCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCC-HHHHHHHHHcCCCC-CCCCcCCH
Confidence 21 11224568999999886 569999999999999999998 999998744 45566666666543 34556789
Q ss_pred hHHHHHHHhcC-CCCCCCCHHHHHc---Ccccc
Q 008504 153 QIKGFIEKCLV-PASERLSAKDLLK---DPFLQ 181 (563)
Q Consensus 153 ~l~~LI~kcL~-dP~kRpSa~ELLk---Hpff~ 181 (563)
.+.+||.+||. +|.+||++.++++ +.|+.
T Consensus 567 ~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 599 (613)
T 2ozo_A 567 ELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 599 (613)
T ss_dssp HHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 99999999997 8999999999854 44443
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.7e-28 Score=248.21 Aligned_cols=172 Identities=27% Similarity=0.427 Sum_probs=138.5
Q ss_pred CEeccCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~-~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
|||||+++|+|.+++.+. ..+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++.....
T Consensus 121 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NIli~-~~~~~kL~Dfg~~~~~~~ 197 (326)
T 2w1i_A 121 LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVE-NENRVKIGDFGLTKVLPQ 197 (326)
T ss_dssp EEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEE-ETTEEEECCCTTCEECCS
T ss_pred EEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEEc-CCCcEEEecCcchhhccc
Confidence 589999999999999876 45999999999999999999999999 99999999999998 457999999999976543
Q ss_pred CC-----CccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCH---------------HHHHHHHh
Q 008504 80 PT-----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNP---------------AQIFKKVT 138 (563)
Q Consensus 80 ~~-----~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~---------------~~i~~~i~ 138 (563)
.. .....+++.|+|||++.+ .++.++|||||||++|+|+||..||...... ..+...+.
T Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (326)
T 2w1i_A 198 DKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 277 (326)
T ss_dssp SCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHH
T ss_pred cccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhh
Confidence 32 123456778999998864 4899999999999999999999888531000 01122233
Q ss_pred cCCCCCccccCCChhHHHHHHHhcC-CCCCCCCHHHHHc
Q 008504 139 SGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 139 ~~~~p~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLk 176 (563)
.+..+ ..+...++.+.+||.+||. +|.+|||+.++++
T Consensus 278 ~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 278 NNGRL-PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp TTCCC-CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred cCCCC-CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 33222 3355678899999999997 8999999999985
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=5.1e-28 Score=266.07 Aligned_cols=171 Identities=24% Similarity=0.399 Sum_probs=144.1
Q ss_pred CEeccCCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhcc
Q 008504 1 MITELFTSGNLRQYRKK--HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k--~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~ 78 (563)
||||||.+|+|.+++.. .+.+++..++.|+.||+.||.|||++| |+||||||+||||+ .++.+||+|||+++...
T Consensus 338 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~-~~~~~kl~DFG~a~~~~ 414 (535)
T 2h8h_A 338 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVG-ENLVCKVADFGLARLIE 414 (535)
T ss_dssp EEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-GGGCEEECCTTSTTTCC
T ss_pred EeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEEc-CCCcEEEcccccceecC
Confidence 69999999999999974 356999999999999999999999999 99999999999997 45799999999997654
Q ss_pred CC---CCccccCCCCccCccccc-ccCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCCCCccccCCChh
Q 008504 79 QP---TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQ 153 (563)
Q Consensus 79 ~~---~~~~~~Gtp~Y~APEvl~-~~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~ 153 (563)
.. ......+++.|+|||++. +.++.++|||||||++|||++ |+.||.. ....++...+..+.... .+...+..
T Consensus 415 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~-~~~~~~~~~i~~~~~~~-~~~~~~~~ 492 (535)
T 2h8h_A 415 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG-MVNREVLDQVERGYRMP-CPPECPES 492 (535)
T ss_dssp CHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTT-CCHHHHHHHHHTTCCCC-CCTTCCHH
T ss_pred CCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCCC-CCCCCCHH
Confidence 32 122335678899999876 458999999999999999999 8999987 44556666666664432 34567889
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHHc
Q 008504 154 IKGFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 154 l~~LI~kcL~-dP~kRpSa~ELLk 176 (563)
+.+||.+||. +|.+|||+.+|++
T Consensus 493 l~~li~~cl~~dP~~RPt~~~l~~ 516 (535)
T 2h8h_A 493 LHDLMCQCWRKEPEERPTFEYLQA 516 (535)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHcCCChhHCcCHHHHHH
Confidence 9999999997 8999999999987
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.95 E-value=5.8e-29 Score=255.27 Aligned_cols=170 Identities=21% Similarity=0.176 Sum_probs=133.6
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCeEeccCccCceEEeCCCC---------------
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLH-SHNPPIIHRDLKCDNIFVNGNHG--------------- 64 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLH-s~gp~IIHrDLKP~NILLd~~~G--------------- 64 (563)
||||||.+|+|.+.+.+ +.+++..++.|+.||+.||.||| ++| |+||||||+|||++.+ |
T Consensus 139 lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~~--ivHrDlKp~NILl~~~-~~~~~~~~~~~~~~~~ 214 (336)
T 2vuw_A 139 IVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLAVAEASLR--FEHRDLHWGNVLLKKT-SLKKLHYTLNGKSSTI 214 (336)
T ss_dssp EEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHHHHHHHHC--CBCSCCCGGGEEEEEC-SCSEEEEEETTEEEEE
T ss_pred EEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHhCC--EeECCCCHHHEEEecc-CCcceeeeccCccccc
Confidence 69999999976666644 67999999999999999999999 999 9999999999999844 4
Q ss_pred -----cEEEecccchhhccCCCCccccCCCCccCcccccccCCchhhHHHhHHH-HHHHhhcCCCCCCCCCHHHHHHHHh
Q 008504 65 -----EVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMC-ILEMVTFEYPYSECKNPAQIFKKVT 138 (563)
Q Consensus 65 -----~VKL~DFGlA~~~~~~~~~~~~Gtp~Y~APEvl~~~ys~ksDIwSLGvi-LyELlTG~~Pf~~~~~~~~i~~~i~ 138 (563)
.+||+|||+++..... ..+||+.|+|||++.+..+.++||||||++ .+++++|..||............+.
T Consensus 215 ~~~~~~vkL~DFG~a~~~~~~---~~~gt~~y~aPE~~~g~~~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~ 291 (336)
T 2vuw_A 215 PSCGLQVSIIDYTLSRLERDG---IVVFCDVSMDEDLFTGDGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKML 291 (336)
T ss_dssp ECTTEEEEECCCTTCBEEETT---EEECCCCTTCSGGGCCCSSHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHH
T ss_pred cCCCceEEEeeccccEecCCC---cEEEeecccChhhhcCCCccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhh
Confidence 8999999999766542 458999999999998877999999998776 7888999999854111122222332
Q ss_pred cCC-----CCCccccCCChhHHHHHHHhcCCCCCCCCHHHHH-cCcccc
Q 008504 139 SGI-----KPASLAKVNDPQIKGFIEKCLVPASERLSAKDLL-KDPFLQ 181 (563)
Q Consensus 139 ~~~-----~p~~l~~~~s~~l~~LI~kcL~dP~kRpSa~ELL-kHpff~ 181 (563)
... .+.......++++++||.+||..+ |+.|+| +||||+
T Consensus 292 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 292 KQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS----SATDLLCQHSLFK 336 (336)
T ss_dssp HTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS----SHHHHHHHCGGGC
T ss_pred hhhccCcccchhhhhhcCHHHHHHHHHHhccC----CHHHHHhcCCCcC
Confidence 211 111222345678999999999832 999999 999995
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.9e-27 Score=268.21 Aligned_cols=171 Identities=27% Similarity=0.494 Sum_probs=142.1
Q ss_pred CEeccCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~-~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
|||||+++|+|.+++...+ .+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++.....
T Consensus 467 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDikp~NILl~-~~~~vkL~DFG~a~~~~~ 543 (656)
T 2j0j_A 467 IIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVS-SNDCVKLGDFGLSRYMED 543 (656)
T ss_dssp EEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEE-ETTEEEECCCCCCCSCCC
T ss_pred EEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchHhEEEe-CCCCEEEEecCCCeecCC
Confidence 5899999999999998654 6999999999999999999999999 99999999999998 457999999999976543
Q ss_pred CC---CccccCCCCccCccccc-ccCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhH
Q 008504 80 PT---ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQI 154 (563)
Q Consensus 80 ~~---~~~~~Gtp~Y~APEvl~-~~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l 154 (563)
.. .....+++.|+|||++. ..++.++|||||||++|+|++ |..||.+ .........+..+..+. .+...++.+
T Consensus 544 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~-~~~~~~~~~i~~~~~~~-~~~~~~~~l 621 (656)
T 2j0j_A 544 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG-VKNNDVIGRIENGERLP-MPPNCPPTL 621 (656)
T ss_dssp ----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHHHTCCCC-CCTTCCHHH
T ss_pred CcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHHcCCCCC-CCccccHHH
Confidence 32 12345678999999886 458999999999999999997 8999987 44555666666554432 455678899
Q ss_pred HHHHHHhcC-CCCCCCCHHHHHc
Q 008504 155 KGFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 155 ~~LI~kcL~-dP~kRpSa~ELLk 176 (563)
.+||.+||. +|.+|||+.++++
T Consensus 622 ~~li~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 622 YSLMTKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHcCCChhHCcCHHHHHH
Confidence 999999997 8999999999986
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=5.7e-28 Score=272.72 Aligned_cols=182 Identities=29% Similarity=0.426 Sum_probs=141.7
Q ss_pred CEeccCCCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCC--cEEEecccchh
Q 008504 1 MITELFTSGNLRQYRKKHK---NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHG--EVKIGDLGLAI 75 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~---~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G--~VKL~DFGlA~ 75 (563)
||||||+||+|.+++...+ .+++..++.++.||+.||.|||++| |+||||||+||+++.+.+ .+||+|||++.
T Consensus 95 LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g--IVHrDLKP~NILl~~~g~~~~vKL~DFG~a~ 172 (676)
T 3qa8_A 95 LAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR--IIHRDLKPENIVLQPGPQRLIHKIIDLGYAK 172 (676)
T ss_dssp CEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT--BCCCCCCSTTEEEECCSSSCEEEECSCCCCC
T ss_pred EEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEeecCCCceeEEEccccccc
Confidence 6999999999999998754 5999999999999999999999999 999999999999984322 48999999997
Q ss_pred hccCC-CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHh-------------cC
Q 008504 76 AMQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVT-------------SG 140 (563)
Q Consensus 76 ~~~~~-~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~-------------~~ 140 (563)
..... ......|++.|+|||++.+ .++.++|||||||++|+|++|..||.....+......+. .+
T Consensus 173 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g 252 (676)
T 3qa8_A 173 ELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTG 252 (676)
T ss_dssp BTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCSS
T ss_pred ccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhcc
Confidence 66543 2345689999999998864 589999999999999999999999976332222111000 00
Q ss_pred --------CCCCccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCccccccc
Q 008504 141 --------IKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 184 (563)
Q Consensus 141 --------~~p~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~ 184 (563)
..+..+....++.+.+||.+||. +|.+|||+.++++||||+...
T Consensus 253 ~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~ 305 (676)
T 3qa8_A 253 AVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALD 305 (676)
T ss_dssp SCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHH
T ss_pred ccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHH
Confidence 00111223345789999999998 899999999999999997543
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.93 E-value=5.2e-27 Score=264.82 Aligned_cols=165 Identities=19% Similarity=0.302 Sum_probs=134.9
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
|||||++||+|.+++.. .+++..++.|+.||+.||.|||++| |+||||||+|||++. +.+||+|||++......
T Consensus 161 lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~g--iiHrDlkp~NIll~~--~~~kl~DFG~a~~~~~~ 234 (681)
T 2pzi_A 161 IVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIG--LVYNDLKPENIMLTE--EQLKLIDLGAVSRINSF 234 (681)
T ss_dssp EEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECS--SCEEECCCTTCEETTCC
T ss_pred EEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCC--CeecccChHHeEEeC--CcEEEEecccchhcccC
Confidence 68999999999998765 7999999999999999999999999 999999999999984 48999999999766543
Q ss_pred CCccccCCCCccCcccccccCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHHHHHH
Q 008504 81 TARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEK 160 (563)
Q Consensus 81 ~~~~~~Gtp~Y~APEvl~~~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~LI~k 160 (563)
....||+.|+|||++.+.++.++|||||||++|+|++|..||.... .............++.+.+||.+
T Consensus 235 --~~~~gt~~y~aPE~~~~~~~~~sDi~slG~~l~~l~~g~~~~~~~~---------~~~~~~~~~~~~~~~~l~~li~~ 303 (681)
T 2pzi_A 235 --GYLYGTPGFQAPEIVRTGPTVATDIYTVGRTLAALTLDLPTRNGRY---------VDGLPEDDPVLKTYDSYGRLLRR 303 (681)
T ss_dssp --SCCCCCTTTSCTTHHHHCSCHHHHHHHHHHHHHHHHSCCCEETTEE---------CSSCCTTCHHHHHCHHHHHHHHH
T ss_pred --CccCCCccccCHHHHcCCCCCceehhhhHHHHHHHHhCCCCCcccc---------cccccccccccccCHHHHHHHhh
Confidence 4567999999999998888999999999999999999988886411 01111111111235689999999
Q ss_pred hcC-CCCCCCCHHHHHcCccccc
Q 008504 161 CLV-PASERLSAKDLLKDPFLQV 182 (563)
Q Consensus 161 cL~-dP~kRpSa~ELLkHpff~~ 182 (563)
||. +|.+||+..+.+.|+|+..
T Consensus 304 ~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 304 AIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp HTCSSGGGSCSSHHHHHHHHHHH
T ss_pred hccCChhhCCCHHHHHHHHHHHH
Confidence 997 8999999999999999864
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.90 E-value=2e-24 Score=218.42 Aligned_cols=147 Identities=16% Similarity=0.147 Sum_probs=115.1
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
|||||++||+|.+++++. .....+..|+.||+.||.|||++| |+||||||+|||++ .+|.+||+++|
T Consensus 108 lv~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~g--ivH~Dikp~NIll~-~~g~~kl~~~~-------- 174 (286)
T 3uqc_A 108 VVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAG--VALSIDHPSRVRVS-IDGDVVLAYPA-------- 174 (286)
T ss_dssp EEEECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEE-TTSCEEECSCC--------
T ss_pred EEEEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCC--CccCCCCcccEEEc-CCCCEEEEecc--------
Confidence 689999999999999643 466678899999999999999999 99999999999998 55799998443
Q ss_pred CCccccCCCCccCcccccccCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHH---HHHHhcCCC-CCccccCCChhHHH
Q 008504 81 TARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQI---FKKVTSGIK-PASLAKVNDPQIKG 156 (563)
Q Consensus 81 ~~~~~~Gtp~Y~APEvl~~~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i---~~~i~~~~~-p~~l~~~~s~~l~~ 156 (563)
|++| ++.++|||||||++|+|+||+.||........+ .+.+..... +.......++.+++
T Consensus 175 ----------~~~~------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 238 (286)
T 3uqc_A 175 ----------TMPD------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISA 238 (286)
T ss_dssp ----------CCTT------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHHH
T ss_pred ----------ccCC------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHHH
Confidence 3343 788999999999999999999999864322111 011111111 11233456789999
Q ss_pred HHHHhcC-CCCCCCCHHHHHcC
Q 008504 157 FIEKCLV-PASERLSAKDLLKD 177 (563)
Q Consensus 157 LI~kcL~-dP~kRpSa~ELLkH 177 (563)
||.+||. ||.+| |+.++++.
T Consensus 239 li~~~l~~dP~~R-s~~el~~~ 259 (286)
T 3uqc_A 239 VAARSVQGDGGIR-SASTLLNL 259 (286)
T ss_dssp HHHHHHCTTSSCC-CHHHHHHH
T ss_pred HHHHHcccCCccC-CHHHHHHH
Confidence 9999997 89999 99999983
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=9.6e-24 Score=234.46 Aligned_cols=117 Identities=15% Similarity=0.131 Sum_probs=86.6
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
|||||++||+|.++|.+.+++++. .|+.||+.||+|||++| ||||||||+|||++ .+|.+||+|||+|+.....
T Consensus 319 LVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~G--IIHRDIKPeNILL~-~dg~vKL~DFGlAr~~~~~ 392 (569)
T 4azs_A 319 LVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQG--FWHDDVRPWNVMVD-ARQHARLIDFGSIVTTPQD 392 (569)
T ss_dssp EEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTT--CEESCCCGGGEEEC-TTSCEEECCCTTEESCC--
T ss_pred EEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCC--ceeccCchHhEEEC-CCCCEEEeecccCeeCCCC
Confidence 699999999999999999889875 47899999999999999 99999999999998 5689999999999766533
Q ss_pred --CCccccCCCCccCcccccccCCchhhHHHhHHHHHHHhhcCCC
Q 008504 81 --TARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTFEYP 123 (563)
Q Consensus 81 --~~~~~~Gtp~Y~APEvl~~~ys~ksDIwSLGviLyELlTG~~P 123 (563)
...+.+||+.|||||++.+.+..++|+|++|+++++|.++..+
T Consensus 393 ~~~~~t~vGTp~YmAPE~l~g~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 393 CSWPTNLVQSFFVFVNELFAENKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp -CCSHHHHHHHHHHHHHHC-----------------CCCCTTHHH
T ss_pred CccccCceechhhccHHHhCCCCCCcccccccccchhhhccccch
Confidence 3445689999999999999888999999999999888766444
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.65 E-value=1.3e-17 Score=183.98 Aligned_cols=112 Identities=19% Similarity=0.259 Sum_probs=97.9
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
||||||+||+|.+++.+ +..|+.||+.||.|||++| |+||||||+|||++. .+||+|||+++.....
T Consensus 416 lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~g--IiHrDiKp~NILl~~---~~kL~DFGla~~~~~~ 482 (540)
T 3en9_A 416 IMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKND--VIHNDLTTSNFIFDK---DLYIIDFGLGKISNLD 482 (540)
T ss_dssp EEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTT--EECTTCCTTSEEESS---SEEECCCTTCEECCCH
T ss_pred EEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCc--CccCCCCHHHEEECC---eEEEEECccCEECCCc
Confidence 68999999999999876 6689999999999999999 999999999999984 8999999999876543
Q ss_pred C---------CccccCCCCccCcccccc---cCCchhhHHHhHHHHHHHhhcCCCCC
Q 008504 81 T---------ARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTFEYPYS 125 (563)
Q Consensus 81 ~---------~~~~~Gtp~Y~APEvl~~---~ys~ksDIwSLGviLyELlTG~~Pf~ 125 (563)
. .....||+.|||||++.. .|+..+|+|+..+-.++.+.++.+|.
T Consensus 483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 1 135689999999999974 58889999999999999888877774
|
| >2v3s_A Serine/threonine-protein kinase OSR1; ATP-binding, magnesium, metal-binding, nucleotide-binding, phosphorylation, polymorphism, transferase; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.59 E-value=1.7e-15 Score=127.06 Aligned_cols=60 Identities=25% Similarity=0.382 Sum_probs=58.3
Q ss_pred CceEEEEeecCCCCCcceeeecccCCCCCHHHHHHHHHHccCCCcccHHHHHHHHHHHHH
Q 008504 261 TSVSLTLRIADSSGRVRNIHFLFYLDSDTALSVAGEMVEQLDLADHDVAFIAEFIDYLIM 320 (563)
Q Consensus 261 ~~i~L~LRi~d~~~~~~~I~F~F~~~~DTa~~vA~EmV~~~~i~~~D~~~iA~~i~~~i~ 320 (563)
.+|+|+||++|+++++++|+|+|.+++|||++||+|||.+|+|++.|+.+||++|+++|.
T Consensus 1 ~pv~LvLRlRn~~rELnDIrFeF~~g~DTaegiA~ELv~AgLVDg~D~~vVAanL~klv~ 60 (96)
T 2v3s_A 1 GPISLVLRLRNSKKELNDIRFEFTPGRDTAEGVSQELISAGLVDGRDLVIVAANLQKIVE 60 (96)
T ss_dssp CCEEEEEEEECTTSCEEEEEEEECTTTCCHHHHHHHHHHTTSSCGGGHHHHHHHHHHHHH
T ss_pred CCeeEEEEeccccchhcceEEEeecCCCcHHHHHHHHHHCCCcccccHHHHHHHHHHHHh
Confidence 368999999999999999999999999999999999999999999999999999999987
|
| >2lru_A Serine/threonine-protein kinase WNK1; autoinhibitory domain, PF2 domain, transferase; NMR {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.19 E-value=5.5e-15 Score=125.39 Aligned_cols=64 Identities=31% Similarity=0.385 Sum_probs=59.4
Q ss_pred CCceEEEEeecCCC---CCcc---eeeecccCCCCCHHHHHHHHHHccCCCcccHHHHHHHHHHHHHHhC
Q 008504 260 DTSVSLTLRIADSS---GRVR---NIHFLFYLDSDTALSVAGEMVEQLDLADHDVAFIAEFIDYLIMKLL 323 (563)
Q Consensus 260 ~~~i~L~LRi~d~~---~~~~---~I~F~F~~~~DTa~~vA~EmV~~~~i~~~D~~~iA~~i~~~i~~l~ 323 (563)
+.+|+|+|||.|++ |+.| +|+|+|++++|||.+||+|||++|+|+++|+..||.+|+..|..+-
T Consensus 23 ~~~i~L~LRi~Dpkk~~gk~KeNeaIeF~Fdle~Dta~eVA~EMVe~~~l~e~D~~~VaklI~~~v~~~~ 92 (98)
T 2lru_A 23 KIAIKLWLRIEDIKKLKGKYKDNEAIEFSFDLERDVPEDVAQEMVESGYVCEGDHKTMAKAIKDRVSLIK 92 (98)
Confidence 57899999999994 8888 9999999999999999999999999999999999999999876553
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.41 E-value=3.3e-14 Score=143.96 Aligned_cols=76 Identities=21% Similarity=0.227 Sum_probs=65.2
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
|||||++||+|.+ +.. .....++.||+.||.|||++| |+||||||+|||++ +|.+||+|||+++.
T Consensus 177 lvmE~~~g~~L~~-l~~------~~~~~i~~qi~~~l~~lH~~g--iiHrDlkp~NILl~--~~~vkl~DFG~a~~---- 241 (282)
T 1zar_A 177 VLMELIDAKELYR-VRV------ENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLVS--EEGIWIIDFPQSVE---- 241 (282)
T ss_dssp EEEECCCCEEGGG-CCC------SCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEE--TTEEEECCCTTCEE----
T ss_pred EEEEecCCCcHHH-cch------hhHHHHHHHHHHHHHHHHHCC--CEeCCCCHHHEEEE--CCcEEEEECCCCeE----
Confidence 6999999999998 421 245579999999999999999 99999999999998 58999999999853
Q ss_pred CCccccCCCCccCccccc
Q 008504 81 TARSVIGTPEFMAPELYE 98 (563)
Q Consensus 81 ~~~~~~Gtp~Y~APEvl~ 98 (563)
+..++|||++.
T Consensus 242 -------~~~~~a~e~l~ 252 (282)
T 1zar_A 242 -------VGEEGWREILE 252 (282)
T ss_dssp -------TTSTTHHHHHH
T ss_pred -------CCCCCHHHHHH
Confidence 45578999875
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.08 E-value=4.1e-11 Score=119.20 Aligned_cols=69 Identities=17% Similarity=0.290 Sum_probs=58.0
Q ss_pred CEeccCCC-C----CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCeEeccCccCceEEeCCCCcEEEecccch
Q 008504 1 MITELFTS-G----NLRQYRKKHKNVDIKVIKNWARQILHGLVYLH-SHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA 74 (563)
Q Consensus 1 LVmEy~~g-G----sL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLH-s~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA 74 (563)
|||||+.+ | +|.++... .++..+..++.||+.||.||| ++| |+||||||+|||++. .++|+|||++
T Consensus 145 lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~g--ivHrDlkp~NILl~~---~~~liDFG~a 216 (258)
T 1zth_A 145 LLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAE--LVHADLSEYNIMYID---KVYFIDMGQA 216 (258)
T ss_dssp EEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSC--EECSSCSTTSEEESS---SEEECCCTTC
T ss_pred EEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHEEEcC---cEEEEECccc
Confidence 68999942 3 78877543 345678899999999999999 999 999999999999974 8999999999
Q ss_pred hhc
Q 008504 75 IAM 77 (563)
Q Consensus 75 ~~~ 77 (563)
...
T Consensus 217 ~~~ 219 (258)
T 1zth_A 217 VTL 219 (258)
T ss_dssp EET
T ss_pred ccC
Confidence 654
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=98.63 E-value=6.3e-09 Score=110.71 Aligned_cols=67 Identities=16% Similarity=0.222 Sum_probs=55.0
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCC----------cEEEec
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHG----------EVKIGD 70 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G----------~VKL~D 70 (563)
|||||+.|++|.++.. ......++.||+.+|.|||++| ||||||||.|||++.+ | .+.|+|
T Consensus 188 LVME~i~G~~L~~l~~------~~~~~~l~~qll~~l~~lH~~g--IVHrDLKp~NILl~~d-gd~~d~~~~~~~~~iID 258 (397)
T 4gyi_A 188 IVMSLVDALPMRQVSS------VPDPASLYADLIALILRLAKHG--LIHGDFNEFNILIREE-KDAEDPSSITLTPIIIX 258 (397)
T ss_dssp EEEECCSCEEGGGCCC------CSCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEEEE-ECSSCTTSEEEEEEECC
T ss_pred EEEEecCCccHhhhcc------cHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEEEeCC-CCcccccccccceEEEE
Confidence 6999999999876432 2245678899999999999999 9999999999999733 3 388999
Q ss_pred ccchhh
Q 008504 71 LGLAIA 76 (563)
Q Consensus 71 FGlA~~ 76 (563)
|+-+..
T Consensus 259 ~~Q~V~ 264 (397)
T 4gyi_A 259 FPQMVS 264 (397)
T ss_dssp CTTCEE
T ss_pred eCCccc
Confidence 997744
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=97.99 E-value=3.6e-06 Score=84.79 Aligned_cols=120 Identities=21% Similarity=0.160 Sum_probs=81.1
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHN------------------------------------ 44 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~g------------------------------------ 44 (563)
+|||+++|.+|..... ..++......++.|+...|..||+..
T Consensus 93 ~vm~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (304)
T 3sg8_A 93 AGFTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQM 170 (304)
T ss_dssp EEEECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHH
T ss_pred EEEcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccH
Confidence 4789999988875433 34788888889999999999998621
Q ss_pred --------------------CCeEeccCccCceEEeCC-CCcEEEecccchhhccCCCCccccCCCCc---cCccccc--
Q 008504 45 --------------------PPIIHRDLKCDNIFVNGN-HGEVKIGDLGLAIAMQQPTARSVIGTPEF---MAPELYE-- 98 (563)
Q Consensus 45 --------------------p~IIHrDLKP~NILLd~~-~G~VKL~DFGlA~~~~~~~~~~~~Gtp~Y---~APEvl~-- 98 (563)
+.++|+|++|.||+++.+ .+.+.|+||+.+..-... ........+ ..|+...
T Consensus 171 ~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~--~Dl~~~~~~~~~~~~~~~~~~ 248 (304)
T 3sg8_A 171 KKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPD--NDFISLMEDDEEYGMEFVSKI 248 (304)
T ss_dssp HHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTT--HHHHTTCCTTTSCCHHHHHHH
T ss_pred HHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChH--HHHHHHHhhccccCHHHHHHH
Confidence 237999999999999853 446789999987542211 000001111 2333221
Q ss_pred -ccC------------CchhhHHHhHHHHHHHhhcCCCC
Q 008504 99 -EEY------------NELVDIYSFGMCILEMVTFEYPY 124 (563)
Q Consensus 99 -~~y------------s~ksDIwSLGviLyELlTG~~Pf 124 (563)
..| ....+.|++|.++|.+.+|..+|
T Consensus 249 l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 249 LNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 111 22368999999999999998776
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=97.73 E-value=1.7e-05 Score=77.49 Aligned_cols=68 Identities=19% Similarity=0.124 Sum_probs=52.3
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHN------------------------------------ 44 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~g------------------------------------ 44 (563)
+||||++|.+|.+.+. +......++.++..+|..||+..
T Consensus 87 lv~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (263)
T 3tm0_A 87 LLMSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED 161 (263)
T ss_dssp EEEECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTT
T ss_pred EEEEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccc
Confidence 5899999999987631 22234578899999999999810
Q ss_pred ---------------------CCeEeccCccCceEEeCCCCcEEEecccch
Q 008504 45 ---------------------PPIIHRDLKCDNIFVNGNHGEVKIGDLGLA 74 (563)
Q Consensus 45 ---------------------p~IIHrDLKP~NILLd~~~G~VKL~DFGlA 74 (563)
+.++|+|++|.||+++. .+.+.|+||+.+
T Consensus 162 ~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~-~~~~~lIDwe~a 211 (263)
T 3tm0_A 162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKD-GKVSGFIDLGRS 211 (263)
T ss_dssp CSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEET-TEEEEECCCTTC
T ss_pred ccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEEC-CcEEEEEEchhc
Confidence 23899999999999973 335579999876
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=97.61 E-value=4e-05 Score=78.83 Aligned_cols=73 Identities=15% Similarity=0.177 Sum_probs=58.0
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-------------------------------------
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSH------------------------------------- 43 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~------------------------------------- 43 (563)
+||||++|..|.+. ....++......++.+++..|..||+.
T Consensus 118 ~vme~v~G~~l~~~--~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 118 YIMEFVSGRVLWDQ--SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp EEEECCCCBCCCCT--TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EEEEecCCeecCCC--ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 58999999887541 123478888999999999999999983
Q ss_pred -------------------CCCeEeccCccCceEEeCCCC-cEEEecccchh
Q 008504 44 -------------------NPPIIHRDLKCDNIFVNGNHG-EVKIGDLGLAI 75 (563)
Q Consensus 44 -------------------gp~IIHrDLKP~NILLd~~~G-~VKL~DFGlA~ 75 (563)
.+.++|+|++|.||+++.+.+ .+.|+||+.+.
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~ 247 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELST 247 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccc
Confidence 134999999999999985433 36899999874
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.43 E-value=8.3e-05 Score=71.54 Aligned_cols=66 Identities=15% Similarity=0.095 Sum_probs=48.1
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHN------------------------------------ 44 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~g------------------------------------ 44 (563)
+||||++|.+|. . ...+ ...++.++...|..||+..
T Consensus 92 ~v~e~i~G~~l~--~---~~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (264)
T 1nd4_A 92 LLLGEVPGQDLL--S---SHLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQ 163 (264)
T ss_dssp EEEECCSSEETT--T---SCCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGT
T ss_pred EEEEecCCcccC--c---CcCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhcc
Confidence 589999998884 1 1122 2356777888888888753
Q ss_pred --------------------CCeEeccCccCceEEeCCCCcEEEecccchh
Q 008504 45 --------------------PPIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 75 (563)
Q Consensus 45 --------------------p~IIHrDLKP~NILLd~~~G~VKL~DFGlA~ 75 (563)
+.++|+|++|.||++++ .+.+.|+||+.+.
T Consensus 164 ~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~-~~~~~liD~~~a~ 213 (264)
T 1nd4_A 164 GLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVEN-GRFSGFIDCGRLG 213 (264)
T ss_dssp TCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEET-TEEEEECCCTTCE
T ss_pred CccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEEC-CcEEEEEcchhcc
Confidence 12999999999999974 3456799999873
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.29 E-value=0.003 Score=62.04 Aligned_cols=121 Identities=17% Similarity=0.163 Sum_probs=79.8
Q ss_pred CHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEeccCccCceEEeCCCCcEEEecccchhhccCCCCccccC
Q 008504 10 NLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHS-HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIG 87 (563)
Q Consensus 10 sL~~~L~k-~~~Lse~~i~~i~~QIL~aL~yLHs-~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~~~~~~~G 87 (563)
+|.+.|.. ..+++++++|.++.|.+.+|.-+-. ..+ ..+=+.|..|++. .+|.|.+.+ +.+. ..
T Consensus 34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~--~~~i~~~~~i~l~-~dG~V~f~~-~~s~----------~~ 99 (229)
T 2yle_A 34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQP--RHRVRSAAQIRVW-RDGAVTLAP-AADD----------AG 99 (229)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCSGGGEEEE-TTSCEEECC-C---------------
T ss_pred cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccC--CceecCCcceEEe-cCCceeccc-cccc----------cc
Confidence 68888874 5689999999999999999877622 221 1233456888987 457777653 1110 12
Q ss_pred CCCccCcccccccCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHHHHHHhcCC
Q 008504 88 TPEFMAPELYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP 164 (563)
Q Consensus 88 tp~Y~APEvl~~~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~LI~kcL~d 164 (563)
...|.|||......+.+.=|||||+++|..+--..|- ..+...++.+..||..|..+
T Consensus 100 ~~~~~~pe~~~~~~te~~~IysLG~tLY~ALDygL~e--------------------~eE~eLS~~LE~LL~~Mt~~ 156 (229)
T 2yle_A 100 EPPPVAGKLGYSQCMETEVIESLGIIIYKALDYGLKE--------------------NEERELSPPLEQLIDHMANT 156 (229)
T ss_dssp -------CCSSSSSCHHHHHHHHHHHHHHHHTTTCCT--------------------TEEECCCHHHHHHHHHHTTC
T ss_pred ccCCCChhhccccchHHHHHHHHHHHHHHHhhcCCCc--------------------ccchhhCHHHHHHHHHHHhc
Confidence 3356788877556678899999999999998543332 23556788999999998753
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=96.07 E-value=0.0073 Score=60.95 Aligned_cols=29 Identities=34% Similarity=0.403 Sum_probs=23.3
Q ss_pred eEeccCccCceEEeC--CCCc-EEEecccchh
Q 008504 47 IIHRDLKCDNIFVNG--NHGE-VKIGDLGLAI 75 (563)
Q Consensus 47 IIHrDLKP~NILLd~--~~G~-VKL~DFGlA~ 75 (563)
++|+|++|.||+++. ..+. +.|+||+.+.
T Consensus 192 ~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~ 223 (306)
T 3tdw_A 192 LIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAA 223 (306)
T ss_dssp EECSCCSGGGEEECTTCSSCCEEEECCCTTCE
T ss_pred eEeCCCCcccEEEecCCCCCceEEEEehhhcC
Confidence 699999999999985 1244 5899999774
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=95.61 E-value=0.012 Score=57.33 Aligned_cols=70 Identities=19% Similarity=0.117 Sum_probs=49.7
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCC-----------------------------------
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNP----------------------------------- 45 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp----------------------------------- 45 (563)
+|||+++|.++.+..... ......++.++...|.-||...+
T Consensus 97 lvme~l~G~~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (272)
T 4gkh_A 97 LLTTAIPGKTAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERN 172 (272)
T ss_dssp EEEECCCSEEHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGT
T ss_pred EEEEeeCCccccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhcccccc
Confidence 589999998888765542 12334566667777777775311
Q ss_pred ---------------------CeEeccCccCceEEeCCCCcEEEecccchh
Q 008504 46 ---------------------PIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 75 (563)
Q Consensus 46 ---------------------~IIHrDLKP~NILLd~~~G~VKL~DFGlA~ 75 (563)
.++|+|+.+.||+++ +.+.+-|+||+.+.
T Consensus 173 ~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~-~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 173 GWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFD-EGKLIGCIDVGRVG 222 (272)
T ss_dssp TCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEE-TTEEEEECCCTTCE
T ss_pred chHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEE-CCeEEEEEECcccc
Confidence 179999999999998 44456699998773
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=94.27 E-value=0.02 Score=58.33 Aligned_cols=29 Identities=14% Similarity=0.277 Sum_probs=24.2
Q ss_pred CeEeccCccCceEEeCCCCcEEEecccchh
Q 008504 46 PIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 75 (563)
Q Consensus 46 ~IIHrDLKP~NILLd~~~G~VKL~DFGlA~ 75 (563)
.++|+|++|.||+++ +.+.+.|+||+.+.
T Consensus 223 ~l~HgDl~~~Nil~~-~~~~~~vIDwe~a~ 251 (357)
T 3ats_A 223 VLLWGDARVGNVLYR-DFQPVAVLDWEMVA 251 (357)
T ss_dssp EEECSSCSGGGEEEE-TTEEEEECCGGGCE
T ss_pred eEEeCCCCCCeEEEe-CCcEEEEEcccccc
Confidence 489999999999998 43457899999873
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=93.79 E-value=0.061 Score=53.60 Aligned_cols=28 Identities=21% Similarity=0.342 Sum_probs=24.3
Q ss_pred CeEeccCccCceEEeCCCCcEEEecccch
Q 008504 46 PIIHRDLKCDNIFVNGNHGEVKIGDLGLA 74 (563)
Q Consensus 46 ~IIHrDLKP~NILLd~~~G~VKL~DFGlA 74 (563)
.++|+|+++.||+++.+ +.+.|+||+.+
T Consensus 223 ~l~HgD~~~~Nil~~~~-~~~~lIDfe~a 250 (346)
T 2q83_A 223 NLCHQDYGTGNTLLGEN-EQIWVIDLDTV 250 (346)
T ss_dssp CEECSSCSTTSEEECGG-GCEEECCCTTC
T ss_pred ceecCCCCcccEEEeCC-CcEEEEehhhc
Confidence 49999999999999643 58999999976
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=90.47 E-value=0.39 Score=47.67 Aligned_cols=28 Identities=21% Similarity=0.215 Sum_probs=23.3
Q ss_pred CeEeccCccCceEEeCCCCcEEEecccchh
Q 008504 46 PIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 75 (563)
Q Consensus 46 ~IIHrDLKP~NILLd~~~G~VKL~DFGlA~ 75 (563)
.++|+|+.|.||+.+ .+.+.|+||..+.
T Consensus 174 ~l~HgDl~~~Nil~~--~~~~~lID~e~a~ 201 (301)
T 3dxq_A 174 AACHCDPLCENFLDT--GERMWIVDWEYSG 201 (301)
T ss_dssp EEECSCCCGGGEEEC--SSCEEECCCTTCE
T ss_pred eeeccCCCcCCEEEC--CCCEEEEeccccc
Confidence 389999999999953 4578999998774
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=90.05 E-value=0.24 Score=51.81 Aligned_cols=28 Identities=21% Similarity=0.452 Sum_probs=23.9
Q ss_pred CeEeccCccCceEEeCCCCcEEEecccchh
Q 008504 46 PIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 75 (563)
Q Consensus 46 ~IIHrDLKP~NILLd~~~G~VKL~DFGlA~ 75 (563)
.++|+|++|.||+++.+ + ++|+||+.+.
T Consensus 233 ~liHGDl~~~Nil~~~~-~-~~lID~e~a~ 260 (420)
T 2pyw_A 233 ALIHGDLHTGSVMVTQD-S-TQVIDPEFSF 260 (420)
T ss_dssp EEECSCCSGGGEEECSS-C-EEECCCTTCE
T ss_pred eEEecCCCCCcEEEeCC-C-CEEEeCcccc
Confidence 49999999999999743 3 9999998873
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=83.70 E-value=0.56 Score=47.07 Aligned_cols=30 Identities=23% Similarity=0.289 Sum_probs=25.0
Q ss_pred CeEeccCccCceEEeCC---CCcEEEecccchh
Q 008504 46 PIIHRDLKCDNIFVNGN---HGEVKIGDLGLAI 75 (563)
Q Consensus 46 ~IIHrDLKP~NILLd~~---~G~VKL~DFGlA~ 75 (563)
.++|||+.+.||+++.+ .+.+.|+||+.+.
T Consensus 184 ~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~ 216 (333)
T 3csv_A 184 VFVHRDFHAQNLLWLPEREGLARVGVIDFQDAK 216 (333)
T ss_dssp EEECSCCSGGGEEECTTSCGGGGEEECCCTTCE
T ss_pred eeEeCCcCcccEEeccCcCCCCCeEEEeCCCcC
Confidence 49999999999999743 1578999999874
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=83.57 E-value=0.59 Score=46.41 Aligned_cols=28 Identities=36% Similarity=0.455 Sum_probs=23.1
Q ss_pred CeEeccCccCceEEeCCCCcEEEecccch
Q 008504 46 PIIHRDLKCDNIFVNGNHGEVKIGDLGLA 74 (563)
Q Consensus 46 ~IIHrDLKP~NILLd~~~G~VKL~DFGlA 74 (563)
.++|+|+++.||+++++ +.+.|+||+.+
T Consensus 188 ~liHgDl~~~Nil~~~~-~~~~lIDf~~a 215 (322)
T 2ppq_A 188 GVIHADLFQDNVFFLGD-ELSGLIDFYFA 215 (322)
T ss_dssp EEECSCCCGGGEEEETT-EEEEECCCTTC
T ss_pred ccCCCCCCccCEEEeCC-ceEEEecchhc
Confidence 38999999999999843 34579999876
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=82.82 E-value=0.96 Score=44.98 Aligned_cols=27 Identities=26% Similarity=0.196 Sum_probs=23.3
Q ss_pred CeEeccCccCceEEeCCCCcEEEecccchh
Q 008504 46 PIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 75 (563)
Q Consensus 46 ~IIHrDLKP~NILLd~~~G~VKL~DFGlA~ 75 (563)
.++|+|+++.||+++ + .+.|+||+.+.
T Consensus 196 ~l~HgD~~~~Nil~~-~--~~~lIDfe~a~ 222 (328)
T 1zyl_A 196 LRLHGDCHAGNILWR-D--GPMFVDLDDAR 222 (328)
T ss_dssp EECCSSCSGGGEEES-S--SEEECCCTTCC
T ss_pred eeeeCCCCcccEeEc-C--CCEEEECCCCC
Confidence 389999999999997 3 78999998763
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 563 | ||||
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-60 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-41 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-40 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-39 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 7e-39 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-38 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-38 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-38 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 4e-38 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 7e-37 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-34 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-34 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-33 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 4e-33 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-32 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-32 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 5e-32 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-31 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-31 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 7e-31 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 8e-31 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-30 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-29 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-29 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-29 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 4e-29 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 7e-29 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-28 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-28 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-28 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-28 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-28 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-28 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 8e-28 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-27 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-27 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-27 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-27 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 6e-27 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-26 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-26 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-26 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 4e-26 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-26 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 6e-26 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 6e-26 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 8e-26 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 9e-26 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-25 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 7e-25 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-24 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 5e-24 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 5e-24 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 6e-24 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 8e-24 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 9e-24 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-23 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-23 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-22 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-19 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-19 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-17 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-11 |
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (508), Expect = 1e-60
Identities = 110/182 (60%), Positives = 138/182 (75%), Gaps = 1/182 (0%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 60
++TEL TSG L+ Y K+ K + IKV+++W RQIL GL +LH+ PPIIHRDLKCDNIF+
Sbjct: 89 LVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT 148
Query: 61 GNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTF 120
G G VKIGDLGLA + A++VIGTPEFMAPE+YEE+Y+E VD+Y+FGMC+LEM T
Sbjct: 149 GPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATS 208
Query: 121 EYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPF 179
EYPYSEC+N AQI+++VTSG+KPAS KV P++K IE C+ ER S KDLL F
Sbjct: 209 EYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAF 268
Query: 180 LQ 181
Q
Sbjct: 269 FQ 270
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 2e-41
Identities = 40/183 (21%), Positives = 86/183 (46%), Gaps = 8/183 (4%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 60
+I E G + + +K D + + ++ + L Y HS +IHRD+K +N+ +
Sbjct: 83 LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLG 140
Query: 61 GNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 119
GE+KI D G ++ ++ GT +++ PE + ++E VD++S G+ E +
Sbjct: 141 SA-GELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLV 199
Query: 120 FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDP 178
+ P+ E + +K+++ + + I + L S+R +++L+ P
Sbjct: 200 GKPPF-EANTYQETYKRISRV--EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHP 256
Query: 179 FLQ 181
++
Sbjct: 257 WIT 259
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 3e-40
Identities = 49/191 (25%), Positives = 89/191 (46%), Gaps = 14/191 (7%)
Query: 1 MITELFTSGNLRQY----RKKHKNVDIKVIKNWARQILHGLVYLHSHN---PPIIHRDLK 53
++ E G+L K+ + +D + + Q+ L H + ++HRDLK
Sbjct: 82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLK 141
Query: 54 CDNIFVNGNHGEVKIGDLGLAIAMQQPT--ARSVIGTPEFMAPELYE-EEYNELVDIYSF 110
N+F++G VK+GD GLA + T A++ +GTP +M+PE YNE DI+S
Sbjct: 142 PANVFLDGK-QNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSL 200
Query: 111 GMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERL 169
G + E+ P+ + ++ K+ G K + ++ I + L R
Sbjct: 201 GCLLYELCALMPPF-TAFSQKELAGKIREG-KFRRIPYRYSDELNEIITRMLNLKDYHRP 258
Query: 170 SAKDLLKDPFL 180
S +++L++P +
Sbjct: 259 SVEEILENPLI 269
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 143 bits (363), Expect = 2e-39
Identities = 59/209 (28%), Positives = 93/209 (44%), Gaps = 11/209 (5%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 60
++ E K + I L GL YLHSHN +IHRD+K NI ++
Sbjct: 92 LVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLS 149
Query: 61 GNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELY----EEEYNELVDIYSFGMCILE 116
G VK+GD G A M A S +GTP +MAPE+ E +Y+ VD++S G+ +E
Sbjct: 150 EP-GLVKLGDFGSASIMAP--ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE 206
Query: 117 MVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLL 175
+ + P N + PA + + F++ CL +R +++ LL
Sbjct: 207 LAERKPPLFNM-NAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLL 265
Query: 176 KDPFLQVENQKEPICDPLKLPIQSLKMLR 204
K F+ E I D ++ +++ L
Sbjct: 266 KHRFVLRERPPTVIMDLIQRTKDAVRELD 294
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 7e-39
Identities = 60/212 (28%), Positives = 98/212 (46%), Gaps = 20/212 (9%)
Query: 1 MITELFTSGNLRQY-RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV 59
++ E G + + + + I+ +Q L L YLH + IIHRDLK NI
Sbjct: 86 ILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK--IIHRDLKAGNILF 143
Query: 60 NGNHGEVKIGDLGLAIAMQQPTAR--SVIGTPEFMAPELY------EEEYNELVDIYSFG 111
+ G++K+ D G++ + R S IGTP +MAPE+ + Y+ D++S G
Sbjct: 144 TLD-GDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLG 202
Query: 112 MCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVN-DPQIKGFIEKCLVP-ASERL 169
+ ++EM E P+ E NP ++ K+ P K F++KCL R
Sbjct: 203 ITLIEMAEIEPPHHE-LNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARW 261
Query: 170 SAKDLLKDPFLQVENQKEPICDPLKLPIQSLK 201
+ LL+ PF+ V++ K P++ I K
Sbjct: 262 TTSQLLQHPFVTVDSNK-----PIRELIAEAK 288
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 1e-38
Identities = 57/188 (30%), Positives = 92/188 (48%), Gaps = 8/188 (4%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 60
++ E G+L + D I R+ L L +LHS+ +IHRD+K DNI +
Sbjct: 94 VVMEYLAGGSLTDVVTETCM-DEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLG 150
Query: 61 GNHGEVKIGDLGLA--IAMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEM 117
+ G VK+ D G I +Q +++GTP +MAPE + + Y VDI+S G+ +EM
Sbjct: 151 MD-GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEM 209
Query: 118 VTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLK 176
+ E PY ++ T+G + + F+ +CL +R SAK+LL+
Sbjct: 210 IEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269
Query: 177 DPFLQVEN 184
FL++
Sbjct: 270 HQFLKIAK 277
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 2e-38
Identities = 56/189 (29%), Positives = 92/189 (48%), Gaps = 16/189 (8%)
Query: 1 MITELFTSGNLRQY-RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV 59
++T+ +L + ++ + + ARQ G+ YLH+ + IIHRDLK +NIF+
Sbjct: 80 IVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS--IIHRDLKSNNIFL 137
Query: 60 NGNHGEVKIGDLGLAIAMQQPTA----RSVIGTPEFMAPELYEEE----YNELVDIYSFG 111
+ + VKIGD GLA + + + G+ +MAPE+ + Y+ D+Y+FG
Sbjct: 138 HED-LTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFG 196
Query: 112 MCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVND---PQIKGFIEKCLVP-ASE 167
+ + E++T + PYS N QI V G L+KV +K + +CL E
Sbjct: 197 IVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDE 256
Query: 168 RLSAKDLLK 176
R +L
Sbjct: 257 RPLFPQILA 265
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 2e-38
Identities = 46/188 (24%), Positives = 83/188 (44%), Gaps = 10/188 (5%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 60
+ E + G L + + + + Q++ G+VYLH I HRD+K +N+ ++
Sbjct: 80 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLD 137
Query: 61 GNHGEVKIGDLGLAIAM----QQPTARSVIGTPEFMAPELYEEE--YNELVDIYSFGMCI 114
+KI D GLA ++ + GT ++APEL + + E VD++S G+ +
Sbjct: 138 ER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVL 196
Query: 115 LEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKD 173
M+ E P+ + + Q + + K D + K LV S R++ D
Sbjct: 197 TAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPD 256
Query: 174 LLKDPFLQ 181
+ KD +
Sbjct: 257 IKKDRWYN 264
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 4e-38
Identities = 53/230 (23%), Positives = 93/230 (40%), Gaps = 45/230 (19%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 60
+ E G+L Q KK + +++ + ++ GL YL + I+HRD+K NI VN
Sbjct: 81 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH-KIMHRDVKPSNILVN 139
Query: 61 GNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 119
GE+K+ D G++ + A S +GT +M+PE L Y+ DI+S G+ ++EM
Sbjct: 140 SR-GEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAV 198
Query: 120 FEYPYS-----------------------------------------ECKNPAQIFKKVT 138
YP ++ +
Sbjct: 199 GRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIV 258
Query: 139 SGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQKE 187
+ P + V + + F+ KCL+ +ER K L+ F++ + +E
Sbjct: 259 NEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEE 308
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 135 bits (342), Expect = 7e-37
Identities = 48/192 (25%), Positives = 89/192 (46%), Gaps = 15/192 (7%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 60
++ +L G L Y + + K + R +L + LH N I+HRDLK +NI ++
Sbjct: 87 LVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLD 144
Query: 61 GNHGEVKIGDLGLAIAMQQ-PTARSVIGTPEFMAPELYEEE-------YNELVDIYSFGM 112
+ +K+ D G + + R V GTP ++APE+ E Y + VD++S G+
Sbjct: 145 DD-MNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGV 203
Query: 113 CILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVND--PQIKGFIEKCLVP-ASERL 169
+ ++ P+ + + + + SG + +D +K + + LV +R
Sbjct: 204 IMYTLLAGSPPFWH-RKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRY 262
Query: 170 SAKDLLKDPFLQ 181
+A++ L PF Q
Sbjct: 263 TAEEALAHPFFQ 274
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 130 bits (329), Expect = 2e-34
Identities = 50/211 (23%), Positives = 90/211 (42%), Gaps = 13/211 (6%)
Query: 1 MITELFTSGNLRQY-RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV 59
MI E + G L + +H + + RQ+ GL ++H +N +H DLK +NI
Sbjct: 100 MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMF 157
Query: 60 NGNH-GEVKIGDLGLAIAMQ-QPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILE 116
E+K+ D GL + + + + GT EF APE+ E + D++S G+
Sbjct: 158 TTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYI 217
Query: 117 MVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVND--PQIKGFIEKCLVP-ASERLSAKD 173
+++ P+ +N + + V S + + K FI K L+ + R++
Sbjct: 218 LLSGLSPFGG-ENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQ 276
Query: 174 LLKDPFLQVENQKEPICDPLKLPIQSLKMLR 204
L+ P+L N ++P +R
Sbjct: 277 ALEHPWLTPGNAP---GRDSQIPSSRYTKIR 304
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 130 bits (329), Expect = 3e-34
Identities = 48/214 (22%), Positives = 90/214 (42%), Gaps = 12/214 (5%)
Query: 1 MITELFTSGNLRQY-RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV 59
+I E + G L + + + N+ RQ GL ++H H+ I+H D+K +NI
Sbjct: 103 LILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMC 160
Query: 60 NGNH-GEVKIGDLGLAIAMQQP-TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILE 116
VKI D GLA + + T EF APE+ + E D+++ G+
Sbjct: 161 ETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYV 220
Query: 117 MVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVN-DPQIKGFIEKCLVP-ASERLSAKDL 174
+++ P++ + + + A + P+ K FI+ L +RL+ D
Sbjct: 221 LLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDA 280
Query: 175 LKDPFLQVENQKEPICDPLKLPIQSLKMLRLPMS 208
L+ P+L+ ++ ++P +R +
Sbjct: 281 LEHPWLKGDHSNL----TSRIPSSRYNKIRQKIK 310
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 2e-33
Identities = 55/206 (26%), Positives = 94/206 (45%), Gaps = 24/206 (11%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 60
+G L +Y +K + D + + +I+ L YLH IIHRDLK +NI +N
Sbjct: 85 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLN 142
Query: 61 GNHGEVKIGDLGLAIAM----QQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCIL 115
+ ++I D G A + +Q A S +GT ++++PE L E+ + D+++ G I
Sbjct: 143 ED-MHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIY 201
Query: 116 EMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAK-- 172
++V P+ N IF+K+ + P+ + +EK LV A++RL +
Sbjct: 202 QLVAGLPPF-RAGNEYLIFQKIIKL--EYDFPEKFFPKARDLVEKLLVLDATKRLGCEEM 258
Query: 173 ----DLLKDPFLQ------VENQKEP 188
L PF + + Q P
Sbjct: 259 EGYGPLKAHPFFESVTWENLHQQTPP 284
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 4e-33
Identities = 45/221 (20%), Positives = 98/221 (44%), Gaps = 12/221 (5%)
Query: 1 MITELFTSGNLRQY-RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV 59
MI E + ++ + ++ + I ++ Q+ L +LHSHN I H D++ +NI
Sbjct: 78 MIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIY 135
Query: 60 -NGNHGEVKIGDLGLAIAMQQP-TARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILE 116
+KI + G A ++ R + PE+ APE+++ + + D++S G +
Sbjct: 136 QTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYV 195
Query: 117 MVTFEYPYSECKNPAQIFKKVTSG--IKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKD 173
+++ P+ + QI + + + K + F+++ LV R++A +
Sbjct: 196 LLSGINPF-LAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASE 254
Query: 174 LLKDPFLQ--VENQKEPICDPLKLPIQSLKMLRLPMSGPSS 212
L+ P+L+ +E + LK +++ ++ S
Sbjct: 255 ALQHPWLKQKIERVSTKVIRTLKHRRYYHTLIKKDLNMVVS 295
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 125 bits (314), Expect = 1e-32
Identities = 42/194 (21%), Positives = 85/194 (43%), Gaps = 10/194 (5%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 60
+I +L + G L + + Q+L + YLH I+HRDLK +N+
Sbjct: 84 LIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG--IVHRDLKPENLLYY 141
Query: 61 --GNHGEVKIGDLGLA-IAMQQPTARSVIGTPEFMAP-ELYEEEYNELVDIYSFGMCILE 116
++ I D GL+ + + GTP ++AP L ++ Y++ VD +S G+
Sbjct: 142 SLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYI 201
Query: 117 MVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVND--PQIKGFIEKCLVP-ASERLSAKD 173
++ P+ + +N A++F+++ +D K FI + +R + +
Sbjct: 202 LLCGYPPFYD-ENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQ 260
Query: 174 LLKDPFLQVENQKE 187
L+ P++ + +
Sbjct: 261 ALQHPWIAGDTALD 274
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 2e-32
Identities = 34/185 (18%), Positives = 79/185 (42%), Gaps = 15/185 (8%)
Query: 1 MITELF-TSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV 59
+I E +L + + + ++ +++ Q+L + + H+ ++HRD+K +NI +
Sbjct: 86 LILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILI 143
Query: 60 NGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEE--YNELVDIYSFGMCILEM 117
+ N GE+K+ D G ++ GT + PE + ++S G+ + +M
Sbjct: 144 DLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDM 203
Query: 118 VTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLK 176
V + P+ + + + + + I CL S+R + +++
Sbjct: 204 VCGDIPFEHDEEIIRGQVFFRQRV---------SSECQHLIRWCLALRPSDRPTFEEIQN 254
Query: 177 DPFLQ 181
P++Q
Sbjct: 255 HPWMQ 259
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 5e-32
Identities = 38/197 (19%), Positives = 80/197 (40%), Gaps = 14/197 (7%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 60
++ E+ G L +Y +++++V K I Q+ G+ YL N +HRDL N+ +
Sbjct: 84 LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLV 141
Query: 61 GNHGEVKIGDLGLAIAMQQP-----TARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCI 114
KI D GL+ A++ ++ APE + +++ D++SFG+ +
Sbjct: 142 TQ-HYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLM 200
Query: 115 LEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKD 173
E ++ +++ + G + A ++ + C R
Sbjct: 201 WEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGC-PREMYDLMNLCWTYDVENRPGFAA 259
Query: 174 L---LKDPFLQVENQKE 187
+ L++ + V N+
Sbjct: 260 VELRLRNYYYDVVNEGH 276
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (303), Expect = 1e-31
Identities = 39/180 (21%), Positives = 76/180 (42%), Gaps = 9/180 (5%)
Query: 1 MITELFTSGNLRQY--RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIF 58
++TE G+L Y + + + ++ + + YL +N +HRDL N+
Sbjct: 78 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVL 135
Query: 59 VNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEM 117
V+ + K+ D GL T + ++ APE L E++++ D++SFG+ + E+
Sbjct: 136 VSED-NVAKVSDFGLTKEAS-STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEI 193
Query: 118 VTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLK 176
+F + +V G K + P + ++ C A+ R S L +
Sbjct: 194 YSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGC-PPAVYEVMKNCWHLDAAMRPSFLQLRE 252
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 4e-31
Identities = 45/198 (22%), Positives = 83/198 (41%), Gaps = 14/198 (7%)
Query: 1 MITELFTSGNLRQY--RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIF 58
++TE + G+L + + K + + + + A QI G+ Y+ N +HRDL+ NI
Sbjct: 88 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANIL 145
Query: 59 VNGNHGEVKIGDLGLAIAMQQP---TARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCI 114
V N K+ D GLA ++ + ++ APE + D++SFG+ +
Sbjct: 146 VGEN-LVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILL 204
Query: 115 LEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKD 173
E+ T ++ +V G + + + + +C ER + +
Sbjct: 205 TELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC-PESLHDLMCQCWRKEPEERPTFEY 263
Query: 174 L---LKDPFLQVENQKEP 188
L L+D F E Q +P
Sbjct: 264 LQAFLEDYFTSTEPQYQP 281
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 7e-31
Identities = 45/248 (18%), Positives = 101/248 (40%), Gaps = 19/248 (7%)
Query: 1 MITELFTSGNLRQY--RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIF 58
++ E G L + + + + I + YLHS N I HRD+K +N+
Sbjct: 86 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLL 143
Query: 59 VN--GNHGEVKIGDLGLAIAMQQPTA-RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCI 114
+ +K+ D G A + + TP ++APE+ E+Y++ D++S G+ +
Sbjct: 144 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 203
Query: 115 LEMVTFEYPYSECKNPAQIFKKVTSGIK------PASLAKVNDPQIKGFIEKCLVP-ASE 167
++ P+ + I + + I+ P ++K I L ++
Sbjct: 204 YILLCGYPPFYS-NHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQ 262
Query: 168 RLSAKDLLKDPFLQ--VENQKEPICDPLKLPIQSLKMLRLPMSGPSSM-DIDSDYKQLSL 224
R++ + + P++ + + P+ L + + S++ + DY+Q+ +
Sbjct: 263 RMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKI 322
Query: 225 STCTESNN 232
+++N
Sbjct: 323 KKIEDASN 330
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (298), Expect = 8e-31
Identities = 43/193 (22%), Positives = 78/193 (40%), Gaps = 14/193 (7%)
Query: 1 MITELFTSGNLRQYRKKHKNV--DIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIF 58
+ITE +G+L + K + I + + A QI G+ ++ N IHRDL+ NI
Sbjct: 84 IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANIL 141
Query: 59 VNGNHGEVKIGDLGLAIAM---QQPTARSVIGTPEFMAP-ELYEEEYNELVDIYSFGMCI 114
V+ + KI D GLA + + ++ AP + + D++SFG+ +
Sbjct: 142 VS-DTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILL 200
Query: 115 LEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKD 173
E+VT ++ + + G + ++ + C +R +
Sbjct: 201 TEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNC-PEELYQLMRLCWKERPEDRPTFDY 259
Query: 174 L---LKDPFLQVE 183
L L+D F E
Sbjct: 260 LRSVLEDFFTATE 272
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (295), Expect = 3e-30
Identities = 51/204 (25%), Positives = 95/204 (46%), Gaps = 11/204 (5%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV- 59
+I EL G L + + +++ + + +QIL+G+ YLHS I H DLK +NI +
Sbjct: 90 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLL 147
Query: 60 --NGNHGEVKIGDLGLAIAMQQPTARS-VIGTPEFMAPELYE-EEYNELVDIYSFGMCIL 115
N +KI D GLA + + GTPEF+APE+ E D++S G+
Sbjct: 148 DRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITY 207
Query: 116 EMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVND--PQIKGFIEKCLVP-ASERLSAK 172
+++ P+ + V++ ++ K FI + LV +R++ +
Sbjct: 208 ILLSGASPF-LGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQ 266
Query: 173 DLLKDPFLQVENQKEPICDPLKLP 196
D L+ P+++ ++ ++ + P
Sbjct: 267 DSLQHPWIKPKDTQQALSSAWSHP 290
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 2e-29
Identities = 32/199 (16%), Positives = 81/199 (40%), Gaps = 15/199 (7%)
Query: 1 MITELFTSGNLRQY-RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV 59
++ E+ G L ++ K + + + + Q+ G+ YL N +HRDL N+ +
Sbjct: 85 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLL 142
Query: 60 NGNHGEVKIGDLGLAIAM-----QQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMC 113
KI D GL+ A+ + ++ APE + +++ D++S+G+
Sbjct: 143 VNR-HYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVT 201
Query: 114 ILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAK 172
+ E +++ + ++ + G + + P++ + C + +R
Sbjct: 202 MWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPEC-PPELYALMSDCWIYKWEDRPDFL 260
Query: 173 DL---LKDPFLQVENQKEP 188
+ ++ + + ++ E
Sbjct: 261 TVEQRMRACYYSLASKVEG 279
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (287), Expect = 2e-29
Identities = 32/182 (17%), Positives = 72/182 (39%), Gaps = 10/182 (5%)
Query: 1 MITELFTSGNLRQY-RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV 59
++ E G L Y R + + + + G+ YL +IHRDL N V
Sbjct: 77 LVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLV 134
Query: 60 NGNHGEVKIGDLGLAIAMQQPTAR---SVIGTPEFMAPE-LYEEEYNELVDIYSFGMCIL 115
+ +K+ D G+ + ++ +PE Y+ D++SFG+ +
Sbjct: 135 G-ENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMW 193
Query: 116 EMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDL 174
E+ + E ++ +++ + +++G + ++ + + C +R + L
Sbjct: 194 EVFSEGKIPYENRSNSEVVEDISTGFRL-YKPRLASTHVYQIMNHCWKERPEDRPAFSRL 252
Query: 175 LK 176
L+
Sbjct: 253 LR 254
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (289), Expect = 4e-29
Identities = 50/186 (26%), Positives = 92/186 (49%), Gaps = 11/186 (5%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 60
+ E G+L + + D+ +A +I+ GL +LHS I++RDLK DNI ++
Sbjct: 80 FVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLD 137
Query: 61 GNHGEVKIGDLGLAIAMQQPTAR--SVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEM 117
G +KI D G+ A+ + GTP+++APE L ++YN VD +SFG+ + EM
Sbjct: 138 -KDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEM 196
Query: 118 VTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAK-DLL 175
+ + P+ ++ ++F + + + + K + K V +RL + D+
Sbjct: 197 LIGQSPF-HGQDEEELFHSIRMDNPF--YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 253
Query: 176 KDPFLQ 181
+ P +
Sbjct: 254 QHPLFR 259
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (286), Expect = 4e-29
Identities = 43/183 (23%), Positives = 79/183 (43%), Gaps = 10/183 (5%)
Query: 1 MITELFTSGNLRQYR-KKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV 59
+I EL T G LR + + ++D+ + +A Q+ L YL S +HRD+ N+ V
Sbjct: 84 IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLV 141
Query: 60 NGNHGEVKIGDLGLAIAMQQPTAR---SVIGTPEFMAPE-LYEEEYNELVDIYSFGMCIL 115
+ + VK+GD GL+ M+ T ++MAPE + + D++ FG+C+
Sbjct: 142 SS-NDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMW 200
Query: 116 EMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDL 174
E++ + + ++ +G + P + + KC S R +L
Sbjct: 201 EILMHGVKPFQGVKNNDVIGRIENGERLPMPPNC-PPTLYSLMTKCWAYDPSRRPRFTEL 259
Query: 175 LKD 177
Sbjct: 260 KAQ 262
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 114 bits (287), Expect = 7e-29
Identities = 50/188 (26%), Positives = 93/188 (49%), Gaps = 14/188 (7%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 60
MI + G L +K + V K +A ++ L YLHS + II+RDLK +NI ++
Sbjct: 81 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLD 138
Query: 61 GNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 119
N G +KI D G A + T ++ GTP+++APE + + YN+ +D +SFG+ I EM+
Sbjct: 139 KN-GHIKITDFGFAKYVPDVT-YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLA 196
Query: 120 FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV------PASERLSAKD 173
P+ + N + ++K+ + + +K + + + + + +D
Sbjct: 197 GYTPFYD-SNTMKTYEKILNA--ELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTED 253
Query: 174 LLKDPFLQ 181
+ P+ +
Sbjct: 254 VKNHPWFK 261
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 113 bits (284), Expect = 1e-28
Identities = 37/196 (18%), Positives = 74/196 (37%), Gaps = 16/196 (8%)
Query: 1 MITELFTSGNLRQY-RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV 59
+ITE +G+L + R+ + + R I G+ YL N +HRDL NI V
Sbjct: 104 IITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN--YVHRDLAARNILV 161
Query: 60 NGNHGEVKIGDLGLAIAMQQPTARSV-------IGTPEFMAPELYE-EEYNELVDIYSFG 111
N N K+ D GL+ ++ T+ + APE + ++ D++S+G
Sbjct: 162 NSN-LVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYG 220
Query: 112 MCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLS 170
+ + E++++ + + + + + C + R
Sbjct: 221 IVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDC-PSALHQLMLDCWQKDRNHRPK 279
Query: 171 AKDLLK--DPFLQVEN 184
++ D ++ N
Sbjct: 280 FGQIVNTLDKMIRNPN 295
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 114 bits (287), Expect = 2e-28
Identities = 46/189 (24%), Positives = 91/189 (48%), Gaps = 11/189 (5%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 60
I +L G+L + +H ++ +A +I+ GL ++H+ +++RDLK NI ++
Sbjct: 84 FILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLD 141
Query: 61 GNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEE--YNELVDIYSFGMCILEMV 118
HG V+I DLGLA + + +GT +MAPE+ ++ Y+ D +S G + +++
Sbjct: 142 -EHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 200
Query: 119 TFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLS-----AK 172
P+ + K + + L P+++ +E L + RL A+
Sbjct: 201 RGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQ 260
Query: 173 DLLKDPFLQ 181
++ + PF +
Sbjct: 261 EVKESPFFR 269
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 112 bits (281), Expect = 2e-28
Identities = 42/192 (21%), Positives = 76/192 (39%), Gaps = 11/192 (5%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 60
++ E LR + K L + H + IIHRD+K NI ++
Sbjct: 88 IVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMIS 145
Query: 61 GNHGEVKIGDLGLAIAMQQP-----TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCI 114
+ VK+ D G+A A+ +VIGT ++++PE + + D+YS G +
Sbjct: 146 ATN-AVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVL 204
Query: 115 LEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVN-DPQIKGFIEKCLVP-ASERLSAK 172
E++T E P++ + ++ V P S + + K L R
Sbjct: 205 YEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTA 264
Query: 173 DLLKDPFLQVEN 184
++ ++V N
Sbjct: 265 AEMRADLVRVHN 276
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (282), Expect = 2e-28
Identities = 59/216 (27%), Positives = 88/216 (40%), Gaps = 32/216 (14%)
Query: 1 MITELFTSGNLRQY-RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV 59
++ E + V + IK+ Q+L GL +LHSH ++HRDLK NI V
Sbjct: 92 LVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILV 149
Query: 60 NGNHGEVKIGDLGLA-IAMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEM 117
+ G++K+ D GLA I Q SV+ T + APE L + Y VD++S G EM
Sbjct: 150 TSS-GQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEM 208
Query: 118 VTFEYPYSECKNPAQIFKKVTSGIKPAS------------------------LAKVNDPQ 153
+ + + Q+ K + P D
Sbjct: 209 FRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDEL 268
Query: 154 IKGFIEKCLVP-ASERLSAKDLLKDPFLQ-VENQKE 187
K + KCL ++R+SA L P+ Q +E KE
Sbjct: 269 GKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCKE 304
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (279), Expect = 2e-28
Identities = 40/183 (21%), Positives = 76/183 (41%), Gaps = 10/183 (5%)
Query: 1 MITELFTSGNLRQY-RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV 59
+ITE +G L Y R+ + + + + + YL S +HRDL N V
Sbjct: 76 IITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLV 133
Query: 60 NGNHGEVKIGDLGLAIAMQQPTARS---VIGTPEFMAPELYE-EEYNELVDIYSFGMCIL 115
N + G VK+ D GL+ + S + PE+ +++ DI++FG+ +
Sbjct: 134 N-DQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMW 192
Query: 116 EMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDL 174
E+ + E ++ + + G++ + ++ + C A ER + K L
Sbjct: 193 EIYSLGKMPYERFTNSETAEHIAQGLRL-YRPHLASEKVYTIMYSCWHEKADERPTFKIL 251
Query: 175 LKD 177
L +
Sbjct: 252 LSN 254
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (283), Expect = 2e-28
Identities = 47/184 (25%), Positives = 83/184 (45%), Gaps = 11/184 (5%)
Query: 1 MITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV 59
+IT+L G L Y ++HK N+ + + NW QI G+ YL ++HRDL N+ V
Sbjct: 87 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLV 144
Query: 60 NGNHGEVKIGDLGLAIAM----QQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCI 114
VKI D GLA + ++ A ++MA E + Y D++S+G+ +
Sbjct: 145 KTP-QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTV 203
Query: 115 LEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKD 173
E++TF + ++I + G + + + KC + A R ++
Sbjct: 204 WELMTFGSKPYDGIPASEISSILEKGERLPQPPIC-TIDVYMIMVKCWMIDADSRPKFRE 262
Query: 174 LLKD 177
L+ +
Sbjct: 263 LIIE 266
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (280), Expect = 8e-28
Identities = 47/206 (22%), Positives = 94/206 (45%), Gaps = 15/206 (7%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 60
+ E G L + + + + + + +I+ L YLHS + +++RD+K +N+ ++
Sbjct: 82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLD 139
Query: 61 GNHGEVKIGDLGLAIAMQQP--TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEM 117
G +KI D GL T ++ GTPE++APE+ E +Y VD + G+ + EM
Sbjct: 140 -KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEM 198
Query: 118 VTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLS-----A 171
+ P+ ++ ++F+ + + P+ K + L +RL A
Sbjct: 199 MCGRLPF-YNQDHERLFELILME--EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDA 255
Query: 172 KDLLKDPFLQVENQKEPICDPLKLPI 197
K++++ F N ++ + L P
Sbjct: 256 KEVMEHRFFLSINWQDVVQKKLLPPF 281
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (276), Expect = 1e-27
Identities = 48/229 (20%), Positives = 80/229 (34%), Gaps = 36/229 (15%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 60
++ + + + + IK + L GL YLH H I+HRDLK +N+ ++
Sbjct: 77 LVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLD 134
Query: 61 GNHGEVKIGDLGLAIAMQQP--TARSVIGTPEFMAPELY--EEEYNELVDIYSFGMCILE 116
N G +K+ D GLA + P + T + APEL Y VD+++ G + E
Sbjct: 135 EN-GVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAE 193
Query: 117 MVTFEYPYS-------------------------ECKNPAQIFKKVTSGIKPASLAKVND 151
++ C P + K GI +
Sbjct: 194 LLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAG 253
Query: 152 PQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQKEPICDPLKLPIQS 199
+ I+ + R++A LK + P C LP +
Sbjct: 254 DDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQ---LPRPN 299
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (275), Expect = 2e-27
Identities = 42/195 (21%), Positives = 77/195 (39%), Gaps = 23/195 (11%)
Query: 1 MITELFTSGNLRQYRKKH----------------KNVDIKVIKNWARQILHGLVYLHSHN 44
+ E GNL + +K + + + ++A + G+ YL
Sbjct: 88 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ 147
Query: 45 PPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVI-GTPEFMAPE-LYEEEYN 102
IHRDL NI V N+ KI D GL+ + +++ +MA E L Y
Sbjct: 148 --FIHRDLAARNILVGENY-VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYT 204
Query: 103 ELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCL 162
D++S+G+ + E+V+ A++++K+ G + D ++ + +C
Sbjct: 205 TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNC-DDEVYDLMRQCW 263
Query: 163 VP-ASERLSAKDLLK 176
ER S +L
Sbjct: 264 REKPYERPSFAQILV 278
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 2e-27
Identities = 42/201 (20%), Positives = 82/201 (40%), Gaps = 14/201 (6%)
Query: 1 MITELFTSGNLRQY-RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV 59
+ITE +G L ++ R+K + + R I G + N +HRDL NI V
Sbjct: 86 IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAG--MKYLANMNYVHRDLAARNILV 143
Query: 60 NGNHGEVKIGDLGLAIAMQQP-----TARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMC 113
N N K+ D GL+ ++ T + APE + ++ D++SFG+
Sbjct: 144 NSN-LVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIV 202
Query: 114 ILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAK 172
+ E++T+ + ++ K + G + + I + +C + R
Sbjct: 203 MWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDC-PSAIYQLMMQCWQQERARRPKFA 261
Query: 173 DLLK--DPFLQVENQKEPICD 191
D++ D ++ + + + D
Sbjct: 262 DIVSILDKLIRAPDSLKTLAD 282
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (272), Expect = 3e-27
Identities = 49/191 (25%), Positives = 78/191 (40%), Gaps = 12/191 (6%)
Query: 1 MITELFTSGNLRQYRKKHKN-VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV 59
M+TEL G+L +KH+ + + +A Q+ G+ YL S IHRDL N+ +
Sbjct: 87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLL 144
Query: 60 NGNHGEVKIGDLGLAIAMQQP-----TARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMC 113
VKIGD GL A+ Q + APE L ++ D + FG+
Sbjct: 145 ATR-DLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVT 203
Query: 114 ILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAK 172
+ EM T+ N +QI K+ + + I + +C +R +
Sbjct: 204 LWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFV 263
Query: 173 DLLKDPFLQVE 183
L D L+ +
Sbjct: 264 ALR-DFLLEAQ 273
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 6e-27
Identities = 44/206 (21%), Positives = 79/206 (38%), Gaps = 34/206 (16%)
Query: 1 MITELFTSGNLRQYRKKHKN-----------------------VDIKVIKNWARQILHGL 37
+I E G+L Y + + + + + +A Q+ G+
Sbjct: 118 LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGM 177
Query: 38 VYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP----TARSVIGTPEFMA 93
+L + +HRDL N+ V VKI D GLA + + ++MA
Sbjct: 178 EFLEFKS--CVHRDLAARNVLVTHG-KVVKICDFGLARDIMSDSNYVVRGNARLPVKWMA 234
Query: 94 PE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSGIKPASLAKVND 151
PE L+E Y D++S+G+ + E+ + PY A +K + +G K
Sbjct: 235 PESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYA-T 293
Query: 152 PQIKGFIEKCLVP-ASERLSAKDLLK 176
+I ++ C + +R S +L
Sbjct: 294 EEIYIIMQSCWAFDSRKRPSFPNLTS 319
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (270), Expect = 1e-26
Identities = 49/232 (21%), Positives = 83/232 (35%), Gaps = 45/232 (19%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 60
++ + + IK + +L+GL Y+H + I+HRD+K N+ +
Sbjct: 94 LVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLIT 151
Query: 61 GNHGEVKIGDLGLAIAMQQPTA------RSVIGTPEFMAPE--LYEEEYNELVDIYSFGM 112
+ G +K+ D GLA A + + T + PE L E +Y +D++ G
Sbjct: 152 RD-GVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGC 210
Query: 113 CILEMVTFEYPYS-----------------------------ECKNPAQIFKKVTSGIKP 143
+ EM T E ++ K +K
Sbjct: 211 IMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKD 270
Query: 144 ASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQKEPICDPLK 194
A V DP I+K LV ++R+ + D L F +P+ LK
Sbjct: 271 RLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF----WSDPMPSDLK 318
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (271), Expect = 1e-26
Identities = 36/214 (16%), Positives = 75/214 (35%), Gaps = 35/214 (16%)
Query: 1 MITELFTSGN---LRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 57
++ + R Y + + + + +K + Q+ L Y+HS I HRD+K N+
Sbjct: 96 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNL 153
Query: 58 FVNGNHGEVKIGDLGLAIAMQQPTA-RSVIGTPEFMAPELY--EEEYNELVDIYSFGMCI 114
++ + +K+ D G A + + S I + + APEL +Y +D++S G +
Sbjct: 154 LLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVL 213
Query: 115 LEMVTFEYPYSECKNPAQIFKKVTSGIKPAS--------------------------LAK 148
E++ + + Q+ + + P
Sbjct: 214 AELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRP 273
Query: 149 VNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQ 181
P+ + L + RL+ + F
Sbjct: 274 RTPPEAIALCSRLLEYTPTARLTPLEACAHSFFD 307
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (269), Expect = 1e-26
Identities = 43/185 (23%), Positives = 76/185 (41%), Gaps = 13/185 (7%)
Query: 1 MITELFTSGNLRQYRK-KHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV 59
++ G+LR + + + N +K + + Q+ G+ + +HRDL N +
Sbjct: 106 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK--FLASKKFVHRDLAARNCML 163
Query: 60 NGNHGEVKIGDLGLAIAMQQPTARS------VIGTPEFMAPE-LYEEEYNELVDIYSFGM 112
+ VK+ D GLA M S ++MA E L +++ D++SFG+
Sbjct: 164 DEKF-TVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGV 222
Query: 113 CILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSA 171
+ E++T P N I + G + DP + + KC P A R S
Sbjct: 223 LLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDP-LYEVMLKCWHPKAEMRPSF 281
Query: 172 KDLLK 176
+L+
Sbjct: 282 SELVS 286
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (265), Expect = 4e-26
Identities = 48/199 (24%), Positives = 84/199 (42%), Gaps = 26/199 (13%)
Query: 1 MITELFTSGNLRQYRKKHK----------------NVDIKVIKNWARQILHGLVYLHSHN 44
+I E + GNLR+Y + + + K + + A Q+ G+ YL S
Sbjct: 96 VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK 155
Query: 45 PPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP----TARSVIGTPEFMAPE-LYEE 99
IHRDL N+ V + +KI D GLA + + ++MAPE L++
Sbjct: 156 --CIHRDLAARNVLVTED-NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR 212
Query: 100 EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIE 159
Y D++SFG+ + E+ T ++FK + G + + ++ +
Sbjct: 213 IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNC-TNELYMMMR 271
Query: 160 KCLVP-ASERLSAKDLLKD 177
C S+R + K L++D
Sbjct: 272 DCWHAVPSQRPTFKQLVED 290
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 106 bits (265), Expect = 4e-26
Identities = 34/181 (18%), Positives = 64/181 (35%), Gaps = 10/181 (5%)
Query: 2 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG 61
++ S R + ARQ+ G+ YL +HRDL N V
Sbjct: 118 LSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHRDLATRNCLVGE 175
Query: 62 NHGEVKIGDLGLAIAMQQPTAR----SVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILE 116
N VKI D GL+ + + +M PE ++ Y D++++G+ + E
Sbjct: 176 N-MVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWE 234
Query: 117 MVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLL 175
+ ++ ++ V G A ++ + C ++R S +
Sbjct: 235 IFSYGLQPYYGMAHEEVIYYVRDGNILACPENC-PLELYNLMRLCWSKLPADRPSFCSIH 293
Query: 176 K 176
+
Sbjct: 294 R 294
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 105 bits (263), Expect = 6e-26
Identities = 47/212 (22%), Positives = 81/212 (38%), Gaps = 34/212 (16%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 60
++ E + ++ K++ Q+L+G+ Y H ++HRDLK N+ +N
Sbjct: 77 LVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLIN 134
Query: 61 GNHGEVKIGDLGLAIAMQQPTAR--SVIGTPEFMAPELYEEE--YNELVDIYSFGMCILE 116
GE+KI D GLA A P + I T + AP++ Y+ +DI+S G E
Sbjct: 135 RE-GELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAE 193
Query: 117 MVTFEYPYSECKNPAQIFK--------------------------KVTSGIKPASLAKVN 150
MV + Q+ + V + S K
Sbjct: 194 MVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGL 253
Query: 151 DPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQ 181
D + K L ++R++AK L+ + +
Sbjct: 254 DESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (264), Expect = 6e-26
Identities = 47/215 (21%), Positives = 80/215 (37%), Gaps = 41/215 (19%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHS------HNPPIIHRDLKC 54
++++ G+L Y ++ V ++ + A GL +LH P I HRDLK
Sbjct: 78 LVSDYHEHGSLFDYLNRYT-VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKS 136
Query: 55 DNIFVNGNHGEVKIGDLGLAIAMQQPT------ARSVIGTPEFMAPELYEE-------EY 101
NI V N G I DLGLA+ T +GT +MAPE+ ++ E
Sbjct: 137 KNILVKKN-GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFES 195
Query: 102 NELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG------IKPASLAKVNDPQIK 155
+ DIY+ G+ E+ ++ + + ++ + P I
Sbjct: 196 FKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIP 255
Query: 156 G-------------FIEKCLVP-ASERLSAKDLLK 176
+ +C + RL+A + K
Sbjct: 256 NRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 106 bits (266), Expect = 8e-26
Identities = 46/188 (24%), Positives = 85/188 (45%), Gaps = 14/188 (7%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 60
M+ E G + + ++ + +A QI+ YLHS + +I+RDLK +N+ ++
Sbjct: 118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLID 175
Query: 61 GNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 119
G +++ D G A ++ T ++ GTPE +APE + + YN+ VD ++ G+ I EM
Sbjct: 176 QQ-GYIQVTDFGFAKRVKGRT-WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAA 233
Query: 120 FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV------PASERLSAKD 173
P+ P QI++K+ SG +K + L + + D
Sbjct: 234 GYPPF-FADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVND 290
Query: 174 LLKDPFLQ 181
+ +
Sbjct: 291 IKNHKWFA 298
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 104 bits (261), Expect = 9e-26
Identities = 46/198 (23%), Positives = 83/198 (41%), Gaps = 13/198 (6%)
Query: 1 MITELFTSGNLRQY--RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIF 58
+ITE T GNL Y + V V+ A QI + YL N IHRDL N
Sbjct: 90 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCL 147
Query: 59 VNGNHGEVKIGDLGLAIAMQQPTARSVIGT---PEFMAP-ELYEEEYNELVDIYSFGMCI 114
V N VK+ D GL+ M T + G ++ AP L +++ D+++FG+ +
Sbjct: 148 VGEN-HLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLL 206
Query: 115 LEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKD 173
E+ T+ + +Q+++ + + ++ + C S+R S +
Sbjct: 207 WEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGC-PEKVYELMRACWQWNPSDRPSFAE 265
Query: 174 LLK--DPFLQVENQKEPI 189
+ + + Q + + +
Sbjct: 266 IHQAFETMFQESSISDEV 283
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 104 bits (259), Expect = 2e-25
Identities = 33/202 (16%), Positives = 73/202 (36%), Gaps = 23/202 (11%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV- 59
M+ EL + + +K + A Q++ + Y+HS N IHRD+K DN +
Sbjct: 80 MVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMG 137
Query: 60 -NGNHGEVKIGDLGLAIAMQQP---------TARSVIGTPEFMAPELYE-EEYNELVDIY 108
V I D GLA + +++ GT + + + E + D+
Sbjct: 138 LGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLE 197
Query: 109 SFGMCILEMVT--FEYPYSECKNPAQIFKKVTSGIKPASLAKVND---PQIKGFIEKCLV 163
S G ++ + + Q +++++ + + + ++ C
Sbjct: 198 SLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRS 257
Query: 164 P-ASERLSA---KDLLKDPFLQ 181
++ + L ++ F +
Sbjct: 258 LRFDDKPDYSYLRQLFRNLFHR 279
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (255), Expect = 7e-25
Identities = 53/220 (24%), Positives = 87/220 (39%), Gaps = 35/220 (15%)
Query: 1 MITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV 59
++ E + + + +IK++ Q+L GL + HSH ++HRDLK N+ +
Sbjct: 78 LVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLI 135
Query: 60 NGNHGEVKIGDLGLAIAMQQPTAR--SVIGTPEFMAPELY--EEEYNELVDIYSFGMCIL 115
N G +K+ D GLA A P + T + APE+ + Y+ VDI+S G
Sbjct: 136 NTE-GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFA 194
Query: 116 EMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVN------------------------- 150
EMVT + Q+F+ + P +
Sbjct: 195 EMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPP 254
Query: 151 -DPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQKEP 188
D + + + L ++R+SAK L PF Q + P
Sbjct: 255 LDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVP 294
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (253), Expect = 2e-24
Identities = 49/213 (23%), Positives = 98/213 (46%), Gaps = 20/213 (9%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 60
+I + G L + + + ++ + +I+ L +LH II+RD+K +NI ++
Sbjct: 106 LILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLD 163
Query: 61 GNHGEVKIGDLGLA---IAMQQPTARSVIGTPEFMAPELY---EEEYNELVDIYSFGMCI 114
N G V + D GL+ +A + A GT E+MAP++ + +++ VD +S G+ +
Sbjct: 164 SN-GHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLM 222
Query: 115 LEMVTFEYPY---SECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLS 170
E++T P+ E + A+I +++ P + K I++ L+ +RL
Sbjct: 223 YELLTGASPFTVDGEKNSQAEISRRILKSEPP--YPQEMSALAKDLIQRLLMKDPKKRLG 280
Query: 171 -----AKDLLKDPFLQVENQKEPICDPLKLPIQ 198
A ++ + F Q N + + P +
Sbjct: 281 CGPRDADEIKEHLFFQKINWDDLAAKKVPAPFK 313
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (249), Expect = 5e-24
Identities = 42/199 (21%), Positives = 82/199 (41%), Gaps = 27/199 (13%)
Query: 1 MITELFTSGNLRQYRKKHKN----------------VDIKVIKNWARQILHGLVYLHSHN 44
+I E GNL Y + +N + ++ + ++ Q+ G+ +L S
Sbjct: 95 VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK 154
Query: 45 PPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP----TARSVIGTPEFMA-PELYEE 99
IHRDL NI ++ VKI D GLA + + ++MA +++
Sbjct: 155 --CIHRDLAARNILLSEK-NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR 211
Query: 100 EYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFI 158
Y D++SFG+ + E+ + PY K + +++ G + P++ +
Sbjct: 212 VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM-RAPDYTTPEMYQTM 270
Query: 159 EKCLVP-ASERLSAKDLLK 176
C S+R + +L++
Sbjct: 271 LDCWHGEPSQRPTFSELVE 289
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (248), Expect = 5e-24
Identities = 40/213 (18%), Positives = 88/213 (41%), Gaps = 35/213 (16%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 60
++ E + + + ++D +++K++ Q+L GL + HS N ++HRDLK N+ +N
Sbjct: 78 LVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLIN 135
Query: 61 GNHGEVKIGDLGLAIAMQQPTARS--VIGTPEFMAPELY--EEEYNELVDIYSFGMCILE 116
+GE+K+ + GLA A P + T + P++ + Y+ +D++S G E
Sbjct: 136 -RNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAE 194
Query: 117 MVTFEYPYSECKNPAQIFKKVTSGI---------------------------KPASLAKV 149
+ P + K++ + ++
Sbjct: 195 LANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPK 254
Query: 150 NDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQ 181
+ + ++ L +R+SA++ L+ P+
Sbjct: 255 LNATGRDLLQNLLKCNPVQRISAEEALQHPYFS 287
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (251), Expect = 6e-24
Identities = 53/233 (22%), Positives = 87/233 (37%), Gaps = 49/233 (21%)
Query: 17 KHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 76
K +++ I + QIL GL Y+HS N ++HRDLK N+ +N ++KI D GLA
Sbjct: 102 KTQHLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLN-TTCDLKICDFGLARV 158
Query: 77 M-----QQPTARSVIGTPEFMAPELYEEE--YNELVDIYSFGMCILEMVTFEYPYSECKN 129
+ T + APE+ Y + +DI+S G + EM++ +
Sbjct: 159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 218
Query: 130 PAQIFKKVTSGIKP----------------------------ASLAKVNDPQIKGFIEKC 161
Q+ + P L D + ++K
Sbjct: 219 LDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKM 278
Query: 162 LVP-ASERLSAKDLLKDPFLQ--VENQKEPICDPL--------KLPIQSLKML 203
L +R+ + L P+L+ + EPI + LP + LK L
Sbjct: 279 LTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKEL 331
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 99 bits (248), Expect = 8e-24
Identities = 42/204 (20%), Positives = 81/204 (39%), Gaps = 24/204 (11%)
Query: 1 MITELFTSGNLRQYRKKHKNV----------DIKVIKNWARQILHGLVYLHSHNPPIIHR 50
+I EL T G+L+ Y + + + + A +I G+ YL+++ +HR
Sbjct: 100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHR 157
Query: 51 DLKCDNIFVNGNHGEVKIGDLGLAIAMQQP----TARSVIGTPEFMAPE-LYEEEYNELV 105
DL N V + VKIGD G+ + + + +M+PE L + +
Sbjct: 158 DLAARNCMVAED-FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYS 216
Query: 106 DIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP- 164
D++SFG+ + E+ T + + Q+ + V G + + C
Sbjct: 217 DVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNC-PDMLFELMRMCWQYN 275
Query: 165 ASERLSAKDLLKDPFLQVENQKEP 188
R S +++ ++ + EP
Sbjct: 276 PKMRPSFLEIIS----SIKEEMEP 295
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 99.5 bits (247), Expect = 9e-24
Identities = 23/181 (12%), Positives = 66/181 (36%), Gaps = 21/181 (11%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 60
++ +L + +K + A+Q+L + +H + +++RD+K DN +
Sbjct: 78 LVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIG 135
Query: 61 ----GNHGEVKIGDLGLAIAMQQP---------TARSVIGTPEFMAPELYE-EEYNELVD 106
N + + D G+ + P +++ GT +M+ + E + D
Sbjct: 136 RPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDD 195
Query: 107 IYSFGMCILEMVT--FEYPYSECKNPAQIFKKVTSGIKPASLAKVND---PQIKGFIEKC 161
+ + G + + + + Q ++++ + L ++ + ++
Sbjct: 196 LEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYA 255
Query: 162 L 162
Sbjct: 256 R 256
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 99 bits (248), Expect = 1e-23
Identities = 38/220 (17%), Positives = 83/220 (37%), Gaps = 44/220 (20%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 60
++ E + + +Q ++ + I+ + +IL L Y HS I+HRD+K N+ ++
Sbjct: 109 LVFEHVNNTDFKQL---YQTLTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMID 163
Query: 61 GNHGEVKIGDLGLAIAMQQ-PTARSVIGTPEFMAPELYEEE--YNELVDIYSFGMCILEM 117
H ++++ D GLA + + F PEL + Y+ +D++S G + M
Sbjct: 164 HEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASM 223
Query: 118 VTFEYPYSECKNPAQIFKKVT-----------------------------------SGIK 142
+ + P+ + ++
Sbjct: 224 IFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFV 283
Query: 143 PASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQ 181
+ + P+ F++K L RL+A++ ++ P+
Sbjct: 284 HSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY 323
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.3 bits (244), Expect = 2e-23
Identities = 39/200 (19%), Positives = 82/200 (41%), Gaps = 27/200 (13%)
Query: 1 MITELFTSGNLRQYRKKHKN------------------VDIKVIKNWARQILHGLVYLHS 42
+ITE G+L + ++ ++ +D++ + +++ Q+ G+ +L S
Sbjct: 104 VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS 163
Query: 43 HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSV----IGTPEFMAPE-LY 97
N IHRDL NI + KI D GLA ++ + V ++MAPE ++
Sbjct: 164 KN--CIHRDLAARNILLTHG-RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIF 220
Query: 98 EEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 157
Y D++S+G+ + E+ + F K+ + ++
Sbjct: 221 NCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDI 280
Query: 158 IEKCLVP-ASERLSAKDLLK 176
++ C +R + K +++
Sbjct: 281 MKTCWDADPLKRPTFKQIVQ 300
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.4 bits (239), Expect = 2e-22
Identities = 54/218 (24%), Positives = 86/218 (39%), Gaps = 37/218 (16%)
Query: 9 GNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKI 68
G KH+ + I+ Q+L GL Y+H+ HRDLK N+ VN + E+KI
Sbjct: 106 GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGII--HRDLKPGNLAVNED-CELKI 162
Query: 69 GDLGLAIAMQQPTARSVIGTPEFMAPELY--EEEYNELVDIYSFGMCILEMVTFEYPYSE 126
D GLA + T + APE+ Y + VDI+S G + EM+T + +
Sbjct: 163 LDFGLARQADSEM-TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKG 221
Query: 127 CKNPAQIFKKVTSGIKP----------------------------ASLAKVNDPQIKGFI 158
+ Q+ + + P AS+ P +
Sbjct: 222 SDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLL 281
Query: 159 EKCLVP-ASERLSAKDLLKDPFLQ--VENQKEPICDPL 193
EK LV A +R++A + L P+ + + + EP
Sbjct: 282 EKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQKY 319
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.4 bits (218), Expect = 1e-19
Identities = 57/237 (24%), Positives = 91/237 (38%), Gaps = 37/237 (15%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 60
+ G K + + ++ QIL GL Y+HS + IIHRDLK N+ VN
Sbjct: 98 VYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVN 155
Query: 61 GNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELY--EEEYNELVDIYSFGMCILEMV 118
E+KI D GLA + T + APE+ YN+ VDI+S G + E++
Sbjct: 156 -EDCELKILDFGLARHTDDEM-TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 213
Query: 119 TFEYPYSECKNPAQIFKKVTSGIKP----------------------------ASLAKVN 150
T + + Q+ + P A++
Sbjct: 214 TGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGA 273
Query: 151 DPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQ--VENQKEPICDPLKLPIQSLKMLR 204
+P +EK LV + +R++A L + + EP+ DP +S +L
Sbjct: 274 NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLI 330
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.5 bits (218), Expect = 1e-19
Identities = 55/250 (22%), Positives = 92/250 (36%), Gaps = 49/250 (19%)
Query: 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 60
++ EL + + + + D + + Q+L G+ +LHS IHRDLK NI V
Sbjct: 99 LVMELMDANLCQVIQMEL---DHERMSYLLYQMLCGIKHLHSAGI--IHRDLKPSNIVVK 153
Query: 61 GNHGEVKIGDLGLAIAMQQPTARS-VIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMV 118
+ +KI D GLA + + T + APE + Y E VDI+S G + EMV
Sbjct: 154 SD-CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212
Query: 119 TFEYPYSECKNPAQIFKKVTSGIKP----------------------------------- 143
+ + Q K + P
Sbjct: 213 RHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSL 272
Query: 144 ----ASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVE-NQKEPICDPLKLPI 197
+ K+ Q + + K LV ++R+S D L+ P++ V + E P ++
Sbjct: 273 FPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYD 332
Query: 198 QSLKMLRLPM 207
+ L +
Sbjct: 333 KQLDEREHTI 342
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 81.6 bits (200), Expect = 2e-17
Identities = 51/234 (21%), Positives = 89/234 (38%), Gaps = 54/234 (23%)
Query: 11 LRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN-----GNHGE 65
+ +H+ + + +K ++Q+L GL Y+H IIH D+K +N+ + N +
Sbjct: 112 ALIKKYEHRGIPLIYVKQISKQLLLGLDYMH-RRCGIIHTDIKPENVLMEIVDSPENLIQ 170
Query: 66 VKIGDLGLAIAMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPY 124
+KI DLG A + + I T E+ +PE L + DI+S I E++T ++ +
Sbjct: 171 IKIADLGNACWYDEHY-TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLF 229
Query: 125 S---------ECKNPAQIFK--------------------------KVTSGIKPASLAKV 149
+ + AQI + + S +K L V
Sbjct: 230 EPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDV 289
Query: 150 ----------NDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQKEPICDP 192
+I F+ L +R A L+ P+L+ E I P
Sbjct: 290 LTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVP 343
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 60.6 bits (146), Expect = 3e-11
Identities = 19/104 (18%), Positives = 36/104 (34%), Gaps = 4/104 (3%)
Query: 13 QYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLG 72
K+ V ++ IL + + I+H DL N+ V+ + I D
Sbjct: 92 IDAKELYRVRVENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLVSEEG--IWIIDFP 147
Query: 73 LAIAMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILE 116
++ + + R ++ + Y DI S IL+
Sbjct: 148 QSVEVGEEGWREILERDVRNIITYFSRTYRTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 563 | |||
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 99.98 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 99.98 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 99.97 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 99.97 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 99.97 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 99.97 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 99.97 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 99.97 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 99.97 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 99.96 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.95 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.41 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 94.5 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 91.15 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 84.61 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 82.55 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 81.11 |
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-43 Score=355.83 Aligned_cols=181 Identities=61% Similarity=1.077 Sum_probs=169.7
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
||||||++|+|.+++.+.+.+++..++.|+.||+.||+|||+++++|+||||||+|||+++.+|.+||+|||+++.....
T Consensus 89 ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~ 168 (270)
T d1t4ha_ 89 LVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS 168 (270)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred EEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC
Confidence 58999999999999999889999999999999999999999999889999999999999866789999999999876666
Q ss_pred CCccccCCCCccCcccccccCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHHHHHH
Q 008504 81 TARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEK 160 (563)
Q Consensus 81 ~~~~~~Gtp~Y~APEvl~~~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~LI~k 160 (563)
.....+||+.|||||++.++|+.++|||||||++|+|++|+.||.+..+...+++.+..+..+..++...++++++||.+
T Consensus 169 ~~~~~~GT~~Y~aPE~~~~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~ 248 (270)
T d1t4ha_ 169 FAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEG 248 (270)
T ss_dssp SBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHH
T ss_pred ccCCcccCccccCHHHhCCCCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHHHHHHHHH
Confidence 66678999999999999989999999999999999999999999988888889999999888888888889999999999
Q ss_pred hcC-CCCCCCCHHHHHcCcccc
Q 008504 161 CLV-PASERLSAKDLLKDPFLQ 181 (563)
Q Consensus 161 cL~-dP~kRpSa~ELLkHpff~ 181 (563)
||. +|.+|||+.|+|+||||+
T Consensus 249 ~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 249 CIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp HSCSSGGGSCCHHHHHTSGGGC
T ss_pred HccCCHhHCcCHHHHhCCcccC
Confidence 998 899999999999999996
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-41 Score=335.81 Aligned_cols=177 Identities=23% Similarity=0.448 Sum_probs=159.0
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
||||||++|+|.+++.+.+.+++..++.|+.||+.||+|||++| |+||||||+|||++ .+|.+||+|||++......
T Consensus 83 ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~--ivHrDiKp~Nill~-~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 83 LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLG-SAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTSCEEECCCCSCSCCCCC
T ss_pred EEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeeeeccccceec-CCCCEeecccceeeecCCC
Confidence 69999999999999999889999999999999999999999999 99999999999998 5579999999999877666
Q ss_pred CCccccCCCCccCccccccc-CCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHHHHH
Q 008504 81 TARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIE 159 (563)
Q Consensus 81 ~~~~~~Gtp~Y~APEvl~~~-ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~LI~ 159 (563)
......||+.|||||++.+. |+.++|||||||++|+|++|+.||.. .+...++..+..+.. .++...++++++||.
T Consensus 160 ~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~~li~ 236 (263)
T d2j4za1 160 RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA-NTYQETYKRISRVEF--TFPDFVTEGARDLIS 236 (263)
T ss_dssp CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHTTCC--CCCTTSCHHHHHHHH
T ss_pred cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCC--CCCccCCHHHHHHHH
Confidence 66677899999999999764 89999999999999999999999976 567777777766543 345677899999999
Q ss_pred HhcC-CCCCCCCHHHHHcCcccccc
Q 008504 160 KCLV-PASERLSAKDLLKDPFLQVE 183 (563)
Q Consensus 160 kcL~-dP~kRpSa~ELLkHpff~~~ 183 (563)
+||. +|.+|||+.|+|+||||+..
T Consensus 237 ~~L~~dp~~R~t~~eil~hp~~~~~ 261 (263)
T d2j4za1 237 RLLKHNPSQRPMLREVLEHPWITAN 261 (263)
T ss_dssp HHTCSSGGGSCCHHHHHTCHHHHHH
T ss_pred HHccCCHhHCcCHHHHHcCcCcCCc
Confidence 9998 89999999999999999743
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-41 Score=336.33 Aligned_cols=179 Identities=26% Similarity=0.422 Sum_probs=154.0
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
||||||+||+|.+++.+++.+++..++.|+.||+.||.|||++| |+||||||+|||++ .+|.+||+|||+|+.....
T Consensus 80 ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~--IiHrDiKp~NILl~-~~~~~KL~DFG~a~~~~~~ 156 (271)
T d1nvra_ 80 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLD-ERDNLKISDFGLATVFRYN 156 (271)
T ss_dssp EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEC-TTCCEEECCCTTCEECEET
T ss_pred EEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC--CccCcccHHHEEEC-CCCCEEEccchhheeeccC
Confidence 69999999999999988889999999999999999999999999 99999999999998 4579999999999765322
Q ss_pred ----CCccccCCCCccCccccccc-C-CchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhH
Q 008504 81 ----TARSVIGTPEFMAPELYEEE-Y-NELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQI 154 (563)
Q Consensus 81 ----~~~~~~Gtp~Y~APEvl~~~-y-s~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l 154 (563)
.....+||+.|||||++.+. + +.++|||||||++|+|+||+.||.........+................++++
T Consensus 157 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 236 (271)
T d1nvra_ 157 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP 236 (271)
T ss_dssp TEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHH
T ss_pred CccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHH
Confidence 23456899999999998653 4 67899999999999999999999875555555555555544444455668899
Q ss_pred HHHHHHhcC-CCCCCCCHHHHHcCccccc
Q 008504 155 KGFIEKCLV-PASERLSAKDLLKDPFLQV 182 (563)
Q Consensus 155 ~~LI~kcL~-dP~kRpSa~ELLkHpff~~ 182 (563)
++||.+||. +|.+|||+.|+|+||||+.
T Consensus 237 ~~li~~~L~~dP~~R~t~~eil~hpwf~~ 265 (271)
T d1nvra_ 237 LALLHKILVENPSARITIPDIKKDRWYNK 265 (271)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred HHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence 999999997 8999999999999999974
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-40 Score=333.74 Aligned_cols=178 Identities=31% Similarity=0.549 Sum_probs=155.4
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC-
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ- 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~- 79 (563)
||||||+||+|.+++.+ +.+++..++.|++||+.||.|||++| |+||||||+|||++ .+|.+||+|||+++.+..
T Consensus 94 ivmEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~-~~~~vkl~DFG~a~~~~~~ 169 (293)
T d1yhwa1 94 VVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPE 169 (293)
T ss_dssp EEEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTCCEEECCCTTCEECCST
T ss_pred EEEEecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCcHHHeEEC-CCCcEeeccchhheeeccc
Confidence 69999999999998876 46999999999999999999999999 99999999999998 458999999999976643
Q ss_pred -CCCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHHH
Q 008504 80 -PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 157 (563)
Q Consensus 80 -~~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~L 157 (563)
......+||+.|+|||++.+ .|+.++|||||||++|+|+||+.||.+......+...+..+......+...++.+++|
T Consensus 170 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 249 (293)
T d1yhwa1 170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDF 249 (293)
T ss_dssp TCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHH
T ss_pred cccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHH
Confidence 23445689999999998875 4899999999999999999999999875555555555555555555667778999999
Q ss_pred HHHhcC-CCCCCCCHHHHHcCccccc
Q 008504 158 IEKCLV-PASERLSAKDLLKDPFLQV 182 (563)
Q Consensus 158 I~kcL~-dP~kRpSa~ELLkHpff~~ 182 (563)
|.+||. +|.+|||+.|+|+||||+.
T Consensus 250 i~~~L~~dP~~R~s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 250 LNRCLDMDVEKRGSAKELLQHQFLKI 275 (293)
T ss_dssp HHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred HHHHccCChhHCcCHHHHhcCHhhCC
Confidence 999997 8999999999999999974
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-40 Score=338.09 Aligned_cols=183 Identities=28% Similarity=0.526 Sum_probs=150.1
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHS-HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs-~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
||||||+||+|.+++.+++.+++..++.++.||+.||.|||+ +| |+||||||+|||++ .+|.+||+|||+|+....
T Consensus 81 iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~--IiHRDiKP~NILl~-~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 81 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVN-SRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp EEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEEC-TTCCEEECCCCCCHHHHH
T ss_pred EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCC--EEccccCHHHeeEC-CCCCEEEeeCCCccccCC
Confidence 699999999999999988899999999999999999999997 58 99999999999998 558999999999987665
Q ss_pred CCCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHH--------------------------
Q 008504 80 PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQ-------------------------- 132 (563)
Q Consensus 80 ~~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~-------------------------- 132 (563)
....+.+||+.|+|||++.+ .|+.++|||||||++|||++|+.||........
T Consensus 158 ~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (322)
T d1s9ja_ 158 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 237 (322)
T ss_dssp HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------------------
T ss_pred CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccc
Confidence 55567799999999999875 599999999999999999999999976432211
Q ss_pred ---------------HHHHHhcCCCCCccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCccccccccC
Q 008504 133 ---------------IFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQK 186 (563)
Q Consensus 133 ---------------i~~~i~~~~~p~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~~~ 186 (563)
....+.....+.......++++++||.+||. ||.+|||+.|+|+||||+..++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~~~ 307 (322)
T d1s9ja_ 238 SSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAE 307 (322)
T ss_dssp --------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHHHS
T ss_pred cccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCCcc
Confidence 1111111222222233457899999999998 89999999999999999865543
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.2e-39 Score=338.99 Aligned_cols=182 Identities=26% Similarity=0.487 Sum_probs=156.9
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
||||||+||+|.+++.+++.+++..++.|+.||+.||.|||++| ||||||||+|||++ ..|.+||+|||+|+.....
T Consensus 84 ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~--iiHrDlKP~NILl~-~~g~iKl~DFGla~~~~~~ 160 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLD-EHGHVRISDLGLACDFSKK 160 (364)
T ss_dssp EEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-SSSCEEECCCTTCEECSSS
T ss_pred EEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCC--ccceeeccceeEEc-CCCcEEEeeeceeeecCCC
Confidence 69999999999999999899999999999999999999999999 99999999999998 5589999999999877766
Q ss_pred CCccccCCCCccCccccc-c-cCCchhhHHHhHHHHHHHhhcCCCCCCCCC--HHHHHHHHhcCCCCCccccCCChhHHH
Q 008504 81 TARSVIGTPEFMAPELYE-E-EYNELVDIYSFGMCILEMVTFEYPYSECKN--PAQIFKKVTSGIKPASLAKVNDPQIKG 156 (563)
Q Consensus 81 ~~~~~~Gtp~Y~APEvl~-~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~--~~~i~~~i~~~~~p~~l~~~~s~~l~~ 156 (563)
.....+||+.|+|||++. + .|+.++|||||||++|+|+||+.||..... ...+...+.. .+...+...++++++
T Consensus 161 ~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~--~~~~~~~~~s~~~~~ 238 (364)
T d1omwa3 161 KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT--MAVELPDSFSPELRS 238 (364)
T ss_dssp CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSS--CCCCCCSSSCHHHHH
T ss_pred cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc--CCCCCCCCCCHHHHH
Confidence 666778999999999885 3 489999999999999999999999976432 2233333222 233456677899999
Q ss_pred HHHHhcC-CCCCCCC-----HHHHHcCccccccccCC
Q 008504 157 FIEKCLV-PASERLS-----AKDLLKDPFLQVENQKE 187 (563)
Q Consensus 157 LI~kcL~-dP~kRpS-----a~ELLkHpff~~~~~~~ 187 (563)
||.+||. ||.+||| |.|+++||||+..+|..
T Consensus 239 li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~~~ 275 (364)
T d1omwa3 239 LLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQM 275 (364)
T ss_dssp HHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCHHH
T ss_pred HHHHHcccCHHHhCCCcccCHHHHHcCccccCCCHHH
Confidence 9999997 8999999 89999999999877654
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-39 Score=327.92 Aligned_cols=179 Identities=30% Similarity=0.547 Sum_probs=151.0
Q ss_pred CEeccCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k-~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
||||||++|+|.+++.+ .+.+++..++.|+.||+.||.|||++| |+||||||+|||++ .+|.+||+|||+|+....
T Consensus 86 lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~--ivHrDiKp~NIll~-~~~~~Kl~DFG~a~~~~~ 162 (288)
T d2jfla1 86 ILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK--IIHRDLKAGNILFT-LDGDIKLADFGVSAKNTR 162 (288)
T ss_dssp EEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEECHH
T ss_pred EEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEEeecChhheeEC-CCCCEEEEechhhhccCC
Confidence 69999999999999765 567999999999999999999999999 99999999999998 557999999999865432
Q ss_pred C--CCccccCCCCccCccccc------ccCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCC-CCccccCC
Q 008504 80 P--TARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK-PASLAKVN 150 (563)
Q Consensus 80 ~--~~~~~~Gtp~Y~APEvl~------~~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~-p~~l~~~~ 150 (563)
. ......||+.|+|||++. ..|+.++|||||||++|+|+||+.||.+.. ..+++..+..+.. ....+...
T Consensus 163 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~~ 241 (288)
T d2jfla1 163 TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELN-PMRVLLKIAKSEPPTLAQPSRW 241 (288)
T ss_dssp HHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSC-GGGHHHHHHHSCCCCCSSGGGS
T ss_pred CcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCC-HHHHHHHHHcCCCCCCCccccC
Confidence 1 233568999999999873 348999999999999999999999998744 4444455554433 33445667
Q ss_pred ChhHHHHHHHhcC-CCCCCCCHHHHHcCcccccc
Q 008504 151 DPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 183 (563)
Q Consensus 151 s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~ 183 (563)
++++++||.+||+ +|.+|||+.|+|+||||+..
T Consensus 242 s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~~ 275 (288)
T d2jfla1 242 SSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVD 275 (288)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCCC
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 8999999999998 89999999999999999753
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-39 Score=327.69 Aligned_cols=182 Identities=29% Similarity=0.462 Sum_probs=157.4
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
||||||+||+|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||+|+.+...
T Consensus 85 ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~NIll~-~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 85 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLN-EDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTSCEEECCCTTCEECC--
T ss_pred EEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhcccc--EEcCcCCccccccC-CCceEEecccccceecccC
Confidence 69999999999999999899999999999999999999999999 99999999999998 5579999999999766432
Q ss_pred ----CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHH
Q 008504 81 ----TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIK 155 (563)
Q Consensus 81 ----~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~ 155 (563)
.....+||+.|+|||++.+ .|+.++|||||||++|+|+||+.||.. .+...++..+..+.. .++...++.++
T Consensus 162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~ 238 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA-GNEYLIFQKIIKLEY--DFPEKFFPKAR 238 (288)
T ss_dssp --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHTTCC--CCCTTCCHHHH
T ss_pred CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCC-cCHHHHHHHHHcCCC--CCCccCCHHHH
Confidence 2345689999999999865 599999999999999999999999987 567777777776643 34567789999
Q ss_pred HHHHHhcC-CCCCCCCHHH------HHcCccccccccCCC
Q 008504 156 GFIEKCLV-PASERLSAKD------LLKDPFLQVENQKEP 188 (563)
Q Consensus 156 ~LI~kcL~-dP~kRpSa~E------LLkHpff~~~~~~~~ 188 (563)
+||.+||. +|.+|||+.| +++||||+..+|...
T Consensus 239 ~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~l 278 (288)
T d1uu3a_ 239 DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 278 (288)
T ss_dssp HHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTG
T ss_pred HHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHHHh
Confidence 99999997 8999999987 688999998877654
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-39 Score=323.53 Aligned_cols=177 Identities=26% Similarity=0.476 Sum_probs=144.2
Q ss_pred CEeccCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCC---CeEeccCccCceEEeCCCCcEEEecccc
Q 008504 1 MITELFTSGNLRQYRKK----HKNVDIKVIKNWARQILHGLVYLHSHNP---PIIHRDLKCDNIFVNGNHGEVKIGDLGL 73 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k----~~~Lse~~i~~i~~QIL~aL~yLHs~gp---~IIHrDLKP~NILLd~~~G~VKL~DFGl 73 (563)
||||||++|+|.+++.+ .+.+++..++.|+.||+.||.|||++|+ +|+||||||+|||++ .+|.+||+|||+
T Consensus 82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~-~~~~vkl~DFG~ 160 (269)
T d2java1 82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLD-GKQNVKLGDFGL 160 (269)
T ss_dssp EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEEC-TTSCEEECCHHH
T ss_pred EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcC-CCCcEEEeeccc
Confidence 58999999999999864 4679999999999999999999999752 499999999999998 458999999999
Q ss_pred hhhccCC--CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCC
Q 008504 74 AIAMQQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVN 150 (563)
Q Consensus 74 A~~~~~~--~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~ 150 (563)
++..... ......||+.|||||++.+ .|+.++|||||||++|+|+||+.||.. .+..++...+..+..+ .++...
T Consensus 161 a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~-~~~~~~~~~i~~~~~~-~~~~~~ 238 (269)
T d2java1 161 ARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA-FSQKELAGKIREGKFR-RIPYRY 238 (269)
T ss_dssp HHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHHTCCC-CCCTTS
T ss_pred eeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCC-CCHHHHHHHHHcCCCC-CCCccc
Confidence 9876543 3345789999999999865 599999999999999999999999986 5667777777776554 355667
Q ss_pred ChhHHHHHHHhcC-CCCCCCCHHHHHcCccc
Q 008504 151 DPQIKGFIEKCLV-PASERLSAKDLLKDPFL 180 (563)
Q Consensus 151 s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff 180 (563)
++++++||.+||. ||.+|||+.|+|+|||+
T Consensus 239 s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 239 SDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 8999999999997 89999999999999996
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.6e-39 Score=326.95 Aligned_cols=180 Identities=23% Similarity=0.402 Sum_probs=145.0
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeC--CCCcEEEecccchhhcc
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG--NHGEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~--~~G~VKL~DFGlA~~~~ 78 (563)
||||||+||+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+||++.. ++|.+||+|||+++...
T Consensus 84 lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 84 LIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG--IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp EEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred EEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhce--eeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence 69999999999999999889999999999999999999999999 999999999999953 45799999999997665
Q ss_pred CC-CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCC--CccccCCChhH
Q 008504 79 QP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP--ASLAKVNDPQI 154 (563)
Q Consensus 79 ~~-~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p--~~l~~~~s~~l 154 (563)
.. .....+||+.|||||++.+ .|+.++|||||||++|+|++|+.||.+ .....+...+..+... .......++.+
T Consensus 162 ~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 240 (307)
T d1a06a_ 162 PGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYD-ENDAKLFEQILKAEYEFDSPYWDDISDSA 240 (307)
T ss_dssp -----------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHTTCCCCCTTTTTTSCHHH
T ss_pred CCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCC-CCHHHHHHHHhccCCCCCCccccCCCHHH
Confidence 43 3445689999999999875 499999999999999999999999987 4566666666665443 23345678899
Q ss_pred HHHHHHhcC-CCCCCCCHHHHHcCcccccc
Q 008504 155 KGFIEKCLV-PASERLSAKDLLKDPFLQVE 183 (563)
Q Consensus 155 ~~LI~kcL~-dP~kRpSa~ELLkHpff~~~ 183 (563)
++||.+||. +|.+|||+.|+|+||||+..
T Consensus 241 ~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 241 KDFIRHLMEKDPEKRFTCEQALQHPWIAGD 270 (307)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred HHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 999999998 89999999999999999854
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-39 Score=332.24 Aligned_cols=182 Identities=25% Similarity=0.489 Sum_probs=160.8
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC-
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ- 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~- 79 (563)
||||||+||+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||+|+....
T Consensus 82 iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NILl~-~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLD-KDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTSCEEECCCTTCBCSCCT
T ss_pred cceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcC--ccccccCHHHeEec-CCCCEEEeecccccccccC
Confidence 69999999999999999999999999999999999999999999 99999999999998 458999999999976543
Q ss_pred -CCCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHHH
Q 008504 80 -PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 157 (563)
Q Consensus 80 -~~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~L 157 (563)
......+||+.|+|||++.+ .|+.++|||||||++|||++|+.||.+ .+...+++.+..+.. .++...++++++|
T Consensus 159 ~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~dl 235 (337)
T d1o6la_ 159 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELILMEEI--RFPRTLSPEAKSL 235 (337)
T ss_dssp TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCC--CCCTTSCHHHHHH
T ss_pred CcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCC-cCHHHHHHHHhcCCC--CCCccCCHHHHHH
Confidence 23456789999999999864 599999999999999999999999987 567777777777653 3566788999999
Q ss_pred HHHhcC-CCCCCCC-----HHHHHcCccccccccCCC
Q 008504 158 IEKCLV-PASERLS-----AKDLLKDPFLQVENQKEP 188 (563)
Q Consensus 158 I~kcL~-dP~kRpS-----a~ELLkHpff~~~~~~~~ 188 (563)
|.+||+ ||.+|++ +.|+++||||+..++...
T Consensus 236 i~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~~~l 272 (337)
T d1o6la_ 236 LAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDV 272 (337)
T ss_dssp HHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHH
T ss_pred HHhhccCCchhhcccccccHHHHHcCcccccCCHHHH
Confidence 999998 8999994 999999999988766543
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.7e-39 Score=328.22 Aligned_cols=177 Identities=31% Similarity=0.503 Sum_probs=155.0
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
||||||.+|+|..++..++++++..++.|++||+.||.|||++| |+||||||+|||++ ++|.+||+|||++.....
T Consensus 92 iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~-~~~~~Kl~DFG~a~~~~~- 167 (309)
T d1u5ra_ 92 LVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLS-EPGLVKLGDFGSASIMAP- 167 (309)
T ss_dssp EEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEE-TTTEEEECCCTTCBSSSS-
T ss_pred EEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEEC-CCCCEEEeecccccccCC-
Confidence 69999999999988888889999999999999999999999999 99999999999998 558999999999976543
Q ss_pred CCccccCCCCccCccccc----ccCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHH
Q 008504 81 TARSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKG 156 (563)
Q Consensus 81 ~~~~~~Gtp~Y~APEvl~----~~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~ 156 (563)
.....||+.|||||++. +.|+.++|||||||++|+|++|..||.+. +.......+..+..+...+...++.+++
T Consensus 168 -~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~s~~~~~ 245 (309)
T d1u5ra_ 168 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-NAMSALYHIAQNESPALQSGHWSEYFRN 245 (309)
T ss_dssp -BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS-CHHHHHHHHHHSCCCCCSCTTSCHHHHH
T ss_pred -CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCC-CHHHHHHHHHhCCCCCCCCCCCCHHHHH
Confidence 34568999999999884 34899999999999999999999999874 4555555566665555556677899999
Q ss_pred HHHHhcC-CCCCCCCHHHHHcCcccccc
Q 008504 157 FIEKCLV-PASERLSAKDLLKDPFLQVE 183 (563)
Q Consensus 157 LI~kcL~-dP~kRpSa~ELLkHpff~~~ 183 (563)
||.+||. ||.+|||+.|+|+||||+..
T Consensus 246 li~~~L~~dP~~Rpt~~ell~Hp~~~~~ 273 (309)
T d1u5ra_ 246 FVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (309)
T ss_dssp HHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred HHHHHCcCChhHCcCHHHHHhCHHhcCC
Confidence 9999998 89999999999999999753
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-38 Score=321.49 Aligned_cols=185 Identities=26% Similarity=0.447 Sum_probs=155.6
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCC---CcEEEecccchhhc
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNH---GEVKIGDLGLAIAM 77 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~---G~VKL~DFGlA~~~ 77 (563)
||||||+||+|.+++.+.+.+++..++.++.||+.||+|||++| |+||||||+||+++.++ +.+||+|||++...
T Consensus 90 iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~--ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~ 167 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 167 (293)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcc--eeecccccceEEEecCCCcccceEecchhhhhhc
Confidence 69999999999999998889999999999999999999999999 99999999999997432 25999999999776
Q ss_pred cCC-CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCC--CccccCCChh
Q 008504 78 QQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP--ASLAKVNDPQ 153 (563)
Q Consensus 78 ~~~-~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p--~~l~~~~s~~ 153 (563)
... ......||+.|+|||++.+ .|+.++|||||||++|+|++|+.||.+ .+..+.+..+..+... ...+...++.
T Consensus 168 ~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 246 (293)
T d1jksa_ 168 DFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG-DTKQETLANVSAVNYEFEDEYFSNTSAL 246 (293)
T ss_dssp TTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHTTCCCCCHHHHTTSCHH
T ss_pred CCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCC-CCHHHHHHHHHhcCCCCCchhcCCCCHH
Confidence 543 3445689999999999875 499999999999999999999999987 5566666666665442 3344567889
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHHcCccccccccCCC
Q 008504 154 IKGFIEKCLV-PASERLSAKDLLKDPFLQVENQKEP 188 (563)
Q Consensus 154 l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~~~~~ 188 (563)
+++||.+||. +|.+|||+.|+|+||||+..++...
T Consensus 247 ~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~~~ 282 (293)
T d1jksa_ 247 AKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQA 282 (293)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHHSTTTCC------
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCcccCCCChhHh
Confidence 9999999998 8999999999999999987665443
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.6e-38 Score=323.59 Aligned_cols=181 Identities=28% Similarity=0.511 Sum_probs=159.7
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
||||||.||+|.+++...+.+++..++.|+.||+.||.|||++| |+||||||+|||++ .+|.+||+|||+|+.....
T Consensus 81 ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NILl~-~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 81 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLD-KNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEEC-TTSCEEECCCSSCEECSSC
T ss_pred eEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCc--EEccccCchheeEc-CCCCEEEecCccceEeccc
Confidence 68999999999999999999999999999999999999999999 99999999999998 5689999999999776543
Q ss_pred CCccccCCCCccCccccccc-CCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHHHHH
Q 008504 81 TARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIE 159 (563)
Q Consensus 81 ~~~~~~Gtp~Y~APEvl~~~-ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~LI~ 159 (563)
....+||+.|||||++.+. |+.++|||||||++|+|+||+.||.+ .+...+...+..+.. .++...++.++++|.
T Consensus 158 -~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~~li~ 233 (316)
T d1fota_ 158 -TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD-SNTMKTYEKILNAEL--RFPPFFNEDVKDLLS 233 (316)
T ss_dssp -BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHCCC--CCCTTSCHHHHHHHH
T ss_pred -cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCC-cCHHHHHHHHHcCCC--CCCCCCCHHHHHHHH
Confidence 3467899999999998764 99999999999999999999999987 566777777766643 345667899999999
Q ss_pred HhcC-CCCCCC-----CHHHHHcCccccccccCCC
Q 008504 160 KCLV-PASERL-----SAKDLLKDPFLQVENQKEP 188 (563)
Q Consensus 160 kcL~-dP~kRp-----Sa~ELLkHpff~~~~~~~~ 188 (563)
+||. +|.+|+ |++++|+||||+..++...
T Consensus 234 ~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~~~l 268 (316)
T d1fota_ 234 RLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKL 268 (316)
T ss_dssp HHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHHH
T ss_pred HHhhhCHHhccccchhhHHHHHcCcccccCCHHHH
Confidence 9997 899996 9999999999998776543
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.3e-38 Score=328.36 Aligned_cols=182 Identities=25% Similarity=0.443 Sum_probs=159.9
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
+||||+.+|+|.+++.+.+.+++..++.|+.||+.||.|||++| ||||||||+|||++ .+|.+||+|||+|+.....
T Consensus 118 ~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~--iiHRDIKP~NILl~-~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp EEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEECSSC
T ss_pred cccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCcCCHHHcccC-CCCCEEeeeceeeeecccc
Confidence 58999999999999999889999999999999999999999999 99999999999998 4589999999999876543
Q ss_pred CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHHHHH
Q 008504 81 TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIE 159 (563)
Q Consensus 81 ~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~LI~ 159 (563)
.....||+.|||||++.+ .|+.++|||||||++|+|+||+.||.+ .+...++..+..+... .+...++++++||.
T Consensus 195 -~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~-~~~~~~~~~i~~~~~~--~p~~~s~~~~~li~ 270 (350)
T d1rdqe_ 195 -TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA-DQPIQIYEKIVSGKVR--FPSHFSSDLKDLLR 270 (350)
T ss_dssp -BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCC--CCTTCCHHHHHHHH
T ss_pred -cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCC-cCHHHHHHHHhcCCCC--CCccCCHHHHHHHH
Confidence 345789999999999875 489999999999999999999999987 5677777777766443 35567899999999
Q ss_pred HhcC-CCCCCC-----CHHHHHcCccccccccCCCC
Q 008504 160 KCLV-PASERL-----SAKDLLKDPFLQVENQKEPI 189 (563)
Q Consensus 160 kcL~-dP~kRp-----Sa~ELLkHpff~~~~~~~~~ 189 (563)
+||. ||.+|+ |+.++++||||+..++....
T Consensus 271 ~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~~~~~ 306 (350)
T d1rdqe_ 271 NLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIY 306 (350)
T ss_dssp HHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHHH
T ss_pred HHhhhCHHhccccccccHHHHHcCccccCCCHHHHH
Confidence 9997 899984 99999999999987765443
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.1e-37 Score=324.55 Aligned_cols=182 Identities=27% Similarity=0.406 Sum_probs=155.7
Q ss_pred CEeccCCCCCHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeC-CCCcEEEecccchhhcc
Q 008504 1 MITELFTSGNLRQYRK-KHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG-NHGEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~-k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~-~~G~VKL~DFGlA~~~~ 78 (563)
||||||+||+|.+++. ..+++++..++.|+.||+.||.|||++| ||||||||+|||++. .+|.+||+|||+++.+.
T Consensus 100 ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~ 177 (350)
T d1koaa2 100 MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 177 (350)
T ss_dssp EEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTSCCEEECCCTTCEECC
T ss_pred EEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcC--CeeeeechhHeeeccCCCCeEEEeecchheecc
Confidence 6999999999999995 4567999999999999999999999999 999999999999963 35789999999998765
Q ss_pred CC-CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCC--CCccccCCChhH
Q 008504 79 QP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK--PASLAKVNDPQI 154 (563)
Q Consensus 79 ~~-~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~--p~~l~~~~s~~l 154 (563)
.. ......||+.|||||++.+ .|+.++|||||||++|+|+||+.||.+ .+....+..+..+.. +.......++.+
T Consensus 178 ~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 256 (350)
T d1koaa2 178 PKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG-ENDDETLRNVKSCDWNMDDSAFSGISEDG 256 (350)
T ss_dssp TTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCSCCGGGGGCCHHH
T ss_pred cccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCCCCcccccCCCHHH
Confidence 43 3345689999999999875 489999999999999999999999986 456666666665543 233344568899
Q ss_pred HHHHHHhcC-CCCCCCCHHHHHcCcccccccc
Q 008504 155 KGFIEKCLV-PASERLSAKDLLKDPFLQVENQ 185 (563)
Q Consensus 155 ~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~~ 185 (563)
++||.+||. ||.+|||+.|+|+||||+....
T Consensus 257 ~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~ 288 (350)
T d1koaa2 257 KDFIRKLLLADPNTRMTIHQALEHPWLTPGNA 288 (350)
T ss_dssp HHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTC
T ss_pred HHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence 999999997 8999999999999999987654
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-38 Score=323.40 Aligned_cols=181 Identities=28% Similarity=0.521 Sum_probs=159.0
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC-
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ- 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~- 79 (563)
||||||++|+|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++ ..|.+||+|||+++....
T Consensus 80 ivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~--iiHrDikp~NiL~~-~~~~~kl~DFG~a~~~~~~ 156 (320)
T d1xjda_ 80 FVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLD-KDGHIKIADFGMCKENMLG 156 (320)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTSCEEECCCTTCBCCCCT
T ss_pred EEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCcccceeec-CCCceeccccchhhhcccc
Confidence 69999999999999999899999999999999999999999999 99999999999998 568999999999976543
Q ss_pred -CCCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHHH
Q 008504 80 -PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 157 (563)
Q Consensus 80 -~~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~L 157 (563)
.......||+.|+|||++.+ .|+.++|||||||++|+|+||+.||.+ .+..+++..+..+.. .++...++.+++|
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~dl 233 (320)
T d1xjda_ 157 DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG-QDEEELFHSIRMDNP--FYPRWLEKEAKDL 233 (320)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCC--CCCTTSCHHHHHH
T ss_pred cccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCC--CCCccCCHHHHHH
Confidence 23345689999999998875 599999999999999999999999987 567777777776643 3566778999999
Q ss_pred HHHhcC-CCCCCCCHH-HHHcCccccccccCC
Q 008504 158 IEKCLV-PASERLSAK-DLLKDPFLQVENQKE 187 (563)
Q Consensus 158 I~kcL~-dP~kRpSa~-ELLkHpff~~~~~~~ 187 (563)
|.+||. +|.+|||+. ++++||||+..++..
T Consensus 234 i~~~L~~dP~~R~s~~~~l~~hpff~~~~~~~ 265 (320)
T d1xjda_ 234 LVKLFVREPEKRLGVRGDIRQHPLFREINWEE 265 (320)
T ss_dssp HHHHSCSSGGGSBTTBSCGGGSGGGTTCCHHH
T ss_pred HHHhcccCCCCCcCHHHHHHhCchhccCCHHH
Confidence 999997 899999995 899999998765543
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.2e-37 Score=312.15 Aligned_cols=178 Identities=26% Similarity=0.489 Sum_probs=154.5
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
||||||+||+|.++++.++.+++..++.|+.||+.||+|||++| |+||||||+||+++ .++.+||+|||+++.....
T Consensus 87 ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~-~~~~~kl~DFG~a~~~~~~ 163 (277)
T d1phka_ 87 LVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLD-DDMNIKLTDFGFSCQLDPG 163 (277)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTCCEEECCCTTCEECCTT
T ss_pred EEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC--CcccccccceEEEc-CCCCeEEccchheeEccCC
Confidence 69999999999999999899999999999999999999999999 99999999999997 5689999999999776543
Q ss_pred -CCccccCCCCccCcccccc-------cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCC--CCccccCC
Q 008504 81 -TARSVIGTPEFMAPELYEE-------EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK--PASLAKVN 150 (563)
Q Consensus 81 -~~~~~~Gtp~Y~APEvl~~-------~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~--p~~l~~~~ 150 (563)
......||+.|+|||++.+ .++.++||||+||++|+|+||+.||.+ .+.......+..+.. +.......
T Consensus 164 ~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~ 242 (277)
T d1phka_ 164 EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH-RKQMLMLRMIMSGNYQFGSPEWDDY 242 (277)
T ss_dssp CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCCCTTTGGGS
T ss_pred CceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCC-CCHHHHHHHHHhCCCCCCCcccccC
Confidence 3445689999999998852 378899999999999999999999987 456666666665543 22333467
Q ss_pred ChhHHHHHHHhcC-CCCCCCCHHHHHcCccccc
Q 008504 151 DPQIKGFIEKCLV-PASERLSAKDLLKDPFLQV 182 (563)
Q Consensus 151 s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~ 182 (563)
++++++||.+||. +|.+|||+.|+|+||||+.
T Consensus 243 s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 243 SDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp CHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 8999999999998 8999999999999999974
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.8e-37 Score=323.11 Aligned_cols=181 Identities=25% Similarity=0.409 Sum_probs=154.9
Q ss_pred CEeccCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeC-CCCcEEEecccchhhcc
Q 008504 1 MITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG-NHGEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~-~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~-~~G~VKL~DFGlA~~~~ 78 (563)
||||||+||+|.+++.+.+ ++++..++.|+.||+.||.|||++| |+||||||+||||+. ..|.+||+|||+|....
T Consensus 103 ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~ 180 (352)
T d1koba_ 103 LILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLN 180 (352)
T ss_dssp EEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred EEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccccccccccccCCCeEEEeecccceecC
Confidence 6999999999999877644 6999999999999999999999999 999999999999973 45799999999998765
Q ss_pred CC-CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCC--CCccccCCChhH
Q 008504 79 QP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK--PASLAKVNDPQI 154 (563)
Q Consensus 79 ~~-~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~--p~~l~~~~s~~l 154 (563)
.. ......||+.|+|||++.+ .|+.++|||||||++|+|+||+.||.+ .+....+..+..+.. +.......++++
T Consensus 181 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 259 (352)
T d1koba_ 181 PDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG-EDDLETLQNVKRCDWEFDEDAFSSVSPEA 259 (352)
T ss_dssp TTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC-SSHHHHHHHHHHCCCCCCSSTTTTSCHHH
T ss_pred CCCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCCCCcccccCCCHHH
Confidence 43 3445689999999999875 499999999999999999999999987 455566666665543 333445678999
Q ss_pred HHHHHHhcC-CCCCCCCHHHHHcCccccccc
Q 008504 155 KGFIEKCLV-PASERLSAKDLLKDPFLQVEN 184 (563)
Q Consensus 155 ~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~ 184 (563)
++||.+||. +|.+|||+.|+|+||||+...
T Consensus 260 ~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~ 290 (352)
T d1koba_ 260 KDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 290 (352)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred HHHHHHHccCChhHCcCHHHHhcCHhhCCCc
Confidence 999999998 899999999999999998643
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-37 Score=314.83 Aligned_cols=181 Identities=22% Similarity=0.340 Sum_probs=147.0
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
||||||.+|++..++...+.+++..++.|++||+.||+|||++| |+||||||+|||++ ..|.+||+|||+++.....
T Consensus 77 ivmE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDiKp~NIli~-~~~~~KL~DFG~a~~~~~~ 153 (299)
T d1ua2a_ 77 LVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLD-ENGVLKLADFGLAKSFGSP 153 (299)
T ss_dssp EEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTCCEEECCCGGGSTTTSC
T ss_pred ehhhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccc--eecccCCcceEEec-CCCccccccCccccccCCC
Confidence 69999999888887777778999999999999999999999999 99999999999998 5589999999999766543
Q ss_pred --CCccccCCCCccCcccccc--cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhc-CCCC------------
Q 008504 81 --TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS-GIKP------------ 143 (563)
Q Consensus 81 --~~~~~~Gtp~Y~APEvl~~--~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~-~~~p------------ 143 (563)
.....+||+.|+|||++.+ .|+.++|||||||++|+|+||..||.+....+.+...... +...
T Consensus 154 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~ 233 (299)
T d1ua2a_ 154 NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 233 (299)
T ss_dssp CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTT
T ss_pred cccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccch
Confidence 3345689999999998753 4899999999999999999999999874443333322211 0000
Q ss_pred ------------CccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCccccccc
Q 008504 144 ------------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 184 (563)
Q Consensus 144 ------------~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~ 184 (563)
.......++.+++||.+||+ ||.+||||.|+|+||||+...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p 287 (299)
T d1ua2a_ 234 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP 287 (299)
T ss_dssp CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred hhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCC
Confidence 00112346789999999998 899999999999999998543
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-37 Score=309.84 Aligned_cols=171 Identities=20% Similarity=0.389 Sum_probs=148.4
Q ss_pred CEeccCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTS-GNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~g-GsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
+||||+.+ ++|.+++.+++.+++..++.|+.||+.||.|||++| |+||||||+|||++.+.+.+||+|||+++....
T Consensus 86 lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~ 163 (273)
T d1xwsa_ 86 LILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKD 163 (273)
T ss_dssp EEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTTCEECCS
T ss_pred EEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--CccccCcccceEEecCCCeEEECccccceeccc
Confidence 58999976 689999998889999999999999999999999999 999999999999987778999999999987666
Q ss_pred CCCccccCCCCccCccccccc--CCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHHH
Q 008504 80 PTARSVIGTPEFMAPELYEEE--YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 157 (563)
Q Consensus 80 ~~~~~~~Gtp~Y~APEvl~~~--ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~L 157 (563)
.......||+.|+|||++.+. ++.++|||||||++|+|+||+.||.. ... +..+. ..++...++++++|
T Consensus 164 ~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~---~~~----i~~~~--~~~~~~~s~~~~~l 234 (273)
T d1xwsa_ 164 TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH---DEE----IIRGQ--VFFRQRVSSECQHL 234 (273)
T ss_dssp SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS---HHH----HHHCC--CCCSSCCCHHHHHH
T ss_pred ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCC---chH----Hhhcc--cCCCCCCCHHHHHH
Confidence 666677899999999988643 46789999999999999999999975 222 22222 22455678999999
Q ss_pred HHHhcC-CCCCCCCHHHHHcCccccc
Q 008504 158 IEKCLV-PASERLSAKDLLKDPFLQV 182 (563)
Q Consensus 158 I~kcL~-dP~kRpSa~ELLkHpff~~ 182 (563)
|.+||. +|.+|||+.|+|+||||+.
T Consensus 235 i~~~L~~dp~~R~s~~eil~hp~~~~ 260 (273)
T d1xwsa_ 235 IRWCLALRPSDRPTFEEIQNHPWMQD 260 (273)
T ss_dssp HHHHTCSSGGGSCCHHHHHTSGGGSS
T ss_pred HHHHccCCHhHCcCHHHHhcCHhhCC
Confidence 999997 8999999999999999974
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-37 Score=320.89 Aligned_cols=181 Identities=20% Similarity=0.362 Sum_probs=147.4
Q ss_pred CEeccCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeC--CCCcEEEecccchhh
Q 008504 1 MITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG--NHGEVKIGDLGLAIA 76 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~--~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~--~~G~VKL~DFGlA~~ 76 (563)
||||||+||+|.+++.++ .++++..++.|+.||+.||+|||++| |+||||||+|||++. +.+.+||+|||+++.
T Consensus 86 ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~--iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~ 163 (335)
T d2ozaa1 86 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 163 (335)
T ss_dssp EEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC--Cccccccccccccccccccccccccccceeee
Confidence 699999999999999874 46999999999999999999999999 999999999999974 346799999999976
Q ss_pred ccC-CCCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHH---HHHHHHhcCCC--CCccccC
Q 008504 77 MQQ-PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPA---QIFKKVTSGIK--PASLAKV 149 (563)
Q Consensus 77 ~~~-~~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~---~i~~~i~~~~~--p~~l~~~ 149 (563)
... .......||+.|+|||++.+ .|+.++|||||||++|+|+||+.||.+..... .+...+..+.. +......
T Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 243 (335)
T d2ozaa1 164 TTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE 243 (335)
T ss_dssp CCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTHHHH
T ss_pred ccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCccccc
Confidence 643 33456689999999999875 49999999999999999999999997633222 22222222221 1122234
Q ss_pred CChhHHHHHHHhcC-CCCCCCCHHHHHcCcccccc
Q 008504 150 NDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 183 (563)
Q Consensus 150 ~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~ 183 (563)
.++++++||.+||. +|.+|||+.|+|+||||+..
T Consensus 244 ~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 278 (335)
T d2ozaa1 244 VSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 278 (335)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence 67899999999997 89999999999999999754
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-37 Score=307.20 Aligned_cols=174 Identities=30% Similarity=0.484 Sum_probs=147.5
Q ss_pred CEeccCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~-~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
||||||++|+|.+++... ..+++..+..|+.||+.||+|||++| ||||||||+|||++ .++.+||+|||+|+....
T Consensus 80 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~--ivHrDlKp~NiLl~-~~~~~Kl~DFGla~~~~~ 156 (276)
T d1uwha_ 80 IVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS--IIHRDLKSNNIFLH-EDLTVKIGDFGLATVKSR 156 (276)
T ss_dssp EEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEE-TTSSEEECCCCCSCC---
T ss_pred EEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCC--EeccccCHHHEEEc-CCCCEEEccccceeeccc
Confidence 689999999999999764 56999999999999999999999999 99999999999998 457999999999976543
Q ss_pred C----CCccccCCCCccCccccc----ccCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCc---ccc
Q 008504 80 P----TARSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPAS---LAK 148 (563)
Q Consensus 80 ~----~~~~~~Gtp~Y~APEvl~----~~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~---l~~ 148 (563)
. ......||+.|||||++. +.|+.++|||||||++|||+||+.||.+......+...+..+..++. .+.
T Consensus 157 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~ 236 (276)
T d1uwha_ 157 WSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRS 236 (276)
T ss_dssp ---------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCT
T ss_pred cCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccc
Confidence 2 234568999999999885 24899999999999999999999999987777777777777655433 345
Q ss_pred CCChhHHHHHHHhcC-CCCCCCCHHHHHcC
Q 008504 149 VNDPQIKGFIEKCLV-PASERLSAKDLLKD 177 (563)
Q Consensus 149 ~~s~~l~~LI~kcL~-dP~kRpSa~ELLkH 177 (563)
..++.+++||.+||. +|.+|||+.+++++
T Consensus 237 ~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 237 NCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 567899999999997 89999999999986
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-36 Score=305.31 Aligned_cols=177 Identities=21% Similarity=0.383 Sum_probs=151.6
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
||||||++|+|.+++.+.+.+++..+..|+.||+.||.|||++| |+||||||+|||++ .+|.+||+|||+++.....
T Consensus 84 lvmE~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~--iiHrDlKp~Nill~-~~~~~kl~DFGla~~~~~~ 160 (277)
T d1xbba_ 84 LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLV-TQHYAKISDFGLSKALRAD 160 (277)
T ss_dssp EEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEE-ETTEEEECCCTTCEECCTT
T ss_pred EEEEcCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCC--cccCCCcchhhccc-ccCcccccchhhhhhcccc
Confidence 69999999999999999999999999999999999999999999 99999999999998 5579999999999765432
Q ss_pred C-----CccccCCCCccCccccc-ccCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCCCCccccCCChh
Q 008504 81 T-----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQ 153 (563)
Q Consensus 81 ~-----~~~~~Gtp~Y~APEvl~-~~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~ 153 (563)
. .....||+.|||||++. +.|+.++|||||||++|||+| |+.||.+ ....++...+..+.++. .+...+++
T Consensus 161 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~-~~~~~~~~~i~~~~~~~-~p~~~~~~ 238 (277)
T d1xbba_ 161 ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG-MKGSEVTAMLEKGERMG-CPAGCPRE 238 (277)
T ss_dssp CSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTT-CCHHHHHHHHHTTCCCC-CCTTCCHH
T ss_pred ccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCC-CCHHHHHHHHHcCCCCC-CCcccCHH
Confidence 1 22346899999999886 458999999999999999998 8999987 45667777777776543 45667899
Q ss_pred HHHHHHHhcC-CCCCCCCHHHH---HcCccccc
Q 008504 154 IKGFIEKCLV-PASERLSAKDL---LKDPFLQV 182 (563)
Q Consensus 154 l~~LI~kcL~-dP~kRpSa~EL---LkHpff~~ 182 (563)
+++||.+||. +|.+|||+.++ |+|+|++.
T Consensus 239 ~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 271 (277)
T d1xbba_ 239 MYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 271 (277)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhhc
Confidence 9999999997 89999999998 56777653
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-36 Score=311.80 Aligned_cols=180 Identities=23% Similarity=0.392 Sum_probs=154.2
Q ss_pred CEeccCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCC-CCcEEEecccchhhcc
Q 008504 1 MITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGN-HGEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~-~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~-~G~VKL~DFGlA~~~~ 78 (563)
||||||+||+|.+++.+.+ .+++..++.|+.||+.||.|||++| |+||||||+|||++.+ .+.+||+|||++....
T Consensus 78 lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~--iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~ 155 (321)
T d1tkia_ 78 MIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155 (321)
T ss_dssp EEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred EEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC--CCcccccccceeecCCCceEEEEcccchhhccc
Confidence 6999999999999998765 6999999999999999999999999 9999999999999742 3589999999997665
Q ss_pred CC-CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCC--CccccCCChhH
Q 008504 79 QP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP--ASLAKVNDPQI 154 (563)
Q Consensus 79 ~~-~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p--~~l~~~~s~~l 154 (563)
.. ......+++.|+|||.+.+ .|+.++|||||||++|+|++|..||.. .+...++..+..+... .......++++
T Consensus 156 ~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 234 (321)
T d1tkia_ 156 PGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLA-ETNQQIIENIMNAEYTFDEEAFKEISIEA 234 (321)
T ss_dssp TTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHTCCCCCHHHHTTSCHHH
T ss_pred cCCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCCCChhhccCCCHHH
Confidence 43 3445679999999998865 489999999999999999999999987 5666777777665432 23334568899
Q ss_pred HHHHHHhcC-CCCCCCCHHHHHcCcccccc
Q 008504 155 KGFIEKCLV-PASERLSAKDLLKDPFLQVE 183 (563)
Q Consensus 155 ~~LI~kcL~-dP~kRpSa~ELLkHpff~~~ 183 (563)
++||.+||. ||.+|||+.|+|+||||+..
T Consensus 235 ~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 235 MDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred HHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 999999998 89999999999999999754
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-36 Score=308.20 Aligned_cols=173 Identities=24% Similarity=0.368 Sum_probs=147.8
Q ss_pred CEeccCCCCCHHHHHHhCC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCce
Q 008504 1 MITELFTSGNLRQYRKKHK-----------------------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 57 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~-----------------------~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NI 57 (563)
||||||++|+|.++++.++ .+++..++.|+.||+.||+|||++| ||||||||+||
T Consensus 118 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~--IiHRDlKp~Ni 195 (325)
T d1rjba_ 118 LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVHRDLAARNV 195 (325)
T ss_dssp EEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--EEETTCSGGGE
T ss_pred EEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCchhcc
Confidence 6999999999999997642 4899999999999999999999999 99999999999
Q ss_pred EEeCCCCcEEEecccchhhccCCC----CccccCCCCccCccccc-ccCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHH
Q 008504 58 FVNGNHGEVKIGDLGLAIAMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPA 131 (563)
Q Consensus 58 LLd~~~G~VKL~DFGlA~~~~~~~----~~~~~Gtp~Y~APEvl~-~~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~ 131 (563)
|++ .++.+||+|||+|+...... .....||+.|||||++. +.|+.++|||||||++|||+| |+.||.+.....
T Consensus 196 ll~-~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~ 274 (325)
T d1rjba_ 196 LVT-HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA 274 (325)
T ss_dssp EEE-TTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH
T ss_pred ccc-cCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHH
Confidence 998 45899999999997654332 22456799999999885 569999999999999999998 899998866666
Q ss_pred HHHHHHhcCCCCCccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcC
Q 008504 132 QIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 177 (563)
Q Consensus 132 ~i~~~i~~~~~p~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkH 177 (563)
.+.+.+..+..+ ..+...++.+++||.+||. +|.+|||+.||++|
T Consensus 275 ~~~~~~~~~~~~-~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 275 NFYKLIQNGFKM-DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp HHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHhcCCCC-CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 666666665443 4566778999999999997 89999999999986
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-36 Score=301.54 Aligned_cols=180 Identities=29% Similarity=0.403 Sum_probs=145.4
Q ss_pred CEeccCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k-~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
|+||||.+|.+...... .+.+++..++.+++||+.||+|||++| |+||||||+|||++ ..|.+||+|||++.....
T Consensus 92 ~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~--ivHrDiKp~NILi~-~~~~~kl~dfg~~~~~~~ 168 (305)
T d1blxa_ 92 LVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVT-SSGQIKLADFGLARIYSF 168 (305)
T ss_dssp EEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTCCEEECSCCSCCCCCG
T ss_pred EEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEecCCCccEEEEc-CCCCeeecchhhhhhhcc
Confidence 58999998877655543 456999999999999999999999999 99999999999998 557999999999865533
Q ss_pred -CCCccccCCCCccCccccc-ccCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcC--C--------------
Q 008504 80 -PTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG--I-------------- 141 (563)
Q Consensus 80 -~~~~~~~Gtp~Y~APEvl~-~~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~--~-------------- 141 (563)
.......||+.|+|||++. ..|+.++|||||||++|||+||+.||.... .......+... .
T Consensus 169 ~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 247 (305)
T d1blxa_ 169 QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS-DVDQLGKILDVIGLPGEEDWPRDVALPR 247 (305)
T ss_dssp GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS-HHHHHHHHHHHHCCCCGGGSCTTCSSCG
T ss_pred cccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCC-HHHHHHHHHHhhCCCchhcccccccchh
Confidence 2345668999999999885 459999999999999999999999998744 33333332210 0
Q ss_pred ---------CCCccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCccccccc
Q 008504 142 ---------KPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 184 (563)
Q Consensus 142 ---------~p~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~ 184 (563)
....+....++.+++||.+||. ||.+|||+.|+|+||||+...
T Consensus 248 ~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~ 300 (305)
T d1blxa_ 248 QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 300 (305)
T ss_dssp GGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred hhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCch
Confidence 0111233457889999999997 899999999999999998654
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-36 Score=301.78 Aligned_cols=173 Identities=25% Similarity=0.440 Sum_probs=142.5
Q ss_pred CEeccCCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCC
Q 008504 1 MITELFTSGNLRQYRKKH----------------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHG 64 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~----------------~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G 64 (563)
+|||||++|+|.+++... ..+++..++.|+.||+.||.|||++| |+||||||+||||+ +++
T Consensus 95 iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--ivHrDlKp~NILl~-~~~ 171 (299)
T d1ywna1 95 VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLS-EKN 171 (299)
T ss_dssp EEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-GGG
T ss_pred EEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC--CcCCcCCccceeEC-CCC
Confidence 589999999999999753 24899999999999999999999999 99999999999998 557
Q ss_pred cEEEecccchhhccCC----CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhc-CCCCCCCCCHHHHHHHHh
Q 008504 65 EVKIGDLGLAIAMQQP----TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVT 138 (563)
Q Consensus 65 ~VKL~DFGlA~~~~~~----~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG-~~Pf~~~~~~~~i~~~i~ 138 (563)
.+||+|||+|+..... ......||+.|+|||++.+ .|+.++|||||||++|||+|| ..||........+...+.
T Consensus 172 ~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~~ 251 (299)
T d1ywna1 172 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 251 (299)
T ss_dssp CEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHH
T ss_pred cEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Confidence 9999999999765432 2334579999999998864 589999999999999999987 567877666677777777
Q ss_pred cCCCCCccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcC
Q 008504 139 SGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 177 (563)
Q Consensus 139 ~~~~p~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkH 177 (563)
.+..+ ..+...++.+++||.+||. +|.+|||+.|+++|
T Consensus 252 ~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 252 EGTRM-RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCCC-CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 77655 3556678999999999997 89999999999987
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-35 Score=299.53 Aligned_cols=177 Identities=19% Similarity=0.406 Sum_probs=151.0
Q ss_pred CEeccCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k-~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
||||||++|+|.+++.. .+.+++..++.|+.||+.||.|||++| |+||||||+|||++ .++.+||+|||+++.+..
T Consensus 85 lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~--iiHrDlKp~Nill~-~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 85 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLV-NRHYAKISDFGLSKALGA 161 (285)
T ss_dssp EEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEE-ETTEEEECCCTTCEECTT
T ss_pred EEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCcCchhheeec-cCCceeeccchhhhcccc
Confidence 69999999999999865 457999999999999999999999999 99999999999998 457999999999976643
Q ss_pred CC-----CccccCCCCccCccccc-ccCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCCCCccccCCCh
Q 008504 80 PT-----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDP 152 (563)
Q Consensus 80 ~~-----~~~~~Gtp~Y~APEvl~-~~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~ 152 (563)
.. .....||+.|+|||++. +.|+.++|||||||++|||+| |+.||.+.. ..++...+..+..+. .+...++
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~-~~~~~~~i~~~~~~~-~p~~~~~ 239 (285)
T d1u59a_ 162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK-GPEVMAFIEQGKRME-CPPECPP 239 (285)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC-THHHHHHHHTTCCCC-CCTTCCH
T ss_pred cccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCC-HHHHHHHHHcCCCCC-CCCcCCH
Confidence 21 22346889999999886 459999999999999999998 899998744 556677777776553 4566789
Q ss_pred hHHHHHHHhcC-CCCCCCCHHHH---HcCccccc
Q 008504 153 QIKGFIEKCLV-PASERLSAKDL---LKDPFLQV 182 (563)
Q Consensus 153 ~l~~LI~kcL~-dP~kRpSa~EL---LkHpff~~ 182 (563)
++.+||.+||. +|.+|||+.++ |+|+|+..
T Consensus 240 ~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~ 273 (285)
T d1u59a_ 240 ELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 273 (285)
T ss_dssp HHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 99999999997 89999999887 67888754
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-35 Score=297.13 Aligned_cols=177 Identities=23% Similarity=0.383 Sum_probs=151.9
Q ss_pred CEeccCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhcc
Q 008504 1 MITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~--~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~ 78 (563)
||||||++|+|.+++... .++++..+..|+.||+.||.|||+++ |+||||||+||||+ +++.+||+|||+|+...
T Consensus 84 iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~--ivHrDiKp~NIll~-~~~~~Kl~DFGla~~~~ 160 (272)
T d1qpca_ 84 IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVS-DTLSCKIADFGLARLIE 160 (272)
T ss_dssp EEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTSCEEECCCTTCEECS
T ss_pred EEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccchhheeee-cccceeeccccceEEcc
Confidence 699999999999987543 35999999999999999999999999 99999999999998 55799999999998765
Q ss_pred CCC---CccccCCCCccCccccc-ccCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhH
Q 008504 79 QPT---ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQI 154 (563)
Q Consensus 79 ~~~---~~~~~Gtp~Y~APEvl~-~~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l 154 (563)
... .....||+.|+|||++. +.|+.++|||||||++|||+||..|+.......++...+..+..+. .+...++.+
T Consensus 161 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~-~p~~~~~~l 239 (272)
T d1qpca_ 161 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV-RPDNCPEEL 239 (272)
T ss_dssp SSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC-CCTTCCHHH
T ss_pred CCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC-CcccChHHH
Confidence 432 23457899999999886 4599999999999999999997776666577778888887776553 456678899
Q ss_pred HHHHHHhcC-CCCCCCCHHHHHc--Ccccc
Q 008504 155 KGFIEKCLV-PASERLSAKDLLK--DPFLQ 181 (563)
Q Consensus 155 ~~LI~kcL~-dP~kRpSa~ELLk--Hpff~ 181 (563)
++||.+||. +|.+|||+.++++ |+||.
T Consensus 240 ~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 240 YQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 999999997 8999999999998 88885
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-35 Score=292.65 Aligned_cols=173 Identities=18% Similarity=0.386 Sum_probs=139.7
Q ss_pred CEeccCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~-~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
||||||++|+|.+++... ..+++..+..|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+++....
T Consensus 77 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~--iiHrDlKp~Nill~-~~~~~Kl~DFGla~~~~~ 153 (263)
T d1sm2a_ 77 LVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVG-ENQVIKVSDFGMTRFVLD 153 (263)
T ss_dssp EEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCTTCSGGGEEEC-GGGCEEECSCC-------
T ss_pred EEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccc--eeecccchhheeec-CCCCeEecccchheeccC
Confidence 689999999999998764 56899999999999999999999999 99999999999998 457999999999976643
Q ss_pred CC---CccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHH
Q 008504 80 PT---ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIK 155 (563)
Q Consensus 80 ~~---~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~ 155 (563)
.. .....||+.|+|||++.+ .|+.++|||||||++|||+|+..|+....+..++...+..+..+. .+...++++.
T Consensus 154 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~-~p~~~~~~l~ 232 (263)
T d1sm2a_ 154 DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY-KPRLASTHVY 232 (263)
T ss_dssp -----------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCC-CCTTSCHHHH
T ss_pred CCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCC-CccccCHHHH
Confidence 32 234578999999998874 599999999999999999996555555567777888887775543 4567789999
Q ss_pred HHHHHhcC-CCCCCCCHHHHHcC
Q 008504 156 GFIEKCLV-PASERLSAKDLLKD 177 (563)
Q Consensus 156 ~LI~kcL~-dP~kRpSa~ELLkH 177 (563)
+||.+||. +|.+|||++++++|
T Consensus 233 ~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 233 QIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHccCCHhHCcCHHHHHHH
Confidence 99999998 89999999999986
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.3e-35 Score=296.70 Aligned_cols=172 Identities=22% Similarity=0.393 Sum_probs=138.4
Q ss_pred CEeccCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~-~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
||||||++|+|.+++... +.+++..++.|+.||+.||.|||++| |+||||||+||||+ .++.+||+|||+++....
T Consensus 104 iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHrDlKp~NILl~-~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 104 IITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN--YVHRDLAARNILVN-SNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp EEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTCCEEECCC--------
T ss_pred EEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCC--CccCccccceEEEC-CCCcEEECCcccceEccC
Confidence 689999999999998874 56999999999999999999999999 99999999999998 558999999999976543
Q ss_pred CC-------CccccCCCCccCccccc-ccCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCCCCccccCC
Q 008504 80 PT-------ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVN 150 (563)
Q Consensus 80 ~~-------~~~~~Gtp~Y~APEvl~-~~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~ 150 (563)
.. .....||+.|||||++. +.|+.++|||||||++|||+| |+.||.+ .....+...+..+..+. .+...
T Consensus 181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~-~~~~~~~~~i~~~~~~~-~~~~~ 258 (299)
T d1jpaa_ 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD-MTNQDVINAIEQDYRLP-PPMDC 258 (299)
T ss_dssp ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHHTTCCCC-CCTTC
T ss_pred CCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCCC-CCccc
Confidence 21 11235789999999886 459999999999999999998 8999987 45667777777765543 34567
Q ss_pred ChhHHHHHHHhcC-CCCCCCCHHHHHcC
Q 008504 151 DPQIKGFIEKCLV-PASERLSAKDLLKD 177 (563)
Q Consensus 151 s~~l~~LI~kcL~-dP~kRpSa~ELLkH 177 (563)
++.+++||.+||. +|.+|||+.|++++
T Consensus 259 ~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 259 PSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred hHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 8899999999997 89999999999875
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=5.8e-35 Score=293.12 Aligned_cols=179 Identities=26% Similarity=0.398 Sum_probs=142.9
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
+||||+.++.+..+....+.+++..++.++.||+.||+|||++| |+||||||+|||++ .+|.+||+|||++......
T Consensus 77 i~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--IvHrDiKp~NIll~-~~~~~kl~DfG~a~~~~~~ 153 (286)
T d1ob3a_ 77 LVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLIN-REGELKIADFGLARAFGIP 153 (286)
T ss_dssp EEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTSCEEECCTTHHHHHCC-
T ss_pred EEEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCc--EEecCCCCceeeEc-CCCCEEecccccceecccC
Confidence 58999998888888777888999999999999999999999999 99999999999998 4589999999999776543
Q ss_pred --CCccccCCCCccCcccccc--cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhc-CC--------------
Q 008504 81 --TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS-GI-------------- 141 (563)
Q Consensus 81 --~~~~~~Gtp~Y~APEvl~~--~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~-~~-------------- 141 (563)
......|++.|+|||.+.+ .++.++|||||||++|+|++|+.||.+......+.+.... +.
T Consensus 154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (286)
T d1ob3a_ 154 VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233 (286)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred ccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhh
Confidence 2334578999999998854 4799999999999999999999999874433333332210 00
Q ss_pred -----------CCCccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCccccc
Q 008504 142 -----------KPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQV 182 (563)
Q Consensus 142 -----------~p~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~ 182 (563)
.........++.+++||.+||+ ||.+|||+.|+|+||||+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred cccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 0011223457889999999998 8999999999999999973
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-34 Score=292.97 Aligned_cols=179 Identities=30% Similarity=0.488 Sum_probs=141.7
Q ss_pred CEeccCCCCCHHHHHH-h-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhcc
Q 008504 1 MITELFTSGNLRQYRK-K-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~-k-~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~ 78 (563)
||||||.++ +.+++. . .+.+++..++.++.||+.||.|||++| ||||||||+|||++ .++.+||+|||+++...
T Consensus 78 iv~e~~~~~-~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~--IiHrDiKpeNIl~~-~~~~~kl~DFG~a~~~~ 153 (298)
T d1gz8a_ 78 LVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLIN-TEGAIKLADFGLARAFG 153 (298)
T ss_dssp EEEECCSEE-HHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTSCEEECSTTHHHHHC
T ss_pred EEEeecCCc-hhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC--EEccccCchheeec-ccCcceeccCCcceecc
Confidence 689999764 444443 3 456999999999999999999999999 99999999999998 45799999999997765
Q ss_pred CC--CCccccCCCCccCcccccc--cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCC----------
Q 008504 79 QP--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPA---------- 144 (563)
Q Consensus 79 ~~--~~~~~~Gtp~Y~APEvl~~--~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~---------- 144 (563)
.. ......||+.|+|||++.. .++.++|||||||++|+|++|+.||.+......+.........+.
T Consensus 154 ~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 233 (298)
T d1gz8a_ 154 VPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 233 (298)
T ss_dssp CCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred CCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccc
Confidence 43 3445589999999998754 368899999999999999999999987544444444332110000
Q ss_pred ----------------ccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCcccccc
Q 008504 145 ----------------SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 183 (563)
Q Consensus 145 ----------------~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~ 183 (563)
......++.+++||.+||. +|.+|||+.|+|+||||+..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp TTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred cccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence 0012345789999999998 89999999999999999754
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-34 Score=300.20 Aligned_cols=182 Identities=20% Similarity=0.340 Sum_probs=144.2
Q ss_pred CEeccCCCCCHHHH---HHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhc
Q 008504 1 MITELFTSGNLRQY---RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM 77 (563)
Q Consensus 1 LVmEy~~gGsL~~~---L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~ 77 (563)
||||||++|.+..+ ......+++..++.|++||+.||+|||++| |+||||||+|||++.+...+||+|||++...
T Consensus 96 lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~--IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 96 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC--CcccCCCcceEEEecCCCceeEecccchhhc
Confidence 58999987643333 334567999999999999999999999999 9999999999999866568999999999766
Q ss_pred cC-CCCccccCCCCccCccccc--ccCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhc-C-------------
Q 008504 78 QQ-PTARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS-G------------- 140 (563)
Q Consensus 78 ~~-~~~~~~~Gtp~Y~APEvl~--~~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~-~------------- 140 (563)
.. ......+|++.|+|||++. ..|+.++|||||||++|||++|+.||........+...+.. +
T Consensus 174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~ 253 (350)
T d1q5ka_ 174 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 253 (350)
T ss_dssp CTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC-
T ss_pred cCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccc
Confidence 43 3345568999999999775 35899999999999999999999999875444433332210 0
Q ss_pred ----CCC--------CccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCccccccc
Q 008504 141 ----IKP--------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 184 (563)
Q Consensus 141 ----~~p--------~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~ 184 (563)
..+ .......++.+.+||.+||. ||.+|||+.|+|+||||+...
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 310 (350)
T d1q5ka_ 254 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310 (350)
T ss_dssp --CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred hhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence 000 01123457899999999998 899999999999999998643
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.5e-34 Score=292.26 Aligned_cols=172 Identities=25% Similarity=0.388 Sum_probs=148.6
Q ss_pred CEeccCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhcc
Q 008504 1 MITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~--~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~ 78 (563)
||||||++|+|.+++.+. ..+++..++.|+.||+.||.|||++| |+||||||+||||+ .+|.+||+|||+++...
T Consensus 90 iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~--iiHrDlKp~NILl~-~~~~~Kl~DFG~a~~~~ 166 (287)
T d1opja_ 90 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVG-ENHLVKVADFGLSRLMT 166 (287)
T ss_dssp EEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-GGGCEEECCCCCTTTCC
T ss_pred EEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC--cccCccccCeEEEC-CCCcEEEccccceeecC
Confidence 689999999999999764 56899999999999999999999999 99999999999998 45799999999998765
Q ss_pred CCCC---ccccCCCCccCccccc-ccCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhH
Q 008504 79 QPTA---RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQI 154 (563)
Q Consensus 79 ~~~~---~~~~Gtp~Y~APEvl~-~~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l 154 (563)
.... ....|++.|+|||++. +.|+.++|||||||++|||++|..||....+...++..+..+..+ ..+...++.+
T Consensus 167 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~-~~~~~~~~~l 245 (287)
T d1opja_ 167 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM-ERPEGCPEKV 245 (287)
T ss_dssp SSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCC-CCCTTCCHHH
T ss_pred CCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCC-CCCccchHHH
Confidence 4322 2235789999999876 569999999999999999999888877667788888877776554 3456678999
Q ss_pred HHHHHHhcC-CCCCCCCHHHHHc
Q 008504 155 KGFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 155 ~~LI~kcL~-dP~kRpSa~ELLk 176 (563)
++||.+||. +|.+|||+.++++
T Consensus 246 ~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 246 YELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHcCCCHhHCcCHHHHHH
Confidence 999999997 8999999999976
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.8e-34 Score=295.01 Aligned_cols=180 Identities=22% Similarity=0.383 Sum_probs=145.7
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
+|||||.+|+|.++. +.+++..++.+++||+.||.|||++| |+||||||+|||++.+++.+||+|||++......
T Consensus 109 ~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~g--IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~ 183 (328)
T d3bqca1 109 LVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 183 (328)
T ss_dssp EEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred EEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcc--cccccccccceEEcCCCCeeeecccccceeccCC
Confidence 589999999998763 56999999999999999999999999 9999999999999866667999999999766543
Q ss_pred -CCccccCCCCccCcccccc--cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhc-------------C-C--
Q 008504 81 -TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS-------------G-I-- 141 (563)
Q Consensus 81 -~~~~~~Gtp~Y~APEvl~~--~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~-------------~-~-- 141 (563)
.....++|+.|+|||++.+ .|+.++||||+||++|+|++|+.||............+.. . .
T Consensus 184 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 263 (328)
T d3bqca1 184 QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 263 (328)
T ss_dssp CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCC
T ss_pred CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccccc
Confidence 3455689999999998754 4899999999999999999999999775544332221110 0 0
Q ss_pred -------------------CCCccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCcccccccc
Q 008504 142 -------------------KPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQ 185 (563)
Q Consensus 142 -------------------~p~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~~ 185 (563)
.+.......++++++||.+||. ||.+|||+.|+|+||||+...+
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~~ 327 (328)
T d3bqca1 264 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK 327 (328)
T ss_dssp CGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSCC
T ss_pred CcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence 0111223357889999999998 8999999999999999986543
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-35 Score=300.44 Aligned_cols=185 Identities=24% Similarity=0.388 Sum_probs=152.8
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
+|||||.+|+|.+++...+.+++..++.++.||+.||.|||++| |+||||||+||+++. +|.+||+|||+++.+...
T Consensus 106 ~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~--ivHrDiKp~Nill~~-~~~vkL~DFG~a~~~~~~ 182 (322)
T d1vzoa_ 106 LILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLDS-NGHVVLTDFGLSKEFVAD 182 (322)
T ss_dssp EEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECT-TSCEEESCSSEEEECCGG
T ss_pred eeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCC--EEeccCCccceeecC-CCCEEEeeccchhhhccc
Confidence 58999999999999999899999999999999999999999999 999999999999984 589999999999765332
Q ss_pred ---CCccccCCCCccCcccccc---cCCchhhHHHhHHHHHHHhhcCCCCCCCC---CHHHHHHHHhcCCCCCccccCCC
Q 008504 81 ---TARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTFEYPYSECK---NPAQIFKKVTSGIKPASLAKVND 151 (563)
Q Consensus 81 ---~~~~~~Gtp~Y~APEvl~~---~ys~ksDIwSLGviLyELlTG~~Pf~~~~---~~~~i~~~i~~~~~p~~l~~~~s 151 (563)
......|++.|+|||.+.+ .++.++|||||||++|+|+||+.||.... ....+.+....... ..+...+
T Consensus 183 ~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~--~~~~~~s 260 (322)
T d1vzoa_ 183 ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP--PYPQEMS 260 (322)
T ss_dssp GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCC--CCCTTSC
T ss_pred ccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCC--CCcccCC
Confidence 2345679999999998853 37889999999999999999999996532 23344444433322 3455678
Q ss_pred hhHHHHHHHhcC-CCCCCC-----CHHHHHcCccccccccCCCCC
Q 008504 152 PQIKGFIEKCLV-PASERL-----SAKDLLKDPFLQVENQKEPIC 190 (563)
Q Consensus 152 ~~l~~LI~kcL~-dP~kRp-----Sa~ELLkHpff~~~~~~~~~~ 190 (563)
+++++||.+||. +|.+|| |++|+|+||||+..++.....
T Consensus 261 ~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~~~l~~ 305 (322)
T d1vzoa_ 261 ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAA 305 (322)
T ss_dssp HHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHT
T ss_pred HHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCHHHHHh
Confidence 999999999998 899999 589999999999876554433
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=8e-35 Score=291.42 Aligned_cols=179 Identities=22% Similarity=0.367 Sum_probs=140.8
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
||||||+||+|.+++...+.+++..++.|+.||+.||.|||++| |+||||||+|||++ ..+.++|+|||.+......
T Consensus 88 lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~--iiHrDiKP~NIll~-~~~~~~l~d~~~~~~~~~~ 164 (277)
T d1o6ya_ 88 IVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMIS-ATNAVKVMDFGIARAIADS 164 (277)
T ss_dssp EEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEE-TTSCEEECCCTTCEECC--
T ss_pred EEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCccccCcccccC-ccccceeehhhhhhhhccc
Confidence 69999999999999999899999999999999999999999999 99999999999998 4579999999988654322
Q ss_pred -----CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCC-CccccCCChh
Q 008504 81 -----TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP-ASLAKVNDPQ 153 (563)
Q Consensus 81 -----~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p-~~l~~~~s~~ 153 (563)
.....+||+.|+|||++.+ .|+.++|||||||++|+|+||+.||..........+.+.....+ .......++.
T Consensus 165 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 244 (277)
T d1o6ya_ 165 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSAD 244 (277)
T ss_dssp --------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCCHH
T ss_pred cccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCCHH
Confidence 2345689999999999875 48999999999999999999999998744334444444444333 2344567899
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHHcCccccc
Q 008504 154 IKGFIEKCLV-PASERLSAKDLLKDPFLQV 182 (563)
Q Consensus 154 l~~LI~kcL~-dP~kRpSa~ELLkHpff~~ 182 (563)
+++||.+||. ||.+||+..+.|.|+|++.
T Consensus 245 l~~li~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 245 LDAVVLKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp HHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred HHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence 9999999997 8999995444455777653
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-34 Score=290.23 Aligned_cols=178 Identities=24% Similarity=0.395 Sum_probs=142.5
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
+|||||.++.+..+......+++..++.+++||+.||.|||++| |+||||||+|||++ .++.+||+|||++......
T Consensus 94 iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~--ivHrDlKp~NILl~-~~~~~kl~dfg~~~~~~~~ 170 (318)
T d3blha1 94 LVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLIT-RDGVLKLADFGLARAFSLA 170 (318)
T ss_dssp EEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTSCEEECCCTTCEECCC-
T ss_pred EEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCC--EEecCcCchheeec-CCCcEEeeecceeeecccc
Confidence 58999998887777666778999999999999999999999999 99999999999998 4579999999999655421
Q ss_pred ------CCccccCCCCccCcccccc--cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhc---CCCCCccc--
Q 008504 81 ------TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS---GIKPASLA-- 147 (563)
Q Consensus 81 ------~~~~~~Gtp~Y~APEvl~~--~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~---~~~p~~l~-- 147 (563)
.....+||+.|+|||++.+ .|+.++|||||||++|+|++|+.||.+. +.......+.. ...+....
T Consensus 171 ~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~ 249 (318)
T d3blha1 171 KNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN-TEQHQLALISQLCGSITPEVWPNV 249 (318)
T ss_dssp ----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCS-SHHHHHHHHHHHHCCCCTTTSTTC
T ss_pred cccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCC-CHHHHHHHHHHhcCCCChhhcccc
Confidence 2334579999999998753 5899999999999999999999999763 33333322221 11111000
Q ss_pred -------------------------cCCChhHHHHHHHhcC-CCCCCCCHHHHHcCccccc
Q 008504 148 -------------------------KVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQV 182 (563)
Q Consensus 148 -------------------------~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~ 182 (563)
...++.+++||.+||+ ||.+|||+.|+|+||||+.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~ 310 (318)
T d3blha1 250 DNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 310 (318)
T ss_dssp CCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSS
T ss_pred chhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhcc
Confidence 1136678899999998 8999999999999999984
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-34 Score=286.91 Aligned_cols=172 Identities=26% Similarity=0.478 Sum_probs=138.0
Q ss_pred CEeccCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k-~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
||||||++|+|.+++.. .+.+++..++.++.||+.||.|||+++ |+||||||+||+++ ..+.+||+|||+++....
T Consensus 84 iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDlKp~NIll~-~~~~~Kl~DfG~a~~~~~ 160 (273)
T d1mp8a_ 84 IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVS-SNDCVKLGDFGLSRYMED 160 (273)
T ss_dssp EEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEE-ETTEEEECC---------
T ss_pred EEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccC--eeccccchhheeec-CCCcEEEccchhheeccC
Confidence 69999999999998765 457999999999999999999999999 99999999999998 457999999999976543
Q ss_pred C---CCccccCCCCccCccccc-ccCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhH
Q 008504 80 P---TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQI 154 (563)
Q Consensus 80 ~---~~~~~~Gtp~Y~APEvl~-~~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l 154 (563)
. ......||+.|+|||++. +.|+.++|||||||++|||+| |..||.. .+..+++..+..+..+. .+...++.+
T Consensus 161 ~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~-~~~~~~~~~i~~~~~~~-~~~~~~~~~ 238 (273)
T d1mp8a_ 161 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG-VKNNDVIGRIENGERLP-MPPNCPPTL 238 (273)
T ss_dssp ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTT-CCGGGHHHHHHTTCCCC-CCTTCCHHH
T ss_pred CcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCCCC-CCCCCCHHH
Confidence 2 223456899999999986 469999999999999999998 7888876 45566777777766543 456678999
Q ss_pred HHHHHHhcC-CCCCCCCHHHHHcC
Q 008504 155 KGFIEKCLV-PASERLSAKDLLKD 177 (563)
Q Consensus 155 ~~LI~kcL~-dP~kRpSa~ELLkH 177 (563)
++||.+||. +|.+|||+.||++|
T Consensus 239 ~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 239 YSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHcCCCHhHCcCHHHHHHH
Confidence 999999997 89999999999986
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-33 Score=291.39 Aligned_cols=178 Identities=30% Similarity=0.445 Sum_probs=143.9
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
|||||| +++|..+++. +++++..++.+++||+.||.|||++| |+||||||+|||++ .++.+||+|||+++.....
T Consensus 100 lv~e~~-~~~l~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~--IiHrDiKp~NIL~~-~~~~~kl~Dfg~a~~~~~~ 174 (346)
T d1cm8a_ 100 LVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVN-EDCELKILDFGLARQADSE 174 (346)
T ss_dssp EEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECCCTTCEECCSS
T ss_pred EEEecc-cccHHHHHHh-ccccHHHHHHHHHHHHHHHHHHHhCC--CcccccCcchhhcc-cccccccccccceeccCCc
Confidence 589999 6688887765 57999999999999999999999999 99999999999998 5589999999999766543
Q ss_pred CCccccCCCCccCcccccc--cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhc-C-----------------
Q 008504 81 TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS-G----------------- 140 (563)
Q Consensus 81 ~~~~~~Gtp~Y~APEvl~~--~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~-~----------------- 140 (563)
.....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+......+...... +
T Consensus 175 -~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (346)
T d1cm8a_ 175 -MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKN 253 (346)
T ss_dssp -CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHH
T ss_pred -cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhh
Confidence 345689999999998854 4789999999999999999999999874433322221110 0
Q ss_pred -------CC---CCccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCccccccc
Q 008504 141 -------IK---PASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 184 (563)
Q Consensus 141 -------~~---p~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~ 184 (563)
.. ........++.+.+||.+||. ||.+|||+.|+|+||||+...
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 254 YMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp HHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred hhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 00 111223457899999999998 899999999999999998643
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-34 Score=284.20 Aligned_cols=172 Identities=23% Similarity=0.431 Sum_probs=148.9
Q ss_pred CEeccCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k-~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
+||||+++|+|.+++.. ...+++..+++|+.||++||.|||++| |+||||||+||+++ +++.+||+|||+++....
T Consensus 76 iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~--iiH~dlk~~Nill~-~~~~~kl~DfG~a~~~~~ 152 (258)
T d1k2pa_ 76 IITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVN-DQGVVKVSDFGLSRYVLD 152 (258)
T ss_dssp EEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--BCCSCCSGGGEEEC-TTCCEEECCCSSCCBCSS
T ss_pred EEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcC--cccccccceeEEEc-CCCcEEECcchhheeccC
Confidence 58999999999999765 467999999999999999999999999 99999999999998 557999999999976543
Q ss_pred CC---CccccCCCCccCccccc-ccCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhH
Q 008504 80 PT---ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQI 154 (563)
Q Consensus 80 ~~---~~~~~Gtp~Y~APEvl~-~~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l 154 (563)
.. .....||+.|+|||++. ..|+.++|||||||++|||+| |+.||... +..++...+..+..+ ..+...++.+
T Consensus 153 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~-~~~~~~~~i~~~~~~-~~p~~~~~~l 230 (258)
T d1k2pa_ 153 DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF-TNSETAEHIAQGLRL-YRPHLASEKV 230 (258)
T ss_dssp SSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS-CHHHHHHHHHTTCCC-CCCTTCCHHH
T ss_pred CCceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCC-CHHHHHHHHHhCCCC-CCcccccHHH
Confidence 32 22356899999999886 459999999999999999998 79999874 567777778777654 3567788999
Q ss_pred HHHHHHhcC-CCCCCCCHHHHHcC
Q 008504 155 KGFIEKCLV-PASERLSAKDLLKD 177 (563)
Q Consensus 155 ~~LI~kcL~-dP~kRpSa~ELLkH 177 (563)
++||.+||. +|.+|||+.++|+|
T Consensus 231 ~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 231 YTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp HHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHccCCHhHCcCHHHHHHH
Confidence 999999998 89999999999987
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-33 Score=291.29 Aligned_cols=178 Identities=25% Similarity=0.371 Sum_probs=142.7
Q ss_pred EeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC--
Q 008504 2 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ-- 79 (563)
Q Consensus 2 VmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~-- 79 (563)
+++|+.+|+|.+++..+ ++++..++.++.||+.||+|||++| ||||||||+|||++ +.|.+||+|||++.....
T Consensus 88 l~~~~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH~~~--iiHRDIKp~NILl~-~~~~~kl~DfG~a~~~~~~~ 163 (345)
T d1pmea_ 88 LVTHLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDH 163 (345)
T ss_dssp EEEECCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECCCTTCEECCGGG
T ss_pred EEEeecCCchhhhhhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCcceEEEC-CCCCEEEcccCceeeccCCC
Confidence 56788899999999864 6999999999999999999999999 99999999999998 568999999999965432
Q ss_pred ---CCCccccCCCCccCcccccc--cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCC-------------
Q 008504 80 ---PTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI------------- 141 (563)
Q Consensus 80 ---~~~~~~~Gtp~Y~APEvl~~--~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~------------- 141 (563)
......+||+.|+|||++.. .|+.++||||+||++|+|++|+.||............+....
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (345)
T d1pmea_ 164 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243 (345)
T ss_dssp CBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCH
T ss_pred ccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhh
Confidence 12345679999999998743 478999999999999999999999987443332222211100
Q ss_pred ------------CC---CccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCcccccc
Q 008504 142 ------------KP---ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 183 (563)
Q Consensus 142 ------------~p---~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~ 183 (563)
.. .......++.+++||.+||. ||.+|||+.|+|+||||+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~ 301 (345)
T d1pmea_ 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 301 (345)
T ss_dssp HHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTT
T ss_pred hhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 00 01123446789999999997 99999999999999999854
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-33 Score=282.23 Aligned_cols=179 Identities=22% Similarity=0.407 Sum_probs=148.9
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
+|+||+.+++|..++..++.+++..++.+++|++.||+|||++| |+||||||+|||++. .+.+||+|||.+......
T Consensus 78 iv~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~--IvHrDiKP~NIli~~-~~~~kl~DFG~a~~~~~~ 154 (292)
T d1unla_ 78 LVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLINR-NGELKLANFGLARAFGIP 154 (292)
T ss_dssp EEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECT-TCCEEECCCTTCEECCSC
T ss_pred EEeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCC--EeeecccCccccccc-CCceeeeecchhhcccCC
Confidence 58999999999999999999999999999999999999999999 999999999999984 579999999999776543
Q ss_pred --CCccccCCCCccCccccccc--CCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCC---------------
Q 008504 81 --TARSVIGTPEFMAPELYEEE--YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI--------------- 141 (563)
Q Consensus 81 --~~~~~~Gtp~Y~APEvl~~~--ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~--------------- 141 (563)
......+++.|+|||++.+. ++.++|||||||++|+|++|+.||....+..+....+....
T Consensus 155 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (292)
T d1unla_ 155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred CccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcc
Confidence 22344678899999988643 68999999999999999999999876666666555543210
Q ss_pred ------------CCCccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCccccc
Q 008504 142 ------------KPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQV 182 (563)
Q Consensus 142 ------------~p~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~ 182 (563)
.........++.+++||.+||+ ||.+||||.|+|+||||+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~ 288 (292)
T d1unla_ 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSS
T ss_pred cccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcC
Confidence 0111223446789999999998 8999999999999999974
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-33 Score=284.33 Aligned_cols=172 Identities=22% Similarity=0.376 Sum_probs=142.8
Q ss_pred CEeccCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~-~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
+|||||.+|+|.+++... +.+++..+..++.||+.||.|||+++ |+||||||+||||+ .++.+||+|||+++....
T Consensus 86 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~--iiHrDlKp~NILl~-~~~~~Kl~DFGla~~~~~ 162 (283)
T d1mqba_ 86 IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVN-SNLVCKVSDFGLSRVLED 162 (283)
T ss_dssp EEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTCCEEECCCCC------
T ss_pred EEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccc--cccCccccceEEEC-CCCeEEEcccchhhcccC
Confidence 589999999999988764 57999999999999999999999999 99999999999998 558999999999976543
Q ss_pred CC-----CccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChh
Q 008504 80 PT-----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQ 153 (563)
Q Consensus 80 ~~-----~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~ 153 (563)
.. .....||+.|||||++.+ .|+.++|||||||++|||++|..||.......+++..+..+..+. .+...++.
T Consensus 163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~-~~~~~~~~ 241 (283)
T d1mqba_ 163 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLP-TPMDCPSA 241 (283)
T ss_dssp -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC-CCTTCBHH
T ss_pred CCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCC-CchhhHHH
Confidence 21 223468999999998864 599999999999999999998777766677888888888876654 44567789
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHHc
Q 008504 154 IKGFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 154 l~~LI~kcL~-dP~kRpSa~ELLk 176 (563)
+++||.+||. +|.+|||+.++++
T Consensus 242 l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 242 IYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHCcCCHhHCcCHHHHHH
Confidence 9999999997 8999999999987
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-33 Score=285.88 Aligned_cols=178 Identities=22% Similarity=0.353 Sum_probs=148.0
Q ss_pred CEeccCCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhcc
Q 008504 1 MITELFTSGNLRQYRKK--HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k--~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~ 78 (563)
||||||++|+|..++.. .+.+++..++.++.||+.||+|||++| |+||||||+||||+ .++.+||+|||+++...
T Consensus 88 lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~--ivH~DlKp~NIll~-~~~~~kl~DfGla~~~~ 164 (285)
T d1fmka3 88 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVG-ENLVCKVADFGLARLIE 164 (285)
T ss_dssp EEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-GGGCEEECCCCTTC---
T ss_pred EEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh--eecccccceEEEEC-CCCcEEEcccchhhhcc
Confidence 69999999999998854 457999999999999999999999999 99999999999998 45899999999997654
Q ss_pred CC---CCccccCCCCccCccccc-ccCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhH
Q 008504 79 QP---TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQI 154 (563)
Q Consensus 79 ~~---~~~~~~Gtp~Y~APEvl~-~~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l 154 (563)
.. ......||+.|+|||++. +.++.++|||||||++|||+||..||.......++...+..+..+. .+...++++
T Consensus 165 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~-~~~~~~~~l 243 (285)
T d1fmka3 165 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP-CPPECPESL 243 (285)
T ss_dssp -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC-CCTTSCHHH
T ss_pred CCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC-CCcccCHHH
Confidence 32 223357899999999886 4699999999999999999998777766677788888887775543 466678899
Q ss_pred HHHHHHhcC-CCCCCCCHHHHHc--Cccccc
Q 008504 155 KGFIEKCLV-PASERLSAKDLLK--DPFLQV 182 (563)
Q Consensus 155 ~~LI~kcL~-dP~kRpSa~ELLk--Hpff~~ 182 (563)
++||.+||. +|.+|||+.+++. |+||..
T Consensus 244 ~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 244 HDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred HHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence 999999997 8999999999988 888864
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-33 Score=286.80 Aligned_cols=173 Identities=27% Similarity=0.447 Sum_probs=145.3
Q ss_pred CEeccCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~-~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
+|+||+.+|+|.+++..+ ..+++..++.|+.||+.||.|||++| |+||||||+|||++ .++.+||+|||+++....
T Consensus 87 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~--iiHrDlKp~NIll~-~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 87 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVK-TPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp EEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEE-ETTEEEECCCSHHHHTTT
T ss_pred EEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcC--cccCcchhhcceeC-CCCCeEeeccccceeccc
Confidence 578999999999988764 57999999999999999999999999 99999999999998 457999999999987643
Q ss_pred CC----CccccCCCCccCccccc-ccCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCCCCccccCCChh
Q 008504 80 PT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQ 153 (563)
Q Consensus 80 ~~----~~~~~Gtp~Y~APEvl~-~~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~ 153 (563)
.. .....||+.|+|||++. +.|+.++|||||||++|||+| |..||.+ .+..++...+..+..+. .+...++.
T Consensus 164 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~-~~~~~~~~~i~~~~~~~-~p~~~~~~ 241 (317)
T d1xkka_ 164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG-IPASEISSILEKGERLP-QPPICTID 241 (317)
T ss_dssp TCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-SCGGGHHHHHHHTCCCC-CCTTBCHH
T ss_pred ccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCC-CCHHHHHHHHHcCCCCC-CCcccCHH
Confidence 22 22346899999999876 459999999999999999998 7888876 45566777777776543 45567889
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHHcCc
Q 008504 154 IKGFIEKCLV-PASERLSAKDLLKDP 178 (563)
Q Consensus 154 l~~LI~kcL~-dP~kRpSa~ELLkHp 178 (563)
+++||.+||. +|.+|||+.|+++|.
T Consensus 242 ~~~li~~cl~~dP~~RPs~~eil~~l 267 (317)
T d1xkka_ 242 VYMIMVKCWMIDADSRPKFRELIIEF 267 (317)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHhCCCChhhCcCHHHHHHHH
Confidence 9999999997 899999999999984
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-33 Score=284.35 Aligned_cols=173 Identities=23% Similarity=0.349 Sum_probs=146.1
Q ss_pred CEeccCCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCC
Q 008504 1 MITELFTSGNLRQYRKKH----------------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHG 64 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~----------------~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G 64 (563)
||||||++|+|.+++.+. ..+++..+..++.||+.||.|||+++ |+||||||+|||++ ..+
T Consensus 88 iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~--iiHrDlkp~NIL~~-~~~ 164 (309)
T d1fvra_ 88 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVG-ENY 164 (309)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-GGG
T ss_pred EEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC--ccccccccceEEEc-CCC
Confidence 689999999999999754 56999999999999999999999999 99999999999998 457
Q ss_pred cEEEecccchhhccCC-CCccccCCCCccCccccc-ccCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCC
Q 008504 65 EVKIGDLGLAIAMQQP-TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK 142 (563)
Q Consensus 65 ~VKL~DFGlA~~~~~~-~~~~~~Gtp~Y~APEvl~-~~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~ 142 (563)
.+||+|||+++..... ......||+.|+|||.+. +.|+.++|||||||++|||++|..|+....+..+++..+..+..
T Consensus 165 ~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~~ 244 (309)
T d1fvra_ 165 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR 244 (309)
T ss_dssp CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCC
T ss_pred ceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCC
Confidence 9999999999755432 223457899999999886 45999999999999999999976543344678888888888765
Q ss_pred CCccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcC
Q 008504 143 PASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 177 (563)
Q Consensus 143 p~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkH 177 (563)
+. .+...++++++||.+||. +|.+|||+.|+++|
T Consensus 245 ~~-~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 245 LE-KPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp CC-CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CC-CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 53 455678899999999997 89999999999987
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-33 Score=280.72 Aligned_cols=171 Identities=28% Similarity=0.439 Sum_probs=147.4
Q ss_pred CEeccCCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCC
Q 008504 1 MITELFTSGNLRQYRKKH----------------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHG 64 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~----------------~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G 64 (563)
+|||||++|+|.+++... ..+++..++.|+.||+.||+|||+++ ||||||||+|||++ .+|
T Consensus 96 ~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~--ivHrDiKp~NiLl~-~~~ 172 (299)
T d1fgka_ 96 VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVT-EDN 172 (299)
T ss_dssp EEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-TTC
T ss_pred EEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC--EEeeeecccceeec-CCC
Confidence 589999999999999754 35899999999999999999999999 99999999999998 557
Q ss_pred cEEEecccchhhccCC----CCccccCCCCccCccccc-ccCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHh
Q 008504 65 EVKIGDLGLAIAMQQP----TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVT 138 (563)
Q Consensus 65 ~VKL~DFGlA~~~~~~----~~~~~~Gtp~Y~APEvl~-~~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~ 138 (563)
.+||+|||+++..... ......|++.|+|||++. +.|+.++|||||||++|||++ |..||.. .+..+++..+.
T Consensus 173 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~-~~~~~~~~~i~ 251 (299)
T d1fgka_ 173 VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG-VPVEELFKLLK 251 (299)
T ss_dssp CEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-CCHHHHHHHHH
T ss_pred CeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCC-CCHHHHHHHHH
Confidence 9999999999765432 233457899999999886 569999999999999999998 5777765 66777888887
Q ss_pred cCCCCCccccCCChhHHHHHHHhcC-CCCCCCCHHHHHc
Q 008504 139 SGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 139 ~~~~p~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLk 176 (563)
.+..+ ..+...++.+++||.+||. +|.+|||+.|+++
T Consensus 252 ~~~~~-~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 252 EGHRM-DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp TTCCC-CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCCCC-CCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 77655 3466678899999999997 8999999999987
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-33 Score=279.44 Aligned_cols=172 Identities=27% Similarity=0.386 Sum_probs=142.6
Q ss_pred CEeccCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k-~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
||||||++|+|.+++.. .+.+++..++.++.||+.||.|||++| |+||||||+|||++. ++.+||+|||+++....
T Consensus 87 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDikp~NIll~~-~~~vkl~DfGl~~~~~~ 163 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLAT-RDLVKIGDFGLMRALPQ 163 (273)
T ss_dssp EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEE-TTEEEECCCTTCEECCC
T ss_pred eeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCC--EeeeeecHHHhcccc-ccceeeccchhhhhccc
Confidence 58999999999998765 456999999999999999999999999 999999999999985 57999999999987644
Q ss_pred CC-----CccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCCCCccccCCCh
Q 008504 80 PT-----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDP 152 (563)
Q Consensus 80 ~~-----~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~ 152 (563)
.. .....|++.|+|||++.+ .++.++|||||||++|||+| |+.||.+ .+...+...+.........+...++
T Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~ 242 (273)
T d1u46a_ 164 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG-LNGSQILHKIDKEGERLPRPEDCPQ 242 (273)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHHTSCCCCCCCTTCCH
T ss_pred CCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCC-cCHHHHHHHHHhCCCCCCCcccccH
Confidence 32 223457889999998865 48999999999999999998 8999987 4555666666555444445566788
Q ss_pred hHHHHHHHhcC-CCCCCCCHHHHHc
Q 008504 153 QIKGFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 153 ~l~~LI~kcL~-dP~kRpSa~ELLk 176 (563)
.+++||.+||. +|.+|||+.+|++
T Consensus 243 ~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 243 DIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHH
Confidence 99999999997 8999999999864
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=5.1e-33 Score=285.73 Aligned_cols=178 Identities=28% Similarity=0.382 Sum_probs=140.0
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
+|++|+.||+|.+++.. +++++..++.+++||+.||+|||++| |+||||||+|||++ .+|.+|++|||++.....
T Consensus 99 ~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~g--iiHrDiKp~NILi~-~~~~~kl~dfg~a~~~~~- 173 (348)
T d2gfsa1 99 YLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTDD- 173 (348)
T ss_dssp EEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTCCEEECCC----CCTG-
T ss_pred EEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCC--CcccccCCcccccc-ccccccccccchhcccCc-
Confidence 36888999999999865 57999999999999999999999999 99999999999998 558999999999965433
Q ss_pred CCccccCCCCccCcccccc--cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcC--CCC-------------
Q 008504 81 TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG--IKP------------- 143 (563)
Q Consensus 81 ~~~~~~Gtp~Y~APEvl~~--~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~--~~p------------- 143 (563)
......|++.|+|||++.+ .++.++|||||||++|+|++|+.||.+.. .......+... ..+
T Consensus 174 ~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 252 (348)
T d2gfsa1 174 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD-HIDQLKLILRLVGTPGAELLKKISSESAR 252 (348)
T ss_dssp GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS-HHHHHHHHHHHHCCCCHHHHTTCCCHHHH
T ss_pred ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCC-HHHHHHHHHHhcCCCChHHhhhccchhhh
Confidence 2345678999999997654 36899999999999999999999998743 33322222111 000
Q ss_pred -----------C---ccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCccccccc
Q 008504 144 -----------A---SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 184 (563)
Q Consensus 144 -----------~---~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~ 184 (563)
. ......++.+++||.+||. ||.+|||+.|+|+||||+...
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~ 308 (348)
T d2gfsa1 253 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 308 (348)
T ss_dssp HHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred hhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCC
Confidence 0 0112357889999999998 899999999999999998643
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.98 E-value=7.9e-33 Score=280.52 Aligned_cols=171 Identities=21% Similarity=0.353 Sum_probs=144.1
Q ss_pred CEeccCCCCCHHHHHHhCC------------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCc
Q 008504 1 MITELFTSGNLRQYRKKHK------------------------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDN 56 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~------------------------~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~N 56 (563)
+||||+.+|+|.+++.... .+++..+..++.||+.||+|||+++ ||||||||+|
T Consensus 93 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~--ivHrDlKp~N 170 (301)
T d1lufa_ 93 LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHRDLATRN 170 (301)
T ss_dssp EEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGG
T ss_pred EEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC--eEeeEEcccc
Confidence 5899999999999997532 3899999999999999999999999 9999999999
Q ss_pred eEEeCCCCcEEEecccchhhccCC----CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCC-CCCCCCCH
Q 008504 57 IFVNGNHGEVKIGDLGLAIAMQQP----TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEY-PYSECKNP 130 (563)
Q Consensus 57 ILLd~~~G~VKL~DFGlA~~~~~~----~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~-Pf~~~~~~ 130 (563)
||++. ++.+||+|||+++..... ......|++.|+|||++.+ .|+.++|||||||++|||++|.. ||.. .+.
T Consensus 171 ILld~-~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~-~~~ 248 (301)
T d1lufa_ 171 CLVGE-NMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG-MAH 248 (301)
T ss_dssp EEECG-GGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT-SCH
T ss_pred eEECC-CCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCC-CCH
Confidence 99984 579999999999765332 2234578899999998865 59999999999999999999964 5655 677
Q ss_pred HHHHHHHhcCCCCCccccCCChhHHHHHHHhcC-CCCCCCCHHHHHc
Q 008504 131 AQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 131 ~~i~~~i~~~~~p~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLk 176 (563)
.++...+..+..+. .+...++++.+||.+||. +|.+|||+.||++
T Consensus 249 ~e~~~~v~~~~~~~-~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 249 EEVIYYVRDGNILA-CPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp HHHHHHHHTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHcCCCCC-CCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 77778888776543 456678899999999997 8999999999965
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=8.3e-33 Score=276.28 Aligned_cols=171 Identities=22% Similarity=0.396 Sum_probs=140.9
Q ss_pred CEeccCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhcc
Q 008504 1 MITELFTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 78 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~--~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~ 78 (563)
|||||+++|+|.+++.+++ .+++..++.|+.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||+++...
T Consensus 78 lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~--ivH~dlkp~Nil~~-~~~~~kl~dfg~s~~~~ 154 (262)
T d1byga_ 78 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVS-EDNVAKVSDFGLTKEAS 154 (262)
T ss_dssp EEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-TTSCEEECCCCC-----
T ss_pred EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc--eeccccchHhheec-CCCCEeecccccceecC
Confidence 5999999999999997643 5999999999999999999999999 99999999999998 55899999999997654
Q ss_pred CCCCccccCCCCccCccccc-ccCCchhhHHHhHHHHHHHhh-cCCCCCCCCCHHHHHHHHhcCCCCCccccCCChhHHH
Q 008504 79 QPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKG 156 (563)
Q Consensus 79 ~~~~~~~~Gtp~Y~APEvl~-~~ys~ksDIwSLGviLyELlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~~l~~ 156 (563)
.. .....+++.|+|||++. +.++.++|||||||++|||+| |+.||.. ....++...+..+..+. .+...++.+++
T Consensus 155 ~~-~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~-~~~~~~~~~i~~~~~~~-~~~~~~~~~~~ 231 (262)
T d1byga_ 155 ST-QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR-IPLKDVVPRVEKGYKMD-APDGCPPAVYE 231 (262)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTT-SCGGGHHHHHTTTCCCC-CCTTCCHHHHH
T ss_pred CC-CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCC-CCHHHHHHHHHcCCCCC-CCccCCHHHHH
Confidence 32 33457899999999885 569999999999999999998 5777765 56677778887776654 45667899999
Q ss_pred HHHHhcC-CCCCCCCHHHHHcC
Q 008504 157 FIEKCLV-PASERLSAKDLLKD 177 (563)
Q Consensus 157 LI~kcL~-dP~kRpSa~ELLkH 177 (563)
||.+||. ||.+|||+.+++++
T Consensus 232 li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 232 VMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHcccCHhHCcCHHHHHHH
Confidence 9999998 89999999999874
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.5e-32 Score=279.10 Aligned_cols=173 Identities=23% Similarity=0.356 Sum_probs=144.3
Q ss_pred CEeccCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccC
Q 008504 1 MITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 79 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~-~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~ 79 (563)
+|||||++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++ +++.+||+|||+++....
T Consensus 106 lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~--iiHrDLK~~NILl~-~~~~~kL~DFG~~~~~~~ 182 (311)
T d1r0pa_ 106 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLD-EKFTVKVADFGLARDMYD 182 (311)
T ss_dssp EEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-TTCCEEECSSGGGCCTTT
T ss_pred EEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccC--cccCCccHHhEeEC-CCCCEEEecccchhhccc
Confidence 589999999999998854 45888999999999999999999999 99999999999998 557999999999976543
Q ss_pred CC------CccccCCCCccCccccc-ccCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCccccCCCh
Q 008504 80 PT------ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDP 152 (563)
Q Consensus 80 ~~------~~~~~Gtp~Y~APEvl~-~~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~s~ 152 (563)
.. .....||+.|+|||.+. +.++.++|||||||++|||+||..||....+..++...+..+..+. .+...++
T Consensus 183 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~-~p~~~~~ 261 (311)
T d1r0pa_ 183 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLL-QPEYCPD 261 (311)
T ss_dssp TTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCC-CCTTCCH
T ss_pred cccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC-CcccCcH
Confidence 21 22346899999999876 5699999999999999999999888877666666777777776553 4566788
Q ss_pred hHHHHHHHhcC-CCCCCCCHHHHHcC
Q 008504 153 QIKGFIEKCLV-PASERLSAKDLLKD 177 (563)
Q Consensus 153 ~l~~LI~kcL~-dP~kRpSa~ELLkH 177 (563)
.+.+||.+||. +|.+||++.|+++|
T Consensus 262 ~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 262 PLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 99999999997 89999999999987
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.5e-32 Score=278.32 Aligned_cols=172 Identities=23% Similarity=0.435 Sum_probs=144.2
Q ss_pred CEeccCCCCCHHHHHHhCC------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCC
Q 008504 1 MITELFTSGNLRQYRKKHK------------------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGN 62 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~------------------~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~ 62 (563)
||||||++|+|.+++.+.. .+++..++.|+.||+.||+|||+++ |+||||||+||+++ .
T Consensus 104 lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~--ivHrDLKp~NIl~~-~ 180 (311)
T d1t46a_ 104 VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNILLT-H 180 (311)
T ss_dssp EEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEE-T
T ss_pred EEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccccccccccc-c
Confidence 5899999999999997643 5899999999999999999999999 99999999999998 4
Q ss_pred CCcEEEecccchhhccCCC----CccccCCCCccCccccc-ccCCchhhHHHhHHHHHHHhhc-CCCCCCCCCHHHHHHH
Q 008504 63 HGEVKIGDLGLAIAMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKK 136 (563)
Q Consensus 63 ~G~VKL~DFGlA~~~~~~~----~~~~~Gtp~Y~APEvl~-~~ys~ksDIwSLGviLyELlTG-~~Pf~~~~~~~~i~~~ 136 (563)
.+.+||+|||+++...... .....||+.|+|||++. +.++.++|||||||++|||+|+ .+||........+.+.
T Consensus 181 ~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~ 260 (311)
T d1t46a_ 181 GRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM 260 (311)
T ss_dssp TTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHH
T ss_pred cCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 5799999999997665322 23457899999999886 4589999999999999999995 5556554455556666
Q ss_pred HhcCCCCCccccCCChhHHHHHHHhcC-CCCCCCCHHHHHc
Q 008504 137 VTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 137 i~~~~~p~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLk 176 (563)
+..+..+ ..+...++.+.+||.+||. +|.+|||+.+|++
T Consensus 261 i~~~~~~-~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 261 IKEGFRM-LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp HHHTCCC-CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HhcCCCC-CCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 6666544 3456678899999999997 8999999999986
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=9.6e-32 Score=273.77 Aligned_cols=171 Identities=24% Similarity=0.427 Sum_probs=145.0
Q ss_pred CEeccCCCCCHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEec
Q 008504 1 MITELFTSGNLRQYRKKH----------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGD 70 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~----------~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~D 70 (563)
||||||.+|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|
T Consensus 100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~--ivHrDlk~~NiLld-~~~~~Kl~D 176 (308)
T d1p4oa_ 100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVA-EDFTVKIGD 176 (308)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGGEEEC-TTCCEEECC
T ss_pred EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeeceEcCCceeec-CCceEEEee
Confidence 589999999999998642 34789999999999999999999999 99999999999998 457999999
Q ss_pred ccchhhccCC----CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcC-CCCCCCCCHHHHHHHHhcCCCCC
Q 008504 71 LGLAIAMQQP----TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFE-YPYSECKNPAQIFKKVTSGIKPA 144 (563)
Q Consensus 71 FGlA~~~~~~----~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~-~Pf~~~~~~~~i~~~i~~~~~p~ 144 (563)
||+++..... ......||+.|+|||.+.+ .++.++|||||||++|||+||. .||.+ .+..+++..+..+..+.
T Consensus 177 FGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~-~~~~~~~~~i~~~~~~~ 255 (308)
T d1p4oa_ 177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG-LSNEQVLRFVMEGGLLD 255 (308)
T ss_dssp TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTT-SCHHHHHHHHHTTCCCC
T ss_pred cccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHhCCCCC
Confidence 9999765432 1233468999999998864 5899999999999999999985 66655 67777777777766543
Q ss_pred ccccCCChhHHHHHHHhcC-CCCCCCCHHHHHc
Q 008504 145 SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 145 ~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLk 176 (563)
.+...++.+.+||.+||. +|.+|||+.++++
T Consensus 256 -~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 256 -KPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp -CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -CcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 455678899999999998 8999999999998
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=3.7e-32 Score=281.64 Aligned_cols=176 Identities=30% Similarity=0.406 Sum_probs=130.1
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
||||||.+|.+. .+ .+.+++..++.+++||+.||.|||++| |+||||||+|||++ .++.+|++|||+++.....
T Consensus 99 iv~Ey~~~~l~~-~~--~~~~~~~~i~~~~~qil~gl~~LH~~g--iiHrDlKP~Nil~~-~~~~~kl~df~~~~~~~~~ 172 (355)
T d2b1pa1 99 LVMELMDANLCQ-VI--QMELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTS 172 (355)
T ss_dssp EEEECCSEEHHH-HH--TSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTCCEEECCCCC-------
T ss_pred EEEeccchHHHH-hh--hcCCCHHHHHHHHHHHHHHHHHhhhcc--cccccCCccccccc-cccceeeechhhhhccccc
Confidence 589999775554 44 356999999999999999999999999 99999999999998 4579999999998765543
Q ss_pred -CCccccCCCCccCcccccc-cCCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHHHHHHhc-------------------
Q 008504 81 -TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS------------------- 139 (563)
Q Consensus 81 -~~~~~~Gtp~Y~APEvl~~-~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i~~~i~~------------------- 139 (563)
.....++|+.|+|||++.+ .++.++||||+||++|+|++|+.||.+... ......+..
T Consensus 173 ~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 251 (355)
T d2b1pa1 173 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY-IDQWNKVIEQLGTPCPEFMKKLQPTVRN 251 (355)
T ss_dssp --------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCCCCHHHHTTSCHHHHH
T ss_pred cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCH-HHHHHHHHHhccCCCHHHHHHhhhhHHH
Confidence 3345579999999998865 589999999999999999999999986433 222222111
Q ss_pred ---CCCCC-----------c-------cccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCcccccc
Q 008504 140 ---GIKPA-----------S-------LAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 183 (563)
Q Consensus 140 ---~~~p~-----------~-------l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~ 183 (563)
..... . .....++.+++||.+||. ||.+||||.|+|+||||+..
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~ 317 (355)
T d2b1pa1 252 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 317 (355)
T ss_dssp HHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred HhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 00000 0 001124578999999998 89999999999999999853
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.97 E-value=1.6e-31 Score=269.51 Aligned_cols=178 Identities=20% Similarity=0.324 Sum_probs=136.8
Q ss_pred CEeccCCCCCHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeC--CCCcEEEecccchhhc
Q 008504 1 MITELFTSGNLRQYRK-KHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG--NHGEVKIGDLGLAIAM 77 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~-k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~--~~G~VKL~DFGlA~~~ 77 (563)
+||||+. |+|.+++. ..+.+++..+..++.||+.||+|||++| |+||||||+|||++. ....+||+|||+|+..
T Consensus 80 ivme~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~ 156 (299)
T d1ckia_ 80 MVMELLG-PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 156 (299)
T ss_dssp EEEECCC-CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred EEEEEcC-CchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHhhccccccCCCceeeeeccCcceec
Confidence 5899995 56666554 4567999999999999999999999999 999999999999853 3457999999999765
Q ss_pred cCC---------CCccccCCCCccCccccccc-CCchhhHHHhHHHHHHHhhcCCCCCCCCCHHHH--HHHHhc---CCC
Q 008504 78 QQP---------TARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTFEYPYSECKNPAQI--FKKVTS---GIK 142 (563)
Q Consensus 78 ~~~---------~~~~~~Gtp~Y~APEvl~~~-ys~ksDIwSLGviLyELlTG~~Pf~~~~~~~~i--~~~i~~---~~~ 142 (563)
... ......||+.|||||++.+. |+.++|||||||++|||+||+.||......... ...... ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 236 (299)
T d1ckia_ 157 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 236 (299)
T ss_dssp BCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSC
T ss_pred cccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCC
Confidence 432 12345799999999988764 999999999999999999999999764332221 111111 112
Q ss_pred CCccccCCChhHHHHHHHhcC-CCCCCCCHH---HHHcCcccc
Q 008504 143 PASLAKVNDPQIKGFIEKCLV-PASERLSAK---DLLKDPFLQ 181 (563)
Q Consensus 143 p~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~---ELLkHpff~ 181 (563)
........++++.+||.+||. +|.+||++. ++|+|+|.+
T Consensus 237 ~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 237 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp HHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred hhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence 223345677899999999996 899999986 456777654
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.1e-31 Score=270.89 Aligned_cols=173 Identities=25% Similarity=0.378 Sum_probs=133.7
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC--------CCCeEeccCccCceEEeCCCCcEEEeccc
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSH--------NPPIIHRDLKCDNIFVNGNHGEVKIGDLG 72 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~--------gp~IIHrDLKP~NILLd~~~G~VKL~DFG 72 (563)
||||||++|+|.+++++. ++++..+..++.|++.||.|||+. | |+||||||+||||+ .+|.+||+|||
T Consensus 78 lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~--IvHrDlKp~NILl~-~~~~~Kl~DFG 153 (303)
T d1vjya_ 78 LVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA--IAHRDLKSKNILVK-KNGTCCIADLG 153 (303)
T ss_dssp EEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE--EECSCCCGGGEEEC-TTSCEEECCCT
T ss_pred EEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC--eeccccCccceEEc-CCCCeEEEecC
Confidence 589999999999999875 699999999999999999999974 6 99999999999998 55899999999
Q ss_pred chhhccCC------CCccccCCCCccCccccccc-------CCchhhHHHhHHHHHHHhhcCCCCCCC------------
Q 008504 73 LAIAMQQP------TARSVIGTPEFMAPELYEEE-------YNELVDIYSFGMCILEMVTFEYPYSEC------------ 127 (563)
Q Consensus 73 lA~~~~~~------~~~~~~Gtp~Y~APEvl~~~-------ys~ksDIwSLGviLyELlTG~~Pf~~~------------ 127 (563)
++...... ......||+.|+|||++.+. ++.++|||||||++|||+||..||...
T Consensus 154 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~ 233 (303)
T d1vjya_ 154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 233 (303)
T ss_dssp TCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred ccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccc
Confidence 99765432 22346799999999988642 677999999999999999998776321
Q ss_pred --CCHHHHHHHHhcCCCCCccccCC-----ChhHHHHHHHhcC-CCCCCCCHHHHHcC
Q 008504 128 --KNPAQIFKKVTSGIKPASLAKVN-----DPQIKGFIEKCLV-PASERLSAKDLLKD 177 (563)
Q Consensus 128 --~~~~~i~~~i~~~~~p~~l~~~~-----s~~l~~LI~kcL~-dP~kRpSa~ELLkH 177 (563)
.....+...+......+.++... ...+.+|+.+||+ +|.+|||+.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 234 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred ccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 12233333333332222222211 2358899999998 89999999999873
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.96 E-value=4.8e-30 Score=259.12 Aligned_cols=173 Identities=15% Similarity=0.249 Sum_probs=138.7
Q ss_pred CEeccCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeC----CCCcEEEecccchh
Q 008504 1 MITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG----NHGEVKIGDLGLAI 75 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~-~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~----~~G~VKL~DFGlA~ 75 (563)
+||||+ +|+|.+++... +.+++..+..++.|++.||.|||++| |+||||||+|||++. ..+.+||+|||+|+
T Consensus 78 ~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~g--iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~ 154 (293)
T d1csna_ 78 LVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 154 (293)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred EEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCC--ceeccCCccceeecCcccccCCceEEcccceeE
Confidence 589999 68999999765 46999999999999999999999999 999999999999963 24689999999997
Q ss_pred hccCC---------CCccccCCCCccCccccccc-CCchhhHHHhHHHHHHHhhcCCCCCCCC--CHHHHHHHHhcC---
Q 008504 76 AMQQP---------TARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTFEYPYSECK--NPAQIFKKVTSG--- 140 (563)
Q Consensus 76 ~~~~~---------~~~~~~Gtp~Y~APEvl~~~-ys~ksDIwSLGviLyELlTG~~Pf~~~~--~~~~i~~~i~~~--- 140 (563)
..... .....+||+.|||||++.+. ++.++|||||||++|+|+||..||.+.. .....+..+...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (293)
T d1csna_ 155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 234 (293)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred EcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCC
Confidence 65432 23346799999999988754 9999999999999999999999997532 333333333221
Q ss_pred CCCCccccCCChhHHHHHHHhcC-CCCCCCCHHHHHc
Q 008504 141 IKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 176 (563)
Q Consensus 141 ~~p~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLk 176 (563)
..+..+....++++.+|+..|+. +|.+||+++.+.+
T Consensus 235 ~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 235 TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp SCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred CChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 22233345567899999999996 8999999877654
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.95 E-value=1.3e-28 Score=253.09 Aligned_cols=165 Identities=25% Similarity=0.393 Sum_probs=123.8
Q ss_pred hCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEeccCccCceEEeCCC-----CcEEEecccchhhccCCCCccccCCCC
Q 008504 17 KHKNVDIKVIKNWARQILHGLVYLHS-HNPPIIHRDLKCDNIFVNGNH-----GEVKIGDLGLAIAMQQPTARSVIGTPE 90 (563)
Q Consensus 17 k~~~Lse~~i~~i~~QIL~aL~yLHs-~gp~IIHrDLKP~NILLd~~~-----G~VKL~DFGlA~~~~~~~~~~~~Gtp~ 90 (563)
....+++..++.++.||+.||.|||+ +| |+||||||+|||++.+. ..++|+|||.+..... .....+||+.
T Consensus 118 ~~~~~~~~~i~~i~~qil~al~~lh~~~~--IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~-~~~~~~gt~~ 194 (362)
T d1q8ya_ 118 EHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE-HYTNSIQTRE 194 (362)
T ss_dssp TTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTB-CCCSCCSCGG
T ss_pred cccCCcHHHHHHHHHHHHHHHHHHhhhcC--cccccCChhHeeeeccCcccccceeeEeeccccccccc-cccccccccc
Confidence 34679999999999999999999998 88 99999999999997432 1499999999875543 3345689999
Q ss_pred ccCccccc-ccCCchhhHHHhHHHHHHHhhcCCCCCCCCCH------HHHHHHHhc-CCC--------------------
Q 008504 91 FMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNP------AQIFKKVTS-GIK-------------------- 142 (563)
Q Consensus 91 Y~APEvl~-~~ys~ksDIwSLGviLyELlTG~~Pf~~~~~~------~~i~~~i~~-~~~-------------------- 142 (563)
|+|||++. ..|+.++||||+||++++|++|+.||...... ..+...+.. +..
T Consensus 195 y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~ 274 (362)
T d1q8ya_ 195 YRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGL 274 (362)
T ss_dssp GCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--C
T ss_pred ccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchh
Confidence 99999876 45999999999999999999999999642211 111111000 000
Q ss_pred C------------------CccccCCChhHHHHHHHhcC-CCCCCCCHHHHHcCccccccc
Q 008504 143 P------------------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 184 (563)
Q Consensus 143 p------------------~~l~~~~s~~l~~LI~kcL~-dP~kRpSa~ELLkHpff~~~~ 184 (563)
. .......++.+++||.+||. ||.+|||++|+|+||||+...
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp~f~~~~ 335 (362)
T d1q8ya_ 275 LRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTL 335 (362)
T ss_dssp BSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCT
T ss_pred hhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcCcccCCCC
Confidence 0 00111224679999999998 999999999999999998443
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.41 E-value=7e-15 Score=137.62 Aligned_cols=102 Identities=20% Similarity=0.229 Sum_probs=73.2
Q ss_pred CEeccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCccCceEEeCCCCcEEEecccchhhccCC
Q 008504 1 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 80 (563)
Q Consensus 1 LVmEy~~gGsL~~~L~k~~~Lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKP~NILLd~~~G~VKL~DFGlA~~~~~~ 80 (563)
|||||++++.+.+ ++...+..++.||+.||.|||++| |+||||||+|||++ + +.++|+|||+|.....+
T Consensus 87 lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~g--iiHrDiKP~NILv~-~-~~~~liDFG~a~~~~~~ 155 (191)
T d1zara2 87 VLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLVS-E-EGIWIIDFPQSVEVGEE 155 (191)
T ss_dssp EEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEE-T-TEEEECCCTTCEETTST
T ss_pred EEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCC--EEEccCChhheeee-C-CCEEEEECCCcccCCCC
Confidence 5899998865533 556667889999999999999999 99999999999998 3 36999999999665433
Q ss_pred CCccccC-CCCccCcccccccCCchhhHHHhHHHH
Q 008504 81 TARSVIG-TPEFMAPELYEEEYNELVDIYSFGMCI 114 (563)
Q Consensus 81 ~~~~~~G-tp~Y~APEvl~~~ys~ksDIwSLGviL 114 (563)
....... ... .-.+.+...|+.++|+||+.--+
T Consensus 156 ~~~~~l~rd~~-~~~~~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 156 GWREILERDVR-NIITYFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp THHHHHHHHHH-HHHHHHHHHHCCCCCHHHHHHHH
T ss_pred CcHHHHHHHHH-HHHHHHcCCCCCcccHHHHHHHH
Confidence 2221100 000 00133456789999999975433
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=94.50 E-value=0.013 Score=54.36 Aligned_cols=27 Identities=37% Similarity=0.427 Sum_probs=22.5
Q ss_pred eEeccCccCceEEeCCCCcEEEecccch
Q 008504 47 IIHRDLKCDNIFVNGNHGEVKIGDLGLA 74 (563)
Q Consensus 47 IIHrDLKP~NILLd~~~G~VKL~DFGlA 74 (563)
++|+|+.|.||+++ +.+.+-|+||+.+
T Consensus 185 l~HgD~~~~Nil~~-~~~~~~lIDwe~a 211 (263)
T d1j7la_ 185 FSHGDLGDSNIFVK-DGKVSGFIDLGRS 211 (263)
T ss_dssp EECSCCCTTSEEEE-TTEEEEECCCTTC
T ss_pred EEEeeccCcceeec-CCceEEEeechhc
Confidence 79999999999998 3334569999877
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=91.15 E-value=0.088 Score=52.60 Aligned_cols=27 Identities=37% Similarity=0.562 Sum_probs=23.2
Q ss_pred CeEeccCccCceEEeCCCCcEEEecccch
Q 008504 46 PIIHRDLKCDNIFVNGNHGEVKIGDLGLA 74 (563)
Q Consensus 46 ~IIHrDLKP~NILLd~~~G~VKL~DFGlA 74 (563)
.++|+|+.|.|||++++ .++|+||..+
T Consensus 224 ~LiHGDl~~gNIlv~~~--~~~vID~E~a 250 (392)
T d2pula1 224 TLIHGDLHTGSIFASEH--ETKVIDPEFA 250 (392)
T ss_dssp EEECSCCCGGGEEECSS--CEEECCCTTC
T ss_pred ceeccCCcCCceeEcCC--ceEEechhhc
Confidence 48999999999999743 5899999876
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=84.61 E-value=0.16 Score=48.34 Aligned_cols=28 Identities=36% Similarity=0.460 Sum_probs=23.6
Q ss_pred eEeccCccCceEEeCCCCcEEEecccchh
Q 008504 47 IIHRDLKCDNIFVNGNHGEVKIGDLGLAI 75 (563)
Q Consensus 47 IIHrDLKP~NILLd~~~G~VKL~DFGlA~ 75 (563)
+||+|+.++||+++++ +..-|.||+.+.
T Consensus 185 iIHgDl~~dNvl~~~~-~v~gvIDF~~~~ 212 (316)
T d2ppqa1 185 VIHADLFQDNVFFLGD-ELSGLIDFYFAC 212 (316)
T ss_dssp EECSCCCGGGEEEETT-EEEEECCCTTCE
T ss_pred cccCCcchhhhhcccc-cceeEecccccc
Confidence 9999999999999854 355799999873
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=82.55 E-value=0.54 Score=45.10 Aligned_cols=27 Identities=30% Similarity=0.287 Sum_probs=21.9
Q ss_pred CeEeccCccCceEEeCCCCcEEEecccchh
Q 008504 46 PIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 75 (563)
Q Consensus 46 ~IIHrDLKP~NILLd~~~G~VKL~DFGlA~ 75 (563)
.+||+|+.+.|||++ + | ..++||+-+.
T Consensus 193 ~liHgDlh~~NvL~~-~-~-~~~IDFdd~~ 219 (325)
T d1zyla1 193 LRLHGDCHAGNILWR-D-G-PMFVDLDDAR 219 (325)
T ss_dssp EECCSSCSGGGEEES-S-S-EEECCCTTCC
T ss_pred eeecCCCCcccEEEe-C-C-ceEEechhcc
Confidence 389999999999996 2 3 4589999774
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=81.11 E-value=0.31 Score=44.22 Aligned_cols=27 Identities=26% Similarity=0.182 Sum_probs=22.6
Q ss_pred eEeccCccCceEEeCCCCcEEEecccch
Q 008504 47 IIHRDLKCDNIFVNGNHGEVKIGDLGLA 74 (563)
Q Consensus 47 IIHrDLKP~NILLd~~~G~VKL~DFGlA 74 (563)
++|+|+.|.||++++ .+.+-|+||+.+
T Consensus 177 liHgD~~~~Nvl~~~-~~~~~iID~~~~ 203 (255)
T d1nd4a_ 177 VTHGDACLPNIMVEN-GRFSGFIDCGRL 203 (255)
T ss_dssp EECSSCCGGGEEEET-TEEEEECCCTTC
T ss_pred EEeCCCCCcceEEeC-CceEEEEEchhc
Confidence 799999999999984 335679999876
|